Citrus Sinensis ID: 010887
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 498 | 2.2.26 [Sep-21-2011] | |||||||
| Q8W4S5 | 614 | Probable LRR receptor-lik | yes | no | 0.961 | 0.780 | 0.704 | 0.0 | |
| C0LGX1 | 607 | Probable LRR receptor-lik | no | no | 0.949 | 0.779 | 0.556 | 1e-150 | |
| C0LGT1 | 613 | Probable LRR receptor-lik | no | no | 0.919 | 0.747 | 0.552 | 1e-149 | |
| Q94F62 | 615 | BRASSINOSTEROID INSENSITI | no | no | 0.929 | 0.752 | 0.490 | 1e-120 | |
| Q94AG2 | 625 | Somatic embryogenesis rec | no | no | 0.949 | 0.756 | 0.475 | 1e-118 | |
| Q93ZS4 | 632 | Protein NSP-INTERACTING K | no | no | 0.935 | 0.737 | 0.455 | 1e-117 | |
| Q8RY65 | 635 | Protein NSP-INTERACTING K | no | no | 0.889 | 0.697 | 0.463 | 1e-116 | |
| Q0WVM4 | 634 | Probable LRR receptor-lik | no | no | 0.929 | 0.730 | 0.471 | 1e-115 | |
| Q9LFS4 | 638 | Protein NSP-INTERACTING K | no | no | 0.907 | 0.708 | 0.458 | 1e-114 | |
| Q9SKG5 | 620 | Somatic embryogenesis rec | no | no | 0.909 | 0.730 | 0.461 | 1e-112 |
| >sp|Q8W4S5|Y5371_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g63710 OS=Arabidopsis thaliana GN=At5g63710 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 694 bits (1792), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 338/480 (70%), Positives = 407/480 (84%), Gaps = 1/480 (0%)
Query: 13 LMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVT 72
L+ + + + F+ S+ +PD+EG AL+++ +LND+ + W FVSPC+SWS+VT
Sbjct: 30 LILQCFMALAFVGITSSTTQPDIEGGALLQLRDSLNDSSNRL-KWTRDFVSPCYSWSYVT 88
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
CR +V++L L S+GF+G +SP+ITKLKFL +LELQ+N LSG LPD LG+M +LQ+LNL+
Sbjct: 89 CRGQSVVALNLASSGFTGTLSPAITKLKFLVTLELQNNSLSGALPDSLGNMVNLQTLNLS 148
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPCM 192
N FSGSIPA+WSQLSNLKHLDLSSNNLTG IP Q FS+ TF+F+GT LICG SL QPC
Sbjct: 149 VNSFSGSIPASWSQLSNLKHLDLSSNNLTGSIPTQFFSIPTFDFSGTQLICGKSLNQPCS 208
Query: 193 SRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCK 252
S PV++S+ KLR + +ASC A ++L LGA+ + ++R+ K+D+FFDVAGEDD K
Sbjct: 209 SSSRLPVTSSKKKLRDITLTASCVASIILFLGAMVMYHHHRVRRTKYDIFFDVAGEDDRK 268
Query: 253 VSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGE 312
+S QL+RFS RE+QLATD+F+ESN+IGQGGFGKVY+G+L D TKVAVKRL DY+SPGGE
Sbjct: 269 ISFGQLKRFSLREIQLATDSFNESNLIGQGGFGKVYRGLLPDKTKVAVKRLADYFSPGGE 328
Query: 313 AAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWP 372
AAFQRE+ LISVA+HKNLL+LIG+CTTSSERILVYP+M+NLSVAYRLRDLK GE+GLDWP
Sbjct: 329 AAFQREIQLISVAVHKNLLRLIGFCTTSSERILVYPYMENLSVAYRLRDLKAGEEGLDWP 388
Query: 373 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432
TRKRVAFG+A+GLEYLHE CNPKIIHRDLKAANILLD+NFE VL DFGLAKLVD LTHV
Sbjct: 389 TRKRVAFGSAHGLEYLHEHCNPKIIHRDLKAANILLDNNFEPVLGDFGLAKLVDTSLTHV 448
Query: 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH 492
TTQ+RGTMGHIAPEYL TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE++LLLDH
Sbjct: 449 TTQVRGTMGHIAPEYLCTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEENILLLDH 508
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGX1|Y5524_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g65240 OS=Arabidopsis thaliana GN=At5g65240 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 532 bits (1370), Expect = e-150, Method: Compositional matrix adjust.
Identities = 280/503 (55%), Positives = 350/503 (69%), Gaps = 30/503 (5%)
Query: 18 LILVIFLNFGH--SSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRN 75
L+++ L F SS PD +G+AL + +L + Q +DWN + V PC +WS V C +
Sbjct: 3 LLIITALVFSSLWSSVSPDAQGDALFALRSSLRASPEQLSDWNQNQVDPC-TWSQVICDD 61
Query: 76 G-NVISLTLG-------------------------SNGFSGKISPSITKLKFLASLELQD 109
+V S+TL NG G I SI L L SL+L+D
Sbjct: 62 KKHVTSVTLSYMNFSSGTLSSGIGILTTLKTLTLKGNGIMGGIPESIGNLSSLTSLDLED 121
Query: 110 NDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 169
N L+ +P LG++ +LQ L L+ N +GSIP + + LS L ++ L SNNL+G IP LF
Sbjct: 122 NHLTDRIPSTLGNLKNLQFLTLSRNNLNGSIPDSLTGLSKLINILLDSNNLSGEIPQSLF 181
Query: 170 SVATFNFTGTHLICGSSLEQPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFAC 229
+ +NFT +L CG + QPC++ SP +S K I+ S A +LL F C
Sbjct: 182 KIPKYNFTANNLSCGGTFPQPCVTESSPSGDSSSRKTGIIAGVVSGIAVILLGFFFFFFC 241
Query: 230 RYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYK 289
+ K + K DVF DVAGE D +++ QLRRF+ RELQLATD FSE N++GQGGFGKVYK
Sbjct: 242 K-DKHKGYKRDVFVDVAGEVDRRIAFGQLRRFAWRELQLATDEFSEKNVLGQGGFGKVYK 300
Query: 290 GVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349
G+LSD TKVAVKRL D+ PGG+ AFQREV +ISVA+H+NLL+LIG+CTT +ER+LVYPF
Sbjct: 301 GLLSDGTKVAVKRLTDFERPGGDEAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPF 360
Query: 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD 409
MQNLSVAY LR++KPG+ LDW RK++A G A GLEYLHE CNPKIIHRD+KAAN+LLD
Sbjct: 361 MQNLSVAYCLREIKPGDPVLDWFRRKQIALGAARGLEYLHEHCNPKIIHRDVKAANVLLD 420
Query: 410 DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLEL 469
++FEAV+ DFGLAKLVD + T+VTTQ+RGTMGHIAPE +STGKSSEKTDVFGYGI LLEL
Sbjct: 421 EDFEAVVGDFGLAKLVDVRRTNVTTQVRGTMGHIAPECISTGKSSEKTDVFGYGIMLLEL 480
Query: 470 VTGQRAIDFSRLEEEEDVLLLDH 492
VTGQRAIDFSRLEEE+DVLLLDH
Sbjct: 481 VTGQRAIDFSRLEEEDDVLLLDH 503
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGT1|Y5129_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g10290 OS=Arabidopsis thaliana GN=At5g10290 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 529 bits (1363), Expect = e-149, Method: Compositional matrix adjust.
Identities = 268/485 (55%), Positives = 341/485 (70%), Gaps = 27/485 (5%)
Query: 33 PDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGN-VISLTLGSNGFSGK 91
PD +G+AL + +L Q +DWN + V+PC +WS V C + N V SLTL FSG
Sbjct: 27 PDAQGDALFALRISLRALPNQLSDWNQNQVNPC-TWSQVICDDKNFVTSLTLSDMNFSGT 85
Query: 92 ISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLK 151
+S + L+ L +L L+ N ++G +P+ G++T L SL+L +N+ +G IP+T L L+
Sbjct: 86 LSSRVGILENLKTLTLKGNGITGEIPEDFGNLTSLTSLDLEDNQLTGRIPSTIGNLKKLQ 145
Query: 152 HLDLSSNNLTG------------------------RIPMQLFSVATFNFTGTHLICGSSL 187
L LS N L G +IP LF + +NFT +L CG
Sbjct: 146 FLTLSRNKLNGTIPESLTGLPNLLNLLLDSNSLSGQIPQSLFEIPKYNFTSNNLNCGGRQ 205
Query: 188 EQPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAG 247
PC+S + +S+ K I+ + VL + C+ + + + DVF DVAG
Sbjct: 206 PHPCVSAVAHSGDSSKPKTGIIAGVVAGVTVVLFGILLFLFCK-DRHKGYRRDVFVDVAG 264
Query: 248 EDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY 307
E D +++ QL+RF+ RELQLATDNFSE N++GQGGFGKVYKGVL DNTKVAVKRL D+
Sbjct: 265 EVDRRIAFGQLKRFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVAVKRLTDFE 324
Query: 308 SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEK 367
SPGG+AAFQREV +ISVA+H+NLL+LIG+CTT +ER+LVYPFMQNLS+A+RLR++K G+
Sbjct: 325 SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHRLREIKAGDP 384
Query: 368 GLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427
LDW TRKR+A G A G EYLHE CNPKIIHRD+KAAN+LLD++FEAV+ DFGLAKLVD
Sbjct: 385 VLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 444
Query: 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV 487
+ T+VTTQ+RGTMGHIAPEYLSTGKSSE+TDVFGYGI LLELVTGQRAIDFSRLEEE+DV
Sbjct: 445 RRTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV 504
Query: 488 LLLDH 492
LLLDH
Sbjct: 505 LLLDH 509
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 432 bits (1110), Expect = e-120, Method: Compositional matrix adjust.
Identities = 249/508 (49%), Positives = 325/508 (63%), Gaps = 45/508 (8%)
Query: 17 WLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNG 76
WLILV+ L S + EG+AL + +L D + W+ V+PC +W HVTC +
Sbjct: 12 WLILVLDLVLRVSG---NAEGDALSALKNSLADPNKVLQSWDATLVTPC-TWFHVTCNSD 67
Query: 77 N-VISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
N V + LG+ SG++ + +L L LEL N+++GT+P+ LG++T L SL+L N
Sbjct: 68 NSVTRVDLGNANLSGQLVMQLGQLPNLQYLELYSNNITGTIPEQLGNLTELVSLDLYLNN 127
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFN--------FTGTHLICGS-S 186
SG IP+T +L L+ L L++N+L+G IP L +V T TG + GS S
Sbjct: 128 LSGPIPSTLGRLKKLRFLRLNNNSLSGEIPRSLTAVLTLQVLDLSNNPLTGDIPVNGSFS 187
Query: 187 LEQPCMSRPSPPVSTSRTKL----------------------RIVVASASCGAFVLLSLG 224
L P+S + TKL RI A A A L
Sbjct: 188 L--------FTPISFANTKLTPLPASPPPPISPTPPSPAGSNRITGAIAGGVAAGAALLF 239
Query: 225 ALFACRYQKLRKLK-HDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGG 283
A+ A R+ K D FFDV E+D +V L QL+RFS RELQ+A+DNFS NI+G+GG
Sbjct: 240 AVPAIALAWWRRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGG 299
Query: 284 FGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343
FGKVYKG L+D T VAVKRL++ + GGE FQ EV +IS+A+H+NLL+L G+C T +ER
Sbjct: 300 FGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 359
Query: 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKA 403
+LVYP+M N SVA LR+ + LDWP R+R+A G+A GL YLH+ C+PKIIHRD+KA
Sbjct: 360 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKA 419
Query: 404 ANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYG 463
ANILLD+ FEAV+ DFGLAKL+D K THVTT +RGT+GHIAPEYLSTGKSSEKTDVFGYG
Sbjct: 420 ANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG 479
Query: 464 ITLLELVTGQRAIDFSRLEEEEDVLLLD 491
+ LLEL+TGQRA D +RL ++DV+LLD
Sbjct: 480 VMLLELITGQRAFDLARLANDDDVMLLD 507
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94AG2|SERK1_ARATH Somatic embryogenesis receptor kinase 1 OS=Arabidopsis thaliana GN=SERK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 426 bits (1094), Expect = e-118, Method: Compositional matrix adjust.
Identities = 243/511 (47%), Positives = 317/511 (62%), Gaps = 38/511 (7%)
Query: 18 LILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGN 77
L L++ N ++EG+AL + L D + W+ V+PC +W HVTC N N
Sbjct: 11 LSLILLPNHSLWLASANLEGDALHTLRVTLVDPNNVLQSWDPTLVNPC-TWFHVTCNNEN 69
Query: 78 -VISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
VI + LG+ SG + P + LK L LEL N+++G +P LG++T+L SL+L N F
Sbjct: 70 SVIRVDLGNAELSGHLVPELGVLKNLQYLELYSNNITGPIPSNLGNLTNLVSLDLYLNSF 129
Query: 137 SGSIPATWSQLSNLKHL------------------------DLSSNNLTGRIPMQ-LFSV 171
SG IP + +LS L+ L DLS+N L+G +P FS+
Sbjct: 130 SGPIPESLGKLSKLRFLRLNNNSLTGSIPMSLTNITTLQVLDLSNNRLSGSVPDNGSFSL 189
Query: 172 AT-FNFTGTHLICGSSLEQPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACR 230
T +F +CG PC P + V + G ++ G
Sbjct: 190 FTPISFANNLDLCGPVTSHPCPGSPPFSPPPPFIQPPPVSTPSGYGITGAIAGGVAAGAA 249
Query: 231 YQKL----------RKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIG 280
R+ D+FFDV E+D +V L QL+RFS RELQ+A+D FS NI+G
Sbjct: 250 LLFAAPAIAFAWWRRRKPLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILG 309
Query: 281 QGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS 340
+GGFGKVYKG L+D T VAVKRL++ +PGGE FQ EV +IS+A+H+NLL+L G+C T
Sbjct: 310 RGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 369
Query: 341 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRD 400
+ER+LVYP+M N SVA LR+ P + LDWPTRKR+A G+A GL YLH+ C+PKIIHRD
Sbjct: 370 TERLLVYPYMANGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRD 429
Query: 401 LKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVF 460
+KAANILLD+ FEAV+ DFGLAKL+D K THVTT +RGT+GHIAPEYLSTGKSSEKTDVF
Sbjct: 430 VKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVF 489
Query: 461 GYGITLLELVTGQRAIDFSRLEEEEDVLLLD 491
GYGI LLEL+TGQRA D +RL ++DV+LLD
Sbjct: 490 GYGIMLLELITGQRAFDLARLANDDDVMLLD 520
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Phosphorylates BRI1 on 'Ser-887' and CDC48 on at least one threonine residue and on 'Ser-41'. Confers embryogenic competence. Acts redundantly with SERK2 as a control point for sporophytic development controlling male gametophyte production. Involved in the brassinolide signaling pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 421 bits (1081), Expect = e-117, Method: Compositional matrix adjust.
Identities = 233/512 (45%), Positives = 321/512 (62%), Gaps = 46/512 (8%)
Query: 17 WLILVIFLNFGHSSREP---DVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTC 73
+L+ V F + ++ P + E AL+ V LND + +W+ + V PC SW V+C
Sbjct: 13 FLVFVWFFDISSATLSPTGVNYEVTALVAVKNELNDPYKVLENWDVNSVDPC-SWRMVSC 71
Query: 74 RNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLAN 133
+G V SL L S SG +SP I L +L S+ LQ+N ++G +P+ +G + LQSL+L+N
Sbjct: 72 TDGYVSSLDLPSQSLSGTLSPRIGNLTYLQSVVLQNNAITGPIPETIGRLEKLQSLDLSN 131
Query: 134 NKFSGSIPATW------------------------SQLSNLKHLDLSSNNLTGRIPMQLF 169
N F+G IPA+ S++ L +D+S NNL+G +P
Sbjct: 132 NSFTGEIPASLGELKNLNYLRLNNNSLIGTCPESLSKIEGLTLVDISYNNLSGSLPK--V 189
Query: 170 SVATFNFTGTHLICGSSLEQPCMSRPSPPV--------STSRTKLRIVVASASCGAFVLL 221
S TF G LICG C + P P S +RT V + +
Sbjct: 190 SARTFKVIGNALICGPKAVSNCSAVPEPLTLPQDGPDESGTRTNGHHVALAFAASFSAAF 249
Query: 222 ----SLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESN 277
+ G RY++ ++ +FFDV + D +VSL L+R++ +EL+ AT++F+ N
Sbjct: 250 FVFFTSGMFLWWRYRRNKQ----IFFDVNEQYDPEVSLGHLKRYTFKELRSATNHFNSKN 305
Query: 278 IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
I+G+GG+G VYKG L+D T VAVKRL+D GGE FQ EV IS+A+H+NLL+L G+C
Sbjct: 306 ILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFC 365
Query: 338 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 397
+++ ERILVYP+M N SVA RL+D GE LDW RK++A GTA GL YLHEQC+PKII
Sbjct: 366 SSNQERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKII 425
Query: 398 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 457
HRD+KAANILLD++FEAV+ DFGLAKL+D + +HVTT +RGT+GHIAPEYLSTG+SSEKT
Sbjct: 426 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 485
Query: 458 DVFGYGITLLELVTGQRAIDFSRLEEEEDVLL 489
DVFG+GI LLEL+TGQ+A+DF R ++ V+L
Sbjct: 486 DVFGFGILLLELITGQKALDFGRSAHQKGVML 517
|
Involved in defense response to geminivirus infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 417 bits (1073), Expect = e-116, Method: Compositional matrix adjust.
Identities = 226/488 (46%), Positives = 308/488 (63%), Gaps = 45/488 (9%)
Query: 39 ALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITK 98
ALI + +L D HG +W+D V PC SW+ +TC +G VI L S SG +S SI
Sbjct: 45 ALIGIKSSLTDPHGVLMNWDDTAVDPC-SWNMITCSDGFVIRLEAPSQNLSGTLSSSIGN 103
Query: 99 LKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSN 158
L L ++ LQ+N ++G +P +G + L++L+L+ N F+G IP T S NL++L +++N
Sbjct: 104 LTNLQTVLLQNNYITGNIPHEIGKLMKLKTLDLSTNNFTGQIPFTLSYSKNLQYLRVNNN 163
Query: 159 NLTGRIPMQLFSVA----------------------TFNFTGTHLICGSSLEQPCMSRPS 196
+LTG IP L ++ TFN G IC + E+ C
Sbjct: 164 SLTGTIPSSLANMTQLTFLDLSYNNLSGPVPRSLAKTFNVMGNSQICPTGTEKDCNGTQP 223
Query: 197 PPVS--------------TSRTKLRIVVA-SASCGAFVLLSLGALFACRYQKLRKLKHDV 241
P+S T K+ +V S +C +++ G L + + R K +
Sbjct: 224 KPMSITLNSSQNKSSDGGTKNRKIAVVFGVSLTCVCLLIIGFGFLL---WWRRRHNKQVL 280
Query: 242 FFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVK 301
FFD+ ++ ++ L LRRF+ +ELQ AT NFS N++G+GGFG VYKG L D + +AVK
Sbjct: 281 FFDINEQNKEEMCLGNLRRFNFKELQSATSNFSSKNLVGKGGFGNVYKGCLHDGSIIAVK 340
Query: 302 RLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD 361
RL+D + GGE FQ E+ +IS+A+H+NLL+L G+CTTSSER+LVYP+M N SVA RL+
Sbjct: 341 RLKDINNGGGEVQFQTELEMISLAVHRNLLRLYGFCTTSSERLLVYPYMSNGSVASRLK- 399
Query: 362 LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421
KP LDW TRKR+A G GL YLHEQC+PKIIHRD+KAANILLDD FEAV+ DFGL
Sbjct: 400 AKPV---LDWGTRKRIALGAGRGLLYLHEQCDPKIIHRDVKAANILLDDYFEAVVGDFGL 456
Query: 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRL 481
AKL+D + +HVTT +RGT+GHIAPEYLSTG+SSEKTDVFG+GI LLEL+TG RA++F +
Sbjct: 457 AKLLDHEESHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRALEFGKA 516
Query: 482 EEEEDVLL 489
+ +L
Sbjct: 517 ANQRGAIL 524
|
Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0WVM4|Y2239_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g23950 OS=Arabidopsis thaliana GN=At2g23950 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 416 bits (1069), Expect = e-115, Method: Compositional matrix adjust.
Identities = 238/505 (47%), Positives = 321/505 (63%), Gaps = 42/505 (8%)
Query: 18 LILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGN 77
L+L F+ SS + E EALI + L+D HG F +W++ V PC SW+ ++C + N
Sbjct: 16 LLLCFFVTCSLSSEPRNPEVEALINIKNELHDPHGVFKNWDEFSVDPC-SWTMISCSSDN 74
Query: 78 -VISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
VI L S SG +S SI L L + LQ+N++SG +P + S+ LQ+L+L+NN+F
Sbjct: 75 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVSLQNNNISGKIPPEICSLPKLQTLDLSNNRF 134
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL----------------------FSVATF 174
SG IP + +QLSNL++L L++N+L+G P L F TF
Sbjct: 135 SGEIPGSVNQLSNLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLRGPVPKFPARTF 194
Query: 175 NFTGTHLICGSSLEQPCM-SRPSPPVSTS-------RTKLRIVVASASCG--AFVLLSLG 224
N G LIC +SL + C S + P+S S RT + V S G V+LSLG
Sbjct: 195 NVAGNPLICKNSLPEICSGSISASPLSVSLRSSSGRRTNILAVALGVSLGFAVSVILSLG 254
Query: 225 ALFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGF 284
F +K R+L D +++ + L LR F+ REL +ATD FS +I+G GGF
Sbjct: 255 --FIWYRKKQRRLTMLRISD--KQEEGLLGLGNLRSFTFRELHVATDGFSSKSILGAGGF 310
Query: 285 GKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344
G VY+G D T VAVKRL+D G + F+ E+ +IS+A+H+NLL+LIGYC +SSER+
Sbjct: 311 GNVYRGKFGDGTVVAVKRLKDVNGTSGNSQFRTELEMISLAVHRNLLRLIGYCASSSERL 370
Query: 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAA 404
LVYP+M N SVA RL+ KP LDW TRK++A G A GL YLHEQC+PKIIHRD+KAA
Sbjct: 371 LVYPYMSNGSVASRLKA-KPA---LDWNTRKKIAIGAARGLFYLHEQCDPKIIHRDVKAA 426
Query: 405 NILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGI 464
NILLD+ FEAV+ DFGLAKL++ + +HVTT +RGT+GHIAPEYLSTG+SSEKTDVFG+GI
Sbjct: 427 NILLDEYFEAVVGDFGLAKLLNHEDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGI 486
Query: 465 TLLELVTGQRAIDFSRLEEEEDVLL 489
LLEL+TG RA++F + ++ +L
Sbjct: 487 LLLELITGMRALEFGKSVSQKGAML 511
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFS4|NIK1_ARATH Protein NSP-INTERACTING KINASE 1 OS=Arabidopsis thaliana GN=NIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 413 bits (1062), Expect = e-114, Method: Compositional matrix adjust.
Identities = 229/500 (45%), Positives = 316/500 (63%), Gaps = 48/500 (9%)
Query: 29 SSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGN-VISLTLGSNG 87
S + + E +AL+++ +L+D HG +W+ V PC SW+ VTC + N VI L S
Sbjct: 34 SPKGVNFEVQALMDIKASLHDPHGVLDNWDRDAVDPC-SWTMVTCSSENFVIGLGTPSQN 92
Query: 88 FSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQL 147
SG +SPSIT L L + LQ+N++ G +P +G +T L++L+L++N F G IP + L
Sbjct: 93 LSGTLSPSITNLTNLRIVLLQNNNIKGKIPAEIGRLTRLETLDLSDNFFHGEIPFSVGYL 152
Query: 148 SNLKHLDLSSNNLTGRIPMQL----------------------FSVATFNFTGTHLICGS 185
+L++L L++N+L+G P+ L F+ TF+ G LIC +
Sbjct: 153 QSLQYLRLNNNSLSGVFPLSLSNMTQLAFLDLSYNNLSGPVPRFAAKTFSIVGNPLICPT 212
Query: 186 SLEQPCMSRPSPPVST-------------SRTKLRIVVASASCG--AFVLLSLGALFACR 230
E C P+S SR + +S G + + +++G R
Sbjct: 213 GTEPDCNGTTLIPMSMNLNQTGVPLYAGGSRNHKMAIAVGSSVGTVSLIFIAVGLFLWWR 272
Query: 231 YQKLRKLKHDVFFDVA-GEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYK 289
++ + FFDV G +VSL LRRF RELQ+AT+NFS N++G+GG+G VYK
Sbjct: 273 ----QRHNQNTFFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYK 328
Query: 290 GVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349
G+L D+T VAVKRL+D + GGE FQ EV +IS+A+H+NLL+L G+C T +E++LVYP+
Sbjct: 329 GILGDSTVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPY 388
Query: 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD 409
M N SVA R++ KP LDW RKR+A G A GL YLHEQC+PKIIHRD+KAANILLD
Sbjct: 389 MSNGSVASRMK-AKPV---LDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLD 444
Query: 410 DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLEL 469
D EAV+ DFGLAKL+D + +HVTT +RGT+GHIAPEYLSTG+SSEKTDVFG+GI LLEL
Sbjct: 445 DYCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL 504
Query: 470 VTGQRAIDFSRLEEEEDVLL 489
VTGQRA +F + ++ V+L
Sbjct: 505 VTGQRAFEFGKAANQKGVML 524
|
Involved in defense response to geminivirus infection via regulation of the nuclear trafficking of RPL10A. Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 405 bits (1042), Expect = e-112, Method: Compositional matrix adjust.
Identities = 225/488 (46%), Positives = 309/488 (63%), Gaps = 35/488 (7%)
Query: 34 DVEGEALIEVLKAL---NDTHGQFTDWNDHFVSPCFSWSHVTCRNGN-VISLTLGSNGFS 89
+ EG+AL ++ +L + + W+ V+PC +W HVTC N V + LG+ S
Sbjct: 30 NAEGDALTQLKNSLSSGDPANNVLQSWDATLVTPC-TWFHVTCNPENKVTRVDLGNAKLS 88
Query: 90 GKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSN 149
GK+ P + +L L LEL N+++G +P+ LG + L SL+L N SG IP++ +L
Sbjct: 89 GKLVPELGQLLNLQYLELYSNNITGEIPEELGDLVELVSLDLYANSISGPIPSSLGKLGK 148
Query: 150 LKHLDLSSNNLTGRIPM-------QLFSVATFNFTGTHLICGSSLEQPCMSRPSPPVSTS 202
L+ L L++N+L+G IPM Q+ ++ +G + GS + P + S
Sbjct: 149 LRFLRLNNNSLSGEIPMTLTSVQLQVLDISNNRLSGDIPVNGSF----SLFTPISFANNS 204
Query: 203 RTKL------------------RIVVASASCGAFVLLSLGALFACRYQK-LRKLKHDVFF 243
T L ++ A A A L A+ A + LR+ D FF
Sbjct: 205 LTDLPEPPPTSTSPTPPPPSGGQMTAAIAGGVAAGAALLFAVPAIAFAWWLRRKPQDHFF 264
Query: 244 DVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRL 303
DV E+D +V L QL+RF+ REL +ATDNFS N++G+GGFGKVYKG L+D VAVKRL
Sbjct: 265 DVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLADGNLVAVKRL 324
Query: 304 QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK 363
++ + GGE FQ EV +IS+A+H+NLL+L G+C T +ER+LVYP+M N SVA LR+
Sbjct: 325 KEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 384
Query: 364 PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423
G LDWP RK +A G+A GL YLH+ C+ KIIHRD+KAANILLD+ FEAV+ DFGLAK
Sbjct: 385 EGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAVVGDFGLAK 444
Query: 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEE 483
L++ +HVTT +RGT+GHIAPEYLSTGKSSEKTDVFGYG+ LLEL+TGQ+A D +RL
Sbjct: 445 LMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLAN 504
Query: 484 EEDVLLLD 491
++D++LLD
Sbjct: 505 DDDIMLLD 512
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 498 | ||||||
| 359480667 | 621 | PREDICTED: probable LRR receptor-like se | 0.959 | 0.769 | 0.762 | 0.0 | |
| 255568877 | 598 | ATP binding protein, putative [Ricinus c | 0.983 | 0.819 | 0.737 | 0.0 | |
| 356512884 | 596 | PREDICTED: probable LRR receptor-like se | 0.969 | 0.810 | 0.735 | 0.0 | |
| 356527105 | 595 | PREDICTED: probable LRR receptor-like se | 0.969 | 0.811 | 0.728 | 0.0 | |
| 224126743 | 595 | predicted protein [Populus trichocarpa] | 0.955 | 0.8 | 0.744 | 0.0 | |
| 224060473 | 594 | predicted protein [Populus trichocarpa] | 0.961 | 0.806 | 0.731 | 0.0 | |
| 357520193 | 597 | Plasma membrane receptor-like kinase [Me | 0.971 | 0.810 | 0.719 | 0.0 | |
| 297793957 | 614 | hypothetical protein ARALYDRAFT_496559 [ | 0.981 | 0.796 | 0.692 | 0.0 | |
| 10177052 | 579 | receptor-like protein kinase [Arabidopsi | 0.941 | 0.810 | 0.717 | 0.0 | |
| 18424740 | 614 | Leucine-rich repeat protein kinase famil | 0.961 | 0.780 | 0.704 | 0.0 |
| >gi|359480667|ref|XP_002272767.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g63710-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 763 bits (1969), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/481 (76%), Positives = 415/481 (86%), Gaps = 3/481 (0%)
Query: 2 FGALHKCC--PPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWND 59
FG L CC P L+ WLIL + L F +SS PDVEGEAL++ LK LND++ + TDWND
Sbjct: 27 FGLL-SCCLVPLKLILSWLILFVMLRFSYSSNGPDVEGEALVDFLKTLNDSNNRITDWND 85
Query: 60 HFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDF 119
HFVSPCFSWS+VTCRNGNVISL+L S GFSG +SPSITKLKFLASL+L+DN+LSG LPD+
Sbjct: 86 HFVSPCFSWSNVTCRNGNVISLSLASKGFSGTLSPSITKLKFLASLDLKDNNLSGALPDY 145
Query: 120 LGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGT 179
L SM +LQ+L+LA N FSGSIP++W QLSN+KHLDLSSN+LTGRIP QLFSV TFNFTG
Sbjct: 146 LSSMINLQNLDLARNNFSGSIPSSWGQLSNIKHLDLSSNDLTGRIPEQLFSVPTFNFTGN 205
Query: 180 HLICGSSLEQPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKH 239
L CGSSL+QPC S + PVST ++KLR+V A C AF+LLSLGA+FA RY K+K
Sbjct: 206 RLTCGSSLQQPCASGSTIPVSTKKSKLRVVTPVAICAAFILLSLGAIFAYRYCYAHKIKR 265
Query: 240 DVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVA 299
DVF DV GED+CK+S Q+RRFS ELQLATD FSESNIIGQGGFGKVY+GVL + TKVA
Sbjct: 266 DVFHDVTGEDECKISFGQVRRFSWHELQLATDEFSESNIIGQGGFGKVYRGVLPNGTKVA 325
Query: 300 VKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRL 359
VKRL DY++PGGEAAFQREV LISVA+HKNLL+LIG+CTT +ERILVYPFMQNLSVAYRL
Sbjct: 326 VKRLSDYHNPGGEAAFQREVQLISVAVHKNLLRLIGFCTTFNERILVYPFMQNLSVAYRL 385
Query: 360 RDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 419
RDLKPGE+GLDWPTR++VAFG A+GLEYLHE CNPKIIHRDLKAANILLDD+FE VL DF
Sbjct: 386 RDLKPGERGLDWPTRRKVAFGAAHGLEYLHEHCNPKIIHRDLKAANILLDDDFEPVLGDF 445
Query: 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479
GLAKL+D KLTHVTTQ+RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS
Sbjct: 446 GLAKLLDTKLTHVTTQVRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 505
Query: 480 R 480
R
Sbjct: 506 R 506
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255568877|ref|XP_002525409.1| ATP binding protein, putative [Ricinus communis] gi|223535300|gb|EEF36976.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 756 bits (1952), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/492 (73%), Positives = 424/492 (86%), Gaps = 2/492 (0%)
Query: 1 MFGALHKCCPPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDH 60
MFGA P L+ LIL+ FL G+ S++PD+EGEALI++L ALND++ + DWN +
Sbjct: 6 MFGAASIWHPLKLVISCLILLNFLCVGYPSKDPDLEGEALIQLLSALNDSNHRVEDWNYY 65
Query: 61 FVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFL 120
VSPCFSWSH+TCRNGNVISL+L +NGFSG +SP+ITKL+FL +LELQ+N+LSG LPD+L
Sbjct: 66 LVSPCFSWSHITCRNGNVISLSLAANGFSGTLSPAITKLRFLVNLELQNNNLSGPLPDYL 125
Query: 121 GSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTH 180
GS+THL++LNLA+NKF GSIP W +L NLKHLD+SSNNLTGR+P Q FSV FNFT T
Sbjct: 126 GSLTHLENLNLASNKFHGSIPIAWGKLFNLKHLDISSNNLTGRVPKQFFSVPEFNFTETS 185
Query: 181 LICGSSLEQPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHD 240
L CGS LE+PC+S+ PVS ++++L I+V +ASCGAF+L LG FA R+ +LR+LK+D
Sbjct: 186 LTCGSRLEEPCVSKSPSPVSPNKSRLSIIVIAASCGAFILFLLG--FAYRHHRLRRLKND 243
Query: 241 VFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAV 300
VF DVAGEDD K+SL Q++RFS RE+QLATDNFS+SNIIGQGGFGKVYKGVLSDNTKVAV
Sbjct: 244 VFVDVAGEDDRKISLGQIKRFSWREIQLATDNFSDSNIIGQGGFGKVYKGVLSDNTKVAV 303
Query: 301 KRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLR 360
KRL D Y PGGEAAF REV +ISVA+H+NLL+LIG+CTTSSERILVYP+MQNLSVA+ LR
Sbjct: 304 KRLSDCYIPGGEAAFHREVQIISVAVHRNLLRLIGFCTTSSERILVYPYMQNLSVAFHLR 363
Query: 361 DLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420
+LKPGE GLDW TR+RVAFG A+GLEYLHE CNPKIIHRDLKAANILLDDNFEAVL DFG
Sbjct: 364 ELKPGETGLDWQTRRRVAFGAAHGLEYLHEHCNPKIIHRDLKAANILLDDNFEAVLGDFG 423
Query: 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480
LA+LVD KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYG+TLLELV G+RAID SR
Sbjct: 424 LARLVDTKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGVTLLELVNGKRAIDLSR 483
Query: 481 LEEEEDVLLLDH 492
L EEEDVLLLDH
Sbjct: 484 LAEEEDVLLLDH 495
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356512884|ref|XP_003525144.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g63710-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 742 bits (1915), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/484 (73%), Positives = 412/484 (85%), Gaps = 1/484 (0%)
Query: 10 PPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWS 69
P ++T+WLI + L G + ++PDVEGEAL++VL LND++ Q TDW+ VSPCFSWS
Sbjct: 10 PLKILTRWLIFLTILQVGCAIKDPDVEGEALLDVLHFLNDSNKQITDWDSFLVSPCFSWS 69
Query: 70 HVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSL 129
HVTCRNG+VISL L S GFSG +SPSITKLK+L+SLELQ+N+LSG LPD++ ++T LQ L
Sbjct: 70 HVTCRNGHVISLALASVGFSGTLSPSITKLKYLSSLELQNNNLSGPLPDYISNLTELQYL 129
Query: 130 NLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQ 189
NLA+N F+GSIPA W +L NLKHLDLSSN LTG IPMQLFSV FNF+ THL CG EQ
Sbjct: 130 NLADNSFNGSIPANWGELPNLKHLDLSSNGLTGSIPMQLFSVPLFNFSDTHLQCGPGFEQ 189
Query: 190 PCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRY-QKLRKLKHDVFFDVAGE 248
C S+ P S ++KL +V ASCGAF LL LGA+F R+ +K + DVF DV+GE
Sbjct: 190 SCASKSENPASAHKSKLAKIVRYASCGAFALLCLGAIFTYRHHRKHWRKSDDVFVDVSGE 249
Query: 249 DDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS 308
D+ K+ QLRRFS RELQLAT NFSE N+IGQGGFGKVYKGVLSDNTKVAVKRL DY++
Sbjct: 250 DESKIFFGQLRRFSWRELQLATKNFSEGNVIGQGGFGKVYKGVLSDNTKVAVKRLIDYHN 309
Query: 309 PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG 368
PGGEAAF+REV LISVA+H+NLL+LIG+CTT++ERILVYPFM+NLSVAYRLRDLKPGEKG
Sbjct: 310 PGGEAAFEREVQLISVAVHRNLLRLIGFCTTTTERILVYPFMENLSVAYRLRDLKPGEKG 369
Query: 369 LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428
LDWPTRKRVAFGTA+GLEYLHEQCNPKIIHRDLKAANILLDD FEAVL DFGLAKLVDA+
Sbjct: 370 LDWPTRKRVAFGTAHGLEYLHEQCNPKIIHRDLKAANILLDDEFEAVLGDFGLAKLVDAR 429
Query: 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 488
+THVTTQ+RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG+RAID SRLEE+EDVL
Sbjct: 430 MTHVTTQVRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGERAIDLSRLEEDEDVL 489
Query: 489 LLDH 492
L+D+
Sbjct: 490 LIDY 493
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356527105|ref|XP_003532154.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g63710-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 739 bits (1907), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 352/483 (72%), Positives = 409/483 (84%)
Query: 10 PPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWS 69
P ++T+WLI + L + ++PDVEGEAL+++L LND++ Q TDW+ VSPCFSWS
Sbjct: 10 PLKILTRWLIFLTILQVSCAIKDPDVEGEALLDLLHFLNDSNKQITDWDSFLVSPCFSWS 69
Query: 70 HVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSL 129
HVTCRNG+VISL L S GFSG +SPSI KLK+L+SLELQ+N+LSG LPD++ ++T LQ L
Sbjct: 70 HVTCRNGHVISLALASVGFSGTLSPSIIKLKYLSSLELQNNNLSGPLPDYISNLTELQYL 129
Query: 130 NLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQ 189
NLA+N F+GSIPA W ++ NLKHLDLSSN LTG IP QLFSV FNFT T L CG EQ
Sbjct: 130 NLADNNFNGSIPAKWGEVPNLKHLDLSSNGLTGSIPKQLFSVPLFNFTDTQLQCGPGFEQ 189
Query: 190 PCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGED 249
PC S+ P S ++KL +V ASCGAF LL LGA+F R + + K DVF DV+GED
Sbjct: 190 PCASKSENPASAHKSKLAKIVRYASCGAFALLCLGAIFTYRQHQKHRRKIDVFVDVSGED 249
Query: 250 DCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP 309
+ K+S QLRRFS RELQLAT NFSE N+IGQGGFGKVYKGVLSDNTKVAVKRL DY++P
Sbjct: 250 ERKISFGQLRRFSWRELQLATKNFSEGNVIGQGGFGKVYKGVLSDNTKVAVKRLIDYHNP 309
Query: 310 GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL 369
GGEAAF+REV LISVA+H+NLL+LIG+CTT++ERILVYPFM+NLSVAYRLRDLKPGEKGL
Sbjct: 310 GGEAAFEREVQLISVAVHRNLLRLIGFCTTTTERILVYPFMENLSVAYRLRDLKPGEKGL 369
Query: 370 DWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429
DWPTRKRVAFGTA+GLEYLHEQCNPKIIHRDLKAANILLDD FEAVL DFGLAKLVDA++
Sbjct: 370 DWPTRKRVAFGTAHGLEYLHEQCNPKIIHRDLKAANILLDDEFEAVLGDFGLAKLVDARM 429
Query: 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL 489
THVTTQ+RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG+RA+D SRLEE+EDVLL
Sbjct: 430 THVTTQVRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGERALDLSRLEEDEDVLL 489
Query: 490 LDH 492
+D+
Sbjct: 490 IDY 492
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224126743|ref|XP_002329462.1| predicted protein [Populus trichocarpa] gi|222870142|gb|EEF07273.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 731 bits (1887), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/477 (74%), Positives = 405/477 (84%), Gaps = 1/477 (0%)
Query: 1 MFGALHKCCPPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDH 60
MFG P L+ LIL+ FL S++EPD EG AL ++L ALND++ Q +W+ +
Sbjct: 1 MFGVFSLWNPLKLVINCLILLNFLKITISTKEPDTEGNALRDLLLALNDSNRQI-NWDTN 59
Query: 61 FVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFL 120
VSPCFSW+HV CRNG+V SL+L S GFSG +SP+I KL+FL +LELQ+N LSG LPD+L
Sbjct: 60 LVSPCFSWTHVICRNGHVESLSLNSLGFSGTLSPAIMKLEFLVTLELQNNSLSGPLPDYL 119
Query: 121 GSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTH 180
G+M HLQ+LNLA+NKFSGSIP TW QLSNLK+LDLSSNNLTGRIP +LFSVA FNFT TH
Sbjct: 120 GNMVHLQNLNLASNKFSGSIPTTWGQLSNLKNLDLSSNNLTGRIPGKLFSVAMFNFTATH 179
Query: 181 LICGSSLEQPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHD 240
L CG SLE+PC+S VSTS+++L+++ SASCGAF+LL L A+ A RY + K K+D
Sbjct: 180 LACGLSLEEPCISGSPLRVSTSKSRLKVIATSASCGAFILLILVAVLAYRYHQFHKEKND 239
Query: 241 VFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAV 300
+F DVAGEDD K++ QLRRFS RELQLATDNFSESNIIGQGG GKVYKG+LSDN KVAV
Sbjct: 240 IFVDVAGEDDRKITFGQLRRFSWRELQLATDNFSESNIIGQGGCGKVYKGILSDNMKVAV 299
Query: 301 KRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLR 360
KRL DYYSPGGEAAFQREV LISVA HKNLL+L+G+CTTSSERILVYP+MQNLSVAYRLR
Sbjct: 300 KRLADYYSPGGEAAFQREVQLISVAFHKNLLKLVGFCTTSSERILVYPYMQNLSVAYRLR 359
Query: 361 DLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420
+LKPGEKGLDWPTRK++AFG A+GLEYLHE CNPKIIHRDLKAANILLDDNFEAVL DFG
Sbjct: 360 ELKPGEKGLDWPTRKKIAFGAAHGLEYLHEHCNPKIIHRDLKAANILLDDNFEAVLGDFG 419
Query: 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 477
LAKLVD K THVTTQ+RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID
Sbjct: 420 LAKLVDTKFTHVTTQVRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 476
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224060473|ref|XP_002300217.1| predicted protein [Populus trichocarpa] gi|222847475|gb|EEE85022.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 728 bits (1878), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/480 (73%), Positives = 408/480 (85%), Gaps = 1/480 (0%)
Query: 1 MFGALHKCCPPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDH 60
MFG P L+ L+L+ FL +SS+EPD EG AL ++L ALND++GQ DW+ +
Sbjct: 1 MFGVFSIRNPLKLVINCLVLLNFLQIINSSKEPDTEGGALRDLLLALNDSNGQI-DWDPN 59
Query: 61 FVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFL 120
VSPC+SW++V C+NG+V+ L+L S G SG +SP+ITKLKFL SLEL++N+LSG+LPD+L
Sbjct: 60 LVSPCYSWTNVYCKNGHVVFLSLNSLGLSGTLSPAITKLKFLVSLELRNNNLSGSLPDYL 119
Query: 121 GSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTH 180
G+M L++LNLA+NKFSGSIP TW QLSNLK LD+SSNNLTGRIP +LFSVATFNFT T+
Sbjct: 120 GNMVQLKNLNLASNKFSGSIPDTWDQLSNLKFLDVSSNNLTGRIPDKLFSVATFNFTATY 179
Query: 181 LICGSSLEQPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHD 240
+ CG S E+PC+SR PVST + +L+++ ASASCGAF LL L + A RYQ+ K K+D
Sbjct: 180 IACGLSFEEPCLSRSPLPVSTRKLRLKVIAASASCGAFGLLILLVVLAYRYQQFHKEKND 239
Query: 241 VFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAV 300
+F DV+GEDD K+S QLRRFS RELQLATDNFSESNIIGQGGFGKVYKG++SDN KVAV
Sbjct: 240 IFVDVSGEDDRKISFGQLRRFSWRELQLATDNFSESNIIGQGGFGKVYKGIISDNMKVAV 299
Query: 301 KRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLR 360
KRL+DYYSPGG+AAF REV LISVA HKNLL+LIG+CTTSSERILVYP+MQNLSVAY LR
Sbjct: 300 KRLEDYYSPGGKAAFLREVQLISVAAHKNLLRLIGFCTTSSERILVYPYMQNLSVAYHLR 359
Query: 361 DLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420
DLKPGEKGLDWPTRKR+AFG A+GLEYLHE CNPKIIHRDLKAANILLDDNFE VL DFG
Sbjct: 360 DLKPGEKGLDWPTRKRIAFGAAHGLEYLHEHCNPKIIHRDLKAANILLDDNFEPVLGDFG 419
Query: 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480
LAKLVD K TH+TTQ+RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID SR
Sbjct: 420 LAKLVDTKFTHITTQVRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDLSR 479
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357520193|ref|XP_003630385.1| Plasma membrane receptor-like kinase [Medicago truncatula] gi|194441092|gb|ACF70844.1| plasma membrane receptor-like kinase [Medicago truncatula] gi|355524407|gb|AET04861.1| Plasma membrane receptor-like kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 725 bits (1871), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/484 (71%), Positives = 413/484 (85%)
Query: 9 CPPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSW 68
P ++ +W I ++ L + ++PD+EGEAL+++L LND++ Q DW+ H VSPCFSW
Sbjct: 9 APFKILMRWFIFLVVLKLSSAIKDPDIEGEALLDLLNYLNDSNNQIQDWDSHLVSPCFSW 68
Query: 69 SHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQS 128
SHVTCRNG+VISLTL S GFSG +SPSIT+LK+L +LELQ+N+LSG +PD++ ++T LQ
Sbjct: 69 SHVTCRNGHVISLTLASIGFSGTLSPSITRLKYLVNLELQNNNLSGPIPDYISNLTDLQY 128
Query: 129 LNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLE 188
LNLANN F+GSIP +W QLS+LK++DLSSN LTG IP QLFSV FNF+ T L CGSS +
Sbjct: 129 LNLANNNFNGSIPVSWGQLSSLKNVDLSSNGLTGTIPTQLFSVPMFNFSDTPLDCGSSFD 188
Query: 189 QPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGE 248
QPC+S+ P ST+++KL + ASCGAFVLL LGA+F R+ + + K DVF DV GE
Sbjct: 189 QPCVSKSDHPASTNKSKLAKAMPYASCGAFVLLCLGAIFTYRHHQKIRHKSDVFVDVLGE 248
Query: 249 DDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS 308
D+ K+S QLRRFS RELQLAT +FSESN+IGQGGFGKVYKGVLSDNTK+AVKRL DY++
Sbjct: 249 DESKISFGQLRRFSLRELQLATKSFSESNVIGQGGFGKVYKGVLSDNTKIAVKRLTDYHN 308
Query: 309 PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG 368
PGGEAAF+REV LISVA+H+NLL+LIG+CTTS+ERILVYPFM+NLSVAY+LRDLK EKG
Sbjct: 309 PGGEAAFEREVDLISVAVHRNLLRLIGFCTTSTERILVYPFMENLSVAYQLRDLKSDEKG 368
Query: 369 LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428
LDWPTRKRVAFGTA+GLEYLHEQCNPKIIHRDLKAANILLDD FE VL DFGLAKLVDA+
Sbjct: 369 LDWPTRKRVAFGTAHGLEYLHEQCNPKIIHRDLKAANILLDDEFEPVLGDFGLAKLVDAR 428
Query: 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 488
+THVTTQ+RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLEL+TGQRAID SRLEEEEDVL
Sbjct: 429 MTHVTTQVRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELITGQRAIDLSRLEEEEDVL 488
Query: 489 LLDH 492
L+DH
Sbjct: 489 LIDH 492
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297793957|ref|XP_002864863.1| hypothetical protein ARALYDRAFT_496559 [Arabidopsis lyrata subsp. lyrata] gi|297310698|gb|EFH41122.1| hypothetical protein ARALYDRAFT_496559 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 698 bits (1801), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 342/494 (69%), Positives = 412/494 (83%), Gaps = 5/494 (1%)
Query: 3 GALHKCC----PPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWN 58
G +H+ C L+ + + + F+ S+ +PD+EG AL+++ +LND+ + W
Sbjct: 16 GFIHRNCFRWNNQKLILQCFMALAFVGVTSSTTQPDIEGGALLQLRDSLNDSSNRL-KWT 74
Query: 59 DHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPD 118
FVSPC+SWS+VTCR +V++L L SNGF+G +SP+ITKLKFL +LELQ+N LSG LP+
Sbjct: 75 RDFVSPCYSWSYVTCRGQSVVALNLASNGFTGTLSPAITKLKFLVTLELQNNSLSGALPE 134
Query: 119 FLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTG 178
LG+M +LQ+LNL+ N FSGSIPA+WSQLSNLKHLDLSSNNLTG IP Q FS+ TF+F+G
Sbjct: 135 SLGNMVNLQTLNLSMNSFSGSIPASWSQLSNLKHLDLSSNNLTGSIPTQFFSIPTFDFSG 194
Query: 179 THLICGSSLEQPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLK 238
T LICG SL QPC S PV++S+ KLR + +ASC A ++L LGA+ + ++R+ K
Sbjct: 195 TQLICGKSLNQPCSSSSRLPVTSSKKKLRDITLTASCVASIILFLGAMVMYHHHRVRQTK 254
Query: 239 HDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKV 298
+D+FFDVAGEDD K+S QLRRFS RE+QLATD+F+ESN+IGQGGFGKVY+G+L D TKV
Sbjct: 255 YDIFFDVAGEDDRKISFGQLRRFSLREIQLATDSFNESNLIGQGGFGKVYRGLLPDKTKV 314
Query: 299 AVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYR 358
AVKRL DY+SPGGEAAFQRE+ LISVA+HKNLL+LIG+CTTSSERILVYP+M+NLSVAYR
Sbjct: 315 AVKRLADYFSPGGEAAFQREIQLISVAVHKNLLRLIGFCTTSSERILVYPYMENLSVAYR 374
Query: 359 LRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 418
LRDLK GE+GLDWPTRKRVAFG+A+GLEYLHE CNPKIIHRDLKAANILLD+NFE VL D
Sbjct: 375 LRDLKAGEEGLDWPTRKRVAFGSAHGLEYLHEHCNPKIIHRDLKAANILLDNNFEPVLGD 434
Query: 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478
FGLAKLVD LTHVTTQ+RGTMGHIAPEYL TGKSSEKTDVFGYGITLLELVTGQRAIDF
Sbjct: 435 FGLAKLVDTSLTHVTTQVRGTMGHIAPEYLCTGKSSEKTDVFGYGITLLELVTGQRAIDF 494
Query: 479 SRLEEEEDVLLLDH 492
SRLEEEE++LLLDH
Sbjct: 495 SRLEEEENILLLDH 508
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|10177052|dbj|BAB10464.1| receptor-like protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 696 bits (1796), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 337/470 (71%), Positives = 402/470 (85%), Gaps = 1/470 (0%)
Query: 23 FLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLT 82
F+ S+ +PD+EG AL+++ +LND+ + W FVSPC+SWS+VTCR +V++L
Sbjct: 5 FVGITSSTTQPDIEGGALLQLRDSLNDSSNRL-KWTRDFVSPCYSWSYVTCRGQSVVALN 63
Query: 83 LGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA 142
L S+GF+G +SP+ITKLKFL +LELQ+N LSG LPD LG+M +LQ+LNL+ N FSGSIPA
Sbjct: 64 LASSGFTGTLSPAITKLKFLVTLELQNNSLSGALPDSLGNMVNLQTLNLSVNSFSGSIPA 123
Query: 143 TWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPCMSRPSPPVSTS 202
+WSQLSNLKHLDLSSNNLTG IP Q FS+ TF+F+GT LICG SL QPC S PV++S
Sbjct: 124 SWSQLSNLKHLDLSSNNLTGSIPTQFFSIPTFDFSGTQLICGKSLNQPCSSSSRLPVTSS 183
Query: 203 RTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFS 262
+ KLR + +ASC A ++L LGA+ + ++R+ K+D+FFDVAGEDD K+S QL+RFS
Sbjct: 184 KKKLRDITLTASCVASIILFLGAMVMYHHHRVRRTKYDIFFDVAGEDDRKISFGQLKRFS 243
Query: 263 CRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLI 322
RE+QLATD+F+ESN+IGQGGFGKVY+G+L D TKVAVKRL DY+SPGGEAAFQRE+ LI
Sbjct: 244 LREIQLATDSFNESNLIGQGGFGKVYRGLLPDKTKVAVKRLADYFSPGGEAAFQREIQLI 303
Query: 323 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 382
SVA+HKNLL+LIG+CTTSSERILVYP+M+NLSVAYRLRDLK GE+GLDWPTRKRVAFG+A
Sbjct: 304 SVAVHKNLLRLIGFCTTSSERILVYPYMENLSVAYRLRDLKAGEEGLDWPTRKRVAFGSA 363
Query: 383 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 442
+GLEYLHE CNPKIIHRDLKAANILLD+NFE VL DFGLAKLVD LTHVTTQ+RGTMGH
Sbjct: 364 HGLEYLHEHCNPKIIHRDLKAANILLDNNFEPVLGDFGLAKLVDTSLTHVTTQVRGTMGH 423
Query: 443 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH 492
IAPEYL TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE++LLLDH
Sbjct: 424 IAPEYLCTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEENILLLDH 473
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18424740|ref|NP_568977.1| Leucine-rich repeat protein kinase family protein [Arabidopsis thaliana] gi|75331406|sp|Q8W4S5.1|Y5371_ARATH RecName: Full=Probable LRR receptor-like serine/threonine-protein kinase At5g63710; Flags: Precursor gi|16974577|gb|AAL31184.1| AT5g63710/MBK5_19 [Arabidopsis thaliana] gi|22655394|gb|AAM98289.1| At5g63710/MBK5_19 [Arabidopsis thaliana] gi|224589745|gb|ACN59404.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332010405|gb|AED97788.1| Leucine-rich repeat protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 694 bits (1792), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 338/480 (70%), Positives = 407/480 (84%), Gaps = 1/480 (0%)
Query: 13 LMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVT 72
L+ + + + F+ S+ +PD+EG AL+++ +LND+ + W FVSPC+SWS+VT
Sbjct: 30 LILQCFMALAFVGITSSTTQPDIEGGALLQLRDSLNDSSNRL-KWTRDFVSPCYSWSYVT 88
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
CR +V++L L S+GF+G +SP+ITKLKFL +LELQ+N LSG LPD LG+M +LQ+LNL+
Sbjct: 89 CRGQSVVALNLASSGFTGTLSPAITKLKFLVTLELQNNSLSGALPDSLGNMVNLQTLNLS 148
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPCM 192
N FSGSIPA+WSQLSNLKHLDLSSNNLTG IP Q FS+ TF+F+GT LICG SL QPC
Sbjct: 149 VNSFSGSIPASWSQLSNLKHLDLSSNNLTGSIPTQFFSIPTFDFSGTQLICGKSLNQPCS 208
Query: 193 SRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCK 252
S PV++S+ KLR + +ASC A ++L LGA+ + ++R+ K+D+FFDVAGEDD K
Sbjct: 209 SSSRLPVTSSKKKLRDITLTASCVASIILFLGAMVMYHHHRVRRTKYDIFFDVAGEDDRK 268
Query: 253 VSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGE 312
+S QL+RFS RE+QLATD+F+ESN+IGQGGFGKVY+G+L D TKVAVKRL DY+SPGGE
Sbjct: 269 ISFGQLKRFSLREIQLATDSFNESNLIGQGGFGKVYRGLLPDKTKVAVKRLADYFSPGGE 328
Query: 313 AAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWP 372
AAFQRE+ LISVA+HKNLL+LIG+CTTSSERILVYP+M+NLSVAYRLRDLK GE+GLDWP
Sbjct: 329 AAFQREIQLISVAVHKNLLRLIGFCTTSSERILVYPYMENLSVAYRLRDLKAGEEGLDWP 388
Query: 373 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432
TRKRVAFG+A+GLEYLHE CNPKIIHRDLKAANILLD+NFE VL DFGLAKLVD LTHV
Sbjct: 389 TRKRVAFGSAHGLEYLHEHCNPKIIHRDLKAANILLDNNFEPVLGDFGLAKLVDTSLTHV 448
Query: 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH 492
TTQ+RGTMGHIAPEYL TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE++LLLDH
Sbjct: 449 TTQVRGTMGHIAPEYLCTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEENILLLDH 508
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 498 | ||||||
| TAIR|locus:2160644 | 614 | AT5G63710 [Arabidopsis thalian | 0.937 | 0.760 | 0.692 | 1.7e-176 | |
| TAIR|locus:2145407 | 613 | AT5G10290 [Arabidopsis thalian | 0.809 | 0.657 | 0.591 | 1.6e-125 | |
| TAIR|locus:2013021 | 625 | SERK1 "somatic embryogenesis r | 0.807 | 0.643 | 0.509 | 1.1e-101 | |
| TAIR|locus:2040471 | 601 | SERK5 "somatic embryogenesis r | 0.921 | 0.763 | 0.463 | 3.9e-99 | |
| TAIR|locus:2026097 | 628 | SERK2 "somatic embryogenesis r | 0.807 | 0.640 | 0.497 | 3.2e-97 | |
| TAIR|locus:2036636 | 632 | NIK3 "NSP-interacting kinase 3 | 0.805 | 0.634 | 0.488 | 1.6e-95 | |
| TAIR|locus:2040461 | 620 | SERK4 "somatic embryogenesis r | 0.801 | 0.643 | 0.501 | 2e-95 | |
| TAIR|locus:2061466 | 634 | AT2G23950 [Arabidopsis thalian | 0.791 | 0.621 | 0.497 | 6.8e-95 | |
| TAIR|locus:2118811 | 648 | SARK "SENESCENCE-ASSOCIATED RE | 0.797 | 0.612 | 0.495 | 4.8e-94 | |
| TAIR|locus:2146102 | 638 | NIK1 "NSP-interacting kinase 1 | 0.791 | 0.617 | 0.5 | 6.1e-94 |
| TAIR|locus:2160644 AT5G63710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1714 (608.4 bits), Expect = 1.7e-176, P = 1.7e-176
Identities = 324/468 (69%), Positives = 388/468 (82%)
Query: 13 LMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVT 72
L+ + + + F+ S+ +PD+EG AL+++ +LND+ + W FVSPC+SWS+VT
Sbjct: 30 LILQCFMALAFVGITSSTTQPDIEGGALLQLRDSLNDSSNRLK-WTRDFVSPCYSWSYVT 88
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
CR +V++L L S+GF+G +SP+ITKLKFL +LELQ+N LSG LPD LG+M +LQ+LNL+
Sbjct: 89 CRGQSVVALNLASSGFTGTLSPAITKLKFLVTLELQNNSLSGALPDSLGNMVNLQTLNLS 148
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPCM 192
N FSGSIPA+WSQLSNLKHLDLSSNNLTG IP Q FS+ TF+F+GT LICG SL QPC
Sbjct: 149 VNSFSGSIPASWSQLSNLKHLDLSSNNLTGSIPTQFFSIPTFDFSGTQLICGKSLNQPCS 208
Query: 193 XXXXXXXXXXXXKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCK 252
KLR + +ASC A ++L LGA+ + ++R+ K+D+FFDVAGEDD K
Sbjct: 209 SSSRLPVTSSKKKLRDITLTASCVASIILFLGAMVMYHHHRVRRTKYDIFFDVAGEDDRK 268
Query: 253 VSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGE 312
+S QL+RFS RE+QLATD+F+ESN+IGQGGFGKVY+G+L D TKVAVKRL DY+SPGGE
Sbjct: 269 ISFGQLKRFSLREIQLATDSFNESNLIGQGGFGKVYRGLLPDKTKVAVKRLADYFSPGGE 328
Query: 313 AAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWP 372
AAFQRE+ LISVA+HKNLL+LIG+CTTSSERILVYP+M+NLSVAYRLRDLK GE+GLDWP
Sbjct: 329 AAFQREIQLISVAVHKNLLRLIGFCTTSSERILVYPYMENLSVAYRLRDLKAGEEGLDWP 388
Query: 373 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432
TRKRVAFG+A+GLEYLHE CNPKIIHRDLKAANILLD+NFE VL DFGLAKLVD LTHV
Sbjct: 389 TRKRVAFGSAHGLEYLHEHCNPKIIHRDLKAANILLDNNFEPVLGDFGLAKLVDTSLTHV 448
Query: 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480
TTQ+RGTMGHIAPEYL TGKSSEKTDVFGYGITLLELVTGQRAIDFSR
Sbjct: 449 TTQVRGTMGHIAPEYLCTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 496
|
|
| TAIR|locus:2145407 AT5G10290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1233 (439.1 bits), Expect = 1.6e-125, P = 1.6e-125
Identities = 239/404 (59%), Positives = 301/404 (74%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ +LTL NG +G+I L L SL+L+DN L+G +P +G++ LQ L L+ NK
Sbjct: 95 NLKTLTLKGNGITGEIPEDFGNLTSLTSLDLEDNQLTGRIPSTIGNLKKLQFLTLSRNKL 154
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPCMXXXX 196
+G+IP + + L NL +L L SN+L+G+IP LF + +NFT +L CG PC+
Sbjct: 155 NGTIPESLTGLPNLLNLLLDSNSLSGQIPQSLFEIPKYNFTSNNLNCGGRQPHPCVSAVA 214
Query: 197 XXXXXXXXKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLT 256
K I+ + VL + C+ + + + DVF DVAGE D +++
Sbjct: 215 HSGDSSKPKTGIIAGVVAGVTVVLFGILLFLFCK-DRHKGYRRDVFVDVAGEVDRRIAFG 273
Query: 257 QLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQ 316
QL+RF+ RELQLATDNFSE N++GQGGFGKVYKGVL DNTKVAVKRL D+ SPGG+AAFQ
Sbjct: 274 QLKRFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVAVKRLTDFESPGGDAAFQ 333
Query: 317 REVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR 376
REV +ISVA+H+NLL+LIG+CTT +ER+LVYPFMQNLS+A+RLR++K G+ LDW TRKR
Sbjct: 334 REVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHRLREIKAGDPVLDWETRKR 393
Query: 377 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 436
+A G A G EYLHE CNPKIIHRD+KAAN+LLD++FEAV+ DFGLAKLVD + T+VTTQ+
Sbjct: 394 IALGAARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRRTNVTTQV 453
Query: 437 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480
RGTMGHIAPEYLSTGKSSE+TDVFGYGI LLELVTGQRAIDFSR
Sbjct: 454 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSR 497
|
|
| TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1008 (359.9 bits), Expect = 1.1e-101, P = 1.1e-101
Identities = 213/418 (50%), Positives = 280/418 (66%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L L SN +G I ++ L L SL+L N SG +P+ LG ++ L+ L L NN
Sbjct: 94 NLQYLELYSNNITGPIPSNLGNLTNLVSLDLYLNSFSGPIPESLGKLSKLRFLRLNNNSL 153
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ-LFSVAT-FNFTGTHLICGSSLEQPC--- 191
+GSIP + + ++ L+ LDLS+N L+G +P FS+ T +F +CG PC
Sbjct: 154 TGSIPMSLTNITTLQVLDLSNNRLSGSVPDNGSFSLFTPISFANNLDLCGPVTSHPCPGS 213
Query: 192 ---------MXXXXXXXXXXXXKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVF 242
+ + + GA +L + A+ +++ + L D+F
Sbjct: 214 PPFSPPPPFIQPPPVSTPSGYGITGAIAGGVAAGAALLFAAPAIAFAWWRRRKPL--DIF 271
Query: 243 FDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKR 302
FDV E+D +V L QL+RFS RELQ+A+D FS NI+G+GGFGKVYKG L+D T VAVKR
Sbjct: 272 FDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILGRGGFGKVYKGRLADGTLVAVKR 331
Query: 303 LQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDL 362
L++ +PGGE FQ EV +IS+A+H+NLL+L G+C T +ER+LVYP+M N SVA LR+
Sbjct: 332 LKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER 391
Query: 363 KPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422
P + LDWPTRKR+A G+A GL YLH+ C+PKIIHRD+KAANILLD+ FEAV+ DFGLA
Sbjct: 392 PPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 451
Query: 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480
KL+D K THVTT +RGT+GHIAPEYLSTGKSSEKTDVFGYGI LLEL+TGQRA D +R
Sbjct: 452 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLAR 509
|
|
| TAIR|locus:2040471 SERK5 "somatic embryogenesis receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 984 (351.4 bits), Expect = 3.9e-99, P = 3.9e-99
Identities = 221/477 (46%), Positives = 300/477 (62%)
Query: 17 WLILVIFLNFGHSSREPDVEGEALIEVLKALND---THGQFTDWNDHFVSPCFSWSHVTC 73
WLIL FL+F S + +ALI + +L+ T+ WN V+PC SW HVTC
Sbjct: 11 WLIL--FLDFV-SRVTGKTQVDALIALRSSLSSGDHTNNILQSWNATHVTPC-SWFHVTC 66
Query: 74 RNGNVIS-LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
N ++ L LGS SG++ P + +L L LEL +N+++G +P+ LG + L SL+L
Sbjct: 67 NTENSVTRLDLGSANLSGELVPQLAQLPNLQYLELFNNNITGEIPEELGDLMELVSLDLF 126
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL-------FSVATFNFTGTHLICGS 185
N SG IP++ +L L+ L L +N+L+G IP L ++ +G + GS
Sbjct: 127 ANNISGPIPSSLGKLGKLRFLRLYNNSLSGEIPRSLTALPLDVLDISNNRLSGDIPVNGS 186
Query: 186 SLEQPCMXXXXXXXXXXXXKLRIVVASASCGAFVLLSLGA--LFACRYQKLRKLKHDVFF 243
+ M + S V ++ GA LFA + RKL+ F
Sbjct: 187 FSQFTSMSFANNKLRPRPASPSPSPSGTSAAIVVGVAAGAALLFALAWWLRRKLQGH-FL 245
Query: 244 DVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRL 303
DV E+D +V L Q +RFS REL +AT+ FS+ N++G+G FG +YKG L+D+T VAVKRL
Sbjct: 246 DVPAEEDPEVYLGQFKRFSLRELLVATEKFSKRNVLGKGRFGILYKGRLADDTLVAVKRL 305
Query: 304 QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK 363
+ + GGE FQ EV +IS+A+H+NLL+L G+C T +ER+LVYP+M N SVA LR+
Sbjct: 306 NEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 365
Query: 364 PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423
G LDWP RK +A G+A GL YLH+ C+ KIIH D+KAANILLD+ FEAV+ DFGLAK
Sbjct: 366 EGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHLDVKAANILLDEEFEAVVGDFGLAK 425
Query: 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480
L++ +HVTT +RGT+GHIAPEYLSTGKSSEKTDVFGYG+ LLEL+TGQ+A D +R
Sbjct: 426 LMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLAR 482
|
|
| TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 966 (345.1 bits), Expect = 3.2e-97, P = 3.2e-97
Identities = 208/418 (49%), Positives = 273/418 (65%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L L SN +G + + L L SL+L N +G +PD LG + L+ L L NN
Sbjct: 97 NLQYLELYSNNITGPVPSDLGNLTNLVSLDLYLNSFTGPIPDSLGKLFKLRFLRLNNNSL 156
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ-LFSVAT-FNFTGTHLICGSSLEQPCMXX 194
+G IP + + + L+ LDLS+N L+G +P FS+ T +F +CG +PC
Sbjct: 157 TGPIPMSLTNIMTLQVLDLSNNRLSGSVPDNGSFSLFTPISFANNLDLCGPVTSRPCPGS 216
Query: 195 XXXX------------XXXXXXKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVF 242
+ + GA +L + AL A + + RK + F
Sbjct: 217 PPFSPPPPFIPPPIVPTPGGYSATGAIAGGVAAGAALLFAAPAL-AFAWWRRRK-PQEFF 274
Query: 243 FDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKR 302
FDV E+D +V L QL+RFS RELQ+ATD+FS NI+G+GGFGKVYKG L+D T VAVKR
Sbjct: 275 FDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGTLVAVKR 334
Query: 303 LQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDL 362
L++ +PGGE FQ EV +IS+A+H+NLL+L G+C T +ER+LVYP+M N SVA LR+
Sbjct: 335 LKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER 394
Query: 363 KPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422
P + L W R+++A G+A GL YLH+ C+PKIIHRD+KAANILLD+ FEAV+ DFGLA
Sbjct: 395 PPSQLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 454
Query: 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480
+L+D K THVTT +RGT+GHIAPEYLSTGKSSEKTDVFGYGI LLEL+TGQRA D +R
Sbjct: 455 RLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLAR 512
|
|
| TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 950 (339.5 bits), Expect = 1.6e-95, P = 1.6e-95
Identities = 206/422 (48%), Positives = 280/422 (66%)
Query: 74 RNGNVI---SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLN 130
R GN+ S+ L +N +G I +I +L+ L SL+L +N +G +P LG + +L L
Sbjct: 93 RIGNLTYLQSVVLQNNAITGPIPETIGRLEKLQSLDLSNNSFTGEIPASLGELKNLNYLR 152
Query: 131 LANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICG------ 184
L NN G+ P + S++ L +D+S NNL+G +P S TF G LICG
Sbjct: 153 LNNNSLIGTCPESLSKIEGLTLVDISYNNLSGSLPK--VSARTFKVIGNALICGPKAVSN 210
Query: 185 -SSLEQPCMXXXX----XXXXXXXXKLRIV-VASASCGAFVLLSLGALFACRYQKLRKLK 238
S++ +P + + AS S FV + G RY++ ++
Sbjct: 211 CSAVPEPLTLPQDGPDESGTRTNGHHVALAFAASFSAAFFVFFTSGMFLWWRYRRNKQ-- 268
Query: 239 HDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKV 298
+FFDV + D +VSL L+R++ +EL+ AT++F+ NI+G+GG+G VYKG L+D T V
Sbjct: 269 --IFFDVNEQYDPEVSLGHLKRYTFKELRSATNHFNSKNILGRGGYGIVYKGHLNDGTLV 326
Query: 299 AVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYR 358
AVKRL+D GGE FQ EV IS+A+H+NLL+L G+C+++ ERILVYP+M N SVA R
Sbjct: 327 AVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSSNQERILVYPYMPNGSVASR 386
Query: 359 LRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 418
L+D GE LDW RK++A GTA GL YLHEQC+PKIIHRD+KAANILLD++FEAV+ D
Sbjct: 387 LKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDEDFEAVVGD 446
Query: 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478
FGLAKL+D + +HVTT +RGT+GHIAPEYLSTG+SSEKTDVFG+GI LLEL+TGQ+A+DF
Sbjct: 447 FGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQKALDF 506
Query: 479 SR 480
R
Sbjct: 507 GR 508
|
|
| TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 949 (339.1 bits), Expect = 2.0e-95, P = 2.0e-95
Identities = 204/407 (50%), Positives = 270/407 (66%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L L SN +G+I + L L SL+L N +SG +P LG + L+ L L NN
Sbjct: 100 NLQYLELYSNNITGEIPEELGDLVELVSLDLYANSISGPIPSSLGKLGKLRFLRLNNNSL 159
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ-LFSVAT-FNFTGTHLICGSSLEQPCMXX 194
SG IP T + + L+ LD+S+N L+G IP+ FS+ T +F L E P
Sbjct: 160 SGEIPMTLTSVQ-LQVLDISNNRLSGDIPVNGSFSLFTPISFANNSLT--DLPEPPPTST 216
Query: 195 XXXXXXXXXXKLRIVVASA-SCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKV 253
++ +A + GA +L ++ A+ + LR+ D FFDV E+D +V
Sbjct: 217 SPTPPPPSGGQMTAAIAGGVAAGAALLFAVPAIAFAWW--LRRKPQDHFFDVPAEEDPEV 274
Query: 254 SLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEA 313
L QL+RF+ REL +ATDNFS N++G+GGFGKVYKG L+D VAVKRL++ + GGE
Sbjct: 275 HLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLADGNLVAVKRLKEERTKGGEL 334
Query: 314 AFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPT 373
FQ EV +IS+A+H+NLL+L G+C T +ER+LVYP+M N SVA LR+ G LDWP
Sbjct: 335 QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPK 394
Query: 374 RKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 433
RK +A G+A GL YLH+ C+ KIIHRD+KAANILLD+ FEAV+ DFGLAKL++ +HVT
Sbjct: 395 RKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHVT 454
Query: 434 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480
T +RGT+GHIAPEYLSTGKSSEKTDVFGYG+ LLEL+TGQ+A D +R
Sbjct: 455 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLAR 501
|
|
| TAIR|locus:2061466 AT2G23950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 944 (337.4 bits), Expect = 6.8e-95, P = 6.8e-95
Identities = 206/414 (49%), Positives = 269/414 (64%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ ++L +N SGKI P I L L +L+L +N SG +P + +++LQ L L NN
Sbjct: 99 NLRQVSLQNNNISGKIPPEICSLPKLQTLDLSNNRFSGEIPGSVNQLSNLQYLRLNNNSL 158
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPC----- 191
SG PA+ SQ+ +L LDLS NNL G +P F TFN G LIC +SL + C
Sbjct: 159 SGPFPASLSQIPHLSFLDLSYNNLRGPVPK--FPARTFNVAGNPLICKNSLPEICSGSIS 216
Query: 192 ---MXXXXXXXXXXXXKLRIVVASASCG--AFVLLSLGALFACRYQKLRKLKHDVFFDVA 246
+ + V S G V+LSLG F +K R+L D
Sbjct: 217 ASPLSVSLRSSSGRRTNILAVALGVSLGFAVSVILSLG--FIWYRKKQRRLTMLRISDK- 273
Query: 247 GEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY 306
+++ + L LR F+ REL +ATD FS +I+G GGFG VY+G D T VAVKRL+D
Sbjct: 274 -QEEGLLGLGNLRSFTFRELHVATDGFSSKSILGAGGFGNVYRGKFGDGTVVAVKRLKDV 332
Query: 307 YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGE 366
G + F+ E+ +IS+A+H+NLL+LIGYC +SSER+LVYP+M N SVA RL+ KP
Sbjct: 333 NGTSGNSQFRTELEMISLAVHRNLLRLIGYCASSSERLLVYPYMSNGSVASRLK-AKPA- 390
Query: 367 KGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426
LDW TRK++A G A GL YLHEQC+PKIIHRD+KAANILLD+ FEAV+ DFGLAKL++
Sbjct: 391 --LDWNTRKKIAIGAARGLFYLHEQCDPKIIHRDVKAANILLDEYFEAVVGDFGLAKLLN 448
Query: 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480
+ +HVTT +RGT+GHIAPEYLSTG+SSEKTDVFG+GI LLEL+TG RA++F +
Sbjct: 449 HEDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGK 502
|
|
| TAIR|locus:2118811 SARK "SENESCENCE-ASSOCIATED RECEPTOR-LIKE KINASE" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 936 (334.5 bits), Expect = 4.8e-94, P = 4.8e-94
Identities = 204/412 (49%), Positives = 267/412 (64%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ ++L +N SGKI P + L L +L+L +N SG +P + ++ LQ L L NN
Sbjct: 102 NLRQVSLQNNNISGKIPPELGFLPKLQTLDLSNNRFSGDIPVSIDQLSSLQYLRLNNNSL 161
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPCMXXXX 196
SG PA+ SQ+ +L LDLS NNL+G +P F TFN G LIC S+ + C
Sbjct: 162 SGPFPASLSQIPHLSFLDLSYNNLSGPVPK--FPARTFNVAGNPLICRSNPPEICSGSIN 219
Query: 197 XX-------XXXXXXKLRIVVA-SASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGE 248
R+ +A S S G+ V+L L C Y+K ++ + + E
Sbjct: 220 ASPLSVSLSSSSGRRSNRLAIALSVSLGSVVILVLALGSFCWYRKKQRRLLILNLNDKQE 279
Query: 249 DDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS 308
+ + L LR F+ REL + TD FS NI+G GGFG VY+G L D T VAVKRL+D
Sbjct: 280 EGLQ-GLGNLRSFTFRELHVYTDGFSSKNILGAGGFGNVYRGKLGDGTMVAVKRLKDING 338
Query: 309 PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG 368
G++ F+ E+ +IS+A+HKNLL+LIGYC TS ER+LVYP+M N SVA +L+ KP
Sbjct: 339 TSGDSQFRMELEMISLAVHKNLLRLIGYCATSGERLLVYPYMPNGSVASKLKS-KPA--- 394
Query: 369 LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428
LDW RKR+A G A GL YLHEQC+PKIIHRD+KAANILLD+ FEAV+ DFGLAKL++
Sbjct: 395 LDWNMRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANILLDECFEAVVGDFGLAKLLNHA 454
Query: 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480
+HVTT +RGT+GHIAPEYLSTG+SSEKTDVFG+GI LLEL+TG RA++F +
Sbjct: 455 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRALEFGK 506
|
|
| TAIR|locus:2146102 NIK1 "NSP-interacting kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 935 (334.2 bits), Expect = 6.1e-94, P = 6.1e-94
Identities = 210/420 (50%), Positives = 269/420 (64%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ + L +N GKI I +L L +L+L DN G +P +G + LQ L L NN
Sbjct: 106 NLRIVLLQNNNIKGKIPAEIGRLTRLETLDLSDNFFHGEIPFSVGYLQSLQYLRLNNNSL 165
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPCMXXXX 196
SG P + S ++ L LDLS NNL+G +P F+ TF+ G LIC + E C
Sbjct: 166 SGVFPLSLSNMTQLAFLDLSYNNLSGPVPR--FAAKTFSIVGNPLICPTGTEPDCNGTTL 223
Query: 197 X--------------XXXXXXXKLRIVVASASCGAFVLLSLGA-LFACRYQKLRKLKHDV 241
K+ I V S S G L+ + LF Q+ + +
Sbjct: 224 IPMSMNLNQTGVPLYAGGSRNHKMAIAVGS-SVGTVSLIFIAVGLFLWWRQRHNQ---NT 279
Query: 242 FFDVA-GEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAV 300
FFDV G +VSL LRRF RELQ+AT+NFS N++G+GG+G VYKG+L D+T VAV
Sbjct: 280 FFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYKGILGDSTVVAV 339
Query: 301 KRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLR 360
KRL+D + GGE FQ EV +IS+A+H+NLL+L G+C T +E++LVYP+M N SVA R++
Sbjct: 340 KRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPYMSNGSVASRMK 399
Query: 361 DLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420
KP LDW RKR+A G A GL YLHEQC+PKIIHRD+KAANILLDD EAV+ DFG
Sbjct: 400 -AKPV---LDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDDYCEAVVGDFG 455
Query: 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480
LAKL+D + +HVTT +RGT+GHIAPEYLSTG+SSEKTDVFG+GI LLELVTGQRA +F +
Sbjct: 456 LAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELVTGQRAFEFGK 515
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8W4S5 | Y5371_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7041 | 0.9618 | 0.7801 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 498 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-46 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-44 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-43 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-42 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-42 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-41 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-40 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-23 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-23 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-22 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-22 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-18 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-17 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-15 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-15 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-15 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-14 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 9e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-13 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-11 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-09 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-08 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-07 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 8e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-06 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-05 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 4e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.001 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 0.001 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.003 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 1e-46
Identities = 71/195 (36%), Positives = 98/195 (50%), Gaps = 12/195 (6%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
+G+GGFG VY KVA+K ++ S RE+ ++ H N+++L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 338 TTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396
+ LV + + S L+D LK E L R+ GLEYLH I
Sbjct: 61 EDENHLYLVMEYCEGGS----LKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GI 113
Query: 397 IHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL-STGKSS 454
IHRDLK NILLD DN + L DFGL+KL+ + + I GT ++APE L G S
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSD-KSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 455 EKTDVFGYGITLLEL 469
EK+D++ G+ L EL
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 1e-44
Identities = 62/204 (30%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 279 IGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 333
+G+G FG+VYKG L TKVAVK L++ S F E ++ H N+++L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 334 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 393
+G CT +V +M + LR L ++A A G+EYL +
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---KLTLKDLLQMALQIAKGMEYLESK-- 121
Query: 394 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-----IRGTMGHIAPEYL 448
+HRDL A N L+ +N + DFGL++ + + I+ APE L
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM----APESL 176
Query: 449 STGKSSEKTDVFGYGITLLELVTG 472
GK + K+DV+ +G+ L E+ T
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 4e-43
Identities = 67/199 (33%), Positives = 93/199 (46%), Gaps = 11/199 (5%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
+G G FG VYK VAVK L+ + +RE+ ++ H N+++LI
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 395
LV + + + L L K++A GLEYLH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSR----GGPLSEDEAKKIALQILRGLEYLHSN---G 118
Query: 396 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK-SS 454
IIHRDLK NILLD+N + DFGLAK + + +TT GT ++APE L G
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGGNGYG 177
Query: 455 EKTDVFGYGITLLELVTGQ 473
K DV+ G+ L EL+TG+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 1e-42
Identities = 64/207 (30%), Positives = 96/207 (46%), Gaps = 17/207 (8%)
Query: 277 NIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+G+G FG+VYKG L T+VAVK L++ S F +E ++ H N+++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 333 LIGYCTTSSERILVYPFMQN---LSV--AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
L+G CT LV +M+ L R P + L A A G+EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---A 444
L + K +HRDL A N L+ ++ + DFGL++ V + G I A
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK--TGGKLPIRWMA 175
Query: 445 PEYLSTGKSSEKTDVFGYGITLLELVT 471
PE L G + K+DV+ +G+ L E+ T
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 1e-42
Identities = 65/203 (32%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 278 IIGQGGFGKVYKGVLSDN-----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+G+G FG+VYKG L +VAVK L++ S F RE ++ H N+++
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 392
L+G CT ++V +M + LR +P K L A A G+EYL +
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK- 122
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ----IRGTMGHIAPEYL 448
IHRDL A N L+ +N + DFGL++ + + IR APE L
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM----APESL 176
Query: 449 STGKSSEKTDVFGYGITLLELVT 471
GK + K+DV+ +G+ L E+ T
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 3e-41
Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 278 IIGQGGFGKVYKGVLSDN-----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+G+G FG+VYKG L +VAVK L++ S F RE ++ H N+++
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 392
L+G CT +V +M+ + LR +P L A A G+EYL +
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFALQIARGMEYLESK- 121
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI-----APEY 447
IHRDL A N L+ +N + DFGL++ + + R G + APE
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDL-----YDDDYYRKRGGKLPIRWMAPES 174
Query: 448 LSTGKSSEKTDVFGYGITLLELVT 471
L GK + K+DV+ +G+ L E+ T
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 6e-40
Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 277 NIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
+G+G FGKVY VA+K ++ RE+ ++ H N+++L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 395
+ LV + + + L+ L + LEYLH +
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKK----RGRLSEDEARFYLRQILSALEYLHSK---G 117
Query: 396 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSE 455
I+HRDLK NILLD++ L DFGLA+ +D +TT + GT ++APE L +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPG-EKLTTFV-GTPEYMAPEVLLGKGYGK 175
Query: 456 KTDVFGYGITLLELVTGQ 473
D++ G+ L EL+TG+
Sbjct: 176 AVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 1e-39
Identities = 124/439 (28%), Positives = 200/439 (45%), Gaps = 67/439 (15%)
Query: 74 RNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLAN 133
+ + +L L N FSG + + L L L+L +N LSG +PD L S L SL+L++
Sbjct: 473 GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSH 532
Query: 134 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSV--------------ATFNFTGT 179
N+ SG IPA++S++ L LDLS N L+G IP L +V + TG
Sbjct: 533 NQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGA 592
Query: 180 HLICGSSL----EQPCMSRPS---PPVS-TSRTKLRIVVASASCGAFVLLSLGALFACRY 231
L +S C + PP +T + + GAF++L+L A F +
Sbjct: 593 FLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVA-FGFVF 651
Query: 232 QKLRK---LKHDVFFDVAGED--------DCKVSLTQLRRFSCRELQLATDNFSESNIIG 280
+ R LK V ED D KVS + + ++ + E N+I
Sbjct: 652 IRGRNNLELKR-----VENEDGTWELQFFDSKVS----KSITINDILSSL---KEENVIS 699
Query: 281 QGGFGKVYKGVLSDN-TKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKNLLQLIGYCT 338
+G G YKG N + VK + D S P E A ++ H N+++LIG C
Sbjct: 700 RGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQ------HPNIVKLIGLCR 753
Query: 339 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 398
+ L++ +++ +++ LR L W R+++A G A L +LH +C+P ++
Sbjct: 754 SEKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVV 806
Query: 399 RDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTD 458
+L I++D E L L L+ + ++APE T +EK+D
Sbjct: 807 GNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-----AYVAPETRETKDITEKSD 860
Query: 459 VFGYGITLLELVTGQRAID 477
++G+G+ L+EL+TG+ D
Sbjct: 861 IYGFGLILIELLTGKSPAD 879
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 2e-33
Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 16/224 (7%)
Query: 272 NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEA-AFQREVHLISVAIHKN 329
++ ++G+G FG VY + D + +AVK ++ E A +RE+ ++S H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 330 LLQLIGYCTTSSERILVYPFMQNL---SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386
+++ G E+ + F++ + S++ L+ L P ++ GL
Sbjct: 61 IVRYYG-SERDEEKNTLNIFLEYVSGGSLSSLLKKFGK----LPEPVIRKYTRQILEGLA 115
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGHIAP 445
YLH I+HRD+K ANIL+D + L DFG AK + D + T +RGT +AP
Sbjct: 116 YLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL 489
E + + D++ G T++E+ TG+ +S L L
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGKPP--WSELGNPMAALY 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 2e-29
Identities = 67/198 (33%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 279 IGQGGFGKVYKG-VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
IG+GGFG+VYK +VA+K + S + E+ ++ H N+++ G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVI-KLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 338 TTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396
E +V F S L+D LK + L V GLEYLH I
Sbjct: 67 LKKDELWIVMEFCSGGS----LKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GI 119
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSE 455
IHRD+KAANILL + E L DFGL+ L D K + GT +APE ++
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVINGKPYDY 176
Query: 456 KTDVFGYGITLLELVTGQ 473
K D++ GIT +EL G+
Sbjct: 177 KADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 65/198 (32%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEA-AFQREVHLISVAIHKNLLQLIGYC 337
IG+G FG V G KVAVK L+D A AF E +++ H NL+QL+G
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDD---STAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 338 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 397
+ +V +M S+ LR G + + A G+EYL E+ +
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLR--SRGRAVITLAQQLGFALDVCEGMEYLEEK---NFV 124
Query: 398 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 457
HRDL A N+L+ ++ A + DFGLAK ++ T APE L K S K+
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKS 180
Query: 458 DVFGYGITLLELVTGQRA 475
DV+ +GI L E+ + R
Sbjct: 181 DVWSFGILLWEIYSFGRV 198
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 67/199 (33%), Positives = 98/199 (49%), Gaps = 19/199 (9%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 336
+G G FG+V+ G + TKVAVK L+ PG AF +E ++ H L+QL
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLK----PGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396
C+ +V +M S+ L+ K L P +A A G+ YL +
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESR---NY 124
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQ--IRGTMGHIAPEYLSTGK 452
IHRDL A NIL+ +N + DFGLA+L+ D + I+ T APE + G+
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAANYGR 180
Query: 453 SSEKTDVFGYGITLLELVT 471
+ K+DV+ +GI L E+VT
Sbjct: 181 FTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 67/223 (30%), Positives = 97/223 (43%), Gaps = 18/223 (8%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAA--FQREVH-LISVAIHKNLLQLIG 335
+G+G FG+VY D VA+K L + F RE+ L S+ N+++L
Sbjct: 8 LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 395
+ LV ++ S+ L + L + LEYLH +
Sbjct: 66 FFQDEGSLYLVMEYVDGGSL-EDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--- 121
Query: 396 IIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHVTTQIR-----GTMGHIAPEYL- 448
IIHRD+K NILLD D L DFGLAKL+ + + GT G++APE L
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 449 --STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL 489
S +S +D++ GITL EL+TG + + L
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL 224
|
Length = 384 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 68/206 (33%), Positives = 103/206 (50%), Gaps = 16/206 (7%)
Query: 273 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLL 331
F+ +G G FG+V++G+ + +VA+K L D + FQ+EV + HK+L+
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQD--FQKEVQALKRLRHKHLI 65
Query: 332 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
L C+ ++ M+ S+ LR P + L + +A A G+ YL EQ
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTT-QIRGTMGHIAPEYL 448
IHRDL A NIL+ ++ + DFGLA+L+ D L+ + T APE
Sbjct: 124 ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT----APEAA 176
Query: 449 STGKSSEKTDVFGYGITLLELVT-GQ 473
S G S K+DV+ +GI L E+ T GQ
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQ 202
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 64/220 (29%), Positives = 102/220 (46%), Gaps = 22/220 (10%)
Query: 261 FSCRELQLATDNFSESNIIGQGGFGKVYKG---VLSDNT--KVAVKRLQDYYSPGGEAAF 315
F R L+ +G+G FGKV L DNT +VAVK L + F
Sbjct: 1 FEKRHLKF-------IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDF 53
Query: 316 QREVHLISVAIHKNLLQLIGYCTTSSERI--LVYPFMQNLSVAYRLRDLKPGEKGLDWPT 373
+RE+ ++ H+N+++ G C R L+ ++ + S+ L+ + ++
Sbjct: 54 EREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ---INLKR 110
Query: 374 RKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 433
+ G++YL Q + IHRDL A NIL++ + DFGLAK++ +
Sbjct: 111 LLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYY 167
Query: 434 TQIRGT--MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
+ G + APE L T K S +DV+ +G+TL EL T
Sbjct: 168 VKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 272 NFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGE-AAFQREVHLISVAIHKN 329
N+ ++IG+G FG VYKG+ L VA+K++ + +E+ L+ H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 389
+++ IG TS ++ + +N S LR + + GL YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGS----LRQIIKKFGPFPESLVAVYVYQVLQGLAYLH 116
Query: 390 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 449
EQ +IHRD+KAANIL + L DFG+A ++ ++ + GT +APE +
Sbjct: 117 EQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLND-VSKDDASVVGTPYWMAPEVIE 172
Query: 450 TGKSSEKTDVFGYGITLLELVTGQ 473
+S +D++ G T++EL+TG
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 63/201 (31%), Positives = 98/201 (48%), Gaps = 19/201 (9%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338
IG+G FG VYKGVL NT+VAVK + P + F +E ++ H N+++LIG C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 339 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG--TAYGLEYLHEQCNPKI 396
+V + S+ LR +K +K + A G+EYL +
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLR-----KKKNRLTVKKLLQMSLDAAAGMEYLESKN---C 114
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI-----APEYLSTG 451
IHRDL A N L+ +N + DFG+++ + + V+ + I APE L+ G
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS----DGLKQIPIKWTAPEALNYG 170
Query: 452 KSSEKTDVFGYGITLLELVTG 472
+ + ++DV+ YGI L E +
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 277 NIIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+IG G FG+V +G L K VA+K L+ S F E ++ H N+++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 392
L G T S +++ +M+N S+ LR+ + + G A G++YL E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEMN 126
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-----IRGTMGHIAPEY 447
+HRDL A NIL++ N + DFGL++ ++ TT+ IR T APE
Sbjct: 127 ---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEA 179
Query: 448 LSTGKSSEKTDVFGYGITLLELVT-GQR 474
++ K + +DV+ +GI + E+++ G+R
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 61/195 (31%), Positives = 94/195 (48%), Gaps = 11/195 (5%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 336
+G G FG+V++G+ ++ T VAVK L+ PG F E ++ H L+QL
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLK----PGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396
CT +V M+ S+ L+ + L P +A A G+ YL Q
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQ--GGAGRALKLPQLIDMAAQVASGMAYLEAQ---NY 124
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK 456
IHRDL A N+L+ +N + DFGLA+++ + + + APE + S K
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184
Query: 457 TDVFGYGITLLELVT 471
+DV+ +GI L E+VT
Sbjct: 185 SDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 3e-23
Identities = 70/221 (31%), Positives = 100/221 (45%), Gaps = 25/221 (11%)
Query: 276 SNIIGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQ---REVHLISVAIHKN 329
N IG G FGKVY V L +AVK R+QD + E+ ++ + H N
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD----NDPKTIKEIADEMKVLELLKHPN 60
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 389
L + Y R VY FM+ S L +L + LD + GL YLH
Sbjct: 61 L---VKYYGVEVHREKVYIFMEYCSGG-TLEELLEHGRILDEHVIRVYTLQLLEGLAYLH 116
Query: 390 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG---HIAPE 446
I+HRD+K ANI LD N L DFG A + T + +++ G ++APE
Sbjct: 117 SH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173
Query: 447 YLSTGKSSEK---TDVFGYGITLLELVTGQRAIDFSRLEEE 484
++ GK D++ G +LE+ TG+R +S L+ E
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRP--WSELDNE 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 3e-23
Identities = 67/206 (32%), Positives = 102/206 (49%), Gaps = 20/206 (9%)
Query: 277 NIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+IG+G FG VY G L D+ AVK L F +E ++ H N+L
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 333 LIGYC-TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR-VAFG--TAYGLEYL 388
L+G C + ++V P+M++ + +R PT K + FG A G+EYL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHN------PTVKDLIGFGLQVAKGMEYL 114
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK---LTHVTTQIRGTMGHIAP 445
+ K +HRDL A N +LD++F + DFGLA+ + K H T + + +A
Sbjct: 115 ASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVT 471
E L T K + K+DV+ +G+ L EL+T
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 4e-23
Identities = 73/200 (36%), Positives = 104/200 (52%), Gaps = 16/200 (8%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 336
+G G FG+V+ G + NTKVAVK L+ PG +F E ++ H L+QL Y
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLK----PGTMSPESFLEEAQIMKKLRHDKLVQL--Y 67
Query: 337 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGE-KGLDWPTRKRVAFGTAYGLEYLHEQCNP 394
S E I +V +M S+ L LK GE + L P +A A G+ Y+ E+ N
Sbjct: 68 AVVSEEPIYIVTEYMSKGSL---LDFLKDGEGRALKLPNLVDMAAQVAAGMAYI-ERMN- 122
Query: 395 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 454
IHRDL++ANIL+ D + DFGLA+L++ + + APE G+ +
Sbjct: 123 -YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 455 EKTDVFGYGITLLELVTGQR 474
K+DV+ +GI L ELVT R
Sbjct: 182 IKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-23
Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 23/211 (10%)
Query: 36 EGEALIEVLKALNDTHGQFT-----DWN-DHFVSPCFSWSHVTCRNGNVIS------LTL 83
E + L+E + AL WN D V WS C+ + L L
Sbjct: 366 ESKTLLEEVSALQTLKSSLGLPLRFGWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGL 425
Query: 84 GSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPAT 143
+ G G I I+KL+ L S+ L N + G +P LGS+T L+ L+L+ N F+GSIP +
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485
Query: 144 WSQLSNLKHLDLSSNNLTGRIPM----QLFSVATFNFTGTHLICGSSLEQPCMSRPSPPV 199
QL++L+ L+L+ N+L+GR+P +L A+FNFT +CG + C P V
Sbjct: 486 LGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRAC--GPHLSV 543
Query: 200 STSRTKLRIVVASASCGAFVLLSLGALFACR 230
+I +A AF+ L + A+ +
Sbjct: 544 GA-----KIGIAFGVSVAFLFLVICAMCWWK 569
|
Length = 623 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 5e-22
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 32/216 (14%)
Query: 279 IGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+G+G FGKV+ G D VAVK L++ S F+RE L++ H+N+++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK----------RVAFGTA 382
G CT I+V+ +M++ + LR P L P ++A A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 383 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 442
G+ YL Q +HRDL N L+ + + DFG+++ V TT GH
Sbjct: 133 SGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDV------YTTDYYRVGGH 183
Query: 443 -------IAPEYLSTGKSSEKTDVFGYGITLLELVT 471
+ PE + K + ++DV+ +G+ L E+ T
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 6e-22
Identities = 66/224 (29%), Positives = 107/224 (47%), Gaps = 26/224 (11%)
Query: 278 IIGQGGFGKVYKGV---LSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
++G G FG VYKGV + K VA+K L++ SP E ++++ H ++++
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG----LDWPTRKRVAFGTAYGLEYL 388
L+G C +S L+ M + +R+ K G L+W + A G+ YL
Sbjct: 74 LLGICLSSQ-VQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQ------IAKGMSYL 125
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---AP 445
E+ +++HRDL A N+L+ + DFGLAKL+D G I A
Sbjct: 126 EEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY--HAEGGKVPIKWMAL 180
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVL 488
E + + K+DV+ YG+T+ EL+T G + + E D+L
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 6e-22
Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 26/209 (12%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
IG+G FGKVY SD +K + S EV ++ H N+ I Y
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI---IKY 64
Query: 337 CTTSSERILVYPFMQ-----NLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYGLEY 387
+ E+ + M+ +LS + + + P E+ LDW + L+Y
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ------LCLALKY 118
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 447
LH + KI+HRD+K NI L N L DFG++K++ + + T + GT +++PE
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE- 173
Query: 448 LSTGKS-SEKTDVFGYGITLLELVTGQRA 475
L K + K+D++ G L EL T +
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-21
Identities = 61/195 (31%), Positives = 94/195 (48%), Gaps = 32/195 (16%)
Query: 6 HKCCPPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPC 65
+ CP + + + FLNF E E E L+ ++ND ++WN C
Sbjct: 6 PQHCPYLIFMLFFL---FLNFSMLHAE---ELELLLSFKSSINDPLKYLSNWNSS-ADVC 58
Query: 66 FSWSHVTCRNGN-VISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPD------ 118
W +TC N + V+S+ L SGKIS +I +L ++ ++ L +N LSG +PD
Sbjct: 59 -LWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTS 117
Query: 119 ----FL-------------GSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLT 161
+L GS+ +L++L+L+NN SG IP S+LK LDL N L
Sbjct: 118 SSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLV 177
Query: 162 GRIPMQLFSVATFNF 176
G+IP L ++ + F
Sbjct: 178 GKIPNSLTNLTSLEF 192
|
Length = 968 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 68/217 (31%), Positives = 104/217 (47%), Gaps = 29/217 (13%)
Query: 279 IGQGGFGKVYKGVLSDNTK-VAVKR--LQDYYSPGGEAAFQ--REVHLISVAIHKNLLQL 333
+G G FG VY+G+ D+ AVK L D G EA Q +E+ L+S H N++Q
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 334 IGYCTTSSERILVY-PFMQNLSVAYRLRDLKPGEKGLDWP-----TRKRVAFGTAYGLEY 387
+G + + ++ + S+A L+ P TR+ + GLEY
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAKLLKKYGS----FPEPVIRLYTRQILL-----GLEY 117
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 447
LH++ +HRD+K ANIL+D N L DFG+AK V +G+ +APE
Sbjct: 118 LHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGSPYWMAPEV 172
Query: 448 L-STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEE 483
+ G D++ G T+LE+ TG+ +S+LE
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGK--PPWSQLEG 207
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 3e-21
Identities = 71/201 (35%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 336
+GQG FG+V+ G + T+VA+K L+ PG AF +E ++ H+ L+QL Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLK----PGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 67
Query: 337 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKG--LDWPTRKRVAFGTAYGLEYLHEQCN 393
S E I +V +M S L D GE G L P +A A G+ Y+ E+ N
Sbjct: 68 AVVSEEPIYIVTEYMSKGS----LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMN 122
Query: 394 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS 453
+HRDL+AANIL+ +N + DFGLA+L++ + + APE G+
Sbjct: 123 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 180
Query: 454 SEKTDVFGYGITLLELVTGQR 474
+ K+DV+ +GI L EL T R
Sbjct: 181 TIKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 3e-21
Identities = 70/206 (33%), Positives = 108/206 (52%), Gaps = 28/206 (13%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
+G G FG+V+ G + +TKVA+K L Q SP AF E +L+ H L++L Y
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP---EAFLAEANLMKQLQHPRLVRL--YA 68
Query: 338 TTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV--AFGTAYGLEYLHEQCNP 394
+ E I ++ +M+N S L D +G+ K + A A G+ ++ E+ N
Sbjct: 69 VVTQEPIYIITEYMENGS----LVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI-ERKN- 122
Query: 395 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGHIAPEYL 448
IHRDL+AANIL+ + + DFGLA+L+ + T + I+ T APE +
Sbjct: 123 -YIHRDLRAANILVSETLCCKIADFGLARLI--EDNEYTAREGAKFPIKWT----APEAI 175
Query: 449 STGKSSEKTDVFGYGITLLELVTGQR 474
+ G + K+DV+ +GI L E+VT R
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 4e-21
Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 24/204 (11%)
Query: 277 NIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPG----GEAAFQREVHLISVAIHKNLL 331
+ +G G +G+VY+GV + VAVK L++ EAA +E+ H NL+
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK------HPNLV 65
Query: 332 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
QL+G CT ++ FM ++ LR+ + ++ +A + +EYL ++
Sbjct: 66 QLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK 123
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQ--IRGTMGHIAPEY 447
IHRDL A N L+ +N + DFGL++L+ D H + I+ T APE
Sbjct: 124 ---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APES 176
Query: 448 LSTGKSSEKTDVFGYGITLLELVT 471
L+ K S K+DV+ +G+ L E+ T
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 4e-21
Identities = 61/210 (29%), Positives = 113/210 (53%), Gaps = 17/210 (8%)
Query: 274 SESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
++ +IG G FG+V++G+L VA+K L+ Y+ F E ++ H N
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--GTAYGLEY 387
+++L G T +++ +M+N ++ LRD GE + + + V G A G++Y
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRD-HDGE----FSSYQLVGMLRGIAAGMKY 122
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAP 445
L + +HRDL A NIL++ N E + DFGL++++ D + T+ T+ + + AP
Sbjct: 123 LSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVT-GQR 474
E ++ K + +DV+ +GI + E+++ G+R
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGER 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 4e-21
Identities = 75/200 (37%), Positives = 105/200 (52%), Gaps = 16/200 (8%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 336
+GQG FG+V+ G + TKVA+K L+ PG AF +E ++ H L+ L Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLK----PGTMMPEAFLQEAQIMKKLRHDKLVPL--Y 67
Query: 337 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGE-KGLDWPTRKRVAFGTAYGLEYLHEQCNP 394
S E I +V FM S+ L LK G+ K L P +A A G+ Y+ E+ N
Sbjct: 68 AVVSEEPIYIVTEFMGKGSL---LDFLKEGDGKYLKLPQLVDMAAQIADGMAYI-ERMN- 122
Query: 395 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 454
IHRDL+AANIL+ DN + DFGLA+L++ + + APE G+ +
Sbjct: 123 -YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 455 EKTDVFGYGITLLELVTGQR 474
K+DV+ +GI L ELVT R
Sbjct: 182 IKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 64/196 (32%), Positives = 97/196 (49%), Gaps = 16/196 (8%)
Query: 279 IGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
IG+G FG+V+ G L +DNT VAVK ++ P +A F +E ++ H N+++LIG C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 338 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 397
T +V +Q LR P L ++ A G+EYL + I
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGP---RLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 398 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI-----APEYLSTGK 452
HRDL A N L+ + + DFG+++ + + T G M I APE L+ G+
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST----GGMKQIPVKWTAPEALNYGR 172
Query: 453 SSEKTDVFGYGITLLE 468
S ++DV+ +GI L E
Sbjct: 173 YSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 1e-20
Identities = 60/191 (31%), Positives = 97/191 (50%), Gaps = 6/191 (3%)
Query: 278 IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
++G+G FG+V+KG L D T VAVK ++ + F E ++ H N+++LIG C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 338 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 397
T +R +Y M+ + L L+ + L + A A G+ YL + I
Sbjct: 62 T---QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCI 115
Query: 398 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 457
HRDL A N L+ +N + DFG+++ D + + + + APE L+ G+ S ++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 458 DVFGYGITLLE 468
DV+ YGI L E
Sbjct: 176 DVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 3e-20
Identities = 67/202 (33%), Positives = 93/202 (46%), Gaps = 24/202 (11%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAF-QREVHLISVAIHKNLLQLIGY 336
IG+G FG+VYK + N VA+K + D E Q+E+ +S + + G
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVI-DLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDL-KPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 395
S+ ++ + S DL KPG LD + GLEYLHE+
Sbjct: 68 FLKGSKLWIIMEYCGGGSC----LDLLKPG--KLDETYIAFILREVLLGLEYLHEE---G 118
Query: 396 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR-----GTMGHIAPEYLST 450
IHRD+KAANILL + + L DFG V +LT T + GT +APE +
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFG----VSGQLTS--TMSKRNTFVGTPFWMAPEVIKQ 172
Query: 451 GKSSEKTDVFGYGITLLELVTG 472
EK D++ GIT +EL G
Sbjct: 173 SGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 3e-20
Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 279 IGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL-- 330
+GQG FG VY+G+ T+VA+K + + S F L ++ K
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEF-----LNEASVMKEFNC 68
Query: 331 ---LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEK---GLDWPTRKRV---AFGT 381
++L+G +T ++V M + LR +P + GL PT ++ A
Sbjct: 69 HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 441
A G+ YL + K +HRDL A N ++ ++ + DFG+ + D T + +
Sbjct: 129 ADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTR--DIYETDYYRKGGKGLL 183
Query: 442 HI---APEYLSTGKSSEKTDVFGYGITLLELVT 471
+ APE L G + K+DV+ +G+ L E+ T
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 6e-20
Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 19/205 (9%)
Query: 279 IGQGGFGKVYKGV-LSDNTK---VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLI 334
+G G FG V KGV L + K VAVK L+ + G+ F RE +++ H +++LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 335 GYCTTSSERILVYPFM--QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 392
G C P M L+ L + + K +A A G+ YL +
Sbjct: 63 GVC-------KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK- 114
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT--MGHIAPEYLST 450
+HRDL A N+LL + +A + DFG+++ + A + G + APE ++
Sbjct: 115 --HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 451 GKSSEKTDVFGYGITLLELVT-GQR 474
GK S K+DV+ YG+TL E + G +
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 277 NIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLI 334
IG+G +G+VYK VA+K+++ + G RE+ L+ H N+++L
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 335 GYCT--TSSERILVYPFMQNLSVAYRLRDL-----KPGEKGLDWPTRKRVAFGTAYGLEY 387
T +V+ +M + DL P K K GL+Y
Sbjct: 65 EIVTSKGKGSIYMVFEYMDH--------DLTGLLDSPEVK-FTESQIKCYMKQLLEGLQY 115
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 447
LH I+HRD+K +NIL++++ L DFGLA+ + + T T+ + PE
Sbjct: 116 LHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172
Query: 448 L--STGKSSEKTDVFGYGITLLELVTG 472
L +T + + D++ G L EL G
Sbjct: 173 LLGAT-RYGPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 65/211 (30%), Positives = 107/211 (50%), Gaps = 18/211 (8%)
Query: 278 IIGQGGFGKVYKGVLS--DNT--KVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQ 332
I+G+G FG V +G LS D + KVAVK ++ D ++ F E + H N+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 333 LIGYCTTSSER------ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--GTAYG 384
LIG C +S +++ PFM++ + L + G P + + F A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI-RGTMGHI 443
+EYL N IHRDL A N +L ++ + DFGL+K + + + +I + + I
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVT-GQ 473
A E L+ + K+DV+ +G+T+ E+ T GQ
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 64/202 (31%), Positives = 90/202 (44%), Gaps = 11/202 (5%)
Query: 277 NIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
+IG G VY + L +N KVA+KR+ ++EV +S H N+++
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 395
E LV P++ S+ ++ P GLD V GLEYLH
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---G 122
Query: 396 IIHRDLKAANILLDDNFEAVLCDFG----LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 451
IHRD+KA NILL ++ + DFG LA D T GT +APE +
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT-FVGTPCWMAPEVMEQV 181
Query: 452 KS-SEKTDVFGYGITLLELVTG 472
K D++ +GIT +EL TG
Sbjct: 182 HGYDFKADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-19
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 273 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEA-----AFQREVHLISVAIH 327
+++ ++G+G +G VY G+ + +AVK+++ S A Q EV L+ H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
N++Q +G C + + F+ S++ L P L P + G+ Y
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGP----LPEPVFCKYTKQILDGVAY 117
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK---LVDAKLTH--VTTQIRGTMGH 442
LH C ++HRD+K N++L N L DFG A+ V TH + + GT
Sbjct: 118 LHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 443 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
+APE ++ K+D++ G T+ E+ TG+
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 3e-19
Identities = 57/213 (26%), Positives = 88/213 (41%), Gaps = 45/213 (21%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLI-------------S 323
+G+G +G VYK + VA+K + +E+ ++ S
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVP---VEEDLQEIIKEISILKQCDSPYIVKYYGS 66
Query: 324 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDL-KPGEKGLDWPTRKRVAFGTA 382
+ +L ++ YC S + D+ K K L + + T
Sbjct: 67 YFKNTDLWIVMEYCGAGS-----------------VSDIMKITNKTLTEEEIAAILYQTL 109
Query: 383 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR---GT 439
GLEYLH K IHRD+KA NILL++ +A L DFG V +LT + GT
Sbjct: 110 KGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFG----VSGQLTDTMAKRNTVIGT 162
Query: 440 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 472
+APE + + K D++ GIT +E+ G
Sbjct: 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 4e-19
Identities = 60/224 (26%), Positives = 107/224 (47%), Gaps = 24/224 (10%)
Query: 265 ELQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQRE 318
E+ L+ F E +G+G FGKVYKG L T VA+K L++ P + F++E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 319 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV-AYRLR-----------DLKPGE 366
L+S H N++ L+G CT +++ ++ + + + +R + +
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 367 KGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV- 425
LD +A A G+EYL +HRDL A N L+ + + DFGL++ +
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLEL 469
A V ++ + + PE + GK + ++D++ +G+ L E+
Sbjct: 176 SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 6e-19
Identities = 59/193 (30%), Positives = 94/193 (48%), Gaps = 12/193 (6%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338
IG G FG V+ G + KVA+K +++ E F E ++ H L+QL G CT
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 339 TSSERILVYPFMQNLSVAYRLRDLKPGEKG-LDWPTRKRVAFGTAYGLEYLHEQCNPKII 397
S LV+ FM++ ++ LR ++G T + G+ YL +I
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLR----AQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122
Query: 398 HRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK 456
HRDL A N L+ +N + DFG+ + V D + T +T + + +PE S K S K
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGTKFPVKWSSPEVFSFSKYSSK 181
Query: 457 TDVFGYGITLLEL 469
+DV+ +G+ + E+
Sbjct: 182 SDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 7e-19
Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 15/197 (7%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEA--AFQREVHLISVAIHKNLLQLIGY 336
+G G FG+V+ G +++TKVAVK L+ PG + AF E +L+ H L++L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK----PGTMSVQAFLEEANLMKTLQHDKLVRLYAV 69
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT--AYGLEYLHEQCNP 394
T ++ +M S L D ++G K + F A G+ Y+ +
Sbjct: 70 VTKEEPIYIITEYMAKGS----LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK--- 122
Query: 395 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 454
IHRDL+AAN+L+ ++ + DFGLA++++ + + APE ++ G +
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 455 EKTDVFGYGITLLELVT 471
K+DV+ +GI L E+VT
Sbjct: 183 IKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 8e-19
Identities = 46/137 (33%), Positives = 73/137 (53%), Gaps = 9/137 (6%)
Query: 362 LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421
LK + + ++A GL YLHE+ KIIHRD+K +NIL++ + LCDFG+
Sbjct: 90 LKEVQGRIPERILGKIAVAVLKGLTYLHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGV 147
Query: 422 A-KLVDAK-LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479
+ +LV++ T V GT ++APE + S K+D++ G++L+EL TG+
Sbjct: 148 SGQLVNSLAKTFV-----GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202
Query: 480 RLEEEEDVLLLDHKVTE 496
+ LL + V E
Sbjct: 203 NDPPDGIFELLQYIVNE 219
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 9e-19
Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 18/207 (8%)
Query: 273 FSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIH-- 327
+ +IG+G +G VY+G V + VA+K + + +P + + QREV L+S
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRV-VALKII-NLDTPDDDVSDIQREVALLSQLRQSQ 60
Query: 328 -KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386
N+ + G ++ + + SV ++ EK + R+ L+
Sbjct: 61 PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIRE-----VLVALK 115
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 446
Y+H+ +IHRD+KAANIL+ + LCDFG+A L++ + +T + GT +APE
Sbjct: 116 YIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPE 171
Query: 447 YLSTGKSSE-KTDVFGYGITLLELVTG 472
++ GK + K D++ GIT+ E+ TG
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 58/199 (29%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
IG+G +G VYK VA+K++ + S G RE+ L+ H N+++L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 337 CTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 395
+ LV+ FM +L Y+L +K ++GL K + GL + H
Sbjct: 67 FRHKGDLYLVFEFMDTDL---YKL--IKDRQRGLPESLIKSYLYQLLQGLAFCHSH---G 118
Query: 396 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS-S 454
I+HRDLK N+L++ L DFGLA+ + + T + T + APE L K S
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTRWYRAPELLLGDKGYS 177
Query: 455 EKTDVFGYGITLLELVTGQ 473
D++ G EL++ +
Sbjct: 178 TPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 4e-18
Identities = 60/210 (28%), Positives = 105/210 (50%), Gaps = 23/210 (10%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEA-------AFQREVHLISVAIHK 328
+IG G FG VY G+ S +AVK+++ S + A RE+ L+ H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 329 NLLQLIGYCTTSSERILVY-PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
N++Q +G + ++ + ++ ++ SVA L + E+ L + GL Y
Sbjct: 67 NIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFVRQILKGLNY 121
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-----IRGTMGH 442
LH N IIHRD+K ANIL+D+ + DFG++K ++A T ++G++
Sbjct: 122 LH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 443 IAPEYLSTGKSSEKTDVFGYGITLLELVTG 472
+APE + + K D++ G ++E++TG
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 7e-18
Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 279 IGQGGFGKVY--KGVLSDNT---KVAVKR-LQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+G+G FGKV + + KV K+ + E +++S H +++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR---KEVEHTLTERNILSRINHPFIVK 57
Query: 333 LIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA---YGLEYL 388
L Y + E++ LV + + L E +R F A LEYL
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHLSK----EGRFS---EERARFYAAEIVLALEYL 109
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 448
H II+RDLK NILLD + L DFGLAK + ++ + T GT ++APE L
Sbjct: 110 HSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVL 165
Query: 449 STGKSSEKTDVFGYGITLLELVTGQ 473
+ D + G+ L E++TG+
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 9e-18
Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 37/221 (16%)
Query: 278 IIGQGGFGKVYKG--VLSDNTK----VAVKRLQDYYSPGGEAAFQREV-HLIS------- 323
+G+G FG+V K V DN VAVK L+D A ++++ L+S
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKD-------DATEKDLSDLVSEMEMMKM 71
Query: 324 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGE----KGLDWPTRKRV-- 377
+ HKN++ L+G CT +V + + ++ LR +P P + +
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 378 ------AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLT 430
A+ A G+E+L + K IHRDL A N+L+ ++ + DFGLA+ +
Sbjct: 132 KDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188
Query: 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
TT R + +APE L + ++DV+ +G+ L E+ T
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 64/219 (29%), Positives = 111/219 (50%), Gaps = 19/219 (8%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEA--AFQREVHLISVAIHKNLLQLIGY 336
+G G FG+V+ + +TKVAVK ++ PG + AF E +++ H L++L +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMK----PGSMSVEAFLAEANVMKTLQHDKLVKL--H 67
Query: 337 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT--AYGLEYLHEQCN 393
+ E I ++ FM S L D ++G P K + F A G+ ++ ++
Sbjct: 68 AVVTKEPIYIITEFMAKGS----LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR-- 121
Query: 394 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS 453
IHRDL+AANIL+ + + DFGLA++++ + + APE ++ G
Sbjct: 122 -NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 180
Query: 454 SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH 492
+ K+DV+ +GI L+E+VT R I + + E + L+
Sbjct: 181 TIKSDVWSFGILLMEIVTYGR-IPYPGMSNPEVIRALER 218
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 65/209 (31%), Positives = 106/209 (50%), Gaps = 17/209 (8%)
Query: 279 IGQGGFGKVYKGVLSDNT---KVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 334
+G+G FG V +G L+ + KVAVK ++ E F E + H N+++LI
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 335 GYCTTSSER------ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT--AYGLE 386
G C + E +++ PFM++ + L + G+ PT+ V F T A G+E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI-RGTMGHIAP 445
YL + IHRDL A N +L++N + DFGL+K + + +I + + IA
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVT-GQ 473
E L+ + K+DV+ +G+T+ E+ T GQ
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQ 212
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 1e-17
Identities = 67/201 (33%), Positives = 102/201 (50%), Gaps = 20/201 (9%)
Query: 278 IIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
IIG+G FG V +G + KVAVK ++ D + AF E +++ HKNL++L+G
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTA----QAFLEETAVMTKLHHKNLVRLLGV 67
Query: 337 CTTSSERILVYPFMQ--NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 394
+ I V M NL R R G + + + A G+EYL +
Sbjct: 68 ILHNGLYI-VMELMSKGNLVNFLRTR----GRALVSVIQLLQFSLDVAEGMEYLESK--- 119
Query: 395 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 454
K++HRDL A NIL+ ++ A + DFGLA++ + + ++ T APE L K S
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFS 175
Query: 455 EKTDVFGYGITLLELVTGQRA 475
K+DV+ YG+ L E+ + RA
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 64/217 (29%), Positives = 95/217 (43%), Gaps = 17/217 (7%)
Query: 269 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVH-LISVAIH 327
T F +IG+G +GKVYK ++ ++ D E + E + L + H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDI-IEDEEEEIKEEYNILRKYSNH 62
Query: 328 KNLLQLIGYCTTSSERI------LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 381
N+ G + LV SV ++ L+ K L + T
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 441
GL YLHE K+IHRD+K NILL N E L DFG++ +D+ L T I GT
Sbjct: 123 LRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPY 178
Query: 442 HIAPEYLSTGKSSEKT-----DVFGYGITLLELVTGQ 473
+APE ++ + + + DV+ GIT +EL G+
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 1e-17
Identities = 64/212 (30%), Positives = 104/212 (49%), Gaps = 27/212 (12%)
Query: 278 IIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 333
+IG G FG+V +G L K VA+K L+ Y+ F E ++ H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 334 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--GTAYGLEYLHEQ 391
G T S +++ FM+N ++ LR G+ + + V G A G++YL E
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLR-QNDGQ----FTVIQLVGMLRGIAAGMKYLSEM 125
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT--------TQIRGTMGHI 443
+HRDL A NIL++ N + DFGL++ ++ + T IR T
Sbjct: 126 ---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT---- 178
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVT-GQR 474
APE ++ K + +DV+ YGI + E+++ G+R
Sbjct: 179 APEAIAYRKFTSASDVWSYGIVMWEVMSYGER 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 68/236 (28%), Positives = 99/236 (41%), Gaps = 44/236 (18%)
Query: 272 NFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
+F +IG+G FGKV D K+ A+K Y + Q+ V SV N
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMK----YMNK------QKCVEKGSVRNVLNE 50
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVA-------YRLRDLKPGEKG-LDWPTRKRVAFGT- 381
+++ E L +PF+ NL + Y + DL G G L + ++V F
Sbjct: 51 RRIL------QE--LNHPFLVNLWYSFQDEENMYLVVDLLLG--GDLRYHLSQKVKFSEE 100
Query: 382 ---------AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432
LEYLH + IIHRD+K NILLD+ + DF +A V +
Sbjct: 101 QVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD--TL 155
Query: 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 488
TT GT G++APE L S D + G+T E + G+R + +
Sbjct: 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR 211
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 56/218 (25%), Positives = 101/218 (46%), Gaps = 22/218 (10%)
Query: 278 IIGQGGFGKVYKGVLSDNTKV-AVKRLQ---------DYYSPGGEAAFQREVHLISVAIH 327
+IG+G +G+VY + ++ AVK+++ D A + E+ + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
N++Q +G+ TT + ++ S+ LR G + + GL Y
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR--TYGR--FEEQLVRFFTEQVLEGLAY 123
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPE 446
LH + I+HRDLKA N+L+D + + DFG++K D + ++G++ +APE
Sbjct: 124 LHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 447 YLSTGKS--SEKTDVFGYGITLLELVTGQRAIDFSRLE 482
+ + S K D++ G +LE+ G+R +S E
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP--WSDEE 216
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 3e-17
Identities = 59/199 (29%), Positives = 88/199 (44%), Gaps = 12/199 (6%)
Query: 279 IGQGGFGKVYKG----VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLI 334
+G G FG V +G VAVK L+ F +E ++ H+NL++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 335 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 394
G T ++V S+ RLR G + T A A G+ YL +
Sbjct: 63 GVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLI--STLCDYAVQIANGMRYLESK--- 116
Query: 395 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--IRGTMGHIAPEYLSTGK 452
+ IHRDL A NILL + + + DFGL + + H + ++ APE L T
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 453 SSEKTDVFGYGITLLELVT 471
S +DV+ +G+TL E+ T
Sbjct: 177 FSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 60/202 (29%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 279 IGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
+G+GGFG+V + K+ A K+L + GE E ++ + + +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILE-KVSSRFIVSLA 59
Query: 336 YC-TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY---GLEYLHEQ 391
Y T + LV M + Y + ++ GE G R F A GLE+LH++
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNV--GEPGFPEA---RAIFYAAQIICGLEHLHQR 114
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 451
+I++RDLK N+LLDD+ + D GLA V+ K GT G++APE L
Sbjct: 115 ---RIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGE 169
Query: 452 KSSEKTDVFGYGITLLELVTGQ 473
D F G TL E++ G+
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
+ E + +G+G G V K L + + A+K + +P + RE+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 330 LLQLIGYCT---TSSERILV-YPFMQNLSVAY---RLRDLKPGEKGLDWPTRKRVAFGTA 382
+++ G +SS I + Y +L Y + R + GEK L ++A
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIAESVL 115
Query: 383 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMG 441
GL YLH + KIIHRD+K +NILL + LCDFG++ +LV++ T GT
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSF 168
Query: 442 HIAPEYLSTGKSSEKTDVFGYGITLLELVTG 472
++APE + S +DV+ G+TLLE+
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQN 199
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 5e-17
Identities = 43/94 (45%), Positives = 56/94 (59%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ISL L N SG+I + +L+ L L L N+ +G +P L S+ LQ L L +NKF
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKF 344
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
SG IP + +NL LDLS+NNLTG IP L S
Sbjct: 345 SGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCS 378
|
Length = 968 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 5e-17
Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 22/204 (10%)
Query: 279 IGQGGFGKVYKG-VLSDNTKVAVKRLQDYYSPGGEAA---FQREVHLISVAIHKNLLQLI 334
+G+G +G V K + VA+K+ ++ S E REV ++ H+N++ L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKE--SEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 335 GYCTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 393
LV+ ++ + L L L+ GL + + + Y H
Sbjct: 67 EAFRRKGRLYLVFEYVERTL-----LELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH-- 119
Query: 394 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL----S 449
IIHRD+K NIL+ ++ LCDFG A+ + A+ T T + APE L +
Sbjct: 120 -NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 450 TGKSSEKTDVFGYGITLLELVTGQ 473
GK DV+ G + EL+ G+
Sbjct: 179 YGKP---VDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 7e-17
Identities = 57/197 (28%), Positives = 90/197 (45%), Gaps = 14/197 (7%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338
+G G FG V+ G VA+K +++ E F E ++ H NL+QL G CT
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIRE--GAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 339 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 398
+V +M N + LR+ + G+ G +W + +EYL IH
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRE-RKGKLGTEWLLD--MCSDVCEAMEYLESNG---FIH 123
Query: 399 RDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---APEYLSTGKSSE 455
RDL A N L+ ++ + DFGLA+ V L T +GT + PE + S
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYV---LDDQYTSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 456 KTDVFGYGITLLELVTG 472
K+DV+ +G+ + E+ +
Sbjct: 181 KSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 9e-17
Identities = 61/200 (30%), Positives = 91/200 (45%), Gaps = 20/200 (10%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338
+G G FGKVYK + A ++ S F E+ ++S H N++ L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 339 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 398
++ ++ F ++ + +L E+GL P + V L +LH K+IH
Sbjct: 73 YENKLWILIEFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIH 126
Query: 399 RDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR----GTMGHIAPEYLSTGKSS 454
RDLKA NILL + + L DFG V AK T Q R GT +APE ++
Sbjct: 127 RDLKAGNILLTLDGDVKLADFG----VSAKNKS-TLQKRDTFIGTPYWMAPEVVACETFK 181
Query: 455 E-----KTDVFGYGITLLEL 469
+ K D++ GITL+EL
Sbjct: 182 DNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 62/221 (28%), Positives = 111/221 (50%), Gaps = 26/221 (11%)
Query: 265 ELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS 323
E + D E ++G+G +G VY LS ++A+K + + S + E+ L S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQP-LHEEIALHS 60
Query: 324 VAIHKNLLQLIGYCTTSSERILVYPFMQNL---SVAYRLRD----LKPGEKGLDWPTRKR 376
H+N++Q +G SE FM+ + S++ LR LK E+ + + T++
Sbjct: 61 YLKHRNIVQYLGSD---SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI 117
Query: 377 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL--CDFGLAKLVDAKLTHVTT 434
+ GL+YLH+ +I+HRD+K N+L+ + + V+ DFG +K + A + T
Sbjct: 118 LE-----GLKYLHDN---QIVHRDIKGDNVLV-NTYSGVVKISDFGTSKRL-AGINPCTE 167
Query: 435 QIRGTMGHIAPEYLSTGKS--SEKTDVFGYGITLLELVTGQ 473
GT+ ++APE + G D++ G T++E+ TG+
Sbjct: 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 36/220 (16%)
Query: 279 IGQGGFGKVYK----GVLS--DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
IGQG FG+V++ G+L T VAVK L++ S +A FQRE L++ H N+++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP------------------GEKGLDWPTR 374
L+G C L++ +M + LR P L +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 375 KRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT 434
+A A G+ YL E+ K +HRDL N L+ +N + DFGL++ + + + +
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 435 Q-----IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLEL 469
+ IR + PE + + + ++DV+ YG+ L E+
Sbjct: 190 ENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 61/213 (28%), Positives = 107/213 (50%), Gaps = 19/213 (8%)
Query: 268 LATDNFSESNIIGQGGFGKVYKGVL---SDNTK--VAVKRLQDYYSPGGEAAFQREVHLI 322
L F + ++G G FG VYKG+ + K VA+K L++ SP E +++
Sbjct: 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 63
Query: 323 SVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 380
+ + ++ +L+G C TS+ +++ + PF L +D + L+W +
Sbjct: 64 ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 117
Query: 381 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRG 438
A G+ YL E+ +++HRDL A N+L+ + DFGLAKL+ D K H +
Sbjct: 118 IAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG-KV 173
Query: 439 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
+ +A E + + ++DV+ YG+T+ EL+T
Sbjct: 174 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 16/208 (7%)
Query: 272 NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQ-DYYSPGGE---AAFQREVHLISVAI 326
N+ ++GQG FG+VY D + +AVK++ D SP + A + E+ L+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 327 HKNLLQLIGYCTTSSERILVY-PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGL 385
H+ ++Q G C E + ++ +M SV +L+ + + TRK G+
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETV---TRK-YTRQILEGV 117
Query: 386 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT--TQIRGTMGHI 443
EYLH I+HRD+K ANIL D L DFG +K + + T + GT +
Sbjct: 118 EYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVT 471
+PE +S K DV+ G T++E++T
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 61/221 (27%), Positives = 95/221 (42%), Gaps = 40/221 (18%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAF-QREVHLISVAIHK 328
+++ IG G +G VYK ++ VA+K ++ PG + Q+E+ ++ H
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK--LEPGDDFEIIQQEISMLKECRHP 60
Query: 329 NLLQLIG-------------YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK 375
N++ G YC S L Y++ E + + R+
Sbjct: 61 NIVAYFGSYLRRDKLWIVMEYCGGGS-----------LQDIYQVTRGPLSELQIAYVCRE 109
Query: 376 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 435
T GL YLHE IHRD+K ANILL ++ + L DFG++ + A + +
Sbjct: 110 -----TLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF 161
Query: 436 IRGTMGHIAPEYL---STGKSSEKTDVFGYGITLLELVTGQ 473
I GT +APE G K D++ GIT +EL Q
Sbjct: 162 I-GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 2e-16
Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 12/203 (5%)
Query: 273 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLL 331
F++ IG+G FG+V+KG+ + KV ++ D E Q+E+ ++S +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 332 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
+ G ++ ++ M+ L L L+PG LD + GL+YLH +
Sbjct: 66 KYYGSYLKDTK---LWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSE 120
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEYLST 450
K IHRD+KAAN+LL ++ E L DFG+A +L D ++ GT +APE +
Sbjct: 121 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQ 175
Query: 451 GKSSEKTDVFGYGITLLELVTGQ 473
K D++ GIT +EL G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 57/221 (25%), Positives = 102/221 (46%), Gaps = 30/221 (13%)
Query: 278 IIGQGGFGKVYKGV------LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 331
+G+G FGKV K + T VAVK L++ S E +L+ H +++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 332 QLIGYCTTSSERILVYPFMQNLSVAYRLR--------------------DLKPGEKGLDW 371
+L G C+ +L+ + + S+ LR P E+ L
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 372 PTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 431
A+ + G++YL E K++HRDL A N+L+ + + + DFGL++ V + ++
Sbjct: 127 GDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 432 VT-TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
V ++ R + +A E L + ++DV+ +G+ L E+VT
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 12/203 (5%)
Query: 273 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLL 331
F++ IG+G FG+VYKG+ + +V ++ D E Q+E+ ++S +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 332 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
+ G ++ ++ M+ L L LKPG L+ + GL+YLH +
Sbjct: 66 RYYGSYLKGTK---LWIIMEYLGGGSALDLLKPGP--LEETYIATILREILKGLDYLHSE 120
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEYLST 450
+ IHRD+KAAN+LL + + L DFG+A +L D ++ T GT +APE +
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQ 175
Query: 451 GKSSEKTDVFGYGITLLELVTGQ 473
K D++ GIT +EL G+
Sbjct: 176 SAYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 3e-16
Identities = 58/213 (27%), Positives = 88/213 (41%), Gaps = 39/213 (18%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ----REVHLISVAIHKNLLQ 332
+G+G +G VYK VA+K+++ G RE+ L+ H N+++
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG---IPSTALREISLLKELKHPNIVK 62
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
L+ T + LV+ + L+ L L K + + GL Y H
Sbjct: 63 LLDVIHTERKLYLVFEYCD-----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---DAKLTH--VTTQIRGTMGHIAPE 446
+I+HRDLK NIL++ + L DFGLA+ TH VT R APE
Sbjct: 118 ---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYR------APE 168
Query: 447 YL------STGKSSEKTDVFGYGITLLELVTGQ 473
L ST D++ G E++TG+
Sbjct: 169 ILLGSKHYSTA-----VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 4e-16
Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 18/203 (8%)
Query: 279 IGQGGFGKVYK---GVLSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 333
+G+G FG V L DNT VAVK+LQ + + F+RE+ ++ H N+++
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ-HSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 334 IGYCTTSSER--ILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHE 390
G C ++ R LV ++ S LRD L+ + LD A G+EYL
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGS----LRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 391 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYL 448
+ + +HRDL NIL++ + DFGL K++ D + V + APE L
Sbjct: 127 K---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183
Query: 449 STGKSSEKTDVFGYGITLLELVT 471
+ K S +DV+ +G+ L EL T
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 5e-16
Identities = 63/224 (28%), Positives = 114/224 (50%), Gaps = 26/224 (11%)
Query: 278 IIGQGGFGKVYKGVL---SDNTK--VAVKRLQDYYSPGGEAAFQREV-HLISVAI--HKN 329
++G G FG V+KG+ D+ K VA+K +QD G FQ H++++ H
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR---SGRQTFQEITDHMLAMGSLDHAY 70
Query: 330 LLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
+++L+G C +S +++ + P L + RD ++ L+W + A G+ Y
Sbjct: 71 IVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYY 124
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAP 445
L E ++HR+L A NILL + + DFG+A L+ D K + ++ + + +A
Sbjct: 125 LEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK-KYFYSEHKTPIKWMAL 180
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVL 488
E + G+ + ++DV+ YG+T+ E+++ G R E D+L
Sbjct: 181 ESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 6e-16
Identities = 65/203 (32%), Positives = 95/203 (46%), Gaps = 23/203 (11%)
Query: 279 IGQGGFGKVY------KGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+G+GGFG+V G L K+ KRL+ G E A + L V H +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK--RKGYEGAMVEKRILAKV--HSRFIV 56
Query: 333 LIGYC-TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY---GLEYL 388
+ Y T ++ LV M + Y + ++ G P R F TA GLE+L
Sbjct: 57 SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEP---RACFYTAQIISGLEHL 113
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEY 447
H++ +II+RDLK N+LLD++ + D GLA +L D + T GT G +APE
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTKGYAGTPGFMAPEL 168
Query: 448 LSTGKSSEKTDVFGYGITLLELV 470
L + D F G+TL E++
Sbjct: 169 LQGEEYDFSVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 63/226 (27%), Positives = 99/226 (43%), Gaps = 58/226 (25%)
Query: 277 NIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REVHLISVAI 326
IG G +G V V KVA+K++ + F RE+ L+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISN--------VFDDLIDAKRILREIKLLRHLR 57
Query: 327 HKNLLQLI-----GYCTTSSERILVYPFMQ-NL-SVAYRLRDLKPGEKGLDWPTRKRVAF 379
H+N++ L+ ++ +V M+ +L V + L T + +
Sbjct: 58 HENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPL----------TDDHIQY 107
Query: 380 GTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK------L 429
Y GL+YLH N +IHRDLK +NIL++ N + +CDFGLA+ VD L
Sbjct: 108 FL-YQILRGLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163
Query: 430 T-HVTTQ-IRGTMGHIAPE-YLSTGKSSEKTDVFGYGITLLELVTG 472
T +V T+ R APE LS+ + ++ D++ G EL+T
Sbjct: 164 TEYVVTRWYR------APELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 1e-15
Identities = 60/235 (25%), Positives = 96/235 (40%), Gaps = 48/235 (20%)
Query: 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRL----------QDYYSPGGEAAFQREV 319
D+F IIG+G F V N + A+K L Y ++EV
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKY------VKIEKEV 54
Query: 320 HLISVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 377
L + H +++L Y T E L V + N + +R LD +
Sbjct: 55 -LTRLNGHPGIIKL--YYTFQDEENLYFVLEYAPNGELLQYIRKYG----SLDEKCTRFY 107
Query: 378 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 437
A LEYLH + IIHRDLK NILLD + + DFG AK++D + + +
Sbjct: 108 AAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGD 164
Query: 438 -------------------GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
GT +++PE L+ + + +D++ G + +++TG+
Sbjct: 165 ATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 1e-15
Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 17/201 (8%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVH-LISVAIHKNLLQLIG 335
+G G FG VY VA+K++ + +YS E REV L + H N+++L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKE 65
Query: 336 YCTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 394
+ E V+ +M NL + R KP + + + GL ++H+
Sbjct: 66 VFRENDELYFVFEYMEGNLYQLMKDRKGKP----FSESVIRSIIYQILQGLAHIHKH--- 118
Query: 395 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL--STGK 452
HRDLK N+L+ + DFGLA+ + ++ + T + T + APE L ST
Sbjct: 119 GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-TDYV-STRWYRAPEILLRSTSY 176
Query: 453 SSEKTDVFGYGITLLELVTGQ 473
SS D++ G + EL T +
Sbjct: 177 SS-PVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 15/225 (6%)
Query: 272 NFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA 325
N E +G+G FG+V+ T V VK LQ ++ F+RE+ +
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 326 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWP---TRKRVAFGT- 381
HKN+++L+G C + ++ + + LR K ++ L P T+++VA T
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 382 -AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 440
A G+++L N + +HRDL A N L+ E + L+K V + +
Sbjct: 126 IALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182
Query: 441 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE 485
+APE + S K+DV+ +G+ + E+ T Q + F L +EE
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT-QGELPFYGLSDEE 226
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 53/199 (26%), Positives = 92/199 (46%), Gaps = 14/199 (7%)
Query: 279 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG-Y 336
+GQG G VYK A+K++ RE+ + +++ G +
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 337 CTTSSERI-LVYPFMQNLSVAYRLRDLKP-GEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 394
I +V +M S+A L+ + E L +A GL+YLH +
Sbjct: 69 Y--KEGEISIVLEYMDGGSLADLLKKVGKIPEPVL-----AYIARQILKGLDYLHTK--R 119
Query: 395 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 454
IIHRD+K +N+L++ E + DFG++K+++ L T + GT+ +++PE + S
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYS 178
Query: 455 EKTDVFGYGITLLELVTGQ 473
D++ G+TLLE G+
Sbjct: 179 YAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 17/206 (8%)
Query: 278 IIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 333
+IG G FG+V G L K VA+K L+ Y+ F E ++ H N++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 334 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--GTAYGLEYLHEQ 391
G T S ++V +M+N S+ LR + + + V G A G++YL +
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLR-----KHDGQFTVIQLVGMLRGIASGMKYLSDM 125
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLS 449
+HRDL A NIL++ N + DFGL++++ D + + T + + APE ++
Sbjct: 126 ---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182
Query: 450 TGKSSEKTDVFGYGITLLELVT-GQR 474
K + +DV+ YGI + E+++ G+R
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGER 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 15/201 (7%)
Query: 278 IIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQ---REVHLISVAIHKNLLQL 333
++G+G +G V K + + VA+K+ S + + RE+ ++ H+NL+ L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF--LESEDDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 334 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 393
I LV+ F+ + L DL+ GLD ++ F G+E+ H +
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTV----LDDLEKYPNGLDESRVRKYLFQILRGIEFCH---S 118
Query: 394 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL-STGK 452
IIHRD+K NIL+ + LCDFG A+ + A V T T + APE L K
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-GEVYTDYVATRWYRAPELLVGDTK 177
Query: 453 SSEKTDVFGYGITLLELVTGQ 473
D++ G + E++TG+
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 3e-15
Identities = 50/126 (39%), Positives = 60/126 (47%), Gaps = 8/126 (6%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI 140
L LG N GKI S+T L L L L N L G +P LG M L+ + L N SG I
Sbjct: 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEI 228
Query: 141 PATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPCMSRPSPPVS 200
P L++L HLDL NNLTG IP L ++ + L Q +S P PP
Sbjct: 229 PYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYL--------FLYQNKLSGPIPPSI 280
Query: 201 TSRTKL 206
S KL
Sbjct: 281 FSLQKL 286
|
Length = 968 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 3e-15
Identities = 61/221 (27%), Positives = 107/221 (48%), Gaps = 20/221 (9%)
Query: 278 IIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
++G G FG VYKG+ + VA+K L + P F E +++ H +L++
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 333 LIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 390
L+G C + + +++ + P L + +D + L+W + A G+ YL E
Sbjct: 74 LLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 391 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM--GHIAPEYL 448
+ +++HRDL A N+L+ + DFGLA+L++ G M +A E +
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD-GGKMPIKWMALECI 183
Query: 449 STGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVL 488
K + ++DV+ YG+T+ EL+T G + D E D+L
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 6e-15
Identities = 65/221 (29%), Positives = 100/221 (45%), Gaps = 25/221 (11%)
Query: 279 IGQGGFGKVYKGVLSDNT-------KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 331
+G+GGFG+V V NT K+ KRL+ GE E ++ ++
Sbjct: 1 LGKGGFGEVC-AVQVKNTGKMYACKKLDKKRLK---KKSGEKMALLEKEILEKVNSPFIV 56
Query: 332 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY---GLEYL 388
L + + LV M + Y + ++ GE+GL+ +RV +A G+ +L
Sbjct: 57 NLAYAFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEM---ERVIHYSAQITCGILHL 111
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 448
H I++RD+K N+LLDD L D GLA V+ K TQ GT G++APE L
Sbjct: 112 HSM---DIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEIL 166
Query: 449 STGKSSEKTDVFGYGITLLELVTGQRAI-DFSRLEEEEDVL 488
S D F G ++ E+V G+ D +E++
Sbjct: 167 KEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 6e-15
Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 26/224 (11%)
Query: 278 IIGQGGFGKVYKGVL---SDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
++G G FG VYKG+ +N K VA+K L++ SP E ++++ + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 333 LIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 390
L+G C TS+ +++ + P+ L +D + L+W + A G+ YL E
Sbjct: 74 LLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127
Query: 391 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI-----AP 445
+++HRDL A N+L+ + DFGLA+L+D T+ G + A
Sbjct: 128 V---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDID----ETEYHADGGKVPIKWMAL 180
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVL 488
E + + + ++DV+ YG+T+ EL+T G + D E D+L
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 6e-15
Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 24/226 (10%)
Query: 265 ELQLATDNFSESNIIGQGGFGKVYKGVL----SDNTK-VAVKRLQDYYSPGGEAAFQREV 319
EL L+ F E +G+ FGK+YKG L D+ + VA+K L+D +P FQ+E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 320 HLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP--------GEKG--- 368
L++ H N++ L+G T +++ ++ + L P E G
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 369 --LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LV 425
LD +A A G+EYL +H+DL A NIL+ + + D GL++ +
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIY 175
Query: 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
A V + + + PE + GK S +D++ +G+ L E+ +
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 8e-15
Identities = 38/88 (43%), Positives = 52/88 (59%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI 140
L L N SG I PSI L+ L SL+L DN LSG +P+ + + +L+ L+L +N F+G I
Sbjct: 265 LFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKI 324
Query: 141 PATWSQLSNLKHLDLSSNNLTGRIPMQL 168
P + L L+ L L SN +G IP L
Sbjct: 325 PVALTSLPRLQVLQLWSNKFSGEIPKNL 352
|
Length = 968 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 9e-15
Identities = 65/203 (32%), Positives = 100/203 (49%), Gaps = 19/203 (9%)
Query: 279 IGQGGFGKV----YKGVLSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+G+G FGKV Y +D T VAVK L+ + +++E++++ H+N+++
Sbjct: 12 LGEGHFGKVSLYCYDPA-NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 392
G C+ + L M+ + + LRD P K L+ A G+ YLH Q
Sbjct: 71 YKGCCSEQGGKGLQL-IMEYVPLG-SLRDYLPKHK-LNLAQLLLFAQQICEGMAYLHSQ- 126
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR----GTMGHIAPEYL 448
IHRDL A N+LLD++ + DFGLAK V H ++R + A E L
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG--HEYYRVREDGDSPVFWYAVECL 182
Query: 449 STGKSSEKTDVFGYGITLLELVT 471
K S +DV+ +G+TL EL+T
Sbjct: 183 KENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 55/219 (25%), Positives = 99/219 (45%), Gaps = 28/219 (12%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNT-----KVAVKRLQDYYSPGGEAAFQREVHLISVA 325
D + S+++ +G FG+++ G+L D +V VK ++D+ S +E L+
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65
Query: 326 IHKNLLQLIGYCTTSSERILV-YPFMQ--NLSVAYRLRDLKPGEKGLDWPTRKRVAFGT- 381
H+N+L ++ C E V YP+M NL + + L T++ V
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 382 -AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 440
A G+ YLH +IH+D+ A N ++D+ + + D L++ + H +
Sbjct: 126 IACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH-------CL 175
Query: 441 GH--------IAPEYLSTGKSSEKTDVFGYGITLLELVT 471
G +A E L + S +DV+ +G+ L EL+T
Sbjct: 176 GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 31/216 (14%)
Query: 277 NIIGQGGFGKVYKGVLSDN---TKVAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLLQ 332
++IG+G FG+V K + + A+KR+++Y S F E+ L + H N++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVA------------FG 380
L+G C L + + ++ LR + E + A
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 381 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 440
A G++YL ++ + IHRDL A NIL+ +N+ A + DFGL++ + ++ TM
Sbjct: 133 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTM 182
Query: 441 GHI-----APEYLSTGKSSEKTDVFGYGITLLELVT 471
G + A E L+ + +DV+ YG+ L E+V+
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 272 NFSESNIIGQGGFGKVYKGVLSDNTKV-AVKR--LQDYYSPGGEAAFQREVHLISVAIHK 328
+F N IG+G FG V+K V + +V A+K+ L E A E +++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-DEARVLAKLDSS 59
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--RVAFGTAYGLE 386
+I Y + ++ + M+ L L ++G P + R GL
Sbjct: 60 ---YIIRYYESFLDKGKLNIVMEYAENG-DLHKLLKMQRGRPLPEDQVWRFFIQILLGLA 115
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 446
+LH + KI+HRD+K+ N+ LD + D G+AKL+ T+ I GT +++PE
Sbjct: 116 HLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN-TNFANTIVGTPYYLSPE 171
Query: 447 YLSTGKSSEKTDVFGYGITLLELVTGQRAID 477
+EK+DV+ G+ L E TG+ D
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 62/224 (27%), Positives = 100/224 (44%), Gaps = 21/224 (9%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338
+G G FG V G VA+K +++ E F E ++ H+ L+QL G CT
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 339 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 398
+V +M N + LR+ K + G+ YL + + IH
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLESK---QFIH 123
Query: 399 RDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQ--IRGTMGHIAPEYLSTGKSS 454
RDL A N L+DD + DFGL++ V D + V ++ +R + PE L K S
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLLYSKFS 179
Query: 455 EKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHKVTEGR 498
K+DV+ +G+ + E+ + + + + R E V KV++G
Sbjct: 180 SKSDVWAFGVLMWEVYSLGK-MPYERFNNSETVE----KVSQGL 218
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 65/200 (32%), Positives = 95/200 (47%), Gaps = 20/200 (10%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338
+G G FGKVYK + +A ++ D S + E+ +++ H N+++L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 339 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 398
+ ++ F +V + +L E+ L P + V T L YLHE KIIH
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 399 RDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR----GTMGHIAPEYLSTGKSS 454
RDLKA NIL + + L DFG V AK T T Q R GT +APE + S
Sbjct: 127 RDLKAGNILFTLDGDIKLADFG----VSAKNTR-TIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 455 E-----KTDVFGYGITLLEL 469
+ K DV+ GITL+E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 18/216 (8%)
Query: 273 FSESNIIGQGGFGKVYKGVL--SDNT--KVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 327
F+ ++G+G FG V + L D + KVAVK L+ D +S F RE + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 328 KNLLQLIGYCTTSSER------ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF-- 379
N+++LIG S + +++ PFM++ + L + GE+ P + V F
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 380 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRG 438
A G+EYL + IHRDL A N +L++N + DFGL+ K+ +
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 439 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQ 473
+ +A E L+ + +DV+ +G+T+ E++T GQ
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 12/206 (5%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 328
+ + IG+G G+VYK + +VA+K++ E E+ ++ H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIIN-EILIMKDCKHP 75
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
N++ E +V +M S+ + ++ P V GLEYL
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIIT---QNFVRMNEPQIAYVCREVLQGLEYL 132
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL-AKLVDAKLTHVTTQIRGTMGHIAPEY 447
H Q +IHRD+K+ NILL + L DFG A+L K + + GT +APE
Sbjct: 133 HSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEV 187
Query: 448 LSTGKSSEKTDVFGYGITLLELVTGQ 473
+ K D++ GI +E+ G+
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 48/176 (27%), Positives = 74/176 (42%), Gaps = 33/176 (18%)
Query: 269 ATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKR-LQDYYSPGGEAAFQREVHLISVAI 326
++ +G+G FG+VYK + VA+K+ L G RE+ ++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 327 HKNLLQLIGYCTTSSERI--------LVYPFM--------QNLSVAYRLRDLKPGEKGLD 370
H N++ LI ++ +V P+M +N SV +K L
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQL- 124
Query: 371 WPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426
G+ YLHE I+HRD+KAANIL+D+ + DFGLA+ D
Sbjct: 125 -----------LEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYD 166
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 26/221 (11%)
Query: 267 QLATDNFSESNIIGQGGFGKVYKGVLS----DNTK--VAVKRLQDYYSPGGEAAFQREVH 320
++ D+ + +G G FG+VY+G+ D + VAVK L + S E+ F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 321 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR---- 376
++S H+N+++LIG R ++ M + LR+ +P + P+
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRP---RPERPSSLTMKDL 118
Query: 377 --VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE---AVLCDFGLAKLVDAKLTH 431
A A G +YL E IHRD+ A N LL A + DFG+A+ D
Sbjct: 119 LFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR--DIYRAS 173
Query: 432 VTTQIRGTMGHIA---PEYLSTGKSSEKTDVFGYGITLLEL 469
+ M I PE G + KTDV+ +G+ L E+
Sbjct: 174 YYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 272 NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKN 329
NF + IG+G +G VYK + VA+K+++ D + G + RE+ L+ H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 330 LLQLIGYCTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
+++L+ T ++ LV+ F+ Q+L + D P G+ P K F GL +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLK---KFMDASPLS-GIPLPLIKSYLFQLLQGLAFC 116
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 448
H +++HRDLK N+L++ L DFGLA+ + T ++ T+ + APE L
Sbjct: 117 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 172
Query: 449 STGK-SSEKTDVFGYGITLLELVTGQRAI 476
K S D++ G E+VT +RA+
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 43/102 (42%), Positives = 57/102 (55%), Gaps = 13/102 (12%)
Query: 377 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVD--AKLTHVT 433
+A T L YL E KIIHRD+K +NILLD N LCDFG++ +LVD AK
Sbjct: 112 IAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK----- 164
Query: 434 TQIRGTMGHIAPEYLSTGKSSE---KTDVFGYGITLLELVTG 472
T+ G ++APE + ++DV+ GITL E+ TG
Sbjct: 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 279 IGQGGFGKVYK----GVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISV-AIHKN 329
+G+G FG+V + G+ VAVK L+D + A E+ L+ + HKN
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRV 377
++ L+G CT ++ + ++ LR +P E+ L +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 378 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQI 436
A+ A G+EYL + + IHRDL A N+L+ ++ + DFGLA+ V D T+
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 437 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
R + +APE L + ++DV+ +GI + E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 39/94 (41%), Positives = 56/94 (59%), Gaps = 10/94 (10%)
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHI 443
L YL E+ +IHRD+K +NILLD + LCDFG++ +LVD+K T+ G ++
Sbjct: 127 LHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK---AKTRSAGCAAYM 181
Query: 444 APEYLSTGKSSEK----TDVFGYGITLLELVTGQ 473
APE + + K DV+ GI+L+EL TGQ
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 5e-14
Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 278 IIGQGGFGKV----YKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 333
IG+G FG V Y+G KVAVK +++ AF E +++ H NL+QL
Sbjct: 13 TIGKGEFGDVMLGDYRG-----NKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQL 64
Query: 334 IGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 392
+G + +V +M S+ LR G L + + +EYL
Sbjct: 65 LGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEAN- 121
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 452
+HRDL A N+L+ ++ A + DFGL K + ++ T APE L K
Sbjct: 122 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKK 175
Query: 453 SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV 487
S K+DV+ +GI L E+ + R + + R+ ++ V
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGR-VPYPRIPLKDVV 209
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 57/209 (27%), Positives = 104/209 (49%), Gaps = 19/209 (9%)
Query: 270 TDNFSESNIIGQGGFGKV--YKGVLSDNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAI 326
T+ + + +G G FG V + L+ VA+K++ +S P RE+ L+
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR 67
Query: 327 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386
H+N++ L + E I + + RL +P EK + + GL+
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELLGTDLH-RLLTSRPLEKQF----IQYFLYQILRGLK 122
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAP 445
Y+H + ++HRDLK +NIL+++N + +CDFGLA++ D ++T +V+T+ + AP
Sbjct: 123 YVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAP 174
Query: 446 EYLST-GKSSEKTDVFGYGITLLELVTGQ 473
E + T K + D++ G E++ G+
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 60/216 (27%), Positives = 104/216 (48%), Gaps = 31/216 (14%)
Query: 277 NIIGQGGFGKVYKGVL-SDNTKV--AVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLLQ 332
++IG+G FG+V + ++ D K+ A+K L+++ S F E+ L + H N++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 333 LIGYCTTSSE---RILVYPFMQNLSVAYRLRDLKPG-----EKG----LDWPTRKRVAFG 380
L+G C I P+ L + R L+ E G L + A
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 381 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 440
A G++YL E+ + IHRDL A N+L+ +N + + DFGL++ + ++ TM
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEE-------VYVKKTM 177
Query: 441 GHI-----APEYLSTGKSSEKTDVFGYGITLLELVT 471
G + A E L+ + K+DV+ +G+ L E+V+
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 7e-14
Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 25/227 (11%)
Query: 267 QLATDNFSESNIIGQGGFGKVYK----GVLSDNTK----VAVKRLQDYYSPGGEAAFQRE 318
+ + D + +G+G FG+V G+ D K VAVK L+D + + E
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70
Query: 319 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP------------G 365
+ ++ + HKN++ L+G CT ++ + ++ LR +P
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 366 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425
++ + + + A G+EYL Q K IHRDL A N+L+ +N + DFGLA+ V
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDV 187
Query: 426 -DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
+ TT R + +APE L + ++DV+ +G+ + E+ T
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 57/222 (25%), Positives = 103/222 (46%), Gaps = 24/222 (10%)
Query: 267 QLATDNFSESNIIGQGGFGKVY----KGVLSDN--TKVAVKRLQDYYSPGGEAAFQREVH 320
++A + + S +GQG FG VY KGV+ D T+VA+K + + S F E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 321 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKRV 377
++ ++++L+G + +++ M + LR L+P P+ K++
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 378 ---AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT 434
A A G+ YL+ K +HRDL A N ++ ++F + DFG+ + +
Sbjct: 122 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDY 174
Query: 435 QIRGTMG-----HIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
+G G ++PE L G + +DV+ +G+ L E+ T
Sbjct: 175 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 9e-14
Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 50/226 (22%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVH--------- 320
D + + +G G +G+V + KVA+K+L P FQ +H
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKL---SRP-----FQSAIHAKRTYRELR 66
Query: 321 LISVAIHKNLLQLIGYCTTSSER------ILVYPFM-QNLSVAYRLRDLKPGEKGLDWPT 373
L+ H+N++ L+ T +S LV M +L+ + + L +
Sbjct: 67 LLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKL----------S 116
Query: 374 RKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429
+ F Y GL+Y+H + IIHRDLK +NI ++++ E + DFGLA+ D ++
Sbjct: 117 DDHIQF-LVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM 172
Query: 430 T-HVTTQIRGTMGHIAPE-YLSTGKSSEKTDVFGYGITLLELVTGQ 473
T +V T + APE L+ ++ D++ G + EL+TG+
Sbjct: 173 TGYV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 9e-14
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 12/203 (5%)
Query: 273 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLL 331
F++ IG+G FG+V+KG+ + +V ++ D E Q+E+ ++S +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 332 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
+ G ++ ++ M+ L L L+ G D + GL+YLH +
Sbjct: 66 KYYGSYLKGTK---LWIIMEYLGGGSALDLLRAGP--FDEFQIATMLKEILKGLDYLHSE 120
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEYLST 450
K IHRD+KAAN+LL + + L DFG+A +L D ++ T GT +APE +
Sbjct: 121 ---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQ 175
Query: 451 GKSSEKTDVFGYGITLLELVTGQ 473
K D++ GIT +EL G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 9e-14
Identities = 57/206 (27%), Positives = 86/206 (41%), Gaps = 17/206 (8%)
Query: 279 IGQGGFGKVYKG---VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
IG G FGKV G +V VK L+ +P + F +EV H N+LQ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWP-TRKRVAFGTAYGLEYLHEQCNP 394
C S +LV F + LR + + +R+A A GL +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119
Query: 395 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT--QIRGTMGHIAPEY----- 447
IH DL N L + + D+GLA L + T + +APE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 448 --LSTGKSSEKTDVFGYGITLLELVT 471
L ++K++++ G+T+ EL T
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-13
Identities = 47/116 (40%), Positives = 61/116 (52%), Gaps = 14/116 (12%)
Query: 83 LGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA 142
LG N SG+I I L L L+L N+L+G +P LG++ +LQ L L NK SG IP
Sbjct: 219 LGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPP 278
Query: 143 TWSQLSNLKHLDLSSNNLTGRIP-----------MQLFSVATFNFTGTHLICGSSL 187
+ L L LDLS N+L+G IP + LFS NFTG + +SL
Sbjct: 279 SIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSN---NFTGKIPVALTSL 331
|
Length = 968 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 12/207 (5%)
Query: 272 NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQ-DYYSPGGE---AAFQREVHLISVAI 326
N+ ++GQG FG+VY +D + +AVK++Q D SP A + E+ L+ +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 327 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386
H+ ++Q G ER L FM+ ++D L ++ G+
Sbjct: 63 HERIVQYYGCLRDPMERTLSI-FME-HMPGGSIKDQLKSYGALTENVTRKYTRQILEGVS 120
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT--TQIRGTMGHIA 444
YLH I+HRD+K ANIL D L DFG +K + T + GT ++
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177
Query: 445 PEYLSTGKSSEKTDVFGYGITLLELVT 471
PE +S K D++ G T++E++T
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 56/192 (29%), Positives = 91/192 (47%), Gaps = 30/192 (15%)
Query: 273 FSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEA----AFQREVHL---ISV 324
+ E IG+G +G VYK L+ VA+K+++ P E + RE+ L +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVR---VPLSEEGIPLSTLREIALLKQLES 57
Query: 325 AIHKNLLQLIGYCTTS-SERI----LVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVA 378
H N+++L+ C ++R LV+ + Q+L+ K + GL T K +
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLS----KCPKPGLPPETIKDLM 113
Query: 379 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD--AKLTHVTTQI 436
G+++LH I+HRDLK NIL+ + + + DFGLA++ LT V
Sbjct: 114 RQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV-- 168
Query: 437 RGTMGHIAPEYL 448
T+ + APE L
Sbjct: 169 --TLWYRAPEVL 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 29/217 (13%)
Query: 279 IGQGGFGKVYK----GVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKN 329
+G+G FG+V G+ D VAVK L+D + + E+ ++ + HKN
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDW-------PTRK------- 375
++ L+G CT ++ + ++ LR +P G+D+ P +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRP--PGMDYSFDTCKLPEEQLTFKDLV 137
Query: 376 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTT 434
A+ A G+EYL Q K IHRDL A N+L+ ++ + DFGLA+ V + TT
Sbjct: 138 SCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 435 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
R + +APE L + ++DV+ +G+ L E+ T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 19/218 (8%)
Query: 262 SCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQ-DYYSPGGEAAFQREV 319
CR + F + N IG+G +G VY+ + + + VA+K+++ D G + RE+
Sbjct: 2 RCRSVT----EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREI 57
Query: 320 HLISVAIHKNLLQLIGYCTTSS-ERI-LVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKR 376
L+ H N+++L + I LV + Q+L+ L D P K
Sbjct: 58 TLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLA---SLLDNMP--TPFSESQVKC 112
Query: 377 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 436
+ GL+YLHE IIHRDLK +N+LL D + DFGLA+ +T ++
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKV 169
Query: 437 RGTMGHIAPEYL-STGKSSEKTDVFGYGITLLELVTGQ 473
T+ + APE L + D++ G L EL+ +
Sbjct: 170 V-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 60/223 (26%), Positives = 89/223 (39%), Gaps = 47/223 (21%)
Query: 277 NIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQR---EVHLISVAIHKNLLQ 332
IG+G FG V K SD + K + Y E Q+ EV+++ H N+++
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEID--YGNMTEKEKQQLVSEVNILRELKHPNIVR 63
Query: 333 LIGYCTTSSERIL------VYPFM---------QNLSVAYRLRDLKPGEKGLDWPTRKRV 377
+RI+ +Y M Q + + R E R+
Sbjct: 64 YY-------DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW------RI 110
Query: 378 AFGTAYGLEYLH--EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD-----AKLT 430
L H ++HRDLK ANI LD N L DFGLAK++ AK T
Sbjct: 111 LTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAK-T 169
Query: 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
+V GT +++PE L+ EK+D++ G + EL
Sbjct: 170 YV-----GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-13
Identities = 33/88 (37%), Positives = 49/88 (55%), Gaps = 1/88 (1%)
Query: 83 LGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA 142
L N FSG++ TKL + L++ +N+L G + M LQ L+LA NKF G +P
Sbjct: 411 LQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPD 470
Query: 143 TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ L++LDLS N +G +P +L S
Sbjct: 471 S-FGSKRLENLDLSRNQFSGAVPRKLGS 497
|
Length = 968 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 22/211 (10%)
Query: 279 IGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+G+G FGKV+ D VAVK L++ S FQRE L++V H+++++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVR 71
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLD-----------WPTRKRVAFGT 381
G CT ++V+ +M++ + LR P K L +A
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTM 440
A G+ YL + +HRDL N L+ + DFG+++ + V + +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 441 GHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
+ PE + K + ++D++ +G+ L E+ T
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 65/220 (29%), Positives = 90/220 (40%), Gaps = 52/220 (23%)
Query: 273 FSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQ---REVHLISVAIHK 328
F++ IG G FG VY + VA+K++ Y +Q +EV + H
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKM-SYSGKQSNEKWQDIIKEVRFLQQLRHP 75
Query: 329 NLLQLIG-------------YCTTSSERIL-VY--PFMQNLSVAYRLRDLKPGEKGLDWP 372
N ++ G YC S+ IL V+ P +Q + +A
Sbjct: 76 NTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKP-LQEVEIA---------------- 118
Query: 373 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432
+ G GL YLH IHRD+KA NILL + L DFG A LV + V
Sbjct: 119 ---AICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV 172
Query: 433 TTQIRGTMGHIAPEY---LSTGKSSEKTDVFGYGITLLEL 469
GT +APE + G+ K DV+ GIT +EL
Sbjct: 173 -----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 31/216 (14%)
Query: 277 NIIGQGGFGKVYKGVLSDN---TKVAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLLQ 332
++IG+G FG+V K + + A+KR+++Y S F E+ L + H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 333 LIGYCTTSSE---RILVYPFMQNLSVAYRLRDLKPG-----EKG----LDWPTRKRVAFG 380
L+G C I P L + R L+ L A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 381 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 440
A G++YL ++ + IHRDL A NIL+ +N+ A + DFGL++ + ++ TM
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTM 170
Query: 441 GHI-----APEYLSTGKSSEKTDVFGYGITLLELVT 471
G + A E L+ + +DV+ YG+ L E+V+
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-13
Identities = 35/90 (38%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI 140
L + +N G+I+ + L L L N G LPD GS L++L+L+ N+FSG++
Sbjct: 433 LDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAV 491
Query: 141 PATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
P LS L L LS N L+G IP +L S
Sbjct: 492 PRKLGSLSELMQLKLSENKLSGEIPDELSS 521
|
Length = 968 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 66/239 (27%), Positives = 111/239 (46%), Gaps = 25/239 (10%)
Query: 277 NIIGQGGFGKVYKGVLSD-------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
N +G G FG+VY+G +D +VAVK L+ + + F +E HL+S H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK---PGEKGLDWPTRKRVAFGTAYGLE 386
+++L+G C + + ++ M+ + LRD + G L + A G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAV-----LCDFGLAK-LVDAKLTHVTTQIRGTM 440
YL + IHRDL A N L+ + + DFGLA+ + + + +
Sbjct: 121 YLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 441 GHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHKVTEGR 498
+APE L GK + ++DV+ +G+ + E++T GQ+ + L +E +L H GR
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP--YPALNNQE---VLQHVTAGGR 231
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 15/203 (7%)
Query: 279 IGQGGFGKVYKG-VLSD--NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
IG G FGKV G V S +V VK L+ S + F E H NLLQ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEK-GLDWPTRKRVAFGTAYGLEYLHEQCNP 394
CT + +LV F + LR + E D T +R+A A GL +LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 395 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QIRGTMGHIAPEYLSTGKS 453
IH DL N LL + + D+GL+ + +VT Q+ + IAPE +
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 454 -------SEKTDVFGYGITLLEL 469
+++++V+ G+T+ EL
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 55/212 (25%), Positives = 101/212 (47%), Gaps = 17/212 (8%)
Query: 272 NFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEA-----AFQREVHLISVA 325
+ + +G G F Y+ + T +AVK++ + E A ++E+ L++
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 326 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGL 385
H ++++++G S L +M SV++ L ++ + +++ GL
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL----RGL 116
Query: 386 EYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLT---HVTTQIRGTMG 441
YLHE +IIHRD+K AN+L+D + + + DFG A + AK T Q+ GT+
Sbjct: 117 SYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173
Query: 442 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
+APE L + DV+ G ++E+ T +
Sbjct: 174 FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 12/209 (5%)
Query: 279 IGQGGFGKVYKG--VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
+G+G + VYKG L+DN VA+K ++ + G REV L+ H N++ L
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396
T LV+ ++ Y L ++ K F GL Y H + K+
Sbjct: 73 IHTEKSLTLVFEYLDKDLKQY----LDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KV 125
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE-YLSTGKSSE 455
+HRDLK N+L+++ E L DFGLA+ + ++ T+ + P+ L + S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYST 184
Query: 456 KTDVFGYGITLLELVTGQRAIDFSRLEEE 484
+ D++G G E+ TG+ S +EE+
Sbjct: 185 QIDMWGVGCIFYEMSTGRPLFPGSTVEEQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 39/104 (37%), Positives = 61/104 (58%), Gaps = 14/104 (13%)
Query: 376 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVD--AKLTHV 432
++A LEYLH + +IHRD+K +N+L++ N + LCDFG++ LVD AK
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK---- 160
Query: 433 TTQIRGTMGHIAPEYLSTGKSSE----KTDVFGYGITLLELVTG 472
T G ++APE ++ + + K+DV+ GIT++EL TG
Sbjct: 161 -TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 64/221 (28%), Positives = 101/221 (45%), Gaps = 37/221 (16%)
Query: 271 DNFSESNIIGQGGFGKVYKGV---LSDN---TKVAVKRLQDYYSPGGEAAFQREVHLIS- 323
+N S +G G FGKV + LS + KVAVK L+ A E+ ++S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 324 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT-- 381
+ H+N++ L+G CT +++ + DL L++ RKR +F T
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYC-------CYGDL------LNFLRRKRESFLTLE 141
Query: 382 ---------AYGLEYL-HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 431
A G+ +L + C IHRDL A N+LL +CDFGLA+ + +
Sbjct: 142 DLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNY 197
Query: 432 VTT-QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
V R + +APE + + ++DV+ YGI L E+ +
Sbjct: 198 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 279 IGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+GQG FG VY+G D T+VAVK + + S F E ++ ++++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEK---GLDWPTRK---RVAFGTAYGLE 386
L+G + ++V M + + LR L+P + G PT + ++A A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG----- 441
YL+ + K +HRDL A N ++ +F + DFG+ + + +G G
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 186
Query: 442 HIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
+APE L G + +D++ +G+ L E+ +
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 6e-13
Identities = 36/99 (36%), Positives = 56/99 (56%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ +L L +N SG+I I L L+L N L G +P+ L ++T L+ L LA+N+
Sbjct: 141 NLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQL 200
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFN 175
G IP Q+ +LK + L NNL+G IP ++ + + N
Sbjct: 201 VGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLN 239
|
Length = 968 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 6e-13
Identities = 72/237 (30%), Positives = 105/237 (44%), Gaps = 30/237 (12%)
Query: 272 NFSESNIIGQGGFGKVYK-GVLSDNTKVAVKR--LQDYYSPGGEAAFQREVHLISVAIHK 328
+F +G+G +G VYK LSDN A+K L E A E+ +++ H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASVNHP 59
Query: 329 NLLQLIGYCTTSSE-RILV----YPFMQNLSVAYRLRDL--KPGEKGLDWPTRKRVAFGT 381
N+ I Y + L Y +LS A R K + W R+
Sbjct: 60 NI---ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQL 112
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 441
GL+ LHEQ KI+HRDLK+ANILL N + D G++K+ K TQI GT
Sbjct: 113 LRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKV--LKKNMAKTQI-GTPH 166
Query: 442 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHKVTEGR 498
++APE S K+D++ G L E+ T + +++ L +KV G+
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD------LRYKVQRGK 217
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 6e-13
Identities = 57/190 (30%), Positives = 79/190 (41%), Gaps = 43/190 (22%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQ--REVHLISVAIHKNLLQL 333
+G+G + VYK VA+K +L + F RE+ L+ H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 334 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY---------- 383
+ S LV+ FM+ DL EK + K + A
Sbjct: 68 LDVFGHKSNINLVFEFMET--------DL---EKVIK---DKSIVLTPADIKSYMLMTLR 113
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---DAKLTH--VTTQIRG 438
GLEYLH I+HRDLK N+L+ + L DFGLA+ + K+TH VT R
Sbjct: 114 GLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYR- 169
Query: 439 TMGHIAPEYL 448
APE L
Sbjct: 170 -----APELL 174
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 328
TD + IG+G +GKVYK D + AVK L E + + L S+ H
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNI-LQSLPNHP 79
Query: 329 NLLQLIGYCTTSSERI-----LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 383
N+++ G + + + LV SV ++ L + LD + +G
Sbjct: 80 NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALL 139
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL-AKLVDAKLTHVTTQIRGTMGH 442
GL++LH N +IIHRD+K NILL L DFG+ A+L +L T+ GT
Sbjct: 140 GLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV--GTPFW 194
Query: 443 IAPEYLSTGKSSE-----KTDVFGYGITLLELVTG 472
+APE ++ + + + DV+ GIT +EL G
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 7e-13
Identities = 41/91 (45%), Positives = 53/91 (58%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI 140
L L N +G I S+ LK L L L N LSG +P + S+ L SL+L++N SG I
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI 300
Query: 141 PATWSQLSNLKHLDLSSNNLTGRIPMQLFSV 171
P QL NL+ L L SNN TG+IP+ L S+
Sbjct: 301 PELVIQLQNLEILHLFSNNFTGKIPVALTSL 331
|
Length = 968 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 7e-13
Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 12/220 (5%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
D++ + +G+G + VYKG N K VA+K ++ G RE L+ H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 389
++ L T LV+ ++ Y D PG GL K F GL Y+H
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYM--DKHPG--GLHPENVKLFLFQLLRGLSYIH 120
Query: 390 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE-YL 448
++ I+HRDLK N+L+ D E L DFGLA+ + +H + T+ + P+ L
Sbjct: 121 QR---YILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLL 176
Query: 449 STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 488
+ + S D++G G +E++ G A F +++ +D L
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAA--FPGMKDIQDQL 214
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 7e-13
Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 40/226 (17%)
Query: 278 IIGQGGFGKVYKG---VLSDNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQ 332
+IG+GG G+VY V S +VA+K++++ S P + F RE + + IH ++
Sbjct: 9 LIGKGGMGEVYLAYDPVCS--RRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 333 LIGYCTTSSERILVY---PFMQNLSVAYRLRDL-------KPGEKGLDWPTRKRVAFGTA 382
+ C S+ VY P+++ ++ L+ + K + +
Sbjct: 67 VYSIC---SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 383 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK-------------- 428
+EY+H + ++HRDLK NILL E V+ D+G A +
Sbjct: 124 ATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 429 LTHVTT---QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
T +I GT ++APE L +SE TD++ G+ L +++T
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 20/200 (10%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338
+G G FGKVYK + +A ++ + S + E+ +++ H +++L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 339 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 398
+ ++ F +V + +L ++GL P + + L+YLH KIIH
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIH 133
Query: 399 RDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR----GTMGHIAPEYL--STGK 452
RDLKA N+LL + + L DFG V AK T Q R GT +APE + T K
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFG----VSAKNVK-TLQRRDSFIGTPYWMAPEVVMCETMK 188
Query: 453 SSE---KTDVFGYGITLLEL 469
+ K D++ GITL+E+
Sbjct: 189 DTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 62/233 (26%), Positives = 109/233 (46%), Gaps = 37/233 (15%)
Query: 267 QLATDNFSESNIIGQGGFGKVYK----GVLSDN----TKVAVKRLQDYYSPGGEAAFQRE 318
++ D +G+G FG+V G+ + TKVAVK L+ + + E
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73
Query: 319 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDW---PTR 374
+ ++ + HKN++ L+G CT ++ + ++ LR +P G+++ PT+
Sbjct: 74 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP--PGMEYCYNPTQ 131
Query: 375 KRV-----------AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423
A+ A G+EYL + K IHRDL A N+L+ ++ + DFGLA+
Sbjct: 132 VPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR 188
Query: 424 LVDAKLTHV-----TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
+ H+ TT R + +APE L + ++DV+ +G+ L E+ T
Sbjct: 189 ----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 38/96 (39%), Positives = 47/96 (48%), Gaps = 10/96 (10%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVD-----AKLTHVTTQI 436
LEYLH + IIHRDLK NIL+D N L DFGL+K LV +I
Sbjct: 105 ALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161
Query: 437 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 472
GT +IAPE + S+ D + G L E + G
Sbjct: 162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 12/207 (5%)
Query: 272 NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQ-DYYSPGGE---AAFQREVHLISVAI 326
N+ ++GQG FG+VY D + +A K++Q D SP +A + E+ L+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 327 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386
H+ ++Q G +E+ L FM+ + ++D L ++ G+
Sbjct: 63 HERIVQYYGCLRDRAEKTLTI-FMEYMP-GGSVKDQLKAYGALTESVTRKYTRQILEGMS 120
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT--TQIRGTMGHIA 444
YLH I+HRD+K ANIL D L DFG +K + T + GT ++
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177
Query: 445 PEYLSTGKSSEKTDVFGYGITLLELVT 471
PE +S K DV+ G T++E++T
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 272 NFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
NF + +G+G + VYKG + VA+K + G + RE+ L+ H+N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP-----GEKG-LDWPTRKRVAFGTAYG 384
++L T ++ +LV+ +M DLK G +G LD T K + G
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDK--------DLKKYMDTHGVRGALDPNTVKSFTYQLLKG 112
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 444
+ + HE +++HRDLK N+L++ E L DFGLA+ + + ++ T+ + A
Sbjct: 113 IAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRA 168
Query: 445 PEYLSTGKS-SEKTDVFGYGITLLELVTG 472
P+ L ++ S D++ G + E++TG
Sbjct: 169 PDVLLGSRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 25/207 (12%)
Query: 279 IGQGGFGKVYKGVLSDNTKV--AVK--RLQDYYSPGGEAAFQ---REVHLISVAIHKNLL 331
+G+G +G VYK VL T V A+K RL+ E+ F E+ ++ A+ ++
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLEL-----DESKFNQIIMELDILHKAVSPYIV 62
Query: 332 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
G + +M S+ +L +G+ +R+ + GL++L E+
Sbjct: 63 DFYGAFFIEGAVYMCMEYMDAGSLD-KLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 451
N IIHRD+K N+L++ N + LCDFG++ + A L T I G ++APE + +G
Sbjct: 122 HN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA--KTNI-GCQSYMAPERIKSG 176
Query: 452 KSSE------KTDVFGYGITLLELVTG 472
++ ++DV+ G+++LE+ G
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 35/105 (33%), Positives = 63/105 (60%), Gaps = 7/105 (6%)
Query: 376 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTT 434
++A GL YL+ +I+HRD+K +NIL++ + LCDFG++ +L+++ +
Sbjct: 107 KIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----IAD 160
Query: 435 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479
GT +++PE + GK + K+DV+ GI+++EL G+ FS
Sbjct: 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS 205
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 39/220 (17%)
Query: 279 IGQGGFGKVYKG------VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+G+G FGKV+ D VAVK L+D + FQRE L++ H+++++
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVK 71
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP--------------GEKGLDWPTRKRVA 378
G C I+V+ +M++ + LR P GE GL +A
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS--QMLHIA 129
Query: 379 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG 438
A G+ YL Q +HRDL N L+ N + DFG+++ V +T
Sbjct: 130 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDV------YSTDYYR 180
Query: 439 TMGH-------IAPEYLSTGKSSEKTDVFGYGITLLELVT 471
GH + PE + K + ++DV+ +G+ L E+ T
Sbjct: 181 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 273 FSESNIIGQGGFGKV------YKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI 326
F + ++G+GGFG+V G + K+ KR++ GE+ E ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK---KRKGESMALNEKQILEKVN 58
Query: 327 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY--- 383
+ ++ L T LV M + + + + GE G + R F A
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GEAGFE---EGRAVFYAAEICC 113
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
GLE LH++ +I++RDLK NILLDD+ + D GLA V T + ++ GT+G++
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYM 168
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
APE + + + D + G L E++ GQ
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 272 NFSESNIIGQGGFGKVY--KGVLSDNTKVAVKRLQDYYSPGGEA-AFQREVHLISVAIHK 328
+ IG+G FGK+Y K SD+ +K + P E A ++EV L++ H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD----LKPGEKGLDWPTRKRVAFGTAYG 384
N++ + +V + + R+ L ++ L W + + G
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ------ISLG 113
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
L+++H++ KI+HRD+K+ NI L N A L DFG+A+ ++ + T + GT ++
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYL 169
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVT 471
+PE + KTD++ G L EL T
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 3e-12
Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 273 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
F ++G G +G+VYKG ++A ++ D E Q L + H+N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 333 LIGYCTTSS------ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386
G + + LV F SV +++ K +W + GL
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLS 125
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 446
+LH+ K+IHRD+K N+LL +N E L DFG++ +D + T I GT +APE
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPE 181
Query: 447 YLSTGKSSE-----KTDVFGYGITLLELVTG 472
++ ++ + K+D++ GIT +E+ G
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 57/194 (29%), Positives = 90/194 (46%), Gaps = 10/194 (5%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338
+G G FG V+ G KVA+K + + E F E ++ H L+QL G CT
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINE--GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 339 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 398
+V FM+N + LR + G+ D + G+EYL E+ + IH
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQ-RQGKLSKD--MLLSMCQDVCEGMEYL-ERNS--FIH 123
Query: 399 RDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 457
RDL A N L+ + DFG+ + V D + T ++ + + PE + K S K+
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS-SSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 458 DVFGYGITLLELVT 471
DV+ +G+ + E+ T
Sbjct: 183 DVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 273 FSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQD--YYSPGGEAAFQREVHLISVAIHKN 329
F + ++G+GGFG+V + K+ A KRL+ GE+ E ++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY---GLE 386
++ L T LV M + + + ++ G G + +R F A GLE
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFE---EERALFYAAEILCGLE 116
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIR---GTMGH 442
LH + ++RDLK NILLDD + D GLA K+ + + IR GT+G+
Sbjct: 117 DLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES------IRGRVGTVGY 167
Query: 443 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
+APE L+ + + D +G G + E++ GQ
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-12
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 279 IGQGGFGKVY------KGVLSDNT--KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
+G+G FGKV +G DNT +VAVK L+ A ++E+ ++ H+N+
Sbjct: 12 LGEGHFGKVELCRYDPEG---DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 331 LQLIGYCTTSSER--ILVYPFMQNLSVAYRLRDLKPGEKG-LDWPTRKRVAFGTAYGLEY 387
++ G CT L+ F+ + S L++ P K ++ + + A G++Y
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGS----LKEYLPRNKNKINLKQQLKYAVQICKGMDY 124
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAP 445
L + + +HRDL A N+L++ + + DFGL K + D + V + + AP
Sbjct: 125 LGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAP 181
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVT 471
E L K +DV+ +G+TL EL+T
Sbjct: 182 ECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 12/209 (5%)
Query: 279 IGQGGFGKVYKG--VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
+G+G + V+KG L++N VA+K ++ + G REV L+ H N++ L
Sbjct: 13 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396
T LV+ ++ + Y L + K F GL Y H++ KI
Sbjct: 72 IHTERCLTLVFEYLDSDLKQY----LDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KI 124
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE-YLSTGKSSE 455
+HRDLK N+L+++ E L DFGLA+ + ++ T+ + P+ L + + S
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYST 183
Query: 456 KTDVFGYGITLLELVTGQRAIDFSRLEEE 484
D++G G L E+ TG+ S ++EE
Sbjct: 184 PIDMWGVGCILYEMATGRPMFPGSTVKEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 7e-12
Identities = 46/148 (31%), Positives = 76/148 (51%), Gaps = 11/148 (7%)
Query: 279 IGQGGFGKVYKGVLSDNTK-VAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
IG+G +G V+K + + VA+KR++ D G ++ RE+ L+ HKN+++L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 337 CTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 395
+ + LV+ + Q+L + D G+ +D K F GL + H
Sbjct: 68 LHSDKKLTLVFEYCDQDLK---KYFDSCNGD--IDPEIVKSFMFQLLKGLAFCHSH---N 119
Query: 396 IIHRDLKAANILLDDNFEAVLCDFGLAK 423
++HRDLK N+L++ N E L DFGLA+
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 8e-12
Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 19/200 (9%)
Query: 298 VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAY 357
VAVK L+ S F +EV ++S N+ +L+G CT ++ +M+N +
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 358 RLRDLKPGEKGLDWPTRKRVAFGT--------AYGLEYLHEQCNPKIIHRDLKAANILLD 409
L+ GL K ++F T A G+ YL E N +HRDL N L+
Sbjct: 109 FLQKHVAETSGLAC-NSKSLSFSTLLYMATQIASGMRYL-ESLN--FVHRDLATRNCLVG 164
Query: 410 DNFEAVLCDFGLAKLVDAKLTHVTTQIRG-TMGHI---APEYLSTGKSSEKTDVFGYGIT 465
N+ + DFG+++ + + +++G I A E + GK + K+DV+ +G+T
Sbjct: 165 KNYTIKIADFGMSRNLYSS---DYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVT 221
Query: 466 LLELVTGQRAIDFSRLEEEE 485
L E++T R + L +++
Sbjct: 222 LWEILTLCREQPYEHLTDQQ 241
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 70/216 (32%), Positives = 96/216 (44%), Gaps = 45/216 (20%)
Query: 279 IGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREV-HLISVAIHKNLLQLIGY 336
IG+G FG+VY+ D ++ A+K L E ++EV H I +N+L
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK-----KEIVAKKEVAHTIG---ERNILV---- 48
Query: 337 CTTSSERILVYPFM-------QNLSVAYRLRDLKPGEKGLDWPTRK-------RVAFGTA 382
T E PF+ Q S Y + D G + L W +K R F A
Sbjct: 49 RTLLDES----PFIVGLKFSFQTDSDLYLVTDYMSGGE-LFWHLQKEGRFSEDRAKFYIA 103
Query: 383 ---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIR 437
LE+LH+ I++RDLK NILLD LCDFGL+K L D K T+
Sbjct: 104 ELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC--- 157
Query: 438 GTMGHIAPEYLSTGKSSEK-TDVFGYGITLLELVTG 472
GT ++APE L K K D + G+ + E+ G
Sbjct: 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 53/201 (26%), Positives = 85/201 (42%), Gaps = 16/201 (7%)
Query: 279 IGQGGFGKVYK-GVLSDNTKVAVKRLQDYYSPGGEAAFQ----REVHLISVAIHKNLLQL 333
IG+G G V+K VA+K++ E RE+ + H +++L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKV---ALRRLEGGIPNQALREIKALQACQHPYVVKL 64
Query: 334 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 393
+ S +LV +M + ++ LRD E+ L K G+ Y+H
Sbjct: 65 LDVFPHGSGFVLVMEYMPS-DLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN-- 118
Query: 394 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL-STGK 452
I+HRDLK AN+L+ + + DFGLA+L + + + T + APE L K
Sbjct: 119 -GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 453 SSEKTDVFGYGITLLELVTGQ 473
D++ G EL+ G
Sbjct: 178 YDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 65/233 (27%), Positives = 105/233 (45%), Gaps = 24/233 (10%)
Query: 273 FSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQD--YYSPGGEAAFQREVHLISVAIHKN 329
F ++G+GGFG+V + K+ A K+L+ GEA E ++ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY---GLE 386
++ L T LV M + + + ++ G G D +R F A GLE
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFD---EQRAIFYAAELCCGLE 116
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR---GTMGHI 443
L + +I++RDLK NILLDD + D GLA + T +R GT+G++
Sbjct: 117 DLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-----VRGRVGTVGYM 168
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHKVTE 496
APE ++ K + D +G G + E++ GQ F + +E +D +V E
Sbjct: 169 APEVINNEKYTFSPDWWGLGCLIYEMIQGQSP--FRKRKERVKREEVDRRVKE 219
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 279 IGQGGFGKVYKGVLSDNTK--VAVKRLQDYYSPGG-------EAAFQREVHLISVAIHKN 329
IG+G +GKV+K N VA+KR++ G E A R + H N
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE---HPN 65
Query: 330 LLQLIGYCTTS-----SERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 383
+++L CT S ++ LV+ + Q+L+ K E G+ T K + F
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD----KVPEPGVPTETIKDMMFQLLR 121
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
GL++LH +++HRDLK NIL+ + + L DFGLA++ ++ T + T+ +
Sbjct: 122 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYR 176
Query: 444 APEYLSTGKSSEKTDVFGYGITLLEL 469
APE L + D++ G E+
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 27/203 (13%)
Query: 297 KVAVKRLQDYYSPGGE---AAFQREVHLISVAIHKNLLQLIGYCTTSSERIL-VYPFMQN 352
+VA+K L+ +P E A F+RE L + H N++ L+ + V+ ++
Sbjct: 5 EVAIKLLRTD-APEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPG 63
Query: 353 LSVAYRLRD---LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL- 408
++ L L GE G R+ L H Q I+HRDLK NI++
Sbjct: 64 RTLREVLAADGALPAGETG-------RLMLQVLDALACAHNQ---GIVHRDLKPQNIMVS 113
Query: 409 --DDNFEAVLCDFGLAKL------VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVF 460
A + DFG+ L D TT++ GT + APE L + +D++
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173
Query: 461 GYGITLLELVTGQRAIDFSRLEE 483
+G+ LE +TGQR + + + E
Sbjct: 174 AWGLIFLECLTGQRVVQGASVAE 196
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 32/215 (14%)
Query: 279 IGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+G+G FGKV+ D VAVK L+D S F RE L++ H+++++
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVK 71
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL---DWPTR------KRVAFGTAY 383
G C I+V+ +M++ + LR P + + P +A A
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH- 442
G+ YL Q +HRDL N L+ +N + DFG+++ V +T GH
Sbjct: 132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDV------YSTDYYRVGGHT 182
Query: 443 ------IAPEYLSTGKSSEKTDVFGYGITLLELVT 471
+ PE + K + ++DV+ G+ L E+ T
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 19/212 (8%)
Query: 273 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKNLL 331
F ++G G +G+VYKG ++A ++ D + E + E++++ + H+N+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TEDEEEEIKLEINMLKKYSHHRNIA 76
Query: 332 QLIGYCTTSS------ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGL 385
G S + LV F SV +++ K DW + GL
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGL 134
Query: 386 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAP 445
+LH K+IHRD+K N+LL +N E L DFG++ +D + T I GT +AP
Sbjct: 135 AHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAP 190
Query: 446 EYLSTGKSSEKT-----DVFGYGITLLELVTG 472
E ++ ++ + T D++ GIT +E+ G
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 11/198 (5%)
Query: 279 IGQGGFGKVYKGVLSDNTK-VAVKR-LQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
IG+G +G V+K + + VA+K+ ++ P + RE+ ++ H NL+ LI
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396
+ LV+ + + +V L +L+ +G+ K++ + T + + H+
Sbjct: 69 FRRKRKLHLVFEYCDH-TV---LNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NC 121
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL-STGKSSE 455
IHRD+K NIL+ + LCDFG A+++ T + T + APE L +
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGDTQYGP 180
Query: 456 KTDVFGYGITLLELVTGQ 473
DV+ G EL+TGQ
Sbjct: 181 PVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 20/213 (9%)
Query: 279 IGQGGFGKVYKG--VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
+G+G + V+KG L++N VA+K ++ + G REV L+ H N++ L
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKG----LDWPTRKRVAFGTAYGLEYLHEQC 392
T LV+ ++ +DLK + K + GL Y H +
Sbjct: 73 VHTDKSLTLVFEYLD--------KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR- 123
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE-YLSTG 451
K++HRDLK N+L+++ E L DFGLA+ + ++ T+ + P+ L +
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSS 180
Query: 452 KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE 484
+ S + D++G G E+ +G+ S +E+E
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 35/102 (34%), Positives = 61/102 (59%), Gaps = 7/102 (6%)
Query: 376 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTT 434
+V+ GL YL E+ +I+HRD+K +NIL++ E LCDFG++ +L+D+ +
Sbjct: 107 KVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 160
Query: 435 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 476
GT +++PE L S ++D++ G++L+EL G+ I
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 53/218 (24%), Positives = 103/218 (47%), Gaps = 20/218 (9%)
Query: 272 NFSESNIIGQGGFGKVY--KGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHK 328
+ + ++G+G FG V+ + +D V +K++ + + A Q E ++ + H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVA----YRLRDLKPGEKGLDWPTRKRVAFGTAYG 384
N+++ ++V + ++A R L + L + + +A
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------ 113
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
L ++H I+HRDLK NILLD + V + DFG++K++ +K T + GT +I
Sbjct: 114 LHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYI 168
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRL 481
+PE ++K+D++ G L EL + +RA + + L
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 64/198 (32%), Positives = 85/198 (42%), Gaps = 20/198 (10%)
Query: 279 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQ---REVHLISVAIHKNLLQLI 334
IG G FG VY S N VAVK++ Y +Q +EV + H N ++
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMS-YSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 335 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 394
G LV + L A L L+ +K L + G GL YLH
Sbjct: 88 GCYLKEHTAWLVMEYC--LGSASDL--LEVHKKPLQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 395 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY---LSTG 451
+IHRD+KA NILL + + L DFG A + V GT +APE + G
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEG 195
Query: 452 KSSEKTDVFGYGITLLEL 469
+ K DV+ GIT +EL
Sbjct: 196 QYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 53/172 (30%), Positives = 80/172 (46%), Gaps = 35/172 (20%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTK--VAVKR-LQDYYSPGGEAAFQREVHLISVAIH 327
+ + IGQG FG+V+K TK VA+K+ L + G RE+ ++ + H
Sbjct: 12 SKYEKLAKIGQGTFGEVFK-ARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKH 70
Query: 328 KNLLQLIGYCTTSSER--------ILVYPF--------MQNLSVAYRLRDLKPGEKGLDW 371
+N++ LI C T + LV+ F + N +V + L ++K K L
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKML-- 128
Query: 372 PTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423
GL Y+H KI+HRD+KAANIL+ + L DFGLA+
Sbjct: 129 ----------LNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 68/259 (26%), Positives = 105/259 (40%), Gaps = 69/259 (26%)
Query: 279 IGQGGFGKVYKGVLSDNTK------VAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLL 331
+G+G FGKV + K VAVK L++ + A E+ LI + H N++
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74
Query: 332 QLIGYCTTSSERILV---YPFMQNLS----------VAYRLRDL-------KPGEKG-LD 370
L+G CT ++V Y NLS YR + K G+K LD
Sbjct: 75 NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134
Query: 371 ------------WPTRKRV-------------------------AFGTAYGLEYLHEQCN 393
+ K + +F A G+E+L +
Sbjct: 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR-- 192
Query: 394 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QIRGTMGHIAPEYLSTGK 452
K IHRDL A NILL +N +CDFGLA+ + +V R + +APE +
Sbjct: 193 -KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKV 251
Query: 453 SSEKTDVFGYGITLLELVT 471
+ ++DV+ +G+ L E+ +
Sbjct: 252 YTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 273 FSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQD--YYSPGGEAAFQREVHLISVAIHKN 329
F ++G+GGFG+V + K+ A K+L+ GEA E ++ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA---YGLE 386
++ L T LV M + + + ++ G D +R F A GLE
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNP--GFD---EERAVFYAAEITCGLE 116
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 446
LH + +I++RDLK NILLDD + D GLA V+ GT+G++APE
Sbjct: 117 DLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAPE 171
Query: 447 YLSTGKSSEKTDVFGYGITLLELVTGQ 473
+ + + D +G G + E++ G+
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 3e-11
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 19/205 (9%)
Query: 279 IGQGGFGKVYKGVLSDNTK---VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
+G G FG V KGV K VA+K L++ RE ++ + ++++IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVA---FGTAYGLEYLHEQC 392
C +E +++ + ++ L G+K D T V + G++YL +
Sbjct: 63 VC--EAEALML---VMEMASGGPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK- 114
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT--MGHIAPEYLST 450
+HRDL A N+LL + A + DFGL+K + A ++ + G + APE ++
Sbjct: 115 --NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF 172
Query: 451 GKSSEKTDVFGYGITLLELVT-GQR 474
K S ++DV+ YGIT+ E + GQ+
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 33/102 (32%), Positives = 60/102 (58%), Gaps = 7/102 (6%)
Query: 376 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTT 434
+++ GL YL E KI+HRD+K +NIL++ E LCDFG++ +L+D+ +
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 156
Query: 435 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 476
GT +++PE L + ++D++ G++L+E+ G+ I
Sbjct: 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 61/230 (26%), Positives = 97/230 (42%), Gaps = 32/230 (13%)
Query: 265 ELQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQRE 318
E+ L+T F E +G+ FGKVYKG L VA+K L+D F+ E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 319 VHLISVAIHKNLLQLIGYCTTSS--ERILVYPFMQNLSVAYRLR----------DLKPGE 366
+ S H N++ L+G T I Y +L +R D K +
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 367 KGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426
L+ + A G+E+L ++H+DL N+L+ D + D GL + V
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 427 AK-----LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
A + + IR ++PE + GK S +D++ YG+ L E+ +
Sbjct: 176 AADYYKLMGNSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 48/203 (23%), Positives = 93/203 (45%), Gaps = 7/203 (3%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ--DYYSPGGEAAFQREVHLISVAI 326
NF IG+G F VYK + L D VA+K++Q + +E+ L+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 327 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386
H N+++ + ++E +V ++ ++ K ++ + T + LE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 446
++H + +I+HRD+K AN+ + L D GL + +K T + + GT +++PE
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 447 YLSTGKSSEKTDVFGYGITLLEL 469
+ + K+D++ G L E+
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 272 NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEA------AFQREVHLISV 324
N+ ++G+G FG+VY +D + +AVK++ + P + A + E+ L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVP--FDPDSQETSKEVNALECEIQLLKN 60
Query: 325 AIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 382
H ++Q G E+ L +M S+ +L+ L +R
Sbjct: 61 LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQIL 116
Query: 383 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT--TQIRGTM 440
G+ YLH I+HRD+K ANIL D L DFG +K + T + GT
Sbjct: 117 QGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173
Query: 441 GHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
++PE +S K DV+ T++E++T
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 38/225 (16%)
Query: 267 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHL-ISVA 325
+L D+F + + +G G G V+K + P G ++ +HL I A
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVS---------------HKPSGLIMARKLIHLEIKPA 45
Query: 326 IHKNL---LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------- 375
I + LQ++ C + F + ++ + + G LD +K
Sbjct: 46 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS--LDQVLKKAGRIPEQ 103
Query: 376 ---RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTH 431
+V+ GL YL E+ KI+HRD+K +NIL++ E LCDFG++ +L+D+
Sbjct: 104 ILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 157
Query: 432 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 476
+ GT +++PE L S ++D++ G++L+E+ G+ I
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 45/211 (21%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGE-AAFQREVHLISVAIHKNLLQLIG- 335
+G G +G VYK L AVK ++ PG + + Q+E+ ++ H N++ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIK--LEPGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 336 ------------YCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 381
YC S + + V + L +AY R+ T
Sbjct: 75 YLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRE-------------------T 115
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 441
GL YLH + +HRD+K ANILL DN + L DFG+A + A + + I GT
Sbjct: 116 LQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPY 171
Query: 442 HIAPEYLSTGKS---SEKTDVFGYGITLLEL 469
+APE + K+ ++ D++ GIT +EL
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 49/205 (23%), Positives = 93/205 (45%), Gaps = 7/205 (3%)
Query: 272 NFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ--DYYSPGGEAAFQREVHLISVAIHK 328
NF IG+G F +VY+ L D VA+K++Q D A +E+ L+ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
N+++ +E +V ++ ++ K ++ + T + LE++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 448
H + +++HRD+K AN+ + L D GL + +K T + + GT +++PE +
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERI 178
Query: 449 STGKSSEKTDVFGYGITLLELVTGQ 473
+ K+D++ G L E+ Q
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQ 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 50/210 (23%), Positives = 106/210 (50%), Gaps = 17/210 (8%)
Query: 267 QLATDNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQREVHLI 322
++ ++ + IG+G FG VY+GV ++ VAVK ++ SP F +E +++
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM 61
Query: 323 SVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAF 379
H ++++LIG T + I+ + P + LR L+ + LD + ++
Sbjct: 62 RQFDHPHIVKLIGVITENPVWIVMELAPLGE-------LRSYLQVNKYSLDLASLILYSY 114
Query: 380 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT 439
+ L YL + + +HRD+ A N+L+ L DFGL++ ++ + + ++ +
Sbjct: 115 QLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLP 171
Query: 440 MGHIAPEYLSTGKSSEKTDVFGYGITLLEL 469
+ +APE ++ + + +DV+ +G+ + E+
Sbjct: 172 IKWMAPESINFRRFTSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 5e-11
Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 30/214 (14%)
Query: 279 IGQGGFGKVYKGVLSDN--TKVAVKRLQDYYSPGGEAAFQR---------EVHLISVAI- 326
+G G FG VYK +N +A+K + + G+ +R EV +I +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 327 HKNLLQLIGYCTTSSERILVYPFM---QNLSVAYRLRDLKPGEKGLDWPTRK--RVAFGT 381
H N+++ Y T E +Y M + + LK EK + + +
Sbjct: 68 HPNIVR---YYKTFLENDRLYIVMDLIEGAPLGEHFNSLK--EKKQRFTEERIWNIFVQM 122
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA--KLVDAKLTHVTTQIRGT 439
L YLH++ +I+HRDL NI+L ++ + + DFGLA K ++KLT V GT
Sbjct: 123 VLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVV----GT 176
Query: 440 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
+ + PE + EK DV+ +G L ++ T Q
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQ 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 56/207 (27%), Positives = 104/207 (50%), Gaps = 29/207 (14%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIG 335
+G G +G V + KVA+K+L + + A+ RE+ L+ H+N++ L+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY-RELTLLKHMQHENVIGLLD 81
Query: 336 YCTTSS------ERILVYPFMQ-NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
T++ + LV P+MQ +L ++ E + + + + GL+Y+
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQTDLQ---KIMGHPLSEDKVQY-----LVYQMLCGLKYI 133
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEY 447
H IIHRDLK N+ ++++ E + DFGLA+ DA++T +V T+ + APE
Sbjct: 134 HSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEV 185
Query: 448 -LSTGKSSEKTDVFGYGITLLELVTGQ 473
L+ ++ D++ G + E++TG+
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 6e-11
Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 5/90 (5%)
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 444
L++LH+ II+RD+K NILLD VL DFGL+K A+ GT+ ++A
Sbjct: 118 LDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174
Query: 445 PEYLSTGKS--SEKTDVFGYGITLLELVTG 472
PE + G + D + G+ EL+TG
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 7e-11
Identities = 49/217 (22%), Positives = 95/217 (43%), Gaps = 30/217 (13%)
Query: 278 IIGQGGFGK--VYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLI 334
++G+G FG+ +Y+ D++ V K + S E+ ++S+ H N++
Sbjct: 7 VLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 335 GYCTTSSERILVYPFMQNLSVAYRLRDLKPG--------EKGLDWPTRKRVA--FGTAYG 384
+ FM + ++ + G +KG + + F
Sbjct: 66 NH------------FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA 113
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 444
+ Y+H+ I+HRD+K NI L L DFG++K++ ++ + T + GT +++
Sbjct: 114 VSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMS 169
Query: 445 PEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRL 481
PE K + K+D++ G L EL+T +R D +
Sbjct: 170 PELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 8e-11
Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 21/202 (10%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
IG+G +G VYKG VA+K+++ + G + RE+ L+ H N++ L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLK------PGEKGLDWPTRKRVAFGTAYGLEYLHE 390
S L++ F+ DLK P + +D K + G+ + H
Sbjct: 68 LMQESRLYLIFEFLS--------MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119
Query: 391 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL-S 449
+ +++HRDLK N+L+D+ L DFGLA+ + T ++ T+ + APE L
Sbjct: 120 R---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVLLG 175
Query: 450 TGKSSEKTDVFGYGITLLELVT 471
+ + S D++ G E+ T
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 9e-11
Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ----REVHLISVA 325
D + + +G G +G V + KVA+K+L Y P F RE+ L+
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKL---YRPFQSELFAKRAYRELRLLKHM 71
Query: 326 IHKNLLQLIGYCT--TSSERI----LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF 379
H+N++ L+ T S +R LV PFM + ++ K E + + + +
Sbjct: 72 KHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQF-----LVY 125
Query: 380 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT 439
GL+Y+H IIHRDLK N+ ++++ E + DFGLA+ D+++T T
Sbjct: 126 QMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV----T 178
Query: 440 MGHIAPEY-LSTGKSSEKTDVFGYGITLLELVTGQ 473
+ APE L+ ++ D++ G + E++TG+
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 66/232 (28%), Positives = 102/232 (43%), Gaps = 54/232 (23%)
Query: 278 IIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
++G+G FGKV+ L N A+K A +++V L+ +
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIK------------ALKKDVVLMDDDVE--------- 40
Query: 337 CTTSSERILV----YPFMQNLSVAYRLRD--------LKPGE--------KGLDWPTRKR 376
CT +R+L +PF+ +L ++ ++ L G+ D P
Sbjct: 41 CTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF 100
Query: 377 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK---LVDAKLTHVT 433
A GL++LH + I++RDLK NILLD + + DFG+ K L DAK T
Sbjct: 101 YAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK----T 153
Query: 434 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE 485
GT +IAPE L K + D + +G+ L E++ GQ F +EEE
Sbjct: 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP--FHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 65/204 (31%), Positives = 90/204 (44%), Gaps = 20/204 (9%)
Query: 273 FSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---REVHLISVAIHK 328
FS+ IG G FG VY + ++ VA+K++ Y +Q +EV + H
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS-YSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
N +Q G LV + L A L L+ +K L V G GL YL
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYC--LGSASDL--LEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY- 447
H + +IHRD+KA NILL + L DFG A ++ V GT +APE
Sbjct: 132 H---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 183
Query: 448 --LSTGKSSEKTDVFGYGITLLEL 469
+ G+ K DV+ GIT +EL
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 30/219 (13%)
Query: 279 IGQGGFGKVYKGV--LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
+G+G + VYKG L+ VA+K ++ + G RE L+ H N++ L
Sbjct: 13 LGEGSYATVYKGRSKLTGQL-VALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLK------PGEKGLDWPTRKRVAFGTAYGLEYLHE 390
T LV+ ++ DLK G GL + F GL Y H+
Sbjct: 72 IHTKKTLTLVFEYLD--------TDLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQ 121
Query: 391 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL--THVTTQIRGTMGHIAPEYL 448
+ +++HRDLK N+L+ + E L DFGLA+ AK + + T+ + P+ L
Sbjct: 122 R---RVLHRDLKPQNLLISERGELKLADFGLAR---AKSVPSKTYSNEVVTLWYRPPDVL 175
Query: 449 --STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE 485
ST S+ D++G G E+ TG+ S E++
Sbjct: 176 LGSTEYSTS-LDMWGVGCIFYEMATGRPLFPGSTDVEDQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 34/99 (34%), Positives = 58/99 (58%), Gaps = 8/99 (8%)
Query: 376 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTT 434
R+A GL YL + KI+HRD+K +N+L++ + LCDFG++ +LV++ +
Sbjct: 99 RIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAK 151
Query: 435 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
GT ++APE +S + +DV+ GI+ +EL G+
Sbjct: 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 278 IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS---PGGEAAFQREVHLISVAIHKN--LLQ 332
IIG+GGFG+VY +D K+ + D GE E ++S+ + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 333 LIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA---YGLEYL 388
+ Y + +++ + M + Y L + G+ + + F A GLE++
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGVF--SEAEMRFYAAEIILGLEHM 113
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 448
H N +++RDLK ANILLD++ + D GLA K H + GT G++APE L
Sbjct: 114 H---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 167
Query: 449 STGKSSEKT-DVFGYGITLLELVTGQ 473
G + + + D F G L +L+ G
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 41/112 (36%), Positives = 59/112 (52%), Gaps = 7/112 (6%)
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPE 446
+H + +IHRD+K+ANILL N L DFG +K+ A ++ V GT ++APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 447 YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHKVTEGR 498
S+K D+F G+ L EL+T +R D +EE + HK GR
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE------VMHKTLAGR 261
|
Length = 496 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 2e-10
Identities = 63/204 (30%), Positives = 89/204 (43%), Gaps = 20/204 (9%)
Query: 273 FSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---REVHLISVAIHK 328
F++ IG G FG VY + N VA+K++ Y +Q +EV + H
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMS-YSGKQSNEKWQDIIKEVKFLQRIKHP 85
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
N ++ G LV + L A L L+ +K L + G GL YL
Sbjct: 86 NSIEYKGCYLREHTAWLVMEYC--LGSASDL--LEVHKKPLQEVEIAAITHGALQGLAYL 141
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY- 447
H +IHRD+KA NILL + + L DFG A + + V GT +APE
Sbjct: 142 HSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVI 193
Query: 448 --LSTGKSSEKTDVFGYGITLLEL 469
+ G+ K DV+ GIT +EL
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-10
Identities = 37/113 (32%), Positives = 60/113 (53%), Gaps = 8/113 (7%)
Query: 74 RNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLAN 133
++ N+ L L +N +G+I + L L L N L G +P LG+ L+ + L +
Sbjct: 354 KHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQD 413
Query: 134 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRI--------PMQLFSVATFNFTG 178
N FSG +P+ +++L + LD+S+NNL GRI +Q+ S+A F G
Sbjct: 414 NSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFG 466
|
Length = 968 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 49/205 (23%), Positives = 93/205 (45%), Gaps = 21/205 (10%)
Query: 298 VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN----- 352
VAVK L+ + F +EV ++S N+++L+G C ++ +M+N
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 353 -LSVAYRLRDLKPGEKG---------LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLK 402
LS + + G + + + VA A G++YL + +HRDL
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLA 165
Query: 403 AANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG--HIAPEYLSTGKSSEKTDVF 460
N L+ +N + DFG+++ + A + Q R + +A E + GK + +DV+
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAG-DYYRIQGRAVLPIRWMAWECILMGKFTTASDVW 224
Query: 461 GYGITLLELVTGQRAIDFSRLEEEE 485
+G+TL E++ + + L +E+
Sbjct: 225 AFGVTLWEILMLCKEQPYGELTDEQ 249
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 3e-10
Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 15/204 (7%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGE-AAFQREVHLISVAIHK 328
++F IG G +G VYK ++ A+K ++ PG + A Q+E+ ++ H
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK--LEPGEDFAVVQQEIIMMKDCKHS 66
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
N++ G + + F S L+D+ L V+ T GL YL
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGS----LQDIYHVTGPLSESQIAYVSRETLQGLYYL 122
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 448
H + +HRD+K ANILL DN L DFG++ + A + + I GT +APE
Sbjct: 123 H---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVA 178
Query: 449 ST---GKSSEKTDVFGYGITLLEL 469
+ G ++ D++ GIT +EL
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 26/202 (12%)
Query: 279 IGQGGFGKVYKGVLS---DNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLI 334
+G G FG V KG+ VAVK L+ D P + RE +++ + ++++I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 335 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWP---TRKRV---AFGTAYGLEYL 388
G C ++ + L +L P K L T K + + G++YL
Sbjct: 63 GICEA-----------ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYL 111
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT--MGHIAPE 446
E +HRDL A N+LL A + DFGL+K + A + + G + APE
Sbjct: 112 EET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE 168
Query: 447 YLSTGKSSEKTDVFGYGITLLE 468
++ K S K+DV+ +G+ + E
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 49/208 (23%), Positives = 99/208 (47%), Gaps = 20/208 (9%)
Query: 298 VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN--LSV 355
VAVK L+ + F +E+ ++S + N+++L+G C + ++ +M+N L+
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 356 AYRLRDLKPG-EKGLDWPTRKR-----VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD 409
R+++ + P+ +A A G++YL + +HRDL N L+
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVG 163
Query: 410 DNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLE 468
+++ + DFG+++ L + + + +A E + GK + +DV+ +G+TL E
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223
Query: 469 LVTGQRAIDFSRLEEEEDVLLLDHKVTE 496
+ F+ +E+ LL D +V E
Sbjct: 224 M--------FTLCKEQPYSLLSDEQVIE 243
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 4e-10
Identities = 58/217 (26%), Positives = 89/217 (41%), Gaps = 52/217 (23%)
Query: 279 IGQGGFGKVYK-GVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
+G GGFG+V V S N A+K + ++ H++ +++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCV-------------KKRHIVETGQQEHIFS----- 42
Query: 338 TTSSER----ILVYPFMQNLSVAYR-------LRDLKPG--------EKGL--DWPTRKR 376
E+ +PF+ L ++ L + G ++GL ++ R
Sbjct: 43 ----EKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFY 98
Query: 377 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKLTHVTTQ 435
+A EYLH + II+RDLK N+LLD N L DFG AK L + T
Sbjct: 99 IACVVL-AFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT--- 151
Query: 436 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 472
GT ++APE + D + GI L EL+TG
Sbjct: 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 40/114 (35%), Positives = 62/114 (54%), Gaps = 11/114 (9%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGTMGH 442
GL++LHE+ II+RDLK N+LLD + DFG+ K + L VTT GT +
Sbjct: 108 GLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDY 162
Query: 443 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL--LLDHKV 494
IAPE LS D + G+ L E++ GQ + ++E+++ +L+ +V
Sbjct: 163 IAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE---GDDEDELFQSILEDEV 213
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 47/205 (22%), Positives = 95/205 (46%), Gaps = 7/205 (3%)
Query: 272 NFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ--REVHLISVAIHK 328
NF IG+G F +VY+ L D VA+K++Q + +A +E+ L+ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
N+++ + +E +V ++ ++ K ++ + T + +E++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 448
H + +++HRD+K AN+ + L D GL + +K T + + GT +++PE +
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERI 178
Query: 449 STGKSSEKTDVFGYGITLLELVTGQ 473
+ K+D++ G L E+ Q
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQ 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 23/206 (11%)
Query: 278 IIGQGGFGKVYKGVLSDNTKVAVKRLQDY----YSPGGEAAFQREVHLISVAIHK-NLLQ 332
IIG+GGFG+VY +D K+ + D G A + L V+ +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 333 LIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA---YGLEYL 388
+ Y + +++ + M + Y L + G+ + K + F GLE++
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHL-----SQHGVF--SEKEMRFYATEIILGLEHM 113
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 448
H N +++RDLK ANILLD++ + D GLA K H + GT G++APE L
Sbjct: 114 H---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 167
Query: 449 STGKSSEKT-DVFGYGITLLELVTGQ 473
G + + + D F G L +L+ G
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 5e-10
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 9/89 (10%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIRGTMG 441
GL YLH Q +IIHRD+K NI ++D + + D G A+ +V + GT+
Sbjct: 169 GLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA----GTVE 221
Query: 442 HIAPEYLSTGKSSEKTDVFGYGITLLELV 470
APE L+ K + K D++ GI L E++
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 270 TDNFSESNIIGQGGFGKVYKGVLS--DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH 327
+D + IG+G +GKV+K VL+ + +K AVK L + E + + L +++ H
Sbjct: 17 SDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDEEIEAEYNI-LKALSDH 74
Query: 328 KNLLQLIGY-----CTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGT 381
N+++ G + LV SV ++ LK GE+ ++ P +
Sbjct: 75 PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER-MEEPIIAYILHEA 133
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL-AKLVDAKLTHVTTQIRGTM 440
GL++LH K IHRD+K NILL L DFG+ A+L +L T+ GT
Sbjct: 134 LMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV--GTP 188
Query: 441 GHIAPEYLSTGKS-----SEKTDVFGYGITLLELVTG 472
+APE ++ + + DV+ GIT +EL G
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 58/198 (29%), Positives = 91/198 (45%), Gaps = 12/198 (6%)
Query: 279 IGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
+G+G + VYKG+ N + VA+K + G RE L+ H N++ L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 338 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 397
T V+ +M Y ++ PG GL + F GL Y+H Q I+
Sbjct: 73 HTKETLTFVFEYMHTDLAQYMIQ--HPG--GLHPYNVRLFMFQLLRGLAYIHGQ---HIL 125
Query: 398 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL--STGKSSE 455
HRDLK N+L+ E L DFGLA+ ++++ T+ + P+ L +T SS
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSSA 184
Query: 456 KTDVFGYGITLLELVTGQ 473
D++G G +E++ GQ
Sbjct: 185 -LDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 6e-10
Identities = 50/213 (23%), Positives = 90/213 (42%), Gaps = 14/213 (6%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTK-VAVKR-LQDYYSPGGEAAFQREVHL---ISVA 325
D + + IG+G +GKVYK + K VA+K+ + G RE+ L +S +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 326 IHKNLLQLIGYCTTSSERILVYPFMQNLSV---AYRLRDLKPGEKGLDWPTRKRVAFGTA 382
I+ L + + + + +Y + L + + + + L T K +
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120
Query: 383 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTMG 441
G+ + H+ ++HRDLK N+L+D + + D GL + + T +I T+
Sbjct: 121 KGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLW 176
Query: 442 HIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 473
+ APE L S D++ G E+ Q
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 7e-10
Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 30/208 (14%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
IG+G +G VYK VA+K+++ + G + RE+ L+ H N+++L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLKP-----GEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
+ ++ LV+ F+ DLK GLD P K + G+ Y H
Sbjct: 67 VHSENKLYLVFEFLD--------LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL---TH--VTTQIRGTMGHIAPE 446
+++HRDLK N+L+D L DFGLA+ + TH VT R APE
Sbjct: 119 ---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYR------APE 169
Query: 447 YLSTGKS-SEKTDVFGYGITLLELVTGQ 473
L + S D++ G E+V +
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 9e-10
Identities = 33/91 (36%), Positives = 48/91 (52%), Gaps = 5/91 (5%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
LE+LH+ II+RD+K NILLD N VL DFGL+K GT+ ++
Sbjct: 117 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173
Query: 444 APEYLSTGKS--SEKTDVFGYGITLLELVTG 472
AP+ + G + D + G+ + EL+TG
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 44/227 (19%)
Query: 278 IIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLI-----SVAIHKNLL 331
++G+G FGKV L + A+K A +++V L + + +L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIK------------ALKKDVVLEDDDVECTMVERRVL 49
Query: 332 QLIG--------YCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 381
L +CT ++ L V ++ + + ++ ++ R F
Sbjct: 50 ALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDE-------ARARFYA 102
Query: 382 A---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG 438
A GL++LH++ II+RDLK N+LLD + + DFG+ K + + G
Sbjct: 103 AEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKE-NMNGEGKASTFCG 158
Query: 439 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE 485
T +IAPE L K +E D + +G+ L E++ GQ F +E+E
Sbjct: 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP--FHGEDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 40/118 (33%), Positives = 64/118 (54%), Gaps = 13/118 (11%)
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR-GTM 440
+ GL +LH + II+RDLK N++LD + DFG+ K + + VTT+ GT
Sbjct: 111 SVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTP 165
Query: 441 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL---LLDHKVT 495
+IAPE ++ + D + YG+ L E++ GQ D E+ED L +++H V+
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD----GEDEDELFQSIMEHNVS 219
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 36/88 (40%), Positives = 48/88 (54%), Gaps = 4/88 (4%)
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 444
LE LH+ +I+RDLK NILLD LCDFGL KL + K T GT ++A
Sbjct: 106 LENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTPEYLA 161
Query: 445 PEYLSTGKSSEKTDVFGYGITLLELVTG 472
PE L ++ D + G+ L E++TG
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 51/198 (25%), Positives = 89/198 (44%), Gaps = 14/198 (7%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQ-------DYYSPGGEAAFQREVHLISVAIHKNLL 331
+G+G FG VY ++ D VA +RL+ +P +E L+S H ++
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 332 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
+ ++ + + + +L +LK K L G+ Y+H++
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 451
+I+HRDLKA NI L +N + DFG+++L+ TT GT +++PE L
Sbjct: 126 ---RILHRDLKAKNIFLKNNLLKI-GDFGVSRLLMGSCDLATT-FTGTPYYMSPEALKHQ 180
Query: 452 KSSEKTDVFGYGITLLEL 469
K+D++ G L E+
Sbjct: 181 GYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 58/234 (24%), Positives = 115/234 (49%), Gaps = 35/234 (14%)
Query: 278 IIGQGGFGKV----YKGVLSDNTKVAVKRLQDYYSPGGE-AAFQREVHLISVAIHKNLLQ 332
++G+G +G+V ++ +D + +K+L + E A ++E L+S H N+
Sbjct: 7 VVGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI-- 61
Query: 333 LIGYCTT-SSERILVY---PFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYG 384
+ Y + E L+Y F + + ++L++ K P + ++W + A
Sbjct: 62 -VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ------IAMA 114
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 444
L+YLHE+ I+HRDLK N+ L + D G+A++++ + +T I GT +++
Sbjct: 115 LQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMS 170
Query: 445 PEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHKVTEGR 498
PE S + K+DV+ G + E+ T + A + +D+ L +++ EG+
Sbjct: 171 PELFSNKPYNYKSDVWALGCCVYEMATLKHAFN------AKDMNSLVYRIIEGK 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 28/169 (16%)
Query: 279 IGQGGFGKVYKGVL---SDNTKVAVKRLQ---DYYSPGGEAAFQREVHLISVAIHKNLLQ 332
IG+G +G+VYK D + A+K+ + + Y+ G + RE+ L+ H+N++
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYT-GISQSACREIALLRELKHENVVS 66
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDL--------KPGEKGLDWPTRKRVAFGTAYG 384
L+ +++ VY L Y DL + + K + + G
Sbjct: 67 LVEVFLEHADK-SVY-----LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 385 LEYLHEQCNPKIIHRDLKAANILL--DDNFEAV--LCDFGLAKLVDAKL 429
+ YLH ++HRDLK ANIL+ + V + D GLA+L +A L
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 15/204 (7%)
Query: 278 IIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 333
I+G G FG++ +G L +K VA+ L+ S F E + H N+++L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 334 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 393
G T + ++V +M N ++ LR E L + G A G++YL E
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEM-- 126
Query: 394 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI--APEYLSTG 451
+H+ L A +L++ + + F +L + K + T + G + APE +
Sbjct: 127 -GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183
Query: 452 KSSEKTDVFGYGITLLELVT-GQR 474
S +DV+ +GI + E+++ G+R
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 62/244 (25%), Positives = 94/244 (38%), Gaps = 40/244 (16%)
Query: 244 DVAGEDDCKVSLTQLRRFSCRELQLATDNFS----ESNIIGQ---GGFGKVYKGVL---S 293
D +++ T + + C E ++D S + NI+ G G+V+
Sbjct: 59 DYDADEESLSPQTDVCQEPC-ETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKHGDE 117
Query: 294 DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 353
KV VK + +PG E + + H+ ++ LI S +V P +
Sbjct: 118 QRKKVIVKAVTGGKTPGREIDILKTIS------HRAIINLIHAYRWKSTVCMVMPKYKCD 171
Query: 354 SVAY-------RLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANI 406
Y L ++ L L YLH + IIHRD+K NI
Sbjct: 172 LFTYVDRSGPLPLEQAITIQRRL------------LEALAYLHGR---GIIHRDVKTENI 216
Query: 407 LLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGIT 465
LD+ AVL DFG A KL T GT+ +PE L+ KTD++ G+
Sbjct: 217 FLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLV 276
Query: 466 LLEL 469
L E+
Sbjct: 277 LFEM 280
|
Length = 392 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 11/196 (5%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
IGQG G VY + ++ +VA+K++ P E E+ ++ H N++ +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN-EILVMRENKHPNIVNYLDSY 85
Query: 338 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 397
E +V ++ S L D+ E +D V LE+LH ++I
Sbjct: 86 LVGDELWVVMEYLAGGS----LTDVVT-ETCMDEGQIAAVCRECLQALEFLHSN---QVI 137
Query: 398 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 457
HRD+K+ NILL + L DFG + + + +T + GT +APE ++ K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 458 DVFGYGITLLELVTGQ 473
D++ GI +E+V G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLIG 335
+IG+G +G V + KVA+K++ D + +A RE+ L+ + H +++++
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 336 YCTTSSERILVYPFMQNLSVAYRL--RDLKPGEKGLDWPTRKRVAF---GTAYGLEYLHE 390
S R +++ V + L DL K D T + F L+Y+H
Sbjct: 67 IMLPPSRREF-----KDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH- 120
Query: 391 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIRGTMGHIAPEYL 448
+ HRDLK NIL + + + +CDFGLA+ D T T + APE
Sbjct: 121 --TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 178
Query: 449 ST--GKSSEKTDVFGYGITLLELVTGQ 473
+ K + D++ G E++TG+
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 24/204 (11%)
Query: 279 IGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQ----REVHLI---SVAIHKNL 330
IG G +G VYK + VA+K ++ E REV L+ H N+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVR---VQTNEDGLPLSTVREVALLKRLEAFDHPNI 64
Query: 331 LQLIGYCTTS-----SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGL 385
++L+ C TS ++ LV+ + Y + PG L T K + GL
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG---LPAETIKDLMRQFLRGL 121
Query: 386 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAP 445
++LH C I+HRDLK NIL+ + L DFGLA++ ++ T + T+ + AP
Sbjct: 122 DFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA--LTPVVVTLWYRAP 176
Query: 446 EYLSTGKSSEKTDVFGYGITLLEL 469
E L + D++ G E+
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 27/91 (29%), Positives = 44/91 (48%), Gaps = 8/91 (8%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
G+E LH++ IIHRD+K N+L+D L DFGL++ + GT ++
Sbjct: 109 GVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG-----LENKKFVGTPDYL 160
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVTGQR 474
APE + + +D + G + E + G
Sbjct: 161 APETILGVGDDKMSDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 52/228 (22%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAF----QREVHLISVA 325
+ + IG+G +G V KVA+K++ SP F RE+ ++
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI----SPFEHQTFCQRTLREIKILRRF 60
Query: 326 IHKNLLQLIGYCTTSS-----ERILVYPFM----------QNLS---VAYRLRDLKPGEK 367
H+N++ ++ S + +V M Q+LS + Y L
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFL-------- 112
Query: 368 GLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427
+ GL+Y+H N ++HRDLK +N+LL+ N + +CDFGLA++ D
Sbjct: 113 -----------YQILRGLKYIH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158
Query: 428 KLTH--VTTQIRGTMGHIAPEYLSTGKSSEKT-DVFGYGITLLELVTG 472
+ H T+ T + APE + K K D++ G L E+++
Sbjct: 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 48/196 (24%), Positives = 95/196 (48%), Gaps = 11/196 (5%)
Query: 298 VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAY 357
VAVK L++ + F +E+ ++S N+++L+ C TS ++ +M+N +
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 358 RLRDLKPGEKGLD-------WPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD 410
L +P E + T +A A G++YL + +HRDL N L+
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGK 165
Query: 411 NFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLEL 469
N+ + DFG+++ L + + + ++ E + GK + +DV+ +G+TL E+
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225
Query: 470 VTGQRAIDFSRLEEEE 485
+T + +S+L +E+
Sbjct: 226 LTLCKEQPYSQLSDEQ 241
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 43/122 (35%), Positives = 62/122 (50%), Gaps = 21/122 (17%)
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIRGT 439
A GL +LH + II+RDLK N++LD + DFG+ K + K T GT
Sbjct: 111 AIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC---GT 164
Query: 440 MGHIAPE---YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL---LLDHK 493
+IAPE Y GKS D + +G+ L E++ GQ D E+ED L +++H
Sbjct: 165 PDYIAPEIIAYQPYGKS---VDWWAFGVLLYEMLAGQPPFD----GEDEDELFQSIMEHN 217
Query: 494 VT 495
V+
Sbjct: 218 VS 219
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 4e-09
Identities = 56/228 (24%), Positives = 100/228 (43%), Gaps = 43/228 (18%)
Query: 263 CRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ----R 317
CR + D + + N I +G +G VY+ VA+K+L+ E F R
Sbjct: 1 CRSV----DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK--MEKEKEG-FPITSLR 53
Query: 318 EVHLISVAIHKNLLQL--IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK 375
E++++ H N++ + + + + +V ++++ DLK
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH--------DLK------SLMETM 99
Query: 376 RVAFGTA----------YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425
+ F + G+ +LH+ I+HRDLK +N+LL++ +CDFGLA+
Sbjct: 100 KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREY 156
Query: 426 DAKLTHVTTQIRGTMGHIAPE-YLSTGKSSEKTDVFGYGITLLELVTG 472
+ L TQ+ T+ + APE L + S D++ G EL+T
Sbjct: 157 GSPLKPY-TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 52/199 (26%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 279 IGQGGFGKVYKG-VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLI-SVAIHKNLLQLIG- 335
IG+G F +V K A+K ++ ++ + RE+ + ++ H N+L+LI
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 336 -YCTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 393
+ + LV+ M NL Y L +K ++ L K + L+++H +
Sbjct: 67 LFDRKTGRLALVFELMDMNL---YEL--IKGRKRPLPEKRVKSYMYQLLKSLDHMH-RNG 120
Query: 394 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE-YLSTGK 452
I HRD+K NIL+ D+ L DFG + + +K + T+ T + APE L+ G
Sbjct: 121 --IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPY--TEYISTRWYRAPECLLTDGY 175
Query: 453 SSEKTDVFGYGITLLELVT 471
K D++ G E+++
Sbjct: 176 YGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 61/200 (30%), Positives = 85/200 (42%), Gaps = 14/200 (7%)
Query: 278 IIGQGGFGKVYKGVLSDNTKV-AVKRLQDYY----SPGGEAAFQREVHLISVAIHKNLLQ 332
+IG+G FGKV + K AVK LQ +R V L +V H L+
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVK-HPFLVG 60
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 392
L T+ + V F+ + + L+ E+ P + A A L YLH
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLH--- 113
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 452
+ I++RDLK NILLD VL DFGL K + TT GT ++APE +
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQP 172
Query: 453 SSEKTDVFGYGITLLELVTG 472
D + G L E++ G
Sbjct: 173 YDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 48/200 (24%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 278 IIGQGGFGK--VYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
++G+G FG+ + + V SD K A+K ++ S ++E L++ H N++
Sbjct: 7 VVGEGSFGRALLVQHVNSDQ-KYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
+V + + +++ + P + L W + G++++HE+
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------MCLGVQHIHEK 119
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 451
+++HRD+K+ NI L N + L DFG A+L+ + + T + GT ++ PE
Sbjct: 120 ---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENM 175
Query: 452 KSSEKTDVFGYGITLLELVT 471
+ K+D++ G L EL T
Sbjct: 176 PYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 6e-09
Identities = 63/201 (31%), Positives = 87/201 (43%), Gaps = 16/201 (7%)
Query: 278 IIGQGGFGKVYKGVLSDNTKV-AVKRLQ-DYYSPGGEAAF---QREVHLISVAIHKNLLQ 332
+IG+G FGKV + K AVK LQ E +R V L +V H L+
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVK-HPFLVG 60
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 392
L T+ + V ++ + + L+ E+ P + A A L YLH
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL- 115
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKL-VDAKLTHVTTQIRGTMGHIAPEYLSTG 451
II+RDLK NILLD VL DFGL K ++ T T+ GT ++APE L
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRKQ 171
Query: 452 KSSEKTDVFGYGITLLELVTG 472
D + G L E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 6e-09
Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 44/226 (19%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHK 328
D F IG+G +G+VYK D VA+K+++ D G RE+ ++ H+
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR 66
Query: 329 NLLQLIGYCTTSSERI----------LVYPFMQNLSVAYRLRDLKPG--EKGLDWPTRKR 376
N++ L T + + LV+ +M + DL G E GL
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH--------DLM-GLLESGL------- 110
Query: 377 VAFGTAY----------GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426
V F + GL Y H +HRD+K +NILL++ + L DFGLA+L +
Sbjct: 111 VHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN 167
Query: 427 AKLTHVTTQIRGTMGHIAPE-YLSTGKSSEKTDVFGYGITLLELVT 471
++ + T T+ + PE L + DV+ G L EL T
Sbjct: 168 SEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 62/201 (30%), Positives = 88/201 (43%), Gaps = 16/201 (7%)
Query: 278 IIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY----SPGGEAAFQREVHLISVAIHKNLLQ 332
+IG+G FGKV SD + AVK LQ +R V L ++ H L+
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK-HPFLVG 60
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 392
L T+ + V ++ + + L+ E+ P + A A + YLH
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL- 115
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKL-VDAKLTHVTTQIRGTMGHIAPEYLSTG 451
II+RDLK NILLD VL DFGL K V+ + T T+ GT ++APE L
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKE 171
Query: 452 KSSEKTDVFGYGITLLELVTG 472
D + G L E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 8e-09
Identities = 63/220 (28%), Positives = 102/220 (46%), Gaps = 53/220 (24%)
Query: 278 IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
++GQG FGKV+ V+++ G A Q ++ + V + K L++
Sbjct: 3 VLGQGSFGKVF----------LVRKIT------GPDAGQ--LYAMKV-LKKATLKVRDRV 43
Query: 338 TTSSER-ILV---YPFMQNLSVAYRLRDLKPGE--------KGLDWPTR--KRVAFGT-- 381
T ER IL +PF+ L A++ G+ +G D TR K V F
Sbjct: 44 RTKMERDILAEVNHPFIVKLHYAFQ----TEGKLYLILDFLRGGDLFTRLSKEVMFTEED 99
Query: 382 --------AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKLTHV 432
A L++LH + II+RDLK NILLD+ L DFGL+K +D +
Sbjct: 100 VKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KK 154
Query: 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 472
GT+ ++APE ++ ++ D + +G+ + E++TG
Sbjct: 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 56.7 bits (136), Expect = 8e-09
Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 11/196 (5%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
IGQG G VY + ++ +VA+K++ P E E+ ++ + N++ +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 85
Query: 338 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 397
E +V ++ S L D+ E +D V L++LH ++I
Sbjct: 86 LVGDELWVVMEYLAGGS----LTDVVT-ETCMDEGQIAAVCRECLQALDFLHSN---QVI 137
Query: 398 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 457
HRD+K+ NILL + L DFG + + + +T + GT +APE ++ K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 458 DVFGYGITLLELVTGQ 473
D++ GI +E+V G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 8e-09
Identities = 34/91 (37%), Positives = 49/91 (53%), Gaps = 8/91 (8%)
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIRGTMGH 442
LE+LH+Q II+RDLK NILLD L DFGL K + + +TH GT+ +
Sbjct: 113 LEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC---GTIEY 166
Query: 443 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
+APE L + D + G + +++TG
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTGA 197
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 9e-09
Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 42/219 (19%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREV-HLISVAIHK 328
D+F +G G FG+V + K A+K L + ++V H+++ K
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKIL-----SKAKIVKLKQVEHVLN---EK 52
Query: 329 NLLQLIG--YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY--- 383
+LQ I + L F + ++ Y + + PG + RK F
Sbjct: 53 RILQSIRHPFLVN-----LYGSFQDDSNL-YLVMEYVPGGELFSH-LRKSGRFPEPVARF 105
Query: 384 -------GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 436
LEYLH + I++RDLK N+LLD + + DFG AK V + T +
Sbjct: 106 YAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTL 158
Query: 437 RGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTG 472
GT ++APE + + GK+ D + GI + E++ G
Sbjct: 159 CGTPEYLAPEIILSKGYGKAV---DWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 40/116 (34%), Positives = 57/116 (49%), Gaps = 9/116 (7%)
Query: 373 TRKRVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429
+ R F A GL+YLHE KI++RDLK N+LLD + DFGL K
Sbjct: 99 SEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGF 154
Query: 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE 485
T+ GT +APE L+ + D +G G+ + E++ G+ F +EEE
Sbjct: 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP--FPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 34/89 (38%), Positives = 50/89 (56%), Gaps = 4/89 (4%)
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 444
LE+LH+ I++RD+K NILLD VL DFGL+K ++ T GT+ ++A
Sbjct: 118 LEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174
Query: 445 PEYL-STGKSSEKTDVFGYGITLLELVTG 472
PE + G + D + GI + EL+TG
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 19/217 (8%)
Query: 278 IIGQGGFGKVYKGVLSDNTKV-AVKRLQD--YYSPGGEAAFQREVHLISVAIHKNLLQLI 334
++G+G FGKV L ++ ++ AVK L+ E ++S+A + L +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 335 GYCTTSSERIL-VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 393
C + +R+ V F+ + + ++ + D + A L +LH++
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK-- 115
Query: 394 PKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIRGTMGHIAPEYLSTG 451
II+RDLK N+LLD L DFG+ K + + K T+ GT +IAPE L
Sbjct: 116 -GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT---TSTFCGTPDYIAPEILQEM 171
Query: 452 KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 488
D + G+ L E++ G + E E+D+
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFE---AENEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 2e-08
Identities = 21/59 (35%), Positives = 33/59 (55%)
Query: 102 LASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNL 160
L SL+L +N L+ + +L+ L+L+ N + P +S L +L+ LDLS NNL
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 17/217 (7%)
Query: 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDY--YSPGGEAAFQREVH 320
R+LQ+ +++ +IG+G FG+V + KV A+K L + A F E
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 321 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 380
+++ A ++QL +C ++ L Y M+ + DL D P K F
Sbjct: 96 IMAFANSPWVVQL--FCAFQDDKYL-YMVMEYMPGG----DLVNLMSNYDVP-EKWAKFY 147
Query: 381 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGT 439
TA + L + +IHRD+K N+LLD + L DFG K+ + + T + GT
Sbjct: 148 TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GT 206
Query: 440 MGHIAPEYLST----GKSSEKTDVFGYGITLLELVTG 472
+I+PE L + G + D + G+ L E++ G
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 49/216 (22%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 267 QLATDNFSE---SNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLI 322
A + SE N IG G G VYK + ++ A+K + + RE+ ++
Sbjct: 67 PSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEIL 126
Query: 323 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 382
H N+++ + E ++ FM S+ G D VA
Sbjct: 127 RDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE--------GTHIADEQFLADVARQIL 178
Query: 383 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 442
G+ YLH + I+HRD+K +N+L++ + DFG+++++ + + + GT+ +
Sbjct: 179 SGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAY 234
Query: 443 IAPEYLSTGKSSEK-----TDVFGYGITLLELVTGQ 473
++PE ++T + D++ G+++LE G+
Sbjct: 235 MSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 2e-08
Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 11/196 (5%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
IGQG G V+ + ++ +VA+K++ P E E+ ++ + N++ +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIIN-EILVMKELKNPNIVNFLDSF 85
Query: 338 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 397
E +V ++ S L D+ E +D V LE+LH ++I
Sbjct: 86 LVGDELFVVMEYLAGGS----LTDVVT-ETCMDEAQIAAVCRECLQALEFLHAN---QVI 137
Query: 398 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 457
HRD+K+ N+LL + L DFG + + + +T + GT +APE ++ K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 458 DVFGYGITLLELVTGQ 473
D++ GI +E+V G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 30/97 (30%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT---TQIRGTM 440
GL+Y+H +IHRDLK +N+L++++ E + DFG+A+ + + T T+ T
Sbjct: 119 GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175
Query: 441 GHIAPE-YLSTGKSSEKTDVFGYGITLLELVTGQRAI 476
+ APE LS + + D++ G E++ G+R +
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 60/200 (30%), Positives = 86/200 (43%), Gaps = 14/200 (7%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYY----SPGGEAAFQREVHLISVAIHKNLLQ 332
+IG+G FGKV ++ AVK LQ +R V L +V H L+
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVG 60
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 392
L T+ + V ++ + Y L+ E+ P + A A L YLH
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLH--- 113
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 452
+ I++RDLK NILLD VL DFGL K + + T+ GT ++APE L
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 453 SSEKTDVFGYGITLLELVTG 472
D + G L E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 57/213 (26%), Positives = 92/213 (43%), Gaps = 37/213 (17%)
Query: 279 IGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQ---------REVHLISVAIHK 328
IG+G +G V S+ N KVA+K++ + AF RE+ L+ H+
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIAN--------AFDNRIDAKRTLREIKLLRHLDHE 64
Query: 329 NLLQLIGYCTTSSERI-----LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 383
N++ + +VY M L + + L + +
Sbjct: 65 NVIAIKDIMPPPHREAFNDVYIVYELMDT-----DLHQIIRSSQTLSDDHCQYFLYQLLR 119
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
GL+Y+H + ++HRDLK +N+LL+ N + +CDFGLA+ K +T + T +
Sbjct: 120 GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYR 175
Query: 444 APEYLSTGKSSEKT---DVFGYGITLLELVTGQ 473
APE L SE T DV+ G EL+ +
Sbjct: 176 APELLLN--CSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 59/219 (26%), Positives = 91/219 (41%), Gaps = 50/219 (22%)
Query: 278 IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY- 336
++G+G FGKV +A + D EV+ I V +LQ
Sbjct: 2 VLGKGSFGKVM---------LAELKGTD------------EVYAIKVLKKDVILQDDDVD 40
Query: 337 CTTSSERILV----YPFMQNLSVAYRLRD--------LKPGE--------KGLDWPTRKR 376
CT + +RIL +PF+ L ++ +D + G+ + D P +
Sbjct: 41 CTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF 100
Query: 377 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTT 434
A L +LH +I+RDLK NILLD L DFG+ K +++ TT
Sbjct: 101 YAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT---TT 154
Query: 435 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
GT +IAPE L + D + G+ + E++ GQ
Sbjct: 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 39/118 (33%), Positives = 62/118 (52%), Gaps = 13/118 (11%)
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR-GTM 440
A GL +LH + II+RDLK N++LD + DFG+ K + VTT+ GT
Sbjct: 111 AIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTP 165
Query: 441 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL---LLDHKVT 495
+IAPE ++ + D + +G+ L E++ GQ + E+ED L +++H V
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE----GEDEDELFQSIMEHNVA 219
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 31/87 (35%), Positives = 46/87 (52%), Gaps = 7/87 (8%)
Query: 386 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAP 445
EYLH + II+RDLK N+LLD+ + DFG AK K+ T + GT ++AP
Sbjct: 132 EYLHS-KD--IIYRDLKPENLLLDNKGHVKVTDFGFAK----KVPDRTFTLCGTPEYLAP 184
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVTG 472
E + + + D + G+ L E + G
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 5e-08
Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 28/211 (13%)
Query: 279 IGQGGFGKVYKGVL----SDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQL 333
IG+G FGK +L D + +K + SP ++EV ++S H N++Q
Sbjct: 8 IGEGSFGK---AILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ- 63
Query: 334 IGYCTTSSERILVYPFMQNLS-------VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386
Y + E +Y M + + L P ++ LDW + L+
Sbjct: 64 --YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQ------ICLALK 115
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 446
++H++ KI+HRD+K+ NI L + L DFG+A+++++ + T I GT +++PE
Sbjct: 116 HVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPE 171
Query: 447 YLSTGKSSEKTDVFGYGITLLELVTGQRAID 477
+ K+D++ G L E+ T + A +
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 68/252 (26%), Positives = 115/252 (45%), Gaps = 45/252 (17%)
Query: 248 EDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNT-KVAVKR-LQD 305
ED+ K+ + R + +L NIIG G FG VY+ + D + KVA+K+ LQD
Sbjct: 50 EDEEKMIDNDINRSPNKSYKLG-------NIIGNGSFGVVYEAICIDTSEKVAIKKVLQD 102
Query: 306 -YYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER-----ILVYPFMQNL--SVAY 357
Y RE+ ++ H N++ L Y T + I + M+ + +V
Sbjct: 103 PQYK-------NRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHK 155
Query: 358 RLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-L 416
++ L K ++ L Y+H + I HRDLK N+L+D N + L
Sbjct: 156 YMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKL 212
Query: 417 CDFGLAKLVDA---KLTHVTTQIRGTMGHIAPEYLSTGKSSEKT--DVFGYGITLLELV- 470
CDFG AK + A ++++ ++ + APE L G ++ T D++ G + E++
Sbjct: 213 CDFGSAKNLLAGQRSVSYICSRF-----YRAPE-LMLGATNYTTHIDLWSLGCIIAEMIL 266
Query: 471 -----TGQRAID 477
+GQ ++D
Sbjct: 267 GYPIFSGQSSVD 278
|
Length = 440 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 49/196 (25%), Positives = 89/196 (45%), Gaps = 11/196 (5%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
IGQG G VY + ++ +VA++++ P E E+ ++ + N++ +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 86
Query: 338 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 397
E +V ++ S L D+ E +D V LE+LH ++I
Sbjct: 87 LVGDELWVVMEYLAGGS----LTDVVT-ETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 398 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 457
HRD+K+ NILL + L DFG + + + + + GT +APE ++ K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 458 DVFGYGITLLELVTGQ 473
D++ GI +E++ G+
Sbjct: 198 DIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 34/215 (15%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTK--VAVKRLQ--DYYSPGGEAAFQREVHLISVAI 326
D+ +G G FG+V+ V ++ A+K + + E E ++
Sbjct: 1 DDLERIKTVGTGTFGRVHL-VRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS 59
Query: 327 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDW-PTRKRVAFGTA--Y 383
H +++L + T +R L Y L + PG + + R + T Y
Sbjct: 60 HPFIIRL--FWTEHDQRFL-----------YMLMEYVPGGELFSYLRNSGRFSNSTGLFY 106
Query: 384 G------LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 437
LEYLH + +I++RDLK NILLD L DFG AK KL T +
Sbjct: 107 ASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAK----KLRDRTWTLC 159
Query: 438 GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 472
GT ++APE + + ++ D + GI + E++ G
Sbjct: 160 GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 4/95 (4%)
Query: 378 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QI 436
+F A G+E+L + K IHRDL A NILL +N +CDFGLA+ + +V
Sbjct: 180 SFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236
Query: 437 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
R + +APE + + ++DV+ +G+ L E+ +
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 4/95 (4%)
Query: 378 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QI 436
+F A G+E+L + K IHRDL A NILL +N +CDFGLA+ + +V
Sbjct: 185 SFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 437 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
R + +APE + + ++DV+ +G+ L E+ +
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 6e-08
Identities = 44/165 (26%), Positives = 77/165 (46%), Gaps = 38/165 (23%)
Query: 279 IGQGGFGKVYKGVLSD---NTKVAVKRLQDYYSPGGEAAFQ---------REV-HLISVA 325
+G+G +G V+K + D VA+K++ D AF+ RE+ L +
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALKKIFD--------AFRNATDAQRTFREIMFLQELG 64
Query: 326 IHKNLLQLIGYCTTSSER--ILVYPFMQ-NLSVAYRLRDLKPGEKGLDWPTRKR-VAFGT 381
H N+++L+ +++ LV+ +M+ +L R + KR + +
Sbjct: 65 DHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIR--------ANILEDVHKRYIMYQL 116
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426
L+Y+H +IHRDLK +NILL+ + L DFGLA+ +
Sbjct: 117 LKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 7e-08
Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 46/217 (21%)
Query: 278 IIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
++G+G FGKV L AVK A +++V LI +
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVK------------ALKKDVVLIDDDVE--------- 40
Query: 337 CTTSSERILVY----PFMQNLSVAYRLRD--------LKPGEKGLDWPTRKRVAF--GTA 382
CT +R+L PF+ +L ++ ++ L G+ + R T
Sbjct: 41 CTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF 100
Query: 383 Y------GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 436
Y GL++LH + II+RDLK N++LD + + DFG+ K +T
Sbjct: 101 YAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-F 156
Query: 437 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
GT +IAPE L K + D + +G+ L E++ GQ
Sbjct: 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 14/204 (6%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
DNF + IG+G G V + + K VAVK++ E F EV ++ H+N
Sbjct: 23 DNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHEN 78
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 389
++++ E +V F++ ++ + + E+ + V L LH
Sbjct: 79 VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLKALSVLH 133
Query: 390 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 449
Q +IHRD+K+ +ILL + L DFG V ++ + + GT +APE +S
Sbjct: 134 AQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELIS 189
Query: 450 TGKSSEKTDVFGYGITLLELVTGQ 473
+ D++ GI ++E+V G+
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 8e-08
Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 21/219 (9%)
Query: 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQ--DYYSPGGEAAFQREVH 320
+L++ ++F +IG+G FG+V + +V A+K L + A F E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 321 LISVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVA 378
+++ A + ++QL + ++ L V +M + + + EK W
Sbjct: 96 IMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK---W-----AR 145
Query: 379 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK-LTHVTTQIR 437
F TA + L + IHRD+K N+LLD + L DFG +DA + T +
Sbjct: 146 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV- 204
Query: 438 GTMGHIAPEYLST----GKSSEKTDVFGYGITLLELVTG 472
GT +I+PE L + G + D + G+ L E++ G
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 6/96 (6%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
GL+YLH + I+HRD+K N+L++ N +CDFGLA++ + + TQ T +
Sbjct: 115 GLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYR 171
Query: 444 APEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDF 478
APE L + + D++ G EL+ R I F
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELL--GRRILF 205
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 53/218 (24%), Positives = 92/218 (42%), Gaps = 39/218 (17%)
Query: 281 QGGFGKVY--------------KGVLSDNTKV--AVKRLQDYYSPGGEAAFQREVHLISV 324
G FGK++ +GV S N + + G AA Q E ++++
Sbjct: 158 AGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILAL 217
Query: 325 AI--HKNLLQLIGYCTTSSERILVYP---FMQNLSVAYRL------RDLKPGEKGLDWPT 373
H+N+L++ E IL +M + L ++ L T
Sbjct: 218 GRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQT 269
Query: 374 RKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 433
R + +EY+H++ K+IHRD+K NI L+ + + VL DFG A + +
Sbjct: 270 R-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFD 325
Query: 434 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
GT+ +PE L+ E TD++ G+ LL++++
Sbjct: 326 YGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 33/222 (14%)
Query: 264 RELQLATDNFSESNIIGQGGFGKV----YKGVLSDNTKVAVKRLQDYYSPGGEAAFQREV 319
R+ ++ ++F+ +G G FG+V YK D VA+KR + + Q++V
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKN--EDFPPVAIKRFEK-----SKIIKQKQV 75
Query: 320 -------HLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK--PGEKGLD 370
+++ H + L G S LV F+ LR K P + G
Sbjct: 76 DHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF 135
Query: 371 WPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430
+ + + F EYL + I++RDLK N+LLD + + DFG AK+VD +
Sbjct: 136 YAAQIVLIF------EYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-- 184
Query: 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 472
T + GT +IAPE L + D + GI + E++ G
Sbjct: 185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 27/89 (30%), Positives = 42/89 (47%), Gaps = 4/89 (4%)
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 444
L YLH +++RDLK N++LD + + DFGL K GT ++A
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLA 163
Query: 445 PEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
PE L D +G G+ + E++ G+
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 44/173 (25%), Positives = 70/173 (40%), Gaps = 36/173 (20%)
Query: 318 EVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 377
E H++ H +++QL G T + L+ P + Y L ++ +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCY-LAA------------KRNI 179
Query: 378 AF--------GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL-VDAK 428
A ++YLHE +IIHRD+KA NI ++ + L DFG A VD
Sbjct: 180 AICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD-- 234
Query: 429 LTHVTTQIR-----GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 476
+ GT+ APE L+ D++ GI L E+ T ++
Sbjct: 235 ----INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 30/210 (14%)
Query: 279 IGQGGFGKVYKGVLSDNTKVA---VKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
IG G FGKV + +T VA VK L+ S + F ++ + H N+LQ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTR-------KRVAFGTAYGLEYL 388
C + +LV+ + + L DLK W R +R+A A G+ ++
Sbjct: 63 QCVEAIPYLLVFEYCE-------LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGH 442
H+ +H DL N L + + D+G+ K ++ T+ +R
Sbjct: 116 HKH---NFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPE 171
Query: 443 IAPEY---LSTGKSSEKTDVFGYGITLLEL 469
+ E+ L T + ++ ++V+ G+TL EL
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 49/208 (23%), Positives = 94/208 (45%), Gaps = 23/208 (11%)
Query: 279 IGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
+GQG F K++KG+ + T+V +K L + E+ F+ ++S HK+L
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFE-AASMMSQLSHKHL 61
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEK-GLDWPTRKRVAFGTAYGLEYLH 389
+ G C E I+V +++ S+ L+ K + W + VA A+ L +L
Sbjct: 62 VLNYGVCVCGDESIMVQEYVKFGSLDTYLK--KNKNLINISW--KLEVAKQLAWALHFLE 117
Query: 390 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH----IAP 445
++ + H ++ A N+LL + + KL D ++ +T + + + P
Sbjct: 118 DK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS-ITVLPKEILLERIPWVPP 173
Query: 446 EYLSTGKS-SEKTDVFGYGITLLELVTG 472
E + ++ S D + +G TL E+ +G
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 24/205 (11%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
+G G +G V KVAVK+L + + S RE+ L+ H+N++ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGE-------KGLDWPTRKRVAFGTAYGLEYLH 389
T ++ ++N + Y + +L + + L + + + GL+Y+H
Sbjct: 83 FTPATS-------IENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH 135
Query: 390 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE-YL 448
+ IIHRDLK +N+ ++++ E + DFGLA+ D ++T T + APE L
Sbjct: 136 ---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYV----ATRWYRAPEIML 188
Query: 449 STGKSSEKTDVFGYGITLLELVTGQ 473
+ ++ D++ G + EL+ G+
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 12/204 (5%)
Query: 278 IIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAA--FQREVHLISVAIHKNLLQLI 334
+IG+G + KV L N ++ A+K ++ E Q E H+ A L +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 335 GYC-TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 393
C T+S LV ++ + + ++ ++ L + A L +LHE+
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER-- 115
Query: 394 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS 453
II+RDLK N+LLD + L D+G+ K T+ GT +IAPE L +
Sbjct: 116 -GIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEEY 173
Query: 454 SEKTDVFGYGITLLELVTGQRAID 477
D + G+ + E++ G+ D
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 55/227 (24%), Positives = 86/227 (37%), Gaps = 40/227 (17%)
Query: 277 NIIGQGGFGKVYKGV-LSDNTKVAVKRLQDY-YSPGGEAAFQ------------REVHLI 322
+G+G +GKV K VA+K+++ S Q RE+ ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 323 SVAIHKNLLQLIG-YCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 380
+ H+N++ L+ Y + I LV M A L+ + + L K +
Sbjct: 75 NEIKHENIMGLVDVYV--EGDFINLVMDIM-----ASDLKKVVDRKIRLTESQVKCILLQ 127
Query: 381 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-------------KLVDA 427
GL LH +HRDL ANI ++ + DFGLA K
Sbjct: 128 ILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 428 KLTHVTTQIRGTMGHIAPEYL-STGKSSEKTDVFGYGITLLELVTGQ 473
+ T T+ + APE L K D++ G EL+TG+
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 49/209 (23%), Positives = 91/209 (43%), Gaps = 17/209 (8%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQ---REVHLISVAI 326
+ F ++G+G +G V K + VA+K+ +D S E + RE+ ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKD--SEENEEVKETTLRELKMLRTLK 58
Query: 327 HKNLLQLIGYCTTSSERILVYPFMQN--LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYG 384
+N+++L + LV+ +++ L + + + P EK + +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEK------VRSYIYQLIKA 112
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 444
+ + H+ I+HRD+K N+L+ N LCDFG A+ + T+ T + +
Sbjct: 113 IHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRS 169
Query: 445 PEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
PE L + D++ G L EL GQ
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 11/196 (5%)
Query: 279 IGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
IG+G G V K VAVK++ E F EV ++ H+N++ +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN-EVVIMRDYHHENVVDMYNSY 88
Query: 338 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 397
E +V F++ ++ + + E+ + V L YLH Q +I
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLHNQ---GVI 140
Query: 398 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 457
HRD+K+ +ILL + L DFG V ++ + + GT +APE +S +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEV 199
Query: 458 DVFGYGITLLELVTGQ 473
D++ GI ++E++ G+
Sbjct: 200 DIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 58/203 (28%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 279 IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAAFQ-REVHLISVAIHKNLLQLI 334
IG G G V Y VL N VA+K+L + A RE+ L+ HKN++ L+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 335 GYCT---TSSERILVYPFMQ----NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
T + E VY M+ NL ++ LD + + G+++
Sbjct: 83 NVFTPQKSLEEFQDVYLVMELMDANLCQVIQME--------LDHERMSYLLYQMLCGIKH 134
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 447
LH + IIHRDLK +NI++ + + DFGLA+ A + + T T + APE
Sbjct: 135 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 189
Query: 448 LSTGKSSEKTDVFGYGITLLELV 470
+ E D++ G + E+V
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 40/141 (28%), Positives = 68/141 (48%), Gaps = 11/141 (7%)
Query: 335 GYCTTSSERIL-VYPFMQNLSVAYRLRDLKPGEKGLDWPTRK----RVAFGTAYGLEYLH 389
G+ + S+ + + P + S + +D + E WP R + A G+++L
Sbjct: 172 GFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTED--SWPLDLDDLLRFSSQVAQGMDFLA 229
Query: 390 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QIRGTMGHIAPEYL 448
+ IHRD+ A N+LL D A +CDFGLA+ + +V R + +APE +
Sbjct: 230 SK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 286
Query: 449 STGKSSEKTDVFGYGITLLEL 469
+ ++DV+ YGI L E+
Sbjct: 287 FDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 10/92 (10%)
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR---GTMG 441
L +LH Q +IHRD+K+ +ILL + L DFG A+++ + + GT
Sbjct: 128 LSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFC----AQVSKEVPRRKSLVGTPY 180
Query: 442 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
+APE +S + D++ GI ++E+V G+
Sbjct: 181 WMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 25/212 (11%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSD---NTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAI 326
D + + IG+G +G VYK D N +A+K+++ + G + RE+ L+
Sbjct: 2 DQYEKVEKIGEGTYGVVYKA--RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ 59
Query: 327 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG-EKGLDWPTRKRVAFGTAY-- 383
H N+++L SE+ L F Y DLK + D+ R+ Y
Sbjct: 60 HGNIVRL--QDVVHSEKRLYLVF------EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQI 111
Query: 384 --GLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTM 440
G+ Y H +++HRDLK N+L+D A+ L DFGLA+ + T ++ T+
Sbjct: 112 LRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TL 167
Query: 441 GHIAPEYLSTGKS-SEKTDVFGYGITLLELVT 471
+ APE L + S D++ G E+V
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 32/91 (35%), Positives = 49/91 (53%), Gaps = 4/91 (4%)
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHI 443
L+ +H + ++HRDLK+ANI L L DFG +K D+ V + GT ++
Sbjct: 182 LDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVTGQR 474
APE + S+K D++ G+ L EL+T R
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 4/96 (4%)
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 441
+ L YLHE+ II+RDLK N+LLD L D+G+ K + T+ GT
Sbjct: 106 SLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPN 161
Query: 442 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 477
+IAPE L D + G+ + E++ G+ D
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 57/201 (28%), Positives = 87/201 (43%), Gaps = 18/201 (8%)
Query: 279 IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAAFQ-REVHLISVAIHKNLLQLI 334
IG G G V + VL N VAVK+L + A RE+ L+ HKN++ L+
Sbjct: 29 IGSGAQGIVCAAFDTVLGIN--VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86
Query: 335 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGE---KGLDWPTRKRVAFGTAYGLEYLHEQ 391
T Q++ + L D + LD + + G+++LH
Sbjct: 87 NVFTPQKS----LEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH-- 140
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 451
+ IIHRDLK +NI++ + + DFGLA+ A + T T + APE +
Sbjct: 141 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGM 197
Query: 452 KSSEKTDVFGYGITLLELVTG 472
E D++ G + ELV G
Sbjct: 198 GYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 8e-07
Identities = 34/86 (39%), Positives = 51/86 (59%), Gaps = 4/86 (4%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKF-LASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
N+ SL L +N + I P I LK L L+L DN + +LP L ++ +L++L+L+ N
Sbjct: 117 NLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND 174
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLT 161
S +P S LSNL +LDLS N ++
Sbjct: 175 LS-DLPKLLSNLSNLNNLDLSGNKIS 199
|
Length = 394 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 8e-07
Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 8/92 (8%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIRGTMG 441
L+YLH + KI++RDLK N++LD + + DFGL K + DA GT
Sbjct: 107 ALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA---TMKTFCGTPE 160
Query: 442 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
++APE L D +G G+ + E++ G+
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
GL+Y+H + IIHRDLK +N+ ++++ E + DFGLA+ D ++T T +
Sbjct: 132 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 184
Query: 444 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 473
APE L+ ++ D++ G + EL+TG+
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 16/208 (7%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338
+G+G +G VYK D L+ G + RE+ L+ H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 339 TSSER--ILVYPFMQN--LSVAYRLRDLKPGEKGLDWPTR--KRVAFGTAYGLEYLHEQC 392
+ S+R L++ + ++ + R K +K + P K + + G+ YLH
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128
Query: 393 NPKIIHRDLKAANILL----DDNFEAVLCDFGLAKLVDAKLTHVT--TQIRGTMGHIAPE 446
++HRDLK ANIL+ + + D G A+L ++ L + + T + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 447 YLSTGKSSEKT-DVFGYGITLLELVTGQ 473
L + K D++ G EL+T +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 18/202 (8%)
Query: 279 IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAAFQ-REVHLISVAIHKNLLQLI 334
IG G G V Y +L N VA+K+L + A RE+ L+ HKN++ L+
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 335 GYCTTSSERILVYPFMQNLSVAYRLRD---LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
T Q++ + L D + + LD + + G+++LH
Sbjct: 90 NVFTPQKS----LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH-- 143
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 451
+ IIHRDLK +NI++ + + DFGLA+ A + + T T + APE +
Sbjct: 144 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 452 KSSEKTDVFGYGITLLELVTGQ 473
E D++ G + E++ G
Sbjct: 201 GYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 49/178 (27%), Positives = 76/178 (42%), Gaps = 33/178 (18%)
Query: 314 AFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPT 373
A Q EV L H N++ TT S ++ PFM S L+ P +G+
Sbjct: 45 ALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFP--EGMSEAL 102
Query: 374 RKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 433
+ FG GL YLH+ IHR++KA++IL+ + GL L + L+H+
Sbjct: 103 IGNILFGALRGLNYLHQN---GYIHRNIKASHILISGD--------GLVSL--SGLSHLY 149
Query: 434 TQIRGTMGH----------------IAPEYLSTGKS--SEKTDVFGYGITLLELVTGQ 473
+ +R ++PE L + K+D++ GIT EL TG+
Sbjct: 150 SLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 378 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QI 436
++ A G+ +L + IHRDL A NILL +CDFGLA+ + +V
Sbjct: 220 SYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNA 276
Query: 437 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLEL 469
R + +APE + + ++DV+ YGI L E+
Sbjct: 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 28/91 (30%), Positives = 47/91 (51%), Gaps = 8/91 (8%)
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--IRGTMGH 442
LEYLH + +++RD+K N++LD + + DFGL K ++ T GT +
Sbjct: 108 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEY 161
Query: 443 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
+APE L D +G G+ + E++ G+
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 32/102 (31%), Positives = 49/102 (48%), Gaps = 4/102 (3%)
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 444
L +LHE+ II+RDLK N+LLD L D+G+ K + T+ GT +IA
Sbjct: 109 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIA 164
Query: 445 PEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEED 486
PE L D + G+ + E++ G+ D + + D
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD 206
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 30/86 (34%), Positives = 47/86 (54%), Gaps = 3/86 (3%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANN 134
N+ L L N + + L L +L+L NDLS LP L ++++L +L+L+ N
Sbjct: 139 KSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGN 196
Query: 135 KFSGSIPATWSQLSNLKHLDLSSNNL 160
K S +P LS L+ LDLS+N++
Sbjct: 197 KIS-DLPPEIELLSALEELDLSNNSI 221
|
Length = 394 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 31/98 (31%), Positives = 48/98 (48%), Gaps = 15/98 (15%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-------KLVDAKLTHVTTQI 436
GL+Y+H + ++HRDLK N+L++ + E +CDFGLA +T
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA-- 171
Query: 437 RGTMGHIAPE-YLSTGKSSEKTDVFGYGITLLELVTGQ 473
T + APE LS ++ DV+ G L EL+ +
Sbjct: 172 --TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 37/109 (33%), Positives = 49/109 (44%), Gaps = 23/109 (21%)
Query: 381 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT------ 434
T LEYLH N I+HRDLK N+L+ L DFGL+K+ L +TT
Sbjct: 110 TVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI---GLMSLTTNLYEGH 163
Query: 435 -----------QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 472
Q+ GT +IAPE + + D + GI L E + G
Sbjct: 164 IEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 36/212 (16%)
Query: 279 IGQGGFGKVYKGVLSDN-----------TKVAVKRLQDYYSPGGEA--AFQREVHLISVA 325
+GQG F +YKGVL V +K L AF L+S
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG----SDHRDSLAFFETASLMSQL 58
Query: 326 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGL 385
HK+L++L G C E I+V +++ + L + L W + VA A L
Sbjct: 59 SHKHLVKLYGVC-VRDENIMVEEYVKFGPLDVFLH-REKNNVSLHW--KLDVAKQLASAL 114
Query: 386 EYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDA--KLTHVTTQIR-GT 439
YL ++ K++H ++ NIL+ N V KL D +T ++ + R
Sbjct: 115 HYLEDK---KLVHGNVCGKNILVARYGLNEGYVPF----IKLSDPGIPITVLSREERVER 167
Query: 440 MGHIAPEYLSTGKSS--EKTDVFGYGITLLEL 469
+ IAPE + G++S D + +G TLLE+
Sbjct: 168 IPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 3/90 (3%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
L+YLH + N +++RDLK N++LD + + DFGL K K GT ++
Sbjct: 107 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYL 163
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
APE L D +G G+ + E++ G+
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 4/90 (4%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
L YLH Q +IHRD+K+ +ILL + L DFG + + + + GT +
Sbjct: 129 ALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWM 184
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
APE +S + D++ GI ++E+V G+
Sbjct: 185 APEVISRTPYGTEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 9e-06
Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 16/208 (7%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338
+G+G +G VYK D L+ G + RE+ L+ H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 339 TSSER--ILVYPFMQN--LSVAYRLRDLKPGEKGLDWP--TRKRVAFGTAYGLEYLHEQC 392
+ ++R L++ + ++ + R K +K + P K + + G+ YLH
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128
Query: 393 NPKIIHRDLKAANILL----DDNFEAVLCDFGLAKLVDAKLTHVT--TQIRGTMGHIAPE 446
++HRDLK ANIL+ + + D G A+L ++ L + + T + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 447 YLSTGKSSEKT-DVFGYGITLLELVTGQ 473
L + K D++ G EL+T +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 56/211 (26%), Positives = 87/211 (41%), Gaps = 36/211 (17%)
Query: 279 IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEA--AFQREVHLISVAIHKNLLQL 333
IG G G V Y V VA+K+L + A A+ RE+ L+ + HKN++ L
Sbjct: 24 IGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAY-RELVLMKLVNHKNIIGL 80
Query: 334 IGYCT------TSSERILVYPFMQ-NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386
+ T + LV M NL ++ LD + + G++
Sbjct: 81 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD--------LDHERMSYLLYQMLCGIK 132
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH----VTTQIRGTMGH 442
+LH + IIHRDLK +NI++ + + DFGLA+ VT R
Sbjct: 133 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR----- 184
Query: 443 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
APE + E D++ G + E++ G
Sbjct: 185 -APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 3e-05
Identities = 30/109 (27%), Positives = 48/109 (44%), Gaps = 9/109 (8%)
Query: 366 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKL 424
E L K++ L LH IIH D+K N+L D + + LCD+GL K+
Sbjct: 103 EGKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159
Query: 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
+ + GT+ + +PE + D + G+ EL+TG+
Sbjct: 160 IGTPSCY-----DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 30/100 (30%), Positives = 52/100 (52%), Gaps = 19/100 (19%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTH--------VTT 434
GL+Y+H + ++HRDLK AN+ ++ ++ + DFGLA++VD +H VT
Sbjct: 126 GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 435 QIRGTMGHIAPE-YLSTGKSSEKTDVFGYGITLLELVTGQ 473
R +P LS ++ D++ G E++TG+
Sbjct: 183 WYR------SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 4e-05
Identities = 17/38 (44%), Positives = 27/38 (71%), Gaps = 2/38 (5%)
Query: 124 THLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLT 161
T+L++L+L+NN+ + +P S L NL+ LDLS N +T
Sbjct: 1 TNLETLDLSNNQIT-DLPP-LSNLPNLETLDLSGNKIT 36
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 17/217 (7%)
Query: 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDY--YSPGGEAAFQREVH 320
R+L++ +++ +IG+G FG+V KV A+K L + A F E
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 321 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 380
+++ A ++QL +V +M + + + EK + T + V
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVV--- 152
Query: 381 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGT 439
L+ +H IHRD+K N+LLD + L DFG K+ + T + GT
Sbjct: 153 --LALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GT 206
Query: 440 MGHIAPEYLST----GKSSEKTDVFGYGITLLELVTG 472
+I+PE L + G + D + G+ L E++ G
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 38/166 (22%), Positives = 69/166 (41%), Gaps = 35/166 (21%)
Query: 335 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDW-------PTRKRVA--------- 378
GY S + Y MQ++ + D++ + P R R
Sbjct: 177 GYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPAL 236
Query: 379 ---------FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429
+ A G+E+L + +HRDL A N+L+ + +CDFGLA+ +
Sbjct: 237 SYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDS 293
Query: 430 THVTTQIRGT----MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
+++ +G+ + +APE + + +DV+ +GI L E+ T
Sbjct: 294 NYIS---KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 5e-05
Identities = 50/215 (23%), Positives = 89/215 (41%), Gaps = 22/215 (10%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHK 328
++F +IG+G FG+V L + KV ++ + + E A RE + V
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 329 NLLQLIGYCTTSSERILV----YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYG 384
+ + Y + + Y L++ + D P + + +A + +
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG-LAKLVDAKLTHVTTQIRGTMGHI 443
L Y +HRD+K NIL+D N L DFG KL++ + + GT +I
Sbjct: 121 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYI 170
Query: 444 APEYLST-----GKSSEKTDVFGYGITLLELVTGQ 473
+PE L GK + D + G+ + E++ G+
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 6e-05
Identities = 42/160 (26%), Positives = 66/160 (41%), Gaps = 8/160 (5%)
Query: 310 GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL 369
G A+ E L+ H +L L+ LV P ++ Y L+P L
Sbjct: 202 GWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARLRP----L 257
Query: 370 DWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD-AK 428
VA ++Y+H + IIHRD+K N+L++ + L DFG A +
Sbjct: 258 GLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314
Query: 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLE 468
T I GT+ APE L+ + D++ G+ + E
Sbjct: 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 49/203 (24%), Positives = 78/203 (38%), Gaps = 15/203 (7%)
Query: 280 GQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338
+ K NT VAVK++ D S Q+E+ H N+L +
Sbjct: 11 EDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI 69
Query: 339 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 398
SE +V P M S L+ P +GL + L+Y+H + IH
Sbjct: 70 VDSELYVVSPLMAYGSCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIH---SKGFIH 124
Query: 399 RDLKAANILLDDNFEAVLCDFGLAKLVD------AKLTHVTTQIRGTMGHIAPEYLSTGK 452
R +KA++ILL + + VL + + + + ++PE L
Sbjct: 125 RSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNL 184
Query: 453 S--SEKTDVFGYGITLLELVTGQ 473
+EK+D++ GIT EL G
Sbjct: 185 QGYNEKSDIYSVGITACELANGH 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 1e-04
Identities = 25/62 (40%), Positives = 37/62 (59%), Gaps = 7/62 (11%)
Query: 125 HLQSLNLANNKFSGSIPATW-SQLSNLKHLDLSSNNLTGRIPMQLF----SVATFNFTGT 179
+L+SL+L+NN+ + IP L NLK LDLS NNLT I + F S+ + + +G
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGN 58
Query: 180 HL 181
+L
Sbjct: 59 NL 60
|
Length = 60 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 30/97 (30%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 379 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG 438
+ A G+E+L + +HRDL A N+LL +CDFGLA+ + +V+ +G
Sbjct: 244 YQVARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS---KG 297
Query: 439 T----MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
+ + +APE + + +DV+ YGI L E+ +
Sbjct: 298 STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 26/83 (31%), Positives = 39/83 (46%), Gaps = 6/83 (7%)
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK 456
+HRD+K N+L+D L DFG A + A + GT +IAPE L+T K
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 457 T------DVFGYGITLLELVTGQ 473
D + G+ E++ G+
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 26/82 (31%), Positives = 42/82 (51%), Gaps = 5/82 (6%)
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-----G 451
+HRD+K N+LLD N L DFG ++ T ++ GT +I+PE L G
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183
Query: 452 KSSEKTDVFGYGITLLELVTGQ 473
K + D + G+ + E++ G+
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 20/56 (35%), Positives = 29/56 (51%), Gaps = 4/56 (7%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT 439
LEYLH I++RDLK NILL ++ +L DF L+K D + ++
Sbjct: 115 ALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE-PPPVSKALRK 166
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 26/82 (31%), Positives = 41/82 (50%), Gaps = 5/82 (6%)
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL-----STG 451
+HRD+K N+LLD N L DFG + A T + GT +I+PE L G
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183
Query: 452 KSSEKTDVFGYGITLLELVTGQ 473
+ + D + G+ + E++ G+
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 28/88 (31%), Positives = 37/88 (42%), Gaps = 4/88 (4%)
Query: 396 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSE 455
IHRDLK N L+D + L DFGL+K + V G+ ++APE L
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV----GSPDYMAPEVLRGKGYDF 177
Query: 456 KTDVFGYGITLLELVTGQRAIDFSRLEE 483
D + G L E + G S E
Sbjct: 178 TVDYWSLGCMLYEFLCGFPPFSGSTPNE 205
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 30/86 (34%), Positives = 55/86 (63%), Gaps = 4/86 (4%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L L +N ++ S++ LK L+ LEL +N LP+ +G++++L++L+L+NN+ S
Sbjct: 213 ELDLSNNSII-ELLSSLSNLKNLSGLELSNN-KLEDLPESIGNLSNLETLDLSNNQ--IS 268
Query: 140 IPATWSQLSNLKHLDLSSNNLTGRIP 165
++ L+NL+ LDLS N+L+ +P
Sbjct: 269 SISSLGSLTNLRELDLSGNSLSNALP 294
|
Length = 394 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 20/43 (46%), Positives = 26/43 (60%), Gaps = 3/43 (6%)
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424
A L+YLH IIHRDLK N+L+ + L DFGL+K+
Sbjct: 114 ALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 36.5 bits (85), Expect = 0.001
Identities = 15/39 (38%), Positives = 21/39 (53%), Gaps = 2/39 (5%)
Query: 36 EGEALIEVLKALN-DTHGQFTDWNDHFVSPCFSWSHVTC 73
+ +AL+ +LN D G + WN PC SW+ VTC
Sbjct: 4 DRDALLAFKSSLNGDPSGALSSWNPSSSDPC-SWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.003
Identities = 18/41 (43%), Positives = 22/41 (53%), Gaps = 2/41 (4%)
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 437
IHRD+K N+LLD L DFGL + K +H T R
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGL--KKSHRTEFYR 161
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.004
Identities = 49/162 (30%), Positives = 73/162 (45%), Gaps = 15/162 (9%)
Query: 314 AFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPT 373
AF L+S H +L + G C SE I+V F+++ + LR K G + W
Sbjct: 62 AFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAW-- 118
Query: 374 RKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA--KLVD--AKL 429
+ VA A L YL + ++H ++ A NILL L + KL D
Sbjct: 119 KITVAQQLASALSYLE---DKNLVHGNVCAKNILLA---RLGLAEGTSPFIKLSDPGVSF 172
Query: 430 THVTTQIR-GTMGHIAPEYLSTGKS-SEKTDVFGYGITLLEL 469
T ++ + R + IAPE + G S S D + +G TLLE+
Sbjct: 173 TALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 498 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.98 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.98 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.98 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.98 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.98 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.98 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.98 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.98 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.98 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.83 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.82 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.71 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.7 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.62 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.52 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.5 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.49 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.35 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.32 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.32 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.27 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.25 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.24 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.23 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.19 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.12 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.08 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.07 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.03 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.97 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.97 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.96 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.93 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.92 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.89 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.89 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.88 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.84 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.83 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.81 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.8 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.76 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.75 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.73 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.71 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.7 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.69 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.65 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.63 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.57 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.56 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.55 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.54 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.51 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.48 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.46 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.44 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.42 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.41 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.4 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.4 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.38 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.36 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.35 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.35 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.33 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.31 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.29 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.24 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.23 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.22 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.22 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.22 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.19 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.18 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.15 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.14 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.12 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.09 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-52 Score=474.21 Aligned_cols=375 Identities=30% Similarity=0.499 Sum_probs=243.8
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|+|++|+++|.+|..+.++++|+.|+|++|+++|.+|..++++++|++|+|++|.++|.+|..++++++|+.|+|+
T Consensus 476 ~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 555 (968)
T PLN00113 476 RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLS 555 (968)
T ss_pred cceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECC
Confidence 45666666666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred CCcCcccCCchhhc---cccccc-----------------------cCCccccCCCCC---CCCCCCCCCCCCcccccee
Q 010887 157 SNNLTGRIPMQLFS---VATFNF-----------------------TGTHLICGSSLE---QPCMSRPSPPVSTSRTKLR 207 (498)
Q Consensus 157 ~N~l~g~ip~~~~~---~~~~~~-----------------------~~n~~~~~~~~~---~~c~~~~~~~~~~~~~~~~ 207 (498)
+|+++|.+|..+.+ +..+++ .||+.+|+.+.. .+|. ...+...+
T Consensus 556 ~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~-------~~~~~~~~ 628 (968)
T PLN00113 556 QNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCK-------RVRKTPSW 628 (968)
T ss_pred CCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCc-------ccccccee
Confidence 66666666654432 333444 445544543211 1111 01112222
Q ss_pred EEEEecccchhhhhhhhhhhhhhhhhhcccccccccccCCCCcccccc-ccccccCHHHHHHHhcCCCCCCeeecccceE
Q 010887 208 IVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSL-TQLRRFSCRELQLATDNFSESNIIGQGGFGK 286 (498)
Q Consensus 208 iiv~~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~el~~~~~~~~~~~~lG~G~~g~ 286 (498)
.+++.++++++++++++++++++++++++.+........+........ .....++.+++ ...+...+.||+|+||.
T Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~ 705 (968)
T PLN00113 629 WFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDI---LSSLKEENVISRGKKGA 705 (968)
T ss_pred eeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHH---HhhCCcccEEccCCCee
Confidence 222222222222222222222222222211111000000000000000 00112233333 34577888999999999
Q ss_pred EEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCCCHHHhhcccCCC
Q 010887 287 VYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG 365 (498)
Q Consensus 287 Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~ 365 (498)
||+|+. .++..||||+++.... ...+|++.+++++||||+++++++.+.+..++||||+++|+|.++++.
T Consensus 706 Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~---- 776 (968)
T PLN00113 706 SYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---- 776 (968)
T ss_pred EEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----
Confidence 999996 5789999999864322 113568889999999999999999999999999999999999999863
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcceeecccccccccCc
Q 010887 366 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAP 445 (498)
Q Consensus 366 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aP 445 (498)
++|..+.+++.|+++||+|||..+.++|+||||||+||+++.++.+++. ||........ ....+|+.|+||
T Consensus 777 ---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aP 847 (968)
T PLN00113 777 ---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAP 847 (968)
T ss_pred ---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCc
Confidence 7999999999999999999997766799999999999999999988875 6655433221 123578999999
Q ss_pred ccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 446 EYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 446 E~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
|++.+..++.++|||||||++|||+||+.||+..
T Consensus 848 E~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~ 881 (968)
T PLN00113 848 ETRETKDITEKSDIYGFGLILIELLTGKSPADAE 881 (968)
T ss_pred ccccCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999999999999999643
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-51 Score=404.60 Aligned_cols=232 Identities=53% Similarity=0.851 Sum_probs=204.4
Q ss_pred cccccCHHHHHHHhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEE
Q 010887 257 QLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336 (498)
Q Consensus 257 ~~~~~~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 336 (498)
..+.|++++++.+|++|+..++||+|+||.||+|.+++++.||||++....... ..+|.+|++++.+++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 456799999999999999999999999999999999999999999887544333 6679999999999999999999999
Q ss_pred EEcCC-ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEE
Q 010887 337 CTTSS-ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV 415 (498)
Q Consensus 337 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 415 (498)
|.+.+ +.++|||||++|+|.++|+..... .++|.+|.+||.++|+||+|||..+.++|+||||||+|||+|+++++|
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 99999 499999999999999999974332 899999999999999999999999998999999999999999999999
Q ss_pred EeecCccccccc-cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCccccccccccccccc
Q 010887 416 LCDFGLAKLVDA-KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHKV 494 (498)
Q Consensus 416 i~DfGl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~~~~~~~~~l~~w~~ 494 (498)
|+|||+++.... ..... ....||.+|+|||+...+..+.|+|||||||+++|++||++|.+..... ....+++|++
T Consensus 218 lsDFGLa~~~~~~~~~~~-~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~--~~~~l~~w~~ 294 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVS-TTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPR--GELSLVEWAK 294 (361)
T ss_pred ccCccCcccCCcccccee-eecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCc--ccccHHHHHH
Confidence 999999976654 22211 1117999999999999999999999999999999999999999976532 2335889874
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=347.53 Aligned_cols=202 Identities=26% Similarity=0.396 Sum_probs=182.3
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
..+|...+.||+|+|++||+|+++ ++..||||.+.... .+...+....|+.+|+.++|||||.+++++..++..++||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 457888888999999999999964 57899999987442 5566778899999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCC------CcEEEeecCc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN------FEAVLCDFGL 421 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~------~~~ki~DfGl 421 (498)
|||.+|+|..+++. .+.+++.+.+.++.|+|.||++||++ +||||||||.|||++.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999997 44799999999999999999999999 99999999999999764 5689999999
Q ss_pred cccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
++.+.+. ......+|++-|||||+++.++|+.|+|+||.|+|+|||++|+.||+...
T Consensus 162 AR~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 162 ARFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hhhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 9988753 34567899999999999999999999999999999999999999999544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=349.06 Aligned_cols=203 Identities=35% Similarity=0.538 Sum_probs=177.6
Q ss_pred CCCCCCeeecccceEEEEEEEcCCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCC-ceEEEEec
Q 010887 272 NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-ERILVYPF 349 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 349 (498)
++...+.+|+|+||+||+|.+.....||||++.... .....++|.+|+.++.+++|||||+++|+|.+.. ..++||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 344456699999999999999666669999998543 2233679999999999999999999999999988 79999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-cEEcCCCCCcEEECCCC-cEEEeecCccccccc
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK-IIHRDLKAANILLDDNF-EAVLCDFGLAKLVDA 427 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-ivH~Dlk~~NILl~~~~-~~ki~DfGl~~~~~~ 427 (498)
|++|+|..+++.. ....+++..++++|.|||+||+|||++ + ||||||||+|||++.++ ++||+|||+++....
T Consensus 122 ~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred CCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 9999999999874 356799999999999999999999999 6 99999999999999997 999999999987765
Q ss_pred cCcceeecccccccccCccccc--CCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLS--TGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.. .......||..|||||++. ..+|+.|+|||||||++|||+||+.||....
T Consensus 197 ~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~ 250 (362)
T KOG0192|consen 197 SK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLA 250 (362)
T ss_pred cc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCC
Confidence 32 2233367999999999999 5689999999999999999999999998644
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=330.02 Aligned_cols=206 Identities=28% Similarity=0.355 Sum_probs=184.8
Q ss_pred HhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
..++|++.++||+|+||.||.++. ++++.+|+|++++.. ...+.+...+|..++.+++||.||+++..+++.+..++
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 457899999999999999999995 468889999997542 33567888999999999999999999999999999999
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
|+||+.||.|..+|.+ +..+++..+.-++.+|+.||.|||+. +||||||||+|||+|++|+++|+|||+++..
T Consensus 103 Vld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 9999999999999986 56799999999999999999999999 9999999999999999999999999999854
Q ss_pred cccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCccc
Q 010887 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLE 482 (498)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~~~ 482 (498)
-.. ...+...+||+.|||||++.+..|+..+|+||+|+++|||++|.+||......
T Consensus 176 ~~~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~ 231 (357)
T KOG0598|consen 176 LKD-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK 231 (357)
T ss_pred ccC-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH
Confidence 332 22345589999999999999999999999999999999999999999876543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=328.07 Aligned_cols=198 Identities=26% Similarity=0.430 Sum_probs=181.1
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCC-ceEEEEec
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-ERILVYPF 349 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 349 (498)
+.+..+.||+|..|+|||++++ +++.+|+|++.....+...+++.+|++++...+||+||.++|.|..+. +..++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4445788999999999999975 578899999976667778899999999999999999999999999998 59999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|++|||...+... +.+++...-+|+.++++||.|||+ . +|+||||||+|||++..|++||||||.++.+.+.
T Consensus 160 MDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred cCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 9999999998863 568999999999999999999996 5 8999999999999999999999999999987764
Q ss_pred CcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
......||..|||||.+++..|+.++||||||+.++|+.+|+-||...
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 445678999999999999999999999999999999999999999875
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=338.52 Aligned_cols=206 Identities=33% Similarity=0.467 Sum_probs=182.1
Q ss_pred hcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
.+.+...+.||+|.||.||.|.++....||+|.++.. .....+|.+|+++|++++|+|||+++|+|..++..+|||||
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~--~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG--SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc--ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 3334447789999999999999988889999999864 34568899999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
|+.|+|.++|+. .....+..++.+.++.|||+||+||+++ ++|||||.++|||++++..+||+|||+++...++.
T Consensus 283 m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 283 MPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred cccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 999999999997 3356789999999999999999999999 99999999999999999999999999999666555
Q ss_pred cceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCccc
Q 010887 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLE 482 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~~~ 482 (498)
........-...|.|||.+..++++.|||||||||+||||+| |+.|+......
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ 411 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE 411 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH
Confidence 444444444678999999999999999999999999999999 99998866543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=317.72 Aligned_cols=208 Identities=25% Similarity=0.343 Sum_probs=184.9
Q ss_pred cCCCCCCeeecccceEEEEEE-EcCCcEEEEEEec-ccCCcchHHHHHHHHHHHHhccCCccceEEE-EEEcCCc-eEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIG-YCTTSSE-RILV 346 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~-~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~~-~~lv 346 (498)
.+|++.++||+|.||+|||+. ..+|..+|.|.++ +..+....++...|+.+|++++|||||++++ -+.++.+ ..+|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 356778899999999999999 6789999999997 3345567788999999999999999999998 4444445 7899
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEEcCCCCCcEEECCCCcEEEeecCcccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK--IIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlk~~NILl~~~~~~ki~DfGl~~~ 424 (498)
|||+..|+|...++.++...+.+++..++++..|+++||.++|.. -++ |.||||||.||+++.+|.+|++|||++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999999998888888999999999999999999999994 224 99999999999999999999999999999
Q ss_pred ccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+.... .......|||.||+||.+...+|+.||||||+||++|||..-++||....
T Consensus 178 l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n 232 (375)
T KOG0591|consen 178 LSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN 232 (375)
T ss_pred hcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc
Confidence 87643 33456789999999999999999999999999999999999999998753
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=333.66 Aligned_cols=207 Identities=26% Similarity=0.415 Sum_probs=188.7
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
..|...++||+|+|+.||+++. ..|..||+|++.+. ..+.......+|+++-+.++|||||+++++|.+.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688899999999999999996 88999999999742 35567788899999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
|+|++++|..+++. .+.++++++..+..||+.||.|||+. +|+|||||-.|+++++++++||+|||+|..+..
T Consensus 98 ELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 99999999999884 56799999999999999999999999 999999999999999999999999999998875
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE 485 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~~~~~~ 485 (498)
+. +.....+|||.|+|||++.....+..+||||+|||+|-||+|++||+....+|..
T Consensus 171 ~~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety 227 (592)
T KOG0575|consen 171 DG-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY 227 (592)
T ss_pred cc-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH
Confidence 42 3345689999999999999989999999999999999999999999988766554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=318.40 Aligned_cols=203 Identities=25% Similarity=0.370 Sum_probs=175.6
Q ss_pred HhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcc------hHHHHHHHHHHHHhccCCccceEEEEEEcCC
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPG------GEAAFQREVHLISVAIHKNLLQLIGYCTTSS 341 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 341 (498)
..+.|.+.+.||+|+||.|-+|.. ++|+.||||+++...... ......+|+++|++++|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 345678899999999999999994 579999999997543222 2233469999999999999999999999999
Q ss_pred ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCC---CcEEEee
Q 010887 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN---FEAVLCD 418 (498)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~ki~D 418 (498)
..|+|+||++||+|.+.+-. .+.+.+...+.++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence 99999999999999999875 45678888899999999999999999 99999999999999655 7899999
Q ss_pred cCccccccccCcceeecccccccccCcccccCCCC---CCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS---SEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 419 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
||+|+.... .......+||+.|.|||++.+..+ ..+.|+||+|||||-++||.+||....
T Consensus 323 FGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~ 385 (475)
T KOG0615|consen 323 FGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY 385 (475)
T ss_pred cchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc
Confidence 999998763 445677899999999999977653 347899999999999999999998543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=321.95 Aligned_cols=204 Identities=28% Similarity=0.386 Sum_probs=178.6
Q ss_pred cCCCCCCeeecccceEEEEEE-EcCCcEEEEEEec-ccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcC--CceEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERILV 346 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~-~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 346 (498)
+.|+..+.||+|.||.||+|+ ..+|+.||+|+++ +...++...-..+||.+|++++||||+++.+...+. ...|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 456778899999999999999 5689999999998 334556677889999999999999999999999877 689999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
+|||+. +|.-.+.. ..-.++.++++.++.|++.||+|+|++ +|.|||||.+|||+|++|.+||+|||+|+++.
T Consensus 197 FeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred Eecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence 999986 66666553 234699999999999999999999999 99999999999999999999999999999888
Q ss_pred ccCcceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCcc
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRL 481 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~~~ 481 (498)
.......+...-|..|+|||++.+. .|+...|+||.|||+.||++|++.|+....
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE 325 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE 325 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH
Confidence 7665545556679999999999875 699999999999999999999999987653
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=299.83 Aligned_cols=201 Identities=26% Similarity=0.338 Sum_probs=182.4
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
.++|+..+.||.|+||+|.+++.+ ++..+|+|++... ......+...+|..+|+.+.||.++++.+.+.+....++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 356888999999999999999954 6888999999743 2334567788999999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|||++||.|.++++. .+.++.+.++-+|.||+.||+|||+. .|++|||||+|||+|.+|++||+|||+++...
T Consensus 123 meyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 999999999999997 45689999999999999999999999 99999999999999999999999999999776
Q ss_pred ccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCcc
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRL 481 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~~ 481 (498)
. .+...+|||.|+|||.++...+...+|+|||||++|||+.|++||.....
T Consensus 196 ~----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 196 G----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred C----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 5 35678999999999999999999999999999999999999999986543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=343.43 Aligned_cols=214 Identities=26% Similarity=0.426 Sum_probs=186.1
Q ss_pred HHHHhcCCCCCCeeecccceEEEEEEEc------CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEc
Q 010887 266 LQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT 339 (498)
Q Consensus 266 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 339 (498)
.++.+.+....+.||+|+||.||+|+.. +...||||.+++..+.+...+|.+|+++++.++|||||+++|.|.+
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 3445566677889999999999999953 3467999999988887789999999999999999999999999999
Q ss_pred CCceEEEEecccCCCHHHhhcccCCC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEEC
Q 010887 340 SSERILVYPFMQNLSVAYRLRDLKPG----------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD 409 (498)
Q Consensus 340 ~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~ 409 (498)
++..++|+|||..|+|.++|+...+. ..+++..+.+.||.|||.||+||-++ .+|||||..+|+|+.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceec
Confidence 99999999999999999999854321 23488999999999999999999999 899999999999999
Q ss_pred CCCcEEEeecCccccccccCcceee-cccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCccc
Q 010887 410 DNFEAVLCDFGLAKLVDAKLTHVTT-QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLE 482 (498)
Q Consensus 410 ~~~~~ki~DfGl~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~~~ 482 (498)
++..+||+|||+++..-..+.+... ...-..+|||||.+..++++.+||||||||||||++| |+-||..-..+
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~ 712 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ 712 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH
Confidence 9999999999999866444433322 3334679999999999999999999999999999999 99999865544
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=317.77 Aligned_cols=221 Identities=21% Similarity=0.267 Sum_probs=191.2
Q ss_pred HHHhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCce
Q 010887 267 QLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (498)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 343 (498)
+...++|+....||+|+||.||+|+- .+|..+|+|++++. ....+......|-.+|...++|+||+++..|++.+..
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 34568999999999999999999995 46899999999854 3445678888999999999999999999999999999
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
||||||++||++...|.. ...|++..+..++.+++-|++-||+. ||+||||||+|+|||..|++||+|||++.
T Consensus 217 YLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred EEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccc
Confidence 999999999999999986 56799999999999999999999999 99999999999999999999999999985
Q ss_pred cccc----------------------c-Cc------c-----------------eeecccccccccCcccccCCCCCCcc
Q 010887 424 LVDA----------------------K-LT------H-----------------VTTQIRGTMGHIAPEYLSTGKSSEKT 457 (498)
Q Consensus 424 ~~~~----------------------~-~~------~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~ 457 (498)
-+.. . .. . ......|||.|||||++.+..|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 3210 0 00 0 00123499999999999999999999
Q ss_pred cchhHHHHHHHHHhCCCCCCCCcccccccccccccccc
Q 010887 458 DVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHKVT 495 (498)
Q Consensus 458 Dv~s~Gvvl~elltG~~p~~~~~~~~~~~~~l~~w~~~ 495 (498)
|+||+|||+||||.|.+||......+... .|+.|...
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~r-kI~nwr~~ 406 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYR-KIVNWRET 406 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhhh
Confidence 99999999999999999999888776654 67888643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=297.58 Aligned_cols=202 Identities=25% Similarity=0.370 Sum_probs=175.1
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCC-cchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
+.|+...++|+|+||.|||++.+ +|+.||||++.+..+ +.-.+-.++|++++++++|+|+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45778889999999999999965 589999999986554 4445678999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|++.- +.+.|..+ ..+++...+.++..|+++|+.|+|++ +++||||||+|||++.++.+|+||||+|+.+..+
T Consensus 82 ~~dhT-vL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 82 YCDHT-VLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ecchH-HHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 99863 33334433 44689999999999999999999999 9999999999999999999999999999988743
Q ss_pred CcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 429 LTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.. ..+....|..|+|||.+.+ .+|....||||.||++.||+||.+.|...+
T Consensus 155 gd-~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S 206 (396)
T KOG0593|consen 155 GD-NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS 206 (396)
T ss_pred cc-hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc
Confidence 22 2345667999999999988 789999999999999999999999988643
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=314.09 Aligned_cols=206 Identities=24% Similarity=0.356 Sum_probs=181.1
Q ss_pred HHhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccC--CcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCce
Q 010887 268 LATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER 343 (498)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 343 (498)
...++|...+.||+|+|++|++|+. ..++.||||++.+.. .+...+-..+|-+.|.+| .||.|++++..|+++...
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3456889999999999999999994 468999999986432 233445667888899999 899999999999999999
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
|+|+||.++|+|.++++.+ +.+++...+.++.+|+.||+|||+. |||||||||+|||+|+||+++|+|||.++
T Consensus 150 YFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred EEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccc
Confidence 9999999999999999974 4689999999999999999999999 99999999999999999999999999999
Q ss_pred cccccCcc----------e--eecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 424 LVDAKLTH----------V--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 424 ~~~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.+.+.... . .....||..|.+||++.....+..+|+|+||||+|+|+.|++||....
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N 291 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN 291 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc
Confidence 87643221 1 134779999999999999999999999999999999999999998654
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=317.11 Aligned_cols=207 Identities=31% Similarity=0.487 Sum_probs=180.3
Q ss_pred CHHHHHHHhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecc-cCCcchHHHHHHHHHHHHhccCCccceEEEEEEcC
Q 010887 262 SCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQD-YYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS 340 (498)
Q Consensus 262 ~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 340 (498)
+.+++++..+++...+.||+|.||+||+|+|.. .||||+++. ..++...+.|.+|+..+++-+|.||+-+.|||..+
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 457788888888999999999999999999853 799999983 34566789999999999999999999999999988
Q ss_pred CceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecC
Q 010887 341 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (498)
Q Consensus 341 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 420 (498)
+. .+|+.+++|-+|..+++... ..++..+...||+|||+||.|||.+ +|+|||||+.||++.+++.+||+|||
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred ce-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccc
Confidence 87 99999999999999999743 5689999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccC-cceeecccccccccCcccccCC---CCCCcccchhHHHHHHHHHhCCCCCC
Q 010887 421 LAKLVDAKL-THVTTQIRGTMGHIAPEYLSTG---KSSEKTDVFGYGITLLELVTGQRAID 477 (498)
Q Consensus 421 l~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~Gvvl~elltG~~p~~ 477 (498)
++.....-. ........|...|||||++... +|+..+||||||+|+|||+||..||.
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys 594 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS 594 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence 986443211 1111234477889999998654 68999999999999999999999998
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=282.70 Aligned_cols=201 Identities=27% Similarity=0.364 Sum_probs=176.0
Q ss_pred cCCCCCCeeecccceEEEEEE-EcCCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
++|...+++|+|.||.||+|+ ..+|+.||+|+++-. ..++-.....+|++.++.++|+||+.+++.+...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 457778999999999999999 457999999999843 344556788999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
||+- +|+..+++ ....++..++..++.++++|++|+|++ .|.||||||.|+|++++|.+||+|||+++.+..+
T Consensus 82 fm~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9974 88888876 345689999999999999999999999 9999999999999999999999999999988765
Q ss_pred CcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 429 LTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
....... .-|..|+|||.+.+ +.|+...||||.|||+.||+-|.+-|...
T Consensus 155 ~~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~ 205 (318)
T KOG0659|consen 155 NRIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD 205 (318)
T ss_pred Ccccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC
Confidence 5443333 46899999999876 46999999999999999999999777654
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=312.36 Aligned_cols=201 Identities=29% Similarity=0.456 Sum_probs=181.8
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
++|.+.+.||+|.||.||||+-+ +.+.||+|.+.+.. .+.+.+...+|+++++.++||||+.+++.+....+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46777889999999999999954 57889999886543 44567889999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+.+ +|...|.+ ...++++.+..++.++..||.|||+. +|.|||+||.|||++..+.+|+||||+++.+...
T Consensus 82 ~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9987 99999986 56799999999999999999999999 9999999999999999999999999999988754
Q ss_pred CcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
...-+...||+-|||||+..+++|+..+|.||+|||+||+.+|++||-...
T Consensus 154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s 204 (808)
T KOG0597|consen 154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS 204 (808)
T ss_pred -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH
Confidence 334466789999999999999999999999999999999999999997654
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=314.11 Aligned_cols=195 Identities=29% Similarity=0.471 Sum_probs=172.7
Q ss_pred HHHHhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 266 LQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 266 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
|++..+.....+-||.|+.|.||+|++ .++.||||+++... +.+|+-|++++||||+.+.|+|......++
T Consensus 119 WeiPFe~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVCtqsPcyCI 189 (904)
T KOG4721|consen 119 WEIPFEEISELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVCTQSPCYCI 189 (904)
T ss_pred ccCCHHHhhhhhhhccCcccceeeeec-cCceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeeecCCceeEE
Confidence 334444445577899999999999998 56899999886422 467889999999999999999999999999
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
|||||..|-|.+.|+. ...+.......+..+||.||.|||.. .|||||||+-||||..+..+||+|||.++..
T Consensus 190 iMEfCa~GqL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 190 IMEFCAQGQLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred eeeccccccHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhh
Confidence 9999999999999986 45678888899999999999999999 9999999999999999999999999999887
Q ss_pred cccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
.+.. ....++||..|||||++.+.+.++|+|||||||||||||||..||..
T Consensus 263 ~~~S--TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkd 313 (904)
T KOG4721|consen 263 SDKS--TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKD 313 (904)
T ss_pred hhhh--hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccc
Confidence 6542 23457899999999999999999999999999999999999999964
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=290.22 Aligned_cols=203 Identities=26% Similarity=0.340 Sum_probs=174.6
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcC--CceEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERIL 345 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 345 (498)
.++|+..+.|++|+||.||+|+++ +++.||+|+++... ..+-.-...+|+.++.+++|||||.+.++.... +..++
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 356788999999999999999964 68889999998433 334456678999999999999999999988754 47899
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
||||++. +|...+.... +++...+++.+..|+++|++|||+. .|+|||||++|+|+.+.|.+||+|||+|+.+
T Consensus 155 VMe~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eHHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhh
Confidence 9999986 7777777543 5789999999999999999999999 8999999999999999999999999999999
Q ss_pred cccCcceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 426 DAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
..+.... +...-|..|+|||.+.+. .|+...|+||+|||+.||+++++.|....
T Consensus 228 gsp~k~~-T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s 282 (419)
T KOG0663|consen 228 GSPLKPY-TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS 282 (419)
T ss_pred cCCcccC-cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc
Confidence 8764433 345569999999999876 48999999999999999999999887643
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=313.54 Aligned_cols=210 Identities=28% Similarity=0.379 Sum_probs=183.6
Q ss_pred HHHhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhcc-CCccceEEEEEEcCCc
Q 010887 267 QLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSE 342 (498)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 342 (498)
....++|...++||+|.||.|+++..+ +++.+|||.+++.. ...+.+....|.+++.... ||.++.++..++++++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 445678999999999999999999965 57789999998543 5567788888998888775 9999999999999999
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcc
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~ 422 (498)
.+.||||..||++..+.+ ...+++..+.-+|..++.||.|||++ +|||||||-+|||+|.+|++||+|||++
T Consensus 444 l~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred EEEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccc
Confidence 999999999999433333 35699999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccc
Q 010887 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE 485 (498)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~~~~~~ 485 (498)
+.--.. ...+.+.+||+.|||||++.+..|+...|+|||||+||||+.|+.||..++.+|-.
T Consensus 516 Ke~m~~-g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F 577 (694)
T KOG0694|consen 516 KEGMGQ-GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF 577 (694)
T ss_pred cccCCC-CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 855422 22567789999999999999999999999999999999999999999977665443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=295.65 Aligned_cols=206 Identities=28% Similarity=0.371 Sum_probs=180.8
Q ss_pred HhcCCCCCCeeecccceEEEEEE-EcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
..++|+..+.||.|..++||+|+ .+.+..||||++.-.....+.+...+|++.++.++||||++++..|..+.+.++||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 34678889999999999999999 56789999999984444455789999999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
.||.+||+.+.++...+ .++++..+..|.+++++||.|||++ |.+|||||+.|||++++|.+||+|||.+..+..
T Consensus 104 pfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred hhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 99999999999997653 4599999999999999999999999 999999999999999999999999999876654
Q ss_pred cCcce---eecccccccccCcccccC--CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 428 KLTHV---TTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 428 ~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
..... .....||+.|||||++.. ..|+.|+||||||+..+||.+|..||...
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~ 235 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKY 235 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccC
Confidence 33211 134579999999999543 46999999999999999999999999743
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=299.74 Aligned_cols=201 Identities=30% Similarity=0.490 Sum_probs=172.1
Q ss_pred cCCCCCCeeecccceEEEEEEEcC-CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCC--ceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS--ERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 347 (498)
.+|...+.||+|+||+||++...+ |...|||.+.....+. .+...+|+++|.+++|||||+.+|.....+ ...+.|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 356778999999999999999654 8999999886443222 677899999999999999999999855555 588999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECC-CCcEEEeecCcccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDFGLAKLVD 426 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~ki~DfGl~~~~~ 426 (498)
||+++|+|.+++.... . .++++.++.+++||++||+|||++ +|+||||||+|||++. ++.+||+|||+++...
T Consensus 96 Ey~~~GsL~~~~~~~g--~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYG--G-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHcC--C-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999999999998743 2 699999999999999999999999 9999999999999999 7999999999998776
Q ss_pred c--cCcceeecccccccccCcccccCCC-CCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 427 A--KLTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 427 ~--~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
. ..........||+.|||||++..+. ...++||||+||++.||+||++||..
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 3 2222334577999999999998643 34599999999999999999999985
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=306.24 Aligned_cols=204 Identities=25% Similarity=0.355 Sum_probs=178.5
Q ss_pred HhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccC---C-cchHHHHHHHHHHHHhcc-CCccceEEEEEEcCCc
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY---S-PGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSE 342 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 342 (498)
..+.|...+.||+|.||.|+.|.. .++..||+|.+.... . ........+|+.+++.++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 456788999999999999999985 468999999765431 1 133456668999999999 9999999999999999
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCC-CcEEEeecCc
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGL 421 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~ki~DfGl 421 (498)
.++||||+.+|+|.+++.+ ...+.+.++..++.|++.|++|+|+. +|+||||||+|+|+|.+ +++||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999986 45688899999999999999999999 99999999999999999 9999999999
Q ss_pred cccccccCcceeecccccccccCcccccCCC-CC-CcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK-SS-EKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+.... .........+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||+...
T Consensus 168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~ 227 (370)
T KOG0583|consen 168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN 227 (370)
T ss_pred ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence 98774 2223345678999999999999977 75 78999999999999999999999754
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=324.79 Aligned_cols=203 Identities=28% Similarity=0.440 Sum_probs=180.5
Q ss_pred cCCCCCCeeecccceEEEEEEEcC----CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
....+.++||.|.||.||+|+++- ...||||.+|...+++...+|+.|..+|.++.||||+++.|+.......++|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 345678899999999999999753 3569999999999999999999999999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
+|||++|+|..+|+.. .+++++.+...+.++||.||.||-+. ++|||||.++|||++.+..+||+|||+++.+.
T Consensus 709 TEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred hhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecc
Confidence 9999999999999863 45699999999999999999999999 99999999999999999999999999999886
Q ss_pred ccCcceeecc--cccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 427 AKLTHVTTQI--RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 427 ~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
++.....+.. .-..+|.|||.+..++++..|||||||||+||.++ |.+||=..
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm 838 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 838 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc
Confidence 5542222222 22468999999999999999999999999999888 99998543
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=310.83 Aligned_cols=204 Identities=21% Similarity=0.259 Sum_probs=176.0
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|+..+.||+|+||+||+|+.. +++.||+|+++... .......+.+|++++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999964 58899999986421 2234467888999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++++||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999875 34689999999999999999999999 999999999999999999999999999875432
Q ss_pred cCc----------------------------------ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCC
Q 010887 428 KLT----------------------------------HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473 (498)
Q Consensus 428 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~ 473 (498)
... .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 0012346999999999999999999999999999999999999
Q ss_pred CCCCCCcc
Q 010887 474 RAIDFSRL 481 (498)
Q Consensus 474 ~p~~~~~~ 481 (498)
.||.....
T Consensus 234 ~Pf~~~~~ 241 (363)
T cd05628 234 PPFCSETP 241 (363)
T ss_pred CCCCCCCH
Confidence 99976543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=297.63 Aligned_cols=195 Identities=33% Similarity=0.499 Sum_probs=164.8
Q ss_pred CCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHh--ccCCccceEEEEEEcCC----ceEE
Q 010887 272 NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISV--AIHKNLLQLIGYCTTSS----ERIL 345 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~~l 345 (498)
..+..+++|+|+||.||||.+ +++.||||++.. .+.+.|.+|-++++. ++|+||++++++-.... +.+|
T Consensus 211 pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred chhhHHHhhcCccceeehhhc-cCceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 344467899999999999998 459999999863 567888898888775 57999999999876555 8899
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCcEEcCCCCCcEEECCCCcEEEeec
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ------CNPKIIHRDLKAANILLDDNFEAVLCDF 419 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------~~~~ivH~Dlk~~NILl~~~~~~ki~Df 419 (498)
|++|.+.|+|.++|+. ..++|....+|+..+++||+|||+. .+|+|+|||||++|||+.+|+++.|+||
T Consensus 286 Vt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 9999999999999985 3589999999999999999999975 5678999999999999999999999999
Q ss_pred CccccccccCcce-eecccccccccCcccccCCC------CCCcccchhHHHHHHHHHhCCCCC
Q 010887 420 GLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGK------SSEKTDVFGYGITLLELVTGQRAI 476 (498)
Q Consensus 420 Gl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~Gvvl~elltG~~p~ 476 (498)
|++..+....... .....||.+|||||++.+.- .-.+.||||+|.|+|||++.-..+
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 9998887544332 23367999999999997643 224689999999999999975544
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=306.42 Aligned_cols=211 Identities=27% Similarity=0.427 Sum_probs=175.4
Q ss_pred HHHhcCCCCCCeeecccceEEEEEEE------cCCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEEc
Q 010887 267 QLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT 339 (498)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 339 (498)
+...++|.+.+.||+|+||.||+|.. .+++.||+|+++..........+.+|++++.++ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 34567899999999999999999974 235679999997554445567899999999999 89999999998876
Q ss_pred CC-ceEEEEecccCCCHHHhhcccCC------------------------------------------------------
Q 010887 340 SS-ERILVYPFMQNLSVAYRLRDLKP------------------------------------------------------ 364 (498)
Q Consensus 340 ~~-~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------ 364 (498)
.+ ..++||||+++|+|.+++.....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 54 57899999999999998874211
Q ss_pred ----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcc-eeeccccc
Q 010887 365 ----GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGT 439 (498)
Q Consensus 365 ----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt 439 (498)
....+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++........ ......++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 023588899999999999999999999 9999999999999999999999999999865432221 12233456
Q ss_pred ccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 440 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 440 ~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
..|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~ 281 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence 78999999999999999999999999999997 999997643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=330.26 Aligned_cols=209 Identities=30% Similarity=0.470 Sum_probs=182.3
Q ss_pred hcCCCCCCeeecccceEEEEEEEcC--Cc----EEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCce
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLSD--NT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 343 (498)
.+..+..+.||+|.||.||+|...+ +. .||+|.++...+.+...+|.+|..+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4556668899999999999999643 33 49999999888889999999999999999999999999999999999
Q ss_pred EEEEecccCCCHHHhhcccCCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecC
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPG---EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 420 (498)
++++|||++|+|..+|++.+.. ...++..+.+.++.|||+|+.||+++ ++|||||.++|+|+++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999975432 45688999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCcceeecc-cccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcc
Q 010887 421 LAKLVDAKLTHVTTQI-RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRL 481 (498)
Q Consensus 421 l~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~~ 481 (498)
+|+.+........... .-...|||||.+..+.++.|+|||||||++||++| |..||...+.
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n 910 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN 910 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch
Confidence 9995543333322222 23468999999999999999999999999999999 8999986544
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=305.34 Aligned_cols=199 Identities=25% Similarity=0.373 Sum_probs=178.3
Q ss_pred hcCCCCCCeeecccceEEEEEE-EcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
...|.....||+|+.|.||.|+ ..+++.||||++.-.. +...+-..+|+.+|+..+|+|||++++.+...++.+.|||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~-Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK-QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc-CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 4467778899999999999999 5578899999996432 2345567899999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
||++|+|.+.+.. ..+++.++..|.+++++||+|||.+ +|+|||||++|||++.++.+||+|||++..+...
T Consensus 351 ym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 351 YMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred ecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 9999999998875 3489999999999999999999999 9999999999999999999999999999888765
Q ss_pred CcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
.. ......||+.|||||+.....|.+|.||||||++++||+-|++||-.
T Consensus 423 ~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln 471 (550)
T KOG0578|consen 423 QS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN 471 (550)
T ss_pred cC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC
Confidence 44 34456799999999999999999999999999999999999999964
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=302.93 Aligned_cols=203 Identities=26% Similarity=0.347 Sum_probs=179.4
Q ss_pred HhcCCCCCCeeecccceEEEEEE-EcCCcEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCccceEEEEEEcCC-ceEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSS-ERIL 345 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~l 345 (498)
..++|...+.||.|+||.||+|+ ...+..||||+++......+...=.||++.|+++. ||||+++.+++.+.+ ..++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 34678888999999999999999 56789999999997666666667789999999999 999999999999888 8999
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
|||||+ .+|.+.++++ +..+++..+..|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+||..
T Consensus 88 VfE~Md-~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhhh-hhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 999996 5888888864 56799999999999999999999999 9999999999999998999999999999987
Q ss_pred cccCcceeecccccccccCccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 426 DAKLTHVTTQIRGTMGHIAPEYLS-TGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
..... .+....|..|+|||++. .+-|+.+.||||+|||++|+.+-++.|....
T Consensus 161 ~SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s 214 (538)
T KOG0661|consen 161 RSKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS 214 (538)
T ss_pred ccCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc
Confidence 65433 34566799999999975 5678999999999999999999999998643
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.85 Aligned_cols=203 Identities=22% Similarity=0.252 Sum_probs=173.8
Q ss_pred CCCCCCeeecccceEEEEEEE-cCCcEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 272 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.|+..+.||+|+||+||+|+. .+++.||+|+++.. ........+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 577889999999999999995 46789999998643 223445678999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++++||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999875 34588999999999999999999999 9999999999999999999999999997543110
Q ss_pred Cc----------------------------------------------ceeecccccccccCcccccCCCCCCcccchhH
Q 010887 429 LT----------------------------------------------HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGY 462 (498)
Q Consensus 429 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~ 462 (498)
.. .......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 00123468999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCCCcc
Q 010887 463 GITLLELVTGQRAIDFSRL 481 (498)
Q Consensus 463 Gvvl~elltG~~p~~~~~~ 481 (498)
||++|||+||+.||.....
T Consensus 235 G~il~elltG~~Pf~~~~~ 253 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTP 253 (381)
T ss_pred hhHHHHHHhCCCCCcCCCH
Confidence 9999999999999976543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=293.76 Aligned_cols=201 Identities=27% Similarity=0.389 Sum_probs=174.2
Q ss_pred CCCCCeeecccceEEEEEEE-cCCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 273 FSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
|+..+.||+|+||.||+|.. .+++.||+|.+.... .......+.+|++++++++|+||+++.+++.+.+..++|+||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66788999999999999995 578999999886422 223345688999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++|+|...+.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 82 MNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999988876432 34689999999999999999999999 99999999999999999999999999997654322
Q ss_pred cceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
......||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 205 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence 1234568999999999999999999999999999999999999998543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=307.97 Aligned_cols=203 Identities=21% Similarity=0.282 Sum_probs=175.6
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|+..+.||+|+||.||+|+.. +++.||+|+++.. ........+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999964 6889999999742 12234567888999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999875 34589999999999999999999999 999999999999999999999999999875432
Q ss_pred cCcc-------------------------------------eeecccccccccCcccccCCCCCCcccchhHHHHHHHHH
Q 010887 428 KLTH-------------------------------------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELV 470 (498)
Q Consensus 428 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ell 470 (498)
.... ......||+.|+|||++....++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 011245899999999999999999999999999999999
Q ss_pred hCCCCCCCCc
Q 010887 471 TGQRAIDFSR 480 (498)
Q Consensus 471 tG~~p~~~~~ 480 (498)
+|+.||....
T Consensus 234 ~G~~Pf~~~~ 243 (364)
T cd05599 234 VGYPPFCSDN 243 (364)
T ss_pred cCCCCCCCCC
Confidence 9999997654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=308.87 Aligned_cols=203 Identities=21% Similarity=0.255 Sum_probs=173.9
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|...+.||+|+||.||++.. .+++.||+|++... ........+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688899999999999999995 46889999998642 12334567889999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999875 34588999999999999999999999 999999999999999999999999999863321
Q ss_pred cCcc----------------------------------------------eeecccccccccCcccccCCCCCCcccchh
Q 010887 428 KLTH----------------------------------------------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFG 461 (498)
Q Consensus 428 ~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s 461 (498)
.... ......||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 001245899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCc
Q 010887 462 YGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 462 ~Gvvl~elltG~~p~~~~~ 480 (498)
|||++|||+||+.||....
T Consensus 234 lGvil~elltG~~Pf~~~~ 252 (377)
T cd05629 234 LGAIMFECLIGWPPFCSEN 252 (377)
T ss_pred cchhhhhhhcCCCCCCCCC
Confidence 9999999999999997644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=302.74 Aligned_cols=200 Identities=23% Similarity=0.276 Sum_probs=176.7
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|++.+.||+|+||.||+|+.. +++.||+|+++... .......+.+|++++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999975 58899999987432 2234567889999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999875 34688999999999999999999999 999999999999999999999999999876543
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCcc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRL 481 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~~ 481 (498)
......||+.|+|||++.+..++.++|||||||++|||++|+.||+....
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 203 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH
Confidence 22345689999999999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=306.68 Aligned_cols=207 Identities=23% Similarity=0.304 Sum_probs=177.4
Q ss_pred HHHHhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCc
Q 010887 266 LQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 342 (498)
Q Consensus 266 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 342 (498)
+....++|+..+.||+|+||.||+++.. +++.+|+|.+... ........+.+|+++++.++||||+++++++.++..
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3445678999999999999999999965 5788999998632 222345668899999999999999999999999999
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcc
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~ 422 (498)
.++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccc
Confidence 9999999999999998864 2478889999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcceeecccccccccCcccccCC----CCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTG----KSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
...............||+.|+|||++... .++.++||||+||++|||+||+.||....
T Consensus 190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~ 251 (370)
T cd05621 190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251 (370)
T ss_pred eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence 87654333223456699999999998654 37889999999999999999999997544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=301.82 Aligned_cols=201 Identities=27% Similarity=0.323 Sum_probs=175.9
Q ss_pred HhcCCCCCCeeecccceEEEEEEEcC--CcEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLSD--NTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (498)
..++|+..+.||+|+||.||+|.... +..||+|++... ........+.+|+++++.++||||+++++++.+.+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34578889999999999999998543 368999998632 12344567889999999999999999999999999999
Q ss_pred EEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccc
Q 010887 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~ 424 (498)
+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 108 lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 99999999999999875 34689999999999999999999999 999999999999999999999999999986
Q ss_pred ccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.... .....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 181 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 232 (340)
T PTZ00426 181 VDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE 232 (340)
T ss_pred cCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence 6432 233568999999999998889999999999999999999999997543
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=307.84 Aligned_cols=202 Identities=22% Similarity=0.236 Sum_probs=172.9
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.|+..+.||+|+||.||+|+.. +++.||+|++.... .......+.+|++++++++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5778999999999999999964 67889999986421 23345678899999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++|+|.+.+.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999998875 24578899999999999999999999 9999999999999999999999999997532100
Q ss_pred C----------------------------------------------cceeecccccccccCcccccCCCCCCcccchhH
Q 010887 429 L----------------------------------------------THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGY 462 (498)
Q Consensus 429 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~ 462 (498)
. ........||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 000112468999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCc
Q 010887 463 GITLLELVTGQRAIDFSR 480 (498)
Q Consensus 463 Gvvl~elltG~~p~~~~~ 480 (498)
||++|||+||+.||....
T Consensus 235 Gvil~elltG~~Pf~~~~ 252 (382)
T cd05625 235 GVILYEMLVGQPPFLAQT 252 (382)
T ss_pred hHHHHHHHhCCCCCCCCC
Confidence 999999999999998644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=300.45 Aligned_cols=199 Identities=23% Similarity=0.310 Sum_probs=176.0
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|+..+.||+|+||.||+|+.. +++.||+|.++... .......+.+|++++++++||||+++++++...+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888999999999999999965 57899999986431 2234567899999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999875 34578899999999999999999999 999999999999999999999999999986643
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.. ....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 219 (329)
T PTZ00263 171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT 219 (329)
T ss_pred Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC
Confidence 22 23568999999999999999999999999999999999999997543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=300.87 Aligned_cols=208 Identities=23% Similarity=0.353 Sum_probs=180.5
Q ss_pred HHHhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 267 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
+.+.+...+.++||+|.||.|.++....+..||||+++.........+|.+|+++|.+++||||++++|+|..++..+++
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 34556677789999999999999999888999999999877777789999999999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
+|||++|+|..++...... ...-....+|+.||+.||+||.+. ++||||+.++|+|+|.++++||+|||+++.+-
T Consensus 614 ~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence 9999999999999864321 145556678999999999999998 99999999999999999999999999999654
Q ss_pred ccCccee-ecccccccccCcccccCCCCCCcccchhHHHHHHHHHh--CCCCCCCC
Q 010887 427 AKLTHVT-TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT--GQRAIDFS 479 (498)
Q Consensus 427 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt--G~~p~~~~ 479 (498)
....+.. ....-..+|||||.+..++++.++|||+|||++||+++ ...||...
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l 744 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL 744 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh
Confidence 4433332 33344679999999999999999999999999999876 67788743
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=296.52 Aligned_cols=199 Identities=24% Similarity=0.291 Sum_probs=175.1
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|+..+.||+|+||.||+|... +++.||+|++.... .......+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999965 68899999986321 2234567889999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++|+|.+++.. ...+++.....++.|++.||+|||+. +++||||||+||++++++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999998875 34689999999999999999999999 999999999999999999999999999886643
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
. .....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~ 202 (291)
T cd05612 154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202 (291)
T ss_pred C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 123458999999999999889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=298.52 Aligned_cols=196 Identities=23% Similarity=0.280 Sum_probs=170.5
Q ss_pred CeeecccceEEEEEEE-cCCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCC
Q 010887 277 NIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 353 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 353 (498)
+.||+|+||.||+++. .+++.||+|+++... .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999996 468899999987432 2344567889999999999999999999999999999999999999
Q ss_pred CHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCccee
Q 010887 354 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 433 (498)
Q Consensus 354 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~~ 433 (498)
+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~ 152 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccc
Confidence 99988875 34689999999999999999999999 99999999999999999999999999987543221 122
Q ss_pred ecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 434 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 434 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
....||+.|+|||++.+..++.++|||||||++|||+||+.||...+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 199 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC
Confidence 34568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=307.21 Aligned_cols=211 Identities=28% Similarity=0.401 Sum_probs=179.3
Q ss_pred HHHHHHhcCCCCCCeeecccceEEEEEEEcC--C--cE-EEEEEecc--cCCcchHHHHHHHHHHHHhccCCccceEEEE
Q 010887 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSD--N--TK-VAVKRLQD--YYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336 (498)
Q Consensus 264 ~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--~--~~-vavK~~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 336 (498)
..|+..-++....++||+|+||.||+|++.. + .. ||||..+. ........+|.+|.++|++++|||||+++|+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3455555666667999999999999999653 2 23 89999984 3456778999999999999999999999999
Q ss_pred EEcCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEE
Q 010887 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL 416 (498)
Q Consensus 337 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki 416 (498)
+......++|||+++||+|.++|+... ..++..++..++.++|+||+|||+. +++||||.++|+|++.+..+||
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKI 303 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKI 303 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEe
Confidence 999999999999999999999999743 2599999999999999999999999 9999999999999999999999
Q ss_pred eecCccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcc
Q 010887 417 CDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRL 481 (498)
Q Consensus 417 ~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~~ 481 (498)
+|||+++.-..-.. ......-...|+|||.+..+.|+.++|||||||++||+++ |..||.....
T Consensus 304 SDFGLs~~~~~~~~-~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~ 368 (474)
T KOG0194|consen 304 SDFGLSRAGSQYVM-KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN 368 (474)
T ss_pred CccccccCCcceee-ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH
Confidence 99999875541111 1111124578999999999999999999999999999999 8999986543
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=307.51 Aligned_cols=203 Identities=23% Similarity=0.242 Sum_probs=173.6
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
+|++.+.||+|+||.||+|+.. +++.||+|++.... .......+.+|++++++++||||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999954 58899999986421 22345678899999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++|+|.+++.. ...++...+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..+...
T Consensus 82 ~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 82 YIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999875 34578899999999999999999999 9999999999999999999999999997532100
Q ss_pred C------------------------------------------cceeecccccccccCcccccCCCCCCcccchhHHHHH
Q 010887 429 L------------------------------------------THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITL 466 (498)
Q Consensus 429 ~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl 466 (498)
. ........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 0001134689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCcc
Q 010887 467 LELVTGQRAIDFSRL 481 (498)
Q Consensus 467 ~elltG~~p~~~~~~ 481 (498)
|||+||+.||.....
T Consensus 235 yell~G~~Pf~~~~~ 249 (376)
T cd05598 235 YEMLVGQPPFLADTP 249 (376)
T ss_pred eehhhCCCCCCCCCH
Confidence 999999999986543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=303.72 Aligned_cols=210 Identities=21% Similarity=0.292 Sum_probs=179.5
Q ss_pred HHHHHHHhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCccceEEEEEEc
Q 010887 263 CRELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT 339 (498)
Q Consensus 263 ~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 339 (498)
.+++....++|+..+.||+|+||.||+++.. +++.+|+|++... ........+.+|+++++.++||||+++++.+..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3455566789999999999999999999965 5788999998632 222345567889999999999999999999999
Q ss_pred CCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeec
Q 010887 340 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 419 (498)
Q Consensus 340 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~Df 419 (498)
....++||||+++|+|.+++.. ..++...+..++.|++.||+|||+. +|+||||||+||++++++++||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999998864 2478888999999999999999999 9999999999999999999999999
Q ss_pred CccccccccCcceeecccccccccCcccccCC----CCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG----KSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 420 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
|+++..............||+.|+|||++... .++.++|||||||++|||++|+.||....
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 251 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence 99987654333233446699999999998654 37889999999999999999999998654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=287.34 Aligned_cols=198 Identities=26% Similarity=0.407 Sum_probs=168.2
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCc-----eEE
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE-----RIL 345 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----~~l 345 (498)
.|...+++|.|+||.||+|... +++.||||++..... --.+|+++|++++|||||+++.++....+ ..+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 3555789999999999999954 578999999864321 22479999999999999999998865432 358
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCC-CcEEEeecCcccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAKL 424 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~ki~DfGl~~~ 424 (498)
|+|||+. +|.+.++.+...+..++...++-+..||.+||+|||+. +|+||||||.|+|+|.+ |.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999985 89999987766677888889999999999999999998 99999999999999977 8999999999998
Q ss_pred ccccCcceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 425 VDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+...... .....|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|...+
T Consensus 176 L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s 230 (364)
T KOG0658|consen 176 LVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS 230 (364)
T ss_pred eccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC
Confidence 8765544 344568999999999875 58999999999999999999999998643
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=282.60 Aligned_cols=205 Identities=26% Similarity=0.362 Sum_probs=175.4
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCC-cchHHHHHHHHHHHHhccCCc-cceEEEEEEcCC------
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKN-LLQLIGYCTTSS------ 341 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~------ 341 (498)
..|+..++||+|+||+||+|+. .+|+.||+|+++-... ++......+|+.+++.++|+| |+++.+++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 3466677899999999999994 5788999999985433 455667789999999999999 999999998877
Q ss_pred ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCc
Q 010887 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (498)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl 421 (498)
..++|+||++. +|..++.........++...++.++.||++||+|||++ +|+||||||.|||++++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 67899999964 88888886554335677789999999999999999999 999999999999999999999999999
Q ss_pred cccccccCcceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
|+...-+... .....+|..|+|||++.+. .|+...||||+|||+.||++++.-|+...
T Consensus 167 Ara~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s 225 (323)
T KOG0594|consen 167 ARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS 225 (323)
T ss_pred HHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc
Confidence 9977644333 2345579999999999876 68999999999999999999999998654
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=295.78 Aligned_cols=196 Identities=23% Similarity=0.293 Sum_probs=169.9
Q ss_pred CeeecccceEEEEEEE-cCCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCC
Q 010887 277 NIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 353 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 353 (498)
+.||+|+||.||+++. .+++.||+|+++... .......+.+|+++++.++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4689999999999996 468999999987432 2334567788999999999999999999999999999999999999
Q ss_pred CHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCccee
Q 010887 354 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 433 (498)
Q Consensus 354 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~~ 433 (498)
+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~ 152 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-cc
Confidence 99888865 34689999999999999999999999 999999999999999999999999999875432211 12
Q ss_pred ecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 434 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 434 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
....||+.|+|||++.+..++.++|||||||++|||+||+.||...+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 199 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence 33568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=294.91 Aligned_cols=194 Identities=27% Similarity=0.311 Sum_probs=169.6
Q ss_pred eecccceEEEEEEEc-CCcEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCCCH
Q 010887 279 IGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV 355 (498)
Q Consensus 279 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 355 (498)
||+|+||.||+|+.. +++.||+|+++.. ........+.+|++++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999965 5788999998642 2334567788999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcceeec
Q 010887 356 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 435 (498)
Q Consensus 356 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~~~~ 435 (498)
.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 998875 34589999999999999999999999 99999999999999999999999999987543222 12234
Q ss_pred ccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 436 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 436 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
..||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~ 197 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN 197 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC
Confidence 568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=303.90 Aligned_cols=205 Identities=22% Similarity=0.290 Sum_probs=175.3
Q ss_pred HHhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceE
Q 010887 268 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (498)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (498)
...++|+..+.||+|+||.||+++.. +++.||+|++... ........+.+|+++++.++||||+++++++.+....+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34568999999999999999999964 6889999998632 22234456788999999999999999999999999999
Q ss_pred EEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccc
Q 010887 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~ 424 (498)
+||||+++|+|.+++.. ..++...+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++..
T Consensus 120 lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 99999999999998864 2478888899999999999999999 999999999999999999999999999986
Q ss_pred ccccCcceeecccccccccCcccccCC----CCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 425 VDAKLTHVTTQIRGTMGHIAPEYLSTG----KSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.............||+.|+|||++... .++.++|||||||++|||+||+.||....
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 251 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence 654322223345689999999998653 47889999999999999999999997644
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=295.01 Aligned_cols=196 Identities=24% Similarity=0.306 Sum_probs=170.6
Q ss_pred CeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCC
Q 010887 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 353 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 353 (498)
+.||+|+||.||+++.. +++.||+|+++... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999954 68899999997432 2344567889999999999999999999999999999999999999
Q ss_pred CHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCccee
Q 010887 354 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 433 (498)
Q Consensus 354 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~~ 433 (498)
+|..++.. ...+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~ 152 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TM 152 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-cc
Confidence 99888865 34689999999999999999999999 999999999999999999999999999875432211 22
Q ss_pred ecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 434 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 434 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
....||+.|+|||++.+..++.++|||||||++|||+||+.||...+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~ 199 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC
Confidence 34568999999999999899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=289.70 Aligned_cols=202 Identities=22% Similarity=0.328 Sum_probs=174.2
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
++|++.+.||+|+||.||+++.. +++.||+|+++... .+.....+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999975 57889999987432 23445678899999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|++++.+...... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 9998877654332 34589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.........|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~ 204 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE 204 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence 322233456899999999999889999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=296.90 Aligned_cols=204 Identities=23% Similarity=0.303 Sum_probs=175.3
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|...+.||+|+||.||+++.. +++.||+|.+... ........+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47888999999999999999965 5788999998642 22234556888999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999752 24588999999999999999999999 999999999999999999999999999986654
Q ss_pred cCcceeecccccccccCcccccC-----CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLST-----GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
..........||+.|+|||++.+ +.++.++|||||||++|||+||+.||....
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 212 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence 33322334568999999999865 467889999999999999999999997543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=302.55 Aligned_cols=204 Identities=22% Similarity=0.274 Sum_probs=175.6
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|+..+.||+|+||.||+++.. +++.||+|+++.. ........+.+|++++.+++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999965 5889999998632 12334567888999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999875 34689999999999999999999999 999999999999999999999999999875432
Q ss_pred cCc----------------------------------ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCC
Q 010887 428 KLT----------------------------------HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473 (498)
Q Consensus 428 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~ 473 (498)
... .......||+.|+|||++.+..++.++|||||||++|||+||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 100 0012346899999999999999999999999999999999999
Q ss_pred CCCCCCcc
Q 010887 474 RAIDFSRL 481 (498)
Q Consensus 474 ~p~~~~~~ 481 (498)
.||.....
T Consensus 234 ~Pf~~~~~ 241 (360)
T cd05627 234 PPFCSETP 241 (360)
T ss_pred CCCCCCCH
Confidence 99976543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=295.34 Aligned_cols=204 Identities=23% Similarity=0.309 Sum_probs=174.8
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|++.+.||+|+||.||+++.. +++.||+|++... ........+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999964 5889999998632 22334567889999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++|+|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 999999999998642 24588999999999999999999999 999999999999999999999999999876654
Q ss_pred cCcceeecccccccccCcccccC-----CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLST-----GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
..........||+.|+|||++.. ..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~ 212 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence 33322333468999999999863 457889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=301.60 Aligned_cols=204 Identities=25% Similarity=0.277 Sum_probs=178.6
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|.+.+.||+|+||+||+|+.. +++.||+|+++... .......+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999965 68999999987432 2245677899999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999998763 4689999999999999999999998 999999999999999999999999999986654
Q ss_pred cC----------------------------cceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 428 KL----------------------------THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 428 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 11123356899999999999999999999999999999999999999865
Q ss_pred cc
Q 010887 480 RL 481 (498)
Q Consensus 480 ~~ 481 (498)
..
T Consensus 234 ~~ 235 (350)
T cd05573 234 TL 235 (350)
T ss_pred CH
Confidence 43
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=289.19 Aligned_cols=202 Identities=27% Similarity=0.386 Sum_probs=172.6
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
++|+..+.||+|+||.||+|+.. +++.||+|+++..........+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888999999999999999965 68899999987544444556788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++ +|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 985 888887642 23578999999999999999999999 99999999999999999999999999987654322
Q ss_pred cceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 430 THVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.. .....+++.|+|||.+.+ ..++.++||||+||++|||+||+.||....
T Consensus 158 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~ 208 (288)
T cd07871 158 KT-YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST 208 (288)
T ss_pred cc-ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 11 223457899999998865 568999999999999999999999997644
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=270.84 Aligned_cols=205 Identities=25% Similarity=0.356 Sum_probs=181.2
Q ss_pred HhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
+.++|++.+.||+|.||.||.|+. +++..||+|++-+.. ..+...++.+|+++-+.++||||+++++++.++...|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 456899999999999999999995 467789999986432 23446789999999999999999999999999999999
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
++||..+|++...|.+.. ...++......++.|+|.|+.|+|.. +++||||||+|+|++.++..||+|||.+-..
T Consensus 100 ilEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 999999999999998533 45688888899999999999999999 9999999999999999999999999997644
Q ss_pred cccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCcc
Q 010887 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRL 481 (498)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~~ 481 (498)
+ .......+||..|.+||...+...+...|+|++||+.||++.|.+||.....
T Consensus 175 p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~ 227 (281)
T KOG0580|consen 175 P---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH 227 (281)
T ss_pred C---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh
Confidence 3 2234567899999999999999999999999999999999999999986553
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=293.75 Aligned_cols=202 Identities=25% Similarity=0.372 Sum_probs=177.4
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.++|+..+.||+|+||.||+++.. ++..+|+|.+.....+.....+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468899999999999999999965 5788999988754444556789999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.. +|+||||||+||++++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999875 345899999999999999999999852 5999999999999999999999999998765432
Q ss_pred CcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
. .....|++.|+|||++.+..++.++|||||||++|||+||+.||...+
T Consensus 158 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 206 (331)
T cd06649 158 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206 (331)
T ss_pred c---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 233468999999999999999999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=295.06 Aligned_cols=200 Identities=25% Similarity=0.305 Sum_probs=171.8
Q ss_pred CCCCCCeeecccceEEEEEEE----cCCcEEEEEEecccC---CcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCce
Q 010887 272 NFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY---SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER 343 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 343 (498)
+|++.+.||+|+||.||+++. .+++.||+|+++... .......+.+|++++..+ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999985 357899999986421 223345678899999999 499999999999999999
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999998875 34589999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCcceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
..............||+.|+|||++.+. .++.++|||||||++|||+||+.||..
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 6544333333445689999999998765 478899999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=285.78 Aligned_cols=205 Identities=23% Similarity=0.326 Sum_probs=175.1
Q ss_pred hcCCCCCCeeecccceEEEEEEEc----CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
.++|++.+.||+|+||.||+|.+. .+..||+|+++...+......|.+|++.+++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 456888999999999999999853 3568999999866555566789999999999999999999999999999999
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999998752 24689999999999999999999999 9999999999999999999999999987654
Q ss_pred cccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
............++..|+|||.+.+..++.++|||||||++||+++ |+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~ 213 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence 3222111122335678999999999999999999999999999775 999997543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=298.97 Aligned_cols=200 Identities=25% Similarity=0.312 Sum_probs=179.4
Q ss_pred CCCCCCeeecccceEEEEEE-EcCCcEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 272 NFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
-|...+.||.|+.|.|..|+ ..+|+.+|||++... .+......+++|+-+|+.+.|||++++++++.+..+.|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 46678899999999999999 468999999999743 344456778999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++|.|.+++-. .+++++.++.+++.||..|+.|+|.. +|+||||||+|+|+|..+++||+|||+|....++
T Consensus 93 yv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 93 YVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred ecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 9999999999986 56799999999999999999999999 9999999999999999999999999999866543
Q ss_pred CcceeecccccccccCcccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
. .-...+|++.|.|||++.+.+| ..++||||.||||+-||||+.|||.+.
T Consensus 166 k--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN 216 (786)
T KOG0588|consen 166 K--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN 216 (786)
T ss_pred c--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc
Confidence 2 3345789999999999999998 568999999999999999999999543
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=291.95 Aligned_cols=196 Identities=28% Similarity=0.345 Sum_probs=169.0
Q ss_pred CeeecccceEEEEEEE----cCCcEEEEEEecccC---CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 277 NIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY---SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
+.||+|+||.||+++. .+++.||+|+++... .......+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 357889999987421 223445678899999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++++|.+++.. ...+.+..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999998875 34578888999999999999999999 99999999999999999999999999987543222
Q ss_pred cceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~ 204 (323)
T cd05584 155 T-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204 (323)
T ss_pred C-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence 1 2233568999999999998889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=294.73 Aligned_cols=204 Identities=23% Similarity=0.305 Sum_probs=174.1
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|+..+.||+|+||.||+++.+ +++.+|+|++... ........+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999965 4678999998632 12233456888999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999752 24589999999999999999999999 999999999999999999999999999876543
Q ss_pred cCcceeecccccccccCccccc-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~ 212 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence 3332333456899999999986 3467899999999999999999999997543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=292.15 Aligned_cols=201 Identities=25% Similarity=0.330 Sum_probs=171.6
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCceEEEE
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 347 (498)
+|+..+.||+|+||.||+|+.. +++.||+|.++... .......+..|.+++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999965 56799999987432 223445677788888777 5889999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++|+|...+.. ...+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999988865 34589999999999999999999999 999999999999999999999999999875432
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~ 205 (323)
T cd05616 154 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205 (323)
T ss_pred CCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC
Confidence 211 2234568999999999999999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=291.62 Aligned_cols=201 Identities=25% Similarity=0.325 Sum_probs=171.7
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCC-ccceEEEEEEcCCceEEEE
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHK-NLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 347 (498)
+|+..+.||+|+||.||+|+.. +++.||+|+++... .......+..|.+++..+.|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999965 56789999987432 234556788899999999765 5888889999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999988875 34588999999999999999999999 999999999999999999999999999874322
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (324)
T cd05587 154 GGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205 (324)
T ss_pred CCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 211 2234568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=288.35 Aligned_cols=206 Identities=23% Similarity=0.366 Sum_probs=172.5
Q ss_pred hcCCCCCCeeecccceEEEEEEEcC-----------------CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccce
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLSD-----------------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 332 (498)
.++|...+.||+|+||.||++.+++ +..||+|.++.........+|.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578889999999999999998533 23699999876544455678999999999999999999
Q ss_pred EEEEEEcCCceEEEEecccCCCHHHhhcccCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcE
Q 010887 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 397 (498)
Q Consensus 333 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iv 397 (498)
+++++.+.+..++||||+++|+|.+++..... ....+++....+++.|++.||+|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 99999999999999999999999998864211 123578899999999999999999999 999
Q ss_pred EcCCCCCcEEECCCCcEEEeecCccccccccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh--CCC
Q 010887 398 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT--GQR 474 (498)
Q Consensus 398 H~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt--G~~ 474 (498)
||||||+||++++++.+||+|||+++........ ......++..|+|||++..+.++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999866443221 1222345788999999988899999999999999999997 456
Q ss_pred CCCC
Q 010887 475 AIDF 478 (498)
Q Consensus 475 p~~~ 478 (498)
||..
T Consensus 241 p~~~ 244 (304)
T cd05096 241 PYGE 244 (304)
T ss_pred CCCc
Confidence 6654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=291.68 Aligned_cols=194 Identities=26% Similarity=0.355 Sum_probs=168.4
Q ss_pred CeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCceEEEEecccC
Q 010887 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFMQN 352 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (498)
+.||+|+||.||+|+.. +++.||+|+++... .......+.+|..++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999964 67899999997432 223456688899999988 699999999999999999999999999
Q ss_pred CCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcce
Q 010887 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (498)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~ 432 (498)
|+|..++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DT 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cc
Confidence 999888764 34689999999999999999999999 99999999999999999999999999987432211 12
Q ss_pred eecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 2345689999999999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=290.44 Aligned_cols=196 Identities=27% Similarity=0.375 Sum_probs=166.7
Q ss_pred CeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHh-ccCCccceEEEEEEcCCceEEEEecccC
Q 010887 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISV-AIHKNLLQLIGYCTTSSERILVYPFMQN 352 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (498)
+.||+|+||.||+|+.. +++.||+|+++... .......+..|.+++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 57889999987432 22344556667777765 4899999999999999999999999999
Q ss_pred CCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcce
Q 010887 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (498)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~ 432 (498)
|+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 999988875 34589999999999999999999999 99999999999999999999999999987543322 22
Q ss_pred eecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~ 200 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Confidence 334568999999999999899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=296.63 Aligned_cols=204 Identities=22% Similarity=0.276 Sum_probs=176.7
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|+..+.||+|+||.||+++.. +++.||+|+++... .......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999964 68899999997432 2334567889999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999998753 24689999999999999999999999 999999999999999999999999999987654
Q ss_pred cCcceeecccccccccCccccc------CCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLS------TGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
..........||+.|+|||++. ...++.++|||||||++|||+||+.||....
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 213 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence 4333333456899999999986 4567899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=284.67 Aligned_cols=197 Identities=26% Similarity=0.380 Sum_probs=170.3
Q ss_pred eecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCCCH
Q 010887 279 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV 355 (498)
Q Consensus 279 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 355 (498)
||+|+||+||++... +++.||+|.+.... .......+..|++++++++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999964 68899999986432 122346678899999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcceeec
Q 010887 356 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 435 (498)
Q Consensus 356 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~~~~ 435 (498)
...+.........+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988865444456799999999999999999999999 999999999999999999999999999876644322 1233
Q ss_pred ccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 436 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 436 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
..||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 56899999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=291.11 Aligned_cols=194 Identities=26% Similarity=0.354 Sum_probs=167.5
Q ss_pred CeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCceEEEEecccC
Q 010887 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFMQN 352 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (498)
+.||+|+||.||+|+.. +++.||+|+++... .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 57899999987432 223456678888888876 799999999999999999999999999
Q ss_pred CCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcce
Q 010887 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (498)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~ 432 (498)
|+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~ 152 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-T 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-c
Confidence 999888764 34689999999999999999999999 999999999999999999999999999875432211 2
Q ss_pred eecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 2345689999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=283.14 Aligned_cols=201 Identities=22% Similarity=0.356 Sum_probs=182.3
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
.+|++.+.||+|.||.|-+|.. ..|+.||||.+++. .++++.-.+.+|+++|+.++||||+.++++|.+.+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4677889999999999999995 67999999999754 34456677899999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||..+|.|.+++.+ .+.+++.++.++++||..|+.|+|.+ +++|||||.+|||+|.++++||+|||++..+..
T Consensus 133 EYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 133 EYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999987 45799999999999999999999999 999999999999999999999999999988765
Q ss_pred cCcceeecccccccccCcccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
. ..-+.++|++-|.+||++.+.+| .+..|-||+||+||-|+-|.-|||..+
T Consensus 206 ~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D 257 (668)
T KOG0611|consen 206 K--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD 257 (668)
T ss_pred c--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch
Confidence 3 23466889999999999999998 568999999999999999999999754
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=292.62 Aligned_cols=196 Identities=23% Similarity=0.292 Sum_probs=169.2
Q ss_pred CeeecccceEEEEEEE-cCCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCC
Q 010887 277 NIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 353 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 353 (498)
+.||+|+||.||+++. .+++.||+|.++... .......+.+|++++..++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4689999999999995 468899999987432 2234567788999999999999999999999999999999999999
Q ss_pred CHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcce
Q 010887 354 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (498)
Q Consensus 354 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~ 432 (498)
+|..++.. ...+++..+..++.|++.||+|||+ . +|+||||||+||++++++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T 152 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence 99888864 3468999999999999999999997 6 899999999999999999999999999875432211 1
Q ss_pred eecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~ 200 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 200 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC
Confidence 233568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=296.57 Aligned_cols=210 Identities=28% Similarity=0.406 Sum_probs=176.1
Q ss_pred HHHhcCCCCCCeeecccceEEEEEEE------cCCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEEc
Q 010887 267 QLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT 339 (498)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 339 (498)
....++|+..+.||+|+||.||+|.. .++..||||+++..........+.+|+++++.+ +||||+++++++..
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 33456788899999999999999973 235689999997554445567889999999999 89999999999999
Q ss_pred CCceEEEEecccCCCHHHhhcccCC-------------------------------------------------------
Q 010887 340 SSERILVYPFMQNLSVAYRLRDLKP------------------------------------------------------- 364 (498)
Q Consensus 340 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 364 (498)
.+..++||||+++|+|.++++....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 9999999999999999998864221
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 365 ----------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 365 ----------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
....+++..+..++.||++||+|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 112578999999999999999999998 9999999999999999999999999999866443
Q ss_pred Ccce-eecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 429 LTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 429 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
.... .....++..|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence 2211 112334567999999999999999999999999999998 88898653
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=287.23 Aligned_cols=201 Identities=27% Similarity=0.380 Sum_probs=171.4
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.++|+..+.||+|+||.||+|+.. +++.||+|+++..........+.+|++++++++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367899999999999999999965 6889999998754444445667899999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|++ +++.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 996 5777776542 34588999999999999999999999 9999999999999999999999999998754332
Q ss_pred CcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 429 LTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
.. ......+++.|+|||++.+ ..++.++||||+||++|||+||+.||..
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 157 SH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred Cc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 21 2233457899999998865 4578899999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=297.06 Aligned_cols=211 Identities=28% Similarity=0.416 Sum_probs=176.5
Q ss_pred HHHHhcCCCCCCeeecccceEEEEEEEc------CCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEE
Q 010887 266 LQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT 338 (498)
Q Consensus 266 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 338 (498)
+....++|+..+.||+|+||.||+|+.. ++..||+|+++..........+.+|+++++.+ +|+||+++++++.
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 3445668999999999999999999842 23579999997655445567789999999999 8999999999999
Q ss_pred cCCceEEEEecccCCCHHHhhcccCC------------------------------------------------------
Q 010887 339 TSSERILVYPFMQNLSVAYRLRDLKP------------------------------------------------------ 364 (498)
Q Consensus 339 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------ 364 (498)
..+..++||||+++|+|.++++....
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 99999999999999999998853210
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcce
Q 010887 365 ------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (498)
Q Consensus 365 ------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~ 432 (498)
....+++.++.+++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.........
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence 113478899999999999999999999 99999999999999999999999999997654332211
Q ss_pred -eecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 433 -TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 433 -~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~ 318 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI 318 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccc
Confidence 122335568999999998899999999999999999998 99999754
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=289.84 Aligned_cols=196 Identities=28% Similarity=0.367 Sum_probs=168.9
Q ss_pred CeeecccceEEEEEEEc-CCcEEEEEEeccc--CCcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCceEEEEecccC
Q 010887 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFMQN 352 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (498)
+.||+|+||.||+|+.. +++.||+|+++.. ........+.+|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999965 5789999998743 2234556778888888876 699999999999999999999999999
Q ss_pred CCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcce
Q 010887 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (498)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~ 432 (498)
|+|..++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~ 152 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT 152 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence 999988875 34589999999999999999999999 99999999999999999999999999987543221 12
Q ss_pred eecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 200 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 234568999999999999899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=289.98 Aligned_cols=196 Identities=27% Similarity=0.377 Sum_probs=168.8
Q ss_pred CeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCceEEEEecccC
Q 010887 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFMQN 352 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (498)
+.||+|+||.||+|+.. +++.||+|+++... .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46899999999999965 57899999987432 234456678899988866 799999999999999999999999999
Q ss_pred CCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcce
Q 010887 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (498)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~ 432 (498)
|+|...+.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-T 152 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-c
Confidence 999988865 34589999999999999999999999 999999999999999999999999999875432221 2
Q ss_pred eecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 200 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC
Confidence 234568999999999999899999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=290.26 Aligned_cols=199 Identities=26% Similarity=0.342 Sum_probs=168.9
Q ss_pred CCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHH---HhccCCccceEEEEEEcCCceEEE
Q 010887 273 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLI---SVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
|++.+.||+|+||.||+|... +++.||+|+++... .......+.+|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999964 68899999997432 223345666676655 466799999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|||+++++|...++. ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999887753 3589999999999999999999999 99999999999999999999999999987543
Q ss_pred ccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 153 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~ 205 (324)
T cd05589 153 GFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205 (324)
T ss_pred CCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Confidence 221 12234568999999999999999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=290.84 Aligned_cols=202 Identities=25% Similarity=0.376 Sum_probs=176.8
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.++|+..+.||+|+||.||++... ++..+|+|.++....+.....+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999965 5788999988754444456779999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++++|.+++.. ...+++.....++.|++.||.|||+.. +++||||||+||++++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999875 345889999999999999999999742 6999999999999999999999999998765432
Q ss_pred CcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.||+...
T Consensus 158 ~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 158 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred c---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 1 223458899999999998889999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=281.81 Aligned_cols=207 Identities=17% Similarity=0.284 Sum_probs=172.1
Q ss_pred ccccCHHHHHHHhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCc--chHHHHHHHHHHHHhccCCccceEEE
Q 010887 258 LRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP--GGEAAFQREVHLISVAIHKNLLQLIG 335 (498)
Q Consensus 258 ~~~~~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~ 335 (498)
++.++.+++ +......||+|++|.||+|.+ +++.||||+++..... ...+.|.+|++++++++||||+++++
T Consensus 12 ~~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g 85 (283)
T PHA02988 12 IKCIESDDI-----DKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85 (283)
T ss_pred ceecCHHHc-----CCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence 344455554 222346899999999999998 7899999999754221 12477889999999999999999999
Q ss_pred EEEc----CCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCC
Q 010887 336 YCTT----SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN 411 (498)
Q Consensus 336 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~ 411 (498)
++.+ ....++||||+++|+|.+++.. ...+++.....++.+++.||.|||+.. +++||||||+||+++++
T Consensus 86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~ 159 (283)
T PHA02988 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTEN 159 (283)
T ss_pred eEEecccCCCceEEEEEeCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCC
Confidence 9876 3467899999999999999875 346899999999999999999999732 67899999999999999
Q ss_pred CcEEEeecCccccccccCcceeecccccccccCcccccC--CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 412 FEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 412 ~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+.+||+|||+++...... ....++..|+|||++.+ ..++.++|||||||++|||+||+.||+...
T Consensus 160 ~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~ 226 (283)
T PHA02988 160 YKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226 (283)
T ss_pred CcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence 999999999988654322 22347889999999976 689999999999999999999999998654
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=283.24 Aligned_cols=205 Identities=27% Similarity=0.333 Sum_probs=169.1
Q ss_pred HhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCC-------------cchHHHHHHHHHHHHhccCCccceEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYS-------------PGGEAAFQREVHLISVAIHKNLLQLI 334 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~niv~l~ 334 (498)
..++|+..+.||+|.||.|-+|+. .+++.||+|++.+... -...+...+|+.+|++++|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 457899999999999999999995 4789999999853210 01235788999999999999999999
Q ss_pred EEEEcC--CceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCC
Q 010887 335 GYCTTS--SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF 412 (498)
Q Consensus 335 ~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~ 412 (498)
++..+. +..|+|+||+..|.+...-.+ ...++..+++++++++..||+|||.+ +|+||||||+|+|++++|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d----~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPD----KPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCC----cccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence 999765 468999999999886543222 22399999999999999999999999 999999999999999999
Q ss_pred cEEEeecCccccccccCcc----eeecccccccccCcccccCCC----CCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 413 EAVLCDFGLAKLVDAKLTH----VTTQIRGTMGHIAPEYLSTGK----SSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 413 ~~ki~DfGl~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
++||+|||.+......... .-....||+.|+|||...++. .+.+.||||+||+||.|+.|+.||-...
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~ 323 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF 323 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence 9999999999876332111 112366999999999998743 3567899999999999999999997654
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=282.17 Aligned_cols=202 Identities=28% Similarity=0.408 Sum_probs=168.0
Q ss_pred cCCCCCCeeecccceEEEEEEEc--CCcEEEEEEecccC-CcchHHHHHHHHHHHHhc---cCCccceEEEEEEc-----
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS--DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVA---IHKNLLQLIGYCTT----- 339 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~----- 339 (498)
++|+..+.||+|+||.||+|+.. +++.||+|+++... .......+.+|+++++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 46789999987433 223345667788777765 69999999998853
Q ss_pred CCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeec
Q 010887 340 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 419 (498)
Q Consensus 340 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~Df 419 (498)
....++|+||++ ++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 345789999997 68888887532 34589999999999999999999999 9999999999999999999999999
Q ss_pred CccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 420 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
|+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 213 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence 999766543 22334568999999999988899999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=295.72 Aligned_cols=194 Identities=24% Similarity=0.325 Sum_probs=168.5
Q ss_pred HhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
..++|+..+.||+|+||.||++.. .+++.||+|... ...+.+|++++++++||||+++++++......++|+
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 346799999999999999999996 467899999643 235678999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
|++. ++|..++.. ...+++.+++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 163 e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 163 PRYK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234 (391)
T ss_pred ecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence 9985 688877764 34589999999999999999999999 999999999999999999999999999975433
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 477 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~ 477 (498)
..........||+.|+|||++.+..++.++|||||||++|||+||+.||-
T Consensus 235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 22222334568999999999999999999999999999999999998764
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=286.14 Aligned_cols=196 Identities=28% Similarity=0.379 Sum_probs=167.5
Q ss_pred CeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHh-ccCCccceEEEEEEcCCceEEEEecccC
Q 010887 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISV-AIHKNLLQLIGYCTTSSERILVYPFMQN 352 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (498)
+.||+|+||.||+|+.. +++.||+|+++... .......+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46899999999999965 57889999987432 22344566778888876 4899999999999999999999999999
Q ss_pred CCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcce
Q 010887 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (498)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~ 432 (498)
|+|.+++.. ...+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-K 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-c
Confidence 999998875 34588999999999999999999999 999999999999999999999999999875322211 2
Q ss_pred eecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Confidence 234568999999999999899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=288.25 Aligned_cols=201 Identities=25% Similarity=0.332 Sum_probs=171.3
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhcc-CCccceEEEEEEcCCceEEEE
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 347 (498)
+|+..+.||+|+||.||+|... +++.||+|+++... .......+..|.+++..+. |++|+++.+++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667899999999999999964 68899999987432 2334566788999988886 567888999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999998865 34589999999999999999999999 999999999999999999999999999875432
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (323)
T cd05615 154 DG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205 (323)
T ss_pred CC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Confidence 21 12234568999999999999899999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=298.01 Aligned_cols=202 Identities=27% Similarity=0.366 Sum_probs=177.8
Q ss_pred CCCCCeeecccceEEEEEE-EcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcC------CceEE
Q 010887 273 FSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------SERIL 345 (498)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~l 345 (498)
|...+.||+|+||.||+|+ -..|+.||||.++........+...+|++++++++|+|||++++.-.+. ..+.+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 4456789999999999999 4579999999999777777888999999999999999999999876543 36789
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEE--CCCC--cEEEeecCc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL--DDNF--EAVLCDFGL 421 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl--~~~~--~~ki~DfGl 421 (498)
|||||.+|||...+.+.. +..++++.+.+.+..+++.||.|||++ +|+||||||.||++ .++| .-||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 999999999999998644 456799999999999999999999998 99999999999988 3434 469999999
Q ss_pred cccccccCcceeecccccccccCccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLS-TGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
|+..+++. ....+.||..|.+||++. .+.|+..+|.|||||++||.+||..||.+..
T Consensus 171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 99887754 456788999999999998 4889999999999999999999999997644
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=305.06 Aligned_cols=209 Identities=24% Similarity=0.281 Sum_probs=178.5
Q ss_pred HhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCC-----
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS----- 341 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 341 (498)
..++|.+.+.||+|+||+||+|+. .+++.||+|++... .+......+.+|+..+..++|+|++++.+.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 456899999999999999999995 57899999998643 34455677889999999999999999988775432
Q ss_pred ---ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEee
Q 010887 342 ---ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 418 (498)
Q Consensus 342 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~D 418 (498)
..++||||+++|+|.+.++........+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEe
Confidence 25799999999999999986544456789999999999999999999999 999999999999999999999999
Q ss_pred cCccccccccCc-ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 419 FGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 419 fGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~ 249 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 999986653322 12234568999999999999999999999999999999999999997644
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=288.37 Aligned_cols=196 Identities=30% Similarity=0.343 Sum_probs=165.4
Q ss_pred CeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHH-HHHhccCCccceEEEEEEcCCceEEEEecccC
Q 010887 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVH-LISVAIHKNLLQLIGYCTTSSERILVYPFMQN 352 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (498)
+.||+|+||.||+|+.. +++.||+|++.... .......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 57899999986422 2223345555654 57889999999999999999999999999999
Q ss_pred CCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcce
Q 010887 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (498)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~ 432 (498)
++|...+.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET 152 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence 999888764 34588889999999999999999998 99999999999999999999999999987542221 12
Q ss_pred eecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence 234568999999999999899999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=288.25 Aligned_cols=196 Identities=30% Similarity=0.355 Sum_probs=165.9
Q ss_pred CeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHH-HHHhccCCccceEEEEEEcCCceEEEEecccC
Q 010887 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVH-LISVAIHKNLLQLIGYCTTSSERILVYPFMQN 352 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (498)
+.||+|+||+||+|+.. +++.||+|++.... .......+.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46899999999999964 68999999986422 2223345555555 45779999999999999999999999999999
Q ss_pred CCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcce
Q 010887 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (498)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~ 432 (498)
|+|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT 152 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence 999988875 34688999999999999999999999 99999999999999999999999999987543221 12
Q ss_pred eecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 200 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC
Confidence 234568999999999999999999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.29 Aligned_cols=205 Identities=20% Similarity=0.279 Sum_probs=176.1
Q ss_pred CCCCCCeeecccceEEEEEEEc-C-CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-D-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
.|...+.||+|++|.||+|... + ++.||+|.+.. ........+.+|+++++.++||||+++++++...+..++||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML-NDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc-CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 3778899999999999999854 3 56788887643 2334456778899999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++|+|.+++.........+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999998875443455789999999999999999999999 99999999999999999999999999998765432
Q ss_pred c-ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 430 T-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 430 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
. .......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~ 275 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 12334568999999999999999999999999999999999999997543
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=286.90 Aligned_cols=194 Identities=26% Similarity=0.359 Sum_probs=168.0
Q ss_pred CeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCceEEEEecccC
Q 010887 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFMQN 352 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (498)
+.||+|+||.||+|+.. +++.||+|+++... .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 57889999997532 223456688899999888 699999999999999999999999999
Q ss_pred CCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcce
Q 010887 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (498)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~ 432 (498)
|+|..++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DT 152 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cc
Confidence 999888764 34689999999999999999999999 99999999999999999999999999987532221 12
Q ss_pred eecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 2345689999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=280.78 Aligned_cols=201 Identities=27% Similarity=0.389 Sum_probs=173.5
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.|+..+.||+|+||+||++... +++.||+|.+.... .......+.+|+++++.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3677899999999999999964 68899999986422 22234567889999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 999999998886432 34689999999999999999999999 9999999999999999999999999998765432
Q ss_pred CcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~ 204 (285)
T cd05605 156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204 (285)
T ss_pred Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCC
Confidence 21 22346889999999999889999999999999999999999999854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=289.45 Aligned_cols=200 Identities=23% Similarity=0.412 Sum_probs=167.7
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCC-----ceE
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-----ERI 344 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 344 (498)
+|+..+.||+|+||.||+|+.. +++.||+|+++... .......+.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4777899999999999999954 68999999987432 2234567889999999999999999999886433 478
Q ss_pred EEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccc
Q 010887 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~ 424 (498)
+||||+. ++|.+.+.. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 688887764 34589999999999999999999999 999999999999999999999999999975
Q ss_pred ccccCcc--eeecccccccccCcccccC--CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 425 VDAKLTH--VTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 425 ~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
....... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~ 211 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 211 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 5322111 1133568999999999865 67899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=289.60 Aligned_cols=196 Identities=26% Similarity=0.322 Sum_probs=170.2
Q ss_pred CeeecccceEEEEEEE----cCCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEeccc
Q 010887 277 NIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQ 351 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 351 (498)
+.||+|+||.||+++. .+++.||+|+++... .......+.+|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999985 357899999987432 22344567889999999999999999999999999999999999
Q ss_pred CCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcc
Q 010887 352 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 431 (498)
Q Consensus 352 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~ 431 (498)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 9999998864 34589999999999999999999999 999999999999999999999999999876543322
Q ss_pred eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 432 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 432 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
......||+.|+|||.+....++.++|||||||++|||+||+.||....
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 202 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD 202 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC
Confidence 2234568999999999998889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=288.64 Aligned_cols=196 Identities=31% Similarity=0.369 Sum_probs=166.3
Q ss_pred CeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHH-HHHhccCCccceEEEEEEcCCceEEEEecccC
Q 010887 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVH-LISVAIHKNLLQLIGYCTTSSERILVYPFMQN 352 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (498)
+.||+|+||.||+|+.. +++.+|+|++.... .......+.+|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999954 68899999986432 2233455666655 46778999999999999999999999999999
Q ss_pred CCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcce
Q 010887 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (498)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~ 432 (498)
|+|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 152 (325)
T cd05604 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-T 152 (325)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-C
Confidence 999888764 34689999999999999999999999 999999999999999999999999999875432211 2
Q ss_pred eecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC
Confidence 234568999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=285.57 Aligned_cols=196 Identities=27% Similarity=0.356 Sum_probs=167.5
Q ss_pred CeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCceEEEEecccC
Q 010887 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFMQN 352 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (498)
+.||+|+||.||+|+.. +++.||+|.++... .......+..|.+++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999965 57899999987432 123455667788888754 899999999999999999999999999
Q ss_pred CCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcce
Q 010887 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (498)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~ 432 (498)
|+|..++.. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.++|+|||+++...... ..
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence 999988865 34588999999999999999999999 99999999999999999999999999987432211 12
Q ss_pred eecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~ 200 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 234568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=285.48 Aligned_cols=203 Identities=28% Similarity=0.443 Sum_probs=172.5
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCc----EEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
.+|+..+.||+|+||.||+|++. ++. .||+|+++..........+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999999999999864 333 38999987555555677899999999999999999999999765 5679
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
+++|+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence 99999999999998753 23588999999999999999999999 9999999999999999999999999999876
Q ss_pred cccCccee-ecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 426 DAKLTHVT-TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 426 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
........ ....++..|+|||++.+..++.++|||||||++|||+| |+.||+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~ 216 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 216 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 54332221 22234678999999999999999999999999999998 999997543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=291.29 Aligned_cols=196 Identities=23% Similarity=0.365 Sum_probs=166.0
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
++|+..+.||+|+||.||+|+.. +++.||+|++...........+.+|+++++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34556789999999999999964 68999999997554445567899999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++++|... ...++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 154 ~~~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 154 MDGGSLEGT--------HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred CCCCccccc--------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 999997542 2346677889999999999999999 99999999999999999999999999998665332
Q ss_pred cceeecccccccccCcccccC-----CCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 430 THVTTQIRGTMGHIAPEYLST-----GKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
. ......||..|+|||++.. ...+.++|||||||++|||++|+.||..
T Consensus 223 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 223 D-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred c-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 2 1233468999999998743 2345689999999999999999999974
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=275.94 Aligned_cols=202 Identities=27% Similarity=0.386 Sum_probs=174.5
Q ss_pred cCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecc
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (498)
++|+..+.||+|+||.||++.+.++..+|+|.++.. .....+|.+|++++++++||||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG--AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC--CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 457778999999999999999988889999987633 234568899999999999999999999999999999999999
Q ss_pred cCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCc
Q 010887 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (498)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~ 430 (498)
++|+|.++++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||.++.......
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 82 ENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999999988752 23589999999999999999999999 999999999999999999999999999886543322
Q ss_pred ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
.......++..|+|||...+..++.++||||||+++|||++ |+.||....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~ 206 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 22222335668999999998889999999999999999999 899997543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=286.31 Aligned_cols=201 Identities=28% Similarity=0.382 Sum_probs=179.9
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
..|+..+.||+|.||.||||.. ..++.||+|++.-.....+..+..+|+.++++++++||.++++.+..+...+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4577789999999999999995 468889999998666667788899999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+.+|++.+.++. ...+++....-|.+++..|+.|||.+ +.+|||||+.|||+.++|.+|++|||.+-.+....
T Consensus 93 ~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 93 CGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 999999999875 23347777778899999999999999 99999999999999999999999999998776554
Q ss_pred cceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
... ....||+.|||||++....|+.|+||||||++.+||.+|.+|+...
T Consensus 166 ~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~ 214 (467)
T KOG0201|consen 166 KRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKL 214 (467)
T ss_pred hcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCccc
Confidence 433 5678999999999999889999999999999999999999999753
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=286.75 Aligned_cols=196 Identities=30% Similarity=0.346 Sum_probs=164.3
Q ss_pred CeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHH-HHHhccCCccceEEEEEEcCCceEEEEecccC
Q 010887 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVH-LISVAIHKNLLQLIGYCTTSSERILVYPFMQN 352 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (498)
+.||+|+||.||+|+.. +++.||+|++.... .......+.+|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46899999999999965 56789999986421 1222334444544 56788999999999999999999999999999
Q ss_pred CCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcce
Q 010887 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (498)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~ 432 (498)
|+|.+.+.. ...++......++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~ 152 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GT 152 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CC
Confidence 999998875 34578888899999999999999999 99999999999999999999999999987543221 12
Q ss_pred eecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 200 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC
Confidence 234568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=278.30 Aligned_cols=199 Identities=32% Similarity=0.509 Sum_probs=169.0
Q ss_pred CCeeecccceEEEEEEEc-----CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecc
Q 010887 276 SNIIGQGGFGKVYKGVLS-----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (498)
.+.||.|.||.||+|.+. .+..|+||.++..........|.+|++.+++++||||++++|++...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 578999999999999976 256799999976555556899999999999999999999999999888899999999
Q ss_pred cCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCc
Q 010887 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (498)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~ 430 (498)
++|+|.+++... ....+++.++..|+.||++||+|||+. +++|+||+++||++++++.+||+|||++........
T Consensus 84 ~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 84 PGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 999999999874 235689999999999999999999999 999999999999999999999999999987632222
Q ss_pred -ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 431 -HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 431 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
...........|+|||.+....++.++||||||+++|||+| |+.||...
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~ 209 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY 209 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 12233446788999999998889999999999999999999 78898754
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=277.09 Aligned_cols=204 Identities=27% Similarity=0.419 Sum_probs=177.0
Q ss_pred HhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
..++|+..+.||+|+||.||+|...++..||+|.+... ....+.+.+|++++++++|+||+++++.+...+..++++|
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG--TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC--chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 35678889999999999999999888889999988642 2346788999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++++|.++++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||+++.....
T Consensus 82 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 82 YMAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred cCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 999999999987532 34588999999999999999999998 9999999999999999999999999999876543
Q ss_pred CcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
.........++..|+|||+.....++.++|||||||++|||+| |+.||...
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 208 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM 208 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC
Confidence 2222222345678999999998889999999999999999999 99999653
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=275.39 Aligned_cols=205 Identities=29% Similarity=0.409 Sum_probs=176.8
Q ss_pred HhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
..++|+..+.||+|++|.||+|...+++.||+|.++... ....+|.+|++++++++||||+++++++...+..+++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 456788899999999999999998788899999987432 345778999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++++|.+++.... ...+++..+..++.|++.|+.|||+. +++||||||+||++++++.++|+|||+++.....
T Consensus 82 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 82 LMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred cccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 999999999987533 34689999999999999999999999 9999999999999999999999999999876533
Q ss_pred CcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
..........+..|+|||+..+..++.++||||||+++|||+| |+.||....
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 209 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT 209 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 2221122223457999999999899999999999999999999 999997543
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=284.19 Aligned_cols=196 Identities=29% Similarity=0.389 Sum_probs=168.6
Q ss_pred CeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCceEEEEecccC
Q 010887 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFMQN 352 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (498)
+.||+|+||.||+|+.. +++.||+|+++... .......+.+|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 57899999987432 234456678899998887 699999999999999999999999999
Q ss_pred CCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcce
Q 010887 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (498)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~ 432 (498)
|+|..++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-T 152 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-c
Confidence 999988875 34689999999999999999999999 999999999999999999999999999875322211 2
Q ss_pred eecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.....|++.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~ 200 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC
Confidence 233568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=288.25 Aligned_cols=205 Identities=25% Similarity=0.382 Sum_probs=183.8
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEec-ccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCc-eEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE-RILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 347 (498)
++|...+.+|+|+||.++.++.+ +++.+++|.+. ...+....+...+|+.++++++|||||.+.+.+..++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56888999999999999999954 67789999987 33444556688999999999999999999999999988 89999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
+|++||++.+.+...+ ...+++.....++.|++.|+.|||++ +|+|||||+.||+++.+..+||+|||+++.+.+
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998644 45689999999999999999999988 999999999999999999999999999999887
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCcc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRL 481 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~~ 481 (498)
... ....+.||+.||+||.+.+.+|..|+||||+||++|||++-+++|...+.
T Consensus 159 ~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m 211 (426)
T KOG0589|consen 159 EDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM 211 (426)
T ss_pred chh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch
Confidence 542 34567899999999999999999999999999999999999999987553
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=291.34 Aligned_cols=210 Identities=27% Similarity=0.406 Sum_probs=176.2
Q ss_pred HHHhcCCCCCCeeecccceEEEEEEEcC------CcEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCccceEEEEEEc
Q 010887 267 QLATDNFSESNIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTT 339 (498)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 339 (498)
....++|.+.+.||+|+||.||+|+... +..||||+++..........|.+|+++++++. ||||+++++++..
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 3346788899999999999999998532 34699999976555455678999999999996 9999999999999
Q ss_pred CCceEEEEecccCCCHHHhhcccCC-------------------------------------------------------
Q 010887 340 SSERILVYPFMQNLSVAYRLRDLKP------------------------------------------------------- 364 (498)
Q Consensus 340 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 364 (498)
.+..++||||+++|+|.++++....
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 9999999999999999988864210
Q ss_pred -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEE
Q 010887 365 -------------------------------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANIL 407 (498)
Q Consensus 365 -------------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIL 407 (498)
....+++.++..++.|+++||+|||+. +++||||||+||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence 013478889999999999999999998 9999999999999
Q ss_pred ECCCCcEEEeecCccccccccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 408 LDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 408 l~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
+++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 999999999999999865432221 1122346788999999998899999999999999999997 99998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=278.06 Aligned_cols=210 Identities=24% Similarity=0.394 Sum_probs=175.8
Q ss_pred HHhcCCCCCCeeecccceEEEEEEEc------CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCC
Q 010887 268 LATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS 341 (498)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 341 (498)
...++|+..+.||+|+||.||+|... .+..||+|+++.........+|.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35678999999999999999999853 246799999865444445677999999999999999999999999999
Q ss_pred ceEEEEecccCCCHHHhhcccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEE
Q 010887 342 ERILVYPFMQNLSVAYRLRDLKPG------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV 415 (498)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 415 (498)
..++|+||+++++|.+++...... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence 999999999999999998753221 23468889999999999999999998 999999999999999999999
Q ss_pred EeecCccccccccCcce-eecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 416 LCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 416 i~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
|+|||+++......... .....++..|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~ 226 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS 226 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999987654322211 112335678999999998889999999999999999999 788987543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=289.85 Aligned_cols=201 Identities=25% Similarity=0.368 Sum_probs=170.4
Q ss_pred CCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCC-----ceE
Q 010887 272 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-----ERI 344 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 344 (498)
+|+..+.||+|+||.||++.. .+++.||+|++.... .......+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999996 478999999986432 2334567889999999999999999999998776 789
Q ss_pred EEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccc
Q 010887 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~ 424 (498)
+|+||+. ++|.+.+.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999997 577776653 34689999999999999999999999 999999999999999999999999999986
Q ss_pred ccccCcceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 425 VDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.............+++.|+|||++.+. .++.++|||||||++|||++|+.||+...
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 209 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence 654333223344578999999998764 47899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=307.01 Aligned_cols=205 Identities=25% Similarity=0.385 Sum_probs=174.7
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCC--cchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|++.+.||+|+||.||+|+.. +++.||+|+++.... +...+.|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47888999999999999999965 588999999975322 234567999999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecC
Q 010887 348 PFMQNLSVAYRLRDLKP-------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 420 (498)
||+++|+|.+++..... ....+++..+.+++.||++||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998864211 123467788899999999999999999 99999999999999999999999999
Q ss_pred ccccccccCc-----------------ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 421 LAKLVDAKLT-----------------HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 421 l~~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
+++....... .......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9986621110 001124589999999999999999999999999999999999999975
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=277.10 Aligned_cols=207 Identities=28% Similarity=0.467 Sum_probs=175.9
Q ss_pred cCCCCCCeeecccceEEEEEEEcCC------cEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLSDN------TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~------~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (498)
++|+..+.||+|+||.||+|..... ..|++|.++..........|.+|++.+++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 4678899999999999999986432 5799999876555555678999999999999999999999999999999
Q ss_pred EEEecccCCCHHHhhcccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCC
Q 010887 345 LVYPFMQNLSVAYRLRDLKPG------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF 412 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~ 412 (498)
+++||+++++|.+++...... ...+++.+...++.|++.||+|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 999999999999998753211 14588999999999999999999999 999999999999999999
Q ss_pred cEEEeecCccccccccCc-ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 413 EAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 413 ~~ki~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
.++|+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS 231 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999999876543221 12223446788999999998899999999999999999998 999987543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=279.43 Aligned_cols=193 Identities=29% Similarity=0.424 Sum_probs=163.1
Q ss_pred HhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHh--ccCCccceEEEEEEcCC----c
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISV--AIHKNLLQLIGYCTTSS----E 342 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~ 342 (498)
...+....+.||+|.||.||+|.| .|..||||++.. .+++.+.+|.+++.. ++|+||+.+++.-..+. +
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS----RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhheeEEEEEecCccccceeeccc-cCCceEEEEecc----cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 345677789999999999999999 688999999864 567888899888875 69999999998765443 6
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEEcCCCCCcEEECCCCcEEEe
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ-----CNPKIIHRDLKAANILLDDNFEAVLC 417 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~ivH~Dlk~~NILl~~~~~~ki~ 417 (498)
.+||++|.+.|||.++|.. ..++....++++..+|.||+|||.. ..|.|.|||||+.|||+..++.+.|+
T Consensus 284 LwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 7899999999999999985 4589999999999999999999964 67899999999999999999999999
Q ss_pred ecCccccccccCcc---eeecccccccccCcccccCCC------CCCcccchhHHHHHHHHHh
Q 010887 418 DFGLAKLVDAKLTH---VTTQIRGTMGHIAPEYLSTGK------SSEKTDVFGYGITLLELVT 471 (498)
Q Consensus 418 DfGl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~Gvvl~ellt 471 (498)
|+|+|-........ ......||.+|||||++...- .-..+||||||.|+||+..
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 99999876654322 235577999999999986532 2345899999999999875
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=274.44 Aligned_cols=193 Identities=27% Similarity=0.382 Sum_probs=166.6
Q ss_pred eecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCCCH
Q 010887 279 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV 355 (498)
Q Consensus 279 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 355 (498)
||+|+||.||+++.. +++.||+|++.... .......+..|++++++++||||+++.+++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999964 58999999986322 122345567799999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcceeec
Q 010887 356 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 435 (498)
Q Consensus 356 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~~~~ 435 (498)
.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 98886432 34589999999999999999999999 99999999999999999999999999987665432 2233
Q ss_pred ccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 436 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 436 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
..|+..|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~ 196 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 4688999999999988899999999999999999999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=289.77 Aligned_cols=212 Identities=27% Similarity=0.411 Sum_probs=186.3
Q ss_pred HHHHHHhcCCCCCCeeecccceEEEEEEEcC-CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCc
Q 010887 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 342 (498)
Q Consensus 264 ~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 342 (498)
++|+....+....++||-|.||.||.|.|+. .-.||||.++... -...+|+.|..+|+.++|||+|+++|+|..+..
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt--MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc--hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 5666667777888999999999999999865 5679999998643 567899999999999999999999999999999
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcc
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~ 422 (498)
.|+|+|||.+|+|.++|+++. +..++.-..+.+|.||+.||+||..+ .+|||||.++|+|+.++..+||+|||++
T Consensus 338 FYIiTEfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred eEEEEecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchh
Confidence 999999999999999999765 34577778899999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCccc
Q 010887 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLE 482 (498)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~~~ 482 (498)
+++..+.........-...|.|||.+....++.|+|||+|||+|||+.| |..||...+..
T Consensus 413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS 473 (1157)
T KOG4278|consen 413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 473 (1157)
T ss_pred hhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH
Confidence 9997654433322333578999999999999999999999999999999 88999876543
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=276.64 Aligned_cols=208 Identities=27% Similarity=0.413 Sum_probs=176.9
Q ss_pred hcCCCCCCeeecccceEEEEEEEcC------CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCce
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 343 (498)
.++|...+.||+|+||.||+|...+ +..||+|.++..........|.+|++++++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3457778999999999999998643 4789999998655544568899999999999999999999999999999
Q ss_pred EEEEecccCCCHHHhhcccC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCc
Q 010887 344 ILVYPFMQNLSVAYRLRDLK----------PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 413 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 413 (498)
++||||+++++|.+++.... .....+++.++..++.|++.|+.|||+. +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 99999999999999997532 1234588999999999999999999999 9999999999999999999
Q ss_pred EEEeecCccccccccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 414 AVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 414 ~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
++|+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~ 229 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS 229 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 999999998765332211 1122345678999999999999999999999999999999 999986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=272.33 Aligned_cols=204 Identities=28% Similarity=0.413 Sum_probs=175.9
Q ss_pred hcCCCCCCeeecccceEEEEEEEcC----CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
.++|+..+.||+|+||.||+|.+.. ...||+|.++..........|.+|+.++++++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578889999999999999999743 357999998765555566789999999999999999999999999999999
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
+|||+++++|.+++... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||+++..
T Consensus 83 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 99999999999998753 23689999999999999999999998 9999999999999999999999999999877
Q ss_pred cccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 426 DAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 426 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
...... ......++..|+|||...+..++.++||||||+++|||++ |+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~ 212 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC
Confidence 522222 1222334678999999998899999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=271.29 Aligned_cols=203 Identities=25% Similarity=0.405 Sum_probs=171.8
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEc-----CCce
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-----SSER 343 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~~ 343 (498)
..|...+.||+|+||.|+.|.. .+|+.||+|++.+. ......+...+|+++++.++|+||+.+.+.+.. -...
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 3455578899999999999995 47899999999743 345567788999999999999999999998876 2368
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
++|+|+| +-+|...++. ++.++......+..|+++||.|+|+. +++||||||+|++++.+...||+|||+|+
T Consensus 102 YiV~elM-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred EEehhHH-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccccee
Confidence 9999999 4567777764 45589999999999999999999999 99999999999999999999999999999
Q ss_pred cccccC-cceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcc
Q 010887 424 LVDAKL-THVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRL 481 (498)
Q Consensus 424 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~~ 481 (498)
...... ....+....|..|+|||++.. .+|+...||||.|||+.||++|++.|.+.+.
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~ 233 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY 233 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch
Confidence 876431 112245667999999999864 5799999999999999999999999987553
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=285.59 Aligned_cols=209 Identities=27% Similarity=0.421 Sum_probs=173.4
Q ss_pred HHhcCCCCCCeeecccceEEEEEEEc------CCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEEcC
Q 010887 268 LATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS 340 (498)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 340 (498)
.+.++|++.+.||+|+||.||+|... +++.||+|+++..........+.+|++++.++ +|+||+++++++...
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 34567889999999999999999742 24789999987544444556788999999999 799999999988755
Q ss_pred -CceEEEEecccCCCHHHhhcccCCC------------------------------------------------------
Q 010887 341 -SERILVYPFMQNLSVAYRLRDLKPG------------------------------------------------------ 365 (498)
Q Consensus 341 -~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------ 365 (498)
...++++||+++++|.+.+......
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 4578999999999999988642210
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcce-eeccccccc
Q 010887 366 ---EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMG 441 (498)
Q Consensus 366 ---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~-~~~~~gt~~ 441 (498)
...++|..+..++.||+.||+|||+. +|+||||||+||++++++.++|+|||+++.+....... .....++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 13689999999999999999999999 99999999999999999999999999998764322211 223345678
Q ss_pred ccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 442 HIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 442 y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~ 279 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 279 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999999999999998 99999753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=280.29 Aligned_cols=202 Identities=25% Similarity=0.388 Sum_probs=171.5
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
++|...+.||+|+||.||+|+.. +++.||+|+++..........+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999965 57889999987544444556788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++ ++.+.+... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 985 777777642 23578999999999999999999999 99999999999999999999999999987654322
Q ss_pred cceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 430 THVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.. .....+++.|+|||.+.+ ..++.++|||||||++|||+||+.||....
T Consensus 159 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 209 (309)
T cd07872 159 KT-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST 209 (309)
T ss_pred cc-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 223457889999998865 468899999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=279.11 Aligned_cols=204 Identities=26% Similarity=0.368 Sum_probs=180.4
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
..+.|..-++||+|+||.||-+... +|+-+|.|++.+. ....+....++|-.++.++..+.||.+--.+.+.+..++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 4467888899999999999999954 5788888877422 223456677899999999999999999888999999999
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
|+..|.||+|..+|.+.. ...+++..+.-+|.+|+.||++||++ +||.||+||+|||+|++|+++|+|.|+|..+
T Consensus 263 VLtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEec
Confidence 999999999999988643 46899999999999999999999999 9999999999999999999999999999988
Q ss_pred cccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
...... ....||.+|||||++++..|+...|+||+||++|||+.|+.||...
T Consensus 338 ~~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 338 PEGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred CCCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 765443 3347999999999999999999999999999999999999999854
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=268.80 Aligned_cols=198 Identities=30% Similarity=0.450 Sum_probs=170.8
Q ss_pred CeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCCCHH
Q 010887 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVA 356 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 356 (498)
++||+|+||.||+|...+++.+|+|+++..........|.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46899999999999988889999999876554445567999999999999999999999999999999999999999999
Q ss_pred HhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcceeecc
Q 010887 357 YRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 436 (498)
Q Consensus 357 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~~~~~ 436 (498)
+++... ...+++..+..++.|++.+|.|+|+. +++||||||+||++++++.+|++|||++..............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 988642 23588999999999999999999998 999999999999999999999999999875543322212222
Q ss_pred cccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 437 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 437 ~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
.++..|+|||+..+..++.++||||||+++||+++ |+.||....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~ 199 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT 199 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC
Confidence 34567999999998899999999999999999999 999997543
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=273.46 Aligned_cols=204 Identities=28% Similarity=0.427 Sum_probs=174.8
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
..+|+..+.||+|+||.||+|... .++.|++|+++.. .....++.+|++++++++||||+++++++...+..+++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 345777899999999999999965 5788999988643 3346789999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 83 FMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred eCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 999999999987532 34589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
.........++..|+|||+..+..++.++|||||||++|||+| |..||+...
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 210 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 210 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 2222222334568999999998999999999999999999998 999987543
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=270.99 Aligned_cols=201 Identities=26% Similarity=0.368 Sum_probs=172.2
Q ss_pred cCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecc
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (498)
.+|+..+.||+|+||.||+|.+.++..+|+|.+.... .....|.+|++++++++||||+++++++...+..++|+||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA--MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 3577789999999999999998777889999886432 23467889999999999999999999999999999999999
Q ss_pred cCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCc
Q 010887 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (498)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~ 430 (498)
++++|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 82 ANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 999999998753 23689999999999999999999999 999999999999999999999999999876543322
Q ss_pred ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
.......++..|+|||...+..++.++||||||+++|||+| |+.||+..
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 205 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF 205 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC
Confidence 21122223457999999999999999999999999999999 89999754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=274.99 Aligned_cols=206 Identities=26% Similarity=0.417 Sum_probs=174.1
Q ss_pred cCCCCCCeeecccceEEEEEEE-----cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
++|+..+.||+|+||.||+|.+ ..+..+++|.++..........|.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4677789999999999999984 24578999999755444556789999999999999999999999999999999
Q ss_pred EEecccCCCHHHhhcccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCC
Q 010887 346 VYPFMQNLSVAYRLRDLKP-------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF 412 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~ 412 (498)
||||+++++|.+++..... ....+++.+...++.|++.||+|||+. +++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999999853211 123578999999999999999999999 999999999999999999
Q ss_pred cEEEeecCccccccccCc-ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 413 EAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 413 ~~ki~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
.+||+|||+++....... .......++..|+|||+..+..++.++||||||+++|||+| |..||...
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF 230 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999986543221 11223345678999999988889999999999999999999 99998653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=293.87 Aligned_cols=200 Identities=27% Similarity=0.372 Sum_probs=164.6
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcC-------
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------- 340 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 340 (498)
...+|...+.||+|+||.||+|... +++.||+|++... .....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~-----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC-----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 3457899999999999999999964 6789999988532 12345799999999999999999876432
Q ss_pred -CceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCC-cEEEee
Q 010887 341 -SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCD 418 (498)
Q Consensus 341 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~ki~D 418 (498)
...++||||+++ ++.+.+.........+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence 135689999985 67776665444456799999999999999999999999 999999999999998665 799999
Q ss_pred cCccccccccCcceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 419 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
||+++....... .....||+.|+|||++.+. .++.++|||||||++|||+||+.||...
T Consensus 215 FGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 274 (440)
T PTZ00036 215 FGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ 274 (440)
T ss_pred cccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999986653222 2234679999999998654 6899999999999999999999999754
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=271.32 Aligned_cols=201 Identities=27% Similarity=0.375 Sum_probs=173.3
Q ss_pred cCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecc
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (498)
++|...+.||+|+||.||+|...++..+|+|.++... .....|.+|++++.+++||||+++++++......++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 4577788999999999999998777789999887432 33567899999999999999999999999888899999999
Q ss_pred cCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCc
Q 010887 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (498)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~ 430 (498)
.+++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||.++.......
T Consensus 82 ~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 82 SNGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 9999999887532 3589999999999999999999999 999999999999999999999999999886644322
Q ss_pred ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
.......++..|+|||...+..++.++||||||+++|||+| |+.||...
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 205 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF 205 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 22222335678999999988889999999999999999999 99998754
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=274.07 Aligned_cols=201 Identities=26% Similarity=0.381 Sum_probs=172.9
Q ss_pred CCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 273 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
|+..+.||+|+||+||+|... +++.+|+|.+.... .......+.+|++++++++|+|++++.+.+..++..++++||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999964 68899999986432 222345678899999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999998886532 34689999999999999999999999 99999999999999999999999999987654322
Q ss_pred cceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
. .....|+..|+|||++.+..++.++|+||||+++|||+||+.||....
T Consensus 157 ~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~ 205 (285)
T cd05632 157 S--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205 (285)
T ss_pred c--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 1 223468999999999998899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=273.90 Aligned_cols=203 Identities=25% Similarity=0.394 Sum_probs=169.8
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCc----EEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
++|...+.||+|+||.||+|.+. +++ .+++|.+..........++..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46778899999999999999964 344 4788887644333445678888889999999999999998754 45678
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
++||+++|+|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 99999999999999753 24589999999999999999999998 9999999999999999999999999999866
Q ss_pred cccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 426 DAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 426 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
...... ......++..|+|||...+..++.++||||||+++|||+| |+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 216 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR 216 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 433221 1233456778999999998899999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=277.00 Aligned_cols=200 Identities=24% Similarity=0.368 Sum_probs=174.3
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
++|++.+.||+|+||.||++... ++..+|+|.++..........+.+|++++.+++||||+++++++..++..++|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46888999999999999999964 57788999887544444556788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++++|.+++.. ...+++..+..++.|+++||+|||+.+ +++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 999999999875 245889999999999999999999732 79999999999999999999999999987654321
Q ss_pred cceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.....++..|+|||...+..++.++|+||||+++|||+||+.||...
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 201 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP 201 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence 23346789999999998888999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=271.78 Aligned_cols=205 Identities=22% Similarity=0.336 Sum_probs=177.3
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|++.+.||+|+||.||+|+. .+++.||+|.++.. ........+.+|+++++.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4788899999999999999995 47899999987632 23344567899999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++++|.+++.........+++..+..++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998875544455689999999999999999999999 999999999999999999999999999886654
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
... ......++..|+|||.+.+..++.++|+||||+++|||+||+.||...
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 321 112345788999999998888999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=273.76 Aligned_cols=200 Identities=28% Similarity=0.391 Sum_probs=172.4
Q ss_pred CCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCC--cchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 273 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
|+..+.||+|+||.||++... +++.||+|.+..... ......+.+|+.++++++|+|++++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999964 688999998864321 22345678899999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++++|.+++.... ...+++.++..++.|++.||.|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 99999999886432 34589999999999999999999998 99999999999999999999999999987654322
Q ss_pred cceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~ 204 (285)
T cd05630 157 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 204 (285)
T ss_pred c--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 1 12346899999999999999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=272.08 Aligned_cols=194 Identities=24% Similarity=0.350 Sum_probs=170.5
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
++|+..+.||+|+||.||+|.. .+++.||+|++...........+.+|++++++++||||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3577789999999999999995 468899999987544445567899999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
++++++..+. .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 9999986542 367888999999999999999999 99999999999999999999999999987654321
Q ss_pred cceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
.....++..|+|||++.+..++.++||||||+++|||+||+.||..
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 2234688999999999998999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=280.10 Aligned_cols=201 Identities=25% Similarity=0.329 Sum_probs=180.2
Q ss_pred hcCCCCCCeeecccceEEEEEEEcC-CcEEEEEEecccCCc--chHHHHHHHHHHHHhcc-CCccceEEEEEEcCCceEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSP--GGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 345 (498)
.+.|+..+.||+|.||.||+++.+. |+.+|+|.+...... .......+|+++|+++. ||||+.+.+.+.+....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 4567888999999999999999765 999999999754332 24578999999999998 9999999999999999999
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCC----CcEEEeecCc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN----FEAVLCDFGL 421 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~----~~~ki~DfGl 421 (498)
|||++.||.|.+.+... .+++..+..++.|++.++.|||+. +++||||||+|+|+... +.+|++|||+
T Consensus 114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999999999864 389999999999999999999998 99999999999999533 4799999999
Q ss_pred cccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+..... .......+||+.|+|||++....|+..+||||.||++|.|++|..||....
T Consensus 186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~ 242 (382)
T KOG0032|consen 186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET 242 (382)
T ss_pred ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence 998876 445567889999999999999999999999999999999999999998755
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=268.99 Aligned_cols=205 Identities=23% Similarity=0.335 Sum_probs=178.9
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecc--cCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQD--YYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|+..+.||+|+||.||+|... +++.|++|.++. .........+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999976 789999998863 223344678999999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++++|..++.........+++.++..++.++++||+|||+. +++||||+|+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999876554456689999999999999999999999 999999999999999999999999999876543
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.... .....++..|+|||+..+..++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 3221 22345788999999999888999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=270.05 Aligned_cols=205 Identities=28% Similarity=0.418 Sum_probs=175.5
Q ss_pred HHhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 268 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
+..++|+..++||+|+||.||+|...+++.||+|++.... .....|.+|++++++++|+|++++++++. .+..++++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS--MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC--CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 3456788899999999999999998889999999987432 34568999999999999999999999864 55689999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++++|.+++.... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 80 EYMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 9999999999886532 34689999999999999999999998 999999999999999999999999999976653
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
..........++..|+|||++....++.++||||||++++||++ |+.||....
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 208 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT 208 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 32222223345678999999998889999999999999999999 999997543
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=270.17 Aligned_cols=203 Identities=31% Similarity=0.446 Sum_probs=173.2
Q ss_pred HhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
..++|++.+.||+|+||.||+|...++..+|+|.++... .....|.+|++++++++|+|++++++++. ....+++||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT--MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC--CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 345788899999999999999998888899999987532 23567999999999999999999999875 456789999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++++|.++++... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 81 YMSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred ecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 999999999987532 34589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
.........++..|+|||+..+.+++.++|+||||+++|||++ |+.||...
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 207 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 3222222335668999999988889999999999999999999 89999653
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=268.82 Aligned_cols=202 Identities=27% Similarity=0.377 Sum_probs=174.0
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCC----cchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYS----PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
++|+..+.||+|++|.||++.. .+++.+++|.+..... ......+.+|++++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5688899999999999999995 4689999998863321 1234678899999999999999999999999999999
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
|+||+++++|.+.+.. ...+++.....++.|++.||+|||+. +++||||+|+||++++++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999998875 34588999999999999999999999 9999999999999999999999999998765
Q ss_pred cccCccee--ecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 426 DAKLTHVT--TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 426 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
........ ....++..|+|||...+..++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 210 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc
Confidence 43221111 2345778999999999988999999999999999999999999653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=269.47 Aligned_cols=209 Identities=25% Similarity=0.264 Sum_probs=177.1
Q ss_pred cCCCCCCeeecccceEEEEEEEcC-CcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|+..+.||.|.-|+||++++.+ +..+|+|++.+.. +.........|-+||+.++||.+..+++.+..+...+++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 455667899999999999999765 5889999996432 2344556677899999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
|||+||+|...++... .+.+++..+.-+|.+++-||+|||.. |||+|||||+|||+.++|++.++||.++....-
T Consensus 157 eyCpGGdL~~LrqkQp--~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQP--GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred ecCCCccHHHHHhhCC--CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999999887643 56799999999999999999999999 999999999999999999999999998643210
Q ss_pred ---------------------------------c-C---------------------cceeecccccccccCcccccCCC
Q 010887 428 ---------------------------------K-L---------------------THVTTQIRGTMGHIAPEYLSTGK 452 (498)
Q Consensus 428 ---------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~ 452 (498)
. . ...+....||-.|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 0 00112345999999999999999
Q ss_pred CCCcccchhHHHHHHHHHhCCCCCCCCccccc
Q 010887 453 SSEKTDVFGYGITLLELVTGQRAIDFSRLEEE 484 (498)
Q Consensus 453 ~~~~~Dv~s~Gvvl~elltG~~p~~~~~~~~~ 484 (498)
.+..+|+|+|||++|||+.|+.||.....++.
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T 343 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET 343 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhh
Confidence 99999999999999999999999988765543
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=267.39 Aligned_cols=203 Identities=26% Similarity=0.351 Sum_probs=177.2
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
+|+..+.||+|++|.||+|... +++.|++|.+... ........+.+|++++++++|||++++++++...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999964 6889999988632 3345677899999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999988632 34689999999999999999999998 99999999999999999999999999988665432
Q ss_pred cceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.. .....|++.|+|||+..+..++.++|+||||+++|||+||+.||....
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 156 NF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred ch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 22 233457889999999999999999999999999999999999997554
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=256.92 Aligned_cols=208 Identities=27% Similarity=0.341 Sum_probs=177.5
Q ss_pred HhcCCCCCCeeecccceEEEEEE-EcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCC-----c
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-----E 342 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~ 342 (498)
..++|.+.+.+|+|||+-||.++ ..++..+|+|++.- .+.++.....+|++..++++|||+++++++...+. +
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c-~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILC-HSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeec-cchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 45678999999999999999999 67889999999863 33567788899999999999999999998875443 5
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcc
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~ 422 (498)
.+++++|+..|+|.+.+.........+++.+.+.|+.++++||++||+. .|+++||||||.|||+.+.+.+++.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence 8999999999999999998776667899999999999999999999997 446999999999999999999999999998
Q ss_pred ccccccCccee--------ecccccccccCccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 423 KLVDAKLTHVT--------TQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 423 ~~~~~~~~~~~--------~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
....-...... .....|..|+|||.+. +...++++|||||||++|+|+.|..||+.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 76542211110 1234789999999985 44578999999999999999999999985
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=270.93 Aligned_cols=202 Identities=30% Similarity=0.420 Sum_probs=172.3
Q ss_pred hcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
.++|.+.+.||+|+||.||+|...++..||+|+++... .....|.+|++++++++||||+++++++. ....++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc--cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 45688899999999999999998777789999987422 23467899999999999999999998874 4567899999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++|+|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||.++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 82 MSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred CCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999997532 34579999999999999999999999 99999999999999999999999999998665433
Q ss_pred cceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
........++..|+|||+..+..++.++||||||+++|||+| |+.||...
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~ 207 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 207 (262)
T ss_pred cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 222223345678999999998899999999999999999999 88888754
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=292.49 Aligned_cols=204 Identities=30% Similarity=0.478 Sum_probs=179.6
Q ss_pred CCCCeeecccceEEEEEEE-cCC----cEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 274 SESNIIGQGGFGKVYKGVL-SDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 274 ~~~~~lG~G~~g~Vy~~~~-~~~----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
...++||+|+||+||||.+ +.+ -+||+|++.+...+....++.+|+-+|+.++|||+++++|+|..+. ..+|++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3478999999999999995 343 4689999998888888999999999999999999999999998877 789999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
||+.|+|.++++.. +..+.....+.+..|||+||.|||.+ ++|||||.++|||+.+-.++||.|||+++....+
T Consensus 778 ~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred hcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999999873 44578888999999999999999999 9999999999999999999999999999988765
Q ss_pred Ccceee-cccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCccccc
Q 010887 429 LTHVTT-QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEE 484 (498)
Q Consensus 429 ~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~~~~~ 484 (498)
...... ...-.+.|||-|.+..+.|+.++|||||||.+||++| |..|++....+|.
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI 909 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI 909 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh
Confidence 544332 2334578999999999999999999999999999999 9999998766543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=264.70 Aligned_cols=203 Identities=24% Similarity=0.311 Sum_probs=176.7
Q ss_pred HhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEec-ccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~-~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
..+.|+..+.||+|.|+.||+... ++|+.+|+|++. ...+..+.++..+|+++-+.++||||+++.+...+....++|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 346777888999999999999884 578999999886 334455778899999999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEEC---CCCcEEEeecCccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD---DNFEAVLCDFGLAK 423 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~ki~DfGl~~ 423 (498)
+|+|.|++|...+-.. ...++..+...++||+.+|+|.|.+ +|||||+||+|+++. ...-+|++|||++.
T Consensus 89 Fe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence 9999999997766542 3467888899999999999999999 999999999999993 44568999999999
Q ss_pred cccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.+.. ........|||+|||||++...+|+..+|||+-||||+-|+.|+.||-..+
T Consensus 162 ~l~~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~ 216 (355)
T KOG0033|consen 162 EVND--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 216 (355)
T ss_pred EeCC--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc
Confidence 8873 344556789999999999999999999999999999999999999998643
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=273.23 Aligned_cols=209 Identities=24% Similarity=0.372 Sum_probs=177.3
Q ss_pred HhcCCCCCCeeecccceEEEEEEEcC------CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCc
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 342 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 342 (498)
..++|...+.||+|+||.||+|...+ +..||+|.+...........+.+|+++++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 45678889999999999999999643 367999998755444556789999999999999999999999999999
Q ss_pred eEEEEecccCCCHHHhhcccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEE
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPG------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL 416 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki 416 (498)
.++||||+++++|.+++...... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEE
Confidence 99999999999999998754321 23478999999999999999999998 9999999999999999999999
Q ss_pred eecCccccccccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 417 CDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 417 ~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
+|||+++........ ......++..|+|||...+..++.++|||||||++||++| |+.||....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 226 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC
Confidence 999998765433221 1223346788999999988889999999999999999998 999987543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=285.55 Aligned_cols=211 Identities=25% Similarity=0.389 Sum_probs=176.7
Q ss_pred HHHHhcCCCCCCeeecccceEEEEEEEc------CCcEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCccceEEEEEE
Q 010887 266 LQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCT 338 (498)
Q Consensus 266 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~ 338 (498)
++...++|...+.||+|+||.||+|++. .+..||+|+++..........+.+|++++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4556667888999999999999999863 246799999986544445567899999999997 999999999999
Q ss_pred cCCceEEEEecccCCCHHHhhcccCC------------------------------------------------------
Q 010887 339 TSSERILVYPFMQNLSVAYRLRDLKP------------------------------------------------------ 364 (498)
Q Consensus 339 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------ 364 (498)
..+..++|+||+++|+|.++++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999874321
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCC
Q 010887 365 ----------------------------------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAA 404 (498)
Q Consensus 365 ----------------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~ 404 (498)
....+++.....++.|++.||+|||+. +++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 113478888999999999999999998 9999999999
Q ss_pred cEEECCCCcEEEeecCccccccccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 405 NILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 405 NILl~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
||++++++.+||+|||+++........ ......++..|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999865332211 1122346788999999998889999999999999999998 89998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=282.43 Aligned_cols=199 Identities=26% Similarity=0.348 Sum_probs=168.3
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCC-----
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS----- 341 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 341 (498)
..++|+..+.||+|+||.||++... ++..||+|++.... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3478999999999999999999964 58899999987432 3345677889999999999999999999886543
Q ss_pred -ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecC
Q 010887 342 -ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (498)
Q Consensus 342 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 420 (498)
..++||||+++ ++...+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 46899999975 45554432 378888999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 421 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
+++...... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||...
T Consensus 169 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 169 LARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred CccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 987543321 223356789999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=272.80 Aligned_cols=208 Identities=25% Similarity=0.416 Sum_probs=178.0
Q ss_pred HhcCCCCCCeeecccceEEEEEEEcC-----CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEc-CCc
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLSD-----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-SSE 342 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~ 342 (498)
..++|...+.||+|+||.||+|...+ +..|++|+++..........+.+|++++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45678889999999999999999765 688999998866555667889999999999999999999998876 467
Q ss_pred eEEEEecccCCCHHHhhcccCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEee
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPG----EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 418 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~D 418 (498)
.+++++|+++++|.+++...... ...+++.++..++.|++.||+|||+. +++|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 88999999999999998754322 15689999999999999999999998 999999999999999999999999
Q ss_pred cCccccccccCcce-eecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 419 FGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 419 fGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
||+++.+....... .....++..|+|||+..+..++.++||||||+++||+++ |+.||+..
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 223 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI 223 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC
Confidence 99998664332221 122345678999999988889999999999999999999 99999753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=275.55 Aligned_cols=206 Identities=28% Similarity=0.441 Sum_probs=172.2
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCc--EEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCceEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNT--KVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 345 (498)
.++|++.+.||+|+||.||+|.+. ++. .+++|+++...+......+.+|++++.++ +||||+++++++...+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 467888999999999999999964 343 46888776544455667889999999999 89999999999999999999
Q ss_pred EEecccCCCHHHhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCc
Q 010887 346 VYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 413 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 413 (498)
|+||+++++|.++++.... ....+++.+++.++.|++.|++|||+. +++||||||+||++++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 9999999999999875321 123589999999999999999999999 9999999999999999999
Q ss_pred EEEeecCccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 414 AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 414 ~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
+||+|||+++....... .....++..|+|||++.+..++.++|||||||++|||+| |..||....
T Consensus 163 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 228 (303)
T cd05088 163 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228 (303)
T ss_pred EEeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC
Confidence 99999999864321111 111223567999999988889999999999999999998 999997543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=274.79 Aligned_cols=212 Identities=29% Similarity=0.422 Sum_probs=178.4
Q ss_pred HHHHhcCCCCCCeeecccceEEEEEEEcC------CcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEE
Q 010887 266 LQLATDNFSESNIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT 338 (498)
Q Consensus 266 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 338 (498)
+....++|+..+.||+|+||.||++.... ...+|+|+++..........+.+|++++.++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 34456678889999999999999998642 3679999987655555567789999999999 7999999999999
Q ss_pred cCCceEEEEecccCCCHHHhhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcE
Q 010887 339 TSSERILVYPFMQNLSVAYRLRDLK------------PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANI 406 (498)
Q Consensus 339 ~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NI 406 (498)
..+..+++|||+++|+|..+++... .....+++..+..++.|++.||+|||+. +++||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence 9999999999999999999986432 2245689999999999999999999998 999999999999
Q ss_pred EECCCCcEEEeecCccccccccCcce-eecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 407 LLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 407 Ll~~~~~~ki~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
++++++.+||+|||+++......... .....++..|+|||+..+..++.++|||||||++|||++ |..||....
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 239 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 239 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence 99999999999999998765432211 122234578999999988899999999999999999998 999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=283.00 Aligned_cols=194 Identities=27% Similarity=0.319 Sum_probs=162.6
Q ss_pred eecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhc---cCCccceEEEEEEcCCceEEEEecccC
Q 010887 279 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA---IHKNLLQLIGYCTTSSERILVYPFMQN 352 (498)
Q Consensus 279 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (498)
||+|+||+||+|+.. +++.||+|++.... .......+..|..++... +||||+++++.+......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999964 58899999986321 122334556677777665 699999999999999999999999999
Q ss_pred CCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcce
Q 010887 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (498)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~ 432 (498)
|+|..++.. ...+++..+..++.||++||+|||+. +|+||||||+||++++++.++|+|||+++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~ 152 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-T 152 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-C
Confidence 999988875 34689999999999999999999999 999999999999999999999999999875432221 2
Q ss_pred eecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 433 TTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.....||..|+|||++.+. .++.++|||||||++|||+||+.||....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~ 201 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC
Confidence 2345689999999998754 47999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=271.12 Aligned_cols=203 Identities=28% Similarity=0.438 Sum_probs=172.0
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCc----EEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (498)
.++|+..+.||+|+||+||+|.+. ++. .||+|+++..........+.+|+.++..+.||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 457888999999999999999853 444 48999987655555677899999999999999999999999754 467
Q ss_pred EEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccc
Q 010887 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~ 424 (498)
++++|+++|+|.+.++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 899999999999998752 34589999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCcce-eecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 425 VDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 425 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
........ .....++..|+|||...+..++.++||||||+++|||+| |+.||+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 215 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 65332221 112234678999999998899999999999999999999 99999754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=273.55 Aligned_cols=205 Identities=25% Similarity=0.426 Sum_probs=171.1
Q ss_pred cCCCCCCeeecccceEEEEEEEcC-C--cEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCceEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLSD-N--TKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 346 (498)
++|++.+.||+|+||.||+|...+ + ..+++|.++........+.|.+|++++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999999754 3 247888887544445567899999999999 799999999999999999999
Q ss_pred EecccCCCHHHhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcE
Q 010887 347 YPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA 414 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 414 (498)
+||+++++|.++++.... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999875321 113588999999999999999999998 99999999999999999999
Q ss_pred EEeecCccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 415 VLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 415 ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
||+|||++........ ......+..|+|||+.....++.++|||||||++|||+| |+.||....
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~ 223 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999864322111 111223457999999988889999999999999999998 999997543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=273.16 Aligned_cols=210 Identities=24% Similarity=0.391 Sum_probs=174.9
Q ss_pred HHhcCCCCCCeeecccceEEEEEEEc------CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCC
Q 010887 268 LATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS 341 (498)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 341 (498)
...++|++.+.||+|+||.||+|..+ .+..||+|.++..........+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678999999999999999999753 245799998875444445567889999999999999999999999999
Q ss_pred ceEEEEecccCCCHHHhhcccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEE
Q 010887 342 ERILVYPFMQNLSVAYRLRDLKP------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV 415 (498)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 415 (498)
..++||||+++|+|.+++..... .....++..+..++.|++.||+|||+. +++||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence 99999999999999999975321 123467788899999999999999999 999999999999999999999
Q ss_pred EeecCccccccccCcce-eecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 416 LCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 416 i~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
++|||+++......... .....++..|+|||...+..++.++|||||||++|||++ |+.||....
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~ 226 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 226 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999987654322111 112234678999999998899999999999999999999 788886533
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=266.00 Aligned_cols=197 Identities=31% Similarity=0.450 Sum_probs=168.2
Q ss_pred CeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCCCH
Q 010887 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV 355 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 355 (498)
+.||+|+||.||+|... +++.+|+|.+...........|.+|++++++++||||+++++++......++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46899999999999964 68899999887555555567899999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCccee-e
Q 010887 356 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT-T 434 (498)
Q Consensus 356 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~~-~ 434 (498)
.+++... ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........... .
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9998642 23589999999999999999999999 999999999999999999999999999876543211111 1
Q ss_pred cccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 435 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 435 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
....+..|+|||.+.++.++.++||||||+++|||++ |..||+..
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~ 200 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL 200 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 1123457999999999899999999999999999998 88898643
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=268.01 Aligned_cols=201 Identities=29% Similarity=0.376 Sum_probs=166.1
Q ss_pred CeeecccceEEEEEEEcC---CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCC
Q 010887 277 NIIGQGGFGKVYKGVLSD---NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 353 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 353 (498)
+.||+|+||.||+|...+ +..+++|.++..........|.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998643 35789998876554455568999999999999999999999999999999999999999
Q ss_pred CHHHhhcccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcce
Q 010887 354 SVAYRLRDLKP-GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (498)
Q Consensus 354 sL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~ 432 (498)
+|.+++..... .....++..+..++.|++.|++|||+. +++|+||||+||+++++++++++|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975332 223567888889999999999999999 99999999999999999999999999987544322211
Q ss_pred -eecccccccccCcccccCC-------CCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 433 -TTQIRGTMGHIAPEYLSTG-------KSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 433 -~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
.....++..|+|||++... .++.++||||||+++|||++ |+.||....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 214 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS 214 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 1234567889999998642 35789999999999999996 999997543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=271.71 Aligned_cols=209 Identities=28% Similarity=0.393 Sum_probs=174.6
Q ss_pred HhcCCCCCCeeecccceEEEEEEEcC------CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCc
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 342 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 342 (498)
.+++|...+.||+|++|.||+|.+.. +..|++|.+...........|.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45678889999999999999999753 567899988755445556789999999999999999999999999999
Q ss_pred eEEEEecccCCCHHHhhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCC---cEEE
Q 010887 343 RILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF---EAVL 416 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~ki 416 (498)
.++||||+++++|.+++..... ....+++..+.+++.||+.||+|||+. +++||||||+||++++++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999875432 123589999999999999999999999 999999999999998654 5999
Q ss_pred eecCccccccccCcce-eecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 417 CDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 417 ~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||+...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~ 226 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999998664322111 112223568999999999999999999999999999997 999997644
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=268.25 Aligned_cols=205 Identities=31% Similarity=0.454 Sum_probs=177.3
Q ss_pred HHhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 268 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
+..++|.+.+.||+|+||.||+|..++++.+++|.+.... ....++.+|++++++++|+||+++++++......++||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 3457889999999999999999998888899999987432 34577999999999999999999999999888999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++++|.+++.... ...+++..+..++.|++.|++|||+. +++|+||||+||++++++.++++|||.+.....
T Consensus 81 e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 81 EYMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 9999999999987632 24689999999999999999999999 999999999999999999999999999876653
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
..........++..|+|||.+.+..++.++||||||++++||+| |+.||...
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 208 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM 208 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 22221222334568999999998889999999999999999999 99999654
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=270.36 Aligned_cols=205 Identities=31% Similarity=0.463 Sum_probs=178.1
Q ss_pred HhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
+..+|+..+.||+|+||.||+|...++..+++|.++... ......+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 456788899999999999999998889999999987432 2345678999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++++|.+++.+.. ...+++..+..++.|++.|++|||+. +++|+||||+||++++++.+||+|||.+......
T Consensus 83 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 83 LMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred ecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 999999999998643 34689999999999999999999999 9999999999999999999999999999766543
Q ss_pred CcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
... .....++..|+|||......++.++||||||++++||++ |+.||....
T Consensus 158 ~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~ 209 (261)
T cd05148 158 VYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN 209 (261)
T ss_pred ccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC
Confidence 222 123345678999999988899999999999999999999 899997543
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=305.00 Aligned_cols=217 Identities=25% Similarity=0.322 Sum_probs=191.8
Q ss_pred HHHHHHHhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCccceEEEEEEc
Q 010887 263 CRELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT 339 (498)
Q Consensus 263 ~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 339 (498)
.++++...++|.+.++||+|+||.|..++.+ .++.||+|++++. ....+...|..|-.+|..-+.+.|+.+.-.|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4667778899999999999999999999965 5788999999753 233556788899999999999999999999999
Q ss_pred CCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeec
Q 010887 340 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 419 (498)
Q Consensus 340 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~Df 419 (498)
....|+|||||+||+|...+..+. .+++..+.-++..|.-||+-||+. |+|||||||+|||+|..|++|++||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence 999999999999999999988642 588889999999999999999999 9999999999999999999999999
Q ss_pred CccccccccCcceeecccccccccCccccc----C-CCCCCcccchhHHHHHHHHHhCCCCCCCCccccccc
Q 010887 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLS----T-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEED 486 (498)
Q Consensus 420 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~~~~~~~ 486 (498)
|.+-.+..+....+....|||.|++||++. + +.|...+|+||+||++|||+.|..||......+.++
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~ 291 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYG 291 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHH
Confidence 999888766555666678999999999985 2 678999999999999999999999998877666554
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=281.15 Aligned_cols=213 Identities=25% Similarity=0.431 Sum_probs=186.6
Q ss_pred CHHHHHHHhcCCCCCCeeecccceEEEEEEEcC---C--cEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEE
Q 010887 262 SCRELQLATDNFSESNIIGQGGFGKVYKGVLSD---N--TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336 (498)
Q Consensus 262 ~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~---~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 336 (498)
+....++..+.....++||+|-||.||+|.+.+ | -.||||..+....+...+.|..|..+|++++||||++++|.
T Consensus 380 ~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv 459 (974)
T KOG4257|consen 380 TVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGV 459 (974)
T ss_pred CCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeee
Confidence 334445566666778899999999999999643 2 35899999987778889999999999999999999999999
Q ss_pred EEcCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEE
Q 010887 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL 416 (498)
Q Consensus 337 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki 416 (498)
|.+.. .++|||.++.|.|..+|.... ..++......++.||+.+|+|||+. ++|||||..+|||+....-+|+
T Consensus 460 ~~e~P-~WivmEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKL 532 (974)
T KOG4257|consen 460 CVEQP-MWIVMELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKL 532 (974)
T ss_pred eeccc-eeEEEecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeee
Confidence 98664 689999999999999998643 4588888999999999999999999 9999999999999999999999
Q ss_pred eecCccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcc
Q 010887 417 CDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRL 481 (498)
Q Consensus 417 ~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~~ 481 (498)
+|||+++.+.++.....+...-...|||||.+.-++++..+|||.|||.+||+++ |..||..-..
T Consensus 533 aDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN 598 (974)
T KOG4257|consen 533 ADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN 598 (974)
T ss_pred cccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc
Confidence 9999999998876666555555678999999999999999999999999999988 9999986543
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=274.13 Aligned_cols=210 Identities=28% Similarity=0.422 Sum_probs=176.4
Q ss_pred HHhcCCCCCCeeecccceEEEEEEEc--------CCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEE
Q 010887 268 LATDNFSESNIIGQGGFGKVYKGVLS--------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT 338 (498)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 338 (498)
...++|.+.+.||+|+||.||+|+.. ++..||+|.++..........+.+|+++++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 44567888999999999999999741 23479999887554445567899999999999 8999999999999
Q ss_pred cCCceEEEEecccCCCHHHhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcE
Q 010887 339 TSSERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANI 406 (498)
Q Consensus 339 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NI 406 (498)
.....+++|||+++|+|.+++..... ....+++.++..++.|++.||+|||+. +++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 99999999999999999999875422 124588999999999999999999999 999999999999
Q ss_pred EECCCCcEEEeecCccccccccCcce-eecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 407 LLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 407 Ll~~~~~~ki~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
++++++.+||+|||.++......... .....++..|+|||+..+..++.++||||||+++|||+| |..||....
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999998665332221 222345678999999988889999999999999999999 788887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=267.50 Aligned_cols=204 Identities=28% Similarity=0.428 Sum_probs=173.9
Q ss_pred cCCCCCCeeecccceEEEEEEEc-C---CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-D---NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
++|++.+.||+|+||.||+|... + +..+|+|.++..........|.+|++++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46778899999999999999863 2 3379999987554445567899999999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|||+++++|.+++... ...+++.++..++.|++.|++|||+. +++||||||+||++++++.++++|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999998753 24589999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCcceee--cccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 427 AKLTHVTT--QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 427 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
........ ...++..|+|||++.+..++.++|+||||+++||+++ |+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~ 214 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS 214 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC
Confidence 43322211 1223568999999998899999999999999999887 999996543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=283.56 Aligned_cols=197 Identities=25% Similarity=0.337 Sum_probs=171.0
Q ss_pred CCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhcc-C-----CccceEEEEEEcCCceE
Q 010887 272 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-H-----KNLLQLIGYCTTSSERI 344 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~~ 344 (498)
+|++.++||+|+||.|-||.. .+++.||||+++... .-..+-..|+.+|..++ | -|+|++++++...++.|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 788999999999999999995 468999999998543 34556678999999987 4 38999999999999999
Q ss_pred EEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCC--CcEEEeecCcc
Q 010887 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN--FEAVLCDFGLA 422 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~--~~~ki~DfGl~ 422 (498)
+|+|.+. -+|.++++... ..+++...+..++.||+.||.+||+. +|||+||||+|||+.+. ..+||+|||.+
T Consensus 265 iVfELL~-~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 265 IVFELLS-TNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeehhhh-hhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccc
Confidence 9999985 59999999754 45699999999999999999999999 99999999999999643 37999999999
Q ss_pred ccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
........ ...-+..|+|||++.+.+|+.+.||||||||+.||+||.+.|....
T Consensus 339 c~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 339 CFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred cccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 87765332 3445789999999999999999999999999999999988887644
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=266.55 Aligned_cols=201 Identities=26% Similarity=0.327 Sum_probs=172.0
Q ss_pred hcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.++++++||||+++++++...+..++|+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 35788899999999999999996 467889999986432 2345678899999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++++|.++++. ...+++..+..++.|++.||+|||+. +|+||||+|+||++++++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 87 YCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 9999999998864 34589999999999999999999999 9999999999999999999999999999866432
Q ss_pred CcceeecccccccccCccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 429 LTHVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.. ......++..|+|||.+. ...++.++|||||||++|||++|+.||...
T Consensus 160 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~ 212 (267)
T cd06646 160 IA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred cc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 21 122345788999999874 345788999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=269.11 Aligned_cols=205 Identities=23% Similarity=0.337 Sum_probs=177.3
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|+..+.||+|+||.||++.. .+++.+++|.+.... .......+.+|+++++.++||||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4677889999999999999995 578999999876422 2234568899999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++++|.+++.........+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998875444456789999999999999999999999 999999999999999999999999999876643
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.... .....++..|+|||...+..++.++|+||||+++|||++|+.||...
T Consensus 159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08229 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 3221 22345788999999998888999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=275.14 Aligned_cols=209 Identities=29% Similarity=0.410 Sum_probs=174.7
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc--------CCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEEc
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS--------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT 339 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 339 (498)
..++|.+.+.||+|+||.||+++.. +...+|+|.++..........+.+|++++.++ +||||+++++++..
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 3467889999999999999999852 23469999987544445567788999999999 79999999999999
Q ss_pred CCceEEEEecccCCCHHHhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEE
Q 010887 340 SSERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANIL 407 (498)
Q Consensus 340 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIL 407 (498)
.+..++|+||+++|+|.+++..... ....+++.++..++.|++.||+|||+. +++||||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheE
Confidence 9999999999999999999975432 123589999999999999999999998 9999999999999
Q ss_pred ECCCCcEEEeecCccccccccCcce-eecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 408 LDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 408 l~~~~~~ki~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
+++++.+||+|||.++......... .....++..|+|||...+..++.++|||||||++|||++ |+.||....
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 9999999999999987654321111 111224568999999998889999999999999999998 888987544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=270.22 Aligned_cols=199 Identities=27% Similarity=0.342 Sum_probs=175.5
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|+..+.||+|+||.||++... +++.+|+|.++... .......+.+|++++++++||||+++++++......++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46788899999999999999965 58899999986432 2344577899999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999875 34689999999999999999999998 999999999999999999999999999886654
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
. .....+++.|+|||.+.+...+.++||||||+++|||++|+.||....
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 3 233457899999999988888999999999999999999999997544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=270.40 Aligned_cols=207 Identities=28% Similarity=0.420 Sum_probs=174.0
Q ss_pred hcCCCCCCeeecccceEEEEEEEc------CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCce
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 343 (498)
.++|.+.+.||+|+||.||++... ++..+|+|.+... .......+.+|++++++++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 457888999999999999999842 2456899988643 234567899999999999999999999999999999
Q ss_pred EEEEecccCCCHHHhhcccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcE
Q 010887 344 ILVYPFMQNLSVAYRLRDLKP---------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA 414 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 414 (498)
++|+||+++++|.+++..... ....+++.++..++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 999999999999999874321 123589999999999999999999999 99999999999999999999
Q ss_pred EEeecCccccccccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 415 VLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 415 ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
+|+|||+++........ ......++..|+|||++.+..++.++|||||||+++||+| |+.||....
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~ 227 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 227 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999998765432211 1122335678999999998889999999999999999999 999987543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=271.12 Aligned_cols=206 Identities=28% Similarity=0.398 Sum_probs=172.8
Q ss_pred CCCCCCeeecccceEEEEEEEc------CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
+|+..+.||+|+||.||+|+.. ....+++|.+...........+.+|+++++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677899999999999999853 2357889988755544556789999999999999999999999999999999
Q ss_pred EEecccCCCHHHhhcccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCc
Q 010887 346 VYPFMQNLSVAYRLRDLKP--------------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAAN 405 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~N 405 (498)
++||+.+++|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 9999999999998864321 123588999999999999999999998 99999999999
Q ss_pred EEECCCCcEEEeecCccccccccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 406 ILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 406 ILl~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
|++++++.+||+|||+++........ ......++..|+|||...+..++.++||||||+++|||+| |+.||+...
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999999998765432221 1122335678999999988889999999999999999999 999997543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=273.02 Aligned_cols=202 Identities=27% Similarity=0.401 Sum_probs=171.6
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
++|...+.||+|+||.||+|+.. +++.||+|.++..........+.+|++++++++||||+++++++......++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888999999999999999965 57899999987544444556778999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
++ ++|...+... ...+++..+..++.|+++||+|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 86 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 5888877653 34588999999999999999999999 99999999999999999999999999987654322
Q ss_pred cceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 430 THVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.. .....+++.|+|||.+.+. .++.++|||||||++|||+||+.||....
T Consensus 159 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~ 209 (301)
T cd07873 159 KT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209 (301)
T ss_pred Cc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 1223468899999988653 57889999999999999999999997544
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=267.64 Aligned_cols=199 Identities=27% Similarity=0.351 Sum_probs=163.1
Q ss_pred eeecccceEEEEEEEcC---CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCCC
Q 010887 278 IIGQGGFGKVYKGVLSD---NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLS 354 (498)
Q Consensus 278 ~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 354 (498)
.||+|+||.||+|...+ ...+++|.+...........|.+|++.++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999998543 346888887654444556788999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcc-e
Q 010887 355 VAYRLRDLKPG-EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH-V 432 (498)
Q Consensus 355 L~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~-~ 432 (498)
|.+++...... ....++.....++.|++.|++|||+. +|+||||||+||++++++.+||+|||++......... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999764322 23357888899999999999999999 9999999999999999999999999998754332211 1
Q ss_pred eecccccccccCcccccC-------CCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 433 TTQIRGTMGHIAPEYLST-------GKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
.....++..|+|||+... ..++.++|||||||++|||++ |+.||...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 122335678999998743 356889999999999999999 78888654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=280.54 Aligned_cols=200 Identities=25% Similarity=0.330 Sum_probs=169.0
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCC-----
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS----- 341 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 341 (498)
..++|+..+.||+|+||.||++... .++.||+|++.... .......+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999954 58899999987533 3344567889999999999999999999886543
Q ss_pred -ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecC
Q 010887 342 -ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (498)
Q Consensus 342 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 420 (498)
..++||||+++ ++...+.. .+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 46899999975 55555532 478889999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 421 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 165 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 165 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred ccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 998654321 2234568999999999999899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=269.80 Aligned_cols=200 Identities=28% Similarity=0.393 Sum_probs=165.3
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCC-cchHHHHHHHHHHHHhc---cCCccceEEEEEEcC-----C
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-PGGEAAFQREVHLISVA---IHKNLLQLIGYCTTS-----S 341 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~-----~ 341 (498)
+|++.+.||+|+||+||+|+.. +++.||+|.++.... ......+.+|+++++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999965 688999999874322 22334566777777665 699999999988643 3
Q ss_pred ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCc
Q 010887 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (498)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl 421 (498)
..++++||+++ ++..++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 47899999984 8888876532 24589999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
++....... .....+|..|+|||++.+..++.++||||+||++|||++|++||...
T Consensus 155 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 155 ARIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred cccccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 986653221 23345789999999999889999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=280.62 Aligned_cols=200 Identities=24% Similarity=0.336 Sum_probs=169.0
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCC-----
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS----- 341 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 341 (498)
..++|...+.||+|+||.||++... .++.||||++.... .......+.+|+.+++.++||||+++++++....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3468999999999999999999954 57889999987432 3344567889999999999999999999875432
Q ss_pred -ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecC
Q 010887 342 -ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (498)
Q Consensus 342 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 420 (498)
..++||||+++ ++...+.. .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 46899999975 66665532 378889999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 421 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+++...... ......+|..|+|||++.+..++.++|||||||++|||+||+.||...+
T Consensus 172 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 172 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred CccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 998654322 1233468999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=301.83 Aligned_cols=211 Identities=20% Similarity=0.277 Sum_probs=173.4
Q ss_pred HHHhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEcC--Cc
Q 010887 267 QLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SE 342 (498)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~ 342 (498)
....++|.+.+.||+|+||+||+|+.. .+..+|+|.+... ........|..|+.++++++||||+++++++... ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 345578999999999999999999965 5678899988633 2334567889999999999999999999988653 45
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCcEEcCCCCCcEEECC--------
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN----PKIIHRDLKAANILLDD-------- 410 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~----~~ivH~Dlk~~NILl~~-------- 410 (498)
.++||||+++|+|..++.........+++..++.|+.||+.||+|||+... .+|+||||||+|||++.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 789999999999999998654444579999999999999999999998521 25999999999999964
Q ss_pred ---------CCcEEEeecCccccccccCcceeecccccccccCcccccC--CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 411 ---------NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 411 ---------~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
...+||+|||++....... ......||+.|+|||++.. ..++.++||||||||+|||+||+.||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 2348999999998664322 2234568999999999854 45889999999999999999999999743
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=271.75 Aligned_cols=205 Identities=24% Similarity=0.344 Sum_probs=171.6
Q ss_pred CCCCCCeeecccceEEEEEEEcC------CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 272 NFSESNIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
+|...+.||+|+||.||+|...+ ++.||+|+++..........|.+|+.++++++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 45667889999999999998632 478999999855444445778999999999999999999999999999999
Q ss_pred EEecccCCCHHHhhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCc
Q 010887 346 VYPFMQNLSVAYRLRDLK------------PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 413 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 413 (498)
++||+.+++|.+++.... .....+++..+..++.|++.||+|||+. +++||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 999999999999985321 1123588999999999999999999999 9999999999999999999
Q ss_pred EEEeecCccccccccCc-ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 414 AVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 414 ~ki~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
+||+|||+++....... .......+++.|+|||.+..+.++.++||||||+++|||+| |..||...
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 230 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999886543221 11223345778999999988889999999999999999998 88888654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=264.59 Aligned_cols=194 Identities=27% Similarity=0.424 Sum_probs=163.7
Q ss_pred eecccceEEEEEEEc---CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCCCH
Q 010887 279 IGQGGFGKVYKGVLS---DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV 355 (498)
Q Consensus 279 lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 355 (498)
||+|+||.||+|.+. .+..||+|++.........+.|.+|++++++++||||+++++++. .+..++||||+++++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 899999999999864 345699999876544455677999999999999999999999875 4567899999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCccee--
Q 010887 356 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT-- 433 (498)
Q Consensus 356 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~~-- 433 (498)
.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...........
T Consensus 82 ~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 82 NKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9988742 34689999999999999999999999 999999999999999999999999999986543322211
Q ss_pred ecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 434 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 434 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
....++..|+|||......++.++|||||||++||+++ |+.||...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 202 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM 202 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC
Confidence 11223578999999988889999999999999999997 99999754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=266.55 Aligned_cols=202 Identities=32% Similarity=0.430 Sum_probs=171.5
Q ss_pred hcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
.++|...+.||+|++|.||+|....+..+|+|++.... .....+.+|++++++++|||++++++++. .+..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 35678889999999999999998777789999876432 34567899999999999999999998875 4567899999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++++|.++++... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 82 MGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999997532 34589999999999999999999998 99999999999999999999999999997664432
Q ss_pred cceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
........++..|+|||+..+..++.++||||||+++|||+| |+.||...
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 207 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 222222345678999999998899999999999999999999 89999754
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=265.72 Aligned_cols=205 Identities=29% Similarity=0.413 Sum_probs=170.1
Q ss_pred CCCCCeeecccceEEEEEEEcC----CcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCc-----
Q 010887 273 FSESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE----- 342 (498)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 342 (498)
|.+.+.||+|+||.||+|.... +..||+|+++.. ........+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999999642 367999998743 233445789999999999999999999998876554
Q ss_pred -eEEEEecccCCCHHHhhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeec
Q 010887 343 -RILVYPFMQNLSVAYRLRDLK--PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 419 (498)
Q Consensus 343 -~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~Df 419 (498)
.++++||+++|+|...+.... .....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 689999999999999886432 1234689999999999999999999998 9999999999999999999999999
Q ss_pred CccccccccCcce-eecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 420 GLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 420 Gl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
|+++......... .....++..|+|||+..+..++.++||||||+++|||++ |..||....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~ 220 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE 220 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 9998765433221 112234678999999988889999999999999999999 889987543
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=272.69 Aligned_cols=208 Identities=28% Similarity=0.402 Sum_probs=176.2
Q ss_pred HHhcCCCCCCeeecccceEEEEEEEc------CCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEEcC
Q 010887 268 LATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS 340 (498)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 340 (498)
...++|...+.||+|+||.||++... .+..||+|+++..........+.+|+++++++ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 44567899999999999999999742 24579999987554445567899999999999 799999999999999
Q ss_pred CceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecC
Q 010887 341 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (498)
Q Consensus 341 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 420 (498)
+..++|+||+.+|+|.++++... ...+++.++..++.|++.||+|||+. +++|+||||+||++++++.++++|||
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCc
Confidence 99999999999999999987532 23489999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 421 LAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 421 l~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
+++........ ......++..|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~ 248 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP 248 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC
Confidence 98865433221 1122345678999999999899999999999999999998 999987543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=267.78 Aligned_cols=200 Identities=29% Similarity=0.399 Sum_probs=176.6
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
++|+..+.||.|++|.||+|+.. +++.|++|.+...........+.+|+++++.++|+|++++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36778899999999999999965 68899999987544445667889999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++++|.+++... .+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999988742 689999999999999999999998 99999999999999999999999999998776432
Q ss_pred cceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
. ......++..|+|||+..+..++.++||||||+++|||+||+.||...
T Consensus 153 ~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~ 201 (274)
T cd06609 153 S-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201 (274)
T ss_pred c-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 2 122345788999999999888999999999999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=267.62 Aligned_cols=199 Identities=28% Similarity=0.393 Sum_probs=168.3
Q ss_pred CCCCCeeecccceEEEEEEE-----cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCC--ceEE
Q 010887 273 FSESNIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS--ERIL 345 (498)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~l 345 (498)
|+..+.||+|+||+||++.. .++..||+|.++....+.....|.+|++++++++||||+++++++...+ ..++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37789999999999988653 3577899999875544445678899999999999999999999886543 5789
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
+|||+++++|.+++.. ..+++.++..++.|+++||+|||+. +++||||||+||++++++.++|+|||+++..
T Consensus 86 v~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 9999999999998864 2489999999999999999999999 9999999999999999999999999998866
Q ss_pred cccCcce--eecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 426 DAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 426 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
....... .....++..|+|||......++.++||||||+++|||+||+.|+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 5432211 11223456799999998888999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=273.34 Aligned_cols=197 Identities=24% Similarity=0.366 Sum_probs=160.3
Q ss_pred CCeeecccceEEEEEEEc---CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEc--CCceEEEEecc
Q 010887 276 SNIIGQGGFGKVYKGVLS---DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT--SSERILVYPFM 350 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~ 350 (498)
.+.||+|+||.||+|+.. +++.||+|.+... .....+.+|++++++++||||+++++++.. ....++++||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT---GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC---CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 468999999999999964 4578999988643 233557899999999999999999998864 34578999998
Q ss_pred cCCCHHHhhcccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEE----CCCCcEEEeecCc
Q 010887 351 QNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGL 421 (498)
Q Consensus 351 ~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~ki~DfGl 421 (498)
.+ ++...+.... .....+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 64 7777665321 1123589999999999999999999999 99999999999999 4667899999999
Q ss_pred cccccccCcc--eeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 422 AKLVDAKLTH--VTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 422 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
++........ ......||+.|+|||++.+ ..++.++||||+||++|||+||+.||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 9876543221 1234568999999999876 45899999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=264.80 Aligned_cols=203 Identities=21% Similarity=0.308 Sum_probs=176.3
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecc
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (498)
+|+..+.||+|+||.||++... +++.+++|.++........+.+.+|++++++++||||+++++.+..++..++++||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677899999999999999964 688999999865444456678889999999999999999999999999999999999
Q ss_pred cCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCc
Q 010887 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (498)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~ 430 (498)
+++++.+++.... ...+++.....++.|++.||.|||+. +++|+||||+||++++++.++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 9999999886432 34578999999999999999999999 999999999999999999999999999876643322
Q ss_pred ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
......++..|+|||+..+..++.++|+||||+++|+|++|+.||+...
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 204 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence 1233457889999999998889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=273.48 Aligned_cols=210 Identities=29% Similarity=0.425 Sum_probs=175.2
Q ss_pred HHhcCCCCCCeeecccceEEEEEEEc--------CCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEE
Q 010887 268 LATDNFSESNIIGQGGFGKVYKGVLS--------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT 338 (498)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 338 (498)
...++|.+.+.||+|+||.||+|... ....+|+|.++..........+.+|+++++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 34567888999999999999999742 24568999987655555567889999999999 6999999999999
Q ss_pred cCCceEEEEecccCCCHHHhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcE
Q 010887 339 TSSERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANI 406 (498)
Q Consensus 339 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NI 406 (498)
..+..++++||+++|+|.+++..... ....+++.++..++.|++.||+|||+. +++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeE
Confidence 98899999999999999999975321 124589999999999999999999998 999999999999
Q ss_pred EECCCCcEEEeecCccccccccCcce-eecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 407 LLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 407 Ll~~~~~~ki~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
++++++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999998664322111 111224467999999988889999999999999999999 888987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=265.14 Aligned_cols=201 Identities=26% Similarity=0.408 Sum_probs=173.4
Q ss_pred CCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCC-----cchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 272 NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS-----PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
+|...+.||+|+||.||+|...+++.+|+|.++.... ......+.+|++++++++|+||+++++++...+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4777899999999999999988899999998863221 12345688999999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
+||+++++|.+++.+ ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 999999999999875 23578999999999999999999998 99999999999999999999999999987553
Q ss_pred ccC-----cceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 427 AKL-----THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 427 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
... ........++..|+|||+..+..++.++||||||+++|||+||+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 211 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccC
Confidence 211 11122345788999999999888999999999999999999999999753
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=271.62 Aligned_cols=206 Identities=22% Similarity=0.361 Sum_probs=171.9
Q ss_pred hcCCCCCCeeecccceEEEEEEEcC---------------CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLSD---------------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLI 334 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 334 (498)
.++|++.+.||+|+||.||+++... ...||+|.++..........|.+|++++++++|||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4578889999999999999988542 1248999987654455567899999999999999999999
Q ss_pred EEEEcCCceEEEEecccCCCHHHhhcccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcE
Q 010887 335 GYCTTSSERILVYPFMQNLSVAYRLRDLKP--------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANI 406 (498)
Q Consensus 335 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NI 406 (498)
+++...+..++||||+++++|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 999999999999999999999999864211 112478999999999999999999999 999999999999
Q ss_pred EECCCCcEEEeecCccccccccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh--CCCCCCC
Q 010887 407 LLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT--GQRAIDF 478 (498)
Q Consensus 407 Ll~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt--G~~p~~~ 478 (498)
++++++.+||+|||++......... ......++..|+|||+...+.++.++|||||||+++||+| |..||+.
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 9999999999999998765432211 1122335678999999998899999999999999999998 5567764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=266.82 Aligned_cols=202 Identities=29% Similarity=0.445 Sum_probs=171.9
Q ss_pred CCCCCCeeecccceEEEEEEEcC-C---cEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 272 NFSESNIIGQGGFGKVYKGVLSD-N---TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
+|+..+.||+|+||.||+|.... + ..||+|.++.........+|.+|++++++++||||+++++++..+...++|+
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778999999999999999643 3 3699999876555556788999999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++++|.+++... ...+++.++..++.|++.|++|||+. +++|+||||+||+++.++.++++|||++.....
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 85 EFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999988753 34589999999999999999999998 999999999999999999999999999876643
Q ss_pred cCccee--eccc--ccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 428 KLTHVT--TQIR--GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 428 ~~~~~~--~~~~--gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
...... .... .+..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~ 215 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 215 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC
Confidence 222111 1111 1357999999999999999999999999999987 99999654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=266.10 Aligned_cols=204 Identities=27% Similarity=0.475 Sum_probs=173.5
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CC---cEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DN---TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
.++|+..+.||+|+||.||+|+.. ++ ..+++|.++..........+.+|++++++++|||++++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 456788899999999999999964 23 36999988755445556789999999999999999999999999999999
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
||||+++++|.+++... ...+++.++..++.|++.|++|||+. +++|+||||+||++++++.+|++|||++...
T Consensus 84 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 99999999999998752 34689999999999999999999999 9999999999999999999999999998766
Q ss_pred cccCcceee--cccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 426 DAKLTHVTT--QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 426 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
......... ....+..|+|||++....++.++|||||||++|||+| |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~ 214 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM 214 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 433221111 1223457999999998889999999999999999998 99999643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=270.39 Aligned_cols=207 Identities=23% Similarity=0.359 Sum_probs=173.0
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-----------------CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccce
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-----------------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 332 (498)
.++|++.+.||+|+||.||++... +...+|+|+++..........|.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 457888999999999999998642 234689999875544556678999999999999999999
Q ss_pred EEEEEEcCCceEEEEecccCCCHHHhhcccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCc
Q 010887 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG-------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAAN 405 (498)
Q Consensus 333 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~N 405 (498)
+++++...+..++||||+++++|.+++...... ...+++.+...++.|++.||+|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 999999999999999999999999998753321 13478899999999999999999999 99999999999
Q ss_pred EEECCCCcEEEeecCccccccccCcce-eecccccccccCcccccCCCCCCcccchhHHHHHHHHHh--CCCCCCCC
Q 010887 406 ILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT--GQRAIDFS 479 (498)
Q Consensus 406 ILl~~~~~~ki~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt--G~~p~~~~ 479 (498)
|++++++.++|+|||+++......... .....++..|+|||....+.++.++|||||||++|||+| |..||...
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 999999999999999987654322111 122334678999999888889999999999999999998 66787643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=262.70 Aligned_cols=203 Identities=21% Similarity=0.316 Sum_probs=177.0
Q ss_pred CCCCCCeeecccceEEEEEEE-cCCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 272 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
+|+..+.||+|+||.||.++. .+++.+++|++... .++.....+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477889999999999999994 46889999988633 3445667889999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++++|.+++.... ...+++.++..++.|+++|++|||+. +++|+||+|+||++++++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999987532 34689999999999999999999998 99999999999999999999999999988665433
Q ss_pred cceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
. ......+++.|+|||+..+..++.++||||||+++|||++|+.||+...
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN 205 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC
Confidence 2 2233557899999999988889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=264.86 Aligned_cols=204 Identities=26% Similarity=0.411 Sum_probs=174.5
Q ss_pred HHhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 268 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
+..++|...+.||+|+||.||++...++..+++|.++.. ......|.+|++++++++|+||+++.+++.. ...+++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 345678889999999999999999878888999988642 2345788999999999999999999999887 7789999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.+.....
T Consensus 80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 80 EFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EeCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 9999999999987532 34578999999999999999999998 999999999999999999999999999876644
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
..........++..|+|||++....++.++|+|||||+++|++| |+.||...
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 207 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 207 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC
Confidence 32222222345678999999998889999999999999999999 89999754
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=265.34 Aligned_cols=203 Identities=28% Similarity=0.408 Sum_probs=167.1
Q ss_pred CCCCeeecccceEEEEEEEcCCc---EEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEcC------Cce
Q 010887 274 SESNIIGQGGFGKVYKGVLSDNT---KVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------SER 343 (498)
Q Consensus 274 ~~~~~lG~G~~g~Vy~~~~~~~~---~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~ 343 (498)
.+.+.||+|+||.||+|.+.++. .+|+|.++.. .+......|.+|++++++++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 45788999999999999975432 5899988743 2344567889999999999999999999987532 246
Q ss_pred EEEEecccCCCHHHhhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCc
Q 010887 344 ILVYPFMQNLSVAYRLRDLK--PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl 421 (498)
++++||+++|+|.+++.... .....+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999998875322 2234589999999999999999999998 999999999999999999999999999
Q ss_pred cccccccCccee-ecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 422 AKLVDAKLTHVT-TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 422 ~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
++.......... ....+++.|+|||+..+..++.++||||||+++|||++ |+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 218 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV 218 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 987654322111 22335678999999999999999999999999999999 88999753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=282.59 Aligned_cols=197 Identities=25% Similarity=0.318 Sum_probs=169.2
Q ss_pred hcCCCCCCeeecccceEEEEEEEc---CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS---DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
..+|.+.+.||+|+||.||++... .+..|++|.+... ....+|++++++++||||+++++++......++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 457999999999999999999853 3567999987542 2346899999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
||++. ++|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||+++...
T Consensus 165 ~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 165 MPKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred ehhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 99986 678777743 35689999999999999999999999 99999999999999999999999999997665
Q ss_pred ccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 427 AKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 427 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
..... ......||+.|+|||++....++.++|||||||++|||++|+.||....
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 43222 1234568999999999999999999999999999999999999996543
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=269.33 Aligned_cols=202 Identities=24% Similarity=0.355 Sum_probs=175.7
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.++|+..+.||+|+||+||++... +++.||+|++.....+.....+.+|+++++.++||||+++++++......++|+|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 356777899999999999999964 5888999988754445556789999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++++|.+++.. .+.+++..+..++.+++.+|.|||+.. +++||||+|+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 9999999988765 345899999999999999999999742 7999999999999999999999999998655322
Q ss_pred CcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
. .....|+..|+|||++.+..++.++|+|||||++|||+||+.||+...
T Consensus 158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~ 206 (284)
T cd06620 158 I---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN 206 (284)
T ss_pred c---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 1 123468899999999988899999999999999999999999998543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=267.07 Aligned_cols=201 Identities=25% Similarity=0.377 Sum_probs=171.9
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
++|+..+.||+|++|.||+|+.. +++.||+|++.... .....+.+.+|++++++++|||++++++++......++|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999975 58899999986432 22344678899999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|++++++...... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999888777653 33589999999999999999999998 9999999999999999999999999999876543
Q ss_pred CcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 429 LTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.. ......++..|+|||++.+ ..++.++||||||+++|||+||+.||...
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~ 204 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGK 204 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 21 1223446789999999866 45789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=268.95 Aligned_cols=206 Identities=26% Similarity=0.394 Sum_probs=175.0
Q ss_pred hcCCCCCCeeecccceEEEEEEEcC-----------------CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccce
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLSD-----------------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 332 (498)
..+|+..+.||+|+||.||+|...+ +..||+|++...........+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578889999999999999998643 24589999886555566788999999999999999999
Q ss_pred EEEEEEcCCceEEEEecccCCCHHHhhcccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCc
Q 010887 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP-------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAAN 405 (498)
Q Consensus 333 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~N 405 (498)
+++++...+..++++||+++++|.+++..... ....+++..+..++.|++.||+|||+. +++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999999999999999999999999876431 123689999999999999999999998 99999999999
Q ss_pred EEECCCCcEEEeecCccccccccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh--CCCCCCC
Q 010887 406 ILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT--GQRAIDF 478 (498)
Q Consensus 406 ILl~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt--G~~p~~~ 478 (498)
|++++++.++|+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 99999999999999998765433221 1223445778999999988889999999999999999998 6677764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=290.30 Aligned_cols=207 Identities=24% Similarity=0.314 Sum_probs=172.9
Q ss_pred HhcCCCCCCeeecccceEEEEEEEcCC-cEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCccceEEE-EEEc------
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLSDN-TKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIG-YCTT------ 339 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~-~~~~------ 339 (498)
...++++.+.|.+|||+.||.|....+ ..||+|++-.. ++.......+|+++|++|. |+|||.+++ ....
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 344566789999999999999997665 99999998754 6678889999999999997 999999999 3322
Q ss_pred CCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeec
Q 010887 340 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 419 (498)
Q Consensus 340 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~Df 419 (498)
.-+.++.||||.+|.|-+++..+.. ..|++.++++|+.++++|+++||.. .|+|||||||-+|||++.+++.|||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence 1367899999999999999986543 3499999999999999999999996 778999999999999999999999999
Q ss_pred CccccccccCcc--ee------ecccccccccCcccc---cCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 420 GLAKLVDAKLTH--VT------TQIRGTMGHIAPEYL---STGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 420 Gl~~~~~~~~~~--~~------~~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
|-+......... .. -...-|+.|+|||++ .+...++|+|||++||+||-|+-...||+..
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 988643322111 00 012368999999997 4667899999999999999999999999854
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=269.42 Aligned_cols=200 Identities=22% Similarity=0.354 Sum_probs=173.9
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
.+|+..+.||+|+||.||+|+. .+++.|++|.+..... .....+.+|+++++.++|||++++++.+......++|+||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc-chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 4688889999999999999995 4688999998864332 3457788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++++|.+++.. ..+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999998864 3478999999999999999999999 99999999999999999999999999987654322
Q ss_pred cceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.. .....+++.|+|||...+..++.++|||||||++|||++|+.||....
T Consensus 171 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~ 220 (296)
T cd06654 171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (296)
T ss_pred cc-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 11 223457889999999998889999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=268.64 Aligned_cols=206 Identities=27% Similarity=0.426 Sum_probs=172.8
Q ss_pred cCCCCCCeeecccceEEEEEEEc------CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (498)
.+|...+.||+|+||.||+|+.. ++..+++|.++.. .......+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc-cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 45777889999999999999842 3456888887642 2344567999999999999999999999999999999
Q ss_pred EEEecccCCCHHHhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCC
Q 010887 345 LVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF 412 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~ 412 (498)
+||||+++++|.+++..... ....+++..+..++.|++.|++|||++ +++||||||+||++++++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 99999999999999875321 123589999999999999999999999 999999999999999999
Q ss_pred cEEEeecCccccccccCc-ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 413 EAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 413 ~~ki~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
.++|+|||++........ .......++..|+|||++.+..++.++||||||+++|||+| |+.||....
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 230 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 230 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999876543221 11223446788999999999899999999999999999999 999986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=266.31 Aligned_cols=203 Identities=28% Similarity=0.443 Sum_probs=172.7
Q ss_pred cCCCCCCeeecccceEEEEEEEcC-Cc----EEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLSD-NT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
.+|+..+.||+|+||.||+|...+ +. .+|+|.++..........+.+|++++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 567788999999999999999643 32 5899988755545566789999999999999999999999987 78899
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
|+||+++|+|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||.++..
T Consensus 86 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 99999999999998753 23589999999999999999999998 9999999999999999999999999999876
Q ss_pred cccCccee-ecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 426 DAKLTHVT-TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 426 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
........ ....++..|+|||......++.++|+||||+++||++| |+.||+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 216 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC
Confidence 54322211 11223568999999988889999999999999999999 999998654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=276.43 Aligned_cols=198 Identities=26% Similarity=0.377 Sum_probs=167.5
Q ss_pred HhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcC------
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------ 340 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 340 (498)
..++|+..+.||+|+||.||+|.. .+++.||+|++.... .......+.+|++++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 457899999999999999999995 467899999987432 223446678999999999999999999887543
Q ss_pred CceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecC
Q 010887 341 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (498)
Q Consensus 341 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 420 (498)
...+++++++ +++|...+.. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence 3468889987 6788777653 3589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 421 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 164 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 164 LARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred cceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 99865432 223457999999999876 56899999999999999999999999753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=266.54 Aligned_cols=203 Identities=24% Similarity=0.356 Sum_probs=168.7
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHH-HHhccCCccceEEEEEEcCCceEEEEe
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHL-ISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
++|++.+.||+|+||.||+|+.. +++.||+|+++..........+..|+.. ++..+||||+++++++...+..++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999965 6899999998754433444566667665 566789999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|++ |+|.+.+.........+++..+..++.|++.||+|||+++ +++||||||+||++++++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 6888877654434467999999999999999999999853 7999999999999999999999999998765432
Q ss_pred CcceeecccccccccCcccccC----CCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 429 LTHVTTQIRGTMGHIAPEYLST----GKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||+.
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 1 1122457889999998864 4568899999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=264.61 Aligned_cols=198 Identities=28% Similarity=0.455 Sum_probs=165.4
Q ss_pred CeeecccceEEEEEEEcC-Cc--EEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCceEEEEecccC
Q 010887 277 NIIGQGGFGKVYKGVLSD-NT--KVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFMQN 352 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (498)
+.||+|+||.||+|...+ +. .+++|.++..........+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999754 33 46888887554455667899999999999 799999999999999999999999999
Q ss_pred CCHHHhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecC
Q 010887 353 LSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (498)
Q Consensus 353 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 420 (498)
|+|.++++.... ....+++.++..++.|++.|++|||+. +++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999875321 123588999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 421 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
++........ ......+..|+|||++....++.++|||||||++|||+| |+.||...
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 215 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 215 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 9863321111 111223567999999988889999999999999999997 99999653
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=262.59 Aligned_cols=200 Identities=26% Similarity=0.392 Sum_probs=176.3
Q ss_pred hcCCCCCCeeecccceEEEEEEEcC-CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.++|+..+.||+|+||.||+|...+ ++.+++|.++... ...++.+|++++++++||||+++++++......++++|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH---HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 3678889999999999999999765 7899999986432 26789999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++++|.+.+... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 79 ~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 79 YCGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred cCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 99999999998642 34689999999999999999999999 9999999999999999999999999998876543
Q ss_pred CcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.. ......++..|+|||++.+..++.++||||||+++|||+||+.||...
T Consensus 153 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~ 202 (256)
T cd06612 153 MA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202 (256)
T ss_pred cc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 22 223344788999999999889999999999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=275.94 Aligned_cols=208 Identities=27% Similarity=0.404 Sum_probs=171.4
Q ss_pred HhcCCCCCCeeecccceEEEEEEE------cCCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCC
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSS 341 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 341 (498)
..++|...+.||+|+||.||+|.. .+++.||||+++..........+.+|++++.++ +||||+++++++...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 446788999999999999999973 346789999997544444567788999999999 6899999999886654
Q ss_pred -ceEEEEecccCCCHHHhhcccCC--------------------------------------------------------
Q 010887 342 -ERILVYPFMQNLSVAYRLRDLKP-------------------------------------------------------- 364 (498)
Q Consensus 342 -~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 364 (498)
..++++||+++|+|.++++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 57899999999999998864211
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcc-eeecc
Q 010887 365 -------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQI 436 (498)
Q Consensus 365 -------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~-~~~~~ 436 (498)
....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++......... .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 012478889999999999999999999 9999999999999999999999999998765332211 11223
Q ss_pred cccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 437 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 437 ~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
.++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 285 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 35678999999988899999999999999999997 99999754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=262.84 Aligned_cols=202 Identities=28% Similarity=0.440 Sum_probs=173.3
Q ss_pred cCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecc
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (498)
.+|+..+.||+|+||.||+|.+.+++.+|+|.++... ....+|.+|++++++++|||++++++++......++|+||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA--MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC--CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 4677789999999999999998778899999886432 33567899999999999999999999999999999999999
Q ss_pred cCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCc
Q 010887 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (498)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~ 430 (498)
++++|.+++... ...+++..+..++.|++.+++|||+. +++|+||||+||+++.++.++|+|||+++.......
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 82 EHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 999999988742 23578999999999999999999999 999999999999999999999999999876543322
Q ss_pred ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
.......++.+|+|||+..++.++.++||||||+++|||++ |+.||....
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 206 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS 206 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 11222234678999999998889999999999999999998 999997543
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=263.36 Aligned_cols=201 Identities=26% Similarity=0.366 Sum_probs=169.7
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC----CcchHHHHHHHHHHHHhccCCccceEEEEEEcC--Cce
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY----SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SER 343 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 343 (498)
++|+..+.||+|+||.||+|... ++..|++|.+.... .......+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999964 58899999875221 122356788999999999999999999988764 356
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
++++||+++++|.+++.. ...+++.....++.|++.||+|||+. +++|+||||+||++++++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 789999999999998875 23478888999999999999999999 99999999999999999999999999987
Q ss_pred cccccCcc--eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 424 LVDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 424 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
........ ......++..|+|||...+..++.++|||||||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 211 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence 65432111 12234578899999999888899999999999999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=262.19 Aligned_cols=194 Identities=28% Similarity=0.427 Sum_probs=163.9
Q ss_pred eeecccceEEEEEEEc---CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCC
Q 010887 278 IIGQGGFGKVYKGVLS---DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 353 (498)
Q Consensus 278 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 353 (498)
.||+|+||.||+|.++ ++..+|+|+++... .....+++.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 57889999987432 2344678999999999999999999999875 45678999999999
Q ss_pred CHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCccee
Q 010887 354 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 433 (498)
Q Consensus 354 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~~ 433 (498)
+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++..........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999864 34589999999999999999999999 999999999999999999999999999987654332211
Q ss_pred --ecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 434 --TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 434 --~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
....++..|+|||.+....++.++|||||||++|||+| |+.||...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 202 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 12234578999999988889999999999999999998 99999753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=263.78 Aligned_cols=199 Identities=22% Similarity=0.340 Sum_probs=161.6
Q ss_pred eeecccceEEEEEEEcCC---cEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCCC
Q 010887 278 IIGQGGFGKVYKGVLSDN---TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLS 354 (498)
Q Consensus 278 ~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 354 (498)
.||+|+||.||+|...++ ..+++|.++..........|.+|+++++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999985443 34567766644444566789999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC-ccee
Q 010887 355 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL-THVT 433 (498)
Q Consensus 355 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~-~~~~ 433 (498)
|.++++.........++.....++.|+++||+|||+. +++||||||+||+++.++.++|+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999986433334567778889999999999999998 99999999999999999999999999976432211 1112
Q ss_pred ecccccccccCcccccC-------CCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 434 TQIRGTMGHIAPEYLST-------GKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 434 ~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
....++..|+|||+... ..++.++|||||||++|||++ |+.||+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 212 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL 212 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Confidence 23457889999998743 245789999999999999997 56788643
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=274.64 Aligned_cols=211 Identities=29% Similarity=0.414 Sum_probs=175.6
Q ss_pred HHHhcCCCCCCeeecccceEEEEEEEcC--------CcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEE
Q 010887 267 QLATDNFSESNIIGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYC 337 (498)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 337 (498)
+....+|++.+.||+|+||.||+|.... ...||+|.++.........++.+|+++++++ +||||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 3344568889999999999999998421 2368999887554455667899999999999 799999999999
Q ss_pred EcCCceEEEEecccCCCHHHhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCc
Q 010887 338 TTSSERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAAN 405 (498)
Q Consensus 338 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~N 405 (498)
...+..++++||+++|+|.+++..... ....+++.++..++.|++.||+|||+. +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 999999999999999999999875321 234588999999999999999999998 99999999999
Q ss_pred EEECCCCcEEEeecCccccccccCcce-eecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 406 ILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 406 ILl~~~~~~ki~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
|++++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 999999999999999987654322111 112234567999999999999999999999999999999 888987544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=267.99 Aligned_cols=203 Identities=26% Similarity=0.339 Sum_probs=175.1
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCC--ceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS--ERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 347 (498)
++|+..+.||.|++|.||++... +++.+|+|.+...........+.+|++++++++||||+++++++.... ..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46778899999999999999974 578899999875544455678999999999999999999999986543 578999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++++|.+++.........+++.....++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988775444455689999999999999999999999 999999999999999999999999999875543
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
... ....++..|+|||...+..++.++||||+|+++|||+||+.||+..
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 221 2344678999999999999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=265.18 Aligned_cols=204 Identities=24% Similarity=0.387 Sum_probs=171.9
Q ss_pred hcCCCCCCeeecccceEEEEEEEcC----CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
.++|...+.||+|+||.||+|...+ ...|++|...........+.+.+|++++++++||||+++++++.. +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3567788999999999999999643 246899988755444566789999999999999999999998875 45789
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
||||+++++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence 99999999999998753 23589999999999999999999998 9999999999999999999999999998866
Q ss_pred cccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
............++..|+|||.+....++.++||||||++++|+++ |+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 213 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 5442222222334568999999988889999999999999999996 999997554
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=265.84 Aligned_cols=199 Identities=31% Similarity=0.432 Sum_probs=171.3
Q ss_pred CCCCCeeecccceEEEEEEEcC-CcEEEEEEecccCCcch-HHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecc
Q 010887 273 FSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGG-EAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (498)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (498)
|+..+.||+|+||+||+++... ++.+|+|++........ .....+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4557899999999999999764 56899999975432222 223456999999999999999999999999999999999
Q ss_pred cCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCc
Q 010887 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (498)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~ 430 (498)
++++|.+++.. ...+++..+..++.|+++||+|||+. +++|+||||+||++++++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NN 152 (260)
T ss_dssp TTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TT
T ss_pred ccccccccccc----cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cc
Confidence 99999999983 35689999999999999999999999 999999999999999999999999999875422 12
Q ss_pred ceeecccccccccCccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 431 HVTTQIRGTMGHIAPEYLS-TGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.......++..|+|||... ...++.++||||+|+++++|++|+.||...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2334566899999999998 788999999999999999999999999865
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=284.08 Aligned_cols=193 Identities=23% Similarity=0.301 Sum_probs=165.9
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
...|.+.+.||+|+||.||++... .++.||+|... ...+.+|++++++++|+||+++++++...+..++|++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 446888999999999999999965 47889999542 2345789999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
++. ++|..++... ...++|.++..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 241 ~~~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 241 KYR-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred ccC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 995 6888877642 23689999999999999999999999 9999999999999999999999999999866433
Q ss_pred Ccc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCC
Q 010887 429 LTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 476 (498)
Q Consensus 429 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~ 476 (498)
... ......||..|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 221 122356899999999999999999999999999999999988654
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=266.21 Aligned_cols=202 Identities=26% Similarity=0.384 Sum_probs=170.3
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
+|+..+.||+|++|.||+|+.. ++..||+|+++... .......+.+|++++++++||||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777899999999999999964 68899999986432 233456788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
++ +++.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 688888765332 35689999999999999999999999 99999999999999999999999999987654322
Q ss_pred cceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 430 THVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
. ......+++.|+|||.+.+. .++.++||||||+++|||+||+.||...
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 156 R-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred c-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 1 11223468899999988654 5788999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=269.12 Aligned_cols=208 Identities=28% Similarity=0.431 Sum_probs=175.0
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc------CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCc
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 342 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 342 (498)
..++|+..+.||+|+||.||+|... ++..||+|.+...........|.+|++++++++||||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3567888999999999999999863 4678999998765544556789999999999999999999999999999
Q ss_pred eEEEEecccCCCHHHhhcccCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCC
Q 010887 343 RILVYPFMQNLSVAYRLRDLKP------------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAA 404 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~ 404 (498)
.++|+||+++++|.+++..... ....+++.+++.++.|++.||+|||+. +++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 9999999999999999874321 123578999999999999999999999 9999999999
Q ss_pred cEEECCCCcEEEeecCccccccccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 405 NILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 405 NILl~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
||++++++.++|+|||+++........ .......+..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999998755332211 1122234667999999998899999999999999999998 88888543
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=267.41 Aligned_cols=203 Identities=23% Similarity=0.406 Sum_probs=172.9
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
++|+..+.||+|+||.||++... ++..||+|.++....+.....+.+|++++.+++||||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999975 68999999887544445567899999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++++|..++.... ....+++..+..++.|++.||.|||+.+ +++|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999988887532 1346899999999999999999999632 89999999999999999999999999987654322
Q ss_pred cceeecccccccccCcccccCCC------CCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 430 THVTTQIRGTMGHIAPEYLSTGK------SSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.....++..|+|||.+.+.. ++.++|+|||||++|||+||+.||+..
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 210 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE 210 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence 22334788999999985543 488999999999999999999999643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=267.62 Aligned_cols=203 Identities=27% Similarity=0.359 Sum_probs=170.3
Q ss_pred HhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++++|...+.||+|+||.||+|.. .+++.|++|++...........+.+|+++++.++|+||+++.+++...+..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 346788899999999999999986 4688999999875444444567789999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+. +++.+.+... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++....
T Consensus 83 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9996 6776666532 24578888999999999999999999 999999999999999999999999999875433
Q ss_pred cCcceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.... .....++..|+|||.+.+. .++.++|||||||++|||+||+.||+..
T Consensus 156 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 156 PSQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred CCCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 2211 1233468899999998754 5788999999999999999999999743
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=265.89 Aligned_cols=202 Identities=27% Similarity=0.399 Sum_probs=170.6
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEEcC------
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS------ 340 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------ 340 (498)
+.+.|+..+.||+|+||.||+|... +++.||+|++... ......+.+|++++.++ +|||++++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC--CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 5667888899999999999999964 5788999998643 24456788999999998 699999999998753
Q ss_pred CceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecC
Q 010887 341 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (498)
Q Consensus 341 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 420 (498)
...+++|||+++++|.+++.... ...+++..+..++.|++.|++|||+. +++|+||||+||++++++.++|+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence 35789999999999999987532 34589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCcceeecccccccccCccccc-----CCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 421 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
++........ ......|+..|+|||++. ...++.++|||||||++|||++|+.||+.
T Consensus 157 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~ 218 (272)
T cd06637 157 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218 (272)
T ss_pred Cceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 9876543222 223356889999999986 34578899999999999999999999964
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=266.20 Aligned_cols=199 Identities=26% Similarity=0.406 Sum_probs=169.7
Q ss_pred CCCCCCeeecccceEEEEEEE-----cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcC--CceE
Q 010887 272 NFSESNIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERI 344 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 344 (498)
.|++.+.||+|+||.||++.. .++..||+|.++..........+.+|++++++++|||++++.+++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467789999999999999984 247789999987554445567899999999999999999999998775 4678
Q ss_pred EEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccc
Q 010887 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~ 424 (498)
+||||+++++|.+++... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||+++.
T Consensus 85 lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence 999999999999998642 23589999999999999999999999 999999999999999999999999999986
Q ss_pred ccccCcc--eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCC
Q 010887 425 VDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 476 (498)
Q Consensus 425 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~ 476 (498)
....... ......++..|+|||+..+..++.++||||||+++|||+|++.|.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 6543221 112344667899999998888999999999999999999987765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=261.81 Aligned_cols=202 Identities=26% Similarity=0.365 Sum_probs=170.5
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC----CcchHHHHHHHHHHHHhccCCccceEEEEEEcC--Cce
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY----SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SER 343 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 343 (498)
.+|+..+.||+|+||.||+|... ++..|++|++.... .......+.+|++++++++||||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999964 58899999886321 123346788999999999999999999988753 457
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
++++||+++++|.+.+.. ...+++.....++.|++.||+|||+. +++||||+|+||++++++.++|+|||+++
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999875 23588999999999999999999998 99999999999999999999999999987
Q ss_pred cccccCcc--eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 424 LVDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 424 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
........ ......++..|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 65432111 112345788999999999888999999999999999999999999744
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=253.63 Aligned_cols=201 Identities=25% Similarity=0.358 Sum_probs=174.3
Q ss_pred HhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCC----cc---hHHHHHHHHHHHHhc-cCCccceEEEEEEc
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYS----PG---GEAAFQREVHLISVA-IHKNLLQLIGYCTT 339 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~---~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 339 (498)
..+.|...+.+|.|..+.|.+... .+++++|+|++..... +. -..+-.+|+.+++++ .||+|+++.+++..
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 345678889999999999999885 4688999998863321 11 235567799999998 59999999999999
Q ss_pred CCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeec
Q 010887 340 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 419 (498)
Q Consensus 340 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~Df 419 (498)
+...++|+|.|+.|.|.++|.. .-.+++....+|++|+..|++|||.+ .||||||||+|||+|++.++||+||
T Consensus 95 ~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred cchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence 9999999999999999999986 45689999999999999999999999 9999999999999999999999999
Q ss_pred CccccccccCcceeecccccccccCccccc------CCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLS------TGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 420 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
|++..+.+.. .-...+|||+|+|||.+. ...|+...|+||.|||+|-|+.|-+||-.
T Consensus 168 GFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH 230 (411)
T KOG0599|consen 168 GFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH 230 (411)
T ss_pred ceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH
Confidence 9999887643 345689999999999874 24588899999999999999999999964
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=261.65 Aligned_cols=204 Identities=24% Similarity=0.303 Sum_probs=179.9
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
..++|+..++||+|.||.|-+++-+ .++.+|+|++++.. ...+...-..|-+++...+||.+..+--.++..+..++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 4567888999999999999999954 68899999998543 33456677889999999999999999888999999999
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
||||..||.|..+|.. ...++++...-+-.+|..||.|||++ +||.||||.+|.++|.||++||+|||+++.-
T Consensus 246 VMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc
Confidence 9999999999998876 45688888888999999999999999 9999999999999999999999999999743
Q ss_pred cccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
-. ........+|||.|+|||++....|....|+|.+|||+|||++|+.||...+
T Consensus 319 I~-~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d 372 (516)
T KOG0690|consen 319 IK-YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD 372 (516)
T ss_pred cc-ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc
Confidence 22 1234567899999999999999999999999999999999999999997543
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=260.80 Aligned_cols=200 Identities=32% Similarity=0.484 Sum_probs=173.9
Q ss_pred CeeecccceEEEEEEEcC----CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccC
Q 010887 277 NIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN 352 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (498)
+.||+|+||.||+|.... +..|++|.++..........+.+|++.+..++|+|++++++++......++|+||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999999654 7889999998654444578899999999999999999999999999999999999999
Q ss_pred CCHHHhhcccCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 353 LSVAYRLRDLKPG-----EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 353 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
++|.+++...... ...+++.++..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999864221 36789999999999999999999998 999999999999999999999999999987654
Q ss_pred cCc-ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 428 KLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 428 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
... .......++..|+|||......++.++||||+|++++||++ |+.||+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 211 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL 211 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence 321 12233457889999999988889999999999999999999 69999765
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=261.91 Aligned_cols=205 Identities=30% Similarity=0.418 Sum_probs=177.9
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
++|+..+.||.|+||+||+|... ++..+++|++...........+.+|++.++.++|+|++++++.+...+..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999954 67889999987544444678899999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++++|.+.+..... ...+++.....++.|++.|++|||+. +++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999875332 24689999999999999999999999 99999999999999999999999999987665433
Q ss_pred cc---eeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 430 TH---VTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 430 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.. ......++..|+|||++... .++.++|+|||||++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 210 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY 210 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc
Confidence 22 12334578899999998877 7899999999999999999999999754
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=266.95 Aligned_cols=202 Identities=26% Similarity=0.393 Sum_probs=170.7
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
++|+..+.||+|++|.||+|... +++.||+|.+...........+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999965 67899999987543333445678899999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++ +|.+++... ...+++.....++.|++.||.|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 85 ~~~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LDT-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 985 898887653 23689999999999999999999999 99999999999999999999999999987543221
Q ss_pred cceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 430 THVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.. .....++..|+|||+..+ ..++.++||||+|+++|||++|+.||....
T Consensus 158 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 158 KT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred cc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 11 122345788999999865 457899999999999999999999996543
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=260.88 Aligned_cols=195 Identities=31% Similarity=0.478 Sum_probs=165.4
Q ss_pred CeeecccceEEEEEEEcC----CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccC
Q 010887 277 NIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN 352 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (498)
+.||+|+||.||+|++.. +..+|+|.+.........+++.+|+++++++.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 468999999999998532 26899999876544446678999999999999999999999875 4567999999999
Q ss_pred CCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcce
Q 010887 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (498)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~ 432 (498)
++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999752 3689999999999999999999999 99999999999999999999999999998665433221
Q ss_pred ee--cccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 433 TT--QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 433 ~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
.. ...++..|+|||...+..++.++||||||+++|||+| |+.||+..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~ 202 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC
Confidence 11 1223467999999999999999999999999999998 99999754
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=268.19 Aligned_cols=210 Identities=25% Similarity=0.355 Sum_probs=174.5
Q ss_pred HHHHHHhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEE---
Q 010887 264 RELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT--- 338 (498)
Q Consensus 264 ~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~--- 338 (498)
+.+..+.++|++.+.||+|+||.||++... +++.+|+|.++.. ......+.+|+.+++++ +||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI--HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc--cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 444557789999999999999999999964 5788999987642 23346788899999999 6999999999884
Q ss_pred --cCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEE
Q 010887 339 --TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL 416 (498)
Q Consensus 339 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki 416 (498)
.++..++||||+++++|.+.+.........+++..+..++.|+++||.|||+. +++||||||+||++++++.++|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEE
Confidence 33467999999999999998875433345689999999999999999999998 9999999999999999999999
Q ss_pred eecCccccccccCcceeecccccccccCcccccC-----CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 417 CDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-----GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 417 ~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
+|||+++....... ......|+..|+|||++.. ..++.++|||||||++|||+||+.||...
T Consensus 166 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~ 232 (286)
T cd06638 166 VDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232 (286)
T ss_pred ccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence 99999876643221 1223458899999998753 45788999999999999999999998754
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=261.98 Aligned_cols=197 Identities=30% Similarity=0.387 Sum_probs=169.0
Q ss_pred CeeecccceEEEEEEEcC--C--cEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccC
Q 010887 277 NIIGQGGFGKVYKGVLSD--N--TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN 352 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (498)
+.||+|++|.||+|.+.+ + ..||+|.+.........+.|.+|++++++++||||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999643 2 36899998765443566789999999999999999999999988 888999999999
Q ss_pred CCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcce
Q 010887 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (498)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~ 432 (498)
++|.+++.+... ..+++.....++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999986432 4689999999999999999999999 99999999999999999999999999998765432211
Q ss_pred --eecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 433 --TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 433 --~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
.....++..|+|||+.....++.++||||||+++|||+| |+.||+..
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 204 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL 204 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 122446788999999998899999999999999999999 99999643
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=261.68 Aligned_cols=201 Identities=27% Similarity=0.438 Sum_probs=171.8
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCc--------chHHHHHHHHHHHHhccCCccceEEEEEEcCCc
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP--------GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 342 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 342 (498)
+|.....||+|++|.||+|... +++.+|+|.+...... ...+.+.+|++++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667889999999999999964 5789999988643221 123568899999999999999999999999999
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcc
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~ 422 (498)
.++++||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999875 24588999999999999999999998 9999999999999999999999999998
Q ss_pred ccccccCcc-----eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 423 KLVDAKLTH-----VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 423 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
+........ ......|+..|+|||.+.+..++.++||||||+++|||+||+.||+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 866532111 112245788999999999888999999999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=267.37 Aligned_cols=199 Identities=23% Similarity=0.357 Sum_probs=174.6
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
.+|+..+.||+|+||.||++.. .+++.||+|.+..... .....+.+|+.+++.++|||++++++++..++..++|+||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 5788899999999999999995 5789999999864332 3456788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++++|.+++.+ ..+++.++..++.|++.||.|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999998864 3478999999999999999999999 99999999999999999999999999987654432
Q ss_pred cceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.. .....+++.|+|||...+..++.++|+|||||++|||+||+.||...
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~ 218 (297)
T cd06656 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (297)
T ss_pred cC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 21 22345788999999999988999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=269.37 Aligned_cols=197 Identities=24% Similarity=0.368 Sum_probs=159.5
Q ss_pred CCeeecccceEEEEEEEc---CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEc--CCceEEEEecc
Q 010887 276 SNIIGQGGFGKVYKGVLS---DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT--SSERILVYPFM 350 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~ 350 (498)
...||+|+||.||+|+.. ++..||+|.+... .....+.+|++++++++||||+++++++.. +...++|+||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT---GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC---CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 467999999999999965 3468999988643 233567899999999999999999998854 44678999998
Q ss_pred cCCCHHHhhcccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEE----CCCCcEEEeecCc
Q 010887 351 QNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGL 421 (498)
Q Consensus 351 ~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~ki~DfGl 421 (498)
++ ++.+.+.... .....+++..+..++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 75 6666654211 1223588999999999999999999999 99999999999999 5677999999999
Q ss_pred cccccccCcc--eeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 422 AKLVDAKLTH--VTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 422 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
++........ ......+|+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 9876543221 1233467899999999876 45789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=260.16 Aligned_cols=203 Identities=24% Similarity=0.335 Sum_probs=173.0
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCC-ceEEEEe
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-ERILVYP 348 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e 348 (498)
+|+..+.||+|++|.||++... +++.+++|++... ......+.+.+|++++++++|+|++++++.+...+ ..++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999964 5788999998643 23345667899999999999999999998876444 5789999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++++|.+++.... ...+++.++..++.+++.|++|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999987532 34589999999999999999999999 9999999999999999999999999998766432
Q ss_pred CcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.. ......+++.|+|||+..+..++.++||||||++++||++|+.||+..+
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 206 (257)
T cd08223 156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD 206 (257)
T ss_pred CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 22 2233457889999999999999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=267.20 Aligned_cols=200 Identities=22% Similarity=0.361 Sum_probs=174.8
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
.+|+..+.||.|++|.||+|.. .+++.|++|.+.... ......+.+|+++++.++|||++++++++...+..++|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 3588889999999999999995 578999999886432 23457788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++++|..++.. ..+++.++..++.|++.|++|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 98 LAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred cCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 999999998864 3589999999999999999999999 99999999999999999999999999987654332
Q ss_pred cceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.. .....++..|+|||.+.+..++.++|||||||++|||+||+.||...+
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~ 219 (296)
T cd06655 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (296)
T ss_pred cc-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 223457889999999998889999999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=262.42 Aligned_cols=205 Identities=24% Similarity=0.354 Sum_probs=172.0
Q ss_pred HHHHhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceE
Q 010887 266 LQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (498)
Q Consensus 266 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (498)
++.+++++.....||+|+||.||+|... ++..|++|.+.... ......+.+|++++++++|+||+++++++..++..+
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 3456677777789999999999999954 57789999886432 345678899999999999999999999999999999
Q ss_pred EEEecccCCCHHHhhcccCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECC-CCcEEEeecCc
Q 010887 345 LVYPFMQNLSVAYRLRDLKPGEKGL--DWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDFGL 421 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~ki~DfGl 421 (498)
+|+||+++++|.+++.... ..+ ++..+..++.|++.||+|||+. +|+||||||+||+++. ++.++|+|||.
T Consensus 82 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~ 155 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGT 155 (268)
T ss_pred EEEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchh
Confidence 9999999999999987521 234 7888899999999999999999 9999999999999976 67999999999
Q ss_pred cccccccCcceeecccccccccCcccccCCC--CCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
+........ ......++..|+|||++.... ++.++||||||+++|||++|+.||..
T Consensus 156 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 156 SKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred heecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 876543221 122345788999999986543 78899999999999999999999964
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=266.91 Aligned_cols=213 Identities=28% Similarity=0.378 Sum_probs=176.5
Q ss_pred cCHHHHHHHhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEE
Q 010887 261 FSCRELQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT 338 (498)
Q Consensus 261 ~~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 338 (498)
+.+.++..+.++|+..+.||+|+||.||++.. .+++.+|+|++... ......+.+|+.++.++ +|||++++++++.
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI--SDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc--ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 33455555688999999999999999999996 46889999988642 23346778899999998 7999999999987
Q ss_pred cCC-----ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCc
Q 010887 339 TSS-----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 413 (498)
Q Consensus 339 ~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 413 (498)
..+ ..++|+||+++++|.+.++........+++..+..++.|++.||+|||+. +++||||||+||++++++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence 543 57899999999999998875443445689999999999999999999998 9999999999999999999
Q ss_pred EEEeecCccccccccCcceeecccccccccCcccccCC-----CCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 414 AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-----KSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 414 ~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
+||+|||++......... .....++..|+|||.+... .++.++|||||||++|||++|+.||...
T Consensus 167 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~ 236 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236 (291)
T ss_pred EEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence 999999998765432211 2234578899999997643 3688999999999999999999999754
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=264.17 Aligned_cols=199 Identities=29% Similarity=0.374 Sum_probs=169.2
Q ss_pred CCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEeccc
Q 010887 273 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQ 351 (498)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 351 (498)
|++.+.||+|+||.||+|... ++..+++|.+... .......+.+|+++++.++|||++++++++...+..++|+||++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC-CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 566788999999999999975 4677888887532 33456788999999999999999999999999999999999999
Q ss_pred CCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcc
Q 010887 352 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 431 (498)
Q Consensus 352 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~ 431 (498)
+++|...+... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 86 ~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~- 158 (282)
T cd06643 86 GGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 158 (282)
T ss_pred CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence 99998887642 34689999999999999999999999 999999999999999999999999999876543221
Q ss_pred eeecccccccccCccccc-----CCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 432 VTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 432 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
......++..|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 211 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc
Confidence 223345789999999974 345788999999999999999999998743
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=260.70 Aligned_cols=202 Identities=25% Similarity=0.347 Sum_probs=171.1
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEeccc----CCcchHHHHHHHHHHHHhccCCccceEEEEEEcC--Cce
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY----YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SER 343 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 343 (498)
.+|...+.||+|+||.||+|.. .++..|++|++... ........+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999996 45889999987522 1234456889999999999999999999998764 357
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
++++||+++++|.+.+.. ...+++.....++.|++.||.|||+. +++|+||||+||++++++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999998874 23578999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCc--ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 424 LVDAKLT--HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 424 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
....... .......++..|+|||++.+..++.++|+|||||+++||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 6543211 1112345788999999999888999999999999999999999999743
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=263.93 Aligned_cols=199 Identities=28% Similarity=0.340 Sum_probs=171.0
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
++|...+.||+|+||.||+|+. .+++.||+|.++... ......+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 4677788999999999999995 468899999886432 23446688899999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++++|.+++.. ...+++.+...++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 88 CGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 999999998864 34689999999999999999999999 99999999999999999999999999987654322
Q ss_pred cceeecccccccccCccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 430 THVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
. ......|+..|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 161 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~ 211 (267)
T cd06645 161 A-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred c-ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccc
Confidence 1 123346889999999874 45688899999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=285.88 Aligned_cols=202 Identities=22% Similarity=0.323 Sum_probs=165.0
Q ss_pred HHHHHhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCC------ccceEEEEE
Q 010887 265 ELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK------NLLQLIGYC 337 (498)
Q Consensus 265 el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~l~~~~ 337 (498)
++....++|++.+.||+|+||+||+|... .++.||||+++.. ......+..|+++++.++|. +++++++++
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV--PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc--hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 33445678999999999999999999964 5788999998642 12344566788888777654 588888888
Q ss_pred EcC-CceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEEcCCCCCcEEECCCC---
Q 010887 338 TTS-SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNF--- 412 (498)
Q Consensus 338 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~--- 412 (498)
... ...++||+++ +++|.+++.. ...+++..+..++.||+.||+|||+ . +|+||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccc
Confidence 765 4678888887 6788888764 3468999999999999999999997 5 899999999999998765
Q ss_pred -------------cEEEeecCccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 413 -------------EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 413 -------------~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||+..
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 499999998764322 223456899999999999999999999999999999999999999864
Q ss_pred c
Q 010887 480 R 480 (498)
Q Consensus 480 ~ 480 (498)
.
T Consensus 349 ~ 349 (467)
T PTZ00284 349 D 349 (467)
T ss_pred C
Confidence 3
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=263.02 Aligned_cols=205 Identities=25% Similarity=0.362 Sum_probs=173.0
Q ss_pred cCCCCCCeeecccceEEEEEEEc------CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (498)
++|+..+.||+|+||.||+|+.+ +.+.+++|.+...........+.+|++++++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888999999999999999964 245789998764333334678999999999999999999999999989999
Q ss_pred EEEecccCCCHHHhhcccCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeec
Q 010887 345 LVYPFMQNLSVAYRLRDLKPG-----EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 419 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~Df 419 (498)
+||||+++++|.+++...... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998754321 12689999999999999999999999 9999999999999999999999999
Q ss_pred CccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCC
Q 010887 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDF 478 (498)
Q Consensus 420 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~ 478 (498)
|++...............++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~ 221 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG 221 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 9987544322222233346778999999988889999999999999999999 7888854
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=268.41 Aligned_cols=205 Identities=26% Similarity=0.298 Sum_probs=174.9
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCc--chHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP--GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|+..+.||+|++|.||+|... +++.+|+|.+...... .....+.+|+++++.++||||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36788899999999999999965 4899999998743322 24567899999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+.+++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999999887432 34689999999999999999999999 999999999999999999999999999875532
Q ss_pred cCcc----------------------------eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 428 KLTH----------------------------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 428 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.... ......|+..|+|||+..+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 2110 011235788999999999888999999999999999999999999754
Q ss_pred c
Q 010887 480 R 480 (498)
Q Consensus 480 ~ 480 (498)
+
T Consensus 236 ~ 236 (316)
T cd05574 236 N 236 (316)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=259.14 Aligned_cols=198 Identities=31% Similarity=0.446 Sum_probs=173.5
Q ss_pred hcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
.++|+..+.||.|+||.||+|.. .++.||+|.++.... ..+.+.+|+.++++++|+||+++++++......++||||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 45788899999999999999987 478999999975432 567899999999999999999999999998999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||.++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 82 MAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 99999999987532 23689999999999999999999999 99999999999999999999999999998664322
Q ss_pred cceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
. ....+..|+|||++..+.++.++||||||+++|||++ |+.||...
T Consensus 157 ~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 203 (256)
T cd05039 157 D----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred c----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence 1 2234568999999988899999999999999999998 99998754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=266.76 Aligned_cols=203 Identities=25% Similarity=0.322 Sum_probs=172.2
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|+..+.||+|+||.||++... .++.|++|.+.... .......+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999965 57889999887432 1234567889999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++++|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999875 34589999999999999999999998 999999999999999999999999999864211
Q ss_pred cCc--------------ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 428 KLT--------------HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 428 ~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
... .......++..|+|||++....++.++|+||||+++|||+||+.||....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~ 220 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 220 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 100 00112346789999999988889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=273.22 Aligned_cols=193 Identities=24% Similarity=0.324 Sum_probs=164.4
Q ss_pred HHhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 268 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
....+|++.+.||+|+||.||+|+.. +++.||+|..... ....|+.++++++||||+++++++......++|
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 34567999999999999999999965 4678999975432 235689999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
+||+. ++|.+++... ...+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 136 ~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 136 LPHYS-SDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EEccC-CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 99995 5888877642 34689999999999999999999999 99999999999999999999999999987543
Q ss_pred ccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCC
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 476 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~ 476 (498)
... ......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 209 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 209 VAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 221 123356899999999999999999999999999999999965544
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=259.70 Aligned_cols=201 Identities=29% Similarity=0.419 Sum_probs=174.6
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCC-cchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
+|+..+.||+|+||.||+|... +++.|++|.++.... +.....+.+|+++++.++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777899999999999999964 688999999874432 24678899999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++++|.+++.. ...+++..+..++.|+++|++|||+. +++|+||+|+||++++++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999998875 33578999999999999999999999 99999999999999999999999999988765433
Q ss_pred cceee---cccccccccCcccccCCC---CCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 430 THVTT---QIRGTMGHIAPEYLSTGK---SSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 430 ~~~~~---~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
..... ...++..|+|||++.... .+.++||||||+++||+++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 32211 345788999999998766 889999999999999999999999743
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=264.32 Aligned_cols=205 Identities=25% Similarity=0.412 Sum_probs=172.2
Q ss_pred cCCCCCCeeecccceEEEEEEEc------CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (498)
.++...+.||+|+||.||++... ++..+++|.++.. .......|.+|+++++.++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 46777899999999999999742 3567889987643 3455678999999999999999999999999999999
Q ss_pred EEEecccCCCHHHhhcccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCc
Q 010887 345 LVYPFMQNLSVAYRLRDLKP-----------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 413 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 413 (498)
+++||+++++|.+++..... ....+++..+..++.|++.|++|||+. +++||||||+||++++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence 99999999999999875322 113589999999999999999999998 9999999999999999999
Q ss_pred EEEeecCccccccccCcce-eecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 414 AVLCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 414 ~ki~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
+||+|||++.......... .....+++.|+|||+..+..++.++|||||||++|||+| |+.||...
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 228 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC
Confidence 9999999987554322111 122335678999999999999999999999999999999 99998643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=270.30 Aligned_cols=199 Identities=20% Similarity=0.217 Sum_probs=165.0
Q ss_pred CCCeeecc--cceEEEEEEE-cCCcEEEEEEecccCC-cchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecc
Q 010887 275 ESNIIGQG--GFGKVYKGVL-SDNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (498)
Q Consensus 275 ~~~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (498)
..++||+| +|++||+++. .+++.||+|+++.... ......+.+|+++++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 7899999995 4689999999974432 234466778999999999999999999999999999999999
Q ss_pred cCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCc
Q 010887 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (498)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~ 430 (498)
++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999986432 23589999999999999999999998 999999999999999999999999986543321111
Q ss_pred c------eeecccccccccCcccccC--CCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 431 H------VTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 431 ~------~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||+.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 0 0112346778999999876 4588999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=266.83 Aligned_cols=201 Identities=27% Similarity=0.403 Sum_probs=171.3
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
++|+..+.||+|+||.||+|..+ +++.||+|++.... .....+.+.+|+++++.++||||+++++++......++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46788899999999999999975 58899999886433 22345678899999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|++++++.+.... ...+++.++..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999888876653 23489999999999999999999999 9999999999999999999999999998766443
Q ss_pred CcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 429 LTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.. ......++..|+|||+..+ ..++.++||||||+++|||++|+.||...
T Consensus 154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~ 204 (286)
T cd07846 154 GE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204 (286)
T ss_pred cc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence 22 1223457889999999865 44788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=260.22 Aligned_cols=202 Identities=27% Similarity=0.328 Sum_probs=175.1
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.++|+..+.||+|+||.||+|... +++.+++|.+..... .....+.+|++++++++||||+++++++......+++||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch-hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 357888999999999999999964 578899999874332 356788999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++++|.+++... ...+++.++..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 81 YCGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred CCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 99999999988752 24689999999999999999999998 9999999999999999999999999998765532
Q ss_pred CcceeecccccccccCcccccCC---CCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTG---KSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.. ......++..|+|||..... .++.++||||||+++|||+||+.||...
T Consensus 155 ~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~ 207 (262)
T cd06613 155 IA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207 (262)
T ss_pred hh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 21 12234578899999999776 7899999999999999999999999754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=258.36 Aligned_cols=199 Identities=28% Similarity=0.423 Sum_probs=173.0
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC----CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY----SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
+|+..+.||+|++|.||+|... +++.|++|.+.... .....+.+.+|+++++.++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999976 78999999886322 123457899999999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
+||+++++|.+++.. ...+++..+..++.|++.|++|||+. +++|+||+|+||++++++.+||+|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999875 24588999999999999999999999 99999999999999999999999999987654
Q ss_pred ccCcceeecccccccccCcccccCCC-CCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
... ......++..|+|||...... ++.++|+||||+++|||++|+.||...
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~ 205 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL 205 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence 432 223455788999999987766 899999999999999999999999654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=263.50 Aligned_cols=200 Identities=26% Similarity=0.396 Sum_probs=176.4
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
++|+..+.||+|++|.||++... +++.+++|++...........+.+|++++++++||||+++++.+......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999975 58899999987655455667899999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
+++++|.+++.... ..+++.....++.|++.|++|||+ . +++|+||||+||++++++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999987532 568899999999999999999999 7 9999999999999999999999999998765432
Q ss_pred CcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
... ...++..|+|||+..+..++.++||||||+++|||++|+.||...
T Consensus 155 ~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 155 LAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred Hhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 221 155788999999999999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=263.06 Aligned_cols=199 Identities=27% Similarity=0.375 Sum_probs=174.3
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecc
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (498)
.|+..+.||+|+||.||+|... ++..||+|.+...........+.+|++++++++||||+++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4667888999999999999965 578999999875444456678999999999999999999999999999999999999
Q ss_pred cCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCc
Q 010887 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (498)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~ 430 (498)
++++|.+++.. ..+++.+...++.|++.|++|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 85 GGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999998863 3578899999999999999999998 999999999999999999999999999976644322
Q ss_pred ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
......++..|+|||++.+..++.++|+|||||++|||+||+.||...
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 204 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 122345788999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=257.45 Aligned_cols=198 Identities=31% Similarity=0.484 Sum_probs=169.7
Q ss_pred CeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCCCHH
Q 010887 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVA 356 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 356 (498)
+.||+|+||.||++...+++.|++|+++..........+.+|++++++++|+||+++++++......++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46899999999999987799999999876544445678999999999999999999999999999999999999999999
Q ss_pred HhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCccee-ec
Q 010887 357 YRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT-TQ 435 (498)
Q Consensus 357 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~~-~~ 435 (498)
+++... ...+++..+..++.+++.+++|||++ +++||||||+||+++.++.++|+|||++........... ..
T Consensus 81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 998652 23578999999999999999999999 999999999999999999999999999876543221111 11
Q ss_pred ccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 436 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 436 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
..++..|+|||.+.++.++.++|+|||||++|||+| |..||....
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~ 200 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS 200 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC
Confidence 223567999999988899999999999999999999 888886543
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=266.22 Aligned_cols=198 Identities=27% Similarity=0.380 Sum_probs=172.0
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecc
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (498)
.|+..+.||+|+||.||+|... ++..||+|.+...........+.+|++++++++||||+++++++..+...++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3555678999999999999864 578899998875444455678999999999999999999999999999999999999
Q ss_pred cCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCc
Q 010887 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (498)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~ 430 (498)
++++|.+++.. ..+++..+..++.|+++|+.|||+. +++|+||+|+||++++++.++++|||++........
T Consensus 85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999988753 3588999999999999999999998 999999999999999999999999999876653221
Q ss_pred ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
......++..|+|||++.+..++.++|||||||++|||+||+.|+..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcc
Confidence 12234578899999999988899999999999999999999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-32 Score=262.34 Aligned_cols=200 Identities=27% Similarity=0.378 Sum_probs=167.9
Q ss_pred cCCCCCCeeecccceEEEEEEEc-----CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcC--Cce
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SER 343 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 343 (498)
++|++.+.||+|+||.||++... ++..||+|+++.. .....+.|.+|++++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 46788899999999999999842 5788999998643 334567889999999999999999999987543 457
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
++|+||+++++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++
T Consensus 83 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred EEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccc
Confidence 8999999999999998753 23589999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCccee--ecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 010887 424 LVDAKLTHVT--TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 477 (498)
Q Consensus 424 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~ 477 (498)
.......... ....++..|+|||+..+..++.++|||||||++|||++|..|+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 7654322111 11223456999999998899999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-32 Score=261.62 Aligned_cols=200 Identities=27% Similarity=0.418 Sum_probs=173.6
Q ss_pred CCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhcc---CCccceEEEEEEcCCceEEEE
Q 010887 272 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI---HKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 347 (498)
.|+..+.||+|+||.||+|.. .+++.|++|.++.........++.+|++++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467788999999999999996 5688999999875545556678899999999997 999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++++|.+++.. ..+++.....++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999988764 2589999999999999999999999 999999999999999999999999999887654
Q ss_pred cCcceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.... .....|+..|+|||+..++ .++.++|+|||||++|||++|+.||....
T Consensus 154 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~ 206 (277)
T cd06917 154 NSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD 206 (277)
T ss_pred Cccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4322 2234588899999988654 46889999999999999999999997543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=259.86 Aligned_cols=205 Identities=24% Similarity=0.309 Sum_probs=175.3
Q ss_pred CCCCCCeeecccceEEEEEEE-cCCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEcC--CceEEEE
Q 010887 272 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERILVY 347 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 347 (498)
+|+..+.||.|+||.||++.. .+++.+++|+++.. ........+.+|++++++++||||+++++++... ...++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477789999999999999995 46788999998743 2344567788999999999999999999987643 4578999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCcEEcCCCCCcEEECCCCcEEEeecCcc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH-----EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-----~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~ 422 (498)
||+++++|.+++.........+++..+..++.|++.||+||| +. +++|+||+|+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999865444567999999999999999999999 66 8999999999999999999999999999
Q ss_pred ccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
......... .....++..|+|||++.+..++.++|+||||+++++|++|+.||+...
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 214 (265)
T cd08217 158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214 (265)
T ss_pred ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence 876543321 223457899999999999889999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=264.04 Aligned_cols=202 Identities=29% Similarity=0.377 Sum_probs=173.3
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.++|++.+.||+|+||.||++... ++..+|+|.++.. .......|.+|++++++++||||+++++.+..+...++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 456888999999999999999964 6789999988632 33456789999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++++|.+++... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 83 FCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred ccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 99999999988752 24589999999999999999999999 9999999999999999999999999998755432
Q ss_pred CcceeecccccccccCccccc-----CCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 429 LTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.. ......++..|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~ 211 (280)
T cd06611 157 LQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211 (280)
T ss_pred cc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence 22 122345789999999974 345678999999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-32 Score=258.52 Aligned_cols=201 Identities=25% Similarity=0.383 Sum_probs=178.0
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
++|+..+.||+|++|.||+|... +++.|++|++.....+.....+.+|++.+.+++|+|++++++++......++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888999999999999999976 48999999987544435578899999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
+++++|.+++... ..+++..+..++.|+++|++|||+ . +++||||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999998753 568999999999999999999999 8 9999999999999999999999999998866543
Q ss_pred CcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.... ....++..|+|||...+..++.++|+||||+++|||+||+.||...
T Consensus 154 ~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 203 (264)
T cd06623 154 LDQC-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPP 203 (264)
T ss_pred CCcc-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 3221 2345788999999999999999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=267.57 Aligned_cols=203 Identities=27% Similarity=0.463 Sum_probs=169.8
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCc----EEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (498)
.++|+..+.||+|+||.||+|.+. ++. .+|+|.+.....+.....+.+|+.+++.++||||+++++++... ...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356778899999999999999853 343 47889887554445556789999999999999999999998754 467
Q ss_pred EEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccc
Q 010887 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~ 424 (498)
++++|+++|+|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence 899999999999988742 23588999999999999999999999 999999999999999999999999999986
Q ss_pred ccccCcce-eecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 425 VDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 425 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
........ .....++..|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~ 215 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 65332221 122345678999999998899999999999999999998 99999753
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=262.39 Aligned_cols=197 Identities=27% Similarity=0.381 Sum_probs=177.9
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecc
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (498)
-|.+.++||+|+||.||+|..+ .|+.+|+|.+.- +.+.+++..|+.++.+.+.|++|+++|.+......++|||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV---~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV---DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc---cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 3666889999999999999954 689999998863 356889999999999999999999999999999999999999
Q ss_pred cCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCc
Q 010887 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (498)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~ 430 (498)
.-|+..+.++-. ++++++.++..+.+..++||+|||.. .-+|||||+.|||++.+|++|++|||.+..+.+...
T Consensus 111 GAGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 111 GAGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred CCCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 999999988742 56799999999999999999999998 889999999999999999999999999987765433
Q ss_pred ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
. ...+.||+.|||||++..-.|+.++||||+|+...||.-|++||..
T Consensus 185 K-RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsD 231 (502)
T KOG0574|consen 185 K-RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSD 231 (502)
T ss_pred h-hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccc
Confidence 2 3557899999999999999999999999999999999999999974
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=264.47 Aligned_cols=202 Identities=24% Similarity=0.360 Sum_probs=173.5
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
++|+..+.||+|+||.||+|... +++.|++|+++... .......+.+|++++++++|+||+++++++...+..++|+|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999965 57899999987432 33445788999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|++++.+...... ...+++.++..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 9998776655543 34589999999999999999999999 9999999999999999999999999998876654
Q ss_pred CcceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.........++..|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 33223335578899999999888 7899999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=263.13 Aligned_cols=200 Identities=30% Similarity=0.462 Sum_probs=168.0
Q ss_pred CeeecccceEEEEEEEcC-------CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 277 NIIGQGGFGKVYKGVLSD-------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
+.||+|+||.||+|+..+ +..+++|.+...........+.+|+++++.++||||+++++++...+..++|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999999643 2578999886544445667899999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCC-----cEEEeecCc
Q 010887 350 MQNLSVAYRLRDLKP---GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-----EAVLCDFGL 421 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-----~~ki~DfGl 421 (498)
+++++|.+++..... ....+++.++..++.|++.||+|||+. +++|+||||+||+++++. .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999975322 224588999999999999999999998 999999999999999877 899999999
Q ss_pred cccccccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 422 AKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 422 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
++........ ......++..|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~ 217 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence 8765432211 1122335678999999999999999999999999999998 99998743
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=266.51 Aligned_cols=208 Identities=25% Similarity=0.341 Sum_probs=176.8
Q ss_pred HHHhcCCCCCCeeecccceEEEEEEEcC-CcEEEEEEecccC--CcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCc
Q 010887 267 QLATDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSE 342 (498)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 342 (498)
++...+|....+||+|+||.|-+|.-+. .+.+|||++++.. ...+.+--..|-++|+.. +-|.++++..++++.+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 4445578899999999999999998654 5679999998543 223344456677777765 46789999999999999
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcc
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~ 422 (498)
.++||||+.||+|..++++. +.+.++.+.-+|.+||-||-|||++ +|+.||||..||++|.+|++||+|||++
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred eeeEEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccc
Confidence 99999999999999999863 4577888999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCccc
Q 010887 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLE 482 (498)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~~~ 482 (498)
+.---+ ...+...+||+.|+|||++...+|...+|+|||||+||||+.|++||+..+.+
T Consensus 498 KEni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~ 556 (683)
T KOG0696|consen 498 KENIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED 556 (683)
T ss_pred cccccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 743222 22345689999999999999999999999999999999999999999976543
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=262.51 Aligned_cols=201 Identities=26% Similarity=0.335 Sum_probs=172.9
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
+|++.+.||+|++|.||+|... +++.|++|++.... .......+.+|++++++++||||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4777899999999999999964 68899999987543 234467899999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+ +++|.+.+.... ..+++.++..++.|+++||+|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999887532 4689999999999999999999999 99999999999999999999999999988765433
Q ss_pred cceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 430 THVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
........++..|+|||.+.+. .++.++||||+|++++||+||+.||...
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 204 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE 204 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence 2222334578999999998654 4689999999999999999998888643
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=276.63 Aligned_cols=195 Identities=30% Similarity=0.385 Sum_probs=169.3
Q ss_pred CCCCCCeeecccceEEEEEEE-cCCcEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 272 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
-|+..+.||+|+||.||-|+. .+...||||++.-. .+.....++..|++.+.+++|||++.+.|++......++|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 356678899999999999994 57788999998622 233345788999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
||- ||-.+.+.-. .+++.+.++..|..+.+.||+|||+. +.||||||+.|||+++.|.+|++|||.+....+
T Consensus 107 YCl-GSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P- 178 (948)
T KOG0577|consen 107 YCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP- 178 (948)
T ss_pred HHh-ccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence 996 4666666542 45788999999999999999999999 999999999999999999999999999987765
Q ss_pred CcceeecccccccccCccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 429 LTHVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
...+.|||.|||||++. .+.|+-|+||||+|++..||.-.++|+-.
T Consensus 179 ----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn 227 (948)
T KOG0577|consen 179 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 227 (948)
T ss_pred ----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC
Confidence 34567999999999974 67899999999999999999999998753
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-32 Score=257.82 Aligned_cols=198 Identities=29% Similarity=0.396 Sum_probs=169.0
Q ss_pred hcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEE-cCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT-TSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e 348 (498)
.++|...+.||+|+||.||++.. .+..+++|.++.. ...+.|.+|++++++++|+|++++++++. ..+..++++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC---chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 35788899999999999999987 4788999988642 34567899999999999999999999765 4456899999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++++|.++++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+|++|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 81 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred CCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 999999999987532 33589999999999999999999999 9999999999999999999999999998755432
Q ss_pred CcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
. ....++..|+|||+.....++.++||||||+++|||++ |+.||....
T Consensus 156 ~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~ 204 (256)
T cd05082 156 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred C----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 2 12234568999999988889999999999999999998 999987543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-32 Score=258.09 Aligned_cols=203 Identities=22% Similarity=0.324 Sum_probs=174.9
Q ss_pred CCCCCCeeecccceEEEEEEE-cCCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 272 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
+|+..+.||+|+||.+|++.. .+++.|++|++... .......++.+|++++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 477889999999999999995 46889999998643 2334557889999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++++|.+.+.... ...+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 99999999887522 23578999999999999999999998 99999999999999999999999999987664432
Q ss_pred cceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.. .....|++.|+|||+..+..++.++|+|||||+++||+||+.||....
T Consensus 156 ~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08218 156 EL-ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN 205 (256)
T ss_pred hh-hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC
Confidence 21 223457889999999998889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=272.96 Aligned_cols=212 Identities=26% Similarity=0.378 Sum_probs=185.0
Q ss_pred HhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
....|.+.+.||+|.|+.|..|+. ..+..||+|.+.+.. .......+.+|+++|..++|||||+++.+...+...++|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 345788899999999999999995 468999999987543 334456689999999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|||..+|.+.+++.. ...+....+..+..|+.++++|+|++ .|+|||||++|||++.++++||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence 999999999999986 33456688889999999999999999 99999999999999999999999999999887
Q ss_pred ccCcceeecccccccccCcccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCcccccccccc
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL 489 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvvl~elltG~~p~~~~~~~~~~~~~l 489 (498)
. .......+|++.|.|||++.+.+| .+++|+||+||++|-|+.|..||+.....+-....+
T Consensus 207 ~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl 268 (596)
T KOG0586|consen 207 Y--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVL 268 (596)
T ss_pred c--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhe
Confidence 4 334566789999999999998876 678999999999999999999999877665444333
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=256.63 Aligned_cols=202 Identities=31% Similarity=0.486 Sum_probs=173.6
Q ss_pred CCCCCeeecccceEEEEEEEcC-----CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 273 FSESNIIGQGGFGKVYKGVLSD-----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
+++.+.||.|+||.||++...+ +..||+|+++..........+.+|++.+..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567889999999999999754 37899999976554446788999999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++++|.+++.... ...+++.++..++.|++.||+|||+. +++|+||||+||++++++.++|+|||+++....
T Consensus 81 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999987532 12289999999999999999999999 999999999999999999999999999987655
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
..........++..|+|||...+..++.++||||+|++++||++ |+.||+..
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~ 208 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM 208 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 42222222336789999999988889999999999999999999 88888753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=258.72 Aligned_cols=192 Identities=25% Similarity=0.354 Sum_probs=159.5
Q ss_pred CeeecccceEEEEEEEcC-------------CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCce
Q 010887 277 NIIGQGGFGKVYKGVLSD-------------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 343 (498)
+.||+|+||.||+|+... ...|++|.+.... ......|.+|+.+++.++||||+++++++......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 468999999999998532 2258888876432 34456788999999999999999999999999999
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCc-------EEE
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE-------AVL 416 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~-------~ki 416 (498)
++||||+++++|..++... ...+++..+..++.||++||+|||+. +++||||||+||+++.++. +++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence 9999999999998887642 34589999999999999999999999 9999999999999987664 899
Q ss_pred eecCccccccccCcceeecccccccccCccccc-CCCCCCcccchhHHHHHHHHH-hCCCCCCCCc
Q 010887 417 CDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS-TGKSSEKTDVFGYGITLLELV-TGQRAIDFSR 480 (498)
Q Consensus 417 ~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~Gvvl~ell-tG~~p~~~~~ 480 (498)
+|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+....
T Consensus 154 ~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (262)
T cd05077 154 SDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT 214 (262)
T ss_pred CCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 999998655322 2234678899999886 466899999999999999998 5888887543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=260.55 Aligned_cols=204 Identities=24% Similarity=0.353 Sum_probs=173.4
Q ss_pred CCCCCCeeecccceEEEEEEEcC--CcEEEEEEeccc---------CCcchHHHHHHHHHHHHh-ccCCccceEEEEEEc
Q 010887 272 NFSESNIIGQGGFGKVYKGVLSD--NTKVAVKRLQDY---------YSPGGEAAFQREVHLISV-AIHKNLLQLIGYCTT 339 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~---------~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~ 339 (498)
+|++.+.||+|+||.||+|.... ++.+|+|.+... ........+.+|++++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778999999999999999765 678999987532 122334567788888875 799999999999999
Q ss_pred CCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEEcCCCCCcEEECCCCcEEEee
Q 010887 340 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNFEAVLCD 418 (498)
Q Consensus 340 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~ki~D 418 (498)
.+..+++|||+++++|.+.+.........+++..++.++.|++.||.|||+ . +++|+||+|+||++++++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999886544445568999999999999999999996 5 799999999999999999999999
Q ss_pred cCccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 419 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
||.+....... ......++..|+|||...+..++.++||||||+++|||++|+.||....
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~ 217 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN 217 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC
Confidence 99998665432 2234567889999999998889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=259.23 Aligned_cols=201 Identities=26% Similarity=0.409 Sum_probs=169.8
Q ss_pred CCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCC---------cchHHHHHHHHHHHHhccCCccceEEEEEEcCC
Q 010887 272 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYS---------PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS 341 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 341 (498)
+|...+.||+|+||.||+|.. .+++.+|+|.++.... ....+.+.+|++++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 466788999999999999985 4688999998753211 012356788999999999999999999999999
Q ss_pred ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCc
Q 010887 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (498)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl 421 (498)
..++|+||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++++|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999998753 4689999999999999999999998 999999999999999999999999999
Q ss_pred cccccccCcc-eeecccccccccCcccccCCC--CCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 422 AKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 422 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
++........ ......++..|+|||...... ++.++|+||||+++||+++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 215 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc
Confidence 8765432211 122345788999999987654 789999999999999999999999643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=258.47 Aligned_cols=196 Identities=31% Similarity=0.456 Sum_probs=161.1
Q ss_pred CeeecccceEEEEEEEcC----CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEc-CCceEEEEeccc
Q 010887 277 NIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-SSERILVYPFMQ 351 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~ 351 (498)
+.||+|+||.||+|.+.+ ...+|+|++...........+.+|+.+++.++||||+++++++.. ++..++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998532 357999988644444556788999999999999999999998764 456789999999
Q ss_pred CCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcc
Q 010887 352 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 431 (498)
Q Consensus 352 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~ 431 (498)
+++|.+++.... ...++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 999999987532 3467888899999999999999998 9999999999999999999999999998755432111
Q ss_pred ---eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhC-CCCCCC
Q 010887 432 ---VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG-QRAIDF 478 (498)
Q Consensus 432 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG-~~p~~~ 478 (498)
......++..|+|||+..+..++.++|||||||++|||++| ..||..
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~ 205 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 205 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 11123456789999999888999999999999999999995 556653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=256.29 Aligned_cols=202 Identities=24% Similarity=0.361 Sum_probs=173.9
Q ss_pred CCCCCCeeecccceEEEEEEE-cCCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 272 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
+|+..+.||+|+||.||++.. .+++.+|+|++... ........+.+|++++++++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477889999999999999996 46888999998643 2344567899999999999999999999999989999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCC-CcEEEeecCcccccccc
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~ki~DfGl~~~~~~~ 428 (498)
+++++|.+++.... ...+++..+..++.+++++++|||+. +++|+||+|+||+++++ +.+|++|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999997532 34589999999999999999999999 99999999999999855 46899999999876543
Q ss_pred CcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.. .....++..|+|||......++.++||||||+++|||++|+.||+..+
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 205 (256)
T cd08220 156 SK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN 205 (256)
T ss_pred cc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc
Confidence 21 223457889999999998889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=261.54 Aligned_cols=200 Identities=25% Similarity=0.322 Sum_probs=170.2
Q ss_pred CCCCCCeeecccceEEEEEEE----cCCcEEEEEEecccC---CcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCce
Q 010887 272 NFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY---SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER 343 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 343 (498)
+|+..+.||+|+||.||+++. .++..||+|+++... .....+.+.+|++++.++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467789999999999999986 368899999987432 123446788899999999 599999999999988889
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
++|+||+++++|.+++.. ...+++.....++.|++.||.|||+. +++||||+|+||++++++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999875 34588999999999999999999998 99999999999999999999999999998
Q ss_pred cccccCcceeecccccccccCcccccCC--CCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTG--KSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
..............|+..|+|||..... .++.++||||||+++|||+||+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 6654322222345588999999998753 467899999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=258.62 Aligned_cols=201 Identities=27% Similarity=0.380 Sum_probs=172.5
Q ss_pred CCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCC-----cchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 272 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYS-----PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
+|+..+.||+|++|.||++.. .+++.+|+|.++.... ......+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999995 5688999999864321 1235688999999999999999999999999999999
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCC-cEEEeecCcccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCDFGLAKL 424 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~ki~DfGl~~~ 424 (498)
|+||+++++|.+++.+ ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++ .++|+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999875 34688999999999999999999999 999999999999998776 599999999877
Q ss_pred ccccCcc---eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 425 VDAKLTH---VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 425 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
....... ......++..|+|||...+..++.++||||+|++++||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 211 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAE 211 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 6543211 112345788999999998888999999999999999999999999743
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=261.34 Aligned_cols=203 Identities=26% Similarity=0.403 Sum_probs=172.5
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecc
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (498)
+|+..+.||+|++|.||+|+.. +++.||+|+++..........+.+|++++++++||||+++++++...+..++|+||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999975 588999999875544455677889999999999999999999999999999999999
Q ss_pred cCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCc
Q 010887 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (498)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~ 430 (498)
++ ++.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++++|||++........
T Consensus 81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 85 88887764322 34689999999999999999999998 999999999999999999999999999976543322
Q ss_pred ceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 431 HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
. .....++..|++||++.+. .++.++|||||||++|||++|+.||....
T Consensus 156 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 205 (284)
T cd07836 156 T-FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205 (284)
T ss_pred c-cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 1223468899999988654 56889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=261.33 Aligned_cols=202 Identities=27% Similarity=0.370 Sum_probs=171.9
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.+.|++.+.||+|+||.||+|+.. +++.+++|.+... .......+.+|+++++.++|||++++++.+..+...++|||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 356888999999999999999965 4788999998643 34456788999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|++++++...+... ...+++..+..++.|++.+++|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 90 ~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 90 FCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred cCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 99999998877542 24589999999999999999999998 9999999999999999999999999998754332
Q ss_pred CcceeecccccccccCccccc-----CCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 429 LTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.. ......++..|+|||++. ...++.++|||||||++|||+||+.||...
T Consensus 164 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 218 (292)
T cd06644 164 LQ-RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218 (292)
T ss_pred cc-ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence 11 122345788999999984 345688999999999999999999998643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=264.99 Aligned_cols=199 Identities=26% Similarity=0.366 Sum_probs=167.2
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
+|+..+.||+|+||.||+|+.. +|+.+++|+++... .......+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4677889999999999999964 68899999986432 223346778899999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
++ +++.+++... ...+++..+..++.||++||.|||+. +++||||||+||+++.++.++|+|||+++......
T Consensus 81 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 97 4777776542 34589999999999999999999999 99999999999999999999999999987654332
Q ss_pred cceeecccccccccCcccccCCC-CCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 430 THVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
.. .....++..|+|||.+.+.. ++.++|||||||++|||+||+.|+..
T Consensus 154 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~ 202 (284)
T cd07839 154 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 202 (284)
T ss_pred CC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 21 12345688999999986644 68999999999999999999988643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=259.83 Aligned_cols=200 Identities=28% Similarity=0.353 Sum_probs=175.9
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
+|+..+.||.|+||.||+|... +++.||+|.+.... .....+.+.+|++++++++||||+++++.+.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999975 58899999986432 22456789999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+.+++|.+++.. ...+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999875 24689999999999999999999998 9999999999999999999999999998766543
Q ss_pred CcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
. ......++..|+|||...+..++.++|+||||+++|+|++|+.||+...
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 2 1233557889999999988889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=257.60 Aligned_cols=189 Identities=29% Similarity=0.411 Sum_probs=160.1
Q ss_pred CeeecccceEEEEEEEcCCc-----------EEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 277 NIIGQGGFGKVYKGVLSDNT-----------KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
+.||+|+||.||+|...+.. .+++|.+..... ....|.+|++++++++||||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR--DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh--hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 46899999999999976433 477787654322 26889999999999999999999999988 77899
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCC-------cEEEee
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-------EAVLCD 418 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-------~~ki~D 418 (498)
|+||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++ .+||+|
T Consensus 78 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 78 VEEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence 999999999999987532 2689999999999999999999998 999999999999999887 799999
Q ss_pred cCccccccccCcceeecccccccccCcccccCC--CCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG--KSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 419 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
||++...... ....++..|+|||++... .++.++|||||||++|||++ |..||...
T Consensus 152 fg~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~ 210 (259)
T cd05037 152 PGIPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL 210 (259)
T ss_pred CCcccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence 9998765431 123456789999999876 78999999999999999999 57777654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=252.88 Aligned_cols=196 Identities=25% Similarity=0.384 Sum_probs=166.7
Q ss_pred CCeeecccceEEEEEE-EcCCcEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCccceEEEEEEcCCceEEEEecccCC
Q 010887 276 SNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYPFMQNL 353 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 353 (498)
.+.||+|+|+.|--++ ..++.++|||++.+. .........+|++++.+.+ |+||+++++++.++...|+|||-|.||
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG 161 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence 4679999999999998 778999999999754 3456778889999999875 999999999999999999999999999
Q ss_pred CHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCC---cEEEeecCccccccc--c
Q 010887 354 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF---EAVLCDFGLAKLVDA--K 428 (498)
Q Consensus 354 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~ki~DfGl~~~~~~--~ 428 (498)
+|..+++. ...+++.++.++..+|+.||.|||.+ +|.||||||+|||-.+.. -+||+||.+..-... +
T Consensus 162 plLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 162 PLLSHIQK----RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred hHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 99999987 45789999999999999999999999 999999999999996443 479999998754321 1
Q ss_pred Ccce----eecccccccccCccccc-----CCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 429 LTHV----TTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 429 ~~~~----~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
-+.. -....|+..|||||+.. ...|+.++|.||+|||+|-|++|++||...
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~ 294 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH 294 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence 1111 12356888999999863 346899999999999999999999999753
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-33 Score=276.15 Aligned_cols=197 Identities=27% Similarity=0.396 Sum_probs=167.7
Q ss_pred CCCeeecccceEEEEEEEc-CCcEEEE---EEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCc--eEEEEe
Q 010887 275 ESNIIGQGGFGKVYKGVLS-DNTKVAV---KRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE--RILVYP 348 (498)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~~-~~~~vav---K~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e 348 (498)
...+||+|+|-+||||.+. +|.+||= |.-.-..++.....|..|+++|+.|+||||++++.++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3678999999999999964 4666643 222223355667899999999999999999999999987665 678999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEEC-CCCcEEEeecCccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~ki~DfGl~~~~~~ 427 (498)
.|..|+|..++++. +.++....++|++||++||.|||++ .|+|+|||||-+||+++ ..|.+||+|.|+|.....
T Consensus 124 L~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999874 3578889999999999999999997 67899999999999996 568999999999998765
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+. ...+.|||.|||||++. ..|+...||||||+.++||+|+..||....
T Consensus 199 s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~ 247 (632)
T KOG0584|consen 199 SH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT 247 (632)
T ss_pred cc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC
Confidence 32 23478999999999987 789999999999999999999999997554
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=258.68 Aligned_cols=198 Identities=28% Similarity=0.387 Sum_probs=172.9
Q ss_pred CCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecc
Q 010887 272 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (498)
-|+..+.||+|+||.||+|.. .++..+|+|.+...........+.+|++++++++||||+++++++..++..++|+||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 366788999999999999986 4678999998865444455678999999999999999999999999999999999999
Q ss_pred cCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCc
Q 010887 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (498)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~ 430 (498)
++++|.+++.. ..+++..+..++.|++.++.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 85 GGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 99999988863 3588999999999999999999998 999999999999999999999999999876643221
Q ss_pred ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
......++..|+|||+..+..++.++|+|||||++|||++|+.||..
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 203 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE 203 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 12234578899999999888899999999999999999999999964
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=265.04 Aligned_cols=195 Identities=24% Similarity=0.311 Sum_probs=169.0
Q ss_pred CCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCC
Q 010887 275 ESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 353 (498)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 353 (498)
....||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++|||++++++++..++..++|+||++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc-cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 3457999999999999964 68899999986432 234567889999999999999999999999999999999999999
Q ss_pred CHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCccee
Q 010887 354 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 433 (498)
Q Consensus 354 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~~ 433 (498)
+|...+.. ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++........ ..
T Consensus 104 ~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~ 174 (297)
T cd06659 104 ALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KR 174 (297)
T ss_pred CHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cc
Confidence 99887753 3589999999999999999999999 999999999999999999999999999875543322 12
Q ss_pred ecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 434 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 434 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
....++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 220 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD 220 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2345789999999999888999999999999999999999999643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=264.32 Aligned_cols=197 Identities=23% Similarity=0.343 Sum_probs=169.6
Q ss_pred CCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEeccc
Q 010887 273 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQ 351 (498)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 351 (498)
|.....||+|+||.||++... ++..||+|.+... .......+.+|+..++.++||||+++++.+...+..++||||++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR-KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc-hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 333567999999999999964 6889999988642 23445678899999999999999999999999999999999999
Q ss_pred CCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcc
Q 010887 352 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 431 (498)
Q Consensus 352 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~ 431 (498)
+++|.+++.. ..+++.++..++.||+.||+|||+. +++||||||+||++++++.++|+|||++.........
T Consensus 103 ~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~ 174 (292)
T cd06658 103 GGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK 174 (292)
T ss_pred CCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence 9999988753 3488999999999999999999999 9999999999999999999999999998755432221
Q ss_pred eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 432 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 432 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.....++..|+|||+..+..++.++|||||||++|||++|+.||...
T Consensus 175 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 221 (292)
T cd06658 175 -RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE 221 (292)
T ss_pred -CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 22345789999999998888999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-32 Score=261.77 Aligned_cols=201 Identities=28% Similarity=0.403 Sum_probs=169.7
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
+|+..+.||+|++|.||+|+.. +++.|++|+++... .......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999964 68899999887432 233446789999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+. ++|..++.... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 68888876532 34689999999999999999999998 99999999999999999999999999987654322
Q ss_pred cceeecccccccccCcccccCCC-CCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 430 THVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.. .....++..|+|||...+.. ++.++||||||+++|||+||+.||...
T Consensus 155 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 155 RT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred cc-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 21 12234678999999886644 588999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-33 Score=276.27 Aligned_cols=193 Identities=27% Similarity=0.418 Sum_probs=166.2
Q ss_pred CeeecccceEEEEEEEcC-CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCCCH
Q 010887 277 NIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV 355 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 355 (498)
-+||+|.||+||.|++.+ ...+|||-+....+ ...+-...|+.+-++++|.|||+++|.+.+++..-+.||.++||+|
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds-r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS-REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccc-hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 379999999999999654 55689998875433 4556778899999999999999999999999998999999999999
Q ss_pred HHhhcccCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEEC-CCCcEEEeecCccccccccCcce
Q 010887 356 AYRLRDLKPGEKGL--DWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHV 432 (498)
Q Consensus 356 ~~~l~~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~ki~DfGl~~~~~~~~~~~ 432 (498)
.+.|+.. -+++ .+.+.-.+..||++||.|||++ .|||||||-+|||++ -.|.+||+|||.++.+..- ...
T Consensus 660 SsLLrsk---WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~ 732 (1226)
T KOG4279|consen 660 SSLLRSK---WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPC 732 (1226)
T ss_pred HHHHHhc---cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC-Ccc
Confidence 9999852 2344 6777888899999999999999 999999999999995 6789999999999877532 233
Q ss_pred eecccccccccCcccccCC--CCCCcccchhHHHHHHHHHhCCCCCC
Q 010887 433 TTQIRGTMGHIAPEYLSTG--KSSEKTDVFGYGITLLELVTGQRAID 477 (498)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gvvl~elltG~~p~~ 477 (498)
+...-||..|||||++..+ .|...+|||||||.+.||.||++||-
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ 779 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFV 779 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCee
Confidence 4556799999999999875 48899999999999999999999995
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=261.03 Aligned_cols=199 Identities=24% Similarity=0.369 Sum_probs=173.6
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
++|...+.||+|+||.||++.. .+++.|++|.+... .......+.+|+.++++++|||++++++++...+..++|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ-QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc-cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 5788899999999999999985 46788999988632 223457789999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++++|.+++.. ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 999999998864 3478999999999999999999999 99999999999999999999999999987654432
Q ss_pred cceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.. .....+++.|+|||.+....++.++|||||||++||+++|+.||...
T Consensus 170 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~ 218 (293)
T cd06647 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (293)
T ss_pred cc-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 22 22345788999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=263.96 Aligned_cols=205 Identities=22% Similarity=0.301 Sum_probs=178.8
Q ss_pred CCCCCCeeecccceEEEEEE-EcCCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 272 NFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
-|...+.||+|.|..|-+|+ .-+|..||||++.+.. +........+|++.|+.++|||||+++++...+...|+|.|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 46667889999999999998 4589999999996432 344567788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEE-CCCCcEEEeecCcccccccc
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL-DDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl-~~~~~~ki~DfGl~~~~~~~ 428 (498)
-++|+|.+++... +.++.+....+++.||..|+.|+|+. .+|||||||+||.+ ..-|-+|+.|||++..+.+.
T Consensus 99 GD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 99 GDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred cCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999863 45699999999999999999999999 89999999999866 67789999999999877664
Q ss_pred CcceeecccccccccCcccccCCCCCC-cccchhHHHHHHHHHhCCCCCCCCccccc
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGKSSE-KTDVFGYGITLLELVTGQRAIDFSRLEEE 484 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~s~Gvvl~elltG~~p~~~~~~~~~ 484 (498)
.. -...+|+..|-|||++.+..|+. ..||||+|||||.|++|+.||+.....|.
T Consensus 173 ~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET 227 (864)
T KOG4717|consen 173 KK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET 227 (864)
T ss_pred ch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh
Confidence 33 34578999999999999998865 57999999999999999999987655444
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=257.58 Aligned_cols=204 Identities=31% Similarity=0.427 Sum_probs=172.9
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCC-----
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSS----- 341 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~----- 341 (498)
++++|+..+.||+|++|.||+|... +++.+++|++.... .....+.+|+++++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 5688999999999999999999975 57889999886432 3457789999999998 6999999999997654
Q ss_pred -ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecC
Q 010887 342 -ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (498)
Q Consensus 342 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 420 (498)
..++||||+++++|.+.+.........+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence 47999999999999998876443345789999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCcceeecccccccccCcccccC-----CCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLST-----GKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 421 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
.+......... .....++..|+|||++.. ..++.++|||||||+++||+||+.||..
T Consensus 159 ~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 220 (275)
T cd06608 159 VSAQLDSTLGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220 (275)
T ss_pred cceecccchhh-hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence 98765432221 223457889999998753 3467899999999999999999999964
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=276.12 Aligned_cols=200 Identities=29% Similarity=0.404 Sum_probs=173.7
Q ss_pred CCCeeecccceEEEEEEEcC--Cc--EEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecc
Q 010887 275 ESNIIGQGGFGKVYKGVLSD--NT--KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (498)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~~~--~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (498)
..++||+|.||.|++|.|.. |+ .||||.++...-.....+|.+|+.+|-+++|||+++++|...+ ....+|+|..
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 36789999999999999853 43 5899999865544477999999999999999999999999988 5678999999
Q ss_pred cCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCc
Q 010887 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (498)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~ 430 (498)
+.|+|.+.|++ .....+-......++.|||.||.||..+ ++|||||.++|+|+-....+||+|||+++.+.....
T Consensus 193 plGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 193 PLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred ccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 99999999997 3356788888899999999999999999 999999999999999999999999999998876544
Q ss_pred cee--ecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 431 HVT--TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 431 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
... ....-...|+|||.+..++++.++|||+|||++|||+| |..||-...
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~ 320 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR 320 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC
Confidence 322 23334578999999999999999999999999999999 788997643
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=259.54 Aligned_cols=210 Identities=26% Similarity=0.382 Sum_probs=173.8
Q ss_pred CHHHHHHHhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEEc
Q 010887 262 SCRELQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT 339 (498)
Q Consensus 262 ~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 339 (498)
++.++..+.+.|+..+.||+|+||.||+|.. .+++.+|+|.+... .....++..|+.++.++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--EDEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC--hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 4455555778899999999999999999996 46788999987532 23456788899999998 69999999999853
Q ss_pred ------CCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCc
Q 010887 340 ------SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 413 (498)
Q Consensus 340 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 413 (498)
....+++|||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +++|+||+|+||++++++.
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence 346789999999999999887533 23578888999999999999999999 9999999999999999999
Q ss_pred EEEeecCccccccccCcceeecccccccccCccccc-----CCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 414 AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 414 ~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
++|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||+||+.||...
T Consensus 160 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 160 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred EEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 99999999875543221 122345788999999875 346788999999999999999999999643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-31 Score=257.89 Aligned_cols=192 Identities=28% Similarity=0.352 Sum_probs=159.0
Q ss_pred eeecccceEEEEEEEc-CCcEEEEEEecccCC--cchHHHHHHHHHHHHh---ccCCccceEEEEEEcCCceEEEEeccc
Q 010887 278 IIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS--PGGEAAFQREVHLISV---AIHKNLLQLIGYCTTSSERILVYPFMQ 351 (498)
Q Consensus 278 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~---l~h~niv~l~~~~~~~~~~~lv~e~~~ 351 (498)
.||+|+||.||++... +++.+|+|.+..... ......+.+|..++.. .+|||++.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 588999998864322 1223344555544443 479999999999999999999999999
Q ss_pred CCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcc
Q 010887 352 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 431 (498)
Q Consensus 352 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~ 431 (498)
+++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++++|||++.......
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 9999988875 34689999999999999999999999 99999999999999999999999999987554322
Q ss_pred eeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 432 VTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 432 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.....|+..|+|||...+ ..++.++|||||||+++||+||+.||...
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 199 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence 123458999999999864 55789999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=255.24 Aligned_cols=197 Identities=31% Similarity=0.445 Sum_probs=168.2
Q ss_pred cCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecc
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (498)
++|++.+.||+|+||.||++.. .++.||+|.++.. .....+.+|+.++++++|||++++++++... ..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD---VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc---chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 4678899999999999999975 6788999988642 2356789999999999999999999998654 478999999
Q ss_pred cCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCc
Q 010887 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (498)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~ 430 (498)
++++|.+++.... ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 81 SKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred CCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 9999999987532 33589999999999999999999998 99999999999999999999999999987543321
Q ss_pred ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcc
Q 010887 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRL 481 (498)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~~ 481 (498)
.....+..|+|||++.+..++.++|+||||+++|||++ |+.||.....
T Consensus 155 ---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 203 (254)
T cd05083 155 ---DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL 203 (254)
T ss_pred ---CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH
Confidence 11233568999999988899999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=258.08 Aligned_cols=194 Identities=28% Similarity=0.380 Sum_probs=166.8
Q ss_pred eecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCCCH
Q 010887 279 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV 355 (498)
Q Consensus 279 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 355 (498)
||+|+||+||++... +++.+++|.+.... .......+.+|++++++++|||++++++.+...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 68899999886322 223455678899999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcceeec
Q 010887 356 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 435 (498)
Q Consensus 356 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~~~~ 435 (498)
.+++.... ...+++.++..++.|++.||.|||+. +++||||+|+||++++++.++|+|||.+....... ....
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~ 153 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKG 153 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccc
Confidence 99887532 24689999999999999999999999 99999999999999999999999999987654321 1223
Q ss_pred ccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 436 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 436 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
..++..|+|||+..+..++.++|||||||+++||++|+.||...
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 197 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR 197 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence 45678999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=283.87 Aligned_cols=203 Identities=20% Similarity=0.298 Sum_probs=160.1
Q ss_pred HhcCCCCCCeeecccceEEEEEEEcC--CcEEEEEE--------------ecc--cCCcchHHHHHHHHHHHHhccCCcc
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLSD--NTKVAVKR--------------LQD--YYSPGGEAAFQREVHLISVAIHKNL 330 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~--------------~~~--~~~~~~~~~~~~e~~~l~~l~h~ni 330 (498)
..++|++.+.||+|+||+||++..+. +...+.|. +.. .........+.+|++++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999987532 11222221 110 0112345678899999999999999
Q ss_pred ceEEEEEEcCCceEEEEecccCCCHHHhhcccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEEC
Q 010887 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD 409 (498)
Q Consensus 331 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~ 409 (498)
+++++++...+..++|++++. +++.+++.... .............++.|++.||+|||+. +|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 999999999999999999986 46666654321 1122234566778999999999999999 999999999999999
Q ss_pred CCCcEEEeecCccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCC
Q 010887 410 DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRA 475 (498)
Q Consensus 410 ~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p 475 (498)
.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|+.+
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 999999999999987754433333445689999999999999999999999999999999998753
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=255.01 Aligned_cols=193 Identities=27% Similarity=0.331 Sum_probs=169.3
Q ss_pred eecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCCCH
Q 010887 279 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV 355 (498)
Q Consensus 279 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 355 (498)
||.|++|.||+++.. +++.+++|++.... .......+.+|++++++++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999975 48899999986432 224557899999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcceeec
Q 010887 356 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 435 (498)
Q Consensus 356 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~~~~ 435 (498)
.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||.+....... ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 999875 23488999999999999999999998 99999999999999999999999999998765432 1223
Q ss_pred ccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 436 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 436 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
..++..|++||.+....++.++|+||||+++|||++|+.||....
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 457889999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=257.86 Aligned_cols=202 Identities=25% Similarity=0.376 Sum_probs=176.4
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
.++.|+..+.||+|++|.||+|... +++.+++|++..... ....+.+|++++++++|+|++++++++......++++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 4566888899999999999999976 688999999874332 5678899999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 95 e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 95 EYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 9999999999998632 3689999999999999999999998 999999999999999999999999999875543
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
... ......++..|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 169 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~ 219 (286)
T cd06614 169 EKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE 219 (286)
T ss_pred chh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 321 122344788999999998888999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=261.13 Aligned_cols=199 Identities=27% Similarity=0.322 Sum_probs=168.9
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCC----cchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS----PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
+|+..+.||+|++|.||+|... +++.|++|+++.... ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3677889999999999999964 688999999974332 22345677899999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|||+ +++|.+++.... ..+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||+++...
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 899999987522 3689999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
..... .....++..|+|||.+.+ ..++.++|||||||+++||++|..||+.
T Consensus 154 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~ 205 (298)
T cd07841 154 SPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG 205 (298)
T ss_pred CCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccC
Confidence 43221 122345788999998854 4578999999999999999999888764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=259.00 Aligned_cols=190 Identities=27% Similarity=0.334 Sum_probs=157.1
Q ss_pred eeecccceEEEEEEEcC-------------------------CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccce
Q 010887 278 IIGQGGFGKVYKGVLSD-------------------------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332 (498)
Q Consensus 278 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 332 (498)
.||+|+||.||+|.+.. ...|++|++.... ......|.+|++++++++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence 58999999999998421 1348888886432 234467888999999999999999
Q ss_pred EEEEEEcCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCC
Q 010887 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF 412 (498)
Q Consensus 333 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~ 412 (498)
+++++......++||||+++|+|..++... ...+++..+..++.|+++||+|||+. +|+||||||+||++++.+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccC
Confidence 999999999999999999999999888642 34689999999999999999999999 999999999999997543
Q ss_pred -------cEEEeecCccccccccCcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHH-HhCCCCCCCC
Q 010887 413 -------EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLEL-VTGQRAIDFS 479 (498)
Q Consensus 413 -------~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~el-ltG~~p~~~~ 479 (498)
.++++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++||| ++|+.||...
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 225 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER 225 (274)
T ss_pred cccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 3799999987644321 12346788999998865 5689999999999999998 4799999754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=259.40 Aligned_cols=204 Identities=23% Similarity=0.309 Sum_probs=168.0
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhcc-CCccceEEEEEEcCCc-----
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSE----- 342 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~----- 342 (498)
++|+..+.||+|+||.||+|... +++.||+|.++... .......+.+|+++++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999965 68899999886432 2234467889999999995 6999999999887665
Q ss_pred eEEEEecccCCCHHHhhcccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECC-CCcEEEeecC
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPG-EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDFG 420 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~ki~DfG 420 (498)
.++||||+++ ++..++...... ...+++..+..++.||+.||+|||+. +++||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 788887653322 35689999999999999999999999 9999999999999998 8899999999
Q ss_pred ccccccccCcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 421 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
+++........ .....+++.|+|||++.+ ..++.++||||||+++|||+||+.||...
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 215 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence 98765432211 122346788999998865 45789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=266.33 Aligned_cols=201 Identities=23% Similarity=0.413 Sum_probs=167.8
Q ss_pred hcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCC-----ce
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-----ER 343 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~ 343 (498)
.++|++.+.||+|+||.||+|.. .+++.||+|.++..........+.+|++++++++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46799999999999999999995 4688999999875434445677889999999999999999998876543 47
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
++|+||+.+ ++...+.. ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.
T Consensus 84 ~lv~e~~~~-~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELMET-DLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 899999974 77666643 3589999999999999999999999 99999999999999999999999999987
Q ss_pred cccccCcce--eecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 424 LVDAKLTHV--TTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 424 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
......... .....|+..|+|||.+.+ ..++.++|||||||++|||+||+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 654322111 123457899999998754 56889999999999999999999999653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=252.51 Aligned_cols=206 Identities=25% Similarity=0.370 Sum_probs=171.4
Q ss_pred hcCCCCCCeeecccceEEEEEEEcC-----CcEEEEEEecccCC-cchHHHHHHHHHHHHhccCCccceEEEEEEc-CCc
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLSD-----NTKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKNLLQLIGYCTT-SSE 342 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~ 342 (498)
...|+....||+|.||.||+|.-.+ +..+|+|+++...+ .+-.....+|+.+++.++|||++.+..++.+ +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3578889999999999999997332 23689999985432 2345677899999999999999999998877 667
Q ss_pred eEEEEecccCCCHHHhhcccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCC----CcEEEe
Q 010887 343 RILVYPFMQNLSVAYRLRDLK-PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN----FEAVLC 417 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~----~~~ki~ 417 (498)
.++++||.+. +|...++..+ .....++...+++|..||+.|+.|||++ =|.||||||.|||+..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence 8999999986 7777776332 2335789999999999999999999999 79999999999999766 999999
Q ss_pred ecCccccccccCcce--eecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 418 DFGLAKLVDAKLTHV--TTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 418 DfGl~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
|+|+++.+.++.... ...+.-|..|+|||.+.+. .|+...||||.|||+.||+|-++.|...
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 999999887654432 2446679999999999886 4899999999999999999999877653
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=257.52 Aligned_cols=203 Identities=27% Similarity=0.383 Sum_probs=172.2
Q ss_pred cCCCCCCeeecccceEEEEEEEc-----CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEc--CCce
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT--SSER 343 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 343 (498)
++|+..+.||+|+||.||+|++. ++..+|+|.++..........|.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35677899999999999999964 3678999999754433356789999999999999999999999877 5578
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
++++||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.+.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 99999999999999987532 2589999999999999999999998 99999999999999999999999999998
Q ss_pred cccccCcce--eecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 424 LVDAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 424 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
......... .....++..|+|||...+..++.++||||||++++||+||+.|+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 765332211 11233456799999998889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=251.53 Aligned_cols=205 Identities=23% Similarity=0.336 Sum_probs=179.3
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
+|+..+.||+|+||.||++... ++..+++|++.... .......+.+|++++++++|||++++.+.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777899999999999999965 58899999987432 235567889999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++++|.+.+.........+++..+..++.+++.||+|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999986543346799999999999999999999999 99999999999999999999999999988665432
Q ss_pred cceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.......|++.|+|||......++.++|+||+|+++++|++|+.||+...
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 207 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence 22333467889999999988889999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=249.22 Aligned_cols=199 Identities=31% Similarity=0.416 Sum_probs=176.0
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecc
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (498)
+|+..+.||+|++|.||++... +++.+++|++..... .....+.+|++++++++|+|++++++++......++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 4677889999999999999975 688999999875433 45678999999999999999999999999999999999999
Q ss_pred cCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCc
Q 010887 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (498)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~ 430 (498)
++++|.+.+.... ..+++..+..++.|++.+++|||+. +++||||+|+||++++++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 80 SGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred CCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 9999999887532 4689999999999999999999998 999999999999999999999999999887665432
Q ss_pred ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.....++..|+|||+.....++.++||||||++++||++|+.||+..
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 23345788999999998888999999999999999999999999754
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=258.81 Aligned_cols=201 Identities=26% Similarity=0.354 Sum_probs=169.4
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcC--CceEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERILV 346 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 346 (498)
++|+..+.||+|+||.||+|... +++.+++|.++... .......+.+|++++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999975 57889999987432 223345678899999999999999999998877 789999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
+||+++ +|.+.+.... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++....
T Consensus 85 ~e~~~~-~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999984 8888876522 3689999999999999999999999 99999999999999999999999999988665
Q ss_pred ccCcceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
..... .....+++.|+|||.+.+. .++.++|+||||+++|||++|+.||...
T Consensus 158 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 158 SPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred CCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 43211 1234468899999998654 4688999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=255.33 Aligned_cols=205 Identities=29% Similarity=0.408 Sum_probs=167.2
Q ss_pred CCCCCeeecccceEEEEEEEc----CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCC------
Q 010887 273 FSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------ 341 (498)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 341 (498)
|.+.+.||+|+||.||+|.+. .++.||+|+++... .....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999853 36789999987432 3445678899999999999999999999886543
Q ss_pred ceEEEEecccCCCHHHhhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeec
Q 010887 342 ERILVYPFMQNLSVAYRLRDLK--PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 419 (498)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~Df 419 (498)
..+++++|+.+|+|..++.... .....+++.....++.|++.||+|||+. +++||||||+||++++++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2368899999999988775321 1223578999999999999999999998 9999999999999999999999999
Q ss_pred CccccccccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 420 GLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 420 Gl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
|.++........ ......++..|++||......++.++||||||+++|||++ |+.||...+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~ 220 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE 220 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC
Confidence 998866432211 1122335678999999988889999999999999999999 889987543
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=258.80 Aligned_cols=197 Identities=31% Similarity=0.387 Sum_probs=167.4
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
..|+..+.||+|+||.||+|... +++.||+|.+... ........+.+|+++++.++|||++++.+++...+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999964 6889999988632 22234467899999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||++ |++.+.+... ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9997 5666665432 23589999999999999999999998 999999999999999999999999999876543
Q ss_pred cCcceeecccccccccCccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
. ....++..|+|||++. ...++.++||||||+++|||+||+.||...
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~ 217 (307)
T cd06607 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (307)
T ss_pred C-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc
Confidence 2 2245788999999874 456888999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=236.25 Aligned_cols=212 Identities=22% Similarity=0.333 Sum_probs=177.1
Q ss_pred HHHHHHhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHh-ccCCccceEEEEEEcCC
Q 010887 264 RELQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISV-AIHKNLLQLIGYCTTSS 341 (498)
Q Consensus 264 ~el~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~ 341 (498)
+.+++..++......||+|++|.|-+.++ .+|+..|+|+++.....+..+...+|+.+..+ ...|.+|.++|......
T Consensus 39 ~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 39 RNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred CccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 33556667777788999999999999884 57999999999877666777788888887655 46999999999999999
Q ss_pred ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCc
Q 010887 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (498)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl 421 (498)
..++.||.|. -||..+-++.......+++...-+||..+.+||.|||++. .++|||+||+|||++.+|++||||||.
T Consensus 119 dvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGI 195 (282)
T KOG0984|consen 119 DVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGI 195 (282)
T ss_pred cEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccccc
Confidence 9999999996 4666665554445677899999999999999999999985 799999999999999999999999999
Q ss_pred cccccccCcceeecccccccccCcccccC----CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLST----GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+-.+.++... +...|-..|||||.+.. ..|+.|+||||+|+.+.||.+++.||+.-.
T Consensus 196 sG~L~dSiAk--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 196 SGYLVDSIAK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred ceeehhhhHH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 9877654322 12346678999999853 368999999999999999999999998543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=230.37 Aligned_cols=202 Identities=26% Similarity=0.391 Sum_probs=171.2
Q ss_pred CCCCCCeeecccceEEEEEEE-cCCcEEEEEEec-ccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 272 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~-~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
+|...++||+|.||+||+|+. +.++.||+|+++ +..+++......+|+-+++.++|+|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 456678899999999999994 467889999998 444555667889999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+.. +|..+.... ++.++...+.+++.|+++||.|.|+. .+.|||+||.|.|++.+|+.|++|||+++.+.-+.
T Consensus 83 cdq-dlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 964 555555443 45689999999999999999999999 99999999999999999999999999999887665
Q ss_pred cceeecccccccccCcccccCCC-CCCcccchhHHHHHHHHHh-CCCCCCCCcc
Q 010887 430 THVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVT-GQRAIDFSRL 481 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~~ 481 (498)
...+. ..-|..|++|.++.+.+ |+...|+||-|||+.|+.. |++.|...+.
T Consensus 156 rcysa-evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv 208 (292)
T KOG0662|consen 156 RCYSA-EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208 (292)
T ss_pred Eeeec-eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH
Confidence 44333 34589999999998876 7888999999999999998 6666665544
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=260.55 Aligned_cols=205 Identities=24% Similarity=0.347 Sum_probs=169.1
Q ss_pred CCCCCCeeecccceEEEEEEEc---CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcC--CceE
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS---DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERI 344 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 344 (498)
+|+..+.||+|+||.||+|... +++.||+|.+.... .......+.+|++++++++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3677889999999999999964 47899999987532 123346778899999999999999999999988 7899
Q ss_pred EEEecccCCCHHHhhcccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECC----CCcEEEeec
Q 010887 345 LVYPFMQNLSVAYRLRDLKP-GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD----NFEAVLCDF 419 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~----~~~~ki~Df 419 (498)
+||||+++ ++.+.+..... ....++...+..++.|++.||+|||+. +++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 66666653322 223689999999999999999999999 9999999999999999 999999999
Q ss_pred CccccccccCcc--eeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 420 GLAKLVDAKLTH--VTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 420 Gl~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
|++......... ......++..|+|||++.+. .++.++||||||++++||++|+.||....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 998866443221 12234578899999988664 57899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=258.81 Aligned_cols=205 Identities=27% Similarity=0.343 Sum_probs=169.9
Q ss_pred HHhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCC----
Q 010887 268 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS---- 341 (498)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 341 (498)
...++|++.+.||+|+||.||+|... +++.||+|+++... .......+.+|++++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999975 57899999987432 2334467788999999999999999999987655
Q ss_pred ------ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEE
Q 010887 342 ------ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV 415 (498)
Q Consensus 342 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 415 (498)
..++|+||+++ ++...+... ...+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 68899999986 666665532 34689999999999999999999999 999999999999999999999
Q ss_pred EeecCccccccccCcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 416 LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 416 i~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
|+|||.+...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||+..
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~ 221 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN 221 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999998765433222222345778999998765 35788999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=254.54 Aligned_cols=204 Identities=26% Similarity=0.318 Sum_probs=177.6
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
+|++.+.||+|+||.||+++.. +++.+++|++.... .......+.+|++++++++|+||+++.+++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4777899999999999999854 67899999987432 334567788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++++|.+++.+.......+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+|++|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 999999999876444446789999999999999999999999 99999999999999999999999999998765541
Q ss_pred cceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCcc
Q 010887 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRL 481 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~~ 481 (498)
.....++..|++||...+..++.++|+||||+++|||++|+.||+..+.
T Consensus 158 ---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~ 206 (256)
T cd08530 158 ---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM 206 (256)
T ss_pred ---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2234578899999999998999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=254.65 Aligned_cols=192 Identities=28% Similarity=0.360 Sum_probs=158.8
Q ss_pred eeecccceEEEEEEE-cCCcEEEEEEecccCC--cchHHHHHHHHHH---HHhccCCccceEEEEEEcCCceEEEEeccc
Q 010887 278 IIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYS--PGGEAAFQREVHL---ISVAIHKNLLQLIGYCTTSSERILVYPFMQ 351 (498)
Q Consensus 278 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~---l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 351 (498)
.||+|+||.||+|.. .+++.||+|.+..... ......+..|..+ ++...||||+++++++...+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 479999999999995 4588999998864321 1222234444433 444579999999999999999999999999
Q ss_pred CCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcc
Q 010887 352 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 431 (498)
Q Consensus 352 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~ 431 (498)
+++|.+++.. ...+++..+..++.|+++|++|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 9999988864 34689999999999999999999998 99999999999999999999999999987554322
Q ss_pred eeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 432 VTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 432 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.....|+..|+|||.+.++ .++.++||||+||++|||++|+.||...
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 1234588999999998754 5889999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=256.23 Aligned_cols=200 Identities=27% Similarity=0.408 Sum_probs=168.5
Q ss_pred CCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecc
Q 010887 273 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (498)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (498)
|+..+.||+|++|.||+|... ++..|++|++.... .......+.+|++++++++|||++++++++.+.+..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566889999999999999964 78999999987432 2334467889999999999999999999999999999999999
Q ss_pred cCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCc
Q 010887 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (498)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~ 430 (498)
+ ++|.+++.... ...+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 68888886532 23689999999999999999999998 999999999999999999999999999876543222
Q ss_pred ceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 431 HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.. ....++..|+|||++.+. .++.++||||||+++|||+||+.||...
T Consensus 155 ~~-~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 155 TY-THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred cc-CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11 223457889999987654 5788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=254.94 Aligned_cols=198 Identities=24% Similarity=0.338 Sum_probs=170.8
Q ss_pred CCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecc
Q 010887 272 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (498)
.|...+.||+|++|.||++.. .+++.+++|++... .......+.+|+.+++.++|||++++++++...+..++++||+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR-KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc-chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 345567999999999999995 46889999988632 2234567889999999999999999999999999999999999
Q ss_pred cCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCc
Q 010887 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (498)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~ 430 (498)
++++|.+++.. ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+........
T Consensus 99 ~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 99 EGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 99999998875 3488999999999999999999999 999999999999999999999999998875543222
Q ss_pred ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
. .....|+..|+|||...+..++.++|||||||++|||++|+.||...
T Consensus 171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~ 218 (285)
T cd06648 171 R-RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE 218 (285)
T ss_pred c-cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC
Confidence 1 22345789999999998888999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=257.54 Aligned_cols=202 Identities=25% Similarity=0.377 Sum_probs=167.0
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
++|+..+.||+|++|.||+|... +++.||+|++.... .......+.+|++++++++||||+++++++......++|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999965 68899999886432 22345678899999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECC-CCcEEEeecCccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~ki~DfGl~~~~~~ 427 (498)
|++ +++.+.+.... ...+++.....++.||+.||+|||+. +++|+||+|+||++++ ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 57777765422 23467888899999999999999999 9999999999999985 56799999999976543
Q ss_pred cCcceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.... .....+++.|+|||++.+. .++.++|||||||++|||+||+.||...
T Consensus 156 ~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~ 207 (294)
T PLN00009 156 PVRT-FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207 (294)
T ss_pred Cccc-cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2211 1223467899999988664 5789999999999999999999999754
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=267.39 Aligned_cols=217 Identities=22% Similarity=0.264 Sum_probs=181.6
Q ss_pred hcCCCCCCeeecccceEEEEEE-EcCCcEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
..-|..++.||-|+||+|.+++ .++...+|+|.+++. ...........|-.||+..+.+.||+++-.|++.+..|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 4457788999999999999999 445667899988642 2334556778899999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|+|++||++...|-. .+-+++..+.-++.++..|+++.|.. |+|||||||+|||||.+|++||+|||++.-+.
T Consensus 708 MdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccce
Confidence 999999999999876 45688888999999999999999999 99999999999999999999999999985331
Q ss_pred ---ccC-----cc---------------------------------eeecccccccccCcccccCCCCCCcccchhHHHH
Q 010887 427 ---AKL-----TH---------------------------------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGIT 465 (498)
Q Consensus 427 ---~~~-----~~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvv 465 (498)
+.. .+ ......||+.|+|||++....|+..+|+||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 000 00 0112449999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCccccccccccccccc
Q 010887 466 LLELVTGQRAIDFSRLEEEEDVLLLDHKV 494 (498)
Q Consensus 466 l~elltG~~p~~~~~~~~~~~~~l~~w~~ 494 (498)
||||+.|+.||-.....|.+. -+..|..
T Consensus 861 l~em~~g~~pf~~~tp~~tq~-kv~nw~~ 888 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQY-KVINWRN 888 (1034)
T ss_pred HHHHhhCCCCccCCCCCccee-eeeehhh
Confidence 999999999998776655543 4667753
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=253.34 Aligned_cols=203 Identities=24% Similarity=0.359 Sum_probs=173.4
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
+|+..+.||+|+||.||+|... ++..+|+|.+... ........+.+|+++++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677899999999999999965 5788999998642 2224556788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCC-cEEEeecCcccccccc
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCDFGLAKLVDAK 428 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~ki~DfGl~~~~~~~ 428 (498)
+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++ .++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999999987532 23579999999999999999999998 999999999999998886 4699999998766543
Q ss_pred CcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.. ......|+..|+|||+..+..++.++|+||||+++|||++|+.||....
T Consensus 156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 206 (257)
T cd08225 156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206 (257)
T ss_pred cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 22 2223457889999999988889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=258.78 Aligned_cols=202 Identities=26% Similarity=0.381 Sum_probs=165.9
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCccceEEEEEEcCCceEEEEec
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
+|+..+.||+|+||.||++... +++.+|+|.+...........+.+|+.++.++. ||||+++++++..+...++++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556778999999999999964 578999999875444455678899999999996 99999999999998899999999
Q ss_pred ccCCCHHHhhccc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 350 MQNLSVAYRLRDL-KPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 350 ~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
+.. ++.+..... ......+++..+..++.|++.||+|||+.. +++||||||+||++++++.++|+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 544433211 112356899999999999999999999742 7999999999999999999999999998765432
Q ss_pred CcceeecccccccccCcccccCC---CCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTG---KSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
... ....|+..|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 162 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 212 (288)
T cd06616 162 IAK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212 (288)
T ss_pred Ccc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence 211 223578899999998776 689999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=259.70 Aligned_cols=203 Identities=28% Similarity=0.349 Sum_probs=168.3
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcC--CceEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERIL 345 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 345 (498)
.++|++.+.||+|+||.||+|... +++.||+|+++... .......+.+|++++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467889999999999999999964 58999999987332 222334567899999999999999999998765 45799
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
|+||+++ +|.+.+... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||++...
T Consensus 86 v~e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999974 787777643 24689999999999999999999999 9999999999999999999999999999876
Q ss_pred cccCcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 426 DAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
...... .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||....
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~ 213 (309)
T cd07845 159 GLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS 213 (309)
T ss_pred CCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 543221 122335788999999865 457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=255.72 Aligned_cols=201 Identities=27% Similarity=0.356 Sum_probs=170.1
Q ss_pred CCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcC--CceEEEEe
Q 010887 273 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERILVYP 348 (498)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 348 (498)
|++.+.||+|++|.||+|+.. +++.+|+|++.... .......+.+|++++++++|||++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566789999999999999965 57899999997543 334456788999999999999999999999888 78999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++ +|.+.+... ...+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 888777642 24689999999999999999999999 9999999999999999999999999999877554
Q ss_pred CcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 429 LTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.........++..|+|||.+.+ ..++.++||||||+++|||+||+.||+...
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~ 206 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST 206 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 3222233456788999997764 457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=254.63 Aligned_cols=197 Identities=24% Similarity=0.310 Sum_probs=164.4
Q ss_pred CCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCccceEEEEEEcC--CceEEEEe
Q 010887 273 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTS--SERILVYP 348 (498)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 348 (498)
|+..+.||+|+||.||+|... +++.||+|+++............+|+..+.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456788999999999999954 688999999875443334445567899999885 99999999999887 78999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|++ +++.+.+... ...+++.++..++.|++.||+|||+. +++||||+|+||++++ +.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 997 5787777642 24689999999999999999999999 9999999999999999 99999999999866433
Q ss_pred CcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 429 LTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
... ....++..|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~ 202 (282)
T cd07831 153 PPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT 202 (282)
T ss_pred CCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC
Confidence 221 22447889999997644 55788999999999999999999999754
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=251.12 Aligned_cols=196 Identities=23% Similarity=0.290 Sum_probs=162.4
Q ss_pred HHHHhcCCCCCCee--ecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCC
Q 010887 266 LQLATDNFSESNII--GQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSS 341 (498)
Q Consensus 266 l~~~~~~~~~~~~l--G~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 341 (498)
.....++|++.+.+ |+|+||.||++.. .++..+|+|.+...... . .|+.....+ +|||++++++.+...+
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~----~--~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN----A--IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc----h--hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 33345667776666 9999999999995 46788999988642211 1 122222222 6999999999999999
Q ss_pred ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCC-cEEEeecC
Q 010887 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCDFG 420 (498)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~ki~DfG 420 (498)
..++||||+++++|.+++.. ...+++.++..++.|+++||.|||+. +++||||||+||+++.++ .++|+|||
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 99999999999999999875 23789999999999999999999999 999999999999999988 99999999
Q ss_pred ccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 421 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
+++...... ...++..|+|||++.+..++.++||||||++++||+||+.||...
T Consensus 156 ~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 209 (267)
T PHA03390 156 LCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED 209 (267)
T ss_pred cceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 987654322 235788999999999989999999999999999999999999843
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=263.74 Aligned_cols=200 Identities=25% Similarity=0.331 Sum_probs=169.3
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCC-----
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS----- 341 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 341 (498)
..++|+..+.||+|+||.||+|... +++.||+|++... ........+.+|++++++++||||+++++++....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3467999999999999999999954 6899999998643 23344567788999999999999999999886442
Q ss_pred -ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecC
Q 010887 342 -ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (498)
Q Consensus 342 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 420 (498)
..++|+||+. +++.+.+.. .++...+..++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 4689999996 477777653 278889999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 421 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+++....... .....++..|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 164 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 164 LARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred cceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 9986644221 223457889999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=252.80 Aligned_cols=195 Identities=27% Similarity=0.335 Sum_probs=168.1
Q ss_pred eecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCCCH
Q 010887 279 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV 355 (498)
Q Consensus 279 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 355 (498)
||+|+||.||+++.. +++.+++|.+.... .......+.+|++++++++||||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 589999999999976 48999999986432 224557789999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCc-----
Q 010887 356 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT----- 430 (498)
Q Consensus 356 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~----- 430 (498)
.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9998752 3689999999999999999999999 999999999999999999999999999875443211
Q ss_pred --ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 431 --HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 431 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.......++..|+|||.......+.++||||||++++|++||+.||....
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 205 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET 205 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 11223457889999999988889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-33 Score=293.78 Aligned_cols=203 Identities=29% Similarity=0.361 Sum_probs=173.8
Q ss_pred hcCCCCCCeeecccceEEEEEE-EcCCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
+-+|....+||.|.||.||-|. .++|...|+|-++-.. .....+...+|+.++..++|||+|+++|+-...+..++.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 4467778899999999999999 5678889999887332 2345677889999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
|||++|+|.+.+.. ....++.....+..|++.|++|||+. +||||||||.||+++.+|.+|++|||.|..+..
T Consensus 1314 EyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999875 33467777778899999999999999 999999999999999999999999999987765
Q ss_pred cCcce---eecccccccccCcccccCCC---CCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 428 KLTHV---TTQIRGTMGHIAPEYLSTGK---SSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 428 ~~~~~---~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
..... -....||+.|||||++.+.. -....||||+|||++||+||++||..-
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~ 1444 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAEL 1444 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhc
Confidence 53222 23467999999999997654 355789999999999999999999743
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=255.80 Aligned_cols=200 Identities=25% Similarity=0.315 Sum_probs=169.7
Q ss_pred CCCCCCeeecccceEEEEEEE----cCCcEEEEEEecccC---CcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCce
Q 010887 272 NFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY---SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER 343 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 343 (498)
+|+..+.||+|++|.||+++. .+++.||+|.++... .......+.+|++++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367788999999999999984 256789999986422 123446788999999999 599999999999988899
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
++||||+++++|.+++.. ...+++..+..++.|++++|+|||+. +++||||+|+||++++++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999988864 34588999999999999999999998 99999999999999999999999999987
Q ss_pred cccccCcceeecccccccccCcccccCCC--CCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
..............|+..|+|||...+.. .+.++||||||+++|||+||+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 66543332233345789999999987655 78899999999999999999999963
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=280.21 Aligned_cols=211 Identities=28% Similarity=0.405 Sum_probs=181.6
Q ss_pred HHHHHhcCCCCCCeeecccceEEEEEEEc--------CCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEE
Q 010887 265 ELQLATDNFSESNIIGQGGFGKVYKGVLS--------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIG 335 (498)
Q Consensus 265 el~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~ 335 (498)
.++...++..+.+.+|+|.||.|++|... ....||||.++......+.+.+..|+++|..+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 45666677777789999999999999843 14569999999887778889999999999998 5999999999
Q ss_pred EEEcCCceEEEEecccCCCHHHhhcccC---C-------CC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCC
Q 010887 336 YCTTSSERILVYPFMQNLSVAYRLRDLK---P-------GE--KGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKA 403 (498)
Q Consensus 336 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~-------~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~ 403 (498)
+|...+..++|+||+..|+|.++|+..+ . .. ..++..+.+.++.|||.|++||++. +++||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999999755 0 01 2388999999999999999999999 999999999
Q ss_pred CcEEECCCCcEEEeecCccccccccCcceeecccc--cccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCC
Q 010887 404 ANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG--TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDF 478 (498)
Q Consensus 404 ~NILl~~~~~~ki~DfGl~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~ 478 (498)
+|||++++..+||+|||+++...+..........+ ...|||||.+....|+.|+|||||||+||||+| |..||..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 99999999999999999999766544443222222 356999999999999999999999999999999 8899975
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=256.48 Aligned_cols=203 Identities=29% Similarity=0.382 Sum_probs=166.5
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCc-----
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE----- 342 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 342 (498)
.++|+..+.||+|+||.||+|... +++.||+|++.... .......+.+|++++++++||||+++++++...+.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357888999999999999999964 68899999886432 22334556789999999999999999999876543
Q ss_pred ---eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeec
Q 010887 343 ---RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 419 (498)
Q Consensus 343 ---~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~Df 419 (498)
.++|+||+.+ ++...+... ...+++.++..++.|++.||+|||+. +++|+||||+||++++++.+||+||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence 4899999974 777776542 23589999999999999999999999 9999999999999999999999999
Q ss_pred CccccccccCcc---eeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 420 GLAKLVDAKLTH---VTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 420 Gl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
|++......... ......++..|+|||.+.+. .++.++||||||+++|||+||+.||...
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 999866433221 11233467889999988654 4788999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=250.15 Aligned_cols=192 Identities=23% Similarity=0.291 Sum_probs=161.1
Q ss_pred CeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHH-HhccCCccceEEEEEEcCCceEEEEecccC
Q 010887 277 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLI-SVAIHKNLLQLIGYCTTSSERILVYPFMQN 352 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (498)
+.||+|+||.||+|... +++.||+|+++... .......+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999964 58899999986432 112233445555444 445899999999999999999999999999
Q ss_pred CCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcce
Q 010887 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (498)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~ 432 (498)
++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999998875 24588999999999999999999998 999999999999999999999999999875433
Q ss_pred eecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.....++..|+|||...+..++.++||||||+++|||+||+.||....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 197 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET 197 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC
Confidence 123457889999999988888999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=255.44 Aligned_cols=202 Identities=25% Similarity=0.391 Sum_probs=167.6
Q ss_pred HhcCCCCCCeeecccceEEEEEEEcC-CcEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCccceEEEEEEcCCceEEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 346 (498)
..++|+..+.||+|+||.||+|...+ ++.||||+++..........+.+|++++.+.. ||||+++++++......+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 44678889999999999999999764 88999999975544445567777888777765 99999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|||+. +++.+..... ...+++..+..++.|+++||+|||+.. +++||||+|+||++++++.+||+|||++....
T Consensus 93 ~e~~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 93 MELMS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eeccC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 99985 4666655432 236899999999999999999999732 89999999999999999999999999987654
Q ss_pred ccCcceeecccccccccCcccccCCC----CCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGK----SSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
..... ....++..|+|||++.+.. ++.++||||||+++|||++|+.||..
T Consensus 167 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 167 DSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred CCCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 32221 2234678999999987654 78899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=254.22 Aligned_cols=190 Identities=25% Similarity=0.389 Sum_probs=158.2
Q ss_pred CeeecccceEEEEEEEcC--------CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 277 NIIGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
+.||+|+||.||+|.... ...+++|.+... .......+.+|+.+++.++|||++++++++..++..++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS-HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch-hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 468999999999998642 234788877532 22445678899999999999999999999999899999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCc--------EEEeecC
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE--------AVLCDFG 420 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~--------~ki~DfG 420 (498)
|+++|+|..+++... ..+++..+..++.||+.||+|||+. +++||||||+||+++.++. ++++|||
T Consensus 80 ~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 80 YVKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred cCCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence 999999999987532 3589999999999999999999999 9999999999999987765 5999999
Q ss_pred ccccccccCcceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCC-CCCCC
Q 010887 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQ-RAIDF 478 (498)
Q Consensus 421 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~-~p~~~ 478 (498)
.+...... ....++..|+|||++.+. .++.++|||||||++|||++|. .|+..
T Consensus 154 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~ 208 (258)
T cd05078 154 ISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA 208 (258)
T ss_pred cccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh
Confidence 88655432 224468899999999864 5789999999999999999995 55544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=246.87 Aligned_cols=202 Identities=28% Similarity=0.410 Sum_probs=176.2
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcC--CceEEEE
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERILVY 347 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 347 (498)
+|...+.||+|++|.||+|... +++.|++|++.... .+...+.+.+|++.+++++||||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999976 68899999986432 234578899999999999999999999999988 7899999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++++|.+++... ..+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999998753 2689999999999999999999998 999999999999999999999999999887765
Q ss_pred cCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 428 KLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 428 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.... ......++..|+|||.......+.++||||||++++||++|+.||....
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4321 1233457889999999988889999999999999999999999997643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=271.92 Aligned_cols=201 Identities=26% Similarity=0.363 Sum_probs=171.4
Q ss_pred hcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
.+.|++...||.|+||.||+|..++....|.-++.+..+.....+|.-|+++|+...||+||++++.+...+..++..||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 34566678899999999999998765554443333455667789999999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
|.||.+...+-.. ...++..++.-+..|++.||.|||++ .|+|||||+.|||++-+|.++++|||.+......
T Consensus 111 C~GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t- 183 (1187)
T KOG0579|consen 111 CGGGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST- 183 (1187)
T ss_pred cCCchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH-
Confidence 9999998777654 35699999999999999999999999 9999999999999999999999999997543321
Q ss_pred cceeecccccccccCccccc-----CCCCCCcccchhHHHHHHHHHhCCCCCC
Q 010887 430 THVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAID 477 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvvl~elltG~~p~~ 477 (498)
......+.|||.|||||+.. ..+|+.++||||||+.|.||..+.+|-.
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh 236 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH 236 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc
Confidence 22345678999999999874 5689999999999999999999998864
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=255.43 Aligned_cols=202 Identities=19% Similarity=0.173 Sum_probs=150.7
Q ss_pred hcCCCCCCeeecccceEEEEEEEcCC----cEEEEEEecccCCcchH----------HHHHHHHHHHHhccCCccceEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGE----------AAFQREVHLISVAIHKNLLQLIG 335 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~----------~~~~~e~~~l~~l~h~niv~l~~ 335 (498)
.++|.+.+.||+|+||.||+|...++ ..+++|........... .....+...+..+.|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 35788999999999999999996543 45566643211111100 11223334455678999999998
Q ss_pred EEEcCC----ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCC
Q 010887 336 YCTTSS----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN 411 (498)
Q Consensus 336 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~ 411 (498)
++.... ..+++++++.. ++.+.+.. ....++..+..++.|++.||+|||+. +|+||||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGN 162 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence 765544 23566666543 45444443 22357888899999999999999999 99999999999999999
Q ss_pred CcEEEeecCccccccccCcc------eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 412 FEAVLCDFGLAKLVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 412 ~~~ki~DfGl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
+.++|+|||+++........ ......||+.|+|||+..+..++.++|||||||+++||+||+.||...
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 99999999999866432111 112245899999999999999999999999999999999999999754
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=261.61 Aligned_cols=201 Identities=22% Similarity=0.364 Sum_probs=168.4
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEc----CCceE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTT----SSERI 344 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~ 344 (498)
++|+..+.||+|+||.||+|... +++.||+|++.... .......+.+|++++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 67888999999999999999954 68999999987532 23445677889999999999999999988753 34578
Q ss_pred EEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccc
Q 010887 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~ 424 (498)
+|+||+. ++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 85 lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 85 VVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 9999996 588887764 34589999999999999999999998 999999999999999999999999999876
Q ss_pred ccccCcc---eeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 425 VDAKLTH---VTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 425 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
....... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 5432211 1123467889999998765 46889999999999999999999999754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=246.26 Aligned_cols=199 Identities=29% Similarity=0.440 Sum_probs=174.5
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
+|+..+.||+|++|.||++... +++.|++|.+.... .+.....+.+|++++++++|||++++++++......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677899999999999999865 57899999987543 224567899999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++++|.+++... ..+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999988752 4689999999999999999999999 99999999999999999999999999998765433
Q ss_pred cceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
.. .....++..|+|||...+..++.++||||+|++++||++|+.||..
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~ 201 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD 201 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 22 2334578899999999888889999999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=254.48 Aligned_cols=194 Identities=24% Similarity=0.332 Sum_probs=168.2
Q ss_pred CCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCCC
Q 010887 276 SNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLS 354 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 354 (498)
...||+|+||.||++.. .++..||+|++... .......+.+|+.+++.++|+|++++++++...+..++||||+++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc-chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 35789999999999996 46889999988532 23456778999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcceee
Q 010887 355 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT 434 (498)
Q Consensus 355 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~~~ 434 (498)
|.+++.. ..+++.....++.|++.|++|||+. +++||||+|+||++++++.++|+|||++........ ...
T Consensus 104 L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~ 174 (292)
T cd06657 104 LTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRK 174 (292)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccc
Confidence 9887753 3478999999999999999999999 999999999999999999999999999876543221 123
Q ss_pred cccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 435 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 435 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
...++..|+|||+..+..++.++|+|||||++|||++|+.||...
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~ 219 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 345788999999998888999999999999999999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=251.19 Aligned_cols=200 Identities=28% Similarity=0.404 Sum_probs=166.9
Q ss_pred CCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCC-cchHHHHHHHHHHHHhc---cCCccceEEEEEEcCCc-----
Q 010887 273 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-PGGEAAFQREVHLISVA---IHKNLLQLIGYCTTSSE----- 342 (498)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~----- 342 (498)
|++.+.||+|+||.||+|+.+ +++.+|+|+++.... ......+.+|++++.++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 556789999999999999976 489999999974332 23345667788777666 59999999999988776
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcc
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~ 422 (498)
.+++|||+.+ ++.+++.... ...+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||.+
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999974 7888876532 23589999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
........ .....++..|+|||++.+..++.++|+|||||++|||+||+.||+...
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 77654322 122346888999999999899999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=260.33 Aligned_cols=202 Identities=25% Similarity=0.388 Sum_probs=168.0
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc-CCcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCC--ce
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSS--ER 343 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~--~~ 343 (498)
..++|+..+.||+|+||.||+|... +++.+|+|++... ........+.+|+++++++ +||||+++++++...+ ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467888999999999999999965 5788999988642 2233456678899999999 9999999999986543 57
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
++|+||++ ++|..++.. ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 588887764 2678999999999999999999998 99999999999999999999999999998
Q ss_pred cccccCcc----eeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 424 LVDAKLTH----VTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 424 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
........ ......|+..|+|||++.+ ..++.++||||||+++|||+||+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~ 216 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence 66433221 1223457889999998755 45788999999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=259.62 Aligned_cols=204 Identities=25% Similarity=0.375 Sum_probs=169.9
Q ss_pred HHHHHHHhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcC
Q 010887 263 CRELQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS 340 (498)
Q Consensus 263 ~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 340 (498)
.+++...+++|+..+.||+|+||.||+|.. .+++.||+|+++... .......+.+|++++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 455666789999999999999999999985 568899999987432 223456788899999999999999999988643
Q ss_pred ------CceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcE
Q 010887 341 ------SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA 414 (498)
Q Consensus 341 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 414 (498)
...+++++++ +++|.+.+.. ..+++..+..++.|+++||+|||+. +++||||||+||++++++.+
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence 2356777776 7788877653 3589999999999999999999999 99999999999999999999
Q ss_pred EEeecCccccccccCcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 415 VLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 415 ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 160 kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 221 (345)
T cd07877 160 KILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221 (345)
T ss_pred EEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999998755332 223457889999998866 46788999999999999999999999643
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=260.08 Aligned_cols=195 Identities=25% Similarity=0.403 Sum_probs=170.3
Q ss_pred CCeeecccceEEEEEEE-cCCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCC
Q 010887 276 SNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 353 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 353 (498)
.++||+|.||+||-|+. ++|+.||||++.+. .......+..+|+.++.+++||.||.+.--|.+.+..+.|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 67899999999999995 57999999999743 44566788999999999999999999999999999999999999765
Q ss_pred CHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCC---CcEEEeecCccccccccCc
Q 010887 354 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN---FEAVLCDFGLAKLVDAKLT 430 (498)
Q Consensus 354 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~ki~DfGl~~~~~~~~~ 430 (498)
-|.-.|.. ..+.+++...+-++.||+.||.|||.+ +|+|+||||+|||+.+. -++||||||+++.+....
T Consensus 649 MLEMILSs---EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks- 721 (888)
T KOG4236|consen 649 MLEMILSS---EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS- 721 (888)
T ss_pred HHHHHHHh---hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh-
Confidence 45444443 245688888899999999999999999 99999999999999543 379999999999987643
Q ss_pred ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
....+.||+.|+|||++....|...-|+||.|||+|--++|.-||..
T Consensus 722 -FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 722 -FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred -hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence 34567899999999999999999999999999999999999999974
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=240.19 Aligned_cols=200 Identities=26% Similarity=0.401 Sum_probs=166.1
Q ss_pred CCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCccceEEEEEEcCCceEEEEecc
Q 010887 273 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYPFM 350 (498)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 350 (498)
.+....||.|..|.|++++.. .|...|||.+.......+.+.++..++++.+-+ .|.||+.+|||..+....+.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 334667999999999999965 588899999987766667778888888877664 899999999999999999999998
Q ss_pred cCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCc
Q 010887 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (498)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~ 430 (498)
.- -....++.. .+++++...-++...+.+||.||.+++ +|+|||+||+|||+|+.|++|+||||++-++.++..
T Consensus 174 s~-C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 174 ST-CAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HH-HHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 53 233333332 345788888899999999999999876 899999999999999999999999999987766543
Q ss_pred ceeecccccccccCcccccC---CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 431 HVTTQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+ +...|-+.|||||.+.. .+|+.++||||||+.++||.||+.||....
T Consensus 248 h--trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~ 298 (391)
T KOG0983|consen 248 H--TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK 298 (391)
T ss_pred c--ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC
Confidence 3 33457789999999864 468999999999999999999999998743
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=254.22 Aligned_cols=195 Identities=30% Similarity=0.394 Sum_probs=165.7
Q ss_pred CCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 273 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
|+..+.||+|+||.||+|+.. ++..+|+|++.... .......+.+|++++++++|||++++++++......++|+||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 666889999999999999964 68899999986332 223446788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+. |++.+.+... ...+++.++..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||++......
T Consensus 107 ~~-g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 107 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 97 4777766532 34589999999999999999999999 9999999999999999999999999998754432
Q ss_pred cceeecccccccccCccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 430 THVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
....++..|+|||++. .+.++.++|||||||++|||++|+.||...
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 227 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 2345788999999973 456889999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=252.59 Aligned_cols=203 Identities=27% Similarity=0.386 Sum_probs=175.7
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc--CCcchHHHHHHHHHHHHhcc-CCccceEEEEEEcCCceEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 346 (498)
++|...+.||+|+||.||+|... +++.|++|++... ........+.+|.+++.+++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999965 6899999998642 22344577889999999998 99999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|||+++++|.+.+.. ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999875 23699999999999999999999998 99999999999999999999999999987664
Q ss_pred ccCc-------------------ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 427 AKLT-------------------HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 427 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.... .......++..|+|||......++.++|+||||++++|+++|+.||....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 3321 11223457889999999988889999999999999999999999998543
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=252.07 Aligned_cols=199 Identities=25% Similarity=0.343 Sum_probs=168.9
Q ss_pred CCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCccceEEEEEEcCCceEEEEecc
Q 010887 273 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYPFM 350 (498)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 350 (498)
|.+.+.||+|++|+||+|+.. +++.|++|++.............+|++.+++++ |||++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566789999999999999975 478899999875443334455667999999999 999999999999999999999999
Q ss_pred cCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCc
Q 010887 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (498)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~ 430 (498)
+|++.+.+.... ...+++..+..++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||.+........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 889988887532 24689999999999999999999998 999999999999999999999999999876654222
Q ss_pred ceeecccccccccCccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 431 HVTTQIRGTMGHIAPEYLS-TGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.....++..|+|||++. ...++.++|+||||++++||+||+.||...
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 12345788999999875 455789999999999999999999999654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=257.58 Aligned_cols=197 Identities=27% Similarity=0.426 Sum_probs=164.2
Q ss_pred hcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCC------
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------ 341 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 341 (498)
.++|...+.||+|+||.||+|+. .+++.||+|+++... .......+.+|++++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 36888899999999999999996 468999999987432 2333467889999999999999999999886543
Q ss_pred ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCc
Q 010887 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (498)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl 421 (498)
..++|+||+.. ++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 45899999864 5555432 3588999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
++...... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus 164 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 164 ARHADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred CcCCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 87653321 22346888999999876 468899999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=258.15 Aligned_cols=201 Identities=27% Similarity=0.409 Sum_probs=172.1
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCC-cchHHHHHHHHHHHHhccCCccceEEEEEEcCC-----ceE
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-----ERI 344 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 344 (498)
+|++.+.||+|++|.||+|+.. +++.+++|++..... ....+.+.+|+++++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999965 488999999875432 445678999999999999999999999988775 789
Q ss_pred EEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccc
Q 010887 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~ 424 (498)
++|+|++ ++|...+.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999998 478777764 33789999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCc--ceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 425 VDAKLT--HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 425 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
...... .......++..|+|||.+.+. .++.++|+||||+++|||++|+.||....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 655431 112334578899999999887 78999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=257.92 Aligned_cols=201 Identities=25% Similarity=0.397 Sum_probs=168.3
Q ss_pred hcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCC-----c
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-----E 342 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~ 342 (498)
.++|...+.||+|+||+||+|+. .+++.||+|.++... .......+.+|+.+++.++|+||+++++++.... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35688899999999999999995 468999999987432 3334567788999999999999999999876543 4
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcc
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~ 422 (498)
.++|+||+. ++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999996 678777764 34689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 423 KLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
....... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 8664432 12233457889999998765 46889999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=254.81 Aligned_cols=203 Identities=27% Similarity=0.379 Sum_probs=165.3
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCC------
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------ 341 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 341 (498)
.++|+..+.||+|+||.||+|... +++.+++|++.... .......+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468889999999999999999965 57899999886432 2223456788999999999999999999875543
Q ss_pred --ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeec
Q 010887 342 --ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 419 (498)
Q Consensus 342 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~Df 419 (498)
..++|++|+.+ ++...+... ...+++..+..++.|+++||+|||+. +++|+||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 35899999875 566666532 34689999999999999999999999 9999999999999999999999999
Q ss_pred CccccccccCcc----------eeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 420 GLAKLVDAKLTH----------VTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 420 Gl~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
|+++........ ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~ 230 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK 230 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCC
Confidence 999765432211 11223467889999987654 5789999999999999999999999743
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=256.62 Aligned_cols=198 Identities=27% Similarity=0.419 Sum_probs=167.4
Q ss_pred HhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCC-----
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS----- 341 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 341 (498)
..++|+..+.||+|+||.||++.. .++..||+|++.... .......+.+|++++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 467899999999999999999995 468899999986432 2234467889999999999999999999887553
Q ss_pred -ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecC
Q 010887 342 -ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (498)
Q Consensus 342 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 420 (498)
..++|++|+ +++|..++.. ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.++++|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999998 6788777653 3589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 421 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
++....... ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...
T Consensus 164 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 164 LARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred cccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 987654321 22356889999999876 45889999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=255.24 Aligned_cols=200 Identities=25% Similarity=0.405 Sum_probs=168.6
Q ss_pred HHHhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEc-CCce
Q 010887 267 QLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-SSER 343 (498)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~ 343 (498)
...+++|+..+.||+|+||.||+|... +++.||+|++.... .......+.+|++++++++||||+++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999954 78999999886432 33445778899999999999999999998876 4578
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
++++||+ +++|...+.. ..+++.....++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+.
T Consensus 86 ~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 8999998 4688877753 3478888899999999999999999 99999999999999999999999999987
Q ss_pred cccccCcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 424 LVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
...... ....++..|+|||.+.+ ..++.++||||||+++|||+||+.||...
T Consensus 157 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~ 209 (328)
T cd07856 157 IQDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK 209 (328)
T ss_pred ccCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 543321 22346788999998766 56899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=248.21 Aligned_cols=203 Identities=23% Similarity=0.354 Sum_probs=169.4
Q ss_pred CCCCCCeeecccceEEEEEEEcC-CcEEEEEEeccc----CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 272 NFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDY----YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
+|.+.+.||+|+||.||+++... +..+++|.++.. ........+.+|++++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47778999999999999999643 445566655431 2233455677899999999999999999999988899999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
+||+++++|.+.+.........+++..+..++.|++.||.|||+. +++|+||+|+||++++ +.++|+|||.++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998876544456799999999999999999999998 9999999999999975 569999999987664
Q ss_pred ccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.... ......++..|+|||...+..++.++|+||||+++|+|++|+.||+..
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~ 208 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ 208 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 3322 223345788999999998888899999999999999999999999743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=254.45 Aligned_cols=197 Identities=26% Similarity=0.300 Sum_probs=162.0
Q ss_pred eeecc--cceEEEEEEE-cCCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCC
Q 010887 278 IIGQG--GFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 353 (498)
Q Consensus 278 ~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 353 (498)
.||+| +||+||+++. .+++.||+|.+.... .....+.+.+|+.+++.++||||+++++++..++..++|+||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 45655 9999999996 478999999987432 3344578899999999999999999999999999999999999999
Q ss_pred CHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcce-
Q 010887 354 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV- 432 (498)
Q Consensus 354 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~- 432 (498)
++.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.+..........
T Consensus 85 ~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 85 SANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 9999887643 23589999999999999999999998 99999999999999999999999998654332111100
Q ss_pred -----eecccccccccCcccccCC--CCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 433 -----TTQIRGTMGHIAPEYLSTG--KSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 433 -----~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 0112245679999998764 4789999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=253.27 Aligned_cols=197 Identities=24% Similarity=0.238 Sum_probs=162.0
Q ss_pred CeeecccceEEEEEEEcCCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCCCH
Q 010887 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV 355 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 355 (498)
+.+|.|+++.||++.. +++.||+|+++.. ........+.+|++++++++||||+++++++...+..+++|||++++++
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3344555555555544 6899999998754 3445667899999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCc-----
Q 010887 356 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT----- 430 (498)
Q Consensus 356 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~----- 430 (498)
.+++.... ...+++.....++.|+++||+|||+. +|+||||||+||+++.++.++|+|||.+........
T Consensus 87 ~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 87 EDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 99988543 23588999999999999999999999 999999999999999999999999998865532211
Q ss_pred -ceeecccccccccCcccccC--CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 431 -HVTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 431 -~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 11122346778999999866 35788999999999999999999999743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=249.19 Aligned_cols=200 Identities=27% Similarity=0.392 Sum_probs=170.9
Q ss_pred CCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecc
Q 010887 273 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (498)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (498)
|+..+.||+|++|.||++... +++.+++|+++... .+.....+.+|++++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456789999999999999964 68889999987543 2345678889999999999999999999999999999999999
Q ss_pred cCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCc
Q 010887 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (498)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~ 430 (498)
++ ++...+... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||.+........
T Consensus 81 ~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 81 DT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred CC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 75 887777642 24689999999999999999999999 999999999999999999999999999877655431
Q ss_pred ceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 431 HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
......++..|+|||.+.+. .++.++|+||||+++|||+||+.||....
T Consensus 154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 203 (283)
T cd05118 154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203 (283)
T ss_pred -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 12224467889999998776 78999999999999999999999997544
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=254.64 Aligned_cols=202 Identities=27% Similarity=0.365 Sum_probs=171.2
Q ss_pred HhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEec-ccCCcchHHHHHHHHHHHHhcc-CCccceEEEEEEcCCceEEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~-~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 346 (498)
....|++.+.||+||.+.||++...+.+.+|+|++. ...+......|.+|++.|.+++ |.+|+++++|-..++..|+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 345688999999999999999998888999988876 4456677899999999999995 99999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|||- .-+|..+|..... ....| .++.+..|++.++.++|+. ||||.||||.|.|+- .|.+||+|||+|..+.
T Consensus 439 mE~G-d~DL~kiL~k~~~--~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKS--IDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ 510 (677)
T ss_pred eecc-cccHHHHHHhccC--CCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence 9985 4689999886432 22334 7788899999999999999 999999999999885 5689999999999887
Q ss_pred ccCcce-eecccccccccCcccccCC-----------CCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 427 AKLTHV-TTQIRGTMGHIAPEYLSTG-----------KSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 427 ~~~~~~-~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
.+.... .....||+.||+||.+... +.++++||||+|||||+|+-|+.||..
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~ 574 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ 574 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence 654433 3456799999999998532 256899999999999999999999964
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-30 Score=254.52 Aligned_cols=202 Identities=24% Similarity=0.281 Sum_probs=165.9
Q ss_pred cCCC-CCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcc-------------hHHHHHHHHHHHHhccCCccceEEE
Q 010887 271 DNFS-ESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPG-------------GEAAFQREVHLISVAIHKNLLQLIG 335 (498)
Q Consensus 271 ~~~~-~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------------~~~~~~~e~~~l~~l~h~niv~l~~ 335 (498)
++|. ..+.||+|+||+||+|... +++.||+|.++...... ....+.+|+++++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 3577999999999999964 68899999986432211 1135788999999999999999999
Q ss_pred EEEcCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEE
Q 010887 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV 415 (498)
Q Consensus 336 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 415 (498)
++...+..++||||+. ++|.+.+.. ...+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence 9999999999999997 688888764 34589999999999999999999998 999999999999999999999
Q ss_pred EeecCccccccccC-------------cceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 416 LCDFGLAKLVDAKL-------------THVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 416 i~DfGl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
|+|||+++...... ........++..|+|||.+.+. .++.++||||||+++|||+||+.||....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999987654111 0111223467889999998764 46889999999999999999999997543
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=250.20 Aligned_cols=195 Identities=31% Similarity=0.386 Sum_probs=165.0
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.|+..+.||+|+||.||+|+.. ++..+++|.+... .......++.+|+++++.++|+|++++++++......++|+|
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666788999999999999964 5788999988632 223345678899999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+. |++.+.+... ...+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 96 YCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred ccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 997 6777766532 24588999999999999999999998 9999999999999999999999999998765432
Q ss_pred CcceeecccccccccCccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 429 LTHVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
....++..|+|||.+. ...++.++|||||||++|||++|+.||..
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 216 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcc
Confidence 2234788999999974 35678899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-29 Score=247.62 Aligned_cols=195 Identities=31% Similarity=0.389 Sum_probs=164.4
Q ss_pred CCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 273 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
|...+.||+|+||+||+|+.. +++.|++|++.... .......+.+|++++++++|||++++++++.+....++|+||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555778999999999999964 68899999986322 223346788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+. +++.+.+... ...+++.++..++.|++.++.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 96 5777766532 34589999999999999999999999 999999999999999999999999999864322
Q ss_pred cceeecccccccccCccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 430 THVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.....|+..|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~ 223 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 12345788999999984 456888999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=241.08 Aligned_cols=194 Identities=28% Similarity=0.306 Sum_probs=168.7
Q ss_pred eecccceEEEEEEEc-CCcEEEEEEecccCC--cchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCCCH
Q 010887 279 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV 355 (498)
Q Consensus 279 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 355 (498)
||+|+||.||++... +++.+++|.+..... ......+.+|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999965 588999999874332 23456889999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcceeec
Q 010887 356 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 435 (498)
Q Consensus 356 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~~~~ 435 (498)
.+++.. ...+++.....++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||++........ ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~ 152 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNT 152 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccC
Confidence 999875 23589999999999999999999998 999999999999999999999999999876654321 2233
Q ss_pred ccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 436 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 436 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
..++..|++||...+...+.++|+||||+++||+++|+.||...+
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 557889999999988888999999999999999999999997543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=252.45 Aligned_cols=200 Identities=25% Similarity=0.350 Sum_probs=163.5
Q ss_pred CCCCCCeeecccceEEEEEEEc-C--CcEEEEEEecccCC-cchHHHHHHHHHHHHhc-cCCccceEEEEEEcC----Cc
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-D--NTKVAVKRLQDYYS-PGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS----SE 342 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~ 342 (498)
+|+..+.||+|+||.||+++.. . +..||+|++..... ......+.+|++++.++ .||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999964 3 67899999874332 23356788999999999 599999999875432 34
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcc
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~ 422 (498)
.+++++|+. ++|.+.+.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 678888886 688887764 34689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcc---eeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 423 KLVDAKLTH---VTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 423 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
+........ ......|+..|+|||+..+ ..++.++|+|||||++|||++|+.||...
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 866432211 1123468899999998765 46899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=244.33 Aligned_cols=220 Identities=24% Similarity=0.301 Sum_probs=189.7
Q ss_pred HHHHHHHhcCCCCCCeeecccceEEEEEEEc------CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEE
Q 010887 263 CRELQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336 (498)
Q Consensus 263 ~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 336 (498)
.+++.+..++++...++.+|.||.||+|.|. +.+.|.||.+++..++-+...+..|--++..+.|||+.++.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4567777888888899999999999999654 3566899999988888888999999999999999999999999
Q ss_pred EEcCC-ceEEEEecccCCCHHHhhcccC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCC
Q 010887 337 CTTSS-ERILVYPFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN 411 (498)
Q Consensus 337 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~ 411 (498)
+.+.. .++..|.++..|+|..+|..++ ...+.++..+...++.|++.|++|||+. ++||.||.++|.++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 97654 5788999999999999998433 2234577888899999999999999999 99999999999999999
Q ss_pred CcEEEeecCccccccccCcce-eecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccc
Q 010887 412 FEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEE 485 (498)
Q Consensus 412 ~~~ki~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~~~~~~ 485 (498)
.++||+|=.+++.+.+.+.+. .........||+||.+....|+..+|||||||++|||+| |+.|+..-+..|.+
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~ 508 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME 508 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH
Confidence 999999999999876655443 233456789999999999999999999999999999999 99999876665544
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=246.52 Aligned_cols=200 Identities=27% Similarity=0.383 Sum_probs=170.6
Q ss_pred CCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecc
Q 010887 273 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (498)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (498)
|+..+.||+|++|.||+|+.. +++.+++|+++... .......+.+|++++++++|+|++++++++...+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456788999999999999965 58999999987543 2334567889999999999999999999999999999999999
Q ss_pred cCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCc
Q 010887 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (498)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~ 430 (498)
+ ++|.+++.... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.++.......
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 8 58999887532 4689999999999999999999999 999999999999999999999999999886654322
Q ss_pred ceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 431 HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
. .....++..|+|||.+.+. .++.++||||||+++|||++|+.||....
T Consensus 154 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 203 (282)
T cd07829 154 T-YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS 203 (282)
T ss_pred c-cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 1 1223456789999998776 78999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=244.51 Aligned_cols=199 Identities=26% Similarity=0.375 Sum_probs=162.9
Q ss_pred CCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHh-ccCCccceEEEEEEcCCceEEEEecccC
Q 010887 275 ESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISV-AIHKNLLQLIGYCTTSSERILVYPFMQN 352 (498)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (498)
....||.|+||+|+|... +.|+..|||+++......+.+++..|.+...+ -+.||||+++|.+..++..++.||.|.
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd- 146 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD- 146 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-
Confidence 356799999999999995 46899999999876666777888888887555 468999999999999999999999996
Q ss_pred CCHHHhhcc-cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcc
Q 010887 353 LSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 431 (498)
Q Consensus 353 gsL~~~l~~-~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~ 431 (498)
-|+..+.+. +.-....+++...-+|..-..+||.||.... .|+|||+||+|||+|..|.+|+||||.+-.+.++..
T Consensus 147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA- 223 (361)
T KOG1006|consen 147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA- 223 (361)
T ss_pred hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHHH-
Confidence 344333221 1122456888888888889999999999875 899999999999999999999999999976654322
Q ss_pred eeecccccccccCcccccC--CCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 432 VTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 432 ~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
.+.-.|-..|||||.+.. ..|+.+|||||+|++|+|+.||+-|++.
T Consensus 224 -kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~ 271 (361)
T KOG1006|consen 224 -KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK 271 (361)
T ss_pred -hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch
Confidence 233457788999999864 3489999999999999999999999973
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=250.29 Aligned_cols=203 Identities=28% Similarity=0.422 Sum_probs=169.6
Q ss_pred CCCCCCeeecccceEEEEEE-EcCCcEEEEEEecccC------CcchHHHHHHHHHHHHhccCCccceEEEEEEc-CCce
Q 010887 272 NFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYY------SPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-SSER 343 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~ 343 (498)
+|-..++||+|+|+.||+|. +...+.||||+-.-.. ...-.+...+|.++-+.+.||.||++++|+.- .+..
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 45557789999999999999 5567889999864211 11223566789999999999999999999964 4567
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEEC---CCCcEEEeecC
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD---DNFEAVLCDFG 420 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~ki~DfG 420 (498)
+-|.||++|-+|.-+|+. .+.+++.++..|+.||+.||.||... .++|+|-||||.|||+- ..|.+||+|||
T Consensus 544 CTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred eeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 889999999999999986 45689999999999999999999986 67899999999999994 56789999999
Q ss_pred ccccccccCcc------eeecccccccccCcccccCC----CCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 421 LAKLVDAKLTH------VTTQIRGTMGHIAPEYLSTG----KSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 421 l~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
+++.++++... .+....||..|++||.+.-+ +.+.|.||||.|||+|+.+-|+.||...
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 99998765433 23557799999999988543 5788999999999999999999999764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=259.37 Aligned_cols=205 Identities=21% Similarity=0.291 Sum_probs=155.4
Q ss_pred HhcCCCCCCeeecccceEEEEEEE-----------------cCCcEEEEEEecccCCcchHHH--------------HHH
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVL-----------------SDNTKVAVKRLQDYYSPGGEAA--------------FQR 317 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~~ 317 (498)
..++|++.++||+|+||.||+|.. .+++.||||+++... .....+ +..
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~-~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDR-QGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccc-hhhHHHHHhhhhhhhcccchhHH
Confidence 567899999999999999999974 235679999986422 122223 344
Q ss_pred HHHHHHhccCCcc-----ceEEEEEEc--------CCceEEEEecccCCCHHHhhcccCC--------------------
Q 010887 318 EVHLISVAIHKNL-----LQLIGYCTT--------SSERILVYPFMQNLSVAYRLRDLKP-------------------- 364 (498)
Q Consensus 318 e~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~-------------------- 364 (498)
|+.++.+++|.++ ++++++|.. .++.++||||+++++|.++++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6777777776654 677777753 3568999999999999999874211
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcceeecccccccccC
Q 010887 365 GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 444 (498)
Q Consensus 365 ~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~a 444 (498)
....++|..+..++.|++.+|+|||+. +|+||||||+||+++.++.+||+|||++...............+|+.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 112357888999999999999999999 99999999999999999999999999997654332221222334789999
Q ss_pred cccccCCCC----------------------CCcccchhHHHHHHHHHhCCC-CCC
Q 010887 445 PEYLSTGKS----------------------SEKTDVFGYGITLLELVTGQR-AID 477 (498)
Q Consensus 445 PE~~~~~~~----------------------~~~~Dv~s~Gvvl~elltG~~-p~~ 477 (498)
||.+..... ..+.||||+||+++||++|.. |+.
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 998754321 234699999999999999875 765
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-31 Score=257.07 Aligned_cols=207 Identities=24% Similarity=0.273 Sum_probs=182.1
Q ss_pred hcCCCCCCeeecccceEEEEEEEcCCc-EEEEEEeccc--CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLSDNT-KVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
..+++....||-|+||.|=++...... .+|+|.+++. ...........|-++|...+.|.||+++-.+.++...|+.
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 345556778999999999999975443 4888888743 3455667788899999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
||-|-||.+...|++ ++.++..+..-++.-+.+|++|||++ +||+|||||+|.++|.+|-+||.|||+++.+.
T Consensus 499 mEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 499 MEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred HHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 999999999999987 55688889999999999999999999 99999999999999999999999999999887
Q ss_pred ccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccc
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE 485 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~~~~~~ 485 (498)
.. ..+...+||+.|.|||++.+...+..+|.||+|+++|||+||++||...+....+
T Consensus 572 ~g--~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY 628 (732)
T KOG0614|consen 572 SG--RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY 628 (732)
T ss_pred cC--CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH
Confidence 64 3456789999999999999999999999999999999999999999987654443
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=252.09 Aligned_cols=199 Identities=25% Similarity=0.382 Sum_probs=163.2
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcC---------
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--------- 340 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------- 340 (498)
.+|...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~-~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC-CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 57888999999999999999964 68899999886433 24567788999999999999999999776544
Q ss_pred -----CceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEEC-CCCcE
Q 010887 341 -----SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFEA 414 (498)
Q Consensus 341 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~ 414 (498)
...++|+||++ ++|.+.+.. ..+++.....++.||+.||.|||+. +++||||||+||+++ +++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence 34689999997 588777653 3588999999999999999999999 999999999999997 45678
Q ss_pred EEeecCccccccccCcce--eecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 415 VLCDFGLAKLVDAKLTHV--TTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 415 ki~DfGl~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
+++|||.++......... .....++..|+|||.+.. ..++.++|||||||++|||++|+.||...
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 222 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999987654322211 122346889999998654 56788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=253.55 Aligned_cols=199 Identities=28% Similarity=0.400 Sum_probs=168.1
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCc----
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE---- 342 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 342 (498)
..++|+..+.||+|++|.||+|+.. +++.||+|++.... .......+.+|++++++++|||++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567889999999999999999975 57899999886432 23345667889999999999999999987766554
Q ss_pred --eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecC
Q 010887 343 --RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (498)
Q Consensus 343 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 420 (498)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +++||||||+||++++++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 78999998 5688887764 3589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 421 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
++...... .....++..|+|||...+ ..++.++|||||||++|||+||+.||....
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~ 220 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD 220 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 98765432 223456888999999865 367889999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=273.06 Aligned_cols=198 Identities=29% Similarity=0.360 Sum_probs=156.7
Q ss_pred HHhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcC------
Q 010887 268 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------ 340 (498)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 340 (498)
.-..+|+..+.||+||||.|||++.+ ||+.||||++.-..+........+|++.+++++|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34567888999999999999999965 89999999998655566677889999999999999999988522110
Q ss_pred --------------------------------------------------------------------------------
Q 010887 341 -------------------------------------------------------------------------------- 340 (498)
Q Consensus 341 -------------------------------------------------------------------------------- 340 (498)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHH
Q 010887 341 ---------------------------------SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387 (498)
Q Consensus 341 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~y 387 (498)
...|+-||||+.-++.+.+++..... .....++++++|+.||.|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHH
Confidence 01245667777666666665422110 356678999999999999
Q ss_pred HHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc-----------------ccCcceeecccccccccCcccccC
Q 010887 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD-----------------AKLTHVTTQIRGTMGHIAPEYLST 450 (498)
Q Consensus 388 LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~ 450 (498)
+|++ ++|||||||.||++|++..+||+|||++.... .......+...||.-|+|||++.+
T Consensus 713 IH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 9999 99999999999999999999999999998721 000112244679999999999976
Q ss_pred CC---CCCcccchhHHHHHHHHHh
Q 010887 451 GK---SSEKTDVFGYGITLLELVT 471 (498)
Q Consensus 451 ~~---~~~~~Dv~s~Gvvl~ellt 471 (498)
.. |+.|+|+||+|||++||+-
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc
Confidence 54 9999999999999999984
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=269.68 Aligned_cols=146 Identities=27% Similarity=0.340 Sum_probs=130.8
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|.+.+.||+|+||.||+|... +++.||+|+++... .......+.+|++++..++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999965 68899999987432 2334577889999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
||+.+++|..++.. ...+++..++.++.||+.||+|||.. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999875 23578899999999999999999998 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=237.03 Aligned_cols=180 Identities=24% Similarity=0.239 Sum_probs=154.0
Q ss_pred ccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCCCHHHhhc
Q 010887 282 GGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLR 360 (498)
Q Consensus 282 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 360 (498)
|.+|.||+++. .+++.+|+|+++... .+.+|...+....||||+++++++...+..++||||+++|+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 89999999996 467899999986421 23455555566679999999999999999999999999999999887
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcceeecccccc
Q 010887 361 DLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 440 (498)
Q Consensus 361 ~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~ 440 (498)
.. ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++++|||.+...... .....++.
T Consensus 78 ~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~ 146 (237)
T cd05576 78 KF----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVEN 146 (237)
T ss_pred Hh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCc
Confidence 52 3589999999999999999999998 9999999999999999999999999987655432 12234567
Q ss_pred cccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 441 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 441 ~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
.|+|||......++.++||||+|+++|||++|+.|++.
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 89999999888899999999999999999999988764
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=233.46 Aligned_cols=204 Identities=25% Similarity=0.346 Sum_probs=174.4
Q ss_pred HHhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCce
Q 010887 268 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER 343 (498)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 343 (498)
...++|...++||+|+|..|-.+++. +.+.+|+|++++.. ...+.+=...|-.+..+. +||.+|-+..+++++...
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 34568888999999999999999964 57789999988532 223334445566666665 699999999999999999
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
++|.||.++|+|.-+... +..+++..+.-+..+|+-||.|||++ +|+.||||..|||+|..|++|++|+|+++
T Consensus 327 ffvieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred EEEEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhh
Confidence 999999999998777664 44689999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.--.+ ...++..+||+.|+|||.+.+..|....|+|++||+++||+.|+.||+.-
T Consensus 400 e~l~~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 400 EGLGP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred cCCCC-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence 54332 23456789999999999999999999999999999999999999999853
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-30 Score=232.30 Aligned_cols=197 Identities=26% Similarity=0.319 Sum_probs=163.0
Q ss_pred HhcCCCC-CCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHH-hccCCccceEEEEEEcC----C
Q 010887 269 ATDNFSE-SNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKNLLQLIGYCTTS----S 341 (498)
Q Consensus 269 ~~~~~~~-~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~----~ 341 (498)
.+++|++ .++||-|-.|.|-.+..+ +++.+|+|++.+. ....+|+++-- .-.|||||.+++++.+. .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 3455654 468999999999999854 6889999999753 23356776533 33699999999988543 3
Q ss_pred ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEEC---CCCcEEEee
Q 010887 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD---DNFEAVLCD 418 (498)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~ki~D 418 (498)
..++|||.|+||.|...+.+.. ...+++.++..|+.||+.|+.|||+. .|.||||||+|+|.. .+..+|++|
T Consensus 133 cLLiVmE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred eeEeeeecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence 5678999999999999998743 55799999999999999999999999 999999999999995 456789999
Q ss_pred cCccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 419 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
||+++.-.... .....+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||-.
T Consensus 208 fGFAK~t~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS 265 (400)
T KOG0604|consen 208 FGFAKETQEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 265 (400)
T ss_pred cccccccCCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccc
Confidence 99998665422 22345669999999999999999999999999999999999999964
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=226.67 Aligned_cols=200 Identities=30% Similarity=0.402 Sum_probs=171.8
Q ss_pred CCCCCeeecccceEEEEEEEcC-CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEeccc
Q 010887 273 FSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQ 351 (498)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 351 (498)
|...+.||+|++|.||++...+ ++.+++|.+...........+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999765 889999998754322257789999999999999999999999999999999999999
Q ss_pred CCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcc
Q 010887 352 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 431 (498)
Q Consensus 352 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~ 431 (498)
+++|.+++..... .+++.....++.++++++.|||+. +++|+|++|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999999875321 178999999999999999999999 9999999999999999999999999998877544211
Q ss_pred eeecccccccccCcccc-cCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 432 VTTQIRGTMGHIAPEYL-STGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 432 ~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
......++..|++||.. ....++.++|||+||++++||++|+.||+.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22334567889999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=253.21 Aligned_cols=208 Identities=27% Similarity=0.387 Sum_probs=177.3
Q ss_pred HHHHHHHhcCCCCCCeeecccceEEEEEE-EcCCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEEc-
Q 010887 263 CRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT- 339 (498)
Q Consensus 263 ~~el~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~- 339 (498)
++.+...++-|++.+.||.|.+|.||+++ .++++.+|+|++.... ....+.+.|.++++.. .|||++.++|++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~--d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE--DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc--cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 33444467789999999999999999999 5678899999886433 3456677888888877 69999999999864
Q ss_pred ----CCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEE
Q 010887 340 ----SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV 415 (498)
Q Consensus 340 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 415 (498)
+++.++|||||.+||..+.++... ...+.|+.+..|..++++|+.+||.. .++|||||-.|||+++++.+|
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEE
Confidence 468999999999999999999766 55799999999999999999999999 899999999999999999999
Q ss_pred EeecCccccccccCcceeecccccccccCcccccC-----CCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 416 LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-----GKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 416 i~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
++|||++..++.... ......||+.|||||++.- ..|+..+|+||+|++..||--|.+|+..
T Consensus 164 LvDFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~D 230 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCD 230 (953)
T ss_pred Eeeeeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccC
Confidence 999999987765432 3445679999999999853 3467889999999999999999999864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=250.18 Aligned_cols=195 Identities=24% Similarity=0.311 Sum_probs=164.5
Q ss_pred HhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCceEEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 346 (498)
.+++|.....+|.|+|+.|-++.. .+++..+||++.+.. .+-.+|+.++... .||||+++.+.+.+..+.++|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 356788888899999999999984 568889999987542 2224566665554 699999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEE-CCCCcEEEeecCccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL-DDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl-~~~~~~ki~DfGl~~~~ 425 (498)
||.+.++-+.+.+.... ... ..+..|+.+|+.++.|||++ ++|||||||+|||+ ++.++++|+|||.++..
T Consensus 395 ~e~l~g~ell~ri~~~~----~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKP----EFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred ehhccccHHHHHHHhcc----hhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 99999999888877522 233 67778999999999999999 99999999999999 69999999999999877
Q ss_pred cccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
... ....+-|..|.|||+....+|+..+|+||||++||||++|+.||....
T Consensus 467 ~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P 517 (612)
T KOG0603|consen 467 ERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHP 517 (612)
T ss_pred chh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCC
Confidence 654 122334789999999999999999999999999999999999998543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-30 Score=230.15 Aligned_cols=201 Identities=26% Similarity=0.388 Sum_probs=165.5
Q ss_pred CCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCC-----ceE
Q 010887 272 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-----ERI 344 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 344 (498)
+.+..+-||.|+||.||.+.+ ++|+.|+.|++.... +-...+.+.+|++++..++|.|++..++..+... +.|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 344578899999999999995 479999999986433 2234578899999999999999999998876654 566
Q ss_pred EEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccc
Q 010887 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~ 424 (498)
.++|.|. +.|+...-..+.++-..++-+..||++||.|||+. +|.||||||.|.|++.+...||||||+++.
T Consensus 134 V~TELmQ-----SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 134 VLTELMQ-----SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHH-----hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccc
Confidence 7777775 23444333466788889999999999999999999 999999999999999999999999999997
Q ss_pred ccccCcceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 425 VDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
...+...-.+...-|..|+|||.+++. .|+...||||.|||+.|++..+..|+...
T Consensus 206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~ 262 (449)
T KOG0664|consen 206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG 262 (449)
T ss_pred cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC
Confidence 765544444444568899999999875 58999999999999999999998887544
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-29 Score=234.09 Aligned_cols=200 Identities=23% Similarity=0.297 Sum_probs=169.4
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccC--Cc----cceEEEEEEcCCc
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH--KN----LLQLIGYCTTSSE 342 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~n----iv~l~~~~~~~~~ 342 (498)
+++|.+...+|+|.||.|-++.+. .+..||+|+++... .-..+..-|++++.++.+ |+ ++.+.+++...+.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~--kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD--KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH--HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 678999999999999999999964 46889999997532 334556779999999842 22 7888889999999
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEEC-------------
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD------------- 409 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~------------- 409 (498)
.++|+|.+ |.|+.+++.... ..+++...+..|+.|++++++|||+. +++|.||||+|||+.
T Consensus 166 iCivfell-G~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred eEEEEecc-ChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCc
Confidence 99999988 558999998633 45789999999999999999999999 999999999999993
Q ss_pred -------CCCcEEEeecCccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCcc
Q 010887 410 -------DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRL 481 (498)
Q Consensus 410 -------~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~~ 481 (498)
.+..+||+|||-++.-.... ..+..|..|+|||++.+-.+++++||||+||||.|+.||...|+..+.
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 24569999999998665432 345579999999999999999999999999999999999999987653
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-30 Score=228.82 Aligned_cols=202 Identities=30% Similarity=0.430 Sum_probs=165.0
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEec-ccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcC--------C
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--------S 341 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------~ 341 (498)
.|+...+||+|.||.||+|+.. .++.||+|++- +...++-.....+|++++..++|+|++.+++.|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 4555778999999999999954 57778888764 333445556678999999999999999999888542 2
Q ss_pred ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCc
Q 010887 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (498)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl 421 (498)
..++|+++++. +|...|.+. ...++..++.+++.++..||.|+|+. .|+|||+||.|||++.++.+||+|||+
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence 36899999975 666666642 35689999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCcce---eecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 422 AKLVDAKLTHV---TTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 422 ~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
++.+..+.... .+...-|..|++||.+.+ ++|+++.|||+-|||+.||.|+.+-++...
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt 233 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT 233 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh
Confidence 98765443222 122345899999999876 568999999999999999999998887644
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=253.47 Aligned_cols=201 Identities=19% Similarity=0.282 Sum_probs=143.7
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc-C----CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEE------E
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS-D----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY------C 337 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~ 337 (498)
..++|+..+.||+|+||.||+|++. + +..||+|++.... ....+..| .+....+.++..++.. .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~---~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG---AVEIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc---hhHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 5678999999999999999999965 4 6899999886422 11111111 1112222222222211 2
Q ss_pred EcCCceEEEEecccCCCHHHhhcccCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCC
Q 010887 338 TTSSERILVYPFMQNLSVAYRLRDLKPG----------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDL 401 (498)
Q Consensus 338 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl 401 (498)
....+.++|+||+++++|.+++...... ........+..++.|++.||+|||+. +|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence 4556789999999999999988642110 01122344567999999999999999 9999999
Q ss_pred CCCcEEECC-CCcEEEeecCccccccccCcceeecccccccccCcccccCC----------------------CCCCccc
Q 010887 402 KAANILLDD-NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG----------------------KSSEKTD 458 (498)
Q Consensus 402 k~~NILl~~-~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 458 (498)
||+|||+++ ++.+||+|||+++..............+++.|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999986 57999999999987654433344456789999999965322 2345679
Q ss_pred chhHHHHHHHHHhCCCCCC
Q 010887 459 VFGYGITLLELVTGQRAID 477 (498)
Q Consensus 459 v~s~Gvvl~elltG~~p~~ 477 (498)
||||||++|||+++..|++
T Consensus 362 VwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred cHHHHHHHHHHHhCcCCCc
Confidence 9999999999999876654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=240.01 Aligned_cols=197 Identities=23% Similarity=0.358 Sum_probs=165.9
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-------CcchHHHHHHHHHHHHhcc---CCccceEEEEEEc
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-------SPGGEAAFQREVHLISVAI---HKNLLQLIGYCTT 339 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~ 339 (498)
.+|+..+.+|+|+||.|+.|.++ +...|++|.+.+.. ........-.|+++|..++ |+||++++++|.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 35788999999999999999975 46678999876421 1111223456999999998 9999999999999
Q ss_pred CCceEEEEecc-cCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEee
Q 010887 340 SSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 418 (498)
Q Consensus 340 ~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~D 418 (498)
++..+++||-. ++.+|.+++.. .+.++++++.-|.+|++-|+++||+. +|||||||-+||.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 99999999965 45678887764 56799999999999999999999999 999999999999999999999999
Q ss_pred cCccccccccCcceeecccccccccCcccccCCCC-CCcccchhHHHHHHHHHhCCCCCC
Q 010887 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAID 477 (498)
Q Consensus 419 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvvl~elltG~~p~~ 477 (498)
||.+...... ......||.+|.|||++.+.+| ...-|||++|++||-++-...||.
T Consensus 714 fgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9998765543 2345679999999999999887 556799999999999998888874
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-27 Score=221.68 Aligned_cols=187 Identities=30% Similarity=0.384 Sum_probs=164.5
Q ss_pred cceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCCCHHHhhcc
Q 010887 283 GFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD 361 (498)
Q Consensus 283 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 361 (498)
+||.||+|... +++.+++|++.........+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48999999987544333268899999999999999999999999999999999999999999998875
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcceeeccccccc
Q 010887 362 LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 441 (498)
Q Consensus 362 ~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~ 441 (498)
.. .+++..+..++.++++++.|||+. +++|+||+|+||++++++.++++|||.+....... ......++..
T Consensus 81 ~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 RG----RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred cc----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 22 288999999999999999999999 99999999999999999999999999998765432 2233457889
Q ss_pred ccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 442 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 442 y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
|++||......++.++||||||++++||++|+.||+.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999888899999999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.4e-28 Score=212.23 Aligned_cols=196 Identities=19% Similarity=0.331 Sum_probs=165.2
Q ss_pred hcCCCCCCeeecccceEEEEEE-EcCCcEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCccceEEEEEEcCC--ceEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSS--ERIL 345 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~~l 345 (498)
.++|++.+++|+|.|++||.|. ..+++.++||+++. ...+.+.+|+.++..+. ||||+++++...++. .+.+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 4678889999999999999999 56788999999974 45677899999999997 999999999987765 4679
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCC-CcEEEeecCcccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAKL 424 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~ki~DfGl~~~ 424 (498)
++||+.+-+...... .++...+...+.++++||.|+|+. ||.|||+||.||++|.. -.++++|+|+|.+
T Consensus 113 iFE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred HhhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhh
Confidence 999999877655432 367777888999999999999999 99999999999999854 4799999999999
Q ss_pred ccccCcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcc
Q 010887 425 VDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRL 481 (498)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~~ 481 (498)
+.+.... .....+..|.-||.+.. +.|+..-|+|||||++..|+..+.||-....
T Consensus 183 YHp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d 238 (338)
T KOG0668|consen 183 YHPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 238 (338)
T ss_pred cCCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC
Confidence 8875433 22345677899999865 5588899999999999999999999976543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=223.48 Aligned_cols=132 Identities=24% Similarity=0.354 Sum_probs=110.8
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhcc-----CC---ccceEEEEEEcC-
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-----HK---NLLQLIGYCTTS- 340 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----h~---niv~l~~~~~~~- 340 (498)
.+|-..++||.|.|++||++.+ .+.+.||+|+.+.. +.-.+..+.||++|++++ |+ .||+++++|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 5788899999999999999995 56788999999743 234466788999999885 33 599999999653
Q ss_pred ---CceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEEC
Q 010887 341 ---SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD 409 (498)
Q Consensus 341 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~ 409 (498)
.+.++|+|++ |-+|..++.... -++++...+++|++|++.||.|||.+| +|+|.||||+|||+.
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 4789999998 557888887543 356999999999999999999999999 999999999999993
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.5e-27 Score=238.95 Aligned_cols=199 Identities=29% Similarity=0.362 Sum_probs=159.4
Q ss_pred CCCCCCeeecccce-EEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCceEEEEec
Q 010887 272 NFSESNIIGQGGFG-KVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 272 ~~~~~~~lG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
-|...+++|.|+-| .||+|.. +++.||||++-. ....-..+|+..+..- +||||+++++.-.++...|+..|.
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee-CCceehHHHHhh----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 35556789999887 5799998 688999999864 2334557899999887 599999998888888889999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECC---C--CcEEEeecCcccc
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---N--FEAVLCDFGLAKL 424 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~--~~~ki~DfGl~~~ 424 (498)
|. .+|++++...........-.....+..|++.||++||+. +||||||||.||||+. + ..++|+|||+++.
T Consensus 585 C~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 585 CA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred hh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 95 589998875211111111134567888999999999998 9999999999999965 3 5789999999998
Q ss_pred ccccCcce--eecccccccccCcccccCCCCCCcccchhHHHHHHHHHhC-CCCCCCC
Q 010887 425 VDAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG-QRAIDFS 479 (498)
Q Consensus 425 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG-~~p~~~~ 479 (498)
+..+.... .....||-||+|||.+....-+..+||||+|||+|+.+|| .+||...
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~ 718 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS 718 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch
Confidence 87554332 3456799999999999998888899999999999999996 8999753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=198.39 Aligned_cols=184 Identities=35% Similarity=0.502 Sum_probs=159.0
Q ss_pred eecccceEEEEEEEcC-CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCCCHHH
Q 010887 279 IGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAY 357 (498)
Q Consensus 279 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 357 (498)
||+|.+|.||++...+ ++.+++|++...........+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 899999998754332245789999999999999999999999999999999999999999999
Q ss_pred hhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECC-CCcEEEeecCccccccccCcceeecc
Q 010887 358 RLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDFGLAKLVDAKLTHVTTQI 436 (498)
Q Consensus 358 ~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~ki~DfGl~~~~~~~~~~~~~~~ 436 (498)
++.... ..+++..+..++.++++++.|||+. +++|+||+|.||++++ ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 987532 3589999999999999999999999 9999999999999999 89999999999986654321 12234
Q ss_pred cccccccCcccccCC-CCCCcccchhHHHHHHHH
Q 010887 437 RGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLEL 469 (498)
Q Consensus 437 ~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~el 469 (498)
.+...|++||..... ..+.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 467889999999877 788999999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.2e-26 Score=208.78 Aligned_cols=195 Identities=27% Similarity=0.330 Sum_probs=161.9
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCC------c
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------E 342 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~ 342 (498)
.+|.....+|.|.. .|.-+.+. .++.||+|++... ......+...+|...+..++|+||++++.++.... +
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 35666777888888 66666633 5788999987633 23344566788999999999999999999987543 5
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcc
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~ 422 (498)
.++|||||. .+|...+.- .++-.+...|..|++.|+.|||+. +|+||||||+||++..+..+||.|||++
T Consensus 96 ~y~v~e~m~-~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVILM------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhhh-hHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence 689999996 466666652 367778889999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
+..... ...+....|..|.|||++.+..+.+.+||||.||++.||++|+-.|..
T Consensus 166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g 219 (369)
T KOG0665|consen 166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG 219 (369)
T ss_pred cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC
Confidence 866543 345667789999999999998899999999999999999999998874
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-26 Score=206.83 Aligned_cols=198 Identities=26% Similarity=0.425 Sum_probs=159.1
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEE-EEcCCceEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGY-CTTSSERILV 346 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-~~~~~~~~lv 346 (498)
.+.|.+.+.+|+|.||.+-+++.+ ..+.+++|-+.... ...++|.+|..---.+ .|.||+.-++. ++..+..+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~--tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ--TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch--hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 457889999999999999999975 46788999886543 4578899998754444 48899987764 5667778899
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEE-C-CCCcEEEeecCcccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL-D-DNFEAVLCDFGLAKL 424 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl-~-~~~~~ki~DfGl~~~ 424 (498)
+||++.|+|.+.+.. .++.+....+++.|++.|+.|+|++ .+||||||.+|||+ + +...+|+||||..+.
T Consensus 101 qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred eccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccc
Confidence 999999999887764 4578888999999999999999999 99999999999999 3 345899999999875
Q ss_pred ccccCcceeecccccccccCcccccCC-----CCCCcccchhHHHHHHHHHhCCCCCCCCcc
Q 010887 425 VDAKLTHVTTQIRGTMGHIAPEYLSTG-----KSSEKTDVFGYGITLLELVTGQRAIDFSRL 481 (498)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~Gvvl~elltG~~p~~~~~~ 481 (498)
.+... ....-+..|.+||..... ...+.+|+|.||++++.++||+.||+....
T Consensus 173 ~g~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~ 230 (378)
T KOG1345|consen 173 VGTTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI 230 (378)
T ss_pred cCcee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc
Confidence 54321 222345678999987543 246788999999999999999999985444
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=230.66 Aligned_cols=159 Identities=36% Similarity=0.607 Sum_probs=140.1
Q ss_pred CCCCChhHHHHHHHHHHHccCCCCCCCCCCCCCCCCCC----CcceeEecC------CceeEEEecccccCccccccccc
Q 010887 29 SSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCF----SWSHVTCRN------GNVISLTLGSNGFSGKISPSITK 98 (498)
Q Consensus 29 ~~~~~~~~~~al~~~~~~~~~~~~~l~~w~~~~~~~c~----~w~gv~c~~------~~v~~l~l~~~~l~g~~~~~~~~ 98 (498)
.....+.|..||+.+|+++.++.. .+|.+ ++|+ .|.||.|.. ..|+.|+|++|+++|.+|+++++
T Consensus 366 ~~~t~~~~~~aL~~~k~~~~~~~~--~~W~g---~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~ 440 (623)
T PLN03150 366 ESKTLLEEVSALQTLKSSLGLPLR--FGWNG---DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISK 440 (623)
T ss_pred ccccCchHHHHHHHHHHhcCCccc--CCCCC---CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhC
Confidence 345567799999999999986643 48975 4553 799999952 14899999999999999999999
Q ss_pred cCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCCCCcCcccCCchhhc----cccc
Q 010887 99 LKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS----VATF 174 (498)
Q Consensus 99 l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~----~~~~ 174 (498)
|++|+.|+|++|+|+|.+|..++.+++|+.|||++|+|+|.+|+.+++|++|+.|+|++|+|+|.+|..+.. +..+
T Consensus 441 L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l 520 (623)
T PLN03150 441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASF 520 (623)
T ss_pred CCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceE
Confidence 999999999999999999999999999999999999999999999999999999999999999999998754 3578
Q ss_pred cccCCccccCCCCCCCCC
Q 010887 175 NFTGTHLICGSSLEQPCM 192 (498)
Q Consensus 175 ~~~~n~~~~~~~~~~~c~ 192 (498)
++.+|+.+|+.+...+|.
T Consensus 521 ~~~~N~~lc~~p~l~~C~ 538 (623)
T PLN03150 521 NFTDNAGLCGIPGLRACG 538 (623)
T ss_pred EecCCccccCCCCCCCCc
Confidence 899999999977656674
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.2e-24 Score=209.06 Aligned_cols=167 Identities=21% Similarity=0.253 Sum_probs=130.0
Q ss_pred HHhcCCCCCCeeecccceEEEEEEEc--CCcEEEEEEecccC----CcchHHHHHHHHHHHHhccCCccceEEEEEEcCC
Q 010887 268 LATDNFSESNIIGQGGFGKVYKGVLS--DNTKVAVKRLQDYY----SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS 341 (498)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 341 (498)
...++|...+.||+|+||+||+|... +++.+|||++.... .......|.+|++++++++|+|+++.+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 35578999999999999999999864 57778999875321 22345679999999999999999864332 24
Q ss_pred ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCC-CCCcEEECCCCcEEEeecC
Q 010887 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDL-KAANILLDDNFEAVLCDFG 420 (498)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl-k~~NILl~~~~~~ki~DfG 420 (498)
..++||||+++++|... . . . . ...++.+++++|+|||+. +|+|||| ||+|||++.++.+||+|||
T Consensus 92 ~~~LVmE~~~G~~L~~~-~---~-~---~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-R---P-H---G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CcEEEEEccCCCCHHHh-C---c-c---c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 57999999999998632 1 1 0 1 146788999999999999 9999999 9999999999999999999
Q ss_pred ccccccccCcce-------eecccccccccCcccccCC
Q 010887 421 LAKLVDAKLTHV-------TTQIRGTMGHIAPEYLSTG 451 (498)
Q Consensus 421 l~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~ 451 (498)
+++......... .....+++.|+|||++...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 998765432111 1345678889999998654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-25 Score=223.29 Aligned_cols=199 Identities=27% Similarity=0.349 Sum_probs=170.2
Q ss_pred HhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
..++|+....+|.|.||.|||++. ..++..|+|+++-.. ..+.....+|+-+++..+||||+.++|-+...+..++.|
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep-~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP-GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccC-CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 346788899999999999999995 568889999997432 245566778999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+.+|+|++.-+. ..++++.+...+.++..+|++|||+. +-+|||||-.||++++.+.+|++|||.+..+..
T Consensus 92 EycgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred EecCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh
Confidence 99999999887664 56789999999999999999999999 889999999999999999999999999876653
Q ss_pred cCcceeecccccccccCccccc---CCCCCCcccchhHHHHHHHHHhCCCCC
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAI 476 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvvl~elltG~~p~ 476 (498)
... ......||+.|||||+.. .+.|.+++|||+.|+...|+---+.|.
T Consensus 165 ti~-KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl 215 (829)
T KOG0576|consen 165 TIA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL 215 (829)
T ss_pred hhh-hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence 222 234567999999999873 466899999999999999987766553
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-24 Score=205.54 Aligned_cols=197 Identities=25% Similarity=0.358 Sum_probs=163.7
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc----CCcEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCccceEEEEEEcCCce
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSER 343 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 343 (498)
..+.|...++||+|.|++||++.+. ..+.||+|.+..... .....+|++++..+. +.||+++.+++..++..
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~---p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS---PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC---chHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 4567888999999999999999953 467899999875433 355789999999985 89999999999999999
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCC-CcEEEeecCcc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLA 422 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~ki~DfGl~ 422 (498)
.+|+||++.....++... ++..+.......+.+||+++|.. |||||||||+|+|.+.. +.-.|.|||++
T Consensus 111 ~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred EEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhH
Confidence 999999999888887765 67888999999999999999999 99999999999999754 46789999998
Q ss_pred ccccccC-------------------------------------------cceeecccccccccCcccccCCC-CCCccc
Q 010887 423 KLVDAKL-------------------------------------------THVTTQIRGTMGHIAPEYLSTGK-SSEKTD 458 (498)
Q Consensus 423 ~~~~~~~-------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~-~~~~~D 458 (498)
....... ........||+||.|||++...+ .++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 7321000 00011245999999999987654 588899
Q ss_pred chhHHHHHHHHHhCCCCCCC
Q 010887 459 VFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 459 v~s~Gvvl~elltG~~p~~~ 478 (498)
|||-|||++-+++++.||--
T Consensus 261 iws~GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFK 280 (418)
T ss_pred eeeccceeehhhcccccccc
Confidence 99999999999999999964
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.6e-25 Score=213.10 Aligned_cols=207 Identities=21% Similarity=0.230 Sum_probs=174.1
Q ss_pred HHHHhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhcc------CCccceEEEEEE
Q 010887 266 LQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI------HKNLLQLIGYCT 338 (498)
Q Consensus 266 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~ 338 (498)
.+..-.+|.+....|+|-|++|.+|... .|+.||||+++... ...+.=++|+++|++|. .-+.++++..|.
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE--~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE--VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch--HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 3445677888889999999999999964 47899999998542 33344578999999996 347899999999
Q ss_pred cCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCC-cEEEe
Q 010887 339 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLC 417 (498)
Q Consensus 339 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~ki~ 417 (498)
...+.|+|+|-+. .+|.+.|+.+.. .-+|....+..++.|+.-||..|... +|+|.||||.|||+++.- .+|||
T Consensus 505 hknHLClVFE~Ls-lNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLC 579 (752)
T KOG0670|consen 505 HKNHLCLVFEPLS-LNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLC 579 (752)
T ss_pred hcceeEEEehhhh-chHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeec
Confidence 9999999999774 689999987654 46789999999999999999999998 999999999999998765 67999
Q ss_pred ecCccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCccc
Q 010887 418 DFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLE 482 (498)
Q Consensus 418 DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~~~ 482 (498)
|||.|....... .++..-+..|.|||++.+-+|+...|+||.||.||||.||+..|......
T Consensus 580 DfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN 641 (752)
T KOG0670|consen 580 DFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN 641 (752)
T ss_pred cCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH
Confidence 999998776532 23444577899999999999999999999999999999999999876543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=192.87 Aligned_cols=202 Identities=21% Similarity=0.258 Sum_probs=163.2
Q ss_pred CCCCCCeeecccceEEEEEEEcCC--cEEEEEEecccCCcchHHHHHHHHHHHHhccC----CccceEEEEE-EcCCceE
Q 010887 272 NFSESNIIGQGGFGKVYKGVLSDN--TKVAVKRLQDYYSPGGEAAFQREVHLISVAIH----KNLLQLIGYC-TTSSERI 344 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~ 344 (498)
+|.+.+.||+|+||.||++..... ..+|+|........... .+..|..++..+.. +++..+++.. ......+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 788999999999999999996553 47888887654332222 67788888888863 5788888888 4677789
Q ss_pred EEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCC-----CcEEEeec
Q 010887 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-----FEAVLCDF 419 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-----~~~ki~Df 419 (498)
+||+.. |.+|.+...... ...++..+..+|+.|++.+|++||+. +++||||||.|+.+... ..+.+.||
T Consensus 98 iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 998876 678888765433 46799999999999999999999999 99999999999999754 46899999
Q ss_pred Ccccccc--ccCcc----e---eecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 420 GLAKLVD--AKLTH----V---TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 420 Gl~~~~~--~~~~~----~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
|+++... ..... . .....||..|++++...+.+.+.+.|+||++.++.|++.|..||....
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 9998332 21111 0 123459999999999999999999999999999999999999996543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-22 Score=224.90 Aligned_cols=147 Identities=14% Similarity=0.113 Sum_probs=112.5
Q ss_pred ccC-CccceEEEEEE-------cCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 010887 325 AIH-KNLLQLIGYCT-------TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396 (498)
Q Consensus 325 l~h-~niv~l~~~~~-------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 396 (498)
++| +||+++++++. ..+..+.++||+ +++|.+++... ...+++.+++.++.||++||+|||++ +|
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 345 57888888772 223456778877 56999999742 34589999999999999999999999 99
Q ss_pred EEcCCCCCcEEECC-------------------CCcEEEeecCccccccccCc---------------ceeecccccccc
Q 010887 397 IHRDLKAANILLDD-------------------NFEAVLCDFGLAKLVDAKLT---------------HVTTQIRGTMGH 442 (498)
Q Consensus 397 vH~Dlk~~NILl~~-------------------~~~~ki~DfGl~~~~~~~~~---------------~~~~~~~gt~~y 442 (498)
+||||||+|||++. ++.+|++|||+++....... .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 44566666776653211000 000113478889
Q ss_pred cCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 443 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 443 ~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
||||++.+..++.++|||||||++|||++|..|+..
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 999999999999999999999999999999988763
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.2e-21 Score=186.57 Aligned_cols=202 Identities=31% Similarity=0.433 Sum_probs=170.6
Q ss_pred CCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcc--hHHHHHHHHHHHHhccCC-ccceEEEEEEcCCceEEEEec
Q 010887 273 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHK-NLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 349 (498)
|...+.||.|+||.||++... ..+++|.+....... ....|.+|+.+++.+.|+ +++++.+.+......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556778999999999999986 888999987554443 478899999999999988 799999999777778999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCC-cEEEeecCcccccccc
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCDFGLAKLVDAK 428 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~ki~DfGl~~~~~~~ 428 (498)
+.++++.+.+...... ..++......+..|++.++.|+|+. +++|||+||+||+++... .++++|||.++.....
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999666542211 3688899999999999999999999 899999999999999988 7999999999855543
Q ss_pred Ccc-----eeecccccccccCcccccC---CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 429 LTH-----VTTQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 429 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
... ......|+..|+|||.... ..+....|+||+|++++++++|+.||....
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 322 2345678999999999987 578889999999999999999999976543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.9e-21 Score=174.78 Aligned_cols=142 Identities=15% Similarity=0.150 Sum_probs=109.4
Q ss_pred CCeeecccceEEEEEEEcCCcEEEEEEecccCC-cch-------H-----------------HHHHHHHHHHHhccCCcc
Q 010887 276 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS-PGG-------E-----------------AAFQREVHLISVAIHKNL 330 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~-------~-----------------~~~~~e~~~l~~l~h~ni 330 (498)
.+.||+|+||.||+|...+|+.||+|+++.... ... . ....+|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 467999999999999988899999999974321 111 1 122349999999988877
Q ss_pred ceEEEEEEcCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCcEEcCCCCCcEEEC
Q 010887 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL-HEQCNPKIIHRDLKAANILLD 409 (498)
Q Consensus 331 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivH~Dlk~~NILl~ 409 (498)
.....+.. ...++||||++++++...... ...++......++.|++.+|.|+ |+. +|+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 54433322 234899999998776543221 24688999999999999999999 687 999999999999998
Q ss_pred CCCcEEEeecCccccccc
Q 010887 410 DNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 410 ~~~~~ki~DfGl~~~~~~ 427 (498)
++.++|+|||++.....
T Consensus 153 -~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 153 -DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred -CCcEEEEEccccccCCC
Confidence 47899999999875543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-21 Score=173.65 Aligned_cols=202 Identities=21% Similarity=0.258 Sum_probs=167.5
Q ss_pred HhcCCCCCCeeecccceEEEEEE-EcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccC-CccceEEEEEEcCCceEEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH-KNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv 346 (498)
...+|...+.||.|+||.+|.|. ..+|..||+|.-+.. ....+...|.++.+.++| ..|..+..|..+.....+|
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~---a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK---AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc---CCCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 44678889999999999999999 678999999987543 234566788999999875 5677777888888899999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECC---CCcEEEeecCccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVLCDFGLAK 423 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~ki~DfGl~~ 423 (498)
|+.. |.||++...-+. ..++..+++-+|.|+..-++|+|.+ +++||||||+|.|..- ...+.++|||+++
T Consensus 90 MdLL-GPsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eecc-CccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence 9987 678888877543 3588889999999999999999999 8999999999999953 3468899999998
Q ss_pred cccccCcc------eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 424 LVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 424 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.+.+.... ......||.+|.+-....+.+.+...|+=|+|.++.+.--|..||+.-.
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 77543222 1133569999999888888888899999999999999999999998654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.8e-21 Score=176.32 Aligned_cols=199 Identities=21% Similarity=0.266 Sum_probs=168.2
Q ss_pred CCCCCCeeecccceEEEEEE-EcCCcEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCccceEEEEEEcCCceEEEEec
Q 010887 272 NFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
+|.+.++||+|.||..+.|+ +-+++.||||.-.. .....+...|.+..+.+. .++|..++-+-+.+-...+|+|.
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr---kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR---KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccc---cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 68889999999999999999 66899999996542 234566778888888875 68999998888888889999998
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECC-----CCcEEEeecCcccc
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-----NFEAVLCDFGLAKL 424 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-----~~~~ki~DfGl~~~ 424 (498)
+ |-||++...-+ ...++..++..+|.|+..-++|+|++ .+|.|||||+|.||.. ...+.|+|||+++.
T Consensus 106 L-GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 106 L-GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred h-CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 7 67888876643 34589999999999999999999999 8999999999999953 34589999999998
Q ss_pred ccccCcce------eecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 425 VDAKLTHV------TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 425 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+.++.... .....||.+||+-....+++-+...|+=|+|-|+++.|-|..||+.-.
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 87654332 234569999999999999999999999999999999999999998643
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.7e-21 Score=176.42 Aligned_cols=172 Identities=12% Similarity=0.078 Sum_probs=133.4
Q ss_pred HhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcch--HH------HHHHHHHHHHhccCCccceEEEEEEcC
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGG--EA------AFQREVHLISVAIHKNLLQLIGYCTTS 340 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--~~------~~~~e~~~l~~l~h~niv~l~~~~~~~ 340 (498)
..++|...+.+|.|+||.||.+.. ++..+|+|.+++...... .. .|.+|++.+.+++|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 467899999999999999999766 577899999975443221 12 268999999999999999999886533
Q ss_pred --------CceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCC
Q 010887 341 --------SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF 412 (498)
Q Consensus 341 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~ 412 (498)
...+++|||++|.+|.+... ++. ....+++.++..+|+. +++|||+||+||++++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence 35789999999999877632 222 3456899999999999 999999999999999988
Q ss_pred cEEEeecCccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHH
Q 010887 413 EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELV 470 (498)
Q Consensus 413 ~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ell 470 (498)
++++|||........... ..+...+.+..++|+|||||.+....
T Consensus 173 -i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999987655321111 11344555677999999999887554
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.9e-20 Score=168.77 Aligned_cols=141 Identities=18% Similarity=0.159 Sum_probs=112.1
Q ss_pred CCeeecccceEEEEEEEcCCcEEEEEEecccCCc-ch------------------------HHHHHHHHHHHHhccCCcc
Q 010887 276 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP-GG------------------------EAAFQREVHLISVAIHKNL 330 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~------------------------~~~~~~e~~~l~~l~h~ni 330 (498)
.+.||+|++|.||+|...+|+.||||+++..... .. ...+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 5689999999999999878999999998754211 00 1223578899999999988
Q ss_pred ceEEEEEEcCCceEEEEecccCCCHHHh-hcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEEcCCCCCcEEE
Q 010887 331 LQLIGYCTTSSERILVYPFMQNLSVAYR-LRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILL 408 (498)
Q Consensus 331 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlk~~NILl 408 (498)
.....+... ..++||||++++++... +. ...++..+...++.|++.++.++|+ . +|+||||||+||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 655544433 34899999998865433 32 2346788899999999999999999 8 99999999999999
Q ss_pred CCCCcEEEeecCccccccc
Q 010887 409 DDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 409 ~~~~~~ki~DfGl~~~~~~ 427 (498)
+ ++.++|+|||++.....
T Consensus 152 ~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E-CCCEEEEEcccceecCC
Confidence 8 78999999999986654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-21 Score=177.56 Aligned_cols=195 Identities=18% Similarity=0.301 Sum_probs=153.5
Q ss_pred CCeeecccceEEEEEEEcCCcEEEEEEec-ccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCCC
Q 010887 276 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLS 354 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~-~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 354 (498)
..+|.+...|+.|+|+|+. ..+++|+++ ...+....++|..|.-.++.+.||||++++|.|..+....++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 4568889999999999954 455567766 23344566889999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcceee
Q 010887 355 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT 434 (498)
Q Consensus 355 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~~~ 434 (498)
|...|++.. .-..+-.++.+++.++|+|++|||+. .|-|.---|.+..|++|++.+++|+ .+-.++.... .
T Consensus 274 lynvlhe~t--~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kfsfqe-----~ 344 (448)
T KOG0195|consen 274 LYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQE-----V 344 (448)
T ss_pred HHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-cccceeeeec-----c
Confidence 999999733 34467788999999999999999996 3334555799999999999999884 1211111110 1
Q ss_pred cccccccccCcccccCCCCC---CcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 435 QIRGTMGHIAPEYLSTGKSS---EKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 435 ~~~gt~~y~aPE~~~~~~~~---~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
...-.+.||+||.++..+.+ ..+|+|||++++||+.|..-||..-.
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadls 393 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLS 393 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCC
Confidence 11235789999999876643 46899999999999999999997543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-20 Score=168.75 Aligned_cols=107 Identities=26% Similarity=0.216 Sum_probs=94.0
Q ss_pred CCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcce
Q 010887 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (498)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~ 432 (498)
|+|.++++.. ...+++.++..++.|+++||+|||+. + ||+||++++++.+|+ ||.++......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 6888888752 34699999999999999999999998 5 999999999999999 99988665422
Q ss_pred eecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
..||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~ 107 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE 107 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 25789999999999999999999999999999999999999643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=163.22 Aligned_cols=186 Identities=16% Similarity=0.080 Sum_probs=137.1
Q ss_pred CCCCeeecccceEEEEEEEcCCcEEEEEEecccCC---cchHHHHHHHHHHHHhcc-CCccceEEEEEEcCCceEEEEec
Q 010887 274 SESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS---PGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 274 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
.....|++|+||+||.+.. .+.+++.+.+..... ......|.+|+++++++. |+++.+++++ +..+++|+|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999997766 778888777764321 112235889999999995 5789999886 456999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCC-CCCcEEECCCCcEEEeecCcccccccc
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDL-KAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl-k~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
+.|.+|...+.. ....+..|++++|+++|+. +|+|||| ||+|||+++++.++|+|||++......
T Consensus 80 I~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 80 LAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred ecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 999888643321 1135778999999999999 9999999 799999999999999999999855543
Q ss_pred Ccc----e--------eecccccccccCcccccCC-CCC-CcccchhHHHHHHHHHhCCCCCCC
Q 010887 429 LTH----V--------TTQIRGTMGHIAPEYLSTG-KSS-EKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 429 ~~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
... . ..-...++.|++|+...-- ..+ ...+.++-|.-+|.++|++.+.-.
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 210 0 0112246677777654221 222 456899999999999999977643
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.5e-20 Score=207.01 Aligned_cols=130 Identities=38% Similarity=0.680 Sum_probs=101.6
Q ss_pred ChhHHHHHHHHHHHccCCCCCCCCCCCCCCCCCCCcceeEecC-CceeEEEecccccCccccccccccCCCCeEEccCCC
Q 010887 33 PDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRN-GNVISLTLGSNGFSGKISPSITKLKFLASLELQDND 111 (498)
Q Consensus 33 ~~~~~~al~~~~~~~~~~~~~l~~w~~~~~~~c~~w~gv~c~~-~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~ 111 (498)
.+.|+.||++||+++.+|.+.+.+|+.. ++||.|.||+|++ ++|+.|+|++|+++|.+|+.+..+++|+.|+|++|+
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~--~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~ 104 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNSS--ADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQ 104 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCCC--CCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCc
Confidence 5579999999999999898889999754 5788999999984 699999999999999999999999999999999999
Q ss_pred CCCccCcccc-cccccceeecccccccCCCCCcccCCCCCCeEeCCCCcCcccCCc
Q 010887 112 LSGTLPDFLG-SMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPM 166 (498)
Q Consensus 112 l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~ 166 (498)
++|.+|..+. .+++|++|+|++|+++|.+|. +.+++|++|+|++|.++|.+|.
T Consensus 105 ~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~ 158 (968)
T PLN00113 105 LSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPN 158 (968)
T ss_pred cCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCCh
Confidence 9999998765 677777777777766655553 2344444444444444444443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.2e-19 Score=192.77 Aligned_cols=200 Identities=21% Similarity=0.186 Sum_probs=162.5
Q ss_pred HHHHHHhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhcc---CCccceEEEEEEcC
Q 010887 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI---HKNLLQLIGYCTTS 340 (498)
Q Consensus 264 ~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~ 340 (498)
.+.++..+.|.+.+.+|+|+||.||+|...+++.||+|.-+.. ...+|---.+++.+|+ -+.|..+...+...
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~----~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPP----NPWEFYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCC----CceeeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 3455566788889999999999999999888999999986642 2233433344555555 24455666666677
Q ss_pred CceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEEC-------CCCc
Q 010887 341 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-------DNFE 413 (498)
Q Consensus 341 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~-------~~~~ 413 (498)
+.-++|++|.+.|+|.+.+. ..+.++|..+..++.|+++.+++||.. +||||||||+|.+|. +..-
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred CcceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccc
Confidence 88899999999999999987 367799999999999999999999999 999999999999993 3446
Q ss_pred EEEeecCcccccccc-CcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCC
Q 010887 414 AVLCDFGLAKLVDAK-LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 474 (498)
Q Consensus 414 ~ki~DfGl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~ 474 (498)
++|+|||.+..+.-- ........++|-.+-.+|+..++.+++++|.|+++-+++-||.|+.
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 899999998755421 1234556778999999999999999999999999999999999984
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.8e-18 Score=155.00 Aligned_cols=139 Identities=19% Similarity=0.294 Sum_probs=106.5
Q ss_pred CCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhc-----cCCccceEEEEEEcCC---ceE
Q 010887 273 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-----IHKNLLQLIGYCTTSS---ERI 344 (498)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~~~ 344 (498)
++..+.||+|+||.||. .+.....+||++.... ....+.+.+|+++++.+ .||||++++|++.++. ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 34578899999999996 4333334688876432 23567899999999999 5799999999998874 323
Q ss_pred -EEEec--ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCcEEcCCCCCcEEECC----CCcEEE
Q 010887 345 -LVYPF--MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGL-EYLHEQCNPKIIHRDLKAANILLDD----NFEAVL 416 (498)
Q Consensus 345 -lv~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~ivH~Dlk~~NILl~~----~~~~ki 416 (498)
+|+|| +.+++|.+++.+. .+++. ..++.+++.++ +|||+. +|+||||||+||+++. +..++|
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEE
Confidence 78999 5579999999651 24544 35677888888 999999 9999999999999963 347999
Q ss_pred ee-cCcccc
Q 010887 417 CD-FGLAKL 424 (498)
Q Consensus 417 ~D-fGl~~~ 424 (498)
+| ||....
T Consensus 151 iDg~G~~~~ 159 (210)
T PRK10345 151 CDNIGESTF 159 (210)
T ss_pred EECCCCcce
Confidence 99 554443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=8.2e-20 Score=183.87 Aligned_cols=186 Identities=25% Similarity=0.260 Sum_probs=155.4
Q ss_pred eecccceEEEEEEE----cCCcEEEEEEecccCCc-chHHHHHHHHHHHHhcc-CCccceEEEEEEcCCceEEEEecccC
Q 010887 279 IGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSP-GGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYPFMQN 352 (498)
Q Consensus 279 lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (498)
+|+|.||.|+.++- +.+..+|+|.+++.... ........|..++...+ ||.++++...++.+...+++.+|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 68999999998762 34677888888743311 12224556778888887 99999999999999999999999999
Q ss_pred CCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcce
Q 010887 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (498)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~ 432 (498)
|.+...+.. ...+++.........++-+++++|+. +++|||+|++||+++.+|++++.|||+++..-.....
T Consensus 82 g~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 82 GDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred chhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999888875 34567777777888899999999999 9999999999999999999999999999866543222
Q ss_pred eecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
+||..|||||++. .....+|.||||++++||+||-.||..
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 7899999999997 567789999999999999999999986
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.7e-19 Score=190.00 Aligned_cols=201 Identities=20% Similarity=0.261 Sum_probs=157.1
Q ss_pred CCCCeeecccceEEEEEEEc-CCcEEEEEEec----ccCCcc-hHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 274 SESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQ----DYYSPG-GEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 274 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
...+++|.|++|.|+.+... .....+.|..+ ...... ....+..|+-+-..+.|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35778999999977777633 33334444332 111111 1122555666677889999988888777777666669
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++ +|...+.. ...+...++-.+..|+..|++|+|+. ++.|||+|++|++++.++.+||+|||.+.....
T Consensus 401 E~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 99998886 24578888999999999999999999 999999999999999999999999999876543
Q ss_pred cCc---ceeecccccccccCcccccCCCCCCc-ccchhHHHHHHHHHhCCCCCCCCccc
Q 010887 428 KLT---HVTTQIRGTMGHIAPEYLSTGKSSEK-TDVFGYGITLLELVTGQRAIDFSRLE 482 (498)
Q Consensus 428 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~s~Gvvl~elltG~~p~~~~~~~ 482 (498)
+.. .......|+..|+|||.+...+|++. .||||.|+++..|++|+.||.....+
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~ 531 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS 531 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence 322 34456789999999999999998765 69999999999999999999876554
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.4e-17 Score=156.65 Aligned_cols=144 Identities=15% Similarity=0.110 Sum_probs=111.6
Q ss_pred CCCCCCeeecccceEEEEEE--EcCCcEEEEEEecccCCcc-----------------------hHHHHHHHHHHHHhcc
Q 010887 272 NFSESNIIGQGGFGKVYKGV--LSDNTKVAVKRLQDYYSPG-----------------------GEAAFQREVHLISVAI 326 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~ 326 (498)
.|++.+.||+|++|.||+|. ..+|+.||+|+++...... ....+.+|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 5689999999987432100 1123568999999997
Q ss_pred CCc--cceEEEEEEcCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-cEEcCCCC
Q 010887 327 HKN--LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK-IIHRDLKA 403 (498)
Q Consensus 327 h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-ivH~Dlk~ 403 (498)
+.. +.+++++ ...++||||+++.++...... ...+...+...++.|++.++.+||+. + ++||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 643 3344432 235899999999887654422 23455666789999999999999999 8 99999999
Q ss_pred CcEEECCCCcEEEeecCccccccc
Q 010887 404 ANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 404 ~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
+||+++ ++.++|+|||.+.....
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccCC
Confidence 999999 88999999999876554
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.2e-17 Score=152.27 Aligned_cols=137 Identities=20% Similarity=0.249 Sum_probs=114.8
Q ss_pred CeeecccceEEEEEEEcCCcEEEEEEecccCCcc-------hHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG-------GEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
+.||+|++|.||+|.. ++..+++|+........ ....+.+|++++..++|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999998 67789999765322111 124578899999999999998888887777888999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
+++++|.+.+... .+ .+..++.+++.+|.++|+. +++|||++|.||+++ ++.++|+|||.+....
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 9999999887641 12 7889999999999999999 999999999999999 7889999999987543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.2e-17 Score=149.90 Aligned_cols=139 Identities=21% Similarity=0.154 Sum_probs=109.3
Q ss_pred CCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCc---------------------chHHHHHHHHHHHHhccCCc-
Q 010887 272 NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP---------------------GGEAAFQREVHLISVAIHKN- 329 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~e~~~l~~l~h~n- 329 (498)
-|...+.||+|+||.||++...+++.||||+++..... .....+.+|..++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 47778999999999999999888999999987532100 01123677888999998874
Q ss_pred -cceEEEEEEcCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEE
Q 010887 330 -LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL 408 (498)
Q Consensus 330 -iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl 408 (498)
+.+.++ ....++||||++++++...... .....++.+++.++.++|+. +++||||||+||++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill 158 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILV 158 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEE
Confidence 444443 2456899999999988654321 23467889999999999998 99999999999999
Q ss_pred CCCCcEEEeecCccccccc
Q 010887 409 DDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 409 ~~~~~~ki~DfGl~~~~~~ 427 (498)
++++.++|+|||++.....
T Consensus 159 ~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 159 DDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cCCCcEEEEECCccccCCC
Confidence 9999999999999865544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.7e-17 Score=149.11 Aligned_cols=133 Identities=20% Similarity=0.274 Sum_probs=108.5
Q ss_pred eeecccceEEEEEEEcCCcEEEEEEecccCCcc-------hHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecc
Q 010887 278 IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG-------GEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (498)
Q Consensus 278 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (498)
.||+|+||.||+|.+ ++..+++|+........ ....+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 479999999999996 67889999865322111 1356778999999999988766666666777789999999
Q ss_pred cCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
++++|.+.+.... . .++.+++.+|.++|+. +++|||++|.||+++ ++.++++|||++....
T Consensus 80 ~g~~l~~~~~~~~----~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhcH----H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 9999988775411 0 7899999999999999 999999999999999 7899999999987643
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.4e-17 Score=171.43 Aligned_cols=140 Identities=21% Similarity=0.278 Sum_probs=113.2
Q ss_pred cCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCc------chHHHHHHHHHHHHhccCCccceEEEEEEcCCceE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP------GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (498)
..|...+.||+|+||.||+|.+.+...++.+++...... .....+.+|++++..++|++++....++......+
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 345668899999999999999755444333333221111 12356889999999999999998888888877889
Q ss_pred EEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccc
Q 010887 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~ 424 (498)
+||||+++++|.+.+. ....++.+++++|.|||+. +++|||+||+||++ +++.++|+|||+++.
T Consensus 413 lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999999988775 3467899999999999999 99999999999999 677999999999986
Q ss_pred cc
Q 010887 425 VD 426 (498)
Q Consensus 425 ~~ 426 (498)
..
T Consensus 477 ~~ 478 (535)
T PRK09605 477 SD 478 (535)
T ss_pred CC
Confidence 54
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.71 E-value=4e-17 Score=154.94 Aligned_cols=200 Identities=23% Similarity=0.250 Sum_probs=130.7
Q ss_pred CCCeeecccceEEEEEEEc-CCcEEEEEEeccc--CCcchHHHHHHHHHHHHhccC----------CccceEEEEEEc--
Q 010887 275 ESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIH----------KNLLQLIGYCTT-- 339 (498)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h----------~niv~l~~~~~~-- 339 (498)
..+.||.|+++.||.+++. +++++|||...-. ......+++.+|.-....+.+ -.++..++....
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 3678999999999999975 4899999987632 233456777777655544322 122222222211
Q ss_pred -------C---C-----ceEEEEecccCCCHHHhhcc---cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCC
Q 010887 340 -------S---S-----ERILVYPFMQNLSVAYRLRD---LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDL 401 (498)
Q Consensus 340 -------~---~-----~~~lv~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl 401 (498)
. . ..+++|+-+ -++|.+.+.. .......+....+..+..|+.+.+++||+. +++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEeccc
Confidence 1 1 225567666 4577666542 222223355566677889999999999999 9999999
Q ss_pred CCCcEEECCCCcEEEeecCccccccccCcceeecccccccccCcccccC--------CCCCCcccchhHHHHHHHHHhCC
Q 010887 402 KAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST--------GKSSEKTDVFGYGITLLELVTGQ 473 (498)
Q Consensus 402 k~~NILl~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~s~Gvvl~elltG~ 473 (498)
+|+|++++++|.+.++||+........... ...+..|.+||.... ..++.+.|.|++|+++|.|.+|+
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 999999999999999999987655442211 234578999998744 24688899999999999999999
Q ss_pred CCCCCCccc
Q 010887 474 RAIDFSRLE 482 (498)
Q Consensus 474 ~p~~~~~~~ 482 (498)
.||+....+
T Consensus 248 lPf~~~~~~ 256 (288)
T PF14531_consen 248 LPFGLSSPE 256 (288)
T ss_dssp -STCCCGGG
T ss_pred CCCCCCCcc
Confidence 999976443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.1e-18 Score=178.68 Aligned_cols=199 Identities=22% Similarity=0.224 Sum_probs=151.0
Q ss_pred CCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHH--HhccCCccceEEEEEEcCCceEEEEec
Q 010887 272 NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLI--SVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l--~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
++...+.||++.|=.|.+|+.+.|. |+||++-+....-..+.|.++++-+ ...+|||.+++.-.-.....-|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4666788999999999999998777 8899887555445556666655544 445899999987776666666777777
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccc--ccc
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL--VDA 427 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~--~~~ 427 (498)
... +|.+++.. ++-+...+.+-|+.|++.|+..+|.. +|.|||||.+|||++.-.-+.|+||.--+- +..
T Consensus 103 vkh-nLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 103 VKH-NLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred Hhh-hhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 754 66666654 45578888899999999999999999 999999999999999999999999986542 111
Q ss_pred cCcc----eeecccccccccCcccccCC----------C-CCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 428 KLTH----VTTQIRGTMGHIAPEYLSTG----------K-SSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 428 ~~~~----~~~~~~gt~~y~aPE~~~~~----------~-~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
+... .......-..|+|||.+... . .+++-||||.|||+.||++ |++||+.+
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS 242 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS 242 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH
Confidence 1111 11222233579999987542 1 4677899999999999999 79999754
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1e-16 Score=161.70 Aligned_cols=156 Identities=28% Similarity=0.421 Sum_probs=129.5
Q ss_pred HhccCCccceEEEEEEcCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc-EEcCC
Q 010887 323 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI-IHRDL 401 (498)
Q Consensus 323 ~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i-vH~Dl 401 (498)
+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....++|.....++++|+.||+|||.. +| .|+.+
T Consensus 2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l 75 (484)
T KOG1023|consen 2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL 75 (484)
T ss_pred cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence 567899999999999999999999999999999999986 345699999999999999999999987 45 99999
Q ss_pred CCCcEEECCCCcEEEeecCcccccccc-CcceeecccccccccCcccccCCC-------CCCcccchhHHHHHHHHHhCC
Q 010887 402 KAANILLDDNFEAVLCDFGLAKLVDAK-LTHVTTQIRGTMGHIAPEYLSTGK-------SSEKTDVFGYGITLLELVTGQ 473 (498)
Q Consensus 402 k~~NILl~~~~~~ki~DfGl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dv~s~Gvvl~elltG~ 473 (498)
+++|.++|....+|++|||+....... .........-..-|.|||.+.... .+++.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999998766421 011111122345799999987642 467799999999999999999
Q ss_pred CCCCCCccccc
Q 010887 474 RAIDFSRLEEE 484 (498)
Q Consensus 474 ~p~~~~~~~~~ 484 (498)
.||+.....++
T Consensus 156 ~~~~~~~~~~~ 166 (484)
T KOG1023|consen 156 GPFDLRNLVED 166 (484)
T ss_pred CccccccccCC
Confidence 99997554443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.7e-15 Score=130.90 Aligned_cols=137 Identities=18% Similarity=0.147 Sum_probs=114.4
Q ss_pred CCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccC--CccceEEEEEEcCCceEEEEecccC
Q 010887 275 ESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH--KNLLQLIGYCTTSSERILVYPFMQN 352 (498)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~ 352 (498)
+.+.+|+|.++.||++...+ ..+++|....... ...+.+|+..++.++| ..+.+++++...++..++++||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 35779999999999999854 7899998864332 5678999999999987 4889999888888889999999988
Q ss_pred CCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
+.+... +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.+....
T Consensus 78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 765432 556677889999999999998644479999999999999998999999999986443
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=2e-15 Score=137.36 Aligned_cols=138 Identities=21% Similarity=0.251 Sum_probs=99.3
Q ss_pred CCeeecccceEEEEEEEcCCcEEEEEEecccCCc-chHHHH----------------------HHHHHHHHhccCCc--c
Q 010887 276 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP-GGEAAF----------------------QREVHLISVAIHKN--L 330 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~----------------------~~e~~~l~~l~h~n--i 330 (498)
.+.||+|+||+||+|...+++.||||+++..... .....+ ..|.+.+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999998743211 111111 34566666665443 3
Q ss_pred ceEEEEEEcCCceEEEEecccCCCHHHh-hcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEEcCCCCCcEEE
Q 010887 331 LQLIGYCTTSSERILVYPFMQNLSVAYR-LRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILL 408 (498)
Q Consensus 331 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlk~~NILl 408 (498)
.+.+++ ...++||||++++.+... +.... .. .....++.+++.++.++|. . +++|+||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 444432 245899999999654321 22111 11 5678899999999999999 7 99999999999999
Q ss_pred CCCCcEEEeecCccccccc
Q 010887 409 DDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 409 ~~~~~~ki~DfGl~~~~~~ 427 (498)
+ ++.++++|||.+.....
T Consensus 149 ~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 149 D-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred E-CCcEEEEECcccccccC
Confidence 9 88999999999875544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2e-16 Score=167.23 Aligned_cols=170 Identities=29% Similarity=0.376 Sum_probs=121.4
Q ss_pred hcCCCCCCeeecccceEEEEEEEcC-CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.++|+.++.|..|+||.||.++++. .+.+|+| +++.. -+.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~------lilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN------LILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccc------hhhhc--cccccCCccee-----------------
Confidence 4578889999999999999999754 5567774 33211 00000 12222222222
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+-...++. .+.++. +++.+++|||+. +|+|||+||+|.+++.-|++|++|||+++..-..
T Consensus 136 ----gDc~tllk~----~g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 ----GDCATLLKN----IGPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred ----chhhhhccc----CCCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 333333433 122332 227789999999 9999999999999999999999999998753211
Q ss_pred C------------cc--eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCccccc
Q 010887 429 L------------TH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE 484 (498)
Q Consensus 429 ~------------~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~~~~~ 484 (498)
. .+ ....++||+.|+|||++....|...+|+|++|+|+||.+-|..||..+..||=
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel 266 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL 266 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH
Confidence 0 00 12346899999999999999999999999999999999999999998755443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.6e-15 Score=144.60 Aligned_cols=144 Identities=24% Similarity=0.283 Sum_probs=105.1
Q ss_pred cCCccceEEEEEEcC---------------------------CceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHH
Q 010887 326 IHKNLLQLIGYCTTS---------------------------SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVA 378 (498)
Q Consensus 326 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 378 (498)
+|||||++.++|.++ ...|+||.-+. -+|.+++.. ...+.....-+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-----CCCchHHHHHHH
Confidence 599999999877542 13456666554 366666653 234555667788
Q ss_pred HHHHHHHHHHHhcCCCCcEEcCCCCCcEEE--CCCC--cEEEeecCccccccccC---ccee--ecccccccccCccccc
Q 010887 379 FGTAYGLEYLHEQCNPKIIHRDLKAANILL--DDNF--EAVLCDFGLAKLVDAKL---THVT--TQIRGTMGHIAPEYLS 449 (498)
Q Consensus 379 ~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl--~~~~--~~ki~DfGl~~~~~~~~---~~~~--~~~~gt~~y~aPE~~~ 449 (498)
.|+++|+.|||+. +|.|||+|++|||+ |+|+ ...|+|||++-.-+... ...+ -..-|...-||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 99999999999999 4444 46899999874332211 1111 1234677899999986
Q ss_pred CCC------CCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 450 TGK------SSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 450 ~~~------~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
..+ ...|+|.|+.|-+.||+++...||..
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 533 24589999999999999999999975
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.8e-14 Score=135.85 Aligned_cols=138 Identities=17% Similarity=0.152 Sum_probs=106.5
Q ss_pred CCeee-cccceEEEEEEEcCCcEEEEEEecccC------------CcchHHHHHHHHHHHHhccCCcc--ceEEEEEEcC
Q 010887 276 SNIIG-QGGFGKVYKGVLSDNTKVAVKRLQDYY------------SPGGEAAFQREVHLISVAIHKNL--LQLIGYCTTS 340 (498)
Q Consensus 276 ~~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~ 340 (498)
...|| .|+.|+||++... +..++||++.... +......+.+|++++.+++|+++ .+.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 46788 8999999999884 7788998874210 11234567889999999998885 6677765433
Q ss_pred C----ceEEEEecccC-CCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEE
Q 010887 341 S----ERILVYPFMQN-LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV 415 (498)
Q Consensus 341 ~----~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 415 (498)
. ..++|+||+++ .+|.+.+.. ..++.. .+.+++.++.+||+. +|+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 2 23599999997 688887754 224433 356899999999999 999999999999999988999
Q ss_pred EeecCcccccc
Q 010887 416 LCDFGLAKLVD 426 (498)
Q Consensus 416 i~DfGl~~~~~ 426 (498)
|+|||.+....
T Consensus 183 LIDfg~~~~~~ 193 (239)
T PRK01723 183 LIDFDRGELRT 193 (239)
T ss_pred EEECCCcccCC
Confidence 99999987654
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.2e-15 Score=149.35 Aligned_cols=123 Identities=27% Similarity=0.359 Sum_probs=106.2
Q ss_pred ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCc
Q 010887 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (498)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl 421 (498)
..++.|+++...+|.+++..... ....++...+.++.|++.|++| + +.+|+|+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 46789999999999999985443 3456888999999999999999 5 899999999999999999999999999
Q ss_pred cccccccC-----cceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh
Q 010887 422 AKLVDAKL-----THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471 (498)
Q Consensus 422 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt 471 (498)
........ ....+...||..||+||.+.+..|+.|+||||+|++++|+++
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 87765543 112244569999999999999999999999999999999998
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.5e-13 Score=140.66 Aligned_cols=146 Identities=23% Similarity=0.254 Sum_probs=102.3
Q ss_pred CCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcch---------------------------------------H
Q 010887 272 NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGG---------------------------------------E 312 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---------------------------------------~ 312 (498)
.|+ .+.||.|++|+||+|++++|+.||||+.+......- +
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 344 467999999999999999999999999864321100 0
Q ss_pred HHHHHHHHHHHhcc-----CCccceEEEEEEcCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHH-HHH
Q 010887 313 AAFQREVHLISVAI-----HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY-GLE 386 (498)
Q Consensus 313 ~~~~~e~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-~L~ 386 (498)
-+|.+|.+.+.+++ ++++.-..-+.......++||||++|+++.+....... .. .+..++.++++ .+.
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~ 271 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLN 271 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHH
Confidence 12445555555542 33332222222334567999999999999877653111 12 23456666666 467
Q ss_pred HHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 387 yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
.+|.. +++|+|++|.||++++++.++++|||++..+++
T Consensus 272 ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 272 QVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 88888 999999999999999999999999999987764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=7e-15 Score=155.18 Aligned_cols=206 Identities=25% Similarity=0.322 Sum_probs=162.1
Q ss_pred cCCCCCCeeecccceEEEEEEEcC--CcEEEEEEecccC-CcchHHHHHHHHHHHHhcc-CCccceEEEEEEcCCceEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLSD--NTKVAVKRLQDYY-SPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 346 (498)
..|...+.||+|.|+.|-...... ...+|+|.+.... +.........|..+-..+. |+|++.+++.....+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 356667779999999998888543 3456666655332 2223334444666666666 99999999999999999999
Q ss_pred EecccCCCHHHhh-cccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCcEEcCCCCCcEEECCCC-cEEEeecCccc
Q 010887 347 YPFMQNLSVAYRL-RDLKPGEKGLDWPTRKRVAFGTAYGLEYLH-EQCNPKIIHRDLKAANILLDDNF-EAVLCDFGLAK 423 (498)
Q Consensus 347 ~e~~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ivH~Dlk~~NILl~~~~-~~ki~DfGl~~ 423 (498)
.+|..++++.+.+ +. .....+.........|+..++.|+| .. ++.|+|+||+|.+++..+ ..+++|||++.
T Consensus 100 ~~~s~g~~~f~~i~~~---~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHP---DSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cCcccccccccccccC---CccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence 9999999988877 32 1224666777888999999999999 77 999999999999999999 99999999998
Q ss_pred cccc-c-Ccceeecccc-cccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCccc
Q 010887 424 LVDA-K-LTHVTTQIRG-TMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLE 482 (498)
Q Consensus 424 ~~~~-~-~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~~~~ 482 (498)
.+.. . ........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++.....
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~ 236 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRK 236 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccc
Confidence 7765 2 2223344667 9999999999885 4466789999999999999999999976553
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=8e-14 Score=118.61 Aligned_cols=103 Identities=29% Similarity=0.534 Sum_probs=94.1
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|.|++|+++ .+||.|+.|.+|+.|++++|++. .+|.++++|++|++|+++-|++. .+|..|+.++.|+.|||
T Consensus 33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldl 109 (264)
T KOG0617|consen 33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL 109 (264)
T ss_pred hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence 37999999999999 99999999999999999999999 99999999999999999999999 99999999999999999
Q ss_pred CCCcCcc-cCCchhhcc---ccccccCCcc
Q 010887 156 SSNNLTG-RIPMQLFSV---ATFNFTGTHL 181 (498)
Q Consensus 156 ~~N~l~g-~ip~~~~~~---~~~~~~~n~~ 181 (498)
++|+++. .+|..++-+ ..+.++.|.+
T Consensus 110 tynnl~e~~lpgnff~m~tlralyl~dndf 139 (264)
T KOG0617|consen 110 TYNNLNENSLPGNFFYMTTLRALYLGDNDF 139 (264)
T ss_pred cccccccccCCcchhHHHHHHHHHhcCCCc
Confidence 9999984 678776544 5677788766
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=8e-12 Score=129.59 Aligned_cols=149 Identities=21% Similarity=0.209 Sum_probs=94.1
Q ss_pred hcCCCCCCeeecccceEEEEEEEcC-CcEEEEEEecccCCcc---------------------------------hH---
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPG---------------------------------GE--- 312 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~---------------------------------~~--- 312 (498)
..+|+. +.||.|++|+||+|++++ |+.||||+.+....+. -.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345775 789999999999999887 9999999987432100 01
Q ss_pred ---HHHHHHHHHHHhcc----CCccceEEEEEE-cCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHH-
Q 010887 313 ---AAFQREVHLISVAI----HKNLLQLIGYCT-TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY- 383 (498)
Q Consensus 313 ---~~~~~e~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~- 383 (498)
-+|.+|..-+.+++ +.+.+.+-..+. .....++||||++|+.+.+.-.- . ....+. ..++...++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l-~--~~g~d~---~~la~~~v~~ 271 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL-R--AAGTDM---KLLAERGVEV 271 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH-H--hcCCCH---HHHHHHHHHH
Confidence 12344444444442 333333333332 24567899999999998764221 1 111121 122222111
Q ss_pred HHHHHHhcCCCCcEEcCCCCCcEEECCCC----cEEEeecCcccccccc
Q 010887 384 GLEYLHEQCNPKIIHRDLKAANILLDDNF----EAVLCDFGLAKLVDAK 428 (498)
Q Consensus 384 ~L~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~ki~DfGl~~~~~~~ 428 (498)
-+..+... +++|+|+||.||+++.++ .+++.|||++..++..
T Consensus 272 ~~~Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 272 FFTQVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHHHHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 12223344 999999999999999888 9999999999877543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.1e-11 Score=110.81 Aligned_cols=132 Identities=20% Similarity=0.157 Sum_probs=96.1
Q ss_pred CCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCCCH
Q 010887 276 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV 355 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 355 (498)
.+.++.|.++.||++... +..+++|....... ....+.+|.+.++.+.+.++++-+-.+. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~-~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD-PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe-CCCCeEEEEecCCCcc
Confidence 456789999999999974 77899998754321 2345678999999887666554332222 3345899999999876
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCcEEcCCCCCcEEECCCCcEEEeecCcccc
Q 010887 356 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC--NPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (498)
Q Consensus 356 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~ 424 (498)
... . . ....++.+++++|+.||+.. ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~--~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTE--D-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc--c-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 432 0 0 11345678999999999982 22369999999999998 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.5e-11 Score=123.10 Aligned_cols=166 Identities=17% Similarity=0.204 Sum_probs=122.7
Q ss_pred EcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCCCHHHhhcccCCCCCCCCH
Q 010887 292 LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDW 371 (498)
Q Consensus 292 ~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~ 371 (498)
..++.+|.|...+.... .......+.++.++.+|||||++++.....++..|+|+|-+. -|..++.. +..
T Consensus 34 k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~ 103 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGK 103 (690)
T ss_pred eccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHH
Confidence 44678888888764433 344566788999999999999999999999999999999875 34455543 223
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcceeecccccccccCcccccCC
Q 010887 372 PTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 451 (498)
Q Consensus 372 ~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 451 (498)
....-.+.||+.||.|||+.| +++|++|.-..|++++.|+.||++|-++.....-.. ......---.|..|+.+...
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcc
Confidence 344556889999999999776 899999999999999999999999998765433211 00111112245666655332
Q ss_pred CCCCcccchhHHHHHHHHHhC
Q 010887 452 KSSEKTDVFGYGITLLELVTG 472 (498)
Q Consensus 452 ~~~~~~Dv~s~Gvvl~elltG 472 (498)
. -..|.|.||++++|++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 235999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.2e-10 Score=105.31 Aligned_cols=139 Identities=17% Similarity=0.196 Sum_probs=99.4
Q ss_pred CCeeecccceEEEEEEEcC-------CcEEEEEEecccC------------C---------cchHHHHH----HHHHHHH
Q 010887 276 SNIIGQGGFGKVYKGVLSD-------NTKVAVKRLQDYY------------S---------PGGEAAFQ----REVHLIS 323 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~------------~---------~~~~~~~~----~e~~~l~ 323 (498)
...||.|.-+.||.|...+ +..+|||+.+... . ......+. +|.+.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998543 4789999875211 0 11122333 7999999
Q ss_pred hccC--CccceEEEEEEcCCceEEEEecccCCCHH-HhhcccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCcEEc
Q 010887 324 VAIH--KNLLQLIGYCTTSSERILVYPFMQNLSVA-YRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL-HEQCNPKIIHR 399 (498)
Q Consensus 324 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivH~ 399 (498)
++.. -++.+++++ ...++||||+.+..+. ..+++ ..++..+...+..+++.+|..+ |+. +++||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 8864 345555553 5678999999865432 22332 2244456677889999999999 777 99999
Q ss_pred CCCCCcEEECCCCcEEEeecCccccccc
Q 010887 400 DLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 400 Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||++.||+++ ++.+.|+|||.+-....
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 9999999997 46799999998865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.24 E-value=8e-12 Score=133.81 Aligned_cols=90 Identities=31% Similarity=0.529 Sum_probs=83.5
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCC-CCCCeEe
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQL-SNLKHLD 154 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l-~~L~~l~ 154 (498)
.+++.|+|++|+|+|.+|+.++.+++|+.|+|++|+|+|.+|+.+++|++|++|+|++|+|+|.+|..++++ .++..++
T Consensus 442 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~ 521 (623)
T PLN03150 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFN 521 (623)
T ss_pred CCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEE
Confidence 478999999999999999999999999999999999999999999999999999999999999999998874 4788999
Q ss_pred CCCCcCcccCC
Q 010887 155 LSSNNLTGRIP 165 (498)
Q Consensus 155 l~~N~l~g~ip 165 (498)
+++|...+.+|
T Consensus 522 ~~~N~~lc~~p 532 (623)
T PLN03150 522 FTDNAGLCGIP 532 (623)
T ss_pred ecCCccccCCC
Confidence 99998776555
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.2e-11 Score=115.92 Aligned_cols=153 Identities=22% Similarity=0.309 Sum_probs=120.9
Q ss_pred HHHHhccCCccceEEEEEEcCC-----ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 010887 320 HLISVAIHKNLLQLIGYCTTSS-----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 394 (498)
Q Consensus 320 ~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 394 (498)
.-+-++.|.|||++..|+.+.. +..++.|||.-|++..+|++.......+....-.++..||..||.|||+ |.|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 3455667999999999986543 5689999999999999999877777778888889999999999999999 578
Q ss_pred CcEEcCCCCCcEEECCCCcEEEeecCccccccccCcc----eeecccccccccCcccccCCCCCCcccchhHHHHHHHHH
Q 010887 395 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH----VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELV 470 (498)
Q Consensus 395 ~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ell 470 (498)
+|+|+++.-+-|++..++-+||. -+.-......... ......+-++|.+||+-.....+..+|||+||.-.+||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig-~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIG-SVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEec-ccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 99999999999999999888883 2222222111110 011123568999999988888888999999999999998
Q ss_pred hCCC
Q 010887 471 TGQR 474 (498)
Q Consensus 471 tG~~ 474 (498)
-|..
T Consensus 277 ilEi 280 (458)
T KOG1266|consen 277 ILEI 280 (458)
T ss_pred Hhee
Confidence 8764
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.8e-10 Score=106.20 Aligned_cols=144 Identities=18% Similarity=0.212 Sum_probs=109.0
Q ss_pred CCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCC--ccceEEEEEEcCC---ceEEEEecc
Q 010887 276 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK--NLLQLIGYCTTSS---ERILVYPFM 350 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~---~~~lv~e~~ 350 (498)
.+.++.|.++.||++...+|+.+++|.............+.+|.++++.+++. ++.+++.+..... ..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 35689999999999998777899999876433222456788999999998764 4566777765542 568999999
Q ss_pred cCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 010887 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC-------------------------------------- 392 (498)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------------------------------------- 392 (498)
++.++...+.. ..++..+...++.++++.|.+||+..
T Consensus 83 ~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 83 DGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 99887665431 23677777788888888888888521
Q ss_pred ---------------CCCcEEcCCCCCcEEECC--CCcEEEeecCcccc
Q 010887 393 ---------------NPKIIHRDLKAANILLDD--NFEAVLCDFGLAKL 424 (498)
Q Consensus 393 ---------------~~~ivH~Dlk~~NILl~~--~~~~ki~DfGl~~~ 424 (498)
...++|+|+++.||++++ ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.3e-09 Score=95.32 Aligned_cols=134 Identities=22% Similarity=0.318 Sum_probs=101.0
Q ss_pred CeeecccceEEEEEEEcCCcEEEEEE-ecccCCcch------HHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 277 NIIGQGGFGKVYKGVLSDNTKVAVKR-LQDYYSPGG------EAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~~~~vavK~-~~~~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
..+++|+-+.+|.+.+.+ .++++|. +++...-.. ...-.+|.+++++++--.|.-..=+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 357899999999998744 3455553 333322111 24457799999998876777667777888888999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
++|-.|.+.+... ...++..+-.-+.-||.. +|+|+||.++||++..+. +.++|||++..-.
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence 9998888888752 235666777778889999 999999999999997664 8999999987443
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.3e-10 Score=117.82 Aligned_cols=200 Identities=24% Similarity=0.201 Sum_probs=151.8
Q ss_pred CCCCCCeeec--ccceEEEEEEE---cCCcEEEEEEecccCC-cchHHHHHHHHHHHHhcc-CCccceEEEEEEcCCceE
Q 010887 272 NFSESNIIGQ--GGFGKVYKGVL---SDNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERI 344 (498)
Q Consensus 272 ~~~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~ 344 (498)
.|.+...+|. |.+|.||.+.. .++..+|+|+=+...+ +.....=.+|...-.+++ |+|.++....+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556788899 99999999996 3577899998543322 233333355666666664 999999888888888888
Q ss_pred EEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCcEEcCCCCCcEEECCC-CcEEEeec
Q 010887 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDF 419 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~ki~Df 419 (498)
+-+|++. .++..+.+... .-++....+.+..+..+ |+.++|.. .++|-|+||.||+...+ ...+++||
T Consensus 195 iqtE~~~-~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeecccc-chhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence 8888876 67776666422 22566677777777777 99999999 99999999999999988 88999999
Q ss_pred CccccccccCcce----eecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 420 GLAKLVDAKLTHV----TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 420 Gl~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
|+...+.+..-.. .....|...|++||... +-++..+|+|++|.+++|..+|..+....
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCC
Confidence 9998776543221 12235778899999874 45788899999999999999988766543
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=7.2e-12 Score=106.81 Aligned_cols=99 Identities=26% Similarity=0.422 Sum_probs=78.4
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccC-CCCCcccCCCCCCeEeC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG-SIPATWSQLSNLKHLDL 155 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~l~l 155 (498)
+++.|+|.+|+|. .+|.+++.|++|+.|+++-|++. .+|..||+++-|+.|||++|+++. .+|..|.-+..|+.|+|
T Consensus 57 nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl 134 (264)
T KOG0617|consen 57 NLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYL 134 (264)
T ss_pred hhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHh
Confidence 6778899999998 88999999999999999999998 889999999999999999888864 46777766777777777
Q ss_pred CCCcCcccCCchhhccccccccC
Q 010887 156 SSNNLTGRIPMQLFSVATFNFTG 178 (498)
Q Consensus 156 ~~N~l~g~ip~~~~~~~~~~~~~ 178 (498)
+.|.|. -+|+.++++..+++-+
T Consensus 135 ~dndfe-~lp~dvg~lt~lqil~ 156 (264)
T KOG0617|consen 135 GDNDFE-ILPPDVGKLTNLQILS 156 (264)
T ss_pred cCCCcc-cCChhhhhhcceeEEe
Confidence 777777 6666666555544433
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=5.1e-09 Score=91.12 Aligned_cols=145 Identities=20% Similarity=0.231 Sum_probs=104.1
Q ss_pred CCCeeecccceEEEEEEEcCCcEEEEE-EecccCC------cchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 275 ESNIIGQGGFGKVYKGVLSDNTKVAVK-RLQDYYS------PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~~~~~~vavK-~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
....+-+|+-+.|+++.+ .|+...|| ++.+.+. .-......+|.+.+.+++--.|.-..-++.+.....++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 467889999999999998 45665555 3322221 112456778999999987666665556777777778999
Q ss_pred ecccC-CCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCC---cEEEeecCccc
Q 010887 348 PFMQN-LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF---EAVLCDFGLAK 423 (498)
Q Consensus 348 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~ki~DfGl~~ 423 (498)
||+++ -++.+++..... ...........+.+|-+.+.-||.. .|+||||..+||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99987 366677664322 1122222357788888999999999 999999999999996544 45899999976
Q ss_pred cc
Q 010887 424 LV 425 (498)
Q Consensus 424 ~~ 425 (498)
.-
T Consensus 165 ~s 166 (229)
T KOG3087|consen 165 VS 166 (229)
T ss_pred cc
Confidence 43
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.97 E-value=2.8e-10 Score=100.78 Aligned_cols=99 Identities=29% Similarity=0.455 Sum_probs=38.4
Q ss_pred ceeEEEecccccCcccccccc-ccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcc-cCCCCCCeEe
Q 010887 77 NVISLTLGSNGFSGKISPSIT-KLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATW-SQLSNLKHLD 154 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~-~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~l~~L~~l~ 154 (498)
+++.|+|.+|+|+ .|. .++ .|++|+.|||++|.|+ .++ .+..|++|++|+|++|+++ .+++.+ ..+++|++|+
T Consensus 20 ~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE
T ss_pred ccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEE
Confidence 6789999999999 665 466 6899999999999999 665 5888999999999999999 676555 4689999999
Q ss_pred CCCCcCcccCCc-----hhhccccccccCCcc
Q 010887 155 LSSNNLTGRIPM-----QLFSVATFNFTGTHL 181 (498)
Q Consensus 155 l~~N~l~g~ip~-----~~~~~~~~~~~~n~~ 181 (498)
|++|+|. .+-. .+.++..+++.|||.
T Consensus 95 L~~N~I~-~l~~l~~L~~l~~L~~L~L~~NPv 125 (175)
T PF14580_consen 95 LSNNKIS-DLNELEPLSSLPKLRVLSLEGNPV 125 (175)
T ss_dssp -TTS----SCCCCGGGGG-TT--EEE-TT-GG
T ss_pred CcCCcCC-ChHHhHHHHcCCCcceeeccCCcc
Confidence 9999998 3321 345667788999986
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.6e-08 Score=96.55 Aligned_cols=143 Identities=13% Similarity=0.056 Sum_probs=101.8
Q ss_pred CCeeecccceEEEEEEEcCCcEEEEEEecccCCcc----------hHHHHHHHHHHHHhccCCcc--ceEEEEEEc----
Q 010887 276 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG----------GEAAFQREVHLISVAIHKNL--LQLIGYCTT---- 339 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~---- 339 (498)
.+.+-+.....|++..+ +|+.+.||+........ ....+.+|.+.+.++...+| .+++++...
T Consensus 27 ~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 27 GEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred CcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 34555555556777766 67889999775322111 11247789888888854433 344555533
Q ss_pred -CCceEEEEecccCC-CHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECC-------
Q 010887 340 -SSERILVYPFMQNL-SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD------- 410 (498)
Q Consensus 340 -~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~------- 410 (498)
...-++|+|++++- +|.+++.+.. ....+...+..++.+++..+.-||.. +|+|+|++++|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCC
Confidence 22468999999986 7888875432 12345667788999999999999999 9999999999999975
Q ss_pred CCcEEEeecCcccc
Q 010887 411 NFEAVLCDFGLAKL 424 (498)
Q Consensus 411 ~~~~ki~DfGl~~~ 424 (498)
+..+.++||+.++.
T Consensus 181 ~~~~~LIDl~r~~~ 194 (268)
T PRK15123 181 DLKLSVIDLHRAQI 194 (268)
T ss_pred CceEEEEECCcccc
Confidence 56899999998864
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.96 E-value=3.8e-10 Score=82.23 Aligned_cols=61 Identities=41% Similarity=0.653 Sum_probs=44.1
Q ss_pred CCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCCCCcC
Q 010887 100 KFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNL 160 (498)
Q Consensus 100 ~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l 160 (498)
++|++|+|++|+|+..-+..|..+++|++|+|++|+++...|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4677777787777733335677778888888888887755556677788888888887764
|
... |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.93 E-value=4.8e-10 Score=113.78 Aligned_cols=197 Identities=22% Similarity=0.211 Sum_probs=144.8
Q ss_pred HHhcCCCCCCeeecccceEEEEEEE--cCCcEEEEEEecccCCcc-hHHHHHHHHHHHHhc-cCCccceEEEEEEcCCce
Q 010887 268 LATDNFSESNIIGQGGFGKVYKGVL--SDNTKVAVKRLQDYYSPG-GEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER 343 (498)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 343 (498)
....+|.....||.|.|+.|++... .++..|++|.+....... +...-..|+-+...+ .|.+++.....+..-...
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3456788899999999999999874 357789999876443222 222223455555554 488888877777777777
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCC-CcEEEeecCcc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLA 422 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~ki~DfGl~ 422 (498)
++--||++++++.....- ...++...++++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||.+
T Consensus 342 ~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred cCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccc
Confidence 788999999988776632 34577788899999999999999998 99999999999999876 78899999998
Q ss_pred ccccccCcceeecccccccc-cCcccccCCCCCCcccchhHHHHHHHHHhCCC
Q 010887 423 KLVDAKLTHVTTQIRGTMGH-IAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 474 (498)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~ 474 (498)
..+.-.. ......+..| .+++......+-.+.|+||||.-+.|.++|..
T Consensus 415 t~~~~~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 415 TRLAFSS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred cccceec---ccccccccccccchhhccccccccccccccccccccccccCcc
Confidence 6432111 0111123334 35566666678889999999999999999874
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.4e-08 Score=91.49 Aligned_cols=127 Identities=23% Similarity=0.299 Sum_probs=82.0
Q ss_pred EEEEEEEcCCcEEEEEEecccCC-------------c------------chHHHHHHHHHHHHhccCCc--cceEEEEEE
Q 010887 286 KVYKGVLSDNTKVAVKRLQDYYS-------------P------------GGEAAFQREVHLISVAIHKN--LLQLIGYCT 338 (498)
Q Consensus 286 ~Vy~~~~~~~~~vavK~~~~~~~-------------~------------~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~ 338 (498)
.||.|...++..+|+|..+.... . .......+|.+.|.++..-+ +.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 48999998999999998753110 0 01234677999999997664 4555543
Q ss_pred cCCceEEEEeccc--CCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCcEEcCCCCCcEEECCCCcEE
Q 010887 339 TSSERILVYPFMQ--NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL-HEQCNPKIIHRDLKAANILLDDNFEAV 415 (498)
Q Consensus 339 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivH~Dlk~~NILl~~~~~~k 415 (498)
...++||||++ +..+ ..+.+.. ++......+..++...+..+ |.. +++|||+.+.||+++++ .+.
T Consensus 79 --~~~~ivME~I~~~G~~~-~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPL-PRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp --ETTEEEEE--EETTEEG-GCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred --eCCEEEEEecCCCccch-hhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 25689999998 4444 3333311 11234556777787766654 677 99999999999999888 999
Q ss_pred EeecCcccccc
Q 010887 416 LCDFGLAKLVD 426 (498)
Q Consensus 416 i~DfGl~~~~~ 426 (498)
|+|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999886554
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.89 E-value=3.1e-10 Score=109.00 Aligned_cols=101 Identities=27% Similarity=0.420 Sum_probs=69.5
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCc-ccCCCCCCeEeC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPAT-WSQLSNLKHLDL 155 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~l~l 155 (498)
+++.|+|++|-+. .+|.+++.+..|+.||+|+|+|. .+|..+..+..|+++-.++|++. .+|++ ++++.+|+.|||
T Consensus 436 kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~-~vd~~~l~nm~nL~tLDL 512 (565)
T KOG0472|consen 436 KLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIG-SVDPSGLKNMRNLTTLDL 512 (565)
T ss_pred cceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhcccccc-ccChHHhhhhhhcceecc
Confidence 4555566655555 55666666666666666666655 55555555555555555556655 44444 999999999999
Q ss_pred CCCcCcccCCchhhcc---ccccccCCcc
Q 010887 156 SSNNLTGRIPMQLFSV---ATFNFTGTHL 181 (498)
Q Consensus 156 ~~N~l~g~ip~~~~~~---~~~~~~~n~~ 181 (498)
.+|.+. .||+.++++ ..+.+.||++
T Consensus 513 ~nNdlq-~IPp~LgnmtnL~hLeL~gNpf 540 (565)
T KOG0472|consen 513 QNNDLQ-QIPPILGNMTNLRHLELDGNPF 540 (565)
T ss_pred CCCchh-hCChhhccccceeEEEecCCcc
Confidence 999999 899988765 6678899987
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.6e-10 Score=119.95 Aligned_cols=112 Identities=30% Similarity=0.480 Sum_probs=97.4
Q ss_pred CCCCCcceeEecCCceeEEEecccccCccccc-cccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCC
Q 010887 63 SPCFSWSHVTCRNGNVISLTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIP 141 (498)
Q Consensus 63 ~~c~~w~gv~c~~~~v~~l~l~~~~l~g~~~~-~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p 141 (498)
+.| |.-..|- .+++.|+|++|+|. ++|. .+.+|..|+.|+||+|+|+ .+|..+.+++.|++|...+|++. ..|
T Consensus 373 d~c--~p~l~~~-~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP 446 (1081)
T KOG0618|consen 373 DSC--FPVLVNF-KHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP 446 (1081)
T ss_pred ccc--hhhhccc-cceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech
Confidence 455 6555543 38999999999999 7775 5899999999999999999 99999999999999999999999 899
Q ss_pred CcccCCCCCCeEeCCCCcCc-ccCCchh--hccccccccCCcc
Q 010887 142 ATWSQLSNLKHLDLSSNNLT-GRIPMQL--FSVATFNFTGTHL 181 (498)
Q Consensus 142 ~~~~~l~~L~~l~l~~N~l~-g~ip~~~--~~~~~~~~~~n~~ 181 (498)
++.+++.|+.+|||.|+|+ +.+|..+ .+|..|+++||..
T Consensus 447 -e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 447 -ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred -hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 8999999999999999998 3455544 4789999999985
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.88 E-value=3.3e-10 Score=114.30 Aligned_cols=102 Identities=30% Similarity=0.449 Sum_probs=68.6
Q ss_pred ceeEEEecccccCc-cccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCc-ccCCCCCCeEe
Q 010887 77 NVISLTLGSNGFSG-KISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPAT-WSQLSNLKHLD 154 (498)
Q Consensus 77 ~v~~l~l~~~~l~g-~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~l~ 154 (498)
++.++++..|+|.. -||++|..|..|+.||||+|+|. +.|..+..-+++-+|+||+|+|. +||.. +.+|+.|-+||
T Consensus 79 ~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLD 156 (1255)
T KOG0444|consen 79 RLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLD 156 (1255)
T ss_pred hhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhc
Confidence 45556666666642 46667777777777777777777 67777777777777777777776 66655 45677777777
Q ss_pred CCCCcCcccCCchh---hccccccccCCcc
Q 010887 155 LSSNNLTGRIPMQL---FSVATFNFTGTHL 181 (498)
Q Consensus 155 l~~N~l~g~ip~~~---~~~~~~~~~~n~~ 181 (498)
||+|+|. .+|+++ ..+.++.+++||+
T Consensus 157 LS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL 185 (1255)
T KOG0444|consen 157 LSNNRLE-MLPPQIRRLSMLQTLKLSNNPL 185 (1255)
T ss_pred cccchhh-hcCHHHHHHhhhhhhhcCCChh
Confidence 7777777 666654 3446666777764
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.5e-08 Score=99.48 Aligned_cols=170 Identities=18% Similarity=0.172 Sum_probs=126.1
Q ss_pred cceEEEEEE-EcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEc----CCceEEEEecccCC-CHH
Q 010887 283 GFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT----SSERILVYPFMQNL-SVA 356 (498)
Q Consensus 283 ~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~g-sL~ 356 (498)
--.+.||+. ..||..|++||++..... .......-+++++++.|+|+|++.+++.. ....++||+|+++. +|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~-~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQ-STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeecccccc-CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 346889999 458999999999532221 11122355788999999999999998873 34678999999864 554
Q ss_pred HhhcccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 357 YRLRDLKP-----------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 357 ~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
+.-..... .....++...+.++.|+..||.++|+. |+.-+-|.+++|+++.+.+++|+..|.....
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 44322111 123467889999999999999999999 9999999999999999999999988887655
Q ss_pred cccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCC
Q 010887 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 474 (498)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~ 474 (498)
..+.. |-+ +-.++-|.=.||.+++-|.||..
T Consensus 444 ~~d~~---------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 444 QEDPT---------------EPL---ESQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred cCCCC---------------cch---hHHhhhhHHHHHHHHHHHhhccc
Confidence 54320 111 11245688899999999999953
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=5.5e-10 Score=119.23 Aligned_cols=208 Identities=17% Similarity=0.196 Sum_probs=141.3
Q ss_pred HHhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecc--cCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceE
Q 010887 268 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQD--YYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (498)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (498)
...+.+.+.+-+-+|.++.++.+.-. .+...+.|.... .....+.+....+-.+.-..+||-++...--+.......
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 45567777788888999999887732 232233332221 111111122222222222233455554443344456778
Q ss_pred EEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccc
Q 010887 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~ 424 (498)
++++|..++++...|+... ..+..-.......+..+++|||.. .+.|+|++|.|.+...+++.+++|||....
T Consensus 881 L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred hhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccc
Confidence 9999999999999988632 344444555667788899999998 799999999999999999999999983321
Q ss_pred cc---------------------ccC-----c----ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCC
Q 010887 425 VD---------------------AKL-----T----HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 474 (498)
Q Consensus 425 ~~---------------------~~~-----~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~ 474 (498)
.. ... . .......+|+.|.+||...+......+|+|+.|++++|.++|..
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 10 000 0 01123458999999999999999999999999999999999999
Q ss_pred CCCCCccc
Q 010887 475 AIDFSRLE 482 (498)
Q Consensus 475 p~~~~~~~ 482 (498)
||...+.+
T Consensus 1034 p~na~tpq 1041 (1205)
T KOG0606|consen 1034 PFNAETPQ 1041 (1205)
T ss_pred CCCCcchh
Confidence 99876544
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.8e-09 Score=70.67 Aligned_cols=42 Identities=40% Similarity=0.699 Sum_probs=29.9
Q ss_pred ChhHHHHHHHHHHHcc-CCCCCCCCCCCCCCCCCCCcceeEec
Q 010887 33 PDVEGEALIEVLKALN-DTHGQFTDWNDHFVSPCFSWSHVTCR 74 (498)
Q Consensus 33 ~~~~~~al~~~~~~~~-~~~~~l~~w~~~~~~~c~~w~gv~c~ 74 (498)
++.|++||++||+++. +|.+.+.+|+.....+||+|.||+|+
T Consensus 1 ~~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 1 PNQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp -HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred CcHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 3679999999999999 57789999997642345599999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.3e-10 Score=109.88 Aligned_cols=99 Identities=25% Similarity=0.408 Sum_probs=61.9
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCccc-CCCCCCeEeC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWS-QLSNLKHLDL 155 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~-~l~~L~~l~l 155 (498)
++..||..+|-+. ++|++++.+.+|..|+|.+|+|. .+| +|+.+..|+.|+++.|++. .+|++.. ++++|..|||
T Consensus 184 ~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDL 259 (565)
T KOG0472|consen 184 RLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDL 259 (565)
T ss_pred HHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeec
Confidence 4566777777776 77777777777777777777777 666 5666666666666666665 5555543 5556666666
Q ss_pred CCCcCcccCCchh---hccccccccCCc
Q 010887 156 SSNNLTGRIPMQL---FSVATFNFTGTH 180 (498)
Q Consensus 156 ~~N~l~g~ip~~~---~~~~~~~~~~n~ 180 (498)
..|+++ ++|.++ .++..++++.|.
T Consensus 260 RdNklk-e~Pde~clLrsL~rLDlSNN~ 286 (565)
T KOG0472|consen 260 RDNKLK-EVPDEICLLRSLERLDLSNND 286 (565)
T ss_pred cccccc-cCchHHHHhhhhhhhcccCCc
Confidence 666666 555544 234445555543
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.80 E-value=3.8e-09 Score=76.91 Aligned_cols=60 Identities=32% Similarity=0.506 Sum_probs=54.0
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccc
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l 136 (498)
+++.|+|++|+|+...+..|.++++|++|++++|.++..-|..|..+++|++|+|++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 688999999999944446789999999999999999976677899999999999999986
|
... |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=8.9e-10 Score=110.53 Aligned_cols=103 Identities=24% Similarity=0.341 Sum_probs=69.1
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCc---ccCCCCCCeE
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPAT---WSQLSNLKHL 153 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~---~~~l~~L~~l 153 (498)
++..|+|++|+|+.--+.+|..|..|++|+|++|+++-.--..|..+++|+.|||++|.|++.|-+. |..|++|+.|
T Consensus 318 kL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL 397 (873)
T KOG4194|consen 318 KLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKL 397 (873)
T ss_pred cceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhe
Confidence 6778888888888555556777777777777777777333445666777777777777777666543 6667777777
Q ss_pred eCCCCcCcccCCc----hhhccccccccCCc
Q 010887 154 DLSSNNLTGRIPM----QLFSVATFNFTGTH 180 (498)
Q Consensus 154 ~l~~N~l~g~ip~----~~~~~~~~~~~~n~ 180 (498)
+|.+|+|. .||. ++.++..|++.+|+
T Consensus 398 ~l~gNqlk-~I~krAfsgl~~LE~LdL~~Na 427 (873)
T KOG4194|consen 398 RLTGNQLK-SIPKRAFSGLEALEHLDLGDNA 427 (873)
T ss_pred eecCceee-ecchhhhccCcccceecCCCCc
Confidence 77777777 6664 33445555555554
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.3e-07 Score=87.87 Aligned_cols=137 Identities=21% Similarity=0.204 Sum_probs=97.5
Q ss_pred CCCCeeecccceEEEEEEEcCCcEEEEEEecccC-------------------C--cchHHHHHHHHHHHHhccCC--cc
Q 010887 274 SESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-------------------S--PGGEAAFQREVHLISVAIHK--NL 330 (498)
Q Consensus 274 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------------~--~~~~~~~~~e~~~l~~l~h~--ni 330 (498)
.+.+.||-|.-+.||.|..++|.++|||.-+... + ........+|.++|.++... .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 3468899999999999999999999999643110 0 11234567899999998654 55
Q ss_pred ceEEEEEEcCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECC
Q 010887 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD 410 (498)
Q Consensus 331 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~ 410 (498)
.+.++ .+...+||||+++-.|... . ++......++..|++-+.-+-.. ||||||+++-||++++
T Consensus 174 P~P~~----~nRHaVvMe~ieG~eL~~~-r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 174 PKPIA----WNRHAVVMEYIEGVELYRL-R--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCccc----cccceeeeehcccceeecc-c--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 55554 3567899999998544321 1 12222334455555555555566 9999999999999999
Q ss_pred CCcEEEeecCcccccc
Q 010887 411 NFEAVLCDFGLAKLVD 426 (498)
Q Consensus 411 ~~~~ki~DfGl~~~~~ 426 (498)
+|.+.++||-.+....
T Consensus 238 dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 238 DGDIVVIDWPQAVPIS 253 (304)
T ss_pred CCCEEEEeCcccccCC
Confidence 9999999998776443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=4.8e-09 Score=105.41 Aligned_cols=103 Identities=27% Similarity=0.400 Sum_probs=84.4
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
.+..|+|++|.|+..-+..|-+|++|+.++|..|.|+ .||.......+|+.|+|.+|.++..-.++++-++.|+.||||
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 3567999999999887888999999999999999999 899877777779999999999885556668888889999999
Q ss_pred CCcCcccCCch-h---hccccccccCCcc
Q 010887 157 SNNLTGRIPMQ-L---FSVATFNFTGTHL 181 (498)
Q Consensus 157 ~N~l~g~ip~~-~---~~~~~~~~~~n~~ 181 (498)
.|.|+ .||.. + -++..|++++|..
T Consensus 158 rN~is-~i~~~sfp~~~ni~~L~La~N~I 185 (873)
T KOG4194|consen 158 RNLIS-EIPKPSFPAKVNIKKLNLASNRI 185 (873)
T ss_pred hchhh-cccCCCCCCCCCceEEeeccccc
Confidence 99888 77643 2 2456777777765
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.3e-09 Score=110.17 Aligned_cols=103 Identities=27% Similarity=0.414 Sum_probs=76.7
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccC-CCCCcccCCCCCCeEeC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG-SIPATWSQLSNLKHLDL 155 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~l~l 155 (498)
+++.|+|++|.|+ .+.-..+...+|++|+||+|+|+ .+|..++.|++|+.|++.+|+|+- -||+.|++|.+|+.+.+
T Consensus 246 ~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~a 323 (1255)
T KOG0444|consen 246 NLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHA 323 (1255)
T ss_pred hhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHh
Confidence 5667777777777 66656666777777777777777 788888888888888888887653 37888888888888888
Q ss_pred CCCcCcccCCchhhc---cccccccCCccc
Q 010887 156 SSNNLTGRIPMQLFS---VATFNFTGTHLI 182 (498)
Q Consensus 156 ~~N~l~g~ip~~~~~---~~~~~~~~n~~~ 182 (498)
++|.|. -+|.+++. +..+.++.|+++
T Consensus 324 anN~LE-lVPEglcRC~kL~kL~L~~NrLi 352 (1255)
T KOG0444|consen 324 ANNKLE-LVPEGLCRCVKLQKLKLDHNRLI 352 (1255)
T ss_pred hccccc-cCchhhhhhHHHHHhccccccee
Confidence 888887 77877753 456667777654
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.4e-08 Score=90.02 Aligned_cols=83 Identities=30% Similarity=0.458 Sum_probs=42.6
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCccc-ccccccceeecccccccCCCC--CcccCCCCCCe
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFL-GSMTHLQSLNLANNKFSGSIP--ATWSQLSNLKH 152 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~-~~l~~L~~L~l~~N~l~g~~p--~~~~~l~~L~~ 152 (498)
.+++.|+|++|+|+ .++ .+..|++|++|+|++|+|+ .+++.+ ..+++|++|+|++|++.. +- ..+..+++|+.
T Consensus 42 ~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~-l~~l~~L~~l~~L~~ 117 (175)
T PF14580_consen 42 DKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISD-LNELEPLSSLPKLRV 117 (175)
T ss_dssp TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---S-CCCCGGGGG-TT--E
T ss_pred cCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCC-hHHhHHHHcCCCcce
Confidence 37899999999999 665 4888999999999999999 676655 469999999999999984 32 35788999999
Q ss_pred EeCCCCcCcc
Q 010887 153 LDLSSNNLTG 162 (498)
Q Consensus 153 l~l~~N~l~g 162 (498)
|+|.+|.++.
T Consensus 118 L~L~~NPv~~ 127 (175)
T PF14580_consen 118 LSLEGNPVCE 127 (175)
T ss_dssp EE-TT-GGGG
T ss_pred eeccCCcccc
Confidence 9999999983
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=3.2e-09 Score=101.97 Aligned_cols=102 Identities=29% Similarity=0.446 Sum_probs=81.1
Q ss_pred CCCCC-CCc---ceeEecC-----------CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccc
Q 010887 61 FVSPC-FSW---SHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTH 125 (498)
Q Consensus 61 ~~~~c-~~w---~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~ 125 (498)
++.+| |+= .-|.|+. ...+.|+|+.|+|+-..|.+|+.|.+|+.||||+|+|+-.-|..|..|++
T Consensus 37 CP~pC~Cs~~~g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~ 116 (498)
T KOG4237|consen 37 CPAPCTCSDVEGGIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLAS 116 (498)
T ss_pred CCCCcccCCCCCceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHh
Confidence 45566 443 4577864 25788999999999444457999999999999999999777999999999
Q ss_pred cceee-cccccccCCCCC-cccCCCCCCeEeCCCCcCccc
Q 010887 126 LQSLN-LANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGR 163 (498)
Q Consensus 126 L~~L~-l~~N~l~g~~p~-~~~~l~~L~~l~l~~N~l~g~ 163 (498)
|..|- +++|+|+ .+|. .|++|.+|+-|.+.-|+++..
T Consensus 117 l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLllNan~i~Ci 155 (498)
T KOG4237|consen 117 LLSLVLYGNNKIT-DLPKGAFGGLSSLQRLLLNANHINCI 155 (498)
T ss_pred hhHHHhhcCCchh-hhhhhHhhhHHHHHHHhcChhhhcch
Confidence 88774 4669999 6665 488888888888888888843
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.65 E-value=4.9e-09 Score=97.33 Aligned_cols=100 Identities=24% Similarity=0.406 Sum_probs=78.4
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
.+++|||++|.|+ .|..++.-++.++.|++|+|.|. .+-. +..|++|+.||||+|.++ .+-..-.+|-+.+.|.|+
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence 5778999999998 88888888899999999999998 5543 888999999999999998 666665667778888888
Q ss_pred CCcCcccCC--chhhccccccccCCcc
Q 010887 157 SNNLTGRIP--MQLFSVATFNFTGTHL 181 (498)
Q Consensus 157 ~N~l~g~ip--~~~~~~~~~~~~~n~~ 181 (498)
.|.+. .+. ..+.++..+++.+|+.
T Consensus 361 ~N~iE-~LSGL~KLYSLvnLDl~~N~I 386 (490)
T KOG1259|consen 361 QNKIE-TLSGLRKLYSLVNLDLSSNQI 386 (490)
T ss_pred hhhHh-hhhhhHhhhhheeccccccch
Confidence 88876 333 1345667777777764
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=2e-07 Score=96.34 Aligned_cols=149 Identities=23% Similarity=0.286 Sum_probs=97.4
Q ss_pred hcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcc---------------------------------------
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--------------------------------------- 310 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------------------- 310 (498)
..+|+ .+-|+.++-|+||+|++++|+.||||+.+....+.
T Consensus 125 F~eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~ 203 (517)
T COG0661 125 FSEFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR 203 (517)
T ss_pred HHHcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence 33454 46789999999999999999999999875422110
Q ss_pred hHHHHHHHHHHHHhcc-----CCccceEEEEEEcCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHH-
Q 010887 311 GEAAFQREVHLISVAI-----HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYG- 384 (498)
Q Consensus 311 ~~~~~~~e~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~- 384 (498)
.+-+|.+|..-+.+++ .+++.-..-|........++|||++|-.+.+...-.. .+.+ +..++..++++
T Consensus 204 ~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d---~k~ia~~~~~~f 277 (517)
T COG0661 204 EELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGID---RKELAELLVRAF 277 (517)
T ss_pred HHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCC---HHHHHHHHHHHH
Confidence 0112344444444442 3444333334445677899999999988877743211 2344 33344433332
Q ss_pred HHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 385 L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
+..+-.. +++|.|.+|.||+++.++++.+.|||+...+++.
T Consensus 278 ~~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 278 LRQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HHHHHhc---CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 2222233 8999999999999999999999999998877543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.57 E-value=6.5e-07 Score=82.58 Aligned_cols=109 Identities=19% Similarity=0.207 Sum_probs=83.6
Q ss_pred hHHHHHHHHHHHHhccCC--ccceEEEEEEcCC----ceEEEEecccCC-CHHHhhcccCCCCCCCCHHHHHHHHHHHHH
Q 010887 311 GEAAFQREVHLISVAIHK--NLLQLIGYCTTSS----ERILVYPFMQNL-SVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 383 (498)
Q Consensus 311 ~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~ 383 (498)
......+|.+.+..+... ...+.+++..... ..++|+|++++. +|.+.+.... ..+......++.+++.
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALAR 129 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHH
Confidence 344567788877777533 3456666665432 347999999874 7888877522 1556677889999999
Q ss_pred HHHHHHhcCCCCcEEcCCCCCcEEECCCC---cEEEeecCcccccc
Q 010887 384 GLEYLHEQCNPKIIHRDLKAANILLDDNF---EAVLCDFGLAKLVD 426 (498)
Q Consensus 384 ~L~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~ki~DfGl~~~~~ 426 (498)
.++-||.. +|+|+|+++.|||++.+. .+.++||+-++...
T Consensus 130 ~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 130 LIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 99999999 999999999999998887 89999999887544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.56 E-value=5.1e-08 Score=105.19 Aligned_cols=96 Identities=29% Similarity=0.441 Sum_probs=55.6
Q ss_pred CceeEEEecccccCcccccccccc-----------------CCCCeEEccCCCCCCccCcccccccccceeecccccccC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKL-----------------KFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 138 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l-----------------~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g 138 (498)
.+++.|+|++|+|+ .+|+...+| .+|+.|+|++|.|+ .+|... ++|+.|+|++|+|+
T Consensus 342 ~~Lq~LdLS~N~Ls-~LP~lp~~L~~L~Ls~N~L~~LP~l~~~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Ls- 415 (788)
T PRK15387 342 SGLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLT- 415 (788)
T ss_pred cccceEecCCCccC-CCCCCCcccceehhhccccccCcccccccceEEecCCccc-CCCCcc---cCCCEEEccCCcCC-
Confidence 36777777777777 344322211 35667777777777 455432 45666677777666
Q ss_pred CCCCcccCCCCCCeEeCCCCcCcccCCchhh---ccccccccCCcc
Q 010887 139 SIPATWSQLSNLKHLDLSSNNLTGRIPMQLF---SVATFNFTGTHL 181 (498)
Q Consensus 139 ~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~---~~~~~~~~~n~~ 181 (498)
.+|..+ .+|+.|+|++|+|+ .+|..+. ++..+++++|++
T Consensus 416 sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~L 457 (788)
T PRK15387 416 SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPL 457 (788)
T ss_pred CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCC
Confidence 455432 34566666666666 6665543 334556666665
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.1e-07 Score=103.19 Aligned_cols=94 Identities=21% Similarity=0.399 Sum_probs=43.1
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
.++.|+|++|+|+ .+|..+. ++|++|+|++|+|+ .+|..+. ++|+.|+|++|+++ .+|..+. ++|+.|+|+
T Consensus 200 ~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls 270 (754)
T PRK15370 200 QITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLF 270 (754)
T ss_pred CCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECc
Confidence 3444555555555 4444332 35555555555555 4444332 23444444444444 4444332 245555555
Q ss_pred CCcCcccCCchhh-ccccccccCCc
Q 010887 157 SNNLTGRIPMQLF-SVATFNFTGTH 180 (498)
Q Consensus 157 ~N~l~g~ip~~~~-~~~~~~~~~n~ 180 (498)
+|+|+ .+|..+. ++..|++++|.
T Consensus 271 ~N~L~-~LP~~l~~sL~~L~Ls~N~ 294 (754)
T PRK15370 271 HNKIS-CLPENLPEELRYLSVYDNS 294 (754)
T ss_pred CCccC-ccccccCCCCcEEECCCCc
Confidence 55555 3444332 34444444443
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=2e-08 Score=96.71 Aligned_cols=93 Identities=29% Similarity=0.394 Sum_probs=82.4
Q ss_pred cccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCCCCcCcccCCchh---hcc
Q 010887 95 SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL---FSV 171 (498)
Q Consensus 95 ~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~---~~~ 171 (498)
-|.+|++|+.|+|++|+|++.-+.+|..+..|+.|.|..|+|.-.--..|.++..|+.|+|.+|+|+-.-|..| .++
T Consensus 269 cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l 348 (498)
T KOG4237|consen 269 CFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSL 348 (498)
T ss_pred HHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEeccccccccee
Confidence 48999999999999999998889999999999999999999985445568999999999999999997666544 677
Q ss_pred ccccccCCccccCCCC
Q 010887 172 ATFNFTGTHLICGSSL 187 (498)
Q Consensus 172 ~~~~~~~n~~~~~~~~ 187 (498)
..+.+-+||+.|.+.+
T Consensus 349 ~~l~l~~Np~~CnC~l 364 (498)
T KOG4237|consen 349 STLNLLSNPFNCNCRL 364 (498)
T ss_pred eeeehccCcccCccch
Confidence 8999999999998743
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.51 E-value=3.6e-06 Score=76.47 Aligned_cols=139 Identities=17% Similarity=0.154 Sum_probs=102.0
Q ss_pred eecccceEEEEEEEcCCcEEEEEEecccC-----CcchHHHHHHHHHHHHhccCCc--cceEEEEEE-cC----CceEEE
Q 010887 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYY-----SPGGEAAFQREVHLISVAIHKN--LLQLIGYCT-TS----SERILV 346 (498)
Q Consensus 279 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~-~~----~~~~lv 346 (498)
-|+||-+-|++.... |+.+-+|+-.... -+.....|.+|...+.++...+ +.++. ++. .. -.-++|
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 467888899998774 4478888764211 1557789999999999886332 44444 332 11 135788
Q ss_pred EecccC-CCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCc--EEEeecCccc
Q 010887 347 YPFMQN-LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE--AVLCDFGLAK 423 (498)
Q Consensus 347 ~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~--~ki~DfGl~~ 423 (498)
+|-+++ -+|.+++.+.. ..+.+...+..+..++++.++-||+. ++.|+|+.+.||+++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 987654 47777775422 23457777889999999999999999 9999999999999986666 9999998776
Q ss_pred c
Q 010887 424 L 424 (498)
Q Consensus 424 ~ 424 (498)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=8.1e-07 Score=86.77 Aligned_cols=194 Identities=16% Similarity=0.161 Sum_probs=123.1
Q ss_pred CCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEE------EcCCc-eEEE
Q 010887 275 ESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYC------TTSSE-RILV 346 (498)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~------~~~~~-~~lv 346 (498)
..+-||+|+-+.+|-.-. -...+.|+...... .... +-++.|.+. .||-+-.-+.+- -+... .-+.
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Ppp-a~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPP-AAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecch--hhchhheeecCCCc-hHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 367799999999986542 12234466553321 1111 122233332 455333211111 11122 4456
Q ss_pred EecccCCCHHHhhcc---cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 347 YPFMQNLSVAYRLRD---LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
|+.+.+..--..+.+ .+..-...+|+..+++++.++.+.+-||.. |.+-||+.++|+|+.+++.+.+.|-.--.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 666655422111111 122234578999999999999999999999 99999999999999999999998855433
Q ss_pred cccccCcceeecccccccccCccccc-----CCCCCCcccchhHHHHHHHHHhC-CCCCCCC
Q 010887 424 LVDAKLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTG-QRAIDFS 479 (498)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvvl~elltG-~~p~~~~ 479 (498)
....+. ......|...|.+||... +..-+...|-|.+||++++++.| ++||...
T Consensus 166 i~~ng~--~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 166 INANGT--LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred eccCCc--eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 222211 222345789999999875 33456788999999999999986 9999753
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=3.2e-08 Score=104.57 Aligned_cols=99 Identities=35% Similarity=0.490 Sum_probs=88.8
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
++.+|+|++|.++ .+|..+..+.+|+.|+++.|.+. ..|.+..++.+|++|+|.+|++. .+|.++..+++|++||+|
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS 122 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLS 122 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccc
Confidence 4899999999999 89999999999999999999999 89999999999999999999999 999999999999999999
Q ss_pred CCcCcccCCchh---hccccccccCC
Q 010887 157 SNNLTGRIPMQL---FSVATFNFTGT 179 (498)
Q Consensus 157 ~N~l~g~ip~~~---~~~~~~~~~~n 179 (498)
+|.|. .+|.-+ .....+.+++|
T Consensus 123 ~N~f~-~~Pl~i~~lt~~~~~~~s~N 147 (1081)
T KOG0618|consen 123 FNHFG-PIPLVIEVLTAEEELAASNN 147 (1081)
T ss_pred hhccC-CCchhHHhhhHHHHHhhhcc
Confidence 99999 888644 33344555555
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.3e-07 Score=99.39 Aligned_cols=101 Identities=27% Similarity=0.499 Sum_probs=84.7
Q ss_pred EecCCceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCC
Q 010887 72 TCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLK 151 (498)
Q Consensus 72 ~c~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~ 151 (498)
.|...+.+.|+|++++++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|++|+|++|+|+ .+|..+. .+|+
T Consensus 174 ~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~ 244 (754)
T PRK15370 174 DCLKNNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQ 244 (754)
T ss_pred hhcccCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--cccc
Confidence 344456889999999999 7887663 68999999999999 7888765 59999999999999 7887664 4799
Q ss_pred eEeCCCCcCcccCCchhh-ccccccccCCccc
Q 010887 152 HLDLSSNNLTGRIPMQLF-SVATFNFTGTHLI 182 (498)
Q Consensus 152 ~l~l~~N~l~g~ip~~~~-~~~~~~~~~n~~~ 182 (498)
.|+|++|+++ .+|..+. ++..|++++|.+.
T Consensus 245 ~L~Ls~N~L~-~LP~~l~s~L~~L~Ls~N~L~ 275 (754)
T PRK15370 245 EMELSINRIT-ELPERLPSALQSLDLFHNKIS 275 (754)
T ss_pred EEECcCCccC-cCChhHhCCCCEEECcCCccC
Confidence 9999999999 8988764 5788899888764
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.4e-07 Score=63.16 Aligned_cols=36 Identities=39% Similarity=0.648 Sum_probs=20.8
Q ss_pred CCCeEEccCCCCCCccCcccccccccceeeccccccc
Q 010887 101 FLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFS 137 (498)
Q Consensus 101 ~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~ 137 (498)
+|++|+|++|+|+ .+|+.|++|++|++|+|++|+|+
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 4566666666666 55555666666666666666655
|
... |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.7e-08 Score=82.14 Aligned_cols=88 Identities=31% Similarity=0.479 Sum_probs=73.6
Q ss_pred ceeEEEecccccCccccccccc-cCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 77 NVISLTLGSNGFSGKISPSITK-LKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~-l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.++.++|++|++. .+|+.|.. ++.++.|+|++|.|+ .+|.++..++.|+.|+++.|.|. ..|..+..|.+|..||.
T Consensus 54 el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds 130 (177)
T KOG4579|consen 54 ELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDS 130 (177)
T ss_pred eEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcC
Confidence 6888899999998 67766654 468889999999998 88999999999999999999988 78888888888999999
Q ss_pred CCCcCcccCCchh
Q 010887 156 SSNNLTGRIPMQL 168 (498)
Q Consensus 156 ~~N~l~g~ip~~~ 168 (498)
.+|.+. +||-.+
T Consensus 131 ~~na~~-eid~dl 142 (177)
T KOG4579|consen 131 PENARA-EIDVDL 142 (177)
T ss_pred CCCccc-cCcHHH
Confidence 888888 777554
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.40 E-value=3.6e-07 Score=98.71 Aligned_cols=92 Identities=24% Similarity=0.361 Sum_probs=54.4
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|.. .++|+.|+|++|+|+ .+|..+ ++|+.|+|+
T Consensus 223 ~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~L~-~Lp~lp---~~L~~L~Ls 290 (788)
T PRK15387 223 HITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNPLT-HLPALP---SGLCKLWIF 290 (788)
T ss_pred CCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccC-cccCc---ccccceeeccCCchh-hhhhch---hhcCEEECc
Confidence 5667777777777 4654 2467777777777777 56643 345666666666666 444322 345555566
Q ss_pred CCcCcccCCchhhccccccccCCcc
Q 010887 157 SNNLTGRIPMQLFSVATFNFTGTHL 181 (498)
Q Consensus 157 ~N~l~g~ip~~~~~~~~~~~~~n~~ 181 (498)
+|+|+ .+|..+.++..+++++|.+
T Consensus 291 ~N~Lt-~LP~~p~~L~~LdLS~N~L 314 (788)
T PRK15387 291 GNQLT-SLPVLPPGLQELSVSDNQL 314 (788)
T ss_pred CCccc-cccccccccceeECCCCcc
Confidence 66655 4554444555555555543
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.40 E-value=2e-07 Score=93.75 Aligned_cols=100 Identities=26% Similarity=0.484 Sum_probs=72.9
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
-+..|-+++|+++ .+|++++.+.+|..||.+.|.+. .+|..++.|.+|+.|.+..|++. .+|+++..| .|..||+|
T Consensus 144 pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfS 219 (722)
T KOG0532|consen 144 PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFS 219 (722)
T ss_pred cceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecc
Confidence 4677778888887 78888887788888888888887 77878888877777777777777 677777644 36777777
Q ss_pred CCcCcccCCchhhcc---ccccccCCcc
Q 010887 157 SNNLTGRIPMQLFSV---ATFNFTGTHL 181 (498)
Q Consensus 157 ~N~l~g~ip~~~~~~---~~~~~~~n~~ 181 (498)
.|+++ .||-.+.++ ..+.+..||+
T Consensus 220 cNkis-~iPv~fr~m~~Lq~l~LenNPL 246 (722)
T KOG0532|consen 220 CNKIS-YLPVDFRKMRHLQVLQLENNPL 246 (722)
T ss_pred cCcee-ecchhhhhhhhheeeeeccCCC
Confidence 77777 777666544 4455566654
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.4e-08 Score=100.33 Aligned_cols=100 Identities=27% Similarity=0.524 Sum_probs=72.2
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
.++.|+|+.|+++ .+|..++.|+ |+.|-+++|+++ .+|++++.+..|..||.+.|++. .+|+.++.+.+|+.|++.
T Consensus 122 ~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vr 197 (722)
T KOG0532|consen 122 ALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVR 197 (722)
T ss_pred HHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHh
Confidence 4566677777777 6776666553 677777777777 67777777777777777777777 677777777777777777
Q ss_pred CCcCcccCCchhhcc--ccccccCCcc
Q 010887 157 SNNLTGRIPMQLFSV--ATFNFTGTHL 181 (498)
Q Consensus 157 ~N~l~g~ip~~~~~~--~~~~~~~n~~ 181 (498)
.|++. .+|+++..| ..|+|+-|..
T Consensus 198 Rn~l~-~lp~El~~LpLi~lDfScNki 223 (722)
T KOG0532|consen 198 RNHLE-DLPEELCSLPLIRLDFSCNKI 223 (722)
T ss_pred hhhhh-hCCHHHhCCceeeeecccCce
Confidence 77777 677777654 5677887764
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.9e-07 Score=62.57 Aligned_cols=40 Identities=38% Similarity=0.676 Sum_probs=34.6
Q ss_pred cccceeecccccccCCCCCcccCCCCCCeEeCCCCcCcccCC
Q 010887 124 THLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP 165 (498)
Q Consensus 124 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip 165 (498)
++|++|+|++|+|+ .+|+.+++|++|+.|++++|+|+ .+|
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~-~i~ 40 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS-DIS 40 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS-BEG
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC-CCc
Confidence 57999999999999 79988999999999999999999 443
|
... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.35 E-value=1e-05 Score=75.68 Aligned_cols=139 Identities=14% Similarity=0.186 Sum_probs=85.2
Q ss_pred CeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCc--cceEEEEEEcCCceEEEEecccCCC
Q 010887 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN--LLQLIGYCTTSSERILVYPFMQNLS 354 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gs 354 (498)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 56899999999984 25567788775422 3345688999998886443 4567777777777789999999863
Q ss_pred -HHHh---------------------hcccCCCCCCCCHHHHHH-HHH----------HHH-HHHHHHHhc-CCCCcEEc
Q 010887 355 -VAYR---------------------LRDLKPGEKGLDWPTRKR-VAF----------GTA-YGLEYLHEQ-CNPKIIHR 399 (498)
Q Consensus 355 -L~~~---------------------l~~~~~~~~~l~~~~~~~-i~~----------~ia-~~L~yLH~~-~~~~ivH~ 399 (498)
+... +|...... ........ +.. .+. ...++|... ..+.++|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~--~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDT--STFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCC--CcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 1111 22111111 11111110 000 011 112233221 23357899
Q ss_pred CCCCCcEEECCCCcEEEeecCcccc
Q 010887 400 DLKAANILLDDNFEAVLCDFGLAKL 424 (498)
Q Consensus 400 Dlk~~NILl~~~~~~ki~DfGl~~~ 424 (498)
|+.|.||++++++ +.|+||+.+..
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcCc
Confidence 9999999999888 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.1e-07 Score=94.95 Aligned_cols=100 Identities=36% Similarity=0.598 Sum_probs=85.0
Q ss_pred ceeEEEecccccCccccccccccC-CCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLK-FLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~-~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.++.|++.+|.++ .+|+....+. +|+.|++++|++. .+|..++.+++|+.|++++|+++ .+|...+.+++|+.|++
T Consensus 117 ~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~l 193 (394)
T COG4886 117 NLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDL 193 (394)
T ss_pred ceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheec
Confidence 5888999999999 8888888885 9999999999998 78888899999999999999998 88877778889999999
Q ss_pred CCCcCcccCCch--h-hccccccccCCc
Q 010887 156 SSNNLTGRIPMQ--L-FSVATFNFTGTH 180 (498)
Q Consensus 156 ~~N~l~g~ip~~--~-~~~~~~~~~~n~ 180 (498)
++|+++ .+|.. . ..+..+.+++|+
T Consensus 194 s~N~i~-~l~~~~~~~~~L~~l~~~~N~ 220 (394)
T COG4886 194 SGNKIS-DLPPEIELLSALEELDLSNNS 220 (394)
T ss_pred cCCccc-cCchhhhhhhhhhhhhhcCCc
Confidence 999999 88874 3 347788888885
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.33 E-value=8.7e-07 Score=102.13 Aligned_cols=103 Identities=23% Similarity=0.370 Sum_probs=72.7
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|+|.+|.|. .++..+..+++|+.|+|++|...+.+|. ++.+++|++|+|++|..-..+|..++++++|+.|++
T Consensus 611 ~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L 688 (1153)
T PLN03210 611 ENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM 688 (1153)
T ss_pred cCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence 36777888888877 6777777788888888877665556764 677778888888777655577777777777888888
Q ss_pred CCCcCcccCCch--hhccccccccCCc
Q 010887 156 SSNNLTGRIPMQ--LFSVATFNFTGTH 180 (498)
Q Consensus 156 ~~N~l~g~ip~~--~~~~~~~~~~~n~ 180 (498)
++|..-+.+|.. +.++..++++|+.
T Consensus 689 ~~c~~L~~Lp~~i~l~sL~~L~Lsgc~ 715 (1153)
T PLN03210 689 SRCENLEILPTGINLKSLYRLNLSGCS 715 (1153)
T ss_pred CCCCCcCccCCcCCCCCCCEEeCCCCC
Confidence 776544467753 3455666666654
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.31 E-value=1e-06 Score=101.52 Aligned_cols=102 Identities=18% Similarity=0.222 Sum_probs=57.7
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|+|+++..-+.+|. ++.+++|+.|+|++|.....+|.++++|++|+.|+|++|..-+.+|..+ ++++|+.|+|+
T Consensus 635 ~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Ls 712 (1153)
T PLN03210 635 GLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLS 712 (1153)
T ss_pred CCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCC
Confidence 556666665543335543 5566666666666655444566666666666666666544333555544 55666666666
Q ss_pred CCcCcccCCchhhccccccccCCc
Q 010887 157 SNNLTGRIPMQLFSVATFNFTGTH 180 (498)
Q Consensus 157 ~N~l~g~ip~~~~~~~~~~~~~n~ 180 (498)
+|...+.+|....++..+++.+|.
T Consensus 713 gc~~L~~~p~~~~nL~~L~L~~n~ 736 (1153)
T PLN03210 713 GCSRLKSFPDISTNISWLDLDETA 736 (1153)
T ss_pred CCCCccccccccCCcCeeecCCCc
Confidence 665555555544555555555554
|
syringae 6; Provisional |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.2e-05 Score=74.25 Aligned_cols=156 Identities=21% Similarity=0.202 Sum_probs=98.6
Q ss_pred cCHHHHHHHhcCCCCCCe---eecccceEEEEEEEcCCcEEEEEEecccCCcch------------------HHH-----
Q 010887 261 FSCRELQLATDNFSESNI---IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGG------------------EAA----- 314 (498)
Q Consensus 261 ~~~~el~~~~~~~~~~~~---lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------~~~----- 314 (498)
.+.+.+....+...+.+. |..|.-+.||+|...++..+|||+.+....... .++
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 344555555555555444 556777899999988899999999864321110 000
Q ss_pred HHHHHHHHHhcc--CCccceEEEEEEcCCceEEEEecccCC-CHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 010887 315 FQREVHLISVAI--HKNLLQLIGYCTTSSERILVYPFMQNL-SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391 (498)
Q Consensus 315 ~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~ 391 (498)
..+|..-|.++. +-.+.+.+++ ....+||||+... .-.-.|.+ .++...+...+..++.+.+.-|-..
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~~~ 185 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLYKE 185 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHHHh
Confidence 123444444443 2222333322 2457999999654 22222332 1233335667778888888888773
Q ss_pred CCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 392 ~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
+ ++||+||+.=|||++ ++.+.|+|+|-+....++
T Consensus 186 a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 186 A--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred c--CcccccchhhheEEE-CCeEEEEECccccccCCC
Confidence 3 899999999999999 889999999988765543
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.24 E-value=2.2e-07 Score=86.46 Aligned_cols=83 Identities=23% Similarity=0.359 Sum_probs=71.5
Q ss_pred cccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCCCCcCcccCC---chhhcc
Q 010887 95 SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP---MQLFSV 171 (498)
Q Consensus 95 ~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip---~~~~~~ 171 (498)
++-....|++||||+|.|+ .|.++..-+|.++.|++|+|.++ .+-. ++.|++|+.||||+|.|+ ++- ..++|+
T Consensus 279 ~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNI 354 (490)
T KOG1259|consen 279 SADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNI 354 (490)
T ss_pred ecchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCE
Confidence 3444578999999999999 89999999999999999999998 5554 889999999999999998 443 467889
Q ss_pred ccccccCCcc
Q 010887 172 ATFNFTGTHL 181 (498)
Q Consensus 172 ~~~~~~~n~~ 181 (498)
..+.+++|..
T Consensus 355 KtL~La~N~i 364 (490)
T KOG1259|consen 355 KTLKLAQNKI 364 (490)
T ss_pred eeeehhhhhH
Confidence 9999999865
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.23 E-value=7.7e-08 Score=99.19 Aligned_cols=103 Identities=31% Similarity=0.441 Sum_probs=78.9
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcc-cccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDF-LGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.++.|+|++|+++. .. .+..|++|++|||+.|.|. .+|.. ...+. |+.|+|.+|.++ ++- .+.+|++|..|||
T Consensus 188 ale~LnLshNk~~~-v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~-tL~-gie~LksL~~LDl 261 (1096)
T KOG1859|consen 188 ALESLNLSHNKFTK-VD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALT-TLR-GIENLKSLYGLDL 261 (1096)
T ss_pred Hhhhhccchhhhhh-hH-HHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHH-hhh-hHHhhhhhhccch
Confidence 57788889998883 33 6888888999999999888 66642 22234 888899999887 443 4678999999999
Q ss_pred CCCcCcccCC---c-hhhccccccccCCccccCC
Q 010887 156 SSNNLTGRIP---M-QLFSVATFNFTGTHLICGS 185 (498)
Q Consensus 156 ~~N~l~g~ip---~-~~~~~~~~~~~~n~~~~~~ 185 (498)
++|-|++.-- - .+..+..|.+.|||..|.+
T Consensus 262 syNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 262 SYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred hHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 9999996432 1 3466788999999998865
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.2e-07 Score=78.28 Aligned_cols=98 Identities=24% Similarity=0.335 Sum_probs=76.9
Q ss_pred eeEEEecccccCcccccc---ccccCCCCeEEccCCCCCCccCcccccc-cccceeecccccccCCCCCcccCCCCCCeE
Q 010887 78 VISLTLGSNGFSGKISPS---ITKLKFLASLELQDNDLSGTLPDFLGSM-THLQSLNLANNKFSGSIPATWSQLSNLKHL 153 (498)
Q Consensus 78 v~~l~l~~~~l~g~~~~~---~~~l~~L~~L~l~~n~l~g~~p~~~~~l-~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l 153 (498)
.-.++|++..|- .++.. +....+|+..+|++|.|. ..|+.|... +.+++|+|++|+|+ .+|.++..++.|+.|
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 345677777765 56654 556677888899999999 788877764 58999999999999 999999999999999
Q ss_pred eCCCCcCcccCCchhhccc---cccccCC
Q 010887 154 DLSSNNLTGRIPMQLFSVA---TFNFTGT 179 (498)
Q Consensus 154 ~l~~N~l~g~ip~~~~~~~---~~~~~~n 179 (498)
++++|.|+ ..|.-+..+. .|+..+|
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~n 133 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPEN 133 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCC
Confidence 99999999 6776555444 4444444
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.22 E-value=2.2e-07 Score=91.73 Aligned_cols=106 Identities=22% Similarity=0.331 Sum_probs=78.6
Q ss_pred CceeEEEecccccCccccccccccCC---CCeEEccCCCCCC----ccCcccccc-cccceeecccccccCC----CCCc
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKF---LASLELQDNDLSG----TLPDFLGSM-THLQSLNLANNKFSGS----IPAT 143 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~---L~~L~l~~n~l~g----~~p~~~~~l-~~L~~L~l~~N~l~g~----~p~~ 143 (498)
.+++.|+|++|.+.+..+..+..+.. |++|++++|.+++ .+...+..+ ++|+.|+|++|.+++. ++..
T Consensus 81 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~ 160 (319)
T cd00116 81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKA 160 (319)
T ss_pred CceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHH
Confidence 38899999999998777777766666 9999999998873 344456666 8889999999998853 3445
Q ss_pred ccCCCCCCeEeCCCCcCccc----CCchhh---ccccccccCCcc
Q 010887 144 WSQLSNLKHLDLSSNNLTGR----IPMQLF---SVATFNFTGTHL 181 (498)
Q Consensus 144 ~~~l~~L~~l~l~~N~l~g~----ip~~~~---~~~~~~~~~n~~ 181 (498)
+..+++|++|++++|.+++. ++..+. ++..+++++|..
T Consensus 161 ~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i 205 (319)
T cd00116 161 LRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGL 205 (319)
T ss_pred HHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCcc
Confidence 66777899999999998853 333343 677777777753
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.5e-05 Score=72.68 Aligned_cols=137 Identities=14% Similarity=0.131 Sum_probs=89.1
Q ss_pred HhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHH---------HHHHHHHHHhccCC---ccceEEEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAA---------FQREVHLISVAIHK---NLLQLIGY 336 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~~e~~~l~~l~h~---niv~l~~~ 336 (498)
...+|...+++-......|.+-.. +++.+++|..+..... ..+. ..+++..+.+++.. .+..++..
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 456777777887777777777666 6788999987653321 1111 23344444444322 22222222
Q ss_pred EE-----cCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCC
Q 010887 337 CT-----TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN 411 (498)
Q Consensus 337 ~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~ 411 (498)
.. .....+++|||++|..+.+... ++. .++..+.+++.-+|+. |++|+|..|.|++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC
Confidence 21 2234578999999987655432 221 3456677889999999 99999999999999865
Q ss_pred CcEEEeecCccc
Q 010887 412 FEAVLCDFGLAK 423 (498)
Q Consensus 412 ~~~ki~DfGl~~ 423 (498)
.+++.||+..+
T Consensus 172 -~i~iID~~~k~ 182 (229)
T PF06176_consen 172 -GIRIIDTQGKR 182 (229)
T ss_pred -cEEEEECcccc
Confidence 48999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.19 E-value=3.3e-07 Score=94.84 Aligned_cols=98 Identities=22% Similarity=0.401 Sum_probs=76.8
Q ss_pred HHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCccee--------ecccccccccCcccccC
Q 010887 379 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT--------TQIRGTMGHIAPEYLST 450 (498)
Q Consensus 379 ~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~~--------~~~~gt~~y~aPE~~~~ 450 (498)
.+++.|+.|+|... ++||++|.|++|.++..+..||+.|+.+.....+..... .-......|.|||++..
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34558999999874 899999999999999999999999998765543211110 11123567999999999
Q ss_pred CCCCCcccchhHHHHHHHHH-hCCCCCCC
Q 010887 451 GKSSEKTDVFGYGITLLELV-TGQRAIDF 478 (498)
Q Consensus 451 ~~~~~~~Dv~s~Gvvl~ell-tG~~p~~~ 478 (498)
...+.++|+||+||++|-+. .|+.-++.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a 212 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAA 212 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhc
Confidence 88899999999999999999 56655554
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.4e-05 Score=82.53 Aligned_cols=145 Identities=21% Similarity=0.252 Sum_probs=90.8
Q ss_pred CCeeecccceEEEEEEEcCCcEEEEEEecccCCcc------------------------------------hHHHHHHHH
Q 010887 276 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG------------------------------------GEAAFQREV 319 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------------~~~~~~~e~ 319 (498)
.+-||..+.|+||+|++++|+.||||+=++..... .+-+|.+|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 46789999999999999999999999865322111 011244444
Q ss_pred HHHH----hccCCccce---EEE-EEEcCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 010887 320 HLIS----VAIHKNLLQ---LIG-YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391 (498)
Q Consensus 320 ~~l~----~l~h~niv~---l~~-~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~ 391 (498)
+-.. .++|-+... +=. |..-.....|+||||+|..+.+.-.-. ...++... ++..+.+ .|++.-
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~---~~gi~~~~---i~~~l~~--~~~~qI 317 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID---KRGISPHD---ILNKLVE--AYLEQI 317 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH---HcCCCHHH---HHHHHHH--HHHHHH
Confidence 3322 334555111 111 223345689999999998876653321 12344443 3333333 233332
Q ss_pred CCCCcEEcCCCCCcEEEC----CCCcEEEeecCcccccccc
Q 010887 392 CNPKIIHRDLKAANILLD----DNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 392 ~~~~ivH~Dlk~~NILl~----~~~~~ki~DfGl~~~~~~~ 428 (498)
...|++|+|-+|.||+++ .++++.+-|||+.......
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 333899999999999998 3678999999998876543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.15 E-value=5.6e-07 Score=92.17 Aligned_cols=182 Identities=16% Similarity=0.125 Sum_probs=131.3
Q ss_pred CCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCc-cceEEEEEEcCCceEEEEecccCC-
Q 010887 276 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN-LLQLIGYCTTSSERILVYPFMQNL- 353 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g- 353 (498)
.+-.++++++.+||.+-...+....+.+... ....-++++|.+++||| .+..++-+..++..+++++|...+
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 3456899999999998655555556655321 33456889999999999 666666666667788999999877
Q ss_pred CHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCccee
Q 010887 354 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 433 (498)
Q Consensus 354 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~~ 433 (498)
+...... ..+-.+...+...+.+.-+++++|+|+. .=+|+| ||+..+ ...+..||+....+.... ..
T Consensus 321 s~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~ 387 (829)
T KOG0576|consen 321 SSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KP 387 (829)
T ss_pred cccccCC---hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--cc
Confidence 2211111 1122244444556677788899999987 558988 777765 678999999987776543 23
Q ss_pred ecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCC
Q 010887 434 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 476 (498)
Q Consensus 434 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~ 476 (498)
....+++.++|||+.....+..+.|+|+.|+=-.++.-|-+|-
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 4566899999999999999999999999998777777676554
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.14 E-value=2.5e-05 Score=73.12 Aligned_cols=145 Identities=17% Similarity=0.187 Sum_probs=85.5
Q ss_pred CCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCc--cceEEEEEEcC---CceEEEEecc
Q 010887 276 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN--LLQLIGYCTTS---SERILVYPFM 350 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~---~~~~lv~e~~ 350 (498)
.+.++.|..+.||+....+ ..+++|..... .......+|..+++.+.... +.+++.+.... ...+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 3578999999999999877 69999987542 35567788888888886443 45666644332 2468899999
Q ss_pred cCCCHHH----------------h---hcccCCCCCCCCHHHH---------HHH------------HHHHHH-HHHHHH
Q 010887 351 QNLSVAY----------------R---LRDLKPGEKGLDWPTR---------KRV------------AFGTAY-GLEYLH 389 (498)
Q Consensus 351 ~~gsL~~----------------~---l~~~~~~~~~l~~~~~---------~~i------------~~~ia~-~L~yLH 389 (498)
++..+.. . ++..........+... ... ...+.+ .++.++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9887776 1 1111111111111110 000 111222 333343
Q ss_pred hc----CCCCcEEcCCCCCcEEEC-CCCcEEEeecCcccc
Q 010887 390 EQ----CNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKL 424 (498)
Q Consensus 390 ~~----~~~~ivH~Dlk~~NILl~-~~~~~ki~DfGl~~~ 424 (498)
+. ....++|+|+.|.||+++ +++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 21 234799999999999999 666668999998753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.12 E-value=5.1e-07 Score=89.14 Aligned_cols=105 Identities=30% Similarity=0.413 Sum_probs=78.8
Q ss_pred ceeEEEecccccCc----ccccccccc-CCCCeEEccCCCCCCc----cCcccccccccceeecccccccCC----CCCc
Q 010887 77 NVISLTLGSNGFSG----KISPSITKL-KFLASLELQDNDLSGT----LPDFLGSMTHLQSLNLANNKFSGS----IPAT 143 (498)
Q Consensus 77 ~v~~l~l~~~~l~g----~~~~~~~~l-~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~ 143 (498)
+++.|+|++|.+++ .+...+..+ ++|+.|+|++|.+++. ++..+..+++|++|+|++|.+++. ++..
T Consensus 109 ~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~ 188 (319)
T cd00116 109 SLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEG 188 (319)
T ss_pred cccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHH
Confidence 49999999999983 344456677 8999999999999954 344566678899999999999853 4555
Q ss_pred ccCCCCCCeEeCCCCcCcccCCc-------hhhccccccccCCcc
Q 010887 144 WSQLSNLKHLDLSSNNLTGRIPM-------QLFSVATFNFTGTHL 181 (498)
Q Consensus 144 ~~~l~~L~~l~l~~N~l~g~ip~-------~~~~~~~~~~~~n~~ 181 (498)
+..+++|+.|+|++|.+++.-.. .+.++..+++++|+.
T Consensus 189 l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l 233 (319)
T cd00116 189 LKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNL 233 (319)
T ss_pred HHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcC
Confidence 66778999999999998743322 223467777777653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.09 E-value=5.5e-05 Score=84.33 Aligned_cols=151 Identities=13% Similarity=0.213 Sum_probs=93.5
Q ss_pred CCeeecccceEEEEEEEcCC---cEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCcc--ceEEEEEEcC---CceEEE
Q 010887 276 SNIIGQGGFGKVYKGVLSDN---TKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNL--LQLIGYCTTS---SERILV 346 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv 346 (498)
.+.++.|.++.+|+....++ ..+++|+............+.+|.++++.+. |.++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56688999999999887654 4677777643222233457889999999995 6665 7777877664 467899
Q ss_pred EecccCCCHHH-----------------------hhcccCCCC-------CCCCHH--HHHHHH---------------H
Q 010887 347 YPFMQNLSVAY-----------------------RLRDLKPGE-------KGLDWP--TRKRVA---------------F 379 (498)
Q Consensus 347 ~e~~~~gsL~~-----------------------~l~~~~~~~-------~~l~~~--~~~~i~---------------~ 379 (498)
|||+++..+.+ .||...... .+..+. +...+. .
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998764321 122211110 011111 111111 1
Q ss_pred HHHHHHHHHHhcC--------CCCcEEcCCCCCcEEECCC-Cc-EEEeecCcccccc
Q 010887 380 GTAYGLEYLHEQC--------NPKIIHRDLKAANILLDDN-FE-AVLCDFGLAKLVD 426 (498)
Q Consensus 380 ~ia~~L~yLH~~~--------~~~ivH~Dlk~~NILl~~~-~~-~ki~DfGl~~~~~ 426 (498)
.+.+.++||..+. .+.++|+|+++.||+++.+ .. .-|.||.++..-+
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 2334466775432 1359999999999999753 33 5689999876443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 498 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-91 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-89 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-38 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-38 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-36 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-36 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-36 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-34 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 9e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 9e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-12 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-12 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 9e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-08 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-05 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-04 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-04 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-04 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-04 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 429 bits (1105), Expect = e-149
Identities = 165/250 (66%), Positives = 204/250 (81%)
Query: 242 FFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVK 301
FFDV E+D +V L QL+RFS RELQ+A+DNFS NI+G+GGFGKVYKG L+D T VAVK
Sbjct: 1 FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 60
Query: 302 RLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD 361
RL++ + GGE FQ EV +IS+A+H+NLL+L G+C T +ER+LVYP+M N SVA LR+
Sbjct: 61 RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 362 LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421
+ LDWP R+R+A G+A GL YLH+ C+PKIIHRD+KAANILLD+ FEAV+ DFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
Query: 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRL 481
AKL+D K THVTT +RGT+GHIAPEYLSTGKSSEKTDVFGYG+ LLEL+TGQRA D +RL
Sbjct: 181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 482 EEEEDVLLLD 491
++DV+LLD
Sbjct: 241 ANDDDVMLLD 250
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 334 bits (858), Expect = e-112
Identities = 97/252 (38%), Positives = 148/252 (58%), Gaps = 19/252 (7%)
Query: 248 EDDCKVSLTQLRRFSCRELQLATDNFSE------SNIIGQGGFGKVYKGVLSDNTKVAVK 301
+VS T+ FS EL+ T+NF E N +G+GGFG VYKG + +NT VAVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60
Query: 302 RL---QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYR 358
+L D + + F +E+ +++ H+NL++L+G+ + + LVY +M N S+ R
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 359 LRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 418
L G L W R ++A G A G+ +LHE IHRD+K+ANILLD+ F A + D
Sbjct: 121 LSC-LDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 419 FGLAKLVDA-KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 477
FGLA+ + T +T++I GT ++APE L G+ + K+D++ +G+ LLE++TG A+D
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 478 FSRLEEEEDVLL 489
R E +LL
Sbjct: 236 EHR---EPQLLL 244
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 313 bits (805), Expect = e-104
Identities = 90/231 (38%), Positives = 133/231 (57%), Gaps = 5/231 (2%)
Query: 256 TQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAF 315
+ R +L+ AT+NF +IG G FGKVYKGVL D KVA+KR S G F
Sbjct: 24 FESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-SSQGIEEF 82
Query: 316 QREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK 375
+ E+ +S H +L+ LIG+C +E IL+Y +M+N ++ L + W R
Sbjct: 83 ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 376 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTT 434
+ G A GL YLH + IIHRD+K+ NILLD+NF + DFG++K + TH++T
Sbjct: 143 EICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST 199
Query: 435 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE 485
++GT+G+I PEY G+ +EK+DV+ +G+ L E++ + AI S E
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV 250
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 2e-64
Identities = 66/241 (27%), Positives = 101/241 (41%), Gaps = 29/241 (12%)
Query: 261 FSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQRE-- 318
L + + +G FG V+K L N VAVK + ++Q E
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIF----PIQDKQSWQNEYE 68
Query: 319 VHLISVAIHKNLLQLIGYCTTSS----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTR 374
V+ + H+N+LQ IG + + L+ F + S++ L+ + W
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNEL 123
Query: 375 KRVAFGTAYGLEYLHE-------QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427
+A A GL YLHE P I HRD+K+ N+LL +N A + DFGLA +A
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183
Query: 428 KLTHV-TTQIRGTMGHIAPEYLSTG-----KSSEKTDVFGYGITLLELVTGQRAIDFSRL 481
+ T GT ++APE L + + D++ G+ L EL + A D
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243
Query: 482 E 482
E
Sbjct: 244 E 244
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 6e-56
Identities = 66/198 (33%), Positives = 100/198 (50%), Gaps = 5/198 (2%)
Query: 277 NIIGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
IG G FG V++ + VAVK L + + F REV ++ H N++ +G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 395
T +V ++ S+ L E+ LD R +A+ A G+ YLH NP
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ-LDERRRLSMAYDVAKGMNYLH-NRNPP 159
Query: 396 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSE 455
I+HR+LK+ N+L+D + +CDFGL++L A + GT +APE L S+E
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLK-ASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218
Query: 456 KTDVFGYGITLLELVTGQ 473
K+DV+ +G+ L EL T Q
Sbjct: 219 KSDVYSFGVILWELATLQ 236
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 1e-54
Identities = 62/251 (24%), Positives = 99/251 (39%), Gaps = 37/251 (14%)
Query: 261 FSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQRE-- 318
+ E L DN +IG+G +G VYKG L D VAVK S F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF----SFANRQNFINEKN 57
Query: 319 VHLISVAIHKNLLQLIGYCTTSS-----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPT 373
++ + + H N+ + I + E +LV + N S+ L DW +
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVS 112
Query: 374 RKRVAFGTAYGLEYLHE------QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD- 426
R+A GL YLH P I HRDL + N+L+ ++ V+ DFGL+ +
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 427 ------AKLTHVTTQIRGTMGHIAPEYL-------STGKSSEKTDVFGYGITLLELVTGQ 473
+ + GT+ ++APE L + ++ D++ G+ E+
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 474 RAIDFSRLEEE 484
+ E
Sbjct: 233 TDLFPGESVPE 243
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 3e-53
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 12/205 (5%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
++G+G FG V K VA+K+++ S AF E+ +S H N+
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE---SESERKAFIVELRQLSRVNHPNI 63
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 390
++L G C + LV + + S+ L +P + G+ YLH
Sbjct: 64 VKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAYLHS 120
Query: 391 QCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 449
+IHRDLK N+LL + +CDFG A + +T+ G+ +APE
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK----GSAAWMAPEVFE 176
Query: 450 TGKSSEKTDVFGYGITLLELVTGQR 474
SEK DVF +GI L E++T ++
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRK 201
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 1e-50
Identities = 69/201 (34%), Positives = 103/201 (51%), Gaps = 16/201 (7%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
IG G FG VYKG + VAVK L +P AF+ EV ++ H N+L +GY
Sbjct: 32 IGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 338 TTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396
T + ++ +V + + S+ Y L E + +A TA G++YLH + I
Sbjct: 90 T--APQLAIVTQWCEGSSL-YHH--LHASETKFEMKKLIDIARQTARGMDYLHAK---SI 141
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAKL-VDAKLTHVTTQIRGTMGHIAPE---YLSTGK 452
IHRDLK+ NI L ++ + DFGLA +H Q+ G++ +APE +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 453 SSEKTDVFGYGITLLELVTGQ 473
S ++DV+ +GI L EL+TGQ
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQ 222
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 4e-50
Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 24/218 (11%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL------QDYYSPGGEAAFQREVHLIS 323
+ IG+GGFG V+KG + D + VA+K L + FQREV ++S
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 324 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 383
H N+++L G +V F+ + +RL D + W + R+ A
Sbjct: 79 NLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIAL 133
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-----LCDFGLAKLVDAKLTHVTTQIRG 438
G+EY+ NP I+HRDL++ NI L E + DFGL++ H + + G
Sbjct: 134 GIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS----VHSVSGLLG 188
Query: 439 TMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQR 474
+APE + +EK D + + + L ++TG+
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 5e-50
Identities = 64/208 (30%), Positives = 92/208 (44%), Gaps = 20/208 (9%)
Query: 277 NIIGQGGFGKVYKGVLSDNTKVAVKRL---QDYYSPGGEAAFQREVHLISVAIHKNLLQL 333
IIG GGFGKVY+ +VAVK D ++E L ++ H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 334 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 393
G C LV F + + L K + A A G+ YLH++
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 394 PKIIHRDLKAANILLDDNFEAV--------LCDFGLAKLVDAKLTHVTTQIRGTMGHIAP 445
IIHRDLK++NIL+ E + DFGLA+ T + G +AP
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR--TTKMSAA-GAYAWMAP 183
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVTGQ 473
E + S+ +DV+ YG+ L EL+TG+
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 5e-50
Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 21/213 (9%)
Query: 277 NIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
++G+G FG+ K + + + +K L + + F +EV ++ H N+L+ IG
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIR-FDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 395
+ +++ ++ ++ + W R A A G+ YLH
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---N 128
Query: 396 IIHRDLKAANILLDDNFEAVLCDFGLAKLVD-------------AKLTHVTTQIRGTMGH 442
IIHRDL + N L+ +N V+ DFGLA+L+ + G
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 443 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQRA 475
+APE ++ EK DVF +GI L E++ A
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 7e-49
Identities = 39/213 (18%), Positives = 80/213 (37%), Gaps = 23/213 (10%)
Query: 272 NFSE---SNIIGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIH 327
+F + + + G+++KG + VK L +S F E + + H
Sbjct: 8 DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 328 KNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDL--KPGEKGLDWPTRKRVAFGTAY 383
N+L ++G C + + +M S L ++ + +D + A A
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGS----LYNVLHEGTNFVVDQSQAVKFALDMAR 122
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
G+ +LH P I L + ++++D++ A + + + + +
Sbjct: 123 GMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVK------FSFQSPGRMYAPAWV 175
Query: 444 APEYLSTGKS---SEKTDVFGYGITLLELVTGQ 473
APE L D++ + + L ELVT +
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 9e-49
Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 277 NIIGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
+IG+G FG+VY G + +VA++ + + + AF+REV H+N++ +G
Sbjct: 39 ELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 395
C + ++ + ++ +RD K LD +++A G+ YLH
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLH---AKG 150
Query: 396 IIHRDLKAANILLDDNFEAVLCDFGLAKLVD----AKLTHVTTQIRGTMGHIAPEYLSTG 451
I+H+DLK+ N+ D+ + V+ DFGL + + G + H+APE +
Sbjct: 151 ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 452 KS---------SEKTDVFGYGITLLELVTGQ 473
S+ +DVF G EL +
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-46
Identities = 60/233 (25%), Positives = 98/233 (42%), Gaps = 37/233 (15%)
Query: 260 RFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREV 319
R R++ L +G+G +G+V++G VAVK S E ++ RE
Sbjct: 4 RTVARDITL-------LECVGKGRYGEVWRGSW-QGENVAVKIF----SSRDEKSWFRET 51
Query: 320 HLISVAI--HKNLLQLIGYCTTSSERI----LVYPFMQNLSVAYRLRDLKPGEKGLDWPT 373
L + + H+N+L I TS L+ + + S+ L+ LD +
Sbjct: 52 ELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLDTVS 106
Query: 374 RKRVAFGTAYGLEYLHE-----QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428
R+ A GL +LH Q P I HRDLK+ NIL+ N + + D GLA +
Sbjct: 107 CLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQS 166
Query: 429 LTHV---TTQIRGTMGHIAPE------YLSTGKSSEKTDVFGYGITLLELVTG 472
+ GT ++APE + S ++ D++ +G+ L E+
Sbjct: 167 TNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-45
Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 37/229 (16%)
Query: 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS 323
+++Q+ IG+G +G+V+ G KVAVK EA++ RE +
Sbjct: 37 KQIQM-------VKQIGKGRYGEVWMGKW-RGEKVAVKVF----FTTEEASWFRETEIYQ 84
Query: 324 VAI--HKNLLQLIGYCTTSSERI----LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 377
+ H+N+L I + L+ + +N S+ L+ LD + ++
Sbjct: 85 TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-----LDAKSMLKL 139
Query: 378 AFGTAYGLEYLHE-----QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432
A+ + GL +LH Q P I HRDLK+ NIL+ N + D GLA + V
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199
Query: 433 ---TTQIRGTMGHIAPE------YLSTGKSSEKTDVFGYGITLLELVTG 472
GT ++ PE + +S D++ +G+ L E+
Sbjct: 200 DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 7e-44
Identities = 59/229 (25%), Positives = 95/229 (41%), Gaps = 37/229 (16%)
Query: 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQRE--VHL 321
R + L IG+G FG+V++G +VAVK S E ++ RE ++
Sbjct: 42 RTIVL-------QESIGKGRFGEVWRGKW-RGEEVAVKIF----SSREERSWFREAEIYQ 89
Query: 322 ISVAIHKNLLQLIGYCTTSSERI----LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 377
+ H+N+L I + LV + ++ S+ L + ++
Sbjct: 90 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKL 144
Query: 378 AFGTAYGLEYLHE-----QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432
A TA GL +LH Q P I HRDLK+ NIL+ N + D GLA D+ +
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 204
Query: 433 T---TQIRGTMGHIAPEYL------STGKSSEKTDVFGYGITLLELVTG 472
GT ++APE L +S ++ D++ G+ E+
Sbjct: 205 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-37
Identities = 59/240 (24%), Positives = 107/240 (44%), Gaps = 34/240 (14%)
Query: 247 GEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVL-----SDNTKVAVK 301
GE + L L+ E + ++G G FG VYKG+ VA+K
Sbjct: 1 GEAPNQALLRILKE---TEFKK-------IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK 50
Query: 302 RLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD 361
L++ SP E ++++ + ++ +L+G C TS+ ++ + M L D
Sbjct: 51 ELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGC----LLD 105
Query: 362 -LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420
++ + + A G+ YL ++ +++HRDL A N+L+ + DFG
Sbjct: 106 YVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFG 162
Query: 421 LAKLVDAKLTHVTTQ-----IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQR 474
LAKL+ A+ + I+ A E + + ++DV+ YG+T+ EL+T G +
Sbjct: 163 LAKLLGAEEKEYHAEGGKVPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 9e-37
Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 16/199 (8%)
Query: 279 IGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
IG+G FG+V+ G L +DNT VAVK ++ P +A F +E ++ H N+++LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 338 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 397
T +V +Q LR L T ++ A G+EYL + I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLESK---CCI 235
Query: 398 HRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQ---IRGTMGHIAPEYLSTGK 452
HRDL A N L+ + + DFG+++ + ++ T APE L+ G+
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----APEALNYGR 291
Query: 453 SSEKTDVFGYGITLLELVT 471
S ++DV+ +GI L E +
Sbjct: 292 YSSESDVWSFGILLWETFS 310
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-36
Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 25/209 (11%)
Query: 277 NIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 331
+G+G FGKV + +VAVK L+ A ++E+ ++ H+N++
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 332 QLIGYCTTSSER--ILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYL 388
+ G CT L+ F+ + S L++ L + ++ + + A G++YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGS----LKEYLPKNKNKINLKQQLKYAVQICKGMDYL 142
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGH 442
+ + +HRDL A N+L++ + + DFGL K ++ + T + +
Sbjct: 143 GSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY--- 196
Query: 443 IAPEYLSTGKSSEKTDVFGYGITLLELVT 471
APE L K +DV+ +G+TL EL+T
Sbjct: 197 -APECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-36
Identities = 62/206 (30%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 275 ESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
+IG+G FG VY G D + A+K L AF RE L+ H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 331 LQLIGYCTTSSERIL-VYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYL 388
L LIG + P+M + L ++ ++ A G+EYL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGD----LLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---AP 445
EQ K +HRDL A N +LD++F + DFGLA+ + + + Q R + A
Sbjct: 141 AEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVT 471
E L T + + K+DV+ +G+ L EL+T
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-35
Identities = 64/203 (31%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 277 NIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+IG+G FG VY G L DN AVK L G + F E ++ H N+L
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 333 LIGYCTTSSERIL-VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
L+G C S L V P+M++ + +R+ A G++YL +
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKYLASK 147
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---APEYL 448
K +HRDL A N +LD+ F + DFGLA+ + K + G + A E L
Sbjct: 148 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 449 STGKSSEKTDVFGYGITLLELVT 471
T K + K+DV+ +G+ L EL+T
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMT 227
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-35
Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 24/210 (11%)
Query: 277 NIIGQGGFGKVYKGVLSD-----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 331
++G G FG V+KGV V +K ++D A + I H +++
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 332 QLIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHE 390
+L+G C SS ++ V ++ S L D ++ L A G+ YL E
Sbjct: 79 RLLGLCPGSSLQL-VTQYLPLGS----LLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE 133
Query: 391 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-----IRGTMGHIAP 445
++HR+L A N+LL + + DFG+A L+ + I+ A
Sbjct: 134 H---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM----AL 186
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVT-GQR 474
E + GK + ++DV+ YG+T+ EL+T G
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-35
Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 16/203 (7%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVKRLQD-YYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
IG+G F VYKG+ +VA LQD + F+ E ++ H N+++
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 336 YCTTSSER----ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
++ + +LV M + ++ L+ K + + GL++LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHT- 147
Query: 392 CNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST 450
P IIHRDLK NI + +V + D GLA L A + GT +APE
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEE 204
Query: 451 GKSSEKTDVFGYGITLLELVTGQ 473
E DV+ +G+ +LE+ T +
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSE 226
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-35
Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 18/200 (9%)
Query: 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
IG G FG V+ G + KVA+K +++ E F E ++ H L+QL G
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 337 CTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 395
C + LV FM++ L D L+ T + G+ YL E
Sbjct: 72 CLEQAPICLVTEFMEHGC----LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---C 124
Query: 396 IIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQ--IRGTMGHIAPEYLSTG 451
+IHRDL A N L+ +N + DFG+ + V D + T+ ++ +PE S
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA----SPEVFSFS 180
Query: 452 KSSEKTDVFGYGITLLELVT 471
+ S K+DV+ +G+ + E+ +
Sbjct: 181 RYSSKSDVWSFGVLMWEVFS 200
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-35
Identities = 59/240 (24%), Positives = 107/240 (44%), Gaps = 34/240 (14%)
Query: 247 GEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSD-----NTKVAVK 301
GE + L L+ E + ++G G FG VYKG+ VA+K
Sbjct: 1 GEAPNQALLRILKE---TEFKK-------IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK 50
Query: 302 RLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD 361
L++ SP E ++++ + ++ +L+G C TS+ ++ + M L D
Sbjct: 51 ELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGC----LLD 105
Query: 362 -LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420
++ + + A G+ YL ++ +++HRDL A N+L+ + DFG
Sbjct: 106 YVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFG 162
Query: 421 LAKLVDAKLTHVTTQ-----IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQR 474
LAKL+ A+ + I+ A E + + ++DV+ YG+T+ EL+T G +
Sbjct: 163 LAKLLGAEEKEYHAEGGKVPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 6e-35
Identities = 42/167 (25%), Positives = 67/167 (40%), Gaps = 34/167 (20%)
Query: 36 EGEALIEVLKALNDTHGQFTDWNDHFVSPCF-SWSHVTC----RNGNVISLTLGS----- 85
+ +AL+++ K L + + W C +W V C + V +L L
Sbjct: 7 DKQALLQIKKDLGN-PTTLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 86 ----------------------NGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSM 123
N G I P+I KL L L + ++SG +PDFL +
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 124 THLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
L +L+ + N SG++P + S L NL + N ++G IP S
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 36/119 (30%), Positives = 51/119 (42%), Gaps = 4/119 (3%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANN 134
N N+ + L N G S K + L N L+ L +G +L L+L NN
Sbjct: 196 NLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNN 254
Query: 135 KFSGSIPATWSQLSNLKHLDLSSNNLTGRIPM--QLFSVATFNFTGTHLICGSSLEQPC 191
+ G++P +QL L L++S NNL G IP L + +CGS L C
Sbjct: 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL-PAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 5e-27
Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 1/95 (1%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L + SG I ++++K L +L+ N LSGTLP + S+ +L + N+
Sbjct: 102 QLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161
Query: 137 SGSIPATWSQLSNL-KHLDLSSNNLTGRIPMQLFS 170
SG+IP ++ S L + +S N LTG+IP +
Sbjct: 162 SGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN 196
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 29/91 (31%), Positives = 43/91 (47%), Gaps = 2/91 (2%)
Query: 78 VISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFS 137
S+T+ N +GKI P+ L LA ++L N L G GS + Q ++LA N +
Sbjct: 176 FTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234
Query: 138 GSIPATWSQLSNLKHLDLSSNNLTGRIPMQL 168
+ NL LDL +N + G +P L
Sbjct: 235 FDLG-KVGLSKNLNGLDLRNNRIYGTLPQGL 264
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-25
Identities = 33/91 (36%), Positives = 48/91 (52%), Gaps = 2/91 (2%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHL-QSLNLANNKFSGS 139
L N SG + PSI+ L L + N +SG +PD GS + L S+ ++ N+ +G
Sbjct: 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGK 189
Query: 140 IPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
IP T++ L NL +DLS N L G + S
Sbjct: 190 IPPTFANL-NLAFVDLSRNMLEGDASVLFGS 219
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 8e-35
Identities = 63/203 (31%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 277 NIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+IG+G FG VY G L DN AVK L G + F E ++ H N+L
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 333 LIGYCTTSSERIL-VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
L+G C S L V P+M++ + +R+ A G+++L +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASK 211
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---APEYL 448
K +HRDL A N +LD+ F + DFGLA+ + K G + A E L
Sbjct: 212 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 449 STGKSSEKTDVFGYGITLLELVT 471
T K + K+DV+ +G+ L EL+T
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMT 291
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 277 NIIGQGGFGKVYKGVLSD----NTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLL 331
I+G+G FG V +G L + KVAVK + D S F E + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 332 QLIGYCT-----TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT--AYG 384
+L+G C + +++ PFM+ + L + P + + F A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI- 443
+EYL + +HRDL A N +L D+ + DFGL+K + + + +G + +
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR----QGRIAKMP 212
Query: 444 ----APEYLSTGKSSEKTDVFGYGITLLELVT 471
A E L+ + K+DV+ +G+T+ E+ T
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 18/200 (9%)
Query: 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
+G G FG V G VA+K +++ E F E ++ H+ L+QL G
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 337 CTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 395
CT ++ +M N L + L+ + +EYL + +
Sbjct: 88 CTKQRPIFIITEYMANGC----LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---Q 140
Query: 396 IIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQ--IRGTMGHIAPEYLSTG 451
+HRDL A N L++D + DFGL++ V D + V ++ +R + PE L
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLMYS 196
Query: 452 KSSEKTDVFGYGITLLELVT 471
K S K+D++ +G+ + E+ +
Sbjct: 197 KFSSKSDIWAFGVLMWEIYS 216
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-34
Identities = 51/204 (25%), Positives = 85/204 (41%), Gaps = 28/204 (13%)
Query: 278 IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
+G G FG V G VAVK +++ E F +E + H L++ G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 338 TTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396
+ +V ++ N L + L+ KGL+ + + G+ +L +
Sbjct: 73 SKEYPIYIVTEYISNGC----LLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QF 125
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAKLVD---------AKLTHVTTQIRGTMGHIAPEY 447
IHRDL A N L+D + + DFG+ + V K ++ + APE
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFP-----VKWS----APEV 176
Query: 448 LSTGKSSEKTDVFGYGITLLELVT 471
K S K+DV+ +GI + E+ +
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFS 200
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-34
Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 23/207 (11%)
Query: 279 IGQGGFGKVYKGVL---SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
+G G FG V +GV VA+K L+ RE ++ + +++LIG
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 394
C + + V L L + + + + G++YL E+
Sbjct: 78 VCQAEALML-VMEMAGGGP----LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK--- 129
Query: 395 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG------TMGHIAPEYL 448
+HRDL A N+LL + A + DFGL+K + A ++ T + G APE +
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECI 185
Query: 449 STGKSSEKTDVFGYGITLLELVT-GQR 474
+ K S ++DV+ YG+T+ E ++ GQ+
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 60/195 (30%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
+GQG FG+V+ G + T+VA+K L+ AF +E ++ H+ L+QL
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396
+ I V +M S+ L+ K L P +A A G+ Y+
Sbjct: 248 VSEEPIYI-VTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK 456
+HRDL+AANIL+ +N + DFGLA+L++ + + APE G+ + K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 457 TDVFGYGITLLELVT 471
+DV+ +GI L EL T
Sbjct: 362 SDVWSFGILLTELTT 376
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-34
Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 26/209 (12%)
Query: 277 NIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 331
+G+G FG V + VAVK+LQ + F+RE+ ++ H N++
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIV 74
Query: 332 QLIGYCTTSSER--ILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYL 388
+ G C ++ R L+ ++ S LRD L+ ++ +D + G+EYL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGS----LRDYLQKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGH 442
+ + IHRDL NIL+++ + DFGL K++ + I
Sbjct: 131 GTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY--- 184
Query: 443 IAPEYLSTGKSSEKTDVFGYGITLLELVT 471
APE L+ K S +DV+ +G+ L EL T
Sbjct: 185 -APESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-34
Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 25/213 (11%)
Query: 277 NIIGQGGFGKVYKGVLSDN----TKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLL 331
++G+G FG V + L KVAVK L D + F RE + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 332 QLIGYCTTSSERI------LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT--AY 383
+L+G S + ++ PFM++ + L + GE + P + V F A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
G+EYL + IHRDL A N +L ++ + DFGL++ + + + +G +
Sbjct: 149 GMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR----QGCASKL 201
Query: 444 -----APEYLSTGKSSEKTDVFGYGITLLELVT 471
A E L+ + +DV+ +G+T+ E++T
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-34
Identities = 44/207 (21%), Positives = 89/207 (42%), Gaps = 22/207 (10%)
Query: 278 IIGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 333
I+G+G FG+VY+GV + VAVK + + + F E ++ H ++++L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 334 IGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 392
IG I + L L+ + L T + + YL
Sbjct: 79 IGIIEEEPTWI-IMELYPYGE----LGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI- 132
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ----IRGTMGHIAPEYL 448
+HRD+ NIL+ L DFGL++ ++ + + + I+ +PE +
Sbjct: 133 --NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----SPESI 186
Query: 449 STGKSSEKTDVFGYGITLLELVT-GQR 474
+ + + +DV+ + + + E+++ G++
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 9e-34
Identities = 63/228 (27%), Positives = 96/228 (42%), Gaps = 30/228 (13%)
Query: 263 CRELQLATDN--FSESNI-----IGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPG 310
Q D F + + +G+G FGKV VAVK L+ P
Sbjct: 16 EVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQ 75
Query: 311 GEAAFQREVHLISVAIHKNLLQLIGYCTTSSER--ILVYPFMQNLSVAYRLRDLKPGEKG 368
+ +++E+ ++ H+++++ G C + LV ++ S LRD P
Sbjct: 76 HRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGS----LRDYLPRHS- 130
Query: 369 LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428
+ A G+ YLH Q IHRDL A N+LLD++ + DFGLAK V
Sbjct: 131 IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187
Query: 429 LTHVTTQIRGT-----MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
+ + G APE L K +DV+ +G+TL EL+T
Sbjct: 188 HEYYRVREDGDSPVFWY---APECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 9e-34
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 277 NIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
IIG G G+V G L + VA+K L+ Y+ F E ++ H N+++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
L G T ++V +M+N S L L+ + + G G+ YL +
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGS----LDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGHIAP 445
+HRDL A N+L+D N + DFGL+++++ T IR T AP
Sbjct: 171 ---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----AP 223
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVT-GQR 474
E ++ S +DV+ +G+ + E++ G+R
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-33
Identities = 60/195 (30%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
+GQG FG+V+ G + T+VA+K L+ AF +E ++ H+ L+QL
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396
+ I V +M S+ L+ K L P +A A G+ Y+
Sbjct: 331 VSEEPIYI-VTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERM---NY 384
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK 456
+HRDL+AANIL+ +N + DFGLA+L++ + + APE G+ + K
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 457 TDVFGYGITLLELVT 471
+DV+ +GI L EL T
Sbjct: 445 SDVWSFGILLTELTT 459
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 277 NIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 331
+ +G+G FG V + VAVK+LQ P + FQRE+ ++ ++
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIV 87
Query: 332 QLIGYCTTSSER--ILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYL 388
+ G + LV ++ + LRD L+ LD + G+EYL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGC----LRDFLQRHRARLDASRLLLYSSQICKGMEYL 143
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI----- 443
+ + +HRDL A NIL++ + DFGLAKL+ + + G
Sbjct: 144 GSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR---EPGQSPIFWY 197
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVT 471
APE LS S ++DV+ +G+ L EL T
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 26/209 (12%)
Query: 277 NIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 331
+G+G FG V + VAVK+LQ + F+RE+ ++ H N++
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIV 105
Query: 332 QLIGYCTTSSER--ILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYL 388
+ G C ++ R L+ ++ S LRD L+ ++ +D + G+EYL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGS----LRDYLQKHKERIDHIKLLQYTSQICKGMEYL 161
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGH 442
+ + IHRDL NIL+++ + DFGL K++ + + I
Sbjct: 162 GTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY--- 215
Query: 443 IAPEYLSTGKSSEKTDVFGYGITLLELVT 471
APE L+ K S +DV+ +G+ L EL T
Sbjct: 216 -APESLTESKFSVASDVWSFGVVLYELFT 243
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 31/216 (14%)
Query: 277 NIIGQGGFGKVYKGVLSDN---TKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKNLLQ 332
++IG+G FG+V K + + A+KR+++Y S F E+ ++ + H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------------RVAFG 380
L+G C L + + ++ LR + E + A
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 381 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 440
A G++YL ++ + IHRDL A NIL+ +N+ A + DFGL++ + ++ TM
Sbjct: 151 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTM 200
Query: 441 GHI-----APEYLSTGKSSEKTDVFGYGITLLELVT 471
G + A E L+ + +DV+ YG+ L E+V+
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-33
Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 25/209 (11%)
Query: 278 IIGQGGFGKVYKGVL---SDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQL 333
+G G FG V KG VAVK L + P + E +++ + ++++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 334 IGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 392
IG C S + V + L L+ + + + G++YL E
Sbjct: 84 IGICEAESWML-VMEMAELGP----LNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEES- 136
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGHIAPE 446
+HRDL A N+LL A + DFGL+K + A + Q ++ APE
Sbjct: 137 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY----APE 190
Query: 447 YLSTGKSSEKTDVFGYGITLLELVT-GQR 474
++ K S K+DV+ +G+ + E + GQ+
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-33
Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 277 NIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
+GQG FG VY+GV T+VA+K + + S F E ++ ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKR---VAFGTAYG 384
++L+G + +++ M + LR L+P L P+ + +A A G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI- 443
+ YL+ K +HRDL A N ++ ++F + DFG+ + + + +G G +
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR----KGGKGLLP 203
Query: 444 ----APEYLSTGKSSEKTDVFGYGITLLELVT 471
+PE L G + +DV+ +G+ L E+ T
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-33
Identities = 49/207 (23%), Positives = 95/207 (45%), Gaps = 22/207 (10%)
Query: 278 IIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 333
IG+G FG V++G+ VA+K ++ S F +E + H ++++L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 334 IGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 392
IG T + I + LR L+ + LD + A+ + L YL +
Sbjct: 82 IGVITENPVWI-IMELCTLGE----LRSFLQVRKYSLDLASLILYAYQLSTALAYLESK- 135
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ----IRGTMGHIAPEYL 448
+ +HRD+ A N+L+ N L DFGL++ ++ + ++ I+ APE +
Sbjct: 136 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESI 189
Query: 449 STGKSSEKTDVFGYGITLLELVT-GQR 474
+ + + +DV+ +G+ + E++ G +
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 9e-33
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 278 IIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+IG G FG+VYKG+L VA+K L+ Y+ F E ++ H N+++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
L G + +++ +M+N + L L+ + + G A G++YL
Sbjct: 111 LEGVISKYKPMMIITEYMENGA----LDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQ-----IRGTMGHIAP 445
+HRDL A NIL++ N + DFGL++++ D TT IR T AP
Sbjct: 167 ---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----AP 219
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVT-GQR 474
E +S K + +DV+ +GI + E++T G+R
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 61/198 (30%), Positives = 93/198 (46%), Gaps = 18/198 (9%)
Query: 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
IG+G FG V G KVAVK +++ + AF E +++ H NL+QL+G
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 337 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 395
+ +V +M S+ LR G L + + +EYL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGN---N 309
Query: 396 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--IRGTMGHIAPEYLSTGKS 453
+HRDL A N+L+ ++ A + DFGL K +A T T + ++ T APE L K
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPVKWT----APEALREKKF 363
Query: 454 SEKTDVFGYGITLLELVT 471
S K+DV+ +GI L E+ +
Sbjct: 364 STKSDVWSFGILLWEIYS 381
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-32
Identities = 61/198 (30%), Positives = 93/198 (46%), Gaps = 18/198 (9%)
Query: 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
IG+G FG V G KVAVK +++ + AF E +++ H NL+QL+G
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA---QAFLAEASVMTQLRHSNLVQLLGV 82
Query: 337 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 395
+ +V +M S+ LR G L + + +EYL
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN---N 137
Query: 396 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--IRGTMGHIAPEYLSTGKS 453
+HRDL A N+L+ ++ A + DFGL K +A T T + ++ T APE L K
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPVKWT----APEALREKKF 191
Query: 454 SEKTDVFGYGITLLELVT 471
S K+DV+ +GI L E+ +
Sbjct: 192 STKSDVWSFGILLWEIYS 209
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-32
Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 8/196 (4%)
Query: 277 NIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
+ +G G +G+VY+GV + VAVK L++ F +E ++ H NL+QL+G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 395
CT ++ FM ++ LR + + + +A + +EYL ++
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEKK---N 338
Query: 396 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSE 455
IHR+L A N L+ +N + DFGL++L+ + + APE L+ K S
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 456 KTDVFGYGITLLELVT 471
K+DV+ +G+ L E+ T
Sbjct: 399 KSDVWAFGVLLWEIAT 414
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-32
Identities = 63/211 (29%), Positives = 87/211 (41%), Gaps = 26/211 (12%)
Query: 278 IIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLL 331
+G G FG V +G VAVK L+ P F REV+ + H+NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 332 QLIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHE 390
+L G T ++ V S L D L+ + T R A A G+ YL
Sbjct: 85 RLYGVVLTPPMKM-VTELAPLGS----LLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 391 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGHIA 444
+ + IHRDL A N+LL + DFGL + + H Q A
Sbjct: 140 K---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC----A 192
Query: 445 PEYLSTGKSSEKTDVFGYGITLLELVT-GQR 474
PE L T S +D + +G+TL E+ T GQ
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 66/204 (32%), Positives = 101/204 (49%), Gaps = 26/204 (12%)
Query: 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
+G G FG+V+ G + +TKVAVK L+ AF E +L+ H+ L++L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396
T I + +M+N S+ L+ P L +A A G+ ++ E+
Sbjct: 77 VTQEPIYI-ITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 130
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAKLVD---------AKLTHVTTQIRGTMGHIAPEY 447
IHRDL+AANIL+ D + DFGLA+L++ AK I+ T APE
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-----IKWT----APEA 181
Query: 448 LSTGKSSEKTDVFGYGITLLELVT 471
++ G + K+DV+ +GI L E+VT
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVT 205
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 16/200 (8%)
Query: 277 NIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
+ +G G +G+VY+GV + VAVK L++ F +E ++ H NL+QL+G
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 395
CT ++ FM ++ LR+ E + +A + +EYL ++
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEKK---N 131
Query: 396 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ----IRGTMGHIAPEYLSTG 451
IHRDL A N L+ +N + DFGL++L+ I+ T APE L+
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 187
Query: 452 KSSEKTDVFGYGITLLELVT 471
K S K+DV+ +G+ L E+ T
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-32
Identities = 43/150 (28%), Positives = 66/150 (44%), Gaps = 9/150 (6%)
Query: 26 FGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGS 85
S+ E LI L D DW+ + +PC ++ VTCR+ V S+ L S
Sbjct: 3 QASPSQSLYREIHQLISFKDVLPD-KNLLPDWSSN-KNPC-TFDGVTCRDDKVTSIDLSS 59
Query: 86 NGFS---GKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA 142
+ +S S+ L L SL L ++ ++G++ F L SL+L+ N SG +
Sbjct: 60 KPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGF-KCSASLTSLDLSRNSLSGPVTT 118
Query: 143 TWS--QLSNLKHLDLSSNNLTGRIPMQLFS 170
S S LK L++SSN L +
Sbjct: 119 LTSLGSCSGLKFLNVSSNTLDFPGKVSGGL 148
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-28
Identities = 32/98 (32%), Positives = 52/98 (53%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
+ +L L N +G+I ++ L + L +N L+G +P ++G + +L L L+
Sbjct: 463 MYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLS 522
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
NN FSG+IPA +L LDL++N G IP +F
Sbjct: 523 NNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-27
Identities = 46/134 (34%), Positives = 68/134 (50%), Gaps = 7/134 (5%)
Query: 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
G+++ L + N SG I I + +L L L ND+SG++PD +G + L L+L++NK
Sbjct: 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIP-MQLFSVATFN---FTGTHLICGSSLEQPC 191
G IP S L+ L +DLS+NNL+G IP M F TF F +CG L C
Sbjct: 692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFE--TFPPAKFLNNPGLCGYPL-PRC 748
Query: 192 MSRPSPPVSTSRTK 205
+ + +
Sbjct: 749 DPSNADGYAHHQRS 762
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-27
Identities = 39/93 (41%), Positives = 52/93 (55%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L L +NGF+GKI P+++ L SL L N LSGT+P LGS++ L+ L L N
Sbjct: 395 TLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNML 454
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 169
G IP + L+ L L N+LTG IP L
Sbjct: 455 EGEIPQELMYVKTLETLILDFNDLTGEIPSGLS 487
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-27
Identities = 35/93 (37%), Positives = 48/93 (51%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
++SL L N SG I S+ L L L+L N L G +P L + L++L L
Sbjct: 415 SNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILD 474
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP 165
N +G IP+ S +NL + LS+N LTG IP
Sbjct: 475 FNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP 507
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-26
Identities = 34/98 (34%), Positives = 53/98 (54%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
+ L L N G+I + +K L +L L NDL+G +P L + T+L ++L+
Sbjct: 439 GSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLS 498
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
NN+ +G IP +L NL L LS+N+ +G IP +L
Sbjct: 499 NNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGD 536
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-26
Identities = 37/97 (38%), Positives = 55/97 (56%), Gaps = 2/97 (2%)
Query: 76 GNVISLTLGSNGFSGKISPSI--TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLAN 133
++++L L SN FSG I P++ L L LQ+N +G +P L + + L SL+L+
Sbjct: 368 ASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSF 427
Query: 134 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
N SG+IP++ LS L+ L L N L G IP +L
Sbjct: 428 NYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMY 464
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-25
Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 2/93 (2%)
Query: 80 SLTLGSNGFSGKISPSIT-KLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 138
L+L N F+G+I ++ L L+L N G +P F GS + L+SL L++N FSG
Sbjct: 273 YLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSG 332
Query: 139 SIPATW-SQLSNLKHLDLSSNNLTGRIPMQLFS 170
+P ++ LK LDLS N +G +P L +
Sbjct: 333 ELPMDTLLKMRGLKVLDLSFNEFSGELPESLTN 365
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-24
Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 3/94 (3%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L + N SG + +++ L L++ N+ S +P FLG + LQ L+++ NK
Sbjct: 179 ELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKL 235
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
SG S + LK L++SSN G IP
Sbjct: 236 SGDFSRAISTCTELKLLNISSNQFVGPIPPLPLK 269
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-24
Identities = 39/96 (40%), Positives = 51/96 (53%), Gaps = 2/96 (2%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLP-DFLGSMTHLQSLNLANNK 135
+ L L N F G + P L SL L N+ SG LP D L M L+ L+L+ N+
Sbjct: 295 TLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNE 354
Query: 136 FSGSIPATWSQLS-NLKHLDLSSNNLTGRIPMQLFS 170
FSG +P + + LS +L LDLSSNN +G I L
Sbjct: 355 FSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQ 390
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-23
Identities = 18/96 (18%), Positives = 33/96 (34%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
F G S + +L + G + + L+++
Sbjct: 581 DGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMS 640
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL 168
N SG IP + L L+L N+++G IP ++
Sbjct: 641 YNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEV 676
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-22
Identities = 37/99 (37%), Positives = 50/99 (50%), Gaps = 6/99 (6%)
Query: 76 GNVISLT---LGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFL-GSMTHLQSLNL 131
L + SN F G I P LK L L L +N +G +PDFL G+ L L+L
Sbjct: 244 STCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDL 301
Query: 132 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ N F G++P + S L+ L LSSNN +G +PM
Sbjct: 302 SGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLL 340
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-21
Identities = 29/98 (29%), Positives = 52/98 (53%), Gaps = 4/98 (4%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
N+ ++L +N +G+I I +L+ LA L+L +N SG +P LG L L+L
Sbjct: 487 SNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLN 546
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
N F+G+IPA + S +++N + G+ + + +
Sbjct: 547 TNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKN 580
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 8e-16
Identities = 26/100 (26%), Positives = 37/100 (37%), Gaps = 6/100 (6%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
R N+ L L +N FSG I + + L L+L N +GT+P + QS +A
Sbjct: 511 GRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK----QSGKIA 566
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSN--NLTGRIPMQLFS 170
N +G K + N G QL
Sbjct: 567 ANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNR 606
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 23/210 (10%)
Query: 277 NIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
++G G FG+V G L VA+K L+ Y+ F E ++ H N+++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
L G T S ++V +M+N S L L+ + + G A G++YL +
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGS----LDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGHIAP 445
+HRDL A NIL++ N + DFGL ++++ T IR T +P
Sbjct: 167 ---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT----SP 219
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVT-GQR 474
E ++ K + +DV+ YGI L E+++ G+R
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-32
Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
+G G FG+V+ + +TKVAVK ++ AF E +++ H L++L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS--VEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396
T I + FM S+ L+ P + A G+ ++ ++
Sbjct: 252 VTKEPIYI-ITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NY 305
Query: 397 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---APEYLSTGKS 453
IHRDL+AANIL+ + + DFGLA++++ + T G I APE ++ G
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGSF 362
Query: 454 SEKTDVFGYGITLLELVT 471
+ K+DV+ +GI L+E+VT
Sbjct: 363 TIKSDVWSFGILLMEIVT 380
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 7e-32
Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 279 IGQGGFGKVYKGVL---SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
+G G FG V +GV VA+K L+ RE ++ + +++LIG
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 394
C + + V L L + + + + G++YL E+
Sbjct: 404 VCQAEALML-VMEMAGGGP----LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK--- 455
Query: 395 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGHIAPEYL 448
+HR+L A N+LL + A + DFGL+K + A ++ T + ++ APE +
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECI 511
Query: 449 STGKSSEKTDVFGYGITLLELVT-GQR 474
+ K S ++DV+ YG+T+ E ++ GQ+
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-32
Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 277 NIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
+G G FG+VY+G +S +VAVK L + S E F E +IS H+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR---VAFGTAYGLEY 387
++ IG S R ++ M + LR+ +P VA A G +Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLC---DFGLAKLVDAKLTHVTTQIR-GTMGHI 443
L E IHRD+ A N LL + DFG+A+ + + + R G +
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-----YRASYYRKGGCAML 207
Query: 444 -----APEYLSTGKSSEKTDVFGYGITLLELVT 471
PE G + KTD + +G+ L E+ +
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 9e-32
Identities = 52/221 (23%), Positives = 93/221 (42%), Gaps = 33/221 (14%)
Query: 277 NIIGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIH 327
+G+G FG+V VAVK L+D + + E+ ++ + H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 328 KNLLQLIGYCTTSSERILVYPFMQN------------LSVAYRLRDLKPGEKGLDWPTRK 375
KN++ L+G CT ++ + + Y + E+ + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 376 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 435
+ A G+EYL Q K IHRDL A N+L+ +N + DFGLA+ ++ + T
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 436 -----IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
++ APE L + ++DV+ +G+ + E+ T
Sbjct: 218 NGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 52/226 (23%), Positives = 93/226 (41%), Gaps = 43/226 (19%)
Query: 277 NIIGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIH 327
+G+G FG+V VAVK L+D + + E+ ++ + H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 328 KNLLQLIGYCTTSSERILVYPFMQN------------LSVAYRLRDLKPGEKGLDWPTRK 375
KN++ L+G CT ++ + + Y + E+ + +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 376 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---------- 425
+ A G+EYL Q K IHRDL A N+L+ +N + DFGLA+ +
Sbjct: 207 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
+ +L ++ APE L + ++DV+ +G+ + E+ T
Sbjct: 264 NGRLP-----VKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 59/213 (27%), Positives = 89/213 (41%), Gaps = 26/213 (12%)
Query: 277 NIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
+G G FG+VY+G +S +VAVK L + S E F E +IS H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR---VAFGTAYGLEY 387
++ IG S R ++ M + LR+ +P VA A G +Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLC---DFGLAKLVDAKLTHVTTQIR-GTMGHI 443
L E IHRD+ A N LL + DFG+A+ + + R G +
Sbjct: 197 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-----YRAGYYRKGGCAML 248
Query: 444 -----APEYLSTGKSSEKTDVFGYGITLLELVT 471
PE G + KTD + +G+ L E+ +
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 3e-31
Identities = 53/220 (24%), Positives = 95/220 (43%), Gaps = 32/220 (14%)
Query: 277 NIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKN 329
+G+G FG+V + + VAVK L++ + A E+ ++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 330 LLQLIGYCTTSSERI-LVYPFMQN------------LSVAYRLRDLKPGEKGLDWPTRKR 376
++ L+G CT + ++ F + V Y++ + L
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 377 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ- 435
+F A G+E+L + K IHRDL A NILL + +CDFGLA+ + +V
Sbjct: 153 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 436 ----IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
++ APE + + ++DV+ +G+ L E+ +
Sbjct: 210 ARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-31
Identities = 53/218 (24%), Positives = 86/218 (39%), Gaps = 30/218 (13%)
Query: 277 NIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
+G+ FGKVYKG L VA+K L+D F+ E L + H N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------------RVA 378
+ L+G T +++ + + + L P + +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 379 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--- 435
A G+EYL ++H+DL N+L+ D + D GL + V A +
Sbjct: 135 AQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 436 --IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
IR APE + GK S +D++ YG+ L E+ +
Sbjct: 192 LPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 4e-31
Identities = 52/222 (23%), Positives = 91/222 (40%), Gaps = 39/222 (17%)
Query: 277 NIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKN 329
+G G FGKV + KVAVK L+ + A E+ ++S + H+N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK----------RVAF 379
++ L+G CT +++ + + LR + +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 380 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV----------DAKL 429
A G+ +L + IHRD+ A N+LL + A + DFGLA+ + +A+L
Sbjct: 172 QVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
++ APE + + ++DV+ YGI L E+ +
Sbjct: 229 P-----VKWM----APESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-31
Identities = 49/217 (22%), Positives = 99/217 (45%), Gaps = 21/217 (9%)
Query: 264 RELQLATDNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQREV 319
R+ ++ + IG+G FG V++G+ + VA+K ++ S F +E
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 442
Query: 320 HLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVA 378
+ H ++++LIG T + I + LR L+ + LD + A
Sbjct: 443 LTMRQFDHPHIVKLIGVITENPVWI-IMELCTLGE----LRSFLQVRKFSLDLASLILYA 497
Query: 379 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--- 435
+ + L YL + + +HRD+ A N+L+ N L DFGL++ ++ + ++
Sbjct: 498 YQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 554
Query: 436 -IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
I+ APE ++ + + +DV+ +G+ + E++
Sbjct: 555 PIKWM----APESINFRRFTSASDVWMFGVCMWEILM 587
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 38/226 (16%)
Query: 277 NIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
+G+G FGKV K T VAVK L++ SP E +++ H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT--------- 381
++L G C+ +L+ + + S+ LR+ + G R +
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 382 -----------AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430
+ G++YL E K++HRDL A NIL+ + + + DFGL++ V + +
Sbjct: 149 MGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 431 HVTTQIRGTMGHI-----APEYLSTGKSSEKTDVFGYGITLLELVT 471
+V + + G I A E L + ++DV+ +G+ L E+VT
Sbjct: 206 YV----KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 33/219 (15%)
Query: 279 IGQGGFGKVYKGVL--------SDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKN 329
+G+G FG+V + TKVAVK L+ + + E+ ++ + HKN
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR----------VAF 379
++ L+G CT ++ + ++ L+ +P + V+
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 380 GT--AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-- 435
A G+EYL + K IHRDL A N+L+ ++ + DFGLA+ + + T
Sbjct: 197 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 436 ---IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
++ APE L + ++DV+ +G+ L E+ T
Sbjct: 254 RLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-30
Identities = 54/221 (24%), Positives = 88/221 (39%), Gaps = 33/221 (14%)
Query: 277 NIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKN 329
+G G FGKV + VAVK L+ A E+ ++S + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 330 LLQLIGYCTTSSERILVYPFMQN--------------LSVAYRLRDLKPGEKGLDWPTRK 375
++ L+G CT +++ + + ++ E LD
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 376 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 435
++ A G+ +L + IHRDL A NILL +CDFGLA+ + +V
Sbjct: 149 SFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 436 -----IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
++ APE + + ++DV+ YGI L EL +
Sbjct: 206 NARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 57/226 (25%), Positives = 99/226 (43%), Gaps = 38/226 (16%)
Query: 277 NIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKN 329
++G G FGKV + +VAVK L++ A E+ +++ + H+N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 330 LLQLIGYCTTSSERILVYPFMQN----------------LSVAYRLRDLKPGEKGLDWPT 373
++ L+G CT S L++ + + Y + E+ L+ T
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 374 RKR---VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430
+ A+ A G+E+L + +HRDL A N+L+ +CDFGLA+ + +
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 431 HVTTQ-----IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
+V ++ APE L G + K+DV+ YGI L E+ +
Sbjct: 228 YVVRGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-29
Identities = 62/247 (25%), Positives = 98/247 (39%), Gaps = 24/247 (9%)
Query: 261 FSCRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREV 319
F + + ++ +G+GGF V L D A+KR+ + QRE
Sbjct: 19 FQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI-LCHEQQDREEAQREA 77
Query: 320 HLISVAIHKNLLQLIGYCTTSSER----ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK 375
+ + H N+L+L+ YC L+ PF + ++ + LK L
Sbjct: 78 DMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL 137
Query: 376 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--------DA 427
+ G GLE +H HRDLK NILL D + VL D G A
Sbjct: 138 WLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQA 194
Query: 428 KLTHVTTQIRGTMGHIAPEYLSTGKS----SEKTDVFGYGITLLELVTGQRAIDFSRLEE 483
R T+ + APE L + +S E+TDV+ G L ++ G+ + + +
Sbjct: 195 LTLQDWAAQRCTISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP--YDMVFQ 251
Query: 484 EEDVLLL 490
+ D + L
Sbjct: 252 KGDSVAL 258
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 31/212 (14%)
Query: 278 IIGQGGFGKVYKGVL--------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
+GQG F K++KGV T+V +K L +F ++S HK+
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSHKH 73
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYL 388
L+ G C E ILV F++ S L LK + ++ + VA A + +L
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGS----LDTYLKKNKNCINILWKLEVAKQLAAAMHFL 129
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAV--------LCDFGLAKLVDAKLTHVTTQIRGTM 440
E +IH ++ A NILL + L D G++ V K + +I
Sbjct: 130 EEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-DILQERIPWV- 184
Query: 441 GHIAPEYLSTGKS-SEKTDVFGYGITLLELVT 471
PE + K+ + TD + +G TL E+ +
Sbjct: 185 ---PPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 31/216 (14%)
Query: 279 IGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+G+G FGKV+ D VAVK L+D + FQRE L++ H+++++
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVK 81
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR------------VAFG 380
G C I+V+ +M++ + LR P L ++ +A
Sbjct: 82 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 381 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQ---- 435
A G+ YL Q +HRDL N L+ N + DFG+++ V V
Sbjct: 142 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198
Query: 436 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
IR PE + K + ++DV+ +G+ L E+ T
Sbjct: 199 IRWM----PPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 57/226 (25%), Positives = 98/226 (43%), Gaps = 38/226 (16%)
Query: 277 NIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
IG+G FG+V++ T VAVK L++ S +A FQRE L++ + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 331 LQLIGYCTTSSERILVYPFMQN--------------------LSVAYRLRDLKPGEKGLD 370
++L+G C L++ +M ++ R R PG L
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 371 WPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430
+ +A A G+ YL E+ K +HRDL N L+ +N + DFGL++ + +
Sbjct: 173 CAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 431 HVTTQIRGTMGHI-----APEYLSTGKSSEKTDVFGYGITLLELVT 471
+ I PE + + + ++DV+ YG+ L E+ +
Sbjct: 230 YK----ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 277 NIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
+G+G FGKV+ D VAVK L++ S FQRE L+++ H+++
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHI 105
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR-----------VAF 379
++ G CT ++V+ +M++ + LR P K L VA
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 380 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQ--- 435
A G+ YL +HRDL N L+ + DFG+++ + V +
Sbjct: 166 QVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 436 -IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
IR PE + K + ++DV+ +G+ L E+ T
Sbjct: 223 PIRWM----PPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 51/215 (23%), Positives = 89/215 (41%), Gaps = 30/215 (13%)
Query: 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNL--LQL 333
IG GG KV++ + A+K + + +++ E+ ++ + ++L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 334 IGYCTTSSERILVYPFM--QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
Y T +Y M N+ + L+ +K +D RK + +H+
Sbjct: 94 YDYEITDQY---IYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTMGHIAPEYL- 448
I+H DLK AN L+ D L DFG+A + T V +Q+ GT+ ++ PE +
Sbjct: 147 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIK 201
Query: 449 ----------STGKSSEKTDVFGYGITLLELVTGQ 473
S K S K+DV+ G L + G+
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 51/215 (23%), Positives = 90/215 (41%), Gaps = 30/215 (13%)
Query: 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNL--LQL 333
IG GG KV++ + A+K + + +++ E+ ++ + ++L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 334 IGYCTTSSERILVYPFMQ--NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
Y T +Y M+ N+ + L+ +K +D RK + +H+
Sbjct: 75 YDYEITDQY---IYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTMGHIAPEYL- 448
I+H DLK AN L+ D L DFG+A + T V +Q+ GT+ ++ PE +
Sbjct: 128 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIK 182
Query: 449 ----------STGKSSEKTDVFGYGITLLELVTGQ 473
S K S K+DV+ G L + G+
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 51/231 (22%), Positives = 101/231 (43%), Gaps = 11/231 (4%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQREVHLISVAIH 327
NF IG+G F +VY+ L D VA+K ++ D A +E+ L+ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
N+++ +E +V ++ ++ K ++ + T + LE+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 447
+H + +++HRD+K AN+ + L D GL + +K T + + GT +++PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 448 LSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHKVTEGR 498
+ + K+D++ G L E+ Q F ++ ++ L K+ +
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSP--FY--GDKMNLYSLCKKIEQCD 254
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 50/235 (21%), Positives = 89/235 (37%), Gaps = 23/235 (9%)
Query: 248 EDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK--RLQ 304
ED+ V LT+ + E + + +G+G FG+V++ + AVK RL+
Sbjct: 35 EDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE 94
Query: 305 DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP 364
E+ + ++ L G + ++ S+ ++ +
Sbjct: 95 V--------FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC 146
Query: 365 GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAK 423
L GLEYLH + +I+H D+KA N+LL + LCDFG A
Sbjct: 147 ----LPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHAL 199
Query: 424 LVDAKLTHVTTQIRGTM-G---HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 474
+ + + G H+APE + K D++ +L ++ G
Sbjct: 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 49/215 (22%), Positives = 88/215 (40%), Gaps = 30/215 (13%)
Query: 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNL--LQL 333
IG GG KV++ + A+K + + +++ E+ ++ + ++L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 334 IGYCTTSSERILVYPFMQ--NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
Y T +Y M+ N+ + L+ +K +D RK + +H+
Sbjct: 122 YDYEITDQY---IYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTMGHIAPEYLS 449
I+H DLK AN L+ D L DFG+A + T V +Q+ G + ++ PE +
Sbjct: 175 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GAVNYMPPEAIK 229
Query: 450 -----------TGKSSEKTDVFGYGITLLELVTGQ 473
K S K+DV+ G L + G+
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 50/225 (22%), Positives = 89/225 (39%), Gaps = 28/225 (12%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
+F +G+GGFG V++ D+ A+KR++ REV ++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 330 LLQLIGY---------CTTSSERILVYPFMQ---NLSVAYRLRDLKPGEKGLDWPTRKRV 377
+++ SS ++ +Y MQ ++ + E+ + +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE-RERSVCLHI 123
Query: 378 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 437
A +E+LH + ++HRDLK +NI + + DFGL +D T
Sbjct: 124 FLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 438 -----------GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471
GT +++PE + S K D+F G+ L EL+
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 20/210 (9%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 328
+ F++ IG+G FG+V+KG+ VA+K + + Q+E+ ++S
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDL-KPGEKGLDWPTRKRVAFGTAYGLEY 387
+ + G ++ ++ ++ S DL +PG LD + GL+Y
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPG--PLDETQIATILREILKGLDY 134
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM-GH---I 443
LH + K IHRD+KAAN+LL ++ E L DFG V +LT T R T G +
Sbjct: 135 LHSE---KKIHRDIKAANVLLSEHGEVKLADFG----VAGQLTD-TQIKRNTFVGTPFWM 186
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
APE + K D++ GIT +EL G+
Sbjct: 187 APEVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-27
Identities = 52/219 (23%), Positives = 90/219 (41%), Gaps = 25/219 (11%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
+F E +IG GGFG+V+K D +KR+ +REV ++ H N
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-----KYNNEKAEREVKALAKLDHVN 65
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRL---------RDL-----KPGEKGLDWPTRK 375
++ G + S L L K + LD
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 376 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 435
+ G++Y+H + K+I+RDLK +NI L D + + DFGL + +
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS- 181
Query: 436 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 474
+GT+ +++PE +S+ ++ D++ G+ L EL+
Sbjct: 182 -KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 55/222 (24%), Positives = 78/222 (35%), Gaps = 45/222 (20%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVH-LISVAIH 327
+F + +G G +G+V+K D AVKR + P A EV V H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 328 KNLLQLIG-------------YCTTSSERILVYPFMQNLS---VAYRLRDLKPGEKGLDW 371
++L C S ++ + +L V LRD
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCGPSLQQHC-EAWGASLPEAQVWGYLRDT--------- 166
Query: 372 PTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 431
L +LH Q ++H D+K ANI L L DFGL +
Sbjct: 167 ----------LLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGA 212
Query: 432 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
Q G ++APE L G DVF G+T+LE+
Sbjct: 213 GEVQE-GDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNM 252
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 46/236 (19%), Positives = 84/236 (35%), Gaps = 37/236 (15%)
Query: 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNT------KVAVK-----RLQDYYSPGGE 312
E QL + +++G+G F +VY+ D K +K ++Y
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFY----- 112
Query: 313 AAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-PGEKGLDW 371
+ + + ++ ++ + +LV ++ + K EK +
Sbjct: 113 -IGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQ 171
Query: 372 PTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA-----------VLCDFG 420
A Y +E +H+ +IIH D+K N +L + F L D G
Sbjct: 172 GLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLG 228
Query: 421 LAKLVDAKL---THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
+ +D KL + T T G E LS + + D FG T+ ++ G
Sbjct: 229 QS--IDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 50/211 (23%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHK 328
+ + IG+G FGK D + +K + S +REV +++ H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG----EKGLDWPTRKRVAFGTAYG 384
N++Q + +V + + + R+ K ++ LDW
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW------FVQICLA 137
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 444
L+++H++ KI+HRD+K+ NI L + L DFG+A+++++ + I GT +++
Sbjct: 138 LKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLS 193
Query: 445 PEYLSTGKSSEKTDVFGYGITLLELVTGQRA 475
PE + K+D++ G L EL T + A
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 60/220 (27%), Positives = 86/220 (39%), Gaps = 27/220 (12%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
D++ +IG G V KVA+KR+ +E+ +S H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVA----YRLRDLKPGEKGLDWPTRKRVAFGTAYGL 385
++ E LV + SV + + + LD T + GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 386 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR-------- 437
EYLH+ IHRD+KA NILL ++ + DFG V A L R
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG----VSAFLATGGDITRNKVRKTFV 187
Query: 438 GT---MGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 473
GT M APE + + K D++ +GIT +EL TG
Sbjct: 188 GTPCWM---APEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 17/229 (7%), Positives = 54/229 (23%), Gaps = 40/229 (17%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQREVHLISVAIHKNLLQLI 334
+ G V+ + A+K + S + + ++ +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 335 GYC--------------------------TTSSERILVYPFMQ--NLSVAYRLRDLKPGE 366
+ +L+ P + L +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 367 KGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426
+ L + ++H N+ + + +L D V
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 427 AKLTHVTTQIRGTMGHIAPEYLSTGKS--SEKTDVFGYGITLLELVTGQ 473
+ + + + E+L+ + + + + G+++ +
Sbjct: 246 TRGPASS----VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 30/233 (12%), Positives = 52/233 (22%), Gaps = 40/233 (17%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAA------------FQREVHLISV 324
++GQ + V P A + +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 325 AIHKNLLQLIGYCTTSS-----------------ERILVYPFMQ--NLSVAYRLRDLKPG 365
+H + R +YP MQ + L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 366 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425
K L R ++ L LH ++H L+ +I+LD L F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 426 DAKLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQ 473
A + A L + D + G+ + +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 55/234 (23%), Positives = 97/234 (41%), Gaps = 13/234 (5%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHK 328
+++ IG G +G+ K SD + K L + + EV+L+ H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 329 NLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386
N+++ + L V + + +A + + LD RV L+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 387 YLHEQCNP--KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 444
H + + ++HRDLK AN+ LD L DFGLA++++ + T + GT +++
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMS 184
Query: 445 PEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHKVTEGR 498
PE ++ +EK+D++ G L EL F L K+ EG+
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPP--F----TAFSQKELAGKIREGK 232
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 32/229 (13%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 328
+F E ++GQG FG+V K D+ A+K+++ ++ + EV L++ H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR--HTEEKLSTILSEVMLLASLNHQ 62
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAY---------RLRDL-KPGEKGLDWPTRKRVA 378
+++ + ++ S + L DL R+
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 379 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV------ 432
L Y+H Q IIHRDLK NI +D++ + DFGLAK V L +
Sbjct: 123 RQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 433 --------TTQIRGTMGHIAPEYLS-TGKSSEKTDVFGYGITLLELVTG 472
T+ I GT ++A E L TG +EK D++ GI E++
Sbjct: 180 LPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 55/213 (25%), Positives = 88/213 (41%), Gaps = 24/213 (11%)
Query: 272 NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNL 330
+F +++G G G + + DN VAVKR+ P + REV L H N+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI----LPECFSFADREVQLLRESDEHPNV 80
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDL-KPGEKGLDWPTRKRVAFGTAYGLEYLH 389
++ +CT + Y ++ A L++ + + + T GL +LH
Sbjct: 81 IRY--FCTEKDRQ-FQYIAIEL--CAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH 135
Query: 390 EQCNPKIIHRDLKAANILLDDNFE-----AVLCDFGLAKLVDA--KLTHVTTQIRGTMGH 442
I+HRDLK NIL+ A++ DFGL K + + + GT G
Sbjct: 136 SL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 443 IAPEYLS---TGKSSEKTDVFGYGITLLELVTG 472
IAPE LS + D+F G +++
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-25
Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 28/217 (12%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 328
+ + +G G FGKVYK A K + + S + E+ +++ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI-ETKSEEELEDYIVEIEILATCDHP 76
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDL-KPGEKGLDWPTRKRVAFGTAYGLEY 387
+++L+G + ++ F +V + ++GL P + V L +
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVD----AIMLELDRGLTEPQIQVVCRQMLEALNF 132
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---- 443
LH + +IIHRDLKA N+L+ + L DFG V AK T Q R + I
Sbjct: 133 LHSK---RIIHRDLKAGNVLMTLEGDIRLADFG----VSAKNLK-TLQKRDSF--IGTPY 182
Query: 444 --APEYLSTGKSSE-----KTDVFGYGITLLELVTGQ 473
APE + + K D++ GITL+E+ +
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 56/215 (26%), Positives = 100/215 (46%), Gaps = 18/215 (8%)
Query: 264 RELQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLI 322
+ +L D+F + + +G G G V+K +A K + P RE+ ++
Sbjct: 26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 85
Query: 323 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP-GEKGLDWPTRKRVAFGT 381
++ G + E + M S+ L+ E+ L +V+
Sbjct: 86 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL-----GKVSIAV 140
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVD--AKLTHVTTQIRG 438
GL YL E+ KI+HRD+K +NIL++ E LCDFG++ +L+D A + V G
Sbjct: 141 IKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFV-----G 192
Query: 439 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
T +++PE L S ++D++ G++L+E+ G+
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 49/218 (22%), Positives = 80/218 (36%), Gaps = 32/218 (14%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVK----------------RLQDYYSPGGEAAFQREVHLI 322
+ QG F K+ DN A+K F+ E+ +I
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 323 SVAIHKNLLQLIGYCTTSSERILVYPFMQN------LSVAYRLRDLKPGEKGLDWPTRKR 376
+ ++ L G T E ++Y +M+N + L + K
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF--IPIQVIKC 155
Query: 377 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 436
+ Y+H + N I HRD+K +NIL+D N L DFG ++ + K +
Sbjct: 156 IIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK-GS-- 210
Query: 437 RGTMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTG 472
RGT + PE+ S + K D++ GI L +
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-25
Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 16/204 (7%)
Query: 278 IIGQGGFGKVYKGVLSDN-TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
++G+G +G VY G N ++A+K + + S + E+ L HKN++Q +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP-LHEEIALHKHLKHKNIVQYLGS 87
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396
+ + + + S++ LR K G + T GL+YLH+ +I
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRS-KWGPLKDNEQTIGFYTKQILEGLKYLHDN---QI 143
Query: 397 IHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGT---MGHIAPEYLSTGK 452
+HRD+K N+L++ + + DFG +K + T GT M APE + G
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYM---APEIIDKGP 199
Query: 453 S--SEKTDVFGYGITLLELVTGQR 474
+ D++ G T++E+ TG+
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKP 223
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 60/213 (28%), Positives = 85/213 (39%), Gaps = 24/213 (11%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGE--AAFQREVHLISVAI 326
FS+ IG G FG VY + ++ VA+K++ E +EV +
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 327 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386
H N +Q G LV + S L+ +K L V G GL
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLG-SA---SDLLEVHKKPLQEVEIAAVTHGALQGLA 168
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT---MGHI 443
YLH +IHRD+KA NILL + L DFG + + + + GT M
Sbjct: 169 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG----SASIMAPANSFV-GTPYWM--- 217
Query: 444 APEYLSTGKSSE---KTDVFGYGITLLELVTGQ 473
APE + + K DV+ GIT +EL +
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 50/238 (21%), Positives = 90/238 (37%), Gaps = 36/238 (15%)
Query: 264 RELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVH-L 321
+ ++L ++ +GGF VY+ + + A+KRL A +EV +
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL-LSNEEEKNRAIIQEVCFM 79
Query: 322 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR----- 376
++ H N++Q + E + L +L G+ +++ +
Sbjct: 80 KKLSGHPNIVQFCSAASIGKEES-----DTGQAEFLLLTELCKGQ-LVEFLKKMESRGPL 133
Query: 377 -------VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429
+ + T ++++H Q P IIHRDLK N+LL + LCDFG A +
Sbjct: 134 SCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYP 192
Query: 430 THVTT-----------QIRGTMGHIAPEYLSTGKS---SEKTDVFGYGITLLELVTGQ 473
+ + T + PE + + EK D++ G L L Q
Sbjct: 193 DYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 45/230 (19%), Positives = 78/230 (33%), Gaps = 37/230 (16%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAI- 326
T F E IG G FG V+K V D A+KR + E REV+ +V
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 327 HKNLLQLIGYCTTSSERILVYPFM---QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 383
H ++ + Y + +E + S+A + + K +
Sbjct: 70 HSHV---VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-------------------LCDFGLAKL 424
GL Y+H ++H D+K +NI + + D G
Sbjct: 127 GLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT- 182
Query: 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 473
+++ + G +A E L + K D+F +T++ +
Sbjct: 183 ---RISSPQVEE-GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 42/221 (19%), Positives = 76/221 (34%), Gaps = 27/221 (12%)
Query: 270 TDNFSESNIIGQG--GFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVA 325
+ +IG+G V V V+R+ + S Q E+H+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 326 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGL 385
H N++ +E +V FM S + G++ + G L
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD--GMNELAIAYILQGVLKAL 141
Query: 386 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI-- 443
+Y+H +HR +KA++IL+ + + L + + Q + +
Sbjct: 142 DYIHHM---GYVHRSVKASHILISVDGKVYLSGLR----SNLSMIS-HGQRQRVVHDFPK 193
Query: 444 ---------APEYLSTGKS--SEKTDVFGYGITLLELVTGQ 473
+PE L K+D++ GIT EL G
Sbjct: 194 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 2e-24
Identities = 42/205 (20%), Positives = 74/205 (36%), Gaps = 27/205 (13%)
Query: 279 IGQGGFGKVYKG---VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
I GG G +Y ++ V +K L +A E ++ +H +++Q+
Sbjct: 88 IAHGGLGWIYLALDRNVNGRP-VVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 336 YCTTSSERILVYPF--MQNLSVAY----RLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 389
+ + + M+ Y L+ K + L L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVME-----YVGGQSLKRSKGQK--LPVAEAIAYLLEILPALSYLH 199
Query: 390 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 449
+++ DLK NI+L + + L D G +++ + GT G APE +
Sbjct: 200 SI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS-----FGYLYGTPGFQAPE-IV 249
Query: 450 TGKSSEKTDVFGYGITLLELVTGQR 474
+ TD++ G TL L
Sbjct: 250 RTGPTVATDIYTVGRTLAALTLDLP 274
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 46/217 (21%), Positives = 94/217 (43%), Gaps = 17/217 (7%)
Query: 266 LQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVH-LIS 323
+++ D+ +G+G +G V K + +AVKR++ + + ++ +
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 324 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 383
+ G + + M + S+ + + + + ++A
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL-AKLVD--AKLTHVTTQIRGTM 440
LE+LH +IHRD+K +N+L++ + +CDFG+ LVD AK G
Sbjct: 121 ALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA-----GCK 173
Query: 441 GHIAPEYLSTGKS----SEKTDVFGYGITLLELVTGQ 473
++APE ++ + S K+D++ GIT++EL +
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 33/223 (14%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIH 327
F ++G G +G+VYKG + A+K + + E ++E++++ + H
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDEEEEIKQEINMLKKYSHH 80
Query: 328 KNLLQLIG-YCTTSSERI-----LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF-- 379
+N+ G + + + LV F SV +++ K +W +A+
Sbjct: 81 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----IAYIC 135
Query: 380 -GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG 438
GL +LH+ K+IHRD+K N+LL +N E L DFG++ +D + T I G
Sbjct: 136 REILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-G 191
Query: 439 T---MGHIAPEYLSTGKSSE-----KTDVFGYGITLLELVTGQ 473
T M APE ++ ++ + K+D++ GIT +E+ G
Sbjct: 192 TPYWM---APEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 42/232 (18%)
Query: 264 RELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVH-L 321
+ ++ + IG+G +G V K V +AVKR++ + ++ +
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 322 ISVAIHKNLLQLIG-------------YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG 368
+ + ++Q G +TS ++ Y + D E+
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFY--------KYVYSVLDDVIPEEI 126
Query: 369 LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL-AKLVD- 426
L ++ T L +L E N KIIHRD+K +NILLD + LCDFG+ +LVD
Sbjct: 127 L-----GKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS 179
Query: 427 -AKLTHVTTQIRGTMGHIAPEYLSTGKS----SEKTDVFGYGITLLELVTGQ 473
AK G ++APE + S ++DV+ GITL EL TG+
Sbjct: 180 IAKTRDA-----GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 29/214 (13%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKR--LQDYYSPGGEAAFQREVHLISVAI 326
+ F +G+G +G VYK + VA+K+ ++ +E+ ++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCD 82
Query: 327 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDL-KPGEKGLDWPTRKRVAFGTAYGL 385
++++ G +++ +V + SV+ D+ + K L + T GL
Sbjct: 83 SPHVVKYYGSYFKNTDLWIVMEYCGAGSVS----DIIRLRNKTLTEDEIATILQSTLKGL 138
Query: 386 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI-- 443
EYLH + IHRD+KA NILL+ A L DFG V +LT T R T+ I
Sbjct: 139 EYLHFM---RKIHRDIKAGNILLNTEGHAKLADFG----VAGQLTD-TMAKRNTV--IGT 188
Query: 444 ----APEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
APE + + D++ GIT +E+ G+
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 49/209 (23%), Positives = 91/209 (43%), Gaps = 19/209 (9%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 328
++ IGQG G VY + ++ +VA++++ + + E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNP 77
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
N++ + E +V ++ S+ + E +D V LE+L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFL 132
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM-GH---IA 444
H ++IHRD+K+ NILL + L DFG A++T R TM G +A
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC----AQITP-EQSKRSTMVGTPYWMA 184
Query: 445 PEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
PE ++ K D++ GI +E++ G+
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 21/220 (9%)
Query: 264 RELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVH-L 321
+ Q ++ +G G G+V+K +AVK+++ + ++ +
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 322 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 381
+ ++Q G T+++ + M + + K + + ++
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCA----EKLKKRMQGPIPERILGKMTVAI 133
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL-AKLVD--AKLTHVTTQIRG 438
L YL E+ +IHRD+K +NILLD+ + LCDFG+ +LVD AK G
Sbjct: 134 VKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA-----G 186
Query: 439 TMGHIAPEYLSTGKSSE-----KTDVFGYGITLLELVTGQ 473
++APE + ++ + DV+ GI+L+EL TGQ
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 33/238 (13%), Positives = 59/238 (24%), Gaps = 51/238 (21%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAA---------------------- 314
++GQ + V P A
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 315 -----FQREVHLISVAIHKNLLQLIGYCTTSS--ERILVYPFMQ--NLSVAYRLRDLKPG 365
F L+ K ++++ R +YP MQ + L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 366 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425
K L R ++ L LH ++H L+ +I+LD L F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 426 DAKLTHVTTQIRGTMGHIAPEYLST-----------GKSSEKTDVFGYGITLLELVTG 472
A++ + G PE + + D + G+ + +
Sbjct: 257 GARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 3e-23
Identities = 54/209 (25%), Positives = 86/209 (41%), Gaps = 30/209 (14%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQLIG 335
+G GG VY N KVA+K + F+REVH S H+N++
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS--- 75
Query: 336 YCTTSSERILVYPFMQNLSVAY---------RLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386
+ + Y L + L T G++
Sbjct: 76 ----------MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK 125
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGHIAP 445
+ H+ +I+HRD+K NIL+D N + DFG+AK + + LT T + GT+ + +P
Sbjct: 126 HAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSP 181
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVTGQR 474
E + E TD++ GI L E++ G+
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEP 210
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 48/211 (22%), Positives = 87/211 (41%), Gaps = 23/211 (10%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 328
IG+G G V +VAVK + D EV ++ H
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM-DLRKQQRRELLFNEVVIMRDYQHF 102
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
N++++ E ++ F+Q ++ + ++ E+ + V L YL
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQI-----ATVCEAVLQALAYL 157
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI----- 443
H Q +IHRD+K+ +ILL + L DFG A+++ R ++ +
Sbjct: 158 HAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFC----AQISK-DVPKRKSL--VGTPYW 207
Query: 444 -APEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
APE +S + + D++ GI ++E+V G+
Sbjct: 208 MAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 5e-23
Identities = 50/200 (25%), Positives = 82/200 (41%), Gaps = 17/200 (8%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+G+GGF K ++ A K L P E+ + H++++
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLL---KPHQREKMSMEISIHRSLAHQHVVG 79
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 392
G+ + +V + S+ + K L P + G +YLH
Sbjct: 80 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKA----LTEPEARYYLRQIVLGCQYLHRN- 134
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 452
++IHRDLK N+ L+++ E + DFGLA V+ + GT +IAPE LS
Sbjct: 135 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKG 191
Query: 453 SSEKTDVFGYGITLLELVTG 472
S + DV+ G + L+ G
Sbjct: 192 HSFEVDVWSIGCIMYTLLVG 211
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 5e-23
Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 13/209 (6%)
Query: 267 QLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLIS 323
Q A ++F +G+G FG VY +A+K L G E +REV + S
Sbjct: 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 324 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 383
H N+L+L GY ++ L+ + +V L+ L D A
Sbjct: 65 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELAN 120
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
L Y H + ++IHRD+K N+LL E + DFG + + GT+ ++
Sbjct: 121 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC---GTLDYL 174
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVTG 472
PE + EK D++ G+ E + G
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 50/200 (25%), Positives = 82/200 (41%), Gaps = 17/200 (8%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+G+GGF K ++ A K L P E+ + H++++
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLL---KPHQREKMSMEISIHRSLAHQHVVG 105
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 392
G+ + +V + S+ + K L P + G +YLH
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN- 160
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 452
++IHRDLK N+ L+++ E + DFGLA V+ + GT +IAPE LS
Sbjct: 161 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKG 217
Query: 453 SSEKTDVFGYGITLLELVTG 472
S + DV+ G + L+ G
Sbjct: 218 HSFEVDVWSIGCIMYTLLVG 237
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 1e-22
Identities = 51/209 (24%), Positives = 83/209 (39%), Gaps = 13/209 (6%)
Query: 267 QLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLIS 323
+ D+F +G+G FG VY + +A+K L G E +RE+ + S
Sbjct: 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 324 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 383
H N+L++ Y L+ F + L+ D A
Sbjct: 70 HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR----FDEQRSATFMEELAD 125
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
L Y HE+ K+IHRD+K N+L+ E + DFG + + GT+ ++
Sbjct: 126 ALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLDYL 179
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVTG 472
PE + EK D++ G+ E + G
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-22
Identities = 50/211 (23%), Positives = 80/211 (37%), Gaps = 34/211 (16%)
Query: 279 IGQGGFGKVYKGVLSDNTK---VAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQL 333
+G+GG G VY+ D + VA+K + + S P QRE +++
Sbjct: 42 VGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP- 98
Query: 334 IGYCTTSSERILVYPFMQNLSVAY---------RLRDLKPGEKGLDWPTRKRVAFGTAYG 384
++ F + Y L + + L P +
Sbjct: 99 ------------IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSA 146
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGHI 443
L+ H HRD+K NIL+ + A L DFG+A D KLT GT+ ++
Sbjct: 147 LDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-LGNTVGTLYYM 202
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVTGQR 474
APE S ++ + D++ L E +TG
Sbjct: 203 APERFSESHATYRADIYALTCVLYECLTGSP 233
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 100 bits (249), Expect = 2e-22
Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 16/215 (7%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 328
+ +G GGFG V + + +VA+K+ + SP + E+ ++ H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 329 NLLQLI------GYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 382
N++ + +L + + + L GL + + +
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ-FENCCGLKEGPIRTLLSDIS 131
Query: 383 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV---LCDFGLAKLVDAKLTHVTTQIRGT 439
L YLHE +IIHRDLK NI+L + + + D G AK +D + T+ GT
Sbjct: 132 SALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--GELCTEFVGT 186
Query: 440 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 474
+ ++APE L K + D + +G E +TG R
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 3e-22
Identities = 47/218 (21%), Positives = 81/218 (37%), Gaps = 21/218 (9%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
+ S+I+GQG V++G A+K + RE ++ HKN
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 330 LLQLIGY--CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
+++L TT+ ++L+ F S+ L + GL V G+ +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNH 127
Query: 388 LHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
L E I+HR++K NI+ D L DFG A+ ++ + GT ++
Sbjct: 128 LREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED--DEQFVSLYGTEEYL 182
Query: 444 APEYLSTGKS--------SEKTDVFGYGITLLELVTGQ 473
P+ D++ G+T TG
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 4e-22
Identities = 54/234 (23%), Positives = 83/234 (35%), Gaps = 45/234 (19%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVH-LISVAIHK 328
+ I+G G G V VAVKR+ D+ E+ L H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD-----IALMEIKLLTESDDHP 69
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDL-------KPGEKGLDWPTRKRVAFGT 381
N+++ TT + ++ L+DL K +
Sbjct: 70 NVIRYYCSETTDRFLYIA---LEL--CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLD-------------DNFEAVLCDFGLAKLVDAK 428
A G+ +LH KIIHRDLK NIL+ +N ++ DFGL K +D+
Sbjct: 125 ASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 429 LTHVTTQIR---GTMGHIAPEYLS-------TGKSSEKTDVFGYGITLLELVTG 472
+ T + GT G APE L + + D+F G +++
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 7e-22
Identities = 53/200 (26%), Positives = 81/200 (40%), Gaps = 16/200 (8%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+G+G F VY+ + +VA+K + G Q EV + H ++L+
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY---KAGMVQRVQNEVKIHCQLKHPSILE 75
Query: 333 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 392
L Y S+ LV N + R LK K + G+ YLH
Sbjct: 76 LYNYFEDSNYVYLVLEMCHNGEM---NRYLKNRVKPFSENEARHFMHQIITGMLYLHSH- 131
Query: 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 452
I+HRDL +N+LL N + DFGLA + T + GT +I+PE +
Sbjct: 132 --GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSA 188
Query: 453 SSEKTDVFGYGITLLELVTG 472
++DV+ G L+ G
Sbjct: 189 HGLESDVWSLGCMFYTLLIG 208
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 63/235 (26%), Positives = 89/235 (37%), Gaps = 43/235 (18%)
Query: 261 FSCRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ--- 316
AT + IG G +G VYK VA+K ++ GG
Sbjct: 3 LGSM----ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPIST 58
Query: 317 -REVHL---ISVAIHKNLLQLIGYCTTSSERI-----LVYPFMQNLSVAYRLRDLK---- 363
REV L + H N+++L+ C TS LV+ + +DL+
Sbjct: 59 VREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD--------QDLRTYLD 110
Query: 364 -PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422
GL T K + GL++LH I+HRDLK NIL+ L DFGLA
Sbjct: 111 KAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLA 167
Query: 423 KL--VDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
++ LT VT R APE L + D++ G E+ +
Sbjct: 168 RIYSYQMALTPVVVTLWYR------APEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 24/209 (11%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAI--HKNLLQL 333
+G GG +V+ L D+ VAVK L+ + P F+RE + A H ++ +
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQ--NAAALNHPAIVAV 77
Query: 334 --IGYCTTSSERILVYPFMQNLSVAY----RLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
G + L Y M+ Y LRD+ E + V L +
Sbjct: 78 YDTG-EAETPAGPLPYIVME-----YVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT--QIRGTMGHIAP 445
H+ IIHRD+K ANI++ + DFG+A+ + VT + GT +++P
Sbjct: 132 SHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVTGQR 474
E ++DV+ G L E++TG+
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 4e-21
Identities = 47/218 (21%), Positives = 81/218 (37%), Gaps = 21/218 (9%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
+ S+I+GQG V++G A+K + RE ++ HKN
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 330 LLQLIGY--CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
+++L TT+ ++L+ F S+ L + GL V G+ +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 388 LHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
L E I+HR++K NI+ D L DFG A+ ++ + GT ++
Sbjct: 128 LREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYL 182
Query: 444 APEYLSTGKS--------SEKTDVFGYGITLLELVTGQ 473
P+ D++ G+T TG
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 2e-20
Identities = 62/239 (25%), Positives = 104/239 (43%), Gaps = 21/239 (8%)
Query: 267 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQ--DYYSPGGEAAFQREVHLIS 323
+ + F + ++G+GGFG+V + K+ A K+L+ GEA E ++
Sbjct: 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE 239
Query: 324 VAIHKNLLQLIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 382
+ ++ L Y + + + LV M + + + G+ G R F A
Sbjct: 240 KVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIY--HMGQAGFP---EARAVFYAA 293
Query: 383 ---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT 439
GLE LH + +I++RDLK NILLDD+ + D GLA V T GT
Sbjct: 294 EICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGT 348
Query: 440 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ---RAIDFSRLEEEEDVLLLDHKVT 495
+G++APE + + + D + G L E++ GQ + EE + L+ +
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE 407
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 3e-20
Identities = 67/240 (27%), Positives = 108/240 (45%), Gaps = 20/240 (8%)
Query: 267 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 323
+ D F + ++G+GGFG+V+ + K+ A K+L + G E +++
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 324 VAIHKNLLQLIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 382
+ ++ L Y + + LV M + Y + ++ G P R F TA
Sbjct: 241 KVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP---RAIFYTA 296
Query: 383 ---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR-G 438
GLE+LH++ II+RDLK N+LLDD+ + D GLA + K T+ G
Sbjct: 297 QIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAG 351
Query: 439 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ---RAIDFSRLEEEEDVLLLDHKVT 495
T G +APE L + D F G+TL E++ + RA +E +L+ VT
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT 411
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 6e-20
Identities = 70/272 (25%), Positives = 110/272 (40%), Gaps = 59/272 (21%)
Query: 229 CRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVY 288
+ + L+ DVF D + + L ++FS IIG+GGFG+VY
Sbjct: 149 YIEEICQNLRGDVFQKFIESDKFTRFCQW--KNVELNIHLTMNDFSVHRIIGRGGFGEVY 206
Query: 289 KGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER-ILV 346
+D K+ A+K L K + G +ER +L
Sbjct: 207 GCRKADTGKMYAMKCLDK----------------------KRIKMKQGETLALNERIMLS 244
Query: 347 ------YPFMQNLSVAYRLRD--------LKPGEKGLDWPTRK-------RVAFGTA--- 382
PF+ +S A+ D + G+ L + + + F A
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGD--LHYHLSQHGVFSEADMRFYAAEII 302
Query: 383 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 442
GLE++H + +++RDLK ANILLD++ + D GLA K H + GT G+
Sbjct: 303 LGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGY 356
Query: 443 IAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 473
+APE L G + + + D F G L +L+ G
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 7e-20
Identities = 53/213 (24%), Positives = 82/213 (38%), Gaps = 40/213 (18%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK--------RLQDYYSPGGEAAFQREVH 320
+N+ I+G+G V + + + AVK A +EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 321 -LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK---- 375
L V+ H N++QL T++ LV+ M+ GE D+ T K
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKK------------GEL-FDYLTEKVTLS 122
Query: 376 -RVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430
+ + LH+ I+HRDLK NILLDD+ L DFG + +D
Sbjct: 123 EKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--G 177
Query: 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYG 463
++ GT ++APE + + GYG
Sbjct: 178 EKLREVCGTPSYLAPEIIECSMNDNHP---GYG 207
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 9e-20
Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 41/232 (17%)
Query: 262 SCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTK--VAVKRLQ-DYYSPGGEAAFQRE 318
CR A + IG+G +GKV+K N VA+KR++ G + RE
Sbjct: 6 LCR----ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE 61
Query: 319 VHL---ISVAIHKNLLQLIGYCTTSSERI-----LVYPFMQNLSVAYRLRDLK-----PG 365
V + + H N+++L CT S LV+ + +DL
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD--------QDLTTYLDKVP 113
Query: 366 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL- 424
E G+ T K + F GL++LH +++HRDLK NIL+ + + L DFGLA++
Sbjct: 114 EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 170
Query: 425 -VDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
LT VT R APE L + D++ G E+ +
Sbjct: 171 SFQMALTSVVVTLWYR------APEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 4e-19
Identities = 49/217 (22%), Positives = 88/217 (40%), Gaps = 33/217 (15%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHK 328
+ + + IG+G +G V+K VA+K+ + P + RE+ ++ H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 329 NLLQLIGYCTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
NL+ L+ LV+ + + L +L ++G+ K + + T + +
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDHTV-----LHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI-----RGTMGH 442
H+ IHRD+K NIL+ + LCDFG A+L+ + ++ R
Sbjct: 118 CHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR----- 169
Query: 443 IAPEYL------STGKSSEKTDVFGYGITLLELVTGQ 473
+PE L DV+ G EL++G
Sbjct: 170 -SPELLVGDTQYGPP-----VDVWAIGCVFAELLSGV 200
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 54/224 (24%), Positives = 92/224 (41%), Gaps = 27/224 (12%)
Query: 259 RRFSCRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQ 316
+ + + + ++G+G +G V K VA+K+ + +
Sbjct: 17 ENLYFQSM----EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM 72
Query: 317 REVHLISVAIHKNLLQLIGYCTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRK 375
RE+ L+ H+NL+ L+ C LV+ F+ + L DL+ GLD+ +
Sbjct: 73 REIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTI-----LDDLELFPNGLDYQVVQ 127
Query: 376 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 435
+ F G+ + H IIHRD+K NIL+ + LCDFG A+ + A +
Sbjct: 128 KYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE 184
Query: 436 I-----RGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 473
+ R APE L + DV+ G + E+ G+
Sbjct: 185 VATRWYR------APELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 6e-19
Identities = 51/251 (20%), Positives = 77/251 (30%), Gaps = 51/251 (20%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK----RLQDYYSPGGEAAFQREVHLISV 324
+ IGQG +G V + A+K +P + EV L+
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 325 AIHKNLLQLIGYCTTSS---------------ERILVYPFMQNLSVAYRLRDLKPGEKGL 369
H N+ +L +++ V+ A + +
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 370 DWPTRKRVAFGTAY---------------------GLEYLHEQCNPKIIHRDLKAANILL 408
+ L YLH Q I HRD+K N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLF 201
Query: 409 --DDNFEAVLCDFGLAKLVDAKLT---HVTTQIRGTMGHIAPEYLSTG--KSSEKTDVFG 461
+ +FE L DFGL+K + T GT +APE L+T K D +
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 462 YGITLLELVTG 472
G+ L L+ G
Sbjct: 262 AGVLLHLLLMG 272
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 7e-19
Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 35/220 (15%)
Query: 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKR-LQDYYSPGGEAAFQ-REVHLISVAIH 327
++ +IG G FG V++ L ++ +VA+K+ LQD F+ RE+ ++ + H
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-------KRFKNRELQIMRIVKH 91
Query: 328 KNLLQLIGYCTTSSERI------LVYPFM-QNLSVAYR-LRDLKPGEKGLDWPTRKRVAF 379
N++ L + ++ ++ LV ++ + + YR R ++ + K +
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETV---YRASRHYAKLKQTMPMLLIKLYMY 148
Query: 380 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDA--KLTH--VTT 434
L Y+H I HRD+K N+LLD + L DFG AK++ A +
Sbjct: 149 QLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR 205
Query: 435 QIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 473
R APE + + + D++ G + EL+ GQ
Sbjct: 206 YYR------APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 7e-19
Identities = 62/212 (29%), Positives = 89/212 (41%), Gaps = 39/212 (18%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK-------RLQDYYSPGGEAAFQREVH- 320
+ ++IG+G V + V + + AVK RL A +RE H
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 321 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK----- 375
L VA H +++ LI +SS LV+ M+ GE D+ T K
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRK------------GEL-FDYLTEKVALSE 199
Query: 376 ---RVAFGT-AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 431
R + + +LH I+HRDLK NILLDDN + L DFG + ++
Sbjct: 200 KETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP--GE 254
Query: 432 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYG 463
++ GT G++APE L K S GYG
Sbjct: 255 KLRELCGTPGYLAPEIL---KCSMDETHPGYG 283
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 63/235 (26%), Positives = 96/235 (40%), Gaps = 45/235 (19%)
Query: 263 CRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVH 320
C E+ + + IGQG FG+V+K KVA+K++ + G RE+
Sbjct: 13 CDEV----SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK 68
Query: 321 LISVAIHKNLLQLIGYCTTSSERI--------LVYPFMQNLSVAYRLRDLK----PGEKG 368
++ + H+N++ LI C T + LV+ F ++ DL
Sbjct: 69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH--------DLAGLLSNVLVK 120
Query: 369 LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA------ 422
KRV GL Y+H KI+HRD+KAAN+L+ + L DFGLA
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLA 177
Query: 423 -KLVDAKLTH--VTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 473
+ T+ VT R PE L + D++G G + E+ T
Sbjct: 178 KNSQPNRYTNRVVTLWYR------PPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 52/215 (24%), Positives = 88/215 (40%), Gaps = 39/215 (18%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVH----LISVAIHK 328
+G+GGFG V+ G L+D +VA+K R+ + EV + + H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--------RVAFG 380
+++L+ + T +LV P + D+ T K R FG
Sbjct: 99 GVIRLLDWFETQEGFMLVLERP------------LPAQDLFDYITEKGPLGEGPSRCFFG 146
Query: 381 -TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRG 438
+++ H + ++HRD+K NIL+D L DFG L+ + G
Sbjct: 147 QVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---G 200
Query: 439 TMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTG 472
T + PE++S + + V+ GI L ++V G
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 21/89 (23%), Positives = 32/89 (35%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ +L L N S S L L+L ++ S++HL +L L N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIP 165
+S LS+L+ L NL
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLEN 117
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 29/108 (26%), Positives = 46/108 (42%), Gaps = 5/108 (4%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L + N F P I T+L+ L L+L L P S++ LQ LN+++N F
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSL 509
Query: 140 IPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVAT----FNFTGTHLIC 183
+ L++L+ LD S N++ +L + N T C
Sbjct: 510 DTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 19/95 (20%), Positives = 43/95 (45%), Gaps = 2/95 (2%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLP-DFLGSMTHLQSLNLANNK 135
++ L L NG +S + L+ L L+ Q ++L S+ +L L++++
Sbjct: 374 SLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 432
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ ++ LS+L+ L ++ N+ +F+
Sbjct: 433 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 9e-17
Identities = 17/91 (18%), Positives = 29/91 (31%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L L + L L++L L N + ++ LQ L +
Sbjct: 56 VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASL 115
Query: 140 IPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
L LK L+++ N + + FS
Sbjct: 116 ENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 19/94 (20%), Positives = 30/94 (31%), Gaps = 1/94 (1%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L L + L L L + N+ + LQ L+ + N
Sbjct: 471 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 530
Query: 137 SGSIPATWSQL-SNLKHLDLSSNNLTGRIPMQLF 169
S S+L L+L+ N+ Q F
Sbjct: 531 MTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSF 564
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 23/94 (24%), Positives = 40/94 (42%), Gaps = 5/94 (5%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDL-SGTLPDFLGSMTHLQSLNLANNK 135
++ L + + I LK L L + N + S LP++ ++T+L+ L+L++NK
Sbjct: 101 SLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK 160
Query: 136 FSGSIPATWSQLSNLK----HLDLSSNNLTGRIP 165
L + LDLS N + P
Sbjct: 161 IQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP 194
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 19/99 (19%), Positives = 36/99 (36%), Gaps = 6/99 (6%)
Query: 77 NVISLTLGSNGF-SGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQ----SLNL 131
+ L + N S K+ + L L L+L N + L + + SL+L
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184
Query: 132 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ N + P + ++ L L L +N + +
Sbjct: 185 SLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQ 222
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 9e-11
Identities = 24/111 (21%), Positives = 40/111 (36%), Gaps = 9/111 (8%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANN 134
N L L + F LK + L G + L+ L+L+ N
Sbjct: 303 NFGWQHLELVNCKFGQ-----FPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRN 357
Query: 135 K--FSGSIPATWSQLSNLKHLDLSSNNLTGRIP--MQLFSVATFNFTGTHL 181
F G + ++LK+LDLS N + + L + +F ++L
Sbjct: 358 GLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNL 408
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 9e-10
Identities = 22/117 (18%), Positives = 43/117 (36%), Gaps = 9/117 (7%)
Query: 78 VISLTLGSNGFSGKIS-PSITKLKFLASLELQDNDLS------GTLPDFLGSMTHLQSLN 130
V L LG G + + L+ L +L +++ L+ + D +T++ S +
Sbjct: 229 VHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFS 288
Query: 131 LANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSL 187
L + +S +HL+L + ++L S+ FT S
Sbjct: 289 LVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSE 343
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 16/104 (15%), Positives = 31/104 (29%), Gaps = 10/104 (9%)
Query: 77 NVISLTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGT---LPDFLGSMTHLQSLNLA 132
+ LTL +N S + I L L L + ++ L +L +
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 133 NNKFS------GSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ + I ++ L+N+ L S +
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF 304
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 22/95 (23%), Positives = 31/95 (32%), Gaps = 9/95 (9%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
NV S +L S + LEL + L S+ L +
Sbjct: 283 NVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSN----- 335
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT--GRIPMQLF 169
G + L +L+ LDLS N L+ G F
Sbjct: 336 KGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDF 370
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 11/62 (17%), Positives = 24/62 (38%), Gaps = 3/62 (4%)
Query: 104 SLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGR 163
+ + + + +PD L ++L+L+ N ++ L+ LDLS +
Sbjct: 11 TYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI 67
Query: 164 IP 165
Sbjct: 68 ED 69
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 16/107 (14%), Positives = 31/107 (28%), Gaps = 28/107 (26%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSM-THLQSLNLANNK 135
++ L + N F + L L L+ N + + L + L LNL N
Sbjct: 495 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 554
Query: 136 F--------------------------SGSIPATWSQLSNLKHLDLS 156
F + P+ + + L+++
Sbjct: 555 FACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP-VLSLNIT 600
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 52/213 (24%), Positives = 86/213 (40%), Gaps = 37/213 (17%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLISVAIHK--NL 330
+G GGFG VY G+ +SDN VA+K R+ D+ EV L+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--------RVAFG-T 381
++L+ + +L+ ++DL D+ T + R F
Sbjct: 111 IRLLDWFERPDSFVLILER------PEPVQDL------FDFITERGALQEELARSFFWQV 158
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTM 440
+ + H ++HRD+K NIL+D N + L DFG L+ + GT
Sbjct: 159 LEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTR 212
Query: 441 GHIAPEYLSTGK-SSEKTDVFGYGITLLELVTG 472
+ PE++ + V+ GI L ++V G
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 3e-18
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 28/214 (13%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKN 329
+ + + +G+G +G VYK S VA+KR++ D G + RE+ L+ H N
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYGL 385
++ LI + LV+ FM+ DLK + GL K + G+
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEK--------DLKKVLDENKTGLQDSQIKIYLYQLLRGV 132
Query: 386 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---DAKLTH--VTTQIRGTM 440
+ H+ +I+HRDLK N+L++ + L DFGLA+ TH VT R
Sbjct: 133 AHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR--- 186
Query: 441 GHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 473
AP+ L K S D++ G E++TG+
Sbjct: 187 ---APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 7e-18
Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 270 TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKR-LQDYYSPGGEAAFQ-REVHLISVAI 326
+++++ +IG G FG VY+ L D VA+K+ LQD F+ RE+ ++
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLD 105
Query: 327 HKNLLQLIGYCTTSSERI------LVYPFM-QNLSVAYR-LRDLKPGEKGLDWPTRKRVA 378
H N+++L + +S E+ LV ++ + + YR R ++ L K
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYM 162
Query: 379 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDA--KLTH--VT 433
+ L Y+H I HRD+K N+LLD + + LCDFG AK + +
Sbjct: 163 YQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 219
Query: 434 TQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 473
R APE + + DV+ G L EL+ GQ
Sbjct: 220 RYYR------APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 7e-18
Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 43/217 (19%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 332
+G+G +GKV + + + AVK +L+ P GEA ++E+ L+ HKN++Q
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR--IPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 333 L--IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWPTRKRVAFGTA------- 382
L + Y + +V + G + + D KR A
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVC------------GMQEMLDSVPEKRFPVCQAHGYFCQL 118
Query: 383 -YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK----LTHVTTQIR 437
GLEYLH Q I+H+D+K N+LL + G+A+ + T+Q
Sbjct: 119 IDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR-TSQ-- 172
Query: 438 GTMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTG 472
G+ PE + S K D++ G+TL + TG
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 1e-17
Identities = 58/218 (26%), Positives = 91/218 (41%), Gaps = 29/218 (13%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHK 328
+ + IG+G +G V+K + VA+KR++ D G ++ RE+ L+ HK
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYG 384
N+++L + + LV+ F DLK LD K F G
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQ--------DLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---DAKLTH--VTTQIRGT 439
L + H + ++HRDLK N+L++ N E L +FGLA+ + VT R
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR-- 168
Query: 440 MGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAI 476
P+ L K S D++ G EL R +
Sbjct: 169 ----PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 2e-17
Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 28/214 (13%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKN 329
+ + IG+G +G VYK + A+K+++ + G + RE+ ++ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYGL 385
+++L T +LV+ + DLK E GL+ T K G+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQ--------DLKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 386 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA---KLTH--VTTQIRGTM 440
Y H++ +++HRDLK N+L++ E + DFGLA+ K TH VT R
Sbjct: 114 AYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR--- 167
Query: 441 GHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 473
AP+ L K S D++ G E+V G
Sbjct: 168 ---APDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 28/214 (13%)
Query: 271 DNFSESNIIGQGGFGKVYKG-VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
+ + + + +G+G + VYKG + VA+K ++ + G REV L+ H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYGL 385
++ L T LV+ ++ +DLK ++ K F GL
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLD--------KDLKQYLDDCGNIINMHNVKLFLFQLLRGL 113
Query: 386 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---DAKLTH--VTTQIRGTM 440
Y H Q K++HRDLK N+L+++ E L DFGLA+ + VT R
Sbjct: 114 AYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYR--- 167
Query: 441 GHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 473
P+ L S + D++G G E+ TG+
Sbjct: 168 ---PPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 29/219 (13%)
Query: 269 ATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQ----REVHL 321
++ F + +G G + VYKG+ + VA+K +L E RE+ L
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS------EEGTPSTAIREISL 56
Query: 322 ISVAIHKNLLQLIGYCTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 380
+ H+N+++L T ++ LV+ FM +L R + +GL+ K +
Sbjct: 57 MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 381 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA---KLTH--VTTQ 435
GL + HE KI+HRDLK N+L++ + L DFGLA+ + VT
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLW 173
Query: 436 IRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 473
R AP+ L ++ S D++ G L E++TG+
Sbjct: 174 YR------APDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 3e-17
Identities = 55/177 (31%), Positives = 78/177 (44%), Gaps = 25/177 (14%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL----QDYYSPGGEAAFQREVHLISVA 325
+ + + +G+G F VYK + N VA+K++ + G RE+ L+
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 326 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGT 381
H N++ L+ S LV+ FM+ DL+ L K T
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFME--------TDLEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---DAKLTH--VT 433
GLEYLH+ I+HRDLK N+LLD+N L DFGLAK + TH VT
Sbjct: 122 LQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVT 175
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-17
Identities = 24/89 (26%), Positives = 41/89 (46%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L L N + + T+ L SL++ N +S P+ + L+ LNL +N+
Sbjct: 26 NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNEL 85
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIP 165
S T++ +NL L L SN++
Sbjct: 86 SQLSDKTFAFCTNLTELHLMSNSIQKIKN 114
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 27/94 (28%), Positives = 37/94 (39%), Gaps = 1/94 (1%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ SL +G N S KL L L LQ N+LS T+L L+L +N
Sbjct: 50 QLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSI 109
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ + NL LDLS N L+ +
Sbjct: 110 QKIKNNPFVKQKNLITLDLSHNGLSS-TKLGTQV 142
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 18/113 (15%), Positives = 36/113 (31%), Gaps = 5/113 (4%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANN 134
N ++ L + G + L L L L+ N + + L+ ++L N
Sbjct: 512 QHNNLA-RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLN 570
Query: 135 KFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVAT----FNFTGTHLIC 183
+ + ++ +LK L+L N +T + C
Sbjct: 571 NLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 6e-16
Identities = 22/91 (24%), Positives = 36/91 (39%), Gaps = 1/91 (1%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L L N S + L L L N + + +L +L+L++N S +
Sbjct: 77 VLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSST 136
Query: 140 IPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
T QL NL+ L LS+N + + +
Sbjct: 137 KLGTQVQLENLQELLLSNNKIQA-LKSEELD 166
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 6e-16
Identities = 18/84 (21%), Positives = 35/84 (41%), Gaps = 1/84 (1%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLP-DFLGSMTHLQSLNLANNKFSG 138
L L N S S + + L L L+L N++ L + ++ + L+ NK+
Sbjct: 385 ILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQ 444
Query: 139 SIPATWSQLSNLKHLDLSSNNLTG 162
+++ + +L+ L L L
Sbjct: 445 LTRNSFALVPSLQRLMLRRVALKN 468
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 26/98 (26%), Positives = 39/98 (39%), Gaps = 4/98 (4%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPD---FLG-SMTHLQSLNLA 132
+ L + N G S T L L L L ++ S F+ + + L LNL
Sbjct: 330 CLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLT 389
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
NK S +S L +L+ LDL N + + Q +
Sbjct: 390 KNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWR 427
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 23/104 (22%), Positives = 36/104 (34%), Gaps = 2/104 (1%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSG--TLPDFLGSMTHLQSLNLANN 134
N+ + L N + S + L L L+ L + P + +L L+L+NN
Sbjct: 431 NIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNN 490
Query: 135 KFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTG 178
+ L L+ LDL NNL + G
Sbjct: 491 NIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKG 534
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 5e-15
Identities = 30/91 (32%), Positives = 40/91 (43%), Gaps = 2/91 (2%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L L SN + K K L +L+L N LS T + +LQ L L+NNK
Sbjct: 98 NLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKI 157
Query: 137 SGSIPA--TWSQLSNLKHLDLSSNNLTGRIP 165
S+LK L+LSSN + P
Sbjct: 158 QALKSEELDIFANSSLKKLELSSNQIKEFSP 188
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 23/96 (23%), Positives = 42/96 (43%), Gaps = 2/96 (2%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSM--THLQSLNLANN 134
N+I+L L NG S + +L+ L L L +N + + L + L+ L L++N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
Query: 135 KFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ P + + L L L++ L + +L
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCL 217
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-14
Identities = 23/111 (20%), Positives = 46/111 (41%), Gaps = 3/111 (2%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKF--LASLELQDNDLSGTLPDFLGSMTHLQSLN 130
N ++ +L+L ++ S + + LK+ L L+L N+L+ D + L+
Sbjct: 219 LANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFF 278
Query: 131 LANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPM-QLFSVATFNFTGTH 180
L N + L N+++L+L + I + L + F+F
Sbjct: 279 LEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLK 329
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 22/97 (22%), Positives = 36/97 (37%), Gaps = 5/97 (5%)
Query: 77 NVISLTLGSNGFSGKISPSIT----KLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
N+ L+L ++ S + + T L L L N +S D + HL+ L+L
Sbjct: 354 NLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLG 413
Query: 133 NNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQL 168
N+ + W L N+ + LS N
Sbjct: 414 LNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSF 450
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 24/117 (20%), Positives = 39/117 (33%), Gaps = 8/117 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
++ L L SNGF L L ++L N+L+ + L+SLNL N
Sbjct: 537 HLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI 596
Query: 137 SGSIPAT-WSQLSNLKHLDLSSNNLTGRIPMQLF-------SVATFNFTGTHLICGS 185
+ NL LD+ N + + +H +C +
Sbjct: 597 TSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNT 653
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 27/98 (27%), Positives = 44/98 (44%), Gaps = 5/98 (5%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLG---SMTHLQSL 129
N ++ L L SN + L L L + L +L + L + T +++L
Sbjct: 168 FANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNL 227
Query: 130 NLANNKFSGSIPATWSQL--SNLKHLDLSSNNLTGRIP 165
+L+N++ S + T+ L +NL LDLS NNL
Sbjct: 228 SLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 18/91 (19%), Positives = 32/91 (35%), Gaps = 4/91 (4%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
+ ++ + + L L N L + L SL++ N S
Sbjct: 8 VADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKL 64
Query: 140 IPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
P +L LK L+L N L+ + + F+
Sbjct: 65 EPELCQKLPMLKVLNLQHNELSQ-LSDKTFA 94
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 21/104 (20%), Positives = 40/104 (38%), Gaps = 10/104 (9%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTL---------PDFLGSMTHLQ 127
+ L N S S+ L + L L+ + ++ + L+
Sbjct: 273 QLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLE 332
Query: 128 SLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGR-IPMQLFS 170
LN+ +N G ++ L NLK+L LS++ + R + + F
Sbjct: 333 HLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFV 376
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 8e-12
Identities = 21/95 (22%), Positives = 39/95 (41%), Gaps = 4/95 (4%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANN 134
+ ++ S LK L L ++DND+ G + + +L+ L+L+N+
Sbjct: 304 KRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNS 363
Query: 135 KFSGS--IPATWSQL--SNLKHLDLSSNNLTGRIP 165
S T+ L S L L+L+ N ++
Sbjct: 364 FTSLRTLTNETFVSLAHSPLHILNLTKNKISKIES 398
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 53/225 (23%), Positives = 87/225 (38%), Gaps = 38/225 (16%)
Query: 270 TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKR-LQDYYSPGGEAAFQ----REVHLIS 323
D F + GQG FG V G VA+K+ +QD F+ + + ++
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-------PRFRNRELQIMQDLA 74
Query: 324 VAIHKNLLQLIGYCTTSSER-------ILVYPFM-QNLSVAYR-LRDLKPGEKGLDWPTR 374
V H N++QL Y T ER +V ++ L +R R+ +
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTL---HRCCRNYYRRQVAPPPILI 131
Query: 375 KRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLV--DAKLTH 431
K F + LH + HRD+K N+L++ + LCDFG AK +
Sbjct: 132 KVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 432 --VTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 473
+ R APE + + + D++ G E++ G+
Sbjct: 191 YICSRYYR------APELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 6e-17
Identities = 24/106 (22%), Positives = 41/106 (38%), Gaps = 9/106 (8%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSG-------TLPDFLGSMTH 125
+ NV S+ L +N S + L+S+ L N L+ + +
Sbjct: 430 FKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYL 489
Query: 126 LQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
L S++L NK + + L L +DLS N+ + P Q +
Sbjct: 490 LTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLN 534
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 6e-17
Identities = 28/87 (32%), Positives = 40/87 (45%), Gaps = 3/87 (3%)
Query: 80 SLTLGSNGF-SGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 138
+ +G N + + S+ K+K L LE N L G LP F GS L SLNLA N+ +
Sbjct: 309 IIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAF-GSEIKLASLNLAYNQITE 367
Query: 139 SIPATWSQLSNLKHLDLSSNNLTGRIP 165
+++L + N L IP
Sbjct: 368 IPANFCGFTEQVENLSFAHNKLKY-IP 393
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 27/143 (18%), Positives = 45/143 (31%), Gaps = 21/143 (14%)
Query: 36 EGEALIEVLKALNDTHGQF--------TDWNDHFVSPCFSWSH---VTC-RNGNVISLTL 83
+ AL E+ ALN + +WN F W V+ NG V L+L
Sbjct: 31 DYLALKEIWDALNGKNWSQQGFGTQPGANWN--FNKELDMWGAQPGVSLNSNGRVTGLSL 88
Query: 84 GSNGFSGKISPSITKLKFLASLELQDNDLSG----TLPDFLGSMTHLQSLNLANNKFSGS 139
G SG++ +I +L L L L + P + + + + +
Sbjct: 89 EGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKT 148
Query: 140 IPATWSQLSNLKHLDLSSNNLTG 162
DL + +
Sbjct: 149 FV---DYDPREDFSDLIKDCINS 168
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 18/99 (18%), Positives = 33/99 (33%), Gaps = 9/99 (9%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF--- 136
+ LK L +E+ + LP FL ++ +Q +N+A N+
Sbjct: 229 NENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISG 288
Query: 137 -----SGSIPATWSQLSNLKHLDLSSNNL-TGRIPMQLF 169
A ++ + + NNL T + L
Sbjct: 289 EQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQ 327
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 11/98 (11%), Positives = 32/98 (32%), Gaps = 9/98 (9%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDL--------SGTLPDFLGSMTHLQS 128
++ + + + K+ + L + + + N +Q
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309
Query: 129 LNLANNKF-SGSIPATWSQLSNLKHLDLSSNNLTGRIP 165
+ + N + + + ++ L L+ N L G++P
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP 347
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 8e-16
Identities = 18/100 (18%), Positives = 35/100 (35%), Gaps = 15/100 (15%)
Query: 80 SLTLGSNGFSG-------KISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
++ N + P+ K ++S+ L +N +S + + + L S+NL
Sbjct: 406 AIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLM 465
Query: 133 NNKFSG-------SIPATWSQLSNLKHLDLSSNNLTGRIP 165
N + + L +DL N LT +
Sbjct: 466 GNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LS 504
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 23/111 (20%), Positives = 41/111 (36%), Gaps = 11/111 (9%)
Query: 77 NVISLTLGSNGFSGKISP--SITKLKFLASLELQDNDLSG-------TLPDFLGSMTHLQ 127
V +L+ N I + +++++ N++ L ++
Sbjct: 378 QVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVS 436
Query: 128 SLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTG 178
S+NL+NN+ S +S S L ++L N LT IP NF
Sbjct: 437 SINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE-IPKNSLKDENENFKN 486
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 18/102 (17%), Positives = 38/102 (37%), Gaps = 11/102 (10%)
Query: 77 NVISLTLGSNGFSGKISPSI--TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSL----- 129
+ S+ L N + +S T L +L ++L N S P + + L+
Sbjct: 489 LLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ 546
Query: 130 -NLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ N+ P + +L L + SN++ + ++
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKITP 587
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 14/113 (12%), Positives = 37/113 (32%), Gaps = 20/113 (17%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
++I + S+ I S + N+++ + + +T L+ + N+ F
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPF 218
Query: 137 SG-------------------SIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ W L +L +++ + ++P L +
Sbjct: 219 VAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKA 271
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 14/100 (14%), Positives = 28/100 (28%), Gaps = 10/100 (10%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQD------NDLSGTLPDFLGSMTHLQSLN 130
++ + L N FS L +++ N P+ + L L
Sbjct: 514 YLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQ 572
Query: 131 LANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ +N + N+ LD+ N +
Sbjct: 573 IGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCP 609
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 6e-15
Identities = 8/83 (9%), Positives = 25/83 (30%), Gaps = 5/83 (6%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
+G++ F + + + T ++ L + + N
Sbjct: 210 QFYMGNSPFVAENICEAWEN-----ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTK 264
Query: 140 IPATWSQLSNLKHLDLSSNNLTG 162
+P L ++ ++++ N
Sbjct: 265 LPTFLKALPEMQLINVACNRGIS 287
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 5/99 (5%), Positives = 24/99 (24%), Gaps = 3/99 (3%)
Query: 80 SLTLGSNGFSGKISPSITKLKF--LASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFS 137
+ + F L + + ++ + +N +
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT 196
Query: 138 GSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNF 176
+ +L+ L+ + ++ + + +
Sbjct: 197 -FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY 234
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 19/84 (22%), Positives = 28/84 (33%), Gaps = 6/84 (7%)
Query: 88 FSGKISPSITKLKFLASLELQDNDLSGTLPD-FLGSMTHLQSLNLANNKFSGSIPATWSQ 146
G + F L D+ G P L S + L+L SG +P Q
Sbjct: 49 QQGFGTQPGANWNFNKEL-----DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQ 103
Query: 147 LSNLKHLDLSSNNLTGRIPMQLFS 170
L+ L+ L L S+ +
Sbjct: 104 LTELEVLALGSHGEKVNERLFGPK 127
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 10/81 (12%), Positives = 23/81 (28%), Gaps = 3/81 (3%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI 140
N + IT L L++ ND+ + + ++ L++ +N
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNE--KITPNISVLDIKDNPNISID 603
Query: 141 PATWSQLSNLKHLDLSSNNLT 161
+ L +
Sbjct: 604 LSYVCPYIEAGMYMLFYDKTQ 624
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 6e-17
Identities = 48/211 (22%), Positives = 86/211 (40%), Gaps = 17/211 (8%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 327
++ + +G G +G+V + + A+K ++ S + EV ++ + H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP-GEKGLDWPTRKRVAFGTAYGLE 386
N+++L + LV + + + E + G+
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDA-----AVIIKQVLSGVT 150
Query: 387 YLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
YLH+ I+HRDLK N+LL + + + DFGL+ + + + GT +I
Sbjct: 151 YLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN--QKKMKERLGTAYYI 205
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVTGQR 474
APE L K EK DV+ G+ L L+ G
Sbjct: 206 APEVLR-KKYDEKCDVWSIGVILFILLAGYP 235
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 9e-17
Identities = 51/205 (24%), Positives = 82/205 (40%), Gaps = 21/205 (10%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRL-------QDYYSPGGEAAFQREVHLISVAIHKNL 330
+G G FG V+ V N +V VK + + E+ ++S H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 390
++++ LV M+ L LD P + + YL
Sbjct: 92 IKVLDIFENQGFFQLV---MEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL 148
Query: 391 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGHIAPEYLS 449
+ IIHRD+K NI++ ++F L DFG A + KL + GT+ + APE L
Sbjct: 149 K---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIEYCAPEVLM 202
Query: 450 TGKSSE--KTDVFGYGITLLELVTG 472
G + +++ G+TL LV
Sbjct: 203 -GNPYRGPELEMWSLGVTLYTLVFE 226
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 57/229 (24%), Positives = 93/229 (40%), Gaps = 43/229 (18%)
Query: 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEA-AFQ---------REV 319
++ I G +G V GV S+ VA+KR+ + S G RE+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 320 HLISVAIHKNLLQLIGYCTTSSERI-----LVYPFMQ-NLSVAYRLRDLKPGEKGLDWPT 373
L++ H N+L L E LV M+ +L+ + + + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLA-----QVIHDQRIVI---S 132
Query: 374 RKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DA 427
+ + + Y GL LH ++HRDL NILL DN + +CDF LA+ DA
Sbjct: 133 PQHIQY-FMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 428 KLT-HVTTQ-IRGTMGHIAPEY-LSTGKSSEKTDVFGYGITLLELVTGQ 473
T +VT + R APE + ++ D++ G + E+ +
Sbjct: 189 NKTHYVTHRWYR------APELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 8/94 (8%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
L+YL Q +IIHRD+K NILLD++ + DF +A ++ + T + GT ++
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYM 181
Query: 444 APEYLSTGKSSEKT---DVFGYGITLLELVTGQR 474
APE S+ K + + D + G+T EL+ G+R
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 46/226 (20%), Positives = 85/226 (37%), Gaps = 42/226 (18%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK-------RLQDYYSPGGEAAFQREVHL 321
D + S +G G G+V KVA++ + + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 322 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG--------EKG-LDWP 372
+ H ++++ + Y + +L G L
Sbjct: 194 LKKLNHPCIIKIKNFFDAED----YYIVL----------ELMEGGELFDKVVGNKRLKEA 239
Query: 373 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKL 429
T K + ++YLHE IIHRDLK N+LL +++ + DFG +K++
Sbjct: 240 TCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-- 294
Query: 430 THVTTQIRGTMGHIAPEYLSTGKS---SEKTDVFGYGITLLELVTG 472
T + + GT ++APE L + + + D + G+ L ++G
Sbjct: 295 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 51/228 (22%), Positives = 91/228 (39%), Gaps = 37/228 (16%)
Query: 262 SCRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREV 319
S + D + +G+G +G+VYK + N VA+KR+ ++ G REV
Sbjct: 29 SATSI----DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREV 84
Query: 320 HLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKR 376
L+ H+N+++L + L++ + + DLK + K
Sbjct: 85 SLLKELQHRNIIELKSVIHHNHRLHLIFEYAE--------NDLKKYMDKNPDVSMRVIKS 136
Query: 377 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-----LCDFGLAKLV---DAK 428
+ G+ + H + + +HRDLK N+LL + + + DFGLA+ +
Sbjct: 137 FLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ 193
Query: 429 LTH--VTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 473
TH +T R PE L + S D++ E++
Sbjct: 194 FTHEIITLWYR------PPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 22/218 (10%)
Query: 266 LQLATDNFSE----SNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ--DYYSPGGEAAFQRE 318
+Q +T FS+ ++G+G FG+V + AVK + + + RE
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 319 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP-GEKGLDWPTRKRV 377
V L+ H N+++L + LV + + K E R+
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA-----ARI 131
Query: 378 AFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTT 434
G+ Y+H+ KI+HRDLK N+LL + + DFGL+ +A +
Sbjct: 132 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMK 186
Query: 435 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 472
GT +IAPE L G EK DV+ G+ L L++G
Sbjct: 187 DKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 28/100 (28%), Positives = 44/100 (44%), Gaps = 14/100 (14%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR------ 437
+E+LH + ++HRDLK +NI + + DFGL +D T
Sbjct: 176 AVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232
Query: 438 -----GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 472
GT +++PE + S K D+F G+ L EL+
Sbjct: 233 HTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 44/191 (23%), Positives = 78/191 (40%), Gaps = 33/191 (17%)
Query: 279 IGQGGFGKVYKGVLSDNT---KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
+G+G +G VYK D A+K+++ G + RE+ L+ H N++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GISMSACREIALLRELKHPNVISLQK 85
Query: 336 YCTTSSERI--LVYPFMQN----LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 389
+ ++R L++ + ++ + +R L K + + G+ YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 390 EQCNPKIIHRDLKAANILLDDNFEAV----LCDFGLAKLVDA---KLTHVTTQI-----R 437
++HRDLK ANIL+ + D G A+L ++ L + + R
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 202
Query: 438 GTMGHIAPEYL 448
APE L
Sbjct: 203 ------APELL 207
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 3e-16
Identities = 22/95 (23%), Positives = 32/95 (33%), Gaps = 10/95 (10%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG- 138
S + LK L +EL + LPDFL + LQSLN+A N+
Sbjct: 471 DANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISA 530
Query: 139 --------SIPATWSQLSNLKHLDLSSNNLTGRIP 165
+ ++ + NNL P
Sbjct: 531 AQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FP 564
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 17/99 (17%), Positives = 41/99 (41%), Gaps = 11/99 (11%)
Query: 80 SLTLGSNGFSGKISPSI--TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNL------ 131
++ L N + +S T L +L+++++ N S + P + + L++ +
Sbjct: 732 TIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDA 789
Query: 132 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
N+ P + +L L + SN++ + +L
Sbjct: 790 EGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKLTP 827
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 16/96 (16%), Positives = 31/96 (32%), Gaps = 12/96 (12%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSG---------TLPDFLGSMTHLQ 127
++ + L + ++ + L L SL + N L D + +Q
Sbjct: 492 DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQ 551
Query: 128 SLNLANNKFSGSIPATW--SQLSNLKHLDLSSNNLT 161
+ N PA+ ++ L LD N +
Sbjct: 552 IFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR 586
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 17/97 (17%), Positives = 29/97 (29%), Gaps = 6/97 (6%)
Query: 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNLAN 133
N +++ + + N+L P L M L L+ +
Sbjct: 524 CNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVH 582
Query: 134 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
NK + A + L L L N + IP +
Sbjct: 583 NKVR-HLEA-FGTNVKLTDLKLDYNQIEE-IPEDFCA 616
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 17/108 (15%), Positives = 36/108 (33%), Gaps = 7/108 (6%)
Query: 77 NVISLTLGSNGFSG-KISPSITKLKFLASLELQDNDLSGTLPDFLGSM-----THLQSLN 130
V L N + + + S++ N + + SM + ++
Sbjct: 620 QVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVT 679
Query: 131 LANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTG 178
L+ N+ ++ S + + LS+N +T IP N+
Sbjct: 680 LSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKN 726
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 4e-13
Identities = 14/102 (13%), Positives = 31/102 (30%), Gaps = 20/102 (19%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSG-------------------TLPDFL 120
+ +N + IS +I +L L + ++ +
Sbjct: 429 QIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSW 487
Query: 121 GSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTG 162
++ L + L N +P L L+ L+++ N
Sbjct: 488 SNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS 529
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 5e-13
Identities = 21/91 (23%), Positives = 31/91 (34%), Gaps = 4/91 (4%)
Query: 80 SLTLGSNGFSG-KISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 138
+G N S S+ K+ L L+ N + L F G+ L L L N+
Sbjct: 552 IFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEAF-GTNVKLTDLKLDYNQIEE 609
Query: 139 SIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 169
+ ++ L S N L IP
Sbjct: 610 IPEDFCAFTDQVEGLGFSHNKLKY-IPNIFN 639
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 7e-13
Identities = 17/120 (14%), Positives = 33/120 (27%), Gaps = 15/120 (12%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQ------DNDLSGTLPDFLGSMTHLQSLNLAN 133
++ + N FS L + ++ N + P + + L L + +
Sbjct: 757 NMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGS 815
Query: 134 NKFSGSIPATWSQLSNLKHLDLSSNNLT-----GRIPMQLFSVATFNFTGTHLICGSSLE 188
N + L LD++ N P + + T I G
Sbjct: 816 NDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDAL 872
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 18/115 (15%), Positives = 42/115 (36%), Gaps = 27/115 (23%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSG------TLPDFLGSMTHLQSLNLANN 134
L + + +P + +K + + L+D + + + +T LQ + AN+
Sbjct: 401 SDLLQDAINR--NPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANS 458
Query: 135 KFSG-------------------SIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
F+ + +WS L +L ++L + ++P L+
Sbjct: 459 PFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYD 513
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 25/175 (14%), Positives = 57/175 (32%), Gaps = 16/175 (9%)
Query: 36 EGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVT--CRNGNVISLTLGSNGFSGKIS 93
+ +AL + +AL+ + ++ + +W+ G+ + L +NG
Sbjct: 270 DYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGR----- 324
Query: 94 PSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHL 153
+ L L G +PD +G +T L+ L+ + + S +
Sbjct: 325 --------VTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMS 376
Query: 154 DLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPCMSRPSPPVSTSRTKLRI 208
+ + + ++F + L+ + P M S +I
Sbjct: 377 EERKHRIRMHYK-KMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQI 430
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 15/102 (14%), Positives = 33/102 (32%), Gaps = 13/102 (12%)
Query: 80 SLTLGSNGFSGK-----ISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANN 134
S+ N + S K +++ L N++ + + + + ++ L+NN
Sbjct: 648 SVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNN 707
Query: 135 KFS-------GSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 169
+ + L +DL N LT +
Sbjct: 708 LMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFR 748
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 19/104 (18%), Positives = 42/104 (40%), Gaps = 17/104 (16%)
Query: 77 NVISLTLGSNGFS-------GKISPSITKLKFLASLELQDNDLSGTLPD--FLGSMTHLQ 127
+ ++ L +N + + L +++L+ N L+ +L D ++ +L
Sbjct: 698 PISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLS 756
Query: 128 SLNLANNKFSGSIPATWSQLSNLKHLDL------SSNNLTGRIP 165
+++++ N FS S P S LK + N + + P
Sbjct: 757 NMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWP 799
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 42/218 (19%), Positives = 75/218 (34%), Gaps = 44/218 (20%)
Query: 264 RELQLATDNFSE-----SNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQR 317
+ + ++ ++G G GKV + K A+K L D ++
Sbjct: 17 QGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD------SPKARQ 70
Query: 318 EV-HLISVAIHKNLLQLIG-YCTTSSERILVYPFMQNLSVAYRLRDLKPG--------EK 367
EV H + +++ ++ Y + + M + G E+
Sbjct: 71 EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM----------ECMEGGELFSRIQER 120
Query: 368 GLDWPTRKRVAFGT---AYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGL 421
G T + A +++LH I HRD+K N+L + + L DFG
Sbjct: 121 GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177
Query: 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 459
AK + T ++APE L K + D+
Sbjct: 178 AKETT---QNALQTPCYTPYYVAPEVLGPEKYDKSCDM 212
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 8e-16
Identities = 46/203 (22%), Positives = 85/203 (41%), Gaps = 33/203 (16%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 328
F ++G G F +V+ A+K + +++ + E+ ++ H+
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCI-KKSPAFRDSSLENEIAVLKKIKHE 66
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-----RVAFGTAY 383
N++ L +++ LV MQ L G + D + + A
Sbjct: 67 NIVTLEDIYESTTHYYLV---MQ----------LVSGGELFDRILERGVYTEKDASLVIQ 113
Query: 384 ----GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQI 436
++YLHE I+HRDLK N+L ++N + ++ DFGL+K+ + +
Sbjct: 114 QVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---NGIMSTA 167
Query: 437 RGTMGHIAPEYLSTGKSSEKTDV 459
GT G++APE L+ S+ D
Sbjct: 168 CGTPGYVAPEVLAQKPYSKAVDC 190
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 9e-16
Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 53/228 (23%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REV 319
+ +G G +G V + KVA+K+L FQ RE+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR--------PFQSEIFAKRAYREL 74
Query: 320 HLISVAIHKNLLQLIGYCTTSSERI------LVYPFMQ-NLSVAYRLRDLKPGEKGLDWP 372
L+ H+N++ L+ T +S LV PFMQ +L L+
Sbjct: 75 LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK-----------F 123
Query: 373 TRKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428
+ +++ + Y GL+Y+H + ++HRDLK N+ ++++ E + DFGLA+ DA+
Sbjct: 124 SEEKIQY-LVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179
Query: 429 LTH-VTTQ-IRGTMGHIAPE-YLSTGKSSEKTDVFGYGITLLELVTGQ 473
+T V T+ R APE LS ++ D++ G + E++TG+
Sbjct: 180 MTGYVVTRWYR------APEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 48/231 (20%), Positives = 84/231 (36%), Gaps = 36/231 (15%)
Query: 259 RRFSCRELQLATDNFSE----SNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEA 313
+++ + +++ D+ + +G G FG V++ + A K + +
Sbjct: 141 KQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV-MTPHESDKE 199
Query: 314 AFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPT 373
++E+ +SV H L+ L +E +++Y FM GE +
Sbjct: 200 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG------------GEL-FEKVA 246
Query: 374 RKRVAF----GTAY------GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL--CDFGL 421
+ Y GL ++HE +H DLK NI+ L DFGL
Sbjct: 247 DEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGL 303
Query: 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 472
+D K GT APE TD++ G+ L++G
Sbjct: 304 TAHLDPK--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 46/234 (19%), Positives = 84/234 (35%), Gaps = 56/234 (23%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL------------QDYYSPGGEAAFQ 316
+++ + +G G +G+V + +++ A+K + +
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 317 REVHLISVAIHKNLLQLIGYCTTSS---------------ERILVYPFMQNLSVAYRLRD 361
E+ L+ H N+++L E+I+ A ++
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ 154
Query: 362 LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCD 418
+ G+ YLH+ I+HRD+K NILL + + D
Sbjct: 155 I-------------------LSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVD 192
Query: 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 472
FGL+ + GT +IAPE L K +EK DV+ G+ + L+ G
Sbjct: 193 FGLSSFFSK--DYKLRDRLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCG 243
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 41/219 (18%), Positives = 81/219 (36%), Gaps = 38/219 (17%)
Query: 259 RRFSCRELQLATDNFSE----SNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEA 313
+++ + +++ + + +G G FG V++ V + K + + P +
Sbjct: 35 KKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFI-NTPYPLDKY 93
Query: 314 AFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWP 372
+ E+ +++ H L+ L E +L+ F+ GE L D
Sbjct: 94 TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG------------GE--LFDRI 139
Query: 373 TRKRVAFGTAY----------GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL--CDFG 420
+ A GL+++HE I+H D+K NI+ + + + DFG
Sbjct: 140 AAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG 196
Query: 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 459
LA ++ + T APE + TD+
Sbjct: 197 LATKLNP--DEIVKVTTATAEFAAPEIVDREPVGFYTDM 233
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 47/211 (22%), Positives = 79/211 (37%), Gaps = 38/211 (18%)
Query: 270 TDNFSE-----SNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVH-L 321
+NF+ S +G+G F V + + S + A K L+ A E+ L
Sbjct: 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVL 82
Query: 322 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGE-------KGLDWPTR 374
++ L +SE IL+ + GE + + +
Sbjct: 83 ELAKSCPRVINLHEVYENTSEIILILEYAAG------------GEIFSLCLPELAEMVSE 130
Query: 375 KRVAFGT---AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV---LCDFGLAKLVDAK 428
V G+ YLH+ I+H DLK NILL + + DFG+++ +
Sbjct: 131 NDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187
Query: 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 459
+I GT ++APE L+ + TD+
Sbjct: 188 --CELREIMGTPEYLAPEILNYDPITTATDM 216
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 54/226 (23%), Positives = 88/226 (38%), Gaps = 51/226 (22%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 327
+ ++ ++G+G FG+V K + AVK + + REV L+ H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 328 KNLLQLIGYCTTSS---------------ERILVYPFMQNLS---VAYRLRDLKPGEKGL 369
N+++L SS + I+ + S A ++ +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEII---KRKRFSEHDAARIIKQV------- 130
Query: 370 DWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVD 426
G+ Y+H+ I+HRDLK NILL + + + + DFGL+
Sbjct: 131 ------------FSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175
Query: 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 472
GT +IAPE L G EK DV+ G+ L L++G
Sbjct: 176 Q--NTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 52/232 (22%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVK-------------------------RLQDYYSPGGE 312
IG+G +G V +DNT A+K G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 313 AAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWP 372
+E+ ++ H N+++L+ +E L Y + + G ++ P
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFE-----L----VNQGPV-MEVP 129
Query: 373 TRKRVAFGTA--------YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424
T K ++ A G+EYLH Q KIIHRD+K +N+L+ ++ + DFG++
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGK---SSEKTDVFGYGITLLELVTGQ 473
++ + GT +APE LS + S + DV+ G+TL V GQ
Sbjct: 187 FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 60/228 (26%), Positives = 100/228 (43%), Gaps = 52/228 (22%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REV 319
+ + +G G +G V V KVA+K+L FQ RE+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--------PFQSELFAKRAYREL 75
Query: 320 HLISVAIHKNLLQLI------GYCTTSSERILVYPFMQ-NLSVAYRLRDLKPGEKGLDWP 372
L+ H+N++ L+ ++ LV PFM +L + L
Sbjct: 76 RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKL---------- 125
Query: 373 TRKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428
R+ F Y GL Y+H IIHRDLK N+ ++++ E + DFGLA+ D++
Sbjct: 126 GEDRIQF-LVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181
Query: 429 LT-HVTTQ-IRGTMGHIAPEY-LSTGKSSEKTDVFGYGITLLELVTGQ 473
+T +V T+ R APE L+ + ++ D++ G + E++TG+
Sbjct: 182 MTGYVVTRWYR------APEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 3e-15
Identities = 47/215 (21%), Positives = 79/215 (36%), Gaps = 49/215 (22%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLIS 323
D++ +G G F V K + A K RL +REV+++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 324 VAIHKNLLQLIGYCTTSSERILVYPFMQ------------NLS---VAYRLRDLKPGEKG 368
H N++ L ++ +L+ + +L+ L+ +
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI------ 117
Query: 369 LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGLAKL 424
LD G+ YLH + +I H DLK NI+L N L DFG+A
Sbjct: 118 LD-------------GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161
Query: 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 459
++A + I GT +APE ++ + D+
Sbjct: 162 IEAG--NEFKNIFGTPEFVAPEIVNYEPLGLEADM 194
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 24/98 (24%), Positives = 37/98 (37%), Gaps = 1/98 (1%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
+V S+ L + F S + L L+L LS LP L ++ L+ L L+
Sbjct: 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLS 309
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
NKF + S +L HL + N +
Sbjct: 310 ANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLE 347
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 18/94 (19%), Positives = 28/94 (29%), Gaps = 1/94 (1%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L N + + ++L L L+L + D S L +L L N
Sbjct: 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
S LKHL ++ I
Sbjct: 94 IFMAETALSGPKALKHLFFIQTGISS-IDFIPLH 126
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-14
Identities = 19/87 (21%), Positives = 33/87 (37%), Gaps = 1/87 (1%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPD-FLGSMTHLQSLNLANNKFSG 138
SL L N + + + L L+L L ++ L+ LNL+++
Sbjct: 380 SLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI 439
Query: 139 SIPATWSQLSNLKHLDLSSNNLTGRIP 165
S + L L+HL+L N+
Sbjct: 440 SSEQLFDGLPALQHLNLQGNHFPKGNI 466
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 9e-14
Identities = 23/97 (23%), Positives = 44/97 (45%), Gaps = 3/97 (3%)
Query: 77 NVISLTLGSNGFSGKISP-SITKLKFLASLELQDNDL--SGTLPDFLGSMTHLQSLNLAN 133
++ L++ N ++ + L+ L L+L +D+ S L +++HLQSLNL+
Sbjct: 326 SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSY 385
Query: 134 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
N+ + + L+ LDL+ L + F
Sbjct: 386 NEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQ 422
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 20/94 (21%), Positives = 34/94 (36%), Gaps = 1/94 (1%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ +L L +N +++ K L L +S L + L+SL L +N
Sbjct: 82 RLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHI 141
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
S LK LD +N + + + S
Sbjct: 142 SSIKLPKGFPTEKLKVLDFQNNAIHY-LSKEDMS 174
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 22/97 (22%), Positives = 35/97 (36%), Gaps = 4/97 (4%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGT---LPDFLGSMTHLQSLNLAN 133
+ L L + L L L LQ N + L ++ L+ L L+
Sbjct: 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF 485
Query: 134 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
S ++ L + H+DLS N LT ++ S
Sbjct: 486 CDLSSIDQHAFTSLKMMNHVDLSHNRLTS-SSIEALS 521
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 17/91 (18%), Positives = 25/91 (27%), Gaps = 1/91 (1%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L L + L +L L N L L L+ L S
Sbjct: 61 FLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSI 120
Query: 140 IPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
L+ L L SN+++ I +
Sbjct: 121 DFIPLHNQKTLESLYLGSNHISS-IKLPKGF 150
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 29/118 (24%), Positives = 47/118 (39%), Gaps = 7/118 (5%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLE---LQDNDLSGTLPDFLGSMTHLQSLNLAN 133
+ L L N F L+ L LE L DLS S+ + ++L++
Sbjct: 450 ALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSH 509
Query: 134 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP---MQLFSVATFNFTGTHLICGSSLE 188
N+ + S S L + +L+L+SN+++ +P L T N L C S
Sbjct: 510 NRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNI 566
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 24/95 (25%), Positives = 33/95 (34%), Gaps = 5/95 (5%)
Query: 80 SLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 138
L L K + S L L L L + L + + LQ LNL N F
Sbjct: 404 LLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK 463
Query: 139 SI---PATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ L L+ L LS +L+ I F+
Sbjct: 464 GNIQKTNSLQTLGRLEILVLSFCDLSS-IDQHAFT 497
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 9e-12
Identities = 24/100 (24%), Positives = 34/100 (34%), Gaps = 3/100 (3%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L G S + K L SL L N +S L+ L+ NN
Sbjct: 106 ALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAI 165
Query: 137 SGSIPATWSQLSNLKH--LDLSSNNLTGRIPMQLFSVATF 174
S L + L+L+ N++ G I F A F
Sbjct: 166 HYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVF 204
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 23/93 (24%), Positives = 39/93 (41%), Gaps = 1/93 (1%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L L S + T LK + ++L N L+ + + L + + LNLA+N
Sbjct: 477 RLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHI 535
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 169
S +P+ LS + ++L N L F
Sbjct: 536 SIILPSLLPILSQQRTINLRQNPLDCTCSNIYF 568
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 16/101 (15%), Positives = 29/101 (28%), Gaps = 6/101 (5%)
Query: 74 RNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLG--SMTHLQSLNL 131
+ +SL L N I P SL + L ++ L
Sbjct: 177 QQATNLSLNLNGN-DIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTF 235
Query: 132 ANNKFSGSIPATWSQLS--NLKHLDLSSNNLTGRIPMQLFS 170
+ PA + L +++ ++L + I F
Sbjct: 236 EDMDDEDISPAVFEGLCEMSVESINLQKHYFFN-ISSNTFH 275
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 18/105 (17%), Positives = 36/105 (34%), Gaps = 21/105 (20%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ + L N + +++ LK + L L N +S LP L ++ +++NL N
Sbjct: 501 MMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPL 559
Query: 137 SGSIPATW--------------------SQLSNLKHLDLSSNNLT 161
+ + L+ + LS L+
Sbjct: 560 DCTCSNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 15/67 (22%), Positives = 27/67 (40%), Gaps = 4/67 (5%)
Query: 104 SLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGR 163
+ ++ L+ +P L + + L + N T+S+L NL LDL+ +
Sbjct: 16 TYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW- 71
Query: 164 IPMQLFS 170
I F
Sbjct: 72 IHEDTFQ 78
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 13/88 (14%), Positives = 24/88 (27%), Gaps = 3/88 (3%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLS-GTLPDFLGSMTHLQSLNLANNK 135
+ L +N ++ L+ +L L N + QSLN +
Sbjct: 154 KLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQ 213
Query: 136 FSGSIPA--TWSQLSNLKHLDLSSNNLT 161
I S + +L +
Sbjct: 214 NLLVIFKGLKNSTIQSLWLGTFEDMDDE 241
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 51/221 (23%), Positives = 84/221 (38%), Gaps = 38/221 (17%)
Query: 270 TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQ---------REV 319
+ IG G G V + VA+K+L FQ RE+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR--------PFQNQTHAKRAYREL 75
Query: 320 HLISVAIHKNLLQLI------GYCTTSSERILVYPFMQ-NLSVAYRLRDLKPGEKGLDWP 372
L+ HKN++ L+ + +V M NL + LD
Sbjct: 76 VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--------MELDHE 127
Query: 373 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432
+ + G+++LH + IIHRDLK +NI++ + + DFGLA+ + +
Sbjct: 128 RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFM 182
Query: 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
T T + APE + E D++ G + E++ G
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 4e-15
Identities = 47/215 (21%), Positives = 75/215 (34%), Gaps = 49/215 (22%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLIS 323
D + +G G F V K S + A K + + +REV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 324 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWPTRKRVAFGTA 382
+H N++ L ++ +L+ + GE L D +A +
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSG------------GE--LFD-----FLAQKES 111
Query: 383 Y--------------GLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGLAKL 424
G+ YLH + KI H DLK NI+L L DFGLA
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 459
++ I GT +APE ++ + D+
Sbjct: 169 IEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADM 201
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 5e-15
Identities = 52/221 (23%), Positives = 84/221 (38%), Gaps = 38/221 (17%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REV 319
+ IG G G V + VA+K+L FQ RE+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR--------PFQNQTHAKRAYREL 112
Query: 320 HLISVAIHKNLLQLI------GYCTTSSERILVYPFMQ-NLSVAYRLRDLKPGEKGLDWP 372
L+ HKN++ L+ + LV M NL + LD
Sbjct: 113 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--------MELDHE 164
Query: 373 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432
+ + G+++LH + IIHRDLK +NI++ + + DFGLA+ + +
Sbjct: 165 RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFM 219
Query: 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
T T + APE + E D++ G + E+V +
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 44/199 (22%), Positives = 73/199 (36%), Gaps = 38/199 (19%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLLQLIG 335
++G G GKV + K A+K LQD +REV + ++++++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVD 122
Query: 336 -YCTTSSERILVYPFMQNLSVAYRLRDLKPG--------EKGLDWPTRKRVAFGT---AY 383
Y + R + M + G ++G T + +
Sbjct: 123 VYENLYAGRKCLLIVM----------ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAV---LCDFGLAKLVDAKLTHVTTQIRGTM 440
++YLH I HRD+K N+L L DFG AK + + T T
Sbjct: 173 AIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTPCYTP 227
Query: 441 GHIAPEYLSTGKSSEKTDV 459
++APE L K + D+
Sbjct: 228 YYVAPEVLGPEKYDKSCDM 246
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 24/113 (21%), Positives = 40/113 (35%), Gaps = 6/113 (5%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L + N F ++ L L+L L ++ LQ LN+++N
Sbjct: 453 LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFL 512
Query: 140 IPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVAT----FNFTGTHLICGSSLE 188
+ ++QL +L LD S N + L FN T + C +
Sbjct: 513 DSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSVACICEHQ 564
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 20/91 (21%), Positives = 32/91 (35%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L L + L L++L L N + P +T L++L K +
Sbjct: 60 WLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASL 119
Query: 140 IPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
QL LK L+++ N + FS
Sbjct: 120 ESFPIGQLITLKKLNVAHNFIHSCKLPAYFS 150
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 18/94 (19%), Positives = 34/94 (36%), Gaps = 1/94 (1%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ ++ L N S S + L L+L ++ + HL +L L N
Sbjct: 33 STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
P ++S L++L++L L +
Sbjct: 93 QSFSPGSFSGLTSLENLVAVETKLAS-LESFPIG 125
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 6e-14
Identities = 26/95 (27%), Positives = 44/95 (46%), Gaps = 2/95 (2%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
++ +L L N S + L L +L + L+ +G + L+ LN+A+N
Sbjct: 81 HLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFI 140
Query: 137 SG-SIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+PA +S L+NL H+DLS N + I +
Sbjct: 141 HSCKLPAYFSNLTNLVHVDLSYNYIQT-ITVNDLQ 174
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 18/95 (18%), Positives = 37/95 (38%), Gaps = 2/95 (2%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLP-DFLGSMTHLQSLNLANNK 135
++ L L NG +S + L+ L L+ Q + L S+ L L+++
Sbjct: 377 SLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTN 435
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ L++L L ++ N+ +F+
Sbjct: 436 TKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFA 470
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 15/85 (17%), Positives = 29/85 (34%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L L L L L + N+L + L +L+ + N+
Sbjct: 474 NLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRI 533
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
S +L +L++N++
Sbjct: 534 ETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 21/99 (21%), Positives = 37/99 (37%), Gaps = 6/99 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSG-TLPDFLGSMTHLQSLNLANNK 135
++ +L + S I +L L L + N + LP + ++T+L ++L+ N
Sbjct: 105 SLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNY 164
Query: 136 FSGSIPATWSQLSNLK----HLDLSSNNLTGRIPMQLFS 170
L LD+S N + I Q F
Sbjct: 165 IQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQ 202
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 25/84 (29%), Positives = 37/84 (44%), Gaps = 7/84 (8%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
SL++ L FL SL L N S + ++ L L+L+ N S S
Sbjct: 311 SLSIIRCQLK---QFPTLDLPFLKSLTLTMNKGSISFK--KVALPSLSYLDLSRNALSFS 365
Query: 140 IPATWSQL--SNLKHLDLSSNNLT 161
++S L ++L+HLDLS N
Sbjct: 366 GCCSYSDLGTNSLRHLDLSFNGAI 389
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 26/94 (27%), Positives = 36/94 (38%), Gaps = 8/94 (8%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
NV +++L + K SL + L L L+SL L NK
Sbjct: 286 NVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTLDL---PFLKSLTLTMNK- 339
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
GSI L +L +LDLS N L+ +S
Sbjct: 340 -GSISFKKVALPSLSYLDLSRNALSF-SGCCSYS 371
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 14/91 (15%), Positives = 26/91 (28%), Gaps = 9/91 (9%)
Query: 80 SLTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGTL------PDFLGSMTHLQ--SLN 130
LTL N S I + L L L + P + + +
Sbjct: 208 ELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFR 267
Query: 131 LANNKFSGSIPATWSQLSNLKHLDLSSNNLT 161
L + L+N+ + L+ ++
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIK 298
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 19/81 (23%), Positives = 38/81 (46%), Gaps = 5/81 (6%)
Query: 90 GKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSN 149
G ++P I + + + + D LS +PD + S ++++L+ N ++S S
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57
Query: 150 LKHLDLSSNNLTGRIPMQLFS 170
L+ LDLS + I + +
Sbjct: 58 LQWLDLSRCEIET-IEDKAWH 77
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 8e-05
Identities = 7/78 (8%), Positives = 21/78 (26%), Gaps = 2/78 (2%)
Query: 104 SLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGR 163
L + + ++ +++LA + + + L + L
Sbjct: 265 EFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLED-VPKHFKWQSLSIIRCQLKQF 322
Query: 164 IPMQLFSVATFNFTGTHL 181
+ L + + T
Sbjct: 323 PTLDLPFLKSLTLTMNKG 340
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 6e-15
Identities = 48/224 (21%), Positives = 85/224 (37%), Gaps = 50/224 (22%)
Query: 261 FSCRELQLATDNFSE------SNIIGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYS 308
F R + + + I+G G FG+V+K + K+A K ++D
Sbjct: 73 FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD--- 129
Query: 309 PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG 368
+ + E+ +++ H NL+QL + ++ +LV ++ GE
Sbjct: 130 ---KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG------------GE-- 172
Query: 369 L-DWPTRKRVAFGTAY----------GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL- 416
L D + G+ ++H+ I+H DLK NIL + +
Sbjct: 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIK 229
Query: 417 -CDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 459
DFGLA+ + GT +APE ++ S TD+
Sbjct: 230 IIDFGLARRYKPR--EKLKVNFGTPEFLAPEVVNYDFVSFPTDM 271
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 6e-15
Identities = 52/204 (25%), Positives = 81/204 (39%), Gaps = 33/204 (16%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 327
+ ++ ++G+G FG+V K + AVK + + REV L+ H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-----RVAFGTA 382
N+++L SS +V +L G + D ++ A
Sbjct: 81 PNIMKLFEILEDSSSFYIV---G----------ELYTGGELFDEIIKRKRFSEHDAARII 127
Query: 383 Y----GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQ 435
G+ Y+H+ I+HRDLK NILL + + + + DFGL+
Sbjct: 128 KQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKD 182
Query: 436 IRGTMGHIAPEYLSTGKSSEKTDV 459
GT +IAPE L G EK DV
Sbjct: 183 RIGTAYYIAPEVLR-GTYDEKCDV 205
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 6e-15
Identities = 43/202 (21%), Positives = 76/202 (37%), Gaps = 26/202 (12%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 328
D F +G G FG V+ S + +K + S + E+ ++ H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLS--------VAYRLRDLKPGEKGLDWPTRKRVAFG 380
N++++ +V M+ V+ + R E + ++ +
Sbjct: 81 NIIKIFEVFEDYHNMYIV---METCEGGELLERIVSAQARGKALSEGYVAELMKQMMN-- 135
Query: 381 TAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQIR 437
L Y H Q ++H+DLK NIL + + DFGLA+L + +T
Sbjct: 136 ---ALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS--DEHSTNAA 187
Query: 438 GTMGHIAPEYLSTGKSSEKTDV 459
GT ++APE + K D+
Sbjct: 188 GTALYMAPEVFK-RDVTFKCDI 208
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 75.0 bits (184), Expect = 6e-15
Identities = 32/99 (32%), Positives = 51/99 (51%), Gaps = 12/99 (12%)
Query: 378 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 437
+F A G+E+L + K IHRDL A NILL + +CDFGLA+ + +V R
Sbjct: 199 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV----R 251
Query: 438 GTMGHI-----APEYLSTGKSSEKTDVFGYGITLLELVT 471
+ APE + + ++DV+ +G+ L E+ +
Sbjct: 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 23/90 (25%), Positives = 39/90 (43%), Gaps = 8/90 (8%)
Query: 271 DNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREV-HLIS 323
D +G+G FG+V + + VAVK L++ + A E+ LI
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 324 VAIHKNLLQLIGYCTTSSERILV-YPFMQN 352
+ H N++ L+G CT ++V F +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKF 111
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 7e-15
Identities = 47/215 (21%), Positives = 75/215 (34%), Gaps = 49/215 (22%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLIS 323
D + +G G F V K S + A K + + +REV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 324 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWPTRKRVAFGTA 382
+H N++ L ++ +L+ + GE L D +A +
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSG------------GE--LFD-----FLAQKES 111
Query: 383 Y--------------GLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGLAKL 424
G+ YLH + KI H DLK NI+L L DFGLA
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 459
++ I GT +APE ++ + D+
Sbjct: 169 IED--GVEFKNIFGTPEFVAPEIVNYEPLGLEADM 201
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 8e-15
Identities = 53/236 (22%), Positives = 91/236 (38%), Gaps = 50/236 (21%)
Query: 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLI 322
++++L ++F +IG+G FG+V L + KV A+K L + E + E
Sbjct: 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW-----EMLKRAETA-- 119
Query: 323 SVAIHKNLLQLIGYCTTSSERILVY---PFMQNLSVA-------YRLRDLKPG------- 365
C +LV ++ L A Y + D G
Sbjct: 120 --------------CFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL 165
Query: 366 EKGLDWPTRKRVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422
K D + F A ++ +H+ +HRD+K NIL+D N L DFG
Sbjct: 166 SKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSC 222
Query: 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT-----DVFGYGITLLELVTGQ 473
+ T ++ GT +I+PE L + + D + G+ + E++ G+
Sbjct: 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 34/203 (16%), Positives = 75/203 (36%), Gaps = 33/203 (16%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 328
+ + + +G+G FG V++ V S K ++ + ++E+ ++++A H+
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHR 61
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG----TAY- 383
N+L L + E ++++ F+ + + +Y
Sbjct: 62 NILHLHESFESMEELVMIFEFISG------------LDI-FERINTSAFELNEREIVSYV 108
Query: 384 -----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL--CDFGLAKLVDAKLTHVTTQI 436
L++LH I H D++ NI+ + + +FG A+ + +
Sbjct: 109 HQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLL 163
Query: 437 RGTMGHIAPEYLSTGKSSEKTDV 459
+ APE S TD+
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDM 186
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 34/93 (36%), Positives = 50/93 (53%), Gaps = 10/93 (10%)
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGTMGHI 443
LEYLH + IIHRDLK NILL+++ + DFG AK++ + GT ++
Sbjct: 143 LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199
Query: 444 APEYLST---GKSSEKTDVFGYGITLLELVTGQ 473
+PE L+ KSS D++ G + +LV G
Sbjct: 200 SPELLTEKSACKSS---DLWALGCIIYQLVAGL 229
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 45/214 (21%), Positives = 79/214 (36%), Gaps = 45/214 (21%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK-------RLQDYYSPGGEAAFQREVHL 321
D + S +G G G+V KVA+K + + E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 322 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG--------EKG-LDWP 372
+ H ++++ + Y + +L G L
Sbjct: 69 LKKLNHPCIIKIKNFFDAED----YYIVL----------ELMEGGELFDKVVGNKRLKEA 114
Query: 373 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKL 429
T K + ++YLHE IIHRDLK N+LL +++ + DFG +K++
Sbjct: 115 TCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-- 169
Query: 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYG 463
T + + GT ++APE L + ++ GY
Sbjct: 170 TSLMRTLCGTPTYLAPEVLVSVGTA------GYN 197
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 40/204 (19%), Positives = 73/204 (35%), Gaps = 31/204 (15%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 327
T+ + +G+G F V + V + + A + S +RE + + H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-----RVAFGTA 382
N+++L + L+ DL G + + + A
Sbjct: 70 PNIVRLHDSISEEGHHYLI---F----------DLVTGGELFEDIVAREYYSEADASHCI 116
Query: 383 Y----GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQ 435
+ + H+ ++HR+LK N+LL L DFGLA V+ +
Sbjct: 117 QQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFG 172
Query: 436 IRGTMGHIAPEYLSTGKSSEKTDV 459
GT G+++PE L + D+
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDL 196
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 52/228 (22%)
Query: 270 TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQ---------REV 319
+ + + +G G +G V + +VAVK+L FQ RE+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR--------PFQSIIHAKRTYREL 79
Query: 320 HLISVAIHKNLLQLI------GYCTTSSERILVYPFMQ-NLSVAYRLRDLKPGEKGLDWP 372
L+ H+N++ L+ ++ LV M +L+ + + L
Sbjct: 80 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL---------- 129
Query: 373 TRKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428
T V F Y GL+Y+H + IIHRDLK +N+ ++++ E + DFGLA+ +
Sbjct: 130 TDDHVQF-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185
Query: 429 LT-HVTTQ-IRGTMGHIAPE-YLSTGKSSEKTDVFGYGITLLELVTGQ 473
+T +V T+ R APE L+ ++ D++ G + EL+TG+
Sbjct: 186 MTGYVATRWYR------APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 46/215 (21%), Positives = 75/215 (34%), Gaps = 49/215 (22%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLIS 323
D + +G G F V K S + A K R + +REV ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 324 VAIHKNLLQLIGYCTTSSERILVYPFMQ------------NLS---VAYRLRDLKPGEKG 368
H N++ L ++ IL+ + +L+ L+ +
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI------ 123
Query: 369 LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGLAKL 424
L+ G+ YLH +I H DLK NI+L + DFGLA
Sbjct: 124 LN-------------GVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 459
+D + I GT +APE ++ + D+
Sbjct: 168 IDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADM 200
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 48/227 (21%), Positives = 99/227 (43%), Gaps = 46/227 (20%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REV 319
++ + IG+G +G V + +VA+K++ F+ RE+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS---------PFEHQTYCQRTLREI 76
Query: 320 HLISVAIHKNLLQLIGYCTTSSERI-----LVYPFMQ-NLSVAYRLRDLKPGEKGLDWPT 373
++ H+N++ + + +V M+ +L + + L +
Sbjct: 77 KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHL----------S 126
Query: 374 RKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429
+ + Y GL+Y+H + ++HRDLK +N+LL+ + +CDFGLA++ D
Sbjct: 127 NDHICYFL-YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182
Query: 430 THVT--TQIRGTMGHIAPEY-LSTGKSSEKTDVFGYGITLLELVTGQ 473
H T+ T + APE L++ ++ D++ G L E+++ +
Sbjct: 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 53/224 (23%), Positives = 89/224 (39%), Gaps = 24/224 (10%)
Query: 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVH 320
+E++L D+F +IG+G F +V + +V A+K + D G + F+ E
Sbjct: 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERD 113
Query: 321 LISVAIHKNLLQLIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF 379
++ + + QL + + LV + + L K GE+ + F
Sbjct: 114 VLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLS--KFGERI----PAEMARF 166
Query: 380 GTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 436
A ++ +H +HRD+K NILLD L DFG + A T +
Sbjct: 167 YLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA 223
Query: 437 RGTMGHIAPEYLSTGKSSEKTDVFG-------YGITLLELVTGQ 473
GT +++PE L T +G G+ E+ GQ
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 58/236 (24%), Positives = 96/236 (40%), Gaps = 44/236 (18%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336
IG+G F KV + +VA+K + +P REV ++ + H N+++L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--------RVAFG-TAYGLEY 387
T L+ + GE D+ R F ++Y
Sbjct: 83 IETEKTLYLIMEYASG------------GE-VFDYLVAHGRMKEKEARSKFRQIVSAVQY 129
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKL-THVTTQIRGTMGHIA 444
H++ I+HRDLKA N+LLD + + DFG + KL G + A
Sbjct: 130 CHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC-----GAPPYAA 181
Query: 445 PEYLSTGKSSE--KTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHKVTEGR 498
PE GK + + DV+ G+ L LV+G ++ F + +++ L +V G+
Sbjct: 182 PELFQ-GKKYDGPEVDVWSLGVILYTLVSG--SLPF----DGQNLKELRERVLRGK 230
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 5e-14
Identities = 50/215 (23%), Positives = 81/215 (37%), Gaps = 41/215 (19%)
Query: 264 RELQLATDNFSE----SNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQRE 318
++L + F++ IG G + + + + N + AVK + E
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP-----TEE 65
Query: 319 VH-LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-- 375
+ L+ H N++ L +V +L G + LD R+
Sbjct: 66 IEILLRYGQHPNIITLKDVYDDGKYVYVV---T----------ELMKGGELLDKILRQKF 112
Query: 376 -------RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAV-LCDFGLAKL 424
V F +EYLH Q ++HRDLK +NIL N E++ +CDFG AK
Sbjct: 113 FSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169
Query: 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 459
+ A+ + T +APE L D+
Sbjct: 170 LRAE-NGLLMTPCYTANFVAPEVLERQGYDAACDI 203
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 43/249 (17%), Positives = 83/249 (33%), Gaps = 60/249 (24%)
Query: 270 TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAF-QREVHLISVAIH 327
+ +S +G G FG V + + + A+K++ + + RE+ ++ V H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDH 59
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTR------------- 374
N+++L+ Y T+ + P + ++
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 375 -----KRVAFGTA---------------Y----GLEYLHEQCNPKIIHRDLKAANILLD- 409
+V Y + ++H I HRD+K N+L++
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNS 176
Query: 410 DNFEAVLCDFGLAKLV--DAKLTH--VTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGI 464
+ LCDFG AK + + R APE + + D++ G
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR------APELMLGATEYTPSIDLWSIGC 230
Query: 465 TLLELVTGQ 473
EL+ G+
Sbjct: 231 VFGELILGK 239
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 6e-14
Identities = 47/204 (23%), Positives = 75/204 (36%), Gaps = 32/204 (15%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 327
+DN+ +G+G F V + V + + A K + S +RE + H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-----RVAFGTA 382
N+++L S LV DL G + + + A
Sbjct: 65 PNIVRLHDSIQEESFHYLV---F----------DLVTGGELFEDIVAREFYSEADASHCI 111
Query: 383 Y----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAV---LCDFGLAKLVDAKLTHVTTQ 435
+ Y H I+HR+LK N+LL + L DFGLA V+ +
Sbjct: 112 QQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHG 166
Query: 436 IRGTMGHIAPEYLSTGKSSEKTDV 459
GT G+++PE L S+ D+
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKPVDI 190
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 9e-14
Identities = 47/202 (23%), Positives = 72/202 (35%), Gaps = 47/202 (23%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLLQLIG 335
+G+G F K V N AVK + EA Q+E+ L H N+++L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLCEGHPNIVKLHE 73
Query: 336 YCTTSS---------------ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 380
ERI +Y +R L
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKL------------------ 115
Query: 381 TAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQIR 437
+ ++H+ ++HRDLK N+L +DN E + DFG A+L + T
Sbjct: 116 -VSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC- 170
Query: 438 GTMGHIAPEYLSTGKSSEKTDV 459
T+ + APE L+ E D+
Sbjct: 171 FTLHYAAPELLNQNGYDESCDL 192
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 9e-14
Identities = 49/216 (22%), Positives = 85/216 (39%), Gaps = 48/216 (22%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
+G+G +G+V V VAVK + + ++E+ + + H+N+++ G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 338 TTSSERILVYPFMQNLSVAYRLRDLKPGE-------KGLDWPTRKRVAFGTA-------- 382
+ + L + GE + A
Sbjct: 75 REGNIQYLFLEYCSG------------GELFDRIEPDI-------GMPEPDAQRFFHQLM 115
Query: 383 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD----AKLTHVTTQIRG 438
G+ YLH I HRD+K N+LLD+ + DFGLA + +L + G
Sbjct: 116 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---G 169
Query: 439 TMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTG 472
T+ ++APE L + +E DV+ GI L ++ G
Sbjct: 170 TLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAG 204
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 37/223 (16%)
Query: 271 DNFSESNIIGQGGFGKVY---KGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAI 326
+NF ++G G +GKV+ K D K+ A+K L+ Q+
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKK------ATIVQKAKTTEHTRT 107
Query: 327 HKNLLQLIG---------YCTTSSERI-LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRK 375
+ +L+ I Y + ++ L+ ++ + L + + E
Sbjct: 108 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH-------- 159
Query: 376 RVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432
V LE+LH+ II+RD+K NILLD N VL DFGL+K A T
Sbjct: 160 EVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER 216
Query: 433 TTQIRGTMGHIAPEYLSTGKSSEKTDV--FGYGITLLELVTGQ 473
GT+ ++AP+ + G S V + G+ + EL+TG
Sbjct: 217 AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 47/204 (23%), Positives = 74/204 (36%), Gaps = 32/204 (15%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 327
+DN+ +G+G F V + V + + A K + S +RE + H
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-----RVAFGTA 382
N+++L S LV DL G + + + A
Sbjct: 88 PNIVRLHDSIQEESFHYLV---F----------DLVTGGELFEDIVAREFYSEADASHCI 134
Query: 383 Y----GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQ 435
+ Y H I+HR+LK N+LL L DFGLA V+ +
Sbjct: 135 QQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHG 189
Query: 436 IRGTMGHIAPEYLSTGKSSEKTDV 459
GT G+++PE L S+ D+
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDI 213
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 20/93 (21%), Positives = 38/93 (40%), Gaps = 3/93 (3%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
++L L S + +L L + + L LPD + L++L LA
Sbjct: 78 ATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLA 135
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP 165
N ++PA+ + L+ L+ L + + +P
Sbjct: 136 RNPLR-ALPASIASLNRLRELSIRACPELTELP 167
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 5e-11
Identities = 23/92 (25%), Positives = 40/92 (43%), Gaps = 1/92 (1%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ SL + ++ S + P+I L L L+L+ P G L+ L L +
Sbjct: 207 NLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSN 265
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL 168
++P +L+ L+ LDL R+P +
Sbjct: 266 LLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLI 297
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 17/91 (18%), Positives = 30/91 (32%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI 140
L L P L L L+D TLP + +T L+ L+L +
Sbjct: 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRL 293
Query: 141 PATWSQLSNLKHLDLSSNNLTGRIPMQLFSV 171
P+ +QL + + + + +
Sbjct: 294 PSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 27/94 (28%), Positives = 42/94 (44%), Gaps = 11/94 (11%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGS---------MTHLQ 127
+ +LTL N + SI L L L ++ LP+ L S + +LQ
Sbjct: 128 GLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQ 186
Query: 128 SLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLT 161
SL L S+PA+ + L NLK L + ++ L+
Sbjct: 187 SLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS 219
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 39/221 (17%)
Query: 271 DNFSESNIIGQGGFGKVY---KGVLSDNTKV-AVKRLQDYYSPGGEAAFQR-EVHLISVA 325
F ++GQG FGKV+ K SD ++ A+K L+ R V
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK------ATLKVRDRVRTKM-- 75
Query: 326 IHKNLLQLIG--------YCTTSSERI-LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRK 375
+++L + Y + ++ L+ F++ + RL +++ E+
Sbjct: 76 -ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-------- 126
Query: 376 RVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432
V F A L++LH II+RDLK NILLD+ L DFGL+K
Sbjct: 127 DVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKK 182
Query: 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
GT+ ++APE ++ ++ D + +G+ + E++TG
Sbjct: 183 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 2e-13
Identities = 60/234 (25%), Positives = 100/234 (42%), Gaps = 39/234 (16%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
+G G FGKV G KVAVK L Q S +RE+ + + H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGE-------KGLDWPTRKRVAFG-TAYGLEY 387
+T ++ +V ++ GE G R F ++Y
Sbjct: 79 VISTPTDFFMVMEYVSG------------GELFDYICKHGRVEEMEARRLFQQILSAVDY 126
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL-VDAKLTHVTTQIRGTMGHIAPE 446
H ++HRDLK N+LLD + A + DFGL+ + D + + G+ + APE
Sbjct: 127 CHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPE 180
Query: 447 YLSTGK--SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHKVTEGR 498
+S G+ + + D++ G+ L L+ G + F ++E V L K+ G
Sbjct: 181 VIS-GRLYAGPEVDIWSCGVILYALLCG--TLPF----DDEHVPTLFKKIRGGV 227
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 2e-13
Identities = 42/200 (21%), Positives = 72/200 (36%), Gaps = 43/200 (21%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLISVAIHKNLL 331
IG+G +G+V V + A K ++D F++E+ ++ H N++
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED------VDRFKQEIEIMKSLDHPNII 69
Query: 332 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-----RVAFGTAY--- 383
+L +++ LV M +L G + + K A
Sbjct: 70 RLYETFEDNTDIYLV---M----------ELCTGGELFERVVHKRVFRESDAARIMKDVL 116
Query: 384 -GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT 439
+ Y H+ + HRDLK N L + L DFGLA + GT
Sbjct: 117 SAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP--GKMMRTKVGT 171
Query: 440 MGHIAPEYLSTGKSSEKTDV 459
+++P+ L G + D
Sbjct: 172 PYYVSPQVLE-GLYGPECDE 190
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 50/221 (22%), Positives = 87/221 (39%), Gaps = 32/221 (14%)
Query: 267 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVA 325
++ + F ++G+G FGKV + A+K L+ + + +
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILK-------KEVIVAKDEVAHTL 196
Query: 326 IHKNLLQLIG--------YCTTSSERI-LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRK 375
+LQ Y + +R+ V + + + L R+ E
Sbjct: 197 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-------- 248
Query: 376 RVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432
R F A L+YLH + N +++RDLK N++LD + + DFGL K K
Sbjct: 249 RARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGAT 305
Query: 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
GT ++APE L D +G G+ + E++ G+
Sbjct: 306 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 50/225 (22%), Positives = 80/225 (35%), Gaps = 52/225 (23%)
Query: 269 ATDNFSES---------NIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQRE 318
+TD+FS +++G+G +V + L + + AVK ++ F RE
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF-RE 60
Query: 319 VH-LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 377
V L H+N+L+LI + LV+ M+ S+ + KR
Sbjct: 61 VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH--------------KRR 106
Query: 378 AFG----------TAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKL 424
F A L++LH + I HRDLK NIL + +CDF L
Sbjct: 107 HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163
Query: 425 VDAKLTHVTTQIR------GTMGHIAPEYLSTGKSSEKTDVFGYG 463
+ G+ ++APE + Y
Sbjct: 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEAS----IYD 204
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 50/206 (24%), Positives = 81/206 (39%), Gaps = 40/206 (19%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL---QDYYSPGGEAAFQREVHLISVA 325
+D F + +G+G VY+ A+K L D + + E+ ++
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD------KKIVRTEIGVLLRL 105
Query: 326 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-----RVAFG 380
H N+++L T +E LV + +L G + D K R A
Sbjct: 106 SHPNIIKLKEIFETPTEISLV---L----------ELVTGGELFDRIVEKGYYSERDAAD 152
Query: 381 TAY----GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVT 433
+ YLHE I+HRDLK N+L + + DFGL+K+V+ +
Sbjct: 153 AVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--QVLM 207
Query: 434 TQIRGTMGHIAPEYLSTGKSSEKTDV 459
+ GT G+ APE L + D+
Sbjct: 208 KTVCGTPGYCAPEILRGCAYGPEVDM 233
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 49/216 (22%), Positives = 85/216 (39%), Gaps = 48/216 (22%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
+G+G +G+V V VAVK + + ++E+ + + H+N+++ G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 338 TTSSERILVYPFMQNLSVAYRLRDLKPGE-------KGLDWPTRKRVAFGTA-------- 382
+ + L + GE + A
Sbjct: 75 REGNIQYLFLEYCSG------------GELFDRIEPDI-------GMPEPDAQRFFHQLM 115
Query: 383 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD----AKLTHVTTQIRG 438
G+ YLH I HRD+K N+LLD+ + DFGLA + +L + G
Sbjct: 116 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---G 169
Query: 439 TMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTG 472
T+ ++APE L + +E DV+ GI L ++ G
Sbjct: 170 TLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAG 204
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-13
Identities = 20/84 (23%), Positives = 38/84 (45%), Gaps = 2/84 (2%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ LT+ + + +P I+ L L L + D++ L +T L L+++++
Sbjct: 67 NIKDLTINNIHAT-NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAH 124
Query: 137 SGSIPATWSQLSNLKHLDLSSNNL 160
SI + L + +DLS N
Sbjct: 125 DDSILTKINTLPKVNSIDLSYNGA 148
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 6e-12
Identities = 14/85 (16%), Positives = 36/85 (42%), Gaps = 1/85 (1%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L + + P+++ L L L++ + ++ + ++ + S++L+ N
Sbjct: 89 NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
I L LK L++ + +
Sbjct: 149 ITDIMPL-KTLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 4e-11
Identities = 14/92 (15%), Positives = 38/92 (41%), Gaps = 4/92 (4%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
++ +TL + + ++ I + L + + + P + +++L+ L +
Sbjct: 45 SLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDV 100
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL 168
+ S L++L LD+S + I ++
Sbjct: 101 TSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-09
Identities = 16/86 (18%), Positives = 30/86 (34%), Gaps = 3/86 (3%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
++ L + + I I L + S++L N + L ++ L+SLN+ +
Sbjct: 113 SLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGV 171
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTG 162
L L S + G
Sbjct: 172 HDYRGI--EDFPKLNQLYAFSQTIGG 195
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 51/236 (21%), Positives = 85/236 (36%), Gaps = 53/236 (22%)
Query: 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLI 322
R+L++ +++ +IG+G FG+V KV A+K L
Sbjct: 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS-----------------K 104
Query: 323 SVAIHKNLLQLIGYCTTSSERILVY---PFMQNLSVA-------YRLRDLKPG------- 365
I ++ I+ + P++ L A Y + + PG
Sbjct: 105 FEMIKRSDSA----FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM 160
Query: 366 -EKGLDWPTRKRVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421
+ K F TA L+ +H IHRD+K N+LLD + L DFG
Sbjct: 161 SNYDVP---EKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 214
Query: 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK----TDVFGYGITLLELVTGQ 473
++ + GT +I+PE L + D + G+ L E++ G
Sbjct: 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 4e-13
Identities = 51/220 (23%), Positives = 91/220 (41%), Gaps = 35/220 (15%)
Query: 271 DNFSESNIIGQGGFGKVY---KGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAI 326
+ F ++G+GG+GKV+ K ++ K+ A+K L+ +
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKK------AMIVRNAKDTAHTKA 70
Query: 327 HKNLLQLIG--------YCTTSSERI-LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRKR 376
+N+L+ + Y + ++ L+ ++ + +L R+ E
Sbjct: 71 ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED--------T 122
Query: 377 VAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 433
F A L +LH++ II+RDLK NI+L+ L DFGL K VT
Sbjct: 123 ACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVT 178
Query: 434 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
GT+ ++APE L + D + G + +++TG
Sbjct: 179 HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 52/228 (22%), Positives = 84/228 (36%), Gaps = 58/228 (25%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
D F +G G FG+V ++ A+K L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-----------------KQKVVKLK 83
Query: 330 LLQLIGYCTTSSERILV---YPFMQNLSVA-------YRLRDLKPGEKG-LDWPTRKRVA 378
++ T + +RIL +PF+ L + Y + + G G + R+
Sbjct: 84 QIE----HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG--GEMFSHLRRIGR 137
Query: 379 FGTA----Y------GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428
F Y EYLH +I+RDLK N+L+D + DFG AK V +
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194
Query: 429 LTHVTTQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQ 473
T + GT +APE + + K+ D + G+ + E+ G
Sbjct: 195 ----TWTLCGTPEALAPEIILSKGYNKA---VDWWALGVLIYEMAAGY 235
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 7e-13
Identities = 22/94 (23%), Positives = 33/94 (35%), Gaps = 4/94 (4%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L L N + + L +L+L N L+ + S + ++L NNK
Sbjct: 170 TLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
I NL+H DL N FS
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 18/94 (19%), Positives = 41/94 (43%), Gaps = 5/94 (5%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
++ +L +N S ++S S + ++ L +N ++ G + +Q L+L N+
Sbjct: 100 SIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI 156
Query: 137 SG-SIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 169
+ + L+HL+L N + + Q+
Sbjct: 157 DTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV 189
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 7e-11
Identities = 19/81 (23%), Positives = 32/81 (39%), Gaps = 2/81 (2%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI 140
+ + ++ + L+L N LS L T L+ LNL++N
Sbjct: 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ET 73
Query: 141 PATWSQLSNLKHLDLSSNNLT 161
LS L+ LDL++N +
Sbjct: 74 LDL-ESLSTLRTLDLNNNYVQ 93
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 16/63 (25%), Positives = 28/63 (44%)
Query: 99 LKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSN 158
++ D+ L L S +++ L+L+ N S A + + L+ L+LSSN
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 159 NLT 161
L
Sbjct: 69 VLY 71
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 22/94 (23%), Positives = 38/94 (40%), Gaps = 8/94 (8%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
NV L L N S + + L L L N L D S++ L++L+L NN
Sbjct: 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETLDL-ESLSTLRTLDLNNNYV 92
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ +++ L ++NN++ R+
Sbjct: 93 Q-ELL----VGPSIETLHAANNNIS-RVSCSRGQ 120
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 16/85 (18%), Positives = 34/85 (40%), Gaps = 8/85 (9%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ +L L +N + + +L +N++S + +++ LANNK
Sbjct: 81 TLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVS--CSRGQGKKNIYLANNKI 132
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
+ S +++LDL N +
Sbjct: 133 TMLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 15/84 (17%), Positives = 35/84 (41%), Gaps = 3/84 (3%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ +L L SN + + P + + L++N L + L +L+ +L N F
Sbjct: 192 KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249
Query: 137 S-GSIPATWSQLSNLKHLDLSSNN 159
G++ +S+ ++ + +
Sbjct: 250 HCGTLRDFFSKNQRVQTVAKQTVK 273
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 9/55 (16%), Positives = 23/55 (41%), Gaps = 1/55 (1%)
Query: 116 LPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ + + + + ++ ++ + N+K LDLS N L+ +I +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLA 55
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 9e-13
Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 39/234 (16%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
+G G FGKV G KVAVK L Q S +RE+ + + H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGE-------KGLDWPTRKRVAFG-TAYGLEY 387
+T S+ +V ++ GE G R F G++Y
Sbjct: 84 VISTPSDIFMVMEYVSG------------GELFDYICKNGRLDEKESRRLFQQILSGVDY 131
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL-VDAKLTHVTTQIRGTMGHIAPE 446
H ++HRDLK N+LLD + A + DFGL+ + D + + G+ + APE
Sbjct: 132 CHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPE 185
Query: 447 YLSTGKSSE--KTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHKVTEGR 498
+S G+ + D++ G+ L L+ G + F +++ V L K+ +G
Sbjct: 186 VIS-GRLYAGPEVDIWSSGVILYALLCG--TLPF----DDDHVPTLFKKICDGI 232
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 68.4 bits (166), Expect = 9e-13
Identities = 39/211 (18%), Positives = 59/211 (27%), Gaps = 44/211 (20%)
Query: 268 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVK--RLQDYYSPGGEAAFQREVHLISVA 325
L T+ IG+G FG+V++ + D+T VA+K ++ G E L +
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 326 IHKNLLQLIGYCTTSSERILVY--------PFMQNLSVAYRLRDLKPG------------ 365
I K L L G +E + + L A+ + G
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 366 -------------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANI 406
K T K + L + HRDL N+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNV 193
Query: 407 LLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 437
LL L K + I
Sbjct: 194 LLKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 54/210 (25%), Positives = 78/210 (37%), Gaps = 39/210 (18%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
IG G FG VAVK ++ + QRE+ H N+++
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 338 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWPTRK-RVAFGTA--------YGLEY 387
T + ++ + GE L + R + A G+ Y
Sbjct: 86 LTPTHLAIIMEYASG------------GE--LYERICNAGRFSEDEARFFFQQLLSGVSY 131
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVL--CDFGLAKL-VDAKLTHVTTQIRGTMGHIA 444
H +I HRDLK N LLD + L CDFG +K V T GT +IA
Sbjct: 132 CHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---GTPAYIA 185
Query: 445 PEYLSTGK--SSEKTDVFGYGITLLELVTG 472
PE L + + DV+ G+TL ++ G
Sbjct: 186 PEVLL-RQEYDGKIADVWSCGVTLYVMLVG 214
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 67.9 bits (167), Expect = 1e-12
Identities = 39/93 (41%), Positives = 50/93 (53%), Gaps = 13/93 (13%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
LEYLH + II+RDLK NILLD N + DFG AK V T + GT +I
Sbjct: 118 ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TYTLCGTPDYI 170
Query: 444 APEYLST---GKSSEKTDVFGYGITLLELVTGQ 473
APE +ST KS D + +GI + E++ G
Sbjct: 171 APEVVSTKPYNKS---IDWWSFGILIYEMLAGY 200
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 46/221 (20%), Positives = 79/221 (35%), Gaps = 44/221 (19%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK----RLQDYYSPGGEAAFQREVHLISV 324
D + +IG+G F V + + + AVK +RE + +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 325 AIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTR--KRVAFGTA 382
H ++++L+ ++ +V+ FM + KR G
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDG------------ADL-CF---EIVKRADAGFV 126
Query: 383 Y--------------GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLV 425
Y L Y H+ IIHRD+K +LL +++ L FG+A +
Sbjct: 127 YSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183
Query: 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITL 466
+ V GT +APE + + DV+G G+ L
Sbjct: 184 G-ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 19/201 (9%), Positives = 51/201 (25%), Gaps = 44/201 (21%)
Query: 279 IGQGGFGKVYKGVLSDNT---KVAVK--RLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 333
G + ++ + D +VA+ Q +S + ++
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 334 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 393
+ T + ++V + L+++ + R A + H
Sbjct: 97 LDVVHTRAGGLVV---AE-WIRGGSLQEV--ADTSPSPVGAIRAMQSLAAAADAAHRA-- 148
Query: 394 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS 453
+ + + + + + VL + +
Sbjct: 149 -GVALSIDHPSRVRVSIDGDVVLAYPATMPDANPQ------------------------- 182
Query: 454 SEKTDVFGYGITLLELVTGQR 474
D+ G G +L L+ +
Sbjct: 183 ---DDIRGIGASLYALLVNRW 200
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 61/234 (26%), Positives = 97/234 (41%), Gaps = 40/234 (17%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 335
+G+G FGKV KVA+K + Q +RE+ + + H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGE-------KGLDWPTRKRVAFG-TAYGLEY 387
TT ++ ++V + GE K R F +EY
Sbjct: 77 VITTPTDIVMVIEYAG-------------GELFDYIVEKKRMTEDEGRRFFQQIICAIEY 123
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL-VDAKLTHVTTQIRGTMGHIAPE 446
H KI+HRDLK N+LLDDN + DFGL+ + D + G+ + APE
Sbjct: 124 CHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE 177
Query: 447 YLSTGKSSE--KTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHKVTEGR 498
++ GK + DV+ GI L ++ G + F ++E + L KV
Sbjct: 178 VIN-GKLYAGPEVDVWSCGIVLYVMLVG--RLPF----DDEFIPNLFKKVNSCV 224
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 22/94 (23%), Positives = 33/94 (35%), Gaps = 4/94 (4%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L L N + + L +L+L N L+ + S + ++L NNK
Sbjct: 170 TLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
I NL+H DL N FS
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 18/94 (19%), Positives = 41/94 (43%), Gaps = 5/94 (5%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
++ +L +N S ++S S + ++ L +N ++ G + +Q L+L N+
Sbjct: 100 SIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI 156
Query: 137 SG-SIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 169
+ + L+HL+L N + + Q+
Sbjct: 157 DTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV 189
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 19/81 (23%), Positives = 32/81 (39%), Gaps = 2/81 (2%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI 140
+ + ++ + L+L N LS L T L+ LNL++N
Sbjct: 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ET 73
Query: 141 PATWSQLSNLKHLDLSSNNLT 161
LS L+ LDL++N +
Sbjct: 74 LD-LESLSTLRTLDLNNNYVQ 93
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 18/71 (25%), Positives = 32/71 (45%), Gaps = 3/71 (4%)
Query: 92 ISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLK 151
I + + K ++ D+ L L S +++ L+L+ N S A + + L+
Sbjct: 5 IKQNGNRYKIE---KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 152 HLDLSSNNLTG 162
L+LSSN L
Sbjct: 62 LLNLSSNVLYE 72
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 22/94 (23%), Positives = 37/94 (39%), Gaps = 8/94 (8%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
NV L L N S + + L L L N L D S++ L++L+L NN
Sbjct: 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETLDL-ESLSTLRTLDLNNNYV 92
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+++ L ++NN++ R+
Sbjct: 93 Q-----ELLVGPSIETLHAANNNIS-RVSCSRGQ 120
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 9e-10
Identities = 16/85 (18%), Positives = 34/85 (40%), Gaps = 8/85 (9%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ +L L +N + + +L +N++S + +++ LANNK
Sbjct: 81 TLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVS--CSRGQGKKNIYLANNKI 132
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
+ S +++LDL N +
Sbjct: 133 TMLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 8e-08
Identities = 15/81 (18%), Positives = 34/81 (41%), Gaps = 3/81 (3%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFS-G 138
+L L SN + + P + + L++N L + L +L+ +L N F G
Sbjct: 195 TLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG 252
Query: 139 SIPATWSQLSNLKHLDLSSNN 159
++ +S+ ++ + +
Sbjct: 253 TLRDFFSKNQRVQTVAKQTVK 273
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 9/55 (16%), Positives = 23/55 (41%), Gaps = 1/55 (1%)
Query: 116 LPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ + + + + ++ ++ + N+K LDLS N L+ +I +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLA 55
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 13/115 (11%), Positives = 30/115 (26%), Gaps = 4/115 (3%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSG----TLPDFLGSMTHLQSLNLANNKF 136
G+ +P +L L E G L + + ++ ++
Sbjct: 289 GHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQY 348
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPC 191
I + L+ L ++ + A + T + L+
Sbjct: 349 RTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHAT 403
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 28/106 (26%), Positives = 47/106 (44%), Gaps = 5/106 (4%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L +G+N S I+ + L L L + N +S L +++ L SL L NN+
Sbjct: 244 QLTWLEIGTNQIS-DINA-VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQL 299
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPM-QLFSVATFNFTGTHL 181
L+NL L LS N++T P+ L + + +F +
Sbjct: 300 GNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 8e-12
Identities = 23/89 (25%), Positives = 40/89 (44%), Gaps = 8/89 (8%)
Query: 75 NGNVISLTLGSNGFSGKIS--PSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
+ L +GSN +IS + L L SL L +N L + +G +T+L +L L+
Sbjct: 264 LTKLKMLNVGSN----QISDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLS 319
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLT 161
N + P + LS + D ++ +
Sbjct: 320 QNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 3e-11
Identities = 21/86 (24%), Positives = 34/86 (39%), Gaps = 5/86 (5%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L L + S + L + SL L N + L +MT L L + +K
Sbjct: 111 NLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKV 167
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTG 162
P + L++L L L+ N +
Sbjct: 168 KDVTP--IANLTDLYSLSLNYNQIED 191
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 4e-11
Identities = 22/89 (24%), Positives = 42/89 (47%), Gaps = 6/89 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L L N + ISP ++ L L +L + N ++ L ++T+L+ L L +
Sbjct: 67 NLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNI 122
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIP 165
S P + L+ + L+L +N+ +
Sbjct: 123 SDISPL--ANLTKMYSLNLGANHNLSDLS 149
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 6e-11
Identities = 22/89 (24%), Positives = 42/89 (47%), Gaps = 5/89 (5%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ SL LG+N +SP ++ + L L + ++ + P + ++T L SL+L N+
Sbjct: 133 KMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQI 189
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIP 165
P + L++L + N +T P
Sbjct: 190 EDISP--LASLTSLHYFTAYVNQITDITP 216
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 1e-10
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 6/86 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
++ SL+L N ISP + L L N ++ P + +MT L SL + NNK
Sbjct: 178 DLYSLSLNYNQIED-ISP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKI 233
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTG 162
+ P + LS L L++ +N ++
Sbjct: 234 TDLSP--LANLSQLTWLEIGTNQISD 257
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 6e-10
Identities = 21/89 (23%), Positives = 36/89 (40%), Gaps = 6/89 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ LT+ + ++P I L L SL L N + L S+T L N+
Sbjct: 156 GLNYLTVTESKVK-DVTP-IANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQI 211
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIP 165
+ P + ++ L L + +N +T P
Sbjct: 212 TDITP--VANMTRLNSLKIGNNKITDLSP 238
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 1e-08
Identities = 19/86 (22%), Positives = 35/86 (40%), Gaps = 6/86 (6%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
+L + +I P L LQ ++ + + + L +A K + S
Sbjct: 4 TLATLPAPIN-QIFP-DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-S 58
Query: 140 IPATWSQLSNLKHLDLSSNNLTGRIP 165
I L+NL++L+L+ N +T P
Sbjct: 59 IQG-IEYLTNLEYLNLNGNQITDISP 83
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 20/104 (19%), Positives = 46/104 (44%), Gaps = 4/104 (3%)
Query: 69 SHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPD--FLGSMTHL 126
S ++ L L NG +S + L+ L L+ Q ++L + + S+ +L
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNL 423
Query: 127 QSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
L++++ + ++ LS+L+ L ++ N+ +F+
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 21/94 (22%), Positives = 33/94 (35%), Gaps = 1/94 (1%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ +L L N S S L L+L ++ S++HL +L L N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+S LS+L+ L NL +
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIG 121
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 27/92 (29%), Positives = 43/92 (46%), Gaps = 2/92 (2%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF-SG 138
+L L N + + L L L + +L+ +G + L+ LN+A+N S
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 139 SIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+P +S L+NL+HLDLSSN + I
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLR 170
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 15/81 (18%), Positives = 26/81 (32%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI 140
L L + L L++L L N + ++ LQ L +
Sbjct: 57 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE 116
Query: 141 PATWSQLSNLKHLDLSSNNLT 161
L LK L+++ N +
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQ 137
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 24/96 (25%), Positives = 39/96 (40%), Gaps = 6/96 (6%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDL-SGTLPDFLGSMTHLQSLNLANNKFSG 138
L + + I LK L L + N + S LP++ ++T+L+ L+L++NK
Sbjct: 104 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163
Query: 139 SIPATWSQLSNLK----HLDLSSNNLTGRIPMQLFS 170
L + LDLS N + I F
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFK 198
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 24/90 (26%), Positives = 41/90 (45%), Gaps = 1/90 (1%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L + N F P I T+L+ L L+L L P S++ LQ LN+A+N+
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSV 509
Query: 140 IPATWSQLSNLKHLDLSSNNLTGRIPMQLF 169
+ +L++L+ + L +N P +
Sbjct: 510 PDGIFDRLTSLQKIWLHTNPWDCSCPRIDY 539
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 22/94 (23%), Positives = 37/94 (39%), Gaps = 7/94 (7%)
Query: 81 LTLGSNG--FSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 138
L L NG F G S S L L+L N + T+ + L+ L+ ++
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK- 409
Query: 139 SIPA--TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ + L NL +LD+S + +F+
Sbjct: 410 QMSEFSVFLSLRNLIYLDISHTHTRV-AFNGIFN 442
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 19/66 (28%), Positives = 29/66 (43%), Gaps = 4/66 (6%)
Query: 98 KLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK--FSGSIPATWSQLSNLKHLDL 155
KLK L L N + + L+ L+L+ N F G + ++LK+LDL
Sbjct: 323 KLKSLKRLTFTSNKGG-NAFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 156 SSNNLT 161
S N +
Sbjct: 381 SFNGVI 386
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 12/67 (17%), Positives = 26/67 (38%), Gaps = 4/67 (5%)
Query: 104 SLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGR 163
+ + + + +PD L ++L+L+ N ++ L+ LDLS +
Sbjct: 11 TYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-T 66
Query: 164 IPMQLFS 170
I +
Sbjct: 67 IEDGAYQ 73
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 37/168 (22%), Positives = 61/168 (36%), Gaps = 36/168 (21%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLLQLIG 335
++G G GKV + K A+K LQD +REV + ++++++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVD 78
Query: 336 -YCTTSSERILVYPFMQNLSVAYRLRDLKPG--------EKGLDWPTRKRVAFGT---AY 383
Y + R + M + G ++G T + +
Sbjct: 79 VYENLYAGRKCLLIVM----------ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 384 GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAK 428
++YLH I HRD+K N+L N L DFG AK +
Sbjct: 129 AIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE 173
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 39/205 (19%), Positives = 73/205 (35%), Gaps = 37/205 (18%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REV 319
D + ++IG G +G V + + VA+K++ F+ RE+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR--------VFEDLIDCKRILREI 103
Query: 320 HLISVAIHKNLLQLIGYCTTSSERI-----LVYPFMQNLSVAYRLRDLK---PGEKGLDW 371
+++ H ++++++ +V D K L
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD--------SDFKKLFRTPVYLTE 155
Query: 372 PTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 431
K + + G++Y+H I+HRDLK AN L++ + +CDFGLA+ VD
Sbjct: 156 LHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENG 212
Query: 432 VTTQIRGTMGHIAPEYLSTGKSSEK 456
+ + K
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLK 237
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 43/196 (21%), Positives = 74/196 (37%), Gaps = 39/196 (19%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REV 319
DN+ ++IG+G +G VY + VA+K++ F+ RE+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR--------MFEDLIDCKRILREI 76
Query: 320 HLISVAIHKNLLQLIGYCTTSSERI-----LVYPFMQNLSVAYRLRDLKPGEKGLDWPTR 374
+++ +++L +V DLK K + T
Sbjct: 77 TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD--------SDLKKLFKTPIFLTE 128
Query: 375 KRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430
+ + Y G ++HE IIHRDLK AN LL+ + +CDFGLA+ ++++
Sbjct: 129 EHIKT-ILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184
Query: 431 HVTTQIRGTMGHIAPE 446
P
Sbjct: 185 TNIVNDLEENEEPGPH 200
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
GL++LH + I++RDLK NILLD + + DFG+ K + T GT +I
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE-NMLGDAKTNTFCGTPDYI 185
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
APE L K + D + +G+ L E++ GQ
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 57/224 (25%), Positives = 85/224 (37%), Gaps = 46/224 (20%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
DNF ++G+G FGKV + + + AVK L+ + Q + + K
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKK------DVILQDD-DVECTMTEKR 75
Query: 330 LLQLIG---------YCTTSSERI-LVYPF------MQNLSVAYRLRDLKPGEKGLDWPT 373
+L L C + +R+ V F M ++ + R
Sbjct: 76 ILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF-------------D 122
Query: 374 RKRVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430
R F A L +LH++ II+RDLK N+LLD L DFG+ K
Sbjct: 123 EARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GICNG 178
Query: 431 HVTTQIRGTMGHIAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 473
T GT +IAPE L D + G+ L E++ G
Sbjct: 179 VTTATFCGTPDYIAPEIL-QEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 5e-12
Identities = 49/221 (22%), Positives = 88/221 (39%), Gaps = 33/221 (14%)
Query: 267 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVA 325
++ ++F ++G+G FGKV + A+K L+ E ++ +
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK------EVIIAKD-EVAHTV 53
Query: 326 IHKNLLQLIG--------YCTTSSERI-LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRK 375
+LQ Y + +R+ V + + + L R+ E+
Sbjct: 54 TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-------- 105
Query: 376 RVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432
R F A LEYLH + +++RD+K N++LD + + DFGL K
Sbjct: 106 RARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGAT 161
Query: 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
GT ++APE L D +G G+ + E++ G+
Sbjct: 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 6e-12
Identities = 33/90 (36%), Positives = 43/90 (47%), Gaps = 4/90 (4%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
L YLH I++RDLK NILLD VL DFGL K + + T+ GT ++
Sbjct: 151 ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNSTTSTFCGTPEYL 206
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
APE L D + G L E++ G
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 6e-12
Identities = 50/243 (20%), Positives = 98/243 (40%), Gaps = 69/243 (28%)
Query: 270 TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQ---------REV 319
+ + +G GG G V+ V +D + +VA+K++ RE+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI----------VLTDPQSVKHALREI 59
Query: 320 HLISVAIHKNLLQLI--------------GYCTTSSERILVYPFMQ-NLSVAYRLRDLKP 364
+I H N++++ G T + +V +M+ +L+ L
Sbjct: 60 KIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL-- 117
Query: 365 GEKGLDWPTRKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDF 419
+ Y GL+Y+H + ++HRDLK AN+ ++ ++ + DF
Sbjct: 118 --------LEEHARL-FMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDF 165
Query: 420 GLAKLVDAKLTH-------VTTQ-IRGTMGHIAPE-YLSTGKSSEKTDVFGYGITLLELV 470
GLA+++D +H + T+ R +P LS ++ D++ G E++
Sbjct: 166 GLARIMDPHYSHKGHLSEGLVTKWYR------SPRLLLSPNNYTKAIDMWAAGCIFAEML 219
Query: 471 TGQ 473
TG+
Sbjct: 220 TGK 222
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 20/94 (21%), Positives = 37/94 (39%), Gaps = 4/94 (4%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L L N + + + L ++L N+L + M L+ L ++NN+
Sbjct: 227 ELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL 284
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
++ + LK LDLS N+L +
Sbjct: 285 V-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ 316
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 19/95 (20%), Positives = 39/95 (41%), Gaps = 5/95 (5%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
++ + L N KI K++ L L + +N L L + + L+ L+L++N
Sbjct: 249 GLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNH 306
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ Q L++L L N++ + +
Sbjct: 307 LL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHH 339
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 17/96 (17%), Positives = 35/96 (36%), Gaps = 5/96 (5%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
N +T ++ K+ ++ + + L L D + +Q L + N
Sbjct: 46 NQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNA 104
Query: 136 FSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+P + + L L L N+L+ +P +F
Sbjct: 105 IR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFH 138
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 20/91 (21%), Positives = 34/91 (37%), Gaps = 5/91 (5%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L + +N ++ + L L+L N L + L++L L +N +
Sbjct: 276 RLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-T 332
Query: 140 IPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ S LK+L LS N+ LF
Sbjct: 333 LKL--STHHTLKNLTLSHNDWDCNSLRALFR 361
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 26/92 (28%), Positives = 43/92 (46%), Gaps = 5/92 (5%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L +G N + P + + L L L+ NDLS + L +L+++NN
Sbjct: 98 LYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-R 155
Query: 140 IPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
I T+ ++L++L LSSN LT + + L
Sbjct: 156 IEDDTFQATTSLQNLQLSSNRLT-HVDLSLIP 186
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 11/91 (12%), Positives = 30/91 (32%), Gaps = 3/91 (3%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI 140
+ + L + +++ + L S ++ LNL + + I
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EI 84
Query: 141 PA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
++ ++ L + N + +P +F
Sbjct: 85 DTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQ 114
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 22/93 (23%), Positives = 32/93 (34%), Gaps = 5/93 (5%)
Query: 80 SLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 138
L L +I + L + N + P ++ L L L N S
Sbjct: 73 LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 130
Query: 139 SIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
S+P + L L +S+NNL RI F
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQ 162
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 16/94 (17%), Positives = 30/94 (31%), Gaps = 11/94 (11%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
++ + N S ++ + L+ N ++ + L L L +N
Sbjct: 187 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNL 238
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ L +DLS N L +I F
Sbjct: 239 T-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFV 269
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 19/86 (22%), Positives = 35/86 (40%), Gaps = 7/86 (8%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
V L N + + + L L+LQ N+L+ L L ++L+ N+
Sbjct: 206 AVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLN-YPGLVEVDLSYNEL 260
Query: 137 SGSIPA-TWSQLSNLKHLDLSSNNLT 161
I + ++ L+ L +S+N L
Sbjct: 261 E-KIMYHPFVKMQRLERLYISNNRLV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 22/86 (25%), Positives = 40/86 (46%), Gaps = 5/86 (5%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
+ L L N S + I L +L + +N+L D + T LQ+L L++N+
Sbjct: 118 LLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR 176
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLT 161
+ + S + +L H ++S N L+
Sbjct: 177 LT-HVDL--SLIPSLFHANVSYNLLS 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 7e-07
Identities = 17/98 (17%), Positives = 38/98 (38%), Gaps = 11/98 (11%)
Query: 74 RNGNVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
+ +L++ +N +I L +L+L N L+ + L + L N++
Sbjct: 139 NTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVS 194
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
N S ++ ++ LD S N++ + +
Sbjct: 195 YNLLS-TLAI----PIAVEELDASHNSIN-VVRGPVNV 226
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 8e-12
Identities = 50/235 (21%), Positives = 94/235 (40%), Gaps = 55/235 (23%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REV 319
+ +F +++G+G +G V VA+K+++ F RE+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE---------PFDKPLFALRTLREI 60
Query: 320 HLISVAIHKNLLQLIGYCTTSSERI-----LVYPFMQ-NLSVAYRLRDLKPGEKGLDWPT 373
++ H+N++ + S ++ MQ +L + L +
Sbjct: 61 KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQML----------S 110
Query: 374 RKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429
+ + Y ++ LH +IHRDLK +N+L++ N + +CDFGLA+++D
Sbjct: 111 DDHIQY-FIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES- 165
Query: 430 THVTTQIRGTMGHI----------APEY-LSTGKSSEKTDVFGYGITLLELVTGQ 473
++ G + APE L++ K S DV+ G L EL +
Sbjct: 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 9e-12
Identities = 52/227 (22%), Positives = 87/227 (38%), Gaps = 44/227 (19%)
Query: 267 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVA 325
L +F +IG+G + KV L ++ A+K ++ E E + V
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKK------ELVNDDE-DIDWVQ 57
Query: 326 IHKNLLQLIG---------YCTTSSERI-LVYPF------MQNLSVAYRLRDLKPGEKGL 369
K++ + C + R+ V + M ++ +L
Sbjct: 58 TEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKL---------- 107
Query: 370 DWPTRKRVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426
+ F +A L YLHE+ II+RDLK N+LLD L D+G+ K
Sbjct: 108 ---PEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-G 160
Query: 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
+ T+ GT +IAPE L D + G+ + E++ G+
Sbjct: 161 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 4/90 (4%)
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 443
GL +L + II+RDLK N++LD + DFG+ K + T GT +I
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTPDYI 188
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
APE ++ + D + +G+ L E++ GQ
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 51/227 (22%), Positives = 87/227 (38%), Gaps = 44/227 (19%)
Query: 267 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVA 325
L +F +IG+G + KV L ++ A++ ++ E E + V
Sbjct: 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKK------ELVNDDE-DIDWVQ 100
Query: 326 IHKNLLQLIG---------YCTTSSERI-LVYPF------MQNLSVAYRLRDLKPGEKGL 369
K++ + C + R+ V + M ++ +L
Sbjct: 101 TEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKL---------- 150
Query: 370 DWPTRKRVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426
+ F +A L YLHE+ II+RDLK N+LLD L D+G+ K
Sbjct: 151 ---PEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-G 203
Query: 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
+ T+ GT +IAPE L D + G+ + E++ G+
Sbjct: 204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 53/227 (23%), Positives = 88/227 (38%), Gaps = 44/227 (19%)
Query: 267 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVA 325
++ +F+ ++G+G FGKV ++ AVK L+ + Q + +
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKK------DVVIQDD-DVECTM 389
Query: 326 IHKNLLQLIGYCTTSSERILVYPFMQNLSVA-------YRLRDLKPG---------EKGL 369
+ K +L L G PF+ L Y + + G
Sbjct: 390 VEKRVLALPGKP----------PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRF 439
Query: 370 DWPTRKRVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426
P F A GL +L + II+RDLK N++LD + DFG+ K +
Sbjct: 440 KEP---HAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-N 492
Query: 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
T GT +IAPE ++ + D + +G+ L E++ GQ
Sbjct: 493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 41/200 (20%), Positives = 77/200 (38%), Gaps = 40/200 (20%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REV 319
+ +G+G +G V+K + VAVK++ D AFQ RE+
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD--------AFQNSTDAQRTFREI 59
Query: 320 HLIS-VAIHKNLLQLIGYCTTSSER--ILVYPFMQ-NLSVAYRLRDLKPGEKGLDWPTRK 375
+++ ++ H+N++ L+ ++R LV+ +M+ +L R L
Sbjct: 60 MILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANIL----------EPV 109
Query: 376 RVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 431
+ Y ++YLH ++HRD+K +NILL+ + DFGL++
Sbjct: 110 HKQY-VVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165
Query: 432 VTTQIRGTMGHIAPEYLSTG 451
+
Sbjct: 166 TNNIPLSINENTENFDDDQP 185
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 19/95 (20%), Positives = 39/95 (41%), Gaps = 5/95 (5%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
++ + L N KI K++ L L + +N L L + + L+ L+L++N
Sbjct: 255 GLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNH 312
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ Q L++L L N++ + +
Sbjct: 313 LL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHH 345
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 20/94 (21%), Positives = 37/94 (39%), Gaps = 4/94 (4%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L L N + + + L ++L N+L + M L+ L ++NN+
Sbjct: 233 ELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL 290
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
++ + LK LDLS N+L +
Sbjct: 291 V-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ 322
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 18/81 (22%), Positives = 32/81 (39%), Gaps = 5/81 (6%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI 140
L + +N ++ + L L+L N L + L++L L +N ++
Sbjct: 283 LYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TL 339
Query: 141 PATWSQLSNLKHLDLSSNNLT 161
S LK+L LS N+
Sbjct: 340 KL--STHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 11/91 (12%), Positives = 30/91 (32%), Gaps = 3/91 (3%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI 140
+ + L + +++ + L S ++ LNL + + I
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EI 90
Query: 141 PA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
++ ++ L + N + +P +F
Sbjct: 91 DTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQ 120
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 6e-09
Identities = 26/96 (27%), Positives = 44/96 (45%), Gaps = 5/96 (5%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
+ L +G N + P + + L L L+ NDLS + L +L+++NN
Sbjct: 100 TIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNN 158
Query: 136 FSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
I T+ ++L++L LSSN LT + + L
Sbjct: 159 LE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIP 192
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 6e-09
Identities = 17/96 (17%), Positives = 35/96 (36%), Gaps = 5/96 (5%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
N +T ++ K+ ++ + + L L D + +Q L + N
Sbjct: 52 NQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNA 110
Query: 136 FSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+P + + L L L N+L+ +P +F
Sbjct: 111 IR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFH 144
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 19/86 (22%), Positives = 35/86 (40%), Gaps = 7/86 (8%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
V L N + + + L L+LQ N+L+ L L ++L+ N+
Sbjct: 212 AVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLN-YPGLVEVDLSYNEL 266
Query: 137 SGSIPA-TWSQLSNLKHLDLSSNNLT 161
I + ++ L+ L +S+N L
Sbjct: 267 E-KIMYHPFVKMQRLERLYISNNRLV 291
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 6e-08
Identities = 22/86 (25%), Positives = 40/86 (46%), Gaps = 5/86 (5%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
+ L L N S + I L +L + +N+L D + T LQ+L L++N+
Sbjct: 124 LLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR 182
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLT 161
+ + S + +L H ++S N L+
Sbjct: 183 LT-HVDL--SLIPSLFHANVSYNLLS 205
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 17/98 (17%), Positives = 38/98 (38%), Gaps = 11/98 (11%)
Query: 74 RNGNVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
+ +L++ +N +I L +L+L N L+ + L + L N++
Sbjct: 145 NTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVS 200
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
N S ++ ++ LD S N++ + +
Sbjct: 201 YNLLS-TLAI----PIAVEELDASHNSIN-VVRGPVNV 232
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 19/82 (23%), Positives = 32/82 (39%), Gaps = 11/82 (13%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
+L L SN + + S+ + L + N LS L ++ L+ ++N +
Sbjct: 175 NLQLSSNRLT-HVDLSL--IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-V 225
Query: 140 IPATWSQLSNLKHLDLSSNNLT 161
+ L L L NNLT
Sbjct: 226 VRG--PVNVELTILKLQHNNLT 245
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 16/89 (17%), Positives = 36/89 (40%), Gaps = 6/89 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ LG + + S T L + +L+ + D + + +L +N +NN+
Sbjct: 25 EKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQL 80
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIP 165
+ P L+ L + +++N + P
Sbjct: 81 TDITPL--KNLTKLVDILMNNNQIADITP 107
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 30/86 (34%), Positives = 42/86 (48%), Gaps = 6/86 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ SL +N S I+P + L L L L N L L S+T+L L+LANN+
Sbjct: 200 NLESLIATNNQISD-ITP-LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQI 255
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTG 162
S P S L+ L L L +N ++
Sbjct: 256 SNLAP--LSGLTKLTELKLGANQISN 279
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 9e-11
Identities = 26/91 (28%), Positives = 39/91 (42%), Gaps = 6/91 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ +L L N I+ LK L L L N++S P + S+T LQ L NNK
Sbjct: 288 ALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV 343
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ 167
S + L+N+ L N ++ P+
Sbjct: 344 SDVSS--LANLTNINWLSAGHNQISDLTPLA 372
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 28/89 (31%), Positives = 40/89 (44%), Gaps = 6/89 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L L +N S ++ L L L+L N +S P L +T L +L L N+
Sbjct: 244 NLTDLDLANNQISN--LAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQL 299
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIP 165
P S L NL +L L NN++ P
Sbjct: 300 EDISP--ISNLKNLTYLTLYFNNISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 24/86 (27%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ + +N + I+P + L L + + +N ++ P L ++T+L L L NN+
Sbjct: 69 NLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQI 124
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTG 162
+ P L+NL L+LSSN ++
Sbjct: 125 TDIDPL--KNLTNLNRLELSSNTISD 148
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 23/89 (25%), Positives = 38/89 (42%), Gaps = 6/89 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
V +L G I + L L + +N L+ P L ++T L + + NN+
Sbjct: 47 QVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 102
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIP 165
+ P + L+NL L L +N +T P
Sbjct: 103 ADITPL--ANLTNLTGLTLFNNQITDIDP 129
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 7e-10
Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 10/93 (10%)
Query: 77 NVISLTLGSNGFSGKIS--PSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANN 134
+ L + SN K+S + KL L SL +N +S P LG +T+L L+L N
Sbjct: 178 TLERLDISSN----KVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGN 231
Query: 135 KFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ 167
+ T + L+NL LDL++N ++ P+
Sbjct: 232 QLKD--IGTLASLTNLTDLDLANNQISNLAPLS 262
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 21/69 (30%), Positives = 31/69 (44%), Gaps = 4/69 (5%)
Query: 94 PSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHL 153
+ L L L++ N +S L +T+L+SL NN+ S P L+NL L
Sbjct: 171 KPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDEL 226
Query: 154 DLSSNNLTG 162
L+ N L
Sbjct: 227 SLNGNQLKD 235
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 19/90 (21%), Positives = 34/90 (37%), Gaps = 5/90 (5%)
Query: 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
G + S T+ + +I T L L +++ T+ + + +L
Sbjct: 1 GPLGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLG 57
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIP 165
SI L+NL ++ S+N LT P
Sbjct: 58 IK-SIDG-VEYLNNLTQINFSNNQLTDITP 85
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 24/94 (25%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L L SN S +++ L L L N ++ P L ++T L+ L++++NK
Sbjct: 135 NLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKV 189
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
S + ++L+NL+ L ++N ++ P+ + +
Sbjct: 190 SD--ISVLAKLTNLESLIATNNQISDITPLGILT 221
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 6e-07
Identities = 16/85 (18%), Positives = 34/85 (40%), Gaps = 4/85 (4%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L+ G N S ++P + L + L L D + ++ +++ ++
Sbjct: 354 NINWLSAGHNQISD-LTP-LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL 411
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
PAT S + D++ N +
Sbjct: 412 I--APATISDGGSYTEPDITWNLPS 434
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 43/214 (20%), Positives = 87/214 (40%), Gaps = 24/214 (11%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVH-LISVAIH 327
D++ +G+G + +V++ + +++N KV VK L+ P + +RE+ L ++
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK----PVKKKKIKREIKILENLRGG 90
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
N++ L R F + D K + L + + L+Y
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNT-----DFKQLYQTLTDYDIRFYMYEILKALDY 145
Query: 388 LHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDA--KLTH-VTTQIRGTMGHI 443
H I+HRD+K N+++D ++ + L D+GLA+ + V ++
Sbjct: 146 CHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FK 197
Query: 444 APEYLSTGKS-SEKTDVFGYGITLLELVTGQRAI 476
PE L + D++ G L ++ +
Sbjct: 198 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 26/103 (25%), Positives = 41/103 (39%), Gaps = 4/103 (3%)
Query: 80 SLTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 138
L L N I + + L L L N + L + L+ L+L NNK S
Sbjct: 197 ELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS- 254
Query: 139 SIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHL 181
+PA L L+ + L +NN+T ++ + F F +
Sbjct: 255 RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYY 296
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 23/95 (24%), Positives = 41/95 (43%), Gaps = 6/95 (6%)
Query: 77 NVISLTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
+ L L +N S ++ L+ L +L L +N +S + LQ L ++ N
Sbjct: 55 DTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
IP + S+L L + N + ++P +FS
Sbjct: 114 LV-EIPP--NLPSSLVELRIHDNRIR-KVPKGVFS 144
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 22/95 (23%), Positives = 37/95 (38%), Gaps = 6/95 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L + + I + + L L L N + + L + L L L +N+
Sbjct: 173 KLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQI 229
Query: 137 SGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
I + S L L+ L L +N L+ R+P L
Sbjct: 230 R-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPD 262
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 13/70 (18%), Positives = 23/70 (32%), Gaps = 2/70 (2%)
Query: 102 LASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF-SGSIPATWSQLSNLKHLDLSSNNL 160
L L + DN + + ++ + + N + L +L +S L
Sbjct: 125 LVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKL 184
Query: 161 TGRIPMQLFS 170
T IP L
Sbjct: 185 T-GIPKDLPE 193
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 22/97 (22%), Positives = 41/97 (42%), Gaps = 8/97 (8%)
Query: 77 NVISLTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
++ +L L +N S KI + + L+ L L + N L +P + L L + +N+
Sbjct: 79 HLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLV-EIPP--NLPSSLVELRIHDNR 134
Query: 136 FSGSIPA-TWSQLSNLKHLDLSSNNLT-GRIPMQLFS 170
+P +S L N+ +++ N L F
Sbjct: 135 IR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 19/104 (18%), Positives = 33/104 (31%), Gaps = 19/104 (18%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANN 134
N I + + S L L L L +N LS +P L + LQ + L N
Sbjct: 225 GHNQIR-MIENGSLSF--------LPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTN 274
Query: 135 KFSGSIPAT-------WSQLSNLKHLDLSSNNLT-GRIPMQLFS 170
+ + + + + L +N + + F
Sbjct: 275 NIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFR 317
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 16/88 (18%), Positives = 34/88 (38%), Gaps = 11/88 (12%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPD-------FLGSMTHLQSLNLA 132
L L +N S ++ + LK L + L N+++ + F + ++L
Sbjct: 245 ELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLF 302
Query: 133 NNKFSGSI--PATWSQLSNLKHLDLSSN 158
NN PAT+ +++ + +
Sbjct: 303 NNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 25/108 (23%), Positives = 43/108 (39%), Gaps = 13/108 (12%)
Query: 76 GNVISLTLGSNGFSGKIS--PSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLAN 133
++ + G+N ++ P + L FL ++ +N L LPD S L+S+ N
Sbjct: 173 PSLEFIAAGNN----QLEELPELQNLPFLTAIYADNNSLK-KLPDLPLS---LESIVAGN 224
Query: 134 NKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHL 181
N +P L L + +N L +P S+ N +L
Sbjct: 225 NILE-ELP-ELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYL 269
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 9e-10
Identities = 21/94 (22%), Positives = 38/94 (40%), Gaps = 9/94 (9%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L + +N P + FL +++ +N L LPD S L+ + NN+
Sbjct: 132 LLEYLGVSNNQLEK--LPELQNSSFLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQL 185
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+P L L + +N+L ++P S
Sbjct: 186 E-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLS 216
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 25/113 (22%), Positives = 38/113 (33%), Gaps = 21/113 (18%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
C + L L + G S + L+ SL N L+ LP+ S+ L N
Sbjct: 68 CLDRQAHELELNNLGLS-SLPELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNNN 122
Query: 133 NNKFSGSIPATWS---------------QLSNLKHLDLSSNNLTGRIPMQLFS 170
S P S LK +D+ +N+L ++P S
Sbjct: 123 LKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPS 174
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 20/86 (23%), Positives = 30/86 (34%), Gaps = 12/86 (13%)
Query: 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
N+ L SN + L+ L + +N L LP L+ L + N
Sbjct: 297 PNLYYLNASSNEIR-SLCDLPPSLE---ELNVSNNKLI-ELPALPPR---LERLIASFNH 348
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLT 161
+ +P NLK L + N L
Sbjct: 349 LA-EVP---ELPQNLKQLHVEYNPLR 370
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 19/86 (22%), Positives = 36/86 (41%), Gaps = 12/86 (13%)
Query: 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
++ +L + N + + L FL E + LS P +L LN ++N+
Sbjct: 257 PSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNE 308
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLT 161
S+ +L+ L++S+N L
Sbjct: 309 IR-SLC---DLPPSLEELNVSNNKLI 330
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 7e-07
Identities = 18/103 (17%), Positives = 30/103 (29%), Gaps = 19/103 (18%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGS-------------MTHLQ 127
S+ + ++ +K ++ P G
Sbjct: 16 PLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAH 74
Query: 128 SLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
L L N S S+P +L+ L S N+LT +P S
Sbjct: 75 ELELNNLGLS-SLP---ELPPHLESLVASCNSLT-ELPELPQS 112
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 13/103 (12%), Positives = 33/103 (32%), Gaps = 15/103 (14%)
Query: 92 ISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLS--- 148
I+P FL ++L+ +P ++ A +++ + P +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 149 ----------NLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHL 181
L+L++ L+ +P + + + L
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESLVASCNSL 103
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 12/79 (15%), Positives = 24/79 (30%), Gaps = 7/79 (8%)
Query: 83 LGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA 142
L N ++ LK L ++ N L PD S ++ L + + +
Sbjct: 382 LRMNSHLAEVPELPQNLK---QLHVETNPLR-EFPDIPES---VEDLRMNSERVVDPYEF 434
Query: 143 TWSQLSNLKHLDLSSNNLT 161
L+ ++
Sbjct: 435 AHETTDKLEDDVFEHHHHH 453
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 29/117 (24%), Positives = 46/117 (39%), Gaps = 7/117 (5%)
Query: 77 NVISLTLGSNGFSGKISPSITK-----LKFLASLELQDNDLSGTLPDFLGSMTHLQSLNL 131
++ L LG N + L L L L N L+ P +T L+ L+L
Sbjct: 452 SLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSL 511
Query: 132 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLE 188
+N+ + + +NL+ LD+S N L P S++ + T IC L
Sbjct: 512 NSNRLT-VLSH-NDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECELS 566
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 22/95 (23%), Positives = 39/95 (41%), Gaps = 3/95 (3%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
+V L L ++ + LK L L L N ++ + + +LQ LNL+ N
Sbjct: 267 SVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNL 325
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ + L + ++DL N++ I Q F
Sbjct: 326 LGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFK 359
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 20/85 (23%), Positives = 31/85 (36%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
++ L L N + + L L L L N L + + ++L N
Sbjct: 291 DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI 350
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
+ T+ L L+ LDL N LT
Sbjct: 351 AIIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 19/88 (21%), Positives = 34/88 (38%), Gaps = 5/88 (5%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTL-PDFLGSMTHLQSLNLANN 134
L L N ++ S L+ L LEL T+ + ++ +L+ L+L ++
Sbjct: 25 TTERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83
Query: 135 KFSGSIPATW-SQLSNLKHLDLSSNNLT 161
K + L +L L L L+
Sbjct: 84 KIY-FLHPDAFQGLFHLFELRLYFCGLS 110
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 27/100 (27%), Positives = 41/100 (41%), Gaps = 7/100 (7%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGT-----LPDFLGSMTHLQSLN 130
++ L L N FS ++ L L L +N L D ++HLQ L
Sbjct: 427 HLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLY 486
Query: 131 LANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
L +N + P +S L+ L+ L L+SN LT +
Sbjct: 487 LNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLP 525
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 21/104 (20%), Positives = 38/104 (36%), Gaps = 5/104 (4%)
Query: 73 CRNGNVISLTLGSNGFSGKISPS--ITKLKFLASLELQDNDLSG-TLPDFLGSMTHLQSL 129
++ L L G S + LK L L+L N + L G + L+S+
Sbjct: 94 QGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSI 153
Query: 130 NLANNKFSGSIPATWSQLS--NLKHLDLSSNNLTGRIPMQLFSV 171
+ ++N+ L L L++N+L R+ +
Sbjct: 154 DFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKC 197
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 17/73 (23%), Positives = 26/73 (35%), Gaps = 2/73 (2%)
Query: 99 LKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI-PATWSQLSNLKHLDLSS 157
L L L N + + LQ L L + +I + L NL+ LDL S
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 158 NNLTGRIPMQLFS 170
+ + + F
Sbjct: 83 SKIY-FLHPDAFQ 94
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 17/126 (13%), Positives = 43/126 (34%), Gaps = 3/126 (2%)
Query: 47 LNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLE 106
+ + + F + V+ V SN S + S+ +
Sbjct: 187 YSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAG 246
Query: 107 LQDNDLSGTLPDFLGSM--THLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRI 164
+++ + + + ++ L+L++ + L +LK L+L+ N + +I
Sbjct: 247 FGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN-KI 305
Query: 165 PMQLFS 170
+ F
Sbjct: 306 ADEAFY 311
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 20/114 (17%), Positives = 42/114 (36%), Gaps = 14/114 (12%)
Query: 58 NDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLP 117
N + ++ + + +L L N + +I + + + L N L TLP
Sbjct: 348 NHIAIIQDQTFKFLE----KLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLP 397
Query: 118 DFLGSMTHLQSLNLANNKFSG-SIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ ++L+ N+ I ++ +L+ L L+ N + Q S
Sbjct: 398 KINLT---ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPS 448
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 13/64 (20%), Positives = 25/64 (39%), Gaps = 4/64 (6%)
Query: 107 LQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPM 166
+ +L+ +P L + L L+ N +++ L L+ L+L S I
Sbjct: 11 YRFCNLT-QVPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK 66
Query: 167 QLFS 170
+ F
Sbjct: 67 EAFR 70
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 62.9 bits (152), Expect = 1e-10
Identities = 26/126 (20%), Positives = 47/126 (37%), Gaps = 7/126 (5%)
Query: 36 EGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPS 95
E LKA++ + D S + +V L L + +
Sbjct: 403 ETLQYFSTLKAVDPMRAAYLDDLRSKF--LLENSVLKMEYADVRVLHLAHKDLT-VL-CH 458
Query: 96 ITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155
+ +L + L+L N L LP L ++ L+ L ++N ++ + L L+ L L
Sbjct: 459 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDGV-ANLPRLQELLL 515
Query: 156 SSNNLT 161
+N L
Sbjct: 516 CNNRLQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 3e-08
Identities = 23/87 (26%), Positives = 35/87 (40%), Gaps = 6/87 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
V L L N + P++ L+ L L+ DN L + + ++ LQ L L NN+
Sbjct: 464 LVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRL 520
Query: 137 SGSIPATW--SQLSNLKHLDLSSNNLT 161
A L L+L N+L
Sbjct: 521 Q-QSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 63.3 bits (153), Expect = 1e-10
Identities = 38/274 (13%), Positives = 80/274 (29%), Gaps = 96/274 (35%)
Query: 226 LFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNII--GQGG 283
R Q KL+ +L +LR N++ G G
Sbjct: 129 YNVSRLQPYLKLRQ--------------ALLELR--------------PAKNVLIDGVLG 160
Query: 284 FGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343
GK T VA+ Y + ++ +++ C +
Sbjct: 161 SGK---------TWVALDVCLSY---KVQCKMDFKIFWLNL----------KNCNSPETV 198
Query: 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKA 403
+ + +Q L L + P +W +R + + + + + + +
Sbjct: 199 LEM---LQKL-----LYQIDP-----NWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN 245
Query: 404 ANILLDDNFEAVLCDFGLAKLVDA-----KLTHVTTQIRG--------TMGHIAPEYLST 450
++L + + + AK +A K +TT+ + T HI+ ++ S
Sbjct: 246 CLLVLLN-----VQN---AKAWNAFNLSCK-ILLTTRFKQVTDFLSAATTTHISLDHHSM 296
Query: 451 GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE 484
+ ++ +LL L E
Sbjct: 297 TLTPDEVK------SLLLKYLD---CRPQDLPRE 321
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 3e-09
Identities = 72/473 (15%), Positives = 138/473 (29%), Gaps = 114/473 (24%)
Query: 28 HSSREPDVEGEALIEVLKALNDT-----HGQF----TDW------NDHFVSPCFS----W 68
+ SR L + L L G T W + V W
Sbjct: 130 NVSRLQPYL--KLRQALLELRPAKNVLIDGVLGSGKT-WVALDVCLSYKVQCKMDFKIFW 186
Query: 69 SHV-TCRNGNVISLTLGSNGFSGKISPSITKL-KFLASLELQDNDLSGTLPDFLGSMTHL 126
++ C + + L +I P+ T ++++L+ + + L L S +
Sbjct: 187 LNLKNCNSPETVLEML--QKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYE 244
Query: 127 QSL----NLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLI 182
L N+ N K W +LS L + T T +
Sbjct: 245 NCLLVLLNVQNAK-------AW------NAFNLSCKIL----------LTTRFKQVTDFL 281
Query: 183 CGSSLEQPCMSRPSPPVSTSRTKLRIVVASASCGAFVL-----------LSL-GAL---F 227
++ + S ++ +++ C L LS+
Sbjct: 282 SAATTTHISLDHHSMTLTPDEV-KSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDG 340
Query: 228 ACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCREL--QLATDNFSESNIIGQGGFG 285
+ + + D + + SL L R++ +L+ F S I
Sbjct: 341 LATWDNWKHVNCDKLTTII-----ESSLNVLEPAEYRKMFDRLSV--FPPSAHIPTILLS 393
Query: 286 KVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE--R 343
++ V+ + V V +L Y + +++ +++I L+L R
Sbjct: 394 LIWFDVIKSDVMVVVNKLHKY------SLVEKQPKESTISIPSIYLELKVKLENEYALHR 447
Query: 344 ILV--YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL--H-EQCNPKIIH 398
+V Y N+ + DL P LD Y ++ H +
Sbjct: 448 SIVDHY----NIPKTFDSDDLIP--PYLD-----------QYFYSHIGHHLKNIEH--PE 488
Query: 399 RDLKAANILLDDNF-EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA---PEY 447
R + LD F E + A + + Q++ +I P+Y
Sbjct: 489 RMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKY 541
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 61.7 bits (149), Expect = 2e-10
Identities = 29/196 (14%), Positives = 56/196 (28%), Gaps = 25/196 (12%)
Query: 65 CFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDF-LGSM 123
S + C + + + L L +++ L L +
Sbjct: 7 PHGSSGLRCTRDGALD-----------SLHHLPGAENLTELYIENQQHLQHLELRDLRGL 55
Query: 124 THLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHL- 181
L++L + + + + L L+LS N L + + + L
Sbjct: 56 GELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQ----GLSLQELV 109
Query: 182 ICGSSLEQPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDV 241
+ G+ L C R + C L+ +C L+ +
Sbjct: 110 LSGNPLHCSCALRWLQRWEEEGL-GGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNA 168
Query: 242 FFDVAGED---DCKVS 254
DV G+D C+V
Sbjct: 169 SVDV-GDDVLLRCQVE 183
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 22/95 (23%), Positives = 34/95 (35%), Gaps = 2/95 (2%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L N S + S + L L L N L+ + L+ L+L++N
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 137 SGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
S+ T+ L L L L L + LF
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFR 126
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 26/93 (27%), Positives = 38/93 (40%), Gaps = 5/93 (5%)
Query: 80 SLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 138
+L L G ++ P + L L L LQDN L D + +L L L N+ S
Sbjct: 109 TLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS- 166
Query: 139 SIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
S+P + L +L L L N + + F
Sbjct: 167 SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFR 198
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 21/92 (22%), Positives = 33/92 (35%), Gaps = 5/92 (5%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L L N + L L L L N +S + L L L N+ +
Sbjct: 134 LYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-H 191
Query: 140 IPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ + L L L L +NNL+ +P + +
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLS-ALPTEALA 222
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 21/103 (20%), Positives = 36/103 (34%), Gaps = 11/103 (10%)
Query: 72 TCRNGNVISLTLGSNGFS---GKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQS 128
C N ++ + G I + + L N +S + +L
Sbjct: 7 VCYNEPKVTTSCPQQGLQAVPVGIPAASQ------RIFLHGNRISHVPAASFRACRNLTI 60
Query: 129 LNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
L L +N + I A ++ L+ L+ LDLS N + F
Sbjct: 61 LWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFH 102
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 21/82 (25%), Positives = 32/82 (39%), Gaps = 4/82 (4%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L L N S + L L L L N ++ P + L +L L N S +
Sbjct: 158 LFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-A 215
Query: 140 IPA-TWSQLSNLKHLDLSSNNL 160
+P + L L++L L+ N
Sbjct: 216 LPTEALAPLRALQYLRLNDNPW 237
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 21/95 (22%), Positives = 37/95 (38%), Gaps = 2/95 (2%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
N+ SL +G N IS + L L L L+ +L+ + L + L L L +
Sbjct: 129 NLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLN 187
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ ++ +L LK L++S +
Sbjct: 188 INAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLY 222
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 7e-10
Identities = 17/92 (18%), Positives = 36/92 (39%), Gaps = 3/92 (3%)
Query: 80 SLTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 138
LTL + I +++ L L L L+ +++ + L+ L +++ +
Sbjct: 156 QLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLD 214
Query: 139 SIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
++ NL L ++ NLT +P
Sbjct: 215 TMTPNCLYGLNLTSLSITHCNLT-AVPYLAVR 245
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 24/121 (19%), Positives = 48/121 (39%), Gaps = 9/121 (7%)
Query: 69 SHVTCRNGNVISLTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQ 127
+ N+ SL++ + + ++ L +L L L N +S L + LQ
Sbjct: 217 TPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQ 275
Query: 128 SLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLF----SVATFNFTGTHLI 182
+ L + + + + L+ L+ L++S N LT + +F ++ T L
Sbjct: 276 EIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
Query: 183 C 183
C
Sbjct: 334 C 334
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 18/92 (19%), Positives = 37/92 (40%), Gaps = 3/92 (3%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L + + ++P+ L SL + +L+ + + +L+ LNL+ N S +
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-T 262
Query: 140 IPATW-SQLSNLKHLDLSSNNLTGRIPMQLFS 170
I + +L L+ + L L + F
Sbjct: 263 IEGSMLHELLRLQEIQLVGGQLA-VVEPYAFR 293
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 25/95 (26%), Positives = 42/95 (44%), Gaps = 3/95 (3%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
++ L L N S + P L L +L L+ N L +++L L+++ NK
Sbjct: 57 HLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENK 115
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ + L NLK L++ N+L I + FS
Sbjct: 116 IVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFS 149
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 27/108 (25%), Positives = 42/108 (38%), Gaps = 17/108 (15%)
Query: 65 CFSWS-HVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSM 123
C + V C +++ G I L+L N + D S
Sbjct: 9 CSAQDRAVLCHRKRFVAVPEG-------IPTETR------LLDLGKNRIKTLNQDEFASF 55
Query: 124 THLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
HL+ L L N S ++ ++ L NL+ L L SN L IP+ +F+
Sbjct: 56 PHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFT 101
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 25/93 (26%), Positives = 33/93 (35%), Gaps = 5/93 (5%)
Query: 80 SLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 138
L + N + + L L SLE+ DNDL + L+ L L +
Sbjct: 108 KLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT- 165
Query: 139 SIPATW-SQLSNLKHLDLSSNNLTGRIPMQLFS 170
SIP S L L L L N+ I F
Sbjct: 166 SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFK 197
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 4e-10
Identities = 23/130 (17%), Positives = 38/130 (29%), Gaps = 15/130 (11%)
Query: 44 LKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKF-- 101
LK L + S + LTL + +G P + +
Sbjct: 70 LKRLTVRAARIPSRILFGALRVLGISGLQ-------ELTLENLEVTGTAPPPLLEATGPD 122
Query: 102 LASLELQDNDLSGTLPDFLGSM-----THLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156
L L L++ + +L + L+ L++A L LDLS
Sbjct: 123 LNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLS 181
Query: 157 SNNLTGRIPM 166
N G +
Sbjct: 182 DNPELGERGL 191
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 4e-08
Identities = 22/106 (20%), Positives = 34/106 (32%), Gaps = 6/106 (5%)
Query: 58 NDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTL 116
N +P S + + L L N L SL L L +
Sbjct: 210 NAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QV 268
Query: 117 PDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTG 162
P L + L L+L+ N+ P+ +L + +L L N
Sbjct: 269 PKGLPA--KLSVLDLSYNRLD-RNPSPD-ELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 4e-04
Identities = 16/93 (17%), Positives = 33/93 (35%), Gaps = 8/93 (8%)
Query: 94 PSITKLKFLASLELQDNDLSGTLPD---FLGSMTHLQSLNLANNKFSGSIPATWSQL--S 148
I K L L ++ + + + ++ LQ L L N + +G+ P +
Sbjct: 62 TDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGP 121
Query: 149 NLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHL 181
+L L+L + + R + + L
Sbjct: 122 DLNILNLRNVSWATRDA---WLAELQQWLKPGL 151
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 6e-10
Identities = 26/91 (28%), Positives = 41/91 (45%), Gaps = 2/91 (2%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L + N F P I T+L+ L L+L L P S++ LQ LN+++N F
Sbjct: 155 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSL 214
Query: 140 IPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ L++L+ LD S N++ Q
Sbjct: 215 DTFPYKCLNSLQVLDYSLNHIM-TSKKQELQ 244
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 19/97 (19%), Positives = 43/97 (44%), Gaps = 6/97 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNLANN 134
++ L L NG +S + L+ L L+ Q ++L + + S+ +L L++++
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHT 136
Query: 135 KFSGSIPATW-SQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ LS+L+ L ++ N+ +F+
Sbjct: 137 HTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 172
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 22/98 (22%), Positives = 40/98 (40%), Gaps = 7/98 (7%)
Query: 77 NVISLTLGSNGFSGKISPSIT--KLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANN 134
+ L+L SNG S K S + L L+L N + T+ + L+ L+ ++
Sbjct: 53 QLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHS 111
Query: 135 KFSGSIPA--TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ + L NL +LD+S + +F+
Sbjct: 112 NLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFN 147
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 27/102 (26%), Positives = 44/102 (43%), Gaps = 16/102 (15%)
Query: 63 SPCF-SWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLG 121
S C S + + C + + S+ G I S T+L EL+ N L
Sbjct: 3 SRCSCSGTEIRCNSKGLTSVPTG-------IPSSATRL------ELESNKLQSLPHGVFD 49
Query: 122 SMTHLQSLNLANNKFS-GSIPA-TWSQLSNLKHLDLSSNNLT 161
+T L L+L++N S + + ++LK+LDLS N +
Sbjct: 50 KLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 91
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 18/83 (21%), Positives = 31/83 (37%), Gaps = 5/83 (6%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L L ++SP+ L L L + N+ + LQ L+ + N +
Sbjct: 180 LDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-T 237
Query: 140 IPATWSQ--LSNLKHLDLSSNNL 160
Q S+L L+L+ N+
Sbjct: 238 SKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 20/148 (13%), Positives = 50/148 (33%), Gaps = 7/148 (4%)
Query: 20 LVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVI 79
L + + + + + +K L TD + + + +
Sbjct: 201 LELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDD 260
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSG-----TLPDFLGSMTHLQSLNLANN 134
G F+ S +++L + ++ ++ + L + ++ + + N+
Sbjct: 261 CTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENS 320
Query: 135 KFSGSIPA-TWSQLSNLKHLDLSSNNLT 161
K +P L +L+ LDLS N +
Sbjct: 321 KVF-LVPCSFSQHLKSLEFLDLSENLMV 347
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 25/96 (26%), Positives = 42/96 (43%), Gaps = 3/96 (3%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
N+ L L S+ + I L L L+L DN LS + G ++ L+ LNL N
Sbjct: 51 NLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNP 109
Query: 136 FSG-SIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ + + + L+NL+ L + + I F+
Sbjct: 110 YQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFA 145
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 25/95 (26%), Positives = 43/95 (45%), Gaps = 2/95 (2%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ SL L N + + L L L+ + ++ D S+ L+ L+L++N
Sbjct: 27 AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86
Query: 137 SGSIPATW-SQLSNLKHLDLSSNNLTGRIPMQLFS 170
S S+ ++W LS+LK+L+L N LF
Sbjct: 87 S-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFP 120
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 22/112 (19%), Positives = 43/112 (38%), Gaps = 11/112 (9%)
Query: 64 PCFSWSHVTCRNGNVISLTLGSNGFSGKISPS---ITKLKFLASLELQDNDLS--GTLPD 118
PC H+ ++ L L N + + L +L L N L +
Sbjct: 326 PCSFSQHLK----SLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGE 381
Query: 119 FLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
L ++ +L SL+++ N F +P + ++ L+LSS + + +
Sbjct: 382 ILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQ 431
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 23/91 (25%), Positives = 35/91 (38%), Gaps = 7/91 (7%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTL---PDFLGSMTHLQSLNLAN 133
V +T+ ++ LK L L+L +N + G+ LQ+L L+
Sbjct: 311 KVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQ 370
Query: 134 NKFSGSIPATW---SQLSNLKHLDLSSNNLT 161
N S+ T L NL LD+S N
Sbjct: 371 NHLR-SMQKTGEILLTLKNLTSLDISRNTFH 400
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 23/92 (25%), Positives = 36/92 (39%), Gaps = 7/92 (7%)
Query: 81 LTLGSNGFS--GKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 138
L L N K + LK L SL++ N +PD ++ LNL++
Sbjct: 366 LVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR- 423
Query: 139 SIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ L+ LD+S+NNL + L
Sbjct: 424 VVK--TCIPQTLEVLDVSNNNLD-SFSLFLPR 452
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 14/84 (16%), Positives = 33/84 (39%), Gaps = 3/84 (3%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI 140
L + +S + L+ + + ++++ + F + L+ L+L+ N
Sbjct: 291 LHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEY 350
Query: 141 PATWS---QLSNLKHLDLSSNNLT 161
+ +L+ L LS N+L
Sbjct: 351 LKNSACKGAWPSLQTLVLSQNHLR 374
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 21/100 (21%), Positives = 40/100 (40%), Gaps = 2/100 (2%)
Query: 77 NVISLTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
N+ +L +G+ +I L L LE++ L L S+ + L L ++
Sbjct: 124 NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSE 183
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFN 175
+ + LS++++L+L NL R V +
Sbjct: 184 SAFLLEIFADILSSVRYLELRDTNLA-RFQFSPLPVDEVS 222
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 18/93 (19%), Positives = 37/93 (39%), Gaps = 6/93 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L + +N S + +L+ L + N L TLPD L + ++ N+
Sbjct: 432 TLEVLDVSNNNLD-SFSLFLPRLQ---ELYISRNKLK-TLPDA-SLFPVLLVMKISRNQL 485
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 169
+ +L++L+ + L +N P +
Sbjct: 486 KSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY 518
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 14/67 (20%), Positives = 28/67 (41%), Gaps = 4/67 (5%)
Query: 104 SLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGR 163
+ + + ++P L ++SL+L+ NK + +NL+ L L S+ +
Sbjct: 9 VCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-T 64
Query: 164 IPMQLFS 170
I F
Sbjct: 65 IEGDAFY 71
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 27/96 (28%), Positives = 41/96 (42%), Gaps = 4/96 (4%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
++ L LG N +I L L +LEL DN L+ ++ L+ L L NN
Sbjct: 100 HLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNP 158
Query: 136 FSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
SIP+ ++++ +L LDL I F
Sbjct: 159 IE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFE 193
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 26/95 (27%), Positives = 45/95 (47%), Gaps = 3/95 (3%)
Query: 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
N+ L LG + P++T L L LE+ N P ++ L+ L + N++
Sbjct: 196 FNLKYLNLGMCNIK-DM-PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQ 253
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
S + L++L L+L+ NNL+ +P LF+
Sbjct: 254 VSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFT 287
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 24/103 (23%), Positives = 37/103 (35%), Gaps = 13/103 (12%)
Query: 73 CR-NGNVISLTLGSNGFS---GKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQS 128
C + + G S I + L L +N++ D + HL+
Sbjct: 50 CSCSNQFSKVVCTRRGLSEVPQGIPSNTRYL------NLMENNIQMIQADTFRHLHHLEV 103
Query: 129 LNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
L L N I ++ L++L L+L N LT IP F
Sbjct: 104 LQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFE 144
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 9e-07
Identities = 24/82 (29%), Positives = 36/82 (43%), Gaps = 4/82 (4%)
Query: 81 LTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L + N F +I P S L L L + ++ +S + + L LNLA+N S S
Sbjct: 223 LEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-S 280
Query: 140 IPA-TWSQLSNLKHLDLSSNNL 160
+P ++ L L L L N
Sbjct: 281 LPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 27/97 (27%), Positives = 42/97 (43%), Gaps = 11/97 (11%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANN 134
+ N I T+ F+G L L +LEL DN L+ ++ L+ L L NN
Sbjct: 96 SRNHIR-TIEIGAFNG--------LANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNN 146
Query: 135 KFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
SIP+ ++++ +L+ LDL I F
Sbjct: 147 PIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFE 182
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 28/94 (29%), Positives = 44/94 (46%), Gaps = 3/94 (3%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L L +I P++T L L L+L N LS P + HLQ L + ++
Sbjct: 186 NLRYLNLAMCNLR-EI-PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI 243
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ L +L ++L+ NNLT +P LF+
Sbjct: 244 QVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFT 276
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 25/97 (25%), Positives = 40/97 (41%), Gaps = 12/97 (12%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANN 134
+ N I + N F L+ L L+L N + + +L +L L +N
Sbjct: 72 HENQIQ-IIKVNSFKH--------LRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122
Query: 135 KFSGSIPATW-SQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ + +IP LS LK L L +N + IP F+
Sbjct: 123 RLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFN 157
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 23/103 (22%), Positives = 37/103 (35%), Gaps = 13/103 (12%)
Query: 73 CR-NGNVISLTLGSNGFS---GKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQS 128
C + + IS + L L +N + + + HL+
Sbjct: 39 CSCSNQFSKVICVRKNLREVPDGISTNTR------LLNLHENQIQIIKVNSFKHLRHLEI 92
Query: 129 LNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
L L+ N +I ++ L+NL L+L N LT IP F
Sbjct: 93 LQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFV 133
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 8e-07
Identities = 20/83 (24%), Positives = 35/83 (42%), Gaps = 4/83 (4%)
Query: 80 SLTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 138
L L N S I P S L L L + + + + ++ L +NLA+N +
Sbjct: 211 ELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT- 268
Query: 139 SIPA-TWSQLSNLKHLDLSSNNL 160
+P ++ L +L+ + L N
Sbjct: 269 LLPHDLFTPLHHLERIHLHHNPW 291
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 26/91 (28%), Positives = 41/91 (45%), Gaps = 4/91 (4%)
Query: 80 SLTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 138
L L N + K+ S+ L LA L L N +S L + HL+ L+L NNK
Sbjct: 196 ELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV- 253
Query: 139 SIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 169
+P + ++ + L +NN++ I F
Sbjct: 254 KVPGGLADHKYIQVVYLHNNNIS-AIGSNDF 283
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 18/94 (19%), Positives = 36/94 (38%), Gaps = 4/94 (4%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ + + + I + L L L N ++ L + +L L L+ N
Sbjct: 172 KLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 228
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
S + + +L+ L L++N L ++P L
Sbjct: 229 SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 261
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 23/100 (23%), Positives = 38/100 (38%), Gaps = 12/100 (12%)
Query: 80 SLTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 138
L L N S + S+ L L L +N L +P L ++Q + L NN S
Sbjct: 220 KLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS- 276
Query: 139 SIPATW-------SQLSNLKHLDLSSNNLT-GRIPMQLFS 170
+I + ++ ++ + L SN + I F
Sbjct: 277 AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 316
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 21/79 (26%), Positives = 36/79 (45%), Gaps = 7/79 (8%)
Query: 92 ISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLK 151
+ P L+LQ+N ++ ++ +L +L L NNK S P ++ L L+
Sbjct: 50 LPPDTA------LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 103
Query: 152 HLDLSSNNLTGRIPMQLFS 170
L LS N L +P ++
Sbjct: 104 RLYLSKNQLK-ELPEKMPK 121
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 12/71 (16%), Positives = 27/71 (38%), Gaps = 3/71 (4%)
Query: 102 LASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI--PATWSQLSNLKHLDLSSNN 159
L L + +N+++ + + + L N S + + L ++ ++ N
Sbjct: 123 LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 182
Query: 160 LTGRIPMQLFS 170
+T IP L
Sbjct: 183 IT-TIPQGLPP 192
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 27/97 (27%), Positives = 42/97 (43%), Gaps = 8/97 (8%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
N+ +L L +N S KISP L L L L N L LP+ LQ L + N+
Sbjct: 77 NLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQLK-ELPE--KMPKTLQELRVHENE 132
Query: 136 FSGSIPA-TWSQLSNLKHLDLSSNNLT-GRIPMQLFS 170
+ + ++ L+ + ++L +N L I F
Sbjct: 133 IT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 9e-06
Identities = 14/87 (16%), Positives = 32/87 (36%), Gaps = 9/87 (10%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSG------TLPDFLGSMTHLQSLNLAN 133
L L +N K+ + K++ + L +N++S P + ++L +
Sbjct: 244 ELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFS 302
Query: 134 NKFSGSI--PATWSQLSNLKHLDLSSN 158
N P+T+ + + L +
Sbjct: 303 NPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 25/91 (27%), Positives = 39/91 (42%), Gaps = 6/91 (6%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L L N S + L L L +L+ L G++ L +L+L++N+ S
Sbjct: 36 LHLSENLLY-TFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQLQ-S 91
Query: 140 IPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+P L L LD+S N LT +P+
Sbjct: 92 LPLLGQTLPALTVLDVSFNRLT-SLPLGALR 121
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 28/91 (30%), Positives = 39/91 (42%), Gaps = 5/91 (5%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L + N + + L L L L+ N+L P L L+ L+LANN +
Sbjct: 105 LDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-E 162
Query: 140 IPA-TWSQLSNLKHLDLSSNNLTGRIPMQLF 169
+PA + L NL L L N+L IP F
Sbjct: 163 LPAGLLNGLENLDTLLLQENSLY-TIPKGFF 192
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 24/91 (26%), Positives = 38/91 (41%), Gaps = 4/91 (4%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
+L L N + L L L++ N L+ L + LQ L L N+ +
Sbjct: 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-T 138
Query: 140 IPA-TWSQLSNLKHLDLSSNNLTGRIPMQLF 169
+P + L+ L L++NNLT +P L
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLT-ELPAGLL 168
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 20/79 (25%), Positives = 30/79 (37%), Gaps = 3/79 (3%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L L N + P + T L L L +N+L+ L + +L +L L N +
Sbjct: 129 LYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186
Query: 140 IPATWSQLSNLKHLDLSSN 158
IP + L L N
Sbjct: 187 IPKGFFGSHLLPFAFLHGN 205
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 52/225 (23%), Positives = 92/225 (40%), Gaps = 47/225 (20%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQREVHLI-----------S 323
+G G F V+ + +NT VA+K R Y EAA + E+ L+
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY---TEAA-EDEIKLLQRVNDADNTKED 81
Query: 324 VAIHKNLLQLIG---YCTTSSERI-LVYPFM-QNLSVAYRLRDL--KPGEKGLDWPTRKR 376
++L+L+ + + + +V+ + +NL L K +G+ K+
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENL------LALIKKYEHRGIPLIYVKQ 135
Query: 377 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD------NFEAVLCDFGLAKLVDAKLT 430
++ GL+Y+H +C IIH D+K N+L++ + + D G A D T
Sbjct: 136 ISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 193
Query: 431 H--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
+ T + R +PE L D++ + EL+TG
Sbjct: 194 NSIQTREYR------SPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 19/93 (20%), Positives = 40/93 (43%), Gaps = 4/93 (4%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI 140
+G +K+ L+ +N L+ T+ + G +T L++L L N+ +
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-EL 363
Query: 141 PAT---WSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+Q+ +L+ LD+S N+++ S
Sbjct: 364 SKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCS 396
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 16/131 (12%), Positives = 43/131 (32%), Gaps = 3/131 (2%)
Query: 34 DVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLT---LGSNGFSG 90
+ + I +L+ + T + ++ + + ++ +L+ + S+ F
Sbjct: 231 ETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGF 290
Query: 91 KISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNL 150
S + + ++ L+ +NN + ++ L+ L
Sbjct: 291 PQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTEL 350
Query: 151 KHLDLSSNNLT 161
+ L L N L
Sbjct: 351 ETLILQMNQLK 361
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 24/127 (18%), Positives = 42/127 (33%), Gaps = 3/127 (2%)
Query: 44 LKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLA 103
L L + + T WN W H T ++ ++ L S T LK L+
Sbjct: 222 LSNLTLNNIETT-WNSFIRILQLVW-HTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALS 279
Query: 104 SLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGR 163
++ + +++ N + S++S HLD S+N LT
Sbjct: 280 IHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT-D 338
Query: 164 IPMQLFS 170
+
Sbjct: 339 TVFENCG 345
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 26/91 (28%), Positives = 42/91 (46%), Gaps = 5/91 (5%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L + N S + K L SL + N L+ T+ L ++ L+L +NK S
Sbjct: 379 LDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-S 435
Query: 140 IPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
IP +L L+ L+++SN L +P +F
Sbjct: 436 IPKQVVKLEALQELNVASNQLK-SVPDGIFD 465
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 21/85 (24%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+++SL + SN + I + + L+L N + ++P + + LQ LN+A+N+
Sbjct: 400 SLLSLNMSSNILTDTIFRCLPPR--IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQL 456
Query: 137 SGSIP-ATWSQLSNLKHLDLSSNNL 160
S+P + +L++L+ + L +N
Sbjct: 457 K-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 16/70 (22%), Positives = 31/70 (44%), Gaps = 6/70 (8%)
Query: 92 ISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLK 151
+S T L + N +S + S++ L+ L +++N+ + + L+
Sbjct: 19 LSQKTTIL------NISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELE 72
Query: 152 HLDLSSNNLT 161
+LDLS N L
Sbjct: 73 YLDLSHNKLV 82
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 33/206 (16%), Positives = 60/206 (29%), Gaps = 8/206 (3%)
Query: 74 RNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNL 131
N + L L N S L L+L N LP G+M+ L+ L L
Sbjct: 67 FNQELEYLDLSHNKLV---KISCHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGL 122
Query: 132 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRI-PMQLFSVATFNFTGTHLICGSSLEQP 190
+ S + L+ K L + + P L T +
Sbjct: 123 STTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFIL 182
Query: 191 CMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDD 250
+S + + + ++ V+ C F+ + + L + ++
Sbjct: 183 DVSVKT-VANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRIL 241
Query: 251 CKVSLTQLRRFSCRELQLATDNFSES 276
V T + FS ++L
Sbjct: 242 QLVWHTTVWYFSISNVKLQGQLDFRD 267
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 19/93 (20%), Positives = 34/93 (36%), Gaps = 10/93 (10%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQS----LNLANNK 135
L++ +N + + L+ +L++ N L +LP H + N+
Sbjct: 164 VLSVRNNQLT-FLPELPESLE---ALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENR 218
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL 168
+ IP L + L N L+ RI L
Sbjct: 219 IT-HIPENILSLDPTCTIILEDNPLSSRIRESL 250
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 24/89 (26%), Positives = 41/89 (46%), Gaps = 11/89 (12%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
C L L S + ++ + LE+ N L +LP+ S L+ L+
Sbjct: 56 CLINQFSELQLNRLNLS-SLPDNLPPQ--ITVLEITQNALI-SLPELPAS---LEYLDAC 108
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLT 161
+N+ S ++P ++LKHLD+ +N LT
Sbjct: 109 DNRLS-TLPE---LPASLKHLDVDNNQLT 133
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 22/95 (23%), Positives = 41/95 (43%), Gaps = 13/95 (13%)
Query: 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
++ L N S + LK L++ +N L+ LP+ L+ +N NN+
Sbjct: 100 ASLEYLDACDNRLS-TLPELPASLK---HLDVDNNQLT-MLPELPAL---LEYINADNNQ 151
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ +P ++L+ L + +N LT +P S
Sbjct: 152 LT-MLPE---LPTSLEVLSVRNNQLT-FLPELPES 181
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 12/91 (13%), Positives = 30/91 (32%), Gaps = 6/91 (6%)
Query: 81 LTLGSNGFSGKISPSITKLKFL----ASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
L + +N + + ++N ++ +P+ + S+ ++ L +N
Sbjct: 185 LDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPL 242
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ 167
S I + SQ + + Q
Sbjct: 243 SSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 14/70 (20%), Positives = 25/70 (35%), Gaps = 6/70 (8%)
Query: 104 SLELQDNDLSGTLPDFLGSMTHLQSLNLAN---NKFSGSIPATWSQLSNLKHLDLSSNNL 160
S N +SGT D+ + + L N+ + ++ L L+ NL
Sbjct: 14 SQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFSELQLNRLNL 71
Query: 161 TGRIPMQLFS 170
+ +P L
Sbjct: 72 S-SLPDNLPP 80
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 33/174 (18%), Positives = 57/174 (32%), Gaps = 43/174 (24%)
Query: 279 IGQGGFGKVYKGV---------LSDNTKVAVKRLQDYYSPGGEAAF-QREVHLISVAIHK 328
+ G +Y+ K ++K E F QR + V K
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 329 NLL--------QLIGYCTTSSE-RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF 379
L +G+ + R LV + +L R L + LD + ++
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLV---LPSLG-----RSL---QSALDVSPKHVLSE 158
Query: 380 GTAY--------GLEYLHEQCNPKIIHRDLKAANILLDDNFEAV--LCDFGLAK 423
+ LE+LHE +H ++ A NI +D ++ L +G A
Sbjct: 159 RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 4e-09
Identities = 25/96 (26%), Positives = 40/96 (41%), Gaps = 5/96 (5%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
N+ SL L N + IS + L L+L N L + L+ L L NN
Sbjct: 65 NLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNH 123
Query: 136 FSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ + ++ L+ L LS N ++ R P++L
Sbjct: 124 IV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIK 157
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 24/81 (29%), Positives = 40/81 (49%), Gaps = 10/81 (12%)
Query: 92 ISPSITKLKFLASLELQDNDLSGTLPD-FLGSMTHLQSLNLANNKFSGSIPA-TWSQLSN 149
+ L +L N+LS + +T+L SL L++N + I + + + N
Sbjct: 37 LPSYTALL------DLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPN 89
Query: 150 LKHLDLSSNNLTGRIPMQLFS 170
L++LDLSSN+L + LFS
Sbjct: 90 LRYLDLSSNHLH-TLDEFLFS 109
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 6e-06
Identities = 24/80 (30%), Positives = 36/80 (45%), Gaps = 10/80 (12%)
Query: 97 TKLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNLANNKFSGSIPA----TWSQLSNL 150
+ L+ L L L +N + + F M LQ L L+ N+ S P ++L L
Sbjct: 109 SDLQALEVLLLYNNHIV-VVDRNAFED-MAQLQKLYLSQNQIS-RFPVELIKDGNKLPKL 165
Query: 151 KHLDLSSNNLTGRIPMQLFS 170
LDLSSN L ++P+
Sbjct: 166 MLLDLSSNKLK-KLPLTDLQ 184
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 21/94 (22%), Positives = 39/94 (41%), Gaps = 10/94 (10%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ +L N + +++ K L L N+++ L L L L+ ++NK
Sbjct: 171 QLTTLDCSFNKIT---ELDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKL 224
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ I + L+ L + D S N LT + + S
Sbjct: 225 T-EID--VTPLTQLTYFDCSVNPLT-ELDVSTLS 254
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 16/86 (18%), Positives = 29/86 (33%), Gaps = 6/86 (6%)
Query: 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
N + + G +T L L+ Q ++ L L L L L N +
Sbjct: 273 HNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTE 329
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLT 161
+ + S + LK L + ++
Sbjct: 330 LT-ELDV--SHNTKLKSLSCVNAHIQ 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 22/85 (25%), Positives = 39/85 (45%), Gaps = 8/85 (9%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ SL ++ + I KL L L N+++ TL L T+L L +NK
Sbjct: 43 TLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKL 97
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
+ ++ + L+ L +L+ +N LT
Sbjct: 98 T-NLDV--TPLTKLTYLNCDTNKLT 119
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 19/82 (23%), Positives = 35/82 (42%), Gaps = 5/82 (6%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
S + + S +L L SL+ ++ ++ + +T L L +N + +
Sbjct: 22 SEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTGI-EKLTGLTKLICTSNNIT-T 78
Query: 140 IPATWSQLSNLKHLDLSSNNLT 161
+ SQ +NL +L SN LT
Sbjct: 79 LD--LSQNTNLTYLACDSNKLT 98
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 16/87 (18%), Positives = 31/87 (35%), Gaps = 9/87 (10%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANN 134
N + L +N + + + L L+ N L+ + + +T L + + N
Sbjct: 190 NKLLNRLNCDTNNIT---KLDLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVN 243
Query: 135 KFSGSIPATWSQLSNLKHLDLSSNNLT 161
+ + S LS L L +L
Sbjct: 244 PLT-ELDV--STLSKLTTLHCIQTDLL 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 21/85 (24%), Positives = 35/85 (41%), Gaps = 9/85 (10%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L SN + + +++ L L N L+ L + +T L LN NK
Sbjct: 65 GLTKLICTSNNIT---TLDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKL 118
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
+ + SQ L +L+ + N LT
Sbjct: 119 T-KLDV--SQNPLLTYLNCARNTLT 140
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 13/87 (14%), Positives = 23/87 (26%), Gaps = 8/87 (9%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANN 134
+ +L I + Q + T L L+
Sbjct: 253 LSKLTTLHCIQTDLL-----EIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAA 307
Query: 135 KFSGSIPATWSQLSNLKHLDLSSNNLT 161
+ + SQ L +L L++ LT
Sbjct: 308 GIT-ELDL--SQNPKLVYLYLNNTELT 331
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 14/60 (23%), Positives = 25/60 (41%), Gaps = 2/60 (3%)
Query: 102 LASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLT 161
AS ++ T + L SL+ N+ + + +L+ L L +SNN+T
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTGI-EKLTGLTKLICTSNNIT 77
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 21/96 (21%), Positives = 41/96 (42%), Gaps = 9/96 (9%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
C N L +G +G + + + + +L + DN+L+ +LP L++L ++
Sbjct: 37 CLNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPP---ELRTLEVS 89
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL 168
N+ + S+P L L +L +P L
Sbjct: 90 GNQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGL 123
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 7e-09
Identities = 22/95 (23%), Positives = 37/95 (38%), Gaps = 12/95 (12%)
Query: 67 SWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHL 126
+H+ + L + N + + L+ L + DN L+ +LP L
Sbjct: 112 PLTHLPALPSGLCKLWIFGNQLT-SLPVLPPGLQ---ELSVSDNQLA-SLPALPS---EL 163
Query: 127 QSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLT 161
L NN+ + S+P S L+ L +S N L
Sbjct: 164 CKLWAYNNQLT-SLPM---LPSGLQELSVSDNQLA 194
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
+ L++ N + + ++L L +N L+ +LP L+ L ++ N+
Sbjct: 181 SGLQELSVSDNQLA-SLPTLPSELY---KLWAYNNRLT-SLPALPSG---LKELIVSGNR 232
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLT 161
+ S+P S LK L +S N LT
Sbjct: 233 LT-SLPVL---PSELKELMVSGNRLT 254
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 17/86 (19%), Positives = 31/86 (36%), Gaps = 8/86 (9%)
Query: 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
+ L + N + + + L SL + N L+ LP+ L ++ ++NL N
Sbjct: 241 SELKELMVSGNRLT-SLPMLPSGLL---SLSVYRNQLT-RLPESLIHLSSETTVNLEGNP 295
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLT 161
S T L + S +
Sbjct: 296 LS---ERTLQALREITSAPGYSGPII 318
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 6e-09
Identities = 18/93 (19%), Positives = 30/93 (32%), Gaps = 3/93 (3%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF-SG 138
L + I + L L L+L N + +L+ L L
Sbjct: 59 LKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGA 118
Query: 139 SIPATW-SQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ + L++L+ L L NN+ P F
Sbjct: 119 VLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFL 151
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 29/128 (22%), Positives = 55/128 (42%), Gaps = 9/128 (7%)
Query: 47 LNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSI-TKLKFLASL 105
L++++ + + +++ V + L + + S+ + L L
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQL 304
Query: 106 ELQDNDLSGTLPD--FLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTG 162
L N+++ + D F G +THL LNL+ N SI + + L L+ LDLS N++
Sbjct: 305 TLAQNEIN-KIDDNAFWG-LTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR- 360
Query: 163 RIPMQLFS 170
+ Q F
Sbjct: 361 ALGDQSFL 368
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 26/94 (27%), Positives = 43/94 (45%), Gaps = 7/94 (7%)
Query: 80 SLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFL-GSMTHLQSLNLANNKFS 137
LTL N + KI + L L L L N L ++ + ++ L+ L+L+ N
Sbjct: 303 QLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR 360
Query: 138 GSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
++ ++ L NLK L L +N L +P +F
Sbjct: 361 -ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFD 392
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 14/68 (20%), Positives = 25/68 (36%), Gaps = 2/68 (2%)
Query: 104 SLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTG 162
++L N ++ + LQ L + I T+ LS+L L L N
Sbjct: 34 YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL- 92
Query: 163 RIPMQLFS 170
++ F+
Sbjct: 93 QLETGAFN 100
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 24/105 (22%), Positives = 31/105 (29%), Gaps = 5/105 (4%)
Query: 81 LTLGSNGFSGKISPSIT--KLKFLASLELQDNDLSGTLPD-FLGSMTHLQSLNLANNKFS 137
LTL G + L L L L+DN++ P F +M L+L NK
Sbjct: 108 LTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK 167
Query: 138 GSIPATWSQL--SNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTH 180
+ L LSS L L N
Sbjct: 168 SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNT 212
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 7e-05
Identities = 19/85 (22%), Positives = 36/85 (42%), Gaps = 2/85 (2%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+++ L L N S L L L+L N + + +L+ L L N+
Sbjct: 324 HLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQL 383
Query: 137 SGSIPA-TWSQLSNLKHLDLSSNNL 160
S+P + +L++L+ + L +N
Sbjct: 384 K-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 15/115 (13%), Positives = 33/115 (28%), Gaps = 17/115 (14%)
Query: 65 CFSWSHVTCRN----------GNVISLTLGSNGFSGKISP-SITKLKFLASLELQDNDLS 113
C + +L L I + + L ++ + + +
Sbjct: 10 CHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTL 68
Query: 114 GTLPD--FLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIP 165
L F ++ + + + N + I +L LK L + + L P
Sbjct: 69 QQLESHSFYN-LSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFP 121
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 5e-06
Identities = 16/98 (16%), Positives = 36/98 (36%), Gaps = 5/98 (5%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDN-DLSGTLPDFLGSMTHLQSLNLANN 134
N+ + + + ++ L + +E+++ +L+ PD L + L+ L + N
Sbjct: 56 NISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNT 115
Query: 135 KFSGSIPAT--WSQLSNLKHLDLSSNNLTGRIPMQLFS 170
P L+++ N IP+ F
Sbjct: 116 GLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQ 152
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 19/95 (20%), Positives = 40/95 (42%), Gaps = 6/95 (6%)
Query: 80 SLTLGSNGFSGKISP-SITKL-KFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFS 137
L + N + I + L +L+L +N + ++ + + T L ++ L NK+
Sbjct: 134 ILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYL 192
Query: 138 GSIPA-TWSQL-SNLKHLDLSSNNLTGRIPMQLFS 170
I + + S LD+S ++T +P +
Sbjct: 193 TVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLE 226
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 7e-04
Identities = 12/68 (17%), Positives = 25/68 (36%), Gaps = 6/68 (8%)
Query: 104 SLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTG 162
+ D+ +P Q+L L +IP+ +S L N+ + +S +
Sbjct: 15 DFRVTCKDIQ-RIPSLP---PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQ 69
Query: 163 RIPMQLFS 170
++ F
Sbjct: 70 QLESHSFY 77
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 22/104 (21%), Positives = 40/104 (38%), Gaps = 3/104 (2%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
+ L +G+ KI L FL LE+ +DL P L S+ ++ L L +
Sbjct: 150 KLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQ 209
Query: 136 FSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTG 178
+ S+++ L+L +L +L + T +
Sbjct: 210 HI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIK 252
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 24/106 (22%), Positives = 49/106 (46%), Gaps = 14/106 (13%)
Query: 69 SHVTCRNGNVISLTLGSNGFS---GKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTH 125
+ ++C + + S + ++ ++ SL+L +N ++ L +
Sbjct: 26 ASLSCDRNGICKGS--SGSLNSIPSGLTEAVK------SLDLSNNRITYISNSDLQRCVN 77
Query: 126 LQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
LQ+L L +N + +I ++S L +L+HLDLS N L+ + F
Sbjct: 78 LQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFK 121
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 18/99 (18%), Positives = 33/99 (33%), Gaps = 12/99 (12%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGT--------LPDFLGSMTHLQSLNL 131
L L + + LEL+D DL + L +++ +
Sbjct: 203 LILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKI 261
Query: 132 ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ + +Q+S L L+ S N L +P +F
Sbjct: 262 TDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFD 298
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 16/94 (17%), Positives = 35/94 (37%), Gaps = 11/94 (11%)
Query: 77 NVISLTLGSNGFSGKISPSI--------TKLKFLASLELQDNDLSGTLPDFLGSMTHLQS 128
+V L L + K ++++ D L + L ++ L
Sbjct: 223 SVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLE 281
Query: 129 LNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLT 161
L + N+ S+P + +L++L+ + L +N
Sbjct: 282 LEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 25/97 (25%), Positives = 46/97 (47%), Gaps = 5/97 (5%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
N+ +L L SNG + I + L L L+L N LS + ++ L LNL N
Sbjct: 77 NLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNP 135
Query: 136 FSGSIP--ATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ ++ + +S L+ L+ L + + + +I + F+
Sbjct: 136 YK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA 171
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 27/85 (31%), Positives = 46/85 (54%), Gaps = 6/85 (7%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ SL+L NG S I+ + L L SL L +N ++ L +T L +L+L +N+
Sbjct: 110 KLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQI 165
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
S I + L+ L++L LS N+++
Sbjct: 166 S-DIVP-LAGLTKLQNLYLSKNHIS 188
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 1e-07
Identities = 29/88 (32%), Positives = 42/88 (47%), Gaps = 12/88 (13%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDN---DLSGTLPDFLGSMTHLQSLNLAN 133
N+ L L N +S + LK L SL L+ N D++G L + L+SL L N
Sbjct: 88 NLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGISDING-----LVHLPQLESLYLGN 140
Query: 134 NKFSGSIPATWSQLSNLKHLDLSSNNLT 161
NK + I S+L+ L L L N ++
Sbjct: 141 NKIT-DITVL-SRLTKLDTLSLEDNQIS 166
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 19/85 (22%), Positives = 34/85 (40%), Gaps = 6/85 (7%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
++ + ++ + I L + L L N L+ P L ++ +L L L NK
Sbjct: 44 SIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKI 99
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
+ + L LK L L N ++
Sbjct: 100 K-DLSSL-KDLKKLKSLSLEHNGIS 122
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 29/99 (29%), Positives = 48/99 (48%), Gaps = 6/99 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ SL LG+N + I+ +++L L +L L+DN +S L +T LQ+L L+ N
Sbjct: 132 QLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHI 187
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFN 175
S + A + L NL L+L S + ++ N
Sbjct: 188 S-DLRAL-AGLKNLDVLELFSQECLNKPINHQSNLVVPN 224
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 4e-06
Identities = 12/71 (16%), Positives = 24/71 (33%), Gaps = 5/71 (7%)
Query: 91 KISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNL 150
+I P L+ ++ + + + + N+ S+ L N+
Sbjct: 13 QIFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQGI-QYLPNV 67
Query: 151 KHLDLSSNNLT 161
L L+ N LT
Sbjct: 68 TKLFLNGNKLT 78
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 40.9 bits (95), Expect = 8e-04
Identities = 19/84 (22%), Positives = 32/84 (38%), Gaps = 4/84 (4%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ +L+L N S I P + L L +L L N +S L + +L L L + +
Sbjct: 154 KLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQEC 209
Query: 137 SGSIPATWSQLSNLKHLDLSSNNL 160
S L + + +L
Sbjct: 210 LNKPINHQSNLVVPNTVKNTDGSL 233
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 28/94 (29%), Positives = 44/94 (46%), Gaps = 8/94 (8%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFL-GSMTHLQSLNLANNKFSG 138
L L N ++ + L L L + +L+ +L +F G + L+ LN+A+N
Sbjct: 81 LILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ- 137
Query: 139 SIPA--TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
S +S L+NL+HLDLSSN + I
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLR 170
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 4e-07
Identities = 21/95 (22%), Positives = 36/95 (37%), Gaps = 9/95 (9%)
Query: 80 SLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNLANNKF 136
+L L N + L L+L ++ T+ D + ++HL +L L N
Sbjct: 32 NLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQS-LSHLSTLILTGNPI 88
Query: 137 SGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
S+ +S LS+L+ L NL +
Sbjct: 89 Q-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIG 121
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 8e-05
Identities = 24/95 (25%), Positives = 37/95 (38%), Gaps = 9/95 (9%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLP----DFLGSMTHLQ-SLNLANN 134
L + N P + L L L+L N + ++ L M L SL+L+ N
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLN 187
Query: 135 KFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 169
+ I + LK L L +N L +P +F
Sbjct: 188 PMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIF 220
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 22/85 (25%), Positives = 40/85 (47%), Gaps = 6/85 (7%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
++ +L L S + ++P + L L L L N ++ P L +T+LQ L++ N +
Sbjct: 108 SIKTLDLTSTQIT-DVTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQV 163
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
S + + LS L L N ++
Sbjct: 164 S-DLTPL-ANLSKLTTLKADDNKIS 186
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 19/85 (22%), Positives = 41/85 (48%), Gaps = 6/85 (7%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L L N +S I L+ + +L+L ++ L +++LQ L L N+
Sbjct: 86 KITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQI 141
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
+ +I + L+NL++L + + ++
Sbjct: 142 T-NISPL-AGLTNLQYLSIGNAQVS 164
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 23/85 (27%), Positives = 39/85 (45%), Gaps = 6/85 (7%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L L N + ISP + L L L + + +S L +++ L +L +NK
Sbjct: 130 NLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKI 185
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
S I + L NL + L +N ++
Sbjct: 186 S-DISP-LASLPNLIEVHLKNNQIS 208
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 15/85 (17%), Positives = 35/85 (41%), Gaps = 6/85 (7%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N I + G + + + + L + +L ++ + + + +L L L +N+
Sbjct: 20 NAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQI 75
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
+ + L+ + L+LS N L
Sbjct: 76 T-DLAPL-KNLTKITELELSGNPLK 98
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 23/85 (27%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L++G+ S ++P + L L +L+ DN +S + L S+ +L ++L NN+
Sbjct: 152 NLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQI 207
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
S + + SNL + L++ +T
Sbjct: 208 S-DVSP-LANTSNLFIVTLTNQTIT 230
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 13/71 (18%), Positives = 28/71 (39%), Gaps = 5/71 (7%)
Query: 91 KISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNL 150
I P L + ++++ T+ + + +L+ + +I L+NL
Sbjct: 11 VIFP-DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNL 65
Query: 151 KHLDLSSNNLT 161
L+L N +T
Sbjct: 66 IGLELKDNQIT 76
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 42/170 (24%), Positives = 67/170 (39%), Gaps = 35/170 (20%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRL----QDYYSPGG---EAAFQREV---HLISVAIHK 328
IGQGGFG +Y ++ + V + G E F + I I
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 329 NLLQLIG-----YCTTSSERILVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRK------- 375
L+ +G + Y FM + R DL +K + ++
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFM----IMDRFGSDL---QKIYEANAKRFSRKTVL 155
Query: 376 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFEAV-LCDFGLAK 423
+++ LEY+HE +H D+KA+N+LL+ N + V L D+GLA
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 7e-08
Identities = 25/98 (25%), Positives = 43/98 (43%), Gaps = 9/98 (9%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNLAN 133
+ + L N I P + K L ++L +N +S L F G + L SL L
Sbjct: 33 TITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQG-LRSLNSLVLYG 89
Query: 134 NKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
NK + +P + L +L+ L L++N + + + F
Sbjct: 90 NKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQ 125
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 9e-06
Identities = 22/74 (29%), Positives = 29/74 (39%), Gaps = 3/74 (4%)
Query: 98 KLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLS 156
L+ L SL L N ++ + LQ L L NK + + + L NL L L
Sbjct: 78 GLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLY 136
Query: 157 SNNLTGRIPMQLFS 170
N L I FS
Sbjct: 137 DNKLQ-TIAKGTFS 149
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 16/61 (26%), Positives = 27/61 (44%)
Query: 98 KLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSS 157
L L L L N ++ D + +L L+L +NK T+S L ++ + L+
Sbjct: 102 GLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQ 161
Query: 158 N 158
N
Sbjct: 162 N 162
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 44/168 (26%), Positives = 62/168 (36%), Gaps = 34/168 (20%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGG----EAAFQREV---HLISVAIHKNL 330
IG GGFG +Y + K A ++ Y G E F + V I I +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 331 LQLIG-----YCTTSSERILVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRK-------RV 377
L +G + + Y FM V RL DL +K ++
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFM----VMERLGIDL---QKISGQ-NGTFKKSTVLQL 156
Query: 378 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV--LCDFGLAK 423
LEY+HE +H D+KAAN+LL L D+GL+
Sbjct: 157 GIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 53/221 (23%), Positives = 86/221 (38%), Gaps = 53/221 (23%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQREVHLISV------AIHK 328
+IG+G FG+V K + VA+K R + + A E+ ++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH---RQA-AEEIRILEHLRKQDKDNTM 159
Query: 329 NLLQLIGY-------CTTSSERILVYPFM-QNLSVAYRLRDLKPGE-KGLDWPTRKRVAF 379
N++ ++ C + + + NL Y L +K + +G P ++ A
Sbjct: 160 NVIHMLENFTFRNHIC-------MTFELLSMNL---YEL--IKKNKFQGFSLPLVRKFAH 207
Query: 380 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV--LCDFGLAKLVDAKLTHVTTQI- 436
L+ LH+ +IIH DLK NILL + + DFG + V T I
Sbjct: 208 SILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH---QRVYTYIQ 261
Query: 437 ----RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
R APE + + D++ G L EL+TG
Sbjct: 262 SRFYR------APEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 8/86 (9%)
Query: 80 SLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNLANNKF 136
L L SN S + +L L L L DN L TLP F + +L++L + +NK
Sbjct: 41 KLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKE-LKNLETLWVTDNKL 97
Query: 137 SGSIPA-TWSQLSNLKHLDLSSNNLT 161
++P + QL NL L L N L
Sbjct: 98 Q-ALPIGVFDQLVNLAELRLDRNQLK 122
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 30/93 (32%), Positives = 43/93 (46%), Gaps = 9/93 (9%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNLANNKFS 137
L L N + P + L L L L N+L +LP F +T L+ L L NN+
Sbjct: 114 LRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVF-DKLTSLKELRLYNNQLK 170
Query: 138 GSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLF 169
+P + +L+ LK L L +N L R+P F
Sbjct: 171 -RVPEGAFDKLTELKTLKLDNNQLK-RVPEGAF 201
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 22/68 (32%), Positives = 36/68 (52%), Gaps = 3/68 (4%)
Query: 104 SLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTG 162
L+LQ N LS +T L+ L L +NK ++PA + +L NL+ L ++ N L
Sbjct: 41 KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ- 98
Query: 163 RIPMQLFS 170
+P+ +F
Sbjct: 99 ALPIGVFD 106
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-07
Identities = 24/82 (29%), Positives = 35/82 (42%), Gaps = 3/82 (3%)
Query: 81 LTLGSNGFS-GKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L L + + GKI + L L L + L L + L+ L L+ N+ G
Sbjct: 29 LVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGG 86
Query: 140 IPATWSQLSNLKHLDLSSNNLT 161
+ +L NL HL+LS N L
Sbjct: 87 LDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-07
Identities = 28/86 (32%), Positives = 41/86 (47%), Gaps = 3/86 (3%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L+L + G +S + KL L LEL +N + G L + +L LNL+ NK
Sbjct: 50 NLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL 107
Query: 137 SG-SIPATWSQLSNLKHLDLSSNNLT 161
S +L LK LDL + +T
Sbjct: 108 KDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 15/85 (17%), Positives = 37/85 (43%), Gaps = 6/85 (7%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N + LG + + +L + + ++++ + T+L+ L+L++N+
Sbjct: 20 NAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQSL--AGMQFFTNLKELHLSHNQI 75
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
S + L+ L+ L ++ N L
Sbjct: 76 S-DLSPL-KDLTKLEELSVNRNRLK 98
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 4e-07
Identities = 23/88 (26%), Positives = 35/88 (39%), Gaps = 13/88 (14%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTL---PDFLGSMTHLQSLNLAN 133
+ L++ N + L + S L L D L + +L+ L++ N
Sbjct: 86 KLEELSVNRN--------RLKNLNGIPSACLSRLFLDNNELRDTDSLIHLKNLEILSIRN 137
Query: 134 NKFSGSIPATWSQLSNLKHLDLSSNNLT 161
NK SI LS L+ LDL N +T
Sbjct: 138 NKLK-SIVML-GFLSKLEVLDLHGNEIT 163
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 18/85 (21%), Positives = 38/85 (44%), Gaps = 6/85 (7%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L L +N + LK L L +++N L ++ LG ++ L+ L+L N+
Sbjct: 107 CLSRLFLDNNELR-DTDS-LIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEI 162
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
+ + ++L + +DL+
Sbjct: 163 T-NTGG-LTRLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 23/85 (27%), Positives = 32/85 (37%), Gaps = 7/85 (8%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L L N S +SP + L L L + N L L L L NN+
Sbjct: 64 NLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNG---IPSACLSRLFLDNNEL 118
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
+ L NL+ L + +N L
Sbjct: 119 R-DTDS-LIHLKNLEILSIRNNKLK 141
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 28/85 (32%), Positives = 42/85 (49%), Gaps = 6/85 (7%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
N+ L L N +S + LK L SL L+ N +S + + L + L+SL L NNK
Sbjct: 91 NLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKI 146
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
+ I S+L+ L L L N ++
Sbjct: 147 T-DITVL-SRLTKLDTLSLEDNQIS 169
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 15/85 (17%), Positives = 31/85 (36%), Gaps = 6/85 (7%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
I L + +L + + ++D+ ++ + + ++ L L NK
Sbjct: 25 ETIKDNLKKKSVT-DAVT-QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKL 80
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
+ I + L NL L L N +
Sbjct: 81 T-DIKP-LANLKNLGWLFLDENKVK 103
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 11/71 (15%), Positives = 23/71 (32%), Gaps = 5/71 (7%)
Query: 91 KISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNL 150
+I L+ ++ + + + + N+ S+ L N+
Sbjct: 16 QIFS-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNV 70
Query: 151 KHLDLSSNNLT 161
L L+ N LT
Sbjct: 71 TKLFLNGNKLT 81
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 6e-07
Identities = 22/86 (25%), Positives = 43/86 (50%), Gaps = 3/86 (3%)
Query: 77 NVISLTLGSNGFS-GKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
+V L L ++ + GK+ + + L L + L+ ++ + L + L+ L L++N+
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNR 75
Query: 136 FSGSIPATWSQLSNLKHLDLSSNNLT 161
SG + + NL HL+LS N +
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-06
Identities = 29/86 (33%), Positives = 42/86 (48%), Gaps = 3/86 (3%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
+ L+ + G + I+ ++ KL L LEL DN +SG L +L LNL+ NK
Sbjct: 43 ELEFLSTINVGLT-SIA-NLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKI 100
Query: 137 SG-SIPATWSQLSNLKHLDLSSNNLT 161
S +L NLK LDL + +T
Sbjct: 101 KDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 8e-07
Identities = 28/169 (16%), Positives = 54/169 (31%), Gaps = 28/169 (16%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQD-NDLSGTLPDFLGSMTHLQSLNLANN 134
++ + + N I + + L L + ++ N+L P+ ++ +LQ L ++N
Sbjct: 55 DLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNT 114
Query: 135 KFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPCMS 193
+P LD+ N I F +F L
Sbjct: 115 GIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWL------------ 161
Query: 194 RPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVF 242
++ ++ + AF L L L +L +DVF
Sbjct: 162 --------NKNGIQEI----HNSAFNGTQLDELNLSDNNNLEELPNDVF 198
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 14/71 (19%), Positives = 23/71 (32%), Gaps = 3/71 (4%)
Query: 102 LASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLS-SNN 159
L L L+ + ++ N I A +S L L + + +NN
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91
Query: 160 LTGRIPMQLFS 170
L I + F
Sbjct: 92 LL-YINPEAFQ 101
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 7e-05
Identities = 17/98 (17%), Positives = 32/98 (32%), Gaps = 7/98 (7%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNLAN 133
N I L I + L +E+ ND+ + F + L + +
Sbjct: 31 NAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSN-LPKLHEIRIEK 88
Query: 134 NKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
I + L NL++L +S+ + +P
Sbjct: 89 ANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKI 125
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 20/118 (16%), Positives = 33/118 (27%), Gaps = 29/118 (24%)
Query: 80 SLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNLANNK- 135
L + + G + L++QDN T+ F+G L L N
Sbjct: 108 YLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI 166
Query: 136 -------FSG---------------SIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
F+G +P + S LD+S + +P
Sbjct: 167 QEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLE 223
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 40.6 bits (95), Expect = 7e-04
Identities = 13/68 (19%), Positives = 28/68 (41%), Gaps = 5/68 (7%)
Query: 104 SLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTG 162
Q++ ++ +P L + L K I +S +L+ +++S N++
Sbjct: 13 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 163 RIPMQLFS 170
I +FS
Sbjct: 69 VIEADVFS 76
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 9e-07
Identities = 21/99 (21%), Positives = 42/99 (42%), Gaps = 10/99 (10%)
Query: 77 NVISLTLGSNGFSGKISPSIT--KLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNLA 132
L L +N F+ + + KL L + +N ++ + + F G + + + L
Sbjct: 33 YTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEG-ASGVNEILLT 89
Query: 133 NNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+N+ ++ + L +LK L L SN +T + F
Sbjct: 90 SNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFI 126
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 16/96 (16%), Positives = 36/96 (37%), Gaps = 5/96 (5%)
Query: 77 NVISLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
+ + +N + I + + L N L + L++L L +N+
Sbjct: 58 QLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNR 116
Query: 136 FSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+ + ++ LS+++ L L N +T + F
Sbjct: 117 IT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFD 150
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 14/62 (22%), Positives = 33/62 (53%), Gaps = 2/62 (3%)
Query: 98 KLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLS 156
L+ L +L L+ N ++ D ++ ++ L+L +N+ + ++ + L +L L+L
Sbjct: 103 GLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLL 161
Query: 157 SN 158
+N
Sbjct: 162 AN 163
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 9e-07
Identities = 26/115 (22%), Positives = 45/115 (39%), Gaps = 24/115 (20%)
Query: 63 SPCFSWSHVTCRN-----------GNVISLTLGSNGFSGKISPS-ITKLKFLASLELQDN 110
S V N +L+L N S ++ I+ L L L L N
Sbjct: 28 FSNELESMVDYSNRNLTHVPKDLPPRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHN 86
Query: 111 DLSGTLP----DFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLT 161
+ +L F L+ L++++N+ +I +++L+HLDLS N+
Sbjct: 87 RIR-SLDFHVFLFN---QDLEYLDVSHNRLQ-NISCCP--MASLRHLDLSFNDFD 134
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 26/107 (24%), Positives = 46/107 (42%), Gaps = 8/107 (7%)
Query: 67 SWSHVTCRNGNVISLTLGSNGF----SGKISPSITKLKFLASLELQDNDLSGTLPDFLGS 122
++ V N+ SL S + + + L L N L+G++ L
Sbjct: 391 NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP 450
Query: 123 MTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 169
++ L+L NN+ SIP + L L+ L+++SN L +P +F
Sbjct: 451 --KVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVF 493
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 21/85 (24%), Positives = 46/85 (54%), Gaps = 5/85 (5%)
Query: 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK 135
+++ L L SN +G + + + L+L +N + ++P + + LQ LN+A+N+
Sbjct: 428 ESILVLNLSSNMLTGSVFRCLPPK--VKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQ 484
Query: 136 FSGSIP-ATWSQLSNLKHLDLSSNN 159
S+P + +L++L+++ L N
Sbjct: 485 LK-SVPDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 16/75 (21%), Positives = 31/75 (41%), Gaps = 7/75 (9%)
Query: 98 KLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIP--ATWSQLSNLKHLDL 155
+ L L++ N L + M L+ L+L+ N F +P + L+ L L L
Sbjct: 98 FNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGL 153
Query: 156 SSNNLTGRIPMQLFS 170
S+ ++ + +
Sbjct: 154 SAAKFR-QLDLLPVA 167
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 8e-06
Identities = 16/79 (20%), Positives = 25/79 (31%)
Query: 83 LGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA 142
+ + F + + L +D S + LN N F+ S+
Sbjct: 312 VKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQ 371
Query: 143 TWSQLSNLKHLDLSSNNLT 161
S L L+ L L N L
Sbjct: 372 GCSTLKRLQTLILQRNGLK 390
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 28/213 (13%), Positives = 69/213 (32%), Gaps = 23/213 (10%)
Query: 44 LKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKL---K 100
+ AL ND ++ R ++++TL + K S + + +
Sbjct: 217 VNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPR 276
Query: 101 FLASLELQDNDLSG-----TLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155
+ L + + ++ ++ L ++ N F S A +S + + L
Sbjct: 277 PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKML 336
Query: 156 SSNNLTGRIPMQLFSVATFNFTGTHLICGSSLEQPCMSRPSPPVSTSRTKLRIVV----- 210
S ++ I M + + T L + Q + ++ +L+ ++
Sbjct: 337 SISDTP-FIHMVCPPSPS---SFTFL----NFTQNVFTDSVFQGCSTLKRLQTLILQRNG 388
Query: 211 -ASASCGAFVLLSLGALFACRYQKLRKLKHDVF 242
+ A + ++ +L L L +
Sbjct: 389 LKNFFKVALMTKNMSSLE-TLDVSLNSLNSHAY 420
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 37/158 (23%), Positives = 59/158 (37%), Gaps = 31/158 (19%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKNLL----- 331
IG G FG +Y G ++ +VA+K E + L I+K +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL---------ECVKTKHPQLHIESKIYKMMQGGVGI 67
Query: 332 -QLIGYCTTSSERILVYPFMQNL--SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
+ ++V M+ L S+ L + + T +A +EY+
Sbjct: 68 PTIRWCGAEGDYNVMV---MELLGPSLED-LFNFCS--RKFSLKTVLLLADQMISRIEYI 121
Query: 389 HEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAK 423
H + IHRD+K N L+ + DFGLAK
Sbjct: 122 HSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 21/85 (24%), Positives = 40/85 (47%), Gaps = 5/85 (5%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
L L +N KIS ++ ++ L L L N + + + L+ L ++ N+
Sbjct: 49 ACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQI 105
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
+ S+ +L NL+ L +S+N +T
Sbjct: 106 A-SLSG-IEKLVNLRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 9e-05
Identities = 15/74 (20%), Positives = 30/74 (40%), Gaps = 4/74 (5%)
Query: 88 FSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQL 147
F + S T+ + + L + + L ++ + L L+ N I ++ S +
Sbjct: 14 FEERKSVVATEAEKV-ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGM 69
Query: 148 SNLKHLDLSSNNLT 161
NL+ L L N +
Sbjct: 70 ENLRILSLGRNLIK 83
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-06
Identities = 18/85 (21%), Positives = 32/85 (37%), Gaps = 3/85 (3%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136
L L I L +++ DN++ L D + L++L + NN+
Sbjct: 20 RDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRI 76
Query: 137 SGSIPATWSQLSNLKHLDLSSNNLT 161
L +L L L++N+L
Sbjct: 77 CRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 14/72 (19%), Positives = 25/72 (34%), Gaps = 11/72 (15%)
Query: 96 ITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWS------QLSN 149
L+ L +L + +N + ++ L L L NN L +
Sbjct: 60 FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-----ELGDLDPLASLKS 114
Query: 150 LKHLDLSSNNLT 161
L +L + N +T
Sbjct: 115 LTYLCILRNPVT 126
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 21/67 (31%), Positives = 35/67 (52%), Gaps = 4/67 (5%)
Query: 104 SLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTG 162
L L N + +P L + HL ++L+NN+ S ++ ++S ++ L L LS N L
Sbjct: 35 ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR- 91
Query: 163 RIPMQLF 169
IP + F
Sbjct: 92 CIPPRTF 98
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 4e-06
Identities = 28/95 (29%), Positives = 49/95 (51%), Gaps = 6/95 (6%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFL-GSMTHLQSLNLANNK 135
+V L L N F+ + ++ K L ++L +N +S TL + +MT L +L L+ N+
Sbjct: 32 DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNR 89
Query: 136 FSGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLF 169
IP T+ L +L+ L L N+++ +P F
Sbjct: 90 LR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAF 122
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 41/200 (20%), Positives = 59/200 (29%), Gaps = 66/200 (33%)
Query: 345 LVYPFMQ-NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKA 403
+V+ + +L + +GL P K++ GL+YLH +C IIH D+K
Sbjct: 122 MVFEVLGHHL---LKWIIKSNY-QGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKP 175
Query: 404 ANILL-------------------------------------------------DDNFEA 414
NILL + +
Sbjct: 176 ENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKV 235
Query: 415 VLCDFGLAKLVDAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 472
+ D G A V T T Q R + E L + D++ EL TG
Sbjct: 236 KIADLGNACWVHKHFTEDIQTRQYR------SLEVLIGSGYNTPADIWSTACMAFELATG 289
Query: 473 QRAIDFSRLEEEEDVLLLDH 492
F EE DH
Sbjct: 290 DYL--FEPHSGEEYTRDEDH 307
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 38/165 (23%), Positives = 62/165 (37%), Gaps = 43/165 (26%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKNLL----- 331
IG+G FG +++G L +N +VA+K E L +K L
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF---------EPRRSDAPQLRDEYRTYKLLAGCTGI 68
Query: 332 -QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-------RVAFGTAY 383
+ + +LV + L L DL LD RK A
Sbjct: 69 PNVYYFGQEGLHNVLV---IDLLG--PSLEDL------LDLCGRKFSVKTVAMAAKQMLA 117
Query: 384 GLEYLHEQCNPKIIHRDLKAANILL----DDNFEAV-LCDFGLAK 423
++ +HE+ +++RD+K N L+ N + + DFG+ K
Sbjct: 118 RVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 26/91 (28%), Positives = 38/91 (41%), Gaps = 10/91 (10%)
Query: 80 SLTLGSNGFSGKISPSIT--KLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNLANNK 135
L L N +IS +L L LEL+ N L+ + F +H+Q L L NK
Sbjct: 33 ELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAF-EGASHIQELQLGENK 89
Query: 136 FSGSIPA-TWSQLSNLKHLDLSSNNLTGRIP 165
I + L LK L+L N ++ +
Sbjct: 90 IK-EISNKMFLGLHQLKTLNLYDNQIS-CVM 118
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 5e-05
Identities = 19/68 (27%), Positives = 30/68 (44%), Gaps = 4/68 (5%)
Query: 104 SLELQDNDLSGTLPD-FLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLT 161
L L DN+L D G + HL L L N+ + I + S+++ L L N +
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK 91
Query: 162 GRIPMQLF 169
I ++F
Sbjct: 92 -EISNKMF 98
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 49/213 (23%), Positives = 86/213 (40%), Gaps = 33/213 (15%)
Query: 277 NIIGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQREVHLISV------AIH 327
++IG+G FG+V K + VA+K + + + A Q EV L+ + +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL---NQA-QIEVRLLELMNKHDTEMK 115
Query: 328 KNLLQLIGYCTTSSERILVYPFM-QNLSVAYRLRDL--KPGEKGLDWPTRKRVAFGTAYG 384
++ L + + LV+ + NL DL +G+ ++ A
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNL------YDLLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAV--LCDFGLAKLVDAKLTH--VTTQIRGTM 440
L +L IIH DLK NILL + + + DFG + + ++ + R
Sbjct: 170 LLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR--- 225
Query: 441 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 473
+PE L D++ G L+E+ TG+
Sbjct: 226 ---SPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 47.3 bits (112), Expect = 8e-06
Identities = 40/163 (24%), Positives = 64/163 (39%), Gaps = 41/163 (25%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKNLL----- 331
IG G FG++Y G + N +VA+K E + L+ I++ L
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL---------ENVKTKHPQLLYESKIYRILQGGTGI 65
Query: 332 -QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-------RVAFGTAY 383
+ + +LV M L L DL ++ +RK +A
Sbjct: 66 PNVRWFGVEGDYNVLV---MDLLG--PSLEDL------FNFCSRKLSLKTVLMLADQMIN 114
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEA---VLCDFGLAK 423
+E++H + +HRD+K N L+ A + DFGLAK
Sbjct: 115 RVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 8e-06
Identities = 36/161 (22%), Positives = 57/161 (35%), Gaps = 35/161 (21%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVK---RLQDYYSPGGEAAFQREVHLISVAIHKNLLQLI 334
IG G FG++ G L N VA+K E F +++ + Q+
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSG-----DGIPQVY 71
Query: 335 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-------RVAFGTAYGLEY 387
+ +V ++ L L DL D R +A +EY
Sbjct: 72 YFGPCGKYNAMV---LELLG--PSLEDL------FDLCDRTFSLKTVLMIAIQLISRMEY 120
Query: 388 LHEQCNPKIIHRDLKAANILL-----DDNFEAVLCDFGLAK 423
+H + +I+RD+K N L+ + DF LAK
Sbjct: 121 VHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 27/91 (29%), Positives = 38/91 (41%), Gaps = 3/91 (3%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L L S G + + L L L L N L +T L +L LANN+ + S
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 140 IPA-TWSQLSNLKHLDLSSNNLTGRIPMQLF 169
+P + L+ L L L N L +P +F
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVF 127
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 27/91 (29%), Positives = 41/91 (45%), Gaps = 5/91 (5%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L L N +S + L L +L L +N L+ +T L L L N+ S
Sbjct: 64 LNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-S 121
Query: 140 IPA-TWSQLSNLKHLDLSSNNLTGRIPMQLF 169
+P+ + +L+ LK L L++N L IP F
Sbjct: 122 LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAF 151
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 28/91 (30%), Positives = 41/91 (45%), Gaps = 5/91 (5%)
Query: 81 LTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L L +N + + + L L L L N L +T L+ L L N+ S
Sbjct: 88 LGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-S 145
Query: 140 IPA-TWSQLSNLKHLDLSSNNLTGRIPMQLF 169
IPA + +L+NL+ L LS+N L +P F
Sbjct: 146 IPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAF 175
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 1e-05
Identities = 26/91 (28%), Positives = 40/91 (43%), Gaps = 3/91 (3%)
Query: 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS 139
L L +N + +L L L L N L +T L LNL+ N+ S
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-S 90
Query: 140 IPA-TWSQLSNLKHLDLSSNNLTGRIPMQLF 169
+P + +L+ LK L L++N L +P +F
Sbjct: 91 LPNGVFDKLTQLKELALNTNQLQ-SLPDGVF 120
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 23/81 (28%), Positives = 34/81 (41%), Gaps = 4/81 (4%)
Query: 82 TLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIP 141
+ +N K I L + L L N L + +T+L L L N+ S+P
Sbjct: 45 QIIANNSDIKSVQGIQYLPNVRYLALGGNKLH-DISAL-KELTNLTYLILTGNQLQ-SLP 101
Query: 142 AT-WSQLSNLKHLDLSSNNLT 161
+ +L+NLK L L N L
Sbjct: 102 NGVFDKLTNLKELVLVENQLQ 122
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 30/92 (32%), Positives = 43/92 (46%), Gaps = 5/92 (5%)
Query: 80 SLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG 138
L L N + + KL L L L +N L +T+L LNLA+N+
Sbjct: 89 YLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ- 146
Query: 139 SIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLF 169
S+P + +L+NL LDLS N L +P +F
Sbjct: 147 SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVF 177
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 9e-04
Identities = 23/67 (34%), Positives = 37/67 (55%), Gaps = 6/67 (8%)
Query: 98 KLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLD 154
+L L L L N L +LP+ F +T+L+ L L N+ S+P + +L+NL +L+
Sbjct: 83 ELTNLTYLILTGNQLQ-SLPNGVFDK-LTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLN 139
Query: 155 LSSNNLT 161
L+ N L
Sbjct: 140 LAHNQLQ 146
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 3e-05
Identities = 18/114 (15%), Positives = 36/114 (31%), Gaps = 14/114 (12%)
Query: 62 VSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKF--LASLEL---QDNDLSGTL 116
+ + S N+ SL + S G + I L L L ++
Sbjct: 179 IKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGD 238
Query: 117 PDFL------GSMTHLQSLNLANNKFSGSIP---ATWSQLSNLKHLDLSSNNLT 161
+ +L+ L + + + + L L+ +D+S+ LT
Sbjct: 239 MNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLT 292
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.9 bits (105), Expect = 4e-05
Identities = 11/102 (10%), Positives = 38/102 (37%), Gaps = 14/102 (13%)
Query: 81 LTLGSNGFSGKISPSI-------TKLKFLASLELQDNDLSGTLPDFLGS---MTHLQSLN 130
L +G + ++ + L L + D + + + + L++++
Sbjct: 226 LYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMD 285
Query: 131 LANNKFSGS----IPATWSQLSNLKHLDLSSNNLTGRIPMQL 168
++ + + ++ +LK +++ N L+ + +L
Sbjct: 286 ISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKEL 327
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 5e-05
Identities = 25/74 (33%), Positives = 35/74 (47%), Gaps = 6/74 (8%)
Query: 98 KLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155
L L L+L N L+ LP F + HL+ L + NK + +P +L++L HL L
Sbjct: 86 SLTQLTVLDLGTNQLT-VLPSAVF-DRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLAL 142
Query: 156 SSNNLTGRIPMQLF 169
N L IP F
Sbjct: 143 DQNQLK-SIPHGAF 155
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 19/59 (32%), Positives = 31/59 (52%), Gaps = 2/59 (3%)
Query: 104 SLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLT 161
L L DN ++ P S+ +L+ L L +N+ ++P + L+ L LDL +N LT
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 8e-05
Identities = 20/99 (20%), Positives = 36/99 (36%), Gaps = 13/99 (13%)
Query: 75 NGNVISLTLGSNGFSGK----ISPSITKLKFLASLELQDNDLSGT-----LPDFLGSMTH 125
+ + L+L + +G +S ++ L L L L DN L L
Sbjct: 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCR 143
Query: 126 LQSLNLANNKFS----GSIPATWSQLSNLKHLDLSSNNL 160
L+ L L S + + + K L +S+N++
Sbjct: 144 LEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 24/100 (24%), Positives = 38/100 (38%), Gaps = 13/100 (13%)
Query: 75 NGNVISLTLGSNGFSGK----ISPSITKLKFLASLELQDNDLSG----TLPDFLGSM-TH 125
+ L G + IS ++ LA L L+ N+L + L +
Sbjct: 27 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCK 86
Query: 126 LQSLNLANNKFS----GSIPATWSQLSNLKHLDLSSNNLT 161
+Q L+L N + G + +T L L+ L LS N L
Sbjct: 87 IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 126
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 18/98 (18%), Positives = 31/98 (31%), Gaps = 19/98 (19%)
Query: 80 SLTLGSNGFSGK----ISPSITKLKFLASLELQDNDLSGT----LPDFLGSMT-HLQSLN 130
L L S ++ + L + +ND++ L L L++L
Sbjct: 146 KLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALK 205
Query: 131 LANNKFSGSIPATWSQLS-------NLKHLDLSSNNLT 161
L + + L +L+ L L SN L
Sbjct: 206 LESCGVT---SDNCRDLCGIVASKASLRELALGSNKLG 240
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 45/241 (18%), Positives = 83/241 (34%), Gaps = 75/241 (31%)
Query: 278 IIGQGGFGKVYKGV--LSDNTKVAVK---RLQDYYSPGGEAAFQREVHLISV------AI 326
+G+G FGKV + + ++VA+K + Y EAA + E++++
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYR----EAA-RLEINVLKKIKEKDKEN 80
Query: 327 HKNLLQLIGY-------CTTSSERILVYPFM-QNLSVAYRLRDL--KPGEKGLDWPTRKR 376
+ + + C + + + +N + + + P +
Sbjct: 81 KFLCVLMSDWFNFHGHMC-------IAFELLGKNT------FEFLKENNFQPYPLPHVRH 127
Query: 377 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-------------------LC 417
+A+ + L +LHE ++ H DLK NIL ++ +
Sbjct: 128 MAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184
Query: 418 DFGLAKLVDAKLTHVTTQI-----RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 472
DFG A H TT + R PE + ++ DV+ G L E G
Sbjct: 185 DFGSATFDH---EHHTTIVATRHYR------PPEVILELGWAQPCDVWSIGCILFEYYRG 235
Query: 473 Q 473
Sbjct: 236 F 236
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 22/103 (21%), Positives = 41/103 (39%), Gaps = 15/103 (14%)
Query: 74 RNGNVISLTLGSN-----GFSGKISPSITKLKFLASLELQDNDLSGT----LPDFLGSMT 124
+ + ++ + N G + + + L L+LQDN + L L S
Sbjct: 185 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 244
Query: 125 HLQSLNLANNKFSG----SIPATWSQLSN--LKHLDLSSNNLT 161
+L+ L L + S ++ +S+L N L+ L L N +
Sbjct: 245 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 17/101 (16%), Positives = 37/101 (36%), Gaps = 13/101 (12%)
Query: 74 RNGNVISLTLGSNGFSGK----ISPSITKLKFLASLELQDNDL-----SGTLPDFLGSMT 124
+ S+ G N + + + L ++++ N + L + L
Sbjct: 157 NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQ 216
Query: 125 HLQSLNLANNKFSG----SIPATWSQLSNLKHLDLSSNNLT 161
L+ L+L +N F+ ++ NL+ L L+ L+
Sbjct: 217 ELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 257
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 19/115 (16%), Positives = 31/115 (26%), Gaps = 27/115 (23%)
Query: 74 RNGNVISLTLGSNGFSGK----------ISPSITKLKFLASLELQDNDLSGT----LPDF 119
++ + ++ K L ++ L DN T L DF
Sbjct: 58 SKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDF 117
Query: 120 LGSMTHLQSLNLANNKFS-------------GSIPATWSQLSNLKHLDLSSNNLT 161
L T L+ L L NN ++ L+ + N L
Sbjct: 118 LSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE 172
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 50/247 (20%), Positives = 79/247 (31%), Gaps = 83/247 (33%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQREVHLISV-----AIHKN 329
+G G FG+V + + AVK R Y+ +A + E ++ + N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT---RSA-KIEADILKKIQNDDINNNN 97
Query: 330 LLQLIGY-------CTTSSERILVYPFM-QNLSVAYRLRDL--KPGEKGLDWPTRKRVAF 379
+++ G C L++ + +L ++ + G K
Sbjct: 98 IVKYHGKFMYYDHMC-------LIFEPLGPSL------YEIITRNNYNGFHIEDIKLYCI 144
Query: 380 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV------------------------ 415
L YL + + H DLK NILLDD +
Sbjct: 145 EILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201
Query: 416 -LCDFGLAKLVDAKLTHV--TTQIRGTMGHIAPE------YLSTGKSSEKTDVFGYGITL 466
L DFG A + T Q R APE + +D++ +G L
Sbjct: 202 KLIDFGCATFKSDYHGSIINTRQYR------APEVILNLGW------DVSSDMWSFGCVL 249
Query: 467 LELVTGQ 473
EL TG
Sbjct: 250 AELYTGS 256
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 4e-04
Identities = 20/67 (29%), Positives = 31/67 (46%), Gaps = 3/67 (4%)
Query: 104 SLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTG 162
LEL+ N L +T L L+L+ N+ S+P + +L+ L L L N L
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ- 89
Query: 163 RIPMQLF 169
+P +F
Sbjct: 90 SLPNGVF 96
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 7e-04
Identities = 31/94 (32%), Positives = 43/94 (45%), Gaps = 9/94 (9%)
Query: 80 SLTLGSNGFSGKISPSI-TKLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNLANNKF 136
L L SN + + KL L L L N + +LPD F +T L L L NK
Sbjct: 32 RLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVF-DKLTKLTILYLHENKL 88
Query: 137 SGSIPA-TWSQLSNLKHLDLSSNNLTGRIPMQLF 169
S+P + +L+ LK L L +N L +P +F
Sbjct: 89 Q-SLPNGVFDKLTQLKELALDTNQLK-SVPDGIF 120
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 498 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.98 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.85 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.83 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.82 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.75 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.73 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.71 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.68 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.66 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.65 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.61 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.59 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.59 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.59 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.59 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.55 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.54 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.53 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.52 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.51 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.51 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.46 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.45 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.45 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.44 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.44 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.44 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.44 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.43 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.43 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.43 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.42 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.42 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.41 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.4 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.4 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.39 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.39 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.39 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.38 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.37 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.37 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.36 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.36 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.36 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.35 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.35 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.35 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.35 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.34 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.34 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.34 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.34 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.33 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.33 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.33 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.33 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.33 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.32 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.32 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.31 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.31 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.31 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.3 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.3 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.29 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.29 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.29 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.29 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.28 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.28 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.26 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.25 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.25 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.25 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.25 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.25 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.25 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.25 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.24 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.24 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.24 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.24 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.23 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.23 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.23 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.22 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.22 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.22 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.22 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.21 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.21 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.19 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.19 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.19 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.18 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.17 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.17 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.13 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.12 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.12 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.12 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.1 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.09 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.08 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.07 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.06 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.04 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.04 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.04 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.03 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.02 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.02 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.01 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.99 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.99 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.99 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.98 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.98 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.97 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.93 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.93 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.91 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.9 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.9 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.88 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.86 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.86 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.84 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.84 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.84 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.83 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.83 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.76 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.67 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.67 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.59 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.56 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.56 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.55 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.55 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.46 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.43 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.38 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.25 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.22 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.18 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.11 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.97 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.96 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.94 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.92 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 97.91 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.86 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.79 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.78 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 97.76 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.73 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.71 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.47 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.37 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.36 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.34 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.31 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.24 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.21 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.13 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.08 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.97 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.96 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.73 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.71 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.67 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.65 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 96.42 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.41 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 96.3 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 95.53 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 95.39 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.75 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.72 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 93.48 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 92.82 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 92.74 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 92.05 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.66 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 90.45 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 89.96 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.95 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 89.6 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 88.13 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.33 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 83.07 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=383.71 Aligned_cols=206 Identities=26% Similarity=0.370 Sum_probs=179.3
Q ss_pred CCCCCCeeecccceEEEEEEEc------CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
+++..+.||+|+||+||+|++. +++.||||+++........++|.+|++++++++|||||+++|+|.+++..++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4555788999999999999963 4678999999876666667899999999999999999999999999999999
Q ss_pred EEecccCCCHHHhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCc
Q 010887 346 VYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 413 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 413 (498)
||||+++|+|.++|..... ....++|.++.+|+.|||+||+|||+. +|+||||||+|||+++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence 9999999999999975321 124699999999999999999999999 9999999999999999999
Q ss_pred EEEeecCccccccccCc-ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 414 AVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 414 ~ki~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
+||+|||+++....... .......||+.|||||++.++.|+.++|||||||++|||+| |+.||....
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~ 252 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 252 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence 99999999987654332 22345679999999999999999999999999999999999 899998643
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-49 Score=381.31 Aligned_cols=207 Identities=27% Similarity=0.398 Sum_probs=179.3
Q ss_pred hcCCCCCCeeecccceEEEEEEEc------CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCce
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 343 (498)
.++|...+.||+|+||+||+|++. ++..||||+++.. +....++|.+|++++++++|||||+++|+|.+++..
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 356777899999999999999864 4678999999753 445678899999999999999999999999999999
Q ss_pred EEEEecccCCCHHHhhcccC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcE
Q 010887 344 ILVYPFMQNLSVAYRLRDLK---------PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA 414 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 414 (498)
++||||+++|+|.++|+... .....++|.++..++.||++||+|||++ +|+||||||+|||+++++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcE
Confidence 99999999999999997532 2245799999999999999999999999 99999999999999999999
Q ss_pred EEeecCccccccccCcce-eecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 415 VLCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 415 ki~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
||+|||+++......... .....||+.|||||++.+..|+.++|||||||++|||+| |+.||....
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~ 235 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 235 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999998765443322 234568999999999999999999999999999999999 899998644
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=379.48 Aligned_cols=204 Identities=33% Similarity=0.485 Sum_probs=171.9
Q ss_pred HHHhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 267 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
++..+++...+.||+|+||+||+|++++ .||||+++.. .++...+.|.+|++++++++|||||+++|++.+ +..++
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 3455678889999999999999999743 6999998743 344566889999999999999999999998864 56899
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
||||+++|+|.++++.. ...++|.++..|+.|||+||+|||++ +|+||||||+|||+++++.+||+|||+|+..
T Consensus 109 VmEy~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp EEECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 99999999999999753 34699999999999999999999999 9999999999999999999999999999876
Q ss_pred cccC-cceeecccccccccCcccccC---CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 426 DAKL-THVTTQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 426 ~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.... ........||+.|||||++.+ ++|+.++|||||||++|||+||+.||...
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~ 240 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHI 240 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCC
Confidence 5432 223345679999999999863 46899999999999999999999999754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=380.60 Aligned_cols=206 Identities=26% Similarity=0.421 Sum_probs=172.6
Q ss_pred cCCCCCCeeecccceEEEEEEEc------CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (498)
++|...+.||+|+||+||+|++. +++.||||+++.. +....++|.+|++++++++|||||+++|+|.+.+..+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45666789999999999999864 4778999999753 4456788999999999999999999999999999999
Q ss_pred EEEecccCCCHHHhhcccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCc
Q 010887 345 LVYPFMQNLSVAYRLRDLKP-----------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 413 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 413 (498)
+||||+++|+|.++++.... ...+++|.++..|+.||++||+|||+. +|+||||||+|||+++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence 99999999999999976432 134699999999999999999999999 9999999999999999999
Q ss_pred EEEeecCccccccccCc-ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 414 AVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 414 ~ki~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
+||+|||+++....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||....
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~ 265 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC
Confidence 99999999987654332 22345679999999999999999999999999999999999 899997644
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=381.82 Aligned_cols=204 Identities=23% Similarity=0.329 Sum_probs=176.1
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
++|++.+.||+|+||+||+|+.. +++.||||+++.. ........|.+|++++++++|||||++++++.+++..++|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57899999999999999999964 6899999999743 344566789999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++|+|.+++.... ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 104 y~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999997532 34578999999999999999999999 9999999999999999999999999999877543
Q ss_pred CcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
. .......||+.|||||++.+..|+.++|||||||++|||+||+.||....
T Consensus 179 ~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 229 (350)
T 4b9d_A 179 V-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS 229 (350)
T ss_dssp H-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred c-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 2 12344679999999999999999999999999999999999999998654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=374.87 Aligned_cols=203 Identities=24% Similarity=0.357 Sum_probs=182.2
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|++.+.||+|+||+||+|+. .+++.||+|++... ........+.+|++++++++|||||++++++.+++..++||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5688999999999999999996 46899999999642 12345678999999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999986 34699999999999999999999999 999999999999999999999999999997754
Q ss_pred cCc-ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 428 KLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 428 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
... ......+||+.|||||++.+..|+.++||||+||++|||+||+.||....
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 238 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 238 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 332 23456789999999999999999999999999999999999999998654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=374.01 Aligned_cols=200 Identities=23% Similarity=0.318 Sum_probs=179.2
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
+.|+..+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 46888899999999999999975 68999999996432 23456688999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++|+|.+++.. ..+++.++..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+++......
T Consensus 153 ~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 153 LEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp CTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 999999999874 3589999999999999999999999 99999999999999999999999999998776443
Q ss_pred cceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
. .....+||+.|||||++.+..|+.++||||+||++|||+||+.||....
T Consensus 225 ~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 274 (346)
T 4fih_A 225 P-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 274 (346)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred C-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 2 2345679999999999999999999999999999999999999997643
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=376.42 Aligned_cols=217 Identities=25% Similarity=0.386 Sum_probs=188.9
Q ss_pred cCHHHHHHHhcCCCCCCeeecccceEEEEEEEcC------CcEEEEEEecccCCcchHHHHHHHHHHHHhccC-CccceE
Q 010887 261 FSCRELQLATDNFSESNIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH-KNLLQL 333 (498)
Q Consensus 261 ~~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l 333 (498)
+...++++..++|+..+.||+|+||+||+|++.. ++.||||+++........++|.+|++++.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 5567788888999999999999999999999643 357999999876666677889999999999965 899999
Q ss_pred EEEEEcC-CceEEEEecccCCCHHHhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcC
Q 010887 334 IGYCTTS-SERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRD 400 (498)
Q Consensus 334 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~D 400 (498)
+|+|.+. +..++|||||++|+|.++|+.... ....++|.++..++.|||+||+|||++ +|+|||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 9999765 467999999999999999975321 134589999999999999999999999 999999
Q ss_pred CCCCcEEECCCCcEEEeecCccccccccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCC
Q 010887 401 LKAANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDF 478 (498)
Q Consensus 401 lk~~NILl~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~ 478 (498)
|||+|||+++++.+||+|||+|+........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999877544332 3345678999999999999999999999999999999998 9999986
Q ss_pred Cc
Q 010887 479 SR 480 (498)
Q Consensus 479 ~~ 480 (498)
..
T Consensus 291 ~~ 292 (353)
T 4ase_A 291 VK 292 (353)
T ss_dssp CC
T ss_pred CC
Confidence 44
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=361.22 Aligned_cols=197 Identities=28% Similarity=0.409 Sum_probs=169.4
Q ss_pred CCCCeeecccceEEEEEEEc-CCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEc----CCceEEEE
Q 010887 274 SESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT----SSERILVY 347 (498)
Q Consensus 274 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 347 (498)
...+.||+|+||+||+|++. ++..||+|++... ........|.+|++++++++|||||++++++.+ +...++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 44567999999999999965 5889999999743 344556789999999999999999999999865 24578999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEEC-CCCcEEEeecCcccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~ki~DfGl~~~~~ 426 (498)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +++|+||||||+|||++ +++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999986 34689999999999999999999998 22399999999999997 47899999999998654
Q ss_pred ccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.. ......||+.|||||++.+ +|+.++|||||||++|||+||+.||...
T Consensus 184 ~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~ 232 (290)
T 3fpq_A 184 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 32 2345679999999998864 6999999999999999999999999753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=369.20 Aligned_cols=197 Identities=23% Similarity=0.268 Sum_probs=171.5
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
+.|+..++||+|+||.||+|+.. +|+.||||+++.... +.+|++++++++|||||++++++.+++..++||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 45777889999999999999964 689999999974322 24799999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCC-cEEEeecCcccccccc
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCDFGLAKLVDAK 428 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~ki~DfGl~~~~~~~ 428 (498)
+++|+|.++++. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++ ++||+|||+++.....
T Consensus 132 ~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 132 LEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999986 34699999999999999999999999 999999999999999987 6999999999877543
Q ss_pred Ccc----eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 429 LTH----VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 429 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||....
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 260 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 260 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 221 1234579999999999999999999999999999999999999997543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=357.47 Aligned_cols=200 Identities=24% Similarity=0.383 Sum_probs=164.0
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|++.+.||+|+||+||+|+. .+++.||+|+++... .......+.+|++++++++||||+++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999995 468999999996432 2344678999999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+ +|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 6899999876 35699999999999999999999999 999999999999999999999999999987654
Q ss_pred cCcceeecccccccccCcccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.. ......||+.|||||++.+..+ +.++||||+||++|||+||+.||+...
T Consensus 165 ~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~ 216 (275)
T 3hyh_A 165 GN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 216 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC
Confidence 32 2345679999999999988876 579999999999999999999998644
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=370.20 Aligned_cols=202 Identities=26% Similarity=0.311 Sum_probs=171.5
Q ss_pred cCCCCCCeeecccceEEEEEEEc----CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
++|++.+.||+|+||+||+|+.. .++.||+|+++... .......+.+|++++++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57899999999999999999852 46789999996432 22334568899999999999999999999999999999
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
||||+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999986 34699999999999999999999999 9999999999999999999999999999865
Q ss_pred cccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
..... ......||+.|||||++.+..|+.++||||+||++|||+||+.||....
T Consensus 177 ~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 230 (304)
T 3ubd_A 177 IDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230 (304)
T ss_dssp ----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC
Confidence 43322 2345679999999999999999999999999999999999999998654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=375.13 Aligned_cols=201 Identities=23% Similarity=0.316 Sum_probs=180.0
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.+.|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..++|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT-CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 356889999999999999999965 68999999996432 3445678999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
||++|+|.++++. ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 229 y~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 229 FLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp CCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred CCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence 9999999999874 3589999999999999999999999 9999999999999999999999999999877644
Q ss_pred CcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||....
T Consensus 301 ~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 351 (423)
T 4fie_A 301 VP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 351 (423)
T ss_dssp CC-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred Cc-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 32 2345679999999999999999999999999999999999999997543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=361.13 Aligned_cols=199 Identities=27% Similarity=0.352 Sum_probs=163.2
Q ss_pred CCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCC----ceEEEE
Q 010887 272 NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS----ERILVY 347 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 347 (498)
+|...+.||+|+||+||+|++ +|+.||||+++... .....+++|+..+.+++|||||++++++.+++ ..++||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 456678999999999999998 68999999996421 22223344566667889999999999998654 578999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEEcCCCCCcEEECCCCcEEEeecCcc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ-----CNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~ 422 (498)
||+++|+|.++++. ..++|..+.+++.|+++||+|||++ ..++|+||||||+|||+|+++++||+|||++
T Consensus 81 Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 99999999999975 3589999999999999999999976 2458999999999999999999999999999
Q ss_pred ccccccCcce---eecccccccccCcccccCC------CCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 423 KLVDAKLTHV---TTQIRGTMGHIAPEYLSTG------KSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 423 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
+......... .....||+.|||||++.+. +++.++|||||||++|||+||+.|+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~ 220 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence 8775443321 2345799999999998754 467899999999999999999887754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=353.83 Aligned_cols=201 Identities=22% Similarity=0.325 Sum_probs=163.8
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCC--------
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-------- 341 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------- 341 (498)
++|+..+.||+|+||+||+|+.. +++.||||+++....+...+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45888999999999999999964 689999999975555556678999999999999999999999987544
Q ss_pred ----ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEe
Q 010887 342 ----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLC 417 (498)
Q Consensus 342 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~ 417 (498)
..++||||+++|+|.+++..... ....++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 25899999999999999985322 23457778899999999999999999 99999999999999999999999
Q ss_pred ecCccccccccCcc-----------eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 418 DFGLAKLVDAKLTH-----------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 418 DfGl~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
|||+|+........ ......||+.|||||++.+..|+.++|||||||++|||++ ||..
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 99999877543221 1233579999999999999999999999999999999997 7753
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=352.50 Aligned_cols=202 Identities=21% Similarity=0.343 Sum_probs=173.2
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcC------Cc
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------SE 342 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~ 342 (498)
++|++.+.||+|+||+||+|+.. +|+.||||+++... .....+.+.+|+++|+.++|||||++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57889999999999999999964 68999999997543 334567789999999999999999999987643 56
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcc
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~ 422 (498)
.++||||++ |+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 134 ~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 799999996 679888875 45799999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccC---cceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 423 KLVDAKL---THVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 423 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+.+.... ........||+.|||||++.+. .++.++||||+||++|||+||+.||....
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~ 267 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN 267 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC
Confidence 8764322 1223456899999999998775 46899999999999999999999998654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=345.68 Aligned_cols=245 Identities=65% Similarity=1.056 Sum_probs=206.0
Q ss_pred CccccccccccccCHHHHHHHhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCC
Q 010887 249 DDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 328 (498)
Q Consensus 249 ~~~~~~~~~~~~~~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ 328 (498)
+...........++.+++....++|+..+.||+|+||.||+|+..+++.||+|+++..........+.+|++++++++||
T Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ 87 (326)
T 3uim_A 8 EDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 87 (326)
T ss_dssp -------CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCT
T ss_pred cCcccccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCC
Confidence 33444455677899999999999999999999999999999998889999999998654444445789999999999999
Q ss_pred ccceEEEEEEcCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEE
Q 010887 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL 408 (498)
Q Consensus 329 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl 408 (498)
||+++++++......++||||+++|+|.+++.........+++..+..++.|++.||+|||+.+.++|+||||||+||++
T Consensus 88 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~ 167 (326)
T 3uim_A 88 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL 167 (326)
T ss_dssp TBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE
T ss_pred CccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE
Confidence 99999999999999999999999999999998766556679999999999999999999999877789999999999999
Q ss_pred CCCCcEEEeecCccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCccccccccc
Q 010887 409 DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 488 (498)
Q Consensus 409 ~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~~~~~~~~~ 488 (498)
++++.+||+|||+++..............||+.|+|||++.+..++.++||||||+++|||+||+.||+........+..
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 247 (326)
T 3uim_A 168 DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247 (326)
T ss_dssp CTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSB
T ss_pred CCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchh
Confidence 99999999999999877655555555567999999999998889999999999999999999999999754433333333
Q ss_pred ccccc
Q 010887 489 LLDHK 493 (498)
Q Consensus 489 l~~w~ 493 (498)
+.+|+
T Consensus 248 ~~~~~ 252 (326)
T 3uim_A 248 LLDWV 252 (326)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 44443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=342.73 Aligned_cols=199 Identities=23% Similarity=0.366 Sum_probs=170.7
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc----CCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCce
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER 343 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 343 (498)
..++|++.+.||+|+||+||+|+.+ .++.||+|++... .....+.+|++++..+ +||||+++++++.+.+..
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~---~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT---SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT---SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc---cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 3578999999999999999999853 4678999998653 3356688999999998 699999999999999999
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCC-CcEEEeecCcc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLA 422 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~ki~DfGl~ 422 (498)
++||||+++|+|.+.+. .+++.++..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+|
T Consensus 96 ~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 99999999999999884 388999999999999999999999 99999999999999876 79999999999
Q ss_pred ccccccCc---------------------------ceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCC
Q 010887 423 KLVDAKLT---------------------------HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQR 474 (498)
Q Consensus 423 ~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~ 474 (498)
+...+... .......||+.|||||++.+. .|+.++||||+||++|||+||+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 86543211 112335699999999999775 48999999999999999999999
Q ss_pred CCCCCc
Q 010887 475 AIDFSR 480 (498)
Q Consensus 475 p~~~~~ 480 (498)
||....
T Consensus 246 Pf~~~~ 251 (361)
T 4f9c_A 246 PFYKAS 251 (361)
T ss_dssp SSSCCS
T ss_pred CCCCCC
Confidence 996543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=361.06 Aligned_cols=200 Identities=28% Similarity=0.352 Sum_probs=172.7
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHH---HHHHHHhccCCccceEEEEEEcCCce
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQR---EVHLISVAIHKNLLQLIGYCTTSSER 343 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~---e~~~l~~l~h~niv~l~~~~~~~~~~ 343 (498)
.++|++.+.||+|+||.||+|+.. +|+.||+|+++... .........+ ++++++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 467999999999999999999965 68999999996321 1122233334 45666777899999999999999999
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
++||||++||+|..++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++++|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence 999999999999999986 34699999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 424 LVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
...... ....+||+.|||||++.. ..|+.++||||+||++|||+||+.||...
T Consensus 341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~ 394 (689)
T 3v5w_A 341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394 (689)
T ss_dssp ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 775432 344679999999999975 57999999999999999999999999754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=353.62 Aligned_cols=202 Identities=23% Similarity=0.318 Sum_probs=180.0
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.++|++.+.||+|+||.||+|+.. +|+.||+|+++.. .......+.+|+++|+.++||||+++++++.+....++|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc-chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 367999999999999999999964 6899999998743 23456788999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCC--CcEEEeecCcccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN--FEAVLCDFGLAKLVD 426 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~--~~~ki~DfGl~~~~~ 426 (498)
|+++|+|.+++... ...+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++.+.
T Consensus 235 ~~~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 235 FMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp CCCCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred ecCCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 99999999988642 34689999999999999999999999 99999999999999854 899999999999876
Q ss_pred ccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
... ......||+.|||||++.+..|+.++||||+||++|||++|+.||....
T Consensus 309 ~~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~ 360 (573)
T 3uto_A 309 PKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 360 (573)
T ss_dssp TTS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred CCC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 532 2345679999999999999999999999999999999999999998654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=336.70 Aligned_cols=214 Identities=23% Similarity=0.316 Sum_probs=185.5
Q ss_pred CHHHHHHHhcCCCCCCeeecccceEEEEEEEcC-CcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEE
Q 010887 262 SCRELQLATDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338 (498)
Q Consensus 262 ~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 338 (498)
..++++...++|+..+.||+|+||+||+|+... ++.||+|+++... .......+.+|.+++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 345666678899999999999999999999764 7889999986421 1122344889999999999999999999999
Q ss_pred cCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEee
Q 010887 339 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 418 (498)
Q Consensus 339 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~D 418 (498)
+.+..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++++||+|
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence 999999999999999999999753 34699999999999999999999999 999999999999999999999999
Q ss_pred cCccccccccCcceeecccccccccCccccc-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCcc
Q 010887 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRL 481 (498)
Q Consensus 419 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~~ 481 (498)
||+++..............||+.|+|||++. ...++.++|||||||++|||+||+.||.....
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~ 286 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 286 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh
Confidence 9999877654444445567999999999987 56789999999999999999999999986543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=320.17 Aligned_cols=214 Identities=41% Similarity=0.697 Sum_probs=187.1
Q ss_pred HHHHHHhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCce
Q 010887 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (498)
Q Consensus 264 ~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 343 (498)
.++...+++|+..+.||+|+||.||+|+..+++.||+|++... .......+.+|++++++++||||+++++++...+..
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC-CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 3344567899999999999999999999888999999988753 345678899999999999999999999999999999
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
++||||+++|+|.+++.........+++.++..++.|+++||+|||+. +++||||||+||++++++.+||+|||+++
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 999999999999999976544445699999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCc-ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCcc
Q 010887 424 LVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRL 481 (498)
Q Consensus 424 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~~ 481 (498)
....... .......||+.|+|||.+.+..++.++||||||+++|||+||+.||.....
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~ 246 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc
Confidence 6543222 222345589999999999988999999999999999999999999976443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=317.07 Aligned_cols=203 Identities=25% Similarity=0.359 Sum_probs=180.1
Q ss_pred hcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
.++|+..+.||+|+||.||+|+. .+++.||+|++... ..+.....+.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45788899999999999999996 57899999999743 34455678899999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++|+|.+++... ..+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 94 e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 999999999999752 4589999999999999999999999 999999999999999999999999999986654
Q ss_pred cCcceeecccccccccCcccccCCCCC-CcccchhHHHHHHHHHhCCCCCCCCcc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSS-EKTDVFGYGITLLELVTGQRAIDFSRL 481 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~Gvvl~elltG~~p~~~~~~ 481 (498)
.. ......||+.|+|||++.+..++ .++||||+||++|||+||+.||+....
T Consensus 167 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 219 (328)
T 3fe3_A 167 GG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 219 (328)
T ss_dssp SC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH
Confidence 32 23446799999999999888775 789999999999999999999986543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=331.22 Aligned_cols=211 Identities=22% Similarity=0.296 Sum_probs=182.8
Q ss_pred HHHHHHHhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEc
Q 010887 263 CRELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTT 339 (498)
Q Consensus 263 ~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 339 (498)
.++++...++|+..+.||+|+||.||+|+.. +++.||+|+++... .......+.+|+++++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3455566789999999999999999999975 58899999986421 11233457899999999999999999999999
Q ss_pred CCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeec
Q 010887 340 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 419 (498)
Q Consensus 340 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~Df 419 (498)
....++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence 9999999999999999999875 2489999999999999999999999 9999999999999999999999999
Q ss_pred CccccccccCcceeecccccccccCcccccCCC----CCCcccchhHHHHHHHHHhCCCCCCCCcc
Q 010887 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK----SSEKTDVFGYGITLLELVTGQRAIDFSRL 481 (498)
Q Consensus 420 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~Gvvl~elltG~~p~~~~~~ 481 (498)
|+++..............||+.|+|||++.+.. ++.++|||||||++|||+||+.||.....
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 278 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 278 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh
Confidence 999877654433344577999999999997665 78999999999999999999999986543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=311.15 Aligned_cols=204 Identities=26% Similarity=0.372 Sum_probs=174.4
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... .....+.|.+|++++++++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 357888999999999999999964 68899999986432 234457899999999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 90 ~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 9999999999999763 4689999999999999999999999 99999999999999999999999999998775
Q ss_pred ccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
...........||+.|+|||.+.+..++.++||||||+++|||+||+.||+...
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 216 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET 216 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 543333445678999999999999999999999999999999999999998654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=317.04 Aligned_cols=203 Identities=23% Similarity=0.290 Sum_probs=178.9
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
.++|+..+.||+|+||.||+|+.. +++.||+|+++... .......+.+|+++++.++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357888999999999999999965 68999999997431 234567789999999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|||+++|+|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999999875 34689999999999999999999999 99999999999999999999999999998643
Q ss_pred ccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 157 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 209 (337)
T 1o6l_A 157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC
Confidence 322 22344678999999999999999999999999999999999999997644
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=329.31 Aligned_cols=214 Identities=22% Similarity=0.268 Sum_probs=185.2
Q ss_pred CHHHHHHHhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEE
Q 010887 262 SCRELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338 (498)
Q Consensus 262 ~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 338 (498)
.+++.....++|+..+.||+|+||.||+|+.. +++.||+|+++... .......+.+|.+++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34556667889999999999999999999975 68999999996421 1223355789999999999999999999999
Q ss_pred cCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEee
Q 010887 339 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 418 (498)
Q Consensus 339 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~D 418 (498)
+.+..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+|
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence 9999999999999999999997532 3589999999999999999999999 999999999999999999999999
Q ss_pred cCccccccccCcceeecccccccccCccccc-------CCCCCCcccchhHHHHHHHHHhCCCCCCCCcc
Q 010887 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS-------TGKSSEKTDVFGYGITLLELVTGQRAIDFSRL 481 (498)
Q Consensus 419 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~~ 481 (498)
||+++..............||+.|+|||++. ...++.++|||||||++|||+||+.||.....
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 275 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST 275 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH
Confidence 9999877654433334567999999999987 45689999999999999999999999986543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=319.31 Aligned_cols=209 Identities=28% Similarity=0.423 Sum_probs=180.9
Q ss_pred hcCCCCCCeeecccceEEEEEEEc--------CCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEEcC
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS--------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS 340 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 340 (498)
.++|...+.||+|+||.||+|+.. ++..||||+++..........+.+|+++++++ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467888999999999999999852 34579999998665556678899999999999 899999999999999
Q ss_pred CceEEEEecccCCCHHHhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEE
Q 010887 341 SERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL 408 (498)
Q Consensus 341 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl 408 (498)
+..++||||+++|+|.+++..... ....+++.++..++.||++||+|||+. +|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 999999999999999999986432 124589999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeecCccccccccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcc
Q 010887 409 DDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRL 481 (498)
Q Consensus 409 ~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~~ 481 (498)
++++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999999999999866543221 1233456789999999999999999999999999999999 9999986443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=306.87 Aligned_cols=201 Identities=22% Similarity=0.348 Sum_probs=179.1
Q ss_pred hcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.++|+..+.||+|+||+||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc-ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 45799999999999999999995 568999999986433 2346778999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++|+|.+++.. ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 98 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp CCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred CCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 9999999999875 2589999999999999999999999 9999999999999999999999999999876544
Q ss_pred CcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.. ......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 170 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 220 (297)
T 3fxz_A 170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (297)
T ss_dssp TC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 32 2334568999999999999999999999999999999999999997543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=319.05 Aligned_cols=204 Identities=20% Similarity=0.215 Sum_probs=176.8
Q ss_pred HHhcCCCCCCeeecccceEEEEEE------EcCCcEEEEEEecccCCcchHHHHHHHHHHHHhcc---CCccceEEEEEE
Q 010887 268 LATDNFSESNIIGQGGFGKVYKGV------LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI---HKNLLQLIGYCT 338 (498)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~ 338 (498)
...++|...+.||+|+||.||+|. ..+++.||+|+++. ....++.+|++++.+++ |+||+++++++.
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP----ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS----CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC----CChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 455778889999999999999994 45688999999864 34567888888888887 999999999999
Q ss_pred cCCceEEEEecccCCCHHHhhcccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECC-------
Q 010887 339 TSSERILVYPFMQNLSVAYRLRDLKP-GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD------- 410 (498)
Q Consensus 339 ~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~------- 410 (498)
..+..++||||+++|+|.+++..... ....+++..+..++.|+++||+|||+. +|+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccc
Confidence 99999999999999999999975322 245699999999999999999999999 9999999999999998
Q ss_pred ----CCcEEEeecCcccccccc-CcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 411 ----NFEAVLCDFGLAKLVDAK-LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 411 ----~~~~ki~DfGl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
++.+||+|||+++..... .........||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 899999999999765422 22233456799999999999999999999999999999999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=321.23 Aligned_cols=203 Identities=25% Similarity=0.347 Sum_probs=176.2
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCceE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERI 344 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 344 (498)
..++|+..+.||+|+||.||+|+.. +++.||+|+++... .......+.+|..++.++ +||||+++++++.+.+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3467889999999999999999975 57889999997432 223345678899999887 8999999999999999999
Q ss_pred EEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccc
Q 010887 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~ 424 (498)
+||||+++|+|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+|||+++.
T Consensus 130 lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 99999999999999886 34689999999999999999999999 999999999999999999999999999985
Q ss_pred ccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||+..
T Consensus 203 ~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 203 GLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp CCCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred cccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 33222 2234567999999999999999999999999999999999999999743
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=319.44 Aligned_cols=206 Identities=28% Similarity=0.360 Sum_probs=175.0
Q ss_pred HHhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCce
Q 010887 268 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER 343 (498)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 343 (498)
...++|+..+.||+|+||.||+|+.. +++.||+|+++... .......+.+|.+++..+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 34578999999999999999999965 58899999997431 233456788999999988 699999999999999999
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
++||||+++|+|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+|||+++
T Consensus 100 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcccccee
Confidence 999999999999999976 34589999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCcc
Q 010887 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRL 481 (498)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~~ 481 (498)
...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 173 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 229 (353)
T 3txo_A 173 EGICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE 229 (353)
T ss_dssp CSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ecccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH
Confidence 543322 223456799999999999988899999999999999999999999986543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=307.40 Aligned_cols=212 Identities=23% Similarity=0.289 Sum_probs=184.5
Q ss_pred cccCHHHHHHHhcC----------CCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccC
Q 010887 259 RRFSCRELQLATDN----------FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH 327 (498)
Q Consensus 259 ~~~~~~el~~~~~~----------~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h 327 (498)
..++.+++..+++. |+..+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++|
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCC
Confidence 34677777777654 566779999999999999976 79999999987433 3456788999999999999
Q ss_pred CccceEEEEEEcCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEE
Q 010887 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANIL 407 (498)
Q Consensus 328 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIL 407 (498)
|||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl 173 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL 173 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEE
Confidence 9999999999999999999999999999998864 3589999999999999999999999 9999999999999
Q ss_pred ECCCCcEEEeecCccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 408 LDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 408 l~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
++.++.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|||+||+.||....
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~ 245 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS 245 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ECCCCcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999876543222 234568999999999999999999999999999999999999997543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=313.89 Aligned_cols=202 Identities=24% Similarity=0.312 Sum_probs=178.9
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCc-----chHHHHHHHHHHHHhccCCccceEEEEEEcCCce
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP-----GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 343 (498)
.+.|++.+.||+|+||.||+|+.. +++.||+|+++..... .....+.+|++++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467888999999999999999965 6899999999754321 2357899999999999999999999999999999
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCC----cEEEeec
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF----EAVLCDF 419 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~ki~Df 419 (498)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||++++++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999875 34699999999999999999999999 999999999999998777 7999999
Q ss_pred CccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 420 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 164 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~ 222 (361)
T 2yab_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222 (361)
T ss_dssp SSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred CCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 9998765432 2234569999999999999999999999999999999999999997643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=306.56 Aligned_cols=204 Identities=26% Similarity=0.443 Sum_probs=178.1
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.++|...+.||+|+||+||+|+.. +++.||+|++.. ........|.+|++++++++||||+++++++.+.+..++|||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR-FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 356788999999999999999975 588999998864 344567889999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++|+|.+++... ...+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 88 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 88 YIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp CCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred ecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 99999999999863 34689999999999999999999999 9999999999999999999999999999876543
Q ss_pred Ccce-------------eecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 429 LTHV-------------TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 429 ~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.... .....||+.|+|||++.+..++.++||||||+++|||++|..|+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~ 226 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL 226 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTS
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchh
Confidence 2211 114568999999999999999999999999999999999999987543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=310.82 Aligned_cols=200 Identities=28% Similarity=0.380 Sum_probs=178.1
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
.++|+..+.||+|+||.||+|+.. +++.||+|+++... .......+.+|..+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357888999999999999999965 68999999987431 123456788999999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++++||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999999986 34689999999999999999999999 99999999999999999999999999998664
Q ss_pred ccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 207 (318)
T 1fot_A 158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207 (318)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 32 234578999999999999999999999999999999999999997644
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=310.76 Aligned_cols=211 Identities=29% Similarity=0.476 Sum_probs=172.8
Q ss_pred HHHHHHhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCc
Q 010887 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 342 (498)
Q Consensus 264 ~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 342 (498)
.++....++|++.+.||+|+||+||+|+. +++.||||++.... .......|.+|++++++++||||+++++++...+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 34444567889999999999999999987 68899999987443 33456789999999999999999999999999999
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEEcCCCCCcEEECCCCcEEEeecC
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK--IIHRDLKAANILLDDNFEAVLCDFG 420 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlk~~NILl~~~~~~ki~DfG 420 (498)
.++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+. + |+||||||+||++++++.+||+|||
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg 184 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFG 184 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred eEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCC
Confidence 9999999999999999985221 12489999999999999999999998 7 9999999999999999999999999
Q ss_pred ccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 421 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+++....... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||....
T Consensus 185 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~ 243 (309)
T 3p86_A 185 LSRLKASTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN 243 (309)
T ss_dssp ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred CCcccccccc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9976543321 2234568999999999999999999999999999999999999998643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=314.51 Aligned_cols=206 Identities=27% Similarity=0.382 Sum_probs=178.8
Q ss_pred HHHhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCc
Q 010887 267 QLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSE 342 (498)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 342 (498)
....++|...+.||+|+||.||+|+.. +++.||+|+++... .......+.+|.+++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 445678999999999999999999975 58899999997431 123456788899999887 89999999999999999
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcc
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~ 422 (498)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++++||+|||++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 9999999999999999975 24589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 166 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (345)
T 1xjd_A 166 KENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222 (345)
T ss_dssp BCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 8543322 12345679999999999999999999999999999999999999998654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=311.25 Aligned_cols=204 Identities=25% Similarity=0.397 Sum_probs=175.2
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.++|+..+.||+|+||.||+|+.. +++.||+|++...........+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 357888999999999999999975 7899999998754444445778999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 9999999998875 34689999999999999999999999 9999999999999999999999999999866432
Q ss_pred Cc-ceeecccccccccCcccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 429 LT-HVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 429 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.. .......||+.|+|||++.+..+ +.++|||||||++|||+||+.||+...
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 212 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSC
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 22 12234678999999999987775 778999999999999999999997543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=316.46 Aligned_cols=201 Identities=26% Similarity=0.367 Sum_probs=177.2
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 357888999999999999999965 57889999986421 234567889999999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|||+.+|+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++++||+|||+++...
T Consensus 94 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 999999999999975 34699999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCcceeecccccccccCcccccC---CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
... ......||+.|+|||++.. ..++.++|||||||++|||+||+.||...
T Consensus 167 ~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~ 220 (384)
T 4fr4_A 167 RET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220 (384)
T ss_dssp TTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred CCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence 432 2345679999999999874 45899999999999999999999999753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=305.72 Aligned_cols=203 Identities=27% Similarity=0.385 Sum_probs=173.9
Q ss_pred hcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.++|+..+.||+|+||+||+|+..+++.||+|+++... .......+.+|++++++++||||+++++++.+....++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 46788899999999999999999889999999997432 33445788999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++ ++.+.+... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 100 ~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FMEK-DLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCSE-EHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCCC-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9985 777777642 34589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 429 LTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 173 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 224 (311)
T 3niz_A 173 VRS-YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT 224 (311)
T ss_dssp CC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccc-ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCC
Confidence 222 233568999999999876 568999999999999999999999997544
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=310.65 Aligned_cols=205 Identities=27% Similarity=0.408 Sum_probs=177.1
Q ss_pred hcCCCCCCeeecccceEEEEEEEc----CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
.++|.+.+.||+|+||.||+|++. .+..||||+++..........|.+|++++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 456788899999999999999974 3456999999876666677889999999999999999999999999999999
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
||||+++|+|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 128 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999752 34699999999999999999999999 9999999999999999999999999999877
Q ss_pred cccCcc--eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 426 DAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 426 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 259 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC
Confidence 543222 2223446778999999998899999999999999999999 999997543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=311.72 Aligned_cols=200 Identities=26% Similarity=0.356 Sum_probs=176.7
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCceEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 346 (498)
++|+..+.||+|+||.||+|+.. +++.||+|+++... .......+.+|.+++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56888999999999999999975 57899999997432 234456788999999987 899999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++++||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999875 24589999999999999999999999 99999999999999999999999999998643
Q ss_pred ccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 162 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 162 RPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 222 223456799999999999999999999999999999999999999975
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=301.43 Aligned_cols=203 Identities=27% Similarity=0.404 Sum_probs=180.0
Q ss_pred hcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
.++|+..+.||+|+||.||+|+..+++.||+|+++... ...+.+.+|++++++++||||+++++++.+....++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc--cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 45788899999999999999999889999999997532 3457799999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++++|.+++... ...+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 87 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 87 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp CTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 9999999999752 34689999999999999999999999 99999999999999999999999999998765443
Q ss_pred cceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~ 212 (269)
T 4hcu_A 161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 212 (269)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC
Confidence 333334556788999999998999999999999999999999 999998654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=309.25 Aligned_cols=203 Identities=25% Similarity=0.316 Sum_probs=168.5
Q ss_pred hcCCCCCCeeecccceEEEEEEE----cCCcEEEEEEecccC---CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCc
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY---SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 342 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 342 (498)
.++|+..+.||+|+||.||+|+. .+++.||+|+++... .......+.+|++++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46788899999999999999997 478999999997532 22345668899999999999999999999999999
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcc
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~ 422 (498)
.++||||+++++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999875 34589999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 169 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 225 (327)
T 3a62_A 169 KESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence 7543322 12334568999999999999999999999999999999999999998644
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=312.12 Aligned_cols=203 Identities=23% Similarity=0.300 Sum_probs=178.4
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
..++|+..+.||+|+||.||+|... +++.||+|+++... .......+.+|++++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3567999999999999999999965 68899999997432 344567889999999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCC---CcEEEeecCccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN---FEAVLCDFGLAK 423 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~ki~DfGl~~ 423 (498)
|||+++|+|.+.+.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.+ +.+||+|||++.
T Consensus 107 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 999999999998875 34689999999999999999999999 99999999999999765 459999999998
Q ss_pred cccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 234 (362)
T 2bdw_A 180 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 234 (362)
T ss_dssp CCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 765432 2234568999999999999999999999999999999999999997543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=312.48 Aligned_cols=205 Identities=24% Similarity=0.317 Sum_probs=178.4
Q ss_pred HHhcCCCCCCeeecccceEEEEEEEcC-CcEEEEEEecccC--CcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCce
Q 010887 268 LATDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER 343 (498)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 343 (498)
...++|+..+.||+|+||.||+|+... ++.||+|+++... .......+.+|.+++..+ +||||+++++++.+.+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 345789999999999999999999764 7889999987431 223456788999999887 799999999999999999
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+|||+++
T Consensus 97 ~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 9999999999999999852 3589999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 170 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 225 (353)
T 2i0e_A 170 ENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225 (353)
T ss_dssp CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC
Confidence 543222 22345679999999999999999999999999999999999999998654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=305.13 Aligned_cols=206 Identities=27% Similarity=0.401 Sum_probs=164.6
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.++|+..+.||+|+||.||+|... +++.||+|+++..........+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467889999999999999999964 6899999999755444556788999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 349 FMQNLSVAYRLRDLK--PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|++ |+|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59988887432 2234689999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
..... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 160 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 213 (317)
T 2pmi_A 160 IPVNT-FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213 (317)
T ss_dssp SCCCC-CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCccc-CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 43222 233568999999999876 468999999999999999999999997654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=315.63 Aligned_cols=205 Identities=29% Similarity=0.441 Sum_probs=167.9
Q ss_pred hcCCCCCCeeecccceEEEEEEEc----CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
.++|+..+.||+|+||.||+|+.. ++..||||+++........+.|.+|++++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 457899999999999999999964 5678999999865555667889999999999999999999999999999999
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
||||+++|+|.++++.. ...+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 124 v~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999752 34689999999999999999999999 9999999999999999999999999999876
Q ss_pred cccCcce--eecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 426 DAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 426 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
....... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~ 255 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 5432221 122335678999999999999999999999999999998 999997543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=315.95 Aligned_cols=218 Identities=25% Similarity=0.396 Sum_probs=186.2
Q ss_pred ccCHHHHHHHhcCCCCCCeeecccceEEEEEEE------cCCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccce
Q 010887 260 RFSCRELQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQ 332 (498)
Q Consensus 260 ~~~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~ 332 (498)
.+...+++...++|+..+.||+|+||.||+|++ .+++.||||+++........+.+.+|++++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 355677778889999999999999999999984 235789999998665556678899999999999 7999999
Q ss_pred EEEEEEcCCc-eEEEEecccCCCHHHhhcccCCC----------------------------------------------
Q 010887 333 LIGYCTTSSE-RILVYPFMQNLSVAYRLRDLKPG---------------------------------------------- 365 (498)
Q Consensus 333 l~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------- 365 (498)
+++++...+. .++||||+++|+|.+++......
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999987654 89999999999999999864321
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 366 ----------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 366 ----------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 12289999999999999999999999 99999999999999999999999999998664432
Q ss_pred cc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 430 TH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 430 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
.. ......||+.|+|||++.+..++.++||||||+++|||+| |+.||....
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 300 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence 22 2334568899999999999999999999999999999999 999997654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=299.22 Aligned_cols=204 Identities=25% Similarity=0.393 Sum_probs=180.8
Q ss_pred HhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
..++|+..+.||+|+||.||+|...++..||+|+++... ....++.+|++++.+++||||+++++++......++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS--MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT--BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC--CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 346788899999999999999999888899999997532 345779999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++++|.+++... ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 84 YISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp CCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred ccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 99999999999753 23589999999999999999999999 9999999999999999999999999999877654
Q ss_pred CcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
.........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||+...
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT 210 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC
Confidence 4333344556788999999998899999999999999999999 999997644
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=312.46 Aligned_cols=199 Identities=24% Similarity=0.312 Sum_probs=177.9
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|+..+.||+|+||.||+|+.. +++.||+|+++... .......+.+|+++++.++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57888999999999999999975 68999999986421 2234577899999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 999999999999863 3589999999999999999999999 999999999999999999999999999987654
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 242 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC
Confidence 2 234568999999999999999999999999999999999999997644
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=299.18 Aligned_cols=218 Identities=40% Similarity=0.688 Sum_probs=189.6
Q ss_pred cccccCHHHHHHHhcCCCCC------CeeecccceEEEEEEEcCCcEEEEEEecccC---CcchHHHHHHHHHHHHhccC
Q 010887 257 QLRRFSCRELQLATDNFSES------NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY---SPGGEAAFQREVHLISVAIH 327 (498)
Q Consensus 257 ~~~~~~~~el~~~~~~~~~~------~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h 327 (498)
....|+..++..++++|... +.||+|+||.||+|.. +++.||+|++.... .......+.+|++++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34678999999999999887 8999999999999987 68899999987432 23456789999999999999
Q ss_pred CccceEEEEEEcCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEE
Q 010887 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANIL 407 (498)
Q Consensus 328 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIL 407 (498)
|||+++++++...+..++||||+++++|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEE
Confidence 9999999999999999999999999999999875332 35699999999999999999999999 9999999999999
Q ss_pred ECCCCcEEEeecCccccccccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 408 LDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 408 l~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+++++.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|||+||+.||+...
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 999999999999999866543222 2234568999999998864 58899999999999999999999998644
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=306.10 Aligned_cols=201 Identities=19% Similarity=0.287 Sum_probs=177.9
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.++|...+.||+|+||.||+|+.. +++.||+|.++.. ......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 357888999999999999999965 5788999998642 3456678999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECC--CCcEEEeecCcccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD--NFEAVLCDFGLAKLVD 426 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~--~~~~ki~DfGl~~~~~ 426 (498)
|+++|+|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++...
T Consensus 82 ~~~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 82 FISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred eCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 99999999998752 34689999999999999999999999 9999999999999987 7899999999998775
Q ss_pred ccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 207 (321)
T 1tki_A 156 PGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp TTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC
Confidence 432 2334568999999999998889999999999999999999999997644
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=306.24 Aligned_cols=202 Identities=23% Similarity=0.296 Sum_probs=178.1
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCc-----chHHHHHHHHHHHHhccCCccceEEEEEEcCCce
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP-----GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 343 (498)
.++|...+.||+|+||.||+|+.. +++.||+|+++..... .....+.+|++++++++||||+++++++......
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356888999999999999999975 5899999998743221 2467899999999999999999999999999999
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCC----cEEEeec
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF----EAVLCDF 419 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~ki~Df 419 (498)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 999999999999999875 34689999999999999999999999 999999999999998887 8999999
Q ss_pred CccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 420 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
|+++....... .....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 163 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 221 (326)
T 2y0a_A 163 GLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221 (326)
T ss_dssp TTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred CCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 99987654322 234568999999999999999999999999999999999999997543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=305.34 Aligned_cols=203 Identities=23% Similarity=0.300 Sum_probs=176.9
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCC--ceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS--ERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 347 (498)
++|...+.||+|+||+||+|+.. +++.||+|+++..........+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 56888999999999999999975 489999999986544456788899999999999999999999998765 678999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEE----CCCCcEEEeecCccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGLAK 423 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~ki~DfGl~~ 423 (498)
||+++++|.+++..... ...+++.++..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp ECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred eCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999986432 23489999999999999999999999 99999999999999 888889999999998
Q ss_pred cccccCcceeecccccccccCccccc--------CCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 424 LVDAKLTHVTTQIRGTMGHIAPEYLS--------TGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
....... .....||+.|+|||++. +..++.++|||||||++|||+||+.||...
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 226 (319)
T 4euu_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (319)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECT
T ss_pred ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 7655332 23456899999999986 577899999999999999999999999743
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=310.81 Aligned_cols=206 Identities=21% Similarity=0.303 Sum_probs=178.3
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc----CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY----YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (498)
.++|+..+.||+|+||.||+|+.. +++.||+|++... ........+.+|++++++++||||+++++++...+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 356888999999999999999964 6899999998632 11234678999999999999999999999999999999
Q ss_pred EEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCc---EEEeecCc
Q 010887 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE---AVLCDFGL 421 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~ki~DfGl 421 (498)
+||||+++++|.+.+.........+++..+..++.||+.||+|||+. +|+||||||+||+++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 99999999999888875433345689999999999999999999999 9999999999999976654 99999999
Q ss_pred cccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
++....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 987654322 233456899999999999999999999999999999999999999764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=312.42 Aligned_cols=213 Identities=27% Similarity=0.427 Sum_probs=183.1
Q ss_pred HHHHHhcCCCCCCeeecccceEEEEEEEc------CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEE
Q 010887 265 ELQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338 (498)
Q Consensus 265 el~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 338 (498)
.+....++|+..+.||+|+||.||+|+.. +++.||+|+++..........|.+|++++++++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 33445678999999999999999999974 347899999986655566788999999999999999999999999
Q ss_pred cCCceEEEEecccCCCHHHhhcccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEE
Q 010887 339 TSSERILVYPFMQNLSVAYRLRDLKPG--------------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 398 (498)
Q Consensus 339 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH 398 (498)
..+..++||||+++|+|.+++...... ...+++.++..++.|+++||+|||+. +|+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 999999999999999999999864321 25699999999999999999999999 9999
Q ss_pred cCCCCCcEEECCCCcEEEeecCccccccccCc-ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCC
Q 010887 399 RDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAI 476 (498)
Q Consensus 399 ~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~ 476 (498)
|||||+||++++++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999986643322 12234557899999999998899999999999999999999 99999
Q ss_pred CCCc
Q 010887 477 DFSR 480 (498)
Q Consensus 477 ~~~~ 480 (498)
....
T Consensus 278 ~~~~ 281 (343)
T 1luf_A 278 YGMA 281 (343)
T ss_dssp TTSC
T ss_pred CCCC
Confidence 7643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=307.09 Aligned_cols=204 Identities=22% Similarity=0.312 Sum_probs=174.0
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCc------
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE------ 342 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------ 342 (498)
.++|+..+.||+|+||.||+|+.. +++.||||+++....+...+.+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 356888999999999999999976 7899999999865555677889999999999999999999999865432
Q ss_pred ---------------------------------------------------eEEEEecccCCCHHHhhcccCCCCCCCCH
Q 010887 343 ---------------------------------------------------RILVYPFMQNLSVAYRLRDLKPGEKGLDW 371 (498)
Q Consensus 343 ---------------------------------------------------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~ 371 (498)
.++||||+++++|.+++..... ....++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence 7899999999999999986432 344677
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCc-----------ceeecccccc
Q 010887 372 PTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-----------HVTTQIRGTM 440 (498)
Q Consensus 372 ~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~-----------~~~~~~~gt~ 440 (498)
..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 88999999999999999999 999999999999999999999999999987764321 1123356899
Q ss_pred cccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 010887 441 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 477 (498)
Q Consensus 441 ~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~ 477 (498)
.|+|||++.+..++.++||||||+++|||++|..|+.
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 9999999999999999999999999999999987753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=318.43 Aligned_cols=207 Identities=30% Similarity=0.430 Sum_probs=179.6
Q ss_pred HHhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 268 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
...++|...+.||+|+||.||+|++. +++.||||+++....+.....|.+|++++++++||||+++++++...+..++|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 34567888999999999999999976 68999999998655555567899999999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 191 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp EECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 9999999999999752 23589999999999999999999999 99999999999999999999999999998654
Q ss_pred ccCccee-ecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 427 AKLTHVT-TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 427 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
....... ....++..|+|||.+....++.++|||||||++|||+| |+.||....
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~ 320 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 3221111 11235678999999998899999999999999999999 999998644
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=310.56 Aligned_cols=212 Identities=28% Similarity=0.435 Sum_probs=178.8
Q ss_pred HHHHhcCCCCCCeeecccceEEEEEEE------cCCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEE
Q 010887 266 LQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT 338 (498)
Q Consensus 266 l~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 338 (498)
++...++|...+.||+|+||.||+|+. .++..||+|+++..........+.+|++++.++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 445667899999999999999999996 245689999998654455567899999999999 8999999999999
Q ss_pred cCCceEEEEecccCCCHHHhhcccCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEc
Q 010887 339 TSSERILVYPFMQNLSVAYRLRDLKPG-------------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHR 399 (498)
Q Consensus 339 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~ 399 (498)
..+..++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +|+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence 999999999999999999999864321 13489999999999999999999999 99999
Q ss_pred CCCCCcEEECCCCcEEEeecCccccccccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCC
Q 010887 400 DLKAANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 477 (498)
Q Consensus 400 Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~ 477 (498)
||||+||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 99999999999999999999999876543322 2234557889999999999999999999999999999998 999997
Q ss_pred CCc
Q 010887 478 FSR 480 (498)
Q Consensus 478 ~~~ 480 (498)
...
T Consensus 277 ~~~ 279 (344)
T 1rjb_A 277 GIP 279 (344)
T ss_dssp TCC
T ss_pred cCC
Confidence 654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=301.39 Aligned_cols=202 Identities=26% Similarity=0.384 Sum_probs=171.9
Q ss_pred cCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
++|+..+.||+|+||.||+|+..+++.||+|+++... .......+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 4688899999999999999999889999999997432 223347788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++ +|.+.+... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 985 888888753 34689999999999999999999999 99999999999999999999999999998665332
Q ss_pred cceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 430 THVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
. ......||+.|+|||.+.+. .++.++|||||||++|||+||+.||....
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (288)
T 1ob3_A 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred c-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 12334689999999998764 58999999999999999999999997643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=324.06 Aligned_cols=206 Identities=28% Similarity=0.402 Sum_probs=182.0
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
.++|...+.||+|+||.||+|+.. +++.||+|+++... .......+.+|++++++++||||+++++++......++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467888899999999999999975 68999999996422 223457789999999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|||+++|+|.+++.........+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999986554456799999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 4322 223457999999999999999999999999999999999999999764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=317.74 Aligned_cols=204 Identities=20% Similarity=0.267 Sum_probs=177.5
Q ss_pred HhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
..++|+..+.||+|+||.||+|.. .+++.+|+|++.... .......+.+|++++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 356788999999999999999996 468899999987433 334567789999999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEEC---CCCcEEEeecCccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD---DNFEAVLCDFGLAK 423 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~ki~DfGl~~ 423 (498)
|||+++|+|.+.+.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++ +++.+||+|||++.
T Consensus 89 ~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999999886 34689999999999999999999999 999999999999998 56789999999998
Q ss_pred cccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 162 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~ 217 (444)
T 3soa_A 162 EVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED 217 (444)
T ss_dssp CCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred EecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc
Confidence 7654332 2234679999999999999999999999999999999999999997543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=308.17 Aligned_cols=201 Identities=25% Similarity=0.396 Sum_probs=175.0
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|.+.+.||+|+||.||+|+. .+++.||+|++.... .......+.+|+++++.++||||+++++++......++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5788899999999999999996 578999999986421 1123457899999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+ +|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.....
T Consensus 89 E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 89 EYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp CCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred ECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 999 6889888875 34689999999999999999999999 999999999999999999999999999987654
Q ss_pred cCcceeecccccccccCcccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCcc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRL 481 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvvl~elltG~~p~~~~~~ 481 (498)
... .....||+.|+|||.+.+..+ +.++|||||||++|||+||+.||+....
T Consensus 161 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~ 213 (336)
T 3h4j_B 161 GNF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI 213 (336)
T ss_dssp SBT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS
T ss_pred Ccc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH
Confidence 322 234568999999999988776 6899999999999999999999986543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=311.47 Aligned_cols=209 Identities=28% Similarity=0.401 Sum_probs=182.0
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc--------CCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEEc
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS--------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT 339 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 339 (498)
..++|...+.||+|+||.||+|+.. .+..||+|+++..........+.+|+++++++ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4567888999999999999999952 23579999998766666678899999999999 89999999999999
Q ss_pred CCceEEEEecccCCCHHHhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEE
Q 010887 340 SSERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANIL 407 (498)
Q Consensus 340 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIL 407 (498)
.+..++||||+++|+|.+++..... ....+++.++..++.|++.||+|||+. +|+||||||+||+
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEE
Confidence 9999999999999999999986432 124599999999999999999999999 9999999999999
Q ss_pred ECCCCcEEEeecCccccccccCc-ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 408 LDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 408 l~~~~~~ki~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
+++++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999987654322 22233457889999999999999999999999999999999 999997654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=314.03 Aligned_cols=208 Identities=29% Similarity=0.382 Sum_probs=179.4
Q ss_pred hcCCCCCCeeecccceEEEEEEEc------CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCce
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 343 (498)
.++|+..+.||+|+||.||+|++. +++.||||+++..........+.+|+.++++++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 456888999999999999999953 45689999998666666778899999999999999999999999999999
Q ss_pred EEEEecccCCCHHHhhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCC---cEEEe
Q 010887 344 ILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF---EAVLC 417 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~ki~ 417 (498)
++||||+++|+|.+++..... ....+++.++..++.|+++||+|||+. +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999986432 234689999999999999999999999 999999999999999555 59999
Q ss_pred ecCccccccccCc-ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 418 DFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 418 DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~ 291 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999986533221 22234567899999999999999999999999999999998 999997644
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=325.62 Aligned_cols=209 Identities=26% Similarity=0.399 Sum_probs=181.0
Q ss_pred HHHHHHhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCce
Q 010887 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (498)
Q Consensus 264 ~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 343 (498)
.++++..++|...+.||+|+||.||+|.+.++..||||+++... ...+.|.+|++++++++||||+++++++. .+..
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 34455677888999999999999999999888999999997532 45788999999999999999999999986 5678
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
++||||+++|+|.++++... ...+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 332 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLAR 332 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred EEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence 99999999999999997532 23578999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
..............++..|+|||++....++.++|||||||++|||+| |+.||....
T Consensus 333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~ 390 (454)
T 1qcf_A 333 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 390 (454)
T ss_dssp GBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC
Confidence 765432222233446789999999998999999999999999999999 999997643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=306.31 Aligned_cols=204 Identities=27% Similarity=0.443 Sum_probs=169.2
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCc----EEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (498)
.++|+..+.||+|+||+||+|++. +++ +||+|.++..........|.+|++++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 356888999999999999999964 343 468888876555567789999999999999999999999998765 78
Q ss_pred EEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccc
Q 010887 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~ 424 (498)
+|++|+.+|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 999999999999999863 34689999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 425 VDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 425 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
....... ......+|..|+|||++.+..++.++|||||||++|||+| |+.||+...
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 224 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC
Confidence 6543322 2233456889999999999999999999999999999999 999998644
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=312.92 Aligned_cols=204 Identities=29% Similarity=0.334 Sum_probs=168.6
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHH-HHhccCCccceEEEEEEcCCceEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHL-ISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
.++|+..+.||+|+||.||+|+.. +++.||+|+++... .......+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357888999999999999999975 57889999997432 22344566777776 567899999999999999999999
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999975 34588999999999999999999999 9999999999999999999999999999864
Q ss_pred cccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCcc
Q 010887 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRL 481 (498)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~~ 481 (498)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 244 (373)
T 2r5t_A 190 IEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT 244 (373)
T ss_dssp BCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH
T ss_pred ccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH
Confidence 3322 223456799999999999999999999999999999999999999976543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=307.41 Aligned_cols=204 Identities=23% Similarity=0.356 Sum_probs=169.7
Q ss_pred hcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCce---
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER--- 343 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~--- 343 (498)
.++|+..+.||+|+||.||+|+. .+++.||+|+++... .+.....+.+|++++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 35788899999999999999996 578899999997543 223456789999999999999999999998766543
Q ss_pred -EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcc
Q 010887 344 -ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (498)
Q Consensus 344 -~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~ 422 (498)
++||||+++++|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 899999999999999975 34689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcc--eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 423 KLVDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 423 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+........ ......||+.|+|||.+.+..++.++||||||+++|||+||+.||....
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 223 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 876543222 2234568999999999999999999999999999999999999998654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=301.77 Aligned_cols=205 Identities=22% Similarity=0.348 Sum_probs=166.2
Q ss_pred HhcCCCCCCeeecccceEEEEEEEcC----CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (498)
..++|+..+.||+|+||.||+|+... +..||+|+++..........+.+|++++++++||||+++++++. .+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 45678889999999999999999643 45699999886555566788999999999999999999999974 55688
Q ss_pred EEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccc
Q 010887 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~ 424 (498)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 92 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccc
Confidence 999999999999999753 34589999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
.............+|+.|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~ 222 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC
Confidence 75543333334456789999999998999999999999999999997 999998644
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=299.36 Aligned_cols=205 Identities=24% Similarity=0.373 Sum_probs=177.9
Q ss_pred HHhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 268 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
...++|+..+.||+|+||.||++...++..||+|+++... ...+++.+|++++.+++||||+++++++.+....++||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC--CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 3456788899999999999999999888899999997532 34578999999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++++|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 99 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 99 EYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred eccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 999999999999753 23589999999999999999999999 999999999999999999999999999987654
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
..........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~ 226 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 226 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC
Confidence 33333333456788999999998999999999999999999999 999998644
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=322.73 Aligned_cols=204 Identities=23% Similarity=0.288 Sum_probs=168.8
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
..++|+..+.||+|+||.||+|+.. +++.||+|+++.. ........+.+|+++++.++||||+++++++...+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3467889999999999999999964 6889999999743 233445678899999999999999999999999999999
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEEcCCCCCcEEECCCCcEEEeecCcccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~ 424 (498)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++.
T Consensus 226 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 226 VMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp EECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 9999999999999875 3468999999999999999999998 7 899999999999999999999999999986
Q ss_pred ccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 299 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 353 (446)
T 4ejn_A 299 GIKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353 (446)
T ss_dssp TCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 443222 2344679999999999999999999999999999999999999997654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=323.46 Aligned_cols=204 Identities=26% Similarity=0.382 Sum_probs=180.1
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
..++|+..+.||+|+||.||+|+.. +++.||+|++.... .......+.+|++++++++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467888999999999999999975 68999999986421 22345678999999999999999999999999999999
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
||||+++|+|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+|||+++..
T Consensus 262 VmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceec
Confidence 999999999999987532 34589999999999999999999999 9999999999999999999999999999876
Q ss_pred cccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 337 ~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~ 388 (576)
T 2acx_A 337 PEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388 (576)
T ss_dssp CTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred ccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 5432 223457999999999999989999999999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=298.10 Aligned_cols=199 Identities=26% Similarity=0.375 Sum_probs=171.2
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
++|+..+.||+|+||+||+|+.. +++.||+|+++... .......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888999999999999999975 58899999997433 33456788999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++ ++.+.+... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9986 555555432 34699999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceeecccccccccCcccccCCC-CCCcccchhHHHHHHHHHhCCCCCC
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAID 477 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvvl~elltG~~p~~ 477 (498)
.. ......||+.|+|||++.+.. ++.++|||||||++|||+||+.|+.
T Consensus 155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~ 203 (292)
T 3o0g_A 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred cc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc
Confidence 22 223456899999999997766 7999999999999999999988864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=309.84 Aligned_cols=213 Identities=25% Similarity=0.357 Sum_probs=182.4
Q ss_pred HHHHHhcCCCCCCeeecccceEEEEEEEcC------CcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEE
Q 010887 265 ELQLATDNFSESNIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYC 337 (498)
Q Consensus 265 el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 337 (498)
+++...++|...+.||+|+||.||+|.... ...||+|.++..........+.+|+++++++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345567889999999999999999999643 2479999998665556678899999999999 899999999999
Q ss_pred EcCCceEEEEecccCCCHHHhhcccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEE
Q 010887 338 TTSSERILVYPFMQNLSVAYRLRDLKP----------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANIL 407 (498)
Q Consensus 338 ~~~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIL 407 (498)
...+..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+||+
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEE
Confidence 999999999999999999999875321 134589999999999999999999999 9999999999999
Q ss_pred ECCCCcEEEeecCccccccccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 408 LDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 408 l~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
+++++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 999999999999999866543322 2233456789999999999999999999999999999999 999997643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=302.81 Aligned_cols=210 Identities=29% Similarity=0.410 Sum_probs=181.5
Q ss_pred HhcCCCCCCeeecccceEEEEEEE------cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCc
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 342 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 342 (498)
..++|...+.||+|+||.||+|.. .+++.||+|+++........+.+.+|++++++++||||+++++++...+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 456788899999999999999986 23578999999866556667889999999999999999999999999999
Q ss_pred eEEEEecccCCCHHHhhcccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCC
Q 010887 343 RILVYPFMQNLSVAYRLRDLKP--------------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLK 402 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk 402 (498)
.++||||+++++|.+++..... ....+++.++..++.|+++||+|||+. +|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccc
Confidence 9999999999999999986432 123489999999999999999999999 99999999
Q ss_pred CCcEEECCCCcEEEeecCccccccccCcce-eecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 403 AANILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 403 ~~NILl~~~~~~ki~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
|+||++++++.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999998765433221 233456789999999998889999999999999999999 999997654
Q ss_pred c
Q 010887 481 L 481 (498)
Q Consensus 481 ~ 481 (498)
.
T Consensus 258 ~ 258 (314)
T 2ivs_A 258 P 258 (314)
T ss_dssp G
T ss_pred H
Confidence 3
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=299.38 Aligned_cols=204 Identities=22% Similarity=0.288 Sum_probs=174.8
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
++|...+.||+|+||.||+|+.. ++..+|+|++...........+.+|++++++++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 56888999999999999999964 68899999998665556678899999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEE---CCCCcEEEeecCcccccc
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~ki~DfGl~~~~~ 426 (498)
+++|+|.+.+.........+++..+..++.|+++||+|||+. +|+||||||+||++ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999999875433346799999999999999999999999 99999999999999 456789999999998665
Q ss_pred ccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
... ......||+.|+|||.+. +.++.++||||||+++|||++|+.||....
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~ 229 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC
Confidence 432 223456899999999885 578999999999999999999999997654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=306.90 Aligned_cols=199 Identities=25% Similarity=0.343 Sum_probs=161.1
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.++|+..+.||+|+||.||+|+.. +++.||+|+++... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 467888999999999999999976 57889999997532 34678899999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECC---CCcEEEeecCccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVLCDFGLAKLV 425 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~ki~DfGl~~~~ 425 (498)
|+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++..
T Consensus 129 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 129 LVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999875 34589999999999999999999999 9999999999999975 889999999999866
Q ss_pred cccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.... ......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 202 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 254 (349)
T 2w4o_A 202 EHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER 254 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT
T ss_pred Cccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc
Confidence 5422 2234568999999999999999999999999999999999999997543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=298.21 Aligned_cols=202 Identities=27% Similarity=0.362 Sum_probs=168.7
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCC-------------------------cchHHHHHHHHHHHH
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-------------------------PGGEAAFQREVHLIS 323 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------------------~~~~~~~~~e~~~l~ 323 (498)
.++|+..+.||+|+||.||+|+.. +++.||+|++..... ......+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 357888999999999999999964 688999999864321 112356899999999
Q ss_pred hccCCccceEEEEEEc--CCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCC
Q 010887 324 VAIHKNLLQLIGYCTT--SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDL 401 (498)
Q Consensus 324 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl 401 (498)
+++||||+++++++.. ....++||||+++++|.+.+. ...+++.++..++.|+++||+|||+. +|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence 9999999999999987 557899999999999877543 34699999999999999999999999 9999999
Q ss_pred CCCcEEECCCCcEEEeecCccccccccCcceeecccccccccCcccccCCC---CCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 402 KAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK---SSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 402 k~~NILl~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
||+||+++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999987654322 233456899999999997765 37789999999999999999999975
Q ss_pred Cc
Q 010887 479 SR 480 (498)
Q Consensus 479 ~~ 480 (498)
..
T Consensus 243 ~~ 244 (298)
T 2zv2_A 243 ER 244 (298)
T ss_dssp SS
T ss_pred cc
Confidence 43
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=308.00 Aligned_cols=206 Identities=20% Similarity=0.218 Sum_probs=177.9
Q ss_pred hcCCCCCCeeecc--cceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 270 TDNFSESNIIGQG--GFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 270 ~~~~~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
.++|++.+.||+| +||.||+|+.. +++.||||+++... .......+.+|++++++++||||+++++++...+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4578889999999 99999999975 68999999997433 33456778889999999999999999999999999999
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
||||+++|+|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||.+...
T Consensus 104 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999998632 34589999999999999999999999 9999999999999999999999999988654
Q ss_pred cccCc------ceeecccccccccCcccccC--CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 426 DAKLT------HVTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 426 ~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
..... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 241 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence 32211 11122468899999999987 679999999999999999999999997543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=307.56 Aligned_cols=202 Identities=21% Similarity=0.288 Sum_probs=177.5
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.++|+..+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.+....++|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 457889999999999999999965 68899999986432 3455688999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECC--CCcEEEeecCcccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD--NFEAVLCDFGLAKLVD 426 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~--~~~~ki~DfGl~~~~~ 426 (498)
|+++|+|.+++... ...+++.++..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||+++...
T Consensus 129 ~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 129 FLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp CCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 99999999988742 34689999999999999999999999 9999999999999974 5789999999998775
Q ss_pred ccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.... .....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 203 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 254 (387)
T 1kob_A 203 PDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 254 (387)
T ss_dssp TTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred CCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC
Confidence 4322 234468999999999999999999999999999999999999998643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=322.25 Aligned_cols=208 Identities=28% Similarity=0.428 Sum_probs=181.9
Q ss_pred HHHhcCCCCCCeeecccceEEEEEEEcC-CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 267 QLATDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
+...++|+..+.||+|+||.||+|++.. +..||||+++... .....|.+|++++++++||||+++++++...+..++
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc--cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 3455678889999999999999999765 7899999997532 356789999999999999999999999999999999
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
||||+++|+|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 294 v~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp EEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred EEEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceec
Confidence 999999999999998633 34689999999999999999999999 9999999999999999999999999999877
Q ss_pred cccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcc
Q 010887 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRL 481 (498)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~~ 481 (498)
............++..|+|||++....++.++|||||||++|||+| |+.||.....
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~ 425 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 425 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 5433322333456789999999998899999999999999999999 9999986543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=302.95 Aligned_cols=200 Identities=20% Similarity=0.202 Sum_probs=175.1
Q ss_pred hcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCceEEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 347 (498)
.++|+..+.||+|+||.||+|+. .+++.||||++.... ....+.+|+++++++ +||||+++++++...+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS---RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC---SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 35788899999999999999996 578899999987432 234578999999999 9999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCc-----EEEeecCcc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE-----AVLCDFGLA 422 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~-----~ki~DfGl~ 422 (498)
||+ +++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++
T Consensus 85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 85 ELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred EeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 999 99999998863 34699999999999999999999999 9999999999999998887 999999999
Q ss_pred ccccccCcc------eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 423 KLVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 423 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
+........ ......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~ 220 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL 220 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccc
Confidence 876543221 123467999999999999999999999999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=298.56 Aligned_cols=196 Identities=28% Similarity=0.416 Sum_probs=167.1
Q ss_pred hcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHh--ccCCccceEEEEEEcC----Cce
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISV--AIHKNLLQLIGYCTTS----SER 343 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~~~ 343 (498)
.++|+..+.||+|+||+||+|+. +++.||||++.. .....+.+|.+++.. ++||||+++++++... ...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS----RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc----ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 46788999999999999999998 789999999864 345667778777776 7899999999987543 357
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCcEEcCCCCCcEEECCCCcEE
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH--------EQCNPKIIHRDLKAANILLDDNFEAV 415 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~ivH~Dlk~~NILl~~~~~~k 415 (498)
++||||+++|+|.++++. ..+++..+..++.|++.||+||| +. +|+||||||+||+++.++.+|
T Consensus 82 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEE
T ss_pred EEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEE
Confidence 899999999999999963 46899999999999999999999 76 999999999999999999999
Q ss_pred EeecCccccccccCcce---eecccccccccCcccccCC------CCCCcccchhHHHHHHHHHhC----------CCCC
Q 010887 416 LCDFGLAKLVDAKLTHV---TTQIRGTMGHIAPEYLSTG------KSSEKTDVFGYGITLLELVTG----------QRAI 476 (498)
Q Consensus 416 i~DfGl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~Gvvl~elltG----------~~p~ 476 (498)
|+|||+++......... .....||+.|+|||++.+. .++.++|||||||++|||+|| +.||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999998665443322 2234689999999999876 455789999999999999999 8888
Q ss_pred CC
Q 010887 477 DF 478 (498)
Q Consensus 477 ~~ 478 (498)
..
T Consensus 234 ~~ 235 (301)
T 3q4u_A 234 YD 235 (301)
T ss_dssp TT
T ss_pred cc
Confidence 54
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=301.87 Aligned_cols=211 Identities=28% Similarity=0.408 Sum_probs=182.4
Q ss_pred HHHhcCCCCCCeeecccceEEEEEEE------cCCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEEc
Q 010887 267 QLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT 339 (498)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 339 (498)
+...++|+..+.||+|+||.||+|+. .+++.||+|+++........+.+.+|+++++++ +||||+++++++..
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 34456788899999999999999985 346789999998655555678899999999999 99999999999999
Q ss_pred CCceEEEEecccCCCHHHhhcccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCc
Q 010887 340 SSERILVYPFMQNLSVAYRLRDLKP--------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAAN 405 (498)
Q Consensus 340 ~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~N 405 (498)
.+..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccce
Confidence 9999999999999999999986432 123589999999999999999999999 99999999999
Q ss_pred EEECCCCcEEEeecCccccccccCcce-eecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 406 ILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 406 ILl~~~~~~ki~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
|++++++.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 999999999999999998776543322 233457789999999999999999999999999999999 999997654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=309.45 Aligned_cols=203 Identities=25% Similarity=0.306 Sum_probs=174.8
Q ss_pred hcCCCCCCeeecccceEEEEEEE----cCCcEEEEEEecccC---CcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCC
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY---SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSS 341 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 341 (498)
.++|+..+.||+|+||.||+|+. .+++.||||+++... .......+.+|+++++++ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35788899999999999999997 368999999987432 123345677899999999 5999999999999999
Q ss_pred ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCc
Q 010887 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (498)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl 421 (498)
..++||||+++++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 999999999999999999862 3589999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCcceeecccccccccCcccccC--CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
++..............||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 265 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence 98765444434445679999999999985 34788999999999999999999999754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=306.08 Aligned_cols=203 Identities=31% Similarity=0.395 Sum_probs=172.0
Q ss_pred HhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCC----ceE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS----ERI 344 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~ 344 (498)
..++|+..+.||+|+||.||+|+.. ++.||||+++.. ......+.+|+.++++++||||+++++++.... ..+
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ--DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC--chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 3467888999999999999999975 799999999642 234556677899999999999999999998754 369
Q ss_pred EEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------CCCCcEEcCCCCCcEEECCCCcEEEe
Q 010887 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ-------CNPKIIHRDLKAANILLDDNFEAVLC 417 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-------~~~~ivH~Dlk~~NILl~~~~~~ki~ 417 (498)
+||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +.++|+||||||+||++++++.+||+
T Consensus 99 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 99999999999999975 3489999999999999999999986 23379999999999999999999999
Q ss_pred ecCccccccccCcc-eeecccccccccCcccccCC-----CCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 418 DFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTG-----KSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 418 DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||+||+.||+..
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 241 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 99999876543322 22335689999999999763 4567889999999999999999999754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=320.63 Aligned_cols=208 Identities=29% Similarity=0.413 Sum_probs=174.3
Q ss_pred HHHHHhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceE
Q 010887 265 ELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (498)
Q Consensus 265 el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (498)
.+++..++|+..+.||+|+||.||+|.+.++..||||+++... ...++|.+|++++++++||||+++++++.. +..+
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 3445567788899999999999999999888899999997533 345789999999999999999999999876 6789
Q ss_pred EEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccc
Q 010887 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~ 424 (498)
+||||+++|+|.+++.... ...+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 255 iv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 329 (452)
T ss_dssp EEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred EEehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCcccee
Confidence 9999999999999997522 24589999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
.............++..|+|||.+....++.++|||||||++|||+| |+.||....
T Consensus 330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 386 (452)
T 1fmk_A 330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 386 (452)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC
Confidence 65433322333456789999999999999999999999999999999 999997643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=298.20 Aligned_cols=199 Identities=25% Similarity=0.249 Sum_probs=167.5
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCceEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 346 (498)
.++|+..+.||+|+||+||+|+.. +++.||||++.... .......+.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 357889999999999999999976 78999999986432 334445666677666665 899999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|||+ +++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 136 ~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred Eecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 9999 67888888753 34699999999999999999999999 99999999999999999999999999988665
Q ss_pred ccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
... ......||+.|+|||++.+ .++.++|||||||++|||++|+.|+..
T Consensus 209 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 209 TAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred cCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 432 2234568999999998875 799999999999999999999776643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=305.69 Aligned_cols=211 Identities=23% Similarity=0.279 Sum_probs=183.5
Q ss_pred ccccCHHHHHHHhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhcc-----CCccc
Q 010887 258 LRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-----HKNLL 331 (498)
Q Consensus 258 ~~~~~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv 331 (498)
...++.++.....++|.+.+.||+|+||.||+|+. .+++.||||+++. .......+..|+++++.++ ||||+
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN--IKKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CHHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc--chhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 34455666666778999999999999999999997 4688999999964 2345567888999999987 99999
Q ss_pred eEEEEEEcCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECC-
Q 010887 332 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD- 410 (498)
Q Consensus 332 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~- 410 (498)
++++++...+..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+|||+++
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDP 173 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCT
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccc
Confidence 9999999999999999999 999999998633 34589999999999999999999999 9999999999999975
Q ss_pred ------------------------CCcEEEeecCccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHH
Q 010887 411 ------------------------NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITL 466 (498)
Q Consensus 411 ------------------------~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl 466 (498)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 249 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence 789999999999865432 2345689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCc
Q 010887 467 LELVTGQRAIDFSR 480 (498)
Q Consensus 467 ~elltG~~p~~~~~ 480 (498)
|||+||+.||....
T Consensus 250 ~ell~g~~pf~~~~ 263 (360)
T 3llt_A 250 AELYTGSLLFRTHE 263 (360)
T ss_dssp HHHHHSSCSCCCSS
T ss_pred HHHHHCCCCCCCCc
Confidence 99999999997643
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=298.94 Aligned_cols=202 Identities=24% Similarity=0.319 Sum_probs=178.5
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCc-----chHHHHHHHHHHHHhccCCccceEEEEEEcCCce
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP-----GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 343 (498)
.++|++.+.||+|+||.||+|+.. +++.||+|+++..... .....+.+|++++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456888999999999999999975 6889999998753321 2467899999999999999999999999999999
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCC----cEEEeec
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF----EAVLCDF 419 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~ki~Df 419 (498)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 999999999999999975 34689999999999999999999999 999999999999999888 7999999
Q ss_pred CccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 420 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
|+++....... .....||+.|+|||.+.+..++.++||||||+++|||+||+.||....
T Consensus 164 g~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 222 (321)
T 2a2a_A 164 GLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222 (321)
T ss_dssp TTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred ccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC
Confidence 99987654322 234568999999999999999999999999999999999999997643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=292.68 Aligned_cols=203 Identities=27% Similarity=0.393 Sum_probs=178.9
Q ss_pred hcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
.++|+..+.||+|+||.||+|...+++.||+|+++... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 45788899999999999999999888999999997533 3457899999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 85 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp CTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 9999999999753 24589999999999999999999999 99999999999999999999999999998765432
Q ss_pred cceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
........++..|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC
Confidence 222233456789999999998899999999999999999999 899997643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=292.42 Aligned_cols=202 Identities=23% Similarity=0.312 Sum_probs=177.7
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
.++|+..+.||+|+||.||+|... +++.||+|++... ........+.+|++++++++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467889999999999999999965 5889999998743 34445678899999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCc---EEEeecCcccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE---AVLCDFGLAKL 424 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~ki~DfGl~~~ 424 (498)
||+++++|.+.+.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999988875 24589999999999999999999999 9999999999999976655 99999999976
Q ss_pred ccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 211 (284)
T 3kk8_A 158 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211 (284)
T ss_dssp CCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc
Confidence 654322 234568999999999999999999999999999999999999997543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=298.23 Aligned_cols=192 Identities=24% Similarity=0.344 Sum_probs=152.7
Q ss_pred CCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCccceEEEEEEcCCceEEEEecccCC
Q 010887 276 SNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYPFMQNL 353 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 353 (498)
.+.||+|+||.||+|+.. +++.||||++.. .....+.+|++++..+. ||||+++++++.+....++||||+++|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK----RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 478999999999999975 689999999864 34567889999999997 999999999999999999999999999
Q ss_pred CHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCC---cEEEeecCccccccccCc
Q 010887 354 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF---EAVLCDFGLAKLVDAKLT 430 (498)
Q Consensus 354 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~ki~DfGl~~~~~~~~~ 430 (498)
+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++.......
T Consensus 92 ~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 92 ELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp BHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 99999986 35699999999999999999999999 999999999999997665 899999999986654322
Q ss_pred ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 165 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 212 (325)
T 3kn6_A 165 -PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSH 212 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred -cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 223456899999999999999999999999999999999999999754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=305.73 Aligned_cols=211 Identities=25% Similarity=0.261 Sum_probs=173.8
Q ss_pred HHHhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc----CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCC
Q 010887 267 QLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY----YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS 341 (498)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 341 (498)
....++|+..+.||+|+||.||+|+.. +++.||+|++... ........+.+|++++++++||||+++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 445678999999999999999999964 6788999998642 23456788999999999999999999999999999
Q ss_pred ceEEEEecccCCCHHHhhcccCCC------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 010887 342 ERILVYPFMQNLSVAYRLRDLKPG------------------------------------EKGLDWPTRKRVAFGTAYGL 385 (498)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~ia~~L 385 (498)
..++||||+++|+|.+++...... ...+++..+..++.|++.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999999998632111 11235677889999999999
Q ss_pred HHHHhcCCCCcEEcCCCCCcEEECCCC--cEEEeecCccccccccCc---ceeecccccccccCcccccC--CCCCCccc
Q 010887 386 EYLHEQCNPKIIHRDLKAANILLDDNF--EAVLCDFGLAKLVDAKLT---HVTTQIRGTMGHIAPEYLST--GKSSEKTD 458 (498)
Q Consensus 386 ~yLH~~~~~~ivH~Dlk~~NILl~~~~--~~ki~DfGl~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~D 458 (498)
+|||+. +|+||||||+||+++.++ .+||+|||+++....... .......||+.|+|||.+.+ ..++.++|
T Consensus 182 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999999 999999999999998776 899999999986643221 12344568999999999865 67899999
Q ss_pred chhHHHHHHHHHhCCCCCCCCc
Q 010887 459 VFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 459 v~s~Gvvl~elltG~~p~~~~~ 480 (498)
|||||+++|||+||+.||....
T Consensus 259 iwslG~il~el~~g~~pf~~~~ 280 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVN 280 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHHHHHHHHHHHCCCCCCCCC
Confidence 9999999999999999997644
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=297.00 Aligned_cols=202 Identities=24% Similarity=0.352 Sum_probs=171.4
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCC-cchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
++|+..+.||+|+||.||+|+.. +++.||+|++..... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57888999999999999999975 589999999865432 2345778899999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++++|.+.+.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999888764 34589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 429 LTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
... .....||+.|+|||.+.+ ..++.++||||||+++|||+||+.||....
T Consensus 156 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 207 (311)
T 4agu_A 156 SDY-YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS 207 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccc-cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 222 234568999999999876 668999999999999999999999997654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=300.76 Aligned_cols=210 Identities=28% Similarity=0.426 Sum_probs=180.4
Q ss_pred HHhcCCCCCCeeecccceEEEEEEEc--------CCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEE
Q 010887 268 LATDNFSESNIIGQGGFGKVYKGVLS--------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT 338 (498)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 338 (498)
...++|...+.||+|+||.||+|+.. ++..||+|+++..........+.+|+++++++ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 34578889999999999999999963 46789999998665556678899999999999 8999999999999
Q ss_pred cCCceEEEEecccCCCHHHhhcccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcE
Q 010887 339 TSSERILVYPFMQNLSVAYRLRDLKPG------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANI 406 (498)
Q Consensus 339 ~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NI 406 (498)
..+..++||||+++|+|.+++...... ...+++.++..++.|++.||+|||+. +|+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceE
Confidence 999999999999999999999864321 23589999999999999999999999 999999999999
Q ss_pred EECCCCcEEEeecCccccccccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 407 LLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 407 Ll~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
+++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||+| |+.||....
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 9999999999999999876543322 1223456789999999988889999999999999999999 999997644
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=303.79 Aligned_cols=212 Identities=26% Similarity=0.402 Sum_probs=164.1
Q ss_pred HHHHhcCCCCCCeeecccceEEEEEEEcCCc----EEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcC
Q 010887 266 LQLATDNFSESNIIGQGGFGKVYKGVLSDNT----KVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS 340 (498)
Q Consensus 266 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~----~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 340 (498)
+....++|+..+.||+|+||.||+|+..... .||+|+++... .....+.+.+|++++++++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 3345678999999999999999999965432 79999997432 345678899999999999999999999999887
Q ss_pred Cce------EEEEecccCCCHHHhhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCC
Q 010887 341 SER------ILVYPFMQNLSVAYRLRDLK--PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF 412 (498)
Q Consensus 341 ~~~------~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~ 412 (498)
... ++|+||+++|+|.+++.... .....+++.++..++.|++.||+|||+. +|+||||||+||++++++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCC
Confidence 655 89999999999999987432 2233689999999999999999999999 999999999999999999
Q ss_pred cEEEeecCccccccccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 413 EAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 413 ~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 244 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE 244 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC
Confidence 9999999999876543222 2233456789999999999999999999999999999999 999998644
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=297.09 Aligned_cols=206 Identities=30% Similarity=0.434 Sum_probs=178.1
Q ss_pred HHHhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 267 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
++..++|+..+.||+|+||.||+|...++..||+|+++... .....+.+|++++++++||||+++++++. .+..++|
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 85 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYII 85 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEE
Confidence 34456788899999999999999999888899999997532 34678999999999999999999999886 4568999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|||+++++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++....
T Consensus 86 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp EECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 99999999999987421 22589999999999999999999999 99999999999999999999999999998776
Q ss_pred ccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
...........++..|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 215 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC
Confidence 543333334456789999999988889999999999999999999 999997643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=298.47 Aligned_cols=207 Identities=28% Similarity=0.431 Sum_probs=183.2
Q ss_pred HHHhcCCCCCCeeecccceEEEEEEEcC-CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 267 QLATDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
+...++|+..+.||+|+||.||+|.... +..||+|+++.. ....+.+.+|++++++++||||+++++++...+..++
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC--STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 3456778889999999999999999764 788999999743 3456889999999999999999999999999999999
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
||||+++++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EEECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEEcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 999999999999997633 35689999999999999999999999 9999999999999999999999999999877
Q ss_pred cccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~ 217 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 6554444444567889999999999999999999999999999999 999997644
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=290.74 Aligned_cols=204 Identities=25% Similarity=0.397 Sum_probs=178.8
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.++|+..+.||+|+||.||+|+.. +++.||+|++...........+.+|+++++.++||||+++++++.+.+..++|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 457888999999999999999975 6899999999755444567889999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+......
T Consensus 86 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999998864 34689999999999999999999999 9999999999999999999999999999866432
Q ss_pred Cc-ceeecccccccccCcccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 429 LT-HVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 429 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.. .......||+.|+|||.+.+..+ +.++||||||+++|||+||+.||+...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 212 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSC
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Confidence 21 12234568999999999987765 778999999999999999999997643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=314.38 Aligned_cols=202 Identities=26% Similarity=0.390 Sum_probs=177.8
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
.++|...+.||+|+||.||+|+.. +++.||||+++... .......+.+|+++++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357888999999999999999975 78999999986421 123456789999999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 95 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999999875 34699999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCcceeecccccccccCcccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||+...
T Consensus 168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 220 (476)
T 2y94_A 168 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH 220 (476)
T ss_dssp TTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC
Confidence 432 2234568999999999988776 689999999999999999999998644
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=296.49 Aligned_cols=204 Identities=22% Similarity=0.305 Sum_probs=168.0
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
.++|...+.||+|+||.||+|+.. +++.||+|+++... .+.....+.+|++++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999975 68899999987542 223357899999999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
+||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 9999999999999862 4589999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
...........|++.|+|||.+.+..++.++||||||+++|||+||+.||....
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 239 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ 239 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch
Confidence 543333344568999999999999999999999999999999999999998644
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=311.93 Aligned_cols=201 Identities=29% Similarity=0.390 Sum_probs=174.3
Q ss_pred HHHhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCC-ceEE
Q 010887 267 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-ERIL 345 (498)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~l 345 (498)
++..++|+..+.||+|+||.||+|.+. ++.||||+++... ..+.|.+|++++++++||||+++++++...+ ..++
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 344567888999999999999999984 7899999997532 4578999999999999999999999987765 6899
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
||||+++|+|.+++.... ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 265 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp EEECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 999999999999998642 33479999999999999999999999 9999999999999999999999999999854
Q ss_pred cccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
.... ....++..|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 340 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 391 (450)
T 1k9a_A 340 SSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 391 (450)
T ss_dssp C----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC
T ss_pred cccc----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 4321 22346889999999999999999999999999999999 999998644
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=306.19 Aligned_cols=203 Identities=24% Similarity=0.370 Sum_probs=164.9
Q ss_pred HhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEeccc-CCcchHHHHHHHHHHHHhcc-CCccceEEEEEEcCC--ce
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSS--ER 343 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~ 343 (498)
..++|+..+.||+|+||.||+|.. .+++.||+|++... ........+.+|+.++..+. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 456899999999999999999996 46899999998643 23455677889999999997 999999999997654 67
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
++||||++ ++|...+.. ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 87 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 99999998 588888874 3589999999999999999999999 99999999999999999999999999998
Q ss_pred cccccC--------------------cceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 424 LVDAKL--------------------THVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 424 ~~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
...... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 653211 111234579999999999976 678999999999999999999999998654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=304.54 Aligned_cols=200 Identities=25% Similarity=0.296 Sum_probs=165.5
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.++|+..+.||+|+||.||+++.. +++.||+|++.... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA--AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST--TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc--cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 467889999999999999999975 68899999997533 234668899999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCc--EEEeecCcccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE--AVLCDFGLAKLVD 426 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~--~ki~DfGl~~~~~ 426 (498)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++...
T Consensus 97 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 97 YASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred eCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 9999999999875 34589999999999999999999999 9999999999999987765 9999999987443
Q ss_pred ccCcceeecccccccccCcccccCCCCCCc-ccchhHHHHHHHHHhCCCCCCCCc
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEK-TDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
... ......||+.|+|||++.+..++.+ +|||||||++|||++|+.||....
T Consensus 170 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (361)
T 3uc3_A 170 LHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 222 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred ccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCc
Confidence 221 2234568999999999988887665 899999999999999999997543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=303.70 Aligned_cols=203 Identities=27% Similarity=0.413 Sum_probs=171.6
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCc----EEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
++|+..+.||+|+||.||+|++. +++ +||+|.+...........+.+|+.++++++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 56888999999999999999964 344 388888865444445567789999999999999999999886 456889
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
|+||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 92 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccccc
Confidence 99999999999998753 24688999999999999999999999 9999999999999999999999999999877
Q ss_pred cccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 426 DAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 426 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
...... ......+|..|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 222 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR 222 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence 544322 2234567889999999999999999999999999999999 999998654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=302.95 Aligned_cols=200 Identities=24% Similarity=0.318 Sum_probs=168.8
Q ss_pred hcCCCCCCeeecccceEEEEEEEcCCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccC--CccceEEEEEEcCCceEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIH--KNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv 346 (498)
.++|++.+.||+|+||.||++...+++.||+|++... ........+.+|++++.+++| |||+++++++......++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4568889999999999999999988999999998743 334456789999999999987 9999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|| +.+++|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++ ++.+||+|||+++...
T Consensus 88 ~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EC-CCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred Ee-CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 99 568899999986 34689999999999999999999999 999999999999997 5789999999998765
Q ss_pred ccCcc-eeecccccccccCcccccC-----------CCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 427 AKLTH-VTTQIRGTMGHIAPEYLST-----------GKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 427 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
..... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||+.
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 222 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence 43322 2234569999999999864 6788999999999999999999999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=306.49 Aligned_cols=196 Identities=24% Similarity=0.294 Sum_probs=167.8
Q ss_pred CCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCCC
Q 010887 276 SNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLS 354 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 354 (498)
.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 56899999999999996 468999999997532 3456789999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEE--CCCCcEEEeecCccccccccCcce
Q 010887 355 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL--DDNFEAVLCDFGLAKLVDAKLTHV 432 (498)
Q Consensus 355 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl--~~~~~~ki~DfGl~~~~~~~~~~~ 432 (498)
|.+++... ...+++..+..++.||++||+|||+. +|+||||||+|||+ ++++.+||+|||+++.......
T Consensus 173 L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 173 LFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp EHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 99988752 24589999999999999999999999 99999999999999 6778999999999987754322
Q ss_pred eecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 433 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 433 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 292 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN 292 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 233468999999999998899999999999999999999999997644
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=299.33 Aligned_cols=217 Identities=25% Similarity=0.400 Sum_probs=185.1
Q ss_pred cCHHHHHHHhcCCCCCCeeecccceEEEEEEE------cCCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceE
Q 010887 261 FSCRELQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQL 333 (498)
Q Consensus 261 ~~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l 333 (498)
+...++....++|...+.||+|+||.||+|+. .+++.||+|+++..........+.+|++++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 44556666778999999999999999999984 246789999998665555667899999999999 79999999
Q ss_pred EEEEEcCC-ceEEEEecccCCCHHHhhcccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcC
Q 010887 334 IGYCTTSS-ERILVYPFMQNLSVAYRLRDLKPG------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRD 400 (498)
Q Consensus 334 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~D 400 (498)
++++...+ ..++||||+++++|.+++...... ...+++..+..++.|++.||+|||+. +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99988765 489999999999999999864321 22388999999999999999999999 999999
Q ss_pred CCCCcEEECCCCcEEEeecCccccccccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCC
Q 010887 401 LKAANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDF 478 (498)
Q Consensus 401 lk~~NILl~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~ 478 (498)
|||+||++++++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999999866543322 2234557889999999999999999999999999999999 9999976
Q ss_pred Cc
Q 010887 479 SR 480 (498)
Q Consensus 479 ~~ 480 (498)
..
T Consensus 254 ~~ 255 (316)
T 2xir_A 254 VK 255 (316)
T ss_dssp CC
T ss_pred cc
Confidence 44
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=301.49 Aligned_cols=215 Identities=24% Similarity=0.377 Sum_probs=184.3
Q ss_pred HHHHHHHhcCCCCCCeeecccceEEEEEEEc------CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEE
Q 010887 263 CRELQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336 (498)
Q Consensus 263 ~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 336 (498)
.++++...++|+..+.||+|+||.||+|+.. +++.||+|++...........+.+|++++++++||||++++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 3455567788999999999999999999864 3678999999866555667789999999999999999999999
Q ss_pred EEcCCceEEEEecccCCCHHHhhcccC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECC
Q 010887 337 CTTSSERILVYPFMQNLSVAYRLRDLK------PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD 410 (498)
Q Consensus 337 ~~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~ 410 (498)
+...+..++||||+++|+|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||++++
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE 173 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcC
Confidence 999999999999999999999987532 1124579999999999999999999999 9999999999999999
Q ss_pred CCcEEEeecCccccccccCcce-eecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 411 NFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 411 ~~~~ki~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
++.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 245 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245 (322)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC
Confidence 9999999999998665432221 123346889999999999999999999999999999999 899997643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=292.66 Aligned_cols=205 Identities=21% Similarity=0.353 Sum_probs=173.5
Q ss_pred HhcCCCCCCeeecccceEEEEEEEcC----CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (498)
..++|...+.||+|+||.||+|++.+ +..||+|+++........+.+.+|++++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34678889999999999999999643 235999999866555667889999999999999999999999765 4568
Q ss_pred EEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccc
Q 010887 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~ 424 (498)
+||||+++++|.+++... ...+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 999999999999999753 24589999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
.............+++.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~ 219 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE 219 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCC
Confidence 65543333344557889999999998899999999999999999999 999997543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=295.74 Aligned_cols=204 Identities=28% Similarity=0.369 Sum_probs=171.4
Q ss_pred HhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccC----CcchHHHHHHHHHHHHhcc---CCccceEEEEEEcC
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY----SPGGEAAFQREVHLISVAI---HKNLLQLIGYCTTS 340 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~ 340 (498)
..++|+..+.||+|+||+||+|+. .+++.||+|+++... .......+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999995 568999999986322 1122356677888777765 99999999999876
Q ss_pred C-----ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEE
Q 010887 341 S-----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV 415 (498)
Q Consensus 341 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 415 (498)
. ..++||||+. ++|.+++.... ...+++.++..++.|++.||+|||+. +|+||||||+||++++++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence 5 4789999997 59999987633 33499999999999999999999999 999999999999999999999
Q ss_pred EeecCccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 416 LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 416 i~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
|+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 161 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 223 (308)
T 3g33_A 161 LADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 223 (308)
T ss_dssp ECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS
T ss_pred EeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999998665432 2344678999999999999999999999999999999999999997644
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=290.17 Aligned_cols=200 Identities=21% Similarity=0.335 Sum_probs=175.8
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.++|+..+.||+|+||.||+|... ++..+|+|++..... .....+.+|++++++++||||+++++++.+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 456888999999999999999975 467899999875432 456789999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEE---CCCCcEEEeecCccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~ki~DfGl~~~~ 425 (498)
|+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||++ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 87 LCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 9999999998875 34589999999999999999999999 99999999999999 88899999999999876
Q ss_pred cccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.... ......||+.|+|||.+.+ .++.++||||||+++|||+||+.||....
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 211 (277)
T 3f3z_A 160 KPGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPT 211 (277)
T ss_dssp CTTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCcc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCC
Confidence 5432 2234568999999999865 48999999999999999999999997644
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=297.03 Aligned_cols=203 Identities=26% Similarity=0.386 Sum_probs=170.7
Q ss_pred hcCCCCCCeeecccceEEEEEEE-----cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcC--Cc
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SE 342 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~ 342 (498)
.++|+..+.||+|+||.||+|++ .+++.||||+++.. .....+.+.+|++++++++||||+++++++... ..
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 45788899999999999999984 35789999999743 345567899999999999999999999998654 45
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcc
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~ 422 (498)
.++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred eEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 78999999999999999763 23589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcc--eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 423 KLVDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 423 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
+........ ......++..|+|||.+.+..++.++||||||+++|||+||..|+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence 876543221 122345678899999999999999999999999999999999998753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=302.33 Aligned_cols=202 Identities=27% Similarity=0.391 Sum_probs=166.6
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
++|...+.||+|+||.||+|+.. +++.||+|+++..........+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888999999999999999975 68899999997543333333556899999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
++ |+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 98 5888888753 34589999999999999999999999 99999999999999999999999999997655332
Q ss_pred cceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 430 THVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
. ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (324)
T 3mtl_A 155 K-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST 205 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred c-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 2233467999999999876 568999999999999999999999998654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=290.36 Aligned_cols=204 Identities=26% Similarity=0.408 Sum_probs=157.8
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|...+.||+|+||.||+|+. .+++.||+|++.... .......+.+|++++++++||||+++++++...+..++|+
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5688899999999999999996 578999999986321 1233577899999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++++|.+++... ...+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 91 EMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp ECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999998752 34689999999999999999999999 999999999999999999999999999986653
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCcc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRL 481 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~~ 481 (498)
... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||.....
T Consensus 165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 217 (278)
T 3cok_A 165 PHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV 217 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC
T ss_pred CCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhH
Confidence 322 12335689999999999988899999999999999999999999986543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=301.21 Aligned_cols=197 Identities=31% Similarity=0.378 Sum_probs=171.6
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
+.|+..+.||+|+||.||+|+. .+++.||||++.... .......+.+|++++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4577889999999999999996 578899999987432 2233467899999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+. |++.+.+... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 6787777642 34689999999999999999999999 999999999999999999999999999986653
Q ss_pred cCcceeecccccccccCccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
. ....||+.|+|||++. ...++.++|||||||++|||+||+.||...
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 256 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2 2346899999999984 567899999999999999999999999754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=289.82 Aligned_cols=201 Identities=23% Similarity=0.315 Sum_probs=174.6
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCC-----cchHHHHHHHHHHHHhccCCccceEEEEEEcCCceE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-----PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (498)
++|+..+.||+|+||.||+|+.. +++.||+|.++.... ......+.+|++++++++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56888999999999999999976 689999999874321 124688999999999999999999999999999999
Q ss_pred EEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCC----cEEEeecC
Q 010887 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF----EAVLCDFG 420 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~ki~DfG 420 (498)
+||||+++++|.+++.. ...+++.++..++.|++.||+|||+. +++||||||+||++++++ .+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999975 34689999999999999999999999 999999999999998877 89999999
Q ss_pred ccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 421 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
++........ .....|++.|+|||.+.+..++.++||||||+++|||+||+.||....
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 215 (283)
T 3bhy_A 158 IAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET 215 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc
Confidence 9986654322 234568999999999999999999999999999999999999997643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.48 Aligned_cols=199 Identities=25% Similarity=0.325 Sum_probs=166.6
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCC------
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------ 341 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 341 (498)
.++|+..+.||+|+||.||+|+.. +++.||||++.... .......+.+|+++++.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467888999999999999999964 68899999997432 3445678899999999999999999999997653
Q ss_pred ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCc
Q 010887 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (498)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl 421 (498)
..++||||++++ +...+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCCC-HHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 469999999865 5555532 389999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 211 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp C-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 98765432 2344678999999999999999999999999999999999999998654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=328.23 Aligned_cols=206 Identities=24% Similarity=0.311 Sum_probs=179.0
Q ss_pred HHhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCce
Q 010887 268 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER 343 (498)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 343 (498)
...++|+..+.||+|+||.||+|+.. +++.||||+++... .......+.+|.+++..+ +||+|+++++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 45678999999999999999999965 57889999987421 223456788899999887 799999999999999999
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
++||||+++|+|..++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++++||+|||+++
T Consensus 418 ~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceee
Confidence 9999999999999999863 4589999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCcc
Q 010887 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRL 481 (498)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~~ 481 (498)
...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 491 ~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~ 547 (674)
T 3pfq_A 491 ENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 547 (674)
T ss_dssp ECCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH
Confidence 643322 223456799999999999999999999999999999999999999986543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=309.32 Aligned_cols=203 Identities=23% Similarity=0.305 Sum_probs=175.7
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCC--ceEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS--ERILV 346 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv 346 (498)
.++|...+.||+|+||.||+|+.. +++.||+|+++..........+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 356888999999999999999975 489999999986544456788899999999999999999999998765 67999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEE----CCCCcEEEeecCcc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGLA 422 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~ki~DfGl~ 422 (498)
|||+++|+|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 999999999999986432 23489999999999999999999999 99999999999999 78888999999999
Q ss_pred ccccccCcceeecccccccccCcccccC--------CCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 423 KLVDAKLTHVTTQIRGTMGHIAPEYLST--------GKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
+....... .....||+.|+|||++.. ..++.++|||||||++|||+||+.||..
T Consensus 164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~ 225 (396)
T 4eut_A 164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (396)
T ss_dssp EECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred eEccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 87654322 234568999999999865 5678899999999999999999999974
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=305.31 Aligned_cols=199 Identities=24% Similarity=0.316 Sum_probs=169.3
Q ss_pred cCCCCCCeeecccceEEEEEEEcCCcEEEEEEeccc-CCcchHHHHHHHHHHHHhcc--CCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAI--HKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|++.+.||+|+||.||+|...+++.||||++... ........+.+|++++.+++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458889999999999999999888999999998643 33455688999999999996 599999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
| +.+++|.+++.. ...+++.++..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++....
T Consensus 136 E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 136 E-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp E-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred e-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9 578899999986 34689999999999999999999999 999999999999996 57999999999987654
Q ss_pred cCcc-eeecccccccccCcccccC-----------CCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 428 KLTH-VTTQIRGTMGHIAPEYLST-----------GKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 428 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 269 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchh
Confidence 3322 2234569999999999865 4688999999999999999999999975
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=291.95 Aligned_cols=202 Identities=27% Similarity=0.424 Sum_probs=174.0
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
+.++|+..+.||+|+||.||+|+.. ++..||+|++.... .......+.+|++++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3467888999999999999999965 56789999986322 12335678999999999999999999999999999999
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
||||+++++|.+.+... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++...
T Consensus 87 v~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 99999999999998763 3589999999999999999999999 9999999999999999999999999998654
Q ss_pred cccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 211 (279)
T 3fdn_A 160 PSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred Cccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc
Confidence 4322 234568999999999999999999999999999999999999998654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=304.32 Aligned_cols=197 Identities=24% Similarity=0.313 Sum_probs=161.6
Q ss_pred cCCCCC-CeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHh-ccCCccceEEEEEEc----CCce
Q 010887 271 DNFSES-NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISV-AIHKNLLQLIGYCTT----SSER 343 (498)
Q Consensus 271 ~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~~~ 343 (498)
++|... +.||+|+||.||+++.. +++.||||+++. ...+.+|++++.+ .+||||+++++++.. ....
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 355554 68999999999999965 688999999863 2456788888754 589999999998865 4568
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECC---CCcEEEeecC
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVLCDFG 420 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~ki~DfG 420 (498)
++||||+++|+|.+++.... ...+++.++..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence 89999999999999998632 34699999999999999999999999 9999999999999987 7899999999
Q ss_pred ccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 421 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+++...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 210 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 267 (400)
T 1nxk_A 210 FAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_dssp TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred cccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 998665322 2234568999999999999999999999999999999999999997543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=303.04 Aligned_cols=201 Identities=23% Similarity=0.303 Sum_probs=175.4
Q ss_pred HhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCC-------cchHHHHHHHHHHHHhccCCccceEEEEEEcC
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYS-------PGGEAAFQREVHLISVAIHKNLLQLIGYCTTS 340 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 340 (498)
..++|+..+.||+|+||.||+|+. .+++.||+|+++.... ......+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 356799999999999999999995 4688999999875321 11334677899999999999999999999999
Q ss_pred CceEEEEecccCC-CHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeec
Q 010887 341 SERILVYPFMQNL-SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 419 (498)
Q Consensus 341 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~Df 419 (498)
+..++||||+..| +|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999777 99998875 34699999999999999999999999 9999999999999999999999999
Q ss_pred CccccccccCcceeecccccccccCcccccCCCC-CCcccchhHHHHHHHHHhCCCCCCC
Q 010887 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 420 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
|+++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..
T Consensus 175 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 175 GSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp TTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred ccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 99987654332 234568999999999988877 7899999999999999999999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=303.85 Aligned_cols=202 Identities=25% Similarity=0.374 Sum_probs=178.4
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.++|+..+.||+|+||.||+|... +++.||+|+++..........+.+|++++++++||||+++++++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 457888999999999999999975 6889999999865555667889999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+ +|+||||||+||+++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999999863 35899999999999999999999842 7999999999999999999999999998765432
Q ss_pred CcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
......||+.|+|||++.+..++.++||||||+++|||+||+.||....
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1234568999999999999999999999999999999999999998654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=323.72 Aligned_cols=209 Identities=29% Similarity=0.411 Sum_probs=180.3
Q ss_pred HHHHHHhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCce
Q 010887 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (498)
Q Consensus 264 ~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 343 (498)
..+++..++|+..+.||+|+||.||+|.+.++..||||+++... ...++|.+|++++++++||||+++++++.+ +..
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 33445667788899999999999999999888899999997533 345789999999999999999999999876 678
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
++||||+++|+|.+++.... ...+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 411 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR 411 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred eEeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccce
Confidence 99999999999999997522 23589999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
..............++..|+|||.+....++.++|||||||++|||+| |+.||....
T Consensus 412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~ 469 (535)
T 2h8h_A 412 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 469 (535)
T ss_dssp TCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC
T ss_pred ecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 765432222233446789999999999999999999999999999999 999997643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=295.53 Aligned_cols=202 Identities=26% Similarity=0.384 Sum_probs=173.2
Q ss_pred cCCCCCCeeecccceEEEEEEE-----cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcC--Cce
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SER 343 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 343 (498)
+.|+..+.||+|+||.||+|++ .+++.||+|+++..........+.+|++++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4577889999999999999984 368899999998655556678899999999999999999999999877 567
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence 8999999999999999653 24589999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCcc--eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 424 LVDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 424 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
........ ......+|..|+|||.+.+..++.++||||||+++|||+||+.|+..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 231 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS 231 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcc
Confidence 77654322 22345678889999999999999999999999999999999998653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=297.57 Aligned_cols=205 Identities=27% Similarity=0.439 Sum_probs=170.2
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCc----EEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (498)
.++|+..+.||+|+||.||+|+.. +++ +|++|.++..........+.+|++++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 357888999999999999999964 343 468888876666677889999999999999999999999998765 78
Q ss_pred EEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccc
Q 010887 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~ 424 (498)
+|++|+.+|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 93 ~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 999999999999999863 34589999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcc
Q 010887 425 VDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRL 481 (498)
Q Consensus 425 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~~ 481 (498)
....... ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||+....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 225 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence 6543222 2233456789999999999999999999999999999999 9999986443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=288.30 Aligned_cols=202 Identities=31% Similarity=0.432 Sum_probs=163.9
Q ss_pred hcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCC---cchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS---PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
.++|+..+.||+|+||.||+|.. .++.||||+++.... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 45788899999999999999997 488999999874322 23357889999999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECC--------CCcEEEee
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD--------NFEAVLCD 418 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~--------~~~~ki~D 418 (498)
|||+++++|.+++.. ..+++..+..++.|++.||+|||+....+++||||||+||++++ ++.+||+|
T Consensus 85 ~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999998863 46899999999999999999999982222999999999999986 77899999
Q ss_pred cCccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 419 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
||+++....... ....||+.|+|||.+.+..++.++||||||+++|||+||+.||....
T Consensus 160 fg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 218 (271)
T 3dtc_A 160 FGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID 218 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred CCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999986654322 23468999999999999999999999999999999999999998643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=290.65 Aligned_cols=203 Identities=25% Similarity=0.386 Sum_probs=178.5
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
.++|...+.||+|+||.||+|... +++.||+|++.... .......+.+|++++++++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 356888999999999999999975 57889999986432 334567889999999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|||+++++|.+++.. ...+++.++..++.|+++||+|||+. +++||||||+||++++++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 999999999998875 34689999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||+...
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 219 (294)
T 2rku_A 167 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219 (294)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 3322 2234568999999999999899999999999999999999999998654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=291.29 Aligned_cols=203 Identities=27% Similarity=0.423 Sum_probs=175.0
Q ss_pred cCCCCCC-eeecccceEEEEEEEc---CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 271 DNFSESN-IIGQGGFGKVYKGVLS---DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 271 ~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
++|.+.+ .||+|+||.||+|.+. ++..||+|+++..........+.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4455555 8999999999999853 57789999998665556678899999999999999999999999 45568999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|||+++++|.+++... ...+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||+++...
T Consensus 88 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999998742 34689999999999999999999999 99999999999999999999999999998775
Q ss_pred ccCcce--eecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 427 AKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 427 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
...... .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 218 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 433222 123446889999999988889999999999999999999 999997643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=290.61 Aligned_cols=201 Identities=27% Similarity=0.384 Sum_probs=179.6
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.+.|+..+.||+|+||.||+|+.. +++.||+|++...........+.+|++++++++||||+++++++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356888999999999999999964 6889999999765555667889999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++++|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 101 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 9999999998863 4589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.. ......||+.|+|||.+.+..++.++||||||+++|||+||+.||...
T Consensus 173 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 222 (303)
T 3a7i_A 173 QI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222 (303)
T ss_dssp BC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc
Confidence 22 223456899999999999999999999999999999999999999754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=308.02 Aligned_cols=201 Identities=22% Similarity=0.361 Sum_probs=163.4
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-------CcchHHHHHHHHHHHHhccCCccceEEEEEEcC
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-------SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS 340 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 340 (498)
..++|...+.||+|+||.||+|... +++.||+|++.... .......+.+|++++++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 4678999999999999999999964 57899999986421 11223358899999999999999999999754
Q ss_pred CceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCC---CcEEEe
Q 010887 341 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN---FEAVLC 417 (498)
Q Consensus 341 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~ki~ 417 (498)
+..++||||+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++.+ ..+||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence 457899999999999888864 45699999999999999999999999 99999999999999654 459999
Q ss_pred ecCccccccccCcceeecccccccccCcccccC---CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 418 DFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 418 DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 285 DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~ 347 (419)
T 3i6u_A 285 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 347 (419)
T ss_dssp CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred ecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 99999876542 22344678999999999853 66888999999999999999999999754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=305.11 Aligned_cols=203 Identities=21% Similarity=0.230 Sum_probs=166.4
Q ss_pred HhcCCCCCCeeecccceEEEEEEEcC------CcEEEEEEecccCCcc----------hHHHHHHHHHHHHhccCCccce
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPG----------GEAAFQREVHLISVAIHKNLLQ 332 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~l~h~niv~ 332 (498)
..++|.+.+.||+|+||.||+|.+.. ++.||+|++....... ....+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34578889999999999999999765 4789999986432100 0112334555566778999999
Q ss_pred EEEEEEcC----CceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEE
Q 010887 333 LIGYCTTS----SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL 408 (498)
Q Consensus 333 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl 408 (498)
+++++... ...++||||+ +++|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence 99998765 3479999999 99999999762 35699999999999999999999999 99999999999999
Q ss_pred C--CCCcEEEeecCccccccccCcce------eecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 409 D--DNFEAVLCDFGLAKLVDAKLTHV------TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 409 ~--~~~~~ki~DfGl~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
+ .++.+||+|||+++......... .....||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 8 88999999999998765432211 1234599999999999999999999999999999999999999985
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=288.69 Aligned_cols=199 Identities=19% Similarity=0.277 Sum_probs=172.6
Q ss_pred hcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcC--CceEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERILV 346 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 346 (498)
.++|+..+.||+|+||.||+|++ +++.||+|+++... .....+.|.+|++++++++||||+++++++... ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 45788899999999999999998 48899999997443 345567899999999999999999999999887 678999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEEcCCCCCcEEECCCCcEEEeecCcccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK--IIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlk~~NILl~~~~~~ki~DfGl~~~ 424 (498)
|||+++|+|.+++.... ...+++.++..++.|++.||+|||+. + ++||||||+||++++++.++|+|||++..
T Consensus 88 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred ecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence 99999999999998632 33689999999999999999999998 6 99999999999999999999999998764
Q ss_pred ccccCcceeecccccccccCcccccCCCCCC---cccchhHHHHHHHHHhCCCCCCCCc
Q 010887 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSE---KTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
... ....||+.|+|||.+.+..++. ++||||||+++|||+||+.||....
T Consensus 163 ~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 215 (271)
T 3kmu_A 163 FQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS 215 (271)
T ss_dssp TSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC
T ss_pred ecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 332 2245789999999998765554 7999999999999999999997543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=297.20 Aligned_cols=204 Identities=28% Similarity=0.459 Sum_probs=170.4
Q ss_pred cCCCCCCeeecccceEEEEEEEcC-----CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLSD-----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
++|+..+.||+|+||.||+|.... +..||+|+++..........+.+|++++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456678999999999999999643 235999999865555667789999999999999999999999999999999
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
||||+++++|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 124 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999752 34689999999999999999999999 9999999999999999999999999999876
Q ss_pred cccCcc--eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 426 DAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 426 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
...... ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 255 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS 255 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC
Confidence 543221 1122346788999999999999999999999999999999 999997543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=288.38 Aligned_cols=200 Identities=18% Similarity=0.235 Sum_probs=174.9
Q ss_pred hcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCceEEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 347 (498)
.++|+..+.||+|+||.||+|+. .+++.||+|++.... ....+.+|+++++++ +|+|++++++++......++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC---ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 45788899999999999999995 578999999986432 234578899999999 7999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCc-----EEEeecCcc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE-----AVLCDFGLA 422 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~-----~ki~DfGl~ 422 (498)
||+ +++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++
T Consensus 86 e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 86 DLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999 99999999853 23589999999999999999999999 9999999999999987776 999999999
Q ss_pred ccccccCcc------eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 423 KLVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 423 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
+........ ......||+.|+|||.+.+..++.++||||||+++|||+||+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 221 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 221 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchh
Confidence 876543321 123456899999999999999999999999999999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=310.28 Aligned_cols=194 Identities=25% Similarity=0.370 Sum_probs=154.6
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcC-----Cce
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-----SER 343 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 343 (498)
++|++.+.||+|+||.||+|+.. +++.||||++.... .....+.+.+|+++++.++||||+++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 67899999999999999999964 68899999987433 334567899999999999999999999998543 468
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
++||||+. ++|...+.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 133 ~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 133 YVVLEIAD-SDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEECCCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEeccc-cchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence 99999985 688888875 35699999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCc--------------------------ceeecccccccccCcccc-cCCCCCCcccchhHHHHHHHHHhC
Q 010887 424 LVDAKLT--------------------------HVTTQIRGTMGHIAPEYL-STGKSSEKTDVFGYGITLLELVTG 472 (498)
Q Consensus 424 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~Gvvl~elltG 472 (498)
....... .......||+.|+|||++ ....++.++|||||||++|||+||
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 7643211 112345689999999986 456799999999999999999993
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=291.34 Aligned_cols=202 Identities=34% Similarity=0.500 Sum_probs=162.6
Q ss_pred HhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
..++|+..+.||+|+||.||+|+.. ..||+|+++... .......|.+|++++++++||||+++++++ .....++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 4567899999999999999999864 359999997443 345567899999999999999999999965 455689999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++++|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 99 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 99 QWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccc
Confidence 999999999998642 35689999999999999999999999 999999999999999999999999999976543
Q ss_pred cC-cceeecccccccccCccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 428 KL-THVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 428 ~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.. ........||+.|+|||.+. ...++.++||||||+++|||+||+.||...
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 228 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc
Confidence 22 12223456899999999986 567888999999999999999999999754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=296.42 Aligned_cols=202 Identities=25% Similarity=0.388 Sum_probs=178.1
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|...+.||+|+||.||+++.. +++.||+|++.... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 56778899999999999999975 47889999986432 3345678899999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++++|.+++.. ...+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 121 e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 121 ELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp CCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 99999999998875 24689999999999999999999999 999999999999999999999999999987653
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||....
T Consensus 194 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 245 (335)
T 2owb_A 194 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 245 (335)
T ss_dssp TTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred Ccc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC
Confidence 322 2234568999999999999899999999999999999999999998654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=297.14 Aligned_cols=206 Identities=26% Similarity=0.375 Sum_probs=178.1
Q ss_pred HHHHHhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCc-------chHHHHHHHHHHHHhc-cCCccceEEE
Q 010887 265 ELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP-------GGEAAFQREVHLISVA-IHKNLLQLIG 335 (498)
Q Consensus 265 el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~l-~h~niv~l~~ 335 (498)
......++|+..+.||+|+||.||+|+.. +|+.||||+++..... .....+.+|++++.++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 33445678999999999999999999975 6899999998743321 1245678999999999 7999999999
Q ss_pred EEEcCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEE
Q 010887 336 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV 415 (498)
Q Consensus 336 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 415 (498)
++......++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+|
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999975 34689999999999999999999999 999999999999999999999
Q ss_pred EeecCccccccccCcceeecccccccccCcccccC------CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 416 LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST------GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 416 i~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
|+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 241 l~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 308 (365)
T 2y7j_A 241 LSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR 308 (365)
T ss_dssp ECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC
Confidence 99999998765432 2234678999999999853 35889999999999999999999999754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=293.14 Aligned_cols=207 Identities=23% Similarity=0.305 Sum_probs=175.9
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEc--CCceEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTT--SSERIL 345 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 345 (498)
.++|+..+.||+|+||.||+|+.. +++.||+|++.... .....+.+.+|++++++++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357888999999999999999975 68999999997432 34556789999999999999999999998854 557899
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----cEEcCCCCCcEEECCCCcEEEeecC
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK-----IIHRDLKAANILLDDNFEAVLCDFG 420 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-----ivH~Dlk~~NILl~~~~~~ki~DfG 420 (498)
||||+++++|.+++.........+++..+..++.|++.||+|||+. + ++||||||+||++++++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999986444455699999999999999999999998 6 9999999999999999999999999
Q ss_pred ccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 421 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+++....... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||....
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 220 (279)
T 2w5a_A 162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220 (279)
T ss_dssp HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence 9986654321 1233568999999999999899999999999999999999999998653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=306.19 Aligned_cols=200 Identities=24% Similarity=0.358 Sum_probs=168.1
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcC-----Cc
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-----SE 342 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 342 (498)
.++|...+.||+|+||.||+|+.. +++.||||+++... .....+.+.+|++++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 467899999999999999999965 57889999997543 334567899999999999999999999999776 56
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcc
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~ 422 (498)
.++||||++ ++|.+.+.. ...+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999987 599998875 35699999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcc---------------------eeecccccccccCcccc-cCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 010887 423 KLVDAKLTH---------------------VTTQIRGTMGHIAPEYL-STGKSSEKTDVFGYGITLLELVTGQRAID 477 (498)
Q Consensus 423 ~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~Gvvl~elltG~~p~~ 477 (498)
+........ ......||+.|+|||++ ....++.++||||+||++|||+||..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 876543211 12456789999999986 55679999999999999999999666554
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=321.27 Aligned_cols=196 Identities=27% Similarity=0.423 Sum_probs=167.6
Q ss_pred eeecccceEEEEEEEc---CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccCCC
Q 010887 278 IIGQGGFGKVYKGVLS---DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLS 354 (498)
Q Consensus 278 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 354 (498)
.||+|+||.||+|.+. ++..||||+++........+.|.+|++++++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999864 4567999999866555678899999999999999999999999976 56899999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCccee-
Q 010887 355 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT- 433 (498)
Q Consensus 355 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~~- 433 (498)
|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++..........
T Consensus 422 L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 422 LHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp HHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred HHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 99998752 34689999999999999999999999 999999999999999999999999999987654322211
Q ss_pred -ecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 434 -TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 434 -~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
....+++.|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 544 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 22335689999999999999999999999999999998 999998654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=299.51 Aligned_cols=210 Identities=26% Similarity=0.317 Sum_probs=172.3
Q ss_pred CHHHHHHHhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCc----------chHHHHHHHHHHHHhccCCccc
Q 010887 262 SCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP----------GGEAAFQREVHLISVAIHKNLL 331 (498)
Q Consensus 262 ~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv 331 (498)
...++....++|...+.||+|+||.||+|...+++.||||++...... ...+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 356778888999999999999999999999888999999998643221 1237899999999999999999
Q ss_pred eEEEEEEcC-----CceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcE
Q 010887 332 QLIGYCTTS-----SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANI 406 (498)
Q Consensus 332 ~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NI 406 (498)
++++++... ...++||||++ |+|.+.+... ...+++..+..++.|++.||+|||+. +|+||||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence 999998543 35789999998 6888877642 34689999999999999999999999 999999999999
Q ss_pred EECCCCcEEEeecCccccccccCcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 407 LLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 407 Ll~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred EEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999997554322 2234568999999999877 678999999999999999999999998654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=298.55 Aligned_cols=203 Identities=23% Similarity=0.358 Sum_probs=165.5
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
..++|+..+.||+|+||+||+|+.. +++.||+|+++... .......+.+|++++++++||||+++++++...+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 4568999999999999999999954 68899999997433 233456788999999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEE-----CCCCcEEEeecCc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL-----DDNFEAVLCDFGL 421 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl-----~~~~~~ki~DfGl 421 (498)
|||+++ +|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||+
T Consensus 112 ~e~~~~-~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EECCSE-EHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EecCCC-CHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999984 99998875 34589999999999999999999999 99999999999999 4556699999999
Q ss_pred cccccccCcceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
++........ .....||+.|+|||++.+. .++.++|||||||++|||+||+.||....
T Consensus 184 a~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 242 (329)
T 3gbz_A 184 ARAFGIPIRQ-FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS 242 (329)
T ss_dssp HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccCCcccc-cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC
Confidence 9876543222 2335679999999999874 48999999999999999999999997643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=296.15 Aligned_cols=203 Identities=26% Similarity=0.400 Sum_probs=171.1
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCC-cchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
.++|+..+.||+|+||.||+|+.. +++.||+|++..... ......+.+|++++++++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 356888999999999999999975 488999999864432 334567889999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||++++++.+.+.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 104 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999998887654 34589999999999999999999999 999999999999999999999999999986654
Q ss_pred cCcceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
... ......||+.|+|||++.+. .++.++||||||+++|||+||+.||....
T Consensus 177 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (331)
T 4aaa_A 177 PGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred Ccc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 322 22345689999999999775 68999999999999999999999998654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=293.44 Aligned_cols=202 Identities=23% Similarity=0.330 Sum_probs=168.2
Q ss_pred cCCCC-CCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSE-SNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~-~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 347 (498)
+.|.+ .+.||+|+||.||+|+. .+++.||||++.... ......+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 45666 37899999999999995 478999999997542 34567889999999985 7999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCc---EEEeecCcccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE---AVLCDFGLAKL 424 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~ki~DfGl~~~ 424 (498)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++..
T Consensus 91 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 999999999999862 4589999999999999999999999 9999999999999988776 99999999876
Q ss_pred ccccCc------ceeecccccccccCcccccC-----CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 425 VDAKLT------HVTTQIRGTMGHIAPEYLST-----GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 425 ~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
...... .......||+.|+|||++.. ..++.++|||||||++|||+||+.||....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 542211 11123458999999999875 457899999999999999999999997643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=303.24 Aligned_cols=202 Identities=30% Similarity=0.448 Sum_probs=163.1
Q ss_pred CCCCCCeeecccceEEEEEEEc--CC--cEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEc-CCceEEE
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS--DN--TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-SSERILV 346 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv 346 (498)
.|...+.||+|+||.||+|++. ++ ..||+|.++..........|.+|++++++++||||+++++++.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3556789999999999999963 22 36899998766566677899999999999999999999999765 4577999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|||+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999752 34588999999999999999999999 99999999999999999999999999998664
Q ss_pred ccCcc---eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 427 AKLTH---VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 427 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
..... ......+|+.|+|||.+.+..++.++||||||+++|||+| |..||...
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~ 300 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 300 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC
Confidence 33211 1233457789999999999999999999999999999999 67787654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=294.02 Aligned_cols=199 Identities=29% Similarity=0.390 Sum_probs=174.1
Q ss_pred CCCCCeeecccceEEEEEEEc-----CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcC--CceEE
Q 010887 273 FSESNIIGQGGFGKVYKGVLS-----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERIL 345 (498)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 345 (498)
|+..+.||+|+||.||++.+. +++.||+|+++....+.....+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 477899999999999998753 57889999998665556678899999999999999999999999874 46789
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 113 v~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 9999999999999975 2489999999999999999999999 9999999999999999999999999999877
Q ss_pred cccCcc--eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 426 DAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 426 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
...... ......+|..|+|||.+.+..++.++||||||+++|||+||+.||...
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 654322 123345788899999999989999999999999999999999999753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=303.28 Aligned_cols=203 Identities=20% Similarity=0.306 Sum_probs=168.6
Q ss_pred HHHhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCC----
Q 010887 267 QLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS---- 341 (498)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 341 (498)
+...++|+..+.||+|+||.||+|+. .+++.||+|++..... ...+|+++++.++||||+++++++....
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 34567899999999999999999996 5789999999864322 2247999999999999999999985432
Q ss_pred ----------------------------------ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHH
Q 010887 342 ----------------------------------ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387 (498)
Q Consensus 342 ----------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~y 387 (498)
..++||||++ |+|.+.+.........+++..+..++.|+++||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 3789999998 58888777544445679999999999999999999
Q ss_pred HHhcCCCCcEEcCCCCCcEEEC-CCCcEEEeecCccccccccCcceeecccccccccCcccccCC-CCCCcccchhHHHH
Q 010887 388 LHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGIT 465 (498)
Q Consensus 388 LH~~~~~~ivH~Dlk~~NILl~-~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvv 465 (498)
||+. +|+||||||+||+++ +++.+||+|||+++....... .....+|+.|+|||.+.+. .++.++||||+||+
T Consensus 157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9999 999999999999997 688999999999987654332 2345679999999998765 48999999999999
Q ss_pred HHHHHhCCCCCCCCc
Q 010887 466 LLELVTGQRAIDFSR 480 (498)
Q Consensus 466 l~elltG~~p~~~~~ 480 (498)
+|||++|+.||....
T Consensus 232 l~ell~g~~pf~~~~ 246 (383)
T 3eb0_A 232 FGELILGKPLFSGET 246 (383)
T ss_dssp HHHHHHSSCSSCCSS
T ss_pred HHHHHhCCCCCCCCC
Confidence 999999999998644
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=287.96 Aligned_cols=199 Identities=32% Similarity=0.525 Sum_probs=169.7
Q ss_pred hcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchH------HHHHHHHHHHHhccCCccceEEEEEEcCCc
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGE------AAFQREVHLISVAIHKNLLQLIGYCTTSSE 342 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~------~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 342 (498)
.++|+..+.||+|+||.||+|+. .+++.||+|++......... +.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 46788899999999999999997 47899999998643322211 67899999999999999999999986554
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEEcCCCCCcEEECCCCc-----EE
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK--IIHRDLKAANILLDDNFE-----AV 415 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlk~~NILl~~~~~-----~k 415 (498)
++||||+++|+|.+.+... ...+++..+..++.|++.||+|||+. + |+||||||+||+++.++. +|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -eEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 7999999999998888752 34699999999999999999999998 7 999999999999988776 99
Q ss_pred EeecCccccccccCcceeecccccccccCcccc--cCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 416 LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL--STGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 416 i~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
|+|||+++.... ......||+.|+|||.+ ....++.++||||||+++|||+||+.||+...
T Consensus 170 l~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 232 (287)
T 4f0f_A 170 VADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232 (287)
T ss_dssp ECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 999999975433 23345689999999998 34557889999999999999999999997543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=288.96 Aligned_cols=201 Identities=26% Similarity=0.380 Sum_probs=176.7
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
.++|+..+.||+|+||.||+|+.. +++.||+|++.... .......+.+|++++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 357888999999999999999975 57789999986321 123356789999999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 9999999999998763 3589999999999999999999999 99999999999999999999999999987554
Q ss_pred ccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||+...
T Consensus 166 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 216 (284)
T 2vgo_A 166 SLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216 (284)
T ss_dssp SSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC
Confidence 322 234568999999999999999999999999999999999999998654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=292.93 Aligned_cols=206 Identities=23% Similarity=0.339 Sum_probs=168.1
Q ss_pred hcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
.++|.+.+.||+|+||.||+|.. .+++.||+|+++.. ........+.+|++++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35688899999999999999996 47899999999742 2344567899999999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|||+++++|.+++.........+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999876444456789999999999999999999999 99999999999999999999999999988665
Q ss_pred ccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.... ......|++.|+|||.+.+..++.++||||||+++|||+||+.||...
T Consensus 188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 4322 223356899999999999999999999999999999999999999754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=296.88 Aligned_cols=206 Identities=28% Similarity=0.445 Sum_probs=172.7
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcE--EEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCceEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTK--VAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 345 (498)
.++|+..+.||+|+||.||+|+.. ++.. +++|+++..........+.+|+++++++ +||||+++++++...+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 357888999999999999999964 4554 4999988655556677899999999999 89999999999999999999
Q ss_pred EEecccCCCHHHhhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCc
Q 010887 346 VYPFMQNLSVAYRLRDLK------------PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 413 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 413 (498)
||||+++++|.+++.... .....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCe
Confidence 999999999999997643 2235689999999999999999999999 9999999999999999999
Q ss_pred EEEeecCccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 414 AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 414 ~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
+||+|||+++...... ......+++.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 181 ~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 246 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246 (327)
T ss_dssp EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc
Confidence 9999999987443221 1223346789999999988889999999999999999998 999997654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=288.07 Aligned_cols=201 Identities=21% Similarity=0.278 Sum_probs=173.8
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc-CCcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCceEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 346 (498)
.++|+..+.||+|+||.||+|+.. +++.||+|+++.. ........+.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467888999999999999999975 7899999999753 3344567889999999999 899999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECC----------------
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---------------- 410 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---------------- 410 (498)
|||+++++|.+++.........+++.++..++.|++.||+|||+. +|+||||||+||+++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999986433335689999999999999999999999 9999999999999984
Q ss_pred ---CCcEEEeecCccccccccCcceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 411 ---NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 411 ---~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
...+||+|||.+....... ...||+.|+|||.+.+. .++.++||||||+++|||++|+.|+..
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 233 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 4479999999998765432 23489999999999766 567899999999999999999987653
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=299.66 Aligned_cols=198 Identities=27% Similarity=0.413 Sum_probs=166.9
Q ss_pred hcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCC------
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------ 341 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 341 (498)
.++|+..+.||+|+||.||+|.. .+++.||+|++.... .......+.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 35788899999999999999996 468999999996432 3344678899999999999999999999997763
Q ss_pred ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCc
Q 010887 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (498)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl 421 (498)
..++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 7899998875 3589999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
++..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 230 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 230 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9876532 234568999999999877 679999999999999999999999998654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=307.97 Aligned_cols=202 Identities=15% Similarity=0.140 Sum_probs=165.2
Q ss_pred hcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEeccc--CCcchHHHHHHHH---HHHHhccCCccceEE-------EE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREV---HLISVAIHKNLLQLI-------GY 336 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~~ 336 (498)
.++|...+.||+|+||+||+|+. .+++.||||+++.. ......+.+.+|+ +.+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45688889999999999999995 56899999999742 2344568899999 555666899999998 66
Q ss_pred EEcCCc-----------------eEEEEecccCCCHHHhhcccC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 010887 337 CTTSSE-----------------RILVYPFMQNLSVAYRLRDLK---PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396 (498)
Q Consensus 337 ~~~~~~-----------------~~lv~e~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 396 (498)
+...+. .++||||+ +|+|.+++.... .....+++..+..++.||+.||+|||+. +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 665532 78999999 689999998531 1122355688889999999999999999 99
Q ss_pred EEcCCCCCcEEECCCCcEEEeecCccccccccCcceeecccccccccCcccccCC-----------CCCCcccchhHHHH
Q 010887 397 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-----------KSSEKTDVFGYGIT 465 (498)
Q Consensus 397 vH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~s~Gvv 465 (498)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999985432 2334567 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCCCc
Q 010887 466 LLELVTGQRAIDFSR 480 (498)
Q Consensus 466 l~elltG~~p~~~~~ 480 (498)
+|||+||+.||....
T Consensus 303 l~elltg~~Pf~~~~ 317 (377)
T 3byv_A 303 IYWIWCADLPITKDA 317 (377)
T ss_dssp HHHHHHSSCCC----
T ss_pred HHHHHHCCCCCcccc
Confidence 999999999997544
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=292.85 Aligned_cols=198 Identities=29% Similarity=0.455 Sum_probs=164.2
Q ss_pred cCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecc
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (498)
++|+..+.||+|+||.||+|+. .++.||+|++.. ....+.|.+|++++++++||||+++++++. +..++||||+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES---ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSS---TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecC---hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 5677889999999999999998 478899999863 345678999999999999999999999876 4478999999
Q ss_pred cCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCc-EEEeecCccccccccC
Q 010887 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE-AVLCDFGLAKLVDAKL 429 (498)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~-~ki~DfGl~~~~~~~~ 429 (498)
++|+|.+++..... ...+++..+..++.|+++||+|||+....+|+||||||+||++++++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp TTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 99999999985321 235789999999999999999999932228999999999999988886 799999999765432
Q ss_pred cceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.....||+.|+|||.+.+..++.++||||||+++|||+||+.||+..
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 12345899999999999999999999999999999999999999743
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=293.69 Aligned_cols=208 Identities=22% Similarity=0.264 Sum_probs=175.7
Q ss_pred HHHHhcCCCCC-CeeecccceEEEEEEEc-CCcEEEEEEeccc-CCcchHHHHHHHHHHHHhcc-CCccceEEEEEEcCC
Q 010887 266 LQLATDNFSES-NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSS 341 (498)
Q Consensus 266 l~~~~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 341 (498)
.+...+.|... +.||+|+||.||+|+.. +++.||+|+++.. ........+.+|++++.++. ||||+++++++...+
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 34445566666 88999999999999965 5899999998743 23345788999999999995 699999999999999
Q ss_pred ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECC---CCcEEEee
Q 010887 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVLCD 418 (498)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~ki~D 418 (498)
..++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred eEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEee
Confidence 9999999999999999886422 35689999999999999999999999 9999999999999987 78999999
Q ss_pred cCccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 419 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
||+++....... .....||+.|+|||++.+..++.++||||||+++|||+||+.||....
T Consensus 178 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (327)
T 3lm5_A 178 FGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED 237 (327)
T ss_dssp GGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999987654322 234568999999999999999999999999999999999999997654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-36 Score=310.80 Aligned_cols=201 Identities=26% Similarity=0.365 Sum_probs=174.5
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
.++|++.+.||+|+||+||+|+.. +++.||+|++... ........+.+|++++++++||||+++++++......++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 457889999999999999999975 6899999998632 22345678999999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEEC---CCCcEEEeecCcccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD---DNFEAVLCDFGLAKL 424 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~ki~DfGl~~~ 424 (498)
||+++|+|.+.+... ..+++..+..++.|++.||+|||+. +|+||||||+||+++ .++.+||+|||+++.
T Consensus 101 e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 999999999988752 4589999999999999999999999 999999999999994 556799999999986
Q ss_pred ccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
..... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||....
T Consensus 174 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 226 (486)
T 3mwu_A 174 FQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 65432 2334568999999999875 58999999999999999999999997643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=287.60 Aligned_cols=199 Identities=31% Similarity=0.416 Sum_probs=170.2
Q ss_pred CCCCCCeeecccceEEEEEEEcC-C---cEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCce-EEE
Q 010887 272 NFSESNIIGQGGFGKVYKGVLSD-N---TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER-ILV 346 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~lv 346 (498)
.|...+.||+|+||+||+|++.+ + ..+|+|+++........+.+.+|++++++++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 34456899999999999999532 2 379999998665556678899999999999999999999999876655 899
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
+||+.+|+|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 9999999999999752 34689999999999999999999999 99999999999999999999999999998664
Q ss_pred ccCc---ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCC
Q 010887 427 AKLT---HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 476 (498)
Q Consensus 427 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~ 476 (498)
.... .......+++.|+|||.+.+..++.++||||||+++|||+||+.|+
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~ 228 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence 4321 1223355788999999999999999999999999999999965554
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=294.68 Aligned_cols=215 Identities=27% Similarity=0.409 Sum_probs=169.5
Q ss_pred HHHHHHhcCCCCCCeeecccceEEEEEEEc----CCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEE
Q 010887 264 RELQLATDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338 (498)
Q Consensus 264 ~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 338 (498)
+++....++|...+.||+|+||.||+|... .+..||+|+++.. ........+.+|++++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 334445678888999999999999999864 2457999998743 23445678999999999999999999999998
Q ss_pred cCCc-----eEEEEecccCCCHHHhhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCC
Q 010887 339 TSSE-----RILVYPFMQNLSVAYRLRDLK--PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN 411 (498)
Q Consensus 339 ~~~~-----~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~ 411 (498)
.... .++|+||+++++|.+++.... .....+++..+..++.|+++||.|||+. +|+||||||+||+++++
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence 7653 489999999999999985322 2345699999999999999999999999 99999999999999999
Q ss_pred CcEEEeecCccccccccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcc
Q 010887 412 FEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRL 481 (498)
Q Consensus 412 ~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~~ 481 (498)
+.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||+| |+.||.....
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 255 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN 255 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH
Confidence 99999999999866543221 1233457889999999999999999999999999999999 8999976543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=310.92 Aligned_cols=201 Identities=26% Similarity=0.379 Sum_probs=177.2
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
.++|+..+.||+|+||.||+|+.. +++.||||++.... .......+.+|++++++++||||+++++++...+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 457888999999999999999975 78999999986432 234578899999999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEE---CCCCcEEEeecCccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAK 423 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~ki~DfGl~~ 423 (498)
+||+.+|+|.+.+.. ...+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 105 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp ECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999998875 34689999999999999999999999 99999999999999 567899999999998
Q ss_pred cccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
...... ......||+.|+|||++.+ .++.++||||+||++|||+||+.||....
T Consensus 178 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 231 (484)
T 3nyv_A 178 HFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN 231 (484)
T ss_dssp HBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Eccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC
Confidence 765432 2234568999999999865 69999999999999999999999998654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=296.47 Aligned_cols=203 Identities=29% Similarity=0.395 Sum_probs=171.8
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcC--------
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-------- 340 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------- 340 (498)
++|+..+.||+|+||.||+|+. .+++.||+|++.... .......+.+|++++++++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5788899999999999999997 578999999986433 333456788999999999999999999999774
Q ss_pred CceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecC
Q 010887 341 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (498)
Q Consensus 341 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 420 (498)
+..++||||+++ ++...+... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 457899999985 777766643 24589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCc---ceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 421 LAKLVDAKLT---HVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 421 l~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+++....... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 233 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 233 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9987653221 12234568999999999876 458999999999999999999999998654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=297.07 Aligned_cols=202 Identities=22% Similarity=0.386 Sum_probs=174.2
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCC-----ce
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-----ER 343 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~ 343 (498)
.++|+..+.||+|+||.||+|+.. +++.||+|++...........+.+|++++.+++||||+++++++.... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 357888999999999999999965 678899999986555556688999999999999999999999997653 57
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
++|+||++ |+|.+.+.. ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 106 ~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 89999998 589888864 3589999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCcce--eecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 424 LVDAKLTHV--TTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 424 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
......... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 236 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC
Confidence 765433221 234578999999998654 458999999999999999999999998654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=309.98 Aligned_cols=201 Identities=23% Similarity=0.340 Sum_probs=173.2
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCc------------chHHHHHHHHHHHHhccCCccceEEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP------------GGEAAFQREVHLISVAIHKNLLQLIGY 336 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~e~~~l~~l~h~niv~l~~~ 336 (498)
.++|.+.+.||+|+||+||+|+.. +++.||+|+++..... .....+.+|++++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467889999999999999999975 5789999998743211 345788999999999999999999999
Q ss_pred EEcCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCC---c
Q 010887 337 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF---E 413 (498)
Q Consensus 337 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~---~ 413 (498)
+.+....++||||+++|+|.+.+.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence 9999999999999999999998875 34589999999999999999999999 999999999999998776 6
Q ss_pred EEEeecCccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 414 AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 414 ~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+||+|||+++...... ......||+.|+|||++. +.++.++||||+||++|||++|+.||....
T Consensus 188 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 251 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251 (504)
T ss_dssp EEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999998775432 233456899999999986 569999999999999999999999998654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=297.66 Aligned_cols=197 Identities=25% Similarity=0.341 Sum_probs=170.5
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCceEEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 346 (498)
..++|+..+.||+|+||.||+++.. +++.||+|+++.... .+.+|++++.++ +||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 3567889999999999999999975 588999999975332 235788888887 799999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCC----CcEEEeecCcc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN----FEAVLCDFGLA 422 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~----~~~ki~DfGl~ 422 (498)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||++.++ +.+||+|||++
T Consensus 95 ~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 95 TELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp ECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 999999999999875 34689999999999999999999999 99999999999998433 35999999999
Q ss_pred ccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 168 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 222 (342)
T 2qr7_A 168 KQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFAN 222 (342)
T ss_dssp EECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred ccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCC
Confidence 87654322 23345689999999999888899999999999999999999999975
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=289.21 Aligned_cols=203 Identities=31% Similarity=0.446 Sum_probs=170.9
Q ss_pred cCCCCCCeeecccceEEEEEEEcCC----cEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEc-CCceEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-SSERIL 345 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~l 345 (498)
.+|+..+.||+|+||.||+|+..++ ..+|+|.++..........+.+|++++++++||||+++++++.. .+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 4577789999999999999996432 35899999866666667889999999999999999999998754 457789
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 105 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999752 34589999999999999999999999 9999999999999999999999999999866
Q ss_pred cccCcc---eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 426 DAKLTH---VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 426 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
...... ......+|+.|+|||.+.+..++.++||||||+++|||+| |..||...
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~ 236 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 236 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC
Confidence 543221 1233457889999999999999999999999999999999 55666543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=297.64 Aligned_cols=198 Identities=24% Similarity=0.341 Sum_probs=163.5
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCC------c
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------E 342 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~ 342 (498)
++|+..+.||+|+||.||+|+.. +++.||||++.... .......+.+|+++++.++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 57888999999999999999964 68899999997432 3345677899999999999999999999997665 6
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcc
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~ 422 (498)
.++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred eEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 7999999985 67777752 488999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 175 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 230 (371)
T 2xrw_A 175 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 8665322 2234568999999999999999999999999999999999999998644
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=285.86 Aligned_cols=202 Identities=24% Similarity=0.364 Sum_probs=169.1
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
.++|.+.+.||+|+||.||+|+.. +++.||+|++.... .......+.+|+++++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 457888999999999999999975 68999999986421 223456889999999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 9999999999999752 3589999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCcceeecccccccccCcccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
... ......+++.|+|||.+.+..+ +.++||||||+++|||++|+.||+...
T Consensus 163 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 215 (276)
T 2h6d_A 163 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215 (276)
T ss_dssp C---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 432 1233468999999999987765 689999999999999999999997643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.51 Aligned_cols=201 Identities=23% Similarity=0.361 Sum_probs=170.9
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
.++|+..+.||+|+||+||+|+.. ++..||+|+++... .......+.+|+++++.++||||+++++++......++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 346888999999999999999975 68899999987432 3344678899999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECC---CCcEEEeecCcccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVLCDFGLAKL 424 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~ki~DfGl~~~ 424 (498)
||+++|+|.+.+.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++.
T Consensus 116 e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999998875 24589999999999999999999999 9999999999999976 44599999999987
Q ss_pred ccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
..... ......||+.|+|||++. ..++.++||||+||++|||++|+.||....
T Consensus 189 ~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 241 (494)
T 3lij_A 189 FENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT 241 (494)
T ss_dssp CBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 65432 233456999999999886 579999999999999999999999998654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=294.91 Aligned_cols=204 Identities=30% Similarity=0.359 Sum_probs=168.4
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCc----chHHHHHHHHHHHHhccCCccceEEEEEEcCCce
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP----GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 343 (498)
..++|+..+.||+|+||.||+|+.. +++.||+|+++..... .....+.+|++++++++||||+++++++...+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4568999999999999999999964 5899999998743211 1234688999999999999999999999999999
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
++||||+++ +|...+... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 88 ~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEEECCSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEEcCCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999986 888877642 34688999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCcceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
....... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~ 217 (346)
T 1ua2_A 161 SFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS 217 (346)
T ss_dssp TTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 7654322 22345689999999998764 58899999999999999999999997654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=289.35 Aligned_cols=205 Identities=20% Similarity=0.280 Sum_probs=160.5
Q ss_pred HhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHH-HHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~-~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
..++|+..+.||+|+||.||+|+. .+++.||+|+++.......... +.++...++.++||||+++++++...+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 346788899999999999999996 4788999999975543333333 44444557788999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|||++ |+|.+.+.........+++..+..++.|++.||+|||+.+ +++||||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99998 4888877654334567999999999999999999999853 79999999999999999999999999998765
Q ss_pred ccCcceeecccccccccCcccc----cCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYL----STGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
.... .....||+.|+|||.+ .+..++.++||||||+++|||+||+.||+.
T Consensus 162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 162 DDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred cccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 4322 2334689999999996 566789999999999999999999999975
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=292.22 Aligned_cols=206 Identities=28% Similarity=0.370 Sum_probs=173.5
Q ss_pred HhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEE----cCCce
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT----TSSER 343 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~ 343 (498)
..++|+..+.||+|+||.||+++. .+++.||+|++... .......+.+|++++++++||||+++++++. .....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 346788899999999999999996 57899999998642 3456678999999999999999999999987 33467
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
++|+||+++|+|.+++.........+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 899999999999999986544456799999999999999999999999 99999999999999999999999999987
Q ss_pred cccccCcc--------eeecccccccccCcccccCCC---CCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 424 LVDAKLTH--------VTTQIRGTMGHIAPEYLSTGK---SSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 424 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
........ ......||+.|+|||.+.... ++.++||||||+++|||++|+.||+.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 65421111 012244799999999987654 68899999999999999999999964
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=289.62 Aligned_cols=200 Identities=23% Similarity=0.348 Sum_probs=173.6
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.++|...+.||+|+||.||+++.. +++.||+|+++... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP-AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc-ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 457888999999999999999975 68999999997432 2344678899999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEE---CCCCcEEEeecCccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~ki~DfGl~~~~ 425 (498)
|+++++|.+.+.. ...+++..+..++.|++.||+|||+. +++||||||+||++ ++++.+||+|||+++..
T Consensus 87 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 9999999998875 23589999999999999999999999 99999999999999 78899999999998755
Q ss_pred cccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.... .....||+.|+|||.+.+..++.++||||||+++|||+||+.||....
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 211 (304)
T 2jam_A 160 QNGI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET 211 (304)
T ss_dssp CCBT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CCCc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 4321 233458999999999999999999999999999999999999997543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=294.45 Aligned_cols=209 Identities=29% Similarity=0.387 Sum_probs=175.5
Q ss_pred HhcCCCCCCeeecccceEEEEEEE------cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCc
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 342 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 342 (498)
..++|...+.||+|+||.||+|++ .++..||+|++...........+.+|+.++++++||||+++++++.....
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 346788999999999999999984 24678999999765556677889999999999999999999999999999
Q ss_pred eEEEEecccCCCHHHhhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECC---CCcEEE
Q 010887 343 RILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVL 416 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~ki 416 (498)
.++||||+++++|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+||+++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999986432 124589999999999999999999999 9999999999999984 456999
Q ss_pred eecCccccccccCc-ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 417 CDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 417 ~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 250 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC
Confidence 99999876543222 12234557899999999998999999999999999999999 999997643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=290.89 Aligned_cols=204 Identities=25% Similarity=0.382 Sum_probs=171.9
Q ss_pred HhcCCCCCC-eeecccceEEEEEEEc---CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCce
Q 010887 269 ATDNFSESN-IIGQGGFGKVYKGVLS---DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (498)
Q Consensus 269 ~~~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 343 (498)
..++|...+ .||+|+||.||+|.+. +++.||||+++... .+...+.+.+|++++++++||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 345677777 9999999999999642 46789999997543 233467899999999999999999999999 56678
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 93 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 999999999999999986 34589999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCccee--ecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 424 LVDAKLTHVT--TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 424 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
.......... ....+++.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 225 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 7654433222 22346788999999988889999999999999999999 999998643
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=303.31 Aligned_cols=199 Identities=27% Similarity=0.348 Sum_probs=164.5
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCC------ce
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------ER 343 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~ 343 (498)
.+|+..+.||+|+||.||+|+.. +++.||||++.... ..+.+|++++++++||||+++++++.... ..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 35777899999999999999975 58999999986432 12347999999999999999999885422 25
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCC-CcEEEeecCcc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLA 422 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~ki~DfGl~ 422 (498)
++||||+++ ++...+.........+++..+..++.||++||+|||+. +|+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhh
Confidence 689999986 56666554333356799999999999999999999999 99999999999999955 57899999999
Q ss_pred ccccccCcceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 205 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~ 261 (420)
T 1j1b_A 205 KQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 261 (420)
T ss_dssp EECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 87654322 2345689999999998765 78999999999999999999999998644
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=285.16 Aligned_cols=197 Identities=27% Similarity=0.407 Sum_probs=169.8
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEc----CCceEE
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT----SSERIL 345 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~l 345 (498)
.|...+.||+|+||.||+|... ++..||+|++... ........+.+|++++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 3666788999999999999964 5788999998743 344566789999999999999999999998865 345789
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEEcCCCCCcEEEC-CCCcEEEeecCcc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK--IIHRDLKAANILLD-DNFEAVLCDFGLA 422 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlk~~NILl~-~~~~~ki~DfGl~ 422 (498)
||||+++++|.+++... ..+++..+..++.|++.||+|||+. + ++||||||+||+++ +++.+||+|||++
T Consensus 107 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 99999999999999763 4589999999999999999999998 7 99999999999997 7899999999999
Q ss_pred ccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
....... .....||+.|+|||.+. +.++.++||||||+++|||+||+.||...
T Consensus 180 ~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 232 (290)
T 1t4h_A 180 TLKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp GGCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence 7554332 23456899999999886 46899999999999999999999999753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=295.21 Aligned_cols=211 Identities=27% Similarity=0.361 Sum_probs=160.1
Q ss_pred HHHhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 267 QLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
....++|+..+.||+|+||.||+|.. .+++.||+|++...........+.+|++++++++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 44567899999999999999999995 46889999998754444556788999999999999999999999999999999
Q ss_pred EEecccCCCHHHhhcccC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCc
Q 010887 346 VYPFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl 421 (498)
||||+++++|.+++.... .....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 999999999999987421 1234689999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCc----ceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 422 AKLVDAKLT----HVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 422 ~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+........ .......||+.|+|||.+.+ ..++.++||||||+++|||+||+.||....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 231 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP 231 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCc
Confidence 876643221 11233568999999999875 568999999999999999999999997643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=289.55 Aligned_cols=192 Identities=21% Similarity=0.327 Sum_probs=169.5
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCccceEEEEEEc--CCceEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTT--SSERILV 346 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv 346 (498)
++|+..+.||+|+||.||+|+. .+++.||+|+++. .....+.+|++++++++ ||||+++++++.. ....++|
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 5788899999999999999995 5789999999863 34578899999999997 9999999999987 5568999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCC-cEEEeecCccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCDFGLAKLV 425 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~ki~DfGl~~~~ 425 (498)
|||+++++|.+.+.. +++.++..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++..
T Consensus 112 ~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 999999999988753 78899999999999999999999 999999999999999776 8999999999876
Q ss_pred cccCcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 426 DAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
..... .....+|..|+|||.+.+ ..++.++|||||||++|||+||+.||..
T Consensus 182 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 182 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 54322 234568999999999877 6789999999999999999999999954
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=317.25 Aligned_cols=197 Identities=26% Similarity=0.390 Sum_probs=166.6
Q ss_pred CeeecccceEEEEEEEc---CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccC
Q 010887 277 NIIGQGGFGKVYKGVLS---DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN 352 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (498)
+.||+|+||.||+|.+. .++.||||+++... .....++|.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 45789999998532 34456889999999999999999999999964 457899999999
Q ss_pred CCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcc-
Q 010887 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH- 431 (498)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~- 431 (498)
|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999975 34689999999999999999999999 9999999999999999999999999999876543321
Q ss_pred -eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcc
Q 010887 432 -VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRL 481 (498)
Q Consensus 432 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~~ 481 (498)
......+|+.|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~ 578 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 578 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 1223446789999999999999999999999999999999 9999986543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=288.18 Aligned_cols=197 Identities=26% Similarity=0.388 Sum_probs=169.7
Q ss_pred hcCCCCCCeeecccceEEEEEEEcC-C-------cEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCC
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLSD-N-------TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS 341 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 341 (498)
.++|...+.||+|+||.||+|+... + ..||+|++... .....+.+.+|++++++++||||+++++++...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG-GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 3568889999999999999999643 3 47999998643 3355678999999999999999999999999999
Q ss_pred ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCc--------
Q 010887 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE-------- 413 (498)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~-------- 413 (498)
..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccce
Confidence 999999999999999999862 23489999999999999999999999 9999999999999998887
Q ss_pred EEEeecCccccccccCcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCC-CCCCC
Q 010887 414 AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQ-RAIDF 478 (498)
Q Consensus 414 ~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~-~p~~~ 478 (498)
+||+|||++...... ....+|+.|+|||.+.+ ..++.++||||||+++|||+||. .|+..
T Consensus 160 ~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~ 221 (289)
T 4fvq_A 160 IKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221 (289)
T ss_dssp EEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred eeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc
Confidence 999999998755432 23457889999999987 67899999999999999999955 45543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=290.27 Aligned_cols=202 Identities=24% Similarity=0.368 Sum_probs=168.8
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-------CcchHHHHHHHHHHHHhccCCccceEEEEEEcC
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-------SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS 340 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 340 (498)
..++|.+.+.||+|+||.||+|+.. +++.||||++.... .......+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467889999999999999999965 57899999986432 112234688999999999999999999998765
Q ss_pred CceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCc---EEEe
Q 010887 341 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE---AVLC 417 (498)
Q Consensus 341 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~ki~ 417 (498)
. .++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEc
Confidence 5 8999999999999998874 35689999999999999999999999 9999999999999987664 9999
Q ss_pred ecCccccccccCcceeecccccccccCccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 418 DFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 418 DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
|||+++...... ......||+.|+|||++. ...++.++|||||||++|||+||+.||....
T Consensus 160 Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (322)
T 2ycf_A 160 DFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223 (322)
T ss_dssp CCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred cCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 999998765421 223456899999999973 5678999999999999999999999997543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=299.01 Aligned_cols=199 Identities=24% Similarity=0.341 Sum_probs=164.9
Q ss_pred cCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCc------eE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE------RI 344 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~ 344 (498)
.+|...+.||+|+||.||+|+...+..+|+|++..... ...+|+++++.++||||+++++++..... .+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 46888999999999999999988877899998864322 12379999999999999999999965443 77
Q ss_pred EEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEEC-CCCcEEEeecCccc
Q 010887 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAK 423 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~ki~DfGl~~ 423 (498)
+||||++++.+.. +.........+++..+..++.|+++||+|||+. +|+||||||+|||++ +++.+||+|||+++
T Consensus 115 lv~e~~~~~l~~~-~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 115 LVLEYVPETVYRA-SRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEECCSEEHHHH-HHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeeccCccHHHH-HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 9999998754433 332222345699999999999999999999999 999999999999998 79999999999998
Q ss_pred cccccCcceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 191 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 246 (394)
T 4e7w_A 191 ILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES 246 (394)
T ss_dssp ECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 7654322 2345689999999998765 58999999999999999999999998654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=300.99 Aligned_cols=199 Identities=22% Similarity=0.302 Sum_probs=173.0
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhc------cCCccceEEEEEEcCCc
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA------IHKNLLQLIGYCTTSSE 342 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~ 342 (498)
..+|+..+.||+|+||.||+|+.. +++.||||+++.. ......+.+|+++++.+ +|+||+++++++.....
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 356888999999999999999965 5789999999742 34456788899998887 46799999999999999
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCc--EEEeecC
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE--AVLCDFG 420 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~--~ki~DfG 420 (498)
.++||||+. ++|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecc
Confidence 999999996 68988887633 34589999999999999999999999 9999999999999999887 9999999
Q ss_pred ccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 421 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 248 ~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 248 SSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 99765432 234568999999999999999999999999999999999999998654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=296.34 Aligned_cols=201 Identities=21% Similarity=0.228 Sum_probs=164.9
Q ss_pred hcCCCCCCeeecccceEEEEEEEc----CCcEEEEEEecccCCcc----------hHHHHHHHHHHHHhccCCccceEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPG----------GEAAFQREVHLISVAIHKNLLQLIG 335 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~l~h~niv~l~~ 335 (498)
.++|...+.||+|+||.||+|+.. .+..+|+|++....... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 356888999999999999999975 56789999987433211 1234667888899999999999999
Q ss_pred EEEc----CCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCC
Q 010887 336 YCTT----SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN 411 (498)
Q Consensus 336 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~ 411 (498)
++.. ....++||||+ +++|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence 9987 67889999999 99999998863 2689999999999999999999999 99999999999999887
Q ss_pred C--cEEEeecCccccccccCcc------eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 412 F--EAVLCDFGLAKLVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 412 ~--~~ki~DfGl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
+ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 7 9999999999876533211 11335689999999999999999999999999999999999999964
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=297.61 Aligned_cols=198 Identities=25% Similarity=0.369 Sum_probs=155.4
Q ss_pred hcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEcC------C
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------S 341 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 341 (498)
.++|+..+.||+|+||.||+|.. .+++.||+|++... ........+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 36788899999999999999995 46889999999743 2334567889999999999999999999999764 4
Q ss_pred ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCc
Q 010887 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (498)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl 421 (498)
..++|+||+ +++|.+++.. ..+++..+..++.||++||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 578999999 6788877753 4589999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 234 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9865432 234568999999999877 678999999999999999999999998654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=289.18 Aligned_cols=204 Identities=28% Similarity=0.419 Sum_probs=172.4
Q ss_pred HhcCCCCCCeeecccceEEEEEEE--cCCcEEEEEEecccC-CcchHHHHHHHHHHHHhc---cCCccceEEEEEE----
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVL--SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVA---IHKNLLQLIGYCT---- 338 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~---- 338 (498)
..++|+..+.||+|+||.||+|+. .+++.||+|+++... .......+.+|+++++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 456899999999999999999997 467899999987432 222234566787777766 8999999999987
Q ss_pred -cCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEe
Q 010887 339 -TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLC 417 (498)
Q Consensus 339 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~ 417 (498)
.....++||||++ |+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 4567889999998 69999987643 34589999999999999999999999 99999999999999999999999
Q ss_pred ecCccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 418 DFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 418 DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
|||+++...... ......||+.|+|||++.+..++.++||||||+++|||+||+.||....
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 223 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999998665322 2234568999999999999999999999999999999999999998644
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=282.97 Aligned_cols=202 Identities=21% Similarity=0.267 Sum_probs=168.8
Q ss_pred HhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEE-EcCCceEEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC-TTSSERILV 346 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv 346 (498)
..++|+..+.||+|+||.||+|+. .+++.||+|++.... ....+.+|+++++.++|++++..+.++ ...+..++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc---cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 357899999999999999999996 578899999876432 223578899999999988877777666 556678999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEE---CCCCcEEEeecCccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAK 423 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~ki~DfGl~~ 423 (498)
|||+ +++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||+++
T Consensus 84 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EECC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEcc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 9999 99999998743 24589999999999999999999999 99999999999999 788999999999998
Q ss_pred cccccCcc------eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 424 LVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 424 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
........ ......||+.|+|||.+.+..++.++|||||||++|||+||+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence 76543321 1234568999999999999999999999999999999999999998643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=285.49 Aligned_cols=197 Identities=25% Similarity=0.399 Sum_probs=171.6
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEc--------
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-------- 339 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 339 (498)
..++|+..+.||+|+||.||+|+.. +++.||+|+++... ..+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 3456888999999999999999975 78999999987432 356789999999999999999998854
Q ss_pred --------CCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCC
Q 010887 340 --------SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN 411 (498)
Q Consensus 340 --------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~ 411 (498)
....++||||+++++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT 158 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC
Confidence 344789999999999999997532 34689999999999999999999999 99999999999999999
Q ss_pred CcEEEeecCccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 010887 412 FEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 477 (498)
Q Consensus 412 ~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~ 477 (498)
+.+||+|||++........ .....||+.|+|||.+.+..++.++||||||+++|||+||..|+.
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp TEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred CCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 9999999999987654322 233468999999999999999999999999999999999998874
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-35 Score=288.53 Aligned_cols=199 Identities=28% Similarity=0.409 Sum_probs=164.2
Q ss_pred HHHHHHhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhc--cCCccceEEEEEEcC-
Q 010887 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA--IHKNLLQLIGYCTTS- 340 (498)
Q Consensus 264 ~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~- 340 (498)
.......++|+..+.||+|+||.||+|+.. ++.||||++.. .....+.+|.+++... +||||+++++++...
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~----~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT----TEEASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEG----GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEec----cccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 333445678999999999999999999985 89999999864 2344556666666554 899999999999877
Q ss_pred ---CceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCcEEcCCCCCcEEECCCC
Q 010887 341 ---SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC-----NPKIIHRDLKAANILLDDNF 412 (498)
Q Consensus 341 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivH~Dlk~~NILl~~~~ 412 (498)
...++||||+++|+|.++++. ..+++..+..++.|++.||+|||+.+ .++|+||||||+||+++.++
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred CCCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence 678999999999999999975 35899999999999999999999752 34799999999999999999
Q ss_pred cEEEeecCccccccccCcce---eecccccccccCcccccCCCCCCc------ccchhHHHHHHHHHhC
Q 010887 413 EAVLCDFGLAKLVDAKLTHV---TTQIRGTMGHIAPEYLSTGKSSEK------TDVFGYGITLLELVTG 472 (498)
Q Consensus 413 ~~ki~DfGl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~s~Gvvl~elltG 472 (498)
.+||+|||+++......... .....||+.|+|||++.+..++.+ +|||||||++|||+||
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg 248 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence 99999999997665433221 124568999999999988776665 9999999999999999
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=292.41 Aligned_cols=203 Identities=27% Similarity=0.355 Sum_probs=175.5
Q ss_pred hcCCCCCCeeecccceEEEEEEE-----cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEc--CCc
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT--SSE 342 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~ 342 (498)
.++|+..+.||+|+||.||+|++ .+++.||+|++... .....+.+.+|++++++++||||+++++++.. ...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 35788899999999999999984 35789999999753 34556779999999999999999999999874 455
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcc
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~ 422 (498)
.++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred EEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccc
Confidence 789999999999999997532 3589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcc--eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 423 KLVDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 423 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
+........ ......+|..|+|||.+.+..++.++||||||+++|||+||+.||...
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 233 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP 233 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccc
Confidence 877543322 123345788899999999888999999999999999999999998653
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=282.29 Aligned_cols=201 Identities=21% Similarity=0.268 Sum_probs=171.6
Q ss_pred hcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEE-EcCCceEEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC-TTSSERILVY 347 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 347 (498)
.++|+..+.||+|+||.||+|+. .+++.||+|++.... ....+.+|+++++.++|++++..+.++ ......++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS---SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc---chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 46788899999999999999996 578999999986432 234688999999999998877766666 5566779999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEE---CCCCcEEEeecCcccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKL 424 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~ki~DfGl~~~ 424 (498)
||+ +++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||+++.
T Consensus 85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 999 99999999742 34689999999999999999999999 99999999999999 4888999999999987
Q ss_pred ccccCcc------eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 425 VDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 425 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
....... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence 6544321 1234568999999999999999999999999999999999999998643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=294.15 Aligned_cols=202 Identities=24% Similarity=0.335 Sum_probs=175.8
Q ss_pred hcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCc--c--------------hHHHHHHHHHHHHhccCCccceE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP--G--------------GEAAFQREVHLISVAIHKNLLQL 333 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~--------------~~~~~~~e~~~l~~l~h~niv~l 333 (498)
.++|...+.||+|+||.||+|.. +++.||+|++...... . ....+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46788999999999999999999 8999999998632111 1 12789999999999999999999
Q ss_pred EEEEEcCCceEEEEecccCCCHHHh------hcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEEcCCCCCcE
Q 010887 334 IGYCTTSSERILVYPFMQNLSVAYR------LRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANI 406 (498)
Q Consensus 334 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlk~~NI 406 (498)
++++...+..++||||+++++|.++ +... ....+++..+..++.|++.||+|||+ . +++||||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence 9999999999999999999999988 4321 14579999999999999999999999 8 999999999999
Q ss_pred EECCCCcEEEeecCccccccccCcceeecccccccccCcccccCC-CCCC-cccchhHHHHHHHHHhCCCCCCCCc
Q 010887 407 LLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSE-KTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 407 Ll~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+++.++.+||+|||.+...... ......||+.|+|||.+.+. .++. ++||||||+++|||+||+.||....
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999876543 23445689999999999887 6666 9999999999999999999998643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=286.10 Aligned_cols=201 Identities=26% Similarity=0.360 Sum_probs=172.3
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
..++|+..+.||+|+||.||+|... +++.||+|++... .....+.+|++++.+++||||+++++++...+..++||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE---SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT---SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch---HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 4567899999999999999999975 5899999998743 23467899999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++++|.+++... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 104 e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 104 EYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp ECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 999999999998732 34689999999999999999999999 999999999999999999999999999986654
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 178 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 228 (314)
T 3com_A 178 TMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228 (314)
T ss_dssp TBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred hcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 322 223456899999999999999999999999999999999999999754
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=292.01 Aligned_cols=202 Identities=24% Similarity=0.389 Sum_probs=172.3
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcC-----Cce
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-----SER 343 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 343 (498)
.++|+..+.||+|+||.||+|+.. +++.||||+++..........+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 457888999999999999999975 68899999997655555667889999999999999999999988754 568
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
++|+||+. ++|.+.+.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999997 589888875 3589999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCcc---------eeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 424 LVDAKLTH---------VTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 424 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
........ ......||+.|+|||++.. ..++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 76532211 1123468999999998754 678999999999999999999999998654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=298.49 Aligned_cols=198 Identities=8% Similarity=0.032 Sum_probs=153.8
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCC--cchHHHHHHHHHHHHhc--cCCccceEE-------EEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS--PGGEAAFQREVHLISVA--IHKNLLQLI-------GYCT 338 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l--~h~niv~l~-------~~~~ 338 (498)
.+|...+.||+|+||.||+|+.. +++.||+|+++.... ......+.+|+++++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45788999999999999999965 688999999985432 23456777886555555 599988755 4443
Q ss_pred cC-----------------CceEEEEecccCCCHHHhhcccCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCC
Q 010887 339 TS-----------------SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTR------KRVAFGTAYGLEYLHEQCNPK 395 (498)
Q Consensus 339 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~~L~yLH~~~~~~ 395 (498)
.. ...++||||++ |+|.+++.... ..+++..+ ..++.||+.||+|||+. +
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ 214 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSK---G 214 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence 32 23799999999 89999998632 23455555 78889999999999999 9
Q ss_pred cEEcCCCCCcEEECCCCcEEEeecCccccccccCcceeecccccccccCcccccC--CCCCCcccchhHHHHHHHHHhCC
Q 010887 396 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQ 473 (498)
Q Consensus 396 ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gvvl~elltG~ 473 (498)
|+||||||+|||+++++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||+||+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999866432 224456799999999987 67999999999999999999999
Q ss_pred CCCCCC
Q 010887 474 RAIDFS 479 (498)
Q Consensus 474 ~p~~~~ 479 (498)
.||...
T Consensus 291 ~Pf~~~ 296 (371)
T 3q60_A 291 LPFGLV 296 (371)
T ss_dssp CSTTBC
T ss_pred CCCCCc
Confidence 999865
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=293.92 Aligned_cols=209 Identities=22% Similarity=0.275 Sum_probs=162.8
Q ss_pred HHHHHHhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCc
Q 010887 264 RELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 342 (498)
Q Consensus 264 ~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 342 (498)
.+.....++|+..+.||+|+||.||+|+.. +++.||||++.... .....+.+|++.++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP--RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT--TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc--cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 445667789999999999999999999974 68999999986432 223456788888999999999999999976443
Q ss_pred -------eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCcEEcCCCCCcEEECC-CC
Q 010887 343 -------RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH--EQCNPKIIHRDLKAANILLDD-NF 412 (498)
Q Consensus 343 -------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--~~~~~~ivH~Dlk~~NILl~~-~~ 412 (498)
.++||||+++ ++...+.........+++..+..++.|++.||.||| +. +|+||||||+||+++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence 7899999986 555444433334567899999999999999999999 77 9999999999999986 89
Q ss_pred cEEEeecCccccccccCcceeecccccccccCcccccCCC-CCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 413 EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 413 ~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.+||+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|||+||+.||....
T Consensus 170 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 236 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236 (360)
T ss_dssp EEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC
Confidence 999999999987654332 23456899999999986654 8999999999999999999999998654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=289.66 Aligned_cols=205 Identities=27% Similarity=0.349 Sum_probs=174.3
Q ss_pred CHHHHHHHhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHh--ccCCccceEEEEEEc
Q 010887 262 SCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISV--AIHKNLLQLIGYCTT 339 (498)
Q Consensus 262 ~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~ 339 (498)
+........++|...+.||+|+||.||+|+. +++.||+|+++. .....+.+|.+++.. ++||||+++++++..
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 3344455667899999999999999999998 589999999864 345678889999887 789999999999988
Q ss_pred CC----ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCcEEcCCCCCcEE
Q 010887 340 SS----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH--------EQCNPKIIHRDLKAANIL 407 (498)
Q Consensus 340 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~ivH~Dlk~~NIL 407 (498)
.. ..++||||+++|+|.+++.. ..+++.++..++.|++.||+||| +. +|+||||||+||+
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIl 179 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNIL 179 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEE
T ss_pred cCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEE
Confidence 76 78999999999999999975 35899999999999999999999 66 9999999999999
Q ss_pred ECCCCcEEEeecCccccccccCcc---eeecccccccccCcccccCCC------CCCcccchhHHHHHHHHHhC------
Q 010887 408 LDDNFEAVLCDFGLAKLVDAKLTH---VTTQIRGTMGHIAPEYLSTGK------SSEKTDVFGYGITLLELVTG------ 472 (498)
Q Consensus 408 l~~~~~~ki~DfGl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~Gvvl~elltG------ 472 (498)
+++++.+||+|||++......... ......||+.|+|||.+.+.. ++.++||||||+++|||+||
T Consensus 180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 259 (342)
T 1b6c_B 180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259 (342)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence 999999999999999876544322 123456899999999997652 34689999999999999999
Q ss_pred ----CCCCCCC
Q 010887 473 ----QRAIDFS 479 (498)
Q Consensus 473 ----~~p~~~~ 479 (498)
+.||...
T Consensus 260 ~~~~~~p~~~~ 270 (342)
T 1b6c_B 260 HEDYQLPYYDL 270 (342)
T ss_dssp CCCCCCTTTTT
T ss_pred ccccccCcccc
Confidence 7787643
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=291.77 Aligned_cols=207 Identities=27% Similarity=0.392 Sum_probs=170.2
Q ss_pred HHHHHhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEEc---
Q 010887 265 ELQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT--- 339 (498)
Q Consensus 265 el~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~--- 339 (498)
++....++|+..+.||+|+||.||+|+. .+++.||+|++... ......+.+|+++++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC--cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 3344567899999999999999999997 46889999998643 23457889999999999 79999999999976
Q ss_pred ---CCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEE
Q 010887 340 ---SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL 416 (498)
Q Consensus 340 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki 416 (498)
....++||||+++++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEE
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEE
Confidence 457899999999999999998632 34689999999999999999999999 9999999999999999999999
Q ss_pred eecCccccccccCcceeecccccccccCccccc-----CCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 417 CDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 417 ~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
+|||++........ ......||+.|+|||.+. ...++.++||||||+++|||+||+.||...
T Consensus 171 ~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 237 (326)
T 2x7f_A 171 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237 (326)
T ss_dssp CCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred eeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 99999886653221 123356899999999987 567899999999999999999999999754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=297.05 Aligned_cols=197 Identities=19% Similarity=0.238 Sum_probs=169.8
Q ss_pred cCCCCCCeeecccceEEEEEEEcC---------CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccce---------
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLSD---------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ--------- 332 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~--------- 332 (498)
++|...+.||+|+||.||+|+... ++.||+|++... ..+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 578889999999999999999764 788999998643 35789999999999999988
Q ss_pred ------EEEEEEc-CCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCc
Q 010887 333 ------LIGYCTT-SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAAN 405 (498)
Q Consensus 333 ------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~N 405 (498)
+++++.. ....++||||+ +++|.+++.... ...+++.++..++.|++.||+|||+. +|+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence 6777766 67789999999 999999998632 25699999999999999999999999 99999999999
Q ss_pred EEECCCC--cEEEeecCccccccccCcc------eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 010887 406 ILLDDNF--EAVLCDFGLAKLVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 477 (498)
Q Consensus 406 ILl~~~~--~~ki~DfGl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~ 477 (498)
|+++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||+||+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 9999999999876543221 1133468999999999999999999999999999999999999998
Q ss_pred CC
Q 010887 478 FS 479 (498)
Q Consensus 478 ~~ 479 (498)
..
T Consensus 270 ~~ 271 (352)
T 2jii_A 270 NC 271 (352)
T ss_dssp GG
T ss_pred cC
Confidence 64
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=282.83 Aligned_cols=203 Identities=24% Similarity=0.333 Sum_probs=175.8
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCC--------cchHHHHHHHHHHHHhcc-CCccceEEEEEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS--------PGGEAAFQREVHLISVAI-HKNLLQLIGYCT 338 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~ 338 (498)
..++|+..+.||+|+||.||+|... +++.||+|+++.... ......+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3467888999999999999999975 688999999864321 122467889999999996 999999999999
Q ss_pred cCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEee
Q 010887 339 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 418 (498)
Q Consensus 339 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~D 418 (498)
.....++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence 99999999999999999999976 34689999999999999999999999 999999999999999999999999
Q ss_pred cCccccccccCcceeecccccccccCccccc------CCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS------TGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 419 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
||++........ .....|++.|+|||++. ...++.++||||||+++|||++|+.||....
T Consensus 168 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 233 (298)
T 1phk_A 168 FGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233 (298)
T ss_dssp CTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc
Confidence 999987654322 23456899999999985 4568899999999999999999999997543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=282.16 Aligned_cols=202 Identities=25% Similarity=0.392 Sum_probs=170.3
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
++|.....||+|+||.||+|.. .+++.||+|++... .......+.+|+++++.++||||+++++++...+..++||||
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC-CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC-chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 3455567999999999999996 46789999998754 234567899999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECC-CCcEEEeecCcccccccc
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~ki~DfGl~~~~~~~ 428 (498)
+++++|.+++.... ....+++..+..++.|++.||+|||+. +++||||||+||+++. ++.+||+|||++......
T Consensus 101 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 101 VPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp CSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred CCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 99999999998632 234577899999999999999999999 9999999999999987 899999999999866532
Q ss_pred CcceeecccccccccCcccccCCC--CCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
.. ......||+.|+|||.+.+.. ++.++||||||+++|||+||+.||..
T Consensus 177 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (295)
T 2clq_A 177 NP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 227 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred CC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence 21 123456899999999987643 78999999999999999999999964
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=282.31 Aligned_cols=205 Identities=25% Similarity=0.360 Sum_probs=171.4
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC---CcchHHHHHHHHHHHHhccCCccceEEEEEEc--CCce
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY---SPGGEAAFQREVHLISVAIHKNLLQLIGYCTT--SSER 343 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 343 (498)
.++|.+.+.||+|+||.||+|... +++.||+|+++... .......+.+|++++++++||||+++++++.. ....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999964 68899999987431 23456789999999999999999999999853 4578
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
++||||++++ +.+.+.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999987 666666433 35689999999999999999999999 99999999999999999999999999998
Q ss_pred cccccC-cceeecccccccccCcccccCCC--CCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 424 LVDAKL-THVTTQIRGTMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 424 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
...... ........||+.|+|||++.+.. ++.++||||||+++|||+||+.||+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch
Confidence 765322 22233456899999999987644 3779999999999999999999998644
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=314.82 Aligned_cols=209 Identities=22% Similarity=0.352 Sum_probs=175.7
Q ss_pred HHHHHhcCCCCCCeeecccceEEEEEEEcC----CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcC
Q 010887 265 ELQLATDNFSESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS 340 (498)
Q Consensus 265 el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 340 (498)
+.....++|+..+.||+|+||.||+|.+.. +..||+|+++..........|.+|+.++++++||||+++++++. .
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 334455778889999999999999999743 45799999876555566688999999999999999999999985 4
Q ss_pred CceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecC
Q 010887 341 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (498)
Q Consensus 341 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 420 (498)
+..++||||+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecC
Confidence 5689999999999999999752 34589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 421 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
+++..............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 597 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 597 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 998775543333334557789999999998999999999999999999997 999997643
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-35 Score=292.45 Aligned_cols=197 Identities=26% Similarity=0.406 Sum_probs=167.6
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCce----
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER---- 343 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~---- 343 (498)
.++|...+.||+|+||.||+|... +++.||+|+++... .......+.+|+++++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 357888999999999999999964 68899999997533 334467889999999999999999999999887654
Q ss_pred --EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCc
Q 010887 344 --ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (498)
Q Consensus 344 --~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl 421 (498)
++||||+. ++|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999998 57777663 2489999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 246 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 246 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9865432 234568999999999887 678999999999999999999999998644
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=284.66 Aligned_cols=204 Identities=25% Similarity=0.368 Sum_probs=171.6
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
..++|++.+.||+|+||.||+|+.. +++.||+|++... .......+.+|++++++++||||+++++++...+..++||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC-CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 3467888999999999999999975 5889999998643 3355678999999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 96 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 96 EFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp ECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred EeCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 999999999988753 24589999999999999999999999 999999999999999999999999998764322
Q ss_pred cCcceeecccccccccCcccc-----cCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYL-----STGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.. .......||+.|+|||.+ ....++.++||||||+++|||+||+.||....
T Consensus 170 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 226 (302)
T 2j7t_A 170 TL-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226 (302)
T ss_dssp HH-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cc-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 11 112334689999999998 46678999999999999999999999997643
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=283.81 Aligned_cols=199 Identities=29% Similarity=0.392 Sum_probs=166.0
Q ss_pred HhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcC-CceEEEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-SERILVY 347 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~ 347 (498)
..++|+..+.||+|+||.||+|.. .++.||+|+++.. ...+.+.+|++++++++||||+++++++... +..++||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch---hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 346788899999999999999987 5889999998743 3567899999999999999999999997655 4689999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred ecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 9999999999997532 22378999999999999999999999 999999999999999999999999999875543
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
.. ....+++.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 170 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 219 (278)
T 1byg_A 170 TQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred cc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 21 22346889999999998999999999999999999999 999998654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=288.20 Aligned_cols=202 Identities=26% Similarity=0.377 Sum_probs=173.9
Q ss_pred hcCCCCCCeeecccceEEEEEEE-----cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCC--c
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS--E 342 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~ 342 (498)
.++|+..+.||+|+||.||++++ .+++.||+|++... .......+.+|++++++++||||+++++++...+ .
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 45678899999999999999984 36889999999753 3456678999999999999999999999987654 6
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcc
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~ 422 (498)
.++||||+++++|.+++... ...+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred eEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcch
Confidence 78999999999999999863 24589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcce--eecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 423 KLVDAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 423 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
+......... .....++..|+|||.+.+..++.++||||||+++|||+||+.|+..
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 8775443221 1234467789999999988899999999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=285.99 Aligned_cols=199 Identities=22% Similarity=0.326 Sum_probs=173.4
Q ss_pred hcCCCCCCeeecccceEEEEEEE--cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCc------cceEEEEEEcCC
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVL--SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN------LLQLIGYCTTSS 341 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~ 341 (498)
.++|++.+.||+|+||.||+|.. .+++.||+|+++.. ......+.+|+++++.++|++ ++++++++...+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 35788899999999999999996 36789999999642 345677899999999988765 999999999999
Q ss_pred ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECC-----------
Q 010887 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD----------- 410 (498)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~----------- 410 (498)
..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred cEEEEEcCC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcc
Confidence 999999999 889999987632 34689999999999999999999999 9999999999999987
Q ss_pred --------CCcEEEeecCccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 411 --------NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 411 --------~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||+||+.||....
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred ccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 668999999999865432 233568999999999999999999999999999999999999998654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=293.94 Aligned_cols=200 Identities=23% Similarity=0.294 Sum_probs=169.8
Q ss_pred hcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhcc--------CCccceEEEEEE--
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI--------HKNLLQLIGYCT-- 338 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~-- 338 (498)
.++|.+.+.||+|+||+||+|+. .+++.||+|+++.. ......+.+|+++++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 46799999999999999999996 46789999999642 345678899999999986 788999999987
Q ss_pred --cCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCC----
Q 010887 339 --TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF---- 412 (498)
Q Consensus 339 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~---- 412 (498)
.....++||||+ ++++.+.+.... ...+++..+..++.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhh
Confidence 556789999999 556666665422 346999999999999999999999864 799999999999998775
Q ss_pred ---------------------------------------------cEEEeecCccccccccCcceeecccccccccCccc
Q 010887 413 ---------------------------------------------EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 447 (498)
Q Consensus 413 ---------------------------------------------~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~ 447 (498)
.+||+|||+++..... .....||+.|+|||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChh
Confidence 7999999999876543 233468999999999
Q ss_pred ccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 448 LSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 448 ~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+.+..++.++|||||||++|||+||+.||+...
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 999999999999999999999999999998644
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=288.86 Aligned_cols=205 Identities=25% Similarity=0.327 Sum_probs=157.5
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCccceEEEEEEc-------
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTT------- 339 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~------- 339 (498)
...+|+..+.||+|+||.||+|+.. +++.||+|++... .......+.+|++++.++. ||||+++++++..
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 3457888999999999999999964 6899999998643 3355678899999999996 9999999999942
Q ss_pred -CCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEEcCCCCCcEEECCCCcEEE
Q 010887 340 -SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK--IIHRDLKAANILLDDNFEAVL 416 (498)
Q Consensus 340 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlk~~NILl~~~~~~ki 416 (498)
....++|+||+. |+|.+++..... ...+++.++..++.|++.||+|||+. + |+||||||+||++++++.+||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEB
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEE
Confidence 334789999996 799888875332 34699999999999999999999998 7 999999999999999999999
Q ss_pred eecCccccccccCcce-----------eecccccccccCcccc---cCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 417 CDFGLAKLVDAKLTHV-----------TTQIRGTMGHIAPEYL---STGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 417 ~DfGl~~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
+|||+++......... .....||+.|+|||++ .+..++.++||||||+++|||+||+.||+..
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 9999998765432211 1134589999999998 5667899999999999999999999999753
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=280.54 Aligned_cols=202 Identities=26% Similarity=0.360 Sum_probs=175.1
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
..++|++.+.||+|+||.||+|+.. +++.||+|++... ........+.+|++++++++||||+++++++......++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 4567999999999999999999975 6889999998643 2345678899999999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCC---CcEEEeecCccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN---FEAVLCDFGLAK 423 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~ki~DfGl~~ 423 (498)
+||+++++|.+.+... ..+++.++..++.|++.||+|||+. +++||||||+||+++.+ +.+||+|||++.
T Consensus 100 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 100 GELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp ECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999888752 3589999999999999999999999 99999999999999754 479999999998
Q ss_pred cccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 424 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
....... .....+|+.|+|||.+.+ .++.++||||||+++|||+||+.||....
T Consensus 173 ~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (287)
T 2wei_A 173 CFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (287)
T ss_dssp TBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC
Confidence 6654322 223457899999998865 58999999999999999999999997643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=297.32 Aligned_cols=201 Identities=23% Similarity=0.347 Sum_probs=153.9
Q ss_pred CCCC-CCeeecccceEEEEEEEc---CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEc--CCceEE
Q 010887 272 NFSE-SNIIGQGGFGKVYKGVLS---DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT--SSERIL 345 (498)
Q Consensus 272 ~~~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 345 (498)
.|++ .++||+|+||.||+|+.. +++.||+|++.... ....+.+|++++++++||||+++++++.. ....++
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS---CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC---CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 3444 558999999999999965 47889999997432 23568899999999999999999999954 567899
Q ss_pred EEecccCCCHHHhhcccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEE----CCCCcEEE
Q 010887 346 VYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVL 416 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~ki 416 (498)
||||+++ +|.+.+.... .....+++..+..++.||+.||+|||+. +|+||||||+|||+ ++++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 7777765321 1223589999999999999999999999 99999999999999 77889999
Q ss_pred eecCccccccccCc--ceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 417 CDFGLAKLVDAKLT--HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 417 ~DfGl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||+||+.||...
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 99999987654322 122346789999999999874 5899999999999999999999999754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=290.05 Aligned_cols=200 Identities=29% Similarity=0.445 Sum_probs=161.4
Q ss_pred HhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHH--HHhccCCccceEEEEEEc-----CC
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHL--ISVAIHKNLLQLIGYCTT-----SS 341 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~-----~~ 341 (498)
..++|+..+.||+|+||.||+|+. +++.||||+++. .....+..|.++ +..++||||+++++.+.. ..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~----~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSF----ANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEG----GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeec----cchhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 346788899999999999999987 689999999864 233445555555 445899999999986532 22
Q ss_pred ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCcEEcCCCCCcEEECCCCcEE
Q 010887 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC------NPKIIHRDLKAANILLDDNFEAV 415 (498)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~ivH~Dlk~~NILl~~~~~~k 415 (498)
..++||||+++|+|.+++... ..++..+..++.|+++||+|||+.+ .++|+||||||+|||++.++.+|
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred eEEEEEecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 468999999999999999752 3589999999999999999999863 33799999999999999999999
Q ss_pred EeecCccccccccCc-------ceeecccccccccCcccccC-------CCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 416 LCDFGLAKLVDAKLT-------HVTTQIRGTMGHIAPEYLST-------GKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 416 i~DfGl~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
|+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 999999987653221 11223568999999999976 3567789999999999999999877654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=283.64 Aligned_cols=201 Identities=23% Similarity=0.377 Sum_probs=163.9
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEE----------
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT---------- 338 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~---------- 338 (498)
.++|...+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 357888999999999999999976 4889999998643 3456678999999999999999999999874
Q ss_pred ----cCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEEC-CCCc
Q 010887 339 ----TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFE 413 (498)
Q Consensus 339 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~ 413 (498)
.....++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++ +++.
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCe
Confidence 3356789999998 699988863 4589999999999999999999999 999999999999997 5679
Q ss_pred EEEeecCccccccccCcc--eeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 414 AVLCDFGLAKLVDAKLTH--VTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 414 ~ki~DfGl~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+||+|||+++........ ......+|..|+|||.+.. ..++.++||||||+++|||+||+.||....
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 229 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence 999999999876532211 1233457899999998865 678999999999999999999999998654
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=283.02 Aligned_cols=203 Identities=24% Similarity=0.314 Sum_probs=169.4
Q ss_pred HHhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEeccc-CCcchHHHHHHHHHHHHhcc--CCccceEEEEEEcCCceE
Q 010887 268 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAI--HKNLLQLIGYCTTSSERI 344 (498)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~ 344 (498)
...++|++.+.||+|+||.||++...+++.||+|++... ........+.+|++++.+++ ||||+++++++...+..+
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 345678889999999999999999888999999998743 33445678999999999997 599999999999999999
Q ss_pred EEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccc
Q 010887 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~ 424 (498)
+||| +.+++|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||++++ +.+||+|||+++.
T Consensus 105 lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQ 175 (313)
T ss_dssp EEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred EEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccccc
Confidence 9999 678899999986 34689999999999999999999999 9999999999999964 8999999999987
Q ss_pred ccccCcc-eeecccccccccCcccccC-----------CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 425 VDAKLTH-VTTQIRGTMGHIAPEYLST-----------GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 425 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
....... ......||+.|+|||.+.+ ..++.++||||||+++|||+||+.||...
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 6543222 1234568999999999875 46888999999999999999999999753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=287.56 Aligned_cols=196 Identities=27% Similarity=0.404 Sum_probs=166.4
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCc------
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE------ 342 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------ 342 (498)
++|...+.||+|+||.||+|+.. +++.||||++.... .......+.+|++++++++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 56888999999999999999964 68899999997543 33446788999999999999999999999987654
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcc
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~ 422 (498)
.++||||++ ++|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 104 ~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred EEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999998 57776653 2489999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 423 KLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+..... .....+|+.|+|||.+.+ ..++.++||||||+++|||+||+.||....
T Consensus 174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 865432 233568999999999877 678999999999999999999999998644
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=283.64 Aligned_cols=204 Identities=30% Similarity=0.386 Sum_probs=164.9
Q ss_pred hcCCCCCCeeecccceEEEEEEEc--CCc--EEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCce
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS--DNT--KVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 343 (498)
.++|+..+.||+|+||+||+|++. +++ .||+|+++... .+...+.+.+|++++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357888999999999999999853 233 68999887432 3345678999999999999999999999998765 8
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
++|+||+++++|.+++... ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 8999999999999998753 24589999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCcce--eecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 424 LVDAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 424 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
......... .....+|..|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 229 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC
Confidence 775443221 223457789999999988889999999999999999999 999997543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=283.54 Aligned_cols=205 Identities=25% Similarity=0.358 Sum_probs=154.0
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHH-HHHhccCCccceEEEEEEcCCceEEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
.++|...+.||+|+||.||+|... +++.||+|+++..........+.+|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467888999999999999999974 688999999986554455566677776 677789999999999999999999999
Q ss_pred ecccCCCHHHhhccc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 348 PFMQNLSVAYRLRDL-KPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 348 e~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
||+++ +|.+.+... ......+++..+..++.|++.||.|||+.. +++||||||+||+++.++.+||+|||+++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 99985 777766531 112456899999999999999999999852 79999999999999999999999999998665
Q ss_pred ccCcceeecccccccccCcccc----cCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYL----STGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.... .....||+.|+|||.+ .+..++.++||||||+++|||+||+.||...
T Consensus 178 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (327)
T 3aln_A 178 DSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred cccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 4322 2234689999999998 4567899999999999999999999999753
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=288.21 Aligned_cols=202 Identities=24% Similarity=0.287 Sum_probs=171.9
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhcc-CC-----ccceEEEEEEcCC
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HK-----NLLQLIGYCTTSS 341 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~~ 341 (498)
..++|+..+.||+|+||+||+|+.. +++.||||+++.. .....++.+|+++++.++ |+ +|+++++++...+
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 4578999999999999999999965 5788999999742 234567788999998885 55 4999999999999
Q ss_pred ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEEC--CCCcEEEeec
Q 010887 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD--DNFEAVLCDF 419 (498)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~--~~~~~ki~Df 419 (498)
..++||||++ ++|.+++.... ...+++..+..++.|++.||.|||.. ..+|+||||||+|||++ .++.+||+||
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred ceEEEEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 9999999996 59999988633 24589999999999999999999952 12899999999999994 5778999999
Q ss_pred CccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 420 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
|+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 206 G~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 206 GSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999876542 234568999999999999999999999999999999999999998654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-34 Score=293.68 Aligned_cols=201 Identities=21% Similarity=0.275 Sum_probs=171.2
Q ss_pred hcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccC-CccceEEEEEEcCCceEEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH-KNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 347 (498)
.++|.+.+.||+|+||.||+|+. .+++.||||++..... ..++.+|+++++.++| +++..+..++...+..++||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS---SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc---cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 36788999999999999999996 5689999998864322 2357899999999987 55666666667778889999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEE---CCCCcEEEeecCcccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKL 424 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~ki~DfGl~~~ 424 (498)
||+ +++|.+++... ...+++.+++.++.||+.||+|||+. +|+||||||+|||+ ++++.+||+|||+++.
T Consensus 83 e~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ECC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 999 99999999753 24599999999999999999999999 99999999999999 6889999999999987
Q ss_pred ccccCcc------eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 425 VDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 425 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~ 217 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 7544322 1224669999999999999999999999999999999999999998643
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=289.05 Aligned_cols=209 Identities=26% Similarity=0.423 Sum_probs=171.6
Q ss_pred HHHHHHHhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCC
Q 010887 263 CRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS 341 (498)
Q Consensus 263 ~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 341 (498)
.+++.+..++|+..+.||+|+||.||+|+... .+|+|+++... .....+.+.+|++++++++||||+++++++...+
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34445566789999999999999999999754 49999987432 2334466788999999999999999999999999
Q ss_pred ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCc
Q 010887 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (498)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl 421 (498)
..++|+||+++++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++ ++.+||+|||+
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred ceEEEeecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCC
Confidence 999999999999999998752 34689999999999999999999999 999999999999998 67999999999
Q ss_pred cccccccC----cceeecccccccccCcccccC---------CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 422 AKLVDAKL----THVTTQIRGTMGHIAPEYLST---------GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 422 ~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
++...... ........||+.|+|||.+.. ..++.++||||||+++|||+||+.||....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 247 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 87553211 111223458999999999864 457889999999999999999999998644
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=294.15 Aligned_cols=200 Identities=25% Similarity=0.299 Sum_probs=157.5
Q ss_pred CCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCceEEEEecc
Q 010887 272 NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFM 350 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 350 (498)
.|...+.||+|+||+||.+...+++.||||++.. .....+.+|++++.++ +||||+++++++.+....++||||+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~----~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI----DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEG----GGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcH----HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 3444688999999999877777899999999864 2345678999999886 8999999999999999999999999
Q ss_pred cCCCHHHhhcccCCCCCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCC-------------CcE
Q 010887 351 QNLSVAYRLRDLKPGEKG---LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-------------FEA 414 (498)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-------------~~~ 414 (498)
+ |+|.+++......... .++..+..++.||+.||+|||+. +|+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 6999999854322111 13345678999999999999999 99999999999999654 589
Q ss_pred EEeecCccccccccCcc---eeecccccccccCcccccC-------CCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 415 VLCDFGLAKLVDAKLTH---VTTQIRGTMGHIAPEYLST-------GKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 415 ki~DfGl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||...
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 99999999877643322 1234569999999999865 678999999999999999999 99999754
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=285.97 Aligned_cols=205 Identities=23% Similarity=0.378 Sum_probs=173.2
Q ss_pred HHHHHhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCc-----chHHHHHHHHHHHHhcc--CCccceEEEE
Q 010887 265 ELQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSP-----GGEAAFQREVHLISVAI--HKNLLQLIGY 336 (498)
Q Consensus 265 el~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~--h~niv~l~~~ 336 (498)
+.....++|+..+.||+|+||.||+|+. .+++.||+|+++..... .....+.+|++++++++ ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 3344567899999999999999999995 46889999998743221 12345678999999996 5999999999
Q ss_pred EEcCCceEEEEecccC-CCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEEC-CCCcE
Q 010887 337 CTTSSERILVYPFMQN-LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFEA 414 (498)
Q Consensus 337 ~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~ 414 (498)
+...+..++|+||+.+ ++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++ +++.+
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~ 189 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGEL 189 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEE
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCE
Confidence 9999999999999986 899999876 34689999999999999999999999 999999999999998 78999
Q ss_pred EEeecCccccccccCcceeecccccccccCcccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 415 VLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 415 ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
||+|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||+||+.||+..
T Consensus 190 kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 190 KLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp EECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred EEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 999999998765432 233568999999999987766 67899999999999999999999753
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=311.40 Aligned_cols=193 Identities=22% Similarity=0.335 Sum_probs=167.9
Q ss_pred hcCCCCCCeeecccceEEEEEEEc--CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCc-----
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS--DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE----- 342 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 342 (498)
.++|++.+.||+|+||.||+|++. +++.||||++...........+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 367889999999999999999975 5899999998765555566789999999999999999999999987665
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcc
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~ 422 (498)
.++||||+++++|.+.+.. .+++.++..++.||+.||+|||+. +|+||||||+||+++++ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccc
Confidence 6999999999999876543 589999999999999999999999 99999999999999886 8999999999
Q ss_pred ccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
+..... ....||+.|+|||++.+.. +.++|||||||++|||++|..||..
T Consensus 229 ~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 229 SRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp EETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred hhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcc
Confidence 876543 3356899999999987654 8899999999999999999998875
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=281.44 Aligned_cols=199 Identities=21% Similarity=0.310 Sum_probs=171.0
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CC-cEEEEEEecccCCcchHHHHHHHHHHHHhccCCc------cceEEEEEEcCC
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DN-TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN------LLQLIGYCTTSS 341 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~ 341 (498)
.++|++.+.||+|+||.||+|... ++ +.||+|+++.. ......+.+|++++++++|++ ++.+.+++...+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 467889999999999999999964 34 68999999642 345677889999999998766 899999999999
Q ss_pred ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEE-------------
Q 010887 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL------------- 408 (498)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl------------- 408 (498)
..++||||+ ++++.+.+.... ...+++.++..++.||+.||+|||+. +|+||||||+||++
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eEEEEEecc-CCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccc
Confidence 999999999 567777766422 34689999999999999999999999 99999999999999
Q ss_pred ------CCCCcEEEeecCccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 409 ------DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 409 ------~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 56789999999999865432 233568999999999999999999999999999999999999998644
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=282.42 Aligned_cols=204 Identities=23% Similarity=0.337 Sum_probs=164.6
Q ss_pred HHHHHhcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCc-----chHHHHHHHHHHHHhc----cCCccceEE
Q 010887 265 ELQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSP-----GGEAAFQREVHLISVA----IHKNLLQLI 334 (498)
Q Consensus 265 el~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l----~h~niv~l~ 334 (498)
+.....++|...+.||+|+||.||+|+. .+++.||+|+++..... .....+.+|++++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3344567899999999999999999995 46889999999643221 1234566799999998 899999999
Q ss_pred EEEEcCCceEEEEec-ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEEC-CCC
Q 010887 335 GYCTTSSERILVYPF-MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNF 412 (498)
Q Consensus 335 ~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~ 412 (498)
+++...+..++|+|| +.+++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++ +++
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTT
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCC
Confidence 999999999999999 789999999986 23589999999999999999999999 999999999999998 889
Q ss_pred cEEEeecCccccccccCcceeecccccccccCcccccCCCCC-CcccchhHHHHHHHHHhCCCCCCC
Q 010887 413 EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS-EKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 413 ~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
.+||+|||+++...... .....||..|+|||++.+..+. .++||||||+++|||+||+.||..
T Consensus 178 ~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp EEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred eEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 99999999998765432 2345689999999998877664 589999999999999999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=304.32 Aligned_cols=204 Identities=25% Similarity=0.377 Sum_probs=176.2
Q ss_pred hcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEc------CCc
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT------SSE 342 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 342 (498)
.++|++.+.||+|+||.||+|.. .+++.||+|+++..........+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 36899999999999999999996 46889999999866566667889999999999999999999998765 567
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCc---EEEeec
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE---AVLCDF 419 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~ki~Df 419 (498)
.++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence 7999999999999999986432 34689999999999999999999999 9999999999999987664 999999
Q ss_pred CccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 420 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
|.+....... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||...
T Consensus 169 G~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~ 226 (676)
T 3qa8_A 169 GYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226 (676)
T ss_dssp CCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcc
Confidence 9998765432 223456899999999999999999999999999999999999999753
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-34 Score=277.29 Aligned_cols=194 Identities=27% Similarity=0.389 Sum_probs=161.5
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEc---------
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT--------- 339 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------- 339 (498)
.++|+..+.||+|+||.||+|+.. +++.||+|+++. .......+.+|++++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH--TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE--EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec--cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 457888999999999999999964 789999999864 23456788999999999999999999998865
Q ss_pred ----CCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEE
Q 010887 340 ----SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV 415 (498)
Q Consensus 340 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 415 (498)
....++||||+++++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence 34678999999999999999852 24578899999999999999999999 999999999999999999999
Q ss_pred EeecCccccccccC-------------cceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHh
Q 010887 416 LCDFGLAKLVDAKL-------------THVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVT 471 (498)
Q Consensus 416 i~DfGl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~ellt 471 (498)
|+|||++....... ........||+.|+|||.+.+. .++.++||||||+++|||++
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 99999998664321 1112335689999999999764 68999999999999999998
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-34 Score=281.48 Aligned_cols=198 Identities=22% Similarity=0.285 Sum_probs=145.7
Q ss_pred hcCCCCC-CeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEc----CCce
Q 010887 270 TDNFSES-NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT----SSER 343 (498)
Q Consensus 270 ~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 343 (498)
.++|.+. +.||+|+||.||+|+.. +++.||+|++... .....+....++.++||||+++++++.. ....
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 4577774 46999999999999976 6899999998642 1222223334567789999999999876 3457
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECC---CCcEEEeecC
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVLCDFG 420 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~ki~DfG 420 (498)
++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 89999999999999998632 34699999999999999999999999 9999999999999976 4559999999
Q ss_pred ccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 421 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+++...... .....+|+.|+|||++.+..++.++||||||+++|||+||+.||....
T Consensus 177 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (336)
T 3fhr_A 177 FAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNT 233 (336)
T ss_dssp TCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred cceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 998665322 233567999999999988889999999999999999999999997543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=284.68 Aligned_cols=200 Identities=22% Similarity=0.343 Sum_probs=168.8
Q ss_pred hcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhcc-----------CCccceEEEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-----------HKNLLQLIGYC 337 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~ 337 (498)
.++|...+.||+|+||.||+|+. .+++.||+|+++. .......+.+|++++++++ ||||+++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG--DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC--CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 35788899999999999999996 4688999999864 2345677889999999886 89999999998
Q ss_pred EcCC----ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEEC----
Q 010887 338 TTSS----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD---- 409 (498)
Q Consensus 338 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~---- 409 (498)
...+ ..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+++ +|+||||||+||+++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEET
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCC
Confidence 7654 678999999 899999988643 345899999999999999999999953 799999999999994
Q ss_pred --CCCcEEEeecCccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 410 --DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 410 --~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||+...
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred CcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 4558999999999876542 223468999999999999999999999999999999999999998543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=288.21 Aligned_cols=193 Identities=17% Similarity=0.162 Sum_probs=163.3
Q ss_pred hcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccC-------CcchHHHHHHHHHHHHhcc---------CCccceE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-------SPGGEAAFQREVHLISVAI---------HKNLLQL 333 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~l~---------h~niv~l 333 (498)
.++|+..+.||+|+||+||+|+. +++.||||+++... .....+.+.+|++++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45688899999999999999998 78999999997432 2334578999999999886 8888888
Q ss_pred EEEEE------------------------------cCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHH
Q 010887 334 IGYCT------------------------------TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 383 (498)
Q Consensus 334 ~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~ 383 (498)
.+.+. ..+..++||||+++|++.+.+.. ..+++.++..++.||+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence 77653 26778999999999987776643 45899999999999999
Q ss_pred HHHHHH-hcCCCCcEEcCCCCCcEEECCCC--------------------cEEEeecCccccccccCcceeecccccccc
Q 010887 384 GLEYLH-EQCNPKIIHRDLKAANILLDDNF--------------------EAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 442 (498)
Q Consensus 384 ~L~yLH-~~~~~~ivH~Dlk~~NILl~~~~--------------------~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y 442 (498)
||+||| +. +|+||||||+|||++.++ .+||+|||+++..... ...||+.|
T Consensus 173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y 243 (336)
T 2vuw_A 173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence 999999 88 999999999999999887 8999999999876542 23689999
Q ss_pred cCcccccCCCCCCcccchhHHHH-HHHHHhCCCCCCC
Q 010887 443 IAPEYLSTGKSSEKTDVFGYGIT-LLELVTGQRAIDF 478 (498)
Q Consensus 443 ~aPE~~~~~~~~~~~Dv~s~Gvv-l~elltG~~p~~~ 478 (498)
+|||++.+.. +.++||||++++ .+++++|..||..
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 9999998766 889999998777 7789999999853
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=275.84 Aligned_cols=200 Identities=23% Similarity=0.344 Sum_probs=150.8
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHH-HHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~-~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
.++|+..+.||+|+||.||+|+.. +++.||+|++........... +.++..+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 456888899999999999999975 689999999975544333333 444455678889999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
||+ ++.+....... ...+++..+..++.|+++||+|||+ . +++||||||+||+++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 44444444321 3468999999999999999999998 5 79999999999999999999999999997665
Q ss_pred ccCcceeecccccccccCccccc-----CCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
.... .....||+.|+|||.+. ...++.++||||||+++|||+||+.||..
T Consensus 177 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (318)
T 2dyl_A 177 DDKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCcc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence 4321 23346899999999984 45688999999999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=289.63 Aligned_cols=200 Identities=26% Similarity=0.345 Sum_probs=158.8
Q ss_pred HhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCceEEEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 347 (498)
...+|...+.||+|+||+||.....+++.||||++..... ..+.+|+++++++ +||||+++++++.+....++||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 3446788899999999997665566899999999964321 2356899999999 7999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECC-----CCcEEEeecCcc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-----NFEAVLCDFGLA 422 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-----~~~~ki~DfGl~ 422 (498)
||+. |+|.+++.... ....+..+..++.||++||+|||+. +|+||||||+||+++. ...+||+|||++
T Consensus 98 E~~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp ECCS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred ECCC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9997 59999987532 2344455678999999999999999 9999999999999943 336889999999
Q ss_pred ccccccCc--ceeecccccccccCccccc---CCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 423 KLVDAKLT--HVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 423 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
+....... .......||+.|+|||++. ...++.++|||||||++|||+| |+.||...
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~ 233 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence 87654322 1233466999999999997 4567889999999999999999 99999643
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-32 Score=264.20 Aligned_cols=174 Identities=10% Similarity=0.032 Sum_probs=151.8
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCC--cchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|++.+.||+|+||.||+|+.. +++.||+|+++.... ......|.+|++.+.+++||||+++++++...+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57888999999999999999975 489999999975433 334578999999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++++|.+++.. .....++.+++.|++.||+|||+. +|+||||||+||++++++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~------~~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EecCCCCHHHHHhc------CCChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 99999999999853 135557889999999999999999 99999999999999999999997443
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCcc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRL 481 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~~ 481 (498)
|++ .++.++|||||||++|||+||+.||.....
T Consensus 175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~ 207 (286)
T 3uqc_A 175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGV 207 (286)
T ss_dssp --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 333 367899999999999999999999986543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.4e-33 Score=281.81 Aligned_cols=203 Identities=15% Similarity=0.097 Sum_probs=155.5
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCC--cchHHHHHHHHHHHHhccC-Cccc---------eEEEE-
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIH-KNLL---------QLIGY- 336 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h-~niv---------~l~~~- 336 (498)
..|...+.||+|+||.||+|++ .+++.||||+++.... ....+.|.+|+.+++.++| +|.. .....
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 3466678999999999999995 4689999999873322 2335789999999999987 2211 11111
Q ss_pred -----------EEc-----CCceEEEEecccCCCHHHhhccc---CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcE
Q 010887 337 -----------CTT-----SSERILVYPFMQNLSVAYRLRDL---KPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 397 (498)
Q Consensus 337 -----------~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iv 397 (498)
... ....+++|++ .+++|.+++... ......+++..+..++.|+++||+|||+. +|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 111 1134556665 468998888522 22345588899999999999999999999 999
Q ss_pred EcCCCCCcEEECCCCcEEEeecCccccccccCcceeecccccccccCcccc----------cCCCCCCcccchhHHHHHH
Q 010887 398 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL----------STGKSSEKTDVFGYGITLL 467 (498)
Q Consensus 398 H~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~s~Gvvl~ 467 (498)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999998865443 334567 999999999 5556888999999999999
Q ss_pred HHHhCCCCCCCCccc
Q 010887 468 ELVTGQRAIDFSRLE 482 (498)
Q Consensus 468 elltG~~p~~~~~~~ 482 (498)
||+||+.||......
T Consensus 309 elltg~~Pf~~~~~~ 323 (413)
T 3dzo_A 309 WIWCADLPNTDDAAL 323 (413)
T ss_dssp HHHHSSCCCCTTGGG
T ss_pred HHHHCCCCCCCcchh
Confidence 999999999865443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-31 Score=257.32 Aligned_cols=175 Identities=23% Similarity=0.351 Sum_probs=149.9
Q ss_pred cCCCCC-CeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHH-HhccCCccceEEEEEEc----CCce
Q 010887 271 DNFSES-NIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLI-SVAIHKNLLQLIGYCTT----SSER 343 (498)
Q Consensus 271 ~~~~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~ 343 (498)
++|... +.||+|+||.||+|.. .+++.||+|+++. ...+.+|++++ +..+||||+++++++.. ....
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 456655 7899999999999996 4688999999863 24567888887 55689999999999876 5678
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECC---CCcEEEeecC
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVLCDFG 420 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~ki~DfG 420 (498)
++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 99999999999999998632 34699999999999999999999999 9999999999999998 7899999999
Q ss_pred ccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 421 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
++.... +..++.++|||||||++|||+||+.||...
T Consensus 166 ~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~ 201 (299)
T 3m2w_A 166 FAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSN 201 (299)
T ss_dssp TCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred cccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 986432 234677899999999999999999999754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-30 Score=272.43 Aligned_cols=185 Identities=13% Similarity=0.049 Sum_probs=130.0
Q ss_pred eecccceEEEEEE-EcCCcEEEEEEecccC---------CcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCceEEEE
Q 010887 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYY---------SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 279 lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---------~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 347 (498)
...|+.|.+..++ ..-|+.+++|++.... .+...++|.+|+++|+++ .|+||+++++++.+++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4456666666555 3458889999986432 123346799999999999 6999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||++|++|.+.+.. ..+++.. +|+.||+.||+|+|++ +||||||||+|||+++++.+||+|||+++....
T Consensus 322 Eyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999986 3445543 5899999999999999 999999999999999999999999999987654
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCC
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRA 475 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p 475 (498)
... ......||++|||||++.+ ++..++|+||+|++++++.++..+
T Consensus 392 ~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 332 2345679999999999865 567789999999998877665433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.1e-27 Score=247.35 Aligned_cols=186 Identities=15% Similarity=0.191 Sum_probs=147.7
Q ss_pred CCCCeeecccceEEEEEEEcCCcEEEEEEecccCCc-c------hHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 274 SESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP-G------GEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 274 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
...+.||+|+||.||+|.. .++.+++|+....... . ..+.|.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3467899999999999954 5788888886532211 1 134589999999999999999777777778888999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|||+++++|.+++.. +..++.|+++||+|||++ +|+||||||+|||+++ .+||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999875 458999999999999999 9999999999999998 99999999999876
Q ss_pred ccCcce------eecccccccccCcccccC--CCCCCcccchhHHHHHHHHHhCCCCCC
Q 010887 427 AKLTHV------TTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAID 477 (498)
Q Consensus 427 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gvvl~elltG~~p~~ 477 (498)
...... .....||+.|||||++.. ..|+..+|+|+..+-..+-+.++.+|.
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 533221 234679999999999976 567888999999999999988887764
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.90 E-value=7.6e-24 Score=207.73 Aligned_cols=149 Identities=27% Similarity=0.499 Sum_probs=135.7
Q ss_pred CCChhHHHHHHHHHHHccCCCCCCCCCCCCCCCCCCC--cceeEecC----CceeEEEecccccCc--cccccccccCCC
Q 010887 31 REPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFS--WSHVTCRN----GNVISLTLGSNGFSG--KISPSITKLKFL 102 (498)
Q Consensus 31 ~~~~~~~~al~~~~~~~~~~~~~l~~w~~~~~~~c~~--w~gv~c~~----~~v~~l~l~~~~l~g--~~~~~~~~l~~L 102 (498)
.|.+.|++||++||+++.||. .+.+|... ++||. |.||+|+. ++|+.|+|++|+++| .+|+.|+++++|
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~~--~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L 78 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPT--TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTT--SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCCC--CCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCC
Confidence 578899999999999999886 78899764 45557 99999985 699999999999999 999999999999
Q ss_pred CeEEccC-CCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCCCCcCcccCCchhh---ccccccccC
Q 010887 103 ASLELQD-NDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF---SVATFNFTG 178 (498)
Q Consensus 103 ~~L~l~~-n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~---~~~~~~~~~ 178 (498)
++|+|++ |.+.|.+|..|+++++|++|+|++|+++|.+|..|.++++|++|+|++|.++|.+|..+. ++..+++++
T Consensus 79 ~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 158 (313)
T 1ogq_A 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCS
T ss_pred CeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcC
Confidence 9999995 999999999999999999999999999999999999999999999999999999998765 557788888
Q ss_pred Cccc
Q 010887 179 THLI 182 (498)
Q Consensus 179 n~~~ 182 (498)
|...
T Consensus 159 N~l~ 162 (313)
T 1ogq_A 159 NRIS 162 (313)
T ss_dssp SCCE
T ss_pred Cccc
Confidence 8753
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-23 Score=202.40 Aligned_cols=153 Identities=13% Similarity=0.045 Sum_probs=120.3
Q ss_pred HHHHHHhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCc-----------------chHHHHHHHHHHHHhcc
Q 010887 264 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP-----------------GGEAAFQREVHLISVAI 326 (498)
Q Consensus 264 ~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~e~~~l~~l~ 326 (498)
..+......|+..+.||+|+||.||+|...+++.||+|.++..... .....+.+|++++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 3344445566677999999999999999977999999999632211 13567899999999998
Q ss_pred CCccceEEEEEEcCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcE
Q 010887 327 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANI 406 (498)
Q Consensus 327 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NI 406 (498)
| +++.+++. .+..++||||+++++|.+ +.. .....++.|++.||+|||+. +|+||||||+||
T Consensus 163 ~---~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NI 224 (282)
T 1zar_A 163 G---LAVPKVYA-WEGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNV 224 (282)
T ss_dssp T---SSSCCEEE-EETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSE
T ss_pred C---CCcCeEEe-ccceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHE
Confidence 4 55555443 356799999999999987 421 12457999999999999999 999999999999
Q ss_pred EECCCCcEEEeecCccccccccCcceeecccccccccCccccc
Q 010887 407 LLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 449 (498)
Q Consensus 407 Ll~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 449 (498)
|++ ++.+||+|||+++. +..|+|||++.
T Consensus 225 Ll~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp EEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred EEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 999 99999999999863 33467888874
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=6.3e-22 Score=217.44 Aligned_cols=152 Identities=27% Similarity=0.368 Sum_probs=123.3
Q ss_pred cCCCCChhHHHHHHHHHHHccCCCCCCCCCCCCCCCCCCCcceeEecCCceeEEEecccccCcc---cc-----------
Q 010887 28 HSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGK---IS----------- 93 (498)
Q Consensus 28 ~~~~~~~~~~~al~~~~~~~~~~~~~l~~w~~~~~~~c~~w~gv~c~~~~v~~l~l~~~~l~g~---~~----------- 93 (498)
+++.+.+.|++||++||+++.||. .+.+|... ++||.|.||+|+.++|+.|+|++++++|. +|
T Consensus 5 ~~~~~~~~~~~all~~k~~~~~~~-~l~~W~~~--~~~C~w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~ 81 (768)
T 3rgz_A 5 SPSQSLYREIHQLISFKDVLPDKN-LLPDWSSN--KNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLES 81 (768)
T ss_dssp ---CCHHHHHHHHHHHHTTCSCTT-SSTTCCTT--SCGGGSTTEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCE
T ss_pred ccccCCHHHHHHHHHHHhhCCCcc-cccCCCCC--CCCcCCcceEECCCcEEEEECCCCCcCCccCccChhHhccCcccc
Confidence 344457889999999999999998 89999844 57889999999988999999999999987 55
Q ss_pred ------------ccccccCCCCeEEccCCCCCCccCc--ccccccccceeecccccccCCCCCcc-cCCCCCCeEeCCCC
Q 010887 94 ------------PSITKLKFLASLELQDNDLSGTLPD--FLGSMTHLQSLNLANNKFSGSIPATW-SQLSNLKHLDLSSN 158 (498)
Q Consensus 94 ------------~~~~~l~~L~~L~l~~n~l~g~~p~--~~~~l~~L~~L~l~~N~l~g~~p~~~-~~l~~L~~l~l~~N 158 (498)
+.|+++++|++|||++|.++|.+|. .+++|++|++|||++|.+++.+|..+ .++++|++|+|++|
T Consensus 82 l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n 161 (768)
T 3rgz_A 82 LFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSAN 161 (768)
T ss_dssp EECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSS
T ss_pred cCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCC
Confidence 4677778888888888888888887 88888888888888888888888775 77888888888888
Q ss_pred cCcccCCch------hhccccccccCCccc
Q 010887 159 NLTGRIPMQ------LFSVATFNFTGTHLI 182 (498)
Q Consensus 159 ~l~g~ip~~------~~~~~~~~~~~n~~~ 182 (498)
.+++.+|.. +.++..+++++|...
T Consensus 162 ~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~ 191 (768)
T 3rgz_A 162 SISGANVVGWVLSDGCGELKHLAISGNKIS 191 (768)
T ss_dssp CCEEETHHHHHHTTCCTTCCEEECCSSEEE
T ss_pred ccCCcCChhhhhhccCCCCCEEECCCCccc
Confidence 888777654 345677778887653
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.83 E-value=2.8e-21 Score=212.32 Aligned_cols=147 Identities=22% Similarity=0.339 Sum_probs=127.7
Q ss_pred CCCCChhHHHHHHHHHHHccCCCCCCCCCCCCC----CCCC-CCc------------ceeEecC-CceeEEEecccccCc
Q 010887 29 SSREPDVEGEALIEVLKALNDTHGQFTDWNDHF----VSPC-FSW------------SHVTCRN-GNVISLTLGSNGFSG 90 (498)
Q Consensus 29 ~~~~~~~~~~al~~~~~~~~~~~~~l~~w~~~~----~~~c-~~w------------~gv~c~~-~~v~~l~l~~~~l~g 90 (498)
++++...|++||++||+++.+| +|+.+. .+|| |.| .||+|+. ++|+.|+|++|+|+|
T Consensus 263 ~~~~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G 337 (876)
T 4ecn_A 263 ETAEYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKG 337 (876)
T ss_dssp CCCHHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEE
T ss_pred ccccchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCC
Confidence 3444567999999999999887 786543 3452 699 9999984 799999999999999
Q ss_pred cccccccccCCCCeEEc-cCCCCCCc------------------------------------------------------
Q 010887 91 KISPSITKLKFLASLEL-QDNDLSGT------------------------------------------------------ 115 (498)
Q Consensus 91 ~~~~~~~~l~~L~~L~l-~~n~l~g~------------------------------------------------------ 115 (498)
.+|++|++|++|++|+| ++|.++|.
T Consensus 338 ~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i 417 (876)
T 4ecn_A 338 RVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPI 417 (876)
T ss_dssp EECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCC
T ss_pred cCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccc
Confidence 99999999999999999 77866555
Q ss_pred ----------------------cCcccccccccceeecccccccC-----------------CCCCccc--CCCCCCeEe
Q 010887 116 ----------------------LPDFLGSMTHLQSLNLANNKFSG-----------------SIPATWS--QLSNLKHLD 154 (498)
Q Consensus 116 ----------------------~p~~~~~l~~L~~L~l~~N~l~g-----------------~~p~~~~--~l~~L~~l~ 154 (498)
||.+|++|++|++|+|++|+|+| .+|+.++ ++++|++|+
T Consensus 418 ~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~ 497 (876)
T 4ecn_A 418 KKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVE 497 (876)
T ss_dssp CCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEE
T ss_pred ccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEE
Confidence 89999999999999999999998 4999988 999999999
Q ss_pred CCCCcCcccCCchhh---ccccccccCCc
Q 010887 155 LSSNNLTGRIPMQLF---SVATFNFTGTH 180 (498)
Q Consensus 155 l~~N~l~g~ip~~~~---~~~~~~~~~n~ 180 (498)
|++|++.|.+|..+. ++..+++++|.
T Consensus 498 Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 498 LYNCPNMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp EESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred CcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence 999999999998765 45678888887
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.3e-20 Score=202.40 Aligned_cols=146 Identities=22% Similarity=0.302 Sum_probs=125.7
Q ss_pred CChhHHHHHHHHHHHccCCCCC--------CCCCCCCCCCCCCCc---ceeEecC-CceeEEEecccccCcccccccccc
Q 010887 32 EPDVEGEALIEVLKALNDTHGQ--------FTDWNDHFVSPCFSW---SHVTCRN-GNVISLTLGSNGFSGKISPSITKL 99 (498)
Q Consensus 32 ~~~~~~~al~~~~~~~~~~~~~--------l~~w~~~~~~~c~~w---~gv~c~~-~~v~~l~l~~~~l~g~~~~~~~~l 99 (498)
....|++||.++++++.++... ..+|+.. .+||.| .||+|+. ++|+.|+|++|+++|.+|++|++|
T Consensus 27 ~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~--~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L 104 (636)
T 4eco_A 27 EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN--KELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQL 104 (636)
T ss_dssp HHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCS--SCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGC
T ss_pred hHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC--CCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcC
Confidence 3346999999999999866443 2369864 567799 9999975 699999999999999999999999
Q ss_pred CCCCeEEccCC---------------------------------------------------------------------
Q 010887 100 KFLASLELQDN--------------------------------------------------------------------- 110 (498)
Q Consensus 100 ~~L~~L~l~~n--------------------------------------------------------------------- 110 (498)
++|++|+|++|
T Consensus 105 ~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~ 184 (636)
T 4eco_A 105 TELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLK 184 (636)
T ss_dssp TTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCC
T ss_pred ccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchh
Confidence 99999999988
Q ss_pred ---------CCCCccCcccccccccceeecccccccCC-----------------CCCccc--CCCCCCeEeCCCCcCcc
Q 010887 111 ---------DLSGTLPDFLGSMTHLQSLNLANNKFSGS-----------------IPATWS--QLSNLKHLDLSSNNLTG 162 (498)
Q Consensus 111 ---------~l~g~~p~~~~~l~~L~~L~l~~N~l~g~-----------------~p~~~~--~l~~L~~l~l~~N~l~g 162 (498)
+|+| ||++|+++++|++|+|++|+|+|. +|+.++ ++++|++|+|++|.+.|
T Consensus 185 ~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~ 263 (636)
T 4eco_A 185 DTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLT 263 (636)
T ss_dssp TTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCS
T ss_pred hhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCc
Confidence 4445 899999999999999999999986 999999 99999999999999999
Q ss_pred cCCchhh---ccccccccCCc
Q 010887 163 RIPMQLF---SVATFNFTGTH 180 (498)
Q Consensus 163 ~ip~~~~---~~~~~~~~~n~ 180 (498)
.+|..+. ++..+++++|.
T Consensus 264 ~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 264 KLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp SCCTTTTTCSSCCEEECTTCT
T ss_pred cChHHHhcCCCCCEEECcCCC
Confidence 9998765 55677888887
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.6e-19 Score=171.75 Aligned_cols=139 Identities=19% Similarity=0.166 Sum_probs=107.2
Q ss_pred CCCCCeeecccceEEEEEEE-cCCcE--EEEEEecccCCc-----------------------chHHHHHHHHHHHHhcc
Q 010887 273 FSESNIIGQGGFGKVYKGVL-SDNTK--VAVKRLQDYYSP-----------------------GGEAAFQREVHLISVAI 326 (498)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~-----------------------~~~~~~~~e~~~l~~l~ 326 (498)
|+..+.||+|+||.||+|.. .+|+. ||||+++..... .....+.+|++.+.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 55678999999999999997 78888 999987532111 01236889999999999
Q ss_pred CCcc--ceEEEEEEcCCceEEEEecccC-C----CHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCcEE
Q 010887 327 HKNL--LQLIGYCTTSSERILVYPFMQN-L----SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH-EQCNPKIIH 398 (498)
Q Consensus 327 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ivH 398 (498)
|+++ ..++++ ...++||||+.+ | +|.+.... .++.....++.|++.+|.||| +. +|+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 8864 334432 357899999953 4 55554332 234457789999999999999 88 9999
Q ss_pred cCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 399 RDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 399 ~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
|||||+|||+++ .++|+|||++.....
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~~~ 221 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTLRH 221 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEETTS
T ss_pred CCCCHHHEEEcC--cEEEEECcccccCCC
Confidence 999999999998 999999999976543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1e-18 Score=191.89 Aligned_cols=118 Identities=36% Similarity=0.612 Sum_probs=111.4
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
..++.|+|++|+++|.+|.+|+++++|+.|+|++|+|+|.||.+|++|++|++|||++|+++|.+|..++++++|++|||
T Consensus 632 ~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~l 711 (768)
T 3rgz_A 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDL 711 (768)
T ss_dssp BCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEEC
T ss_pred ccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEEC
Confidence 36889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCcCcccCCc--hhhccccccccCCccccCCCCCCCCCCC
Q 010887 156 SSNNLTGRIPM--QLFSVATFNFTGTHLICGSSLEQPCMSR 194 (498)
Q Consensus 156 ~~N~l~g~ip~--~~~~~~~~~~~~n~~~~~~~~~~~c~~~ 194 (498)
++|+|+|.||. .+.++...+|.||+.+||.++. +|...
T Consensus 712 s~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~~ 751 (768)
T 3rgz_A 712 SNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDPS 751 (768)
T ss_dssp CSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCSC
T ss_pred cCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCCCC
Confidence 99999999996 4677888999999999999886 78643
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.75 E-value=2.8e-19 Score=176.27 Aligned_cols=149 Identities=17% Similarity=0.282 Sum_probs=129.0
Q ss_pred CCCCChhHHHHHHHHHHHc-cCCCCCCCCCC---CCCCCCCCCcceeEecC----------CceeEEEecccccCccccc
Q 010887 29 SSREPDVEGEALIEVLKAL-NDTHGQFTDWN---DHFVSPCFSWSHVTCRN----------GNVISLTLGSNGFSGKISP 94 (498)
Q Consensus 29 ~~~~~~~~~~al~~~~~~~-~~~~~~l~~w~---~~~~~~c~~w~gv~c~~----------~~v~~l~l~~~~l~g~~~~ 94 (498)
...+..+|++||++||.++ .|+.+.+.+|. .. ...||.|.|+.|.. .+|+.|+|++|+++ .+|+
T Consensus 21 ~~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~-~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~ 98 (328)
T 4fcg_A 21 GSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSN-NPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPD 98 (328)
T ss_dssp --CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTT-CTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCS
T ss_pred ccccCchHHHHHHHHHHhccCCchhhhhhhcccccc-cccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcCh
Confidence 3455678999999999998 47777778894 22 24556999999952 68999999999999 9999
Q ss_pred cccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCCCCcCcccCCchh------
Q 010887 95 SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL------ 168 (498)
Q Consensus 95 ~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~------ 168 (498)
.++++++|++|+|++|.++ .+|..++.+++|++|+|++|+++ .+|..++++++|++|+|++|++.+.+|..+
T Consensus 99 ~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~ 176 (328)
T 4fcg_A 99 QAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176 (328)
T ss_dssp CGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-C
T ss_pred hhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccch
Confidence 9999999999999999999 99999999999999999999999 899999999999999999999999999864
Q ss_pred ------hccccccccCCcc
Q 010887 169 ------FSVATFNFTGTHL 181 (498)
Q Consensus 169 ------~~~~~~~~~~n~~ 181 (498)
.++..+++++|..
T Consensus 177 ~~~~~l~~L~~L~L~~n~l 195 (328)
T 4fcg_A 177 GEHQGLVNLQSLRLEWTGI 195 (328)
T ss_dssp CCEEESTTCCEEEEEEECC
T ss_pred hhhccCCCCCEEECcCCCc
Confidence 4567778888765
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.73 E-value=6e-18 Score=153.45 Aligned_cols=125 Identities=26% Similarity=0.398 Sum_probs=109.8
Q ss_pred CCCCC-CCcceeEecC-----------CceeEEEecccccCccccc-cccccCCCCeEEccCCCCCCccCcccccccccc
Q 010887 61 FVSPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQ 127 (498)
Q Consensus 61 ~~~~c-~~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~-~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~ 127 (498)
++..| |.|..+.|+. .+++.|+|++|+|++..+. .|+++++|++|+|++|+|++..|..|..+++|+
T Consensus 2 CP~~C~C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 81 (192)
T 1w8a_A 2 CPAMCHCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQ 81 (192)
T ss_dssp CCTTSEEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCC
T ss_pred cCCCCEECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCC
Confidence 34556 6899999974 2789999999999965554 489999999999999999998899999999999
Q ss_pred eeecccccccCCCCCcccCCCCCCeEeCCCCcCcccCCchhh---ccccccccCCccccCC
Q 010887 128 SLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF---SVATFNFTGTHLICGS 185 (498)
Q Consensus 128 ~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~---~~~~~~~~~n~~~~~~ 185 (498)
+|+|++|+|++..|..|.++++|++|+|++|+|++.+|..+. ++..+++++|++.|.+
T Consensus 82 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 82 ELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp EEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred EEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 999999999988888899999999999999999988887654 6678899999998764
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.3e-17 Score=149.72 Aligned_cols=124 Identities=25% Similarity=0.426 Sum_probs=109.1
Q ss_pred CCCCC-CCcceeEecC-----------CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccce
Q 010887 61 FVSPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQS 128 (498)
Q Consensus 61 ~~~~c-~~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~ 128 (498)
++..| |.|..|.|++ .+++.|+|++|+|+ .+|..|.++++|++|+|++|.|++..|..|..+++|++
T Consensus 4 CP~~C~C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~ 82 (193)
T 2wfh_A 4 CPTECTCLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLT 82 (193)
T ss_dssp CCTTCEEETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred CCCCCEeCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCE
Confidence 45556 6889999974 26899999999999 89999999999999999999999877888999999999
Q ss_pred eecccccccCCCCCcccCCCCCCeEeCCCCcCcccCCch----hhccccccccCCccccCCC
Q 010887 129 LNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ----LFSVATFNFTGTHLICGSS 186 (498)
Q Consensus 129 L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~----~~~~~~~~~~~n~~~~~~~ 186 (498)
|+|++|+|++..|..|.++++|++|+|++|.|+ .+|.. +.++..+++++|++.|.+.
T Consensus 83 L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 83 LILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp EECCSSCCCBCCTTTTTTCTTCCEEECCSSCCC-BCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred EECCCCccCEeCHHHhCCCCCCCEEECCCCCCC-eeChhhhhcCccccEEEeCCCCeecCCc
Confidence 999999999888888999999999999999999 56653 3567889999999998753
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.1e-16 Score=142.99 Aligned_cols=123 Identities=25% Similarity=0.363 Sum_probs=104.5
Q ss_pred CCCC-CCcceeEecC-----------CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCccccccccccee
Q 010887 62 VSPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSL 129 (498)
Q Consensus 62 ~~~c-~~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L 129 (498)
++.| |+|.+|.|+. .+++.|+|++|++++..+..++++++|++|+|++|+|++..|..+..+++|++|
T Consensus 2 p~~C~C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 81 (177)
T 2o6r_A 2 PSRCSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTIL 81 (177)
T ss_dssp CTTCEEETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCEeCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEE
Confidence 3455 6999999974 268999999999996666678999999999999999996666678999999999
Q ss_pred ecccccccCCCCCcccCCCCCCeEeCCCCcCcccCCch----hhccccccccCCccccCC
Q 010887 130 NLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ----LFSVATFNFTGTHLICGS 185 (498)
Q Consensus 130 ~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~----~~~~~~~~~~~n~~~~~~ 185 (498)
+|++|+|++..|..+.++++|++|+|++|.|+ .+|.. +.++..+++++|++.|.+
T Consensus 82 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 82 YLHENKLQSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred ECCCCCccccCHHHhhCCcccCEEECcCCcce-EeCHHHhcCCcccCEEEecCCCeeccC
Confidence 99999999777777899999999999999999 56653 346788999999987753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=2.1e-17 Score=163.76 Aligned_cols=140 Identities=14% Similarity=0.127 Sum_probs=100.1
Q ss_pred CCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCC-------------cchHHHH--------HHHHHHHHhccCCcc
Q 010887 272 NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS-------------PGGEAAF--------QREVHLISVAIHKNL 330 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------~~~~~~~--------~~e~~~l~~l~h~ni 330 (498)
-|++.+.||+|++|.||+|...+|+.||||+++.... ....... .+|...+.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3888999999999999999998999999998753210 0111122 345556666654443
Q ss_pred ceEEEEEEcCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECC
Q 010887 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD 410 (498)
Q Consensus 331 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~ 410 (498)
....-+.. ...++||||++++++...... +....++.|++.+|.|||+. +||||||||.|||+++
T Consensus 176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIRE 240 (397)
T ss_dssp SCCCEEEE--ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEE
T ss_pred CCCeeeec--cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeC
Confidence 22211211 234799999998887543321 12356889999999999998 9999999999999987
Q ss_pred CC----------cEEEeecCcccccc
Q 010887 411 NF----------EAVLCDFGLAKLVD 426 (498)
Q Consensus 411 ~~----------~~ki~DfGl~~~~~ 426 (498)
++ .+.|+||+-+-...
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCCcccccccccceEEEEeCCcccCC
Confidence 76 38999999876544
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.5e-16 Score=147.35 Aligned_cols=123 Identities=22% Similarity=0.295 Sum_probs=101.7
Q ss_pred CCCCCC-CCcceeEecC-----------CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccc
Q 010887 60 HFVSPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQ 127 (498)
Q Consensus 60 ~~~~~c-~~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~ 127 (498)
.++..| |.|..|.|.. .+++.|+|++|+|++..+..|..+++|++|+|++|+|++..|..|..+++|+
T Consensus 4 ~CP~~C~C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~ 83 (220)
T 2v9t_B 4 HCPAACTCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLN 83 (220)
T ss_dssp CSCTTSEEETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCC
T ss_pred CCCCCCEECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCC
Confidence 456667 7899999974 2688999999999966666899999999999999999988899999999999
Q ss_pred eeecccccccCCCCCcccCCCCCCeEeCCCCcCcccCCchh---hccccccccCCccc
Q 010887 128 SLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL---FSVATFNFTGTHLI 182 (498)
Q Consensus 128 ~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~---~~~~~~~~~~n~~~ 182 (498)
+|+|++|+|++..+..|.++++|++|+|++|.|++..|..+ .++..+++++|...
T Consensus 84 ~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 141 (220)
T 2v9t_B 84 SLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141 (220)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred EEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCC
Confidence 99999999995444457889999999999999997666554 45677888888753
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.65 E-value=3.9e-16 Score=145.60 Aligned_cols=118 Identities=25% Similarity=0.299 Sum_probs=101.9
Q ss_pred CCCCcceeEecC-----------CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecc
Q 010887 64 PCFSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132 (498)
Q Consensus 64 ~c~~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~ 132 (498)
..|+|.+|.|+. .+++.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 17 ~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 96 (229)
T 3e6j_A 17 CSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLG 96 (229)
T ss_dssp CEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECC
Confidence 335999999974 268899999999998888899999999999999999985545667999999999999
Q ss_pred cccccCCCCCcccCCCCCCeEeCCCCcCcccCCchhh---ccccccccCCccc
Q 010887 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF---SVATFNFTGTHLI 182 (498)
Q Consensus 133 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~---~~~~~~~~~n~~~ 182 (498)
+|+|++..+..|..+++|++|+|++|+|+ .+|..+. ++..+++++|...
T Consensus 97 ~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~ 148 (229)
T 3e6j_A 97 TNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK 148 (229)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCC
T ss_pred CCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCC
Confidence 99999766667899999999999999999 8997664 5677888888764
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.7e-15 Score=138.88 Aligned_cols=121 Identities=24% Similarity=0.306 Sum_probs=100.7
Q ss_pred CCCC-CCcceeEecC-----------CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCccccccccccee
Q 010887 62 VSPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSL 129 (498)
Q Consensus 62 ~~~c-~~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L 129 (498)
++.| |.|.+|.|+. .+++.|+|++|++++..+..++++++|++|+|++|++++..+..|..+++|++|
T Consensus 2 p~~C~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 81 (208)
T 2o6s_A 2 PSRCSCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYL 81 (208)
T ss_dssp CTTCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCEECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEE
Confidence 3455 6999999974 268999999999996666678999999999999999996656668899999999
Q ss_pred ecccccccCCCCCcccCCCCCCeEeCCCCcCcccCCch---hhccccccccCCccc
Q 010887 130 NLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ---LFSVATFNFTGTHLI 182 (498)
Q Consensus 130 ~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~---~~~~~~~~~~~n~~~ 182 (498)
+|++|++++..+..+.++++|++|+|++|.|++..|.. +.++..+++++|...
T Consensus 82 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 137 (208)
T 2o6s_A 82 NLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK 137 (208)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred ECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccc
Confidence 99999999666666899999999999999999544433 356788889998763
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=1.7e-15 Score=140.32 Aligned_cols=121 Identities=20% Similarity=0.261 Sum_probs=86.1
Q ss_pred CCCCC-CCcceeEecCC-----------ceeEEEecccccCccccc-cccccCCCCeEEccCCCCCCccCcccccccccc
Q 010887 61 FVSPC-FSWSHVTCRNG-----------NVISLTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQ 127 (498)
Q Consensus 61 ~~~~c-~~w~gv~c~~~-----------~v~~l~l~~~~l~g~~~~-~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~ 127 (498)
++..| |.|..+.|++. .++.|+|++|+|++..|. .|.++++|++|+|++|+|++..|..|..+++|+
T Consensus 5 CP~~C~C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~ 84 (220)
T 2v70_A 5 CPEKCRCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVN 84 (220)
T ss_dssp CCTTCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred CCCCCEECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCC
Confidence 44556 57888888642 466788888888865443 467788888888888888766666777788888
Q ss_pred eeecccccccCCCCCcccCCCCCCeEeCCCCcCcccCCchh---hccccccccCCcc
Q 010887 128 SLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL---FSVATFNFTGTHL 181 (498)
Q Consensus 128 ~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~---~~~~~~~~~~n~~ 181 (498)
+|+|++|+|++..|..|.++++|++|+|++|+|++..|..+ .++..+++++|..
T Consensus 85 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 141 (220)
T 2v70_A 85 EILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQI 141 (220)
T ss_dssp EEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCC
T ss_pred EEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcC
Confidence 88888888876666667777788888888888776556544 3456667777755
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=2.5e-15 Score=139.16 Aligned_cols=111 Identities=17% Similarity=0.240 Sum_probs=100.7
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 57 ~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 136 (220)
T 2v70_A 57 PQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSL 136 (220)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEEC
T ss_pred CCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEEC
Confidence 48999999999999777778999999999999999999877888999999999999999999888999999999999999
Q ss_pred CCCcCcccCCchhh---ccccccccCCccccCCC
Q 010887 156 SSNNLTGRIPMQLF---SVATFNFTGTHLICGSS 186 (498)
Q Consensus 156 ~~N~l~g~ip~~~~---~~~~~~~~~n~~~~~~~ 186 (498)
++|+|++..|..+. ++..+++++|++.|.++
T Consensus 137 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 137 YDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp TTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 99999977776654 56788999999988753
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.59 E-value=1e-15 Score=149.73 Aligned_cols=113 Identities=31% Similarity=0.468 Sum_probs=98.8
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|+|++|.+++.+|..+.++++|+.|+|++|.+++.+|. +..+++|++|+|++|+++|.+|..+.++++|++|+|+
T Consensus 198 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 276 (313)
T 1ogq_A 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVS 276 (313)
T ss_dssp CCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECC
T ss_pred cccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECc
Confidence 377888888888888888888899999999999999877665 8889999999999999999999999999999999999
Q ss_pred CCcCcccCCch--hhccccccccCCccccCCCCCCCC
Q 010887 157 SNNLTGRIPMQ--LFSVATFNFTGTHLICGSSLEQPC 191 (498)
Q Consensus 157 ~N~l~g~ip~~--~~~~~~~~~~~n~~~~~~~~~~~c 191 (498)
+|+|+|.+|.. +.++..+++.+|+.+|+.|+. +|
T Consensus 277 ~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~-~C 312 (313)
T 1ogq_A 277 FNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp SSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred CCcccccCCCCccccccChHHhcCCCCccCCCCC-CC
Confidence 99999999974 567788999999999998764 45
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.59 E-value=2.8e-15 Score=132.92 Aligned_cols=103 Identities=19% Similarity=0.302 Sum_probs=68.7
Q ss_pred EEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCCCCc
Q 010887 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNN 159 (498)
Q Consensus 80 ~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~ 159 (498)
.|++++|+|+ .+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus 13 ~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~ 89 (170)
T 3g39_A 13 TVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89 (170)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence 4566666776 5666553 677777777777776667777777777777777777775555556777777777777777
Q ss_pred CcccCCchh---hccccccccCCccccCC
Q 010887 160 LTGRIPMQL---FSVATFNFTGTHLICGS 185 (498)
Q Consensus 160 l~g~ip~~~---~~~~~~~~~~n~~~~~~ 185 (498)
|++..|..+ .++..+++++|++.|.+
T Consensus 90 l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 90 LKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred cCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 774333223 44566777777776654
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.55 E-value=1.6e-14 Score=128.48 Aligned_cols=103 Identities=21% Similarity=0.332 Sum_probs=88.1
Q ss_pred eEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCCCC
Q 010887 79 ISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSN 158 (498)
Q Consensus 79 ~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N 158 (498)
+.+++++|+|+ .+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 57899999997 8888775 89999999999999888999999999999999999999655555789999999999999
Q ss_pred cCcccCCch----hhccccccccCCccccCC
Q 010887 159 NLTGRIPMQ----LFSVATFNFTGTHLICGS 185 (498)
Q Consensus 159 ~l~g~ip~~----~~~~~~~~~~~n~~~~~~ 185 (498)
+|+ .+|.. +.++..+++++|++.|.+
T Consensus 92 ~l~-~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 92 HLK-SIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp CCC-CCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred ccc-eeCHHHhccccCCCEEEeCCCCccccc
Confidence 999 45553 356788899999987754
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.54 E-value=9.9e-15 Score=144.75 Aligned_cols=112 Identities=18% Similarity=0.319 Sum_probs=86.3
Q ss_pred CCCC--CCcceeEecCCceeEEEeccc-ccCccccccccccCCCCeEEccC-CCCCCccCcccccccccceeeccccccc
Q 010887 62 VSPC--FSWSHVTCRNGNVISLTLGSN-GFSGKISPSITKLKFLASLELQD-NDLSGTLPDFLGSMTHLQSLNLANNKFS 137 (498)
Q Consensus 62 ~~~c--~~w~gv~c~~~~v~~l~l~~~-~l~g~~~~~~~~l~~L~~L~l~~-n~l~g~~p~~~~~l~~L~~L~l~~N~l~ 137 (498)
++.| |.|..|.|+ ++ +|+ .+|. |..+++|++|+|++ |+|++..|..|+.|++|++|+|++|+|+
T Consensus 2 p~~c~~C~~~~v~~~----------~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 69 (347)
T 2ifg_A 2 PDACCPHGSSGLRCT----------RDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69 (347)
T ss_dssp CSSSCCSSSSCEECC----------SSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCC
T ss_pred CCcCccccCCEEEcC----------CCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccc
Confidence 3455 688777775 34 677 5777 88888888888886 8888766677888888888888888888
Q ss_pred CCCCCcccCCCCCCeEeCCCCcCcccCCchhh---ccccccccCCccccCCC
Q 010887 138 GSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF---SVATFNFTGTHLICGSS 186 (498)
Q Consensus 138 g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~---~~~~~~~~~n~~~~~~~ 186 (498)
+..|..|.+|++|+.|+|++|+|+ .+|..++ +|..|++.+|++.|.+.
T Consensus 70 ~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~~~L~~l~l~~N~~~c~c~ 120 (347)
T 2ifg_A 70 FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCA 120 (347)
T ss_dssp EECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred eeCHHHhcCCcCCCEEeCCCCccc-eeCHHHcccCCceEEEeeCCCccCCCc
Confidence 877778888888888888888888 4555432 26778888888887654
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.53 E-value=1.7e-14 Score=127.82 Aligned_cols=105 Identities=23% Similarity=0.302 Sum_probs=91.8
Q ss_pred CCCCC-CCcceeEecC-----------CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccce
Q 010887 61 FVSPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQS 128 (498)
Q Consensus 61 ~~~~c-~~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~ 128 (498)
++..| |.|..+.|+. .+++.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++
T Consensus 3 CP~~C~C~~~~l~~s~n~l~~ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~ 82 (170)
T 3g39_A 3 CPSQCSCSGTTVDCSGKSLASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQ 82 (170)
T ss_dssp CC-CCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred CcCcCCcCCCEEEeCCCCcCccCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCE
Confidence 45566 6899999974 26889999999999888889999999999999999999666666899999999
Q ss_pred eecccccccCCCCCcccCCCCCCeEeCCCCcCcccCC
Q 010887 129 LNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP 165 (498)
Q Consensus 129 L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip 165 (498)
|+|++|+|++..|..|.++++|++|+|++|.+++..+
T Consensus 83 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 83 LSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred EECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 9999999997666679999999999999999997654
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.52 E-value=4e-15 Score=154.50 Aligned_cols=113 Identities=23% Similarity=0.208 Sum_probs=91.2
Q ss_pred CcceeEecC-CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccc-cccccceeecccccccCCCCCcc
Q 010887 67 SWSHVTCRN-GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLG-SMTHLQSLNLANNKFSGSIPATW 144 (498)
Q Consensus 67 ~w~gv~c~~-~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~ 144 (498)
.+.++.|.. .+++.|+|++|.|++..|..++++++|++|+|++|.|++.+|..+. .+++|++|+|++|.|++. |. +
T Consensus 110 ~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~ 187 (487)
T 3oja_A 110 NISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-Q 187 (487)
T ss_dssp CCCCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-C
T ss_pred cCCCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-c
Confidence 566666653 4789999999999988888899999999999999999998888886 789999999999999865 33 3
Q ss_pred cCCCCCCeEeCCCCcCcccCCchh---hccccccccCCccc
Q 010887 145 SQLSNLKHLDLSSNNLTGRIPMQL---FSVATFNFTGTHLI 182 (498)
Q Consensus 145 ~~l~~L~~l~l~~N~l~g~ip~~~---~~~~~~~~~~n~~~ 182 (498)
..+++|+.|+|++|.|++ +|+.+ .++..+++++|...
T Consensus 188 ~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~ 227 (487)
T 3oja_A 188 VVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV 227 (487)
T ss_dssp CCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC
T ss_pred ccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCc
Confidence 468889999999999985 55544 45677788888764
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.51 E-value=3.9e-14 Score=128.17 Aligned_cols=111 Identities=21% Similarity=0.381 Sum_probs=97.4
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++.+|..|..+++|++|+|
T Consensus 54 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 133 (192)
T 1w8a_A 54 PHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNL 133 (192)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEEC
T ss_pred CCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEe
Confidence 48999999999999888999999999999999999999888888999999999999999999999999999999999999
Q ss_pred CCCcCcccCCch-hh-ccccccccCCccccCCC
Q 010887 156 SSNNLTGRIPMQ-LF-SVATFNFTGTHLICGSS 186 (498)
Q Consensus 156 ~~N~l~g~ip~~-~~-~~~~~~~~~n~~~~~~~ 186 (498)
++|.+++..+.. +. .+....+.++...|..|
T Consensus 134 ~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 134 ASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp TTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred CCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence 999999987743 21 23444566777777654
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.51 E-value=2.5e-14 Score=135.16 Aligned_cols=106 Identities=24% Similarity=0.293 Sum_probs=85.2
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
.++.|+|++|++++..+..|.++++|++|+|++|.|++..|..|..+++|++|+|++|++++..|..|.++++|++|+|+
T Consensus 36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 115 (251)
T 3m19_A 36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLG 115 (251)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcC
Confidence 47788899999987777788889999999999999988777778888999999999999886666778888889999999
Q ss_pred CCcCcccCCch---hhccccccccCCccc
Q 010887 157 SNNLTGRIPMQ---LFSVATFNFTGTHLI 182 (498)
Q Consensus 157 ~N~l~g~ip~~---~~~~~~~~~~~n~~~ 182 (498)
+|.|++..|.. +.++..+++++|...
T Consensus 116 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 144 (251)
T 3m19_A 116 GNQLKSLPSGVFDRLTKLKELRLNTNQLQ 144 (251)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCcCCCcChhHhccCCcccEEECcCCcCC
Confidence 99888433322 356677788888653
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.8e-13 Score=125.31 Aligned_cols=110 Identities=24% Similarity=0.285 Sum_probs=94.2
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|+|++|++++..+..|.++++|++|+|++|+|++..|..+..+++|++|+|++|++++..|..+.++++|++|+|
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 131 (208)
T 2o6s_A 52 TSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRL 131 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEEC
Confidence 37999999999999655556899999999999999999666666899999999999999999766667899999999999
Q ss_pred CCCcCcccCCch---hhccccccccCCccccCC
Q 010887 156 SSNNLTGRIPMQ---LFSVATFNFTGTHLICGS 185 (498)
Q Consensus 156 ~~N~l~g~ip~~---~~~~~~~~~~~n~~~~~~ 185 (498)
++|.+++..+.. +.++..+++++|++.|..
T Consensus 132 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 164 (208)
T 2o6s_A 132 YQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC 164 (208)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCT
T ss_pred CCCccceeCHHHhccCCCccEEEecCCCeecCC
Confidence 999999544432 456788999999987764
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.45 E-value=1.9e-13 Score=130.70 Aligned_cols=107 Identities=27% Similarity=0.306 Sum_probs=78.8
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|+|++|++++..+..++++++|++|+|++|++++..|..++.+++|++|+|++|++++..|..++++++|++|+|
T Consensus 85 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 164 (272)
T 3rfs_A 85 TNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDL 164 (272)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEEC
Confidence 36788888888888666666788888888888888888666666778888888888888888666666777888888888
Q ss_pred CCCcCcccCCch---hhccccccccCCccc
Q 010887 156 SSNNLTGRIPMQ---LFSVATFNFTGTHLI 182 (498)
Q Consensus 156 ~~N~l~g~ip~~---~~~~~~~~~~~n~~~ 182 (498)
++|++++..|.. +.++..+++++|...
T Consensus 165 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 194 (272)
T 3rfs_A 165 SYNQLQSLPEGVFDKLTQLKDLRLYQNQLK 194 (272)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CCCCcCccCHHHhcCCccCCEEECCCCcCC
Confidence 888888544432 345667777777653
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.45 E-value=2e-13 Score=128.97 Aligned_cols=105 Identities=22% Similarity=0.307 Sum_probs=74.8
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|+|++|.|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus 60 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 139 (251)
T 3m19_A 60 KLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLN 139 (251)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred cCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECc
Confidence 67778888888877666667778888888888888876556667777778888888887775555556777777777777
Q ss_pred CCcCcccCCchh---hccccccccCCcc
Q 010887 157 SNNLTGRIPMQL---FSVATFNFTGTHL 181 (498)
Q Consensus 157 ~N~l~g~ip~~~---~~~~~~~~~~n~~ 181 (498)
+|+|++..|..+ .++..+++++|..
T Consensus 140 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l 167 (251)
T 3m19_A 140 TNQLQSIPAGAFDKLTNLQTLSLSTNQL 167 (251)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCcCCccCHHHcCcCcCCCEEECCCCcC
Confidence 777774333233 4556677777765
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.44 E-value=1.8e-13 Score=140.35 Aligned_cols=119 Identities=24% Similarity=0.322 Sum_probs=98.8
Q ss_pred CCCCC-C--CcceeEecC-----------CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCccccccccc
Q 010887 61 FVSPC-F--SWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHL 126 (498)
Q Consensus 61 ~~~~c-~--~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L 126 (498)
++..| | .|..|.|.. .+++.|+|++|+|++..+..|.++++|++|+|++|.|++..|..|.++++|
T Consensus 35 Cp~~C~C~~~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L 114 (440)
T 3zyj_A 35 CPSVCSCSNQFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114 (440)
T ss_dssp CCSSSEECTTSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSC
T ss_pred CCCCCEeCCCCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccC
Confidence 34445 3 477899974 268899999999998888899999999999999999997777899999999
Q ss_pred ceeecccccccCCCCCcccCCCCCCeEeCCCCcCcccCCc-h---hhccccccccCCc
Q 010887 127 QSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPM-Q---LFSVATFNFTGTH 180 (498)
Q Consensus 127 ~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~-~---~~~~~~~~~~~n~ 180 (498)
++|+|++|+|++..+..|.++++|++|+|++|.+++ +|. . +.++..+++++|.
T Consensus 115 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~l~~~~ 171 (440)
T 3zyj_A 115 NTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSLRRLDLGELK 171 (440)
T ss_dssp CEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCE-ECTTTTTTCTTCCEEECCCCT
T ss_pred CEEECCCCcCCeeCHhHhhccccCceeeCCCCcccc-cCHHHhhhCcccCEeCCCCCC
Confidence 999999999996666679999999999999999994 543 3 3456677777754
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.44 E-value=2.2e-13 Score=131.56 Aligned_cols=104 Identities=25% Similarity=0.291 Sum_probs=75.3
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|+|++|+|+ .+|..+..+++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|.++++|+.|+|+
T Consensus 78 ~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 156 (290)
T 1p9a_G 78 VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA 156 (290)
T ss_dssp TCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred cCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECC
Confidence 6777888888877 677777777888888888888875555667777888888888888775555556777778888888
Q ss_pred CCcCcccCCch----hhccccccccCCccc
Q 010887 157 SNNLTGRIPMQ----LFSVATFNFTGTHLI 182 (498)
Q Consensus 157 ~N~l~g~ip~~----~~~~~~~~~~~n~~~ 182 (498)
+|+|+ .+|.. +.++..+++++|...
T Consensus 157 ~N~l~-~l~~~~~~~l~~L~~L~L~~N~l~ 185 (290)
T 1p9a_G 157 NNNLT-ELPAGLLNGLENLDTLLLQENSLY 185 (290)
T ss_dssp TSCCS-CCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCcCC-ccCHHHhcCcCCCCEEECCCCcCC
Confidence 88777 45543 345566777777653
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.44 E-value=1.8e-13 Score=140.70 Aligned_cols=119 Identities=23% Similarity=0.307 Sum_probs=99.8
Q ss_pred CCCCC-C--CcceeEecC-----------CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCccccccccc
Q 010887 61 FVSPC-F--SWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHL 126 (498)
Q Consensus 61 ~~~~c-~--~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L 126 (498)
++..| | .|..|.|.. .+++.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|
T Consensus 46 Cp~~C~C~~~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L 125 (452)
T 3zyi_A 46 CPSVCSCSNQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASL 125 (452)
T ss_dssp CCTTSEECSSSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred CCCCCEECCCCcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccC
Confidence 34455 3 367899964 268999999999998888899999999999999999998888999999999
Q ss_pred ceeecccccccCCCCCcccCCCCCCeEeCCCCcCcccCCc-h---hhccccccccCCc
Q 010887 127 QSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPM-Q---LFSVATFNFTGTH 180 (498)
Q Consensus 127 ~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~-~---~~~~~~~~~~~n~ 180 (498)
++|+|++|+|++..+..|.++++|++|+|++|.|+ .+|. . +.++..+++++|.
T Consensus 126 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~~~ 182 (452)
T 3zyi_A 126 NTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELK 182 (452)
T ss_dssp CEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCT
T ss_pred CEEECCCCcCCccChhhhcccCCCCEEECCCCCcc-eeCHhHHhcCCcccEEeCCCCC
Confidence 99999999999666667999999999999999999 4554 3 3456667777644
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=1.1e-13 Score=148.19 Aligned_cols=111 Identities=26% Similarity=0.369 Sum_probs=99.1
Q ss_pred CceeEEEecccccC-ccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEe
Q 010887 76 GNVISLTLGSNGFS-GKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 154 (498)
Q Consensus 76 ~~v~~l~l~~~~l~-g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ 154 (498)
..++.|+|++|.+. +.+|..|..+++|++|+|++|+|++..|..|.+|++|++|+|++|+|++..|..|.++++|++|+
T Consensus 469 ~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~ 548 (635)
T 4g8a_A 469 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 548 (635)
T ss_dssp TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEE
T ss_pred hhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEE
Confidence 36889999999754 45677899999999999999999988899999999999999999999988888899999999999
Q ss_pred CCCCcCcccCCchhh----ccccccccCCccccCCC
Q 010887 155 LSSNNLTGRIPMQLF----SVATFNFTGTHLICGSS 186 (498)
Q Consensus 155 l~~N~l~g~ip~~~~----~~~~~~~~~n~~~~~~~ 186 (498)
|++|+|++..|..+. ++..+++++|++.|.+.
T Consensus 549 Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 549 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp CTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred CCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 999999988887664 56789999999999764
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.43 E-value=1.7e-13 Score=136.65 Aligned_cols=123 Identities=19% Similarity=0.201 Sum_probs=103.4
Q ss_pred CCCCCC-CCcceeEecC-----------CceeEEEecccccCcccccccc-ccCCCCeEEccCCCCCCccCccccccccc
Q 010887 60 HFVSPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSIT-KLKFLASLELQDNDLSGTLPDFLGSMTHL 126 (498)
Q Consensus 60 ~~~~~c-~~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~~~-~l~~L~~L~l~~n~l~g~~p~~~~~l~~L 126 (498)
.++..| |.|..|.|.. ..++.|+|++|+|++..+..+. ++++|++|+|++|+|++..|..|.++++|
T Consensus 11 ~Cp~~C~C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L 90 (361)
T 2xot_A 11 SCPANCLCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNL 90 (361)
T ss_dssp TCCTTCEEETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred CCCCCCEECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCC
Confidence 355667 6899999974 2578999999999976666777 99999999999999997777789999999
Q ss_pred ceeecccccccCCCCCcccCCCCCCeEeCCCCcCcccCCchh---hccccccccCCccc
Q 010887 127 QSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL---FSVATFNFTGTHLI 182 (498)
Q Consensus 127 ~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~---~~~~~~~~~~n~~~ 182 (498)
++|+|++|+|++..+..|.++++|+.|+|++|+|++..|..+ .+|..|++++|...
T Consensus 91 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 149 (361)
T 2xot_A 91 RYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS 149 (361)
T ss_dssp CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred CEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC
Confidence 999999999997667779999999999999999996656544 46677888888764
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.43 E-value=9.3e-14 Score=150.95 Aligned_cols=102 Identities=27% Similarity=0.390 Sum_probs=84.6
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
.++.|+|++|.+. .+|+.+.+|++|++|+|++|.|+ .+|..|++|++|++|+|++|+|+ .+|..|++|++|++|+|+
T Consensus 225 ~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~ 301 (727)
T 4b8c_D 225 LWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFF 301 (727)
T ss_dssp CCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECC
T ss_pred CCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECC
Confidence 4566888888888 78888888888999999999888 88888888999999999999988 888888888889999999
Q ss_pred CCcCcccCCchhh---ccccccccCCccc
Q 010887 157 SNNLTGRIPMQLF---SVATFNFTGTHLI 182 (498)
Q Consensus 157 ~N~l~g~ip~~~~---~~~~~~~~~n~~~ 182 (498)
+|.|+ .||..+. +|..|++++|++.
T Consensus 302 ~N~l~-~lp~~~~~l~~L~~L~L~~N~l~ 329 (727)
T 4b8c_D 302 DNMVT-TLPWEFGNLCNLQFLGVEGNPLE 329 (727)
T ss_dssp SSCCC-CCCSSTTSCTTCCCEECTTSCCC
T ss_pred CCCCC-ccChhhhcCCCccEEeCCCCccC
Confidence 98887 7887664 4566778888764
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.43 E-value=2.3e-13 Score=133.86 Aligned_cols=106 Identities=23% Similarity=0.333 Sum_probs=95.9
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|+|++|+++ .+|..++++++|++|+|++|.++ .+|+.++.+++|++|+|++|++.+.+|..++++++|++|+|
T Consensus 183 ~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L 260 (328)
T 4fcg_A 183 VNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLIL 260 (328)
T ss_dssp TTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEEC
T ss_pred CCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEEC
Confidence 47999999999999 89999999999999999999999 58888999999999999999999999999999999999999
Q ss_pred CCCcCcccCCchhh---ccccccccCCcccc
Q 010887 156 SSNNLTGRIPMQLF---SVATFNFTGTHLIC 183 (498)
Q Consensus 156 ~~N~l~g~ip~~~~---~~~~~~~~~n~~~~ 183 (498)
++|++.+.+|..+. ++..+++++|+...
T Consensus 261 ~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~ 291 (328)
T 4fcg_A 261 KDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291 (328)
T ss_dssp TTCTTCCBCCTTGGGCTTCCEEECTTCTTCC
T ss_pred CCCCchhhcchhhhcCCCCCEEeCCCCCchh
Confidence 99999999998665 45678889987643
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.42 E-value=1.5e-13 Score=118.82 Aligned_cols=103 Identities=22% Similarity=0.321 Sum_probs=74.4
Q ss_pred ceeEEEecccccC-ccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 77 NVISLTLGSNGFS-GKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 77 ~v~~l~l~~~~l~-g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
+++.|+|++|+++ +.+|+.+..+++|++|+|++|.+++. ..++.+++|++|+|++|++++.+|..+.++++|++|++
T Consensus 18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 95 (149)
T 2je0_A 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95 (149)
T ss_dssp GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence 6777888888877 77777777788888888888877754 66777788888888888887667777777778888888
Q ss_pred CCCcCccc-CCchh---hccccccccCCcc
Q 010887 156 SSNNLTGR-IPMQL---FSVATFNFTGTHL 181 (498)
Q Consensus 156 ~~N~l~g~-ip~~~---~~~~~~~~~~n~~ 181 (498)
++|.+++. .|..+ .++..+++++|+.
T Consensus 96 s~N~i~~~~~~~~~~~l~~L~~L~l~~N~l 125 (149)
T 2je0_A 96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEV 125 (149)
T ss_dssp TTSCCCSHHHHGGGGGCTTCCEEECTTCGG
T ss_pred CCCcCCChHHHHHHhhCCCCCEEeCcCCcc
Confidence 88887752 22333 3456667777754
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.42 E-value=3.7e-13 Score=128.51 Aligned_cols=105 Identities=27% Similarity=0.312 Sum_probs=60.5
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
.++.|+|++|++++..+..|.++++|++|+|++|.++...+..+..+++|++|+|++|++++..+..+.++++|++|+|+
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 117 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence 35566666666664444456666666666666666663333334566666666666666664444455666666666666
Q ss_pred CCcCcccCCch---hhccccccccCCcc
Q 010887 157 SNNLTGRIPMQ---LFSVATFNFTGTHL 181 (498)
Q Consensus 157 ~N~l~g~ip~~---~~~~~~~~~~~n~~ 181 (498)
+|.+++..|.. +.++..+++++|..
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 145 (270)
T 2o6q_A 118 RNQLKSLPPRVFDSLTKLTYLSLGYNEL 145 (270)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCccCeeCHHHhCcCcCCCEEECCCCcC
Confidence 66666433322 23455556666543
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=2.3e-13 Score=145.62 Aligned_cols=106 Identities=22% Similarity=0.200 Sum_probs=89.6
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
.++.|+|++|+|++..|.+|.++++|++|||++|+|++..|..|.+|++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus 53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls 132 (635)
T 4g8a_A 53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 132 (635)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECT
T ss_pred CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECC
Confidence 68999999999996666789999999999999999997667789999999999999999996566678999999999999
Q ss_pred CCcCcccCCch---hhccccccccCCccc
Q 010887 157 SNNLTGRIPMQ---LFSVATFNFTGTHLI 182 (498)
Q Consensus 157 ~N~l~g~ip~~---~~~~~~~~~~~n~~~ 182 (498)
+|+|++..|.. +.++..+++++|...
T Consensus 133 ~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~ 161 (635)
T 4g8a_A 133 ETNLASLENFPIGHLKTLKELNVAHNLIQ 161 (635)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCC
T ss_pred CCcCCCCChhhhhcCcccCeeccccCccc
Confidence 99999543333 356677888888653
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.40 E-value=4.9e-13 Score=118.86 Aligned_cols=107 Identities=21% Similarity=0.290 Sum_probs=89.0
Q ss_pred CCCCC-CCcceeEecC-----------CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccce
Q 010887 61 FVSPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQS 128 (498)
Q Consensus 61 ~~~~c-~~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~ 128 (498)
++..| |....+.|++ .+++.|+|++|+|++..|..|+++++|++|+|++|+|++..|..|..+++|++
T Consensus 6 CP~~C~C~~~~l~~~~n~l~~iP~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~ 85 (174)
T 2r9u_A 6 CPSQCSCDQTLVNCQNIRLASVPAGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQ 85 (174)
T ss_dssp SCTTSEECSSEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred CCCCCEECCcEEEeCCCCCCccCCCcCCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhE
Confidence 34455 4666777763 26889999999999888889999999999999999999654555789999999
Q ss_pred eecccccccCCCCCcccCCCCCCeEeCCCCcCcccCCchh
Q 010887 129 LNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL 168 (498)
Q Consensus 129 L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~ 168 (498)
|+|++|+|++..|..|.++++|++|+|++|.+.. .|..+
T Consensus 86 L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c-~~~~~ 124 (174)
T 2r9u_A 86 LDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDC-ECRDI 124 (174)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCSEEECCSSCBCT-TBGGG
T ss_pred EECCCCccceeCHHHhccccCCCEEEeCCCCccc-ccccH
Confidence 9999999996555569999999999999999995 44433
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.40 E-value=7e-13 Score=126.59 Aligned_cols=105 Identities=25% Similarity=0.305 Sum_probs=64.0
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|+|++|.+++..+..+.++++|++|+|++|++++..|..|..+++|++|+|++|++++..+..|.++++|++|+|+
T Consensus 86 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 165 (270)
T 2o6q_A 86 NLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLY 165 (270)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEec
Confidence 56677777777764444455666677777777777665555556666666666666666664444446666666666666
Q ss_pred CCcCcccCCchh---hccccccccCCcc
Q 010887 157 SNNLTGRIPMQL---FSVATFNFTGTHL 181 (498)
Q Consensus 157 ~N~l~g~ip~~~---~~~~~~~~~~n~~ 181 (498)
+|.+++..|..+ .++..+++++|..
T Consensus 166 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l 193 (270)
T 2o6q_A 166 NNQLKRVPEGAFDKLTELKTLKLDNNQL 193 (270)
T ss_dssp SSCCSCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCcCcEeChhHhccCCCcCEEECCCCcC
Confidence 666663322222 3455566666644
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=2.2e-13 Score=139.99 Aligned_cols=119 Identities=23% Similarity=0.299 Sum_probs=100.1
Q ss_pred CCCCCcce--eEecC----------CceeEEEecccccCccccccccccCCCCeEEccCCCCCCcc-Cccccccccccee
Q 010887 63 SPCFSWSH--VTCRN----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTL-PDFLGSMTHLQSL 129 (498)
Q Consensus 63 ~~c~~w~g--v~c~~----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~-p~~~~~l~~L~~L 129 (498)
..| .|.+ |.|+. .+++.|+|++|.+++..|..|+++++|++|+|++|.+.+.+ |..|..+++|++|
T Consensus 6 ~~c-~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L 84 (455)
T 3v47_A 6 SEC-SVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIIL 84 (455)
T ss_dssp -CC-EEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEE
T ss_pred cee-EEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEE
Confidence 444 5554 88864 35899999999999888889999999999999999998777 4578999999999
Q ss_pred ecccccccCCCCCcccCCCCCCeEeCCCCcCcccCCch-----hhccccccccCCccc
Q 010887 130 NLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ-----LFSVATFNFTGTHLI 182 (498)
Q Consensus 130 ~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~-----~~~~~~~~~~~n~~~ 182 (498)
+|++|++++..|..|+++++|++|+|++|.+++.+|.. +.++..+++++|...
T Consensus 85 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~ 142 (455)
T 3v47_A 85 KLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK 142 (455)
T ss_dssp ECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCC
T ss_pred eCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccC
Confidence 99999999888999999999999999999999766543 456778888888753
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=4e-13 Score=138.09 Aligned_cols=108 Identities=24% Similarity=0.311 Sum_probs=60.3
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|+|++|.+++..|..|+++++|++|+|++|.+++..|..++.+++|++|+|++|++++..|..|.++++|++|+|+
T Consensus 300 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 379 (455)
T 3v47_A 300 DLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALD 379 (455)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECC
Confidence 45555555555555555555555566666666665555445555556666666666666655555555556666666666
Q ss_pred CCcCcccCCc----hhhccccccccCCccccCC
Q 010887 157 SNNLTGRIPM----QLFSVATFNFTGTHLICGS 185 (498)
Q Consensus 157 ~N~l~g~ip~----~~~~~~~~~~~~n~~~~~~ 185 (498)
+|+|++ +|. .+.++..+++++|++.|.+
T Consensus 380 ~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~ 411 (455)
T 3v47_A 380 TNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSC 411 (455)
T ss_dssp SSCCSC-CCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred CCcccc-CCHhHhccCCcccEEEccCCCcccCC
Confidence 666653 332 1234455555666555543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.39 E-value=3.8e-13 Score=130.80 Aligned_cols=105 Identities=22% Similarity=0.349 Sum_probs=71.1
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCC-ccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSG-TLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g-~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
+++.|+|++|.+++..|..+.++++|++|+|++|.+++ .+|..+..+++|++|+|++|++++..|..+.++++|++|+|
T Consensus 127 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 206 (306)
T 2z66_A 127 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 206 (306)
T ss_dssp TCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEEC
Confidence 56777777777776666667777777777777777765 46667777777777777777777666666777777777777
Q ss_pred CCCcCcccCCchh---hccccccccCCcc
Q 010887 156 SSNNLTGRIPMQL---FSVATFNFTGTHL 181 (498)
Q Consensus 156 ~~N~l~g~ip~~~---~~~~~~~~~~n~~ 181 (498)
++|.+++..+..+ .++..+++++|..
T Consensus 207 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 235 (306)
T 2z66_A 207 SHNNFFSLDTFPYKCLNSLQVLDYSLNHI 235 (306)
T ss_dssp TTSCCSBCCSGGGTTCTTCCEEECTTSCC
T ss_pred CCCccCccChhhccCcccCCEeECCCCCC
Confidence 7777774333333 3456666666655
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.38 E-value=3e-13 Score=119.41 Aligned_cols=83 Identities=31% Similarity=0.382 Sum_probs=38.9
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCC-CCCcccCCCCCCeEeC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS-IPATWSQLSNLKHLDL 155 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~-~p~~~~~l~~L~~l~l 155 (498)
+++.|+|++|.+++. +.++.+++|++|+|++|.+++.+|..+..+++|++|+|++|++++. .+..+.++++|++|++
T Consensus 50 ~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l 127 (168)
T 2ell_A 50 NLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDL 127 (168)
T ss_dssp GCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEEC
T ss_pred CCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEe
Confidence 444455555554432 3444445555555555555444444444445555555555554421 1134444455555555
Q ss_pred CCCcCc
Q 010887 156 SSNNLT 161 (498)
Q Consensus 156 ~~N~l~ 161 (498)
++|.++
T Consensus 128 ~~N~l~ 133 (168)
T 2ell_A 128 FNCEVT 133 (168)
T ss_dssp CSSGGG
T ss_pred eCCcCc
Confidence 555554
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=9.3e-13 Score=136.30 Aligned_cols=121 Identities=22% Similarity=0.343 Sum_probs=103.0
Q ss_pred CCCCC-C--CcceeEecC-----------CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCccccccccc
Q 010887 61 FVSPC-F--SWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHL 126 (498)
Q Consensus 61 ~~~~c-~--~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L 126 (498)
++..| | .|..|.|.. .+++.|+|++|+|++..|..|.++++|++|+|++|.+++..|..|.++++|
T Consensus 3 Cp~~C~C~~~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L 82 (477)
T 2id5_A 3 CPPRCECSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82 (477)
T ss_dssp CSTTCEEETTTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred ccCCCeECCCCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccC
Confidence 44555 3 578999974 268899999999998878899999999999999999998889999999999
Q ss_pred ceeecccccccCCCCCcccCCCCCCeEeCCCCcCcccCCchh---hccccccccCCcc
Q 010887 127 QSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL---FSVATFNFTGTHL 181 (498)
Q Consensus 127 ~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~---~~~~~~~~~~n~~ 181 (498)
++|+|++|++++..+..|.++++|++|+|++|.+++..|..+ .++..+++++|..
T Consensus 83 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l 140 (477)
T 2id5_A 83 RTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDL 140 (477)
T ss_dssp CEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTC
T ss_pred CEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCcc
Confidence 999999999996555568999999999999999997777554 4567788888865
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=4.5e-13 Score=141.14 Aligned_cols=115 Identities=22% Similarity=0.225 Sum_probs=100.3
Q ss_pred CCcceeEecC-------------CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecc
Q 010887 66 FSWSHVTCRN-------------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132 (498)
Q Consensus 66 ~~w~gv~c~~-------------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~ 132 (498)
|.|.|+ |+. .+++.|+|++|++++..|.+|+++++|++|+|++|++++..|..|+++++|++|+|+
T Consensus 4 C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls 82 (549)
T 2z81_A 4 CDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLS 82 (549)
T ss_dssp ECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECT
T ss_pred CCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECC
Confidence 489888 862 279999999999998888899999999999999999998888999999999999999
Q ss_pred cccccCCCCCcccCCCCCCeEeCCCCcCcc-cCCchh---hccccccccCCcc
Q 010887 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTG-RIPMQL---FSVATFNFTGTHL 181 (498)
Q Consensus 133 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g-~ip~~~---~~~~~~~~~~n~~ 181 (498)
+|++++..|..|+++++|++|+|++|.+++ .+|..+ .++..+++++|..
T Consensus 83 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~ 135 (549)
T 2z81_A 83 DNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVET 135 (549)
T ss_dssp TSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSS
T ss_pred CCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCcc
Confidence 999998777779999999999999999996 455544 5667788888863
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=6.2e-13 Score=127.96 Aligned_cols=105 Identities=24% Similarity=0.249 Sum_probs=68.9
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|+|++|++++..|..+.++++|++|+|++|.+++..+..++.+++|++|+|++|++++..+..+.++++|++|+|+
T Consensus 106 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 185 (285)
T 1ozn_A 106 RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185 (285)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECC
Confidence 56777777777776656667777777777777777775445556677777777777777764444456667777777777
Q ss_pred CCcCcccCCchhh---ccccccccCCcc
Q 010887 157 SNNLTGRIPMQLF---SVATFNFTGTHL 181 (498)
Q Consensus 157 ~N~l~g~ip~~~~---~~~~~~~~~n~~ 181 (498)
+|.+++..|..+. ++..+++++|..
T Consensus 186 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l 213 (285)
T 1ozn_A 186 QNRVAHVHPHAFRDLGRLMTLYLFANNL 213 (285)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CCcccccCHhHccCcccccEeeCCCCcC
Confidence 7777765555443 445566666654
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.36 E-value=1.3e-12 Score=128.59 Aligned_cols=122 Identities=22% Similarity=0.356 Sum_probs=100.6
Q ss_pred CCCCCCCCCC-CCcceeEecC-----------CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccc
Q 010887 56 DWNDHFVSPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSM 123 (498)
Q Consensus 56 ~w~~~~~~~c-~~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l 123 (498)
.|...++..| |.|..+.|+. .+++.|+|++|++++..|..|.++++|++|+|++|++++..|..|+++
T Consensus 22 ~~~~~cp~~c~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 101 (332)
T 2ft3_A 22 TYSAMCPFGCHCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPL 101 (332)
T ss_dssp ---CCCCSSCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTC
T ss_pred cccCCCCCCCcccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCc
Confidence 4554455555 6899999973 268999999999997777789999999999999999998889999999
Q ss_pred cccceeecccccccCCCCCcccCCCCCCeEeCCCCcCcccCCch----hhccccccccCCcc
Q 010887 124 THLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ----LFSVATFNFTGTHL 181 (498)
Q Consensus 124 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~----~~~~~~~~~~~n~~ 181 (498)
++|++|+|++|+++ .+|..+. ++|++|++++|.++ .+|.. +.++..+++++|..
T Consensus 102 ~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~l 159 (332)
T 2ft3_A 102 RKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPL 159 (332)
T ss_dssp TTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCC-CCCSGGGSSCSSCCEEECCSCCC
T ss_pred CCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccC-ccCHhHhCCCccCCEEECCCCcc
Confidence 99999999999999 7888766 89999999999999 45543 34667788888876
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=1.3e-12 Score=137.81 Aligned_cols=102 Identities=24% Similarity=0.373 Sum_probs=90.4
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
.++.|+|++|+|++ +|. |++|++|+.|+|++|+|+ .+|..|++|++|++|+|++|+|++ +| .++++++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 57889999999995 776 999999999999999999 899999999999999999999996 78 89999999999999
Q ss_pred CCcCcccC-Cchhh---ccccccccCCcccc
Q 010887 157 SNNLTGRI-PMQLF---SVATFNFTGTHLIC 183 (498)
Q Consensus 157 ~N~l~g~i-p~~~~---~~~~~~~~~n~~~~ 183 (498)
+|+|++.+ |..+. ++..+++++|++..
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~ 547 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 547 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCC
Confidence 99999776 87664 55778899998643
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=5.7e-13 Score=142.13 Aligned_cols=108 Identities=25% Similarity=0.305 Sum_probs=66.5
Q ss_pred ceeEEEecccccCc-cccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 77 NVISLTLGSNGFSG-KISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 77 ~v~~l~l~~~~l~g-~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
+++.|+|++|.+++ .+|..++.+++|++|+|++|++++.+|..++.+++|++|+|++|++++.+|..+.++++|+.|+|
T Consensus 449 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l 528 (606)
T 3vq2_A 449 SLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDC 528 (606)
T ss_dssp TCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEEC
Confidence 55666666666665 24555666666666666666666655666666666666666666666655666666666666666
Q ss_pred CCCcCcccCCchhh----ccccccccCCccccCC
Q 010887 156 SSNNLTGRIPMQLF----SVATFNFTGTHLICGS 185 (498)
Q Consensus 156 ~~N~l~g~ip~~~~----~~~~~~~~~n~~~~~~ 185 (498)
++|+|+ .+|..+. ++..+++++|++.|.+
T Consensus 529 ~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c 561 (606)
T 3vq2_A 529 SFNRIE-TSKGILQHFPKSLAFFNLTNNSVACIC 561 (606)
T ss_dssp TTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSS
T ss_pred CCCcCc-ccCHhHhhhcccCcEEEccCCCcccCC
Confidence 666666 5555443 2445666666666654
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=1.8e-12 Score=127.50 Aligned_cols=125 Identities=19% Similarity=0.275 Sum_probs=100.7
Q ss_pred CCCCCCCCCCCC-CCcceeEecC-----------CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccc
Q 010887 54 FTDWNDHFVSPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLG 121 (498)
Q Consensus 54 l~~w~~~~~~~c-~~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~ 121 (498)
+..|...++..| |.|..+.|+. ..++.|+|++|++++..+..|+++++|++|+|++|.+++..|..|+
T Consensus 18 i~~~~~~cp~~c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 97 (330)
T 1xku_A 18 IEPMGPVCPFRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFA 97 (330)
T ss_dssp ----CCCCCTTCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTT
T ss_pred cccccCCCCCCCcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhc
Confidence 345665555566 6899999973 2688999999999977666899999999999999999988899999
Q ss_pred cccccceeecccccccCCCCCcccCCCCCCeEeCCCCcCcccCCchh---hccccccccCCcc
Q 010887 122 SMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL---FSVATFNFTGTHL 181 (498)
Q Consensus 122 ~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~---~~~~~~~~~~n~~ 181 (498)
++++|++|+|++|+++ .+|..+. ++|++|++++|.+++..|..+ .++..+++++|..
T Consensus 98 ~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 157 (330)
T 1xku_A 98 PLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPL 157 (330)
T ss_dssp TCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCC
T ss_pred CCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcC
Confidence 9999999999999999 7887765 799999999999995444333 4567778888765
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.35 E-value=9e-14 Score=154.13 Aligned_cols=108 Identities=26% Similarity=0.350 Sum_probs=79.0
Q ss_pred ceeEEEecccccC-----ccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCC
Q 010887 77 NVISLTLGSNGFS-----GKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLK 151 (498)
Q Consensus 77 ~v~~l~l~~~~l~-----g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~ 151 (498)
+++.|+|++|.++ +..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+. ++|+
T Consensus 452 ~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~ 529 (844)
T 3j0a_A 452 SLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLE 529 (844)
T ss_dssp TCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCC
T ss_pred ccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--cccc
Confidence 4555555555554 23334566777777777777777776677777778888888888887765555444 6788
Q ss_pred eEeCCCCcCcccCCchhhccccccccCCccccCCC
Q 010887 152 HLDLSSNNLTGRIPMQLFSVATFNFTGTHLICGSS 186 (498)
Q Consensus 152 ~l~l~~N~l~g~ip~~~~~~~~~~~~~n~~~~~~~ 186 (498)
.|+|++|+|+|.+|..+.++..+++++|++.|.++
T Consensus 530 ~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 530 ILDISRNQLLAPNPDVFVSLSVLDITHNKFICECE 564 (844)
T ss_dssp EEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSS
T ss_pred EEECCCCcCCCCChhHhCCcCEEEecCCCcccccc
Confidence 88888888888788778888999999999999765
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.35 E-value=6.4e-13 Score=131.99 Aligned_cols=113 Identities=21% Similarity=0.279 Sum_probs=95.1
Q ss_pred CCcceeEecC-------------CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecc
Q 010887 66 FSWSHVTCRN-------------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132 (498)
Q Consensus 66 ~~w~gv~c~~-------------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~ 132 (498)
|.|.|+ |+. .+++.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|+
T Consensus 30 C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (353)
T 2z80_A 30 CDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLS 108 (353)
T ss_dssp ECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECC
Confidence 488887 641 278999999999996655689999999999999999998778889999999999999
Q ss_pred cccccCCCCCcccCCCCCCeEeCCCCcCcccCCc-----hhhccccccccCCc
Q 010887 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPM-----QLFSVATFNFTGTH 180 (498)
Q Consensus 133 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~-----~~~~~~~~~~~~n~ 180 (498)
+|++++..+..++++++|++|+|++|+++ .+|. .+.++..+++++|.
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~ 160 (353)
T 2z80_A 109 YNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMD 160 (353)
T ss_dssp SSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESS
T ss_pred CCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCc
Confidence 99999544444899999999999999999 5765 34567778888874
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.34 E-value=6.6e-13 Score=129.62 Aligned_cols=105 Identities=18% Similarity=0.227 Sum_probs=87.3
Q ss_pred CceeEEEecccccCccccccc--cccCCCCeEEccCCCCCCccCcccccc-----cccceeecccccccCCCCCcccCCC
Q 010887 76 GNVISLTLGSNGFSGKISPSI--TKLKFLASLELQDNDLSGTLPDFLGSM-----THLQSLNLANNKFSGSIPATWSQLS 148 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~--~~l~~L~~L~l~~n~l~g~~p~~~~~l-----~~L~~L~l~~N~l~g~~p~~~~~l~ 148 (498)
.+++.|+|++|++++.+|..+ +.+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..|..|++++
T Consensus 95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~ 173 (312)
T 1wwl_A 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173 (312)
T ss_dssp SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCS
T ss_pred CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCC
Confidence 378899999999998888876 8899999999999999976 8888887 8999999999999887778899999
Q ss_pred CCCeEeCCCCcCcccC--C-----chhhccccccccCCcc
Q 010887 149 NLKHLDLSSNNLTGRI--P-----MQLFSVATFNFTGTHL 181 (498)
Q Consensus 149 ~L~~l~l~~N~l~g~i--p-----~~~~~~~~~~~~~n~~ 181 (498)
+|++|+|++|++.|.+ | ..+.++..+++++|..
T Consensus 174 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l 213 (312)
T 1wwl_A 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM 213 (312)
T ss_dssp SCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCC
T ss_pred CCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcC
Confidence 9999999999987653 2 3445677788888754
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=2.2e-12 Score=124.05 Aligned_cols=105 Identities=22% Similarity=0.221 Sum_probs=91.4
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeeccccc-ccCCCCCcccCCCCCCeEeC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK-FSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~-l~g~~p~~~~~l~~L~~l~l 155 (498)
+++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|..+++|++|+|++|. ++...|..+.++++|++|+|
T Consensus 33 ~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l 112 (285)
T 1ozn_A 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (285)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEEC
Confidence 68899999999997666789999999999999999998779999999999999999997 77666888999999999999
Q ss_pred CCCcCcccCCchh---hccccccccCCcc
Q 010887 156 SSNNLTGRIPMQL---FSVATFNFTGTHL 181 (498)
Q Consensus 156 ~~N~l~g~ip~~~---~~~~~~~~~~n~~ 181 (498)
++|.+++..|..+ .++..+++++|..
T Consensus 113 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 141 (285)
T 1ozn_A 113 DRCGLQELGPGLFRGLAALQYLYLQDNAL 141 (285)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCCcCCEECHhHhhCCcCCCEEECCCCcc
Confidence 9999997666544 4667788888865
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.34 E-value=1.5e-12 Score=114.79 Aligned_cols=104 Identities=26% Similarity=0.338 Sum_probs=92.5
Q ss_pred CceeEEEecccccC-ccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEe
Q 010887 76 GNVISLTLGSNGFS-GKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 154 (498)
Q Consensus 76 ~~v~~l~l~~~~l~-g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ 154 (498)
.+++.|+|++|+++ +.+|..+..+++|++|+|++|.+++. ..++.+++|++|+|++|++++.+|..+.++++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 37999999999998 89999999999999999999999965 7899999999999999999988888888899999999
Q ss_pred CCCCcCcccCC--chh---hccccccccCCccc
Q 010887 155 LSSNNLTGRIP--MQL---FSVATFNFTGTHLI 182 (498)
Q Consensus 155 l~~N~l~g~ip--~~~---~~~~~~~~~~n~~~ 182 (498)
|++|.+++ +| ..+ .++..+++++|+..
T Consensus 102 Ls~N~l~~-~~~~~~l~~l~~L~~L~l~~N~l~ 133 (168)
T 2ell_A 102 LSGNKLKD-ISTLEPLKKLECLKSLDLFNCEVT 133 (168)
T ss_dssp CBSSSCCS-SGGGGGGSSCSCCCEEECCSSGGG
T ss_pred ccCCccCc-chhHHHHhcCCCCCEEEeeCCcCc
Confidence 99999995 44 444 46778899999764
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.34 E-value=2e-12 Score=119.51 Aligned_cols=111 Identities=23% Similarity=0.276 Sum_probs=97.6
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|+|++|.|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 56 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 135 (220)
T 2v9t_B 56 KKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSL 135 (220)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEEC
Confidence 47999999999999888999999999999999999999544455789999999999999999888999999999999999
Q ss_pred CCCcCcccCCchh---hccccccccCCccccCCC
Q 010887 156 SSNNLTGRIPMQL---FSVATFNFTGTHLICGSS 186 (498)
Q Consensus 156 ~~N~l~g~ip~~~---~~~~~~~~~~n~~~~~~~ 186 (498)
++|+|++..|..+ .++..+++++|++.|.+.
T Consensus 136 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 169 (220)
T 2v9t_B 136 YDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH 169 (220)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence 9999996554434 456789999999988653
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.33 E-value=2.7e-12 Score=122.67 Aligned_cols=105 Identities=26% Similarity=0.345 Sum_probs=77.3
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|+|++|.+++ + +.+.++++|++|+|++|.+++..|..++.+++|++|+|++|++++..|..++++++|++|+|
T Consensus 63 ~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 140 (272)
T 3rfs_A 63 PNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNL 140 (272)
T ss_dssp TTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEEC
Confidence 367888888888875 3 36778888888888888888666666778888888888888888666666778888888888
Q ss_pred CCCcCcccCCch---hhccccccccCCccc
Q 010887 156 SSNNLTGRIPMQ---LFSVATFNFTGTHLI 182 (498)
Q Consensus 156 ~~N~l~g~ip~~---~~~~~~~~~~~n~~~ 182 (498)
++|.+++..|.. +.++..+++++|...
T Consensus 141 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 170 (272)
T 3rfs_A 141 AHNQLQSLPKGVFDKLTNLTELDLSYNQLQ 170 (272)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCccCccCHHHhccCccCCEEECCCCCcC
Confidence 888888544432 345677777777653
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.33 E-value=2.7e-12 Score=136.69 Aligned_cols=126 Identities=15% Similarity=0.192 Sum_probs=71.2
Q ss_pred CCCCCCCCCCCCCC----CcceeEecC------------------CceeEEEecccccCccccccccccCCCCeEEccCC
Q 010887 53 QFTDWNDHFVSPCF----SWSHVTCRN------------------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDN 110 (498)
Q Consensus 53 ~l~~w~~~~~~~c~----~w~gv~c~~------------------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n 110 (498)
.+++|.+. .+|| .|.++.|+. .+++.|++++|.+....+..+.++++|++|+|++|
T Consensus 8 ~l~~~~~~--~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n 85 (597)
T 3oja_B 8 NVKPRQPE--YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDL 85 (597)
T ss_dssp ---CCCSE--ECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTS
T ss_pred cccCCCCC--CcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCC
Confidence 46788765 4555 377666641 13455666666666322233555666666666666
Q ss_pred CCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCCCCcCcccCCch----hhccccccccCCcc
Q 010887 111 DLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ----LFSVATFNFTGTHL 181 (498)
Q Consensus 111 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~----~~~~~~~~~~~n~~ 181 (498)
.|++..|..|+.+++|++|+|++|.+++..|..|+++++|++|+|++|.|+ .+|.. +.++..+++++|..
T Consensus 86 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~Ls~N~l 159 (597)
T 3oja_B 86 QIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNL 159 (597)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCC-CCCHHHhccCCCCCEEEeeCCcC
Confidence 666555556666666666666666666555555666666666666666666 34432 23445555666544
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.33 E-value=1.6e-12 Score=129.65 Aligned_cols=105 Identities=24% Similarity=0.300 Sum_probs=84.7
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|.++++|+.|+|
T Consensus 64 ~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 143 (361)
T 2xot_A 64 TNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYL 143 (361)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred cccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEEC
Confidence 37888999999998666667888899999999999988666667888888999999999888777888888888888888
Q ss_pred CCCcCcccCCchh-------hccccccccCCcc
Q 010887 156 SSNNLTGRIPMQL-------FSVATFNFTGTHL 181 (498)
Q Consensus 156 ~~N~l~g~ip~~~-------~~~~~~~~~~n~~ 181 (498)
++|+|+ .+|..+ .++..+++++|.+
T Consensus 144 ~~N~l~-~l~~~~~~~~~~l~~L~~L~L~~N~l 175 (361)
T 2xot_A 144 SQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKL 175 (361)
T ss_dssp CSSCCC-SCCGGGTC----CTTCCEEECCSSCC
T ss_pred CCCcCC-eeCHHHhcCcccCCcCCEEECCCCCC
Confidence 888888 566543 4566677777765
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.33 E-value=1.7e-12 Score=132.99 Aligned_cols=107 Identities=25% Similarity=0.375 Sum_probs=78.2
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|+|++|+++ .+| .+..+++|++|+|++|.|++..|..|..+++|++|+|++|++++..|..|.++++|+.|+|+
T Consensus 186 ~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 263 (440)
T 3zyj_A 186 NLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLA 263 (440)
T ss_dssp SCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECT
T ss_pred ccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECC
Confidence 4566666666666 454 36677777777777777777667778888888888888888887777778888888888888
Q ss_pred CCcCcccCCch----hhccccccccCCccccCCC
Q 010887 157 SNNLTGRIPMQ----LFSVATFNFTGTHLICGSS 186 (498)
Q Consensus 157 ~N~l~g~ip~~----~~~~~~~~~~~n~~~~~~~ 186 (498)
+|+|++ +|.. +.++..+++++|++.|.+.
T Consensus 264 ~N~l~~-~~~~~~~~l~~L~~L~L~~Np~~CdC~ 296 (440)
T 3zyj_A 264 HNNLTL-LPHDLFTPLHHLERIHLHHNPWNCNCD 296 (440)
T ss_dssp TSCCCC-CCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred CCCCCc-cChhHhccccCCCEEEcCCCCccCCCC
Confidence 888884 4432 3456777888888888764
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.33 E-value=7.6e-13 Score=123.90 Aligned_cols=103 Identities=15% Similarity=0.191 Sum_probs=88.1
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCC-CCCccCcccccccccceeeccc-ccccCCCCCcccCCCCCCeE
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDND-LSGTLPDFLGSMTHLQSLNLAN-NKFSGSIPATWSQLSNLKHL 153 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~-l~g~~p~~~~~l~~L~~L~l~~-N~l~g~~p~~~~~l~~L~~l 153 (498)
.+++.|+|++|++++..+..|+++++|++|+|++|. +++..|..|..+++|++|+|++ |++++..|..|.++++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 479999999999996666689999999999999997 8855556899999999999998 99996666789999999999
Q ss_pred eCCCCcCcccCCc--hhhccc---cccccCC
Q 010887 154 DLSSNNLTGRIPM--QLFSVA---TFNFTGT 179 (498)
Q Consensus 154 ~l~~N~l~g~ip~--~~~~~~---~~~~~~n 179 (498)
++++|.+++ +|. .+.++. .+++++|
T Consensus 111 ~l~~n~l~~-lp~~~~l~~L~~L~~L~l~~N 140 (239)
T 2xwt_C 111 GIFNTGLKM-FPDLTKVYSTDIFFILEITDN 140 (239)
T ss_dssp EEEEECCCS-CCCCTTCCBCCSEEEEEEESC
T ss_pred eCCCCCCcc-ccccccccccccccEEECCCC
Confidence 999999995 885 334445 7778888
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.32 E-value=9.4e-13 Score=113.67 Aligned_cols=88 Identities=31% Similarity=0.347 Sum_probs=80.1
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCC-CCCcccCCCCCCeEe
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS-IPATWSQLSNLKHLD 154 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~-~p~~~~~l~~L~~l~ 154 (498)
.+++.|+|++|.+++. +.++++++|++|+|++|.+++.+|..+..+++|++|+|++|++++. .|..+.++++|++|+
T Consensus 42 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~ 119 (149)
T 2je0_A 42 EELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLD 119 (149)
T ss_dssp TTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEE
T ss_pred CCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEe
Confidence 4899999999999965 7799999999999999999988999998999999999999999963 458899999999999
Q ss_pred CCCCcCcccCC
Q 010887 155 LSSNNLTGRIP 165 (498)
Q Consensus 155 l~~N~l~g~ip 165 (498)
+++|.+++..+
T Consensus 120 l~~N~l~~~~~ 130 (149)
T 2je0_A 120 LFNCEVTNLND 130 (149)
T ss_dssp CTTCGGGGSTT
T ss_pred CcCCcccchHH
Confidence 99999996544
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.32 E-value=4e-12 Score=122.67 Aligned_cols=101 Identities=21% Similarity=0.341 Sum_probs=61.8
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|+|++|.|++ ++.. +.+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus 56 ~L~~L~L~~n~l~~-~~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~ 132 (290)
T 1p9a_G 56 RLTQLNLDRAELTK-LQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLK 132 (290)
T ss_dssp TCCEEECTTSCCCE-EECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECT
T ss_pred CCCEEECCCCccCc-ccCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECC
Confidence 56666666666663 3332 56666666666666666 566666666666666666666665445556666666666666
Q ss_pred CCcCcccCCch----hhccccccccCCcc
Q 010887 157 SNNLTGRIPMQ----LFSVATFNFTGTHL 181 (498)
Q Consensus 157 ~N~l~g~ip~~----~~~~~~~~~~~n~~ 181 (498)
+|+|++ +|.. +.++..+++++|..
T Consensus 133 ~N~l~~-~~~~~~~~l~~L~~L~L~~N~l 160 (290)
T 1p9a_G 133 GNELKT-LPPGLLTPTPKLEKLSLANNNL 160 (290)
T ss_dssp TSCCCC-CCTTTTTTCTTCCEEECTTSCC
T ss_pred CCCCCc-cChhhcccccCCCEEECCCCcC
Confidence 666663 3332 23455566666654
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.31 E-value=2.5e-12 Score=132.17 Aligned_cols=107 Identities=23% Similarity=0.353 Sum_probs=84.1
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|+|++|++++ +| .+..+++|++|+|++|.|++..|..|.++++|++|+|++|++++..|..|.++++|+.|+|+
T Consensus 197 ~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 274 (452)
T 3zyi_A 197 NLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLA 274 (452)
T ss_dssp TCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECC
Confidence 56667777777773 44 47778888888888888887778888888888888888888888778888888888999999
Q ss_pred CCcCcccCCch----hhccccccccCCccccCCC
Q 010887 157 SNNLTGRIPMQ----LFSVATFNFTGTHLICGSS 186 (498)
Q Consensus 157 ~N~l~g~ip~~----~~~~~~~~~~~n~~~~~~~ 186 (498)
+|+|+ .+|.. +.++..+++++|++.|.+.
T Consensus 275 ~N~l~-~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 275 HNNLS-SLPHDLFTPLRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp SSCCS-CCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred CCcCC-ccChHHhccccCCCEEEccCCCcCCCCC
Confidence 88888 44432 3456778889998888765
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.31 E-value=2e-12 Score=117.33 Aligned_cols=103 Identities=21% Similarity=0.255 Sum_probs=73.5
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|+|++|.++ . ++.+..+++|++|+|++|.+++..|..++.+++|++|+|++|++++..|..++++++|++|+|+
T Consensus 67 ~L~~L~l~~n~~~-~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~ 144 (197)
T 4ezg_A 67 NIKDLTINNIHAT-N-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLS 144 (197)
T ss_dssp TCSEEEEESCCCS-C-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECC
T ss_pred CCCEEEccCCCCC-c-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEcc
Confidence 6777888877655 2 3367777888888888888877777777788888888888888877777777778888888888
Q ss_pred CCcCcccCCc--hhhccccccccCCcc
Q 010887 157 SNNLTGRIPM--QLFSVATFNFTGTHL 181 (498)
Q Consensus 157 ~N~l~g~ip~--~~~~~~~~~~~~n~~ 181 (498)
+|.+-+.+|. .+.++..+++++|..
T Consensus 145 ~n~~i~~~~~l~~l~~L~~L~l~~n~i 171 (197)
T 4ezg_A 145 YNGAITDIMPLKTLPELKSLNIQFDGV 171 (197)
T ss_dssp SCTBCCCCGGGGGCSSCCEEECTTBCC
T ss_pred CCCCccccHhhcCCCCCCEEECCCCCC
Confidence 8873335652 234456677777654
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=3.2e-12 Score=122.27 Aligned_cols=105 Identities=21% Similarity=0.204 Sum_probs=90.1
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|+|++|++++..+..|.++++|++|+|++|++++..|..+..+++|++|+|++|++++..|..|.++++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 58999999999997666689999999999999999997667789999999999999999998777889999999999999
Q ss_pred CCcCcccCCchh---hccccccccCCcc
Q 010887 157 SNNLTGRIPMQL---FSVATFNFTGTHL 181 (498)
Q Consensus 157 ~N~l~g~ip~~~---~~~~~~~~~~n~~ 181 (498)
+|.+++..+..+ .++..+++++|..
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l 136 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLI 136 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCC
T ss_pred CCCccccCchhcccCCCCCEEECcCCcc
Confidence 999996544333 5667788888865
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.30 E-value=7.5e-13 Score=143.83 Aligned_cols=104 Identities=25% Similarity=0.365 Sum_probs=93.5
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|+|++|.|+ .+|++|++|++|++|+|++|.|+ .+|..|++|++|++|+|++|.|+ .||..|++|++|++|+|
T Consensus 247 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L 323 (727)
T 4b8c_D 247 DFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGV 323 (727)
T ss_dssp CSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEEC
T ss_pred CCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeC
Confidence 47899999999999 99999999999999999999999 89999999999999999999998 89999999999999999
Q ss_pred CCCcCcccCCchhhcc----ccccccCCccc
Q 010887 156 SSNNLTGRIPMQLFSV----ATFNFTGTHLI 182 (498)
Q Consensus 156 ~~N~l~g~ip~~~~~~----~~~~~~~n~~~ 182 (498)
++|.|+|.+|..+..+ ..+++.+|.+.
T Consensus 324 ~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~ 354 (727)
T 4b8c_D 324 EGNPLEKQFLKILTEKSVTGLIFYLRDNRPE 354 (727)
T ss_dssp TTSCCCSHHHHHHHHHHHHHHHHHHHHCCCC
T ss_pred CCCccCCCChHHHhhcchhhhHHhhccCccc
Confidence 9999999999877543 22456666553
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.30 E-value=3.7e-12 Score=136.61 Aligned_cols=104 Identities=18% Similarity=0.322 Sum_probs=59.1
Q ss_pred ceeEEEecccccCcccccccc--ccCCCCeEEccCCCCCCccCcccccccccceeec------ccccccCCCCCcccCCC
Q 010887 77 NVISLTLGSNGFSGKISPSIT--KLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNL------ANNKFSGSIPATWSQLS 148 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~--~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l------~~N~l~g~~p~~~~~l~ 148 (498)
+++.|+|++|+|+ .+|..+. .+++|++|+|++|+|++ +|..++++++|++|+| ++|++.+.+|..+++++
T Consensus 489 ~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~ 566 (636)
T 4eco_A 489 LLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCP 566 (636)
T ss_dssp GCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCS
T ss_pred CccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCC
Confidence 4555566666655 5555554 55666666666666654 5555556666666655 34555555665565666
Q ss_pred CCCeEeCCCCcCcccCCchh-hccccccccCCcccc
Q 010887 149 NLKHLDLSSNNLTGRIPMQL-FSVATFNFTGTHLIC 183 (498)
Q Consensus 149 ~L~~l~l~~N~l~g~ip~~~-~~~~~~~~~~n~~~~ 183 (498)
+|++|+|++|+| +.||..+ .++..+++++|+..|
T Consensus 567 ~L~~L~Ls~N~l-~~ip~~~~~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 567 SLTQLQIGSNDI-RKVNEKITPNISVLDIKDNPNIS 601 (636)
T ss_dssp SCCEEECCSSCC-CBCCSCCCTTCCEEECCSCTTCE
T ss_pred CCCEEECCCCcC-CccCHhHhCcCCEEECcCCCCcc
Confidence 666666666666 3555543 344555555555544
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.29 E-value=3.7e-12 Score=113.35 Aligned_cols=90 Identities=22% Similarity=0.310 Sum_probs=80.1
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|+|++|+|++..+..++++++|++|+|++|+|++..|..+..+++|++|+|++|+|++..+..+.++++|++|+|
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 131 (177)
T 2o6r_A 52 TQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWL 131 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred ccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEe
Confidence 47999999999999666666899999999999999999776777899999999999999999655555788999999999
Q ss_pred CCCcCcccCC
Q 010887 156 SSNNLTGRIP 165 (498)
Q Consensus 156 ~~N~l~g~ip 165 (498)
++|.+++..|
T Consensus 132 ~~N~~~~~~~ 141 (177)
T 2o6r_A 132 HTNPWDCSCP 141 (177)
T ss_dssp CSSCBCCCHH
T ss_pred cCCCeeccCc
Confidence 9999998776
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=4.6e-12 Score=135.06 Aligned_cols=105 Identities=18% Similarity=0.235 Sum_probs=73.1
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|+|++|++++..+..|+++++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..|+++++|++|+|+
T Consensus 33 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 112 (606)
T 3vq2_A 33 STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAV 112 (606)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECT
T ss_pred CcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEcc
Confidence 57777777777776666677777777777777777776666677777777777777777776667777777777777777
Q ss_pred CCcCcccCCchh---hccccccccCCcc
Q 010887 157 SNNLTGRIPMQL---FSVATFNFTGTHL 181 (498)
Q Consensus 157 ~N~l~g~ip~~~---~~~~~~~~~~n~~ 181 (498)
+|.+++..|..+ .++..+++++|..
T Consensus 113 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l 140 (606)
T 3vq2_A 113 ETKLASLESFPIGQLITLKKLNVAHNFI 140 (606)
T ss_dssp TSCCCCSSSSCCTTCTTCCEEECCSSCC
T ss_pred CCccccccccccCCCCCCCEEeCCCCcc
Confidence 777764333333 3445566666654
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=4.4e-12 Score=114.68 Aligned_cols=90 Identities=24% Similarity=0.289 Sum_probs=81.7
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|+|++|.|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|.++++|+.|+|
T Consensus 54 ~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 133 (193)
T 2wfh_A 54 KHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAI 133 (193)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEe
Confidence 48999999999999777778999999999999999999877888999999999999999999655557999999999999
Q ss_pred CCCcCcccCC
Q 010887 156 SSNNLTGRIP 165 (498)
Q Consensus 156 ~~N~l~g~ip 165 (498)
++|.+.+.-.
T Consensus 134 ~~N~~~C~c~ 143 (193)
T 2wfh_A 134 GANPLYCDCN 143 (193)
T ss_dssp CSSCEECSGG
T ss_pred CCCCeecCCc
Confidence 9999986544
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=2.9e-12 Score=142.07 Aligned_cols=115 Identities=19% Similarity=0.188 Sum_probs=73.2
Q ss_pred CcceeEecCCceeEEEecccccCccccccccccCCCCeEEccCCCCCCcc-CcccccccccceeecccccccCCCCCccc
Q 010887 67 SWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTL-PDFLGSMTHLQSLNLANNKFSGSIPATWS 145 (498)
Q Consensus 67 ~w~gv~c~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~-p~~~~~l~~L~~L~l~~N~l~g~~p~~~~ 145 (498)
.|..|.+...+++.|+|++|.|++..|.+|.++++|++|+|++|.+.+.+ |..|++|++|++|+|++|++++..|..|+
T Consensus 15 ~L~~vP~lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~ 94 (844)
T 3j0a_A 15 NLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQ 94 (844)
T ss_dssp CSSCCCSSCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSC
T ss_pred CCCCCCCCCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHcc
Confidence 56666664457788888888877666666666666666666666555555 55566666666666666666665666666
Q ss_pred CCCCCCeEeCCCCcCcccCCch-----hhccccccccCCcc
Q 010887 146 QLSNLKHLDLSSNNLTGRIPMQ-----LFSVATFNFTGTHL 181 (498)
Q Consensus 146 ~l~~L~~l~l~~N~l~g~ip~~-----~~~~~~~~~~~n~~ 181 (498)
++++|++|+|++|.+++.+|.. +.++..+++++|..
T Consensus 95 ~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l 135 (844)
T 3j0a_A 95 GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQI 135 (844)
T ss_dssp SCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCC
T ss_pred CCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcc
Confidence 6666666666666666555432 23444555555543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.28 E-value=3.3e-12 Score=135.03 Aligned_cols=105 Identities=21% Similarity=0.357 Sum_probs=66.0
Q ss_pred ceeEEEecccccCcccc-ccccccCCCCeEEccCCCCCCccCcccccccccceeeccccccc-CCCCCcccCCCCCCeEe
Q 010887 77 NVISLTLGSNGFSGKIS-PSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFS-GSIPATWSQLSNLKHLD 154 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~-~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~-g~~p~~~~~l~~L~~l~ 154 (498)
+++.|+|++|.+++..| ..+.++++|++|+|++|.+++.+|..+..+++|++|+|++|+++ +.+|..+..+++|++|+
T Consensus 397 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~ 476 (570)
T 2z63_A 397 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476 (570)
T ss_dssp TCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred CCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEE
Confidence 56666777777665544 34666666666666666666666666666666666666666665 45666666666666666
Q ss_pred CCCCcCcccCCchhh---ccccccccCCcc
Q 010887 155 LSSNNLTGRIPMQLF---SVATFNFTGTHL 181 (498)
Q Consensus 155 l~~N~l~g~ip~~~~---~~~~~~~~~n~~ 181 (498)
|++|++++..|..+. ++..+++++|..
T Consensus 477 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 506 (570)
T 2z63_A 477 LSQCQLEQLSPTAFNSLSSLQVLNMASNQL 506 (570)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CCCCccccCChhhhhcccCCCEEeCCCCcC
Confidence 666666655554443 345556666544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=4.8e-12 Score=133.42 Aligned_cols=87 Identities=26% Similarity=0.332 Sum_probs=82.1
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCC-CCcccCCCCCCeEe
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI-PATWSQLSNLKHLD 154 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~-p~~~~~l~~L~~l~ 154 (498)
.+++.|+|++|+|+ .+|..|++|++|++|+|++|+|++ +| .++.|++|++|+|++|+|++.+ |..|+++++|+.|+
T Consensus 463 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~ 539 (567)
T 1dce_A 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN 539 (567)
T ss_dssp TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEE
T ss_pred ccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEE
Confidence 48999999999999 999999999999999999999996 88 8999999999999999999877 99999999999999
Q ss_pred CCCCcCcccCC
Q 010887 155 LSSNNLTGRIP 165 (498)
Q Consensus 155 l~~N~l~g~ip 165 (498)
|++|+|++..|
T Consensus 540 L~~N~l~~~~~ 550 (567)
T 1dce_A 540 LQGNSLCQEEG 550 (567)
T ss_dssp CTTSGGGGSSS
T ss_pred ecCCcCCCCcc
Confidence 99999997655
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.26 E-value=9.1e-12 Score=115.80 Aligned_cols=109 Identities=27% Similarity=0.330 Sum_probs=94.6
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|+ .+|..+.++++|++|+|
T Consensus 64 ~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L 142 (229)
T 3e6j_A 64 INLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLAL 142 (229)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEEC
T ss_pred cCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEEC
Confidence 37999999999998554556899999999999999999766667899999999999999999 89999999999999999
Q ss_pred CCCcCcccCCch---hhccccccccCCccccCC
Q 010887 156 SSNNLTGRIPMQ---LFSVATFNFTGTHLICGS 185 (498)
Q Consensus 156 ~~N~l~g~ip~~---~~~~~~~~~~~n~~~~~~ 185 (498)
++|+|++..+.. +.++..+++.+|++.|.+
T Consensus 143 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 143 DQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred CCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 999999433333 356788999999998864
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=2.8e-11 Score=114.77 Aligned_cols=146 Identities=16% Similarity=0.125 Sum_probs=112.3
Q ss_pred HhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCccceEEEEEEcCCceEEEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 347 (498)
..+.|+....++.|+.+.||++... ++.+++|+...... .....+.+|.++++.+. +..+.+++++....+..++||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 4456777778888899999999854 68999999864221 22345889999999885 667888999998888899999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC----------------------------------- 392 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~----------------------------------- 392 (498)
||++|.++.+.+.. ......++.+++++|+.||+..
T Consensus 90 e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 90 SEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp ECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 99999998775321 1123478889999999999810
Q ss_pred ---------------------CCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 393 ---------------------NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 393 ---------------------~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
.+.++|+|+++.||+++++..+.|+||+.+..-
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence 135899999999999987656679999987533
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=6.9e-12 Score=133.73 Aligned_cols=115 Identities=17% Similarity=0.163 Sum_probs=98.6
Q ss_pred cceeEecC-----------CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccc
Q 010887 68 WSHVTCRN-----------GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKF 136 (498)
Q Consensus 68 w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l 136 (498)
+..|.|.. ..++.|+|++|.|++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|++
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 56678853 3689999999999988788999999999999999999988899999999999999999999
Q ss_pred cCCCCCcccCCCCCCeEeCCCCcCcccCCch---hhccccccccCCccc
Q 010887 137 SGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ---LFSVATFNFTGTHLI 182 (498)
Q Consensus 137 ~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~---~~~~~~~~~~~n~~~ 182 (498)
++..|..|+++++|++|+|++|.+++..|.. +.++..+++++|...
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~ 142 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS 142 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCC
T ss_pred cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCccc
Confidence 9888999999999999999999999643433 456677888888764
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=1e-11 Score=122.01 Aligned_cols=101 Identities=18% Similarity=0.312 Sum_probs=51.4
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|+|++|+++ .+|..+. ++|++|+|++|.+++..|..+..+++|++|+|++|++++..|..+.++++|++|+|+
T Consensus 172 ~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 248 (330)
T 1xku_A 172 KLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 248 (330)
T ss_dssp TCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECC
T ss_pred CcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECC
Confidence 4555555555555 3444332 455555555555554445555555555555555555554444455555555555555
Q ss_pred CCcCcccCCchhh---ccccccccCCcc
Q 010887 157 SNNLTGRIPMQLF---SVATFNFTGTHL 181 (498)
Q Consensus 157 ~N~l~g~ip~~~~---~~~~~~~~~n~~ 181 (498)
+|.++ .+|..+. ++..+++++|+.
T Consensus 249 ~N~l~-~lp~~l~~l~~L~~L~l~~N~i 275 (330)
T 1xku_A 249 NNKLV-KVPGGLADHKYIQVVYLHNNNI 275 (330)
T ss_dssp SSCCS-SCCTTTTTCSSCCEEECCSSCC
T ss_pred CCcCc-cCChhhccCCCcCEEECCCCcC
Confidence 55555 4554332 234444555543
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.25 E-value=5.3e-12 Score=112.26 Aligned_cols=100 Identities=19% Similarity=0.218 Sum_probs=58.1
Q ss_pred ceeEEEecccccCccccccccccC-CCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCc-ccCCCCCCeEe
Q 010887 77 NVISLTLGSNGFSGKISPSITKLK-FLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPAT-WSQLSNLKHLD 154 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~-~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~l~ 154 (498)
+++.|+|++|+++ .+|. +..+. +|++|+|++|.|++. +.++.+++|++|+|++|+|++ +|+. +.++++|++|+
T Consensus 20 ~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~ 94 (176)
T 1a9n_A 20 RDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICR-IGEGLDQALPDLTELI 94 (176)
T ss_dssp SCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCE-ECSCHHHHCTTCCEEE
T ss_pred CceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccc-cCcchhhcCCCCCEEE
Confidence 5666666666666 3433 44444 666666666666643 456666666666666666663 3333 36666666666
Q ss_pred CCCCcCcccCCc--hh---hccccccccCCccc
Q 010887 155 LSSNNLTGRIPM--QL---FSVATFNFTGTHLI 182 (498)
Q Consensus 155 l~~N~l~g~ip~--~~---~~~~~~~~~~n~~~ 182 (498)
|++|.|+ .+|. .+ .++..+++++|+..
T Consensus 95 L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~ 126 (176)
T 1a9n_A 95 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 126 (176)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred CCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC
Confidence 6666664 4554 33 33455566666553
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.25 E-value=7.6e-12 Score=111.25 Aligned_cols=99 Identities=17% Similarity=0.248 Sum_probs=84.0
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcc-cccccccceeecccccccCCCCC--cccCCCCCCeE
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDF-LGSMTHLQSLNLANNKFSGSIPA--TWSQLSNLKHL 153 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~-~~~l~~L~~L~l~~N~l~g~~p~--~~~~l~~L~~l 153 (498)
+++.|+|++|.|++. +.++.+++|++|+|++|.|++ +|+. +..+++|++|+|++|+++ .+|. .+.++++|+.|
T Consensus 43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L 118 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICR-IGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYL 118 (176)
T ss_dssp CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCE-ECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEE
T ss_pred CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccc-cCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEE
Confidence 899999999999964 679999999999999999995 5544 599999999999999996 7887 89999999999
Q ss_pred eCCCCcCcccCCch----hh---ccccccccCCc
Q 010887 154 DLSSNNLTGRIPMQ----LF---SVATFNFTGTH 180 (498)
Q Consensus 154 ~l~~N~l~g~ip~~----~~---~~~~~~~~~n~ 180 (498)
++++|.++ .+|.. +. ++..+++++|.
T Consensus 119 ~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~ 151 (176)
T 1a9n_A 119 CILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVK 151 (176)
T ss_dssp ECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECC
T ss_pred EecCCCCC-CcHhHHHHHHHHCCccceeCCCcCC
Confidence 99999999 67764 43 44556666654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.25 E-value=1.8e-12 Score=136.25 Aligned_cols=103 Identities=26% Similarity=0.391 Sum_probs=79.2
Q ss_pred Cccee-EecCCceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCccc
Q 010887 67 SWSHV-TCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWS 145 (498)
Q Consensus 67 ~w~gv-~c~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~ 145 (498)
.|.|+ .|...+++.|+|++|+|++ +|+.+. ++|++|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +.
T Consensus 49 ~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~ 119 (571)
T 3cvr_A 49 AVSLLKECLINQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LP 119 (571)
T ss_dssp HHHHHHHHHHTTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CC
T ss_pred hhhhccccccCCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hh
Confidence 59999 7887789999999999996 887663 78888888888888 677 456788888888888885 776 55
Q ss_pred CCCCCCeEeCCCCcCcccCCchhhccccccccCCcc
Q 010887 146 QLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHL 181 (498)
Q Consensus 146 ~l~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~n~~ 181 (498)
+ +|++|+|++|+|++ +|..+.++..+++++|..
T Consensus 120 ~--~L~~L~Ls~N~l~~-lp~~l~~L~~L~Ls~N~l 152 (571)
T 3cvr_A 120 A--SLKHLDVDNNQLTM-LPELPALLEYINADNNQL 152 (571)
T ss_dssp T--TCCEEECCSSCCSC-CCCCCTTCCEEECCSSCC
T ss_pred c--CCCEEECCCCcCCC-CCCcCccccEEeCCCCcc
Confidence 4 77777777777775 666555666677777654
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.25 E-value=9.4e-12 Score=123.19 Aligned_cols=110 Identities=23% Similarity=0.179 Sum_probs=87.0
Q ss_pred CceeEEEecc-cccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEe
Q 010887 76 GNVISLTLGS-NGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 154 (498)
Q Consensus 76 ~~v~~l~l~~-~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ 154 (498)
.+++.|+|++ |.|++..|..|++|++|++|+|++|+|++..|..|.+|++|++|||++|+|++..|..+..++ |+.|+
T Consensus 31 ~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~ 109 (347)
T 2ifg_A 31 ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELV 109 (347)
T ss_dssp SCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEE
T ss_pred CCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEE
Confidence 3799999996 999977778899999999999999999998888999999999999999999965555565555 99999
Q ss_pred CCCCcCcccCCc-hhhc---cccccccCCccccCCC
Q 010887 155 LSSNNLTGRIPM-QLFS---VATFNFTGTHLICGSS 186 (498)
Q Consensus 155 l~~N~l~g~ip~-~~~~---~~~~~~~~n~~~~~~~ 186 (498)
|++|.|...-.. .+.. .....+..+...|..+
T Consensus 110 l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~ 145 (347)
T 2ifg_A 110 LSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQ 145 (347)
T ss_dssp CCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSS
T ss_pred eeCCCccCCCccHHHHHHHHhCcccccccCCCCCCC
Confidence 999999964331 1211 1233445566667543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=1.3e-11 Score=118.04 Aligned_cols=106 Identities=15% Similarity=0.235 Sum_probs=86.6
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|+|++|++++..+..|.++++|++|+|++|.+++..|..+..+++|++|+|++|++++..+..++++++|++|+|
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 131 (276)
T 2z62_A 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131 (276)
T ss_dssp TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred cCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEEC
Confidence 37889999999998666667888999999999999998777788888999999999999998766667888999999999
Q ss_pred CCCcCcc-cCCchhh---ccccccccCCcc
Q 010887 156 SSNNLTG-RIPMQLF---SVATFNFTGTHL 181 (498)
Q Consensus 156 ~~N~l~g-~ip~~~~---~~~~~~~~~n~~ 181 (498)
++|.+++ .+|..+. ++..+++++|..
T Consensus 132 ~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l 161 (276)
T 2z62_A 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161 (276)
T ss_dssp CSSCCCCCCCCGGGGGCTTCCEEECCSSCC
T ss_pred cCCccceecCchhhccCCCCCEEECCCCCC
Confidence 9999885 4676654 456677777754
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=6.1e-12 Score=134.13 Aligned_cols=93 Identities=24% Similarity=0.216 Sum_probs=52.1
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCc---cCcccccccccceeecccccccCCCCCcccCCCCCCeE
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGT---LPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHL 153 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~---~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l 153 (498)
+++.|+|++|.+++..|..++.+++|++|+|++|.+++. .+..+..+++|++|+|++|++++..|..|.++++|++|
T Consensus 426 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 505 (606)
T 3t6q_A 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHV 505 (606)
T ss_dssp TCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred cCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEE
Confidence 455666666666655555555566666666666655542 22345555555555555555555555555555555555
Q ss_pred eCCCCcCcccCCchhh
Q 010887 154 DLSSNNLTGRIPMQLF 169 (498)
Q Consensus 154 ~l~~N~l~g~ip~~~~ 169 (498)
+|++|++++.+|..+.
T Consensus 506 ~Ls~N~l~~~~~~~l~ 521 (606)
T 3t6q_A 506 DLSHNRLTSSSIEALS 521 (606)
T ss_dssp ECCSSCCCGGGGGGGT
T ss_pred ECCCCccCcCChhHhC
Confidence 5555555555554443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.24 E-value=2.1e-12 Score=141.95 Aligned_cols=106 Identities=25% Similarity=0.408 Sum_probs=94.3
Q ss_pred CceeEEEecccccCc-----------------ccccccc--ccCCCCeEEccCCCCCCccCcccccccccceeeccccc-
Q 010887 76 GNVISLTLGSNGFSG-----------------KISPSIT--KLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK- 135 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g-----------------~~~~~~~--~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~- 135 (498)
.+++.|+|++|.|+| .+|++++ +|++|++|+|++|++.|.+|..|++|++|++|+|++|+
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~ 527 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG 527 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCC
Confidence 489999999999998 4999988 99999999999999999999999999999999999998
Q ss_pred ccC-CCCCcccCCC-------CCCeEeCCCCcCcccCCc--hhh---ccccccccCCccc
Q 010887 136 FSG-SIPATWSQLS-------NLKHLDLSSNNLTGRIPM--QLF---SVATFNFTGTHLI 182 (498)
Q Consensus 136 l~g-~~p~~~~~l~-------~L~~l~l~~N~l~g~ip~--~~~---~~~~~~~~~n~~~ 182 (498)
|+| .+|..+++++ +|++|+|++|.|+ .+|. .+. ++..+++++|...
T Consensus 528 lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~ 586 (876)
T 4ecn_A 528 ISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR 586 (876)
T ss_dssp SCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC
T ss_pred cccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc
Confidence 998 8998777665 9999999999999 8998 554 5577888888764
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.24 E-value=9.3e-12 Score=125.29 Aligned_cols=104 Identities=17% Similarity=0.233 Sum_probs=86.1
Q ss_pred ceeEEEecccccCcccccc-ccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 77 NVISLTLGSNGFSGKISPS-ITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~-~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
+++.|++++|.++ .+|+. +.++++|++|+|++|.+++..|..|..+++|++|+|++|++++..|..|+++++|++|+|
T Consensus 46 ~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 46 NQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 5778999999988 56654 688999999999999998766778999999999999999999777778899999999999
Q ss_pred CCCcCcccCCch----hhccccccccCCccc
Q 010887 156 SSNNLTGRIPMQ----LFSVATFNFTGTHLI 182 (498)
Q Consensus 156 ~~N~l~g~ip~~----~~~~~~~~~~~n~~~ 182 (498)
++|.++ .+|.. +.++..+++++|...
T Consensus 125 ~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~ 154 (390)
T 3o6n_A 125 ERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE 154 (390)
T ss_dssp CSSCCC-CCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCccC-cCCHHHhcCCCCCcEEECCCCccC
Confidence 999998 67754 346677888888653
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.24 E-value=6.2e-12 Score=130.09 Aligned_cols=109 Identities=22% Similarity=0.320 Sum_probs=94.2
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|+|++|++++..+..+.++++|++|+|++|.+++..+..|..+++|+.|+|++|++++..|..|.++++|+.|+|+
T Consensus 225 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 304 (477)
T 2id5_A 225 NLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVS 304 (477)
T ss_dssp CCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECC
T ss_pred cccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECC
Confidence 68889999999994433578999999999999999997778889999999999999999998889999999999999999
Q ss_pred CCcCcccCCch----hhccccccccCCccccCCC
Q 010887 157 SNNLTGRIPMQ----LFSVATFNFTGTHLICGSS 186 (498)
Q Consensus 157 ~N~l~g~ip~~----~~~~~~~~~~~n~~~~~~~ 186 (498)
+|+|++ +|.. +.++..+++++|++.|.+.
T Consensus 305 ~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~c~c~ 337 (477)
T 2id5_A 305 GNQLTT-LEESVFHSVGNLETLILDSNPLACDCR 337 (477)
T ss_dssp SSCCSC-CCGGGBSCGGGCCEEECCSSCEECSGG
T ss_pred CCcCce-eCHhHcCCCcccCEEEccCCCccCccc
Confidence 999995 5543 3567889999999988753
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.23 E-value=8.7e-12 Score=113.02 Aligned_cols=100 Identities=14% Similarity=0.226 Sum_probs=80.6
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|+|++|+++ .+| .+..+++|++|+|++|.++ .++.+..+++|++|+|++|++++..|..++++++|++|+|+
T Consensus 45 ~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls 120 (197)
T 4ezg_A 45 SLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120 (197)
T ss_dssp TCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECC
T ss_pred CccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEec
Confidence 6888888888888 667 6888888888888888665 34478888888888888888888788888888888888888
Q ss_pred CCcCcccCCchhh---ccccccccCCc
Q 010887 157 SNNLTGRIPMQLF---SVATFNFTGTH 180 (498)
Q Consensus 157 ~N~l~g~ip~~~~---~~~~~~~~~n~ 180 (498)
+|.+++..|..+. ++..+++++|.
T Consensus 121 ~n~i~~~~~~~l~~l~~L~~L~L~~n~ 147 (197)
T 4ezg_A 121 HSAHDDSILTKINTLPKVNSIDLSYNG 147 (197)
T ss_dssp SSBCBGGGHHHHTTCSSCCEEECCSCT
T ss_pred CCccCcHhHHHHhhCCCCCEEEccCCC
Confidence 8888876776554 45667788876
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=1.5e-11 Score=132.89 Aligned_cols=105 Identities=25% Similarity=0.306 Sum_probs=75.2
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|+|++|++++..+..|+++++|++|+|++|.+++..|..++++++|++|+|++|++++..+..|+++++|++|+|+
T Consensus 26 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~ 105 (680)
T 1ziw_A 26 NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLM 105 (680)
T ss_dssp TCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECC
T ss_pred CCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECC
Confidence 67788888888886666678888888888888888887777777778888888888887774333457777777777777
Q ss_pred CCcCcccCCchh---hccccccccCCcc
Q 010887 157 SNNLTGRIPMQL---FSVATFNFTGTHL 181 (498)
Q Consensus 157 ~N~l~g~ip~~~---~~~~~~~~~~n~~ 181 (498)
+|.+++..|..+ .++..+++++|..
T Consensus 106 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 133 (680)
T 1ziw_A 106 SNSIQKIKNNPFVKQKNLITLDLSHNGL 133 (680)
T ss_dssp SSCCCCCCSCTTTTCTTCCEEECCSSCC
T ss_pred CCccCccChhHccccCCCCEEECCCCcc
Confidence 777774443433 3456666776654
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.23 E-value=1.2e-11 Score=120.10 Aligned_cols=107 Identities=20% Similarity=0.339 Sum_probs=87.2
Q ss_pred CceeEEEecccccCcccc-ccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccC-CCCCcccCCCCCCeE
Q 010887 76 GNVISLTLGSNGFSGKIS-PSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG-SIPATWSQLSNLKHL 153 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~-~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~l 153 (498)
.+++.|+|++|++++..+ ..+.++++|++|+|++|.+++..|..+..+++|++|+|++|.+++ .+|..+.++++|++|
T Consensus 101 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 180 (306)
T 2z66_A 101 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 180 (306)
T ss_dssp TTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred CCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEE
Confidence 478888999998885544 478888999999999999888888888888999999999998886 578888888999999
Q ss_pred eCCCCcCcccCCchh---hccccccccCCccc
Q 010887 154 DLSSNNLTGRIPMQL---FSVATFNFTGTHLI 182 (498)
Q Consensus 154 ~l~~N~l~g~ip~~~---~~~~~~~~~~n~~~ 182 (498)
+|++|.+++..|..+ .++..+++++|...
T Consensus 181 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 212 (306)
T 2z66_A 181 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF 212 (306)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECTTSCCS
T ss_pred ECCCCCcCCcCHHHhcCCCCCCEEECCCCccC
Confidence 999999887666655 45677788888754
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.22 E-value=5.7e-12 Score=126.86 Aligned_cols=101 Identities=20% Similarity=0.268 Sum_probs=87.2
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|+|++|.+++. +.+..+++|++|+|++|.+++..|..+..+++|++|+|++|+++ .+|..+..+++|++|+|+
T Consensus 227 ~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~ 303 (390)
T 3o6n_A 227 ELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLS 303 (390)
T ss_dssp SCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCC-EEECSSSCCTTCCEEECC
T ss_pred cccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCc-ccCcccCCCCCCCEEECC
Confidence 788999999999864 57899999999999999999888999999999999999999998 577778889999999999
Q ss_pred CCcCcccCCchh---hccccccccCCcc
Q 010887 157 SNNLTGRIPMQL---FSVATFNFTGTHL 181 (498)
Q Consensus 157 ~N~l~g~ip~~~---~~~~~~~~~~n~~ 181 (498)
+|+++ .+|..+ .++..+++++|+.
T Consensus 304 ~n~l~-~~~~~~~~l~~L~~L~L~~N~i 330 (390)
T 3o6n_A 304 HNHLL-HVERNQPQFDRLENLYLDHNSI 330 (390)
T ss_dssp SSCCC-CCGGGHHHHTTCSEEECCSSCC
T ss_pred CCcce-ecCccccccCcCCEEECCCCcc
Confidence 99998 677654 5667788888875
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.22 E-value=8.6e-12 Score=130.47 Aligned_cols=107 Identities=23% Similarity=0.260 Sum_probs=90.4
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCC--ccCcccccccccceeecccccccCCCCCc-ccCCCCCCe
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSG--TLPDFLGSMTHLQSLNLANNKFSGSIPAT-WSQLSNLKH 152 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~ 152 (498)
.+++.|+|++|.+++.+|..++++++|++|+|++|++++ .+|..++.+++|++|+|++|++++.+|.. +..+++|++
T Consensus 324 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~ 403 (520)
T 2z7x_B 324 SPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLS 403 (520)
T ss_dssp CCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCE
T ss_pred CcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCE
Confidence 478889999999998888889999999999999999986 67788888999999999999998767765 778888899
Q ss_pred EeCCCCcCcccCCchh-hccccccccCCccc
Q 010887 153 LDLSSNNLTGRIPMQL-FSVATFNFTGTHLI 182 (498)
Q Consensus 153 l~l~~N~l~g~ip~~~-~~~~~~~~~~n~~~ 182 (498)
|+|++|.+++.+|..+ .++..+++++|...
T Consensus 404 L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~ 434 (520)
T 2z7x_B 404 LNMSSNILTDTIFRCLPPRIKVLDLHSNKIK 434 (520)
T ss_dssp EECCSSCCCGGGGGSCCTTCCEEECCSSCCC
T ss_pred EECcCCCCCcchhhhhcccCCEEECCCCccc
Confidence 9999998888888777 47888888888654
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.22 E-value=1.3e-11 Score=130.35 Aligned_cols=102 Identities=25% Similarity=0.369 Sum_probs=64.7
Q ss_pred ceeEEEecccccCc--cccccccccCCCCeEEccCCCCCCccCcc-cccccccceeecccccccCCCCCcccCCCCCCeE
Q 010887 77 NVISLTLGSNGFSG--KISPSITKLKFLASLELQDNDLSGTLPDF-LGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHL 153 (498)
Q Consensus 77 ~v~~l~l~~~~l~g--~~~~~~~~l~~L~~L~l~~n~l~g~~p~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l 153 (498)
+++.|+|++|++++ .+|..++++++|++|+|++|.+++.+|.. +..+++|++|+|++|++++.+|..+. ++|+.|
T Consensus 378 ~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L 455 (562)
T 3a79_B 378 RLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVL 455 (562)
T ss_dssp SCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEE
T ss_pred CCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEE
Confidence 67777888877775 33456777777777777777777656654 55666666666666666665555443 456666
Q ss_pred eCCCCcCcccCCchhh---ccccccccCCcc
Q 010887 154 DLSSNNLTGRIPMQLF---SVATFNFTGTHL 181 (498)
Q Consensus 154 ~l~~N~l~g~ip~~~~---~~~~~~~~~n~~ 181 (498)
+|++|+|+ .||..++ ++..+++++|..
T Consensus 456 ~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l 485 (562)
T 3a79_B 456 DLHNNRIM-SIPKDVTHLQALQELNVASNQL 485 (562)
T ss_dssp ECCSSCCC-CCCTTTTSSCCCSEEECCSSCC
T ss_pred ECCCCcCc-ccChhhcCCCCCCEEECCCCCC
Confidence 66666666 5555443 334455555554
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.22 E-value=1.5e-11 Score=128.67 Aligned_cols=104 Identities=27% Similarity=0.340 Sum_probs=79.6
Q ss_pred CceeEEEecccccCc--cccccccccCCCCeEEccCCCCCCccCcc-cccccccceeecccccccCCCCCcccCCCCCCe
Q 010887 76 GNVISLTLGSNGFSG--KISPSITKLKFLASLELQDNDLSGTLPDF-LGSMTHLQSLNLANNKFSGSIPATWSQLSNLKH 152 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g--~~~~~~~~l~~L~~L~l~~n~l~g~~p~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~ 152 (498)
.+++.|+|++|++++ .+|..++++++|++|+|++|.+++.+|.. +..+++|++|+|++|++++.+|..+. ++|+.
T Consensus 348 ~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~ 425 (520)
T 2z7x_B 348 TELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKV 425 (520)
T ss_dssp SSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCE
T ss_pred CCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCE
Confidence 378888888888886 56677888888888888888888767765 67788888888888888777776654 67888
Q ss_pred EeCCCCcCcccCCchhh---ccccccccCCccc
Q 010887 153 LDLSSNNLTGRIPMQLF---SVATFNFTGTHLI 182 (498)
Q Consensus 153 l~l~~N~l~g~ip~~~~---~~~~~~~~~n~~~ 182 (498)
|+|++|+++ .+|..++ ++..+++++|...
T Consensus 426 L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~ 457 (520)
T 2z7x_B 426 LDLHSNKIK-SIPKQVVKLEALQELNVASNQLK 457 (520)
T ss_dssp EECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC
T ss_pred EECCCCccc-ccchhhhcCCCCCEEECCCCcCC
Confidence 888888887 7776553 4466677777653
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.21 E-value=1.8e-11 Score=119.24 Aligned_cols=105 Identities=20% Similarity=0.192 Sum_probs=87.7
Q ss_pred ceeEEEecccccCccccccc--cccCCCCeEEccCCCCCCccC----cccccccccceeecccccccCCCCCcccCCCCC
Q 010887 77 NVISLTLGSNGFSGKISPSI--TKLKFLASLELQDNDLSGTLP----DFLGSMTHLQSLNLANNKFSGSIPATWSQLSNL 150 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~--~~l~~L~~L~l~~n~l~g~~p----~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L 150 (498)
+++.|+|++|.+++.+|..+ +.+++|++|+|++|.+++..| ..+..+++|++|+|++|++++..|..++++++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 48999999999999999888 899999999999999998766 345678999999999999998888889999999
Q ss_pred CeEeCCCCcCccc--C-----CchhhccccccccCCcc
Q 010887 151 KHLDLSSNNLTGR--I-----PMQLFSVATFNFTGTHL 181 (498)
Q Consensus 151 ~~l~l~~N~l~g~--i-----p~~~~~~~~~~~~~n~~ 181 (498)
++|+|++|++.+. + +..+.++..+++++|..
T Consensus 172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l 209 (310)
T 4glp_A 172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGM 209 (310)
T ss_dssp CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCC
T ss_pred CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCC
Confidence 9999999998752 2 12455677788888765
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.21 E-value=6.2e-12 Score=122.54 Aligned_cols=105 Identities=21% Similarity=0.316 Sum_probs=86.4
Q ss_pred CceeEEEecccccCcc--ccc--cccccCCCCeEEccCCCCCCccCc----ccccccccceeecccccccCCCCCcccCC
Q 010887 76 GNVISLTLGSNGFSGK--ISP--SITKLKFLASLELQDNDLSGTLPD----FLGSMTHLQSLNLANNKFSGSIPATWSQL 147 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~--~~~--~~~~l~~L~~L~l~~n~l~g~~p~----~~~~l~~L~~L~l~~N~l~g~~p~~~~~l 147 (498)
.+++.|+|++|++.+. ++. .++.+++|++|+|++|+++ .+|. .++.+++|++|||++|+|++.+|+.+..+
T Consensus 169 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 247 (310)
T 4glp_A 169 PALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC 247 (310)
T ss_dssp TTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred CCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence 4799999999998863 332 3478999999999999997 4444 25778999999999999998889888877
Q ss_pred ---CCCCeEeCCCCcCcccCCchh-hccccccccCCccc
Q 010887 148 ---SNLKHLDLSSNNLTGRIPMQL-FSVATFNFTGTHLI 182 (498)
Q Consensus 148 ---~~L~~l~l~~N~l~g~ip~~~-~~~~~~~~~~n~~~ 182 (498)
++|++|+|++|+|+ .+|..+ .++..+++++|...
T Consensus 248 ~~~~~L~~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N~l~ 285 (310)
T 4glp_A 248 MWSSALNSLNLSFAGLE-QVPKGLPAKLRVLDLSSNRLN 285 (310)
T ss_dssp CCCTTCCCEECCSSCCC-SCCSCCCSCCSCEECCSCCCC
T ss_pred cCcCcCCEEECCCCCCC-chhhhhcCCCCEEECCCCcCC
Confidence 69999999999999 788766 47888899998764
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.19 E-value=1.8e-11 Score=129.45 Aligned_cols=107 Identities=23% Similarity=0.298 Sum_probs=96.5
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCC--ccCcccccccccceeecccccccCCCCCc-ccCCCCCCe
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSG--TLPDFLGSMTHLQSLNLANNKFSGSIPAT-WSQLSNLKH 152 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~ 152 (498)
.+++.|+|++|.+++.+|..++++++|++|+|++|++++ .+|..++++++|++|+|++|++++.+|.. +..+++|++
T Consensus 353 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~ 432 (562)
T 3a79_B 353 SSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILV 432 (562)
T ss_dssp CCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCE
T ss_pred CCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCE
Confidence 479999999999999899999999999999999999996 45678999999999999999999877765 888999999
Q ss_pred EeCCCCcCcccCCchh-hccccccccCCccc
Q 010887 153 LDLSSNNLTGRIPMQL-FSVATFNFTGTHLI 182 (498)
Q Consensus 153 l~l~~N~l~g~ip~~~-~~~~~~~~~~n~~~ 182 (498)
|+|++|++++.+|..+ .++..+++++|...
T Consensus 433 L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~ 463 (562)
T 3a79_B 433 LNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM 463 (562)
T ss_dssp EECCSSCCCGGGGSSCCTTCSEEECCSSCCC
T ss_pred EECCCCCCCcchhhhhcCcCCEEECCCCcCc
Confidence 9999999999999888 58999999999764
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.19 E-value=3.1e-11 Score=128.56 Aligned_cols=107 Identities=18% Similarity=0.162 Sum_probs=84.3
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|+|++|.|++..|..|+.+++|++|+|++|.|++..|..|+++++|++|+|++|.|++..|..|+++++|++|+|
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 36888888888888777778888888888888888888777777888888888888888888444444688888888888
Q ss_pred CCCcCcccCCchh---hccccccccCCccc
Q 010887 156 SSNNLTGRIPMQL---FSVATFNFTGTHLI 182 (498)
Q Consensus 156 ~~N~l~g~ip~~~---~~~~~~~~~~n~~~ 182 (498)
++|.|++..|..+ .++..+++++|...
T Consensus 155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 184 (597)
T 3oja_B 155 SNNNLERIEDDTFQATTSLQNLQLSSNRLT 184 (597)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECTTSCCS
T ss_pred eCCcCCCCChhhhhcCCcCcEEECcCCCCC
Confidence 8888887666544 45667777877653
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.19 E-value=1.7e-11 Score=120.52 Aligned_cols=101 Identities=21% Similarity=0.288 Sum_probs=58.5
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|+|++|+++ .+|..+. ++|++|+|++|.+++..|..+..+++|++|+|++|++++..|..+..+++|+.|+|+
T Consensus 173 ~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 249 (332)
T 2ft3_A 173 KLNYLRISEAKLT-GIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLD 249 (332)
T ss_dssp CCSCCBCCSSBCS-SCCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECC
T ss_pred ccCEEECcCCCCC-ccCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECC
Confidence 4555666666666 3554443 566666666666665555556666666666666666665555556666666666666
Q ss_pred CCcCcccCCchhh---ccccccccCCcc
Q 010887 157 SNNLTGRIPMQLF---SVATFNFTGTHL 181 (498)
Q Consensus 157 ~N~l~g~ip~~~~---~~~~~~~~~n~~ 181 (498)
+|+++ .+|..+. ++..+++++|+.
T Consensus 250 ~N~l~-~lp~~l~~l~~L~~L~l~~N~l 276 (332)
T 2ft3_A 250 NNKLS-RVPAGLPDLKLLQVVYLHTNNI 276 (332)
T ss_dssp SSCCC-BCCTTGGGCTTCCEEECCSSCC
T ss_pred CCcCe-ecChhhhcCccCCEEECCCCCC
Confidence 66666 5555443 334455555554
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.18 E-value=6.1e-12 Score=122.70 Aligned_cols=106 Identities=14% Similarity=0.196 Sum_probs=89.9
Q ss_pred CceeEEEecccccCcccccccccc-----CCCCeEEccCCCCCCccCcccccccccceeecccccccCC--CCCcc--cC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKL-----KFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS--IPATW--SQ 146 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l-----~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~--~p~~~--~~ 146 (498)
.+++.|+|++|++++. |+.++.+ ++|++|+|++|++++..|..|+.+++|++|+|++|+++|. +|..+ ++
T Consensus 121 ~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 199 (312)
T 1wwl_A 121 PDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLK 199 (312)
T ss_dssp CCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTS
T ss_pred CCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhcc
Confidence 4899999999999977 8888888 9999999999999988889999999999999999999876 34455 88
Q ss_pred CCCCCeEeCCCCcCcc--cCCchh----hccccccccCCccc
Q 010887 147 LSNLKHLDLSSNNLTG--RIPMQL----FSVATFNFTGTHLI 182 (498)
Q Consensus 147 l~~L~~l~l~~N~l~g--~ip~~~----~~~~~~~~~~n~~~ 182 (498)
+++|++|+|++|.|++ .+|..+ .++..+++++|...
T Consensus 200 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~ 241 (312)
T 1wwl_A 200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLR 241 (312)
T ss_dssp CTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCC
T ss_pred CCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCC
Confidence 9999999999999993 344433 47888999998763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.17 E-value=5.4e-11 Score=112.36 Aligned_cols=130 Identities=14% Similarity=0.046 Sum_probs=97.4
Q ss_pred ecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCc--cceEEEEEEcCCceEEEEecccCCCHHH
Q 010887 280 GQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN--LLQLIGYCTTSSERILVYPFMQNLSVAY 357 (498)
Q Consensus 280 G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~ 357 (498)
+.|..+.||++...+|+.+++|..... ....+.+|.++++.+.+.+ +.+++++....+..++||||++|.++.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence 456669999998777888999987643 2245778999999887555 455888888777889999999998873
Q ss_pred hhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------------
Q 010887 358 RLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC--------------------------------------------- 392 (498)
Q Consensus 358 ~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--------------------------------------------- 392 (498)
... .+ ...++.++++.|+.||+..
T Consensus 104 -~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 104 -SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp -TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred -cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 211 11 2356777888888888641
Q ss_pred ----------CCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 393 ----------NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 393 ----------~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
...++|+|++|.||+++++..+.|+||+.+...
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 113999999999999987766679999987643
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.17 E-value=4.3e-11 Score=129.42 Aligned_cols=90 Identities=18% Similarity=0.295 Sum_probs=60.5
Q ss_pred ccccCCCCeEEccCCCCCCccCc-ccccccccceeecccccccCCCCCcccCCCCCCeEeCCCCcCcccCCc----hhhc
Q 010887 96 ITKLKFLASLELQDNDLSGTLPD-FLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPM----QLFS 170 (498)
Q Consensus 96 ~~~l~~L~~L~l~~n~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~----~~~~ 170 (498)
+.++++|++|+|++|+++ .+|. .|..+++|++|+|++|++++..|..|.++++|+.|+|++|+|++..|. .+.+
T Consensus 532 ~~~l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~ 610 (680)
T 1ziw_A 532 LKGLSHLHILNLESNGFD-EIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRN 610 (680)
T ss_dssp TTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTT
T ss_pred hcCCCCCCEEECCCCCCC-CCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccc
Confidence 455555666666666665 4443 467777777777777777754444567777788888888887754443 2456
Q ss_pred cccccccCCccccCCC
Q 010887 171 VATFNFTGTHLICGSS 186 (498)
Q Consensus 171 ~~~~~~~~n~~~~~~~ 186 (498)
+..+++++|++.|.++
T Consensus 611 L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 611 LTELDMRFNPFDCTCE 626 (680)
T ss_dssp CSEEECTTCCCCBCCC
T ss_pred cCEEEccCCCcccCCc
Confidence 6778888888888764
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.13 E-value=4.1e-11 Score=117.05 Aligned_cols=104 Identities=22% Similarity=0.186 Sum_probs=82.8
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccc-cccccceeecccccccCCCCCcccCCCCCCeEe
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLG-SMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 154 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ 154 (498)
.+++.|+|++|++++..|..++.+++|++|+|++|.+++..|..+. .+++|++|+|++|++++ +|. ...+++|++|+
T Consensus 120 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~-~~~l~~L~~L~ 197 (317)
T 3o53_A 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKG-QVVFAKLKTLD 197 (317)
T ss_dssp SSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE-EEC-CCCCTTCCEEE
T ss_pred CCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc-ccc-ccccccCCEEE
Confidence 3688999999999977777888999999999999999977777764 68899999999999884 443 33588899999
Q ss_pred CCCCcCcccCCchh---hccccccccCCccc
Q 010887 155 LSSNNLTGRIPMQL---FSVATFNFTGTHLI 182 (498)
Q Consensus 155 l~~N~l~g~ip~~~---~~~~~~~~~~n~~~ 182 (498)
|++|.++ .+|..+ .++..+++++|...
T Consensus 198 Ls~N~l~-~l~~~~~~l~~L~~L~L~~N~l~ 227 (317)
T 3o53_A 198 LSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227 (317)
T ss_dssp CCSSCCC-EECGGGGGGTTCSEEECTTSCCC
T ss_pred CCCCcCC-cchhhhcccCcccEEECcCCccc
Confidence 9999998 466554 45677788888764
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=3.2e-11 Score=126.93 Aligned_cols=106 Identities=24% Similarity=0.359 Sum_probs=88.5
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccC-CCCCcccCCCCCCeEe
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSG-SIPATWSQLSNLKHLD 154 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~l~ 154 (498)
.+++.|+|++|++++..|..|+++++|++|+|++|.+++..|..|+++++|++|+|++|++++ .+|..++++++|++|+
T Consensus 50 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~ 129 (549)
T 2z81_A 50 ANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR 129 (549)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEE
T ss_pred CcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEE
Confidence 478999999999998777889999999999999999997777779999999999999999986 4677889999999999
Q ss_pred CCCCcCcccCCc-hh---hccccccccCCcc
Q 010887 155 LSSNNLTGRIPM-QL---FSVATFNFTGTHL 181 (498)
Q Consensus 155 l~~N~l~g~ip~-~~---~~~~~~~~~~n~~ 181 (498)
+++|.+.+.+|. .+ .++..+++++|..
T Consensus 130 L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l 160 (549)
T 2z81_A 130 IGNVETFSEIRRIDFAGLTSLNELEIKALSL 160 (549)
T ss_dssp EEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred CCCCccccccCHhhhhcccccCeeeccCCcc
Confidence 999986667764 33 4556777777765
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.12 E-value=9.6e-11 Score=123.75 Aligned_cols=105 Identities=15% Similarity=0.242 Sum_probs=60.2
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|+|++|++++..|..|+++++|++|+|++|.+++..|..|+.+++|++|+|++|++++..+..++++++|++|+|+
T Consensus 53 ~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~ 132 (570)
T 2z63_A 53 ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132 (570)
T ss_dssp SCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECC
T ss_pred CceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEecC
Confidence 45566666666664444556666666666666666665445556666666666666666653333346666666666666
Q ss_pred CCcCcc-cCCchhh---ccccccccCCcc
Q 010887 157 SNNLTG-RIPMQLF---SVATFNFTGTHL 181 (498)
Q Consensus 157 ~N~l~g-~ip~~~~---~~~~~~~~~n~~ 181 (498)
+|.+++ .+|..+. ++..+++++|..
T Consensus 133 ~n~l~~~~lp~~~~~l~~L~~L~l~~n~l 161 (570)
T 2z63_A 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161 (570)
T ss_dssp SSCCCCCCCCGGGGGCTTCCEEECTTSCC
T ss_pred CCccceecChhhhcccCCCCEEeCcCCcc
Confidence 666664 3555443 344555555543
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.12 E-value=3.6e-11 Score=124.63 Aligned_cols=33 Identities=15% Similarity=0.008 Sum_probs=26.3
Q ss_pred cchHHHHHHHHHHHHhccCCccceEEEEEEcCC
Q 010887 309 PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS 341 (498)
Q Consensus 309 ~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 341 (498)
..+.++|.+|++.+.+++|+|+|+++|||....
T Consensus 320 ~~g~~eF~~Eve~L~~i~HrNLV~L~gyC~s~~ 352 (487)
T 3oja_A 320 GQGSETERLECERENQARQREIDALKEQYRTVI 352 (487)
T ss_dssp -----CHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred cccHHHHHHHHHHHhcccccchhhHHHHhcChH
Confidence 345788999999999999999999999997765
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.10 E-value=8.1e-11 Score=109.98 Aligned_cols=104 Identities=16% Similarity=0.221 Sum_probs=85.9
Q ss_pred CceeEEEecccc-cCccccccccccCCCCeEEccC-CCCCCccCcccccccccceeecccccccCCCCCcccCCCCCC--
Q 010887 76 GNVISLTLGSNG-FSGKISPSITKLKFLASLELQD-NDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLK-- 151 (498)
Q Consensus 76 ~~v~~l~l~~~~-l~g~~~~~~~~l~~L~~L~l~~-n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~-- 151 (498)
.+++.|+|++|. +++..+..|.++++|++|+|++ |++++..|..|..+++|++|+|++|++++ +|. +.++++|+
T Consensus 55 ~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L 132 (239)
T 2xwt_C 55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIF 132 (239)
T ss_dssp TTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSE
T ss_pred CCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccc
Confidence 379999999997 8855555899999999999998 99996666789999999999999999995 887 88899998
Q ss_pred -eEeCCCC-cCcccCCchh---hccc-cccccCCcc
Q 010887 152 -HLDLSSN-NLTGRIPMQL---FSVA-TFNFTGTHL 181 (498)
Q Consensus 152 -~l~l~~N-~l~g~ip~~~---~~~~-~~~~~~n~~ 181 (498)
+|++++| .+++..+..+ .++. .+++++|..
T Consensus 133 ~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l 168 (239)
T 2xwt_C 133 FILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF 168 (239)
T ss_dssp EEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCC
T ss_pred cEEECCCCcchhhcCcccccchhcceeEEEcCCCCC
Confidence 9999999 8984333334 4556 788888865
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.09 E-value=4e-10 Score=111.98 Aligned_cols=143 Identities=13% Similarity=0.156 Sum_probs=105.9
Q ss_pred CCeeecccceEEEEEEEcCCcEEEEEEec--ccCCcchHHHHHHHHHHHHhcc--CCccceEEEEEEcC---CceEEEEe
Q 010887 276 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQ--DYYSPGGEAAFQREVHLISVAI--HKNLLQLIGYCTTS---SERILVYP 348 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e 348 (498)
.+.++.|.++.||+....+ ..+++|+.. ..........+.+|.++++.+. +..+.+++.++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 5678999999999998754 678888765 3221123457788999999987 45578888888766 34789999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC------------------------------------ 392 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------ 392 (498)
|++|..+.+.. ...++..++..++.++++.|+.||+..
T Consensus 122 ~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 122 FVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred ecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99987764311 224678888899999999999999731
Q ss_pred -------------------CCCcEEcCCCCCcEEECCCCc--EEEeecCccccc
Q 010887 393 -------------------NPKIIHRDLKAANILLDDNFE--AVLCDFGLAKLV 425 (498)
Q Consensus 393 -------------------~~~ivH~Dlk~~NILl~~~~~--~ki~DfGl~~~~ 425 (498)
.+.++|||+++.||++++++. +.|+||+.+..-
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 247999999999999987753 689999988644
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.08 E-value=1e-10 Score=115.93 Aligned_cols=100 Identities=19% Similarity=0.268 Sum_probs=85.1
Q ss_pred C-CCcceeEecC-----------CceeEEEecccccCccccc-cccccCCCCeEEccCCCCCCccCc-ccccccccce-e
Q 010887 65 C-FSWSHVTCRN-----------GNVISLTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGTLPD-FLGSMTHLQS-L 129 (498)
Q Consensus 65 c-~~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~-~~~~l~~L~~L~l~~n~l~g~~p~-~~~~l~~L~~-L 129 (498)
| |+|..|.|+. .+++.|+|++|+|+ .+|+ .|.+|++|++|+|++|++.+.+|. .|.+|++|+. +
T Consensus 7 C~C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l 85 (350)
T 4ay9_X 7 CHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR 85 (350)
T ss_dssp SEEETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEE
T ss_pred cEeeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhh
Confidence 5 6899999974 26889999999999 5664 699999999999999999878875 5788998775 6
Q ss_pred ecccccccCCCCCcccCCCCCCeEeCCCCcCcccCC
Q 010887 130 NLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP 165 (498)
Q Consensus 130 ~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip 165 (498)
+++.|++++..|..|.++++|++|++++|.|++..+
T Consensus 86 ~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~ 121 (350)
T 4ay9_X 86 IEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPD 121 (350)
T ss_dssp EEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCC
T ss_pred cccCCcccccCchhhhhccccccccccccccccCCc
Confidence 778899997778889999999999999999994333
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.07 E-value=2.5e-12 Score=116.73 Aligned_cols=102 Identities=23% Similarity=0.290 Sum_probs=83.0
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|+|++|++++ +| .+.++++|++|+|++|.++ .+|..+..+++|++|+|++|++++ +| .+.++++|++|+|
T Consensus 48 ~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l 122 (198)
T 1ds9_A 48 KACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEE
T ss_pred CCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEEC
Confidence 478899999999985 77 8888999999999999998 788888888999999999999985 66 6888889999999
Q ss_pred CCCcCcccCCc-----hhhccccccccCCcccc
Q 010887 156 SSNNLTGRIPM-----QLFSVATFNFTGTHLIC 183 (498)
Q Consensus 156 ~~N~l~g~ip~-----~~~~~~~~~~~~n~~~~ 183 (498)
++|++++ +|. .+.++..+++++|+..+
T Consensus 123 ~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~l~~ 154 (198)
T 1ds9_A 123 SNNKITN-WGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp SEEECCC-HHHHHHHTTTTTCSEEEECSCHHHH
T ss_pred CCCcCCc-hhHHHHHhcCCCCCEEEecCCcccc
Confidence 9999883 332 34466778888887644
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.06 E-value=2.4e-11 Score=129.11 Aligned_cols=114 Identities=24% Similarity=0.466 Sum_probs=77.4
Q ss_pred CCCCCCCCCCCCCCcceeE--------ecCCceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccc
Q 010887 54 FTDWNDHFVSPCFSWSHVT--------CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTH 125 (498)
Q Consensus 54 l~~w~~~~~~~c~~w~gv~--------c~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~ 125 (498)
+.+|... .+||.|.|.. |...+++.|++++|+|+ .+|..+. ++|++|+|++|+|+ .+|. .+++
T Consensus 12 w~~W~~~--~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~ 82 (622)
T 3g06_A 12 WSAWRRA--APAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPE 82 (622)
T ss_dssp HHHHHHT--CCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTT
T ss_pred HHHHHhc--CCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCC
Confidence 4456543 4566886643 23346788888888888 7777665 67888888888877 5666 4677
Q ss_pred cceeecccccccCCCCCcccCCCCCCeEeCCCCcCcccCCchhhccccccccCCcc
Q 010887 126 LQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHL 181 (498)
Q Consensus 126 L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~n~~ 181 (498)
|++|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|..+.++..+++++|..
T Consensus 83 L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~l~~~l~~L~~L~L~~N~l 133 (622)
T 3g06_A 83 LRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLT-HLPALPSGLCKLWIFGNQL 133 (622)
T ss_dssp CCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCC-CCCCCCTTCCEEECCSSCC
T ss_pred CCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCC-CCCCCCCCcCEEECCCCCC
Confidence 778888888777 5665 5567777777777777 4555556666666666654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.04 E-value=3.6e-12 Score=115.66 Aligned_cols=101 Identities=21% Similarity=0.332 Sum_probs=87.9
Q ss_pred ceeEEEecccccCccccc------cccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCC
Q 010887 77 NVISLTLGSNGFSGKISP------SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNL 150 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~------~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L 150 (498)
+++.++|+.+.++|.+|+ .++++++|++|+|++|.+++ +| .+..+++|++|+|++|+++ .+|..+..+++|
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 566777888888888776 89999999999999999996 88 9999999999999999999 899888889999
Q ss_pred CeEeCCCCcCcccCCc--hhhccccccccCCcc
Q 010887 151 KHLDLSSNNLTGRIPM--QLFSVATFNFTGTHL 181 (498)
Q Consensus 151 ~~l~l~~N~l~g~ip~--~~~~~~~~~~~~n~~ 181 (498)
++|+|++|.+++ +|. .+.++..+++++|..
T Consensus 96 ~~L~L~~N~l~~-l~~~~~l~~L~~L~l~~N~i 127 (198)
T 1ds9_A 96 EELWISYNQIAS-LSGIEKLVNLRVLYMSNNKI 127 (198)
T ss_dssp SEEEEEEEECCC-HHHHHHHHHSSEEEESEEEC
T ss_pred CEEECcCCcCCc-CCccccCCCCCEEECCCCcC
Confidence 999999999995 663 234677888888865
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.04 E-value=2.4e-10 Score=110.17 Aligned_cols=101 Identities=31% Similarity=0.429 Sum_probs=80.8
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|+|++|.+++ +| .+..+++|++|+|++|++++ + +.+..+++|++|+|++|++++. +.+.++++|+.|+|
T Consensus 90 ~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L 163 (291)
T 1h6t_A 90 KNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSL 163 (291)
T ss_dssp TTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEEC
T ss_pred CCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEc
Confidence 478999999999985 44 48899999999999999985 4 4688899999999999999854 57888999999999
Q ss_pred CCCcCcccCC-chhhccccccccCCccc
Q 010887 156 SSNNLTGRIP-MQLFSVATFNFTGTHLI 182 (498)
Q Consensus 156 ~~N~l~g~ip-~~~~~~~~~~~~~n~~~ 182 (498)
++|.+++..| ..+.++..+++++|...
T Consensus 164 ~~N~l~~~~~l~~l~~L~~L~L~~N~i~ 191 (291)
T 1h6t_A 164 EDNQISDIVPLAGLTKLQNLYLSKNHIS 191 (291)
T ss_dssp CSSCCCCCGGGTTCTTCCEEECCSSCCC
T ss_pred cCCccccchhhcCCCccCEEECCCCcCC
Confidence 9999985444 12345677888888653
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.04 E-value=1.4e-10 Score=115.04 Aligned_cols=105 Identities=24% Similarity=0.317 Sum_probs=88.5
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCC--cccCCCCCCeE
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPA--TWSQLSNLKHL 153 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~--~~~~l~~L~~l 153 (498)
.+++.|+|++|++++..|..|+++++|++|+|++|++++..+..++++++|++|+|++|+++ .+|. .+.++++|++|
T Consensus 76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L 154 (353)
T 2z80_A 76 VNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQIL 154 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEE
T ss_pred CCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEE
Confidence 48999999999999877888999999999999999999544444899999999999999999 5665 78999999999
Q ss_pred eCCCCc-CcccCCchh---hccccccccCCcc
Q 010887 154 DLSSNN-LTGRIPMQL---FSVATFNFTGTHL 181 (498)
Q Consensus 154 ~l~~N~-l~g~ip~~~---~~~~~~~~~~n~~ 181 (498)
++++|. +++..|..+ .++..+++++|..
T Consensus 155 ~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l 186 (353)
T 2z80_A 155 RVGNMDTFTKIQRKDFAGLTFLEELEIDASDL 186 (353)
T ss_dssp EEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred ECCCCccccccCHHHccCCCCCCEEECCCCCc
Confidence 999995 664444444 4567788888865
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.03 E-value=2.2e-10 Score=113.10 Aligned_cols=102 Identities=27% Similarity=0.414 Sum_probs=79.6
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|+|++|++++ +++ +..+++|++|+|++|.+++ + +.+..+++|++|+|++|++++ +| .+..+++|+.|++
T Consensus 221 ~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~L 294 (347)
T 4fmz_A 221 TRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISD-IS-VLNNLSQLNSLFL 294 (347)
T ss_dssp TTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEEC
T ss_pred CcCCEEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCC-Ch-hhcCCCCCCEEEC
Confidence 478889999999884 444 8888899999999998885 4 467888888888888888885 43 5788888888888
Q ss_pred CCCcCcccCCchh---hccccccccCCcccc
Q 010887 156 SSNNLTGRIPMQL---FSVATFNFTGTHLIC 183 (498)
Q Consensus 156 ~~N~l~g~ip~~~---~~~~~~~~~~n~~~~ 183 (498)
++|.+++..|..+ .++..+++++|+...
T Consensus 295 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 325 (347)
T 4fmz_A 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325 (347)
T ss_dssp CSSCCCGGGHHHHHTCTTCSEEECCSSSCCC
T ss_pred cCCcCCCcChhHhhccccCCEEEccCCcccc
Confidence 8888887666544 456677888887644
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.02 E-value=4.1e-10 Score=118.27 Aligned_cols=92 Identities=25% Similarity=0.370 Sum_probs=68.4
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +.+ +|++|+|++|+|++ +|. .+++|+.|+|+
T Consensus 81 ~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls 148 (571)
T 3cvr_A 81 QITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINAD 148 (571)
T ss_dssp TCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECC
T ss_pred CCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCC
Confidence 6788888888888 677 456788888888888885 776 655 78888888888875 666 56777777777
Q ss_pred CCcCcccCCchhhccccccccCCcc
Q 010887 157 SNNLTGRIPMQLFSVATFNFTGTHL 181 (498)
Q Consensus 157 ~N~l~g~ip~~~~~~~~~~~~~n~~ 181 (498)
+|.|++ +|..+.++..+++++|.+
T Consensus 149 ~N~l~~-lp~~l~~L~~L~Ls~N~L 172 (571)
T 3cvr_A 149 NNQLTM-LPELPTSLEVLSVRNNQL 172 (571)
T ss_dssp SSCCSC-CCCCCTTCCEEECCSSCC
T ss_pred CCccCc-CCCcCCCcCEEECCCCCC
Confidence 777774 776666777777777764
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.02 E-value=8.3e-11 Score=114.90 Aligned_cols=98 Identities=23% Similarity=0.264 Sum_probs=84.6
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|+|++|++++..|..|.++++|++|+|++|.+++..| +..+++|++|+|++|++++ +| ..++|++|+++
T Consensus 35 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~-l~----~~~~L~~L~l~ 107 (317)
T 3o53_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-LL----VGPSIETLHAA 107 (317)
T ss_dssp GCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEE-EE----ECTTCCEEECC
T ss_pred CCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccc-cc----CCCCcCEEECC
Confidence 78999999999998777889999999999999999996555 8999999999999999984 43 34889999999
Q ss_pred CCcCcccCCchhhccccccccCCcc
Q 010887 157 SNNLTGRIPMQLFSVATFNFTGTHL 181 (498)
Q Consensus 157 ~N~l~g~ip~~~~~~~~~~~~~n~~ 181 (498)
+|.+++..+..+.++..+++++|..
T Consensus 108 ~n~l~~~~~~~~~~L~~L~l~~N~l 132 (317)
T 3o53_A 108 NNNISRVSCSRGQGKKNIYLANNKI 132 (317)
T ss_dssp SSCCSEEEECCCSSCEEEECCSSCC
T ss_pred CCccCCcCccccCCCCEEECCCCCC
Confidence 9999977777778888888888876
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.01 E-value=6.4e-10 Score=105.55 Aligned_cols=100 Identities=28% Similarity=0.403 Sum_probs=76.1
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|+|++|+|++ +|+ +.++++|++|+|++|++++ +|.... ++|++|+|++|++++ +| .+.++++|+.|+|
T Consensus 63 ~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~L 135 (263)
T 1xeu_A 63 TNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLFLDNNELRD-TD-SLIHLKNLEILSI 135 (263)
T ss_dssp TTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEECCSSCCSB-SG-GGTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCC-cCcccc--CcccEEEccCCccCC-Ch-hhcCcccccEEEC
Confidence 478889999998884 444 8888899999999998884 554333 888888888888885 44 5888888999999
Q ss_pred CCCcCcccCCc--hhhccccccccCCcccc
Q 010887 156 SSNNLTGRIPM--QLFSVATFNFTGTHLIC 183 (498)
Q Consensus 156 ~~N~l~g~ip~--~~~~~~~~~~~~n~~~~ 183 (498)
++|++++ +|. .+.++..+++++|....
T Consensus 136 s~N~i~~-~~~l~~l~~L~~L~L~~N~i~~ 164 (263)
T 1xeu_A 136 RNNKLKS-IVMLGFLSKLEVLDLHGNEITN 164 (263)
T ss_dssp TTSCCCB-CGGGGGCTTCCEEECTTSCCCB
T ss_pred CCCcCCC-ChHHccCCCCCEEECCCCcCcc
Confidence 9998884 452 34556777888887643
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.00 E-value=6.9e-10 Score=105.30 Aligned_cols=99 Identities=19% Similarity=0.296 Sum_probs=83.5
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|+|++|+++ .+| .+..+++|++|+|++|+|++ +|+ +..+++|++|+|++|++++ +|... . ++|+.|+|
T Consensus 41 ~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~-l~~~~-~-~~L~~L~L 113 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKN-LNGIP-S-ACLSRLFL 113 (263)
T ss_dssp TTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSC-CTTCC-C-SSCCEEEC
T ss_pred CcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCC-cCccc-c-CcccEEEc
Confidence 47999999999999 677 79999999999999999995 554 9999999999999999995 66533 3 99999999
Q ss_pred CCCcCcccCCc--hhhccccccccCCccc
Q 010887 156 SSNNLTGRIPM--QLFSVATFNFTGTHLI 182 (498)
Q Consensus 156 ~~N~l~g~ip~--~~~~~~~~~~~~n~~~ 182 (498)
++|.+++ +|. .+.++..+++++|...
T Consensus 114 ~~N~l~~-~~~l~~l~~L~~L~Ls~N~i~ 141 (263)
T 1xeu_A 114 DNNELRD-TDSLIHLKNLEILSIRNNKLK 141 (263)
T ss_dssp CSSCCSB-SGGGTTCTTCCEEECTTSCCC
T ss_pred cCCccCC-ChhhcCcccccEEECCCCcCC
Confidence 9999995 553 3456778889988753
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.99 E-value=8e-10 Score=113.43 Aligned_cols=96 Identities=21% Similarity=0.344 Sum_probs=65.7
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|+|++|++++ +| +++++++|++|++++|++++ +|..+ ++|++|+|++|++++ +| .++++++|++|+++
T Consensus 132 ~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~ 203 (454)
T 1jl5_A 132 LLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYAD 203 (454)
T ss_dssp TCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECC
T ss_pred CCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECC
Confidence 56667777777764 66 47777777777777777774 56543 467777777777774 56 57777777777777
Q ss_pred CCcCcccCCchhhccccccccCCcc
Q 010887 157 SNNLTGRIPMQLFSVATFNFTGTHL 181 (498)
Q Consensus 157 ~N~l~g~ip~~~~~~~~~~~~~n~~ 181 (498)
+|.+++ +|....++..+++++|..
T Consensus 204 ~N~l~~-l~~~~~~L~~L~l~~n~l 227 (454)
T 1jl5_A 204 NNSLKK-LPDLPLSLESIVAGNNIL 227 (454)
T ss_dssp SSCCSS-CCCCCTTCCEEECCSSCC
T ss_pred CCcCCc-CCCCcCcccEEECcCCcC
Confidence 777774 665556677777777754
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.99 E-value=7.4e-10 Score=106.76 Aligned_cols=99 Identities=31% Similarity=0.461 Sum_probs=77.5
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|+|++|++++ +++ +.++++|++|+|++|.+++ +| .+..+++|++|+|++|++++ + +.+.++++|+.|+|
T Consensus 68 ~~L~~L~L~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l 141 (291)
T 1h6t_A 68 PNVTKLFLNGNKLTD-IKP-LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL 141 (291)
T ss_dssp TTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEEC
T ss_pred CCCCEEEccCCccCC-Ccc-cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEc
Confidence 478889999999885 444 8888999999999998884 44 48888999999999999885 4 46888889999999
Q ss_pred CCCcCcccCCc--hhhccccccccCCcc
Q 010887 156 SSNNLTGRIPM--QLFSVATFNFTGTHL 181 (498)
Q Consensus 156 ~~N~l~g~ip~--~~~~~~~~~~~~n~~ 181 (498)
++|.+++ ++. .+.++..+++++|..
T Consensus 142 ~~n~l~~-~~~l~~l~~L~~L~L~~N~l 168 (291)
T 1h6t_A 142 GNNKITD-ITVLSRLTKLDTLSLEDNQI 168 (291)
T ss_dssp CSSCCCC-CGGGGGCTTCSEEECCSSCC
T ss_pred cCCcCCc-chhhccCCCCCEEEccCCcc
Confidence 9998885 432 345667778888765
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.99 E-value=4.5e-10 Score=109.21 Aligned_cols=101 Identities=23% Similarity=0.376 Sum_probs=84.1
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|+|++|++++ +|+ +..+++|++|+|++|.+++ +|. ++.+++|++|+|++|++++ +|. +.++++|+.|+|
T Consensus 107 ~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l 180 (308)
T 1h6u_A 107 QSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITN-ISP-LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKA 180 (308)
T ss_dssp TTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEEC
T ss_pred CCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCc-Ccc-ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEEC
Confidence 379999999999995 554 9999999999999999995 444 8899999999999999995 554 899999999999
Q ss_pred CCCcCcccCCc--hhhccccccccCCcccc
Q 010887 156 SSNNLTGRIPM--QLFSVATFNFTGTHLIC 183 (498)
Q Consensus 156 ~~N~l~g~ip~--~~~~~~~~~~~~n~~~~ 183 (498)
++|.+++ +|. .+.++..+++++|....
T Consensus 181 ~~n~l~~-~~~l~~l~~L~~L~L~~N~l~~ 209 (308)
T 1h6u_A 181 DDNKISD-ISPLASLPNLIEVHLKNNQISD 209 (308)
T ss_dssp CSSCCCC-CGGGGGCTTCCEEECTTSCCCB
T ss_pred CCCccCc-ChhhcCCCCCCEEEccCCccCc
Confidence 9999995 443 34567788899887643
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.98 E-value=8.1e-10 Score=107.41 Aligned_cols=100 Identities=20% Similarity=0.373 Sum_probs=85.2
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|+|++|.+++ ++ .+..+++|++|+|++|.+++ +|. +..+++|++|+|++|++++. |. +.++++|++|+|
T Consensus 85 ~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l 158 (308)
T 1h6u_A 85 TKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNI-SP-LAGLTNLQYLSI 158 (308)
T ss_dssp CSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-GG-GGGCTTCCEEEC
T ss_pred CCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcC-cc-ccCCCCccEEEc
Confidence 489999999999995 44 69999999999999999995 554 99999999999999999954 43 899999999999
Q ss_pred CCCcCcccCCc--hhhccccccccCCccc
Q 010887 156 SSNNLTGRIPM--QLFSVATFNFTGTHLI 182 (498)
Q Consensus 156 ~~N~l~g~ip~--~~~~~~~~~~~~n~~~ 182 (498)
++|.+++ +|. .+.++..+++++|...
T Consensus 159 ~~n~l~~-~~~l~~l~~L~~L~l~~n~l~ 186 (308)
T 1h6u_A 159 GNAQVSD-LTPLANLSKLTTLKADDNKIS 186 (308)
T ss_dssp CSSCCCC-CGGGTTCTTCCEEECCSSCCC
T ss_pred cCCcCCC-ChhhcCCCCCCEEECCCCccC
Confidence 9999995 553 3456778889988763
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.98 E-value=4.4e-10 Score=109.01 Aligned_cols=187 Identities=19% Similarity=0.192 Sum_probs=121.3
Q ss_pred CCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCc--cceEEEEEEcCC---ceEEEEec
Q 010887 276 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKN--LLQLIGYCTTSS---ERILVYPF 349 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~ 349 (498)
.+.++.|....||+.. ..+++|+... ......+.+|.++++.+. +.. +.+++......+ ..++||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~---~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH---SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS---HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC---cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 5668999999999863 5688887643 234577899999998884 333 334444433332 34789999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ-------------------------------------- 391 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-------------------------------------- 391 (498)
++|.++..... ..++..++..++.++++.++.||+.
T Consensus 98 i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 98 IKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 99988765332 1356777778888888888888861
Q ss_pred -----------------CCCCcEEcCCCCCcEEECC--CCcEEEeecCccccccccCcceeec-------------cccc
Q 010887 392 -----------------CNPKIIHRDLKAANILLDD--NFEAVLCDFGLAKLVDAKLTHVTTQ-------------IRGT 439 (498)
Q Consensus 392 -----------------~~~~ivH~Dlk~~NILl~~--~~~~ki~DfGl~~~~~~~~~~~~~~-------------~~gt 439 (498)
..+.++|+|++|.||++++ +..+.|+||+.+..-.....-.... ....
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 1235799999999999988 4567899999886543211100000 0000
Q ss_pred ccccC-cccccCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 010887 440 MGHIA-PEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 477 (498)
Q Consensus 440 ~~y~a-PE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~ 477 (498)
.+... |+.... .....+.|+++.++|++.+|+.+|-
T Consensus 252 Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 252 YKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred cCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 01111 222111 1122589999999999999998763
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.97 E-value=6.9e-10 Score=117.70 Aligned_cols=100 Identities=31% Similarity=0.454 Sum_probs=71.5
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|+|++|.|++ +| .+..|++|+.|+|++|.|++ + +.+..|++|+.|+|++|+|++. ..+..+++|+.|+|
T Consensus 87 ~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~L 160 (605)
T 1m9s_A 87 KNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSL 160 (605)
T ss_dssp TTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEEC
T ss_pred CCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEEC
Confidence 467888888888874 44 57788888888888888874 3 3577788888888888888753 46777788888888
Q ss_pred CCCcCcccCCc-hhhccccccccCCcc
Q 010887 156 SSNNLTGRIPM-QLFSVATFNFTGTHL 181 (498)
Q Consensus 156 ~~N~l~g~ip~-~~~~~~~~~~~~n~~ 181 (498)
++|.|++..|. .+.+|..|++++|.+
T Consensus 161 s~N~l~~~~~l~~l~~L~~L~Ls~N~i 187 (605)
T 1m9s_A 161 EDNQISDIVPLAGLTKLQNLYLSKNHI 187 (605)
T ss_dssp CSSCCCCCGGGTTCTTCCEEECCSSCC
T ss_pred cCCcCCCchhhccCCCCCEEECcCCCC
Confidence 88888765441 234556667777754
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.93 E-value=8.1e-11 Score=120.88 Aligned_cols=100 Identities=18% Similarity=0.158 Sum_probs=59.1
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCccccccccc-------------ceeecccccccCCCCC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHL-------------QSLNLANNKFSGSIPA 142 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L-------------~~L~l~~N~l~g~~p~ 142 (498)
.+++.|++++|++ |.+|++|++|++|++|+|++|.++|.+|.+++++++| ++|++++|++++ +|.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPE 88 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCS
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCC
Confidence 3788899999999 7999999999999999999999999999998888765 888888888884 554
Q ss_pred cccCCCCCCeEeCCCCcCcccCCchhhccccccccCCcc
Q 010887 143 TWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHL 181 (498)
Q Consensus 143 ~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~n~~ 181 (498)
. .++|++|++++|.+++ +|..+.++..+++++|..
T Consensus 89 ~---~~~L~~L~l~~n~l~~-lp~~~~~L~~L~l~~n~l 123 (454)
T 1jl5_A 89 L---PPHLESLVASCNSLTE-LPELPQSLKSLLVDNNNL 123 (454)
T ss_dssp C---CTTCSEEECCSSCCSS-CCCCCTTCCEEECCSSCC
T ss_pred C---cCCCCEEEccCCcCCc-cccccCCCcEEECCCCcc
Confidence 2 3577777777777775 776666677777766654
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.93 E-value=1.5e-09 Score=115.20 Aligned_cols=100 Identities=31% Similarity=0.431 Sum_probs=76.7
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|+|++|.|++.. + +..|++|+.|+|++|.|++ +| .+..|++|++|+|++|+|++ +| .+.++++|+.|+|
T Consensus 65 ~~L~~L~Ls~N~l~~~~-~-l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~L 138 (605)
T 1m9s_A 65 PNVTKLFLNGNKLTDIK-P-LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESLYL 138 (605)
T ss_dssp TTCCEEECTTSCCCCCG-G-GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-CG-GGGGCTTCSEEEC
T ss_pred CCCCEEEeeCCCCCCCh-h-hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-Cc-cccCCCccCEEEC
Confidence 47888888888888544 3 8888888888888888884 44 68888888888888888885 43 5788888888888
Q ss_pred CCCcCcccCCc--hhhccccccccCCccc
Q 010887 156 SSNNLTGRIPM--QLFSVATFNFTGTHLI 182 (498)
Q Consensus 156 ~~N~l~g~ip~--~~~~~~~~~~~~n~~~ 182 (498)
++|.|++ ++. .+.+|..|++++|...
T Consensus 139 s~N~l~~-l~~l~~l~~L~~L~Ls~N~l~ 166 (605)
T 1m9s_A 139 GNNKITD-ITVLSRLTKLDTLSLEDNQIS 166 (605)
T ss_dssp CSSCCCC-CGGGGSCTTCSEEECCSSCCC
T ss_pred CCCccCC-chhhcccCCCCEEECcCCcCC
Confidence 8888885 332 3456677788887653
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.91 E-value=1.4e-10 Score=116.52 Aligned_cols=86 Identities=22% Similarity=0.405 Sum_probs=45.2
Q ss_pred ceeEEEecccccC-cccc---ccccccCCCCeEEccCCCCC--C---ccCcccccccccceeeccccccc----CCCCCc
Q 010887 77 NVISLTLGSNGFS-GKIS---PSITKLKFLASLELQDNDLS--G---TLPDFLGSMTHLQSLNLANNKFS----GSIPAT 143 (498)
Q Consensus 77 ~v~~l~l~~~~l~-g~~~---~~~~~l~~L~~L~l~~n~l~--g---~~p~~~~~l~~L~~L~l~~N~l~----g~~p~~ 143 (498)
+++.|+|++|+++ +.+| ..+..+++|++|+|++|+|+ | .+|..+..+++|++|+|++|.++ +.+|..
T Consensus 160 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~ 239 (386)
T 2ca6_A 160 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 239 (386)
T ss_dssp CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHH
T ss_pred CCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHH
Confidence 5555555555555 3333 24445555555555555555 2 23335555555555555555554 345555
Q ss_pred ccCCCCCCeEeCCCCcCcc
Q 010887 144 WSQLSNLKHLDLSSNNLTG 162 (498)
Q Consensus 144 ~~~l~~L~~l~l~~N~l~g 162 (498)
+.++++|++|+|++|.+++
T Consensus 240 l~~~~~L~~L~L~~n~i~~ 258 (386)
T 2ca6_A 240 LKSWPNLRELGLNDCLLSA 258 (386)
T ss_dssp GGGCTTCCEEECTTCCCCH
T ss_pred HccCCCcCEEECCCCCCch
Confidence 5555555555555555554
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.90 E-value=1.8e-09 Score=111.28 Aligned_cols=98 Identities=28% Similarity=0.406 Sum_probs=59.5
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|+|++|.+++. ++ +..+++|++|+|++|++++..| ++.+++|+.|+|++|++++..| +..+++|+.|+++
T Consensus 266 ~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~ 339 (466)
T 1o6v_A 266 KLTELKLGANQISNI-SP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFY 339 (466)
T ss_dssp TCSEEECCSSCCCCC-GG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECC
T ss_pred CCCEEECCCCccCcc-cc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECC
Confidence 567777777777743 33 6667777777777777764333 5666677777777776665544 5566666666666
Q ss_pred CCcCcccCCc--hhhccccccccCCcc
Q 010887 157 SNNLTGRIPM--QLFSVATFNFTGTHL 181 (498)
Q Consensus 157 ~N~l~g~ip~--~~~~~~~~~~~~n~~ 181 (498)
+|.+++. |. .+.++..+++++|+.
T Consensus 340 ~n~l~~~-~~l~~l~~L~~L~l~~n~l 365 (466)
T 1o6v_A 340 NNKVSDV-SSLANLTNINWLSAGHNQI 365 (466)
T ss_dssp SSCCCCC-GGGTTCTTCCEEECCSSCC
T ss_pred CCccCCc-hhhccCCCCCEEeCCCCcc
Confidence 6666642 21 223445555555554
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.90 E-value=2.5e-09 Score=109.85 Aligned_cols=96 Identities=26% Similarity=0.273 Sum_probs=58.8
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|+|++|...+.+ .++.+++|++|+|++|++++ +| ++.+++|+.|+|++|++++. .++++++|+.|+|+
T Consensus 149 ~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls 220 (457)
T 3bz5_A 149 QLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCS 220 (457)
T ss_dssp TCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECC
T ss_pred cCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECc
Confidence 5666777776555555 36666667777777776664 44 56666666666666666643 25666666666666
Q ss_pred CCcCcccCCc-hhhccccccccCCcc
Q 010887 157 SNNLTGRIPM-QLFSVATFNFTGTHL 181 (498)
Q Consensus 157 ~N~l~g~ip~-~~~~~~~~~~~~n~~ 181 (498)
+|++++ +|. .+.++..+++++|..
T Consensus 221 ~N~l~~-ip~~~l~~L~~L~l~~N~l 245 (457)
T 3bz5_A 221 SNKLTE-IDVTPLTQLTYFDCSVNPL 245 (457)
T ss_dssp SSCCSC-CCCTTCTTCSEEECCSSCC
T ss_pred CCcccc-cCccccCCCCEEEeeCCcC
Confidence 666664 441 234455566666654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.88 E-value=1.2e-09 Score=112.15 Aligned_cols=100 Identities=17% Similarity=0.183 Sum_probs=80.1
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCC-------
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLS------- 148 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~------- 148 (498)
.+++.|+|++|++++. .++.+++|++|+|++|++++ +| ++.+++|++|+|++|++++..+..+.+|+
T Consensus 191 ~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n 264 (457)
T 3bz5_A 191 KLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQT 264 (457)
T ss_dssp TTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTC
T ss_pred CCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCC
Confidence 3788999999999964 48889999999999999996 77 88899999999999999986665666665
Q ss_pred CCCeEeCCCCcCcccCCc-hhhccccccccCCcc
Q 010887 149 NLKHLDLSSNNLTGRIPM-QLFSVATFNFTGTHL 181 (498)
Q Consensus 149 ~L~~l~l~~N~l~g~ip~-~~~~~~~~~~~~n~~ 181 (498)
+|+.|++++|.+.|.+|. .+.++..+++++|+.
T Consensus 265 ~L~~L~l~~n~~~~~~~~~~l~~L~~L~Ls~n~~ 298 (457)
T 3bz5_A 265 DLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQ 298 (457)
T ss_dssp CCSCCCCTTCTTCCEEECTTCTTCCCCCCTTCTT
T ss_pred CCCEEECCCCccCCcccccccccCCEEECCCCcc
Confidence 567777888887777774 346677888888864
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.86 E-value=4.5e-10 Score=111.83 Aligned_cols=105 Identities=25% Similarity=0.314 Sum_probs=59.8
Q ss_pred ceeEEEecccccCcccc----ccccccC-CCCeEEccCCCCCCccCcccccc-----cccceeecccccccCCCCCcccC
Q 010887 77 NVISLTLGSNGFSGKIS----PSITKLK-FLASLELQDNDLSGTLPDFLGSM-----THLQSLNLANNKFSGSIPATWSQ 146 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~----~~~~~l~-~L~~L~l~~n~l~g~~p~~~~~l-----~~L~~L~l~~N~l~g~~p~~~~~ 146 (498)
+++.|+|++|.+++..+ ..+..++ +|++|+|++|.|++..+..+..+ ++|++|+|++|++++..+..+..
T Consensus 23 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~ 102 (362)
T 3goz_A 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVK 102 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred CceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHH
Confidence 46666666666664444 4455565 66666666666665555555554 66666666666666555443332
Q ss_pred ----C-CCCCeEeCCCCcCcccCCchh--------hccccccccCCcc
Q 010887 147 ----L-SNLKHLDLSSNNLTGRIPMQL--------FSVATFNFTGTHL 181 (498)
Q Consensus 147 ----l-~~L~~l~l~~N~l~g~ip~~~--------~~~~~~~~~~n~~ 181 (498)
+ ++|++|+|++|.+++..+..+ .++..+++++|..
T Consensus 103 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l 150 (362)
T 3goz_A 103 TLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDL 150 (362)
T ss_dssp HHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCG
T ss_pred HHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcC
Confidence 2 566666666666664333222 2455566666544
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.86 E-value=2.5e-09 Score=113.59 Aligned_cols=73 Identities=33% Similarity=0.460 Sum_probs=39.2
Q ss_pred CCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCCCCcCcccCCchhhc---cccccc
Q 010887 100 KFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS---VATFNF 176 (498)
Q Consensus 100 ~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~---~~~~~~ 176 (498)
++|++|+|++|+|++ +| ..+++|++|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..+.+ +..+++
T Consensus 221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L 291 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL 291 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEEC
T ss_pred CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEe
Confidence 455666666666653 44 23455556666666655 4554 3455556666666665 55554433 334455
Q ss_pred cCCcc
Q 010887 177 TGTHL 181 (498)
Q Consensus 177 ~~n~~ 181 (498)
++|++
T Consensus 292 ~~N~l 296 (622)
T 3g06_A 292 EGNPL 296 (622)
T ss_dssp CSCCC
T ss_pred cCCCC
Confidence 55554
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.84 E-value=3.9e-09 Score=108.71 Aligned_cols=98 Identities=29% Similarity=0.442 Sum_probs=51.1
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|+|++|.+++ + +.+..+++|++|+|++|.+++..| +..+++|++|+|++|++++..| +..+++|+.|+|+
T Consensus 222 ~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~ 295 (466)
T 1o6v_A 222 NLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELN 295 (466)
T ss_dssp TCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECC
T ss_pred CCCEEECCCCCccc-c-hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcC
Confidence 45666666666653 2 235556666666666666654333 5555555566665555553222 5555555555555
Q ss_pred CCcCcccCC-chhhccccccccCCc
Q 010887 157 SNNLTGRIP-MQLFSVATFNFTGTH 180 (498)
Q Consensus 157 ~N~l~g~ip-~~~~~~~~~~~~~n~ 180 (498)
+|++++..| ..+.++..+++++|.
T Consensus 296 ~n~l~~~~~~~~l~~L~~L~L~~n~ 320 (466)
T 1o6v_A 296 ENQLEDISPISNLKNLTYLTLYFNN 320 (466)
T ss_dssp SSCCSCCGGGGGCTTCSEEECCSSC
T ss_pred CCcccCchhhcCCCCCCEEECcCCc
Confidence 555553222 122334445555554
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.84 E-value=2.1e-10 Score=112.76 Aligned_cols=103 Identities=18% Similarity=0.201 Sum_probs=86.0
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCc-cCcccccccccceeecccccccCCCCCcccCCCCCCeEe
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGT-LPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 154 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~-~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ 154 (498)
.+++.|+|++|.+++..+. +.++++|++|+|++|.+++. +|..+..+++|++|+|++|++++.+|..++++++|++|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 4788999999999976655 67899999999999999876 888889999999999999999888888899999999999
Q ss_pred CCCC-cCccc-CCch---hhccccccccCC
Q 010887 155 LSSN-NLTGR-IPMQ---LFSVATFNFTGT 179 (498)
Q Consensus 155 l~~N-~l~g~-ip~~---~~~~~~~~~~~n 179 (498)
|++| .+++. +|.. +.++..+++++|
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~ 178 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWC 178 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCC
Confidence 9999 68763 5543 356677888887
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.84 E-value=1.9e-10 Score=113.05 Aligned_cols=114 Identities=19% Similarity=0.260 Sum_probs=97.9
Q ss_pred CCCCCcceeEecCCceeEEEecccccCcccccccccc--CCCCeEEccCCCCCCccCcccccccccceeecccccccCC-
Q 010887 63 SPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKL--KFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGS- 139 (498)
Q Consensus 63 ~~c~~w~gv~c~~~~v~~l~l~~~~l~g~~~~~~~~l--~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~- 139 (498)
.-|..|.++.|+...++.|+|++|.+. |..+..+ ++|+.|++++|.+++.+|. +..+++|++|+|++|.+++.
T Consensus 34 ~vc~~W~~~~~~~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~ 109 (336)
T 2ast_B 34 GVCKRWYRLASDESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVST 109 (336)
T ss_dssp SSCHHHHHHHTCSTTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHH
T ss_pred HHHHHHHHHhcCchhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHH
Confidence 456689999988777999999999988 5667787 9999999999999977665 67899999999999999976
Q ss_pred CCCcccCCCCCCeEeCCCCcCcccCCchh---hccccccccCCc
Q 010887 140 IPATWSQLSNLKHLDLSSNNLTGRIPMQL---FSVATFNFTGTH 180 (498)
Q Consensus 140 ~p~~~~~l~~L~~l~l~~N~l~g~ip~~~---~~~~~~~~~~n~ 180 (498)
+|..+.++++|++|+|++|.+++.+|..+ .++..+++++|.
T Consensus 110 ~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~ 153 (336)
T 2ast_B 110 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS 153 (336)
T ss_dssp HHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCB
T ss_pred HHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCC
Confidence 88889999999999999999998887655 456777888874
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.83 E-value=4.5e-09 Score=103.68 Aligned_cols=99 Identities=22% Similarity=0.380 Sum_probs=73.7
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|++++|.+++..+ +..+++|++|+|++|.+++ +|. +..+++|++|+|++|++++ + +.+..+++|++|++
T Consensus 199 ~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l 272 (347)
T 4fmz_A 199 TSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNV 272 (347)
T ss_dssp TTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEEC
T ss_pred CccceeecccCCCCCCch--hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEc
Confidence 367888888888885433 7788888888888888884 444 7788888888888888874 4 35778888888888
Q ss_pred CCCcCcccCCc--hhhccccccccCCcc
Q 010887 156 SSNNLTGRIPM--QLFSVATFNFTGTHL 181 (498)
Q Consensus 156 ~~N~l~g~ip~--~~~~~~~~~~~~n~~ 181 (498)
++|.+++ +|. .+.++..+++++|..
T Consensus 273 ~~n~l~~-~~~~~~l~~L~~L~L~~n~l 299 (347)
T 4fmz_A 273 GSNQISD-ISVLNNLSQLNSLFLNNNQL 299 (347)
T ss_dssp CSSCCCC-CGGGGGCTTCSEEECCSSCC
T ss_pred cCCccCC-ChhhcCCCCCCEEECcCCcC
Confidence 8888884 442 345667777887765
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.83 E-value=4.5e-10 Score=112.78 Aligned_cols=106 Identities=24% Similarity=0.331 Sum_probs=68.4
Q ss_pred CceeEEEecccccCc----ccccccccc---------CCCCeEEccCCCCC-CccC---cccccccccceeeccccccc-
Q 010887 76 GNVISLTLGSNGFSG----KISPSITKL---------KFLASLELQDNDLS-GTLP---DFLGSMTHLQSLNLANNKFS- 137 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g----~~~~~~~~l---------~~L~~L~l~~n~l~-g~~p---~~~~~l~~L~~L~l~~N~l~- 137 (498)
.+++.|+|++|++++ .++..+..+ ++|++|+|++|+++ +.+| ..+..+++|++|+|++|+++
T Consensus 122 ~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~ 201 (386)
T 2ca6_A 122 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP 201 (386)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCH
T ss_pred CCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCH
Confidence 467777777777753 345556566 67777777777776 4455 45666777777777777776
Q ss_pred -C---CCCCcccCCCCCCeEeCCCCcCc----ccCCchh---hccccccccCCcc
Q 010887 138 -G---SIPATWSQLSNLKHLDLSSNNLT----GRIPMQL---FSVATFNFTGTHL 181 (498)
Q Consensus 138 -g---~~p~~~~~l~~L~~l~l~~N~l~----g~ip~~~---~~~~~~~~~~n~~ 181 (498)
| .+|..+.++++|++|+|++|.++ +.+|..+ .++..+++++|..
T Consensus 202 ~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i 256 (386)
T 2ca6_A 202 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLL 256 (386)
T ss_dssp HHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCC
T ss_pred hHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCC
Confidence 3 34446677777777777777775 4555443 3455666666653
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.76 E-value=1.5e-09 Score=107.91 Aligned_cols=105 Identities=28% Similarity=0.337 Sum_probs=74.5
Q ss_pred ceeEEEecccccCcccccccccc-----CCCCeEEccCCCCCCccCcccccc-----cccceeecccccccCCCCCccc-
Q 010887 77 NVISLTLGSNGFSGKISPSITKL-----KFLASLELQDNDLSGTLPDFLGSM-----THLQSLNLANNKFSGSIPATWS- 145 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l-----~~L~~L~l~~n~l~g~~p~~~~~l-----~~L~~L~l~~N~l~g~~p~~~~- 145 (498)
+++.|+|++|++++..+..++.+ ++|++|+|++|.+++..+..+... ++|++|+|++|++++..+..+.
T Consensus 52 ~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~ 131 (362)
T 3goz_A 52 SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQ 131 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred ceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHH
Confidence 68888888888887767666665 888888888888887666655554 7888888888888765554433
Q ss_pred ---C-CCCCCeEeCCCCcCcccCCchh--------hccccccccCCcc
Q 010887 146 ---Q-LSNLKHLDLSSNNLTGRIPMQL--------FSVATFNFTGTHL 181 (498)
Q Consensus 146 ---~-l~~L~~l~l~~N~l~g~ip~~~--------~~~~~~~~~~n~~ 181 (498)
. .++|++|+|++|.++..-+..+ .++..+++++|..
T Consensus 132 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l 179 (362)
T 3goz_A 132 AFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNL 179 (362)
T ss_dssp HHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCG
T ss_pred HHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCC
Confidence 3 2578888888888885333322 2567777777755
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.67 E-value=4.4e-09 Score=99.13 Aligned_cols=68 Identities=24% Similarity=0.343 Sum_probs=58.2
Q ss_pred cccCCCCeEEccCCCCCC--ccCcccccccccceeecccccccCCCCCcccCCC--CCCeEeCCCCcCcccCCc
Q 010887 97 TKLKFLASLELQDNDLSG--TLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLS--NLKHLDLSSNNLTGRIPM 166 (498)
Q Consensus 97 ~~l~~L~~L~l~~n~l~g--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~--~L~~l~l~~N~l~g~ip~ 166 (498)
.++++|+.|+|++|+|++ .+|..+..+++|++|+|++|+|++. ..+..++ +|++|+|++|.+++.+|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~ 238 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRD 238 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSS
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCc
Confidence 568899999999999998 6778888999999999999999964 3455555 899999999999988873
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.59 E-value=3.7e-09 Score=108.46 Aligned_cols=106 Identities=18% Similarity=0.237 Sum_probs=83.4
Q ss_pred CceeEEEecccccCcccccccccc-----CCCCeEEccCCCCCCc----cCcccccccccceeecccccccCCCCCcccC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKL-----KFLASLELQDNDLSGT----LPDFLGSMTHLQSLNLANNKFSGSIPATWSQ 146 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l-----~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~ 146 (498)
.+++.|+|++|.+++..+..+... ++|++|+|++|.+++. +|..+..+++|++|+|++|++++..+..+.+
T Consensus 284 ~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 363 (461)
T 1z7x_W 284 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 363 (461)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHH
T ss_pred CCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHH
Confidence 479999999999986555444443 6999999999999876 6777788899999999999998665554443
Q ss_pred -----CCCCCeEeCCCCcCcc----cCCchh---hccccccccCCcc
Q 010887 147 -----LSNLKHLDLSSNNLTG----RIPMQL---FSVATFNFTGTHL 181 (498)
Q Consensus 147 -----l~~L~~l~l~~N~l~g----~ip~~~---~~~~~~~~~~n~~ 181 (498)
.++|++|+|++|.+++ .+|..+ .++..+++++|+.
T Consensus 364 ~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i 410 (461)
T 1z7x_W 364 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 410 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSC
T ss_pred HHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCC
Confidence 6799999999999986 677654 4667788888875
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.56 E-value=6.3e-08 Score=95.73 Aligned_cols=104 Identities=16% Similarity=0.210 Sum_probs=83.4
Q ss_pred EecCCceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCc-ccccccccceeecccccccCCCCC-cccCCCC
Q 010887 72 TCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPD-FLGSMTHLQSLNLANNKFSGSIPA-TWSQLSN 149 (498)
Q Consensus 72 ~c~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~ 149 (498)
.|+. ++++.++++|+ .+|..+ .++|++|+|++|+|+ .||+ .|.+|++|++|+|++|++.+.+|. .|.++++
T Consensus 8 ~C~~---~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~ 80 (350)
T 4ay9_X 8 HCSN---RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80 (350)
T ss_dssp EEET---TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTT
T ss_pred EeeC---CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchh
Confidence 5654 35788999999 899877 478999999999999 5664 689999999999999999877875 5789998
Q ss_pred CCe-EeCCCCcCcccCCchh---hccccccccCCccc
Q 010887 150 LKH-LDLSSNNLTGRIPMQL---FSVATFNFTGTHLI 182 (498)
Q Consensus 150 L~~-l~l~~N~l~g~ip~~~---~~~~~~~~~~n~~~ 182 (498)
|.. +.+++|+|+...|..+ .++..+++++|...
T Consensus 81 l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~ 117 (350)
T 4ay9_X 81 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK 117 (350)
T ss_dssp CCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCS
T ss_pred hhhhhcccCCcccccCchhhhhccccccccccccccc
Confidence 775 6777899995445443 45677888888653
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.56 E-value=3.4e-08 Score=93.04 Aligned_cols=77 Identities=25% Similarity=0.347 Sum_probs=66.5
Q ss_pred CceeEEEecccccCc--cccccccccCCCCeEEccCCCCCCccCccccccc--ccceeecccccccCCCCC-------cc
Q 010887 76 GNVISLTLGSNGFSG--KISPSITKLKFLASLELQDNDLSGTLPDFLGSMT--HLQSLNLANNKFSGSIPA-------TW 144 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g--~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~--~L~~L~l~~N~l~g~~p~-------~~ 144 (498)
.+++.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. .++..++ +|++|+|++|.+++.+|. .+
T Consensus 170 ~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il 247 (267)
T 3rw6_A 170 PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIR 247 (267)
T ss_dssp TTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHH
T ss_pred CCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHHH
Confidence 479999999999998 6667788999999999999999965 4566666 999999999999998884 36
Q ss_pred cCCCCCCeEe
Q 010887 145 SQLSNLKHLD 154 (498)
Q Consensus 145 ~~l~~L~~l~ 154 (498)
..+++|+.||
T Consensus 248 ~~~P~L~~LD 257 (267)
T 3rw6_A 248 ERFPKLLRLD 257 (267)
T ss_dssp HHCTTCCEES
T ss_pred HHCcccCeEC
Confidence 7889998887
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.55 E-value=4.3e-09 Score=107.98 Aligned_cols=106 Identities=20% Similarity=0.227 Sum_probs=72.1
Q ss_pred CceeEEEecccccCccc----ccc-ccccCCCCeEEccCCCCCCc----cCcccccccccceeecccccccCCCCCcccC
Q 010887 76 GNVISLTLGSNGFSGKI----SPS-ITKLKFLASLELQDNDLSGT----LPDFLGSMTHLQSLNLANNKFSGSIPATWSQ 146 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~----~~~-~~~l~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~ 146 (498)
.+++.|+|++|.+++.- ++. +..+++|++|+|++|.+++. +|..+..+++|++|+|++|.+++..+..+..
T Consensus 227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 306 (461)
T 1z7x_W 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 306 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH
Confidence 47888888888877532 122 23578888888888888854 6777777888888888888887544433332
Q ss_pred -----CCCCCeEeCCCCcCccc----CCchh---hccccccccCCcc
Q 010887 147 -----LSNLKHLDLSSNNLTGR----IPMQL---FSVATFNFTGTHL 181 (498)
Q Consensus 147 -----l~~L~~l~l~~N~l~g~----ip~~~---~~~~~~~~~~n~~ 181 (498)
.++|++|+|++|.+++. +|..+ .++..+++++|..
T Consensus 307 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i 353 (461)
T 1z7x_W 307 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRL 353 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBC
T ss_pred HhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCcc
Confidence 25788888888888754 33332 4556777777753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=1.7e-06 Score=81.84 Aligned_cols=136 Identities=14% Similarity=0.121 Sum_probs=95.2
Q ss_pred eeecccce-EEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCccceEEEEEEcCCceEEEEecccCCC
Q 010887 278 IIGQGGFG-KVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYPFMQNLS 354 (498)
Q Consensus 278 ~lG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs 354 (498)
.+..|..| .||+.... ++..+++|+-.. .....+.+|.+.++.+. +--+.++++++.+.+..++|||++++.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 45556665 69998854 466788997642 34567888999998875 3336678888888889999999999987
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 010887 355 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC------------------------------------------ 392 (498)
Q Consensus 355 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------------ 392 (498)
+.+..... ......+..++++.|+.||+..
T Consensus 107 ~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 107 AFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred ccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 76554321 1122344555555555555320
Q ss_pred -------------CCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 393 -------------NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 393 -------------~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
.+.++|+|+.+.||++++++.+-|+||+.+..-
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 123799999999999998777779999987644
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=3e-06 Score=81.93 Aligned_cols=138 Identities=20% Similarity=0.211 Sum_probs=94.8
Q ss_pred CCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCC---ccceEEEEEE-cCCceEEEEeccc
Q 010887 276 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK---NLLQLIGYCT-TSSERILVYPFMQ 351 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~ 351 (498)
.+.++.|....||+. +..+++|+-. .......+.+|.++++.+.+. .+.+++.+.. ..+..++||+|++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~---~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK---SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES---SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC---CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 456788999999998 5678888743 223457789999999999753 2556666664 4456789999999
Q ss_pred CCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 010887 352 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ---------------------------------------- 391 (498)
Q Consensus 352 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~---------------------------------------- 391 (498)
|.++...... .++..+...++.++++.|+.||+.
T Consensus 97 G~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 97 GQILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp SEECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred CeECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 9887653211 133444445555555555555532
Q ss_pred -----------------CCCCcEEcCCCCCcEEECC---CCc-EEEeecCcccccc
Q 010887 392 -----------------CNPKIIHRDLKAANILLDD---NFE-AVLCDFGLAKLVD 426 (498)
Q Consensus 392 -----------------~~~~ivH~Dlk~~NILl~~---~~~-~ki~DfGl~~~~~ 426 (498)
..+.++|+|+++.||++++ ++. ..|+||+.+..-.
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 2335699999999999987 455 4899999876544
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.38 E-value=3.3e-08 Score=98.48 Aligned_cols=85 Identities=19% Similarity=0.253 Sum_probs=44.0
Q ss_pred ceeEEEecccccCccccccc-----cccCCCCeEEccCCCCCC----ccCcccccccccceeecccccccCC----CCCc
Q 010887 77 NVISLTLGSNGFSGKISPSI-----TKLKFLASLELQDNDLSG----TLPDFLGSMTHLQSLNLANNKFSGS----IPAT 143 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~-----~~l~~L~~L~l~~n~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~----~p~~ 143 (498)
+++.|+|++|+|+..-...+ ...++|++|+|++|.|+. .++..+..+++|++|||++|+|+.. ++..
T Consensus 127 ~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~ 206 (372)
T 3un9_A 127 RARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQ 206 (372)
T ss_dssp TEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHH
T ss_pred hccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHH
Confidence 45555555555543222222 123556666666666543 2333444555666666666665531 2344
Q ss_pred ccCCCCCCeEeCCCCcCc
Q 010887 144 WSQLSNLKHLDLSSNNLT 161 (498)
Q Consensus 144 ~~~l~~L~~l~l~~N~l~ 161 (498)
+...++|+.|+|++|.|+
T Consensus 207 L~~~~~L~~L~Ls~N~i~ 224 (372)
T 3un9_A 207 LDRNRQLQELNVAYNGAG 224 (372)
T ss_dssp GGGCSCCCEEECCSSCCC
T ss_pred HhcCCCcCeEECCCCCCC
Confidence 555556666666666665
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.22 E-value=1.1e-07 Score=94.62 Aligned_cols=88 Identities=22% Similarity=0.270 Sum_probs=73.3
Q ss_pred CceeEEEecccccCc----cccccccccCCCCeEEccCCCCCCc----cCcccccccccceeecccccccCC----CCCc
Q 010887 76 GNVISLTLGSNGFSG----KISPSITKLKFLASLELQDNDLSGT----LPDFLGSMTHLQSLNLANNKFSGS----IPAT 143 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g----~~~~~~~~l~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~ 143 (498)
.+++.|+|++|.|+. .++..+..+++|++|+|++|.|+.. ++..+...++|++|+|++|.|+.. ++..
T Consensus 155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~ 234 (372)
T 3un9_A 155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARA 234 (372)
T ss_dssp CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHH
T ss_pred CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHH
Confidence 479999999999975 3555668899999999999999853 466778889999999999999853 4555
Q ss_pred ccCCCCCCeEeCCCCcCccc
Q 010887 144 WSQLSNLKHLDLSSNNLTGR 163 (498)
Q Consensus 144 ~~~l~~L~~l~l~~N~l~g~ 163 (498)
+...++|++|||++|.|+..
T Consensus 235 L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 235 AREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp HHHCSSCCEEECTTSSCCHH
T ss_pred HHhCCCCCEEeccCCCCCHH
Confidence 66789999999999999854
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=4.1e-06 Score=82.68 Aligned_cols=81 Identities=6% Similarity=-0.020 Sum_probs=54.5
Q ss_pred CCee-ecccceEEEEEEEc-------CCcEEEEEEecccC--CcchHHHHHHHHHHHHhccC---CccceEEEEEEcC--
Q 010887 276 SNII-GQGGFGKVYKGVLS-------DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIH---KNLLQLIGYCTTS-- 340 (498)
Q Consensus 276 ~~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~-- 340 (498)
.+.| +.|....+|+.... +++.+++|+..... .......+.+|.++++.+.. -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 78889999998764 26678888765321 00012456788888887753 2466778777655
Q ss_pred -CceEEEEecccCCCHH
Q 010887 341 -SERILVYPFMQNLSVA 356 (498)
Q Consensus 341 -~~~~lv~e~~~~gsL~ 356 (498)
+..++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999987654
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.11 E-value=3.4e-07 Score=81.69 Aligned_cols=105 Identities=18% Similarity=0.280 Sum_probs=77.3
Q ss_pred CceeEEEeccc-ccCcc----ccccccccCCCCeEEccCCCCCCc----cCcccccccccceeecccccccCC----CCC
Q 010887 76 GNVISLTLGSN-GFSGK----ISPSITKLKFLASLELQDNDLSGT----LPDFLGSMTHLQSLNLANNKFSGS----IPA 142 (498)
Q Consensus 76 ~~v~~l~l~~~-~l~g~----~~~~~~~l~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~p~ 142 (498)
..++.|+|++| .|... +...+...++|++|+|++|.|... +...+...++|++|+|++|.|+.. +..
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~ 115 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 115 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHH
Confidence 47899999999 88742 445667788999999999999743 445556668899999999999853 566
Q ss_pred cccCCCCCCeEeC--CCCcCcccCCc----hh---hccccccccCCc
Q 010887 143 TWSQLSNLKHLDL--SSNNLTGRIPM----QL---FSVATFNFTGTH 180 (498)
Q Consensus 143 ~~~~l~~L~~l~l--~~N~l~g~ip~----~~---~~~~~~~~~~n~ 180 (498)
.+...++|++|+| ++|.|+..--. .+ .++..+++++|.
T Consensus 116 ~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~ 162 (185)
T 1io0_A 116 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 162 (185)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCC
Confidence 7888889999999 88998843221 22 235566666653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.97 E-value=4.4e-05 Score=74.50 Aligned_cols=142 Identities=18% Similarity=0.221 Sum_probs=79.2
Q ss_pred CeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhcc-----CCccceEE-E--EEEcCCceEEEEe
Q 010887 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-----HKNLLQLI-G--YCTTSSERILVYP 348 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lv~e 348 (498)
+.++.|..+.||+....++ .+++|+... . ......|.++++.+. .|.++... | +....+..+++++
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~--~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR--P---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECS--C---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCC--C---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 3456677899999987554 588998864 1 223334555555443 23333310 0 1123556789999
Q ss_pred cccCCCHH--------------HhhcccCC----C-C-----CCCCHHHHH-----------------------------
Q 010887 349 FMQNLSVA--------------YRLRDLKP----G-E-----KGLDWPTRK----------------------------- 375 (498)
Q Consensus 349 ~~~~gsL~--------------~~l~~~~~----~-~-----~~l~~~~~~----------------------------- 375 (498)
|++|.++. ..+|.... . . ..-.|....
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986532 11221110 0 0 012332211
Q ss_pred --HHHHHHHHHHHHHHh----------cCCCCcEEcCCCCCcEEECCCCcEEEeecCcccc
Q 010887 376 --RVAFGTAYGLEYLHE----------QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (498)
Q Consensus 376 --~i~~~ia~~L~yLH~----------~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~ 424 (498)
.+...+.+++++|+. .....++|+|+++.||+++.++.+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111223446666763 1234799999999999998888899999998753
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.96 E-value=8.5e-07 Score=79.07 Aligned_cols=86 Identities=17% Similarity=0.198 Sum_probs=71.1
Q ss_pred CceeEEEecccccCcc----ccccccccCCCCeEEccCCCCCCc----cCcccccccccceeec--ccccccCC----CC
Q 010887 76 GNVISLTLGSNGFSGK----ISPSITKLKFLASLELQDNDLSGT----LPDFLGSMTHLQSLNL--ANNKFSGS----IP 141 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~----~~~~~~~l~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~L~l--~~N~l~g~----~p 141 (498)
.+++.|+|++|.|... +...+...++|++|+|++|.|+.. +...+...++|++|+| ++|.|+.. +.
T Consensus 65 ~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~ 144 (185)
T 1io0_A 65 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA 144 (185)
T ss_dssp CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH
T ss_pred CCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHH
Confidence 4799999999999852 445566778999999999999854 5667788899999999 88999854 44
Q ss_pred CcccCCCCCCeEeCCCCcCc
Q 010887 142 ATWSQLSNLKHLDLSSNNLT 161 (498)
Q Consensus 142 ~~~~~l~~L~~l~l~~N~l~ 161 (498)
..+...++|++|+|++|.+.
T Consensus 145 ~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 145 NMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCcCEEeccCCCCC
Confidence 55667799999999999986
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.94 E-value=8e-06 Score=79.68 Aligned_cols=88 Identities=17% Similarity=0.255 Sum_probs=71.5
Q ss_pred CceeEEEecccccCcccc-ccccccCCCCeEEccCCCCCCccCcccccccccc-eeecccccccCCCCCcccCCCCCCeE
Q 010887 76 GNVISLTLGSNGFSGKIS-PSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQ-SLNLANNKFSGSIPATWSQLSNLKHL 153 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~-~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~-~L~l~~N~l~g~~p~~~~~l~~L~~l 153 (498)
.+++.|+|++|+++ .|| ..|.++++|+.|+|++| ++..-+..|.++++|+ .|+|.+ +++..-+..|.++++|+.|
T Consensus 226 ~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 226 PNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp TTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred CCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 37899999999998 555 46999999999999998 7744456688999999 999988 7774445779999999999
Q ss_pred eCCCCcCcccCCch
Q 010887 154 DLSSNNLTGRIPMQ 167 (498)
Q Consensus 154 ~l~~N~l~g~ip~~ 167 (498)
++++|+++ .|+..
T Consensus 303 ~l~~n~i~-~I~~~ 315 (329)
T 3sb4_A 303 LATGDKIT-TLGDE 315 (329)
T ss_dssp EECSSCCC-EECTT
T ss_pred EeCCCccC-ccchh
Confidence 99999998 66653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.92 E-value=6.1e-05 Score=75.45 Aligned_cols=76 Identities=14% Similarity=0.147 Sum_probs=49.5
Q ss_pred CCeeecccceEEEEEEEc-CCcEEEEEEecccCC------cchHHHHHHHHHHHHhccC--Cccc-eEEEEEEcCCceEE
Q 010887 276 SNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS------PGGEAAFQREVHLISVAIH--KNLL-QLIGYCTTSSERIL 345 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~e~~~l~~l~h--~niv-~l~~~~~~~~~~~l 345 (498)
.+.+|.|.++.||++... +++.+++|....... +.....+..|.++++.+.. +..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 567899999999999754 468899997653211 1123456778888887743 3444 45443 3455689
Q ss_pred EEecccCC
Q 010887 346 VYPFMQNL 353 (498)
Q Consensus 346 v~e~~~~g 353 (498)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=97.91 E-value=8.9e-07 Score=93.65 Aligned_cols=85 Identities=13% Similarity=0.120 Sum_probs=41.1
Q ss_pred ceeEEEecccccCccccccccc-cCCCCeEEcc----CCCCCCc-----cCcccccccccceeeccc--ccccCCCCCcc
Q 010887 77 NVISLTLGSNGFSGKISPSITK-LKFLASLELQ----DNDLSGT-----LPDFLGSMTHLQSLNLAN--NKFSGSIPATW 144 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~-l~~L~~L~l~----~n~l~g~-----~p~~~~~l~~L~~L~l~~--N~l~g~~p~~~ 144 (498)
+++.|+|+.|++++..+..++. +++|+.|+|+ .|.+++. ++..+..+++|++|+|++ |.+++..+..+
T Consensus 379 ~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~ 458 (592)
T 3ogk_B 379 ELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYI 458 (592)
T ss_dssp TCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHH
T ss_pred cCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHH
Confidence 5666666666666555555544 5666666664 4555542 233344444555555542 22333333332
Q ss_pred cC-CCCCCeEeCCCCcCc
Q 010887 145 SQ-LSNLKHLDLSSNNLT 161 (498)
Q Consensus 145 ~~-l~~L~~l~l~~N~l~ 161 (498)
+. +++|+.|+|++|.++
T Consensus 459 ~~~~~~L~~L~L~~n~l~ 476 (592)
T 3ogk_B 459 GQYSPNVRWMLLGYVGES 476 (592)
T ss_dssp HHSCTTCCEEEECSCCSS
T ss_pred HHhCccceEeeccCCCCC
Confidence 22 444444444444444
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.86 E-value=0.0001 Score=71.13 Aligned_cols=140 Identities=14% Similarity=0.199 Sum_probs=93.4
Q ss_pred CCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhcc---CCccceEEEEEEcCCceEEEEeccc
Q 010887 275 ESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI---HKNLLQLIGYCTTSSERILVYPFMQ 351 (498)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~ 351 (498)
..+.++.|....+|+... ++..+++|+... .....|.+|.+.++.+. ...+.+++.+....+..++||||++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~----~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINER----SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEG----GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCc----ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 356789999999999986 567888897653 24667889999888874 2567888888888888999999999
Q ss_pred CCCHH-----------HhhcccCC-C-----------------CCCCCHHHHH---HHHH----------------HHHH
Q 010887 352 NLSVA-----------YRLRDLKP-G-----------------EKGLDWPTRK---RVAF----------------GTAY 383 (498)
Q Consensus 352 ~gsL~-----------~~l~~~~~-~-----------------~~~l~~~~~~---~i~~----------------~ia~ 383 (498)
+..+. -.+|.... . ...-+|.... ++.. .+..
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 87542 12333221 0 0012455332 1111 1111
Q ss_pred H-HHHHHh-cCCCCcEEcCCCCCcEEECCCCcEEEeecC
Q 010887 384 G-LEYLHE-QCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (498)
Q Consensus 384 ~-L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 420 (498)
. ...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 123321 2356899999999999999887 8899984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.79 E-value=8.6e-05 Score=74.97 Aligned_cols=80 Identities=11% Similarity=0.050 Sum_probs=49.3
Q ss_pred CCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcceeecccccccccCcccccCC---CCCCcccchhHHHHHHHH
Q 010887 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG---KSSEKTDVFGYGITLLEL 469 (498)
Q Consensus 393 ~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~Gvvl~el 469 (498)
.+.++|||+++.||++++++ ++|+||+.+..-.+...-...-..-...|.+|+..... ......++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 34899999999999998776 99999998875443211110000012346666655321 112234556788888888
Q ss_pred HhCC
Q 010887 470 VTGQ 473 (498)
Q Consensus 470 ltG~ 473 (498)
++++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7763
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.78 E-value=3.9e-06 Score=88.67 Aligned_cols=102 Identities=14% Similarity=0.155 Sum_probs=75.2
Q ss_pred CceeEEEecccccCcccccccc-ccCCCCeEEccCC-CCCCc-cCcccccccccceeecccccccCCCCCccc----CCC
Q 010887 76 GNVISLTLGSNGFSGKISPSIT-KLKFLASLELQDN-DLSGT-LPDFLGSMTHLQSLNLANNKFSGSIPATWS----QLS 148 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~-~l~~L~~L~l~~n-~l~g~-~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~----~l~ 148 (498)
.+++.|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+. .++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 4788999999998887777776 6889999999988 55533 555556789999999999998875544443 667
Q ss_pred CCCeEeCCCCcCcccCCc--------hhhccccccccCC
Q 010887 149 NLKHLDLSSNNLTGRIPM--------QLFSVATFNFTGT 179 (498)
Q Consensus 149 ~L~~l~l~~N~l~g~ip~--------~~~~~~~~~~~~n 179 (498)
+|++|++++|. +.++. .+.++..+++.+|
T Consensus 185 ~L~~L~l~~~~--~~~~~~~l~~l~~~~~~L~~L~L~~~ 221 (594)
T 2p1m_B 185 SLVSLNISCLA--SEVSFSALERLVTRCPNLKSLKLNRA 221 (594)
T ss_dssp CCCEEECTTCC--SCCCHHHHHHHHHHCTTCCEEECCTT
T ss_pred cCcEEEecccC--CcCCHHHHHHHHHhCCCCcEEecCCC
Confidence 89999999887 23331 1256677777776
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=97.76 E-value=1.1e-05 Score=85.31 Aligned_cols=78 Identities=14% Similarity=0.181 Sum_probs=32.3
Q ss_pred ceeEEEecccccCcc----ccccccccCCCCeEEccCCCCC----CccCcccccccccceeecccccccCCCCCcccCCC
Q 010887 77 NVISLTLGSNGFSGK----ISPSITKLKFLASLELQDNDLS----GTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLS 148 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~----~~~~~~~l~~L~~L~l~~n~l~----g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~ 148 (498)
+++.|+|++|.+++. ++..+.++++|++|+|++|.++ +.++..+.++++|++|+|++|.+++ +|..+.+++
T Consensus 165 ~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~ 243 (592)
T 3ogk_B 165 KIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAA 243 (592)
T ss_dssp TCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCT
T ss_pred CCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhh
Confidence 344444444444333 2223334444444444444444 2223333344444444444444442 333333333
Q ss_pred CCCeEeC
Q 010887 149 NLKHLDL 155 (498)
Q Consensus 149 ~L~~l~l 155 (498)
+|+.|++
T Consensus 244 ~L~~L~l 250 (592)
T 3ogk_B 244 NLEEFCG 250 (592)
T ss_dssp TCCEEEE
T ss_pred HHHhhcc
Confidence 3333333
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.73 E-value=2e-06 Score=90.92 Aligned_cols=104 Identities=9% Similarity=0.056 Sum_probs=58.5
Q ss_pred ceeEEEecccccCcccccccc-ccCCCCeEEcc--C----CCCCC-----ccCcccccccccceeecccccccCCCCCcc
Q 010887 77 NVISLTLGSNGFSGKISPSIT-KLKFLASLELQ--D----NDLSG-----TLPDFLGSMTHLQSLNLANNKFSGSIPATW 144 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~-~l~~L~~L~l~--~----n~l~g-----~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~ 144 (498)
+++.|.+..|++++.....+. .+++|+.|+|+ + |.+++ .++.-+..+++|+.|+|++ .+++..+..+
T Consensus 373 ~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l 451 (594)
T 2p1m_B 373 KLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYI 451 (594)
T ss_dssp TCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHH
T ss_pred hHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHH
Confidence 566677777777665555554 46777777777 3 45541 1222245566666666655 5554444444
Q ss_pred cC-CCCCCeEeCCCCcCcccCCch----hhccccccccCCcc
Q 010887 145 SQ-LSNLKHLDLSSNNLTGRIPMQ----LFSVATFNFTGTHL 181 (498)
Q Consensus 145 ~~-l~~L~~l~l~~N~l~g~ip~~----~~~~~~~~~~~n~~ 181 (498)
.. +++|+.|+|++|.+++..+.. +.++..+++++|+.
T Consensus 452 ~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~ 493 (594)
T 2p1m_B 452 GTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF 493 (594)
T ss_dssp HHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSC
T ss_pred HHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCC
Confidence 44 566666666666665443322 24555666666553
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.0002 Score=68.23 Aligned_cols=78 Identities=21% Similarity=0.257 Sum_probs=56.1
Q ss_pred CCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCC---ccceEEEEEEcCCceEEEEe
Q 010887 272 NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK---NLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~~~~~lv~e 348 (498)
.....+.+|.|..+.||+.+..+|+.|++|+-.... ......|.+|.+.|+.+.-. -+.+++++ +..++|||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e 90 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME 90 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence 344467789999999999999999999999865332 23345688999999888422 23444443 23478999
Q ss_pred cccCCC
Q 010887 349 FMQNLS 354 (498)
Q Consensus 349 ~~~~gs 354 (498)
|++++.
T Consensus 91 ~l~~~~ 96 (288)
T 3f7w_A 91 WVDERP 96 (288)
T ss_dssp CCCCCC
T ss_pred eecccC
Confidence 998764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.47 E-value=3.3e-05 Score=67.51 Aligned_cols=83 Identities=11% Similarity=0.115 Sum_probs=64.4
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCC-CCCccCcccccc----cccceeeccccc-ccCCCCCcccCCCCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDND-LSGTLPDFLGSM----THLQSLNLANNK-FSGSIPATWSQLSNL 150 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~-l~g~~p~~~~~l----~~L~~L~l~~N~-l~g~~p~~~~~l~~L 150 (498)
+++.|||+++.++..-=..+.++++|+.|+|+++. ++..-=..|..+ ++|++|+|+++. +|..-=..+.++++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 79999999999876544567899999999999985 775433445553 479999999974 774333457789999
Q ss_pred CeEeCCCCc
Q 010887 151 KHLDLSSNN 159 (498)
Q Consensus 151 ~~l~l~~N~ 159 (498)
++|+|++..
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 999999875
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.37 E-value=3.7e-05 Score=75.87 Aligned_cols=106 Identities=20% Similarity=0.243 Sum_probs=73.2
Q ss_pred CceeEEEecccccCcccccccc--ccCCCCeEEccC--CCCCCc-----cCccc--ccccccceeecccccccCCCCCcc
Q 010887 76 GNVISLTLGSNGFSGKISPSIT--KLKFLASLELQD--NDLSGT-----LPDFL--GSMTHLQSLNLANNKFSGSIPATW 144 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~--~l~~L~~L~l~~--n~l~g~-----~p~~~--~~l~~L~~L~l~~N~l~g~~p~~~ 144 (498)
.+++.|+|..++++...-..++ .+++|++|+|+. |...|. +...+ ..+++|++|+|++|.+++..+..+
T Consensus 193 ~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~l 272 (362)
T 2ra8_A 193 PNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMF 272 (362)
T ss_dssp TTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHH
T ss_pred CCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHH
Confidence 4799999999888754444454 789999999864 222221 11122 247899999999999875444333
Q ss_pred c---CCCCCCeEeCCCCcCccc----CCch---hhccccccccCCcc
Q 010887 145 S---QLSNLKHLDLSSNNLTGR----IPMQ---LFSVATFNFTGTHL 181 (498)
Q Consensus 145 ~---~l~~L~~l~l~~N~l~g~----ip~~---~~~~~~~~~~~n~~ 181 (498)
. .+++|++|+|+.|.|++. ++.. +.++..++++.|..
T Consensus 273 a~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i 319 (362)
T 2ra8_A 273 LESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319 (362)
T ss_dssp HHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBC
T ss_pred HhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcC
Confidence 3 578999999999999863 3333 45677788877743
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00025 Score=58.90 Aligned_cols=36 Identities=22% Similarity=0.309 Sum_probs=17.5
Q ss_pred cceeecccccccCCCCCcccCCCCCCeEeCCCCcCc
Q 010887 126 LQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLT 161 (498)
Q Consensus 126 L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~ 161 (498)
|++|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 33 l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 33 TTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp CSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 455555555555222223445555555555555443
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.34 E-value=3e-05 Score=76.59 Aligned_cols=103 Identities=17% Similarity=0.182 Sum_probs=72.0
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccc--cccccceeeccc--ccccCC-----CCCcc--
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLG--SMTHLQSLNLAN--NKFSGS-----IPATW-- 144 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~--~l~~L~~L~l~~--N~l~g~-----~p~~~-- 144 (498)
.++++|+|++|.-. .+++ +. +++|+.|+|..+.++......+. .+++|++|+|+. |...|. +...+
T Consensus 172 P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~ 248 (362)
T 2ra8_A 172 PLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSK 248 (362)
T ss_dssp TTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCT
T ss_pred CCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhc
Confidence 58999999987311 3444 43 89999999999988755444555 689999999963 333222 11122
Q ss_pred cCCCCCCeEeCCCCcCcccCCch------hhccccccccCCcc
Q 010887 145 SQLSNLKHLDLSSNNLTGRIPMQ------LFSVATFNFTGTHL 181 (498)
Q Consensus 145 ~~l~~L~~l~l~~N~l~g~ip~~------~~~~~~~~~~~n~~ 181 (498)
..+++|++|+|++|.+....+.. +.++..|+++.|..
T Consensus 249 ~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L 291 (362)
T 2ra8_A 249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVL 291 (362)
T ss_dssp TTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCC
T ss_pred CCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCC
Confidence 35789999999999998544332 34678888887754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.31 E-value=0.0011 Score=63.46 Aligned_cols=143 Identities=9% Similarity=0.028 Sum_probs=76.8
Q ss_pred CCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccc-eEEEEEEcCCceEEEEecc-
Q 010887 273 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL-QLIGYCTTSSERILVYPFM- 350 (498)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~- 350 (498)
+...+.|+.|....+|+. +.+++|+....... .....+|.+.++.+...++. +++++ ..+..+++++|+
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~ 90 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIA 90 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCT
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecC
Confidence 334678899999999998 56888877542111 11224677777776533343 44443 444457899999
Q ss_pred cCCCHHH------------------hhcccCCC-CCCCCH-HHHHHHHH--------------HHHHHHH----HHHh-c
Q 010887 351 QNLSVAY------------------RLRDLKPG-EKGLDW-PTRKRVAF--------------GTAYGLE----YLHE-Q 391 (498)
Q Consensus 351 ~~gsL~~------------------~l~~~~~~-~~~l~~-~~~~~i~~--------------~ia~~L~----yLH~-~ 391 (498)
++.++.. .+|..... ....+. .....+.. .+.+.+. .+.. .
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 5544321 11211110 000111 11111100 1111111 1111 1
Q ss_pred CCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 392 ~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
..+.++|+|+.+.||+ .+++.+.++||..+..-
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 2335899999999999 55667899999987643
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00072 Score=56.06 Aligned_cols=56 Identities=20% Similarity=0.367 Sum_probs=45.1
Q ss_pred EEEecccccC-ccccccccccCCCCeEEccCCCCCCccCcccccccccceeeccccccc
Q 010887 80 SLTLGSNGFS-GKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFS 137 (498)
Q Consensus 80 ~l~l~~~~l~-g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~ 137 (498)
.++.++++|+ ..+|..+ ..+|++|+|++|+|+..-+..|..+++|++|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 6788888886 4667543 357999999999999444556788999999999999886
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0023 Score=61.74 Aligned_cols=160 Identities=13% Similarity=0.080 Sum_probs=85.8
Q ss_pred cCHHHHHHHhcCCCC-----CCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCc--cceE
Q 010887 261 FSCRELQLATDNFSE-----SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN--LLQL 333 (498)
Q Consensus 261 ~~~~el~~~~~~~~~-----~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l 333 (498)
++.+++......|.. .+.++.|....+|+....++ .+++|+...... ...+..|.+++..+.... +.++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~---~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC---HHHHHHHHHHHHHHHHCCCCCCcc
Confidence 344455444445544 23466788899999987655 678888764222 233456777766664222 2233
Q ss_pred EEE------EEcCCceEEEEecccCCCHHH--------------hhcccC----CCC-CC---CCHHHHHH---------
Q 010887 334 IGY------CTTSSERILVYPFMQNLSVAY--------------RLRDLK----PGE-KG---LDWPTRKR--------- 376 (498)
Q Consensus 334 ~~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~----~~~-~~---l~~~~~~~--------- 376 (498)
+.. ....+..+++++|++|..+.. .+|... ... .. ..|.....
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 211 112345689999998764311 122111 000 00 12322111
Q ss_pred ---HHHHHHHHHHHHHhc----CCCCcEEcCCCCCcEEECCCCcEEEeecCcccc
Q 010887 377 ---VAFGTAYGLEYLHEQ----CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (498)
Q Consensus 377 ---i~~~ia~~L~yLH~~----~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~ 424 (498)
+...+.+.++++++. ....++|+|+.+.||+++++..+.|+||+.+..
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011244455666532 234789999999999998776568999997753
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.13 E-value=0.00042 Score=67.30 Aligned_cols=77 Identities=13% Similarity=0.052 Sum_probs=65.3
Q ss_pred ceeEEEecccccCccccccccccCCCC-eEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLA-SLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~-~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
+++.|+|++| +...-+..|.++++|+ .|+|.+ +++..-+..|.+|++|+.|+|++|+++..-+..|.++++|+.++.
T Consensus 251 ~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 251 YLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp TCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred CCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 7999999998 7744445799999999 999999 787444688999999999999999999555567999999999874
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0019 Score=62.73 Aligned_cols=34 Identities=32% Similarity=0.369 Sum_probs=28.2
Q ss_pred CCCcEEcCCCCCcEEECCC----CcEEEeecCcccccc
Q 010887 393 NPKIIHRDLKAANILLDDN----FEAVLCDFGLAKLVD 426 (498)
Q Consensus 393 ~~~ivH~Dlk~~NILl~~~----~~~ki~DfGl~~~~~ 426 (498)
...++|||+.+.||+++.+ ..+.|+||+.+..-.
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 3479999999999999874 678999999876443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0043 Score=59.90 Aligned_cols=144 Identities=13% Similarity=0.101 Sum_probs=81.5
Q ss_pred CeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCc--cceEEEE-----EEcCCceEEEEec
Q 010887 277 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN--LLQLIGY-----CTTSSERILVYPF 349 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lv~e~ 349 (498)
..++ |....||+....+|+.+++|...... .....+..|.+++..+.... +.+++.. ....+..+.+++|
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~--~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC--CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 3466 88889999887777789999886321 23456667888777765222 3334332 1123455789999
Q ss_pred ccCCCHHH--------------hhcccC----C-CCCCCCHHHH----HHH---------------HHHHHHHHHHHHhc
Q 010887 350 MQNLSVAY--------------RLRDLK----P-GEKGLDWPTR----KRV---------------AFGTAYGLEYLHEQ 391 (498)
Q Consensus 350 ~~~gsL~~--------------~l~~~~----~-~~~~l~~~~~----~~i---------------~~~ia~~L~yLH~~ 391 (498)
++|..+.. .+|... . .....++... ..+ ...+.+.++.+...
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 98754320 122110 0 0112222211 000 11111223333321
Q ss_pred ----CCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 392 ----CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 392 ----~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
....++|||+++.||+++ + .+.|+||+.+..-
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 234689999999999999 4 8999999877543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0031 Score=63.65 Aligned_cols=73 Identities=15% Similarity=0.160 Sum_probs=49.4
Q ss_pred CCeeecccceEEEEEEEcC--------CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCcc-ceEEEEEEcCCceEEE
Q 010887 276 SNIIGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL-LQLIGYCTTSSERILV 346 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv 346 (498)
.+.|+.|-...+|++...+ ++.+++|+.... .....+.+|..+++.+...++ .++++.+.+ .+|
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v 150 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 150 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence 4567888889999998753 478889987431 112455689988888864444 456665432 389
Q ss_pred EecccCCCH
Q 010887 347 YPFMQNLSV 355 (498)
Q Consensus 347 ~e~~~~gsL 355 (498)
++|++|-++
T Consensus 151 ~e~l~G~~l 159 (429)
T 1nw1_A 151 EEYIPSRPL 159 (429)
T ss_dssp ECCCCEEEC
T ss_pred EEEeCCccc
Confidence 999986443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0066 Score=60.00 Aligned_cols=144 Identities=17% Similarity=0.196 Sum_probs=83.3
Q ss_pred CCeeecccceEEEEEEEcC--------CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCcc-ceEEEEEEcCCceEEE
Q 010887 276 SNIIGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL-LQLIGYCTTSSERILV 346 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv 346 (498)
.+.+..|-...+|+....+ ++.+++|+.... ........+|.++++.+...++ .++++++.+ .+|
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 4566778889999998742 478888885321 1234566789999888753333 455555433 289
Q ss_pred EecccCCCHHHh-----------------hcccC-CCCCCCC--HHHHHHHHHHHH-------------------HHHHH
Q 010887 347 YPFMQNLSVAYR-----------------LRDLK-PGEKGLD--WPTRKRVAFGTA-------------------YGLEY 387 (498)
Q Consensus 347 ~e~~~~gsL~~~-----------------l~~~~-~~~~~l~--~~~~~~i~~~ia-------------------~~L~y 387 (498)
+||++|.++... +|... +...... |.+..++..++. ..+++
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 999997654311 12111 1111222 344444443332 12333
Q ss_pred HH----hc-CCCCcEEcCCCCCcEEECCC----CcEEEeecCccccc
Q 010887 388 LH----EQ-CNPKIIHRDLKAANILLDDN----FEAVLCDFGLAKLV 425 (498)
Q Consensus 388 LH----~~-~~~~ivH~Dlk~~NILl~~~----~~~ki~DfGl~~~~ 425 (498)
|. .. ....++|+|+.+.||+++++ +.+.++||..+..-
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~ 255 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN 255 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence 33 21 22368999999999999876 78999999987643
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.71 E-value=0.00045 Score=61.45 Aligned_cols=85 Identities=11% Similarity=0.209 Sum_probs=63.0
Q ss_pred CCceeEEEeccc-ccCc----cccccccccCCCCeEEccCCCCCCc----cCcccccccccceeecccccccCC----CC
Q 010887 75 NGNVISLTLGSN-GFSG----KISPSITKLKFLASLELQDNDLSGT----LPDFLGSMTHLQSLNLANNKFSGS----IP 141 (498)
Q Consensus 75 ~~~v~~l~l~~~-~l~g----~~~~~~~~l~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~p 141 (498)
+..++.|+|++| +|.. .+...+..-+.|+.|+|++|+|... |-+.+..-+.|++|+|++|+|+.. |-
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala 119 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 119 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHH
Confidence 457899999985 7763 2445677778999999999999743 334455667899999999999743 44
Q ss_pred CcccCCCCCCeEeCCCCc
Q 010887 142 ATWSQLSNLKHLDLSSNN 159 (498)
Q Consensus 142 ~~~~~l~~L~~l~l~~N~ 159 (498)
..+..-+.|+.|+|++|.
T Consensus 120 ~aL~~N~tL~~L~L~n~~ 137 (197)
T 1pgv_A 120 RSTLVTQSIVEFKADNQR 137 (197)
T ss_dssp HHTTTTCCCSEEECCCCS
T ss_pred HHHhhCCceeEEECCCCc
Confidence 456666789999998763
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.67 E-value=0.0048 Score=60.81 Aligned_cols=73 Identities=11% Similarity=0.031 Sum_probs=43.1
Q ss_pred CCeeecccceEEEEEEEcC---------CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCcc-ceEEEEEEcCCceEE
Q 010887 276 SNIIGQGGFGKVYKGVLSD---------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL-LQLIGYCTTSSERIL 345 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~l 345 (498)
.+.++.|....+|+....+ ++.+++|+..... ....+...|.++++.+...++ .++++.. . .++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~ 111 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV--DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR 111 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG--GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc--cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence 3456778889999998754 2678888764321 111123577888877754444 3565543 2 368
Q ss_pred EEecccCCC
Q 010887 346 VYPFMQNLS 354 (498)
Q Consensus 346 v~e~~~~gs 354 (498)
|++|++|.+
T Consensus 112 v~e~i~G~~ 120 (369)
T 3c5i_A 112 IEEWLYGDP 120 (369)
T ss_dssp EEECCCSEE
T ss_pred EEEEecCCc
Confidence 999998754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.65 E-value=0.013 Score=59.47 Aligned_cols=74 Identities=16% Similarity=0.126 Sum_probs=46.9
Q ss_pred CCeeecccceEEEEEEEcC-CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCcc-ceEEEEEEcCCceEEEEecccCC
Q 010887 276 SNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL-LQLIGYCTTSSERILVYPFMQNL 353 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g 353 (498)
.+.|+.|-...+|+....+ +..+++|+...... . ..+-.+|..+++.+...++ .++++.+ . + ..|++|+++.
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~-~idR~~E~~vl~~L~~~gl~P~ll~~~-~-~--G~v~e~I~G~ 186 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-E-IINREREKKISCILYNKNIAKKIYVFF-T-N--GRIEEFMDGY 186 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-S-CSCHHHHHHHHHHHTTSSSBCCEEEEE-T-T--EEEEECCCSE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-h-hcCHHHHHHHHHHHHhcCCCCCEEEEe-C-C--eEEEEeeCCc
Confidence 4567888899999999765 47788887643211 1 1112578888888875555 4566655 2 2 3599999875
Q ss_pred CH
Q 010887 354 SV 355 (498)
Q Consensus 354 sL 355 (498)
++
T Consensus 187 ~l 188 (458)
T 2qg7_A 187 AL 188 (458)
T ss_dssp EC
T ss_pred cC
Confidence 43
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=96.42 E-value=0.0034 Score=62.77 Aligned_cols=99 Identities=15% Similarity=0.188 Sum_probs=51.0
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCC-----CccCcccccccccceeecccccccCCCCCcccCCCCCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLS-----GTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLK 151 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~-----g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~ 151 (498)
.++.+.| .++++..-+..|.++++|+.++|.+|.+. ..-+..|..|++|+.++|. |.++-.-...|.++++|+
T Consensus 249 ~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~ 326 (401)
T 4fdw_A 249 GITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVT 326 (401)
T ss_dssp CCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCC
T ss_pred CccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCcc
Confidence 3444455 23344222345666666666666666554 1223456666666666666 335522233466666677
Q ss_pred eEeCCCCcCcccCCchh---hccccccccCC
Q 010887 152 HLDLSSNNLTGRIPMQL---FSVATFNFTGT 179 (498)
Q Consensus 152 ~l~l~~N~l~g~ip~~~---~~~~~~~~~~n 179 (498)
.++|.+| ++ .|+... .++..+.+.+|
T Consensus 327 ~l~lp~~-l~-~I~~~aF~~~~L~~l~l~~n 355 (401)
T 4fdw_A 327 QLTIPAN-VT-QINFSAFNNTGIKEVKVEGT 355 (401)
T ss_dssp EEEECTT-CC-EECTTSSSSSCCCEEEECCS
T ss_pred EEEECcc-cc-EEcHHhCCCCCCCEEEEcCC
Confidence 7766443 44 343321 14455555555
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.41 E-value=0.02 Score=55.60 Aligned_cols=33 Identities=21% Similarity=0.341 Sum_probs=28.3
Q ss_pred CCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 394 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 394 ~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
..++|+|+.+.||++++++.+.|+||+.+..-.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP 238 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence 478999999999999988889999998776443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=96.30 E-value=0.0051 Score=61.45 Aligned_cols=85 Identities=12% Similarity=0.144 Sum_probs=67.1
Q ss_pred ceeEEEecccccC-----ccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCC
Q 010887 77 NVISLTLGSNGFS-----GKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLK 151 (498)
Q Consensus 77 ~v~~l~l~~~~l~-----g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~ 151 (498)
+++.|+|.+|.+. ..-+..|.++++|+.++|. |+++-.-...|.+|++|+.|+|.+| ++..-+..|.++ +|+
T Consensus 272 ~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~ 348 (401)
T 4fdw_A 272 ELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIK 348 (401)
T ss_dssp TCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCC
T ss_pred CCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCC
Confidence 7889999988775 2334579999999999999 5577344567889999999999665 663445679999 999
Q ss_pred eEeCCCCcCcccCC
Q 010887 152 HLDLSSNNLTGRIP 165 (498)
Q Consensus 152 ~l~l~~N~l~g~ip 165 (498)
.+++++|.+. .++
T Consensus 349 ~l~l~~n~~~-~l~ 361 (401)
T 4fdw_A 349 EVKVEGTTPP-QVF 361 (401)
T ss_dssp EEEECCSSCC-BCC
T ss_pred EEEEcCCCCc-ccc
Confidence 9999999877 343
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.53 E-value=0.0019 Score=57.36 Aligned_cols=87 Identities=13% Similarity=0.129 Sum_probs=63.8
Q ss_pred CCceeEEEecccccCccc----cccccccCCCCeEEccCCCCCCc----cCcccccccccceeeccccc---ccC----C
Q 010887 75 NGNVISLTLGSNGFSGKI----SPSITKLKFLASLELQDNDLSGT----LPDFLGSMTHLQSLNLANNK---FSG----S 139 (498)
Q Consensus 75 ~~~v~~l~l~~~~l~g~~----~~~~~~l~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~L~l~~N~---l~g----~ 139 (498)
+..|+.|+|++|+|...- ...+..-+.|++|+|++|.|... |-+.+..-+.|+.|+|++|. +.. .
T Consensus 69 N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ 148 (197)
T 1pgv_A 69 SKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMD 148 (197)
T ss_dssp CSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHH
T ss_pred CCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHH
Confidence 458999999999998533 33455668999999999999853 33445556789999998763 332 2
Q ss_pred CCCcccCCCCCCeEeCCCCcCc
Q 010887 140 IPATWSQLSNLKHLDLSSNNLT 161 (498)
Q Consensus 140 ~p~~~~~l~~L~~l~l~~N~l~ 161 (498)
|-..+..-+.|+.|+++.|.+.
T Consensus 149 ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 149 MMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHHhCCCcCeEeccCCCcc
Confidence 4445666688999999887654
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=95.39 E-value=0.0031 Score=54.96 Aligned_cols=70 Identities=11% Similarity=0.167 Sum_probs=51.2
Q ss_pred ccccccccCCCCeEEccCCCCCCccCcccccccccceeeccccc-ccCCCCCcccCC----CCCCeEeCCCCc-Cc
Q 010887 92 ISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNK-FSGSIPATWSQL----SNLKHLDLSSNN-LT 161 (498)
Q Consensus 92 ~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~-l~g~~p~~~~~l----~~L~~l~l~~N~-l~ 161 (498)
+|.....-..|+.|||+++.++..--..+..+++|++|+|+++. ++..-=..++.+ ++|++|+|+++. +|
T Consensus 53 LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~IT 128 (176)
T 3e4g_A 53 LPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVT 128 (176)
T ss_dssp SCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCC
T ss_pred CCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCC
Confidence 34433233579999999999886555667889999999999985 664333345554 479999999975 66
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.75 E-value=0.1 Score=52.25 Aligned_cols=143 Identities=11% Similarity=0.109 Sum_probs=83.4
Q ss_pred CCeeecccceEEEEEEEcC--------CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCcc-ceEEEEEEcCCceEEE
Q 010887 276 SNIIGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL-LQLIGYCTTSSERILV 346 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv 346 (498)
.+.+..|-...+|+....+ ++.+++|+..... ....+-.+|.++++.+...++ .++++.+ . .+.|
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I 148 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRI 148 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEE
Confidence 3456778889999999753 5788888864321 111123578888877753333 3455432 2 3789
Q ss_pred EecccCCCHHH-----------------hhccc-------CC--CCCCCCHHHHHHHHHHH-------------------
Q 010887 347 YPFMQNLSVAY-----------------RLRDL-------KP--GEKGLDWPTRKRVAFGT------------------- 381 (498)
Q Consensus 347 ~e~~~~gsL~~-----------------~l~~~-------~~--~~~~l~~~~~~~i~~~i------------------- 381 (498)
++|++|.++.. .+|.. .. ...+.-|.+..++..++
T Consensus 149 ~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l 228 (424)
T 3mes_A 149 EEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKI 228 (424)
T ss_dssp EECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHH
T ss_pred EEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHH
Confidence 99999865321 01111 10 11122244443333221
Q ss_pred HHHHHHHHhc---------------------CCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 382 AYGLEYLHEQ---------------------CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 382 a~~L~yLH~~---------------------~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
...+++|.+. ....++|+|+.+.||+ ++++.+.++||..+..-
T Consensus 229 ~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~ 292 (424)
T 3mes_A 229 LEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAIN 292 (424)
T ss_dssp HHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred HHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCcC
Confidence 2233343311 1235899999999999 78889999999987643
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=93.48 E-value=0.077 Score=52.54 Aligned_cols=99 Identities=12% Similarity=0.277 Sum_probs=61.7
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
.++.+.+..+..+ .-...|.++++|+.+.+. +.++..-...|.++++|+.++|..| ++-.-..+|.++.+|+.+.|.
T Consensus 266 ~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip 342 (394)
T 4gt6_A 266 YLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIP 342 (394)
T ss_dssp SCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEC
T ss_pred cccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEEC
Confidence 4666777654433 333467778888888885 4455222345777888888888654 552224467788888888885
Q ss_pred CCcCcccCCchh----hccccccccCCc
Q 010887 157 SNNLTGRIPMQL----FSVATFNFTGTH 180 (498)
Q Consensus 157 ~N~l~g~ip~~~----~~~~~~~~~~n~ 180 (498)
++ ++ .|+... .+|..+.+.+|.
T Consensus 343 ~s-v~-~I~~~aF~~C~~L~~i~~~~~~ 368 (394)
T 4gt6_A 343 SS-VT-KIPESAFSNCTALNNIEYSGSR 368 (394)
T ss_dssp TT-CC-BCCGGGGTTCTTCCEEEESSCH
T ss_pred cc-cC-EEhHhHhhCCCCCCEEEECCce
Confidence 44 55 565432 345666676664
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=92.82 E-value=0.086 Score=52.19 Aligned_cols=66 Identities=18% Similarity=0.232 Sum_probs=39.0
Q ss_pred cccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCC-CCcccCCCCCCeEeCCCCcCcccCC
Q 010887 95 SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSI-PATWSQLSNLKHLDLSSNNLTGRIP 165 (498)
Q Consensus 95 ~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~-p~~~~~l~~L~~l~l~~N~l~g~ip 165 (498)
.+..+.+|+.+.+..+ ++..-+..|.++++|+.++|.++ ++ .| ..+|.++++|+.+++..| ++ .|+
T Consensus 292 ~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~-l~-~I~ 358 (394)
T 4fs7_A 292 TFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS-LR-KIG 358 (394)
T ss_dssp TTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT-CC-EEC
T ss_pred cccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc-cc-Eeh
Confidence 4566677777777654 44222345666777777777543 54 33 345667777777777655 44 444
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=92.74 E-value=0.21 Score=49.36 Aligned_cols=68 Identities=19% Similarity=0.358 Sum_probs=46.8
Q ss_pred ccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCC-CcccCCCCCCeEeCCCCcCcccCCc
Q 010887 94 PSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIP-ATWSQLSNLKHLDLSSNNLTGRIPM 166 (498)
Q Consensus 94 ~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~l~l~~N~l~g~ip~ 166 (498)
..|.+++.|+.+.+..+..+ .-...|.++++|+.+.+. +.++ .|+ ..|.++.+|+.++|..| ++ .|..
T Consensus 259 ~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~-~I~~ 327 (394)
T 4gt6_A 259 HAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-IT-QILD 327 (394)
T ss_dssp TTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CC-EECT
T ss_pred ceeeecccccEEecccccce-ecCcccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-cc-EehH
Confidence 45777888888888766543 334567788888888885 4455 344 45888888888888654 44 4443
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=92.05 E-value=0.17 Score=49.57 Aligned_cols=86 Identities=13% Similarity=0.150 Sum_probs=56.7
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
.++.+.+..+ ++..-...+.++.+|+.+.+..+ +...-...|..+++|+.+++.+|.++-.-+..|.++.+|+.++|.
T Consensus 241 ~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp 318 (379)
T 4h09_A 241 ALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLP 318 (379)
T ss_dssp SCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECC
T ss_pred cceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcC
Confidence 5677777665 44233346777888888888654 552233457778888888888887773334568888888888886
Q ss_pred CCcCcccCCc
Q 010887 157 SNNLTGRIPM 166 (498)
Q Consensus 157 ~N~l~g~ip~ 166 (498)
+| ++ .|+.
T Consensus 319 ~~-l~-~I~~ 326 (379)
T 4h09_A 319 TA-LK-TIQV 326 (379)
T ss_dssp TT-CC-EECT
T ss_pred cc-cc-EEHH
Confidence 54 44 4443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.66 E-value=1.8 Score=42.76 Aligned_cols=29 Identities=31% Similarity=0.520 Sum_probs=24.7
Q ss_pred cEEcCCCCCcEEE------CCCCcEEEeecCcccc
Q 010887 396 IIHRDLKAANILL------DDNFEAVLCDFGLAKL 424 (498)
Q Consensus 396 ivH~Dlk~~NILl------~~~~~~ki~DfGl~~~ 424 (498)
++|+|+.+.||++ +++..+.++||..+..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=90.45 E-value=0.66 Score=41.51 Aligned_cols=100 Identities=17% Similarity=0.104 Sum_probs=64.4
Q ss_pred CCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcc
Q 010887 352 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 431 (498)
Q Consensus 352 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~ 431 (498)
.-+|.+.|..+ ..++++.+++.++.|.+.+|.-+-.+.. + ..+=+.|..|++..+|.+...+ ..+.
T Consensus 32 ~vSL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 32 ALSLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred cccHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc--------
Confidence 34788888854 4689999999999999999877632111 1 1223456889999999988753 1110
Q ss_pred eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh
Q 010887 432 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 471 (498)
Q Consensus 432 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt 471 (498)
.....+.|||... ...+.+.=|||+|+++|.-+-
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0123456888763 345677889999999998776
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=89.96 E-value=0.47 Score=46.37 Aligned_cols=87 Identities=17% Similarity=0.177 Sum_probs=57.2
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
.+..+.+..+ +...-...+.++..|+.+.+..+ ++..-...+.++.+|+.+.+..+ ++..-...|.++++|+.+++.
T Consensus 218 ~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~ 294 (379)
T 4h09_A 218 NLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMD 294 (379)
T ss_dssp SCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEEC
T ss_pred ccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccccccccc
Confidence 4555665543 33233446778888888888766 55333456777888888888654 442233457888888888888
Q ss_pred CCcCcccCCch
Q 010887 157 SNNLTGRIPMQ 167 (498)
Q Consensus 157 ~N~l~g~ip~~ 167 (498)
+|.++ .|+..
T Consensus 295 ~~~i~-~I~~~ 304 (379)
T 4h09_A 295 NSAIE-TLEPR 304 (379)
T ss_dssp CTTCC-EECTT
T ss_pred ccccc-eehhh
Confidence 88777 56543
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.95 E-value=0.7 Score=41.17 Aligned_cols=85 Identities=8% Similarity=0.016 Sum_probs=62.2
Q ss_pred cCCccceEEEEEEcCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCc
Q 010887 326 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAAN 405 (498)
Q Consensus 326 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~N 405 (498)
.||++++. ..-.+.++..+.|+.-+.+.-...++ .++...+++++.+|+....+++.. +|--++|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik-------~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK-------SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG-------GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH-------hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence 58888876 45556666666666554333233333 378889999999999888666654 788899999
Q ss_pred EEECCCCcEEEeecCccc
Q 010887 406 ILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 406 ILl~~~~~~ki~DfGl~~ 423 (498)
++++.++.+++.=.|+-.
T Consensus 110 L~f~~~~~p~i~~RGik~ 127 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQN 127 (215)
T ss_dssp EEECTTSCEEESCCEETT
T ss_pred EEEcCCCCEEEEEccCcc
Confidence 999999999998777643
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=89.60 E-value=1.1 Score=40.10 Aligned_cols=84 Identities=11% Similarity=0.088 Sum_probs=61.7
Q ss_pred cCCccceEEEEEEcCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCcEEcCCCCC
Q 010887 326 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE-YLHEQCNPKIIHRDLKAA 404 (498)
Q Consensus 326 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~-yLH~~~~~~ivH~Dlk~~ 404 (498)
.||.+ -...-.+.+...+.++.-+++.-...++ .++...+++++.+++.... +++. -+|--++|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 47777 4455567777777777665544444443 3688899999998888766 5554 378889999
Q ss_pred cEEECCCCcEEEeecCccc
Q 010887 405 NILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 405 NILl~~~~~~ki~DfGl~~ 423 (498)
|+++|.++.++|.-.|+-.
T Consensus 114 NL~f~~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKE 132 (219)
T ss_dssp GEEECTTCCEEESCCEETT
T ss_pred eEEEeCCCcEEEEEcCCcc
Confidence 9999999999998877644
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=88.13 E-value=0.3 Score=48.22 Aligned_cols=78 Identities=14% Similarity=0.139 Sum_probs=60.4
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCcc-CcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTL-PDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~-p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
+++.+.+..+ +.-.-+.+|.++++|+.++|..+ ++ .| ...|.++++|+.++|..| ++-.-..+|.++++|+.+++
T Consensus 298 ~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~l 373 (394)
T 4fs7_A 298 SLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVEL 373 (394)
T ss_dssp TCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEE
T ss_pred cccccccccc-cceechhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEE
Confidence 6888888765 65233457999999999999755 76 45 567899999999999877 66333457999999999998
Q ss_pred CCC
Q 010887 156 SSN 158 (498)
Q Consensus 156 ~~N 158 (498)
..|
T Consensus 374 p~~ 376 (394)
T 4fs7_A 374 PKR 376 (394)
T ss_dssp EGG
T ss_pred CCC
Confidence 654
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.33 E-value=0.1 Score=52.86 Aligned_cols=61 Identities=8% Similarity=0.033 Sum_probs=17.5
Q ss_pred CCeeecccceEEEEEEEcC-CcEEEE------EEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEc
Q 010887 276 SNIIGQGGFGKVYKGVLSD-NTKVAV------KRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT 339 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~-~~~vav------K~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 339 (498)
.+.+| ||.||+|.+.. ..+||| |..+.. .+......|.+|..++.+.+|||+++.+++...
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 45566 99999999854 367888 776642 233445678899999999999999999887643
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.07 E-value=0.14 Score=32.87 Aligned_cols=20 Identities=10% Similarity=0.149 Sum_probs=8.4
Q ss_pred EEEecccchhhhhhhhhhhh
Q 010887 209 VVASASCGAFVLLSLGALFA 228 (498)
Q Consensus 209 iv~~~~~~~~~ll~~~~~~~ 228 (498)
|.+++++++++++++++.++
T Consensus 13 IA~gVVgGv~~~~ii~~~~~ 32 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIG 32 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHH
T ss_pred EEeehhHHHHHHHHHHHHHH
Confidence 34444444444443333333
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 498 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-59 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-54 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-53 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-51 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-51 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-51 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-50 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-50 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-50 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-49 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-49 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-49 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-48 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-47 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-47 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-47 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-47 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-47 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-46 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-45 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-45 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-44 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-43 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-43 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-42 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-42 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-42 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-40 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-40 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-39 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-39 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-38 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-38 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-38 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-35 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-33 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-33 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-32 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-28 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-12 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 0.004 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 6e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 7e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.002 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.002 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.003 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 3e-59
Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 10/221 (4%)
Query: 266 LQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISV 324
++L D+F + + +G G G V+K +A K + P RE+ ++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 325 AIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYG 384
++ G + E + M S L + + +V+ G
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGS----LDQVLKKAGRIPEQILGKVSIAVIKG 116
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 444
L YL E+ KI+HRD+K +NIL++ E LCDFG++ + + GT +++
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMS 171
Query: 445 PEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE 485
PE L S ++D++ G++L+E+ G+ I +E E
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 212
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 4e-54
Identities = 67/219 (30%), Positives = 106/219 (48%), Gaps = 14/219 (6%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKN 329
+ IG G FG VYKG VAVK L +P AF+ EV ++ H N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 389
+L +GY T + + +V + + S+ + L ++ + +A TA G++YLH
Sbjct: 66 ILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLH 121
Query: 390 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD-AKLTHVTTQIRGTMGHIAPEYL 448
+ IIHRDLK+ NI L ++ + DFGLA + +H Q+ G++ +APE +
Sbjct: 122 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 449 STGKS---SEKTDVFGYGITLLELVTGQRAIDFSRLEEE 484
S ++DV+ +GI L EL+TGQ ++
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 217
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 5e-53
Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 8/214 (3%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
+ +G G FG+V+ G + +TKVAVK L+ AF E +L+ H+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRL 70
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 390
++L T ++ +M+N S+ L+ P L +A A G+ ++ E
Sbjct: 71 VRLYAVVT-QEPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 391 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST 450
+ IHRDL+AANIL+ D + DFGLA+L++ + + APE ++
Sbjct: 128 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 451 GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE 484
G + K+DV+ +GI L E+VT R E
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 1e-51
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 8/214 (3%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
++ +GQG FG+V+ G + T+VA+K L+ AF +E ++ H+ L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKL 74
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 390
+QL + +V +M S K L P +A A G+ Y+
Sbjct: 75 VQLYAVVSEE-PIYIVTEYMSKGS--LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 391 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST 450
+HRDL+AANIL+ +N + DFGLA+L++ + + APE
Sbjct: 132 MN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188
Query: 451 GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE 484
G+ + K+DV+ +GI L EL T R + E
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 222
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 2e-51
Identities = 50/210 (23%), Positives = 87/210 (41%), Gaps = 7/210 (3%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHK 328
+++ IG G +G+ K SD + K L + + EV+L+ H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 329 NLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386
N+++ + L V + + +A + + LD RV L+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 387 YLHEQ--CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 444
H + ++HRDLK AN+ LD L DFGLA++++ T GT +++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMS 182
Query: 445 PEYLSTGKSSEKTDVFGYGITLLELVTGQR 474
PE ++ +EK+D++ G L EL
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMP 212
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 3e-51
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 10/215 (4%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
+ IG G FG V+ G + KVA+K +++ E F E ++ H L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKL 62
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWPTRKRVAFGTAYGLEYLH 389
+QL G C + LV+ FM++ L D ++GL T + G+ YL
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGC----LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 390 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 449
E C +IHRDL A N L+ +N + DFG+ + V +T + + +PE S
Sbjct: 119 EAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175
Query: 450 TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE 484
+ S K+DV+ +G+ + E+ + + +R E
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 172 bits (437), Expect = 2e-50
Identities = 60/231 (25%), Positives = 103/231 (44%), Gaps = 23/231 (9%)
Query: 261 FSCRELQLATDNFSES---------NIIGQGGFGKVYKGVLSDNTK----VAVKRLQDYY 307
F+ + A F++ +IG G FG+V G L K VA+K L+ Y
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 308 SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEK 367
+ F E ++ H N++ L G T S+ +++ FM+N S+ LR +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDG 123
Query: 368 GLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427
+ G A G++YL + +HRDL A NIL++ N + DFGL++ ++
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 428 KLTHVTT----QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 474
+ T + + APE + K + +DV+ YGI + E+++
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-50
Identities = 51/218 (23%), Positives = 97/218 (44%), Gaps = 10/218 (4%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
+++ +G+G +G+V V VAVK + + ++E+ + + H+N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 389
+++ G+ + + L + + R+ + G+ P +R G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 390 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA-KLTHVTTQIRGTMGHIAPEYL 448
I HRD+K N+LLD+ + DFGLA + + ++ GT+ ++APE L
Sbjct: 121 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 449 STGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE 485
+ +E DV+ GI L ++ G+ D +E
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 215
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (431), Expect = 9e-50
Identities = 61/247 (24%), Positives = 105/247 (42%), Gaps = 30/247 (12%)
Query: 265 ELQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQRE 318
L+ +N IG+G FG+V++ T VAVK L++ S +A FQRE
Sbjct: 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE 66
Query: 319 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK--------------- 363
L++ + N+++L+G C L++ +M + LR +
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 364 -----PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 418
PG L + +A A G+ YL E+ K +HRDL N L+ +N + D
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIAD 183
Query: 419 FGLAKLV-DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 477
FGL++ + A + + PE + + + ++DV+ YG+ L E+ +
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 478 FSRLEEE 484
+ EE
Sbjct: 244 YGMAHEE 250
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (428), Expect = 1e-49
Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 13/207 (6%)
Query: 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIH 327
++F +G+G FG VY +A+K L G E +REV + S H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
N+L+L GY ++ L+ + +V L+ L D A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSY 121
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 447
H + ++IHRD+K N+LL E + DFG + + + GT+ ++ PE
Sbjct: 122 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEM 175
Query: 448 LSTGKSSEKTDVFGYGITLLELVTGQR 474
+ EK D++ G+ E + G+
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKP 202
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-49
Identities = 55/217 (25%), Positives = 98/217 (45%), Gaps = 13/217 (5%)
Query: 264 RELQLATDNFSESNI-IGQGGFGKVYKGVL---SDNTKVAVKRLQDYYSPGGEAAFQREV 319
++L L DN ++I +G G FG V +GV VA+K L+ RE
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 320 HLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF 379
++ + +++LIG C +LV + L + + + +
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLH 116
Query: 380 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIR 437
+ G++YL E+ +HRDL A N+LL + A + DFGL+K + D + +
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 438 GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 474
+ APE ++ K S ++DV+ YG+T+ E ++ +
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 210
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-49
Identities = 48/204 (23%), Positives = 85/204 (41%), Gaps = 8/204 (3%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
+ + +G G FG V G VA+K +++ E F E ++ H+ L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKL 61
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 390
+QL G CT ++ +M N + L L+ + +EYL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCL---LNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 391 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST 450
+ +HRDL A N L++D + DFGL++ V + + + PE L
Sbjct: 119 KQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 451 GKSSEKTDVFGYGITLLELVTGQR 474
K S K+D++ +G+ + E+ + +
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGK 199
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 3e-49
Identities = 59/225 (26%), Positives = 110/225 (48%), Gaps = 13/225 (5%)
Query: 267 QLATDNFSESNIIGQGGFGKVYKGVLSDNT-----KVAVKRLQDYYSPGGEAAFQREVHL 321
++ + +IG G FG+VYKG+L ++ VA+K L+ Y+ F E +
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 322 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 381
+ H N+++L G + +++ +M+N ++ LR+ + + G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGI 119
Query: 382 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGT 439
A G++YL N +HRDL A NIL++ N + DFGL++++ D + T+ T+ +
Sbjct: 120 AAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 440 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE 484
+ APE +S K + +DV+ +GI + E++T + E
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 221
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 9e-49
Identities = 54/205 (26%), Positives = 88/205 (42%), Gaps = 16/205 (7%)
Query: 277 NIIGQGGFGKVYKGVLSD-NTKVAVKRLQD-YYSPGGEAAFQREVHLISVAIHKNLLQLI 334
IG+G F VYKG+ ++ +VA LQD + F+ E ++ H N+++
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 335 GYCTTSSER----ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 390
++ + +LV M + + L+ K + + GL++LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGT----LKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 391 QCNPKIIHRDLKAANILLDD-NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 449
+ P IIHRDLK NI + + D GLA L + GT +APE
Sbjct: 131 R-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMYE 186
Query: 450 TGKSSEKTDVFGYGITLLELVTGQR 474
K E DV+ +G+ +LE+ T +
Sbjct: 187 -EKYDESVDVYAFGMCMLEMATSEY 210
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 5e-48
Identities = 59/245 (24%), Positives = 103/245 (42%), Gaps = 31/245 (12%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTK------VAVKRLQDYYSPGGEAAFQREVHLIS- 323
+N ++G G FGKV +K VAVK L++ A E+ +++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 324 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP------------------- 364
+ H+N++ L+G CT S L++ + + LR +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 365 GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424
L + A+ A G+E+L + +HRDL A N+L+ +CDFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 425 VDAKLTHVT-TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEE 483
+ + +V R + +APE L G + K+DV+ YGI L E+ + + +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP-YPGIPV 272
Query: 484 EEDVL 488
+ +
Sbjct: 273 DANFY 277
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-47
Identities = 64/212 (30%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 272 NFSESNIIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIH 327
+F+E +IG+G FG VY G L DN AVK L G + F E ++ H
Sbjct: 30 HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 328 KNLLQLIGYCT-TSSERILVYPFMQNLSVAYRLRDLKPGEKG-LDWPTRKRVAFGTAYGL 385
N+L L+G C + ++V P+M++ LR+ E A G+
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGD----LRNFIRNETHNPTVKDLIGFGLQVAKGM 143
Query: 386 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---DAKLTHVTTQIRGTMGH 442
+ K +HRDL A N +LD+ F + DFGLA+ + + H T + +
Sbjct: 144 ---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 200
Query: 443 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 474
+A E L T K + K+DV+ +G+ L EL+T
Sbjct: 201 MALESLQTQKFTTKSDVWSFGVLLWELMTRGA 232
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 2e-47
Identities = 58/205 (28%), Positives = 88/205 (42%), Gaps = 14/205 (6%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 330
IG+G FG V G KVAVK +++ AF E +++ H NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNL 62
Query: 331 LQLIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 389
+QL+G + +V +M S+ LR G L + + +EYL
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 390 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 449
+HRDL A N+L+ ++ A + DFGL K + + + APE L
Sbjct: 121 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG----KLPVKWTAPEALR 173
Query: 450 TGKSSEKTDVFGYGITLLELVTGQR 474
K S K+DV+ +GI L E+ + R
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGR 198
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 163 bits (414), Expect = 2e-47
Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 8/217 (3%)
Query: 259 RRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQR 317
+ + ++ + + + +G G +G+VY+GV + VAVK L++ F +
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLK 62
Query: 318 EVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 377
E ++ H NL+QL+G CT ++ FM ++ LR+ E + +
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYM 120
Query: 378 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 437
A + +EYL + IHRDL A N L+ +N + DFGL++L+ +
Sbjct: 121 ATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177
Query: 438 GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 474
+ APE L+ K S K+DV+ +G+ L E+ T
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 214
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 164 bits (415), Expect = 3e-47
Identities = 60/211 (28%), Positives = 83/211 (39%), Gaps = 18/211 (8%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAI 326
FS+ IG G FG VY + ++ VA+K++ S +EV +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 327 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386
H N +Q G LV + + KP L V G GL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLA 129
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 446
YLH +IHRD+KA NILL + L DFG A ++ GT +APE
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPE 181
Query: 447 YLST---GKSSEKTDVFGYGITLLELVTGQR 474
+ G+ K DV+ GIT +EL +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKP 212
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 5e-47
Identities = 56/220 (25%), Positives = 101/220 (45%), Gaps = 21/220 (9%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDN---TKVAVKRLQDYYSPGGEAAFQREVHLIS-VAI 326
++ ++IG+G FG+V K + + A+KR+++Y S F E+ ++ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 327 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGE------------KGLDWPTR 374
H N++ L+G C L + + ++ LR + E L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 375 KRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT 434
A A G++YL + + IHRDL A NIL+ +N+ A + DFGL++ + + T
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184
Query: 435 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 474
R + +A E L+ + +DV+ YG+ L E+V+
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 7e-47
Identities = 58/246 (23%), Positives = 98/246 (39%), Gaps = 25/246 (10%)
Query: 271 DNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLIS- 323
+ S +G G FGKV + VAVK L+ A E+ ++S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 324 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD--------------LKPGEKGL 369
+ H N++ L+G CT +++ + + LR ++ E L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 370 DWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429
D ++ A G+ +L + IHRDL A NILL +CDFGLA+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 430 TH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 488
+ V R + +APE + + ++DV+ YGI L EL + + + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 489 LLDHKV 494
++
Sbjct: 260 MIKEGF 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 5e-46
Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 14/211 (6%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 328
D + +G G FGKVYK + A K + D S + E+ +++ H
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI-DTKSEEELEDYMVEIDILASCDHP 69
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
N+++L+ + ++ F +V + +L+ + L + V T L YL
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYL 126
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 448
H+ KIIHRDLKA NIL + + L DFG++ + + GT +APE +
Sbjct: 127 HDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPEVV 182
Query: 449 STGKS-----SEKTDVFGYGITLLELVTGQR 474
S K DV+ GITL+E+ +
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEP 213
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-45
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 14/206 (6%)
Query: 275 ESNIIGQGGFGKVYKGVLSD---NTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNL 330
E +G G FG V KG VAVK L+ + P + E +++ + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 331 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 390
+++IG C S +LV + L + + + + G++YL E
Sbjct: 71 VRMIGICEAES-WMLVMEMAELGP----LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 125
Query: 391 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--IRGTMGHIAPEYL 448
+HRDL A N+LL A + DFGL+K + A + Q + + APE +
Sbjct: 126 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 449 STGKSSEKTDVFGYGITLLELVTGQR 474
+ K S K+DV+ +G+ + E + +
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQ 208
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 5e-45
Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 26/212 (12%)
Query: 279 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338
IG+G FG+V++G +VAVK + E++ + H+N+L I
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSS--REERSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 339 ----TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC-- 392
T ++ LV + ++ S+ L + ++A TA GL +LH +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 393 ---NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK---LTHVTTQIRGTMGHIAPE 446
P I HRDLK+ NIL+ N + D GLA D+ + GT ++APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 447 YLST------GKSSEKTDVFGYGITLLELVTG 472
L +S ++ D++ G+ E+
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARR 214
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 4e-44
Identities = 46/206 (22%), Positives = 91/206 (44%), Gaps = 11/206 (5%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 328
++ IGQG G VY + ++ +VA++++ + + E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNP 77
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
N++ + E +V ++ S+ + E +D V LE+L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFL 132
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 448
H ++IHRD+K+ NILL + L DFG + + + +T + GT +APE +
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVV 188
Query: 449 STGKSSEKTDVFGYGITLLELVTGQR 474
+ K D++ GI +E++ G+
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEP 214
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 1e-43
Identities = 49/208 (23%), Positives = 85/208 (40%), Gaps = 11/208 (5%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIH 327
++F I+G+G F V L+ + + A+K L + RE ++S H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
++L + + +N L D + LEY
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPE 446
LH + IIHRDLK NILL+++ + DFG AK++ + GT +++PE
Sbjct: 124 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 447 YLSTGKSSEKTDVFGYGITLLELVTGQR 474
L+ + + +D++ G + +LV G
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLP 208
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-43
Identities = 51/210 (24%), Positives = 98/210 (46%), Gaps = 13/210 (6%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDN-----TKVAVKRLQDYYSPGGEAAFQREVHLISVA 325
F + ++G G FG VYKG+ VA+K L++ SP E ++++
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 326 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGL 385
+ ++ +L+G C TS+ +++ L ++ + + A G+
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGM 124
Query: 386 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA-KLTHVTTQIRGTMGHIA 444
YL ++ +++HRDL A N+L+ + DFGLAKL+ A + + + + +A
Sbjct: 125 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 445 PEYLSTGKSSEKTDVFGYGITLLELVTGQR 474
E + + ++DV+ YG+T+ EL+T
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGS 211
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 152 bits (384), Expect = 2e-42
Identities = 48/207 (23%), Positives = 81/207 (39%), Gaps = 12/207 (5%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
D++ +G G FG V++ + A K + + ++E+ +SV H
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPT 84
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 389
L+ L +E +++Y FM + ++ D + GL ++H
Sbjct: 85 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMH 141
Query: 390 EQCNPKIIHRDLKAANILL--DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 447
E +H DLK NI+ + E L DFGL +D K + T GT APE
Sbjct: 142 ENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEV 196
Query: 448 LSTGKSSEKTDVFGYGITLLELVTGQR 474
TD++ G+ L++G
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLS 223
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 4e-42
Identities = 52/223 (23%), Positives = 99/223 (44%), Gaps = 16/223 (7%)
Query: 265 ELQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQRE 318
E ++A + + S +GQG FG VY+GV T+VA+K + + S F E
Sbjct: 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 319 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG------LDWP 372
++ ++++L+G + +++ M + LR L+P
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 373 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTH 431
++A A G+ YL+ K +HRDL A N ++ ++F + DFG+ + + +
Sbjct: 134 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 432 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 474
+ + ++PE L G + +DV+ +G+ L E+ T
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 233
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 5e-42
Identities = 46/209 (22%), Positives = 93/209 (44%), Gaps = 13/209 (6%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAI 326
+ IG+G FG V++G+ VA+K ++ S F +E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 327 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG-LDWPTRKRVAFGTAYGL 385
H ++++LIG T + ++ LR K LD + A+ + L
Sbjct: 67 HPHIVKLIGVIT-ENPVWIIMELCTLGE----LRSFLQVRKYSLDLASLILYAYQLSTAL 121
Query: 386 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAP 445
YL + + +HRD+ A N+L+ N L DFGL++ ++ + ++ + + +AP
Sbjct: 122 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 446 EYLSTGKSSEKTDVFGYGITLLELVTGQR 474
E ++ + + +DV+ +G+ + E++
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGV 207
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 1e-41
Identities = 60/213 (28%), Positives = 86/213 (40%), Gaps = 17/213 (7%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTK----VAVKRL--QDYYSPGGEAAFQREVHLISV 324
+ +G G FG V +G + VAVK L P F REV+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 325 AIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG-LDWPTRKRVAFGTAY 383
H+NL++L G T ++ V S L D +G T R A A
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGS----LLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH--VTTQIRGTMG 441
G+ YL + IHRDL A N+LL + DFGL + + H + +
Sbjct: 123 GMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 442 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 474
APE L T S +D + +G+TL E+ T +
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 212
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 148 bits (374), Expect = 8e-41
Identities = 58/230 (25%), Positives = 97/230 (42%), Gaps = 17/230 (7%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRL--QDYYSPGGEAAFQREVHLISV--- 324
++FS IIG+GGFG+VY +D A+K L + GE E ++S+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 325 AIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYG 384
++ + T + + M + Y L + A G
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF----SEADMRFYAAEIILG 119
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 444
LE++H + +++RDLK ANILLD++ + D GLA K H + GT G++A
Sbjct: 120 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMA 173
Query: 445 PEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHK 493
PE L G + D F G L +L+ G + +++ ++ +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 223
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 144 bits (365), Expect = 4e-40
Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 14/207 (6%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIH 327
+F +G G FG+V+ + A+K L + E ++S+ H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
++++ G + + ++ +++ L L + P K A LEY
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 447
LH + II+RDLK NILLD N + DFG AK V VT + GT +IAPE
Sbjct: 120 LHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEV 172
Query: 448 LSTGKSSEKTDVFGYGITLLELVTGQR 474
+ST ++ D + +GI + E++ G
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 145 bits (367), Expect = 6e-40
Identities = 41/207 (19%), Positives = 77/207 (37%), Gaps = 12/207 (5%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
D + +G G FG V++ V + K + P + + E+ +++ H
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-YPLDKYTVKNEISIMNQLHHPK 87
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 389
L+ L E +L+ F+ + R+ + GL+++H
Sbjct: 88 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMH 144
Query: 390 EQCNPKIIHRDLKAANILLD--DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 447
E I+H D+K NI+ + + DFGLA ++ + T APE
Sbjct: 145 EH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--DEIVKVTTATAEFAAPEI 199
Query: 448 LSTGKSSEKTDVFGYGITLLELVTGQR 474
+ TD++ G+ L++G
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLS 226
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 143 bits (362), Expect = 7e-40
Identities = 49/204 (24%), Positives = 89/204 (43%), Gaps = 8/204 (3%)
Query: 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKN 329
+ + IG+G +G VYK + A+K+++ + G + RE+ ++ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 389
+++L T +LV+ + + L E GL+ T K G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQ----DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 390 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 449
++ +++HRDLK N+L++ E + DFGLA+ + T +I +
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 450 TGKSSEKTDVFGYGITLLELVTGQ 473
+ K S D++ G E+V G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 142 bits (360), Expect = 1e-39
Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 25/219 (11%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--------QDYYSPGGEAAFQREVHL 321
+N+ I+G+G V + + + AVK + A +EV +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 322 IS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 380
+ V+ H N++QL T++ LV+ M+ + L + + L +++
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRA 118
Query: 381 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 440
+ LH+ I+HRDLK NILLDD+ L DFG + +D ++ GT
Sbjct: 119 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVCGTP 173
Query: 441 GHIAPEYLSTG------KSSEKTDVFGYGITLLELVTGQ 473
++APE + ++ D++ G+ + L+ G
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 1e-39
Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 8/206 (3%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHK 328
+NF + IG+G +G VYK VA+K+++ D + G + RE+ L+ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
N+++L+ T ++ LV+ F+ + G+ P K F GL +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL---TGIPLPLIKSYLFQLLQGLAFC 118
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 448
H ++HRDLK N+L++ L DFGLA+ + T ++ L
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 449 STGKSSEKTDVFGYGITLLELVTGQR 474
S D++ G E+VT +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRA 201
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (360), Expect = 2e-39
Identities = 49/215 (22%), Positives = 93/215 (43%), Gaps = 13/215 (6%)
Query: 264 RELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLI 322
++ + D + +++G G F +V VA+K + G E + + E+ ++
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 323 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 382
H N++ L + L+ + + R+ + R+ F
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF----YTERDASRLIFQVL 117
Query: 383 YGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT 439
++YLH+ I+HRDLK N+L D++ + ++ DFGL+K+ D V + GT
Sbjct: 118 DAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGT 172
Query: 440 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 474
G++APE L+ S+ D + G+ L+ G
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP 207
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-39
Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 17/221 (7%)
Query: 262 SCRELQLATDNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRL-QDYYSPGGEAAFQRE 318
CR A + IG+G +GKV+K + + VA+KR+ G + RE
Sbjct: 2 LCR----ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE 57
Query: 319 VHL---ISVAIHKNLLQLIGYCTTSS--ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPT 373
V + + H N+++L CT S + +++ K E G+ T
Sbjct: 58 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET 117
Query: 374 RKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 433
K + F GL++LH +++HRDLK NIL+ + + L DFGLA++ ++
Sbjct: 118 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-- 172
Query: 434 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 474
T + T+ + APE L + D++ G E+ +
Sbjct: 173 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 213
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 3e-39
Identities = 54/208 (25%), Positives = 85/208 (40%), Gaps = 12/208 (5%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAI- 326
++F ++G+G FGKV+ N A+K L E ++S+A
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 327 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386
H L + T V ++ + Y ++ D A GL+
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQ 117
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 446
+LH + I++RDLK NILLD + + DFG+ K T GT +IAPE
Sbjct: 118 FLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPE 173
Query: 447 YLSTGKSSEKTDVFGYGITLLELVTGQR 474
L K + D + +G+ L E++ GQ
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQS 201
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 7e-39
Identities = 59/236 (25%), Positives = 101/236 (42%), Gaps = 25/236 (10%)
Query: 271 DNFSESNIIGQGGFGKVYKGVL--------SDNTKVAVKRLQDYYSPGGEAAFQREVHLI 322
D +G+G FG+V + TKVAVK L+ + + E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 323 S-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG------------EKGL 369
+ HKN++ L+G CT ++ + ++ L+ +P E+ L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 370 DWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429
A+ A G+EYL K IHRDL A N+L+ ++ + DFGLA+ +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 430 THVTTQ-IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE 484
+ T R + +APE L + ++DV+ +G+ L E+ T + EE
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-38
Identities = 44/208 (21%), Positives = 91/208 (43%), Gaps = 8/208 (3%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 328
++ + IG+G +G V + +VA+K++ + RE+ ++ H+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
N++ + + + ++ + L L + L + GL+Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYFLYQILRGLKYI 125
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT--TQIRGTMGHIAPE 446
H ++HRDLK +N+LL+ + +CDFGLA++ D H T+ T + APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 447 YLSTG-KSSEKTDVFGYGITLLELVTGQ 473
+ ++ D++ G L E+++ +
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 3e-38
Identities = 57/236 (24%), Positives = 102/236 (43%), Gaps = 24/236 (10%)
Query: 271 DNFSESNIIGQGGFGKVYKGV------LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISV 324
D +G+G FG+V + + VAVK L++ + A E+ ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 325 AIH-KNLLQLIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKP------------GEKGLD 370
H N++ L+G CT + ++ F + +++ LR + + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 371 WPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430
+F A G+E+L + K IHRDL A NILL + +CDFGLA+ +
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 431 HV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE 485
+V R + +APE + + ++DV+ +G+ L E+ + + +EE
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 6e-38
Identities = 39/207 (18%), Positives = 84/207 (40%), Gaps = 13/207 (6%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
+ + + +G+G FG V++ V S K ++ + ++E+ ++++A H+N
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHRN 62
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 389
+L L + E ++++ F+ L + R+ L+ L++LH
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLH 119
Query: 390 EQCNPKIIHRDLKAANILLDDNFEAV--LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 447
I H D++ NI+ + + +FG A+ + + + APE
Sbjct: 120 SH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--GDNFRLLFTAPEYYAPEV 174
Query: 448 LSTGKSSEKTDVFGYGITLLELVTGQR 474
S TD++ G + L++G
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGIN 201
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 137 bits (345), Expect = 1e-37
Identities = 48/214 (22%), Positives = 87/214 (40%), Gaps = 16/214 (7%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAI 326
+D + I+G GG +V+ L + VAVK L P F+RE +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 327 HKNLLQLIGYCTTSSERI----LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 382
H ++ + + +V ++ +++ + P + V
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADAC 121
Query: 383 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTM 440
L + H+ IIHRD+K ANI++ + DFG+A+ + V T + GT
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 441 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 474
+++PE ++DV+ G L E++TG+
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 212
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 2e-37
Identities = 62/203 (30%), Positives = 89/203 (43%), Gaps = 14/203 (6%)
Query: 277 NIIGQGGFGKVYKGV-LSDNTKVAVKRL----QDYYSPGGEAAFQREVHLISVAIHKNLL 331
+ +G+G F VYK + N VA+K++ + G RE+ L+ H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 332 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
L+ S LV+ FM+ +K L K T GLEYLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 392 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 451
I+HRDLK N+LLD+N L DFGLAK + T Q+ T + APE L
Sbjct: 120 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175
Query: 452 KS-SEKTDVFGYGITLLELVTGQ 473
+ D++ G L EL+
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRV 198
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 3e-37
Identities = 52/212 (24%), Positives = 85/212 (40%), Gaps = 18/212 (8%)
Query: 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 329
+++++ +IG G FG VY+ L VA+K++ + RE+ ++ H N
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCN 74
Query: 330 LLQLIGYCTTSSER------ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 383
+++L + +S E+ LV ++ R ++ L K +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 384 GLEYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 442
L Y+H I HRD+K N+LLD D LCDFG AK + + I
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYR 189
Query: 443 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 474
+ DV+ G L EL+ GQ
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQP 221
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 5e-35
Identities = 51/223 (22%), Positives = 81/223 (36%), Gaps = 19/223 (8%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLISV 324
D + +G G F V K S + A K R + +REV ++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 325 AIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYG 384
H N++ L ++ IL+ + L D ++ L G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAG----GELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 385 LEYLHEQCNPKIIHRDLKAANILLDDN----FEAVLCDFGLAKLVDAKLTHVTTQIRGTM 440
+ YLH I H DLK NI+L D + DFGLA +D + I GT
Sbjct: 126 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GNEFKNIFGTP 180
Query: 441 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEE 483
+APE ++ + D++ G+ L++G +E
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 223
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 5e-35
Identities = 50/207 (24%), Positives = 85/207 (41%), Gaps = 19/207 (9%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVKRL-----QDYYSPGGEAAFQREVHLIS--VAIHKN 329
++G GGFG VY G+ +SDN VA+K + D+ EV L+ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 330 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 389
+++L+ + +L+ + + L D L + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQD---LFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 390 EQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 448
++HRD+K NIL+D + E L DFG L+ V T GT + PE++
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWI 181
Query: 449 STGK-SSEKTDVFGYGITLLELVTGQR 474
+ V+ GI L ++V G
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDI 208
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 1e-34
Identities = 48/230 (20%), Positives = 86/230 (37%), Gaps = 24/230 (10%)
Query: 278 IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIG 335
++G G GKV + K A+K LQD +REV L A ++++++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVD 72
Query: 336 YCTTSSER----ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 391
++V + + R++ G++ + ++YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 392 CNPKIIHRDLKAANILLDDNFE---AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 448
I HRD+K N+L L DFG AK + + T T ++APE L
Sbjct: 131 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVL 185
Query: 449 STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHKVTEGR 498
K + D++ G+ + L+ G F + ++ G+
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPP--FYSNHGLAISPGMKTRIRMGQ 233
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 3e-34
Identities = 49/206 (23%), Positives = 84/206 (40%), Gaps = 9/206 (4%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHK 328
+ + IG+G +G V+K + VA+KR++ D G ++ RE+ L+ HK
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
N+++L + + LV+ F + LD K F GL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 448
H + ++HRDLK N+L++ N E L +FGLA+ + + ++
Sbjct: 118 HSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 449 STGKSSEKTDVFGYGITLLELVTGQR 474
S D++ G EL R
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 1e-33
Identities = 45/207 (21%), Positives = 80/207 (38%), Gaps = 11/207 (5%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIH 327
++F ++G+G FGKV + A+K L + + A E ++ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
L L T V + + + L + T +R F A +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-------FTEERARFYGAEIVSA 117
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 447
L + +++RD+K N++LD + + DFGL K + GT ++APE
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEV 176
Query: 448 LSTGKSSEKTDVFGYGITLLELVTGQR 474
L D +G G+ + E++ G+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 126 bits (318), Expect = 1e-33
Identities = 35/207 (16%), Positives = 72/207 (34%), Gaps = 21/207 (10%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 337
IG+G FG +++G L +N +VA+K + E + + + Y
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 338 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 397
++ + S+ L + T A ++ +HE+ ++
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEK---SLV 123
Query: 398 HRDLKAANILLDDNFEAV-----LCDFGLAKLVDAKLTHV------TTQIRGTMGHIAPE 446
+RD+K N L+ + DFG+ K +T + GT +++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 447 YLSTGKSSEKTDVFGYGITLLELVTGQ 473
+ S + D+ G + + G
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGS 210
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 125 bits (315), Expect = 3e-33
Identities = 43/240 (17%), Positives = 77/240 (32%), Gaps = 22/240 (9%)
Query: 265 ELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS 323
EL++ + + IG G FG +Y G ++ +VA+K E +
Sbjct: 2 ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC---VKTKHPQLHIESKIYK 57
Query: 324 VAIHKNLLQLIGYCTTSSER-ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 382
+ + I +C + ++V + + T +A
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMI 113
Query: 383 YGLEYLHEQCNPKIIHRDLKAANIL---LDDNFEAVLCDFGLAKLVDAKLTHV------T 433
+EY+H + IHRD+K N L + DFGLAK TH
Sbjct: 114 SRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 170
Query: 434 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHK 493
+ GT + + + S + D+ G L+ G + + +
Sbjct: 171 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 126 bits (318), Expect = 4e-33
Identities = 45/207 (21%), Positives = 75/207 (36%), Gaps = 14/207 (6%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIH 327
D F +G G FG+V A+K L Q E ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
L++L +S +V ++ + P + A EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAG----GEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 447
LH +I+RDLK N+L+D + DFG AK ++ T + GT +APE
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEI 209
Query: 448 LSTGKSSEKTDVFGYGITLLELVTGQR 474
+ + ++ D + G+ + E+ G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 2e-32
Identities = 44/205 (21%), Positives = 85/205 (41%), Gaps = 8/205 (3%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHK 328
+ + +G G +G V V KVA+K+L + + S RE+ L+ H+
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
N++ L+ T F + + L + + + GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 389 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 448
H HRDLK N+ ++++ E + DFGLA+ D+++ T + L
Sbjct: 138 HAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVTRWYRAPEVIL 191
Query: 449 STGKSSEKTDVFGYGITLLELVTGQ 473
+ + ++ D++ G + E++TG+
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 8e-32
Identities = 58/226 (25%), Positives = 93/226 (41%), Gaps = 25/226 (11%)
Query: 263 CRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVH 320
C E+ + + IGQG FG+V+K KVA+K++ + G RE+
Sbjct: 6 CDEV----SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK 61
Query: 321 LISVAIHKNLLQLIGYCTTSSERI--------LVYPFMQNLSVAYRLRDLKPGEKGLDWP 372
++ + H+N++ LI C T + LV+ F ++ L
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLS 117
Query: 373 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-- 430
KRV L L+ KI+HRD+KAAN+L+ + L DFGLA+
Sbjct: 118 EIKRVMQML---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 174
Query: 431 -HVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQR 474
+ T T+ + PE L + D++G G + E+ T
Sbjct: 175 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 114 bits (285), Expect = 9e-29
Identities = 45/228 (19%), Positives = 89/228 (39%), Gaps = 20/228 (8%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHK 328
D++ +G+G + +V++ + +++N KV VK L P + +RE+ ++ +
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL----KPVKKKKIKREIKILENLRGGP 90
Query: 329 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 388
N++ L R F D K + L + + L+Y
Sbjct: 91 NIITLADIVKDPVSRTPALVFEH-----VNNTDFKQLYQTLTDYDIRFYMYEILKALDYC 145
Query: 389 HEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE- 446
H I+HRD+K N+++D ++ + L D+GLA+ + + PE
Sbjct: 146 HSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPEL 200
Query: 447 YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHKV 494
+ D++ G L ++ + F + D L+ KV
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEP--FFHGHDNYDQLVRIAKV 246
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 2e-28
Identities = 43/206 (20%), Positives = 85/206 (41%), Gaps = 8/206 (3%)
Query: 270 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIH 327
+ + + +G G +G V +VAVK+L + + S RE+ L+ H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
+N++ L+ T + + + + L + + + GL+Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 447
+H HRDLK +N+ ++++ E + DFGLA+ D +T +
Sbjct: 137 IHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIM 190
Query: 448 LSTGKSSEKTDVFGYGITLLELVTGQ 473
L+ ++ D++ G + EL+TG+
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 4e-28
Identities = 51/214 (23%), Positives = 82/214 (38%), Gaps = 17/214 (7%)
Query: 271 DNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRL---QDYYSPGGEAAFQREVHLIS 323
+NF ++G G +GKV+ A+K L + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 324 VAIHK-NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 382
L+ L T ++ L+ ++ + L + T V
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-------FTEHEVQIYVG 136
Query: 383 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 442
+ L II+RD+K NILLD N VL DFGL+K A T GT+ +
Sbjct: 137 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196
Query: 443 IAPEYLSTGKS--SEKTDVFGYGITLLELVTGQR 474
+AP+ + G S + D + G+ + EL+TG
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 8e-28
Identities = 48/207 (23%), Positives = 84/207 (40%), Gaps = 12/207 (5%)
Query: 271 DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHK 328
+ IG G G V + VA+K+L + + + RE+ L+ HK
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 329 NLLQLIGYCTTSS--ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 386
N++ L+ T E + L A + ++ LD + + G++
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIK 133
Query: 387 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 446
+LH IHRDLK +NI++ + + DFGLA+ + + T T + APE
Sbjct: 134 HLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPE 188
Query: 447 YLSTGKSSEKTDVFGYGITLLELVTGQ 473
+ E D++ G + E+V +
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 111 bits (277), Expect = 1e-27
Identities = 44/234 (18%), Positives = 89/234 (38%), Gaps = 22/234 (9%)
Query: 279 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-----------VAI 326
+G G F V+ + +NT VA+K ++ A + E+ L+
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRG--DKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 327 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWPTRKRVAFGTAYGL 385
++L+L+ + + + + L +K E K+++ GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 386 EYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGTMGHI 443
+Y+H +C IIH D+K N+L++ + L +A L +A T +
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 444 APEYLSTGKSSEKTDVFGYGITLLELVTGQ---RAIDFSRLEEEEDVLLLDHKV 494
+PE L D++ + EL+TG + +++D + ++
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.8 bits (214), Expect = 2e-20
Identities = 20/159 (12%), Positives = 42/159 (26%), Gaps = 20/159 (12%)
Query: 277 NIIGQGGFGKVYKGVLSDNTKVAVK---------RLQDYYSPGGEAAFQREVHLISVAIH 327
++G+G V+ + VK + G+ F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 328 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 387
+ L +L G + + + V +
Sbjct: 66 RALQKLQGLAV-------PKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAK 118
Query: 388 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426
+ + I+H DL N+L+ + + DF + V
Sbjct: 119 FYHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVG 153
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 70.0 bits (170), Expect = 1e-13
Identities = 26/157 (16%), Positives = 52/157 (33%), Gaps = 10/157 (6%)
Query: 2 FGALHKCCPPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHF 61
+L L + + L+ E + + + T + N++
Sbjct: 237 LASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNEN- 295
Query: 62 VSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLG 121
N+ LTL N S ++ L L L +N +S L
Sbjct: 296 ---QLEDISPISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFANNKVSD--VSSLA 348
Query: 122 SMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSN 158
++T++ L+ +N+ S P + L+ + L L+
Sbjct: 349 NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 64.6 bits (156), Expect = 7e-12
Identities = 23/69 (33%), Positives = 35/69 (50%), Gaps = 4/69 (5%)
Query: 99 LKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSN 158
LK L L L N++S P + S+T LQ L ANNK S ++ + L+N+ L N
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHN 361
Query: 159 NLTGRIPMQ 167
++ P+
Sbjct: 362 QISDLTPLA 370
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 52.7 bits (125), Expect = 5e-08
Identities = 34/136 (25%), Positives = 49/136 (36%), Gaps = 6/136 (4%)
Query: 57 WNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTL 116
S S V + N+ SL +N S I L L L N L
Sbjct: 178 ERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD-- 233
Query: 117 PDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNF 176
L S+T+L L+LANN+ S P S L+ L L L +N ++ P+ + T
Sbjct: 234 IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLE 291
Query: 177 TGTHLICGSSLEQPCM 192
+ + S
Sbjct: 292 LNENQLEDISPISNLK 307
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 2e-06
Identities = 33/138 (23%), Positives = 49/138 (35%), Gaps = 25/138 (18%)
Query: 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLA 132
N+ L+L N ++ L L L+L +N +S P L +T L L L
Sbjct: 216 GILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLG 271
Query: 133 NNKFSGSIP--------------------ATWSQLSNLKHLDLSSNNLTGRIPM-QLFSV 171
N+ S P + S L NL +L L NN++ P+ L +
Sbjct: 272 ANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKL 331
Query: 172 ATFNFTGTHLICGSSLEQ 189
F + SSL
Sbjct: 332 QRLFFANNKVSDVSSLAN 349
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 44.2 bits (103), Expect = 2e-05
Identities = 14/69 (20%), Positives = 27/69 (39%), Gaps = 4/69 (5%)
Query: 99 LKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSN 158
L L +++ T+ + + +L SI L+NL ++ S+N
Sbjct: 21 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDGV-EYLNNLTQINFSNN 76
Query: 159 NLTGRIPMQ 167
LT P++
Sbjct: 77 QLTDITPLK 85
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 68.2 bits (165), Expect = 3e-13
Identities = 23/115 (20%), Positives = 38/115 (33%), Gaps = 1/115 (0%)
Query: 51 HGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDN 110
+ D + + V + + + K L L+L++N
Sbjct: 195 ANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNN 254
Query: 111 DLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP 165
+ GTLP L + L SLN++ N G IP L ++N P
Sbjct: 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 65.2 bits (157), Expect = 3e-12
Identities = 24/71 (33%), Positives = 34/71 (47%), Gaps = 3/71 (4%)
Query: 123 MTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP--MQLFSVATFNFTGTH 180
+L L+L NN+ G++P +QL L L++S NNL G IP L +
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302
Query: 181 LICGSSLEQPC 191
+CGS L C
Sbjct: 303 CLCGSPLP-AC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 52.4 bits (124), Expect = 5e-08
Identities = 24/128 (18%), Positives = 48/128 (37%), Gaps = 26/128 (20%)
Query: 36 EGEALIEVLKALNDTHGQFTDWNDHFVSPC-FSWSHVTCRNGNVISLTLGSNGFSGKISP 94
+ +AL+++ K L + + W C +W V C
Sbjct: 7 DKQALLQIKKDLGN-PTTLSSWLPT-TDCCNRTWLGVLCDTD------------------ 46
Query: 95 SITKLKFLASLELQDNDLSG--TLPDFLGSMTHLQSLNLANN-KFSGSIPATWSQLSNLK 151
T+ + +L+L +L +P L ++ +L L + G IP ++L+ L
Sbjct: 47 --TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLH 104
Query: 152 HLDLSSNN 159
+L ++ N
Sbjct: 105 YLYITHTN 112
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 56.6 bits (135), Expect = 2e-09
Identities = 22/96 (22%), Positives = 37/96 (38%), Gaps = 13/96 (13%)
Query: 67 SWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHL 126
V C + + + + P L+LQ+N ++ ++ +L
Sbjct: 11 HLRVVQCSDLGLEKVPKD-------LPPDTA------LLDLQNNKITEIKDGDFKNLKNL 57
Query: 127 QSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTG 162
+L L NNK S P ++ L L+ L LS N L
Sbjct: 58 HTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE 93
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 44.3 bits (103), Expect = 2e-05
Identities = 34/182 (18%), Positives = 59/182 (32%), Gaps = 12/182 (6%)
Query: 10 PPSLMTKWLILVIFLNFGHSSREPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCFSWS 69
P + L + N R+ G + V++ + N F
Sbjct: 95 PEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSY 154
Query: 70 HVTCRNG----------NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDF 119
++ L L N + + S+ L LA L L N +S
Sbjct: 155 IRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGS 214
Query: 120 LGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGT 179
L + HL+ L+L NNK +P + ++ + L +NN++ I F +N
Sbjct: 215 LANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA-IGSNDFCPPGYNTKKA 272
Query: 180 HL 181
Sbjct: 273 SY 274
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 43.1 bits (100), Expect = 4e-05
Identities = 25/122 (20%), Positives = 50/122 (40%), Gaps = 3/122 (2%)
Query: 41 IEVLKALNDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLK 100
++ L Q +++ ++ V+ L SG + + +K
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 150
Query: 101 FLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNL 160
L+ + + D +++ T+P G L L+L NK + A+ L+NL L LS N++
Sbjct: 151 KLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 207
Query: 161 TG 162
+
Sbjct: 208 SA 209
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 41.6 bits (96), Expect = 1e-04
Identities = 12/45 (26%), Positives = 18/45 (40%)
Query: 124 THLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQL 168
L+L NNK + + L NL L L +N ++ P
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF 75
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 36.9 bits (84), Expect = 0.004
Identities = 21/117 (17%), Positives = 35/117 (29%), Gaps = 24/117 (20%)
Query: 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNL----- 131
N+ +L L +N S + L L L L N L ++ L+
Sbjct: 56 NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKV 115
Query: 132 ------------------ANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
K SG + + L ++ ++ N+T IP L
Sbjct: 116 RKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPP 171
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.5 bits (134), Expect = 3e-09
Identities = 15/74 (20%), Positives = 27/74 (36%), Gaps = 5/74 (6%)
Query: 102 LASLELQDNDLSGT-LPDFLGSMTHLQSLNLANNKFSG----SIPATWSQLSNLKHLDLS 156
+ SL++Q +LS + L + Q + L + + I + L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 157 SNNLTGRIPMQLFS 170
SN L +
Sbjct: 64 SNELGDVGVHCVLQ 77
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.9 bits (122), Expect = 1e-07
Identities = 23/135 (17%), Positives = 45/135 (33%), Gaps = 14/135 (10%)
Query: 48 NDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKF-----L 102
+ + C +S V +N ++ L + +N + + L
Sbjct: 312 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVL 371
Query: 103 ASLELQDNDLSGT----LPDFLGSMTHLQSLNLANNKFSGSIPATWSQ-----LSNLKHL 153
L L D D+S + L L + L+ L+L+NN + + L+ L
Sbjct: 372 RVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQL 431
Query: 154 DLSSNNLTGRIPMQL 168
L + + +L
Sbjct: 432 VLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 4e-07
Identities = 15/93 (16%), Positives = 30/93 (32%), Gaps = 10/93 (10%)
Query: 77 NVISLTLGSNGFSGK-ISPSITKLKFLASLELQDNDLSG----TLPDFLGSMTHLQSLNL 131
++ SL + S + + L+ + L D L+ + L L LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 132 ANNKFSGSIP-----ATWSQLSNLKHLDLSSNN 159
+N+ + ++ L L +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 2e-05
Identities = 21/125 (16%), Positives = 37/125 (29%), Gaps = 4/125 (3%)
Query: 57 WNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTL 116
+ + S+ S +++ L+D +
Sbjct: 302 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELC 361
Query: 117 PDFLGSMTHLQSLNLANNKFSG----SIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVA 172
+ L+ L LA+ S S+ AT +L+ LDLS+N L +QL
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 173 TFNFT 177
Sbjct: 422 RQPGC 426
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 2e-04
Identities = 11/57 (19%), Positives = 19/57 (33%), Gaps = 1/57 (1%)
Query: 126 LQSLNLANNKFSGS-IPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHL 181
+QSL++ + S + L + + L LT + S N L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.7 bits (127), Expect = 2e-08
Identities = 23/124 (18%), Positives = 37/124 (29%), Gaps = 9/124 (7%)
Query: 48 NDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLEL 107
D + ++ ++ + N S +I L L +
Sbjct: 232 RDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNV 291
Query: 108 QDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ 167
+N L LP L+ L + N + +P NLK L + N L P
Sbjct: 292 SNNKLI-ELPALPPR---LERLIASFNHLA-EVP---ELPQNLKQLHVEYNPLRE-FPDI 342
Query: 168 LFSV 171
SV
Sbjct: 343 PESV 346
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.1 bits (97), Expect = 1e-04
Identities = 19/61 (31%), Positives = 29/61 (47%), Gaps = 8/61 (13%)
Query: 102 LASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLT 161
LEL + LS +LP+ HL+SL + N + +P +LK L + +NNL
Sbjct: 40 AHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELP---ELPQSLKSLLVDNNNLK 91
Query: 162 G 162
Sbjct: 92 A 92
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 37.9 bits (86), Expect = 0.002
Identities = 15/60 (25%), Positives = 23/60 (38%), Gaps = 5/60 (8%)
Query: 124 THLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFNFTGTHLIC 183
L L N S S+P +L+ L S N+LT +P S+ + +L
Sbjct: 38 RQAHELELNNLGLS-SLP---ELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 47.5 bits (111), Expect = 6e-07
Identities = 28/144 (19%), Positives = 46/144 (31%), Gaps = 1/144 (0%)
Query: 48 NDTHGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLEL 107
+ ++ L LG N + L L +L L
Sbjct: 50 FGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109
Query: 108 QDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ 167
DN +S +P + L SLNLA+N F+ + W L+ L+ P +
Sbjct: 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGAPSK 168
Query: 168 LFSVATFNFTGTHLICGSSLEQPC 191
+ V + + C S + C
Sbjct: 169 VRDVQIKDLPHSEFKCSSENSEGC 192
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.1 bits (106), Expect = 2e-06
Identities = 19/104 (18%), Positives = 31/104 (29%), Gaps = 24/104 (23%)
Query: 81 LTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLG------------------- 121
L L + + + +L + L+L N L P
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60
Query: 122 --SMTHLQSLNLANNKF-SGSIPATWSQLSNLKHLDLSSNNLTG 162
++ LQ L L NN+ + L L+L N+L
Sbjct: 61 VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 4e-06
Identities = 16/48 (33%), Positives = 25/48 (52%), Gaps = 4/48 (8%)
Query: 109 DNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156
DN +S P L S+ +L ++L NN+ S P + SNL + L+
Sbjct: 182 DNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 9e-05
Identities = 13/51 (25%), Positives = 24/51 (47%), Gaps = 2/51 (3%)
Query: 117 PDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ 167
L +++ L +L +NK S P + L NL + L +N ++ P+
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLA 214
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 5e-04
Identities = 15/83 (18%), Positives = 27/83 (32%), Gaps = 4/83 (4%)
Query: 51 HGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDN 110
G + S + +L N S + L L + L++N
Sbjct: 148 AGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNN 205
Query: 111 DLSGTLPDFLGSMTHLQSLNLAN 133
+S P L + ++L + L N
Sbjct: 206 QISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.001
Identities = 10/62 (16%), Positives = 25/62 (40%), Gaps = 4/62 (6%)
Query: 99 LKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSN 158
L + ++++ T+ + + +L+ + +I L+NL L+L N
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDN 73
Query: 159 NL 160
+
Sbjct: 74 QI 75
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.9 bits (107), Expect = 4e-06
Identities = 13/65 (20%), Positives = 23/65 (35%), Gaps = 3/65 (4%)
Query: 95 SITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLD 154
++K+ + +L+ LP L L+L+ N AT + L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 155 LSSNN 159
L
Sbjct: 62 LDRAE 66
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.6 bits (106), Expect = 7e-06
Identities = 24/123 (19%), Positives = 39/123 (31%), Gaps = 2/123 (1%)
Query: 65 CFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMT 124
GN+ L L N S + L L L L N ++ P +
Sbjct: 142 QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201
Query: 125 HLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS--VATFNFTGTHLI 182
L +L L N S + L L++L L+ N + + F + + +
Sbjct: 202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVP 261
Query: 183 CGS 185
C
Sbjct: 262 CSL 264
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (96), Expect = 1e-04
Identities = 17/77 (22%), Positives = 31/77 (40%), Gaps = 4/77 (5%)
Query: 86 NGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWS 145
N S + ++ L+ L L L DN LQ ++++ S+P
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWVCD-CRARPLWAWLQKFRGSSSEVPCSLPQ--- 266
Query: 146 QLSNLKHLDLSSNNLTG 162
+L+ L++N+L G
Sbjct: 267 RLAGRDLKRLAANDLQG 283
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (103), Expect = 7e-06
Identities = 15/133 (11%), Positives = 33/133 (24%), Gaps = 2/133 (1%)
Query: 111 DLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFS 170
+L + + + L+L K I + L +D S N + L
Sbjct: 6 ELIEQAAQYT-NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPLLR 63
Query: 171 VATFNFTGTHLICGSSLEQPCMSRPSPPVSTSRTKLRIVVASASCGAFVLLSLGALFACR 230
+ IC + + L + + L+ +
Sbjct: 64 RLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNP 123
Query: 231 YQKLRKLKHDVFF 243
+ + V +
Sbjct: 124 VTNKKHYRLYVIY 136
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.6 bits (98), Expect = 8e-05
Identities = 13/66 (19%), Positives = 22/66 (33%), Gaps = 11/66 (16%)
Query: 107 LQDNDLSGTLPDFLGSM------THLQSLNLANNKFSGSIP-----ATWSQLSNLKHLDL 155
L D LS + LQ+L L N+ ++ +L L+L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 156 SSNNLT 161
+ N +
Sbjct: 310 NGNRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.4 bits (95), Expect = 2e-04
Identities = 10/93 (10%), Positives = 28/93 (30%), Gaps = 11/93 (11%)
Query: 102 LASLELQDNDLSG----TLPDFLGSMTHLQSLNLANNKFSG----SIPATWSQLSNLKHL 153
+ L+ + ++ ++ L ++ + L+ N + + +L+
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 154 DLSSN---NLTGRIPMQLFSVATFNFTGTHLIC 183
+ S + IP L + L
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHT 97
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.6 bits (85), Expect = 0.003
Identities = 17/112 (15%), Positives = 33/112 (29%), Gaps = 12/112 (10%)
Query: 51 HGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSI------TKLKFLAS 104
N + + N+ L L S + + ++ + L +
Sbjct: 218 KVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQT 277
Query: 105 LELQDNDLSGTLPDFLGS-----MTHLQSLNLANNKFSGSIPATWSQLSNLK 151
L LQ N++ L + M L L L N+F ++ +
Sbjct: 278 LRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREVF 328
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.1 bits (95), Expect = 1e-04
Identities = 15/38 (39%), Positives = 21/38 (55%), Gaps = 2/38 (5%)
Query: 120 LGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSS 157
L +T LQ+L L+ N S + A + L NL L+L S
Sbjct: 174 LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 4e-04
Identities = 11/87 (12%), Positives = 25/87 (28%), Gaps = 4/87 (4%)
Query: 97 TKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156
L+ ++ + + + + N+ L N+ L L+
Sbjct: 21 DAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLN 76
Query: 157 SNNLTGRIPMQLFSVATFNFTGTHLIC 183
N LT P+ + F + +
Sbjct: 77 GNKLTDIKPLANLKNLGWLFLDENKVK 103
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 2e-04
Identities = 15/115 (13%), Positives = 32/115 (27%), Gaps = 3/115 (2%)
Query: 51 HGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDN 110
D D+ + + + L L NG + + + +N
Sbjct: 128 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNN 187
Query: 111 DLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP 165
+L D + L+++ + L L+ NL ++P
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP 239
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (89), Expect = 4e-04
Identities = 18/93 (19%), Positives = 34/93 (36%), Gaps = 3/93 (3%)
Query: 75 NGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGT--LPDFLGSMTHLQSLNLA 132
+ L S+ + + + L SL L +N L + + +L+ LNL+
Sbjct: 41 QNIDVVLNRRSS-MAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLS 99
Query: 133 NNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIP 165
N+ + L+ L L N+L+
Sbjct: 100 GNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.002
Identities = 12/64 (18%), Positives = 26/64 (40%), Gaps = 5/64 (7%)
Query: 111 DLSGT--LPDFLGSMT--HLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPM 166
DL+G PD G + + + + + +S ++H+DLS++ +
Sbjct: 6 DLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVSTLH 64
Query: 167 QLFS 170
+ S
Sbjct: 65 GILS 68
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.4 bits (85), Expect = 0.002
Identities = 17/121 (14%), Positives = 34/121 (28%), Gaps = 4/121 (3%)
Query: 51 HGQFTDWNDHFVSPCFSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQD- 109
+ + V V S +L +L L L
Sbjct: 151 TQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC 210
Query: 110 NDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLF 169
D+ LG + L++L + G++ L HL ++ ++ T +
Sbjct: 211 YDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLL---KEALPHLQINCSHFTTIARPTIG 267
Query: 170 S 170
+
Sbjct: 268 N 268
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 37.0 bits (84), Expect = 0.003
Identities = 16/56 (28%), Positives = 23/56 (41%), Gaps = 9/56 (16%)
Query: 115 TLPDFLGS---MTHLQSLNLANNKFSGSIP------ATWSQLSNLKHLDLSSNNLT 161
T+ D + + + + G IP AT S L KHL LS+NN+
Sbjct: 6 TIKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE 61
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 498 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.91 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.66 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.57 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.5 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.41 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.4 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.32 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.31 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.31 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.31 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.29 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.21 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.07 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.04 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.98 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.96 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 98.93 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.84 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.75 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.75 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.75 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.72 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.72 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.71 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.66 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.61 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.59 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.57 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.34 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.26 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.24 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.09 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.08 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.06 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.87 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.78 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.77 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.75 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.66 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.53 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.39 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.32 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.1 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.6 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.55 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.66 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.39 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 94.74 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-47 Score=360.69 Aligned_cols=203 Identities=25% Similarity=0.399 Sum_probs=176.2
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
++|++.+.||+|+||+||+|+.. +++.||||+++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57888999999999999999974 68999999997544444556799999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999874 45699999999999999999999999 99999999999999999999999999998765432
Q ss_pred c-ceeecccccccccCcccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 430 T-HVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 430 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
. .......||+.|||||++.+..+ +.++||||+||++|||+||+.||+...
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~ 210 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC
Confidence 2 22345679999999999988776 578999999999999999999997543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=360.25 Aligned_cols=203 Identities=33% Similarity=0.507 Sum_probs=171.3
Q ss_pred HHhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 268 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
+..++|+..+.||+|+||+||+|+++ ..||||+++.. .++...+.|.+|++++++++||||+++++++.+ +..++|
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 44678999999999999999999864 36999999743 345667899999999999999999999998754 568999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|||+++|+|.+++... ...+++.++..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 82 ~Ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EECCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 9999999999999753 34699999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCc-ceeecccccccccCcccccC---CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 427 AKLT-HVTTQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 427 ~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.... .......||+.|||||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~ 212 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 212 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCC
Confidence 4322 23345679999999999864 35789999999999999999999999754
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-46 Score=354.80 Aligned_cols=200 Identities=27% Similarity=0.403 Sum_probs=167.1
Q ss_pred cCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecc
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (498)
++|+..+.||+|+||+||+|++.+++.||||+++.. ....++|.+|++++++++||||++++|++..++..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC--cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 467888999999999999999988999999999753 344678999999999999999999999999999999999999
Q ss_pred cCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCc
Q 010887 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (498)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~ 430 (498)
++|+|.+++... ...+++..+..++.||++||+|||+. +|+||||||+|||+|+++.+||+|||+++.......
T Consensus 83 ~~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 83 EHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 999999988752 35689999999999999999999999 999999999999999999999999999987765444
Q ss_pred ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhC-CCCCCC
Q 010887 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG-QRAIDF 478 (498)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG-~~p~~~ 478 (498)
.......||+.|+|||++.+..++.++|||||||++|||+|+ ++||..
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~ 205 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 205 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC
Confidence 444456789999999999999999999999999999999995 555554
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=353.61 Aligned_cols=200 Identities=27% Similarity=0.412 Sum_probs=179.1
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|++.+.||+|+||+||+|+.. +++.||+|++... ........+.+|++++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 56888999999999999999975 6889999998632 12345678899999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++|+|.+++.. ...+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999985 34689999999999999999999999 999999999999999999999999999986654
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.. .....||+.|||||++.+..++.++|||||||++|||+||+.||+...
T Consensus 159 ~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 208 (263)
T d2j4za1 159 SR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 208 (263)
T ss_dssp CC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred Cc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC
Confidence 32 234679999999999999999999999999999999999999998654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=360.34 Aligned_cols=203 Identities=30% Similarity=0.441 Sum_probs=177.1
Q ss_pred HHHhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 267 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
++..++|+..+.||+|+||+||+|++++++.||||+++.. ....+.|.+|++++++++|||||++++++.+ +..++|
T Consensus 9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG--SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred ecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC--cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence 3455678889999999999999999988899999999753 2456789999999999999999999998754 567899
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|||+++|+|.+++.... ...++|.++..++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 86 ~Ey~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp EECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEcc
Confidence 99999999999876432 23589999999999999999999999 99999999999999999999999999999876
Q ss_pred ccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 477 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~ 477 (498)
...........||+.|+|||++.+..++.++|||||||++|||+||..|+.
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~ 211 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 554444455678999999999999999999999999999999999655543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-47 Score=369.78 Aligned_cols=203 Identities=25% Similarity=0.375 Sum_probs=181.2
Q ss_pred HhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
..++|++.+.||+|+||+||+|+.. +++.||+|+++....+.....+.+|++++++++||||+++++++.+.+..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4578999999999999999999964 688999999986555666788999999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++|+|.+++.+ ...+++..+..++.|++.||.|||+++ +|+||||||+|||+++++++||+|||+|+...+
T Consensus 84 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999975 345899999999999999999999631 799999999999999999999999999987654
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.. .....||+.|+|||++.+.+|+.++||||+||++|||+||+.||....
T Consensus 158 ~~---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 158 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp HT---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred Cc---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 32 234679999999999999999999999999999999999999997654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=358.65 Aligned_cols=209 Identities=22% Similarity=0.301 Sum_probs=169.2
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEcC--CceEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERILV 346 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 346 (498)
++|++.+.||+|+||+||+|+.. +|+.||+|+++.. .++...+.+.+|++++++++||||+++++++.+. ...++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57889999999999999999964 6889999998743 3445567899999999999999999999998753 457899
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCcEEcCCCCCcEEECCCCcEEEeecCcccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC--NPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~ 424 (498)
|||+++|+|.+++.........+++..+..++.|++.||+|||++. ..+|+||||||+|||+++++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998754434567999999999999999999999872 12499999999999999999999999999987
Q ss_pred ccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
...... ......||+.|||||++.+..++.++|||||||++|||+||+.||....
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~ 218 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 218 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC
Confidence 764332 2345679999999999999999999999999999999999999998644
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-46 Score=360.50 Aligned_cols=207 Identities=28% Similarity=0.413 Sum_probs=183.1
Q ss_pred HHHHHHhcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCc
Q 010887 264 RELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE 342 (498)
Q Consensus 264 ~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 342 (498)
+++++..++|+..+.||+|+||+||+|++. +++.||||+++.. ....++|.+|++++++++|||||++++++.+.+.
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT--CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc--cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 344556678888999999999999999975 5888999998753 3456789999999999999999999999999999
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcc
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~ 422 (498)
.++||||+++|+|.+++.... ...+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||++
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a 162 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS 162 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred eEEEeecccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccce
Confidence 999999999999999997532 45789999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 010887 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 477 (498)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~ 477 (498)
+..............|++.|+|||++.+..++.++|||||||++|||+||+.|+.
T Consensus 163 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~ 217 (287)
T d1opja_ 163 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217 (287)
T ss_dssp TTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred eecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 9876655444455668899999999999999999999999999999999776654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-45 Score=352.10 Aligned_cols=200 Identities=22% Similarity=0.349 Sum_probs=179.0
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc-ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 4699999999999999999995 468999999987433 23467899999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++|+|.+.+.. ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++......
T Consensus 99 ~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp CTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred cCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 999999988764 3589999999999999999999999 99999999999999999999999999998775433
Q ss_pred cceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 430 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
. ......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 171 ~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 220 (293)
T d1yhwa1 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (293)
T ss_dssp C-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred c-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC
Confidence 2 2344679999999999999999999999999999999999999997543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=354.48 Aligned_cols=203 Identities=24% Similarity=0.352 Sum_probs=177.6
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|++.+.||+|+||+||+|+.. +++.||||+++.. ..+.....+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56889999999999999999974 6899999998632 12345678999999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999998875 34699999999999999999999999 999999999999999999999999999987754
Q ss_pred cCc-ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 428 KLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 428 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
... .......||+.|+|||++.+..++.++||||+||++|||+||+.||....
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 214 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 214 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC
Confidence 322 22345679999999999999999999999999999999999999998654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-45 Score=345.14 Aligned_cols=203 Identities=24% Similarity=0.372 Sum_probs=182.5
Q ss_pred cCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecc
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (498)
++|+..+.||+|+||+||+|++++++.||||+++.. ....++|.+|++++++++||||++++|++.+++..++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~--~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS--SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC--cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 678999999999999999999988889999999753 345678999999999999999999999999999999999999
Q ss_pred cCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCc
Q 010887 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (498)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~ 430 (498)
++|++..++... ...+++..+.+++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 82 ANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 999999987653 34689999999999999999999999 999999999999999999999999999987765544
Q ss_pred ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcc
Q 010887 431 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRL 481 (498)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~~ 481 (498)
.......||+.|+|||.+.+.+++.++|||||||++|||+| |+.||+....
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~ 207 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 207 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH
Confidence 44445668999999999999999999999999999999998 8999986543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-45 Score=356.14 Aligned_cols=204 Identities=28% Similarity=0.420 Sum_probs=167.8
Q ss_pred cCCCCCCeeecccceEEEEEEEcC-C---cEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLSD-N---TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
++|+..+.||+|+||+||+|++.. + ..||||++.........+.|.+|++++++++|||||+++|++..++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 456667899999999999999753 2 258999987666666778899999999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|||+++|+|.+++... ...++|.++..++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 106 ~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999988752 34699999999999999999999999 99999999999999999999999999998775
Q ss_pred ccCcce----eecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 427 AKLTHV----TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 427 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
...... .....||+.|||||.+.++.++.++|||||||++|||+| |+.||....
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~ 238 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC
Confidence 433221 122457899999999999999999999999999999998 899997543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-45 Score=349.81 Aligned_cols=203 Identities=27% Similarity=0.434 Sum_probs=175.8
Q ss_pred cCCCCCCe-eecccceEEEEEEEc---CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 271 DNFSESNI-IGQGGFGKVYKGVLS---DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 271 ~~~~~~~~-lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
++|...+. ||+|+||+||+|.++ ++..||||+++....+...+.|.+|++++++++|||||+++|++.. +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45555664 999999999999864 3457999999876666677899999999999999999999999865 468899
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|||+++|+|.+++... ...+++.++..++.|+++||+|||++ +|+||||||+||++++++.+||+|||+++...
T Consensus 87 mE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999987642 34699999999999999999999999 99999999999999999999999999998776
Q ss_pred ccCcce--eecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 427 AKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 427 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
...... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~ 217 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 217 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC
Confidence 443222 233568899999999999999999999999999999998 999998543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-45 Score=351.57 Aligned_cols=202 Identities=28% Similarity=0.356 Sum_probs=176.8
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
+.|++.+.||+|+||+||+|+.. +++.||||+++.. .....+.|.+|++++++++||||+++++++.+++..++||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 46888999999999999999964 6889999998743 345567899999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+++|+|.+++.+. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 91 ~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 91 CAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp CTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred CCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 9999999987653 34699999999999999999999999 99999999999999999999999999997654322
Q ss_pred cceeecccccccccCccccc-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 430 THVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
. ......||+.|+|||++. ...|+.++|||||||++|||+||+.||....
T Consensus 165 ~-~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~ 219 (288)
T d2jfla1 165 Q-RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 219 (288)
T ss_dssp H-HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred c-cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC
Confidence 1 223456999999999984 4568899999999999999999999997643
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.4e-45 Score=354.10 Aligned_cols=202 Identities=24% Similarity=0.362 Sum_probs=162.7
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.+.|+..+.||+|+||+||+|+.. +++.||||++...........+.+|++++++++||||+++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 356888999999999999999975 6889999999755444455778899999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEEC---CCCcEEEeecCccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD---DNFEAVLCDFGLAKLV 425 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~ki~DfGl~~~~ 425 (498)
|+++|+|.+++.. ...+++.++..++.||+.||+|||+. +|+||||||+||++. +++.+||+|||+++..
T Consensus 88 ~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999975 45699999999999999999999999 999999999999994 5789999999999866
Q ss_pred cccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 426 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.... ......||+.|||||++.+..++.++|||||||++|||+||+.||....
T Consensus 161 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 213 (307)
T d1a06a_ 161 DPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN 213 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC
Confidence 5432 2334679999999999999999999999999999999999999997643
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=355.51 Aligned_cols=211 Identities=28% Similarity=0.441 Sum_probs=177.8
Q ss_pred HHHhcCCCCCCeeecccceEEEEEEEcC-C-----cEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEEc
Q 010887 267 QLATDNFSESNIIGQGGFGKVYKGVLSD-N-----TKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT 339 (498)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 339 (498)
++..++|+..+.||+|+||+||+|++.. + ..||+|++...........|.+|++++.++ +|||||++++++.+
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 3455788899999999999999999643 2 369999997655556667899999999998 89999999999999
Q ss_pred CCceEEEEecccCCCHHHhhcccCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcC
Q 010887 340 SSERILVYPFMQNLSVAYRLRDLKP-------------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRD 400 (498)
Q Consensus 340 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~D 400 (498)
.+..++||||+++|+|.++++.... ....+++..++.++.||++||+|||++ +|+|||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRD 189 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 189 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence 9999999999999999999975431 123589999999999999999999999 999999
Q ss_pred CCCCcEEECCCCcEEEeecCccccccccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCC
Q 010887 401 LKAANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDF 478 (498)
Q Consensus 401 lk~~NILl~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~ 478 (498)
|||+||+++.++.+||+|||+++........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||..
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876554333 2234568999999999999999999999999999999998 8999975
Q ss_pred Cc
Q 010887 479 SR 480 (498)
Q Consensus 479 ~~ 480 (498)
..
T Consensus 270 ~~ 271 (325)
T d1rjba_ 270 IP 271 (325)
T ss_dssp CC
T ss_pred CC
Confidence 43
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-44 Score=342.06 Aligned_cols=197 Identities=28% Similarity=0.409 Sum_probs=168.7
Q ss_pred CCCCeeecccceEEEEEEEc-CCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEc----CCceEEEE
Q 010887 274 SESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT----SSERILVY 347 (498)
Q Consensus 274 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 347 (498)
...+.||+|+||+||+|+.. +++.||+|++... ......+.|.+|++++++++||||+++++++.. ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 44568999999999999975 5789999998744 344556789999999999999999999999864 34578999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEEC-CCCcEEEeecCcccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~ki~DfGl~~~~~ 426 (498)
||+++|+|.+++.. ...+++.++..++.||++||+|||++ +++|+||||||+|||++ +++.+||+|||+++...
T Consensus 92 E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999976 34689999999999999999999998 12399999999999996 57899999999998654
Q ss_pred ccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.. ......||+.|||||++.+ +++.++|||||||++|||+||+.||...
T Consensus 167 ~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~ 215 (270)
T d1t4ha_ 167 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 215 (270)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc
Confidence 32 2345679999999998865 6999999999999999999999999754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=347.93 Aligned_cols=202 Identities=27% Similarity=0.450 Sum_probs=169.3
Q ss_pred cCCCCCCeeecccceEEEEEEEcCC-----cEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLSDN-----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
+.|+..++||+|+||+||+|.++.+ ..||||+++....+....+|.+|++++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577789999999999999997543 36999999866666667789999999999999999999999999999999
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
||||+.++++.+.+... ...++|.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 87 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999887753 34699999999999999999999999 9999999999999999999999999999876
Q ss_pred cccCcc--eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 426 DAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 426 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
...... ......||+.|+|||++.+..++.++|||||||++|||+||..|+..
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~ 215 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 215 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc
Confidence 543222 22345689999999999999999999999999999999997666543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-45 Score=350.53 Aligned_cols=203 Identities=30% Similarity=0.417 Sum_probs=170.7
Q ss_pred HHhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 268 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
+..++|++.+.||+|+||+||+|++++++.||||+++... ...++|.+|++++++++|||||++++++. .++.++||
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~ 90 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVT 90 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc--CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEE
Confidence 3456788999999999999999999888899999997433 44678999999999999999999999985 45689999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++|++...+.... ...++|.+++.++.||+.||+|||+. +|+||||||+|||+|+++++||+|||+++....
T Consensus 91 Ey~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 91 EYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp CCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EecCCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccC
Confidence 9999999998887532 34599999999999999999999999 999999999999999999999999999987765
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
..........||+.|+|||++..+.++.++|||||||++|||+||..|+..
T Consensus 166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~ 216 (285)
T d1fmka3 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 216 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC
Confidence 444444456689999999999999999999999999999999997666544
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-44 Score=352.60 Aligned_cols=204 Identities=23% Similarity=0.289 Sum_probs=181.7
Q ss_pred hcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEE
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 346 (498)
.++|++.+.||+|+||.||+|+. .+++.||+|+++... .......+.+|++++++++||||+++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 36788999999999999999996 478999999997431 234567889999999999999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 84 ~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccc
Confidence 999999999999886 34689999999999999999999999 99999999999999999999999999998665
Q ss_pred ccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCcc
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRL 481 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~~ 481 (498)
.... ......||+.|+|||++.+..|+.++||||+||++|||+||+.||.....
T Consensus 157 ~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~ 210 (337)
T d1o6la_ 157 SDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210 (337)
T ss_dssp CTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH
Confidence 4322 23456799999999999999999999999999999999999999986543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.7e-44 Score=349.60 Aligned_cols=199 Identities=28% Similarity=0.383 Sum_probs=178.8
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. ......+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5688899999999999999997 46899999998642 12345678999999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+++|++...+.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 84 E~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999998876 44688999999999999999999999 999999999999999999999999999987654
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
. .....||+.|||||++.+..++.++||||+||++|||+||+.||....
T Consensus 157 ~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 205 (316)
T d1fota_ 157 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 205 (316)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred c----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC
Confidence 3 234679999999999999999999999999999999999999998654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-44 Score=350.27 Aligned_cols=196 Identities=30% Similarity=0.373 Sum_probs=173.0
Q ss_pred CCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCC--cchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 272 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.|+..+.||+|+||+||+|+. .+++.||||+++.... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 488899999999999999996 4688899999874332 2345679999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++|++...+.. ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 96 ~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp CCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 9999999776654 35699999999999999999999999 9999999999999999999999999999866542
Q ss_pred CcceeecccccccccCcccccC---CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 429 LTHVTTQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
....||+.|||||++.+ ..|+.++|||||||++|||+||+.||...
T Consensus 169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~ 217 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (309)
T ss_dssp -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC
Confidence 23569999999999854 46899999999999999999999999754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=343.67 Aligned_cols=196 Identities=27% Similarity=0.399 Sum_probs=167.7
Q ss_pred CeeecccceEEEEEEEcC---CcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecccC
Q 010887 277 NIIGQGGFGKVYKGVLSD---NTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN 352 (498)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 352 (498)
+.||+|+||+||+|.+++ ++.||||+++.. .++...+.|.+|++++++++|||||++++++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998643 467999999743 334456789999999999999999999999865 457899999999
Q ss_pred CCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCcce
Q 010887 353 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 432 (498)
Q Consensus 353 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~~ 432 (498)
|+|.++++. ...+++.++..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999886 34699999999999999999999999 99999999999999999999999999998775443332
Q ss_pred --eecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 433 --TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 433 --~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~ 215 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 215 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC
Confidence 234568999999999999999999999999999999998 899998543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=342.08 Aligned_cols=202 Identities=24% Similarity=0.292 Sum_probs=178.8
Q ss_pred hcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccC-----CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCce
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-----SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 343 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 343 (498)
.++|+..+.||+|+||+||+|+. .+|+.||||+++... .....+.|.+|++++++++||||+++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35789999999999999999997 468999999986432 223468899999999999999999999999999999
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCC----cEEEeec
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF----EAVLCDF 419 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~ki~Df 419 (498)
++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+|++||
T Consensus 89 ~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence 999999999999999976 34699999999999999999999999 999999999999998776 4999999
Q ss_pred CccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 420 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 162 G~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 220 (293)
T d1jksa_ 162 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 220 (293)
T ss_dssp TTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC
Confidence 9998775432 2334568999999999999999999999999999999999999998644
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.1e-43 Score=350.70 Aligned_cols=201 Identities=23% Similarity=0.322 Sum_probs=178.9
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
++|++.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC-SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc-chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 57999999999999999999964 6899999999743 234567899999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEEC--CCCcEEEeecCccccccc
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD--DNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~--~~~~~ki~DfGl~~~~~~ 427 (498)
+++|+|.+++.+. ...+++.++..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++....
T Consensus 105 ~~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 9999999988642 34699999999999999999999999 999999999999995 467899999999987765
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.. ......||+.|||||++.+..++.++||||+||++|||+||+.||....
T Consensus 179 ~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 229 (350)
T d1koaa2 179 KQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 229 (350)
T ss_dssp TS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cc--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC
Confidence 33 2344678999999999999999999999999999999999999997654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-44 Score=342.42 Aligned_cols=206 Identities=22% Similarity=0.341 Sum_probs=167.9
Q ss_pred HhcCCCCCCeeecccceEEEEEEEcC----CcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceE
Q 010887 269 ATDNFSESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (498)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (498)
..++|+..+.||+|+||.||+|++.. +..||||+++..........|.+|++++++++||||+++++++. .+..+
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 45678889999999999999999643 34689999876666666788999999999999999999999985 46789
Q ss_pred EEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccc
Q 010887 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~ 424 (498)
+||||+++|++.+++... ...+++..+..++.||++||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 84 iv~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhee
Confidence 999999999999887642 34689999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcc
Q 010887 425 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRL 481 (498)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~~ 481 (498)
.............||+.|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~ 215 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 215 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH
Confidence 76544444455668999999999999999999999999999999998 8999986543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.8e-43 Score=348.09 Aligned_cols=202 Identities=21% Similarity=0.296 Sum_probs=179.3
Q ss_pred hcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.++|++.+.||+|+||.||+|+. .+++.||||+++... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 35789999999999999999996 468999999987532 3456788999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEEC--CCCcEEEeecCcccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD--DNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~--~~~~~ki~DfGl~~~~~ 426 (498)
|+++|+|.+.+... ...+++.++..++.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+++...
T Consensus 107 ~~~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 107 FLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp CCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCChHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecC
Confidence 99999998877642 34699999999999999999999999 999999999999997 67899999999998876
Q ss_pred ccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
... ......||+.|+|||++.+..++.++||||+||++|||+||+.||....
T Consensus 181 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 232 (352)
T d1koba_ 181 PDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 232 (352)
T ss_dssp TTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred CCC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 533 2344668999999999999999999999999999999999999997643
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-43 Score=344.67 Aligned_cols=215 Identities=27% Similarity=0.410 Sum_probs=184.0
Q ss_pred HHHHHHHhcCCCCCCeeecccceEEEEEEEc------CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEE
Q 010887 263 CRELQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 336 (498)
Q Consensus 263 ~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 336 (498)
+.+++...++|+..+.||+|+||+||+|+++ +++.||||+++........++|.+|++++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3455567788999999999999999999964 3578999999866666667889999999999999999999999
Q ss_pred EEcCCceEEEEecccCCCHHHhhcccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 010887 337 CTTSSERILVYPFMQNLSVAYRLRDLKP--------------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 396 (498)
Q Consensus 337 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 396 (498)
+...+..+++|||+++|+|.+++..... ....+++..+..++.|++.||+|||+. ++
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 9999999999999999999999874321 124589999999999999999999999 99
Q ss_pred EEcCCCCCcEEECCCCcEEEeecCccccccccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCC-C
Q 010887 397 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ-R 474 (498)
Q Consensus 397 vH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~-~ 474 (498)
+||||||+|||+|.++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+||. +
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 99999999999999999999999999866543322 234466889999999999999999999999999999999996 5
Q ss_pred CCCCCc
Q 010887 475 AIDFSR 480 (498)
Q Consensus 475 p~~~~~ 480 (498)
||....
T Consensus 242 p~~~~~ 247 (301)
T d1lufa_ 242 PYYGMA 247 (301)
T ss_dssp TTTTSC
T ss_pred CCCCCC
Confidence 776543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-43 Score=348.10 Aligned_cols=199 Identities=24% Similarity=0.304 Sum_probs=178.9
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY 347 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 347 (498)
++|++.+.||+|+||.||+|+.. +|+.||||++... ........+.+|+++++.++||||+++++++......++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57889999999999999999974 6899999998632 12344677899999999999999999999999999999999
Q ss_pred ecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccc
Q 010887 348 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 427 (498)
Q Consensus 348 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~ 427 (498)
||+.+|+|..++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999876 34689999999999999999999999 999999999999999999999999999987754
Q ss_pred cCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 428 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 428 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
. .....||+.|||||++.+..++.++|||||||++|||+||+.||....
T Consensus 194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 242 (350)
T d1rdqe_ 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC
Confidence 3 234569999999999999999999999999999999999999997643
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-43 Score=342.16 Aligned_cols=204 Identities=27% Similarity=0.440 Sum_probs=171.2
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCc----EEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 345 (498)
++|+..+.||+|+||+||+|++. +++ +||+|+++...+....++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46888999999999999999964 333 68999998666667788999999999999999999999999875 5678
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
+++|+.+|+|.+.+... ...+++..+..++.||++||+|||++ +|+||||||+|||++.++++||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 89999999999887752 45699999999999999999999999 9999999999999999999999999999877
Q ss_pred cccCcce-eecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcc
Q 010887 426 DAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRL 481 (498)
Q Consensus 426 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~~ 481 (498)
....... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||+....
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~ 219 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 219 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH
Confidence 5443322 234568999999999999999999999999999999999 7899986543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=340.01 Aligned_cols=202 Identities=26% Similarity=0.372 Sum_probs=177.2
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHHHHHHH-hccCCccceEEEEEEcCCceEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLIS-VAIHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv 346 (498)
++|++.+.||+|+||+||+|+.. +++.||||+++... .......+.+|..++. .++||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57888999999999999999965 68899999996321 2344566777877765 68999999999999999999999
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 426 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~ 426 (498)
|||+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999986 34589999999999999999999999 99999999999999999999999999998665
Q ss_pred ccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.... ......||+.|+|||++.+..++.++||||+||++|||+||+.||....
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~ 207 (320)
T d1xjda_ 155 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 207 (320)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC
Confidence 4322 2344679999999999999999999999999999999999999998654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.3e-43 Score=334.28 Aligned_cols=204 Identities=23% Similarity=0.338 Sum_probs=170.5
Q ss_pred hcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCC----c
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS----E 342 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~ 342 (498)
.++|++.+.||+|+||+||+|+. .+++.||||+++... .+.....|.+|+++++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 36789999999999999999996 478999999997543 2344568999999999999999999999987654 3
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcc
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~ 422 (498)
.++||||+++++|.+++.. ...+++.++..++.||+.||+|||+. +|+||||||+|||++.++..+++|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 7899999999999998875 34689999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccCc--ceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 423 KLVDAKLT--HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 423 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
........ .......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 218 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 218 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC
Confidence 76543322 22345679999999999999999999999999999999999999998644
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.3e-42 Score=343.33 Aligned_cols=201 Identities=28% Similarity=0.364 Sum_probs=172.0
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccC--CcchHHHHHHH---HHHHHhccCCccceEEEEEEcCCce
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQRE---VHLISVAIHKNLLQLIGYCTTSSER 343 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e---~~~l~~l~h~niv~l~~~~~~~~~~ 343 (498)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... .......+.+| +++++.++||||+++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 367899999999999999999965 68999999985321 11223344444 6666677899999999999999999
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 83 ~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceee
Confidence 999999999999999976 34588999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 424 LVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
...... .....||+.|+|||++.. ..++.++|||||||++|||+||+.||....
T Consensus 156 ~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 210 (364)
T d1omwa3 156 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 210 (364)
T ss_dssp ECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred ecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCC
Confidence 765432 234579999999999875 568999999999999999999999998643
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.8e-42 Score=328.29 Aligned_cols=201 Identities=24% Similarity=0.339 Sum_probs=176.2
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCc--------chHHHHHHHHHHHHhcc-CCccceEEEEEEcC
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSP--------GGEAAFQREVHLISVAI-HKNLLQLIGYCTTS 340 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 340 (498)
++|+..+.||+|+||+||+|+. .+++.||||+++..... .....+.+|++++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6788999999999999999996 47889999998643211 12346889999999997 99999999999999
Q ss_pred CceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecC
Q 010887 341 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (498)
Q Consensus 341 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 420 (498)
+..++||||+++|+|.++++. ...+++.++..++.||++||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 999999999999999999975 34699999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCcceeecccccccccCccccc------CCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLS------TGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 421 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
+++...... ......||+.|+|||.+. ...++.++||||+||++|||+||+.||....
T Consensus 156 ~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~ 219 (277)
T d1phka_ 156 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 219 (277)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred heeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC
Confidence 998776532 234467999999999985 3457889999999999999999999998654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=336.35 Aligned_cols=216 Identities=25% Similarity=0.365 Sum_probs=172.9
Q ss_pred CHHHHHHHhcCCCCCCeeecccceEEEEEEEc------CCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEE
Q 010887 262 SCRELQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLI 334 (498)
Q Consensus 262 ~~~el~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~ 334 (498)
...++++..++|+..+.||+|+||.||+|++. +++.||||+++........+.+.+|.+.+.++ +|+||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 44556666788999999999999999999963 24689999998666666678889999988887 689999999
Q ss_pred EEEEcCC-ceEEEEecccCCCHHHhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCC
Q 010887 335 GYCTTSS-ERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDL 401 (498)
Q Consensus 335 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl 401 (498)
+++...+ ..++||||+++|+|.++++.... ....+++.++..++.||++||+|||++ +|+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcC
Confidence 9987654 57899999999999999975321 134589999999999999999999999 9999999
Q ss_pred CCCcEEECCCCcEEEeecCccccccccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCC-CCCCCC
Q 010887 402 KAANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ-RAIDFS 479 (498)
Q Consensus 402 k~~NILl~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~-~p~~~~ 479 (498)
||+|||+++++++||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+||. .||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876543332 233467999999999999999999999999999999999974 578654
Q ss_pred c
Q 010887 480 R 480 (498)
Q Consensus 480 ~ 480 (498)
.
T Consensus 241 ~ 241 (299)
T d1ywna1 241 K 241 (299)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-42 Score=333.54 Aligned_cols=201 Identities=19% Similarity=0.286 Sum_probs=177.3
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
.++|++.+.||+|+||+||+|+.. +++.||+|.++.. ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 367889999999999999999975 6889999999753 2345678899999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCC--CcEEEeecCcccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN--FEAVLCDFGLAKLVD 426 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~--~~~ki~DfGl~~~~~ 426 (498)
|+++|+|.+++... ...+++.++..++.||+.||+|||+. +|+||||||+|||++.+ ..+||+|||+++...
T Consensus 82 ~~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 82 FISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 99999999998752 33689999999999999999999999 99999999999999754 589999999998765
Q ss_pred ccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 427 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 427 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
... ......+|+.|+|||...+..++.++||||+||++|||+||+.||....
T Consensus 156 ~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~ 207 (321)
T d1tkia_ 156 PGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp TTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cCC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC
Confidence 432 2344568999999999999999999999999999999999999998654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-43 Score=331.27 Aligned_cols=198 Identities=29% Similarity=0.395 Sum_probs=165.2
Q ss_pred hcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcC-CceEEEEe
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-SERILVYP 348 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e 348 (498)
.++|+..+.||+|+||.||+|++ .++.||||+++.. ...++|.+|++++++++||||++++|++.+. +..++|||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 45677789999999999999998 5788999999753 4557899999999999999999999999654 56799999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+++|+|.+++.... ...++|..+++++.||+.||.|||+. +|+||||||+||+++.++.+|++|||+++.....
T Consensus 82 y~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 82 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp CCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred ccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC
Confidence 999999999997532 23589999999999999999999999 9999999999999999999999999999866542
Q ss_pred CcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
. ....+|..|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 157 ~----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~ 205 (262)
T d1byga_ 157 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 205 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred C----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC
Confidence 2 23457889999999999999999999999999999999 688877543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-41 Score=329.47 Aligned_cols=197 Identities=31% Similarity=0.459 Sum_probs=171.2
Q ss_pred CCeeecccceEEEEEEEcCC----cEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEc-CCceEEEEecc
Q 010887 276 SNIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-SSERILVYPFM 350 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 350 (498)
.++||+|+||+||+|++.++ ..||||+++.........+|.+|++++++++||||++++|++.. +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999997542 25899999866666677899999999999999999999999875 45789999999
Q ss_pred cCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCc
Q 010887 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (498)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~ 430 (498)
++|+|.+++... ...+++..+.+++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 999999988753 34578999999999999999999999 999999999999999999999999999987654322
Q ss_pred c---eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 431 H---VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 431 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
. ......||+.|+|||.+.+..++.++||||||+++|||+||+.||..
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~ 236 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence 2 12235689999999999999999999999999999999998888764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=330.08 Aligned_cols=197 Identities=30% Similarity=0.330 Sum_probs=166.7
Q ss_pred CCeeecccceEEEEEEE-cCCcEEEEEEecccCCc----chHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEecc
Q 010887 276 SNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSP----GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM 350 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 350 (498)
.++||+|+||+||+|+. .+++.||||+++..... .....+.+|++++++++||||+++++++..++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 57899999999999996 46899999998643221 12356889999999999999999999999999999999999
Q ss_pred cCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccCc
Q 010887 351 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 430 (498)
Q Consensus 351 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~~ 430 (498)
.++++...... ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred cchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 99887766543 45688999999999999999999999 999999999999999999999999999987654332
Q ss_pred ceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 431 HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 431 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
. .....||+.|+|||++... .++.++|||||||++|||+||+.||....
T Consensus 156 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 205 (299)
T d1ua2a_ 156 A-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS 205 (299)
T ss_dssp C-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred c-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC
Confidence 2 2345689999999998654 57999999999999999999999997543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-42 Score=333.99 Aligned_cols=205 Identities=27% Similarity=0.428 Sum_probs=171.9
Q ss_pred cCCCCCCeeecccceEEEEEEEcC-Cc--EEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEEcCCceEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLSD-NT--KVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILV 346 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 346 (498)
++|+..+.||+|+||.||+|++.+ +. .||||+++........+.|.+|++++.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 678888999999999999999754 33 57888887655556677899999999998 799999999999999999999
Q ss_pred EecccCCCHHHhhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcE
Q 010887 347 YPFMQNLSVAYRLRDLK------------PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA 414 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 414 (498)
|||+++|+|.++++... .....+++..+.+++.||++||.|||+. +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 99999999999997531 2345799999999999999999999999 99999999999999999999
Q ss_pred EEeecCccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCC-CCCCCCc
Q 010887 415 VLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ-RAIDFSR 480 (498)
Q Consensus 415 ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~-~p~~~~~ 480 (498)
||+|||+++....... .....||..|+|||.+.+..++.++|||||||++|||+||. .||....
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~ 231 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 231 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC
Confidence 9999999986554322 23345899999999999999999999999999999999976 4676543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-42 Score=334.62 Aligned_cols=213 Identities=24% Similarity=0.375 Sum_probs=183.4
Q ss_pred HHHHHhcCCCCCCeeecccceEEEEEEEc------CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEE
Q 010887 265 ELQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 338 (498)
Q Consensus 265 el~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 338 (498)
++++..++|+..+.||+|+||+||+|.+. +++.||||+++..........|.+|++++++++||||+++++++.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 34455678888999999999999999863 357899999986666666778999999999999999999999999
Q ss_pred cCCceEEEEecccCCCHHHhhcccC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCC
Q 010887 339 TSSERILVYPFMQNLSVAYRLRDLK------PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF 412 (498)
Q Consensus 339 ~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~ 412 (498)
..+..++||||+++|+|.+++.... .....+++..+.+++.|+++||.|||+. +|+||||||+|||+++++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCc
Confidence 9999999999999999999886421 2234579999999999999999999999 999999999999999999
Q ss_pred cEEEeecCccccccccCcce-eecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCC-CCCCCCc
Q 010887 413 EAVLCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ-RAIDFSR 480 (498)
Q Consensus 413 ~~ki~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~-~p~~~~~ 480 (498)
++||+|||+++......... .....||+.|+|||.+.+..++.++||||||+++|||+||+ .||....
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~ 240 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 240 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC
Confidence 99999999998775443322 23346899999999999999999999999999999999985 6776544
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-42 Score=332.68 Aligned_cols=210 Identities=28% Similarity=0.412 Sum_probs=181.5
Q ss_pred HHHhcCCCCCCeeecccceEEEEEEE------cCCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEEc
Q 010887 267 QLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT 339 (498)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 339 (498)
++..++|+..+.||+|+||.||+|++ .+++.||||+++.........+|.+|+++++++ +|||||++++++.+
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 34557888899999999999999985 245689999998766666778899999999999 69999999999999
Q ss_pred CCceEEEEecccCCCHHHhhcccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCc
Q 010887 340 SSERILVYPFMQNLSVAYRLRDLKP--------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAAN 405 (498)
Q Consensus 340 ~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~N 405 (498)
.+..++||||+++|+|.++++.... ....+++..+..++.||++||+|||++ +++||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence 9999999999999999999975331 234689999999999999999999999 99999999999
Q ss_pred EEECCCCcEEEeecCccccccccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 010887 406 ILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 479 (498)
Q Consensus 406 ILl~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~ 479 (498)
|+++.++.+|++|||.++........ ......||+.|+|||++.++.++.++|||||||++|||+| |++||+..
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999877654333 2344678999999999999999999999999999999999 55555443
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-42 Score=328.39 Aligned_cols=203 Identities=31% Similarity=0.385 Sum_probs=164.5
Q ss_pred cCCCCCCeeecccceEEEEEEEcC--C--cEEEEEEecccC--CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLSD--N--TKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 344 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 344 (498)
++|+..+.||+|+||+||+|++.. + ..||||+++... .+...+.|.+|++++++++||||++++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568888999999999999998532 2 368999987432 33456789999999999999999999999965 4678
Q ss_pred EEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccc
Q 010887 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~ 424 (498)
+||||+++|++.+.+... ...+++..+..++.||++||.|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence 999999999999887753 34599999999999999999999999 999999999999999999999999999997
Q ss_pred ccccCcce--eecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 425 VDAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 425 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
........ .....|+..|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~ 219 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC
Confidence 75543332 233457889999999999999999999999999999998 899997543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-41 Score=330.35 Aligned_cols=210 Identities=29% Similarity=0.402 Sum_probs=177.5
Q ss_pred HHhcCCCCCCeeecccceEEEEEEEcC--------CcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEE
Q 010887 268 LATDNFSESNIIGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT 338 (498)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 338 (498)
+..++|+..+.||+|+||.||+|+... +..||||+++.........++.+|...+.++ +||||+++++++.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 345788889999999999999998532 2479999998766666778899999999888 8999999999999
Q ss_pred cCCceEEEEecccCCCHHHhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcE
Q 010887 339 TSSERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANI 406 (498)
Q Consensus 339 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NI 406 (498)
+++..++||||+++|+|.+++..... ....+++.+++.++.||+.||+|||+. +|+||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccce
Confidence 99999999999999999999975431 235689999999999999999999999 999999999999
Q ss_pred EECCCCcEEEeecCccccccccCcc-eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 010887 407 LLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR 480 (498)
Q Consensus 407 Ll~~~~~~ki~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~ellt-G~~p~~~~~ 480 (498)
|++.++.+||+|||+++........ ......+|+.|+|||.+.++.|+.++|||||||++|||+| |+.||....
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 9999999999999999877654332 2344668999999999999999999999999999999998 688887544
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=328.66 Aligned_cols=203 Identities=28% Similarity=0.397 Sum_probs=171.5
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
++|++.+.||+|+||+||+|+. .+++.||||+++... .+.....+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788999999999999999996 568999999996432 23345789999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
|+.++.+...... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~~~~~~~~---~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQDLKKFMDAS---ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEEHHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCchhhhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 9986554443332 245699999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceeecccccccccCcccccCCC-CCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
.. ......||+.|+|||...... ++.++||||+||++|||++|+.||+...
T Consensus 156 ~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~ 207 (298)
T d1gz8a_ 156 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207 (298)
T ss_dssp SB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC
Confidence 32 233456899999999887765 4789999999999999999999997543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=333.51 Aligned_cols=197 Identities=24% Similarity=0.313 Sum_probs=169.2
Q ss_pred hcCCCCC-CeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccceEEEEEEc----CCc
Q 010887 270 TDNFSES-NIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT----SSE 342 (498)
Q Consensus 270 ~~~~~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~ 342 (498)
.++|.+. +.||+|+||+||+|+. .+++.||||++++ ...+.+|++++.++ +||||+++++++.+ ...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 3577776 4699999999999996 5689999999864 24567899987655 89999999999865 346
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECC---CCcEEEeec
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVLCDF 419 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~ki~Df 419 (498)
.++||||+++|+|.+++.... ...+++.++..++.||+.||+|||+. +|+||||||+|||+++ ++.+||+||
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEECCCCCcHHHHHHhcC--CCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccc
Confidence 799999999999999997532 34699999999999999999999999 9999999999999975 567999999
Q ss_pred CccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 420 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 420 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
|+++...... ......||+.|+|||++.+..|+.++|||||||++|||+||+.||...
T Consensus 159 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~ 216 (335)
T d2ozaa1 159 GFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 216 (335)
T ss_dssp TTCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEET
T ss_pred ceeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCC
Confidence 9998765432 234467999999999999999999999999999999999999999754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-41 Score=327.28 Aligned_cols=198 Identities=28% Similarity=0.378 Sum_probs=162.5
Q ss_pred CCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHH--HHHHHHhccCCccceEEEEEEcCC----ceEE
Q 010887 272 NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQR--EVHLISVAIHKNLLQLIGYCTTSS----ERIL 345 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~--e~~~l~~l~h~niv~l~~~~~~~~----~~~l 345 (498)
+|...+.||+|+||.||+|++ +|+.||||+++.. ....+.+ |+..+.+++||||+++++++...+ ..++
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 455678899999999999997 6889999998642 2334444 445556789999999999997654 5789
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEEcCCCCCcEEECCCCcEEEeecC
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ-----CNPKIIHRDLKAANILLDDNFEAVLCDFG 420 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 420 (498)
||||+++|+|.+++++ ..++|.++.+++.|++.||+|+|+. ...+|+||||||+|||+++++.+||+|||
T Consensus 79 v~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 9999999999999985 3589999999999999999999973 12389999999999999999999999999
Q ss_pred ccccccccCcc---eeecccccccccCcccccCCC------CCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 421 LAKLVDAKLTH---VTTQIRGTMGHIAPEYLSTGK------SSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 421 l~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
+++........ ......||+.|+|||++.... ++.++|||||||++|||+||..|+...
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~ 221 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcc
Confidence 99877544322 223467999999999987542 577899999999999999999887643
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.3e-41 Score=324.22 Aligned_cols=201 Identities=25% Similarity=0.359 Sum_probs=173.0
Q ss_pred cCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEec
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF 349 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 349 (498)
++|+..+.||+|+||+||+|+.++++.||||+++... .+.....+.+|++++++++||||+++++++..++..+++++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788899999999999999999999999999997432 334467899999999999999999999999999999999999
Q ss_pred ccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccccccC
Q 010887 350 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 429 (498)
Q Consensus 350 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~~ 429 (498)
+.++.+...... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhh----cCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 998777666553 45699999999999999999999999 99999999999999999999999999998765433
Q ss_pred cceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 430 THVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 430 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
. ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||...
T Consensus 155 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~ 204 (286)
T d1ob3a_ 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred c-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence 2 22334588999999998764 4689999999999999999999999754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-41 Score=322.21 Aligned_cols=199 Identities=24% Similarity=0.384 Sum_probs=169.3
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccC-Cc----chHHHHHHHHHHHHhcc--CCccceEEEEEEcCCc
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SP----GGEAAFQREVHLISVAI--HKNLLQLIGYCTTSSE 342 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~----~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~ 342 (498)
++|++.+.||+|+||+||+|+. .+++.||||+++... .. .....+.+|++++++++ ||||+++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5788899999999999999996 468999999986422 11 12234678999999997 8999999999999999
Q ss_pred eEEEEecccC-CCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECC-CCcEEEeecC
Q 010887 343 RILVYPFMQN-LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDFG 420 (498)
Q Consensus 343 ~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~ki~DfG 420 (498)
.++||||+.+ +++.+.+.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 9999999976 577777765 34689999999999999999999999 9999999999999985 4799999999
Q ss_pred ccccccccCcceeecccccccccCcccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 421 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 421 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
+++...... .....||+.|+|||++.+.++ +.++||||+||++|||+||+.||...
T Consensus 157 ~a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 157 SGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp TCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred cceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 998665432 334679999999999987765 56789999999999999999999753
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=323.99 Aligned_cols=203 Identities=28% Similarity=0.403 Sum_probs=168.9
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-C-CcEEEEEEecccC-CcchHHHHHHHHHHHHhc---cCCccceEEEEEEc----
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-D-NTKVAVKRLQDYY-SPGGEAAFQREVHLISVA---IHKNLLQLIGYCTT---- 339 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~---- 339 (498)
.++|++.+.||+|+||+||+|+.. + ++.||||+++... .+.....+.+|+++++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999963 4 5679999986432 223334566787777665 79999999999853
Q ss_pred -CCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEee
Q 010887 340 -SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 418 (498)
Q Consensus 340 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~D 418 (498)
....++++||+.++.+...... ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 2357899999998877655443 245689999999999999999999999 999999999999999999999999
Q ss_pred cCccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 419 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 419 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
||+++...... ......||+.|+|||++.+.+|+.++||||+||++|||+||+.||....
T Consensus 160 fg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~ 219 (305)
T d1blxa_ 160 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 219 (305)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC
Confidence 99988654432 2345679999999999999999999999999999999999999998653
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-39 Score=320.68 Aligned_cols=202 Identities=21% Similarity=0.377 Sum_probs=170.3
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCC----ceEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS----ERIL 345 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~l 345 (498)
++|+..+.||+|+||+||+|+. .+++.||||+++........+.+.+|++++++++||||+++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 4688899999999999999996 5799999999976555556778999999999999999999999997653 3356
Q ss_pred EEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCccccc
Q 010887 346 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 425 (498)
Q Consensus 346 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~ 425 (498)
+++|+.+|+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++..
T Consensus 88 l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 6677889999999874 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred cccCcc--eeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 426 DAKLTH--VTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 426 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
...... ......||+.|+|||++.. ..++.++||||+||++|||+||+.||+...
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~ 217 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence 543222 2244568999999999854 567889999999999999999999997644
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-39 Score=316.76 Aligned_cols=204 Identities=28% Similarity=0.359 Sum_probs=169.4
Q ss_pred hcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEcC-------
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------- 340 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 340 (498)
.++|++.+.||+|+||+||+|+. .+++.||||++... ..+....++.+|++++++++||||+++++++...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36788899999999999999996 47899999998633 3344567889999999999999999999988653
Q ss_pred -CceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeec
Q 010887 341 -SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF 419 (498)
Q Consensus 341 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~Df 419 (498)
...++||||++++.+...... ...++...+..++.|++.||.|||+. +|+||||||+|||+++++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence 357899999998877655443 45689999999999999999999999 9999999999999999999999999
Q ss_pred CccccccccCcc---eeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 420 GLAKLVDAKLTH---VTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 420 Gl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
|+++........ ......||+.|+|||.+.+. .++.++||||+||++|||+||+.||+...
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~ 226 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 226 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC
Confidence 999866543221 12335689999999998765 68999999999999999999999997543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=318.33 Aligned_cols=204 Identities=25% Similarity=0.307 Sum_probs=175.8
Q ss_pred cCCCCCCeeecccceEEEEEEEc----CCcEEEEEEecccC---CcchHHHHHHHHHHHHhccC-CccceEEEEEEcCCc
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYY---SPGGEAAFQREVHLISVAIH-KNLLQLIGYCTTSSE 342 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~ 342 (498)
++|++.+.||+|+||+||+|+.. +|+.||||+++... .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56899999999999999999852 47899999986422 22345678899999999977 899999999999999
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcc
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~ 422 (498)
.++++||+.+|+|.+++... ..++......++.|++.||+|+|+. +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 99999999999999998863 3567889999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCcceeecccccccccCcccccCC--CCCCcccchhHHHHHHHHHhCCCCCCCCcc
Q 010887 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTG--KSSEKTDVFGYGITLLELVTGQRAIDFSRL 481 (498)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gvvl~elltG~~p~~~~~~ 481 (498)
+..............|++.|+|||.+... .++.++||||+||++|||+||+.||.....
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~ 237 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 237 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 87765544445566799999999999765 468899999999999999999999976543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9.7e-39 Score=308.38 Aligned_cols=200 Identities=18% Similarity=0.245 Sum_probs=171.3
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccC-CccceEEEEEEcCCceEEEEe
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH-KNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 348 (498)
++|++.+.||+|+||+||+|+.. +++.||||++..... ...+.+|++.++.+.| +|++.+++++......++|||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 57889999999999999999964 688999998864332 2346788899999875 899999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECC-----CCcEEEeecCccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-----NFEAVLCDFGLAK 423 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-----~~~~ki~DfGl~~ 423 (498)
|+ +++|.+.+... ...+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++
T Consensus 82 ~~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeE
Confidence 98 68998888753 34689999999999999999999999 9999999999999964 5789999999998
Q ss_pred cccccCcc------eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 424 LVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 424 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
........ ......||+.|||||.+.+..++.++|||||||++|||+||+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~ 217 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 217 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCcc
Confidence 76543221 1234579999999999999999999999999999999999999997543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-39 Score=317.30 Aligned_cols=198 Identities=26% Similarity=0.336 Sum_probs=163.5
Q ss_pred CCCCCCeeecccceEEEEEEEc-CCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceEEEEEEcCC------ceE
Q 010887 272 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------ERI 344 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~ 344 (498)
+|+..++||+|+||+||+|+.. +++.||||+++.... .+.+|++++++++||||+++++++.... ..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 4777889999999999999975 689999999975322 2247999999999999999999985432 368
Q ss_pred EEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCC-cEEEeecCccc
Q 010887 345 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCDFGLAK 423 (498)
Q Consensus 345 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~ki~DfGl~~ 423 (498)
+||||++++.+..... .......+++.++..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++
T Consensus 96 lv~Ey~~~~~~~~l~~-~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEECCSEEHHHHHHH-HHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEeccCCccHHHHHh-hhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchh
Confidence 9999998765444332 222355799999999999999999999999 999999999999999775 89999999998
Q ss_pred cccccCcceeecccccccccCcccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 424 LVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
....... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||....
T Consensus 172 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~ 227 (350)
T d1q5ka_ 172 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 227 (350)
T ss_dssp ECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred hccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC
Confidence 7654332 234568999999998765 568999999999999999999999997654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-38 Score=306.66 Aligned_cols=200 Identities=27% Similarity=0.349 Sum_probs=175.0
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCCceEEEEe
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP 348 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 348 (498)
++|++.+.||+|+||+||+|+. .+++.||||+++.. ..+.....+.+|+++++.++||||+++++++......++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5788899999999999999996 46889999999743 334557889999999999999999999999999999999999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcccccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 428 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~~~~~ 428 (498)
++.++++...+.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 9999998887764 45689999999999999999999999 9999999999999999999999999999877654
Q ss_pred CcceeecccccccccCcccccCCC-CCCcccchhHHHHHHHHHhCCCCCCC
Q 010887 429 LTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDF 478 (498)
Q Consensus 429 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvvl~elltG~~p~~~ 478 (498)
... .....++..|+|||.+.... ++.++||||+||++|||++|+.||..
T Consensus 155 ~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 204 (292)
T d1unla_ 155 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp CSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred Ccc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence 322 23345678899999987665 68999999999999999999999743
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-38 Score=315.29 Aligned_cols=198 Identities=27% Similarity=0.407 Sum_probs=165.2
Q ss_pred hcCCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEcCC------
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------ 341 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 341 (498)
.++|+..+.||+|+||+||+|... +++.||||+++.. .++...+.+.+|++++++++||||+++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 357888999999999999999964 6899999999743 33445678899999999999999999999997665
Q ss_pred ceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCc
Q 010887 342 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 421 (498)
Q Consensus 342 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl 421 (498)
..++||||+ +.++....+. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 468999999 5567666653 3599999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCcceeecccccccccCcccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 422 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
++...... ....||+.|+|||.+.+. .++.++||||+||++|||++|+.||....
T Consensus 168 a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~ 223 (346)
T d1cm8a_ 168 ARQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223 (346)
T ss_dssp CEECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC
Confidence 98765432 345689999999998764 56899999999999999999999997653
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.4e-38 Score=307.91 Aligned_cols=194 Identities=20% Similarity=0.320 Sum_probs=167.5
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCccceEEEEEEcC--CceEEE
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTS--SERILV 346 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv 346 (498)
++|++.+.||+|+||+||+|+. .+++.||||+++. ...+.+.+|+++++++. ||||+++++++... ...++|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~----~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH----HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 5799999999999999999996 4689999999864 34567899999999995 99999999998754 458899
Q ss_pred EecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCC-cEEEeecCccccc
Q 010887 347 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCDFGLAKLV 425 (498)
Q Consensus 347 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~ki~DfGl~~~~ 425 (498)
|||+.+++|.... ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 111 ~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 111 FEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceec
Confidence 9999999986653 2489999999999999999999999 999999999999998655 6999999999876
Q ss_pred cccCcceeecccccccccCcccccCCC-CCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 426 DAKLTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
..... .....+|+.|+|||.+.+.. ++.++||||+||+++||++|+.||....
T Consensus 181 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 181 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 54322 34456899999999987654 7999999999999999999999997543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.1e-38 Score=303.53 Aligned_cols=200 Identities=20% Similarity=0.225 Sum_probs=164.6
Q ss_pred cCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccceE-EEEEEcCCceEEEEe
Q 010887 271 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL-IGYCTTSSERILVYP 348 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l-~~~~~~~~~~~lv~e 348 (498)
++|++.+.||+|+||.||+|++ .+++.||||++..... ..++.+|+++++.++|+|++.. .++..+.+..++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 5688999999999999999996 4688999998875322 2457889999999987775555 455567778889999
Q ss_pred cccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEEC---CCCcEEEeecCccccc
Q 010887 349 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD---DNFEAVLCDFGLAKLV 425 (498)
Q Consensus 349 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~ki~DfGl~~~~ 425 (498)
|+. +++...+... ...+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+++..
T Consensus 84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LLG-PSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CCC-CBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EcC-Cchhhhhhhc---cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 985 5555555432 34699999999999999999999999 999999999999985 4557999999999877
Q ss_pred cccCcc------eeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 426 DAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 426 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
...... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~ 217 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 217 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccc
Confidence 543321 2234579999999999999999999999999999999999999997543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-37 Score=307.98 Aligned_cols=197 Identities=25% Similarity=0.318 Sum_probs=160.5
Q ss_pred cCCCCCCeeecccceEEEEEEEc-CCcEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCccceEEEEEEcC------Cc
Q 010887 271 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------SE 342 (498)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~ 342 (498)
++|++.+.||+|+||+||+|++. +++.||||+++.. .+......+.+|++++++++||||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57888999999999999999975 6899999999744 3344556789999999999999999999999643 56
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcc
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~ 422 (498)
.++||||+.++.+.. +. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~l~~~-~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDANLCQV-IQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEEHHHH-HT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchHHHHh-hh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 799999997765543 32 2489999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
+...... ......+|+.|+|||++.+..++.++||||+||+++||++|+.||...
T Consensus 167 ~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~ 221 (355)
T d2b1pa1 167 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence 8665432 234456899999999999999999999999999999999999999754
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-37 Score=307.90 Aligned_cols=199 Identities=24% Similarity=0.369 Sum_probs=167.8
Q ss_pred hcCCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccC-CcchHHHHHHHHHHHHhccCCccceEEEEEEcC-----Cc
Q 010887 270 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-----SE 342 (498)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 342 (498)
.++|++.+.||+|+||+||+|+. .+++.||||+++... +....+.+.+|++++++++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46799999999999999999996 478999999997433 334567789999999999999999999998643 34
Q ss_pred eEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEeecCcc
Q 010887 343 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 422 (498)
Q Consensus 343 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~ 422 (498)
.+++++|+.+|+|.+++.. ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||.+
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 5777888899999998863 3599999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccCcceeecccccccccCcccccCCC-CCCcccchhHHHHHHHHHhCCCCCCCCc
Q 010887 423 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSR 480 (498)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvvl~elltG~~p~~~~~ 480 (498)
...... .....||+.|+|||...+.. ++.++||||+||++|||++|+.||...+
T Consensus 169 ~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~ 223 (348)
T d2gfsa1 169 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223 (348)
T ss_dssp -CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC
Confidence 765432 23456899999999876654 6889999999999999999999997643
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=1.9e-32 Score=272.30 Aligned_cols=198 Identities=22% Similarity=0.246 Sum_probs=158.0
Q ss_pred CCCCCCeeecccceEEEEEEE-cCCcEEEEEEecccCCcchHHHHHHHHHHHHhcc-----------CCccceEEEEEEc
Q 010887 272 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-----------HKNLLQLIGYCTT 339 (498)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~ 339 (498)
+|++.+.||+|+||+||+|+. .+|+.||||+++.. ......+.+|+++++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc--ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 488899999999999999996 47899999999742 234567788999888775 5789999988764
Q ss_pred C--CceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEEcCCCCCcEEECCCC----
Q 010887 340 S--SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNF---- 412 (498)
Q Consensus 340 ~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~---- 412 (498)
. ...+++++++..+......... .....+++..+..++.||+.||+|||+ . +|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTT
T ss_pred ccccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccc
Confidence 3 4456666666554433332221 224568999999999999999999998 5 899999999999997655
Q ss_pred --cEEEeecCccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 010887 413 --EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 479 (498)
Q Consensus 413 --~~ki~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl~elltG~~p~~~~ 479 (498)
.++++|||.+...... .....||+.|+|||++....++.++||||+||+++||++|+.||...
T Consensus 168 ~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred cceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 3999999998765432 23456899999999999999999999999999999999999999754
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.91 E-value=4.6e-25 Score=214.09 Aligned_cols=149 Identities=28% Similarity=0.513 Sum_probs=133.3
Q ss_pred CCChhHHHHHHHHHHHccCCCCCCCCCCCCCCCCCC--CcceeEecCC----ceeEEEecccccCc--cccccccccCCC
Q 010887 31 REPDVEGEALIEVLKALNDTHGQFTDWNDHFVSPCF--SWSHVTCRNG----NVISLTLGSNGFSG--KISPSITKLKFL 102 (498)
Q Consensus 31 ~~~~~~~~al~~~~~~~~~~~~~l~~w~~~~~~~c~--~w~gv~c~~~----~v~~l~l~~~~l~g--~~~~~~~~l~~L 102 (498)
.|.+.|++||++||+++.||. .+++|... ++|| .|.||+|+.. ||+.|+|++|+++| .+|++|++|++|
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~-~l~sW~~~--~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L 78 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPT--TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTT--SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCHHHHHHHHHHHHHCCCCC-cCCCCCCC--CCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccc
Confidence 478999999999999999875 68999754 4566 5999999852 79999999999998 588999999999
Q ss_pred CeEEccC-CCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCCCCcCcccCCchhhcc---ccccccC
Q 010887 103 ASLELQD-NDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSV---ATFNFTG 178 (498)
Q Consensus 103 ~~L~l~~-n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~---~~~~~~~ 178 (498)
++|+|++ |+++|.+|++|++|++|++|+|++|+|++..|..+.++.+|+.+++++|.+.+.+|..+.++ ..+++++
T Consensus 79 ~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~ 158 (313)
T d1ogqa_ 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCS
T ss_pred cccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccc
Confidence 9999997 99999999999999999999999999999999999999999999999999999999888665 5567777
Q ss_pred Cccc
Q 010887 179 THLI 182 (498)
Q Consensus 179 n~~~ 182 (498)
|...
T Consensus 159 n~l~ 162 (313)
T d1ogqa_ 159 NRIS 162 (313)
T ss_dssp SCCE
T ss_pred cccc
Confidence 7653
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=1.5e-23 Score=188.14 Aligned_cols=169 Identities=11% Similarity=0.079 Sum_probs=120.3
Q ss_pred CCCeeecccceEEEEEEEcCCcEEEEEEecccCCc-----------------chHHHHHHHHHHHHhccCCccceEEEEE
Q 010887 275 ESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP-----------------GGEAAFQREVHLISVAIHKNLLQLIGYC 337 (498)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~e~~~l~~l~h~niv~l~~~~ 337 (498)
+.+.||+|+||+||+|+..+|+.||||+++..... .....+.+|.+.+.++.|++++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 46889999999999999989999999987532110 1123456788889999999999887653
Q ss_pred EcCCceEEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCcEEECCCCcEEEe
Q 010887 338 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLC 417 (498)
Q Consensus 338 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~ 417 (498)
..+++|||+++..+.. ++......++.|++++++|||+. +|+||||||+|||++++ .++|+
T Consensus 84 ----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp ----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred ----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence 3479999998765432 23344568999999999999999 99999999999999865 58999
Q ss_pred ecCccccccccCcceeecccccccccCcccccCCCCCCcccchhHHHHH
Q 010887 418 DFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITL 466 (498)
Q Consensus 418 DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvvl 466 (498)
|||.+.....+....... .+...+ .|.+ .++|+.++|+||..--+
T Consensus 145 DFG~a~~~~~~~~~~~l~--rd~~~~-~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWREILE--RDVRNI-ITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHHHHHH--HHHHHH-HHHH-HHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcHHHHH--HHHHHH-HHHH-cCCCCCcccHHHHHHHH
Confidence 999987664332110000 000000 1111 35678899999976443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.66 E-value=8.9e-17 Score=143.51 Aligned_cols=125 Identities=26% Similarity=0.403 Sum_probs=106.5
Q ss_pred CCCCC-CCcceeEecC-----------CceeEEEecccccCcccc-ccccccCCCCeEEccCCCCCCccCcccccccccc
Q 010887 61 FVSPC-FSWSHVTCRN-----------GNVISLTLGSNGFSGKIS-PSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQ 127 (498)
Q Consensus 61 ~~~~c-~~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~-~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~ 127 (498)
+|..| |.|..|.|++ .+++.|+|++|.|++.++ ..|+++++|+.|+|++|.+.+..+..+..+++|+
T Consensus 2 CP~~C~C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~ 81 (192)
T d1w8aa_ 2 CPAMCHCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQ 81 (192)
T ss_dssp CCTTSEEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCC
T ss_pred cCCCCEEcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccc
Confidence 34556 5899999974 268999999999987664 5689999999999999999988899999999999
Q ss_pred eeecccccccCCCCCcccCCCCCCeEeCCCCcCcccCCch---hhccccccccCCccccCC
Q 010887 128 SLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQ---LFSVATFNFTGTHLICGS 185 (498)
Q Consensus 128 ~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~---~~~~~~~~~~~n~~~~~~ 185 (498)
+|+|++|+|++..|..|.++++|++|+|++|+|++-.|.. +.++..+++++|++.|.+
T Consensus 82 ~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~ 142 (192)
T d1w8aa_ 82 ELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp EEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred eeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc
Confidence 9999999999777778999999999999999999533433 346788999999987764
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.57 E-value=8.5e-16 Score=147.91 Aligned_cols=113 Identities=31% Similarity=0.462 Sum_probs=101.9
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
....+++.++.+.|.+|..+..+++|+.|++++|.+++.+| .++.+++|++|+|++|+|+|.+|+.|+++++|++|+|+
T Consensus 198 ~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls 276 (313)
T d1ogqa_ 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVS 276 (313)
T ss_dssp CCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECC
T ss_pred ccccccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECc
Confidence 34468888899999999999999999999999999998765 68999999999999999999999999999999999999
Q ss_pred CCcCcccCCc--hhhccccccccCCccccCCCCCCCC
Q 010887 157 SNNLTGRIPM--QLFSVATFNFTGTHLICGSSLEQPC 191 (498)
Q Consensus 157 ~N~l~g~ip~--~~~~~~~~~~~~n~~~~~~~~~~~c 191 (498)
+|+|+|.||. .+.++..+++.+|+.+||.|++ +|
T Consensus 277 ~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp-~c 312 (313)
T d1ogqa_ 277 FNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp SSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred CCcccccCCCcccCCCCCHHHhCCCccccCCCCC-CC
Confidence 9999999996 3667888999999999998774 45
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.50 E-value=2.8e-14 Score=117.22 Aligned_cols=98 Identities=23% Similarity=0.390 Sum_probs=84.7
Q ss_pred EEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCCCCc
Q 010887 80 SLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNN 159 (498)
Q Consensus 80 ~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~ 159 (498)
.|+|++|+|+ .++ .+..+++|++|+|++|.|+ .+|+.++.+++|++|++++|+|+ .+| .+.++++|++|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCc
Confidence 6899999999 666 4999999999999999998 78989999999999999999999 566 58999999999999999
Q ss_pred CcccCC--chh---hccccccccCCcccc
Q 010887 160 LTGRIP--MQL---FSVATFNFTGTHLIC 183 (498)
Q Consensus 160 l~g~ip--~~~---~~~~~~~~~~n~~~~ 183 (498)
++ .+| ..+ .++..+++++|+...
T Consensus 77 i~-~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 77 LQ-QSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CC-SSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred cC-CCCCchhhcCCCCCCEEECCCCcCCc
Confidence 99 444 234 456788999998744
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=1.8e-13 Score=117.21 Aligned_cols=108 Identities=19% Similarity=0.273 Sum_probs=85.6
Q ss_pred CCcceeEecCCceeEEEecccccCccccccccccCCCCeEEccCC-CCCCccCcccccccccceeecccccccCCCCCcc
Q 010887 66 FSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDN-DLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATW 144 (498)
Q Consensus 66 ~~w~gv~c~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n-~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~ 144 (498)
+.+.+|.|. ++++. .+|..+..+++|++|+|++| .|+..-+..|.++++|+.|+|++|+|+..-|..|
T Consensus 8 ~~~~~l~c~----------~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f 76 (156)
T d2ifga3 8 HGSSGLRCT----------RDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76 (156)
T ss_dssp SSSSCEECC----------SSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGG
T ss_pred CCCCeEEec----------CCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccc
Confidence 356666664 45555 66777888999999999766 4884445678899999999999999996667779
Q ss_pred cCCCCCCeEeCCCCcCcccCCchhh---ccccccccCCccccCC
Q 010887 145 SQLSNLKHLDLSSNNLTGRIPMQLF---SVATFNFTGTHLICGS 185 (498)
Q Consensus 145 ~~l~~L~~l~l~~N~l~g~ip~~~~---~~~~~~~~~n~~~~~~ 185 (498)
..+++|++|+|++|+|+ .+|...+ ++..+++++|++.|.+
T Consensus 77 ~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~C~C 119 (156)
T d2ifga3 77 HFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSC 119 (156)
T ss_dssp GSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred cccccccceeccCCCCc-ccChhhhccccccccccCCCcccCCc
Confidence 99999999999999999 7877654 4678899999998865
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.40 E-value=3.4e-13 Score=119.75 Aligned_cols=111 Identities=21% Similarity=0.368 Sum_probs=94.4
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|+|++|.+.+..+..+..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|
T Consensus 54 ~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L 133 (192)
T d1w8aa_ 54 PHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNL 133 (192)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEEC
T ss_pred ceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccc
Confidence 38999999999999888889999999999999999999766778999999999999999999777788999999999999
Q ss_pred CCCcCcccCCchh--hccccccccCCccccCCC
Q 010887 156 SSNNLTGRIPMQL--FSVATFNFTGTHLICGSS 186 (498)
Q Consensus 156 ~~N~l~g~ip~~~--~~~~~~~~~~n~~~~~~~ 186 (498)
++|.+.+..+... ..+....+.+|...|..|
T Consensus 134 ~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 134 ASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp TTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred cccccccccchHHHhhhhhhhcccCCCeEeCCC
Confidence 9999986554322 234556666777666543
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.32 E-value=7.1e-13 Score=125.22 Aligned_cols=110 Identities=21% Similarity=0.266 Sum_probs=94.4
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
..++.+++++|.|++..+..|..+++|+.|+|++|+|++..|..|..+++|++|++++|++++..|..|.++++|++|++
T Consensus 129 ~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l 208 (284)
T d1ozna_ 129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208 (284)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred cccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccc
Confidence 36888999999999665667888999999999999999777888899999999999999999888999999999999999
Q ss_pred CCCcCcccCCchh---hccccccccCCccccCC
Q 010887 156 SSNNLTGRIPMQL---FSVATFNFTGTHLICGS 185 (498)
Q Consensus 156 ~~N~l~g~ip~~~---~~~~~~~~~~n~~~~~~ 185 (498)
++|.+++..|..+ .++..+++++|++.|.+
T Consensus 209 ~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C 241 (284)
T d1ozna_ 209 FANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241 (284)
T ss_dssp CSSCCSCCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred cccccccccccccccccccCEEEecCCCCCCCc
Confidence 9999996555444 45678899999998864
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.31 E-value=9e-13 Score=113.43 Aligned_cols=101 Identities=19% Similarity=0.196 Sum_probs=84.8
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
++..|+|++|+|+ .+|..+..+++|+.|||++|.|+ .++ .+..+++|++|+|++|+++...+..+..+++|++|+|+
T Consensus 19 ~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~ 95 (162)
T d1a9na_ 19 RDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 95 (162)
T ss_dssp SCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred cCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceec
Confidence 6889999999999 67877788999999999999999 675 58999999999999999994334445789999999999
Q ss_pred CCcCcccCCc-----hhhccccccccCCcc
Q 010887 157 SNNLTGRIPM-----QLFSVATFNFTGTHL 181 (498)
Q Consensus 157 ~N~l~g~ip~-----~~~~~~~~~~~~n~~ 181 (498)
+|+++ .++. .+.++..+++++|+.
T Consensus 96 ~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i 124 (162)
T d1a9na_ 96 NNSLV-ELGDLDPLASLKSLTYLCILRNPV 124 (162)
T ss_dssp SCCCC-CGGGGGGGGGCTTCCEEECCSSGG
T ss_pred ccccc-ccccccccccccccchhhcCCCcc
Confidence 99998 4442 345677888899876
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.31 E-value=2.2e-12 Score=120.53 Aligned_cols=108 Identities=26% Similarity=0.344 Sum_probs=79.1
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|+|++|.+....+..+..+.+|++|++++|.+++..|..+..+++|+.|++++|+|++..|..|..+++|++|+|+
T Consensus 101 ~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls 180 (266)
T d1p9ag_ 101 ALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180 (266)
T ss_dssp TCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECC
T ss_pred ccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecc
Confidence 44445555555544444445555666666666666664445556778899999999999997777778999999999999
Q ss_pred CCcCcccCCchhh---ccccccccCCccccCC
Q 010887 157 SNNLTGRIPMQLF---SVATFNFTGTHLICGS 185 (498)
Q Consensus 157 ~N~l~g~ip~~~~---~~~~~~~~~n~~~~~~ 185 (498)
+|+|+ .||.+++ ++..++++||++.|.+
T Consensus 181 ~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp SSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred cCCCc-ccChhHCCCCCCCEEEecCCCCCCCc
Confidence 99999 8998765 4567889999998875
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.31 E-value=1.9e-12 Score=105.96 Aligned_cols=83 Identities=27% Similarity=0.363 Sum_probs=75.3
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCC--CcccCCCCCCeE
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIP--ATWSQLSNLKHL 153 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p--~~~~~l~~L~~l 153 (498)
.+++.|+|++|.|+ .+|++++.+++|+.|++++|.|+ .+| .++.+++|++|++++|+++. +| ..++.+++|++|
T Consensus 20 ~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i~~-~~~~~~l~~~~~L~~L 95 (124)
T d1dcea3 20 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQ-SAAIQPLVSCPRLVLL 95 (124)
T ss_dssp TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCCCS-SSTTGGGGGCTTCCEE
T ss_pred CCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCccCC-CCCchhhcCCCCCCEE
Confidence 37999999999999 78989999999999999999999 566 59999999999999999994 44 468999999999
Q ss_pred eCCCCcCcc
Q 010887 154 DLSSNNLTG 162 (498)
Q Consensus 154 ~l~~N~l~g 162 (498)
++++|+++.
T Consensus 96 ~l~~N~i~~ 104 (124)
T d1dcea3 96 NLQGNSLCQ 104 (124)
T ss_dssp ECTTSGGGG
T ss_pred ECCCCcCCc
Confidence 999999984
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.29 E-value=3.7e-12 Score=108.78 Aligned_cols=85 Identities=25% Similarity=0.207 Sum_probs=73.6
Q ss_pred ceeEEEecccc-cCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 77 NVISLTLGSNG-FSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 77 ~v~~l~l~~~~-l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
++++|+|++|+ |+..-+.+|.++++|+.|+|++|+|+..-|..|..+++|++|+|++|+|+ .+|.......+|+.|+|
T Consensus 32 ~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L 110 (156)
T d2ifga3 32 NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVL 110 (156)
T ss_dssp CCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEEC
T ss_pred ccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhcccccccccc
Confidence 89999998775 88444567999999999999999999666788999999999999999999 77776555568999999
Q ss_pred CCCcCcc
Q 010887 156 SSNNLTG 162 (498)
Q Consensus 156 ~~N~l~g 162 (498)
++|.+..
T Consensus 111 ~~Np~~C 117 (156)
T d2ifga3 111 SGNPLHC 117 (156)
T ss_dssp CSSCCCC
T ss_pred CCCcccC
Confidence 9999963
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.21 E-value=1.2e-11 Score=117.86 Aligned_cols=105 Identities=24% Similarity=0.278 Sum_probs=92.5
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|++++|.+++..+..+.+++.+++|++++|.+++..|..+.++++|++|+|++|+|+ .+|+.|.++++|++|+|+
T Consensus 172 ~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls 250 (305)
T d1xkua_ 172 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLH 250 (305)
T ss_dssp TCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECC
T ss_pred ccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECC
Confidence 6889999999999888889999999999999999999877888999999999999999998 789999999999999999
Q ss_pred CCcCcccCCchh----------hccccccccCCcccc
Q 010887 157 SNNLTGRIPMQL----------FSVATFNFTGTHLIC 183 (498)
Q Consensus 157 ~N~l~g~ip~~~----------~~~~~~~~~~n~~~~ 183 (498)
+|+|+ .|+... .++..+++++|++.+
T Consensus 251 ~N~i~-~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~ 286 (305)
T d1xkua_ 251 NNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 286 (305)
T ss_dssp SSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred CCccC-ccChhhccCcchhcccCCCCEEECCCCcCcc
Confidence 99999 666432 346778899998754
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.07 E-value=4.5e-11 Score=102.52 Aligned_cols=90 Identities=18% Similarity=0.220 Sum_probs=75.9
Q ss_pred ecCCceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCC--CcccCCCCC
Q 010887 73 CRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIP--ATWSQLSNL 150 (498)
Q Consensus 73 c~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p--~~~~~l~~L 150 (498)
+...+++.|+|++|.|+ .++ .|..+++|++|+|++|+++...|..+..+++|++|+|++|+++ .++ ..+.++++|
T Consensus 38 ~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~-~~~~l~~l~~l~~L 114 (162)
T d1a9na_ 38 ATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSL 114 (162)
T ss_dssp GGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTC
T ss_pred cccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceecccccc-cccccccccccccc
Confidence 44458999999999999 665 5999999999999999999433444567999999999999998 555 368899999
Q ss_pred CeEeCCCCcCcccCCc
Q 010887 151 KHLDLSSNNLTGRIPM 166 (498)
Q Consensus 151 ~~l~l~~N~l~g~ip~ 166 (498)
++|++++|.++ ..|.
T Consensus 115 ~~L~l~~N~i~-~~~~ 129 (162)
T d1a9na_ 115 TYLCILRNPVT-NKKH 129 (162)
T ss_dssp CEEECCSSGGG-GSTT
T ss_pred chhhcCCCccc-cccc
Confidence 99999999998 5663
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.04 E-value=1.9e-10 Score=109.25 Aligned_cols=105 Identities=25% Similarity=0.412 Sum_probs=62.3
Q ss_pred CCCCC-CCcceeEecCCceeEEEecccccCccccccccccCCCCeEEccCCCCCCccC-cccccccccceeecccccccC
Q 010887 61 FVSPC-FSWSHVTCRNGNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLP-DFLGSMTHLQSLNLANNKFSG 138 (498)
Q Consensus 61 ~~~~c-~~w~gv~c~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p-~~~~~l~~L~~L~l~~N~l~g 138 (498)
++..| |.|.+|.|++ ++|+ .+|+.+. ++|++|+|++|+|+ .+| ..|.++++|++|++++|.++.
T Consensus 4 ~p~~c~c~~~~~~C~~----------~~L~-~lP~~l~--~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~ 69 (305)
T d1xkua_ 4 CPFRCQCHLRVVQCSD----------LGLE-KVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISK 69 (305)
T ss_dssp CCTTCEEETTEEECTT----------SCCC-SCCCSCC--TTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCCCCEecCCEEEecC----------CCCC-ccCCCCC--CCCCEEECcCCcCC-CcChhHhhccccccccccccccccc
Confidence 45566 6899999974 3344 5555442 45666666666666 343 356666666666666666665
Q ss_pred CCCCcccCCCCCCeEeCCCCcCcccCCchh-hccccccccCCc
Q 010887 139 SIPATWSQLSNLKHLDLSSNNLTGRIPMQL-FSVATFNFTGTH 180 (498)
Q Consensus 139 ~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~-~~~~~~~~~~n~ 180 (498)
..|..|.++++|++|++++|+++ .+|..+ ..+..+....|.
T Consensus 70 i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~~~~l~~L~~~~n~ 111 (305)
T d1xkua_ 70 ISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENE 111 (305)
T ss_dssp BCTTTTTTCTTCCEEECCSSCCS-BCCSSCCTTCCEEECCSSC
T ss_pred cchhhhhCCCccCEecccCCccC-cCccchhhhhhhhhccccc
Confidence 44555666666666666666666 455433 233444444443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.98 E-value=4.4e-10 Score=105.55 Aligned_cols=106 Identities=25% Similarity=0.268 Sum_probs=85.5
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|+|++|++....+..+..+++|+.+++++|+|++..|..|..+++|++|+|++|+|++..|..|.++++|+.+++
T Consensus 105 ~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l 184 (284)
T d1ozna_ 105 GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184 (284)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred ccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhh
Confidence 36888888888888666667888888899999999988655677888888999999999988767777888889999999
Q ss_pred CCCcCcccCCchhh---ccccccccCCcc
Q 010887 156 SSNNLTGRIPMQLF---SVATFNFTGTHL 181 (498)
Q Consensus 156 ~~N~l~g~ip~~~~---~~~~~~~~~n~~ 181 (498)
++|++++..|..+. ++..+++++|..
T Consensus 185 ~~N~l~~i~~~~f~~l~~L~~L~l~~N~i 213 (284)
T d1ozna_ 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNL 213 (284)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred hhccccccChhHhhhhhhccccccccccc
Confidence 99998877776654 456777877765
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.96 E-value=9.5e-12 Score=110.67 Aligned_cols=101 Identities=25% Similarity=0.319 Sum_probs=85.1
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|+|++|+|+ .++ .+..|++|++|+|++|.|+ .+|..+..+++|++|++++|+++ .++ .+.++++|+.|+|
T Consensus 48 ~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L 122 (198)
T d1m9la_ 48 KACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEEE
T ss_pred cccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-ccccccccccccc
Confidence 47999999999999 665 5999999999999999998 78877777889999999999999 454 5888999999999
Q ss_pred CCCcCcccCCc-----hhhccccccccCCccc
Q 010887 156 SSNNLTGRIPM-----QLFSVATFNFTGTHLI 182 (498)
Q Consensus 156 ~~N~l~g~ip~-----~~~~~~~~~~~~n~~~ 182 (498)
++|+++ .++. .+.++..++++||+..
T Consensus 123 ~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 123 SNNKIT-NWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp SEEECC-CHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred ccchhc-cccccccccCCCccceeecCCCccc
Confidence 999998 4442 3456778889999763
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.93 E-value=1.3e-09 Score=101.39 Aligned_cols=82 Identities=24% Similarity=0.361 Sum_probs=49.1
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|+|++|+|+ .+|. ++.+++|++|+|++|+++ .+|..+..+++|+.|+|++|.+.+..+..+..+.+|+.|+++
T Consensus 56 ~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~ 132 (266)
T d1p9ag_ 56 RLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLK 132 (266)
T ss_dssp TCCEEECTTSCCC-EEEC-CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECT
T ss_pred ccccccccccccc-cccc-cccccccccccccccccc-ccccccccccccccccccccccceeecccccccccccccccc
Confidence 5677777777776 4543 456677777777777766 345566666666666666666654444444444455555555
Q ss_pred CCcCc
Q 010887 157 SNNLT 161 (498)
Q Consensus 157 ~N~l~ 161 (498)
+|.++
T Consensus 133 ~n~l~ 137 (266)
T d1p9ag_ 133 GNELK 137 (266)
T ss_dssp TSCCC
T ss_pred ccccc
Confidence 55444
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.84 E-value=2.9e-09 Score=94.30 Aligned_cols=99 Identities=23% Similarity=0.405 Sum_probs=68.9
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|++++|+++ .++ .+..+++|++|+|++|++++ +|+ ++++++|++|++++|.+. .+| .+.++++|+.|+++
T Consensus 41 ~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~ 114 (199)
T d2omxa2 41 QVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLF 114 (199)
T ss_dssp TCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECC
T ss_pred CCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccC-ccc-ccCCcccccccccccccc-ccc-cccccccccccccc
Confidence 6777888888877 454 47778888888888888874 333 777888888888888776 455 37777888888888
Q ss_pred CCcCcccCC-chhhccccccccCCcc
Q 010887 157 SNNLTGRIP-MQLFSVATFNFTGTHL 181 (498)
Q Consensus 157 ~N~l~g~ip-~~~~~~~~~~~~~n~~ 181 (498)
+|.+....+ ..+.++..+++++|..
T Consensus 115 ~~~~~~~~~~~~l~~L~~L~l~~n~l 140 (199)
T d2omxa2 115 NNQITDIDPLKNLTNLNRLELSSNTI 140 (199)
T ss_dssp SSCCCCCGGGTTCTTCSEEECCSSCC
T ss_pred ccccccccccchhhhhHHhhhhhhhh
Confidence 777774322 2345566677777654
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.75 E-value=8.6e-09 Score=91.98 Aligned_cols=79 Identities=23% Similarity=0.351 Sum_probs=48.6
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
.++.|++++|+++ .++ .+..+++|++|+|++|+|++ +| .++.+++|++|++++|+++ .+| .+.++++|+.|+++
T Consensus 47 ~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 47 SIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLE 120 (210)
T ss_dssp TCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECT
T ss_pred CccEEECcCCCCC-Cch-hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc-ccc-cccccccccccccc
Confidence 4566666666666 333 26666666666666666663 33 2456666666666666666 344 35666666666666
Q ss_pred CCcCc
Q 010887 157 SNNLT 161 (498)
Q Consensus 157 ~N~l~ 161 (498)
+|.++
T Consensus 121 ~~~~~ 125 (210)
T d1h6ta2 121 HNGIS 125 (210)
T ss_dssp TSCCC
T ss_pred ccccc
Confidence 66665
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.75 E-value=3.8e-09 Score=103.01 Aligned_cols=97 Identities=29% Similarity=0.425 Sum_probs=79.0
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
....+.+..|.+++ + +.+..+++++.|+|++|++++. + .+..+++|++|+|++|+|+ .+| .++++++|++|+|+
T Consensus 286 ~l~~l~~~~n~l~~-~-~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~ 359 (384)
T d2omza2 286 ALTNLELNENQLED-I-SPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAG 359 (384)
T ss_dssp TCSEEECCSSCCSC-C-GGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECC
T ss_pred cccccccccccccc-c-cccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECC
Confidence 56788999999985 3 3588899999999999999964 4 3889999999999999998 455 68999999999999
Q ss_pred CCcCcccCC-chhhccccccccCC
Q 010887 157 SNNLTGRIP-MQLFSVATFNFTGT 179 (498)
Q Consensus 157 ~N~l~g~ip-~~~~~~~~~~~~~n 179 (498)
+|+|++-.| ..+.++..+++++|
T Consensus 360 ~N~l~~l~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 360 HNQISDLTPLANLTRITQLGLNDQ 383 (384)
T ss_dssp SSCCCBCGGGTTCTTCSEEECCCE
T ss_pred CCcCCCChhhccCCCCCEeeCCCC
Confidence 999996544 23456677777776
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.75 E-value=5.3e-09 Score=101.92 Aligned_cols=100 Identities=24% Similarity=0.354 Sum_probs=81.9
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|++++|++++. + .+..+..++.++++.|.+++ + ..+..++++++|+|++|++++. + .+..+++|++|++
T Consensus 263 ~~L~~L~l~~~~l~~~-~-~~~~~~~l~~l~~~~n~l~~-~-~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L 336 (384)
T d2omza2 263 TKLTELKLGANQISNI-S-PLAGLTALTNLELNENQLED-I-SPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFF 336 (384)
T ss_dssp TTCSEEECCSSCCCCC-G-GGTTCTTCSEEECCSSCCSC-C-GGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEEC
T ss_pred ccCCEeeccCcccCCC-C-cccccccccccccccccccc-c-cccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEEC
Confidence 3789999999999954 3 38889999999999999985 3 4588899999999999999964 4 3889999999999
Q ss_pred CCCcCcccCCc--hhhccccccccCCccc
Q 010887 156 SSNNLTGRIPM--QLFSVATFNFTGTHLI 182 (498)
Q Consensus 156 ~~N~l~g~ip~--~~~~~~~~~~~~n~~~ 182 (498)
++|+|+ .+|. .+.++..+++++|...
T Consensus 337 ~~n~l~-~l~~l~~l~~L~~L~l~~N~l~ 364 (384)
T d2omza2 337 ANNKVS-DVSSLANLTNINWLSAGHNQIS 364 (384)
T ss_dssp CSSCCC-CCGGGGGCTTCCEEECCSSCCC
T ss_pred CCCCCC-CChhHcCCCCCCEEECCCCcCC
Confidence 999998 4552 2345677889988764
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.72 E-value=5.9e-09 Score=95.05 Aligned_cols=96 Identities=19% Similarity=0.307 Sum_probs=77.8
Q ss_pred CCcceeEecC-----------CceeEEEecccccCccccc-cccccCCCCeEEccCCCCCCccCc-ccccccccceeecc
Q 010887 66 FSWSHVTCRN-----------GNVISLTLGSNGFSGKISP-SITKLKFLASLELQDNDLSGTLPD-FLGSMTHLQSLNLA 132 (498)
Q Consensus 66 ~~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~-~~~~l~~L~~L~l~~n~l~g~~p~-~~~~l~~L~~L~l~ 132 (498)
|.+..|.|.. .++++|+|++|.|+ .+|+ .|.++++|++|+|++|.+...+|. .|..++++++|++.
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 4788899963 26888999999998 5554 688999999999999998866644 57889999999875
Q ss_pred -cccccCCCCCcccCCCCCCeEeCCCCcCcc
Q 010887 133 -NNKFSGSIPATWSQLSNLKHLDLSSNNLTG 162 (498)
Q Consensus 133 -~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g 162 (498)
.|+++...|..|.++++|++|++++|.+..
T Consensus 87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~ 117 (242)
T d1xwdc1 87 KANNLLYINPEAFQNLPNLQYLLISNTGIKH 117 (242)
T ss_dssp CCTTCCEECTTSEECCTTCCEEEEESCCCCS
T ss_pred ccccccccccccccccccccccccchhhhcc
Confidence 467876777778899999999999998873
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.72 E-value=1.2e-08 Score=90.14 Aligned_cols=99 Identities=28% Similarity=0.528 Sum_probs=78.4
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|+|++|++++ +++ ++++++|++|++++|.+. .+| .+.++++|+.|++++|.+.. ++ .+.++++|+.|++
T Consensus 62 ~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~-~~-~~~~l~~L~~L~l 135 (199)
T d2omxa2 62 NNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITD-ID-PLKNLTNLNRLEL 135 (199)
T ss_dssp TTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEEC
T ss_pred CCcCcCccccccccC-ccc-ccCCcccccccccccccc-ccc-cccccccccccccccccccc-cc-ccchhhhhHHhhh
Confidence 489999999999995 444 999999999999999988 565 48889999999999998874 33 4778899999999
Q ss_pred CCCcCcccCCc--hhhccccccccCCcc
Q 010887 156 SSNNLTGRIPM--QLFSVATFNFTGTHL 181 (498)
Q Consensus 156 ~~N~l~g~ip~--~~~~~~~~~~~~n~~ 181 (498)
++|++. .+|. ...++..+++.+|..
T Consensus 136 ~~n~l~-~~~~l~~~~~L~~L~l~~n~l 162 (199)
T d2omxa2 136 SSNTIS-DISALSGLTSLQQLNFSSNQV 162 (199)
T ss_dssp CSSCCC-CCGGGTTCTTCSEEECCSSCC
T ss_pred hhhhhc-ccccccccccccccccccccc
Confidence 999987 4552 334566677777654
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.71 E-value=3.1e-10 Score=100.61 Aligned_cols=87 Identities=21% Similarity=0.331 Sum_probs=74.6
Q ss_pred cccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCCCCcCcccCCc--hh
Q 010887 91 KISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPM--QL 168 (498)
Q Consensus 91 ~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~--~~ 168 (498)
.+|.++..|++|++|+|++|+|+ .++ .|..|++|++|+|++|+|+ .+|..+..+++|+.|++++|+++ .++. .+
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~~~~~l 114 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSGIEKL 114 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHHHHHHH
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-cccccccc
Confidence 56678999999999999999999 676 5999999999999999998 78876666788999999999999 5553 44
Q ss_pred hccccccccCCcc
Q 010887 169 FSVATFNFTGTHL 181 (498)
Q Consensus 169 ~~~~~~~~~~n~~ 181 (498)
.++..+++++|..
T Consensus 115 ~~L~~L~L~~N~i 127 (198)
T d1m9la_ 115 VNLRVLYMSNNKI 127 (198)
T ss_dssp HHSSEEEESEEEC
T ss_pred ccccccccccchh
Confidence 6778889998865
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.66 E-value=2.3e-08 Score=89.10 Aligned_cols=100 Identities=30% Similarity=0.416 Sum_probs=77.3
Q ss_pred CceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeC
Q 010887 76 GNVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDL 155 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l 155 (498)
.+++.|+|++|+|++ +++ ++++++|++|++++|+|+ .+| .+..+++|+.|++++|.++ .++ .+.++++|+.+++
T Consensus 68 ~~L~~L~L~~n~i~~-l~~-~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~-~~~-~l~~l~~l~~l~~ 141 (210)
T d1h6ta2 68 PNVTKLFLNGNKLTD-IKP-LANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYL 141 (210)
T ss_dssp TTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCC-CCG-GGGGCTTCCEEEC
T ss_pred CCCCEEeCCCccccC-ccc-cccCcccccccccccccc-ccc-ccccccccccccccccccc-ccc-ccccccccccccc
Confidence 379999999999995 553 789999999999999998 466 5888999999999999887 444 5777888888888
Q ss_pred CCCcCcccCC-chhhccccccccCCcc
Q 010887 156 SSNNLTGRIP-MQLFSVATFNFTGTHL 181 (498)
Q Consensus 156 ~~N~l~g~ip-~~~~~~~~~~~~~n~~ 181 (498)
++|.+++..+ ..+.++..+++++|..
T Consensus 142 ~~n~l~~~~~~~~l~~L~~l~l~~n~l 168 (210)
T d1h6ta2 142 GNNKITDITVLSRLTKLDTLSLEDNQI 168 (210)
T ss_dssp CSSCCCCCGGGGGCTTCSEEECCSSCC
T ss_pred ccccccccccccccccccccccccccc
Confidence 8888874221 2345666677777654
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.61 E-value=1.6e-08 Score=91.26 Aligned_cols=93 Identities=22% Similarity=0.302 Sum_probs=72.5
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
.+..+.++++.+.... .+.+.++|+.|++++|.+++.. .++++++|+.|+|++|++++ +|+ +.++++|++|+|+
T Consensus 130 ~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls 203 (227)
T d1h6ua2 130 NLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLK 203 (227)
T ss_dssp TCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECT
T ss_pred chhhhhchhhhhchhh--hhccccccccccccccccccch--hhcccccceecccCCCccCC-Chh-hcCCCCCCEEECc
Confidence 6778888888887543 3778899999999999998433 38899999999999999984 553 8899999999999
Q ss_pred CCcCcccCCc--hhhccccccc
Q 010887 157 SNNLTGRIPM--QLFSVATFNF 176 (498)
Q Consensus 157 ~N~l~g~ip~--~~~~~~~~~~ 176 (498)
+|+++ .+|+ .+.++..+++
T Consensus 204 ~N~lt-~i~~l~~l~~L~~L~l 224 (227)
T d1h6ua2 204 NNQIS-DVSPLANTSNLFIVTL 224 (227)
T ss_dssp TSCCC-BCGGGTTCTTCCEEEE
T ss_pred CCcCC-CCcccccCCCCCEEEe
Confidence 99999 4653 3344444444
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.59 E-value=3.4e-08 Score=89.02 Aligned_cols=99 Identities=22% Similarity=0.302 Sum_probs=78.8
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.++++++...+.. .+...+.++.+.++.+.+.... .+...++|++|++++|.+++. + .++++++|+.|+|+
T Consensus 108 ~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~Ls 181 (227)
T d1h6ua2 108 SIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDL-T-PLANLSKLTTLKAD 181 (227)
T ss_dssp TCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECC
T ss_pred cccccccccccccccc--hhccccchhhhhchhhhhchhh--hhccccccccccccccccccc-h-hhcccccceecccC
Confidence 6888999998887533 3777889999999999988543 367889999999999998843 3 38899999999999
Q ss_pred CCcCcccCCc--hhhccccccccCCccc
Q 010887 157 SNNLTGRIPM--QLFSVATFNFTGTHLI 182 (498)
Q Consensus 157 ~N~l~g~ip~--~~~~~~~~~~~~n~~~ 182 (498)
+|+++ .+|. .+.++..+++++|+..
T Consensus 182 ~n~l~-~l~~l~~l~~L~~L~Ls~N~lt 208 (227)
T d1h6ua2 182 DNKIS-DISPLASLPNLIEVHLKNNQIS 208 (227)
T ss_dssp SSCCC-CCGGGGGCTTCCEEECTTSCCC
T ss_pred CCccC-CChhhcCCCCCCEEECcCCcCC
Confidence 99998 4653 4567788888888653
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.57 E-value=4.8e-08 Score=93.53 Aligned_cols=91 Identities=24% Similarity=0.327 Sum_probs=50.8
Q ss_pred ceeEEEecccccCccccccccccCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCC
Q 010887 77 NVISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLS 156 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~ 156 (498)
+++.|+|++++|+ .+|+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .++.- .+.|++|+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence 4666777777766 56642 356666777777776 666543 34556666666665 44421 1246666666
Q ss_pred CCcCcccCCc--hhhccccccccCCc
Q 010887 157 SNNLTGRIPM--QLFSVATFNFTGTH 180 (498)
Q Consensus 157 ~N~l~g~ip~--~~~~~~~~~~~~n~ 180 (498)
+|.++ .+|. .+.++..+++.+|.
T Consensus 107 ~n~l~-~lp~~~~l~~L~~L~l~~~~ 131 (353)
T d1jl5a_ 107 NNQLE-KLPELQNSSFLKIIDVDNNS 131 (353)
T ss_dssp SSCCS-SCCCCTTCTTCCEEECCSSC
T ss_pred ccccc-cccchhhhccceeecccccc
Confidence 66666 4553 22344445554443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.34 E-value=2.2e-06 Score=78.35 Aligned_cols=149 Identities=17% Similarity=0.141 Sum_probs=96.1
Q ss_pred HHHHHhcCCCCCCeeecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCccceEEEEEEcCCce
Q 010887 265 ELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSER 343 (498)
Q Consensus 265 el~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 343 (498)
++......|+..+..+.++.+.||+... +++.+++|+...... .....+.+|...+..+. +--+.+++.+...++..
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~-~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcc-cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 3444445565554444444578999875 566677888753321 22345677888877764 33356778888888888
Q ss_pred EEEEecccCCCHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------
Q 010887 344 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC------------------------------- 392 (498)
Q Consensus 344 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------- 392 (498)
++||+++++.++.+..... .. ...++.++++.++.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEEeccccccccccccc------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 9999999998875543210 01 2234445555555555321
Q ss_pred -------------------------CCCcEEcCCCCCcEEECCCCcEEEeecCcccc
Q 010887 393 -------------------------NPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (498)
Q Consensus 393 -------------------------~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~ 424 (498)
.+.++|+|+.|.||++++++..-|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12378999999999999876667999998764
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.26 E-value=8.2e-07 Score=84.61 Aligned_cols=68 Identities=28% Similarity=0.361 Sum_probs=44.1
Q ss_pred cCCCCeEEccCCCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeEeCCCCcCcccCCchhhcccccc
Q 010887 99 LKFLASLELQDNDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHLDLSSNNLTGRIPMQLFSVATFN 175 (498)
Q Consensus 99 l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~~~ 175 (498)
+++|++|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|.. +++|++|+|++|+|+ .+|....++..++
T Consensus 283 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~~~L~~L~ 350 (353)
T d1jl5a_ 283 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIPESVEDLR 350 (353)
T ss_dssp CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCCTTCCEEE
T ss_pred CCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCccccccCeeE
Confidence 467777777777777 66653 456777777777777 66643 346777777777777 6665444444443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.24 E-value=6e-07 Score=81.23 Aligned_cols=99 Identities=15% Similarity=0.233 Sum_probs=79.1
Q ss_pred eEEEecccccCccccccccccCCCCeEEccCCCCCCccCc-ccccccccceeecccccccCCCCC-cccCCCCCCeEeCC
Q 010887 79 ISLTLGSNGFSGKISPSITKLKFLASLELQDNDLSGTLPD-FLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLS 156 (498)
Q Consensus 79 ~~l~l~~~~l~g~~~~~~~~l~~L~~L~l~~n~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~l~l~ 156 (498)
..++.++++++ .+|+.+. +++++|+|++|+|+ .+|. .|.++++|++|+|++|.+...+|. .|.+++.++++++.
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 46888899999 8988763 68999999999999 5554 689999999999999999876654 58899999999876
Q ss_pred -CCcCcccCCchh---hccccccccCCcc
Q 010887 157 -SNNLTGRIPMQL---FSVATFNFTGTHL 181 (498)
Q Consensus 157 -~N~l~g~ip~~~---~~~~~~~~~~n~~ 181 (498)
.|++....|..+ .++..+++.+|..
T Consensus 87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l 115 (242)
T d1xwdc1 87 KANNLLYINPEAFQNLPNLQYLLISNTGI 115 (242)
T ss_dssp CCTTCCEECTTSEECCTTCCEEEEESCCC
T ss_pred ccccccccccccccccccccccccchhhh
Confidence 477875555434 4567777877754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.09 E-value=6.3e-06 Score=74.81 Aligned_cols=142 Identities=15% Similarity=0.096 Sum_probs=84.0
Q ss_pred eecccc-eEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCC--ccceEEEEEEcCCceEEEEecccCCCH
Q 010887 279 IGQGGF-GKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK--NLLQLIGYCTTSSERILVYPFMQNLSV 355 (498)
Q Consensus 279 lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL 355 (498)
+..|.. ..||+...+++..+++|..... ....+.+|.+.++.+... .+.+++++..+++..++||+|+++-++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~----~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCcc----CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 344543 6899999888888899976532 223456777777766433 356678887888888999999987654
Q ss_pred HHh-----------------hcccCCCCCCC--CHHHHHHHH--------------------HHHHHHHHHHHhc----C
Q 010887 356 AYR-----------------LRDLKPGEKGL--DWPTRKRVA--------------------FGTAYGLEYLHEQ----C 392 (498)
Q Consensus 356 ~~~-----------------l~~~~~~~~~l--~~~~~~~i~--------------------~~ia~~L~yLH~~----~ 392 (498)
.+. ||.......+. .+.....-. ......+..+... .
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence 321 11110000001 111000000 0011122333222 1
Q ss_pred CCCcEEcCCCCCcEEECCCCcEEEeecCcccc
Q 010887 393 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 424 (498)
Q Consensus 393 ~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~~ 424 (498)
.+.++|+|+.|.||+++++..+-|+||+.+..
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 22479999999999999876678999998754
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.08 E-value=1.4e-07 Score=80.13 Aligned_cols=74 Identities=23% Similarity=0.241 Sum_probs=56.1
Q ss_pred cccccccccCCCCeEEccCCCCCCc--cCcccccccccceeecccccccCCCCC-cccCCCCCCeEeCCCCcCcccCC
Q 010887 91 KISPSITKLKFLASLELQDNDLSGT--LPDFLGSMTHLQSLNLANNKFSGSIPA-TWSQLSNLKHLDLSSNNLTGRIP 165 (498)
Q Consensus 91 ~~~~~~~~l~~L~~L~l~~n~l~g~--~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~l~l~~N~l~g~ip 165 (498)
.++.....+++|++|+|++|+|+.. ++..+..+++|+.|||++|+++ .+++ ...+..+|+.|++++|.++....
T Consensus 56 ~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 56 TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFR 132 (162)
T ss_dssp HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcc
Confidence 4444456789999999999999842 3455778999999999999998 5554 33344578999999999986554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.06 E-value=4e-07 Score=77.19 Aligned_cols=78 Identities=24% Similarity=0.265 Sum_probs=61.8
Q ss_pred CceeEEEecccccCcc--ccccccccCCCCeEEccCCCCCCccCc-ccccccccceeecccccccCCCCCc-------cc
Q 010887 76 GNVISLTLGSNGFSGK--ISPSITKLKFLASLELQDNDLSGTLPD-FLGSMTHLQSLNLANNKFSGSIPAT-------WS 145 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~--~~~~~~~l~~L~~L~l~~n~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~~p~~-------~~ 145 (498)
.+++.|+|++|+|+.. ++..+..+++|+.|+|++|.|+ .+++ ......+|+.|+|++|.++...... +.
T Consensus 65 ~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~ 143 (162)
T d1koha1 65 PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRE 143 (162)
T ss_dssp TTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHT
T ss_pred CCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHH
Confidence 4799999999999943 2345788999999999999999 5554 3334457999999999998766543 66
Q ss_pred CCCCCCeEe
Q 010887 146 QLSNLKHLD 154 (498)
Q Consensus 146 ~l~~L~~l~ 154 (498)
.+++|+.||
T Consensus 144 ~~P~L~~LD 152 (162)
T d1koha1 144 RFPKLLRLD 152 (162)
T ss_dssp TSTTCCEET
T ss_pred HCCCCCEEC
Confidence 789999886
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.87 E-value=9e-07 Score=87.39 Aligned_cols=104 Identities=18% Similarity=0.265 Sum_probs=59.6
Q ss_pred ceeEEEecccccCccc-cccccccCCCCeEEccCCCCCC----ccCcccccccccceeecccccccCC----CCCcccC-
Q 010887 77 NVISLTLGSNGFSGKI-SPSITKLKFLASLELQDNDLSG----TLPDFLGSMTHLQSLNLANNKFSGS----IPATWSQ- 146 (498)
Q Consensus 77 ~v~~l~l~~~~l~g~~-~~~~~~l~~L~~L~l~~n~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~- 146 (498)
+|+.||+++|++++.- ..-+..+++|+.|+|++|.|+- .|+..+..+++|++|||++|+|+.. +...+..
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 4677777777776421 2234556777777777777662 3444556677777777777776421 2222222
Q ss_pred CCCCCeEeCCCCcCccc----CCch---hhccccccccCCc
Q 010887 147 LSNLKHLDLSSNNLTGR----IPMQ---LFSVATFNFTGTH 180 (498)
Q Consensus 147 l~~L~~l~l~~N~l~g~----ip~~---~~~~~~~~~~~n~ 180 (498)
..+|++|+|++|.++.. ++.. ..++..+++++|.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~ 123 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 123 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSB
T ss_pred CCCCCEEECCCCCccccccccccchhhcccccccccccccc
Confidence 23577777777777632 2222 2345566666665
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.78 E-value=1.7e-06 Score=82.61 Aligned_cols=106 Identities=20% Similarity=0.267 Sum_probs=64.2
Q ss_pred CceeEEEecccccCcc-----ccccccccCCCCeEEccCCCCCCc----cCcccccccccceeecccccccCC----CCC
Q 010887 76 GNVISLTLGSNGFSGK-----ISPSITKLKFLASLELQDNDLSGT----LPDFLGSMTHLQSLNLANNKFSGS----IPA 142 (498)
Q Consensus 76 ~~v~~l~l~~~~l~g~-----~~~~~~~l~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~p~ 142 (498)
..++.|+|++|+++.. +...+..+++|+.|+|++|.++.. +...+..+++|++|+|++|.|++. +-.
T Consensus 186 ~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~ 265 (344)
T d2ca6a1 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 265 (344)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred hhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHH
Confidence 3677777777777631 334566677777777777776532 444566677777777777777643 222
Q ss_pred cccC--CCCCCeEeCCCCcCccc----CCch----hhccccccccCCcc
Q 010887 143 TWSQ--LSNLKHLDLSSNNLTGR----IPMQ----LFSVATFNFTGTHL 181 (498)
Q Consensus 143 ~~~~--l~~L~~l~l~~N~l~g~----ip~~----~~~~~~~~~~~n~~ 181 (498)
.+.. .+.|++|++++|+++.. +... ..++..++++||.+
T Consensus 266 ~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~ 314 (344)
T d2ca6a1 266 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 314 (344)
T ss_dssp HHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBS
T ss_pred HhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcC
Confidence 2222 34677778877777632 1111 22456667777665
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.77 E-value=1.9e-06 Score=85.00 Aligned_cols=86 Identities=28% Similarity=0.381 Sum_probs=68.1
Q ss_pred ceeEEEecccccCc----cccccccccCCCCeEEccCCCCCCc----cCccccc-ccccceeecccccccCC----CCCc
Q 010887 77 NVISLTLGSNGFSG----KISPSITKLKFLASLELQDNDLSGT----LPDFLGS-MTHLQSLNLANNKFSGS----IPAT 143 (498)
Q Consensus 77 ~v~~l~l~~~~l~g----~~~~~~~~l~~L~~L~l~~n~l~g~----~p~~~~~-l~~L~~L~l~~N~l~g~----~p~~ 143 (498)
+++.|+|++|+|+. .++..+..+++|++|||++|.|+.. +...+.. .++|++|+|++|+++.. ++..
T Consensus 28 ~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~ 107 (460)
T d1z7xw1 28 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 107 (460)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccch
Confidence 56789999999883 4455678899999999999998632 2233322 35799999999999854 5677
Q ss_pred ccCCCCCCeEeCCCCcCcc
Q 010887 144 WSQLSNLKHLDLSSNNLTG 162 (498)
Q Consensus 144 ~~~l~~L~~l~l~~N~l~g 162 (498)
+..+++|++|+|++|.++.
T Consensus 108 l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 108 LRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TTSCTTCCEEECCSSBCHH
T ss_pred hhccccccccccccccchh
Confidence 8899999999999999884
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.75 E-value=6.5e-06 Score=76.30 Aligned_cols=62 Identities=19% Similarity=0.174 Sum_probs=36.5
Q ss_pred cccCCCCeEEccCC-CCCCccCcccccccccceeeccc-ccccCCCCCcccCCCCCCeEeCCCC
Q 010887 97 TKLKFLASLELQDN-DLSGTLPDFLGSMTHLQSLNLAN-NKFSGSIPATWSQLSNLKHLDLSSN 158 (498)
Q Consensus 97 ~~l~~L~~L~l~~n-~l~g~~p~~~~~l~~L~~L~l~~-N~l~g~~p~~~~~l~~L~~l~l~~N 158 (498)
.++++|++|+|++| .+++..+..+.++++|++|+|++ +.+++.....++++++|+.|+++++
T Consensus 172 ~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 172 RRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp HHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 34566666666653 45555555666666666666666 3455555555666666666666655
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.66 E-value=7.9e-05 Score=72.11 Aligned_cols=77 Identities=14% Similarity=0.126 Sum_probs=47.3
Q ss_pred CCeeecccceEEEEEEEcC-CcEEEEEEeccc------CCcchHHHHHHHHHHHHhcc-C--CccceEEEEEEcCCceEE
Q 010887 276 SNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDY------YSPGGEAAFQREVHLISVAI-H--KNLLQLIGYCTTSSERIL 345 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~------~~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~l 345 (498)
.+.||.|....||++...+ ++.++||.-... ..+........|.+.++.+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4468999999999999654 678899864321 11122233456777777653 2 234455443 4556689
Q ss_pred EEecccCCC
Q 010887 346 VYPFMQNLS 354 (498)
Q Consensus 346 v~e~~~~gs 354 (498)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998654
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.53 E-value=5.8e-06 Score=78.84 Aligned_cols=86 Identities=20% Similarity=0.327 Sum_probs=49.1
Q ss_pred ceeEEEecccccCc----cccccccccCCCCeEEccCCCCCCc-----cCcccccccccceeecccccccCC----CCCc
Q 010887 77 NVISLTLGSNGFSG----KISPSITKLKFLASLELQDNDLSGT-----LPDFLGSMTHLQSLNLANNKFSGS----IPAT 143 (498)
Q Consensus 77 ~v~~l~l~~~~l~g----~~~~~~~~l~~L~~L~l~~n~l~g~-----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~ 143 (498)
.++.+++++|.++. .+...+...+.|+.|+|++|+++.. +...+..+++|++|+|++|.++.. +...
T Consensus 159 ~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~ 238 (344)
T d2ca6a1 159 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 238 (344)
T ss_dssp CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHH
T ss_pred ccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccccc
Confidence 34555555555542 1223344556677777777766531 233455666677777777766532 3344
Q ss_pred ccCCCCCCeEeCCCCcCcc
Q 010887 144 WSQLSNLKHLDLSSNNLTG 162 (498)
Q Consensus 144 ~~~l~~L~~l~l~~N~l~g 162 (498)
+..+++|++|+|++|.|++
T Consensus 239 l~~~~~L~~L~Ls~n~i~~ 257 (344)
T d2ca6a1 239 LKSWPNLRELGLNDCLLSA 257 (344)
T ss_dssp GGGCTTCCEEECTTCCCCH
T ss_pred ccccccchhhhhhcCccCc
Confidence 5566677777777776663
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.39 E-value=6e-05 Score=69.52 Aligned_cols=94 Identities=18% Similarity=0.216 Sum_probs=70.0
Q ss_pred CceeEEEeccc-ccCccccccccccCCCCeEEccC-CCCCCccCcccccccccceeecccccccCCCCCcccCCCCCCeE
Q 010887 76 GNVISLTLGSN-GFSGKISPSITKLKFLASLELQD-NDLSGTLPDFLGSMTHLQSLNLANNKFSGSIPATWSQLSNLKHL 153 (498)
Q Consensus 76 ~~v~~l~l~~~-~l~g~~~~~~~~l~~L~~L~l~~-n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l 153 (498)
.+++.|+|+++ .+++.....++++++|++|+|++ +.++......++++++|++|+++++--.+.++.-... +..|
T Consensus 175 ~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~~~d~~l~~l~~~---lp~L 251 (284)
T d2astb2 175 PNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEA---LPHL 251 (284)
T ss_dssp TTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTSSCTTCHHHHHHH---STTS
T ss_pred ccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCCCCHHHHHHHHHh---Cccc
Confidence 37999999885 68888888899999999999999 6788777788999999999999887222222221223 4445
Q ss_pred eCCCCcCcccCCchhhccc
Q 010887 154 DLSSNNLTGRIPMQLFSVA 172 (498)
Q Consensus 154 ~l~~N~l~g~ip~~~~~~~ 172 (498)
+++.+.++...++.+++..
T Consensus 252 ~i~~~~ls~~~~~~~~~~~ 270 (284)
T d2astb2 252 QINCSHFTTIARPTIGNKK 270 (284)
T ss_dssp EESCCCSCCTTCSSCSSTT
T ss_pred cccCccCCCCCCCccCccc
Confidence 6688888876666665443
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.32 E-value=3e-05 Score=65.54 Aligned_cols=86 Identities=10% Similarity=0.201 Sum_probs=64.1
Q ss_pred CceeEEEeccc-ccCcc----ccccccccCCCCeEEccCCCCCCc----cCcccccccccceeecccccccCC----CCC
Q 010887 76 GNVISLTLGSN-GFSGK----ISPSITKLKFLASLELQDNDLSGT----LPDFLGSMTHLQSLNLANNKFSGS----IPA 142 (498)
Q Consensus 76 ~~v~~l~l~~~-~l~g~----~~~~~~~l~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~p~ 142 (498)
..+++|+|+++ .++.. +-..+...++|++|+|++|.+... +...+...+.|++|+|++|.++.. +-.
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~ 94 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 94 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence 37899999874 46532 334577778999999999998743 233445568899999999998753 334
Q ss_pred cccCCCCCCeEeCCCCcCc
Q 010887 143 TWSQLSNLKHLDLSSNNLT 161 (498)
Q Consensus 143 ~~~~l~~L~~l~l~~N~l~ 161 (498)
.+...++|++|+|++|.+.
T Consensus 95 aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 95 STLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HTTTTCCCSEEECCCCSSC
T ss_pred HHHhCCcCCEEECCCCcCC
Confidence 5777788999999999776
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.10 E-value=0.00083 Score=62.85 Aligned_cols=136 Identities=14% Similarity=0.108 Sum_probs=77.4
Q ss_pred ceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccc--eEEE-----EEEcCCceEEEEecccCCCHH
Q 010887 284 FGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL--QLIG-----YCTTSSERILVYPFMQNLSVA 356 (498)
Q Consensus 284 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv--~l~~-----~~~~~~~~~lv~e~~~~gsL~ 356 (498)
--.||++..++|+.+++|+.+... ....++..|.+.+..+....+. ..+. .....+..+.++++++|..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~--~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC--CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 468999999999999999886432 3456677888888777533221 1111 122344567889998764321
Q ss_pred --------------Hhhcc----cC-CCCCCCCHHH-------------------HHHHHHHHHHHHHHHHh----cCCC
Q 010887 357 --------------YRLRD----LK-PGEKGLDWPT-------------------RKRVAFGTAYGLEYLHE----QCNP 394 (498)
Q Consensus 357 --------------~~l~~----~~-~~~~~l~~~~-------------------~~~i~~~ia~~L~yLH~----~~~~ 394 (498)
-.++. .. ......++.. +..+...+.+.++.+.. ....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 11111 10 0111122111 11122222333333322 2234
Q ss_pred CcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 395 KIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 395 ~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
+++|+|+.+.|||++++ ..++||+-+.
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred eeecCCCCcccEEEeCC--ceEEechhcc
Confidence 78999999999999754 4588999876
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.60 E-value=0.01 Score=54.62 Aligned_cols=159 Identities=13% Similarity=0.103 Sum_probs=79.0
Q ss_pred cCHHHHHHHhcCCCCCCee-----ecccceEEEEEEEcCCcEEEEEEecccCCcchHHHHHHHHHHHHhccCCccc--eE
Q 010887 261 FSCRELQLATDNFSESNII-----GQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL--QL 333 (498)
Q Consensus 261 ~~~~el~~~~~~~~~~~~l-----G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv--~l 333 (498)
.+.+|++....+|...+.. ..|---+.|+.+..+| .+++|+.....+. .+...|++++..+...++. ..
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~~---~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCCH---HHHHHHHHHHHhhhhcccccccc
Confidence 3556777777778765544 3566688999998665 4888987543222 2334455666655432221 11
Q ss_pred EE------EEEcCCceEEEEecccCCCHH--------------Hhhccc----CC-CCCCCCHHHHH-------------
Q 010887 334 IG------YCTTSSERILVYPFMQNLSVA--------------YRLRDL----KP-GEKGLDWPTRK------------- 375 (498)
Q Consensus 334 ~~------~~~~~~~~~lv~e~~~~gsL~--------------~~l~~~----~~-~~~~l~~~~~~------------- 375 (498)
+. +.........++.+..+.... ..++.. .. ...........
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 10 111233445566666553311 111100 00 00000000000
Q ss_pred --HHHHHHHHHHHHHHh----cCCCCcEEcCCCCCcEEECCCCcEEEeecCccc
Q 010887 376 --RVAFGTAYGLEYLHE----QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 423 (498)
Q Consensus 376 --~i~~~ia~~L~yLH~----~~~~~ivH~Dlk~~NILl~~~~~~ki~DfGl~~ 423 (498)
.+...+....+++-. ....+++|+|+.+.||+++.+...-|.||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 011112222222222 123479999999999999988777899999875
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.55 E-value=0.0003 Score=59.11 Aligned_cols=87 Identities=14% Similarity=0.115 Sum_probs=64.8
Q ss_pred CCceeEEEecccccCcc----ccccccccCCCCeEEccCCCCCCc----cCcccccccccceeecccccccCC-------
Q 010887 75 NGNVISLTLGSNGFSGK----ISPSITKLKFLASLELQDNDLSGT----LPDFLGSMTHLQSLNLANNKFSGS------- 139 (498)
Q Consensus 75 ~~~v~~l~l~~~~l~g~----~~~~~~~l~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~------- 139 (498)
+..++.|+|++|.+... +...+...+.|++|+|++|.|+.. +-..+...+.|++|+|++|.+...
T Consensus 43 n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~ 122 (167)
T d1pgva_ 43 SKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMD 122 (167)
T ss_dssp CSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHH
T ss_pred CCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHH
Confidence 35799999999999743 233455678999999999999853 233456678899999999976521
Q ss_pred CCCcccCCCCCCeEeCCCCcCc
Q 010887 140 IPATWSQLSNLKHLDLSSNNLT 161 (498)
Q Consensus 140 ~p~~~~~l~~L~~l~l~~N~l~ 161 (498)
+...+..-++|+.|+++.+...
T Consensus 123 l~~~L~~n~sL~~l~l~~~~~~ 144 (167)
T d1pgva_ 123 MMMAIEENESLLRVGISFASME 144 (167)
T ss_dssp HHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHHhCCCccEeeCcCCCch
Confidence 3445666789999999877543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.66 E-value=0.033 Score=52.96 Aligned_cols=73 Identities=15% Similarity=0.145 Sum_probs=48.0
Q ss_pred CCeeecccceEEEEEEEcCC--------cEEEEEEecccCCcchHHHHHHHHHHHHhccCCccc-eEEEEEEcCCceEEE
Q 010887 276 SNIIGQGGFGKVYKGVLSDN--------TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL-QLIGYCTTSSERILV 346 (498)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv 346 (498)
.+.|+.|-.-.+|++...++ +.|.+++.-. . .......+|.++++.+.-.++. ++++++. -..|
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I 119 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P--ETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRL 119 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c--chhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceE
Confidence 45678899999999987543 4566665532 2 2234456888888887544554 6666653 2678
Q ss_pred EecccCCCH
Q 010887 347 YPFMQNLSV 355 (498)
Q Consensus 347 ~e~~~~gsL 355 (498)
++|+++-++
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999987543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.39 E-value=0.0014 Score=54.55 Aligned_cols=86 Identities=16% Similarity=0.253 Sum_probs=52.7
Q ss_pred CceeEEEecc-cccCcc----ccccccccCCCCeEEccCCCCCCcc----CcccccccccceeecccccccCC----CCC
Q 010887 76 GNVISLTLGS-NGFSGK----ISPSITKLKFLASLELQDNDLSGTL----PDFLGSMTHLQSLNLANNKFSGS----IPA 142 (498)
Q Consensus 76 ~~v~~l~l~~-~~l~g~----~~~~~~~l~~L~~L~l~~n~l~g~~----p~~~~~l~~L~~L~l~~N~l~g~----~p~ 142 (498)
..++.|+|++ +.++.. +-..+...++|++|+|++|.++... -..+...+.|+.|++++|.++.. +-.
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 3677777776 445421 2334556778888888888776432 22344567788888888777532 334
Q ss_pred cccCCCCCCeEeC--CCCcCc
Q 010887 143 TWSQLSNLKHLDL--SSNNLT 161 (498)
Q Consensus 143 ~~~~l~~L~~l~l--~~N~l~ 161 (498)
.+...++|+.++| ++|.+.
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCC
T ss_pred HHHhCccccEEeeccCCCcCc
Confidence 5666777776554 455554
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=94.74 E-value=0.0022 Score=53.33 Aligned_cols=87 Identities=18% Similarity=0.208 Sum_probs=65.3
Q ss_pred CCceeEEEecccccCcc----ccccccccCCCCeEEccCCCCCCc----cCcccccccccceeec--ccccccC----CC
Q 010887 75 NGNVISLTLGSNGFSGK----ISPSITKLKFLASLELQDNDLSGT----LPDFLGSMTHLQSLNL--ANNKFSG----SI 140 (498)
Q Consensus 75 ~~~v~~l~l~~~~l~g~----~~~~~~~l~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~L~l--~~N~l~g----~~ 140 (498)
+.+++.|+|++|.++.. +...+...++|+.|++++|.++.. +-..+...++|+.++| ++|.+.. .+
T Consensus 45 n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~L 124 (166)
T d1io0a_ 45 NTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEI 124 (166)
T ss_dssp CCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHH
T ss_pred CCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHH
Confidence 35799999999998753 233566789999999999998743 3356677788987554 6777753 35
Q ss_pred CCcccCCCCCCeEeCCCCcCc
Q 010887 141 PATWSQLSNLKHLDLSSNNLT 161 (498)
Q Consensus 141 p~~~~~l~~L~~l~l~~N~l~ 161 (498)
...+.+.++|+.|+++.|...
T Consensus 125 a~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 125 ANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHhCCCcCEEeCcCCCCc
Confidence 556778899999999887654
|